In IN O
spite NN O
of IN O
medical JJ O
help NN O
: : O
the DT O
puzzle NN O
of IN O
an DT O
eighteenth JJ O
- HYPH O
century NN O
Prime NNP O
Minister NNP O
' POS O
s POS O
illness NN O
. . O

Abstract JJ O

Medical NNP O
History NNP O
, , O
1990 CD O
, , O
34 CD O
: : O
178 CD O
- SYM O
184 CD O
. . O

IN IN O
SPITE NN O
OF IN O
MEDICAL JJ O
HELP NN O
: : O
THE DT O
PUZZLE NN O
OF IN O
AN DT O

EIGHTEENTH JJ O
- HYPH O
CENTURY NN O
PRIME JJ O
MINISTER NN O
' POS O
S NN O

ILLNESS NNP O

by IN O

MARJORIE NNP O
BLOY NNP O
* NFP O

Charles NNP O
Watson NNP O
Wentworth NNP O
, , O
second JJ O
Marquis NNP O
of IN O
Rockingham NNP O
, , O
died VBD O
suddenly RB O
and CC O
unexpectedly RB O
on IN O
1 CD O
July NNP O
1782 CD O
, , O
when WRB O
he PRP O
was VBD O
only RB O
52 CD O
years NNS O
old JJ O
. . O

He PRP O
had VBD O
suffered VBN O
- HYPH O
or CC O
enjoyed VBN O
- HYPH O
ill JJ O
health NN O
all PDT O
his PRP$ O
life NN O
but CC O
in IN O
1782 CD O
appeared VBD O
to TO O
be VB O
no RB O
worse JJR O
than IN O
he PRP O
had VBD O
ever RB O
been VBN O
. . O

His PRP$ O
death NN O
in IN O
London NNP O
terminated VBD O
his PRP$ O
second JJ O
period NN O
of IN O
office NN O
as IN O
Prime NNP O
Minister NNP O
, , O
to IN O
which WDT O
he PRP O
had VBD O
been VBN O
appointed VBN O
only RB O
14 CD O
weeks NNS O
earlier RBR O
. . O

In IN O
May NNP O
he PRP O
had VBD O
reported VBN O
to IN O
the DT O
Duke NNP O
of IN O
Portland NNP O
that IN O
he PRP O
had VBD O
"""" `` O
for IN O
some DT O
weeks NNS O
past RB O
undergone VBN O
much JJ O
Pain NN O
and CC O
much JJ O
inconvenience NN O
from IN O
something NN O
similar JJ O
to IN O
my PRP$ O
old JJ O
Complaint NNP O
in IN O
my PRP$ O
Side NNP O
and CC O
Stomach NNP O
"""" '' O
but CC O
that IN O
he PRP O
felt VBD O
much RB O
better RBR O
than IN O
he PRP O
had VBD O
. . O
' '' O
By IN O
17 CD O
June NNP O
he PRP O
was VBD O
recovering VBG O
from IN O
both CC O
influenza NN O
and CC O
his PRP$ O
"""" `` O
old JJ O
complaint NN O
"""" '' O
. , O
2 CD O
On IN O
1 CD O
July NNP O
he PRP O
died VBD O
and CC O
on IN O
the DT O
20th NN O
he PRP O
was VBD O
interred VBN O
in IN O
York NNP O
Minster NNP O
. . O

The DT O
first JJ O
recorded VBN O
bout NN O
of IN O
illness NN O
suffered VBN O
by IN O
the DT O
marquis NN O
, , O
then RB O
Lord NNP O
Higham NNP O
, , O
was VBD O
in IN O
July NNP O
1741 CD O
when WRB O
the DT O
11 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
was VBD O
"""" `` O
a DT O
little JJ O
indisposed JJ O
, , O
something NN O
Feaverish JJ O
I PRP O
guess VBP O
it PRP O
proceeds VBZ O
from IN O
Worms NNPS O
and CC O
will MD O
Soon RB O
be VB O
removed VBN O
"""" '' O
. , O
3 NFP O
He PRP O
also RB O
had VBD O
a DT O
rash NN O
and CC O
it PRP O
was VBD O
thought VBN O
that IN O
the DT O
cause NN O
of IN O
the DT O
problem NN O
was VBD O
that IN O
the DT O
boy NN B-Species
had VBD O
overheated VBN O
himself PRP O
. . O
4 NFP O
He PRP O
was VBD O
still RB O
ill JJ O
at IN O
the DT O
beginning NN O
of IN O
August NNP O
: : O
he PRP O
had VBD O
been VBN O
"""" `` O
much RB O
out IN O
of IN O
order NN O
"""" '' O
for IN O
a DT O
long JJ O
time NN O
but CC O
had VBD O
been VBN O
recommended VBN O
to TO O
take VB O
warm JJ O
baths NNS O
by IN O
Dr NNP O
Wilmot NNP O
and CC O
Mr NNP O
Ranby NNP O
when WRB O
they PRP O
were VBD O
consulted VBN O
in IN O
London NNP O
. . O
5 NFP O
Charles NNP O
' POS O
s POS O
aunt NN O
, , O
Lady NNP O
Isabella NNP O
Finch NNP O
, , O
was VBD O
sure JJ O
that IN O
the DT O
baths NNS O
"""" '' O
and CC O
other JJ O
Things NNS O
They PRP O
' '' O
ll `` O
prescribe VBP O
will MD O
in IN O
a DT O
short JJ O
Time NN O
entirely RB O
Cure VB O
his PRP$ O
Complaints NNS O
w '' O
[ -LRB- O
hic PRP O
] -RRB- O
h CC O
neither DT O
of IN O
Them PRP O
thought VBD O
proceed VBP O
from IN O
any DT O
dangerous JJ O
Causes NNPS O
"""" '' O
. , O
6 CD O
In IN O
spite NN O
of IN O
Lady NNP O
Isabella NNP O
' POS O
s POS O
hopes NNS O
, , O
Charles NNP O
did VBD O
not RB O
greatly RB O
improve VB O
, , O
even RB O
though IN O
his PRP$ O
mother NN O
believed VBD O
that IN O
he PRP O
continued VBD O
mending VBG O
every DT O
day NN O
. . O

The DT O
main JJ O
reason NN O
that IN O
Higham NNP O
and CC O
his PRP$ O
mother NN O
had VBD O
gone VBN O
to IN O
London NNP O
to TO O
consult VB O
Dr NNP O
Wilmot NNP O
and CC O
Mr NNP O

* NFP O
Marjorie NNP O
Bloy NNP O
, , O
Ph NNP O
. . O
D NNP O
. . O
, , O
18 CD O
Farm NNP O
View NNP O
Road NNP O
, , O
Kimberworth NNP O
, , O
Rotherham NNP O
, , O
S NNP O
. . O

Yorks NNS O
. . O

S61 CD O
2BA NNP O
. . O

The DT O
Rockingham NNP O
Papers NNPS O
are VBP O
in IN O
the DT O
holdings NNS O
of IN O
the DT O
Wentworth NNP O
Woodhouse NNP O
Muniments NNPS O
at IN O
Sheffield NNP O
City NNP O
Archives NNPS O
Department NNP O
, , O
Sheffield NNP O
City NNP O
Library NNP O
. . O

I PRP O
am VBP O
grateful JJ O
to IN O
Dr NNP O
R NNP O
. . O

S UH O
. . O

Morton NNP O
for IN O
his PRP$ O
advice NN O
and CC O
help VBP O
with IN O
the DT O
diagnostic JJ O
sections NNS O
of IN O
this DT O
essay NN O
. . O

' '' O
WWM NNP O
, , O
RI NNP O
- HYPH O
2094 CD O
. . O

Rockingham NNP O
to IN O
Portland NNP O
, , O
25 CD O
May NNP O
1782 CD O
. . O

2WWM NNP O
, , O
RI NNP O
- HYPH O
2094 CD O
. . O

Rockingham NNP O
to IN O
Charlemont NNP O
, , O
17 CD O
June NNP O
1782 CD O
. . O

3 CD O
WWM NNP O
, , O
M8 NNP O
- HYPH O
25 CD O
. . O

Malton NNP O
to IN O
Nottingham NNP O
, , O
after IN O
16 CD O
June NNP O
1741 CD O
. . O

4 LS O
WWM NNP O
, , O
M8 NNP O
- HYPH O
26 CD O
. . O

Lady NNP O
Finch NNP O
to IN O
Lady NNP O
Malton NNP O
, , O
30 CD O
July NNP O
1741 CD O
. . O

5 CD O
WWM NNP O
, , O
M8 NNP O
- HYPH O
28 CD O
. . O

Winchelsea NNP O
to IN O
Malton NNP O
, , O
7 CD O
August NNP O
1741 CD O
. . O

6 CD O
WWM NNP O
, , O
M8 NNP O
- HYPH O
29 CD O
. . O

Lady NNP O
Finch NNP O
to IN O
Malton NNP O
, , O
7 CD O
August NNP O
1741 CD O
. . O

178 CD O

An DT O
eighteenth JJ O
- HYPH O
century NN O
Prime NNP O
Minister NNP O
' POS O
s POS O
illness NN O

Ranby NNP O
was VBD O
his PRP$ O
mother NN O
' POS O
s POS O
concern NN O
about IN O
a DT O
"""" `` O
swelling VBG O
in IN O
a DT O
certain JJ O
part NN O
which WDT O
was VBD O
larger JJR O
than IN O
when WRB O
we PRP O
left VBD O
Wentworth NNP O
"""" '' O
. . O

The DT O
doctors NNS O
hoped VBD O
that IN O
it PRP O
would MD O
burst VB O
outwards RB O
"""" `` O
which WDT O
they PRP O
assure VBP O
me PRP O
will MD O
be VB O
the DT O
safest JJS O
way NN O
and CC O
give VB O
the DT O
poor JJ O
Monkey NNP O
but CC O
very RB O
little JJ O
pain NN O
' '' O
7 CD O

On IN O
20 CD O
August NNP O
Lord NNP O
Winchelsea NNP O
, , O
Higham NNP O
' POS O
s POS O
uncle NN O
, , O
surprised JJ O
to TO O
see VB O
the DT O
boy NN B-Species
so RB O
well RB O
and CC O
brisk JJ O
, , O
hoped VBD O
that IN O
Charles NNP O
was VBD O
"""" `` O
now RB O
safe JJ O
from IN O
this DT O
complaint NN O
"""" '' O
- , O
the DT O
same JJ O
one NN O
from IN O
which WDT O
he PRP O
had VBD O
suffered VBN O
in IN O
1738 CD O
- SYM O
39 CD O
- , O
but CC O
thought VBD O
that IN O
he PRP O
would MD O
never RB O
be VB O
safe JJ O
"""" `` O
if IN O
he PRP O
continues VBZ O
the DT O
practice NN O
of IN O
overheating VBG O
himself PRP O
and CC O
then RB O
drinking VBG O
Cold NNP O
Water NNP O
"""" '' O
. . O

He PRP O
said VBD O
that IN O
Charles NNP O
was VBD O
of IN O
a DT O
"""" `` O
pretty RB O
healthy JJ O
strong JJ O
Constitution NNP O
"""" '' O
; : O
8 CD O
Lady NNP O
Malton NNP O
was VBD O
not RB O
so RB O
sure JJ O
. . O

The DT O
same JJ O
day NN O
she PRP O
wrote VBD O
a DT O
progress NN O
report NN O
to IN O
her PRP$ O
husband NN O
saying VBG O
that IN O
Charles NNP O
' POS O
s POS O
swelling NN O
continued VBD O
to TO O
grow VB O
, , O
as IN O
did VBD O
the DT O
pain NN O
"""" `` O
in IN O
that DT O
part NN O
( , O
but CC O
not RB O
the DT O
lease NN O
[ -LRB- O
sic NN O
] -RRB- O
trouble NN O
in IN O
making VBG O
Water NNP O
or CC O
going VBG O
to IN O
Stool NNP O
) , O
& CC O
less JJR O
Fever NN O
than IN O
c NN O
[ -LRB- O
oulJd NNP O
be VB O
imagined VBN O
where WRB O
Matter NNP O
is VBZ O
as IN O
they PRP O
now RB O
imagine VBP O
certainly RB O
gathering VBG O
and CC O
must MD O
end VB O
in IN O
an DT O
operation NN O
"""" '' O
. . O

In IN O
spite NN O
of IN O
it PRP O
all DT O
, , O
Charles NNP O
was VBD O
in IN O
fine JJ O
spirits NNS O
. . O
9 CD O
Lady NNP O
Malton NNP O
dosed VBD O
the DT O
boy NN B-Species
with IN O
cinchona NN B-Species
bark NN O
, , O
which WDT O
removed VBD O
the DT O
pains NNS O
in IN O
his PRP$ O
legs NNS O
and CC O
reduced VBD O
his PRP$ O
fever NN O
, , O
and CC O
she PRP O
was VBD O
convinced VBN O
that IN O
they PRP O
would MD O
soon RB O
have VB O
"""" `` O
a DT O
clear JJ O
Stage NN O
to TO O
act VB O
in IN O
a DT O
proper JJ O
manner NN O
a DT O
[ -LRB- O
bou FW O
] -RRB- O
t CC O
his PRP$ O
other JJ O
Complaints NNS O
w '' O
[ -LRB- O
hic PRP O
] -RRB- O
h '' O
the DT O
Learned VBN O
assure VBP O
me PRP O
are VBP O
to TO O
be VB O
conquered VBN O
also RB O
"""" '' O
. . O

10 CD O
Charles NNP O
was VBD O
soon RB O
allowed VBN O
to TO O
eat VB O
meat NN O
and CC O
Mr NNP O
Ranby NNP O
still RB O
assured VBD O
her PRP O
that IN O
the DT O
swelling NN O
would MD O
break VB O
outwards RB O
. . O

1 LS O
"""" `` O
Three CD O
days NNS O
later RBR O
he PRP O
decided VBD O
to TO O
lance VB O
it PRP O
, , O
even RB O
though IN O
Dr NNP O
Bourne NNP O
disagreed VBD O
. . O

The DT O
boy NN B-Species
' POS O
s POS O
mother NN O
was VBD O
puzzled JJ O
because IN O
the DT O
swelling NN O
"""" `` O
sometimes RB O
pushes VBZ O
forward RB O
very RB O
fast RB O
then RB O
retires VBZ O
a DT O
little RB O
"""" '' O
but CC O
the DT O
doctor NN O
and CC O
Ranby NNP O
seemed VBD O
happy JJ O
with IN O
his PRP$ O
condition NN O
. . O
' '' O
2 LS O
At IN O
this DT O
point NN O
the DT O
letters NNS O
cease VBP O
, , O
presumably RB O
because IN O
Malton NNP O
arrived VBD O
in IN O
London NNP O
with IN O
his PRP$ O
daughters NNS O
, , O
to TO O
have VB O
them PRP O
inoculated VBN O
against IN O
smallpox NN B-Species
, , O
but CC O
a DT O
later JJ O
letter NN O
states VBZ O
that IN O
surgery NN O
to TO O
open VB O
the DT O
swelling NN O
was VBD O
not RB O
undertaken VBN O
. . O

13 CD O

By IN O
the DT O
end NN O
of IN O
October NNP O
the DT O
correspondence NN O
had VBD O
recommenced VBN O
. . O

Charles NNP O
was VBD O
ill JJ O
again RB O
. . O

He PRP O
was VBD O
just RB O
the DT O
same JJ O
as IN O
when WRB O
he PRP O
left VBD O
Kensington NNP O
, , O
so RB O
John NNP O
Bourne NNP O
had VBD O
bled VBN O
him PRP O
and CC O
the DT O
child NN B-Species
had VBD O
started VBN O
on IN O
Sir NNP O
Edward NNP O
Hulse NNP O
' POS O
s POS O
prescription NN O
, , O
unfortunately RB O
not RB O
defined VBN O
in IN O
the DT O
letter NN O
, , O
but CC O
which WDT O
was VBD O
apparently RB O
as RB O
bad JJ O
as IN O
the DT O
last JJ O
one NN O
, , O
if IN O
not RB O
worse JJR O
. . O

Lady NNP O
Malton NNP O
thought VBD O
that IN O
"""" `` O
with IN O
such PDT O
a DT O
State NNP O
of IN O
Blood NNP O
the DT O
Continuation NNP O
of IN O
Health NNP O
cannot MD O
be VB O
expected VBN O
"""" '' O
but CC O
was VBD O
hopeful JJ O
that IN O
the DT O
"""" `` O
Cinnabar NNP O
may MD O
prove VB O
a DT O
more RBR O
Efficacious JJ O
remedie NN O
than IN O
any DT O
than IN O
has VBZ O
been VBN O
tryed VBN O
yet RB O
"""" '' O
"""" '' O
. , O
"""" '' O
4 LS O
That DT O
night NN O
she PRP O
applied VBD O
"""" `` O
a DT O
Blister NNP O
. , O
. , O
. , O
without IN O
the DT O
least JJS O
Symptom NN O
or CC O
tendency NN O
to IN O
anything NN O
like IN O
Strangury NNP O
"""" '' O
. . O

He PRP O
bore VBD O
the DT O
treatment NN O
well RB O
, , O
as IN O
he PRP O
had VBD O
done VBN O
three CD O
years NNS O
previously RB O
, , O
and CC O
it PRP O
seemed VBD O
so RB O
successful JJ O
that IN O
Lady NNP O
Malton NNP O
was VBD O
"""" `` O
determined JJ O
to TO O
keep VB O
it PRP O
running VBG O
full RB O
as RB O
long RB O
as IN O
I PRP O
did VBD O
last JJ O
time NN O
by IN O
the DT O
help NN O
of IN O
John NNP O
Borne NNP O
[ -LRB- O
sic NN O
] -RRB- O
with IN O
much JJ O
ease NN O
to IN O
the DT O
Dear NNP O
Child NNP B-Species
"""" '' O
. . O
' '' O
5 CD O
She PRP O

7 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
51 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
18 CD O
August NNP O
1741 CD O
. . O

8 CD O
WWM NNP O
, , O
M2 NNP O
- HYPH O
84 CD O
. . O

Winchelsea NNP O
to IN O
Malton NNP O
, , O
20 CD O
August NNP O
1741 CD O
. . O

9 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
52 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
20 CD O
August NNP O
1741 CD O
. . O

' '' O
0 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
53 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
25 CD O
August NNP O
1741 CD O
. . O

WWM NNP O
, , O
M7 NNP O
- HYPH O
54 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
29 CD O
August NNP O
1741 CD O
. . O

WWM NNP O
, , O
M7 NNP O
- HYPH O
55 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
1 CD O
September NNP O
1741 CD O
. . O

3 CD O
WWM NNP O
, , O
R170 CD O
- HYPH O
20 CD O
. . O

Nicol6 NNP O
Scanagati NNP O
of IN O
Padua NNP O
, , O
20 CD O
July NNP O
1750 CD O
. . O

I PRP O
am VBP O
grateful JJ O
to IN O
Fr NNP O
John NNP O
McMahon NNP O
and CC O
Dr NNP O
Stephen NNP O
Bemrose NNP O
for IN O
their PRP$ O
translations NNS O
of IN O
this DT O
letter NN O
. . O

4 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
14 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
31 CD O
October NNP O
1741 CD O
. . O

5 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
19 CD O
. . O

Lady NNP O
Malton NNP O
to IN O
Lady NNP O
Finch NNP O
, , O
2 CD O
November NNP O
1741 CD O
. . O

179 CD O

Marjorie NNP O
Bloy NNP O

continued VBD O
with IN O
the DT O
blister NN O
and CC O
applied VBD O
"""" `` O
ointment NN O
with IN O
flyes NNS O
"""" '' O
, , O
apparently RB O
some DT O
sort NN O
of IN O
irritant JJ O
potion NN O
, , O
with IN O
no DT O
sign NN O
of IN O
strangury NN O
. . O

Charles NNP O
found VBD O
her PRP$ O
treatment NN O
"""" `` O
not RB O
near IN O
the DT O
pain NN O
he PRP O
expected VBD O
"""" '' O
and CC O
she PRP O
was VBD O
"""" `` O
full JJ O
of IN O
hopes NNS O
that IN O
he PRP O
will MD O
rec VB O
[ -LRB- O
eiv NN O
] -RRB- O
e `` O
great JJ O
benefit NN O
from IN O
it PRP O
"""" '' O
. . O
1 NFP O

Apart RB O
from IN O
his PRP$ O
other JJ O
troubles NNS O
, , O
one CD O
of IN O
Charles NNP O
' POS O
s POS O
knees NNS O
had VBD O
swollen VBN O
but CC O
this DT O
had VBD O
much RB O
abated VBN O
since IN O
the DT O
application NN O
of IN O
the DT O
blisters NNS O
which WDT O
Lady NNP O
Malton NNP O
believed VBD O
"""" `` O
must MD O
be VB O
acting VBG O
upon IN O
the DT O
whole JJ O
Mass NNP O
of IN O
Blood NNP O
"""" '' O
since IN O
it PRP O
had VBD O
"""" `` O
reached VBN O
the DT O
remote JJ O
part NN O
"""" '' O
. . O

She PRP O
thought VBD O
that IN O
Sir NNP O
Edward NNP O
Hulse NNP O
' POS O
s POS O
powders NNS O
were VBD O
too RB O
slow JJ O
in IN O
taking VBG O
effect NN O
although IN O
the DT O
boy NN B-Species
took VBD O
them PRP O
very RB O
quietly RB O
. . O
' '' O
7 CD O
Sir NNP O
Edward NNP O
did VBD O
not RB O
"""" `` O
apprehend VB O
any DT O
great JJ O
danger NN O
from IN O
the DT O
Siziness NNP O
[ -LRB- O
thickness NN O
] -RRB- O
of IN O
Charles NNP O
' POS O
blood NN O
"""" '' O
; : O
Lady NNP O
Malton NNP O
thought VBD O
that IN O
the DT O
condition NN O
was VBD O
the DT O
cause NN O
of IN O
all PDT O
the DT O
child NN B-Species
' '' O
s POS O
problems NNS O
, , O
which WDT O
would MD O
not RB O
end VB O
until IN O
it PRP O
was VBD O
set VBN O
to IN O
rights NNS O
. . O

At IN O
any DT O
rate NN O
, , O
he PRP O
was VBD O
fit JJ O
enough RB O
to TO O
go VB O
hunting NN O
. . O
' '' O
8 CD O
Charles NNP O
continued VBD O
in IN O
the DT O
same JJ O
state NN O
of IN O
health NN O
. . O

He PRP O
slept VBD O
well RB O
at IN O
night NN O
, , O
ate VBD O
more RBR O
than IN O
his PRP$ O
mother NN O
thought VBD O
was VBD O
good JJ O
for IN O
him PRP O
, , O
and CC O
was VBD O
able JJ O
to TO O
exercise VB O
strenuously RB O
without IN O
tiring VBG O
. . O

He PRP O
put VBD O
on RP O
no DT O
weight NN O
though RB O
, , O
and CC O
"""" `` O
as IN O
for IN O
them PRP O
swellings NNS O
at IN O
his PRP$ O
throat NN O
, , O
they PRP O
are VBP O
almost RB O
gone VBN O
one CD O
day NN O
and CC O
rise VB O
the DT O
next JJ O
"""" '' O
. . O

His PRP$ O
mother NN O
did VBD O
not RB O
expect VB O
a DT O
speedy JJ O
recovery NN O
and CC O
"""" `` O
if IN O
the DT O
D NNP O
[ -LRB- O
octo NN O
] -RRB- O
rs VBZ O
think VBP O
him PRP O
in IN O
a DT O
good JJ O
state NN O
of IN O
health NN O
now RB O
, , O
I PRP O
s MD O
[ -LRB- O
houl NN O
] -RRB- O
d `` O
be VB O
glad JJ O
to TO O
see VB O
him PRP O
in IN O
a DT O
better JJR O
"""" '' O
. . O
' '' O
9 NFP O
He PRP O
began VBD O
to TO O
improve VB O
and CC O
by IN O
the DT O
end NN O
of IN O
November NNP O
even RB O
she PRP O
thought VBD O
he PRP O
was VBD O
on IN O
the DT O
mend NN O
and CC O
gaining VBG O
weight NN O
. . O
20 CD O
Unfortunately RB O
, , O
Lady NNP O
Malton NNP O
again RB O
had VBD O
cause NN O
for IN O
concern NN O
over IN O
his PRP$ O
health NN O
in IN O
January NNP O
1742 CD O
when WRB O
he PRP O
began VBD O
to TO O
suffer VB O
from IN O
an DT O
intermittent JJ O
hoarseness NN O
. . O
2 LS O
' '' O
Otherwise RB O
he PRP O
was VBD O
as RB O
well JJ O
as IN O
one PRP O
could MD O
expect VB O
, , O
with IN O
no DT O
other JJ O
complaints NNS O
. . O
22 CD O
It PRP O
was VBD O
not RB O
to TO O
last VB O
. . O

In IN O
May NNP O
1742 CD O
Charles NNP O
and CC O
his PRP$ O
mother NN O
were VBD O
again RB O
in IN O
Bristol NNP O
, , O
taking VBG O
the DT O
waters NNS O
because IN O
he PRP O
had VBD O
been VBN O
indisposed VBN O
. . O

Lady NNP O
Malton NNP O
thought VBD O
the DT O
waters NNS O
were VBD O
doing VBG O
them PRP O
good JJ O
because IN O
they PRP O
were VBD O
both RB O
being VBG O
violently RB O
sick JJ O
. . O
23 CD O
However RB O
, , O
Charles NNP O
had VBD O
had VBN O
no DT O
dinner NN O
on IN O
25 CD O
or CC O
26 CD O
May NNP O
and CC O
was VBD O
hot JJ O
, , O
lazy JJ O
, , O
and CC O
inclined JJ O
to TO O
stir VB O
, , O
"""" '' O
from IN O
which WDT O
I PRP O
conclude VBP O
he PRP O
is VBZ O
not RB O
well JJ O
, , O
. . O

. . O
. , O
and CC O
therefore RB O
Intend VBP O
to TO O
give VB O
him PRP O
a DT O
gentle JJ O
Vomit NNP O
. . O
. , O
. , O
and CC O
to TO O
let VB O
him PRP O
take VB O
his PRP$ O
old JJ O
Remedie NNP O
the DT O
Salt NNP O
Draughts NNPS O
for IN O
a DT O
few JJ O
Daies NNS O
which WDT O
I PRP O
dare VBP O
say VBP O
will MD O
set VB O
him PRP O
quite RB O
to IN O
rights NNS O
"""" '' O
. . O
24 CD O
By IN O
29 CD O
May NNP O
Dr NNP O
Boume NNP O
had VBD O
bled VBN O
the DT O
boy NN B-Species
"""" `` O
which WDT O
succeeded VBD O
very RB O
well RB O
but CC O
. , O
. , O
. . O
found VBD O
it PRP O
[ -LRB- O
his PRP$ O
blood NN O
] -RRB- O
as RB O
bad JJ O
as IN O
ever RB O
"""" '' O
. . O

The DT O
waters NNS O
were VBD O
not RB O
working VBG O
"""" `` O
but CC O
there EX O
is VBZ O
a DT O
great JJ O
deal NN O
for IN O
them PRP O
to TO O
do VB O
which WDT O
grant VBP O
God NNP O
they PRP O
may MD O
effect VB O
"""" '' O
. . O

The DT O
weather NN O
had VBD O
turned VBN O
warm JJ O
so IN O
Lady NNP O
Malton NNP O
had VBD O
"""" `` O
shorn VBN O
him PRP O
. , O
. , O
. , O
which WDT O
has VBZ O
display NN O
' '' O
d `` O
a DT O
most RBS O
scabby JJ O
head NN O
and CC O
indeed RB O
several JJ O
other JJ O
untoward JJ O
Blotches NNPS O
he PRP O
has VBZ O
out RB O
upon IN O
other JJ O
parts NNS O
of IN O
his PRP$ O
Body NNP O
"""" '' O
, , O
which WDT O
made VBD O
her PRP O
uneasy JJ O
. . O
25 CD O
The DT O
blotches NNS O
on IN O
his PRP$ O
head NN O
were VBD O
not RB O
numerous JJ O
"""" `` O
yet CC O
they PRP O
made VBD O
up RP O
in IN O
quality NN O
for IN O
so RB O
virulent JJ O
a DT O
Corrosive NNP O
Humour NNP O
is VBZ O
not RB O
easily RB O
conceived VBN O
without IN O
seeing VBG O
it PRP O
"""" '' O
. . O

The DT O
pustules NNS O
on IN O
his PRP$ O
body NN O
were VBD O
of IN O
the DT O
same JJ O
sort NN O

16 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
17 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
4 CD O
November NNP O
1741 CD O
. . O

7 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
18 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
4 CD O
November NNP O
1741 CD O
. . O

18 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
16 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
7 CD O
November NNP O
1741 CD O
. . O

' '' O
9WWM NNP O
, , O
M7 NNP O
- HYPH O
15 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
9 CD O
November NNP O
1741 CD O
. . O

20 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
22 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
25 CD O
November NNP O
1741 CD O
. . O

21 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
1 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
25 CD O
January NNP O
1742 CD O
. . O

22 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
4 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
8 CD O
February NNP O
1742 CD O
and CC O
WWM NNP O
, , O
M7 NNP O
- HYPH O
9 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
22 CD O
February NNP O
1742 CD O
. . O

23 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
29 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
12 CD O
May NNP O
1742 CD O
. . O

24 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
35 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
26 CD O
May NNP O
1742 CD O
. . O

25 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
36 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
29 CD O
May NNP O
1742 CD O
. . O

180 CD O

An DT O
eighteenth JJ O
- HYPH O
century NN O
Prime NNP O
Minister NNP O
' POS O
s POS O
illness NN O

and CC O
his PRP$ O
mother NN O
intended VBD O
to TO O
put VB O
plasters NNS O
on IN O
them PRP O
to TO O
prevent VB O
them PRP O
from IN O
spreading VBG O
. . O

Charles NNP O
was VBD O
also RB O
feverish JJ O
; : O
his PRP$ O
glands NNS O
were VBD O
swollen VBN O
and CC O
his PRP$ O
pulse NN O
was VBD O
erratic JJ O
"""" `` O
but CC O
out IN O
of IN O
compassion NN O
to IN O
you PRP O
I PRP O
must MD O
tell VB O
you PRP O
that IN O
he PRP O
is VBZ O
with IN O
me PRP O
as IN O
Brisk NNP O
and CC O
lively JJ O
as IN O
you PRP O
ever RB O
Saw VBD O
him PRP O
"""" '' O
. . O

Lady NNP O
Malton NNP O
had VBD O
called VBN O
in RP O
two CD O
eminent JJ O
Bristol NNP O
men NNS B-Species
, , O
Dr NNP O
Logan NNP O
and CC O
Mr NNP O
Pye NNP O
, , O
to TO O
treat VB O
the DT O
boy NN B-Species
; : O
Mr NNP O
Pye NNP O
prescribed VBD O
"""" `` O
the DT O
Precipitate NNP O
Per FW O
se FW O
"""" '' O
as IN O
the DT O
cure NN O
for IN O
the DT O
"""" `` O
hectic NN O
"""" '' O
. . O

Pye NNP O
made VBD O
it PRP O
himself PRP O
and CC O
said VBD O
that IN O
it PRP O
was VBD O
the DT O
only JJ O
remedy NN O
that WDT O
would MD O
work VB O
. . O

Clearly RB O
Charles NNP O
was VBD O
impatient JJ O
to TO O
be VB O
cured VBN O
because IN O
he PRP O
told VBD O
his PRP$ O
mother NN O
to TO O
give VB O
him PRP O
the DT O
medicine NN O
"""" `` O
to TO O
cure VB O
me PRP O
which WDT O
I PRP O
am VBP O
sure JJ O
it PRP O
will MD O
do VB O
or CC O
shoot VB O
me PRP O
through IN O
the DT O
head NN O
at IN O
once RB O
"""" '' O
. . O

She PRP O
thought VBD O
that IN O
this DT O
attitude NN O
was VBD O
"""" `` O
odd JJ O
from IN O
one CD O
of IN O
his PRP$ O
Age NN O
and CC O
[ -LRB- O
it PRP O
] -RRB- O
does VBZ O
not RB O
a DT O
little JJ O
disturb NN O
"""" '' O
. , O
26 CD O
The DT O
blotches NNS O
began VBD O
to TO O
burst VB O
and CC O
indent JJ O
but CC O
the DT O
doctor NN O
thought VBD O
that IN O
all DT O
would MD O
be VB O
well RB O
in IN O
the DT O
end NN O
. . O
27 CD O
Meanwhile RB O
, , O
Charles NNP O
was VBD O
still RB O
losing VBG O
weight NN O
even RB O
though IN O
"""" `` O
he PRP O
had VBD O
none NN O
to TO O
spare VB O
before RB O
"""" '' O
and CC O
he PRP O
was VBD O
inclined VBN O
to TO O
be VB O
lazy JJ O
which WDT O
was VBD O
not RB O
his PRP$ O
natural JJ O
turn NN O
. . O

His PRP$ O
father NN O
recommended VBD O
some DT O
unknown JJ O
cure NN O
which WDT O
he PRP O
called VBD O
Gascoin NNP O
' '' O
s POS O
Powder NNP O
- : O
a DT O
dose NN O
of IN O
five CD O
grains NNS O
made VBN O
up RP O
with IN O
syrup NN O
into IN O
a DT O
pill NN O
- : O
every DT O
night NN O
. . O

To TO O
make VB O
matters NNS O
worse JJR O
, , O
the DT O
doctors NNS O
disagreed VBD O
about IN O
the DT O
treatment NN O
. . O

"""" `` O
Dr NNP O
Pye NNP O
is VBZ O
Vehemently RB O
for IN O
the DT O
P NNP O
. . O

Per IN O
se FW O
, , O
Dr NNP O
Logan NNP O
saies VBZ O
that IN O
it PRP O
is VBZ O
a DT O
Medicine NNP O
that WDT O
may MD O
prove VB O
too RB O
rough JJ O
in IN O
its PRP$ O
operation NN O
for IN O
his PRP$ O
Constitution NNP O
& CC O
therefore RB O
begs VBZ O
a DT O
tryal NN O
of IN O
Beazor NNP O
mineral NN O
[ -LRB- O
gall NN O
stones NNS O
from IN O
a DT O
goat NN B-Species
] -RRB- O
and CC O
Viper NNP O
Broth NNP O
"""" '' O
. . O

The DT O
Bristol NNP O
water NN O
had VBD O
not RB O
yet RB O
acted VBN O
"""" `` O
because IN O
his PRP$ O
case NN O
is VBZ O
of IN O
too RB O
obstinate JJ O
a DT O
Nature NNP O
"""" '' O
and CC O
Lady NNP O
Malton NNP O
herself PRP O
was VBD O
satisfied JJ O
that IN O
since IN O
nothing NN O
else RB O
had VBD O
worked VBN O
to TO O
cure VB O
the DT O
boy NN B-Species
, , O
the DT O
time NN O
had VBD O
come VBN O
to TO O
try VB O
mercurials NNS O
, , O
even RB O
though IN O
she PRP O
knew VBD O
that IN O
they PRP O
were VBD O
"""" `` O
powerful JJ O
and CC O
perhaps RB O
in IN O
some DT O
cases NNS O
hazardous JJ O
medicines NNS O
"""" '' O
. , O
28 CD O
She PRP O
wanted VBD O
to TO O
see VB O
some DT O
remedy NN O
succeed VB O
but CC O
was VBD O
"""" `` O
afraid JJ O
of IN O
violent JJ O
ones NNS O
and CC O
at IN O
the DT O
same JJ O
time NN O
vastly RB O
distrustfull JJ O
[ -LRB- O
sic NN O
] -RRB- O
of IN O
mild JJ O
ones NNS O
"""" '' O
. . O

It PRP O
would MD O
appear VB O
that IN O
the DT O
"""" `` O
precipitate JJ O
Per FW O
se FW O
"""" '' O
, , O
probably RB O
mercury NN O
- HYPH O
based VBN O
, , O
could MD O
be VB O
a DT O
kill NN O
- HYPH O
or CC O
- HYPH O
cure NN O
remedy NN O
. . O

Her PRP$ O
"""" `` O
terrors NNS O
"""" '' O
did VBD O
not RB O
arise VB O
from IN O
any DT O
immediate JJ O
danger NN O
to IN O
her PRP$ O
son NN O
, , O
and CC O
her PRP$ O
"""" `` O
perfect JJ O
Knowledge NN O
"""" '' O
of IN O
his PRP$ O
disorder NN O
convinced VBD O
her PRP O
that IN O
whatever WDT O
remedies NNS O
he PRP O
took VBD O
, , O
the DT O
cure NN O
was VBD O
in IN O
the DT O
hands NNS O
of IN O
God NNP O
. . O
29 CD O

To TO O
add VB O
to IN O
Charles NNP O
' POS O
disorders NNS O
, , O
on IN O
12 CD O
June NNP O
he PRP O
developed VBD O
a DT O
"""" `` O
very RB O
inflamed JJ O
bad JJ O
Eye NNP O
. . O
. , O
. . O
the DT O
same JJ O
Eye NN O
that WDT O
. . O
. . O
. . O

he PRP O
did VBD O
not RB O
see VB O
so RB O
well RB O
of IN O
[ -LRB- O
as IN O
] -RRB- O
the DT O
other JJ O
. . O
. . O
. . O

He PRP O
sais VBZ O
[ -LRB- O
sic NN O
] -RRB- O
that IN O
from IN O
that DT O
eye NN O
Alone RB O
he PRP O
can MD O
Scarcely RB O
distinguish VB O
anything NN O
"""" '' O
. . O

The DT O
doctors NNS O
suggested VBD O
bathing VBG O
the DT O
eye NN O
: : O
Lady NNP O
Malton NNP O
knew VBD O
that IN O
the DT O
"""" `` O
frightful JJ O
symptoms NNS O
"""" '' O
which WDT O
were VBD O
"""" `` O
shocking JJ O
to TO O
behold VB O
"""" '' O
were VBD O
a DT O
result NN O
of IN O
"""" `` O
the DT O
Same JJ O
as IN O
produces VBZ O
all PDT O
the DT O
rest NN O
of IN O
his PRP$ O
complaints NNS O
in IN O
whichever WDT O
Shape NN O
they PRP O
appear VBP O
"""" '' O
. . O

30 CD O
The DT O
eye NN O
was VBD O
very RB O
bloodshot JJ O
and CC O
inflamed JJ O
; : O
the DT O
eyelid NN O
was VBD O
swollen VBN O
so IN O
he PRP O
could MD O
hardly RB O
open VB O
it PRP O
. . O

The DT O
other JJ O
eye NN O
was VBD O
dull JJ O
and CC O
"""" `` O
he PRP O
had VBD O
very RB O
little JJ O
sight NN O
of IN O
it PRP O
"""" '' O
. , O
31 CD O
By IN O
14 CD O
June NNP O
the DT O
eye NN O
problem NN O
had VBD O
eased VBN O
somewhat RB O
but CC O
Lady NNP O
Malton NNP O
could MD O
find VB O
no DT O
cause NN O
to TO O
attribute VB O
the DT O
improvement NN O
to IN O
any DT O
of IN O
the DT O
"""" `` O
cures NNS O
"""" '' O
. . O

Charles NNP O
was VBD O
still RB O
being VBG O
subjected VBN O
to IN O
Bristol NNP O
water NN O
, , O
Beazor NNP O
mineral NN O
, , O
Viper NN O
broth NN O
, , O
cinnabar NN O
and CC O
the DT O
precipitate JJ O
per FW O
se FW O
. . O
32 CD O
She PRP O
decided VBD O
to TO O
take VB O
the DT O
boy NN B-Species
home RB O
to IN O
Wentworth NNP O
because IN O
he PRP O
was VBD O

26 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
38 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
1 CD O
June NNP O
1742 CD O
. . O

27 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
39 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
2 CD O
June NNP O
1742 CD O
. . O

28 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
41 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
5 CD O
June NNP O
1742 CD O
. . O

29 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
43 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
7 CD O
June NNP O
1742 CD O
. . O

30 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
45 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
12 CD O
June NNP O
1742 CD O
. . O

31 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
56 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
undated JJ O
: : O
12 CD O
June NNP O
? . O

1742 CD O
. . O

32 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
46 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
14 CD O
June NNP O
? . O

1742 CD O
. . O

181 CD O

Marjorie NNP O
Bloy NNP O

more RBR O
likely JJ O
to TO O
recover VB O
there RB O
than IN O
anywhere RB O
else RB O
. . O
33 CD O
He PRP O
still RB O
ate VBD O
and CC O
slept VBD O
well RB O
and CC O
was VBD O
"""" `` O
pretty RB O
cheerful JJ O
but CC O
his PRP$ O
looks NNS O
are VBP O
bitter JJ O
bad JJ O
still RB O
. . O

The DT O
flesh NN O
he PRP O
lost VBD O
in IN O
the DT O
Accidental NNP O
Feavour NNP O
he PRP O
has VBZ O
not RB O
Recover VB O
' '' O
d VBN O
and CC O
his PRP$ O
complexion NN O
is VBZ O
of IN O
the DT O
most RBS O
sickly JJ O
sort NN O
his PRP$ O
hands NNS O
of IN O
the DT O
same JJ O
Hue NNP O
his PRP$ O
legs NNS O
are VBP O
tollerable JJ O
[ -LRB- O
sic NN O
] -RRB- O
well RB O
"""" '' O
. . O
34 CD O

They PRP O
returned VBD O
to IN O
Wentworth NNP O
in IN O
short JJ O
stages NNS O
and CC O
by IN O
6 CD O
September NNP O
Higham NNP O
was VBD O
"""" `` O
perfectly RB O
recovered VBN O
. . O

. , O
. , O
after IN O
the DT O
long JJ O
and CC O
successful JJ O
Care NN O
that WDT O
Lady NNP O
Malton NNP O
has VBZ O
taken VBN O
"""" '' O
of IN O
him PRP O
. . O
35 CD O
In IN O
May NNP O
1743 CD O
he PRP O
was VBD O
inoculated VBN O
against IN O
smallpox NN B-Species
and CC O
made VBD O
a DT O
perfect JJ O
recovery NN O
after IN O
which WDT O
he PRP O
caught VBD O
cold JJ O
"""" '' O
by IN O
stripping VBG O
when WRB O
He PRP O
was VBD O
hot JJ O
"""" '' O
. . O
36 CD O
Lord NNP O
Higham NNP O
does VBZ O
not RB O
seem VB O
to TO O
have VB O
been VBN O
seriously RB O
ill JJ O
after IN O
that DT O
until IN O
, , O
at IN O
the DT O
age NN O
of IN O
19 CD O
, , O
he PRP O
undertook VBD O
his PRP$ O
Grand NNP O
Tour NNP O
in IN O
1749 CD O
. . O

In IN O
July NNP O
1750 CD O
, , O
by IN O
then RB O
Lord NNP O
Malton NNP O
, , O
he PRP O
had VBD O
cause NN O
to TO O
consult VB O
Nicolo NNP O
Scanagati NNP O
in IN O
Padua NNP O
for IN O
the DT O
treatment NN O
of IN O
gonorrhoea NN O
. . O

Scanagati NNP O
produced VBD O
a DT O
lengthy JJ O
medical JJ O
report NN O
of IN O
Malton NNP O
' POS O
s POS O
treatment NN O
, , O
presumably RB O
for IN O
his PRP$ O
English JJ O
doctor NN O
' POS O
s POS O
enlightenment NN O
. . O
37 CD O
The DT O
initial JJ O
treatment NN O
was VBD O
an DT O
"""" `` O
electuary NN O
, , O
consisting VBG O
of IN O
three CD O
ounces NNS O
of IN O
emollient JJ O
, , O
three CD O
drams NNS O
of IN O
powdered JJ O
jalap NN B-Species
, , O
a DT O
half JJ O
[ -LRB- O
dram NN O
] -RRB- O
of IN O
purified JJ O
nitre NN O
, , O
bound VBN O
together RB O
with IN O
lemon NN B-Species
juice NN O
taken VBN O
twice RB O
a DT O
day NN O
"""" '' O
. . O

The DT O
result NN O
was VBD O
satisfactory JJ O
: : O
"""" `` O
The DT O
dark JJ O
greenish JJ O
poison NN O
was VBD O
oozing VBG O
slowly RB O
from IN O
his PRP$ O
penis NN O
, , O
which WDT O
was VBD O
all DT O
contracted VBN O
and CC O
the DT O
sharp JJ O
and CC O
constant JJ O
pain NN O
extended VBD O
from IN O
the DT O
perineum NN O
up IN O
to IN O
the DT O
urinary JJ O
bladder NN O
, , O
producing VBG O
small JJ O
swellings NNS O
now RB O
in IN O
this DT O
place NN O
, , O
now RB O
in IN O
that DT O
. . O
"""" `` O
There EX O
was VBD O
a DT O
fierce JJ O
burning VBG O
sensation NN O
in IN O
the DT O
glands NNS O
, , O
which WDT O
prevented VBD O
him PRP O
from IN O
sleeping VBG O
. . O

Because IN O
of IN O
this DT O
, , O
it PRP O
seemed VBD O
reasonable JJ O
to TO O
bathe VB O
that DT O
part NN O
in IN O
tepid JJ O
water NN O
and CC O
milk NN O
, , O
and CC O
to TO O
apply VB O
poultices NNS O
to IN O
the DT O
areas NNS O
affected VBN O
by IN O
swelling NN O
and CC O
contractions NNS O
, , O
together RB O
with IN O
cold JJ O
drinks NNS O
and CC O
a DT O
few JJ O
grains NNS O
of IN O
laudanum NN O
at IN O
night NN O
. . O

Malton NNP O
was VBD O
blooded VBN O
regularly RB O
besides IN O
being VBG O
given VBN O
purgatives NNS O
; : O
the DT O
treatment NN O
then RB O
moved VBD O
on RP O
to IN O
the DT O
administration NN O
of IN O
mercury NN O
, , O
both CC O
internal JJ O
and CC O
on IN O
the DT O
gums NNS O
, , O
since IN O
it PRP O
was VBD O
widely RB O
believed VBN O
at IN O
the DT O
time NN O
that IN O
gonorrhoea NN O
and CC O
syphilis NNS O
were VBD O
steps NNS O
of IN O
the DT O
same JJ O
disease NN O
, , O
"""" `` O
the DT O
Venereal NNP O
"""" '' O
. . O

Scanagati NNP O
at IN O
this DT O
point NN O
ruled VBD O
out RP O
the DT O
suggestion NN O
of IN O
syphilitic JJ O
chancre NN O
because IN O
Malton NNP O
' POS O
s POS O
urine NN O
was VBD O
fine JJ O
and CC O
light JJ O
with IN O
a DT O
pungent JJ O
odour NN O
. . O

Scanagati NNP O
did VBD O
ask VB O
if IN O
Malton NNP O
had VBD O
previously RB O
ever RB O
had VBN O
a DT O
similar JJ O
peculiarity NN O
of IN O
his PRP$ O
urine NN O
. . O

Malton NNP O
replied VBD O
that IN O
when WRB O
he PRP O
was VBD O
very RB O
young JJ O
and CC O
still RB O
inexperienced JJ O
sexually RB O
, , O
for IN O
some DT O
time NN O
following VBG O
a DT O
fever NN O
he PRP O
had VBD O
had VBN O
the DT O
same JJ O
unusual JJ O
urine NN O
, , O
and CC O
indeed RB O
that IN O
on IN O
one CD O
occasion NN O
this DT O
symptom NN O
coincided VBD O
with IN O
certain JJ O
tumours NNS O
on IN O
the DT O
testicles NNS O
. . O

It PRP O
was VBD O
only RB O
by IN O
chance NN O
that IN O
he PRP O
had VBD O
not RB O
had VBN O
recourse NN O
to IN O
surgery NN O
, , O
the DT O
reason NN O
being VBG O
that IN O
he PRP O
was VBD O
also RB O
afflicted VBN O
with IN O
a DT O
throat NN O
infection NN O
- , O
to IN O
which WDT O
he PRP O
was VBD O
prone JJ O
- : O
and CC O
therefore RB O
had VBD O
his PRP$ O
vein NN O
opened VBN O
four CD O
times NNS O
. . O

Thereupon RB O
the DT O
inflammation NN O
subsided VBD O
, , O
and CC O
equally RB O
the DT O
tumours NNS O
and CC O
sediment NN O
disappeared VBD O
. . O

He PRP O
told VBD O
me PRP O
that IN O
as IN O
a DT O
youth NN O
he PRP O
had VBD O
sometimes RB O
experienced VBN O
some DT O
difficulty NN O
and CC O
a DT O
burning VBG O
sensation NN O
when WRB O
urinating VBG O
, , O
which WDT O
subsided VBD O
when WRB O
his PRP$ O
blood NN O
was VBD O
let VBN O
and CC O
with IN O
the DT O
application NN O
of IN O
poultices NNS O
. . O

I PRP O
observed VBD O
that IN O
from IN O
time NN O
to IN O
time NN O
his PRP$ O
face NN O
and CC O
body NN O
were VBD O
covered VBN O
with IN O
purplish JJ O
spots NNS O
, , O
which WDT O
, , O
having VBG O
produced VBN O
a DT O
little JJ O
fluid NN O
, , O
would MD O
disappearas NNS O
indeed RB O
happened VBD O
in IN O
the DT O
course NN O
of IN O
the DT O
cure NN O
, , O
at IN O
the DT O
end NN O
of IN O
which WDT O
his PRP$ O
face NN O
was VBD O
entirely RB O

33 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
47 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
15 CD O
June NNP O
1742 CD O
. . O

34 CD O
WWM NNP O
, , O
M7 NNP O
- HYPH O
48 CD O
. . O

Lady NNP O
to IN O
Lord NNP O
Malton NNP O
, , O
16 CD O
June NNP O
1742 CD O
. . O

35 CD O
WWM NNP O
, , O
M2 NNP O
- HYPH O
104 CD O
/ SYM O
5 CD O
. . O

Lady NNP O
Finch NNP O
to IN O
Lady NNP O
Malton NNP O
, , O
6 CD O
September NNP O
1742 CD O
. . O

36 CD O
WWM NNP O
, , O
M2 NNP O
- HYPH O
135 CD O
. . O

Lady NNP O
Finch NNP O
to IN O
Malton NNP O
, , O
18 CD O
June NNP O
1742 CD O
. . O

37 CD O
WWM NNP O
, , O
R170 CD O
- HYPH O
20 CD O
. . O

Nicol6 NNP O
Scanagati NNP O
' POS O
s POS O
report NN O
. . O

182 CD O

An DT O
eighteenth JJ O
- HYPH O
century NN O
Prime NNP O
Minister NNP O
' POS O
s POS O
illness NN O

free JJ O
from IN O
these DT O
spots NNS O
. . O

From IN O
this DT O
observation NN O
, , O
it PRP O
seemed VBD O
to IN O
me PRP O
simple JJ O
to TO O
deduce VB O
both CC O
the DT O
original JJ O
cause NN O
and CC O
the DT O
more RBR O
immediate JJ O
cause NN O
of IN O
the DT O
said VBN O
sediment NN O
: : O
namely RB O
a DT O
natural JJ O
complexion NN O
of IN O
humours NNS O
which WDT O
are VBP O
exacerbated VBN O
by IN O
muriatic JJ O
[ -LRB- O
i LS O
. . O
e NFP O
. . O
, , O
acidic JJ O
] -RRB- O
sourness NN O
, , O
together RB O
with IN O
the DT O
marked JJ O
inflammation NN O
of IN O
the DT O
blood NN O
and CC O
the DT O
motion NN O
of IN O
the DT O
contracted VBN O
poison NN O
. . O

Scanagati NNP O
then RB O
recommended VBD O
the DT O
continuation NN O
of IN O
the DT O
electuary NN O
made VBN O
of IN O
emollient NN O
, , O
guaiacum NN O
resin NN O
, , O
balsam NN O
, , O
rhubarb NN B-Species
, , O
and CC O
nitre NN O
. . O

What WP O
does VBZ O
all PDT O
this DT O
add VB O
up RP O
to IN O
in IN O
terms NNS O
of IN O
diagnosis NN O
? . O

The DT O
early JJ O
illness NN O
is VBZ O
a DT O
mystery NN O
. . O

Did VBD O
he PRP O
have VB O
an DT O
inguinal JJ O
hernia NN O
; : O
or CC O
perhaps RB O
mumps NNS O
or CC O
epididymitis NN O
? . O

His PRP$ O
was VBD O
a DT O
childless JJ O
marriage NN O
. . O

He PRP O
seems VBZ O
to TO O
have VB O
been VBN O
too RB O
fit JJ O
for IN O
the DT O
illness NN O
to TO O
have VB O
been VBN O
rheumatic JJ O
fever NN O
. . O

Cystitis NNP O
was VBD O
not RB O
uncommon JJ O
and CC O
this DT O
could MD O
certainly RB O
lead VB O
to IN O
"""" `` O
strangury NN O
"""" '' O
. . O

Perhaps RB O
Rockingham NNP O
suffered VBD O
from IN O
a DT O
congenital JJ O
defect NN O
of IN O
his PRP$ O
urinogenitary JJ O
system NN O
which WDT O
would MD O
result VB O
in IN O
recurrent JJ O
attacks NNS O
of IN O
cystitis NN O
and CC O
might MD O
cause VB O
long JJ O
- HYPH O
term NN O
damage NN O
to IN O
the DT O
urinary JJ O
tract NN O
and CC O
eventual JJ O
destruction NN O
of IN O
the DT O
kidneys NNS O
, , O
precipitating VBG O
sudden JJ O
and CC O
unexpected JJ O
death NN O
. . O

Another DT O
possibility NN O
might MD O
be VB O
diabetes NNS O
. . O

Rockingham NNP O
had VBD O
a DT O
urinary JJ O
infection NN O
and CC O
certainly RB O
suffered VBD O
from IN O
recurrent JJ O
skin NN O
infections NNS O
, , O
although IN O
it PRP O
appears VBZ O
from IN O
Scanagati NNP O
' POS O
s POS O
report NN O
that IN O
these DT O
cleared VBD O
up RP O
when WRB O
mercury NN O
was VBD O
administered VBN O
. . O

Certainly RB O
the DT O
marquis NN O
complained VBD O
often RB O
about IN O
pains NNS O
in IN O
his PRP$ O
side NN O
and CC O
stomach NN O
and CC O
made VBD O
no DT O
secret NN O
of IN O
his PRP$ O
"""" `` O
old JJ O
complaint NN O
"""" '' O
. . O

He PRP O
was VBD O
noticeably RB O
less RBR O
physically RB O
active JJ O
as IN O
he PRP O
moved VBD O
into IN O
his PRP$ O
thirties NNS O
and CC O
only RB O
occasionally RB O
exerted VBD O
himself PRP O
by IN O
riding VBG O
any DT O
distance NN O
, , O
even RB O
though IN O
he PRP O
had VBD O
enjoyed VBN O
hunting NN O
when WRB O
he PRP O
was VBD O
younger JJR O
. . O

He PRP O
found VBD O
the DT O
pains NNS O
caused VBN O
by IN O
his PRP$ O
"""" `` O
old JJ O
complaint NN O
"""" '' O
made VBD O
him PRP O
feel VB O
so RB O
ill JJ O
that IN O
he PRP O
was VBD O
unable JJ O
to TO O
concentrate VB O
on IN O
"""" `` O
any DT O
Manner NNP O
of IN O
Business NNP O
"""" '' O
and CC O
on IN O
occasion NN O
it PRP O
seemed VBD O
likely JJ O
to TO O
prevent VB O
him PRP O
from IN O
attending VBG O
Parliament NNP O
. . O
38 CD O
He PRP O
may MD O
well RB O
have VB O
suffered VBN O
from IN O
a DT O
problem NN O
with IN O
gallstones NNS O
from IN O
an DT O
early JJ O
age NN O
. . O
39 CD O
He PRP O
appears VBZ O
to TO O
have VB O
suffered VBN O
from IN O
a DT O
nervous JJ O
disorder NN O
which WDT O
manifested VBD O
itself PRP O
in IN O
severe JJ O
palpitations NNS O
, , O
trembling VBG O
, , O
and CC O
other JJ O
types NNS O
of IN O
physical JJ O
discomforts NNS O
such JJ O
as IN O
boils NNS O
and CC O
headaches NNS O
with IN O
which WDT O
he PRP O
was VBD O
frequently RB O
afflicted VBN O
. . O
40 CD O
He PRP O
probably RB O
had VBD O
constipation NN O
too RB O
, , O
since IN O
he PRP O
was VBD O
always RB O
dosing VBG O
himself PRP O
with IN O
purgatives NNS O
. . O

In IN O
fact NN O
in IN O
April NNP O
1772 CD O
the DT O
Duke NNP O
of IN O
Richmond NNP O
decided VBD O
that IN O
Rockingham NNP O
' POS O
s POS O
real JJ O
problem NN O
was VBD O
a DT O
"""" `` O
surfeit NN O
of IN O
physick NN O
"""" '' O
41 CD O
although IN O
Edmund NNP O
Burke NNP O
noted VBD O
in IN O
June NNP O
1772 CD O
that IN O
the DT O
marquis NN O
had VBD O
had VBN O
a DT O
long JJ O
and CC O
severe JJ O
illness NN O
. . O
42 CD O
Whatever WDT O
his PRP$ O
many JJ O
and CC O
varied JJ O
ailments NNS O
, , O
Rockingham NNP O
survived VBD O
until IN O
he PRP O
was VBD O
52 CD O
in IN O
spite NN O
of IN O
the DT O
attentions NNS O
of IN O
both DT O
doctors NNS O
and CC O
quacks NNS O
and CC O
that IN O
, , O
for IN O
the DT O
mid JJ O
- HYPH O
eighteenth JJ O
century NN O
, , O
was VBD O
a DT O
good JJ O
age NN O
. . O

The DT O
mystery NN O
still RB O
remains VBZ O
, , O
however RB O
. . O

Contemporary JJ O
opinion NN O
had VBD O
it PRP O
that IN O
he PRP O
died VBD O
of IN O
pneumonia NN O
but CC O
it PRP O
must MD O
have VB O
struck VBN O

38 CD O
WWM NNP O
, , O
R153 CD O
- HYPH O
1 CD O
. . O

Rockingham NNP O
to IN O
Burke NNP O
, , O
31 CD O
October NNP O
1767 CD O
; : O
WWM NNP O
, , O
RI NNP O
- HYPH O
1238 CD O
. . O

Rockingham NNP O
to IN O
Dowdeswell NNP O
, , O
20 CD O
October NNP O
1769 CD O
; : O
WWM NNP O
, , O
RI NNP O
- HYPH O
1928 CD O
. . O

Rockingham NNP O
to IN O
Savile NNP O
, , O
September NNP O
1780 CD O
. . O

39 CD O
Ross NNP O
J NNP O
. . O

S UH O
. . O

Hoffman NNP O
, , O
The DT O
Marquis NNP O
. . O

A DT O
study NN O
of IN O
Lord NNP O
Rockingham NNP O
, , O
1730 CD O
- HYPH O
1782 CD O
, , O
New NNP O
York NNP O
, , O
Fordham NNP O
University NNP O
Press NNP O
, , O
1973 CD O
, , O
p NN O
. . O

35 CD O
. . O

This DT O
is VBZ O
the DT O
only JJ O
recent JJ O
biography NN O
of IN O
the DT O
second JJ O
Marquis NNP O
of IN O
Rockingham NNP O
, , O
and CC O
does VBZ O
not RB O
deal VB O
with IN O
his PRP$ O
illnesses NNS O
. . O

Although IN O
he PRP O
does VBZ O
not RB O
give VB O
the DT O
source NN O
of IN O
his PRP$ O
information NN O
, , O
Hoffman NNP O
asserts VBZ O
that IN O
Rockingham NNP O
was VBD O
in IN O
Bath NNP O
between IN O
March NNP O
and CC O
August NNP O
1761 CD O
suffering VBG O
from IN O
gallstones NNS O
. . O

The DT O
marquis NN O
would MD O
then RB O
have VB O
been VBN O
31 CD O
years NNS O
old JJ O
. . O

40 CD O
Historical NNP O
Manuscripts NNPS O
Commission NNP O
, , O
Lindley NNP O
Wood NNP O
, , O
p FW O
. . O

184 CD O
. . O

41 CD O
WWM NNP O
, , O
RI NNP O
- HYPH O
1403 CD O
. . O

Richmond NNP O
to IN O
Rockingham NNP O
, , O
26 CD O
April NNP O
1772 CD O
. . O

42 CD O
Burke NNP O
to IN O
James NNP O
de NNP O
Lancey NNP O
, , O
30 CD O
June NNP O
1772 CD O
. . O

The DT O
correspondence NN O
of IN O
Edmund NNP O
Burke NNP O
, , O
vol NN O
. . O

2 CD O
, , O
ed UH O
. . O

T NNP O
. . O

W UH O
. . O

Copeland NNP O
and CC O
others NNS O
, , O
Cambridge NNP O
University NNP O
Press NNP O
, , O
1958 CD O
- SYM O
1978 CD O
, , O
p NN O
. . O

311 CD O
. . O

183 CD O

Marjorie NNP O
Bloy NNP O

suddenly RB O
: : O
it PRP O
was VBD O
only RB O
two CD O
weeks NNS O
from IN O
him PRP O
"""" `` O
recovering VBG O
"""" '' O
to IN O
dying VBG O
. . O

Another DT O
almost RB O
contemporary JJ O
account NN O
of IN O
the DT O
marquis NN O
' POS O
s POS O
death NN O
came VBD O
from IN O
the DT O
Earl NNP O
of IN O
Albemarle NNP O
. . O

He PRP O
noted VBD O
that IN O
Rockingham NNP O
had VBD O
"""" `` O
for IN O
some DT O
time NN O
past NN O
been VBN O
afflicted VBN O
with IN O
water NN O
on IN O
the DT O
chest NN O
: : O
and CC O
to IN O
this DT O
well RB O
- HYPH O
known VBN O
malady NN O
was VBD O
superadded VBN O
the DT O
then RB O
novel JJ O
disease NN O
of IN O
influenza NN O
"""" '' O
. , O
43 CD O
This DT O
conceivably RB O
could MD O
be VB O
an DT O
uninformed JJ O
account NN O
, , O
handed VBN O
down RP O
orally RB O
by IN O
surviving VBG O
members NNS O
of IN O
the DT O
marquis NN O
' POS O
s POS O
family NN O
, , O
of IN O
emphysema NN O
. . O

More RBR O
fascinating JJ O
than IN O
the DT O
diagnosis NN O
of IN O
the DT O
cause NN O
of IN O
death NN O
, , O
however RB O
, , O
is VBZ O
- : O
what WP O
was VBD O
wrong JJ O
with IN O
him PRP O
during IN O
his PRP$ O
lifetime NN O
? . O

Or CC O
is VBZ O
it PRP O
yet RB O
another DT O
example NN O
of IN O
the DT O
"""" `` O
English NNP O
disease NN O
"""" '' O
: : O
hypochondria NN O
? . O

43Albemarle NNP O
, , O
George NNP O
Thomas NNP O
, , O
Earl NNP O
of IN O
, , O
Memoirs NNPS O
of IN O
the DT O
Marquis NNP O
of IN O
Rockingham NNP O
and CC O
his PRP$ O
contemporaries NNS O
, , O
London NNP O
, , O
Richard NNP O
Bentley NNP O
, , O
2 CD O
vols NNS O
. . O
, , O
1852 CD O
, , O
vol FW O
. . O

2 CD O
, , O
p UH O
. . O

483 CD O
. . O

This DT O
is VBZ O
the DT O
only JJ O
contemporary JJ O
work NN O
concerning VBG O
Rockingham NNP O
, , O
but CC O
does VBZ O
not RB O
mention VB O
his PRP$ O
early JJ O
life NN O
and CC O
illnesses NNS O
. . O

184 CD O

Tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
mammalian JJ O
Fox NNP O
- HYPH O
1 CD O
homologs NNS O
are VBP O
associated VBN O
with IN O
tissue NN O
- HYPH O
specific JJ O
splicing NN O
activities NNS O

Abstract JJ O

An DT O
intronic JJ O
hexanucleotide NN O
UGCAUG NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
critical JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
tissue NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
of IN O
pre NN O
- HYPH O
mRNAs NNS O
in IN O
a DT O
wide JJ O
range NN O
of IN O
tissues NNS O
. . O

Vertebrate NNP O
Fox NNP O
- HYPH O
1 CD O
has VBZ O
been VBN O
shown VBN O
to TO O
bind VB O
to IN O
this DT O
element NN O
, , O
in IN O
a DT O
highly RB O
sequence NN O
- HYPH O
specific JJ O
manner NN O
, , O
through IN O
its PRP$ O
RNA NNP O
recognition NN O
motif NN O
( , O
RRM NNP O
) -RRB- O
. . O

In IN O
mammals NNS O
, , O
there EX O
are VBP O
at IN O
least JJS O
two CD O
Fox NNP O
- HYPH O
1 CD O
- HYPH O
related VBN O
genes NNS O
, , O
ataxin NN O
- HYPH O
2 CD O
binding NN O
protein NN O
1 CD O
( SYM O
A2BP1 NN O
) -RRB- O
/ SYM O
Fox NNP O
- HYPH O
1 CD O
and CC O
Fxh NNP O
/ SYM O
Rbm9 NNP O
, , O
which WDT O
encode VBP O
an DT O
identical JJ O
RRM NN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
both CC O
mouse NNP B-Species
Fxh NNP O
and CC O
A2BP1 NNP O
transcripts NNS O
undergo VBP O
tissue NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
, , O
generating VBG O
protein NN O
isoforms NNS O
specific JJ O
to IN O
brain NN O
and CC O
muscle NN O
. . O

These DT O
tissue NN O
- HYPH O
specific JJ O
isoforms NNS O
are VBP O
characterized VBN O
for IN O
their PRP$ O
abilities NNS O
to TO O
regulate VB O
neural JJ O
cell NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
of IN O
a DT O
cassette NN O
exon NN O
, , O
N30 NNP O
, , O
in IN O
the DT O
non NN O
- HYPH O
muscle NN O
myosin NN O
heavy JJ O
chain NN O
II NNP O
- HYPH O
B NNP O
pre NNP O
- HYPH O
mRNA NNP O
, , O
previously RB O
shown VBN O
to TO O
be VB O
regulated VBN O
through IN O
an DT O
intronic JJ O
distal JJ O
downstream NN O
enhancer NN O
( : O
IDDE NNP O
) -RRB- O
. . O

All DT O
Fxh NNP O
and CC O
A2BP1 NNP O
isoforms NNS O
with IN O
the DT O
RRM NNP O
are VBP O
capable JJ O
of IN O
binding VBG O
to IN O
the DT O
IDDE NNP O
in IN O
vitro FW O
through IN O
the DT O
UGCAUG NNP O
elements NNS O
. . O

Each DT O
isoform NN O
, , O
however RB O
, , O
shows VBZ O
quantitative JJ O
differences NNS O
in IN O
splicing VBG O
activity NN O
and CC O
nuclear JJ O
distribution NN O
in IN O
transfected VBN O
cells NNS O
. . O

All DT O
Fxh NNP O
isoforms NNS O
and CC O
a DT O
brain NN O
isoform NN O
of IN O
A2BP1 NN O
show VBP O
a DT O
predominant JJ O
nuclear JJ O
localization NN O
. . O

Brain NN O
isoforms NNS O
of IN O
both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
promote VBP O
N30 NNP O
splicing VBG O
much RB O
more RBR O
efficiently RB O
than IN O
do VBP O
the DT O
muscle NN O
- HYPH O
specific JJ O
isoforms NNS O
. . O

Skeletal JJ O
muscles NNS O
express VBP O
additional JJ O
isoforms NNS O
that WDT O
lack VBP O
a DT O
part NN O
of IN O
the DT O
RRM NNP O
. . O

These DT O
isoforms NNS O
are VBP O
incapable JJ O
of IN O
activating VBG O
neural JJ O
cell NN O
- HYPH O
specific JJ O
splicing NN O
and CC O
, , O
moreover RB O
, , O
can MD O
inhibit VB O
UGCAUG NNP O
- HYPH O
dependent JJ O
N30 NNP O
splicing NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
tissue NN O
- HYPH O
specific JJ O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
play VBP O
an DT O
important JJ O
role NN O
in IN O
determining VBG O
tissue NN O
specificity NN O
of IN O
UGCAUG NNP O
- HYPH O
mediated VBN O
alternative JJ O
splicing NN O
. . O

INTRODUCTION NN O

Alternative JJ O
splicing NN O
of IN O
pre NN O
- HYPH O
mRNA NN O
is VBZ O
one CD O
of IN O
the DT O
fundamental JJ O
mechanisms NNS O
for IN O
the DT O
regulation NN O
of IN O
gene NN O
expression NN O
in IN O
higher JJR O
eukaryotes NNS O
( , O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Developmentally RB O
regulated VBN O
, , O
cell NN O
type NN O
- HYPH O
or CC O
tissue NN O
- HYPH O
specific JJ O
, , O
and CC O
signal NN O
- HYPH O
induced VBN O
alternative JJ O
splicing NN O
of IN O
pre NN O
- HYPH O
mRNAs NNS O
takes VBZ O
place NN O
in IN O
multicellular JJ O
organisms NNS O
throughout IN O
their PRP$ O
lifetimes NNS O
. . O

Misregulation NN O
or CC O
abnormalities NNS O
in IN O
pre JJ O
- HYPH O
mRNA NN O
splicing NN O
, , O
in IN O
some DT O
instances NNS O
, , O
leads VBZ O
to IN O
cellular JJ O
dysfunctions NNS O
found VBN O
in IN O
human JJ B-Species
and CC O
animal NN O
diseases NNS O
( , O
3 CD O
- SYM O
5 CD O
) -RRB- O
. . O

Using VBG O
various JJ O
model NN O
systems NNS O
of IN O
regulated VBN O
alternative JJ O
splicing NN O
, , O
a DT O
number NN O
of IN O
pre JJ O
- HYPH O
mRNA NN O
features NNS O
that WDT O
influence VBP O
alternative JJ O
splice NN O
site NN O
selection NN O
have VBP O
been VBN O
defined VBN O
( : O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

These DT O
include VBP O
enhancer NN O
and CC O
repressor NN O
RNA NNP O
sequences NNS O
located VBN O
in IN O
exons NNS O
and CC O
introns NNS O
. . O

Identification NN O
of IN O
RNA NN O
- HYPH O
binding VBG O
proteins NNS O
targeting VBG O
these DT O
cis NN O
- HYPH O
regulatory JJ O
elements NNS O
is VBZ O
currently RB O
in IN O
progress NN O
. . O

In IN O
vertebrates NNS O
, , O
participation NN O
of IN O
the DT O
SR NNP O
family NN O
proteins NNS O
and CC O
hnRNP NN O
proteins NNS O
, , O
such JJ O
as IN O
PTB NNP O
and CC O
hnRNPA1 NN O
, , O
in IN O
alternative JJ O
splicing NN O
regulation NN O
via IN O
binding VBG O
to IN O
the DT O
cis NN O
- HYPH O
regulatory JJ O
elements NNS O
have VBP O
been VBN O
shown VBN O
in IN O
many JJ O
tissue NN O
- HYPH O
specific JJ O
splicing VBG O
models NNS O
( , O
6 CD O
, , O
7 CD O
) -RRB- O
. . O

Although IN O
these DT O
RNA NN O
- HYPH O
binding VBG O
proteins NNS O
are VBP O
ubiquitously RB O
expressed VBN O
, , O
their PRP$ O
different JJ O
abundance NN O
in IN O
different JJ O
cells NNS O
, , O
differences NNS O
in IN O
their PRP$ O
post NN O
- HYPH O
translational JJ O
modifications NNS O
in IN O
different JJ O
cellular JJ O
contexts NNS O
and CC O
their PRP$ O
different JJ O
abilities NNS O
to TO O
assemble VB O
multiprotein NN O
complexes NNS O
in IN O
different JJ O
pre JJ O
- HYPH O
mRNA NN O
contexts NNS O
are VBP O
thought VBN O
to TO O
contribute VB O
to IN O
the DT O
determination NN O
of IN O
cell NN O
type NN O
- HYPH O
specific JJ O
patterns NNS O
of IN O
alternative JJ O
splicing NN O
. . O

For IN O
the DT O
last JJ O
few JJ O
years NNS O
, , O
tissue NN O
- HYPH O
specific JJ O
and CC O
tissue NN O
- HYPH O
enriched VBN O
RNA NNP O
- HYPH O
binding VBG O
proteins NNS O
have VBP O
begun VBN O
to TO O
be VB O
identified VBN O
as IN O
splicing VBG O
regulators NNS O
. . O

These DT O
include VBP O
brain NN O
- HYPH O
specific JJ O
( , O
or CC O
enriched VBN O
) , O
Nova NNP O
- HYPH O
1 CD O
, , O
nPTB NNP O
( , O
brPTB NNP O
) -RRB- O
and CC O
some DT O
of IN O
the DT O
CELF NNP O
family NN O
proteins NNS O
( , O
8 CD O
- HYPH O
12 CD O
) -RRB- O
. . O

Discovery NN O
of IN O
these DT O
proteins NNS O
has VBZ O
had VBN O
a DT O
great JJ O
impact NN O
on IN O
studies NNS O
aimed VBN O
at IN O
understanding VBG O
the DT O
molecular JJ O
mechanisms NNS O
of IN O
alternative JJ O
splicing NN O
regulation NN O
. . O

One CD O
of IN O
the DT O
intronic JJ O
cis NN O
- HYPH O
elements NNS O
, , O
which WDT O
are VBP O
involved VBN O
in IN O
tissue NN O
- HYPH O
specific JJ O
or CC O
differentiation NN O
stage NN O
- HYPH O
dependent JJ O
regulation NN O
of IN O
alternative JJ O
splicing NN O
, , O
is VBZ O
the DT O
hexanucleotide NN O
UGCAUG NNP O
. . O

The DT O
importance NN O
of IN O
this DT O
element NN O
was VBD O
originally RB O
recognized VBN O
in IN O
fibronectin NNP O
pre NN O
- HYPH O
mRNA NNP O
by IN O
Huh NNP O
and CC O
Hynes NNP O
( HYPH O
13 CD O
) -RRB- O
. . O

Since IN O
then RB O
, , O
alternative JJ O
splicing NN O
specific JJ O
to IN O
a DT O
variety NN O
of IN O
tissues NNS O
or CC O
cell NN O
types NNS O
, , O
including VBG O
neural JJ O
cells NNS O
, , O
muscles NNS O
, , O
epithelial JJ O
cells NNS O
and CC O
erythrocytes NNS O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
modulated VBN O
via IN O
this DT O
element NN O
( : O
14 CD O
- HYPH O
21 CD O
) -RRB- O
. . O

Recently RB O
, , O
Jin NNP O
et FW O
al NNP O
. . O

( : O
21 CD O
) , O
discovered VBD O
that IN O
a DT O
zebrafish JJ B-Species
homolog NN O
of IN O
Caenorhabditis NNP B-Species
elegans FW I-Species
Fox NNP O
- HYPH O
1 CD O
( SYM O
22 CD O
) -RRB- O
could MD O
bind VB O
specifically RB O
to IN O
the DT O
pentanucleotide NN O
GCAUG NN O
by IN O
in FW O
vitro FW O
selection NN O
from IN O
randomized JJ O
RNA NNP O
sequences NNS O
. . O

This DT O
pentanucleotide NN O
is VBZ O
almost RB O
identical JJ O
to IN O
the DT O
hexanucleotide NN O
UGCAUG NNP O
except IN O
for IN O
the DT O
first JJ O
U NN O
. . O

Moreover RB O
, , O
the DT O
zebrafish JJ B-Species
Fox NNP O
- HYPH O
1 CD O
homolog NN O
, , O
as RB O
well RB O
as IN O
the DT O
mouse NN B-Species
Fox NNP O
- HYPH O
1 CD O
homolog NN O
, , O
are VBP O
capable JJ O
of IN O
repressing VBG O
the DT O
inclusion NN O
of IN O
an DT O
alternative JJ O
cassette NN O
exon NN O
of IN O
the DT O
ATP NNP O
synthase NN O
F1 NN O
gamma NN O
pre NN O
- HYPH O
mRNA NN O
via IN O
binding NN O
to IN O
GCAUG NNP O
, , O
which WDT O
mimics VBZ O
muscle NN O
- HYPH O
specific JJ O
exclusion NN O
of IN O
this DT O
exon NN O
. . O

This DT O
mouse NN B-Species
homolog NN O
is VBZ O
identical JJ O
to IN O
the DT O
ataxin NN O
- HYPH O
2 CD O
binding VBG O
protein NN O
1 CD O
( SYM O
A2BP1 NN O
) -RRB- O
, , O
which WDT O
has VBZ O
been VBN O
previously RB O
cloned VBN O
in IN O
humans NNS B-Species
and CC O
mice NNS B-Species
as IN O
the DT O
cDNA NN O
encoding VBG O
a DT O
protein NN O
, , O
which WDT O
interacts VBZ O
with IN O
ataxin NN O
- HYPH O
2 CD O
, , O
the DT O
product NN O
of IN O
the DT O
causative JJ O
gene NN O
for IN O
spinocerebellar NN O
ataxia NN O
type NN O
2 CD O
( SYM O
23 CD O
, , O
24 CD O
) -RRB- O
. . O

In IN O
addition NN O
to IN O
A2BP1 NNP O
/ SYM O
Fox NNP O
- HYPH O
1 CD O
, , O
another DT O
mouse NN B-Species
homolog NN O
of IN O
C NNP B-Species
. . I-Species
elegans NNP I-Species
Fox NNP O
- HYPH O
1 CD O
, , O
Fxh NNP O
, , O
has VBZ O
been VBN O
independently RB O
cloned VBN O
as IN O
a DT O
cDNA NN O
, , O
which WDT O
is VBZ O
induced VBN O
by IN O
androgen NN O
in IN O
motor NN O
neurons NNS O
( SYM O
25 CD O
) -RRB- O
. . O

Of IN O
note NN O
is VBZ O
that IN O
A2BP1 NNP O
/ SYM O
Fox NNP O
- HYPH O
1 CD O
and CC O
Fxh NNP O
share VBP O
an DT O
identical JJ O
RNA NNP O
recognition NN O
motif NN O
( -LRB- O
RRM NNP O
) -RRB- O
at IN O
the DT O
amino NN O
acid NN O
level NN O
. . O

Therefore RB O
, , O
two CD O
genes NNS O
in IN O
the DT O
mouse NN B-Species
genome NN O
encode VBP O
homologs NNS O
of IN O
nematode NN O
Fox NNP O
- HYPH O
1 CD O
. . O

According VBG O
to IN O
the DT O
names NNS O
given VBN O
by IN O
the DT O
first JJ O
cDNA NNP O
cloning NN O
, , O
we PRP O
used VBD O
the DT O
nomenclature NN O
of IN O
A2BP1 NNP O
and CC O
Fxh NNP O
in IN O
this DT O
report NN O
. . O

A2BP1 NNP O
and CC O
Fxh NNP O
have VBP O
been VBN O
named VBN O
A2BP1 NNP O
and CC O
Rbm9 NNP O
, , O
respectively RB O
, , O
in IN O
the DT O
human JJ B-Species
and CC O
mouse NN B-Species
genomes NNS O
. . O

We PRP O
have VBP O
been VBN O
studying VBG O
regulatory JJ O
mechanisms NNS O
of IN O
neural JJ O
cell NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
using VBG O
the DT O
non AFX O
- HYPH O
muscle NN O
myosin NN O
heavy JJ O
chain NN O
II NNP O
- HYPH O
B NNP O
( -LRB- O
NMHC NNP O
- HYPH O
B NNP O
) -RRB- O
gene NN O
as IN O
a DT O
model NN O
system NN O
( : O
14 CD O
, , O
26 CD O
) -RRB- O
. . O

NMHC NNP O
- HYPH O
B NNP O
mRNA NNP O
is VBZ O
expressed VBN O
ubiquitously RB O
. . O

However RB O
, , O
an DT O
alternative JJ O
exon NN O
, , O
N30 NNP O
, , O
which WDT O
encodes VBZ O
a DT O
30 CD O
nt NN O
coding VBG O
sequence NN O
, , O
is VBZ O
included VBN O
in IN O
the DT O
mRNAs NNS O
from IN O
some DT O
neural JJ O
cells NNS O
, , O
but CC O
is VBZ O
skipped VBN O
in IN O
those DT O
from IN O
all DT O
other JJ O
cells NNS O
in IN O
mammals NNS O
and CC O
birds NNS O
( : O
27 CD O
, , O
28 CD O
) -RRB- O
. . O

In IN O
cultured JJ O
cells NNS O
, , O
a DT O
switch NN O
in IN O
N30 NNP O
splicing NN O
from IN O
exclusion NN O
to IN O
inclusion NN O
can MD O
be VB O
seen VBN O
in IN O
neural JJ O
retinoblastoma NN O
Y79 NNP O
cells NNS O
during IN O
the DT O
post NN O
- HYPH O
mitotic JJ O
and CC O
differentiated JJ O
stages NNS O
triggered VBN O
by IN O
butyrate NN O
treatment NN O
. . O

We PRP O
have VBP O
previously RB O
defined VBN O
an DT O
intronic JJ O
distal JJ O
downstream NN O
enhancer NN O
( , O
IDDE NNP O
) -RRB- O
, , O
which WDT O
confers VBZ O
neural JJ O
cell NN O
specificity NN O
on IN O
N30 NNP O
inclusion NN O
, , O
using VBG O
this DT O
cell NN O
line NN O
( : O
14 CD O
) -RRB- O
. . O

The DT O
IDDE NNP O
includes VBZ O
two CD O
copies NNS O
of IN O
UGCAUG NNP O
. . O

Mutation NN O
of IN O
these DT O
hexanucleotides NNS O
results VBZ O
in IN O
N30 NNP O
skipping VBG O
in IN O
post NN O
- HYPH O
mitotic NN O
differentiated VBN O
Y79 NNP O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
possible JJ O
involvement NN O
of IN O
A2BP1 NNP O
and CC O
Fxh NNP O
in IN O
the DT O
regulation NN O
of IN O
N30 NN O
splicing NN O
. . O

To IN O
this DT O
end NN O
, , O
we PRP O
have VBP O
isolated VBN O
cDNA NNP O
clones NNS O
for IN O
A2BP1 NNP O
and CC O
Fxh NNP O
from IN O
brain NN O
and CC O
muscles NNS O
. . O

cDNA NNP O
cloning NN O
revealed VBD O
the DT O
existence NN O
of IN O
tissue NN O
- HYPH O
specific JJ O
( HYPH O
enriched VBN O
) -RRB- O
isoforms NNS O
of IN O
both CC O
A2BP1 NNP O
and CC O
Fxh NNP O
. . O

Of IN O
importance NN O
, , O
different JJ O
isoforms NNS O
of IN O
A2BP1 NNP O
and CC O
Fxh NNP O
show VBP O
different JJ O
activities NNS O
with IN O
respect NN O
to IN O
N30 NNP O
splicing NN O
as RB O
well RB O
as IN O
different JJ O
subcellular JJ O
localizations NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Database NN O
disposition NN O

The DT O
sequences NNS O
reported VBN O
in IN O
this DT O
paper NN O
have VBP O
been VBN O
deposited VBN O
in IN O
the DT O
GenBank NNP O
database NN O
with IN O
accession NN O
numbers NNS O
AY659951 CD O
( SYM O
F011 CD O
) -RRB- O
, , O
AY659952 NNP O
( -LRB- O
F411 CD O
) -RRB- O
, , O
AY659953 NNP O
( SYM O
F402 CD O
) -RRB- O
, , O
AY659954 NNP O
( SYM O
A016 CD O
) -RRB- O
, , O
AY659955 NNP O
( SYM O
A030 CD O
) -RRB- O
, , O
AY659956 CD O
( SYM O
A713 CD O
) -RRB- O
, , O
AY659957 CD O
( SYM O
A715 CD O
) -RRB- O
and CC O
AY659958 CD O
( SYM O
A704 CD O
) -RRB- O
. . O

RNA NNP O
preparation NN O
and CC O
RT NNP O
- HYPH O
PCR NNP O

Total JJ O
RNAs NNS O
were VBD O
isolated VBN O
from IN O
mouse NN B-Species
tissues NNS O
and CC O
cultured VBN O
cells NNS O
using VBG O
an DT O
RNA NNP O
isolation NN O
kit NN O
( , O
Stratagene NNP O
) , O
or CC O
an DT O
RNeasy JJ O
mini NN O
kit NN O
( , O
Qiagen NNP O
) -RRB- O
. . O

To TO O
obtain VB O
the DT O
full JJ O
- HYPH O
length NN O
coding VBG O
regions NNS O
of IN O
cDNAs NNS O
for IN O
Fxh NNP O
and CC O
A2BP1 NNP O
, , O
RT NNP O
- HYPH O
PCRs NNPS O
were VBD O
performed VBN O
using VBG O
Superscript NNP O
II NNP O
RNase NNP O
H NNP O
- HYPH O
reverse JJ O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
Pfu NNP O
Turbo NNP O
DNA NNP O
polymerase NN O
( -LRB- O
Stratagene NNP O
) -RRB- O
. . O

The DT O
PCR NNP O
primers NNS O
used VBD O
to TO O
obtain VB O
all DT O
Fxh NNP O
cDNAs NNS O
were VBD O
5 CD O
' '' O
- HYPH O
ctcaggcctccactagttAT NNP O
- HYPH O
3 CD O
' '' O
and CC O
5 CD O
' '' O
- HYPH O
ctcaggcctcctctagaaGT NN O
- HYPH O
3 CD O
' '' O
. . O

The DT O
upstream JJ O
primers NNS O
for IN O
the DT O
brain NN O
( , O
A016 CD O
and CC O
A030 CD O
) -RRB- O
and CC O
muscle NN O
( -LRB- O
A713 CD O
, , O
A715 CD O
and CC O
A704 CD O
) -RRB- O
A2BP1 NN O
cDNAs NNS O
were VBD O
5 CD O
' '' O
- HYPH O
ctcaggcctccactagtgAT NN O
- HYPH O
3 CD O
' '' O
and CC O
5 CD O
' '' O
- HYPH O
ctcaggcctccactagtcAT NN O
- HYPH O
3 CD O
' '' O
, , O
respectively RB O
, , O
and CC O
the DT O
downstream JJ O
primer NN O
for IN O
all DT O
A2BP1 NN O
cDNAs NNS O
was VBD O
5 CD O
' '' O
- HYPH O
ctcaggcctcctctagagAT NN O
- HYPH O
3 CD O
' '' O
. . O

Lower JJR O
case NN O
letters NNS O
represent VBP O
adapter NN O
sequences NNS O
including VBG O
restriction NN O
enzyme NN O
sites NNS O
. . O

5 CD O
' '' O
Rapid JJ O
amplification NN O
of IN O
cDNA NNP O
ends VBZ O
( : O
RACE NNP O
) -RRB- O
was VBD O
performed VBN O
using VBG O
Marathon NNP O
- HYPH O
Ready NNP O
cDNA NNP O
( , O
BD NNP O
Biosciences NNP O
Clontech NNP O
) -RRB- O
. . O

For IN O
the DT O
analysis NN O
of IN O
minigene NN O
and CC O
NMHC NNP O
- HYPH O
B NNP O
mRNAs NNP O
, , O
RT NNP O
- HYPH O
PCRs NNPS O
were VBD O
performed VBN O
as IN O
described VBN O
previously RB O
( , O
14 CD O
, , O
26 CD O
) -RRB- O
. . O

Sequences NNS O
of IN O
primers NNS O
P1 NN O
- HYPH O
P9 NN O
shown VBN O
in IN O
Figures NNS O
1 CD O
, , O
4 CD O
and CC O
6 CD O
are VBP O
as IN O
follows VBZ O
: : O
P1 CD O
, , O
5 CD O
' '' O
- HYPH O
AATTCACCCAGCAACCAGAA NNP O
- HYPH O
3 CD O
' '' O
; : O
P2 CD O
, , O
5 CD O
' '' O
- HYPH O
TAGAGGGATGTAAGTGTTGA NNP O
- HYPH O
3 CD O
' '' O
; : O
P3 NNP O
, , O
5 CD O
' '' O
- HYPH O
CAGAGGGCGGACAGTGTATG NNP O
- HYPH O
3 CD O
' '' O
; : O
P4 NNP O
, , O
5 CD O
' '' O
- HYPH O
GGCGGCAGGGGCGAGGGCAT NNP O
- HYPH O
3 CD O
' '' O
; : O
P5 CD O
, , O
5 CD O
' '' O
- HYPH O
CCGTGGTCGCACCGTGTACA NNP O
- HYPH O
3 CD O
' '' O
; : O
P6 CD O
, , O
5 CD O
' '' O
- HYPH O
CAGCGGCAGTGGCAGGGGTG NNP O
- HYPH O
3 CD O
' '' O
; : O
P7 CD O
, , O
5 CD O
' '' O
- HYPH O
AGGAAGAAAGGACCATAATA NNP O
- HYPH O
3 CD O
' '' O
; : O
P8 CD O
, , O
5 CD O
' '' O
- HYPH O
CCTCCACCCAGCTCCAGTTG NNP O
- HYPH O
3 CD O
' '' O
; : O
and CC O
P9 CD O
, , O
5 CD O
' '' O
- HYPH O
CCTGTAGTTATTAAATCCTT NNP O
- HYPH O
3 CD O
' '' O
. . O

Preparation NN O
of IN O
expression NN O
constructs VBZ O
and CC O
minigenes NNS O

The DT O
cDNAs NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
were VBD O
introduced VBN O
into IN O
a DT O
plasmid JJ O
pCS3 NN O
+ SYM O
MT NNP O
, , O
which WDT O
contains VBZ O
a DT O
myc NN O
- HYPH O
epitope NN O
, , O
and CC O
its PRP$ O
modified VBN O
version NN O
pCS3 NN O
+ CC O
MT NNP O
+ SYM O
NLS NNP O
, , O
which WDT O
in IN O
addition NN O
contains VBZ O
the DT O
nuclear JJ O
localization NN O
signal NN O
( -LRB- O
NLS NNP O
) -RRB- O
of IN O
the DT O
SV40 NN B-Species
large JJ O
T NN O
antigen NN O
( SYM O
26 CD O
) -RRB- O
. . O

Minigenes NNP O
G NNP O
, , O
J NNP O
without IN O
the DT O
IDDE NNP O
, , O
and CC O
H NN O
with IN O
the DT O
wild JJ O
- HYPH O
type NN O
IDDE NN O
are VBP O
the DT O
same JJ O
as IN O
minigenes NNS O
W NNP O
, , O
D4 NNP O
and CC O
Cm0 NNP O
, , O
respectively RB O
in IN O
ref NN O
. . O

( : O
14 CD O
) -RRB- O
. . O

The DT O
201 CD O
nt NN O
IDDEs NNS O
with IN O
mutations NNS O
were VBD O
generated VBN O
by IN O
recombinant JJ O
PCR NN O
using VBG O
the DT O
appropriate JJ O
primers NNS O
, , O
which WDT O
included VBD O
mutated VBN O
sequences NNS O
. . O

The DT O
hexanucleotide NN O
TGCATG NNP O
sequences NNS O
at IN O
the DT O
5 CD O
' '' O
and CC O
3 CD O
' '' O
sides NNS O
were VBD O
changed VBN O
to IN O
GTTACT NNP O
and CC O
ACCTAC NNP O
, , O
respectively RB O
. . O

Electrophoresis NN O
mobility NN O
shift NN O
assay NN O

Template JJ O
DNAs NNS O
for IN O
in FW O
vitro FW O
RNA NNP O
transcription NN O
were VBD O
prepared VBN O
by IN O
PCR NNP O
using VBG O
the DT O
wild JJ O
- HYPH O
type NN O
and CC O
mutant JJ O
IDDEs NNS O
in IN O
the DT O
minigenes NNS O
as IN O
templates NNS O
and CC O
an DT O
upstream JJ O
primer NN O
that WDT O
included VBD O
the DT O
T7 NNP O
promoter NN O
sequence NN O
at IN O
the DT O
5 CD O
' '' O
end NN O
. . O

The DT O
probe NN O
and CC O
competitor NN O
RNAs NNS O
were VBD O
transcribed VBN O
by IN O
T7 NNP O
RNA NNP O
polymerase NN O
in IN O
the DT O
presence NN O
of IN O
[ -LRB- O
alpha NN O
- HYPH O
32P CD O
] -RRB- O
UTP NN O
and CC O
a DT O
trace NN O
amount NN O
of IN O
[ -LRB- O
35S NN O
] -RRB- O
UTP NNP O
alpha NN O
S NNP O
, , O
respectively RB O
, , O
using VBG O
a DT O
MAXIscript NNP O
kit NN O
( , O
Ambion NNP O
) -RRB- O
. . O

Mole JJ O
concentrations NNS O
of IN O
synthesized VBN O
RNAs NNS O
were VBD O
estimated VBN O
by IN O
radioactivities NNS O
. . O

Fxh NNP O
and CC O
A2BP1 NN O
proteins NNS O
with IN O
a DT O
myc NN O
tag NN O
were VBD O
synthesized VBN O
in IN O
vitro FW O
by IN O
using VBG O
a DT O
TNT NNP O
quick RB O
- HYPH O
coupled JJ O
transcription NN O
/ SYM O
translation NN O
system NN O
( -LRB- O
Promega NNP O
) -RRB- O
from IN O
pCS3 NNP O
+ SYM O
MT NNP O
constructs NNS O
, , O
which WDT O
include VBP O
the DT O
SP6 NNP O
promoter NN O
. . O

Binding VBG O
reactions NNS O
were VBD O
carried VBN O
out RP O
in IN O
a DT O
10 CD O
mu NN O
l NN O
mixture NN O
that WDT O
contains VBZ O
10 CD O
mM NN O
HEPES NNP O
( -LRB- O
pH NN O
7 CD O
. . O
9 CD O
) -RRB- O
, , O
2 CD O
mM NN O
MgCl2 NNP O
, , O
50 CD O
mM NN O
KCl NNP O
, , O
5 CD O
% NN O
glycerol NN O
, , O
0 CD O
. . O
5 CD O
mM NN O
DTT NN O
, , O
5 CD O
mu NN O
g NN O
tRNA NN O
, , O
1 CD O
mu NN O
l CC O
reticulocyte NN O
lysate NN O
reaction NN O
mixture NN O
and CC O
15 CD O
fmol NN O
of IN O
probe NN O
, , O
on IN O
ice NN O
for IN O
20 CD O
- SYM O
30 CD O
min NN O
. . O

An DT O
aliquot NN O
of IN O
5 CD O
mu NN O
g NN O
of IN O
heparin NN O
was VBD O
added VBN O
to IN O
the DT O
reaction NN O
10 CD O
min NN O
before IN O
gel NN O
electrophoresis NN O
. . O

The DT O
reaction NN O
mixtures NNS O
were VBD O
analyzed VBN O
by IN O
electrophoresis NN O
in IN O
a DT O
6 CD O
% NN O
polyacrylamide NN O
gel NN O
using VBG O
a DT O
0 CD O
. . O
5 CD O
x SYM O
TBE NN O
buffer NN O
( , O
Invitrogen NN O
) -RRB- O
. . O

Cell NN O
culture NN O
and CC O
transfection NN O

The DT O
human JJ B-Species
retinoblastoma NN O
cell NN O
line NN O
Y79 NNP O
was VBD O
cultured VBN O
and CC O
transfected VBN O
with IN O
DNAs NNS O
as IN O
described VBN O
previously RB O
( , O
14 CD O
, , O
26 CD O
) -RRB- O
. . O

Total JJ O
amounts NNS O
of IN O
transfected VBN O
DNAs NNS O
were VBD O
adjusted VBN O
to TO O
be VB O
constant JJ O
by IN O
addition NN O
of IN O
the DT O
empty JJ O
vector NN O
. . O

Either CC O
Lipofectin NNP O
( : O
Invitrogen NNP O
) , O
or CC O
Effectene NN O
transfection NN O
reagent NN O
( , O
Qiagen NNP O
) -RRB- O
was VBD O
used VBN O
for IN O
the DT O
transfection NN O
. . O

For IN O
stable JJ O
transfection NN O
, , O
the DT O
pCS3 NN O
+ SYM O
MT NNP O
expression NN O
constructs VBZ O
were VBD O
co NN O
- HYPH O
transfected VBN O
with IN O
a DT O
plasmid NN O
carrying VBG O
a DT O
neomycin NN O
resistant JJ O
gene NN O
and CC O
selected VBN O
by IN O
0 CD O
. . O
2 CD O
mM NN O
geneticin NN O
( : O
Invitrogen NNP O
) -RRB- O
. . O

For IN O
differentiation NN O
of IN O
Y79 NNP O
cells NNS O
, , O
cells NNS O
were VBD O
plated VBN O
on IN O
the DT O
poly NN O
- HYPH O
d NN O
- HYPH O
lysine NN O
- HYPH O
coated VBN O
plates NNS O
and CC O
then RB O
treated VBN O
with IN O
2 CD O
. . O
0 CD O
- SYM O
2 CD O
. . O
5 CD O
mM NN O
sodium NN O
butyrate NN O
for IN O
4 CD O
- SYM O
5 CD O
days NNS O
. . O

HeLa NNP O
cells NNS O
were VBD O
cultured VBN O
as IN O
described VBN O
and CC O
transfected VBN O
with IN O
DNA NNP O
using VBG O
Effectene NNP O
reagent NN O
( , O
14 CD O
, , O
26 CD O
) -RRB- O
. . O

Immunoblot NNP O
analysis NN O

Samples NNS O
that WDT O
required VBD O
both CC O
protein NN O
and CC O
mRNA NN O
analysis NN O
were VBD O
split VBN O
upon IN O
harvesting NN O
. . O

Total JJ O
cell NN O
proteins NNS O
were VBD O
subjected VBN O
to IN O
SDS NNP O
- HYPH O
PAGE NN O
and CC O
blotted VBN O
as IN O
described VBN O
previously RB O
( : O
26 CD O
) -RRB- O
. . O

The DT O
primary JJ O
antibodies NNS O
used VBN O
are VBP O
monoclonal JJ O
antibodies NNS O
to IN O
a DT O
myc NN O
- HYPH O
epitope NN O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
green JJ O
fluorescent NN O
protein NN O
( -LRB- O
GFP NNP O
) -RRB- O
( , O
Clontech NNP O
) -RRB- O
. . O

Binding VBG O
of IN O
antibodies NNS O
was VBD O
detected VBN O
with IN O
the DT O
SuperSignal NNP O
System NNP O
( -LRB- O
Pierce NNP O
) -RRB- O
or CC O
ECL NNP O
( : O
Amersham NNP O
) -RRB- O
. . O

Immunofluorescent JJ O
microscopy NN O

HeLa NNP O
or CC O
Y79 CD O
cells NNS O
grown VBN O
in IN O
a DT O
four CD O
- HYPH O
chamber NN O
glass NN O
slide NN O
were VBD O
transfected VBN O
as IN O
described VBN O
above RB O
. . O

Cells NNS O
were VBD O
fixed VBN O
with IN O
10 CD O
% NN O
formaldehyde NN O
24 CD O
- SYM O
48 CD O
h NN O
after IN O
transfection NN O
, , O
and CC O
permealized VBN O
with IN O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
then RB O
blocked VBN O
with IN O
5 CD O
% NN O
goat NN B-Species
serum NN O
. . O

Primary JJ O
antibodies NNS O
used VBN O
were VBD O
mouse NN B-Species
anti AFX O
- HYPH O
myc NN O
( , O
Invitrogen NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti AFX O
- HYPH O
NMHC NNP O
- HYPH O
B NN O
( SYM O
29 CD O
) -RRB- O
. . O

Secondary JJ O
antibodies NNS O
were VBD O
Alexa NNP O
Fluor NNP O
594 CD O
goat NN B-Species
anti JJ O
- HYPH O
mouse NN B-Species
IgG NNP O
and CC O
Alexa NNP O
Fluor NNP O
488 CD O
goat JJ B-Species
anti JJ O
- HYPH O
rabbit NN B-Species
IgG NNP O
( -LRB- O
Molecular NNP O
Probes NNPS O
) -RRB- O
. . O

DAPI NNP O
was VBD O
used VBN O
for IN O
DNA NN O
staining VBG O
. . O

Specimens NNS O
were VBD O
mounted VBN O
in IN O
ProLong NNP O
antifed JJ O
kit NN O
( , O
Molecular NNP O
Probe NNP O
) -RRB- O
. . O

The DT O
images NNS O
were VBD O
collected VBN O
using VBG O
Leica NNP O
SP NNP O
confocal JJ O
microscopy NN O
( : O
Leica NNP O
) -RRB- O
. . O

RESULTS NNS O

Tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
and CC O
their PRP$ O
subcellular JJ O
distribution NN O

The DT O
A2BP1 NNP O
mRNAs NNS O
are VBP O
detected VBN O
almost RB O
exclusively RB O
in IN O
brain NN O
and CC O
striated VBN O
muscles NNS O
( , O
heart NN O
and CC O
skeletal JJ O
muscles NNS O
) , O
in IN O
adult NN O
mice NNS B-Species
, , O
whereas IN O
the DT O
Fxh NNP O
mRNAs NNS O
are VBP O
expressed VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
tissues NNS O
with IN O
the DT O
highest JJS O
expression NN O
in IN O
brain NN O
and CC O
heart NN O
[ -LRB- O
( , O
21 CD O
, , O
25 CD O
) -RRB- O
and CC O
S NNP O
. . O
Kawamoto NNP O
, , O
unpublished JJ O
data NNS O
] -RRB- O
. . O

These DT O
expression NN O
profiles NNS O
prompted VBD O
us PRP O
to TO O
characterize VB O
the DT O
mRNAs NNS O
of IN O
A2BP1 NNP O
and CC O
Fxh NNP O
in IN O
brain NN O
and CC O
muscles NNS O
. . O

We PRP O
have VBP O
cloned VBN O
cDNAs NNS O
for IN O
two CD O
gene NN O
transcripts NNS O
from IN O
brain NN O
, , O
heart NN O
and CC O
skeletal JJ O
muscles NNS O
by IN O
RT NNP O
- HYPH O
PCR NNP O
and CC O
5 CD O
' '' O
RACE NN O
. . O

The DT O
isolated VBN O
cDNAs NNS O
are VBP O
schematically RB O
presented VBN O
with IN O
genomic JJ O
structures NNS O
in IN O
Figure NNP O
1 CD O
( , O
for IN O
amino NN O
acid NN O
sequences NNS O
see VBP O
also RB O
Figure NNP O
8 CD O
) -RRB- O
. . O

Both DT O
gene NN O
transcripts NNS O
are VBP O
found VBN O
to TO O
undergo VB O
tissue NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
. . O

In IN O
both DT O
cases NNS O
, , O
brain NN O
and CC O
striated VBN O
muscles NNS O
express VBP O
unique JJ O
splice NN O
variants NNS O
generated VBN O
by IN O
mutually RB O
exclusive JJ O
splicing NN O
of IN O
exons NNS O
B40 NNP O
and CC O
M43 NNP O
, , O
respectively RB O
, , O
which WDT O
provide VBP O
different JJ O
coding VBG O
sequences NNS O
in IN O
the DT O
middle NN O
of IN O
the DT O
carboxyl NN O
half NN O
of IN O
the DT O
molecules NNS O
. . O

Southern JJ O
blot NN O
analysis NN O
of IN O
the DT O
RT NNP O
- HYPH O
PCR NNP O
products NNS O
of IN O
the DT O
Fxh NNP O
mRNAs NNP O
from IN O
the DT O
different JJ O
tissues NNS O
probed VBN O
by IN O
oligonucleotides NNS O
corresponding VBG O
to IN O
B40 NNP O
and CC O
M43 NNP O
shows VBZ O
that IN O
M43 NNP O
is VBZ O
exclusively RB O
used VBN O
in IN O
heart NN O
and CC O
skeletal JJ O
muscles NNS O
, , O
while IN O
B40 NN O
is VBZ O
predominantly RB O
used VBN O
in IN O
brain NN O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

Digestion NN O
of IN O
the DT O
RT NNP O
- HYPH O
PCR NNP O
products NNS O
of IN O
the DT O
A2BP1 NNP O
mRNAs NNS O
with IN O
restriction NN O
enzymes NNS O
unique JJ O
to IN O
B40 NNP O
and CC O
M43 NNP O
demonstrates VBZ O
that IN O
B40 NN O
and CC O
M43 NNP O
are VBP O
used VBN O
almost RB O
exclusively RB O
in IN O
brain NN O
and CC O
muscles NNS O
, , O
respectively RB O
( : O
Figure NNP O
2B NNP O
) -RRB- O
. . O

A2BP1 NNP O
contains VBZ O
an DT O
additional JJ O
cassette NN O
type NN O
alternative NN O
exon NN O
A53 NNP O
, , O
consisting VBG O
of IN O
53 CD O
nt NN O
. . O

Inclusion NN O
and CC O
exclusion NN O
of IN O
exon NN O
A53 NN O
results VBZ O
in IN O
two CD O
different JJ O
amino NN O
acid NN O
sequences NNS O
at IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
region NN O
owing VBG O
to IN O
a DT O
frame NN O
shift NN O
. . O

In IN O
the DT O
case NN O
of IN O
the DT O
A2BP1 NN O
gene NN O
, , O
moreover RB O
, , O
it PRP O
appears VBZ O
that IN O
brain NN O
and CC O
striated VBN O
muscle NN O
utilize VBP O
alternative JJ O
promoters NNS O
, , O
resulting VBG O
in IN O
different JJ O
amino NN O
acid NN O
sequences NNS O
at IN O
the DT O
N NNP O
- HYPH O
terminus NN O
. . O

The DT O
5 CD O
' '' O
RACE NN O
of IN O
skeletal JJ O
muscle NN O
mRNAs NNS O
yielded VBD O
essentially RB O
a DT O
single JJ O
species NN O
of IN O
sequence NN O
with IN O
29 CD O
unique JJ O
N NNP O
- HYPH O
terminal JJ O
amino NN O
acids NNS O
. . O

The DT O
5 CD O
' '' O
RACE NN O
using VBG O
brain NN O
mRNAs NNS O
; : O
however RB O
, , O
yielded VBD O
multiple JJ O
products NNS O
with IN O
multiple JJ O
deduced VBN O
amino NN O
acid NN O
sequences NNS O
, , O
all DT O
of IN O
which WDT O
differ VBP O
from IN O
the DT O
muscle NN O
amino NN O
acid NN O
sequence NN O
at IN O
the DT O
very JJ O
N NNP O
- HYPH O
terminus NN O
. . O

Here RB O
, , O
we PRP O
focus VBP O
our PRP$ O
analysis NN O
on IN O
a DT O
clone NN O
containing VBG O
nine CD O
unique JJ O
amino NN O
acids NNS O
at IN O
the DT O
N NNP O
- HYPH O
terminus NN O
, , O
which WDT O
was VBD O
obtained VBN O
most RBS O
frequently RB O
. . O

Exon NNP O
- HYPH O
intron NN O
organization NN O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
shows VBZ O
remarkable JJ O
similarities NNS O
and CC O
a DT O
RRM NN O
is VBZ O
encoded VBN O
in IN O
four CD O
exons NNS O
( -LRB- O
Figure NNP O
1B NN O
) -RRB- O
. . O

Of IN O
note NN O
is VBZ O
that IN O
the DT O
significant JJ O
amounts NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NN O
mRNAs NNS O
from IN O
skeletal JJ O
muscles NNS O
are VBP O
missing VBG O
a DT O
part NN O
of IN O
the DT O
RRM NNP O
by IN O
exon NN O
skipping NN O
. . O

Typically RB O
, , O
as IN O
shown VBN O
in IN O
Figure NNP O
2C NNP O
, , O
they PRP O
lack VBP O
the DT O
93 CD O
nt NN O
exon NN O
that WDT O
encodes VBZ O
RNP1 NN O
, , O
one CD O
of IN O
the DT O
two CD O
most RBS O
critical JJ O
motifs NNS O
of IN O
the DT O
RRM NNP O
( SYM O
30 CD O
) -RRB- O
. . O

Some DT O
of IN O
them PRP O
lack VBP O
almost RB O
the DT O
entire JJ O
RRM NN O
( : O
e ADD O
. . O
g LS O
. . O
F402 CD O
in IN O
Figure NN O
1A NN O
) -RRB- O
. . O

To TO O
examine VB O
the DT O
subcellular JJ O
distribution NN O
of IN O
each DT O
isoform NN O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
, , O
myc NN O
- HYPH O
tagged VBN O
proteins NNS O
were VBD O
transiently RB O
expressed VBN O
in IN O
cultured JJ O
cells NNS O
and CC O
immunostained VBN O
with IN O
an DT O
anti AFX O
- HYPH O
myc NN O
antibody NN O
. . O

Initially RB O
, , O
HeLa NNP O
cells NNS O
were VBD O
used VBN O
to TO O
investigate VB O
subcellular JJ O
localization NN O
, , O
since IN O
these DT O
cells NNS O
are VBP O
more RBR O
suited JJ O
for IN O
these DT O
studies NNS O
. . O

Representative JJ O
confocal JJ O
images NNS O
are VBP O
shown VBN O
in IN O
Figure NNP O
3A NNP O
. . O

DAPI NNP O
and CC O
anti JJ O
- HYPH O
NMHC NNP O
- HYPH O
B NN O
antibodies NNS O
serve VBP O
as IN O
markers NNS O
for IN O
nuclei NNS O
and CC O
cytoplasm NN O
, , O
respectively RB O
. . O

As IN O
noted VBN O
, , O
the DT O
ratio NN O
of IN O
protein NN O
distributed VBN O
between IN O
nuclei NNS O
and CC O
cytoplasm NN O
differs VBZ O
among IN O
the DT O
proteins NNS O
. . O

All DT O
isoforms NNS O
of IN O
Fxh NNP O
have VBP O
a DT O
predominant JJ O
nuclear JJ O
localization NN O
. . O

The DT O
brain NN O
isoform NN O
of IN O
A2BP1 NNP O
without IN O
the DT O
A53 NNP O
exon NN O
( , O
A016 CD O
) -RRB- O
localizes VBZ O
to IN O
both CC O
nuclei NNS O
and CC O
cytoplasm NN O
, , O
whereas IN O
the DT O
other JJ O
brain NN O
isoform NN O
with IN O
the DT O
A53 NNP O
exon NN O
( , O
A030 CD O
) -RRB- O
localizes VBZ O
predominantly RB O
to IN O
cytoplasm NN O
with IN O
only RB O
a DT O
minimum NN O
being VBG O
in IN O
the DT O
nuclei NNS O
. . O

The DT O
relative JJ O
amounts NNS O
of IN O
both DT O
muscle NN O
isoforms NNS O
of IN O
A2BP1 NNP O
( SYM O
A713 CD O
and CC O
A715 CD O
) -RRB- O
are VBP O
somewhat RB O
between IN O
the DT O
amounts NNS O
of IN O
the DT O
two CD O
brain NN O
isoforms NNS O
. . O

These DT O
data NNS O
are VBP O
summarized VBN O
in IN O
Figure NNP O
1A CD O
. . O

The DT O
subcellular JJ O
distribution NN O
of IN O
representative JJ O
isoforms NNS O
( , O
F011 CD O
, , O
A016 CD O
and CC O
A030 CD O
) -RRB- O
was VBD O
also RB O
examined VBN O
in IN O
retinoblastoma NN O
Y79 CD O
cells NNS O
, , O
which WDT O
were VBD O
used VBN O
as IN O
host NN O
cells NNS O
for IN O
the DT O
transfection NN O
experiments NNS O
in IN O
order NN O
to TO O
characterize VB O
splicing VBG O
activities NNS O
of IN O
Fxh NNP O
and CC O
A2BP NN O
proteins NNS O
( , O
see VB O
below RB O
) -RRB- O
. . O

Although IN O
Y79 CD O
cells NNS O
have VBP O
a DT O
spherical JJ O
shape NN O
and CC O
have VBP O
only RB O
thin JJ O
cytoplasm NN O
, , O
exogenously RB O
expressed VBN O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
show VBP O
a DT O
similar JJ O
subcellular JJ O
distribution NN O
as IN O
in IN O
HeLa NNP O
cells NNS O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
. . O

F011 CD O
localizes VBZ O
predominantly RB O
to IN O
nuclei NNS O
, , O
A016 CD O
to IN O
both CC O
nuclei NNS O
and CC O
cytoplasm NN O
and CC O
A030 NN O
predominantly RB O
to IN O
cytoplasm NN O
. . O

Specific JJ O
interaction NN O
of IN O
Fxh NNP O
and CC O
A2BP1 NN O
with IN O
IDDE NNP O
via IN O
a DT O
hexanucleotide NN O
UGCAUG NNP O

Fxh NNP O
and CC O
A2BP1 NNP O
share VBP O
an DT O
identical JJ O
RRM NN O
and CC O
A2BP1 NNP O
has VBZ O
been VBN O
reported VBN O
to TO O
bind VB O
specifically RB O
to IN O
the DT O
pentanucleotide NN O
GCAUG NNP O
through IN O
this DT O
RRM NNP O
( SYM O
21 CD O
) -RRB- O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that IN O
the DT O
IDDE NNP O
of IN O
the DT O
NMHC NNP O
- HYPH O
B NNP O
transcript NN O
, , O
which WDT O
is VBZ O
indispensable JJ O
for IN O
the DT O
regulation NN O
of IN O
neural JJ O
cell NN O
- HYPH O
specific JJ O
cassette NN O
type NN O
exon NN O
N30 NNP O
splicing NN O
, , O
has VBZ O
two CD O
copies NNS O
of IN O
GCAUG NNP O
( : O
14 CD O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
investigated VBD O
whether IN O
Fxh NNP O
and CC O
/ SYM O
or CC O
A2BP1 NNP O
bound VBD O
to IN O
the DT O
IDDE NNP O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( -LRB- O
EMSAs NNP O
) -RRB- O
were VBD O
carried VBN O
out RP O
using VBG O
labeled VBN O
IDDE NN O
and CC O
in IN O
vitro FW O
transcribed VBN O
and CC O
translated VBN O
Fxh NNP O
and CC O
A2BP1 NNP O
, , O
which WDT O
include VBP O
a DT O
myc NN O
- HYPH O
epitope NN O
. . O

Since IN O
all DT O
Fxh NNP O
and CC O
A2BP1 NNP O
isoforms NNS O
, , O
except IN O
F402 NNP O
and CC O
A704 CD O
, , O
contain VBP O
the DT O
identical JJ O
RRM NN O
, , O
representative JJ O
isoforms NNS O
were VBD O
analyzed VBN O
. . O

The DT O
expression NN O
of IN O
F011 CD O
in IN O
reticulocyte NN O
lysate NN O
causes VBZ O
the DT O
formation NN O
of IN O
a DT O
RNA NN O
- HYPH O
protein NN O
complex NN O
whose WP$ O
migration NN O
shift NN O
distinguishes VBZ O
it PRP O
from IN O
those DT O
of IN O
the DT O
control NN O
reticulocyte NN O
lysate NN O
( , O
C NN O
in IN O
Figure NNP O
4B NNP O
, , O
lanes NNS O
3 CD O
and CC O
10 CD O
) -RRB- O
. . O

The DT O
unlabeled JJ O
wild JJ O
- HYPH O
type NN O
IDDE NNP O
competes VBZ O
with IN O
the DT O
probe NN O
efficiently RB O
for IN O
the DT O
formation NN O
of IN O
the DT O
specific JJ O
complex NN O
C NNP O
( -LRB- O
Figure NNP O
4B NNP O
, , O
lane NN O
4 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
mutant JJ O
mc NN O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
, , O
which WDT O
has VBZ O
a DT O
mutation NN O
in IN O
both DT O
copies NNS O
of IN O
UGCAUG NNP O
, , O
does VBZ O
not RB O
( -LRB- O
Figure NN O
4B NN O
, , O
lane NN O
7 CD O
) -RRB- O
. . O

The DT O
mutant JJ O
ma NN O
, , O
which WDT O
has VBZ O
a DT O
mutation NN O
in IN O
the DT O
hexanucleotide NN O
at IN O
the DT O
5 CD O
' '' O
side NN O
, , O
shows VBZ O
less RBR O
efficient JJ O
competition NN O
, , O
compared VBN O
with IN O
mb NN O
, , O
which WDT O
has VBZ O
a DT O
mutation NN O
in IN O
the DT O
3 CD O
' '' O
side NN O
of IN O
the DT O
hexanucleotide NN O
( -LRB- O
Figure NNP O
4B NNP O
, , O
lanes NNS O
5 CD O
and CC O
6 CD O
) -RRB- O
, , O
indicating VBG O
that IN O
the DT O
nucleotides NNS O
at IN O
the DT O
5 CD O
' '' O
side NN O
are VBP O
more RBR O
important JJ O
than IN O
those DT O
at IN O
the DT O
3 CD O
' '' O
side NN O
. . O

The DT O
presence NN O
of IN O
an DT O
anti AFX O
- HYPH O
myc NN O
antibody NN O
, , O
but CC O
not RB O
a DT O
non NN O
- HYPH O
specific JJ O
antibody NN O
, , O
inhibits VBZ O
the DT O
formation NN O
of IN O
the DT O
specific JJ O
complex NN O
( -LRB- O
Figure NNP O
4B NNP O
, , O
lane NN O
8 CD O
) -RRB- O
. . O

Synthesis NN O
of IN O
the DT O
full JJ O
- HYPH O
length NN O
F011 CD O
protein NN O
using VBG O
a DT O
reticulocyte NN O
lysate NN O
and CC O
specificity NN O
of IN O
the DT O
myc NN O
antibody NN O
for IN O
the DT O
expressed VBN O
protein NN O
are VBP O
verified VBN O
by IN O
immunoblot NN O
analysis NN O
( -LRB- O
Figure NNP O
4B NNP O
, , O
lanes NNS O
11 CD O
and CC O
12 CD O
) -RRB- O
. . O

A016 CD O
and CC O
A030 NN O
show VBP O
essentially RB O
identical JJ O
results NNS O
to IN O
those DT O
with IN O
F011 CD O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
Fxh NNP O
and CC O
A2BP1 NNP O
can MD O
bind VB O
to IN O
the DT O
IDDE NNP O
and CC O
that IN O
the DT O
hexanucleotide NN O
UGCAUG NNP O
is VBZ O
required VBN O
for IN O
their PRP$ O
binding NN O
. . O

Fxh NNP O
and CC O
A2BP1 NN O
enhance VBP O
N30 NNP O
inclusion NN O
in IN O
a DT O
UGCAUG NNP O
- HYPH O
dependent JJ O
manner NN O

To TO O
study VB O
whether IN O
Fxh NNP O
and CC O
A2BP1 NNP O
regulate VBP O
neural JJ O
cell NN O
- HYPH O
specific JJ O
splicing NN O
via IN O
binding NN O
to IN O
UGCAUG NNP O
, , O
the DT O
Fxh NNP O
and CC O
A2BP1 NNP O
expression NN O
constructs NNS O
were VBD O
co NN O
- HYPH O
transfected VBN O
into IN O
retinoblastoma NN O
Y79 NNP O
cells NNS O
with IN O
a DT O
number NN O
of IN O
the DT O
reporter NN O
minigene NN O
constructs NNS O
, , O
which WDT O
include VBP O
the DT O
wild JJ O
- HYPH O
type NN O
or CC O
a DT O
mutant JJ O
version NN O
of IN O
UGCAUG NNP O
in IN O
the DT O
IDDE NNP O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

Minigenes NNP O
H NNP O
and CC O
J NN O
consist VBP O
of IN O
the DT O
exons NNS O
E5 NNP O
, , O
N30 NNP O
and CC O
E6 NNP O
and CC O
their PRP$ O
flanking VBG O
introns NNS O
with IN O
some DT O
deletions NNS O
in IN O
the DT O
introns NNS O
. . O

The DT O
IDDE NNP O
with IN O
or CC O
without IN O
mutations NNS O
in IN O
the DT O
hexanucleotide NN O
is VBZ O
included VBN O
or CC O
excluded VBN O
between IN O
N30 NNP O
and CC O
E6 NNP O
. . O

As IN O
described VBN O
above RB O
, , O
each DT O
isoform NN O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
enters VBZ O
the DT O
nucleus NN O
to IN O
a DT O
different JJ O
extent NN O
. . O

To TO O
see VB O
the DT O
effects NNS O
of IN O
different JJ O
proteins NNS O
on IN O
N30 NNP O
splicing NN O
itself PRP O
, , O
independent JJ O
of IN O
their PRP$ O
differential JJ O
properties NNS O
in IN O
nuclear JJ O
localization NN O
, , O
an DT O
exogenous JJ O
NLS NNP O
was VBD O
added VBN O
to IN O
the DT O
expressed VBN O
proteins NNS O
. . O

Since IN O
Fxh NNP O
and CC O
A2BP1 NNP O
proteins NNS O
contain VBP O
the DT O
identical JJ O
RRM NNP O
, , O
and CC O
F011 NNP O
, , O
A016 NNP O
and CC O
A030 NNP O
all DT O
show VBP O
the DT O
same JJ O
UGCAUG NNP O
- HYPH O
dependent JJ O
binding NN O
to IN O
the DT O
IDDE NNP O
in IN O
vitro FW O
, , O
F011 CD O
and CC O
A030 CD O
were VBD O
used VBN O
for IN O
these DT O
experiments NNS O
. . O

Host NN O
cells NNS O
Y79 CD O
at IN O
the DT O
proliferating VBG O
stage NN O
exclude VBP O
the DT O
N30 CD O
exon NN O
in IN O
~ $ O
90 CD O
% NN O
of IN O
the DT O
endogenous JJ O
NMHC NNP O
- HYPH O
B NN O
mRNAs NNS O
( : O
e LS O
. . O
g LS O
. . O
see VB O
Figure NNP O
6A NN O
, , O
lane NN O
1 CD O
) -RRB- O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4C NNP O
, , O
the DT O
mRNAs NNS O
derived VBN O
from IN O
minigene NN O
J NNP O
exclude VBP O
N30 NNP O
without IN O
exogenous JJ O
expression NN O
of IN O
Fxh NNP O
or CC O
A2BP1 NN O
in IN O
Y79 CD O
cells NNS O
, , O
similar JJ O
to IN O
the DT O
endogenous JJ O
NMHC NNP O
- HYPH O
B NNP O
mRNAs NNP O
( -LRB- O
Figure NNP O
4C NNP O
, , O
upper JJ O
panel NN O
, , O
lanes NNS O
1 CD O
- HYPH O
5 CD O
) -RRB- O
. . O

However RB O
, , O
in IN O
the DT O
presence NN O
of IN O
exogenous JJ O
expression NN O
of IN O
F011 NNP O
and CC O
A030 CD O
, , O
the DT O
N30 NNP O
inclusion NN O
is VBZ O
increased VBN O
( -LRB- O
Figure NNP O
4C NNP O
, , O
upper JJ O
panel NN O
, , O
lanes NNS O
7 CD O
and CC O
12 CD O
) -RRB- O
. . O

The DT O
N30 NNP O
inclusion NN O
is VBZ O
absolutely RB O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
the DT O
IDDE NNP O
( -LRB- O
Figure NNP O
4C NNP O
, , O
upper JJ O
panel NN O
, , O
lanes NNS O
6 CD O
and CC O
11 CD O
) -RRB- O
. . O

Moreover RB O
, , O
mutation NN O
of IN O
either DT O
one CD O
of IN O
the DT O
two CD O
copies NNS O
of IN O
UGCAUG NNP O
( : O
ma FW O
, , O
mb UH O
) -RRB- O
abolishes VBZ O
the DT O
inclusion NN O
of IN O
N30 NNP O
( -LRB- O
Figure NNP O
4C NNP O
, , O
upper JJ O
panel NN O
, , O
lanes NNS O
8 CD O
- SYM O
10 CD O
, , O
13 CD O
- HYPH O
15 CD O
) -RRB- O
. . O

In IN O
the DT O
context NN O
of IN O
minigene NN O
H NN O
, , O
which WDT O
contains VBZ O
shorter JJR O
introns NNS O
, , O
the DT O
larger JJR O
extent NN O
of IN O
N30 NNP O
inclusion NN O
is VBZ O
induced VBN O
by IN O
either CC O
F011 NNP O
or CC O
A030 CD O
overexpression NN O
( -LRB- O
Figure NNP O
4C NNP O
, , O
middle JJ O
panel NN O
, , O
lanes NNS O
7 CD O
and CC O
12 CD O
) -RRB- O
. . O

The DT O
N30 NNP O
inclusion NN O
of IN O
the DT O
minigene NN O
H NNP O
mRNAs NNPS O
also RB O
depends VBZ O
on IN O
the DT O
presence NN O
of IN O
the DT O
IDDE NNP O
( -LRB- O
Figure NNP O
4C NNP O
, , O
middle JJ O
panel NN O
, , O
lanes NNS O
6 CD O
and CC O
11 CD O
) -RRB- O
. . O

Mutation NN O
of IN O
both DT O
copies NNS O
of IN O
UGCAUG NNP O
( : O
mc NN O
) -RRB- O
results VBZ O
in IN O
a DT O
complete JJ O
loss NN O
of IN O
N30 NNP O
inclusion NN O
( -LRB- O
Figure NNP O
4C NNP O
, , O
middle JJ O
panel NN O
, , O
lanes NNS O
10 CD O
and CC O
15 CD O
) -RRB- O
. . O

The DT O
mutant JJ O
ma NN O
shows VBZ O
stronger JJR O
inhibition NN O
of IN O
N30 NNP O
inclusion NN O
compared VBN O
with IN O
mb NNP O
( -LRB- O
Figure NNP O
4C NNP O
, , O
middle JJ O
panel NN O
, , O
lanes NNS O
8 CD O
and CC O
9 CD O
) -RRB- O
. . O

This DT O
observation NN O
is VBZ O
consistent JJ O
with IN O
the DT O
competition NN O
experiments NNS O
of IN O
the DT O
EMSA NNP O
shown VBN O
in IN O
Figure NNP O
4B NNP O
, , O
indicating VBG O
that IN O
the DT O
5 CD O
' '' O
hexanucleotide NN O
is VBZ O
more RBR O
important JJ O
than IN O
the DT O
3 CD O
' '' O
hexanucleotide NN O
for IN O
binding NN O
of IN O
Fxh NNP O
or CC O
A2BP1 NN O
to IN O
the DT O
IDDE NNP O
as RB O
well RB O
as IN O
an DT O
activation NN O
of IN O
N30 NN O
splicing NN O
. . O

Comparable JJ O
amounts NNS O
of IN O
F011 CD O
and CC O
A030 CD O
are VBP O
expressed VBN O
in IN O
each DT O
transfection NN O
as IN O
verified VBN O
by IN O
immunoblots NNS O
using VBG O
an DT O
anti AFX O
- HYPH O
myc NN O
antibody NN O
( -LRB- O
Figure NNP O
4C NNP O
, , O
lower JJR O
panel NN O
, , O
lanes NNS O
6 CD O
- HYPH O
17 CD O
) -RRB- O
. . O

Since IN O
minigenes NNS O
J NNP O
and CC O
H NN O
lack VBP O
a DT O
portion NN O
of IN O
the DT O
intron NN O
between IN O
exons NNS O
N30 NNP O
and CC O
E6 CD O
and CC O
, , O
therefore RB O
, , O
the DT O
IDDE NNP O
is VBZ O
located VBN O
~ SYM O
100 CD O
nt NN O
downstream NN O
of IN O
N30 CD O
, , O
instead RB O
of IN O
1 CD O
. . O
5 CD O
kb NN O
as IN O
in IN O
the DT O
native JJ O
gene NN O
, , O
we PRP O
also RB O
analyzed VBD O
the DT O
effects NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NN O
on IN O
the DT O
N30 NNP O
splicing NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
minigene NN O
G NN O
, , O
which WDT O
includes VBZ O
full JJ O
- HYPH O
length NN O
introns NNS O
among IN O
E5 NNP O
, , O
N30 NNP O
and CC O
E6 NNP O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4C NNP O
( , O
right JJ O
panel NN O
) -RRB- O
, , O
both CC O
F011 NNP O
and CC O
A030 NNP O
are VBP O
capable JJ O
of IN O
promoting VBG O
N30 NNP O
inclusion NN O
, , O
with IN O
F011 CD O
showing VBG O
a DT O
higher JJR O
activity NN O
( -LRB- O
Figure NNP O
4C NNP O
, , O
lanes NNS O
16 CD O
and CC O
17 CD O
) -RRB- O
. . O

Although IN O
A030 NNP O
can MD O
promote VB O
N30 NNP O
inclusion NN O
as RB O
efficiently RB O
as IN O
F011 CD O
in IN O
the DT O
contexts NNS O
of IN O
the DT O
minigene NN O
J NNP O
and CC O
H NN O
transcripts NNS O
, , O
it PRP O
can MD O
do VB O
so RB O
less RBR O
efficiently RB O
than IN O
F011 CD O
in IN O
the DT O
context NN O
of IN O
the DT O
minigene NN O
G NN O
transcript NN O
. . O

Interpretation NN O
of IN O
this DT O
observation NN O
will MD O
be VB O
discussed VBN O
below RB O
. . O

Taken VBN O
together RB O
, , O
Fxh NNP O
and CC O
A2BP1 NNP O
can MD O
activate VB O
N30 NNP O
inclusion NN O
in IN O
an DT O
IDDE NN O
- HYPH O
dependent JJ O
manner NN O
. . O

The DT O
hexanucleotide NN O
motif NN O
UGCAUG NNP O
is VBZ O
indispensable JJ O
for IN O
this DT O
activation NN O
. . O

Differential JJ O
activities NNS O
of IN O
alternatively RB O
spliced VBN O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
in IN O
promoting VBG O
N30 NNP O
inclusion NN O

Both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
mRNAs NNS O
are VBP O
expressed VBN O
in IN O
brain NN O
and CC O
A2BP1 NN O
is VBZ O
also RB O
expressed VBN O
in IN O
striated VBN O
muscles NNS O
and CC O
Fxh NNP O
is VBZ O
expressed VBN O
in IN O
an DT O
even RB O
wider JJR O
variety NN O
of IN O
tissues NNS O
. . O

As IN O
demonstrated VBN O
above RB O
, , O
however RB O
, , O
both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
transcripts NNS O
undergo VBP O
tissue NN O
- HYPH O
dependent JJ O
alternative JJ O
splicing NN O
, , O
producing VBG O
muscle NN O
- HYPH O
specific JJ O
and CC O
brain NN O
- HYPH O
enriched VBN O
isoforms NNS O
. . O

Therefore RB O
, , O
the DT O
relative JJ O
activity NN O
of IN O
individual JJ O
isoform NN O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
in IN O
promoting VBG O
N30 NNP O
inclusion NN O
was VBD O
compared VBN O
using VBG O
minigene NN O
G NNP O
. . O

First RB O
, , O
in IN O
order NN O
to TO O
evaluate VB O
the DT O
relative JJ O
specific JJ O
activity NN O
of IN O
each DT O
isoform NN O
in IN O
the DT O
splicing NN O
reaction NN O
separately RB O
from IN O
its PRP$ O
ability NN O
to TO O
localize VB O
to IN O
nuclei NNS O
, , O
an DT O
exogenous JJ O
NLS NNP O
was VBD O
included VBN O
in IN O
the DT O
expressed VBN O
protein NN O
to TO O
equalize VB O
the DT O
nuclear JJ O
concentration NN O
of IN O
the DT O
expressed VBN O
protein NN O
in IN O
these DT O
experiments NNS O
. . O

Essentially RB O
, , O
all DT O
of IN O
the DT O
expressed VBN O
proteins NNS O
with IN O
the DT O
exogenous JJ O
NLS NNP O
are VBP O
localized VBN O
to IN O
the DT O
nucleus NN O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

Therefore RB O
, , O
the DT O
relative JJ O
nuclear JJ O
concentrations NNS O
of IN O
the DT O
expressed VBN O
proteins NNS O
can MD O
be VB O
estimated VBN O
easily RB O
by IN O
immunoblots NNS O
. . O

As IN O
shown VBN O
in IN O
immunoblots NNS O
in IN O
Figure NNP O
5A NNP O
, , O
similar JJ O
quantities NNS O
of IN O
proteins NNS O
are VBP O
expressed VBN O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
. . O

Expression NN O
of IN O
the DT O
brain NN O
isoform NN O
F011 CD O
causes VBZ O
a DT O
dose NN O
- HYPH O
dependent JJ O
increase NN O
in IN O
N30 NNP O
inclusion NN O
and CC O
the DT O
extent NN O
of IN O
N30 NNP O
inclusion NN O
reaches VBZ O
a DT O
plateau NN O
with IN O
~ $ O
85 CD O
% NN O
of IN O
the DT O
mRNAs NNS O
including VBG O
N30 NNP O
. . O

In IN O
contrast NN O
, , O
inclusion NN O
of IN O
N30 NNP O
promoted VBN O
by IN O
F411 NNP O
, , O
the DT O
predominant JJ O
isoform NN O
from IN O
skeletal JJ O
muscles NNS O
, , O
reaches VBZ O
a DT O
plateau NN O
with IN O
only RB O
40 CD O
% NN O
of IN O
the DT O
mRNAs NNS O
. . O

With IN O
respect NN O
to IN O
A2BP1 NNP O
, , O
the DT O
brain NN O
isoform NN O
A030 NN O
shows VBZ O
higher JJR O
activity NN O
in IN O
N30 NNP O
inclusion NN O
than IN O
the DT O
muscle NN O
isoform NN O
A715 CD O
, , O
which WDT O
shows VBZ O
almost RB O
no DT O
activation NN O
, , O
as IN O
shown VBN O
in IN O
Figure NNP O
5A NNP O
. . O

Including VBG O
additional JJ O
isoforms NNS O
, , O
the DT O
activities NNS O
of IN O
individual JJ O
isoforms NNS O
with IN O
an DT O
exogenous JJ O
NLS NNP O
in IN O
promoting VBG O
N30 NNP O
inclusion NN O
are VBP O
shown VBN O
in IN O
Figure NNP O
5B NNP O
( , O
lanes NNS O
8 CD O
- SYM O
13 CD O
) -RRB- O
and CC O
are VBP O
also RB O
summarized VBN O
in IN O
Figure NNP O
1A CD O
( : O
nls NNS O
) -RRB- O
. . O

Special JJ O
care NN O
was VBD O
taken VBN O
to TO O
ensure VB O
that IN O
a DT O
similar JJ O
quantity NN O
of IN O
each DT O
protein NN O
was VBD O
expressed VBN O
and CC O
, , O
if IN O
not RB O
, , O
different JJ O
amounts NNS O
were VBD O
tested VBN O
to TO O
obtain VB O
comparable JJ O
expression NN O
. . O

In IN O
the DT O
presence NN O
of IN O
the DT O
exogenous JJ O
NLS NNP O
( , O
nls NNS O
) -RRB- O
, , O
F011 CD O
and CC O
A016 NNP O
show VBP O
the DT O
highest JJS O
activities NNS O
among IN O
all DT O
isoforms NNS O
tested VBN O
. . O

A30 NNP O
shows VBZ O
a DT O
considerably RB O
lower JJR O
activity NN O
than IN O
A016 CD O
. . O

Each DT O
of IN O
the DT O
muscle NN O
isoforms NNS O
( -LRB- O
F411 CD O
, , O
A713 CD O
and CC O
A715 CD O
) -RRB- O
has VBZ O
a DT O
lower JJR O
activity NN O
than IN O
that DT O
of IN O
their PRP$ O
brain NN O
counterparts NNS O
( , O
F011 CD O
, , O
A016 NNP O
and CC O
A030 CD O
, , O
respectively RB O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
isoforms NNS O
lacking VBG O
a DT O
part NN O
or CC O
all DT O
of IN O
the DT O
RRM NNP O
( -LRB- O
F402 CD O
and CC O
A704 CD O
) -RRB- O
have VBP O
no DT O
activity NN O
for IN O
N30 NNP O
inclusion NN O
. . O

Next RB O
, , O
the DT O
splicing VBG O
activities NNS O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
proteins NNS O
without IN O
an DT O
exogenous JJ O
NLS NNP O
were VBD O
examined VBN O
. . O

Representative JJ O
data NNS O
are VBP O
shown VBN O
in IN O
Figure NNP O
5B NNP O
( : O
lanes NNS O
2 CD O
- SYM O
7 CD O
) -RRB- O
and CC O
the DT O
relative JJ O
activities NNS O
are VBP O
summarized VBN O
in IN O
Figure NNP O
1A CD O
( : O
wt PRP O
) -RRB- O
. . O

The DT O
protein NN O
amounts NNS O
detected VBN O
by IN O
immunoblots NNS O
in IN O
these DT O
experiments NNS O
represent VBP O
the DT O
total JJ O
amounts NNS O
of IN O
the DT O
proteins NNS O
distributed VBN O
to IN O
both CC O
the DT O
nuclei NNS O
and CC O
the DT O
cytoplasm NN O
. . O

The DT O
splicing NN O
activities NNS O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
proteins NNS O
are VBP O
consistent JJ O
with IN O
the DT O
activities NNS O
that WDT O
combine VBP O
the DT O
splicing VBG O
activities NNS O
of IN O
the DT O
proteins NNS O
with IN O
the DT O
exogenous JJ O
NLS NNP O
and CC O
the DT O
activities NNS O
of IN O
the DT O
native JJ O
proteins NNS O
to TO O
localize VB O
to IN O
nuclei NNS O
. . O

In IN O
the DT O
absence NN O
of IN O
the DT O
exogenous JJ O
NLS NNP O
( , O
wt PRP O
) -RRB- O
, , O
the DT O
brain NN O
isoforms VBZ O
F011 CD O
, , O
and CC O
A016 CD O
to IN O
a DT O
lesser JJR O
extent NN O
, , O
are VBP O
still RB O
capable JJ O
of IN O
activating VBG O
N30 NNP O
inclusion NN O
efficiently RB O
. . O

The DT O
muscle NN O
isoforms NNS O
for IN O
both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
( SYM O
F411 CD O
, , O
A713 CD O
and CC O
A715 CD O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
brain NN O
isoform NN O
A030 CD O
, , O
show VBP O
only RB O
minimal JJ O
activities NNS O
. . O

Therefore RB O
, , O
F011 NNP O
and CC O
A016 NNP O
appear VBP O
to TO O
have VB O
the DT O
most RBS O
physiological JJ O
relevance NN O
to IN O
N30 NNP O
splicing NN O
activation NN O
. . O

Overexpression NN O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
activates VBZ O
N30 CD O
inclusion NN O
of IN O
endogenous JJ O
NMHC NNP O
- HYPH O
B NN O
mRNAs NNS O

The DT O
human JJ B-Species
NMHC NNP O
- HYPH O
B NN O
gene NN O
consists VBZ O
of IN O
41 CD O
constitutive JJ O
exons NNS O
and CC O
3 CD O
alternative JJ O
exons NNS O
. . O

Its PRP$ O
pre NN O
- HYPH O
mRNA NNP O
is VBZ O
~ $ O
156 CD O
kb NN O
in IN O
length NN O
and CC O
it PRP O
is VBZ O
much RB O
more RBR O
complex JJ O
than IN O
the DT O
pre NN O
- HYPH O
mRNA NN O
from IN O
the DT O
minigenes NNS O
. . O

In IN O
addition NN O
, , O
the DT O
minigene NN O
pre NN O
- HYPH O
mRNAs NNS O
are VBP O
driven VBN O
by IN O
a DT O
heterologous JJ O
promoter NN O
. . O

Therefore RB O
, , O
we PRP O
next RB O
examined VBD O
if IN O
Fxh NNP O
and CC O
A2BP1 NNP O
were VBD O
capable JJ O
of IN O
promoting VBG O
N30 NNP O
inclusion NN O
of IN O
the DT O
endogenous JJ O
transcript NN O
. . O

Y79 CD O
cells NNS O
were VBD O
stably RB O
transfected VBN O
with IN O
the DT O
expression NN O
construct NN O
for IN O
F011 NNP O
or CC O
A016 CD O
. . O

Both CC O
F011 NNP O
and CC O
A016 CD O
are VBP O
enriched VBN O
in IN O
the DT O
brain NN O
and CC O
show VBP O
higher JJR O
activation NN O
of IN O
N30 NNP O
inclusion NN O
in IN O
the DT O
minigene NN O
transcripts NNS O
. . O

mRNAs NNS O
encoding VBG O
endogenous JJ O
NMHC NNP O
- HYPH O
B NNP O
were VBD O
analyzed VBN O
by IN O
using VBG O
RT NNP O
- HYPH O
PCR NNP O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
6 CD O
, , O
the DT O
inclusion NN O
of IN O
exon NN O
N30 NNP O
with IN O
and CC O
without IN O
another DT O
alternative JJ O
exon NN O
, , O
R18 NN O
, , O
in IN O
the DT O
endogenous JJ O
mRNAs NNS O
is VBZ O
markedly RB O
increased VBN O
in IN O
the DT O
clones NNS O
which WDT O
were VBD O
stably RB O
transfected VBN O
with IN O
the DT O
construct NN O
for IN O
F011 NNP O
or CC O
A016 CD O
containing VBG O
an DT O
exogenous JJ O
NLS NNP O
( -LRB- O
Figure NNP O
6 CD O
, , O
lanes NNS O
4 CD O
and CC O
5 CD O
) -RRB- O
. . O

Although IN O
to IN O
a DT O
lesser JJR O
extent NN O
, , O
transfection NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
constructs NNS O
without IN O
an DT O
exogenous JJ O
NLS NNP O
also RB O
results VBZ O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
N30 NNP O
inclusion NN O
( -LRB- O
Figure NNP O
6 CD O
, , O
lanes NNS O
2 CD O
and CC O
3 CD O
) -RRB- O
. . O

Thus RB O
, , O
exogenously RB O
expressed VBN O
Fxh NNP O
and CC O
A2BP1 NNP O
are VBP O
capable JJ O
of IN O
activating VBG O
N30 NNP O
inclusion NN O
not RB O
only RB O
in IN O
the DT O
transcripts NNS O
from IN O
the DT O
minigenes NNS O
, , O
but CC O
also RB O
in IN O
those DT O
from IN O
the DT O
native JJ O
NMHC NNP O
- HYPH O
B NN O
gene NN O
in IN O
Y79 CD O
cells NNS O
. . O

Fxh NNP O
may MD O
cooperate VB O
with IN O
other JJ O
factor NN O
( -LRB- O
s NNS O
) -RRB- O
to TO O
promote VB O
N30 NNP O
inclusion NN O

To TO O
address VB O
the DT O
role NN O
of IN O
endogenous JJ O
Fxh NNP O
and CC O
its PRP$ O
potential JJ O
interaction NN O
with IN O
other JJ O
proteins NNS O
in IN O
promoting VBG O
N30 NNP O
inclusion NN O
, , O
we PRP O
made VBD O
use NN O
of IN O
an DT O
isoform NN O
of IN O
Fxh NNP O
, , O
F402 CD O
, , O
which WDT O
lacks VBZ O
the DT O
RRM NNP O
. . O

The DT O
mutant JJ O
proteins NNS O
lacking VBG O
an DT O
RRM NN O
for IN O
other JJ O
RNA NN O
- HYPH O
binding VBG O
proteins NNS O
have VBP O
previously RB O
been VBN O
reported VBN O
to TO O
function VB O
in IN O
a DT O
dominant JJ O
- HYPH O
negative JJ O
fashion NN O
and CC O
inhibit VB O
the DT O
activities NNS O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
proteins NNS O
( , O
26 CD O
, , O
31 CD O
) -RRB- O
. . O

Therefore RB O
, , O
the DT O
effects NNS O
of IN O
F402 CD O
on IN O
the DT O
N30 NNP O
inclusion NN O
of IN O
minigene NN O
H NNP O
mRNAs NNS O
were VBD O
examined VBN O
in IN O
the DT O
context NN O
of IN O
the DT O
Y79 CD O
cells NNS O
treated VBN O
with IN O
butyrate NN O
. . O

Upon IN O
butyrate JJ O
treatment NN O
, , O
as IN O
reported VBN O
previously RB O
, , O
Y79 CD O
cells NNS O
enter VBP O
in IN O
a DT O
post NN O
- HYPH O
mitotic JJ O
and CC O
differentiated JJ O
stage NN O
, , O
and CC O
importantly RB O
, , O
the DT O
endogenous JJ O
as RB O
well RB O
as IN O
the DT O
minigene NN O
mRNAs NNS O
in IN O
those DT O
cells NNS O
include VBP O
N30 NNP O
to IN O
a DT O
large JJ O
extent NN O
, , O
unlike IN O
those DT O
in IN O
the DT O
untreated JJ O
cells NNS O
that WDT O
predominantly RB O
exclude VBP O
N30 NNP O
( SYM O
14 CD O
) -RRB- O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
7 CD O
, , O
in IN O
the DT O
absence NN O
of IN O
exogenous JJ O
expression NN O
of IN O
F402 CD O
, , O
large JJ O
quantities NNS O
of IN O
the DT O
mRNAs NNS O
derived VBN O
from IN O
minigene NN O
H NN O
- HYPH O
wt NNP O
, , O
which WDT O
contains VBZ O
the DT O
wild JJ O
- HYPH O
type NN O
IDDE NNP O
, , O
include VBP O
N30 NNP O
( , O
Figure NNP O
7 CD O
, , O
upper JJ O
panel NN O
, , O
lane NN O
4 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
only RB O
small JJ O
quantities NNS O
of IN O
N30 NNP O
inclusion NN O
are VBP O
detected VBN O
in IN O
the DT O
mRNAs NNS O
from IN O
minigene NN O
H NN O
- HYPH O
mc NN O
, , O
which WDT O
has VBZ O
mutations NNS O
in IN O
both DT O
copies NNS O
of IN O
UGCAUG NNP O
in IN O
the DT O
IDDE NNP O
( -LRB- O
Figure NNP O
7 CD O
, , O
upper JJ O
panel NN O
, , O
lane NN O
8 CD O
) -RRB- O
. . O

Therefore RB O
, , O
the DT O
butyrate NN O
- HYPH O
treated VBN O
Y79 CD O
cells NNS O
contain VBP O
factor NN O
( , O
s VBZ O
) -RRB- O
, , O
which WDT O
are VBP O
capable JJ O
of IN O
activating VBG O
the DT O
UGCAUG NNP O
- HYPH O
dependent JJ O
N30 NNP O
inclusion NN O
. . O

Co NN O
- HYPH O
transfection NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
minigene NN O
H NN O
- HYPH O
wt NNP O
with IN O
the DT O
F402 CD O
expression NN O
construct NN O
causes VBZ O
a DT O
dose NN O
- HYPH O
dependent JJ O
inhibition NN O
of IN O
N30 NNP O
inclusion NN O
( -LRB- O
Figure NNP O
7 CD O
, , O
lanes NNS O
1 CD O
- HYPH O
3 CD O
) -RRB- O
, , O
indicating VBG O
that IN O
F402 NNP O
has VBZ O
an DT O
antagonistic JJ O
effect NN O
on IN O
the DT O
endogenous JJ O
factors NNS O
with IN O
respect NN O
to IN O
N30 NNP O
inclusion NN O
. . O

Notably RB O
, , O
the DT O
UGCAUG NNP O
- HYPH O
independent JJ O
N30 NNP O
inclusion NN O
seen VBN O
in IN O
the DT O
mutant JJ O
minigene NN O
H NN O
- HYPH O
mc NN O
is VBZ O
not RB O
affected VBN O
by IN O
the DT O
co NN O
- HYPH O
expression NN O
of IN O
F402 CD O
( -LRB- O
Figure NNP O
7 CD O
, , O
lanes NNS O
5 CD O
- HYPH O
7 CD O
) -RRB- O
, , O
indicating VBG O
that IN O
the DT O
inhibitory JJ O
activity NN O
of IN O
F402 NNP O
depends VBZ O
on IN O
the DT O
UGCAUG NNP O
element NN O
. . O

The DT O
parallel JJ O
experiment NN O
with IN O
the DT O
F011 NNP O
expression NN O
construct NN O
does VBZ O
not RB O
show VB O
a DT O
significant JJ O
effect NN O
on IN O
N30 NNP O
splicing NN O
in IN O
either CC O
the DT O
wild JJ O
- HYPH O
type NN O
or CC O
mutant JJ O
minigene NN O
( , O
Figure NNP O
7 CD O
, , O
lanes NNS O
9 CD O
- HYPH O
16 CD O
) -RRB- O
. . O

This DT O
may MD O
be VB O
due IN O
to IN O
the DT O
fact NN O
that IN O
N30 NNP O
inclusion NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
minigene NN O
mRNAs NNS O
has VBZ O
already RB O
reached VBN O
a DT O
maximal JJ O
level NN O
and CC O
is VBZ O
consistent JJ O
with IN O
the DT O
idea NN O
that IN O
butyrate NN O
- HYPH O
treated VBN O
Y79 CD O
cells NNS O
contain VBP O
sufficient JJ O
amounts NNS O
of IN O
protein NN O
( , O
s VBZ O
) -RRB- O
functionally RB O
equivalent JJ O
to IN O
F011 CD O
, , O
which WDT O
can MD O
promote VB O
N30 NNP O
inclusion NN O
in IN O
a DT O
UGCAUG NNP O
- HYPH O
dependent JJ O
manner NN O
. . O

Since IN O
F402 NNP O
does VBZ O
not RB O
bind VB O
to IN O
the DT O
UGCAUG NNP O
element NN O
, , O
and CC O
has VBZ O
a DT O
UGCAUG NNP O
- HYPH O
dependent JJ O
antagonistic JJ O
effect NN O
on IN O
N30 NNP O
splicing NN O
, , O
it PRP O
most RBS O
probably RB O
disrupts VBZ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
of IN O
the DT O
endogenous JJ O
proteins NNS O
that WDT O
are VBP O
required VBN O
for IN O
the DT O
UGCAUG NNP O
- HYPH O
dependent JJ O
activation NN O
of IN O
N30 NNP O
splicing NN O
. . O

Endogenous NNP O
Fxh NNP O
( , O
and CC O
/ SYM O
or CC O
A2BP1 CD O
) -RRB- O
would MD O
be VB O
a DT O
good JJ O
candidate NN O
whose WP$ O
function NN O
could MD O
be VB O
antagonized VBN O
by IN O
exogenously RB O
expressed VBN O
F402 CD O
. . O

Thus RB O
, , O
this DT O
observation NN O
suggests VBZ O
that IN O
the DT O
endogenous JJ O
Fxh NNP O
has VBZ O
an DT O
effect NN O
on IN O
the DT O
activation NN O
of IN O
N30 NNP O
splicing NN O
and CC O
that IN O
other JJ O
proteins NNS O
cooperate VBP O
with IN O
Fxh NNP O
for IN O
N30 NNP O
activation NN O
. . O

Since IN O
muscle NN O
cells NNS O
express VBP O
the DT O
RRM NN O
- HYPH O
defective JJ O
isoforms NNS O
to IN O
a DT O
significant JJ O
extent NN O
( -LRB- O
Figure NNP O
2C NNP O
) -RRB- O
and CC O
the DT O
wild JJ O
- HYPH O
type NN O
F402 CD O
localize VBP O
to IN O
nuclei NNS O
efficiently RB O
, , O
this DT O
also RB O
raises VBZ O
the DT O
possibility NN O
that IN O
the DT O
RRM NN O
- HYPH O
defective JJ O
isoforms NNS O
may MD O
have VB O
an DT O
inhibitory JJ O
function NN O
on IN O
the DT O
N30 NNP O
splicing NN O
in IN O
muscle NN O
cells NNS O
. . O

DISCUSSION NN O

Two CD O
major JJ O
findings NNS O
are VBP O
described VBN O
in IN O
this DT O
report NN O
. . O

First RB O
, , O
Fxh NNP O
and CC O
A2BP1 NNP O
facilitate VBP O
neural JJ O
cell NN O
- HYPH O
specific JJ O
inclusion NN O
of IN O
the DT O
cassette NN O
- HYPH O
type NN O
exon NN O
via IN O
binding NN O
to IN O
the DT O
specific JJ O
intronic JJ O
sequence NN O
UGCAUG NNP O
. . O

In IN O
addition NN O
to IN O
a DT O
minigene NN O
model NN O
system NN O
, , O
Fxh NNP O
and CC O
A2BP1 NNP O
are VBP O
capable JJ O
of IN O
facilitating VBG O
N30 NNP O
inclusion NN O
of IN O
the DT O
endogenous JJ O
pre NN O
- HYPH O
mRNA NN O
. . O

This DT O
result NN O
provides VBZ O
an DT O
important JJ O
demonstration NN O
of IN O
physiological JJ O
relevance NN O
and CC O
supports VBZ O
the DT O
notion NN O
that IN O
the DT O
NMHC NNP O
- HYPH O
B NNP O
pre NNP O
- HYPH O
mRNA NNP O
is VBZ O
likely JJ O
to TO O
be VB O
the DT O
true JJ O
target NN O
for IN O
Fxh NNP O
or CC O
A2BP1 NNP O
- HYPH O
mediated VBN O
regulation NN O
. . O

However RB O
, , O
whether IN O
the DT O
endogenous JJ O
Fxh NNP O
or CC O
A2BP1 NNP O
regulates VBZ O
endogenous JJ O
NMHC NNP O
- HYPH O
B NNP O
pre NN O
- HYPH O
mRNA NN O
splicing NN O
needs VBZ O
to TO O
be VB O
determined VBN O
in IN O
a DT O
future JJ O
study NN O
. . O

In IN O
vertebrates NNS O
, , O
small JJ O
interfering VBG O
RNAs NNS O
and CC O
gene NN O
targeting NN O
strategies NNS O
have VBP O
recently RB O
been VBN O
used VBN O
successfully RB O
to TO O
address VB O
the DT O
roles NNS O
of IN O
endogenous JJ O
splicing VBG O
regulators NNS O
in IN O
alternative JJ O
splicing NN O
of IN O
endogenous JJ O
target NN O
pre NN O
- HYPH O
mRNAs NNS O
( SYM O
8 CD O
, , O
32 CD O
- HYPH O
36 CD O
) -RRB- O
. . O

A DT O
second JJ O
and CC O
more RBR O
novel JJ O
finding NN O
is VBZ O
the DT O
identification NN O
of IN O
tissue NN O
- HYPH O
specific JJ O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
with IN O
different JJ O
splicing NN O
activities NNS O
as RB O
well RB O
as IN O
different JJ O
subcellular JJ O
localizations NNS O
. . O

This DT O
finding NN O
raises VBZ O
the DT O
possibility NN O
that IN O
the DT O
products NNS O
of IN O
the DT O
Fxh NNP O
and CC O
A2BP1 NNP O
genes NNS O
can MD O
contribute VB O
to IN O
a DT O
mechanism NN O
as IN O
to IN O
how WRB O
tissue NN O
specificity NN O
of IN O
alternative JJ O
splicing NN O
is VBZ O
achieved VBN O
. . O

Many JJ O
splicing VBG O
factors NNS O
are VBP O
detected VBN O
not RB O
only RB O
in IN O
the DT O
nuclei NNS O
, , O
but CC O
also RB O
in IN O
the DT O
cytoplasm NN O
( , O
37 CD O
) -RRB- O
. . O

They PRP O
are VBP O
shuttling VBG O
between IN O
the DT O
nucleus NN O
and CC O
the DT O
cytoplasm NN O
and CC O
, , O
in IN O
some DT O
instances NNS O
, , O
extracellular JJ O
stimuli NNS O
trigger VBP O
changes NNS O
in IN O
subcellular JJ O
distribution NN O
of IN O
these DT O
proteins NNS O
. . O

Such JJ O
translocations NNS O
have VBP O
been VBN O
reported VBN O
for IN O
hnRNPA1 NNP O
and CC O
PTB NNP O
( : O
38 CD O
, , O
39 CD O
) -RRB- O
. . O

Moreover RB O
, , O
a DT O
number NN O
of IN O
RNA NNP O
- HYPH O
binding VBG O
proteins NNS O
have VBP O
been VBN O
demonstrated VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
multiple JJ O
steps NNS O
during IN O
gene NN O
expression NN O
in IN O
different JJ O
subcellular JJ O
compartments NNS O
, , O
such JJ O
as IN O
pre NN O
- HYPH O
mRNA NN O
processing NN O
in IN O
nuclei NN O
, , O
mRNA NN O
export NN O
from IN O
nuclei NNS O
to IN O
cytoplasm NN O
and CC O
mRNA NN O
localization NN O
, , O
stability NN O
and CC O
translation NN O
in IN O
cytoplasm NN O
( SYM O
37 CD O
, , O
40 CD O
) -RRB- O
. . O

Therefore RB O
, , O
not RB O
surprisingly RB O
, , O
Fxh NNP O
and CC O
A2BP1 NNP O
isoforms NNS O
were VBD O
found VBN O
to TO O
be VB O
distributed VBN O
in IN O
both CC O
the DT O
nuclei NNS O
and CC O
the DT O
cytoplasm NN O
in IN O
HeLa NNP O
and CC O
Y79 NNP O
cells NNS O
. . O

However RB O
, , O
the DT O
relative JJ O
ratios NNS O
of IN O
proteins NNS O
distributed VBN O
between IN O
the DT O
two CD O
subcellular JJ O
compartments NNS O
at IN O
steady JJ O
- HYPH O
state NN O
differ VBP O
among IN O
the DT O
isoforms NNS O
. . O

In IN O
agreement NN O
with IN O
Jin NNP O
et FW O
al NNP O
. . O

( : O
21 CD O
) -RRB- O
, , O
substantial JJ O
amounts NNS O
of IN O
the DT O
brain NN O
isoform NN O
A016 NN O
are VBP O
detected VBN O
in IN O
nuclei NNS O
. . O

Other JJ O
A2BP1 NNP O
isoforms NNS O
, , O
the DT O
brain NN O
isoform NN O
A030 NN O
and CC O
the DT O
muscle NN O
isoforms NNS O
A713 NN O
and CC O
A715 NN O
, , O
are VBP O
only RB O
poorly RB O
detected VBN O
in IN O
nuclei NNS O
. . O

This DT O
observation NN O
is VBZ O
consistent JJ O
with IN O
the DT O
reports NNS O
where WRB O
endogenous JJ O
A2BP1 NNP O
in IN O
cerebellar JJ O
Purkinje NNP O
cells NNS O
, , O
hippocampus NN O
neurons NNS O
and CC O
cardiac JJ O
myocytes NNS O
were VBD O
shown VBN O
to TO O
be VB O
localized VBN O
essentially RB O
to IN O
the DT O
cytoplasm NN O
( , O
23 CD O
, , O
24 CD O
) -RRB- O
. . O

Thus RB O
, , O
inclusion NN O
and CC O
exclusion NN O
of IN O
A53 NN O
and CC O
differences NNS O
in IN O
the DT O
very JJ O
N JJ O
- HYPH O
terminal NN O
sequences NNS O
results VBZ O
in IN O
A2BP1 NN O
isoforms NNS O
with IN O
a DT O
distinct JJ O
subcellular JJ O
localization NN O
. . O

It PRP O
is VBZ O
likely JJ O
that IN O
A2BP1 NNP O
proteins NNS O
have VBP O
multiple JJ O
roles NNS O
, , O
involving VBG O
both CC O
nuclear JJ O
and CC O
cytoplasmic JJ O
events NNS O
. . O

In IN O
contrast NN O
, , O
all DT O
three CD O
Fxh NNP O
isoforms NNS O
predominantly RB O
localized VBN O
to IN O
the DT O
nuclei NNS O
. . O

Therefore RB O
, , O
in IN O
terms NNS O
of IN O
their PRP$ O
localization NN O
, , O
Fxh NNP O
proteins NNS O
are VBP O
better JJR O
candidates NNS O
for IN O
regulators NNS O
of IN O
the DT O
pre JJ O
- HYPH O
mRNA NN O
splicing NN O
that WDT O
takes VBZ O
place NN O
in IN O
nuclei NNS O
. . O

Of IN O
note NN O
, , O
however RB O
, , O
our PRP$ O
preliminary JJ O
results NNS O
of IN O
5 CD O
' '' O
RACE NNP O
, , O
as RB O
well RB O
as IN O
the DT O
EST NNP O
database NN O
, , O
detect VBP O
multiple JJ O
5 CD O
' '' O
end NN O
sequences NNS O
for IN O
both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
mRNAs NNS O
, , O
which WDT O
are VBP O
presumably RB O
generated VBN O
by IN O
alternative JJ O
promoters NNS O
and CC O
alternative JJ O
splicing NN O
. . O

The DT O
diversity NN O
of IN O
the DT O
5 CD O
' '' O
end NN O
cDNA NNP O
sequences NNS O
leads VBZ O
to IN O
the DT O
generation NN O
of IN O
a DT O
number NN O
of IN O
unique JJ O
N NNP O
- HYPH O
terminal JJ O
amino NN O
acid NN O
sequences NNS O
. . O

Therefore RB O
, , O
this DT O
study NN O
does VBZ O
not RB O
exclude VB O
the DT O
possible JJ O
existence NN O
of IN O
other JJ O
isoforms NNS O
with IN O
different JJ O
subcellular JJ O
localizations NNS O
for IN O
both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
. . O

Our PRP$ O
study NN O
also RB O
does VBZ O
not RB O
exclude VB O
the DT O
possibility NN O
that IN O
some DT O
of IN O
the DT O
isoforms NNS O
translocate VBP O
between IN O
the DT O
nucleus NN O
and CC O
the DT O
cytoplasm NN O
following VBG O
stimuli NNS O
. . O

The DT O
main JJ O
aim NN O
of IN O
this DT O
study NN O
is VBZ O
to TO O
determine VB O
the DT O
relative JJ O
activities NNS O
of IN O
tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NN O
in IN O
neural JJ O
cell NN O
- HYPH O
specific JJ O
and CC O
UGCAUG NNP O
element NN O
- HYPH O
dependent JJ O
alternative JJ O
splicing NN O
. . O

To TO O
obtain VB O
an DT O
indication NN O
of IN O
the DT O
relative JJ O
specific JJ O
activity NN O
of IN O
each DT O
isoform NN O
in IN O
transfected VBN O
cells NNS O
, , O
the DT O
same JJ O
amounts NNS O
of IN O
the DT O
expressed VBN O
proteins NNS O
should MD O
be VB O
available JJ O
for IN O
the DT O
splicing VBG O
reaction NN O
in IN O
the DT O
nuclei NNS O
. . O

For IN O
this DT O
reason NN O
, , O
an DT O
exogenous JJ O
NLS NNP O
was VBD O
included VBN O
in IN O
the DT O
expressed VBN O
proteins NNS O
. . O

Essentially RB O
, , O
all DT O
of IN O
the DT O
expressed VBN O
proteins NNS O
with IN O
the DT O
exogenous JJ O
NLS NNP O
localized VBN O
to IN O
nuclei NNS O
. . O

Thus RB O
, , O
the DT O
amounts NNS O
of IN O
the DT O
expressed VBN O
proteins NNS O
determined VBN O
by IN O
immunoblots NNS O
represent VBP O
the DT O
nuclear JJ O
concentrations NNS O
. . O

The DT O
analysis NN O
using VBG O
the DT O
proteins NNS O
expressed VBN O
with IN O
the DT O
exogenous JJ O
NLS NNP O
allowed VBD O
us PRP O
to TO O
compare VB O
directly RB O
the DT O
splicing VBG O
activities NNS O
of IN O
these DT O
proteins NNS O
. . O

Furthermore RB O
, , O
this DT O
analysis NN O
also RB O
allowed VBD O
us PRP O
to TO O
define VB O
the DT O
critical JJ O
regions NNS O
of IN O
the DT O
proteins NNS O
for IN O
splicing VBG O
activation NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
5 CD O
, , O
the DT O
splicing NN O
activities NNS O
of IN O
the DT O
various JJ O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
are VBP O
intrinsically RB O
different JJ O
, , O
regardless RB O
of IN O
the DT O
subcellular JJ O
localization NN O
properties NNS O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
proteins NNS O
. . O

Among IN O
the DT O
isoforms NNS O
tested VBN O
in IN O
this DT O
study NN O
, , O
F011 NNP O
and CC O
A016 NNP O
, , O
which WDT O
include VBP O
B40 NNP O
, , O
are VBP O
found VBN O
to TO O
have VB O
higher JJR O
activities NNS O
in IN O
promoting VBG O
N30 NNP O
inclusion NN O
. . O

When WRB O
the DT O
primary JJ O
amino NN O
acid NN O
sequences NNS O
, , O
outside RB O
of IN O
the DT O
RRM NNP O
, , O
of IN O
these DT O
two CD O
proteins NNS O
are VBP O
compared VBN O
, , O
the DT O
C NN O
- HYPH O
terminal JJ O
regions NNS O
( , O
amino NN O
acids NNS O
190 CD O
- HYPH O
377 CD O
of IN O
F011 CD O
) -RRB- O
show VBP O
a DT O
higher JJR O
homology NN O
with IN O
71 CD O
% NN O
identity NN O
, , O
whereas IN O
the DT O
N NNP O
- HYPH O
terminal JJ O
regions NNS O
( , O
amino NN O
acids NNS O
1 CD O
- SYM O
112 CD O
of IN O
F011 CD O
) -RRB- O
show VBP O
only RB O
53 CD O
% NN O
identity NN O
. . O

The DT O
C NNP O
- HYPH O
terminal JJ O
region NN O
includes VBZ O
four CD O
subregions NNS O
of IN O
nearly RB O
identical JJ O
stretches NNS O
of IN O
amino NN O
acids NNS O
( : O
Figure NNP O
8 CD O
, , O
I NNP O
- HYPH O
IV NN O
) -RRB- O
. . O

One CD O
subregion NN O
( -LRB- O
II NN O
) -RRB- O
includes VBZ O
13 CD O
amino NN O
acids NNS O
encoded VBN O
by IN O
exon NNP O
B40 NNP O
. . O

Substitution NN O
of IN O
this DT O
subregion NN O
with IN O
exon NNP O
M43 NNP O
in IN O
Fxh NNP O
causes VBZ O
substantial JJ O
changes NNS O
in IN O
amino NN O
acid NN O
sequences NNS O
resulting VBG O
in IN O
only RB O
a DT O
21 CD O
% NN O
identity NN O
in IN O
this DT O
region NN O
between IN O
F011 CD O
and CC O
F411 CD O
. . O

Another DT O
subregion NN O
( -LRB- O
IV NN O
) -RRB- O
is VBZ O
located VBN O
at IN O
the DT O
C NNP O
- HYPH O
terminal NN O
end NN O
and CC O
A030 NNP O
lacks VBZ O
this DT O
homologous JJ O
region NN O
by IN O
the DT O
inclusion NN O
of IN O
exon NNP O
A53 NNP O
, , O
which WDT O
results VBZ O
in IN O
a DT O
frame NN O
shift NN O
. . O

Since IN O
F411 NNP O
and CC O
A030 NNP O
show VBP O
poor JJ O
splicing NN O
activation NN O
compared VBN O
with IN O
F011 CD O
and CC O
A016 CD O
, , O
respectively RB O
, , O
these DT O
two CD O
subregions NNS O
of IN O
F011 CD O
and CC O
A016 CD O
appear VBP O
to TO O
serve VB O
as IN O
activation NN O
domains NNS O
, , O
presumably RB O
by IN O
interacting VBG O
with IN O
other JJ O
proteins NNS O
. . O

This DT O
notion NN O
is VBZ O
supported VBN O
by IN O
the DT O
finding NN O
that IN O
the DT O
RRM NNP O
- HYPH O
lacking VBG O
isoform NN O
F402 CD O
, , O
which WDT O
includes VBZ O
the DT O
same JJ O
subregions NNS O
II NN O
and CC O
IV NN O
as IN O
F011 CD O
, , O
functions VBZ O
apparently RB O
as IN O
a DT O
dominant JJ O
- HYPH O
negative JJ O
mutant NN O
to IN O
the DT O
wild JJ O
- HYPH O
type NN O
Fxh NNP O
, , O
consistent JJ O
with IN O
the DT O
interpretation NN O
that IN O
the DT O
mutant JJ O
and CC O
wild JJ O
- HYPH O
type NN O
are VBP O
competing VBG O
to TO O
interact VB O
with IN O
other JJ O
protein NN O
( , O
s NN O
) -RRB- O
. . O

To IN O
date NN O
, , O
Fyn NNP O
tyrosine NN O
kinase NN O
and CC O
estrogen NN O
receptor NN O
- HYPH O
alpha NN O
have VBP O
been VBN O
reported VBN O
to TO O
interact VB O
with IN O
Fxh NNP O
, , O
and CC O
ataxin NN O
- HYPH O
2 CD O
with IN O
A2BP1 NNP O
( : O
23 CD O
, , O
41 CD O
, , O
42 CD O
) -RRB- O
. . O

Whether IN O
these DT O
proteins NNS O
participate VBP O
in IN O
the DT O
regulation NN O
of IN O
pre JJ O
- HYPH O
mRNA NN O
splicing NN O
is VBZ O
currently RB O
unknown JJ O
. . O

Of IN O
interest NN O
, , O
A030 NNP O
with IN O
the DT O
exogenous JJ O
NLS NNP O
activates VBZ O
N30 NNP O
splicing NN O
as RB O
efficiently RB O
as IN O
F011 CD O
in IN O
the DT O
pre NN O
- HYPH O
mRNAs NNS O
derived VBN O
from IN O
minigenes NNS O
J NNP O
and CC O
H NNP O
, , O
which WDT O
contain VBP O
the DT O
shorter JJR O
intron NN O
, , O
whereas IN O
this DT O
isoform NN O
poorly RB O
activates VBZ O
N30 NNP O
splicing NN O
in IN O
the DT O
pre NN O
- HYPH O
mRNA NN O
from IN O
minigene NN O
G NNP O
, , O
which WDT O
contains VBZ O
the DT O
full JJ O
- HYPH O
length NN O
intron NN O
. . O

This DT O
observation NN O
implies VBZ O
that IN O
the DT O
interactions NNS O
of IN O
A030 CD O
with IN O
different JJ O
factors NNS O
are VBP O
required VBN O
in IN O
the DT O
different JJ O
pre JJ O
- HYPH O
mRNA NN O
contexts NNS O
. . O

Therefore RB O
, , O
the DT O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
described VBN O
here RB O
may MD O
have VB O
different JJ O
effects NNS O
on IN O
other JJ O
UGCAUG NNP O
- HYPH O
regulated VBN O
alternative JJ O
splicing NN O
. . O

The DT O
involvement NN O
of IN O
the DT O
hexanucleotide NN O
UGCAUG NNP O
in IN O
regulated VBN O
alternative JJ O
splicing NN O
has VBZ O
been VBN O
experimentally RB O
demonstrated VBN O
in IN O
a DT O
number NN O
of IN O
neural JJ O
cell NN O
- HYPH O
specific JJ O
, , O
as RB O
well RB O
as IN O
other JJ O
tissue NN O
- HYPH O
specific JJ O
, , O
model NN O
systems NNS O
( , O
13 CD O
- HYPH O
21 CD O
) -RRB- O
. . O

This DT O
hexanucleotide NN O
element NN O
plays VBZ O
a DT O
role NN O
, , O
in IN O
most JJS O
cases NNS O
, , O
as IN O
an DT O
enhancer NN O
in IN O
regulating VBG O
alternative JJ O
splicing NN O
of IN O
cassette NN O
- HYPH O
type NN O
exons NNS O
as RB O
well RB O
as IN O
mutually RB O
exclusive JJ O
exons NNS O
. . O

Furthermore RB O
, , O
computational JJ O
analysis NN O
has VBZ O
revealed VBN O
that IN O
UGCAUG NNP O
is VBZ O
over RB O
- HYPH O
represented VBN O
in IN O
the DT O
introns NNS O
in IN O
which WDT O
splicing NN O
is VBZ O
regulated VBN O
, , O
compared VBN O
with IN O
the DT O
constitutively RB O
spliced VBN O
introns NNS O
( SYM O
43 CD O
) -RRB- O
. . O

This DT O
analysis NN O
also RB O
pointed VBD O
to IN O
the DT O
UGCAUG NNP O
element NN O
as IN O
playing VBG O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
tissue NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
tissues NNS O
, , O
but CC O
not RB O
in IN O
specific JJ O
tissues NNS O
. . O

To IN O
date NN O
, , O
KH NNP O
- HYPH O
type NN O
splicing NN O
regulatory JJ O
protein NN O
( -LRB- O
KSRP NNP O
) -RRB- O
( , O
44 CD O
) -RRB- O
, , O
A2BP1 NNP O
( SYM O
21 CD O
) -RRB- O
and CC O
Fxh NNP O
( , O
this DT O
study NN O
) -RRB- O
are VBP O
known VBN O
to TO O
be VB O
capable JJ O
of IN O
binding NN O
to IN O
UGCAUG NNP O
. . O

KSRP NNP O
is VBZ O
expressed VBN O
ubiquitously RB O
and CC O
tissue NN O
- HYPH O
specific JJ O
variants NNS O
of IN O
this DT O
gene NN O
have VBP O
not RB O
been VBN O
described VBN O
so RB O
far RB O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
described VBN O
the DT O
existence NN O
of IN O
tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
Fxh NNP O
and CC O
A2BP1 NNP O
, , O
which WDT O
, , O
while IN O
not RB O
identical JJ O
in IN O
some DT O
areas NNS O
of IN O
the DT O
molecule NN O
, , O
may MD O
contain VB O
the DT O
same JJ O
RRM NNP O
. . O

The DT O
physiological JJ O
relevance NN O
of IN O
these DT O
isoforms NNS O
is VBZ O
that IN O
they PRP O
have VBP O
different JJ O
splicing VBG O
activities NNS O
and CC O
different JJ O
subcellular JJ O
localizations NNS O
. . O

The DT O
brain NN O
isoforms NNS O
promote VBP O
N30 NNP O
inclusion NN O
more RBR O
efficiently RB O
than IN O
the DT O
muscle NN O
isoforms NNS O
of IN O
both CC O
Fxh NNP O
and CC O
A2BP1 NNP O
. . O

The DT O
isoforms NNS O
lacking VBG O
the DT O
RRM NN O
are VBP O
normally RB O
expressed VBN O
to IN O
a DT O
significant JJ O
extent NN O
in IN O
skeletal JJ O
muscles NNS O
. . O

This DT O
isoform NN O
is VBZ O
incapable JJ O
of IN O
activating VBG O
N30 NN O
splicing NN O
and CC O
, , O
moreover RB O
, , O
can MD O
inhibit VB O
N30 NNP O
inclusion NN O
. . O

The DT O
properties NNS O
of IN O
these DT O
isoforms NNS O
are VBP O
consistent JJ O
with IN O
Fxh NNP O
and CC O
A2BP1 NNP O
acting VBG O
as IN O
regulators NNS O
for IN O
N30 NNP O
splicing NN O
, , O
since IN O
N30 NNP O
is VBZ O
included VBN O
in IN O
neuronal JJ O
cells NNS O
, , O
but CC O
excluded VBN O
in IN O
muscles NNS O
. . O

Therefore RB O
, , O
despite IN O
the DT O
tissue NN O
- HYPH O
independent JJ O
occurrence NN O
of IN O
UGCAUG NNP O
as IN O
a DT O
regulatory JJ O
element NN O
, , O
given VBN O
the DT O
tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
the DT O
UGCAUG NNP O
- HYPH O
binding VBG O
proteins NNS O
( , O
Fxh NNP O
and CC O
A2BP1 NNP O
) -RRB- O
with IN O
different JJ O
activities NNS O
, , O
the DT O
hexanucleotide NN O
UGCAUG NNP O
could MD O
confer VB O
tissue NN O
specificity NN O
on IN O
regulated VBN O
splicing NN O
. . O

One CD O
of IN O
the DT O
major JJ O
problems NNS O
in IN O
understanding VBG O
the DT O
mechanisms NNS O
responsible JJ O
for IN O
alternative JJ O
pre NN O
- HYPH O
mRNA NN O
splicing NN O
is VBZ O
the DT O
manner NN O
in IN O
which WDT O
tissue NN O
specificity NN O
is VBZ O
determined VBN O
. . O

In IN O
vertebrates NNS O
, , O
to IN O
date NN O
, , O
only RB O
a DT O
few JJ O
tissue NN O
- HYPH O
specific JJ O
proteins NNS O
have VBP O
been VBN O
identified VBN O
as IN O
splicing VBG O
regulators NNS O
( : O
8 CD O
- SYM O
12 CD O
) -RRB- O
. . O

Here RB O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
the DT O
tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
the DT O
sequence NN O
- HYPH O
specific JJ O
RNA NN O
- HYPH O
binding VBG O
proteins NNS O
, , O
which WDT O
themselves PRP O
are VBP O
generated VBN O
by IN O
alternative JJ O
splicing NN O
, , O
have VBP O
different JJ O
activities NNS O
in IN O
tissue NN O
- HYPH O
specific JJ O
alternative JJ O
splicing NN O
of IN O
target NN O
pre NN O
- HYPH O
mRNA NN O
. . O

Therefore RB O
, , O
these DT O
isoforms NNS O
play VBP O
a DT O
role NN O
in IN O
the DT O
determination NN O
of IN O
tissue NN O
specificity NN O
of IN O
target NN O
pre NN O
- HYPH O
mRNA NN O
splicing NN O
. . O

The DT O
discovery NN O
of IN O
these DT O
tissue NN O
- HYPH O
dependent JJ O
isoforms NNS O
of IN O
the DT O
UGCAUG NNP O
- HYPH O
binding VBG O
proteins NNS O
with IN O
different JJ O
splicing NN O
activities NNS O
adds VBZ O
an DT O
important JJ O
new JJ O
dimension NN O
to IN O
the DT O
molecular JJ O
mechanisms NNS O
responsible JJ O
for IN O
regulating VBG O
tissue NN O
- HYPH O
dependent JJ O
alternative JJ O
splicing NN O
mediated VBN O
via IN O
UGCAUG NNP O
. . O

Mutations NNS O
of IN O
PIK3CA NN O
in IN O
gastric JJ O
adenocarcinoma NN O

Abstract JJ O

Background NN O

Activation NN O
of IN O
the DT O
phosphatidylinositol NN O
3 CD O
- HYPH O
kinase NN O
( -LRB- O
PI3K NN O
) -RRB- O
through IN O
mutational JJ O
inactivation NN O
of IN O
PTEN NNP O
tumour NN O
suppressor NN O
gene NN O
is VBZ O
common JJ O
in IN O
diverse JJ O
cancer NN O
types NNS O
, , O
but CC O
rarely RB O
reported VBN O
in IN O
gastric JJ O
cancer NN O
. . O

Recently RB O
, , O
mutations NNS O
in IN O
PIK3CA NNP O
, , O
which WDT O
encodes VBZ O
the DT O
p110 JJ O
alpha NN O
catalytic JJ O
subunit NN O
of IN O
PI3K NNP O
, , O
have VBP O
been VBN O
identified VBN O
in IN O
various JJ O
human JJ B-Species
cancers NNS O
, , O
including VBG O
3 CD O
of IN O
12 CD O
gastric JJ O
cancers NNS O
. . O

Eighty CD O
percent NN O
of IN O
these DT O
reported VBN O
mutations NNS O
clustered VBN O
within IN O
2 CD O
regions NNS O
involving VBG O
the DT O
helical NN O
and CC O
kinase NN O
domains NNS O
. . O

In IN O
vitro FW O
study NN O
on IN O
one CD O
of IN O
the DT O
"""" `` O
hot JJ O
- HYPH O
spot NN O
"""" '' O
mutants NNS O
has VBZ O
demonstrated VBN O
it PRP O
as IN O
an DT O
activating VBG O
mutation NN O
. . O

Methods NNS O

Based VBN O
on IN O
these DT O
data NNS O
, , O
we PRP O
initiated VBD O
PIK3CA NNP O
mutation NN O
screening NN O
in IN O
94 CD O
human JJ B-Species
gastric JJ O
cancers NNS O
by IN O
direct JJ O
sequencing NN O
of IN O
the DT O
gene NN O
regions NNS O
in IN O
which WDT O
80 CD O
% NN O
of IN O
all PDT O
the DT O
known VBN O
PIK3CA NNP O
mutations NNS O
were VBD O
found VBN O
. . O

We PRP O
also RB O
examined VBD O
PIK3CA NNP O
expression NN O
level NN O
by IN O
extracting VBG O
data NNS O
from IN O
the DT O
previous JJ O
large JJ O
- HYPH O
scale NN O
gene NN O
expression NN O
profiling NN O
study NN O
. . O

Using VBG O
Significance NNP O
Analysis NNP O
of IN O
Microarrays NNP O
( : O
SAM NNP O
) -RRB- O
, , O
we PRP O
further RB O
searched VBD O
for IN O
genes NNS O
that WDT O
show VBP O
correlating VBG O
expression NN O
with IN O
PIK3CA NNP O
. . O

Results NNS O

We PRP O
have VBP O
identified VBN O
PIK3CA NNP O
mutations NNS O
in IN O
4 CD O
cases NNS O
( : O
4 CD O
. . O
3 CD O
% NN O
) -RRB- O
, , O
all DT O
involving VBG O
the DT O
previously RB O
reported VBN O
hotspots NNS O
. . O

Among IN O
these DT O
4 CD O
cases NNS O
, , O
3 CD O
tumours NNS O
demonstrated VBD O
microsatellite NN O
instability NN O
and CC O
2 CD O
tumours NNS O
harboured VBD O
concurrent JJ O
KRAS NNP O
mutation NN O
. . O

Data NNS O
extracted VBN O
from IN O
microarray JJ O
studies NNS O
showed VBD O
an DT O
increased VBN O
expression NN O
of IN O
PIK3CA NNP O
in IN O
gastric JJ O
cancers NNS O
when WRB O
compared VBN O
with IN O
the DT O
non AFX O
- HYPH O
neoplastic JJ O
gastric JJ O
mucosae NN O
( : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

SAM NNP O
further RB O
identified VBD O
2910 CD O
genes NNS O
whose WP$ O
expression NN O
levels NNS O
were VBD O
positively RB O
associated VBN O
with IN O
that DT O
of IN O
PIK3CA NNP O
. . O

Conclusion NN O

Our PRP$ O
data NNS O
suggested VBD O
that IN O
activation NN O
of IN O
the DT O
PI3K NNP O
signalling NN O
pathway NN O
in IN O
gastric JJ O
cancer NN O
may MD O
be VB O
achieved VBN O
through IN O
up IN O
- HYPH O
regulation NN O
or CC O
mutation NN O
of IN O
PIK3CA NNP O
, , O
in IN O
which WDT O
the DT O
latter JJ O
may MD O
be VB O
a DT O
consequence NN O
of IN O
mismatch NN O
repair NN O
deficiency NN O
. . O

Background NN O

The DT O
phosphatidylinositol NN O
3 CD O
- HYPH O
kinase NN O
( -LRB- O
PI3K NNP O
) NN O
- HYPH O
AKT NN O
signalling NN O
pathway NN O
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
diverse JJ O
cellular JJ O
processes NNS O
, , O
including VBG O
cell NN O
growth NN O
, , O
survival NN O
and CC O
motility NN O
. . O

Abnormal JJ O
activation NN O
of IN O
this DT O
pathway NN O
is VBZ O
frequently RB O
observed VBN O
in IN O
various JJ O
cancer NN O
types NNS O
, , O
leading VBG O
to IN O
aberrant JJ O
cell NN O
cycle NN O
progression NN O
, , O
altered VBN O
adhesion NN O
and CC O
motility NN O
, , O
inhibition NN O
of IN O
apoptosis NN O
and CC O
induction NN O
of IN O
angiogenesis NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
previously RB O
reported VBN O
that IN O
genetic JJ O
alterations NNS O
involving VBG O
various JJ O
members NNS O
along IN O
this DT O
signalling VBG O
pathway NN O
could MD O
lead VB O
to IN O
its PRP$ O
activation NN O
in IN O
cancer NN O
. . O

These DT O
include VBP O
mutation NN O
, , O
allelic JJ O
loss NN O
or CC O
promoter NN O
methylation NN O
of IN O
the DT O
negative JJ O
regulator NN O
PTEN NNP O
[ -LRB- O
2 CD O
] -RRB- O
; , O
or CC O
alternatively RB O
, , O
chromosomal JJ O
amplification NN O
or CC O
over IN O
- HYPH O
expression NN O
of IN O
the DT O
positive JJ O
regulators NNS O
PIK3CA NNP O
[ -LRB- O
3 CD O
- SYM O
5 CD O
] -RRB- O
and CC O
the DT O
various JJ O
AKT NNP O
kinases NNS O
[ -LRB- O
6 CD O
, , O
7 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
changes NNS O
in IN O
other JJ O
related JJ O
pathways NNS O
that WDT O
are VBP O
commonly RB O
altered VBN O
in IN O
cancer NN O
, , O
such JJ O
as IN O
those DT O
involved VBN O
in IN O
growth NN O
factor NN O
stimulation NN O
via IN O
the DT O
G NN O
- HYPH O
protein NN O
- HYPH O
coupled VBN O
receptors NNS O
or CC O
through IN O
direct JJ O
interaction NN O
with IN O
the DT O
activated VBN O
form NN O
of IN O
small JJ O
GTPase NNP O
RAS NNP O
, , O
can MD O
also RB O
lead VB O
to IN O
PI3K NNP O
- HYPH O
AKT NNP O
pathway NN O
activation NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Activation NN O
of IN O
this DT O
pathway NN O
results VBZ O
in IN O
the DT O
phosphorylation NN O
of IN O
AKT NNP O
at IN O
Thr NNP O
- HYPH O
308 CD O
/ SYM O
309 CD O
and CC O
Ser NNP O
- HYPH O
473 CD O
/ SYM O
474 CD O
. . O

These DT O
phosphorylated JJ O
forms NNS O
of IN O
AKT NNP O
proteins NNS O
have VBP O
been VBN O
detected VBN O
by IN O
Western JJ O
blot NN O
or CC O
immunohistochemistry NN O
in IN O
various JJ O
cancer NN O
types NNS O
, , O
suggesting VBG O
the DT O
frequent JJ O
activation NN O
of IN O
PI3K NNP O
- HYPH O
AKT NNP O
pathway NN O
in IN O
the DT O
carcinogenic JJ O
process NN O
[ -LRB- O
7 CD O
, , O
9 CD O
] -RRB- O
. . O

Although IN O
genetic JJ O
changes NNS O
along IN O
the DT O
PI3K NNP O
- HYPH O
AKT NNP O
pathway NN O
have VBP O
been VBN O
repeatedly RB O
documented VBN O
in IN O
brain NN O
, , O
ovarian NN O
, , O
endometrial JJ O
, , O
breast NN O
, , O
prostate NN O
and CC O
thyroid NN O
cancers NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
, , O
reports NNS O
on IN O
its PRP$ O
mechanism NN O
of IN O
activation NN O
in IN O
gastric JJ O
cancer NN O
are VBP O
limited VBN O
. . O

Gastric JJ O
cancer NN O
is VBZ O
the DT O
second JJ O
most RBS O
common JJ O
cancer NN O
worldwide RB O
but CC O
its PRP$ O
molecular JJ O
basis NN O
of IN O
tumourigenesis NN O
is VBZ O
still RB O
poorly RB O
understood VBN O
. . O

Previous JJ O
immunohistochemical JJ O
study NN O
has VBZ O
demonstrated VBN O
the DT O
presence NN O
of IN O
the DT O
phosphorylated VBN O
form NN O
of IN O
AKT NNP O
in IN O
78 CD O
% NN O
of IN O
gastric JJ O
cancer NN O
[ -LRB- O
10 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
activation NN O
of IN O
this DT O
pathway NN O
may MD O
also RB O
be VB O
common JJ O
in IN O
gastric JJ O
cancer NN O
. . O

Though IN O
loss NN O
of IN O
heterozygosity NN O
( -LRB- O
LOH NNP O
) -RRB- O
involving VBG O
the DT O
PTEN NNP O
locus NN O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
47 CD O
% NN O
of IN O
gastric JJ O
cancer NN O
in IN O
a DT O
recent JJ O
study NN O
, , O
mutation NN O
or CC O
promoter NN O
methylation NN O
was VBD O
absent JJ O
even RB O
in IN O
cases NNS O
with IN O
LOH NNP O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Thus RB O
data NNS O
from IN O
this DT O
study NN O
could MD O
not RB O
support VB O
the DT O
two CD O
- HYPH O
hit VBN O
inactivation NN O
of IN O
PTEN NNP O
in IN O
gastric JJ O
cancer NN O
, , O
while IN O
the DT O
biological JJ O
significance NN O
of IN O
PTEN NNP O
haploinsufficiency NN O
remains VBZ O
controversial JJ O
. . O

Alternatively RB O
, , O
amplification NN O
of IN O
AKT1 NNP O
has VBZ O
been VBN O
reported VBN O
in IN O
a DT O
single JJ O
case NN O
of IN O
gastric JJ O
cancer NN O
[ -LRB- O
12 CD O
] -RRB- O
, , O
and CC O
amplification NN O
of IN O
PIK3CA NNP O
associated VBN O
with IN O
elevated VBN O
mRNA NN O
levels NNS O
has VBZ O
been VBN O
found VBN O
in IN O
36 CD O
% NN O
of IN O
gastric JJ O
cancer NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

More RBR O
recently RB O
, , O
Samuels NNP O
et FW O
al NNP O
. , O
screened VBD O
a DT O
diverse JJ O
spectrum NN O
of IN O
human JJ B-Species
cancers NNS O
for IN O
mutation NN O
in IN O
16 CD O
PI3K NNP O
or CC O
PI3K NNP O
- HYPH O
like JJ O
genes NNS O
and CC O
found VBD O
a DT O
high JJ O
frequency NN O
of IN O
somatic JJ O
mutation NN O
in IN O
PIK3CA NNP O
, , O
which WDT O
encodes VBZ O
the DT O
p110 NN O
alpha NN O
catalytic JJ O
subunit NN O
. . O

Major JJ O
screening NN O
in IN O
colorectal JJ O
cancer NN O
( -LRB- O
CRC NNP O
) -RRB- O
identified VBD O
PIK3CA NNP O
mutations NNS O
in IN O
74 CD O
out IN O
of IN O
234 CD O
( , O
32 CD O
% NN O
) , O
cases NNS O
, , O
while IN O
mutations NNS O
were VBD O
also RB O
noted VBN O
in IN O
3 CD O
out IN O
of IN O
12 CD O
( : O
25 CD O
% NN O
) SYM O
gastric JJ O
cancers NNS O
. . O

Reported VBN O
mutations NNS O
were VBD O
mostly RB O
of IN O
missense JJ O
type NN O
, , O
and CC O
clustered VBN O
within IN O
2 CD O
regions NNS O
in IN O
the DT O
helical JJ O
and CC O
kinase NN O
domains NNS O
. . O

Expression NN O
of IN O
a DT O
"""" `` O
hot JJ O
- HYPH O
spot NN O
"""" '' O
mutant JJ O
, , O
H1047R NN O
, , O
conferred VBD O
a DT O
significant JJ O
up JJ O
- HYPH O
regulation NN O
of IN O
lipid JJ O
kinase NN O
activity NN O
of IN O
PIK3CA NNP O
, , O
suggesting VBG O
it PRP O
as IN O
an DT O
activating VBG O
mutation NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
examined VBN O
a DT O
series NN O
of IN O
94 CD O
human JJ B-Species
gastric JJ O
adenocarcinomas NNS O
for IN O
PIK3CA NNP O
mutation NN O
. . O

We PRP O
have VBP O
also RB O
examined VBN O
PIK3CA NNP O
expression NN O
level NN O
by IN O
extracting VBG O
data NNS O
from IN O
a DT O
large JJ O
- HYPH O
scale NN O
gene NN O
expression NN O
profiling NN O
study NN O
previously RB O
performed VBN O
for IN O
these DT O
cases NNS O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
. . O

Using VBG O
SAM NNP O
, , O
genes NNS O
with IN O
significant JJ O
correlating VBG O
expression NN O
with IN O
PIK3CA NNP O
have VBP O
also RB O
been VBN O
identified VBN O
. . O

Methods NNS O

Patient NN B-Species
samples NNS O
preparation NN O

DNA NN O
samples NNS O
used VBN O
for IN O
sequencing NN O
were VBD O
prepared VBN O
from IN O
frozen JJ O
tumour NN O
and CC O
non JJ O
- HYPH O
tumour NN O
gastric JJ O
mucosae NN O
from IN O
94 CD O
gastric JJ O
cancer NN O
patients NNS B-Species
who WP O
underwent VBD O
gastrectomy NN O
in IN O
the DT O
Department NNP O
of IN O
Surgery NNP O
, , O
Queen NNP O
Mary NNP O
Hospital NNP O
, , O
The DT O
University NNP O
of IN O
Hong NNP O
Kong NNP O
, , O
as IN O
previously RB O
described VBN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Majority NN O
of IN O
the DT O
frozen VBN O
samples NNS O
( , O
n CD O
= SYM O
81 CD O
) -RRB- O
showed VBD O
tumour NN O
component NN O
of IN O
over IN O
70 CD O
% NN O
, , O
whereas IN O
in IN O
13 CD O
cases NNS O
a DT O
lower JJR O
proportion NN O
between IN O
50 CD O
to TO O
70 CD O
% NN O
was VBD O
accepted VBN O
due IN O
to IN O
the DT O
tumours NNS O
' POS O
inherent JJ O
diffuse JJ O
infiltrative JJ O
nature NN O
with IN O
entrapment NN O
of IN O
non JJ O
- HYPH O
neoplastic JJ O
components NNS O
. . O

Analysis NN O
for IN O
microsatellite NN O
instability NN O
( , O
MSI NNP O
) -RRB- O
, , O
BRAF NNP O
and CC O
KRAS NNP O
mutation NN O
have VBP O
been VBN O
performed VBN O
and CC O
reported VBN O
previously RB O
[ -LRB- O
16 CD O
] -RRB- O
. . O

RNA NN O
preparation NN O
and CC O
gene NN O
expression NN O
profiling NN O
using VBG O
a DT O
cDNA NNP O
microarray NN O
containing VBG O
44 CD O
, , O
500 CD O
cDNA NN O
clones NNS O
, , O
representing VBG O
around IN O
30 CD O
, , O
300 CD O
unique JJ O
genes NNS O
, , O
has VBZ O
been VBN O
performed VBN O
and CC O
reported VBN O
in IN O
90 CD O
of IN O
these DT O
tumours NNS O
in IN O
comparison NN O
to IN O
22 CD O
non JJ O
- HYPH O
tumour NN O
gastric JJ O
mucosae NN O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
. . O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
Ethics NNP O
Committee NNP O
of IN O
the DT O
University NNP O
of IN O
Hong NNP O
Kong NNP O
. . O

Mutational JJ O
screening NN O

Mutation NN O
screening NN O
of IN O
PIK3CA NNP O
was VBD O
performed VBN O
for IN O
exons NNS O
9 CD O
and CC O
20 CD O
, , O
covering VBG O
the DT O
mutational JJ O
hotspots NNS O
; : O
and CC O
for IN O
exon NN O
18 CD O
, , O
from IN O
which WDT O
a DT O
mutation NN O
was VBD O
found VBN O
in IN O
a DT O
gastric JJ O
cancer NN O
. . O

Mutations NNS O
in IN O
these DT O
3 CD O
exons NNS O
constituted VBD O
80 CD O
% NN O
of IN O
all DT O
PIK3CA NNP O
mutations NNS O
detected VBN O
in IN O
the DT O
previous JJ O
study NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

PIK3CA NNP O
intron NN O
- HYPH O
specific JJ O
external JJ O
amplification NN O
primers NNS O
and CC O
internal JJ O
sequencing NN O
primers NNS O
were VBD O
designed VBN O
according VBG O
to IN O
the DT O
previous JJ O
study NN O
[ -LRB- O
13 CD O
] -RRB- O
with IN O
some DT O
modifications NNS O
[ -LRB- O
see VB O
Additional JJ O
file NN O
1 CD O
] -RRB- O
. . O

In IN O
particular JJ O
, , O
primers NNS O
for IN O
exon NN O
9 CD O
have VBP O
been VBN O
modified VBN O
to TO O
avoid VB O
amplification NN O
of IN O
homologous JJ O
sequences NNS O
located VBN O
in IN O
other JJ O
chromosomes NNS O
. . O

PCR NN O
products NNS O
were VBD O
generated VBN O
using VBG O
the DT O
external JJ O
primers NNS O
and CC O
directly RB O
sequenced VBN O
using VBG O
the DT O
internal JJ O
primers NNS O
with IN O
the DT O
DYEnamic NNP O
( -LRB- O
TM NNP O
) -RRB- O
ET NNP O
Terminator NNP O
Cycle NNP O
Sequencing NNP O
Kit NNP O
( , O
Amersham NNP O
Biosciences NNP O
, , O
Freiburg NNP O
, , O
Germany NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
instruction NN O
. . O

Electrophoresis NN O
was VBD O
performed VBN O
in IN O
the DT O
ABI NNP O
Prism NNP O
( -LRB- O
R NNP O
) SYM O
3700 CD O
DNA NNP O
Analyzer NNP O
( , O
Applied NNP O
Biosystems NNP O
, , O
Foster NNP O
City NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
each DT O
exon NN O
, , O
PCR NNP O
products NNS O
were VBD O
generated VBN O
from IN O
2 CD O
independent JJ O
PCR NN O
reactions NNS O
for IN O
sequencing NN O
of IN O
the DT O
forward JJ O
and CC O
reverse JJ O
strands NNS O
. . O

For IN O
exon NNP O
9 CD O
, , O
2 CD O
independent JJ O
PCR NN O
followed VBN O
by IN O
sequencing NN O
of IN O
the DT O
forward JJ O
strand NN O
were VBD O
performed VBN O
. . O

Analysis NN O
of IN O
the DT O
chromatograms NNS O
was VBD O
performed VBN O
using VBG O
the DT O
mutation NN O
analysis NN O
software NN O
Mutation NNP O
Explorer NNP O
( -LRB- O
TM NNP O
) -RRB- O
( , O
SoftGenetics NNP O
, , O
State NNP O
College NNP O
, , O
PA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Extraction NN O
of IN O
expression NN O
data NNS O
and CC O
statistical JJ O
analysis NN O

Gene NN O
expression NN O
data NNS O
were VBD O
extracted VBN O
from IN O
the DT O
microarray NN O
database NN O
containing VBG O
126 CD O
samples NNS O
( : O
90 CD O
gastric JJ O
cancers NNS O
, , O
14 CD O
lymph JJ O
node NN O
metastasis NN O
and CC O
22 CD O
non JJ O
- HYPH O
tumour NN O
gastric JJ O
mucosae NN O
) -RRB- O
based VBN O
on IN O
a DT O
3 CD O
- HYPH O
fold NN O
signal NN O
above IN O
background NN O
ratio NN O
for IN O
either DT O
channel NN O
and CC O
with IN O
80 CD O
% NN O
good JJ O
data NNS O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Gene NNP O
expression NN O
data NNS O
from IN O
20 CD O
, , O
336 CD O
cDNA NN O
clones NNS O
satisfied VBD O
this DT O
selection NN O
criteria NNS O
and CC O
were VBD O
extracted VBN O
, , O
which WDT O
included VBD O
a DT O
cDNA NNP O
clone NN O
corresponding VBG O
to IN O
PIK3CA NNP O
( , O
IMAGE NN O
clone NN O
number NN O
345430 CD O
, , O
GenBank NNP O
accession NN O
no UH O
. . O
W72473 CD O
) -RRB- O
. . O

Expression NN O
data NNS O
for IN O
PIK3CA NNP O
was VBD O
extracted VBN O
and CC O
the DT O
differences NNS O
in IN O
expression NN O
levels NNS O
between IN O
tumour NN O
and CC O
non JJ O
- HYPH O
tumour NN O
tissues NNS O
were VBD O
examined VBN O
using VBG O
the DT O
Student NNP O
' '' O
s POS O
t NN O
- HYPH O
Test NN O
. . O

SAM NNP O
was VBD O
performed VBN O
to TO O
identify VB O
genes NNS O
with IN O
significant JJ O
correlating VBG O
expression NN O
with IN O
PIK3CA NNP O
[ -LRB- O
17 CD O
] -RRB- O
. . O

The DT O
missing VBG O
values NNS O
in IN O
the DT O
dataset NN O
were VBD O
estimated VBN O
by IN O
a DT O
K NNP O
- HYPH O
nearest JJS O
neighbours NNS O
impute NN O
algorithm NN O
using VBG O
10 CD O
nearest JJS O
neighbour NN O
[ -LRB- O
18 CD O
] -RRB- O
followed VBN O
by IN O
5000 CD O
permutations NNS O
in IN O
the DT O
SAM NNP O
analysis NN O
. . O

Results NNS O

Among IN O
the DT O
94 CD O
gastric JJ O
adenocarcinoma NN O
analysed VBN O
, , O
we PRP O
have VBP O
detected VBN O
PIK3CA NNP O
mutation NN O
in IN O
4 CD O
cases NNS O
. . O

Two CD O
cases NNS O
harboured VBD O
the DT O
mutation NN O
A3140G NNP O
( -LRB- O
H1047R NN O
) -RRB- O
in IN O
exon NN O
20 CD O
, , O
and CC O
the DT O
other JJ O
2 CD O
cases NNS O
with IN O
mutations NNS O
G1624A NNP O
( -LRB- O
E542K NNP O
) -RRB- O
and CC O
G1633A NN O
( -LRB- O
E545K NN O
) -RRB- O
in IN O
exon NN O
9 CD O
. . O

Representative JJ O
sequence NN O
chromatograms NNS O
are VBP O
shown VBN O
in IN O
figure NN O
1 CD O
. . O

All DT O
four CD O
mutations NNS O
were VBD O
absent JJ O
in IN O
the DT O
corresponding VBG O
non JJ O
- HYPH O
neoplastic JJ O
mucosae NN O
and CC O
thus RB O
were VBD O
confirmed VBN O
as IN O
somatic JJ O
mutations NNS O
. . O

Though IN O
the DT O
overall JJ O
mutation NN O
frequency NN O
( : O
4 CD O
. . O
3 CD O
% NN O
) -RRB- O
was VBD O
lower JJR O
than IN O
that DT O
of IN O
the DT O
previous JJ O
study NN O
, , O
the DT O
nature NN O
of IN O
the DT O
4 CD O
mutations NNS O
found VBN O
were VBD O
consistent JJ O
with IN O
those DT O
identified VBN O
at IN O
the DT O
reported VBN O
hotspots NNS O
. . O

In IN O
particular JJ O
, , O
the DT O
H1047R NN O
mutation NN O
has VBZ O
been VBN O
reported VBN O
in IN O
2 CD O
gastric JJ O
cancers NNS O
and CC O
15 CD O
colorectal JJ O
cancers NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

While IN O
the DT O
E542K NNP O
and CC O
the DT O
E545K NNP O
mutations NNS O
were VBD O
not RB O
found VBN O
in IN O
gastric JJ O
cancer NN O
in IN O
the DT O
previous JJ O
series NN O
, , O
a DT O
large JJ O
number NN O
of IN O
colorectal JJ O
tumours NNS O
did VBD O
harbour VB O
these DT O
2 CD O
mutations NNS O
. . O

PIK3CA NNP O
mutation NN O
spectrum NN O
and CC O
their PRP$ O
corresponding VBG O
clinico JJ O
- HYPH O
pathological JJ O
features NNS O
were VBD O
listed VBN O
in IN O
Table NNP O
1 CD O
. . O

We PRP O
noted VBD O
a DT O
higher JJR O
tendency NN O
of IN O
high JJ O
- HYPH O
level NN O
MSI NNP O
in IN O
gastric JJ O
cancers NNS O
with IN O
PIK3CA NNP O
mutations NNS O
( : O
3 CD O
in IN O
4 CD O
, , O
75 CD O
% NN O
) -RRB- O
than IN O
in IN O
those DT O
without IN O
( : O
18 CD O
in IN O
90 CD O
, , O
20 CD O
% NN O
) -RRB- O
. . O

Moreover RB O
, , O
though IN O
the DT O
overall JJ O
incidence NN O
of IN O
KRAS NNP O
mutation NN O
in IN O
the DT O
studied VBN O
population NN O
was VBD O
low JJ O
( : O
8 CD O
in IN O
94 CD O
) CD O
, , O
2 CD O
of IN O
the DT O
4 CD O
gastric JJ O
cancers NNS O
with IN O
PIK3CA NNP O
mutation NN O
also RB O
harboured VBD O
a DT O
KRAS NNP O
mutation NN O
. . O

Since IN O
over IN O
- HYPH O
expression NN O
of IN O
PIK3CA NNP O
has VBZ O
been VBN O
reported VBN O
in IN O
gastric JJ O
cancer NN O
[ -LRB- O
11 CD O
] -RRB- O
, , O
we PRP O
have VBP O
also RB O
extracted VBN O
PIK3CA NNP O
expression NN O
data NNS O
from IN O
our PRP$ O
previous JJ O
cDNA NN O
microarray NN O
study NN O
of IN O
these DT O
cases NNS O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
. . O

We PRP O
have VBP O
confirmed VBN O
that IN O
expression NN O
level NN O
of IN O
PIK3CA NNP O
was VBD O
significantly RB O
higher JJR O
in IN O
gastric JJ O
cancers NNS O
( : O
n CD O
= SYM O
87 CD O
, , O
mean VB O
= SYM O
0 CD O
. . O
99 CD O
, , O
SD NN O
= SYM O
0 CD O
. . O
428 CD O
) -RRB- O
when WRB O
compared VBN O
with IN O
non JJ O
- HYPH O
neoplastic JJ O
gastric JJ O
mucosae NN O
( : O
n NN O
= SYM O
22 CD O
, , O
mean JJ O
= : O
- HYPH O
0 CD O
. . O
418 CD O
, , O
SD NN O
= SYM O
0 CD O
. . O
426 CD O
; : O
Student NN O
' '' O
s NNS O
t SYM O
- HYPH O
Test NN O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Using VBG O
PIK3CA NNP O
expression NN O
level NN O
as IN O
a DT O
continuous JJ O
variable NN O
for IN O
SAM NNP O
analysis NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
we PRP O
found VBD O
2910 CD O
cDNA NNP O
clones NNS O
( , O
corresponding VBG O
to IN O
about RB O
2546 CD O
unique JJ O
genes NNS O
) , O
whose WP$ O
expression NN O
associated VBN O
positively RB O
with IN O
PIK3CA NNP O
expression NN O
( , O
median JJ O
number NN O
of IN O
false JJ O
significant JJ O
= SYM O
0 CD O
. . O
372 CD O
, , O
Delta NNP O
= SYM O
1 CD O
. . O
107 CD O
) -RRB- O
[ -LRB- O
see VB O
Additional JJ O
file NN O
2 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
no DT O
gene NN O
was VBD O
found VBN O
to TO O
be VB O
negatively RB O
associated VBN O
with IN O
PIK3CA NNP O
expression NN O
. . O

Discussion NN O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
reported VBN O
the DT O
presence NN O
of IN O
PIK3CA NN O
gene NN O
mutation NN O
in IN O
4 CD O
. . O
3 CD O
% NN O
of IN O
gastric JJ O
cancer NN O
. . O

A DT O
high JJ O
tendency NN O
( : O
3 CD O
in IN O
4 CD O
) -RRB- O
of IN O
mismatch NN O
repair NN O
deficiency NN O
was VBD O
noted VBN O
in IN O
cases NNS O
harbouring VBG O
PIK3CA NNP O
mutation NN O
. . O

Though IN O
the DT O
small JJ O
number NN O
of IN O
PIK3CA NNP O
mutations NNS O
in IN O
our PRP$ O
study NN O
may MD O
not RB O
justify VB O
statistical JJ O
claim NN O
of IN O
significance NN O
; : O
suggestion NN O
of IN O
such JJ O
, , O
despite IN O
of IN O
its PRP$ O
not RB O
being VBG O
mentioned VBN O
by IN O
the DT O
authors NNS O
, , O
can MD O
be VB O
found VBN O
from IN O
a DT O
previous JJ O
study NN O
in IN O
CRC NNP O
by IN O
Samuels NNP O
et FW O
al NNP O
. . O
. . O

From IN O
their PRP$ O
study NN O
of IN O
33 CD O
MSI NNP O
and CC O
201 CD O
microsatellite NN O
stable JJ O
( , O
MSS NNP O
) -RRB- O
CRC NNP O
cases NNS O
, , O
PIK3CA NNP O
mutation NN O
was VBD O
present JJ O
in IN O
48 CD O
% NN O
of IN O
the DT O
MSI NNP O
tumours NNS O
, , O
but CC O
only RB O
in IN O
29 CD O
% NN O
of IN O
the DT O
MSS NNP O
tumours NNS O
. . O

A DT O
significant JJ O
association NN O
would MD O
have VB O
been VBN O
revealed VBN O
if IN O
statistical JJ O
analysis NN O
had VBD O
been VBN O
applied VBN O
( : O
Fisher NNP O
' POS O
s NNS O
exact JJ O
test NN O
, , O
p NN O
= SYM O
0 CD O
. . O
14 CD O
) -RRB- O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Gastrointestinal JJ O
tract NN O
cancers NNS O
with IN O
MSI NNP O
are VBP O
known VBN O
to TO O
have VB O
a DT O
different JJ O
molecular JJ O
pathway NN O
of IN O
tumour NN O
evolution NN O
compared VBN O
with IN O
their PRP$ O
MSS NNP O
counterparts NNS O
[ -LRB- O
19 CD O
, , O
20 CD O
] -RRB- O
. . O

This DT O
can MD O
be VB O
attributed VBN O
to IN O
their PRP$ O
propensity NN O
for IN O
frameshift NN O
mutations NNS O
in IN O
repeat NN O
sequences NNS O
, , O
resulting VBG O
in IN O
selective JJ O
disruption NN O
of IN O
genes NNS O
with IN O
such JJ O
sequences NNS O
within IN O
their PRP$ O
coding VBG O
regions NNS O
. . O

With IN O
2 CD O
poly JJ O
- HYPH O
adenine NN O
tracts NNS O
within IN O
its PRP$ O
coding VBG O
region NN O
, , O
PTEN NNP O
can MD O
be VB O
inactivated VBN O
through IN O
frameshift NN O
mutations NNS O
in IN O
MSI NNP O
CRC NNP O
, , O
resulting VBG O
in IN O
the DT O
selective JJ O
targeting NN O
of IN O
the DT O
PI3K NNP O
- HYPH O
AKT NNP O
signalling NN O
pathway NN O
[ -LRB- O
21 CD O
, , O
22 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
also RB O
known VBN O
that IN O
mismatch NN O
repair NN O
deficiency NN O
would MD O
lead VB O
to IN O
an DT O
elevated JJ O
rate NN O
of IN O
missense JJ O
mutation NN O
due IN O
to IN O
impaired VBN O
single JJ O
nucleotide NN O
mismatch NN O
repair NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Thus RB O
, , O
the DT O
observed VBN O
higher JJR O
incidence NN O
of IN O
PIK3CA NNP O
missense NN O
mutation NN O
in IN O
MSI NNP O
colorectal JJ O
and CC O
gastric JJ O
cancers NNS O
suggests VBZ O
yet RB O
another DT O
mechanism NN O
for IN O
the DT O
activation NN O
of IN O
the DT O
PI3K NNP O
- HYPH O
AKT NNP O
signalling NN O
pathway NN O
through IN O
mismatch NN O
repair NN O
deficiency NN O
. . O

Our PRP$ O
data NNS O
also RB O
showed VBD O
a DT O
higher JJR O
tendency NN O
of IN O
KRAS NNP O
mutation NN O
in IN O
cases NNS O
with IN O
PIK3CA NNP O
mutations NNS O
( , O
2 CD O
in IN O
4 CD O
) -RRB- O
than IN O
in IN O
those DT O
without IN O
( SYM O
6 CD O
in IN O
90 CD O
) -RRB- O
. . O

Yet RB O
again RB O
due IN O
to IN O
the DT O
low JJ O
incidence NN O
of IN O
both DT O
mutations NNS O
in IN O
our PRP$ O
samples NNS O
, , O
statistical JJ O
significance NN O
may MD O
not RB O
be VB O
claimed VBN O
. . O

In IN O
the DT O
study NN O
by IN O
Samuels NNP O
et FW O
al NNP O
. . O
, , O
some DT O
of IN O
the DT O
colorectal JJ O
tumours NNS O
with IN O
PIK3CA NNP O
mutation NN O
also RB O
harboured VBD O
KRAS NNP O
or CC O
BRAF NNP O
mutation NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
PI3K NNP O
- HYPH O
AKT NNP O
pathway NN O
is VBZ O
known VBN O
to TO O
have VB O
a DT O
close JJ O
association NN O
with IN O
the DT O
RAS NNP O
- HYPH O
MEKK NNP O
signalling NN O
pathway NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Constitutively RB O
active JJ O
RAS NNP O
can MD O
interact VB O
with IN O
the DT O
catalytic JJ O
subunit NN O
of IN O
PI3K NNP O
and CC O
lead VB O
to IN O
its PRP$ O
activation NN O
. . O

Ras NNP O
- HYPH O
dependent JJ O
PI3K NNP O
activation NN O
contributes VBZ O
to IN O
the DT O
transforming VBG O
phenotype NN O
by IN O
mediating VBG O
anchorage NN O
- HYPH O
independent JJ O
growth NN O
, , O
cytoskeletal JJ O
reorganisation NN O
and CC O
apoptosis NN O
evasion NN O
. . O

It PRP O
has VBZ O
been VBN O
observed VBN O
that IN O
genes NNS O
involved VBN O
in IN O
the DT O
same JJ O
signalling NN O
pathway NN O
may MD O
manifest VB O
mutations NNS O
in IN O
cancer NN O
cells NNS O
in IN O
a DT O
mutually RB O
exclusive JJ O
manner NN O
, , O
presumably RB O
due IN O
to IN O
the DT O
lack NN O
of IN O
selective JJ O
growth NN O
advantage NN O
in IN O
having VBG O
a DT O
second JJ O
hit NN O
in IN O
the DT O
already RB O
altered VBN O
pathway NN O
. . O

A DT O
prominent JJ O
example NN O
is VBZ O
the DT O
mutually RB O
exclusive JJ O
occurrence NN O
of IN O
the DT O
BRAF NNP O
hotspot NN O
mutation NN O
( , O
V600E NN O
) -RRB- O
and CC O
KRAS NNP O
mutations NNS O
in IN O
colorectal JJ O
cancer NN O
[ -LRB- O
24 CD O
, , O
25 CD O
] -RRB- O
. . O

However RB O
, , O
there EX O
exist VBP O
other JJ O
examples NNS O
of IN O
alterations NNS O
in IN O
multiple JJ O
components NNS O
of IN O
the DT O
same JJ O
signalling NN O
pathway NN O
that WDT O
may MD O
lead VB O
to IN O
a DT O
multi JJ O
- HYPH O
level NN O
modulation NN O
of IN O
its PRP$ O
activity NN O
. . O

For IN O
example NN O
, , O
non NNP O
- HYPH O
V600E NN O
BRAF NN O
mutations NNS O
tend VBP O
to TO O
occur VB O
together RB O
with IN O
KRAS NNP O
mutations NNS O
[ -LRB- O
26 CD O
] -RRB- O
, , O
and CC O
inactivation NN O
of IN O
the DT O
secreted VBN O
frizzled VBN O
- HYPH O
related VBN O
proteins NNS O
( , O
antagonists NNS O
of IN O
WNT NNP O
) -RRB- O
by IN O
promoter NN O
methylation NN O
frequently RB O
coincides VBZ O
with IN O
mutations NNS O
in IN O
the DT O
Adenomatous NNP O
Polyposis NNP O
Coli NNP O
gene NN O
to TO O
achieve VB O
multi JJ O
- HYPH O
level NN O
activation NN O
of IN O
the DT O
WNT NNP O
signalling NN O
pathway NN O
in IN O
colorectal JJ O
cancers NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

Whether IN O
PIK3CA NNP O
functions VBZ O
independently RB O
from IN O
RAS NNP O
, , O
or CC O
acts VBZ O
synergistically RB O
with IN O
RAS NNP O
to TO O
produce VB O
additive JJ O
effects NNS O
on IN O
the DT O
activation NN O
of IN O
the DT O
same JJ O
pathway NN O
awaits VBZ O
further JJ O
clarification NN O
. . O

By IN O
extracting VBG O
data NNS O
from IN O
microarray NN O
, , O
we PRP O
have VBP O
confirmed VBN O
the DT O
up JJ O
- HYPH O
regulation NN O
of IN O
PIK3CA NNP O
expression NN O
in IN O
gastric JJ O
cancer NN O
tissues NNS O
compared VBN O
with IN O
the DT O
non AFX O
- HYPH O
neoplastic JJ O
gastric JJ O
mucosae NN O
and CC O
identified VBD O
a DT O
large JJ O
number NN O
of IN O
genes NNS O
that WDT O
showed VBD O
a DT O
significant JJ O
positive JJ O
correlation NN O
in IN O
expression NN O
level NN O
with IN O
PIK3CA NNP O
. . O

These DT O
genes NNS O
participate VBP O
in IN O
diverse JJ O
cellular JJ O
processes NNS O
with IN O
177 CD O
as IN O
putative JJ O
cell NN O
cycle NN O
- HYPH O
regulated VBN O
genes NNS O
[ -LRB- O
28 CD O
] -RRB- O
and CC O
126 CD O
mapped VBD O
to IN O
genes NNS O
with IN O
known VBN O
functions NNS O
in IN O
cell NN O
cycle NN O
regulation NN O
, , O
cell NN O
proliferation NN O
or CC O
DNA NN O
replication NN O
[ -LRB- O
see VBP O
Additional JJ O
file NN O
2 CD O
] -RRB- O
. . O

While IN O
some DT O
of IN O
these DT O
genes NNS O
maybe RB O
induced VBN O
by IN O
PIK3CA NNP O
, , O
others NNS O
maybe RB O
co VBP O
- HYPH O
ordinately RB O
regulated VBN O
by IN O
common JJ O
upstream JJ O
signals NNS O
. . O

Expression NN O
data NNS O
set VBN O
at IN O
one CD O
point NN O
was VBD O
limited VBN O
in IN O
differentiating VBG O
the DT O
above JJ O
cause NN O
and CC O
consequence NN O
, , O
yet CC O
it PRP O
certainly RB O
revealed VBD O
the DT O
complexity NN O
of IN O
the DT O
carcinogenic JJ O
process NN O
and CC O
the DT O
intricate JJ O
relationship NN O
of IN O
PIK3CA NNP O
signalling VBG O
with IN O
other JJ O
cellular JJ O
processes NNS O
. . O

Contrary JJ O
to IN O
our PRP$ O
expectation NN O
, , O
the DT O
incidence NN O
of IN O
PIK3CA NNP O
mutation NN O
found VBN O
in IN O
the DT O
current JJ O
study NN O
( : O
4 CD O
% NN O
) -RRB- O
is VBZ O
much RB O
lower JJR O
compared VBN O
with IN O
that DT O
observed VBN O
by IN O
Samuel NNP O
et FW O
al NNP O
. . O

( : O
25 CD O
% NN O
) -RRB- O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
reason NN O
for IN O
discrepancy NN O
may MD O
simply RB O
be VB O
a DT O
result NN O
of IN O
sample NN O
bias NN O
as IN O
the DT O
previous JJ O
study NN O
involved VBD O
only RB O
a DT O
small JJ O
number NN O
of IN O
gastric JJ O
cancers NNS O
( , O
n CD O
= SYM O
12 CD O
) -RRB- O
. . O

However RB O
, , O
ethnic JJ O
differences NNS O
can MD O
also RB O
be VB O
another DT O
possibility NN O
. . O

The DT O
diverse JJ O
pathological JJ O
spectrum NN O
and CC O
aetiological JJ O
factors NNS O
of IN O
gastric JJ O
cancers NNS O
in IN O
different JJ O
geographical JJ O
locations NNS O
may MD O
be VB O
paralleled VBN O
by IN O
differences NNS O
in IN O
molecular JJ O
pathway NN O
of IN O
tumour NN O
development NN O
. . O

Since IN O
our PRP$ O
current JJ O
study NN O
is VBZ O
only RB O
based VBN O
on IN O
a DT O
Chinese JJ O
population NN O
with IN O
an DT O
intermediate JJ O
gastric JJ O
cancer NN O
incidence NN O
, , O
further JJ O
studies NNS O
involving VBG O
patients NNS B-Species
from IN O
different JJ O
ethnic JJ O
groups NNS O
will MD O
be VB O
able JJ O
to TO O
address VB O
this DT O
possibility NN O
. . O

Conclusion NN O

Large JJ O
- HYPH O
scale NN O
screening NN O
of IN O
gastric JJ O
adenocarcinomas NNS O
for IN O
PIK3CA NNP O
mutations NNS O
revealed VBD O
a DT O
mutation NN O
incidence NN O
of IN O
4 CD O
. . O
3 CD O
% NN O
. . O

Increased VBN O
PIK3CA NNP O
expression NN O
level NN O
was VBD O
observed VBN O
in IN O
gastric JJ O
tumours NNS O
compared VBN O
with IN O
non JJ O
- HYPH O
neoplastic JJ O
mucosae NN O
. . O

This DT O
increase NN O
in IN O
PIK3CA NNP O
level NN O
was VBD O
associated VBN O
with IN O
the DT O
elevated JJ O
expression NN O
of IN O
a DT O
large JJ O
number NN O
of IN O
genes NNS O
, , O
which WDT O
may MD O
constitute VB O
the DT O
upstream JJ O
regulators NNS O
or CC O
downstream JJ O
targets NNS O
of IN O
PIK3CA NNP O
along IN O
the DT O
PI3K NNP O
signalling NN O
pathway NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

VSWL NNP O
carried VBD O
out RP O
the DT O
molecular JJ O
analysis NN O
, , O
performed VBD O
data NN O
analysis NN O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

CWW NNP O
, , O
TLC NNP O
, , O
WZ NNP O
assisted VBD O
in IN O
the DT O
molecular JJ O
analysis NN O
. . O

KMC NNP O
provided VBD O
the DT O
clinical JJ O
data NNS O
. . O

ASWC NNP O
assisted VBD O
in IN O
data NNS O
analysis NN O
and CC O
edited VBD O
the DT O
manuscript NN O
. . O

SS NNP O
and CC O
XC NNP O
participated VBD O
in IN O
the DT O
microarray NN O
study NN O
and CC O
data NNS O
analysis NN O
. . O

STY NNP O
and CC O
SYL NNP O
conceived VBD O
of IN O
the DT O
study NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
, , O
coordination NN O
and CC O
data NN O
analysis NN O
, , O
and CC O
edited VBD O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Supplementary JJ O
Material NN O

Identification NN O
of IN O
kinectin NN O
as IN O
a DT O
novel NN O
Beh NNP O
c FW O
et FW O
' '' O
s NN O
disease NN O
autoantigen NN O

Abstract JJ O

There EX O
has VBZ O
been VBN O
some DT O
evidence NN O
that IN O
Beh NNP O
c NNP O
et FW O
' '' O
s VBZ O
disease NN O
( , O
BD NN O
) -RRB- O
has VBZ O
a DT O
significant JJ O
autoimmune JJ O
component NN O
but CC O
the DT O
molecular JJ O
identity NN O
of IN O
putative JJ O
autoantigens NNS O
has VBZ O
not RB O
been VBN O
well RB O
characterized VBN O
. . O

In IN O
the DT O
initial JJ O
analysis NN O
of IN O
the DT O
autoantibody NN O
profile NN O
in IN O
39 CD O
Chinese JJ O
BD NNP O
patients NNS B-Species
, , O
autoantibodies NNS O
to IN O
cellular JJ O
proteins NNS O
were VBD O
uncovered VBN O
in IN O
23 CD O
% NN O
as IN O
determined VBN O
by IN O
immunoblotting NN O
. . O

We PRP O
have VBP O
now RB O
identified VBN O
one CD O
of IN O
the DT O
major JJ O
autoantibody NN O
specificities NNS O
using VBG O
expression NN O
cloning NN O
. . O

Serum NN O
from IN O
a DT O
BD NNP O
patient NN B-Species
was VBD O
used VBN O
as IN O
a DT O
probe NN O
to TO O
immunoscreen VB O
a DT O
lambda NN O
ZAP NNP O
expression NN O
cDNA NNP O
library NN O
. . O

Candidate NN O
autoantigen NN O
cDNAs NNS O
were VBD O
characterized VBN O
by IN O
direct JJ O
nucleotide NN O
sequencing NN O
and CC O
their PRP$ O
expressed JJ O
products NNS O
were VBD O
examined VBN O
for IN O
reactivity NN O
to IN O
the DT O
entire JJ O
panel NN O
of IN O
BD NNP O
sera NN O
using VBG O
immunoprecipitation NN O
. . O

Reactivity NN O
was VBD O
also RB O
examined VBN O
with IN O
normal JJ O
control NN O
sera NN O
and CC O
disease NN O
control NN O
sera NN O
from IN O
patients NNS B-Species
with IN O
lupus NN O
and CC O
Sj NNP O
o NNP O
gren NNP O
' POS O
s NN O
syndrome NN O
. . O

Six CD O
independent JJ O
candidate NN O
clones NNS O
were VBD O
isolated VBN O
from IN O
the DT O
cDNA NNP O
library NN O
screen NN O
and CC O
were VBD O
identified VBN O
as IN O
overlapping JJ O
partial JJ O
human JJ B-Species
kinectin NN O
cDNAs NNS O
. . O

The DT O
finding NN O
that IN O
kinectin NN O
was VBD O
an DT O
autoantigen NN O
was VBD O
verified VBN O
in IN O
9 CD O
out IN O
of IN O
39 CD O
( , O
23 CD O
% NN O
) SYM O
BD NN O
patient NN B-Species
sera NN O
by IN O
immunoprecipitation NN O
of IN O
the DT O
in FW O
vitro FW O
translation NN O
products NNS O
. . O

Sera NNP O
from IN O
controls NNS O
showed VBD O
no DT O
reactivity NN O
. . O

The DT O
significance NN O
of IN O
kinectin NN O
as IN O
a DT O
participant NN O
in IN O
autoimmune JJ O
pathogenesis NN O
in IN O
BD NN O
and CC O
the DT O
potential JJ O
use NN O
of IN O
autoantibody NN O
to IN O
kinectin NN O
in IN O
serodiagnostics NNS O
are VBP O
discussed VBN O
. . O

Introduction NN O

Beh NNP O
c FW O
et FW O
' '' O
s VBZ O
disease NN O
( : O
BD NN O
) -RRB- O
is VBZ O
a DT O
systemic JJ O
vasculitic JJ O
disease NN O
typified VBN O
by IN O
a DT O
triad NN O
of IN O
symptoms NNS O
including VBG O
recurrent JJ O
oral JJ O
ulcers NNS O
, , O
genital JJ O
ulcers NNS O
and CC O
uveitis NN O
. . O

In IN O
addition NN O
, , O
skin NN O
, , O
joint NN O
, , O
large JJ O
vessels NNS O
, , O
nervous JJ O
system NN O
and CC O
gastrointestinal JJ O
systems NNS O
may MD O
be VB O
involved VBN O
. . O

BD NNP O
is VBZ O
a DT O
global JJ O
disease NN O
but CC O
has VBZ O
the DT O
highest JJS O
prevalence NN O
in IN O
the DT O
region NN O
along IN O
the DT O
ancient JJ O
' `` O
Silk NNP O
Road NNP O
' '' O
in IN O
China NNP O
. . O

The DT O
etiopathogenesis NN O
of IN O
the DT O
disease NN O
remains VBZ O
unclear JJ O
but CC O
microbial JJ O
agent NN O
triggers VBZ O
, , O
environmental JJ O
factors NNS O
, , O
genetic JJ O
predisposition NN O
, , O
neutrophil NN O
hyperfunction NN O
, , O
endothelial JJ O
cell NN O
dysfunction NN O
and CC O
immunological JJ O
abnormalities NNS O
involving VBG O
both CC O
T NN O
and CC O
B NN O
cells NNS O
have VBP O
been VBN O
implicated VBN O
. . O

Increasing VBG O
amounts NNS O
of IN O
research NN O
evidence NN O
supports VBZ O
the DT O
possibility NN O
that IN O
it PRP O
is VBZ O
an DT O
immune NN O
- HYPH O
mediated VBN O
vasculitis NN O
, , O
and CC O
that IN O
abnormal JJ O
T NN O
- HYPH O
cell NN O
and CC O
B NN O
- HYPH O
cell NN O
reactions NNS O
and CC O
autoantigen NN O
- HYPH O
driven VBN O
autoimmunity NN O
play VBP O
pivotal JJ O
roles NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Systemic JJ O
lupus NN O
erythematosus NN O
( , O
SLE NNP O
) -RRB- O
is VBZ O
the DT O
prototypic JJ O
systemic JJ O
autoimmune JJ O
rheumatic JJ O
disease NN O
with IN O
autoantibodies NNS O
against IN O
cellular JJ O
( , O
particularly RB O
nuclear JJ O
) , O
antigens NNS O
, , O
some DT O
of IN O
which WDT O
are VBP O
critically RB O
implicated VBN O
in IN O
the DT O
autoimmune JJ O
pathology NN O
while IN O
others NNS O
provide VBP O
valuable JJ O
serodiagnostic JJ O
markers NNS O
for IN O
the DT O
disease NN O
. . O

Unlike IN O
the DT O
picture NN O
in IN O
SLE NNP O
and CC O
other JJ O
related JJ O
rheumatic JJ O
diseases NNS O
, , O
in IN O
BD NN O
, , O
antinuclear JJ O
antibodies NNS O
and CC O
antibodies NNS O
to IN O
neutrophil NN O
cytoplasmic JJ O
antigens NNS O
etc FW O
. . O
are VBP O
not RB O
present JJ O
. . O

To IN O
date NN O
, , O
since IN O
neither CC O
a DT O
specific JJ O
autoantibody NN O
nor CC O
pathognomonic JJ O
pathological JJ O
index NN O
is VBZ O
available JJ O
to TO O
help VB O
establish VB O
the DT O
diagnosis NN O
of IN O
BD NNP O
, , O
it PRP O
is VBZ O
largely RB O
or CC O
solely RB O
based VBN O
on IN O
clinical JJ O
manifestations NNS O
[ -LRB- O
2 CD O
] -RRB- O
, , O
and CC O
a DT O
dilemma NN O
in IN O
diagnosis NN O
is VBZ O
not RB O
a DT O
rare JJ O
occurrence NN O
in IN O
clinical JJ O
practice NN O
. . O

Nevertheless RB O
, , O
since IN O
the DT O
1960s NNS O
, , O
there EX O
have VBP O
been VBN O
reports NNS O
of IN O
autoantibodies NNS O
against IN O
certain JJ O
unknown JJ O
components NNS O
of IN O
human JJ B-Species
oral JJ O
mucosa NN O
in IN O
sera NN O
of IN O
patients NNS B-Species
with IN O
BD NNP O
. . O

Since IN O
then RB O
, , O
sporadic JJ O
reports NNS O
on IN O
findings NNS O
of IN O
autoantibodies NNS O
in IN O
this DT O
disease NN O
have VBP O
been VBN O
described VBN O
, , O
such JJ O
as IN O
antibodies NNS O
to IN O
retinal JJ O
antigen NN O
( , O
s NN O
) -RRB- O
, , O
heat NN O
shock NN O
protein NN O
( , O
HSP NNP O
) -RRB- O
of IN O
some DT O
strains NNS O
of IN O
Streptococcus NNP B-Species
sanguis NN I-Species
cross NN O
- HYPH O
reactive JJ O
with IN O
human JJ B-Species
HSP NNP O
polypeptide NN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
antibodies NNS O
to IN O
endothelial JJ O
cell NN O
antigens NNS O
( , O
AECA NNP O
) -RRB- O
and CC O
antibodies NNS O
to IN O
alpha NN O
- HYPH O
tropomyosin NN O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
, , O
attesting VBG O
to IN O
the DT O
complicated JJ O
humoral JJ O
immune JJ O
disorders NNS O
in IN O
this DT O
disease NN O
. . O

This DT O
investigation NN O
was VBD O
aimed VBN O
at IN O
defining VBG O
target NN O
cellular JJ O
autoantigens NNS O
using VBG O
time NN O
- HYPH O
tested VBN O
and CC O
well RB O
- HYPH O
established VBN O
molecular JJ O
techniques NNS O
. . O

Immunoscreening NN O
of IN O
expression NN O
libraries NNS O
using VBG O
BD NN O
sera NN O
was VBD O
used VBN O
since IN O
this DT O
approach NN O
has VBZ O
been VBN O
successfully RB O
employed VBN O
in IN O
the DT O
characterization NN O
of IN O
many JJ O
clinically RB O
relevant JJ O
antigens NNS O
in IN O
systemic JJ O
rheumatic JJ O
diseases NNS O
such JJ O
as IN O
SS NNP O
- HYPH O
A NNP O
/ SYM O
Ro NNP O
[ -LRB- O
6 CD O
- SYM O
9 CD O
] -RRB- O
and CC O
SS NN O
- HYPH O
B NN O
/ SYM O
La NNP O
[ -LRB- O
10 CD O
] -RRB- O
antigens NNS O
in IN O
Sj NNP O
o FW O
gren NNP O
' POS O
s NN O
syndrome NN O
( , O
SjS NNP O
) -RRB- O
and CC O
centromere NN O
antigen NN O
CENP NN O
- HYPH O
B NN O
[ -LRB- O
11 CD O
] -RRB- O
in IN O
scleroderma NN O
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
been VBN O
successful JJ O
in IN O
using VBG O
this DT O
strategy NN O
to TO O
identify VB O
interesting JJ O
autoantigens NNS O
that WDT O
have VBP O
other JJ O
biological JJ O
significance NN O
. . O

Examples NNS O
of IN O
these DT O
include VBP O
NOR90 NNP O
/ SYM O
hUBF NNP O
[ -LRB- O
12 CD O
] -RRB- O
, , O
p80 NN O
- HYPH O
coilin NN O
[ -LRB- O
13 CD O
] -RRB- O
, , O
Golgi NNP O
autoantigens NNS O
[ -LRB- O
14 CD O
- HYPH O
16 CD O
] -RRB- O
and CC O
, , O
more RBR O
recently RB O
, , O
GW182 NNP O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Materials NNS O
and CC O
methods NNS O

Patients NNS B-Species
and CC O
sera NN O

The DT O
currently RB O
used VBN O
empirical JJ O
criteria NNS O
for IN O
the DT O
diagnosis NN O
of IN O
BD NN O
in IN O
this DT O
study NN O
were VBD O
the DT O
criteria NNS O
proposed VBN O
by IN O
the DT O
International NNP O
Study NNP O
Group NNP O
for IN O
BD NNP O
( , O
abbreviated VBN O
as IN O
' `` O
International NNP O
Criteria NNP O
' '' O
) -RRB- O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
study NN O
subjects NNS O
of IN O
39 CD O
Chinese JJ O
BD NNP O
patients NNS B-Species
comprised VBD O
17 CD O
males NNS O
and CC O
22 CD O
females NNS O
, , O
mean VBP O
age NN O
37 CD O
+ CD O
/ SYM O
- HYPH O
11 CD O
. . O
3 CD O
years NNS O
old JJ O
, , O
who WP O
were VBD O
divided VBN O
into IN O
two CD O
subgroups NNS O
: : O
25 CD O
typical JJ O
BD NNP O
patients NNS B-Species
( , O
Group NNP O
I NNP O
, , O
satisfying VBG O
the DT O
International NNP O
Criteria NNP O
) -RRB- O
and CC O
14 CD O
clinically RB O
diagnosed VBN O
BD NNP O
patients NNS B-Species
who WP O
had VBD O
recurrent JJ O
oral JJ O
ulcers NNS O
and CC O
one CD O
of IN O
the DT O
symptoms NNS O
of IN O
genital JJ O
ulcers NNS O
, , O
eye NN O
symptoms NNS O
or CC O
skin NN O
lesions NNS O
as IN O
defined VBN O
by IN O
the DT O
International NNP O
Criteria NNP O
, , O
as RB O
well RB O
as IN O
additional JJ O
symptom NN O
( , O
s VBZ O
) -RRB- O
closely RB O
related VBN O
to IN O
BD NNP O
as IN O
listed VBN O
in IN O
the DT O
International NNP O
Criteria NNP O
, , O
that WDT O
is VBZ O
, , O
gastrointestinal JJ O
ulcerations NNS O
, , O
deep JJ O
vein NN O
thrombosis NN O
or CC O
arthralgia NN O
/ SYM O
arthritis NN O
without IN O
evidence NN O
that IN O
the DT O
latter JJ O
symptoms NNS O
might MD O
be VB O
related VBN O
to IN O
any DT O
other JJ O
disease NN O
( -LRB- O
Group NNP O
II NNP O
, , O
defined VBN O
as IN O
' `` O
probable JJ O
BD NN O
' '' O
in IN O
this DT O
study NN O
) -RRB- O
. . O

Disease NN O
controls NNS O
included VBD O
10 CD O
patients NNS B-Species
with IN O
SLE NNP O
and CC O
10 CD O
with IN O
SjS NNP O
, , O
all DT O
satisfying VBG O
corresponding VBG O
international JJ O
classification NN O
criteria NNS O
. . O

All DT O
BD NN O
patients NNS B-Species
and CC O
disease NN O
controls NNS O
involved VBN O
in IN O
the DT O
study NN O
were VBD O
patients NNS B-Species
treated VBN O
at IN O
the DT O
Rheumatology NNP O
Department NNP O
of IN O
Ren NNP O
Ji NNP O
Hospital NNP O
, , O
Shanghai NNP O
, , O
China NNP O
, , O
where WRB O
their PRP$ O
clinical JJ O
data NNS O
and CC O
serum NN O
samples NNS O
were VBD O
collected VBN O
. . O

Twenty CD O
normal JJ O
control NN O
sera NN O
were VBD O
randomly RB O
selected VBN O
from IN O
healthy JJ O
blood NN O
donors NNS O
working VBG O
in IN O
the DT O
same JJ O
hospital NN O
. . O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
institution NN O
review NN O
board NN O
of IN O
Ren NNP O
Ji NNP O
Hospital NNP O
which WDT O
is VBZ O
affiliated VBN O
with IN O
Shanghai NNP O
Second NNP O
Medical NNP O
University NNP O
, , O
and CC O
each DT O
patient NN B-Species
involved VBN O
gave VBD O
informed JJ O
consent NN O
. . O

All DT O
serum JJ O
samples NNS O
were VBD O
preserved VBN O
at IN O
- SYM O
20 CD O
degrees NNS O
C NN O
or CC O
- SYM O
70 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

Cell NN O
lines NNS O
and CC O
cell NN O
extracts NNS O

HeLa NNP O
( , O
ATCC NNP O
CCL NNP O
2 CD O
. . O
2 CD O
) -RRB- O
and CC O
T24 CD O
( , O
human JJ B-Species
transitional JJ O
cell NN O
bladder NN O
carcinoma NN O
) -RRB- O
were VBD O
obtained VBN O
from IN O
the DT O
American NNP O
Type NNP O
Culture NNP O
Collection NNP O
( , O
Rockville NNP O
, , O
MD NNP O
, , O
USA NNP O
) -RRB- O
. . O

A DT O
bovine JJ B-Species
aortic JJ O
endothelial JJ O
cell NN O
line NN O
was VBD O
kindly RB O
provided VBN O
by IN O
Dr NNP O
Eugene NNP O
G NNP O
Levin NNP O
from IN O
the DT O
Scripps NNP O
Research NNP O
Institute NNP O
( : O
La NNP O
Jolla NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Cells NNS O
were VBD O
cultured VBN O
in IN O
DMEM NNP O
containing VBG O
10 CD O
% NN O
calf NN B-Species
serum NN O
, , O
harvested VBN O
and CC O
extracted VBN O
in IN O
Buffer NNP O
A NNP O
( SYM O
150 CD O
mM NN O
NaCl NNP O
, , O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH7 NN O
. . O
2 CD O
, , O
0 CD O
. . O
5 CD O
% NN O
Nonidet NNP O
P NN O
- HYPH O
40 CD O
) , O
with IN O
protease NN O
inhibitor NN O
( , O
Complete JJ O
( -LRB- O
TM NN O
) -RRB- O
; : O
Boehringer NNP O
Mannheim NNP O
, , O
Indianapolis NNP O
, , O
IN NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
the DT O
preparation NN O
of IN O
whole JJ O
cell NN O
extract NN O
, , O
10 CD O
volumes NNS O
of IN O
Laemmli NNP O
gel NN O
sample NN O
buffer NN O
[ -LRB- O
18 CD O
] -RRB- O
were VBD O
added VBN O
to IN O
the DT O
cell NN O
pellet NN O
, , O
boiled VBN O
for IN O
3 CD O
min NN O
and CC O
stored VBN O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

Western JJ O
blot NN O

Whole JJ O
cell NN O
lysates NNS O
from IN O
bovine JJ B-Species
aortic JJ O
endothelial JJ O
cell NN O
, , O
HeLa NNP O
and CC O
T24 NNP O
cells NNS O
were VBD O
resolved VBN O
individually RB O
by IN O
discontinuous JJ O
7 CD O
. . O
5 CD O
% NN O
gel NN O
SDS NN O
- HYPH O
PAGE NN O
according VBG O
to IN O
Laemmli NNP O
' POS O
s NN O
method NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Immunoblotting NN O
was VBD O
performed VBN O
as IN O
described VBN O
by IN O
Towbin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
19 CD O
] -RRB- O
with IN O
modifications NNS O
. . O

Nitrocellulose NN O
strips NNS O
were VBD O
blocked VBN O
with IN O
3 CD O
% NN O
nonfat JJ O
milk NN O
in IN O
PBS NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
Tween NNP O
- HYPH O
20 CD O
( HYPH O
PBS NN O
- HYPH O
T NN O
) -RRB- O
and CC O
then RB O
incubated VBN O
with IN O
BD NN O
patient NN B-Species
sera NN O
and CC O
normal JJ O
control NN O
sera NN O
( , O
1 CD O
: : O
100 CD O
dilution NN O
) -RRB- O
at IN O
room NN O
temperature NN O
for IN O
1 CD O
h NN O
. . O

Filters NNS O
were VBD O
washed VBN O
extensively RB O
with IN O
PBS NNP O
- HYPH O
T NNP O
to TO O
remove VB O
any DT O
unbound JJ O
antibodies NNS O
. . O

Bound JJ O
antibodies NNS O
were VBD O
detected VBN O
with IN O
polyvalent JJ O
, , O
peroxidase NN O
- HYPH O
conjugated VBN O
goat NN B-Species
anti JJ O
- HYPH O
human JJ B-Species
Ig NN O
and CC O
visualized VBN O
by IN O
incubating VBG O
the DT O
nitrocellulose NN O
strips NNS O
in IN O
chemiluminescent NN O
reagents NNS O
( , O
NEN NNP O
Life NNP O
Science NNP O
Products NNPS O
Inc NNP O
. . O
, , O
Boston NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
and CC O
exposing VBG O
to IN O
Kodak NNP O
XAR NNP O
- HYPH O
5 CD O
films NNS O
. . O

Screening NN O
of IN O
phage NN O
cDNA NN O
expression NN O
library NN O
with IN O
antibody NN O
probes NNS O

Serum NN O
from IN O
a DT O
BD NN O
patient NN B-Species
showing VBG O
the DT O
highest JJS O
antibody NN O
titer NN O
in IN O
immunoblotting NN O
was VBD O
selected VBN O
as IN O
a DT O
probe NN O
and CC O
used VBN O
at IN O
a DT O
dilution NN O
of IN O
1 CD O
: SYM O
300 CD O
for IN O
initial JJ O
immunoscreening NN O
of IN O
approximately RB O
106 CD O
recombinants NNS O
from IN O
a DT O
T24 CD O
cDNA NN O
expression NN O
library NN O
. . O

The DT O
latter JJ O
was VBD O
constructed VBN O
in IN O
lambda NN O
ZAPExpress NNP O
vector NN O
( , O
Stratagene NNP O
, , O
La NNP O
Jolla NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
and CC O
screened VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
20 CD O
- SYM O
22 CD O
] -RRB- O
. . O

All DT O
screenings NNS O
were VBD O
performed VBN O
on IN O
duplicate JJ O
isopropyl NN O
beta NN O
- HYPH O
D NN O
- HYPH O
thiogalactoside NN O
( -LRB- O
IPTG NNP O
) -RRB- O
pre NN O
- HYPH O
impregnated VBN O
nitrocellulose NN O
filters NNS O
, , O
and CC O
immunoreactive JJ O
clones NNS O
were VBD O
detected VBN O
by IN O
chemiluminescence NN O
. . O

Positive JJ O
phages NNS O
were VBD O
subsequently RB O
plaque NN O
purified VBN O
to IN O
100 CD O
% NN O
by IN O
two CD O
repeated VBN O
rounds NNS O
of IN O
screening NN O
at IN O
low JJ O
plaque NN O
densities NNS O
. . O

Before IN O
screening VBG O
the DT O
cDNA NNP O
library NN O
, , O
the DT O
BD NNP O
serum NN O
was VBD O
extensively RB O
adsorbed VBN O
against IN O
bacteria NNS O
and CC O
wild JJ O
- HYPH O
type NN O
lambda NN O
ZAP NN O
phage NN O
mixture NN O
to TO O
reduce VB O
background NN O
binding NN O
. . O

Analysis NN O
of IN O
candidate NN O
cDNAs NNS O

Purified JJ O
candidate NN O
plaques NNS O
were VBD O
subcloned VBN O
in IN O
vivo NN O
into IN O
pBK NNP O
- HYPH O
CMV NNP O
plasmids NNS O
using VBG O
ExAssist NNP O
( -LRB- O
TM NNP O
) -RRB- O
helper NN O
phage NN O
as IN O
recommended VBN O
in IN O
the DT O
manufacturer NN O
' POS O
s NN O
instructions NNS O
( -LRB- O
Stratagene NNP O
) -RRB- O
. . O

The DT O
recombinant JJ O
pBK NN O
- HYPH O
CMV NNP O
plasmids NNS O
were VBD O
then RB O
purified VBN O
using VBG O
QIAprep NNP O
Spin NNP O
Minprep NNP O
Kit NNP O
( , O
Qiagen NNP O
, , O
Valencia NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Restriction NN O
enzyme NN O
digestion NN O
of IN O
plasmids NNS O
with IN O
EcoRI NNP O
and CC O
XhoI NN O
and CC O
electrophoresis NN O
in IN O
a DT O
standard JJ O
1 CD O
. . O
0 CD O
% NN O
agarose NN O
gel NN O
was VBD O
used VBN O
to TO O
analyze VB O
the DT O
length NN O
of IN O
cDNA NN O
insert NN O
of IN O
each DT O
candidate NN O
plasmid NN O
. . O

The DT O
complete JJ O
nucleotide NN O
sequence NN O
was VBD O
determined VBN O
using VBG O
Bigdye NN O
terminator NN O
sequencing NN O
and CC O
a DT O
semi NN O
- HYPH O
automated VBN O
sequencer NN O
model NN O
377 CD O
( , O
ABI NNP O
, , O
Foster NNP O
City NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Both DT O
nucleotide NN O
and CC O
deduced VBN O
amino NN O
acid NN O
sequences NNS O
were VBD O
analyzed VBN O
for IN O
similarity NN O
with IN O
known VBN O
sequences NNS O
using VBG O
BLAST NN O
search NN O
[ -LRB- O
23 CD O
] -RRB- O
and CC O
ExPASy NNP O
Proteomics NNPS O
tools NNS O
. . O

Secondary JJ O
structure NN O
analysis NN O
for IN O
coiled VBN O
- HYPH O
coil NN O
motifs NNS O
was VBD O
conducted VBN O
with IN O
the DT O
software NN O
program NN O
COILS NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Immunoprecipitation NN O
of IN O
in FW O
vitro FW O
translation NN O
products NNS O

Candidate NN O
cDNA NNP O
clones NNS O
were VBD O
used VBN O
as IN O
templates NNS O
for IN O
in FW O
vitro FW O
transcription NN O
and CC O
translation NN O
and CC O
the DT O
products NNS O
were VBD O
used VBN O
as IN O
substrates NNS O
for IN O
immunoprecipitation NN O
to TO O
confirm VB O
the DT O
specificity NN O
of IN O
reaction NN O
with IN O
BD NNP O
sera NN O
. . O

In IN O
brief JJ O
, , O
1 CD O
mu NN O
g NN O
of IN O
the DT O
pBK NNP O
- HYPH O
CMV NNP O
plasmid NN O
identified VBN O
in IN O
the DT O
screening NN O
outlined VBN O
above RB O
was VBD O
added VBN O
as IN O
template NN O
in IN O
a DT O
50 CD O
- HYPH O
mu NN O
l JJ O
reaction NN O
for IN O
the DT O
coupled VBN O
in FW O
vitro FW O
transcription NN O
and CC O
translation NN O
reaction NN O
with IN O
a DT O
rabbit NN B-Species
reticulocyte NN O
lysate NN O
system NN O
( , O
Promega NNP O
, , O
Madison NNP O
, , O
WI NNP O
, , O
USA NNP O
) , O
in IN O
the DT O
presence NN O
of IN O
35S NNP O
- HYPH O
methionine NN O
( , O
Trans NNP O
- HYPH O
35S NNP O
label NN O
; , O
ICN NNP O
Biochemicals NNP O
, , O
Costa NNP O
Mesa NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
and CC O
RNasin NNP O
( -LRB- O
R NNP O
) -RRB- O
Ribonuclease NNP O
Inhibitor NNP O
( -LRB- O
Stratagene NNP O
) -RRB- O
as IN O
recommended VBN O
by IN O
the DT O
manufacturer NN O
( , O
Promega NNP O
) -RRB- O
. . O

Translation NN O
was VBD O
carried VBN O
out RP O
at IN O
30 CD O
degrees NNS O
C NN O
for IN O
1 CD O
. . O
5 CD O
h NN O
. . O

Products NNS O
were VBD O
analyzed VBN O
in IN O
a DT O
12 CD O
. . O
5 CD O
% NN O
gel NN O
SDS NN O
- HYPH O
PAGE NNP O
and CC O
stored VBN O
at IN O
- HYPH O
80 CD O
degrees NNS O
C NN O
for IN O
further JJ O
immunoprecipitation NN O
analysis NN O
. . O

The DT O
in FW O
vitro FW O
translation NN O
proteins NNS O
were VBD O
examined VBN O
for IN O
reactivity NN O
by IN O
sera NN O
using VBG O
immunoprecipitation NN O
described VBN O
[ -LRB- O
8 CD O
, , O
25 CD O
] -RRB- O
. . O

Results NNS O
and CC O
discussion NN O

Autoantibody NN O
detection NN O
in IN O
sera NN O
from IN O
BD NNP O
patients NNS B-Species

Initial JJ O
examination NN O
of IN O
a DT O
group NN O
of IN O
39 CD O
BD NN O
patients NNS B-Species
using VBG O
indirect JJ O
immunofluorescence NN O
( , O
IIF NNP O
) -RRB- O
on IN O
a DT O
HEp NNP O
- HYPH O
2 CD O
cell NN O
substrate NN O
did VBD O
not RB O
yield VB O
any DT O
characteristic JJ O
nuclear JJ O
or CC O
cytoplasmic JJ O
staining NN O
patterns NNS O
. . O

BD NNP O
is VBZ O
thought VBN O
by IN O
some DT O
to TO O
be VB O
a DT O
vasculitic JJ O
disease NN O
involving VBG O
pathophysiology NN O
of IN O
endothelial JJ O
cells NNS O
, , O
and CC O
antibody NN O
to IN O
endothelial JJ O
cell NN O
antigen NN O
( -LRB- O
AECA NNP O
) -RRB- O
has VBZ O
been VBN O
reported VBN O
. . O

Reports NNS O
on IN O
the DT O
prevalence NN O
of IN O
AECA NNP O
have VBP O
varied VBN O
largely RB O
and CC O
alpha NN O
- HYPH O
enolase NN O
was VBD O
reported VBN O
as IN O
one CD O
of IN O
the DT O
putative JJ O
target NN O
antigens NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
use NN O
of IN O
bovine JJ B-Species
aortic JJ O
endothelial JJ O
cells NNS O
as IN O
substrate NN O
for IN O
IIF NNP O
did VBD O
not RB O
provide VB O
any DT O
additional JJ O
data NNS O
. . O

However RB O
, , O
Western JJ O
blot NN O
analysis NN O
of IN O
the DT O
BD NNP O
sera NN O
began VBD O
to TO O
show VB O
some DT O
interesting JJ O
autoreactivity NN O
using VBG O
cell NN O
lysates NNS O
from IN O
both CC O
HeLa NNP O
and CC O
bovine JJ B-Species
aortic JJ O
endothelial JJ O
cells NNS O
. . O

HeLa NNP O
cells NNS O
were VBD O
initially RB O
used VBN O
for IN O
this DT O
analysis NN O
because IN O
they PRP O
are VBP O
commonly RB O
used VBN O
in IN O
the DT O
laboratory NN O
as IN O
Western JJ O
blot NN O
substrate NN O
. . O

Fig NN O
. . O

1 CD O
illustrates VBZ O
the DT O
common JJ O
reactivity NN O
to IN O
49 CD O
kDa NN O
and CC O
120 CD O
kDa NN O
proteins NNS O
in IN O
the DT O
endothelial JJ O
cell NN O
lysates NNS O
. . O

These DT O
antigens NNS O
were VBD O
also RB O
detected VBN O
in IN O
HeLa NNP O
and CC O
T24 NNP O
cells NNS O
; : O
the DT O
latter JJ O
cell NN O
line NN O
was VBD O
analyzed VBN O
because IN O
our PRP$ O
laboratory NN O
at IN O
The DT O
Scripps NNP O
Research NNP O
Institute NNP O
has VBZ O
produced VBN O
an DT O
excellent JJ O
expression NN O
cDNA NN O
library NN O
from IN O
the DT O
T24 NNP O
line NN O
and CC O
the DT O
positive JJ O
result NN O
with IN O
the DT O
T24 CD O
cell NN O
extracts NNS O
allowed VBD O
us PRP O
to TO O
screen VB O
the DT O
T24 NNP O
library NN O
. . O

Ig NN O
isotype NN O
analysis NN O
showed VBD O
that IN O
all DT O
reactivity NN O
was VBD O
largely RB O
IgG NNP O
antibodies NNS O
. . O

Since IN O
the DT O
49 CD O
kDa NN O
and CC O
120 CD O
kDa NN O
bands NNS O
were VBD O
observed VBN O
in IN O
cell NN O
extracts NNS O
from IN O
bovine NN B-Species
as RB O
well RB O
as IN O
human JJ B-Species
cell NN O
lines NNS O
, , O
these DT O
autoantigens NNS O
might MD O
be VB O
evolutionarily RB O
conserved VBN O
. . O

In IN O
total NN O
, , O
nine CD O
out IN O
of IN O
39 CD O
BD NN O
sera NN O
( : O
23 CD O
% NN O
) -RRB- O
had VBD O
autoantibody NN O
to IN O
the DT O
49 CD O
kDa NN O
antigen NN O
and CC O
eight CD O
( : O
20 CD O
% NN O
) -RRB- O
to IN O
the DT O
120 CD O
kDa NN O
antigen NN O
. . O

Four CD O
BD NN O
sera NN O
( : O
10 CD O
% NN O
) -RRB- O
reacted VBN O
with IN O
both DT O
proteins NNS O
. . O

Additionally RB O
, , O
sera NN O
that WDT O
showed VBD O
common JJ O
reactivity NN O
to IN O
the DT O
120 CD O
kDa NN O
protein NN O
also RB O
demonstrated VBD O
a DT O
common JJ O
band NN O
that WDT O
migrated VBD O
at IN O
~ $ O
150 CD O
kDa NNS O
, , O
although IN O
it PRP O
appeared VBD O
weaker JJR O
than IN O
the DT O
120 CD O
kDa NN O
band NN O
. . O

These DT O
antigens NNS O
appeared VBD O
to TO O
have VB O
different JJ O
molecular JJ O
weights NNS O
than IN O
those DT O
of IN O
the DT O
known VBN O
autoantigens NNS O
in IN O
systemic JJ O
rheumatic JJ O
diseases NNS O
. . O

In IN O
addition NN O
, , O
other JJ O
reactive JJ O
bands NNS O
were VBD O
detected VBN O
but CC O
they PRP O
were VBD O
not RB O
as RB O
commonly RB O
shared VBN O
as IN O
the DT O
49 CD O
kDa NN O
and CC O
120 CD O
kDa NN O
bands NNS O
. . O

The DT O
49 CD O
kDa NN O
protein NN O
was VBD O
shown VBN O
to TO O
be VB O
distinct JJ O
from IN O
48 CD O
kDa NNP O
SS NNP O
- HYPH O
B NNP O
/ SYM O
La NNP O
or CC O
50 CD O
kDa NN O
Jo NNP O
- HYPH O
1 CD O
proteins NNS O
( : O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
120 CD O
kDa NNP O
antigen NN O
was VBD O
also RB O
shown VBN O
to TO O
migrate VB O
differently RB O
from IN O
alanyl NN O
tRNA NNP O
synthetase NN O
in IN O
another DT O
Western JJ O
blot NN O
analysis NN O
( , O
data NNS O
not RB O
shown VBN O
) , O
and CC O
did VBD O
not RB O
share VB O
any DT O
apparent JJ O
crossreactive JJ O
epitopes NNS O
with IN O
the DT O
49 CD O
kDa NN O
antigen NN O
. . O

Western JJ O
blot NN O
analyses NNS O
of IN O
20 CD O
normal JJ O
control NN O
sera NN O
did VBD O
not RB O
show VB O
the DT O
reactivities NNS O
observed VBN O
with IN O
BD NNP O
sera NN O
. . O

In IN O
order NN O
to TO O
further RB O
characterize VB O
these DT O
autoreactivities NNS O
, , O
a DT O
serum NN O
sample NN O
from IN O
the DT O
Group NNP O
I NNP O
definitive JJ O
BD NNP O
patients NNS B-Species
with IN O
the DT O
strongest JJS O
reactivity NN O
to IN O
49 CD O
kDa NN O
and CC O
120 CD O
kDa NN O
antigens NNS O
( -LRB- O
Fig NNP O
. . O
1 CD O
, , O
lane NN O
2 CD O
) -RRB- O
was VBD O
selected VBN O
as IN O
antibody NN O
probe NN O
for IN O
expression NN O
library NN O
screening NN O
. . O

Kinectin NNP O
identified VBD O
as IN O
a DT O
novel JJ O
BD NN O
autoantigen NN O

After IN O
screening VBG O
500 CD O
, , O
0 CD O
clones NNS O
from IN O
the DT O
T24 NNP O
cell NN O
lambda NN O
ZAPExpress NNP O
expression NN O
library NN O
, , O
seven CD O
immunoreactive JJ O
clones NNS O
were VBD O
isolated VBN O
and CC O
plaque NN O
purified VBN O
in IN O
two CD O
to IN O
three CD O
rounds NNS O
to TO O
achieve VB O
100 CD O
% NN O
homogeneity NN O
. . O

The DT O
cDNA NNP O
inserts NNS O
were VBD O
subcloned VBN O
in IN O
vivo NN O
into IN O
pBK NNP O
- HYPH O
CMV NNP O
plasmids NNS O
, , O
analyzed VBN O
by IN O
restriction NN O
digestion NN O
using VBG O
EcoRI NNP O
and CC O
XhoI NNP O
enzymes NNS O
, , O
and CC O
submitted VBN O
to IN O
direct JJ O
nucleotide NN O
sequencing NN O
across IN O
the DT O
polylinker NN O
arms NNS O
. . O

The DT O
cDNA NNP O
inserts NNS O
represented VBD O
six CD O
independent JJ O
clones NNS O
designated VBN O
BD41 NNP O
( , O
identical JJ O
to IN O
BD44 NNP O
) -RRB- O
, , O
BD481 NNP O
, , O
BD42 NNP O
, , O
BD47 NNP O
, , O
BD482 NNP O
and CC O
BD49 NNP O
. . O

Their PRP$ O
identities NNS O
were VBD O
established VBN O
as IN O
overlapping JJ O
partial JJ O
cDNAs NNS O
of IN O
human JJ B-Species
kinectin NN O
, , O
ranging VBG O
from IN O
1 CD O
. . O
9 CD O
kb NN O
to IN O
3 CD O
kb NNS O
( , O
Fig NNP O
. . O
2a CD O
) -RRB- O
. . O

The DT O
full JJ O
- HYPH O
length NN O
human JJ B-Species
kinectin NN O
( , O
GenBank NNP O
accession NN O
number NN O
NM NNP O
_ SYM O
182926 CD O
[ -LRB- O
27 CD O
] -RRB- O
) -RRB- O
has VBZ O
4 CD O
, , O
816 CD O
bases NNS O
containing VBG O
an DT O
open JJ O
reading NN O
frame NN O
coding VBG O
1 CD O
, , O
357 CD O
amino NN O
acid NN O
residues NNS O
with IN O
molecular JJ O
mass NN O
156 CD O
kDa NN O
. . O

All DT O
six CD O
cDNAs NNS O
lacked VBD O
the DT O
5 CD O
' '' O
portion NN O
of IN O
the DT O
kinectin NN O
sequence NN O
to IN O
different JJ O
degrees NNS O
but CC O
spanned VBD O
a DT O
sequence NN O
of IN O
kinectin NN O
that WDT O
extended VBD O
to IN O
the DT O
3 CD O
' '' O
- HYPH O
untranslated JJ O
region NN O
. . O

Secondary JJ O
structure NN O
analysis NN O
of IN O
kinectin NN O
protein NN O
using VBG O
the DT O
program NN O
COILS NNS O
identified VBD O
a DT O
long JJ O
region NN O
of IN O
alpha NN O
- HYPH O
helical NN O
coiled VBN O
- HYPH O
coil NN O
domain NN O
that WDT O
extended VBD O
from IN O
amino NN O
acid NN O
residue NN O
327 CD O
to IN O
the DT O
C NNP O
- HYPH O
terminus NN O
( : O
Fig NNP O
. . O
2a CD O
, , O
hatched VBN O
boxes NNS O
) -RRB- O
. . O

In IN O
vitro FW O
coupled JJ O
transcription NN O
and CC O
translation NN O
of IN O
BD44 NN O
and CC O
BD42 NN O
clones NNS O
directed VBN O
the DT O
synthesis NN O
of IN O
[ -LRB- O
35S NNP O
] -RRB- O
- HYPH O
methionine NN O
- HYPH O
labeled VBN O
polypeptides NNS O
that WDT O
migrated VBD O
at IN O
95 CD O
and CC O
60 CD O
kDa NN O
, , O
respectively RB O
, , O
in IN O
addition NN O
to IN O
smaller JJR O
polypeptides NNS O
( : O
Fig NNP O
. . O
2b CD O
) -RRB- O
. . O

These DT O
products NNS O
had VBD O
predicted VBN O
molecular JJ O
weights NNS O
of IN O
103 CD O
kDa NNS O
and CC O
75 CD O
kDa NNS O
. . O

Kinectin NNP O
was VBD O
initially RB O
identified VBN O
in IN O
chick JJ B-Species
embryo NN O
brain NN O
microsome NN O
as IN O
an DT O
integral JJ O
membrane NN O
protein NN O
anchored VBN O
in IN O
endoplasmic JJ O
reticulum NN O
and CC O
involved VBN O
in IN O
kinesin NN O
- HYPH O
driven VBN O
vesicle NN O
motility NN O
along IN O
microtubules NNS O
[ -LRB- O
28 CD O
, , O
29 CD O
] -RRB- O
. . O

Kinectin NNP O
consists VBZ O
of IN O
a DT O
120 CD O
- HYPH O
kDa NN O
and CC O
a DT O
160 CD O
- HYPH O
kDa NN O
polypeptide NN O
interacting VBG O
through IN O
the DT O
alpha NN O
- HYPH O
helical NN O
coiled VBN O
- HYPH O
coil NN O
domain NN O
to TO O
form VB O
a DT O
heterodimer NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
full JJ O
- HYPH O
length NN O
kinectin NN O
is VBZ O
the DT O
160 CD O
kDa NN O
polypeptide NN O
containing VBG O
an DT O
N NNP O
- HYPH O
terminal JJ O
transmembrane NN O
helix NN O
followed VBN O
by IN O
a DT O
bipartite JJ O
nuclear JJ O
localization NN O
sequence NN O
and CC O
two CD O
C NN O
- HYPH O
terminal JJ O
leucine NN O
zipper NN O
motifs NNS O
. . O

We PRP O
presume VBP O
that IN O
the DT O
120 CD O
kDa NN O
polypeptide NN O
detected VBN O
in IN O
Western JJ O
blot NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
is VBZ O
the DT O
truncated VBN O
version NN O
of IN O
the DT O
160 CD O
- HYPH O
kDa NN O
polypeptide NN O
, , O
lacking VBG O
the DT O
N NNP O
- HYPH O
terminal JJ O
first JJ O
232 CD O
amino NN O
acids NNS O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
N NNP O
- HYPH O
terminus NN O
of IN O
the DT O
160 CD O
- HYPH O
kDa NN O
polypeptide NN O
consists VBZ O
of IN O
a DT O
transmembrane NN O
domain NN O
that WDT O
anchors VBZ O
kinectin NN O
to IN O
endoplasmic JJ O
reticulum NN O
[ -LRB- O
30 CD O
, , O
31 CD O
] -RRB- O
. . O

This DT O
120 CD O
kDa NN O
polypeptide NN O
is VBZ O
probably RB O
the DT O
predominant JJ O
form NN O
detected VBN O
in IN O
the DT O
Western JJ O
blot NN O
analysis NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
because IN O
of IN O
its PRP$ O
preferential JJ O
solubility NN O
due IN O
to IN O
the DT O
omission NN O
of IN O
the DT O
N NNP O
- HYPH O
terminal JJ O
transmembrane NN O
domain NN O
. . O

Other JJ O
functions NNS O
for IN O
kinectin NN O
have VBP O
been VBN O
reported VBN O
. . O

Yeast NN B-Species
two CD O
- HYPH O
hybrid NN O
screen NN O
studies NNS O
from IN O
several JJ O
laboratories NNS O
have VBP O
revealed VBN O
the DT O
interaction NN O
of IN O
the DT O
Rho NNP O
family NN O
of IN O
GTPase NNP O
with IN O
kinectin NN O
, , O
and CC O
have VBP O
shown VBN O
the DT O
functional JJ O
links NNS O
among IN O
RhoG NNP O
, , O
kinectin NN O
and CC O
kinesin NN O
, , O
with IN O
kinectin NN O
as IN O
a DT O
key JJ O
effector NN O
of IN O
RhoG NNP O
microtubule NN O
- HYPH O
dependent JJ O
cellular JJ O
activity NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Kinectin NNP O
was VBD O
also RB O
identified VBN O
as IN O
an DT O
important JJ O
constituent NN O
of IN O
integrin NN O
- HYPH O
based VBN O
adhesion NN O
complexes NNS O
, , O
which WDT O
link VBP O
integrins NNS O
to IN O
the DT O
cytoskeleton NN O
and CC O
recruit VBP O
signaling VBG O
molecules NNS O
[ -LRB- O
33 CD O
] -RRB- O
. . O

A DT O
new JJ O
study NN O
reported VBD O
that IN O
a DT O
kinectin NN O
isoform NN O
lacking VBG O
a DT O
major JJ O
portion NN O
of IN O
the DT O
kinesin NN O
- HYPH O
binding VBG O
domain NN O
is VBZ O
very RB O
probably RB O
the DT O
most RBS O
conservative JJ O
form NN O
of IN O
kinectin NN O
; : O
it PRP O
does VBZ O
not RB O
bind VB O
kinesin NN O
but CC O
act VB O
as IN O
a DT O
membrane NN O
anchor NN O
for IN O
the DT O
translation NN O
elongation NN O
factor NN O
- HYPH O
1 CD O
delta NN O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Prevalence NN O
and CC O
specificity NN O
of IN O
anti JJ O
- HYPH O
kinectin NN O
autoantibodies NNS O

The DT O
in FW O
vitro FW O
[ -LRB- O
35S NNP O
] -RRB- O
- HYPH O
methionine NN O
- HYPH O
labeled VBN O
translation NN O
product NN O
of IN O
BD44 NN O
, , O
representing VBG O
the DT O
largest JJS O
recombinant JJ O
kinectin NN O
fragment NN O
available JJ O
, , O
was VBD O
used VBN O
as IN O
the DT O
antigen NN O
substrate NN O
in IN O
an DT O
immunoprecipitation NN O
assay NN O
. . O

Out IN O
of IN O
39 CD O
BD NN O
patient NN B-Species
sera NN O
, , O
nine CD O
( SYM O
23 CD O
% NN O
) -RRB- O
recognized VBN O
the DT O
BD44 NN O
translation NN O
product NN O
( -LRB- O
Fig NNP O
. . O
3 CD O
) -RRB- O
, , O
whereas IN O
sera NN O
from IN O
20 CD O
normal JJ O
controls NNS O
, , O
10 CD O
SLE NNP O
and CC O
10 CD O
SjS NNP O
patients NNS B-Species
did VBD O
not RB O
show VB O
reactivity NN O
. . O

Among IN O
the DT O
nine CD O
anti AFX O
- HYPH O
kinectin NN O
positive JJ O
patients NNS B-Species
, , O
six CD O
( , O
6 CD O
/ SYM O
25 CD O
, , O
24 CD O
% NN O
) -RRB- O
were VBD O
from IN O
Group NNP O
I NNP O
( , O
definitive JJ O
BD NN O
) , O
including VBG O
the DT O
BD NNP O
patient NN B-Species
whose WP$ O
serum NN O
was VBD O
used VBN O
in IN O
the DT O
immunoscreening NN O
of IN O
expression NN O
cDNA NNP O
library NN O
, , O
and CC O
three CD O
( SYM O
3 CD O
/ SYM O
14 CD O
, , O
21 CD O
. . O
4 CD O
% NN O
) -RRB- O
patients NNS B-Species
were VBD O
from IN O
the DT O
Group NNP O
II NNP O
( , O
probable JJ O
BD NNP O
) -RRB- O
in IN O
this DT O
study NN O
. . O

According VBG O
to IN O
the DT O
Fisher NNP O
Exact NNP O
Probability NNP O
calculation NN O
( : O
P NN O
= SYM O
1 CD O
. . O
0 CD O
) -RRB- O
, , O
there EX O
is VBZ O
no DT O
statistically RB O
significant JJ O
difference NN O
for IN O
antibody NN O
to IN O
kinectin NN O
between IN O
the DT O
two CD O
groups NNS O
. . O

The DT O
combined VBN O
data NNS O
substantiated VBD O
the DT O
finding NN O
that IN O
kinectin NN O
is VBZ O
an DT O
autoantigen NN O
that WDT O
can MD O
be VB O
recognized VBN O
by IN O
sera NNS O
from IN O
23 CD O
% NN O
of IN O
Chinese JJ O
BD NNP O
patients NNS B-Species
in IN O
this DT O
study NN O
with IN O
at RB O
least RBS O
one CD O
immunoreactive JJ O
region NN O
or CC O
autoepitope NN O
residing VBG O
within IN O
the DT O
BD44 NNP O
encoded VBN O
polypeptide NN O
. . O

Currently RB O
, , O
there EX O
are VBP O
more JJR O
than IN O
six CD O
diagnostic JJ O
/ SYM O
classification NN O
criteria NNS O
for IN O
BD NNP O
, , O
among IN O
which WDT O
the DT O
International NNP O
Criteria NNP O
have VBP O
been VBN O
applied VBN O
most RBS O
extensively RB O
due IN O
to IN O
its PRP$ O
relatively RB O
high JJ O
sensitivity NN O
( : O
91 CD O
% NN O
) -RRB- O
and CC O
specificity NN O
( : O
96 CD O
% NN O
) -RRB- O
[ -LRB- O
2 CD O
] -RRB- O
. . O

As IN O
discussed VBN O
above RB O
, , O
differential JJ O
diagnosis NN O
of IN O
BD NN O
might MD O
be VB O
confusing JJ O
in IN O
clinical JJ O
practice NN O
since IN O
no DT O
specific JJ O
laboratory NN O
test NN O
is VBZ O
available JJ O
, , O
and CC O
some DT O
patients NNS B-Species
may MD O
have VB O
symptoms NNS O
and CC O
signs NNS O
strongly RB O
suggestive JJ O
of IN O
BD NN O
but CC O
do VBP O
not RB O
fully RB O
satisfy VB O
the DT O
International NNP O
Criteria NNP O
, , O
as IN O
in IN O
the DT O
Group NNP O
II NNP O
( , O
probable JJ O
BD NNP O
) , O
patients NNS B-Species
in IN O
our PRP$ O
study NN O
group NN O
. . O

A DT O
number NN O
of IN O
investigators NNS O
have VBP O
pointed VBN O
out RP O
that IN O
a DT O
comprehensive JJ O
analysis NN O
of IN O
the DT O
clinical JJ O
data NNS O
for IN O
a DT O
given VBN O
patient NN B-Species
is VBZ O
very RB O
important JJ O
for IN O
correct JJ O
clinical JJ O
diagnosis NN O
of IN O
BD NNP O
, , O
and CC O
that IN O
classification NN O
/ SYM O
diagnosis NN O
criteria NNS O
, , O
including VBG O
the DT O
International NNP O
Criteria NNP O
, , O
should MD O
be VB O
followed VBN O
but CC O
should MD O
not RB O
be VB O
exclusive JJ O
. . O

The DT O
observation NN O
that IN O
three CD O
out IN O
of IN O
14 CD O
patients NNS B-Species
in IN O
the DT O
probable JJ O
BD NN O
group NN O
also RB O
had VBD O
antibody NN O
to IN O
kinectin NN O
and CC O
the DT O
similar JJ O
percentage NN O
of IN O
positive JJ O
reactors NNS O
between IN O
this DT O
group NN O
and CC O
Group NNP O
I NNP O
( : O
21 CD O
. . O
4 CD O
% NN O
versus IN O
24 CD O
% NN O
) -RRB- O
supports VBZ O
this DT O
notion NN O
. . O

The DT O
further JJ O
use NN O
of IN O
non JJ O
- HYPH O
clinical JJ O
parameters NNS O
such JJ O
as IN O
immunological JJ O
biomarkers NNS O
as IN O
adjuncts NNS O
to TO O
identify VB O
BD NN O
patients NNS B-Species
could MD O
be VB O
of IN O
help NN O
in IN O
the DT O
classification NN O
of IN O
this DT O
disease NN O
entity NN O

While IN O
our PRP$ O
work NN O
was VBD O
ongoing JJ O
, , O
anti JJ O
- HYPH O
kinectin NN O
antibodies NNS O
were VBD O
reported VBN O
in IN O
sera NN O
from IN O
patients NNS B-Species
with IN O
hepatocellular JJ O
carcinoma NN O
( -LRB- O
HCC NNP O
) -RRB- O
[ -LRB- O
35 CD O
, , O
36 CD O
] -RRB- O
and CC O
aplastic JJ O
anemia NN O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
. . O

The DT O
first JJ O
HCC NNP O
report NN O
[ -LRB- O
35 CD O
] -RRB- O
identified VBD O
kinectin NN O
as IN O
a DT O
tumor NN O
- HYPH O
associated VBN O
antigen NN O
from IN O
the DT O
screening NN O
of IN O
an DT O
autologous JJ O
cDNA NNP O
library NN O
constructed VBN O
from IN O
the DT O
cancer NN O
of IN O
a DT O
30 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
patient NN B-Species
from IN O
Guangxi NNP O
, , O
China NNP O
. . O

This DT O
report NN O
stated VBD O
that IN O
four CD O
out IN O
of IN O
five CD O
HCC NNP O
patients NNS B-Species
tested VBN O
were VBD O
positive JJ O
for IN O
anti JJ O
- HYPH O
kinectin NN O
antibody NN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

In IN O
2004 CD O
, , O
another DT O
laboratory NN O
also RB O
reported VBD O
the DT O
cloning NN O
of IN O
kinectin NN O
as IN O
a DT O
tumor NN O
- HYPH O
associated VBN O
antigen NN O
from IN O
a DT O
( , O
presumably RB O
) , O
different JJ O
30 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
Chinese JJ O
HCC NNP O
patient NN B-Species
[ -LRB- O
36 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
anti JJ O
- HYPH O
kinectin NN O
antibodies NNS O
were VBD O
not RB O
detected VBN O
in IN O
other JJ O
studies NNS O
of IN O
HCC NNP O
patients NNS B-Species
associated VBN O
with IN O
our PRP$ O
laboratory NN O
[ -LRB- O
39 CD O
, , O
40 CD O
] -RRB- O
. . O

The DT O
reports NNS O
of IN O
anti JJ O
- HYPH O
kinectin NN O
antibodies NNS O
in IN O
aplastic JJ O
anemia NN O
are VBP O
also RB O
very RB O
interesting JJ O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
. . O

The DT O
initial JJ O
report NN O
by IN O
Hirano NNP O
et FW O
al NNP O
. , O
identified VBD O
kinectin NN O
by IN O
screening VBG O
an DT O
aplastic JJ O
anemia NN O
patient NN B-Species
for IN O
candidate NN O
antigens NNS O
using VBG O
a DT O
Clontech NNP O
human JJ B-Species
fetal JJ O
liver NN O
cDNA NN O
expression NN O
library NN O
and CC O
it PRP O
was VBD O
concluded VBN O
that IN O
seven CD O
out IN O
of IN O
18 CD O
aplastic JJ O
anemia NN O
patients NNS B-Species
were VBD O
positive JJ O
for IN O
anti JJ O
- HYPH O
kinectin NN O
while IN O
none NN O
of IN O
the DT O
normal JJ O
or CC O
disease NN O
controls NNS O
had VBD O
this DT O
antibody NN O
[ -LRB- O
37 CD O
] -RRB- O
. . O

In IN O
their PRP$ O
recent JJ O
report NN O
, , O
Hirano NNP O
et NN O
al NN O
. . O
reported VBD O
that IN O
anti JJ O
- HYPH O
kinectin NN O
antibodies NNS O
were VBD O
found VBN O
in IN O
39 CD O
% NN O
of IN O
aplastic JJ O
anemia NN O
patients NNS B-Species
from IN O
the DT O
United NNP O
States NNP O
but CC O
only RB O
in IN O
three CD O
out IN O
of IN O
30 CD O
( SYM O
10 CD O
% NN O
) , O
cases NNS O
in IN O
Japan NNP O
[ -LRB- O
38 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
study NN O
reported VBN O
here RB O
, , O
kinectin NN O
antibodies NNS O
were VBD O
only RB O
detected VBN O
in IN O
BD NNP O
patients NNS B-Species
and CC O
not RB O
in IN O
normal JJ O
controls NNS O
and CC O
SLE NNP O
and CC O
SjS NNP O
disease NN O
controls NNS O
. . O

None NN O
of IN O
the DT O
BD NNP O
patients NNS B-Species
with IN O
anti JJ O
- HYPH O
kinectin NN O
had VBD O
signs NNS O
of IN O
HCC NNP O
or CC O
aplastic JJ O
anemia NN O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
and CC O
at IN O
up IN O
to TO O
4 CD O
years NNS O
of IN O
follow NN O
- HYPH O
up NN O
. . O

Mapping VBG O
of IN O
epitope NN O
( , O
s FW O
) -RRB- O
recognized VBN O
by IN O
anti JJ O
- HYPH O
kinectin NN O
antibodies NNS O
may MD O
shed VB O
light NN O
on IN O
the DT O
question NN O
of IN O
whether IN O
different JJ O
autoepitopes NNS O
reside VBP O
within IN O
the DT O
kinectin NN O
molecule NN O
recognized VBN O
by IN O
sera NNS O
from IN O
different JJ O
diseases NNS O
. . O

Kinectin NNP O
- : O
a DT O
new JJ O
member NN O
of IN O
coiled VBN O
- HYPH O
coil NN O
cytoplasmic JJ O
autoantigens NNS O

We PRP O
have VBP O
recently RB O
reviewed VBN O
the DT O
literature NN O
on IN O
the DT O
growing VBG O
number NN O
of IN O
cytoplasmic JJ O
autoantigens NNS O
rich JJ O
in IN O
alpha NN O
- HYPH O
helical NN O
coiled VBN O
- HYPH O
coil NN O
domains NNS O
as IN O
typified VBN O
from IN O
our PRP$ O
study NN O
of IN O
Golgi NNP O
autoantigens NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Golgi NNP O
autoantigens NNS O
are VBP O
generally RB O
high JJ O
molecular JJ O
weight NN O
proteins NNS O
between IN O
100 CD O
and CC O
350 CD O
kDa NN O
and CC O
rich JJ O
in IN O
coiled VBN O
- HYPH O
coil NN O
domains NNS O
in IN O
the DT O
central JJ O
region NN O
with IN O
non NN O
- HYPH O
coiled VBN O
- HYPH O
coil NN O
or CC O
globular JJ O
domains NNS O
at IN O
both CC O
N CD O
and CC O
C NN O
termini NN O
. . O

Golgi NNP O
autoantigens NNS O
are VBP O
displayed VBN O
on IN O
the DT O
cytoplasmic JJ O
face NN O
of IN O
the DT O
Golgi NNP O
complex NN O
and CC O
are VBP O
not RB O
localized VBN O
to IN O
apoptotic JJ O
blebs NNS O
during IN O
apoptosis NN O
[ -LRB- O
42 CD O
] -RRB- O
. . O

Giantin NNP O
, , O
the DT O
highest JJS O
molecular JJ O
weight NN O
Golgi NNP O
autoantigen NN O
reported VBN O
, , O
is VBZ O
the DT O
predominant JJ O
target NN O
of IN O
human JJ B-Species
anti JJ O
- HYPH O
Golgi NNP O
complex JJ O
antibodies NNS O
and CC O
multiple JJ O
non AFX O
- HYPH O
cross JJ O
- HYPH O
reactive JJ O
epitopes NNS O
have VBP O
been VBN O
mapped VBN O
spanning VBG O
the DT O
350 CD O
kDa NN O
protein NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

Other JJ O
high JJ O
molecular JJ O
weight NN O
autoantigens NNS O
with IN O
similar JJ O
features NNS O
have VBP O
been VBN O
reported VBN O
in IN O
cytoplasmic JJ O
and CC O
mitotic JJ O
organelles NNS O
suggesting VBG O
that IN O
these DT O
selected VBN O
proteins NNS O
become VBP O
autoimmunogenic JJ O
based VBN O
on IN O
their PRP$ O
subcellular JJ O
association NN O
and CC O
molecular JJ O
features NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

For IN O
example NN O
, , O
in IN O
the DT O
endosomal JJ O
compartment NN O
, , O
the DT O
two CD O
known VBN O
autoantigens NNS O
are VBP O
early JJ O
endosomal JJ O
protein NN O
EEA1 NNP O
( -LRB- O
180 CD O
kDa FW O
) -RRB- O
[ -LRB- O
44 CD O
] -RRB- O
and CC O
CLIP NNP O
- HYPH O
170 CD O
( SYM O
170 CD O
kDa FW O
) -RRB- O
[ -LRB- O
45 CD O
] -RRB- O
. . O

There EX O
is VBZ O
also RB O
a DT O
series NN O
of IN O
centrosomal JJ O
autoantigens NNS O
identified VBN O
as IN O
coiled VBN O
- HYPH O
coil NN O
- HYPH O
rich JJ O
proteins NNS O
including VBG O
pericentrin NN O
, , O
a DT O
220 CD O
kDa NN O
protein NN O
[ -LRB- O
46 CD O
] -RRB- O
, , O
ninein NN O
, , O
a DT O
protein NN O
with IN O
alternatively RB O
spliced VBN O
products NNS O
of IN O
245 CD O
and CC O
249 CD O
kDa NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
Cep250 NNP O
( , O
250 CD O
kDa FW O
) -RRB- O
and CC O
Cep110 NNP O
( -LRB- O
110 CD O
kDa FW O
) -RRB- O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Centromere NNP O
autoantigens NNS O
have VBP O
been VBN O
described VBN O
but CC O
the DT O
two CD O
interesting JJ O
ones NNS O
related VBN O
to IN O
this DT O
discussion NN O
are VBP O
CENP NNP O
- HYPH O
E NNP O
[ -LRB- O
49 CD O
] -RRB- O
and CC O
CENP NNP O
- HYPH O
F NNP O
[ -LRB- O
50 CD O
] -RRB- O
; : O
both DT O
are VBP O
high JJ O
molecular JJ O
weight NN O
proteins NNS O
( , O
312 CD O
to TO O
400 CD O
kDa NNS O
) -RRB- O
and CC O
have VBP O
the DT O
same JJ O
type NN O
of IN O
overall JJ O
structure NN O
as IN O
discussed VBN O
above RB O
. . O

NuMA NNP O
is VBZ O
another DT O
large JJ O
coiled VBN O
- HYPH O
coil NN O
protein NN O
located VBN O
at IN O
the DT O
mitotic JJ O
spindle NN O
pole NN O
and CC O
is VBZ O
the DT O
most RBS O
common JJ O
target NN O
autoantigen NN O
in IN O
sera NN O
with IN O
mitotic JJ O
spindle NN O
apparatus NN O
staining VBG O
[ -LRB- O
51 CD O
] -RRB- O
. . O

Non NNP O
- HYPH O
muscle NN O
myosin NN O
( : O
~ $ O
200 CD O
kDa NN O
) -RRB- O
is VBZ O
a DT O
cytoskeletal JJ O
autoantigen NN O
[ -LRB- O
52 CD O
] -RRB- O
that WDT O
falls VBZ O
in IN O
the DT O
same JJ O
group NN O
of IN O
high JJ O
molecular JJ O
weight NN O
and CC O
coiled VBN O
- HYPH O
coil NN O
- HYPH O
rich JJ O
autoantigens NNS O
. . O

These DT O
endosomal JJ O
, , O
centrosomal JJ O
, , O
mitotic JJ O
apparatus NN O
and CC O
intracellular JJ O
autoantigens NNS O
are VBP O
, , O
like IN O
the DT O
golgins NNS O
, , O
proteins NNS O
with IN O
high JJ O
molecular JJ O
weights NNS O
and CC O
an DT O
overall JJ O
high JJ O
content NN O
of IN O
coiled VBN O
- HYPH O
coil NN O
domains NNS O
. . O

The DT O
combination NN O
of IN O
these DT O
two CD O
physical JJ O
features NNS O
in IN O
autoantigens NNS O
may MD O
contribute VB O
to IN O
the DT O
induction NN O
and CC O
production NN O
of IN O
autoimmune JJ O
antibodies NNS O
in IN O
certain JJ O
disease NN O
states NNS O
. . O

Kinectin NNP O
is VBZ O
an DT O
integral JJ O
membrane NN O
protein NN O
largely RB O
confined VBN O
to IN O
the DT O
endoplasmic JJ O
reticulum NN O
[ -LRB- O
28 CD O
, , O
31 CD O
] -RRB- O
and CC O
it PRP O
fits VBZ O
into IN O
this DT O
new JJ O
category NN O
of IN O
autoantigens NNS O
that WDT O
are VBP O
large JJ O
coiled VBN O
- HYPH O
coil NN O
rich JJ O
proteins NNS O
( : O
> NFP O
= SYM O
100 CD O
kDa NN O
) -RRB- O
in IN O
the DT O
cytoplasm NN O
. . O

Conclusion NN O

Here RB O
we PRP O
report VBP O
the DT O
detection NN O
of IN O
kinectin NN O
autoantibody NN O
in IN O
23 CD O
% NN O
of IN O
Chinese JJ O
patients NNS B-Species
with IN O
BD NNP O
. . O

The DT O
identity NN O
of IN O
kinectin NN O
as IN O
a DT O
BD NN O
- HYPH O
related VBN O
autoantigen NN O
has VBZ O
not RB O
been VBN O
reported VBN O
to IN O
date NN O
. . O

Autoantibody NN O
reaction NN O
against IN O
kinectin NN O
in IN O
BD NN O
observed VBN O
in IN O
this DT O
study NN O
further RB O
confirms VBZ O
the DT O
autoimmune JJ O
involvement NN O
in IN O
BD NN O
and CC O
may MD O
provide VB O
new JJ O
inroads NNS O
into IN O
elucidating VBG O
the DT O
immunopathogenesis NN O
of IN O
the DT O
disease NN O
. . O

In IN O
an DT O
effort NN O
to TO O
clarify VB O
the DT O
association NN O
of IN O
BD NNP O
with IN O
antibody NN O
to IN O
kinectin NN O
, , O
it PRP O
is VBZ O
essential JJ O
to TO O
measure VB O
antibody NN O
to IN O
kinectin NN O
in IN O
larger JJR O
patient NN B-Species
populations NNS O
including VBG O
both DT O
BD NN O
, , O
probable JJ O
BD NN O
and CC O
important JJ O
autoimmune JJ O
rheumatic JJ O
diseases NNS O
such JJ O
as IN O
SLE NNP O
, , O
SjS NNP O
, , O
rheumatoid NN O
arthritis NN O
etc FW O
. , O
, , O
as RB O
well RB O
as IN O
those DT O
diseases NNS O
not RB O
easily RB O
differentiated VBN O
from IN O
BD NN O
, , O
such JJ O
as IN O
recurrent JJ O
aphthous JJ O
oral JJ O
ulcer NN O
, , O
Reiter NNP O
' POS O
s NN O
syndrome NN O
, , O
inflammatory JJ O
bowel NN O
diseases NNS O
etc FW O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
further JJ O
analysis NN O
of IN O
the DT O
association NN O
of IN O
anti JJ O
- HYPH O
kinectin NN O
antibody NN O
with IN O
different JJ O
manifestations NNS O
or CC O
disease NN O
' '' O
subtypes NNS O
' '' O
of IN O
BD NNP O
is VBZ O
another DT O
important JJ O
project NN O
. . O

Anti JJ O
- HYPH O
kinectin NN O
is VBZ O
clearly RB O
only RB O
one CD O
of IN O
the DT O
antigen NN O
- HYPH O
antibody NN O
systems NNS O
identified VBN O
because IN O
there EX O
were VBD O
many JJ O
other JJ O
antibodies NNS O
observed VBN O
in IN O
the DT O
Western JJ O
blot NN O
analysis NN O
of IN O
BD NNP O
sera NN O
. . O

Using VBG O
other JJ O
sera NN O
for IN O
immunoscreening NN O
would MD O
probably RB O
lead VB O
to IN O
the DT O
identification NN O
of IN O
other JJ O
potentially RB O
important JJ O
antigen NN O
- HYPH O
antibody NN O
systems NNS O
. . O

Abbreviations NNS O

AECA NNP O
= , O
antibody NN O
to IN O
endothelial JJ O
cell NN O
antigen NN O
; : O
BD NN O
= : O
Beh NN O
c NN O
et NN O
' '' O
s NN O
disease NN O
; : O
DMEM NN O
= : O
Dulbecco NNP O
' '' O
s NN O
modified VBN O
Eagle NNP O
' '' O
s NNS O
medium NN O
; : O
HCC NNP O
= SYM O
hepatocellular JJ O
carcinoma NN O
; : O
HSP NNP O
= SYM O
heat NN O
shock NN O
protein NN O
; : O
IIF NN O
= : O
indirect JJ O
immunofluorescence NN O
; : O
PBS NN O
= : O
phosphate NN O
buffered VBN O
saline NN O
; : O
SjS NN O
= : O
Sj NNP O
o FW O
gren FW O
' '' O
s NN O
syndrome NN O
; : O
SLE NN O
= : O
systemic JJ O
lupus NN O
erythematosus NN O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

YL NNP O
performed VBD O
the DT O
study NN O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

PY NNP O
provided VBD O
technical JJ O
help NN O
throughout IN O
the DT O
study NN O
. . O

SLC NNP O
and CC O
EMT NNP O
conceived VBD O
the DT O
study NN O
, , O
participated VBD O
in IN O
the DT O
design NN O
and CC O
helped VBD O
in IN O
the DT O
analysis NN O
of IN O
the DT O
data NNS O
. . O

EKLC NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
, , O
interpreted VBD O
data NNS O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

EndoNet NN O
: : O
an DT O
information NN O
resource NN O
about IN O
endocrine NN O
networks NNS O

Abstract JJ O

EndoNet NNP O
is VBZ O
a DT O
new JJ O
database NN O
that WDT O
provides VBZ O
information NN O
about IN O
the DT O
components NNS O
of IN O
endocrine NN O
networks NNS O
and CC O
their PRP$ O
relations NNS O
. . O

It PRP O
focuses VBZ O
on IN O
the DT O
endocrine NN O
cell NN O
- HYPH O
to IN O
- HYPH O
cell NN O
communication NN O
and CC O
enables VBZ O
the DT O
analysis NN O
of IN O
intercellular JJ O
regulatory JJ O
pathways NNS O
in IN O
humans NNS B-Species
. . O

In IN O
the DT O
EndoNet NNP O
data NN O
model NN O
, , O
two CD O
classes NNS O
of IN O
components NNS O
span VBP O
a DT O
bipartite JJ O
directed VBN O
graph NN O
. . O

One CD O
class NN O
represents VBZ O
the DT O
hormones NNS O
( , O
in IN O
the DT O
broadest JJS O
sense NN O
) , O
secreted VBN O
by IN O
defined VBN O
donor NN O
cells NNS O
. . O

The DT O
other JJ O
class NN O
consists VBZ O
of IN O
the DT O
acceptor NN O
or CC O
target NN O
cells NNS O
expressing VBG O
the DT O
corresponding VBG O
hormone NN O
receptors NNS O
. . O

The DT O
identity NN O
and CC O
anatomical JJ O
environment NN O
of IN O
cell NN O
types NNS O
, , O
tissues NNS O
and CC O
organs NNS O
is VBZ O
defined VBN O
through IN O
references NNS O
to IN O
the DT O
CYTOMER NNP O
( -LRB- O
R NNP O
) -RRB- O
ontology NN O
. . O

With IN O
the DT O
EndoNet NNP O
user NN O
interface NN O
, , O
it PRP O
is VBZ O
possible JJ O
to TO O
query VB O
the DT O
database NN O
for IN O
hormones NNS O
, , O
receptors NNS O
or CC O
tissues NNS O
and CC O
to TO O
combine VB O
several JJ O
items NNS O
from IN O
different JJ O
search NN O
rounds NNS O
in IN O
one CD O
complex JJ O
result NN O
set VBN O
, , O
from IN O
which WDT O
a DT O
network NN O
can MD O
be VB O
reconstructed VBN O
and CC O
visualized VBN O
. . O

For IN O
each DT O
entity NN O
, , O
a DT O
detailed JJ O
characteristics NNS O
page NN O
is VBZ O
available JJ O
. . O

Some DT O
well RB O
- HYPH O
established VBN O
endocrine NN O
pathways NNS O
are VBP O
offered VBN O
as IN O
showcases NNS O
in IN O
the DT O
form NN O
of IN O
predefined VBN O
result NN O
sets NNS O
. . O

These DT O
sets NNS O
can MD O
be VB O
used VBN O
as IN O
a DT O
starting VBG O
point NN O
for IN O
a DT O
more RBR O
complex JJ O
query NN O
or CC O
for IN O
obtaining VBG O
a DT O
quick JJ O
overview NN O
. . O

The DT O
EndoNet NNP O
database NN O
is VBZ O
accessible JJ O
at IN O
. . O

INTRODUCTION NN O

Theoretical JJ O
analyses NNS O
in IN O
the DT O
post NN O
- HYPH O
sequencing VBG O
era NN O
, , O
in IN O
particular JJ O
in IN O
the DT O
context NN O
of IN O
systems NNS O
biology NN O
approaches NNS O
, , O
increasingly RB O
investigate VBP O
the DT O
properties NNS O
of IN O
all DT O
kinds NNS O
of IN O
pathways NNS O
and CC O
networks NNS O
such JJ O
as IN O
metabolic JJ O
and CC O
signaling NN O
pathways NNS O
. . O

It PRP O
is VBZ O
commonly RB O
accepted VBN O
that IN O
we PRP O
need VBP O
formal JJ O
descriptions NNS O
of IN O
these DT O
networks NNS O
to TO O
make VB O
systematic JJ O
use NN O
of IN O
the DT O
overwhelming JJ O
body NN O
of IN O
facts NNS O
gathered VBN O
over IN O
decades NNS O
of IN O
laboratory NN O
work NN O
both CC O
in IN O
narrow JJ O
or CC O
global JJ O
scale NN O
. . O

Corresponding VBG O
databases NNS O
have VBP O
been VBN O
created VBN O
and CC O
are VBP O
available JJ O
now RB O
for IN O
metabolic JJ O
networks NNS O
( , O
KEGG NNP O
) -RRB- O
( , O
1 CD O
, , O
2 CD O
) NN O
, , O
protein NN O
interaction NN O
networks NNS O
( , O
BIND NNP O
and CC O
DIP NNP O
) -RRB- O
( , O
3 CD O
, , O
4 CD O
) SYM O
and CC O
signaling NN O
pathways NNS O
( , O
CSNDB NNP O
, , O
Patika NNP O
and CC O
TRANSPATH NNP O
( -LRB- O
R NNP O
) -RRB- O
) -RRB- O
( , O
5 CD O
- SYM O
8 CD O
) -RRB- O
, , O
just RB O
to TO O
name VB O
a DT O
few JJ O
. . O

So RB O
far RB O
, , O
however RB O
, , O
their PRP$ O
main JJ O
focus NN O
is VBZ O
on IN O
intracellular JJ O
processes NNS O
. . O

Intercellular JJ O
signaling NN O
is VBZ O
addressed VBN O
only RB O
insofar RB O
as IN O
usually RB O
the DT O
pathways NNS O
modeled VBN O
start VBP O
with IN O
extracellular JJ O
ligands NNS O
, , O
and CC O
as IN O
there EX O
exist VBP O
catalogs NNS O
and CC O
databases NNS O
about IN O
secreted VBN O
proteins NNS O
, , O
or CC O
the DT O
' `` O
secretome NN O
' '' O
, , O
of IN O
certain JJ O
systems NNS O
( : O
9 CD O
- SYM O
12 CD O
) -RRB- O
. . O

This DT O
shortcoming NN O
is VBZ O
part NN O
of IN O
the DT O
more RBR O
comprehensive JJ O
problem NN O
, , O
the DT O
genotype NN O
- HYPH O
phenotype NN O
gap NN O
: : O
from IN O
a DT O
certain JJ O
genotype NN O
, , O
we PRP O
are VBP O
able JJ O
to TO O
infer VB O
a DT O
' `` O
molecular JJ O
phenotype NN O
' '' O
, , O
but CC O
for IN O
correlating VBG O
it PRP O
with IN O
a DT O
more RBR O
complex JJ O
phenotype NN O
such JJ O
as IN O
a DT O
biological JJ O
process NN O
, , O
or CC O
even RB O
a DT O
certain JJ O
disease NN O
and CC O
its PRP$ O
clinical JJ O
appearance NN O
, , O
we PRP O
still RB O
depend VBP O
largely RB O
on IN O
the DT O
mere JJ O
description NN O
of IN O
an DT O
observed VBN O
correlation NN O
. . O

There EX O
is VBZ O
no DT O
way NN O
to TO O
infer VB O
such PDT O
a DT O
phenotype NN O
through IN O
all PDT O
the DT O
different JJ O
layers NNS O
of IN O
increasing VBG O
complexity NN O
between IN O
genomic JJ O
DNA NN O
sequences NNS O
and CC O
the DT O
physiological JJ O
function NN O
of IN O
whole JJ O
organs NNS O
and CC O
their PRP$ O
interplay NN O
within IN O
an DT O
organism NN O
. . O

There EX O
may MD O
be VB O
principal JJ O
barriers NNS O
preventing VBG O
such PDT O
an DT O
inference NN O
across IN O
different JJ O
complexity NN O
levels NNS O
, , O
but CC O
even RB O
to TO O
explore VB O
these DT O
limits NNS O
, , O
we PRP O
have VBP O
to TO O
make VB O
attempts NNS O
to TO O
bridge VB O
the DT O
genotype NN O
- HYPH O
phenotype NN O
gap NN O
. . O

We PRP O
have VBP O
to TO O
do VB O
the DT O
next JJ O
step NN O
towards IN O
modeling VBG O
intercellular JJ O
networks NNS O
that WDT O
are VBP O
inextricably RB O
linked VBN O
to IN O
the DT O
physiology NN O
of IN O
multicellular JJ O
organisms NNS O
( SYM O
13 CD O
) -RRB- O
. . O

Being VBG O
one CD O
of IN O
the DT O
most RBS O
complex JJ O
constructs NNS O
in IN O
the DT O
body NN O
, , O
the DT O
endocrine NN O
system NN O
comprises VBZ O
numerous JJ O
cells NNS O
and CC O
tissues NNS O
that WDT O
secrete VBP O
hormones NNS O
which WDT O
pass VBP O
through IN O
the DT O
body NN O
, , O
activate VBP O
specific JJ O
receptors NNS O
of IN O
target NN O
cells NNS O
and CC O
initiate VBP O
there RB O
multiple JJ O
intracellular JJ O
signaling NN O
pathways NNS O
. . O

Here RB O
, , O
we PRP O
present VBP O
a DT O
new JJ O
database NN O
, , O
EndoNet NNP O
, , O
which WDT O
provides VBZ O
information NN O
about IN O
the DT O
components NNS O
of IN O
endocrine NN O
networks NNS O
and CC O
their PRP$ O
relations NNS O
, , O
and CC O
enables VBZ O
the DT O
analysis NN O
of IN O
intercellular JJ O
regulatory JJ O
pathways NNS O
in IN O
humans NNS B-Species
. . O

The DT O
EndoNet NNP O
database NN O
is VBZ O
accessible JJ O
at IN O
. . O

RESULTS NNS O

The DT O
biological JJ O
schema NN O
of IN O
endocrine NN O
actions NNS O

Development NN O
and CC O
function NN O
of IN O
different JJ O
organs NNS O
as RB O
well RB O
as IN O
the DT O
response NN O
of IN O
a DT O
whole JJ O
multicellular JJ O
organism NN O
to IN O
its PRP$ O
environment NN O
is VBZ O
coordinated VBN O
through IN O
a DT O
complex JJ O
communication NN O
system NN O
between IN O
specialized JJ O
cells NNS O
that WDT O
are VBP O
part NN O
of IN O
its PRP$ O
organs NNS O
. . O

This DT O
communication NN O
is VBZ O
mostly RB O
mediated VBN O
by IN O
hormones NNS O
. . O

In IN O
a DT O
broader JJR O
sense NN O
, , O
this DT O
functional JJ O
class NN O
of IN O
biomolecules NNS O
also RB O
comprises VBZ O
growth NN O
factors NNS O
, , O
cytokines NNS O
, , O
chemokines NNS O
and CC O
other JJ O
signal NN O
transmitters NNS O
. . O

This DT O
generic JJ O
view NN O
is VBZ O
supported VBN O
, , O
for IN O
instance NN O
, , O
by IN O
the DT O
definition NN O
given VBN O
for IN O
' `` O
hormone NN O
activity NN O
' '' O
by IN O
Gene NNP O
Ontology NNP O
( : O
GO NNP O
) -RRB- O
( : O
14 CD O
) -RRB- O
: : O
' '' O
Any DT O
substance NN O
formed VBN O
in IN O
very RB O
small JJ O
amounts NNS O
in IN O
one CD O
specialized JJ O
organ NN O
or CC O
group NN O
of IN O
cells NNS O
and CC O
carried VBN O
( , O
sometimes RB O
in IN O
the DT O
bloodstream NN O
) , O
to IN O
another DT O
organ NN O
or CC O
group NN O
of IN O
cells NNS O
, , O
in IN O
the DT O
same JJ O
organism NN O
, , O
upon IN O
which WDT O
it PRP O
has VBZ O
a DT O
specific JJ O
regulatory JJ O
action NN O
' '' O
. . O

This DT O
definition NN O
is VBZ O
also RB O
broad JJ O
enough RB O
to TO O
include VB O
modes NNS O
of IN O
hormonal JJ O
actions NNS O
as RB O
diverse JJ O
as IN O
endocrine NN O
, , O
paracrine NN O
and CC O
autocrine NN O
effects NNS O
. . O

Accordingly RB O
, , O
with IN O
the DT O
term NN O
' `` O
hormone NN O
' '' O
one PRP O
might MD O
refer VB O
to IN O
any DT O
extracellular JJ O
substance NN O
that WDT O
induces VBZ O
specific JJ O
responses NNS O
in IN O
target NN O
cell NN O
and CC O
helps VBZ O
to TO O
coordinate VB O
growth NN O
, , O
differentiation NN O
, , O
gene NN O
expression NN O
and CC O
metabolic JJ O
activities NNS O
of IN O
various JJ O
cells NNS O
, , O
tissues NNS O
and CC O
organs NNS O
in IN O
multicellular JJ O
organisms NNS O
( SYM O
15 CD O
) -RRB- O
. . O

Hormones NNS O
can MD O
be VB O
classified VBN O
based VBN O
on IN O
their PRP$ O
chemical JJ O
nature NN O
, , O
solubility NN O
, , O
the DT O
distance NN O
over IN O
which WDT O
the DT O
signal NN O
acts VBZ O
and CC O
so RB O
on RB O
( , O
15 CD O
, , O
16 CD O
) -RRB- O
. . O

From IN O
the DT O
viewpoint NN O
of IN O
genome NN O
- HYPH O
phenotype NN O
relations NNS O
, , O
it PRP O
is VBZ O
reasonable JJ O
to TO O
distinguish VB O
between IN O
polypeptide NN O
, , O
thus RB O
, , O
genome NN O
- HYPH O
encoded VBN O
hormones NNS O
, , O
on IN O
one CD O
hand NN O
, , O
and CC O
those DT O
low JJ O
- HYPH O
molecular JJ O
weight NN O
hormones NNS O
such JJ O
as IN O
steroids NNS O
, , O
with IN O
only RB O
the DT O
machinery NN O
of IN O
their PRP$ O
synthesis NN O
being VBG O
genome NN O
- HYPH O
encoded VBN O
, , O
on IN O
the DT O
other JJ O
hand NN O
. . O

Another DT O
classification NN O
of IN O
hormones NNS O
, , O
which WDT O
seems VBZ O
to TO O
be VB O
overlapping VBG O
with IN O
the DT O
previous JJ O
one NN O
refers VBZ O
to IN O
the DT O
intracellular JJ O
location NN O
of IN O
their PRP$ O
receptors NNS O
and CC O
, , O
thus RB O
, , O
how WRB O
the DT O
subsequent JJ O
signal NN O
is VBZ O
further RB O
transduced VBN O
: : O
membrane NN O
- HYPH O
bound VBN O
receptors NNS O
usually RB O
trigger VBP O
more RBR O
or CC O
less RBR O
complex JJ O
signaling NN O
cascades NNS O
towards IN O
the DT O
nucleus NN O
, , O
whereas IN O
nuclear JJ O
receptors NNS O
, , O
mainly RB O
bound VBN O
by IN O
low JJ O
- HYPH O
molecular JJ O
weight NN O
hormones NNS O
, , O
have VBP O
a DT O
very RB O
short JJ O
signaling NN O
pathway NN O
downstream RB O
since IN O
they PRP O
act VBP O
as IN O
transcription NN O
factors NNS O
themselves PRP O
( : O
15 CD O
, , O
16 CD O
) -RRB- O
. . O

In IN O
intercellular JJ O
communication NN O
, , O
we PRP O
can MD O
basically RB O
differentiate VB O
between IN O
two CD O
kinds NNS O
of IN O
cells NNS O
: : O
donor NN O
cells NNS O
which WDT O
synthesize VBP O
and CC O
secrete VBP O
a DT O
hormone NN O
, , O
and CC O
acceptor NN O
cells NNS O
which WDT O
express VBP O
a DT O
hormone NN O
receptor NN O
( -LRB- O
Figure NN O
1a NN O
) -RRB- O
. . O

Donor NN O
cells NNS O
become VBP O
active JJ O
under IN O
the DT O
influence NN O
of IN O
an DT O
external JJ O
, , O
mostly RB O
environmental JJ O
, , O
stimulus NN O
. . O

In IN O
the DT O
acceptor NN O
cell NN O
, , O
binding NN O
of IN O
the DT O
hormone NN O
to IN O
a DT O
receptor NN O
triggers VBZ O
an DT O
intracellular JJ O
signal NN O
transduction NN O
cascade NN O
with IN O
different JJ O
kinds NNS O
of IN O
end NN O
nodes NNS O
and CC O
effects NNS O
: : O
transcription NN O
factors NNS O
affecting VBG O
the DT O
gene NN O
expression NN O
program NN O
of IN O
the DT O
acceptor NN O
cell NN O
, , O
metabolic JJ O
enzymes NNS O
controlling VBG O
the DT O
cell NN O
' POS O
s NNS O
metabolism NN O
, , O
structural JJ O
components NNS O
which WDT O
define VBP O
the DT O
acceptor NN O
' POS O
s NNS O
morphological JJ O
features NNS O
, , O
or CC O
components NNS O
of IN O
the DT O
secretory NN O
apparatus NN O
regulating VBG O
the DT O
release NN O
of IN O
other JJ O
extracellular JJ O
molecules NNS O
. . O

If IN O
synthesis NN O
and CC O
secretion NN O
of IN O
another DT O
hormone NN O
is VBZ O
among IN O
the DT O
effects NNS O
exerted VBN O
by IN O
receptor NN O
activation NN O
, , O
the DT O
acceptor NN O
is VBZ O
turned VBN O
into IN O
a DT O
donor NN O
cell NN O
, , O
thus RB O
becoming VBG O
an DT O
internal JJ O
node NN O
of IN O
the DT O
organism NN O
' POS O
s NN O
endocrine NN O
network NN O
. . O

Acceptor NN O
cells NNS O
which WDT O
do VBP O
not RB O
become VB O
producers NNS O
of IN O
another DT O
hormone NN O
are VBP O
called VBN O
' `` O
terminal JJ O
target NN O
cells NNS O
' '' O
of IN O
the DT O
endocrine NN O
network NN O
, , O
but CC O
finally RB O
constitute VBP O
the DT O
overall JJ O
physiological JJ O
effect NN O
of IN O
the DT O
respective JJ O
hormonal JJ O
pathway NN O
, , O
or CC O
simply RB O
the DT O
phenotype NN O
( -LRB- O
Figure NNP O
1a NN O
) -RRB- O
. . O

The DT O
EndoNet NNP O
data NNS O
model NN O

In IN O
the DT O
EndoNet NNP O
data NN O
model NN O
, , O
two CD O
classes NNS O
of IN O
entities NNS O
- : O
- HYPH O
hormones NNS O
( , O
in IN O
the DT O
broadest JJS O
sense NN O
) , O
and CC O
their PRP$ O
acceptor NN O
or CC O
target NN O
cells NNS O
expressing VBG O
the DT O
corresponding VBG O
receptors NNS O
- : O
- HYPH O
span VBP O
a DT O
bipartite JJ O
directed VBN O
graph NN O
. . O

Since IN O
one CD O
and CC O
the DT O
same JJ O
hormone NN O
may MD O
be VB O
secreted VBN O
by IN O
multiple JJ O
cell NN O
types NNS O
( : O
donor NN O
cells NNS O
) -RRB- O
, , O
each DT O
such JJ O
secretion NN O
event NN O
is VBZ O
represented VBN O
by IN O
a DT O
hormone NN O
node NN O
on IN O
its PRP$ O
own JJ O
. . O

Similarly RB O
, , O
each DT O
cell NN O
type NN O
known VBN O
to TO O
express VB O
a DT O
hormone NN O
receptor NN O
( , O
acceptor NN O
cell NN O
) -RRB- O
leads VBZ O
to IN O
an DT O
individual JJ O
node NN O
. . O

The DT O
graph NN O
' '' O
s NN O
edges NNS O
represent VBP O
hormone NN O
transport NN O
and CC O
binding NN O
to IN O
a DT O
receptor NN O
( , O
intercellular JJ O
edges NNS O
) -RRB- O
, , O
on IN O
one CD O
hand NN O
, , O
and CC O
triggering NN O
or CC O
inhibition NN O
of IN O
hormone NN O
secretion NN O
by IN O
a DT O
receptor NN O
activated VBN O
by IN O
hormone NN O
binding NN O
( : O
intracellular JJ O
edges NNS O
) -RRB- O
, , O
on IN O
the DT O
other JJ O
hand NN O
. . O

Optionally RB O
, , O
an DT O
edge NN O
representing VBG O
the DT O
transport NN O
of IN O
a DT O
hormone NN O
can MD O
be VB O
subdivided VBN O
by IN O
introducing VBG O
the DT O
transport NN O
medium NN O
( , O
usually RB O
blood NN O
) -RRB- O
as IN O
an DT O
additional JJ O
, , O
intermediary JJ O
node NN O
. . O

Thus RB O
, , O
in IN O
the DT O
conceptual JJ O
schema NN O
of IN O
the DT O
EndoNet NNP O
database NN O
( -LRB- O
Figure NNP O
1b NNP O
) -RRB- O
, , O
the DT O
links NNS O
between IN O
cells NNS O
/ SYM O
organs NNS O
and CC O
hormone NN O
define VBP O
donor NN O
cells NNS O
( , O
' '' O
D NN O
' '' O
) -RRB- O
, , O
those DT O
between IN O
cells NNS O
/ SYM O
organs NNS O
and CC O
receptors NNS O
acceptor NN O
cells NNS O
( , O
' '' O
A NN O
' '' O
) -RRB- O
. . O

If IN O
an DT O
acceptor NN O
cell NN O
synthesizes VBZ O
another DT O
hormone NN O
in IN O
response NN O
to IN O
an DT O
incoming JJ O
signal NN O
, , O
it PRP O
becomes VBZ O
an DT O
internal JJ O
node NN O
in IN O
the DT O
emerging VBG O
hormonal JJ O
network NN O
. . O

In IN O
EndoNet NNP O
, , O
the DT O
pathway NN O
between IN O
a DT O
hormone NN O
receptor NN O
expressed VBN O
in IN O
an DT O
acceptor NN O
cell NN O
and CC O
a DT O
hormone NN O
synthesized VBN O
in IN O
the DT O
same JJ O
cell NN O
( , O
intracellular JJ O
edge NN O
) -RRB- O
is VBZ O
handled VBN O
as IN O
a DT O
black JJ O
box NN O
. . O

In IN O
case NN O
of IN O
genome NN O
- HYPH O
encoded VBN O
peptide NN O
hormones NNS O
, , O
cross NN O
- HYPH O
references NNS O
to IN O
entries NNS O
in IN O
the DT O
TRANSPATH NNP O
( -LRB- O
R NNP O
) -RRB- O
database NN O
, , O
which WDT O
describe VBP O
the DT O
signaling NN O
cascade NN O
starting VBG O
from IN O
the DT O
hormone NN O
' POS O
s NN O
receptor NN O
and CC O
ending VBG O
at IN O
the DT O
hormone NN O
' '' O
s NN O
gene NN O
, , O
are VBP O
provided VBN O
, , O
if IN O
available JJ O
. . O

Datasets NNS O
on IN O
non JJ O
- HYPH O
peptide NN O
hormones NNS O
will MD O
in IN O
future NN O
be VB O
enriched VBN O
by IN O
a DT O
specific JJ O
metabolic JJ O
add NN O
- HYPH O
on IN O
which WDT O
will MD O
include VB O
references NNS O
to IN O
the DT O
databases NNS O
KEGG NNP O
( , O
1 CD O
) -RRB- O
and CC O
BRENDA NNP O
( SYM O
17 CD O
) -RRB- O
, , O
allowing VBG O
for IN O
further JJ O
characterization NN O
of IN O
the DT O
steps NNS O
performed VBN O
during IN O
the DT O
hormone NN O
' '' O
s NN O
synthesis NN O
and CC O
the DT O
regulation NN O
of IN O
both CC O
activity NN O
and CC O
expression NN O
of IN O
the DT O
enzymes NNS O
involved VBN O
. . O

By IN O
now RB O
, , O
the DT O
EndoNet NNP O
structure NN O
already RB O
allows VBZ O
for IN O
including VBG O
descriptions NNS O
of IN O
the DT O
physiological JJ O
effects NNS O
induced VBN O
by IN O
hormone NN O
binding NN O
( , O
see VB O
below RB O
, , O
Future NNP O
Developments NNPS O
) -RRB- O
. . O

The DT O
contents NNS O
of IN O
EndoNet NNP O

In IN O
the DT O
present JJ O
version NN O
of IN O
EndoNet NNP O
, , O
and CC O
as IN O
a DT O
first JJ O
approach NN O
, , O
we PRP O
consider VBP O
the DT O
endocrine NN O
( , O
hormonal JJ O
) -RRB- O
network NN O
of IN O
the DT O
human JJ B-Species
body NN O
. . O

For IN O
each DT O
molecule NN O
( , O
hormone NN O
or CC O
receptor NN O
) -RRB- O
, , O
a DT O
primary JJ O
name NN O
and CC O
synonyms NNS O
are VBP O
given VBN O
. . O

In IN O
case NN O
of IN O
peptide NN O
hormones NNS O
, , O
the DT O
sequence NN O
of IN O
the DT O
processed JJ O
polypeptide NN O
, , O
rather RB O
than IN O
that DT O
of IN O
the DT O
protein NN O
precursor NN O
, , O
is VBZ O
specified VBN O
. . O

For IN O
a DT O
multimeric JJ O
protein NN O
hormone NN O
, , O
the DT O
subunit NN O
composition NN O
as RB O
well RB O
as IN O
the DT O
sequences NNS O
of IN O
all DT O
subunits NNS O
are VBP O
stored VBN O
; : O
the DT O
same JJ O
holds VBZ O
true JJ O
for IN O
hormone NN O
receptors NNS O
. . O

Additionally RB O
, , O
all DT O
peptide NN O
hormone NN O
and CC O
receptor NN O
datasets NNS O
have VBP O
links NNS O
to IN O
HumanPSD NNP O
( -LRB- O
TM NNP O
) -RRB- O
( , O
18 CD O
) -RRB- O
and CC O
to IN O
the DT O
Swiss NNP O
- HYPH O
Prot NNP O
database NN O
, , O
The DT O
structures NNS O
of IN O
non JJ O
- HYPH O
peptide NN O
hormones NNS O
can MD O
be VB O
accessed VBN O
through IN O
the DT O
corresponding VBG O
hyperlinks NNS O
to IN O
the DT O
KEGG NNP O
COMPOUND NNP O
section NN O
. . O

Finally RB O
, , O
all DT O
molecules NNS O
may MD O
have VB O
links NNS O
to IN O
the DT O
TRANSPATH NNP O
( -LRB- O
R NNP O
) -RRB- O
database NN O
. . O

As IN O
described VBN O
, , O
EndoNet NNP O
utilizes VBZ O
data NNS O
about IN O
the DT O
tissues NNS O
from IN O
which WDT O
hormones NNS O
are VBP O
secreted VBN O
and CC O
in IN O
which WDT O
receptors NNS O
are VBP O
expressed VBN O
to TO O
define VB O
donor NN O
and CC O
acceptor NN O
cells NNS O
, , O
respectively RB O
. . O

The DT O
identity NN O
and CC O
anatomical JJ O
environment NN O
of IN O
cell NN O
types NNS O
, , O
tissues NNS O
and CC O
organs NNS O
is VBZ O
defined VBN O
through IN O
references NNS O
to IN O
the DT O
CYTOMER NNP O
( -LRB- O
R NNP O
) -RRB- O
ontology NN O
( , O
19 CD O
, , O
20 CD O
) -RRB- O
; : O
in IN O
the DT O
numerous JJ O
cases NNS O
where WRB O
the DT O
receptors NNS O
are VBP O
ubiquitously RB O
expressed VBN O
, , O
just RB O
the DT O
root NN O
term NN O
' `` O
human JJ B-Species
body NN O
' '' O
is VBZ O
linked VBN O
. . O

Data NNS O
on IN O
whether IN O
a DT O
hormone NN O
' '' O
s NNS O
synthesis NN O
is VBZ O
triggered VBN O
or CC O
inhibited VBN O
by IN O
another DT O
hormone NN O
through IN O
its PRP$ O
respective JJ O
receptor NN O
in IN O
a DT O
particular JJ O
cell NN O
was VBD O
obtained VBN O
by IN O
manual JJ O
selection NN O
from IN O
textbooks NNS O
[ -LRB- O
e ADD O
. . O
g LS O
. . O
( : O
16 CD O
) -RRB- O
, , O
] -RRB- O
, , O
monographies NNS O
( , O
21 CD O
) -RRB- O
, , O
original JJ O
literature NN O
, , O
the DT O
EST NNP O
library NN O
information NN O
and CC O
the DT O
linked VBN O
databases NNS O
( , O
TRANSPATH NNP O
( -LRB- O
R NNP O
) -RRB- O
, , O
HumanPSD NNP O
( , O
TM NNP O
) -RRB- O
and CC O
Swiss NNP O
- HYPH O
Prot NNP O
) -RRB- O
. . O

The DT O
contents NNS O
of IN O
EndoNet NNP O
are VBP O
summarized VBN O
in IN O
Table NNP O
1 CD O
. . O

Web NN O
interface NN O
, , O
queries NNS O
and CC O
visualization NN O

EndoNet NN O
can MD O
be VB O
accessed VBN O
through IN O
the DT O
WWW NNP O
via IN O
a DT O
JSP NNP O
- HYPH O
based VBN O
web NN O
interface NN O
. . O

Hormones NNS O
, , O
receptors NNS O
and CC O
tissues NNS O
can MD O
be VB O
queried VBN O
for IN O
their PRP$ O
names NNS O
, , O
and CC O
detailed JJ O
information NN O
on IN O
all DT O
identified VBN O
components NNS O
is VBZ O
available JJ O
through IN O
individual JJ O
characteristics NNS O
pages NNS O
. . O

Each DT O
hormone NN O
' '' O
s NNS O
individual JJ O
entry NN O
page NN O
displays VBZ O
its PRP$ O
source NN O
and CC O
target VB O
tissues NNS O
( , O
donor NN O
and CC O
acceptor NN O
cells NNS O
) -RRB- O
as RB O
well RB O
as IN O
its PRP$ O
receptors NNS O
, , O
along IN O
with IN O
some DT O
molecular JJ O
data NNS O
. . O

Similarly RB O
, , O
each DT O
receptor NN O
entry NN O
exhibits VBZ O
the DT O
tissues NNS O
in IN O
which WDT O
the DT O
receptor NN O
is VBZ O
expressed VBN O
, , O
and CC O
the DT O
hormones NNS O
it PRP O
interacts VBZ O
with IN O
. . O

Finally RB O
, , O
each DT O
tissue NN O
entry NN O
lists VBZ O
the DT O
hormone NN O
receptors NNS O
that WDT O
are VBP O
found VBN O
in IN O
, , O
as RB O
well RB O
as IN O
the DT O
hormones NNS O
that WDT O
are VBP O
synthesized VBN O
and CC O
secreted VBN O
by IN O
the DT O
tissue NN O
. . O

It PRP O
is VBZ O
also RB O
indicated VBN O
whether IN O
the DT O
corresponding VBG O
tissue NN O
exerts VBZ O
gender NN O
- HYPH O
specific JJ O
properties NNS O
; : O
additional JJ O
information NN O
based VBN O
on IN O
the DT O
CYTOMER NNP O
( -LRB- O
R NNP O
) -RRB- O
ontology NN O
is VBZ O
available JJ O
through IN O
the DT O
corresponding VBG O
link NN O
on IN O
the DT O
tissue NN O
detail NN O
page NN O
. . O

Instead RB O
of IN O
searching VBG O
for IN O
a DT O
name NN O
of IN O
a DT O
hormone NN O
, , O
one PRP O
can MD O
also RB O
browse VB O
the DT O
hierarchical JJ O
hormone NN O
classification NN O
featured VBN O
by IN O
EndoNet NNP O
( : O
available JJ O
at IN O
the DT O
' `` O
Search NNP O
' '' O
page NN O
) -RRB- O
. . O

Each DT O
query NN O
result NN O
can MD O
be VB O
used VBN O
as IN O
starting VBG O
point NN O
for IN O
an DT O
extended JJ O
query NN O
. . O

Different JJ O
items NNS O
of IN O
interest NN O
can MD O
be VB O
selected VBN O
and CC O
added VBN O
to IN O
a DT O
common JJ O
result NN O
set VBN O
. . O

Since IN O
several JJ O
search NN O
results NNS O
can MD O
be VB O
combined VBN O
, , O
it PRP O
is VBZ O
possible JJ O
to TO O
create VB O
sets NNS O
with IN O
multiple JJ O
search NN O
parameters NNS O
. . O

At IN O
any DT O
step NN O
of IN O
this DT O
incremental JJ O
retrieval NN O
process NN O
, , O
the DT O
sets NNS O
of IN O
hormones NNS O
, , O
receptors NNS O
and CC O
tissues NNS O
obtained VBN O
so RB O
far RB O
can MD O
be VB O
used VBN O
as IN O
starting VBG O
points NNS O
for IN O
reconstructing VBG O
a DT O
network NN O
by IN O
a DT O
depth NN O
- HYPH O
first JJ O
graph NN O
traversal JJ O
algorithm NN O
. . O

The DT O
maximum JJ O
number NN O
of IN O
steps NNS O
can MD O
be VB O
selected VBN O
separately RB O
for IN O
the DT O
upstream JJ O
and CC O
downstream JJ O
part NN O
of IN O
the DT O
reconstruction NN O
process NN O
. . O

Subsequently RB O
, , O
the DT O
graph NN O
will MD O
be VB O
displayed VBN O
using VBG O
a DT O
Graphviz NNP O
- HYPH O
based VBN O
visualization NN O
method NN O
[ -LRB- O
( SYM O
22 CD O
) -RRB- O
, , O
] -RRB- O
. . O

In IN O
the DT O
resulting VBG O
image NN O
, , O
hormones NNS O
and CC O
receptors NNS O
are VBP O
represented VBN O
as IN O
nodes NNS O
grouped VBN O
together RB O
into IN O
subgraphs NNS O
representing VBG O
the DT O
tissues NNS O
( , O
cells NNS O
/ SYM O
organs NNS O
) , O
they PRP O
are VBP O
secreted VBN O
from IN O
or CC O
expressed VBN O
in IN O
, , O
respectively RB O
( : O
Figure NN O
2 CD O
) -RRB- O
. . O

Autocrine NN O
loops NNS O
( : O
donor NN O
and CC O
acceptor NN O
cell NN O
being VBG O
identical JJ O
) -RRB- O
are VBP O
treated VBN O
specially RB O
for IN O
visualization NN O
. . O

On IN O
demand NN O
, , O
the DT O
hormones NNS O
' POS O
transport NN O
media NN O
can MD O
be VB O
included VBN O
in IN O
the DT O
visualization NN O
of IN O
intercellular JJ O
edges NNS O
, , O
enabling VBG O
the DT O
user NN O
to TO O
choose VB O
between IN O
different JJ O
complexities NNS O
of IN O
output NN O
. . O

Intracellular JJ O
edges NNS O
, , O
which WDT O
connect VBP O
a DT O
receptor NN O
to IN O
a DT O
hormone NN O
, , O
represent VBP O
the DT O
influence NN O
of IN O
a DT O
receptor NN O
' POS O
s NN O
activation NN O
on IN O
the DT O
secretion NN O
of IN O
a DT O
hormone NN O
from IN O
the DT O
same JJ O
cell NN O
and CC O
are VBP O
displayed VBN O
differently RB O
, , O
depending VBG O
on IN O
whether IN O
this DT O
influence NN O
is VBZ O
triggering VBG O
or CC O
inhibitory NN O
in IN O
nature NN O
. . O

The DT O
graph NN O
is VBZ O
displayed VBN O
as IN O
a DT O
clickable JJ O
image NN O
map NN O
, , O
linking VBG O
each DT O
entity NN O
to IN O
its PRP$ O
detailed JJ O
characteristics NNS O
page NN O
, , O
thus RB O
making VBG O
the DT O
database NN O
entries NNS O
accessible JJ O
from IN O
the DT O
graphical JJ O
overview NN O
of IN O
a DT O
network NN O
, , O
too RB O
. . O

The DT O
graph NN O
is VBZ O
available JJ O
in IN O
two CD O
different JJ O
formats NNS O
: : O
PNG NNP O
and CC O
SVG NNP O
. . O

While IN O
virtually RB O
every DT O
browser NN O
supports VBZ O
PNG NNP O
( : O
a DT O
' `` O
pixel NN O
' '' O
or CC O
' `` O
bitmap NN O
' '' O
format NN O
) -RRB- O
, , O
only RB O
a DT O
few JJ O
of IN O
them PRP O
provide VBP O
a DT O
zoom NN O
functionality NN O
for IN O
bitmap NN O
pictures NNS O
. . O

Scalable JJ O
vector NN O
graphics NNS O
, , O
( , O
SVG NNP O
) -RRB- O
provides VBZ O
more JJR O
functionality NN O
( , O
including VBG O
perfect JJ O
image NN O
quality NN O
throughout IN O
all DT O
zoom NN O
factors NNS O
) -RRB- O
, , O
but CC O
until IN O
now RB O
most JJS O
browsers NNS O
do VBP O
not RB O
support VB O
SVG NNP O
natively RB O
and CC O
require VB O
an DT O
SVG NNP O
plugin NN O
( : O
) -RRB- O
for IN O
displaying VBG O
this DT O
vector NN O
- HYPH O
based VBN O
format NN O
. . O

Some DT O
well RB O
- HYPH O
established VBN O
endocrine NN O
pathways NNS O
are VBP O
offered VBN O
as IN O
showcases NNS O
in IN O
the DT O
form NN O
of IN O
predefined VBN O
result NN O
sets NNS O
. . O

For IN O
instance NN O
, , O
sets NNS O
representing VBG O
the DT O
hypothalamic JJ O
- HYPH O
hypophyseal JJ O
axis NN O
with IN O
a DT O
focus NN O
on IN O
either CC O
thyroid NN O
hormones NNS O
, , O
adrenal JJ O
hormones NNS O
, , O
growth NN O
hormones NNS O
or CC O
prolactin NN O
are VBP O
provided VBN O
. . O

These DT O
predefined VBN O
sets NNS O
can MD O
be VB O
used VBN O
for IN O
obtaining VBG O
a DT O
quick JJ O
overview NN O
or CC O
as IN O
starting VBG O
points NNS O
for IN O
more JJR O
complex JJ O
queries NNS O
. . O

FUTURE JJ O
DEVELOPMENTS NNS O

Among IN O
the DT O
important JJ O
improvements NNS O
of IN O
EndoNet NNP O
which WDT O
we PRP O
are VBP O
currently RB O
working VBG O
on IN O
is VBZ O
the DT O
possibility NN O
to TO O
represent VB O
intercellular JJ O
communication NN O
at IN O
different JJ O
levels NNS O
of IN O
the DT O
hierarchical JJ O
organization NN O
of IN O
organs NNS O
, , O
tissues NNS O
and CC O
cells NNS O
in IN O
the DT O
organism NN O
, , O
as RB O
well RB O
as IN O
to TO O
distinguish VB O
between IN O
such JJ O
communications NNS O
in IN O
male JJ O
and CC O
female JJ O
organisms NNS O
. . O

These DT O
options NNS O
will MD O
be VB O
introduced VBN O
by IN O
a DT O
tighter JJR O
integration NN O
with IN O
the DT O
CYTOMER NNP O
- HYPH O
based VBN O
ontology NN O
( , O
19 CD O
, , O
20 CD O
) -RRB- O
. . O

The DT O
next JJ O
step NN O
will MD O
be VB O
to TO O
expand VB O
the DT O
contents NNS O
of IN O
EndoNet NNP O
towards IN O
the DT O
details NNS O
of IN O
the DT O
processes NNS O
occurring VBG O
in IN O
the DT O
transport NN O
medium NN O
, , O
usually RB O
the DT O
blood NN O
. . O

Since IN O
not RB O
all DT O
hormones NNS O
are VBP O
transported VBN O
as IN O
free JJ O
molecules NNS O
and CC O
some DT O
hydrophobic JJ O
hormones NNS O
( : O
e LS O
. . O
g LS O
. . O
steroids NNS O
and CC O
thyroids NNS O
) -RRB- O
need VBP O
to TO O
be VB O
bound VBN O
to IN O
specific JJ O
carrier NN O
proteins NNS O
, , O
proper JJ O
description NN O
of IN O
such JJ O
transporters NNS O
and CC O
their PRP$ O
interaction NN O
with IN O
the DT O
corresponding VBG O
hormones NNS O
will MD O
be VB O
required VBN O
. . O

It PRP O
is VBZ O
planned VBN O
to TO O
involve VB O
quantitative JJ O
data NNS O
about IN O
the DT O
regular JJ O
or CC O
pathological JJ O
levels NNS O
of IN O
the DT O
hormones NNS O
, , O
the DT O
overall JJ O
kinetics NNS O
of IN O
each DT O
hormone NN O
in IN O
the DT O
blood NN O
( , O
monotonous JJ O
decay NN O
, , O
oscillating VBG O
concentrations NNS O
, , O
increase NN O
in IN O
response NN O
to IN O
certain JJ O
stimuli NN O
, , O
etc FW O
. . O
) -RRB- O
, , O
its PRP$ O
turnover NN O
and CC O
metabolic JJ O
products NNS O
, , O
etc FW O
. . O

That DT O
will MD O
allow VB O
utilization NN O
of IN O
EndoNet NNP O
contents NNS O
for IN O
diagnostic JJ O
purposes NNS O
. . O

In IN O
future NN O
, , O
the DT O
EndoNet NNP O
data NN O
model NN O
will MD O
be VB O
extended VBN O
in IN O
order NN O
to TO O
incorporate VB O
external JJ O
stimuli NN O
( : O
e LS O
. . O
g LS O
. . O
light NN O
) -RRB- O
and CC O
physiological JJ O
states NNS O
( , O
stress NN O
, , O
age NN O
, , O
etc FW O
. . O
) -RRB- O
in IN O
a DT O
formalized JJ O
manner NN O
, , O
allowing VBG O
to TO O
determine VB O
whether IN O
or CC O
not RB O
and CC O
in IN O
which WDT O
quantity NN O
a DT O
hormone NN O
will MD O
be VB O
secreted VBN O
under IN O
the DT O
given VBN O
circumstances NNS O
. . O

EndoNet NN O
will MD O
then RB O
link VB O
the DT O
physiological JJ O
effects NNS O
of IN O
hormones NNS O
with IN O
the DT O
intracellular JJ O
molecular JJ O
processes NNS O
leading VBG O
to IN O
its PRP$ O
synthesis NN O
and CC O
secretion NN O
in IN O
the DT O
donor NN O
cells NNS O
, , O
and CC O
to IN O
the DT O
effects NNS O
on IN O
its PRP$ O
acceptor NN O
cells NNS O
. . O

At IN O
many JJ O
places NNS O
of IN O
these DT O
intracellular JJ O
and CC O
intercellular JJ O
networks NNS O
, , O
genetically RB O
determined VBN O
aberrations NNS O
may MD O
cause VB O
specific JJ O
, , O
sometimes RB O
pathological JJ O
phenotypes NNS O
. . O

Thus RB O
, , O
EndoNet NNP O
will MD O
enable VB O
to TO O
bridge VB O
the DT O
gap NN O
between IN O
known VBN O
genotypes NNS O
and CC O
their PRP$ O
molecular JJ O
and CC O
clinical JJ O
phenotypes NNS O
in IN O
this DT O
area NN O
of IN O
medical JJ O
research NN O
and CC O
its PRP$ O
applications NNS O
. . O

DISCUSSION NN O

At IN O
its PRP$ O
present JJ O
state NN O
, , O
EndoNet NNP O
provides VBZ O
a DT O
high JJ O
coverage NN O
of IN O
molecules NNS O
that WDT O
are VBP O
conventionally RB O
considered VBN O
as IN O
hormones NNS O
as RB O
well RB O
as IN O
other JJ O
molecules NNS O
that WDT O
are VBP O
involved VBN O
in IN O
intercellular JJ O
communication NN O
, , O
such JJ O
as IN O
growth NN O
factors NNS O
, , O
lymphokines NNS O
and CC O
chemokines NNS O
and CC O
their PRP$ O
known VBN O
receptors NNS O
. . O

The DT O
aim NN O
of IN O
the DT O
database NN O
is VBZ O
to TO O
provide VB O
a DT O
useful JJ O
resource NN O
for IN O
studying VBG O
the DT O
principal JJ O
features NNS O
of IN O
hormonal JJ O
networks NNS O
in IN O
a DT O
comprehensive JJ O
way NN O
, , O
as IN O
it PRP O
was VBD O
done VBN O
more RBR O
exemplarily RB O
in IN O
the DT O
past NN O
for IN O
these DT O
kinds NNS O
of IN O
networks NNS O
( , O
23 CD O
) -RRB- O
, , O
but CC O
was VBD O
done VBN O
globally RB O
for IN O
many JJ O
other JJ O
intracellular JJ O
network NN O
types NNS O
, , O
such JJ O
as IN O
metabolic JJ O
, , O
protein NN O
interaction NN O
and CC O
transcription NN O
networks NNS O
[ -LRB- O
reviewed VBN O
in IN O
( : O
24 CD O
, , O
25 CD O
) -RRB- O
] -RRB- O
. . O

EndoNet NNP O
database NN O
certainly RB O
is VBZ O
not RB O
yet RB O
complete JJ O
but CC O
will MD O
grow VB O
rapidly RB O
. . O

Gender NN O
differences NNS O
in IN O
factors NNS O
influencing VBG O
insulin NN O
resistance NN O
in IN O
elderly JJ O
hyperlipemic JJ O
non JJ O
- HYPH O
diabetic JJ O
subjects NNS O

Abstract JJ O

Background NN O

The DT O
increase NN O
in IN O
the DT O
prevalence NN O
of IN O
insulin NN O
resistance NN O
- HYPH O
related VBN O
metabolic JJ O
syndrome NN O
, , O
a DT O
disorder NN O
that WDT O
greatly RB O
increases VBZ O
the DT O
risk NN O
of IN O
diabetes NN O
, , O
heart NN O
attack NN O
and CC O
stroke NN O
, , O
is VBZ O
alarming JJ O
. . O

One CD O
of IN O
the DT O
most RBS O
frequent JJ O
and CC O
early JJ O
symptoms NNS O
of IN O
metabolic JJ O
syndrome NN O
is VBZ O
hypertriglyceridemia NN O
. . O

We PRP O
examined VBD O
the DT O
gender NN O
differences NNS O
between IN O
various JJ O
metabolic JJ O
factors NNS O
related VBN O
to IN O
insulin JJ O
resistance NN O
in IN O
elderly JJ O
non NN O
- HYPH O
diabetic JJ O
men NNS B-Species
and CC O
postmenopausal JJ O
women NNS B-Species
of IN O
comparable JJ O
age NN O
suffering VBG O
from IN O
hypertriglyceridemia NN O
, , O
and CC O
compared VBD O
them PRP O
with IN O
healthy JJ O
subjects NNS O
of IN O
equal JJ O
age NN O
. . O

Results NNS O

The DT O
indexes NNS O
of IN O
insulin NN O
resistance NN O
HOMA NNP O
IR NNP O
and CC O
QUICKI NNP O
were VBD O
significantly RB O
higher JJR O
in IN O
both CC O
hyperlipemic JJ O
men NNS B-Species
and CC O
women NNS B-Species
than IN O
in IN O
controls NNS O
; : O
95 CD O
% NN O
confidence NN O
limits NNS O
of IN O
hyperlipemic JJ O
subjects NNS O
did VBD O
not RB O
overlap VB O
with IN O
controls NNS O
. . O

In IN O
both CC O
normolipemic JJ O
and CC O
hyperlipemic JJ O
men NNS B-Species
and CC O
women NNS B-Species
serum NN O
leptin NN O
correlated VBD O
significantly RB O
with IN O
insulin NN O
resistance NN O
, , O
while IN O
HDL NNP O
- HYPH O
cholesterol NN O
correlated VBN O
inversely RB O
with IN O
HOMA NNP O
- HYPH O
IR NN O
only RB O
in IN O
women NNS B-Species
( , O
both CC O
normo NN O
- HYPH O
and CC O
hyperlipemic NN O
) -RRB- O
, , O
and CC O
serum JJ O
tumor NN O
necrosis NN O
factor NN O
alpha NN O
( , O
TNF NNP O
alpha NN O
) -RRB- O
only RB O
in IN O
hyperlipemic JJ O
women NNS B-Species
. . O

According VBG O
to IN O
results NNS O
of IN O
multiple JJ O
regression NN O
analysis NN O
with IN O
HOMA NNP O
- HYPH O
IR NNP O
as IN O
a DT O
dependent JJ O
variable NN O
, , O
leptin NN O
played VBD O
a DT O
significant JJ O
role NN O
in IN O
determining VBG O
insulin NN O
resistance NN O
in IN O
both DT O
genders NNS O
, , O
but CC O
- , O
aside RB O
from IN O
leptin NN O
- HYPH O
triglycerides NNS O
, , O
TNF NNP O
alpha NN O
and CC O
decreased VBD O
HDL NNP O
- HYPH O
cholesterol NN O
were VBD O
significant JJ O
determinants NNS O
in IN O
women NNS B-Species
, , O
while IN O
body NN O
mass NN O
index NN O
and CC O
decreased VBN O
HDL NNP O
- HYPH O
cholesterol NN O
were VBD O
significant JJ O
determinants NNS O
in IN O
men NNS B-Species
. . O

The DT O
coefficient NN O
of IN O
determination NN O
( , O
R2 NN O
) -RRB- O
of IN O
HOMA NN O
IR NN O
by IN O
above RB O
mentioned VBN O
metabolic JJ O
variables NNS O
was VBD O
in IN O
women NNS B-Species
above IN O
60 CD O
% NN O
, , O
in IN O
men NNS B-Species
only RB O
about RB O
40 CD O
% NN O
. . O

Conclusion NN O

The DT O
significant JJ O
role NN O
of IN O
serum NN O
leptin NN O
in IN O
determination NN O
of IN O
insulin NN O
resistance NN O
in IN O
both CC O
elderly JJ O
men NNS B-Species
and CC O
postmenopausal JJ O
women NNS B-Species
of IN O
equal JJ O
age NN O
was VBD O
confirmed VBN O
. . O

However RB O
, , O
the DT O
study NN O
also RB O
revealed VBD O
significant JJ O
gender NN O
differences NNS O
: : O
in IN O
women NNS B-Species
a DT O
strong JJ O
influence NN O
of IN O
triglycerides NNS O
, , O
TNF NNP O
alpha NN O
and CC O
decreased VBN O
HDL NNP O
- HYPH O
cholesterol NN O
, , O
in IN O
men NNS B-Species
only RB O
a DT O
mild JJ O
role NN O
of IN O
BMI NN O
and CC O
decreased VBN O
HDL NNP O
- HYPH O
cholesterol NN O
. . O

Background NN O

In IN O
association NN O
with IN O
pandemic JJ O
obesity NN O
the DT O
prevalence NN O
of IN O
the DT O
insulin NN O
resistance NN O
- HYPH O
related VBN O
metabolic JJ O
syndrome NN O
is VBZ O
constantly RB O
growing VBG O
[ -LRB- O
1 CD O
] -RRB- O
. . O

As IN O
a DT O
consequence NN O
of IN O
this DT O
fact NN O
, , O
type NN O
2 CD O
diabetes NN O
mellitus NN O
and CC O
cardiovascular JJ O
mortality NN O
occurs VBZ O
in IN O
much RB O
younger JJR O
age NN O
groups NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

A DT O
typical JJ O
hyperlipemia NN O
, , O
consisting VBG O
of IN O
an DT O
increase NN O
of IN O
serum NN O
triglycerides NNS O
and CC O
a DT O
decrease NN O
of IN O
serum JJ O
HDL NN O
- HYPH O
cholesterol NN O
, , O
is VBZ O
a DT O
characteristic NN O
and CC O
an DT O
early JJ O
symptom NN O
of IN O
this DT O
syndrome NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

With IN O
increasing VBG O
age NN O
, , O
body NN O
mass NN O
index NN O
( , O
BMI NN O
) -RRB- O
and CC O
adiposity NN O
, , O
insulin NN O
sensitivity NN O
declines VBZ O
and CC O
the DT O
number NN O
of IN O
cardiovascular JJ O
risk NN O
factors NNS O
increases VBZ O
in IN O
both DT O
genders NNS O
[ -LRB- O
4 CD O
- SYM O
6 CD O
] -RRB- O
. . O

It PRP O
was VBD O
repeatedly RB O
demonstrated VBN O
that IN O
plasma NN O
concentration NN O
of IN O
leptin NN O
- , O
a DT O
hormone NN O
produced VBN O
mainly RB O
by IN O
adipose JJ O
tissue NN O
- , O
is VBZ O
substantially RB O
higher JJR O
in IN O
all DT O
age NN O
groups NNS O
of IN O
women NNS B-Species
than IN O
in IN O
men NNS B-Species
[ -LRB- O
7 CD O
- SYM O
10 CD O
] -RRB- O
. . O

This DT O
may MD O
be VB O
caused VBN O
by IN O
different JJ O
size NN O
and CC O
/ SYM O
or CC O
distribution NN O
of IN O
fat JJ O
tissue NN O
compartments NNS O
influenced VBN O
by IN O
hormones NNS O
: : O
estrogens NNS O
stimulate VBP O
, , O
whereas IN O
testosterone NN O
inhibits VBZ O
leptin NN O
secretion NN O
. . O

In IN O
women NNS B-Species
subcutaneous JJ O
fat JJ O
mass NN O
prevails VBZ O
- , O
and CC O
during IN O
augmentation NN O
of IN O
overweight JJ O
it PRP O
increases VBZ O
- : O
while IN O
in IN O
men NNS B-Species
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
mass NN O
prevails VBZ O
[ -LRB- O
11 CD O
- SYM O
13 CD O
] -RRB- O
. . O

Subcutaneous JJ O
fat NN O
in IN O
particular JJ O
serves VBZ O
as IN O
a DT O
substantial JJ O
source NN O
of IN O
tumor NN O
necrosis NN O
factor NN O
alpha NN O
( , O
TNF NNP O
alpha NN O
) -RRB- O
, , O
which WDT O
represents VBZ O
one CD O
of IN O
the DT O
factors NNS O
that WDT O
interfere VBP O
with IN O
insulin NN O
signal NN O
transduction NN O
into IN O
the DT O
cells NNS O
[ -LRB- O
14 CD O
- SYM O
16 CD O
] -RRB- O
. . O

Leptin NNP O
, , O
TNF NNP O
alpha NN O
and CC O
some DT O
other JJ O
factors NNS O
are VBP O
abundantly RB O
expressed VBN O
in IN O
adipose NN O
tissue NN O
and CC O
contribute VBP O
to IN O
the DT O
insulin NN O
resistance NN O
that WDT O
accompanies VBZ O
overweight JJ O
and CC O
obesity NN O
. . O

Leptin NN O
correlates VBZ O
positively RB O
with IN O
hyperinsulinemia NN O
, , O
BMI NN O
, , O
fat NN O
mass NN O
and CC O
hypertriglyceridemia NN O
, , O
respectively RB O
, , O
and CC O
correlates VBZ O
inversely RB O
with IN O
HDL NNP O
- HYPH O
cholesterol NN O
and CC O
lean JJ O
body NN O
mass NN O
[ -LRB- O
17 CD O
- SYM O
25 CD O
] -RRB- O
. . O

The DT O
incidence NN O
and CC O
mortality NN O
of IN O
ischemic JJ O
heart NN O
disease NN O
and CC O
of IN O
other JJ O
consequences NNS O
of IN O
atherosclerosis NN O
increases VBZ O
with IN O
age NN O
in IN O
both DT O
genders NNS O
, , O
especially RB O
after IN O
the DT O
age NN O
of IN O
sixty CD O
. . O

In IN O
premenopausal JJ O
women NNS B-Species
, , O
however RB O
, , O
the DT O
incidence NN O
of IN O
these DT O
disorders NNS O
is VBZ O
considerably RB O
less RBR O
frequent JJ O
than IN O
in IN O
men NNS B-Species
of IN O
appropriate JJ O
age NN O
. . O

After IN O
the DT O
menopause NN O
the DT O
prevalence NN O
of IN O
metabolic JJ O
syndrome NN O
and CC O
cardiovascular JJ O
mortality NN O
in IN O
women NNS B-Species
gradually RB O
increases VBZ O
, , O
attaining VBG O
values NNS O
comparable JJ O
to IN O
men NNS B-Species
at IN O
about RB O
the DT O
age NN O
of IN O
70 CD O
[ -LRB- O
2 CD O
, , O
26 CD O
] -RRB- O
. . O

Paradoxically RB O
, , O
it PRP O
takes VBZ O
place NN O
at IN O
the DT O
time NN O
when WRB O
serum NN O
leptin NN O
concentration NN O
in IN O
women NNS B-Species
has VBZ O
relatively RB O
decreased VBN O
[ -LRB- O
27 CD O
, , O
28 CD O
] -RRB- O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
analyze VB O
the DT O
interrelations NNS O
between IN O
several JJ O
metabolic JJ O
variables NNS O
and CC O
factors NNS O
related VBN O
to IN O
insulin NN O
resistance NN O
in IN O
groups NNS O
of IN O
both CC O
normal JJ O
and CC O
hyperlipemic JJ O
postmenopausal JJ O
women NNS B-Species
and CC O
men NNS B-Species
of IN O
appropriate JJ O
age NN O
, , O
and CC O
to TO O
attempt VB O
to TO O
elucidate VB O
the DT O
gender NN O
differences NNS O
and CC O
some DT O
pathophysiologic JJ O
mechanisms NNS O
of IN O
these DT O
differences NNS O
. . O

We PRP O
compared VBD O
homeostatic JJ O
indexes NNS O
of IN O
insulin NN O
resistance NN O
HOMA NNP O
IR NNP O
and CC O
QUICKI NNP O
, , O
serum NN O
lipid NN O
and CC O
insulin NN O
parameters NNS O
, , O
uric NN O
acid NN O
, , O
leptin NN O
and CC O
TNF NNP O
alpha NN O
between IN O
groups NNS O
of IN O
subjects NNS O
without IN O
apparent JJ O
symptoms NNS O
of IN O
metabolic JJ O
syndrome NN O
, , O
and CC O
groups NNS O
showing VBG O
mild JJ O
hypertriglyceridemia NN O
with IN O
decreased VBN O
HDL NNP O
- HYPH O
cholesterol NN O
. . O

In IN O
addition NN O
, , O
serum JJ O
concentration NN O
of IN O
the DT O
heart NN O
fraction NN O
of IN O
fatty JJ O
acid NN O
binding NN O
protein NN O
( , O
hFATP NN O
) -RRB- O
was VBD O
explored VBN O
as IN O
a DT O
factor NN O
that WDT O
might MD O
reflect VB O
the DT O
regulative JJ O
role NN O
of IN O
PPAR NN O
gamma NN O
in IN O
lipid NN O
homeostasis NN O
[ -LRB- O
29 CD O
, , O
30 CD O
] -RRB- O
, , O
and CC O
serum NN O
IgG NN O
anticardiolipin NN O
( -LRB- O
ACL NNP O
- HYPH O
IgG NNP O
) -RRB- O
was VBD O
investigated VBN O
as IN O
an DT O
indirect JJ O
indicator NN O
of IN O
oxidized VBN O
lipid NN O
fractions NNS O
related VBN O
to IN O
atherosclerotic JJ O
complications NNS O
[ -LRB- O
31 CD O
, , O
32 CD O
] -RRB- O
. . O

Methods NNS O

Subjects NNS O

The DT O
study NN O
was VBD O
carried VBN O
out RP O
on IN O
70 CD O
out IN O
- HYPH O
patients NNS B-Species
of IN O
the DT O
Metabolic NNP O
Center NNP O
at IN O
the DT O
hospital NN O
in IN O
Sternberk NNP O
, , O
Czech NNP O
Republic NNP O
. . O

From IN O
these DT O
, , O
40 CD O
patients NNS B-Species
( , O
20 CD O
men NNS B-Species
and CC O
20 CD O
women NNS B-Species
) -RRB- O
were VBD O
selected VBN O
with IN O
mild JJ O
hyperlipidemia NN O
, , O
i PRP O
. . O
e LS O
. . O
with IN O
plasma NN O
triglyceride NN O
concentration NN O
exceeding VBG O
2 CD O
. . O
0 CD O
mmol NN O
/ SYM O
l NN O
, , O
total JJ O
cholesterol NN O
exceeding VBG O
6 CD O
. . O
0 CD O
mmol NN O
/ SYM O
l NN O
, , O
LDL NN O
cholesterol NN O
exceeding VBG O
4 CD O
. . O
0 CD O
mmol NN O
/ SYM O
l NN O
, , O
and CC O
with IN O
HDL NNP O
cholesterol NN O
concentration NN O
in IN O
men NNS B-Species
under IN O
1 CD O
. . O
0 CD O
mmol NN O
/ SYM O
l NN O
, , O
and CC O
in IN O
women NNS B-Species
under IN O
1 CD O
. . O
2 CD O
mmol NN O
/ SYM O
l NN O
. . O

These DT O
groups NNS O
were VBD O
denominated VBN O
as IN O
"""" `` O
hyperlipemic JJ O
"""" '' O
. . O

Two CD O
other JJ O
groups NNS O
( , O
10 CD O
men NNS B-Species
and CC O
20 CD O
women NNS B-Species
) -RRB- O
with IN O
approximately RB O
normal JJ O
serum JJ O
values NNS O
of IN O
these DT O
variables NNS O
were VBD O
taken VBN O
as IN O
"""" `` O
controls NNS O
"""" '' O
. . O

The DT O
average JJ O
age NN O
in IN O
men NNS B-Species
was VBD O
59 CD O
. . O
1 CD O
+ CD O
/ SYM O
- SYM O
10 CD O
. . O
6 CD O
y NN O
, , O
and CC O
in IN O
women NNS B-Species
59 CD O
. . O
4 CD O
+ NFP O
/ SYM O
- SYM O
10 CD O
. . O
1 CD O
y NN O
, , O
respectively RB O
. . O

The DT O
differences NNS O
between IN O
lipid JJ O
parameters NNS O
of IN O
hyperlipemic NN O
and CC O
control NN O
groups NNS O
were VBD O
highly RB O
statistically RB O
significant JJ O
, , O
while IN O
the DT O
age NN O
differences NNS O
were VBD O
insignificant JJ O
( , O
see VB O
Table NNP O
1 CD O
) -RRB- O
. . O

None NN O
of IN O
the DT O
patients NNS B-Species
had VBD O
clinically RB O
apparent JJ O
diabetes NN O
mellitus NN O
, , O
but CC O
some DT O
of IN O
the DT O
hyperlipemic JJ O
patients NNS B-Species
exerted VBD O
impaired VBN O
glucose NN O
tolerance NN O
or CC O
impaired VBN O
fasting VBG O
glucose NN O
( , O
values NNS O
between IN O
6 CD O
. . O
1 CD O
and CC O
7 CD O
. . O
0 CD O
mmol NN O
/ SYM O
l CD O
, , O
or CC O
between IN O
6 CD O
. SYM O
1 CD O
and CC O
7 CD O
. . O
8 CD O
mmol NN O
/ SYM O
l CD O
, , O
respectively RB O
) -RRB- O
. . O

None NN O
of IN O
the DT O
patients NNS B-Species
was VBD O
treated VBN O
with IN O
insulin NN O
, , O
peroral JJ O
antidiabetics NNS O
or CC O
antihyperlipemic JJ O
drugs NNS O
; : O
some DT O
of IN O
them PRP O
were VBD O
treated VBN O
with IN O
antihypertensive JJ O
therapy NN O
. . O

No DT O
signs NNS O
of IN O
major JJ O
clinical JJ O
or CC O
laboratory JJ O
symptoms NNS O
of IN O
other JJ O
diseases NNS O
were VBD O
present JJ O
in IN O
any DT O
group NN O
of IN O
the DT O
explored VBN O
patients NNS B-Species
. . O

Blood NN O
samples NNS O
were VBD O
obtained VBN O
in IN O
the DT O
morning NN O
via IN O
a DT O
venipuncture NN O
after IN O
overnight JJ O
fasting NN O
. . O

After IN O
clotting VBG O
the DT O
serum NN O
was VBD O
separated VBN O
and CC O
stored VBN O
at IN O
- SYM O
20 CD O
degrees NNS O
until IN O
used JJ O
. . O

An DT O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
all DT O
probands NNS O
. . O

Body NN O
mass NN O
indexes NNS O
( , O
BMI NNP O
) -RRB- O
, , O
defined VBN O
as IN O
weight NN O
in IN O
kilograms NNS O
divided VBN O
by IN O
the DT O
square NN O
of IN O
height NN O
in IN O
meters NNS O
, , O
were VBD O
calculated VBN O
. . O

Biochemical JJ O
methods NNS O

Serum NN O
leptin NN O
concentrations NNS O
were VBD O
measured VBN O
by IN O
a DT O
sandwich NN O
ELISA NNP O
test NN O
kit NN O
( , O
Human NNP B-Species
Leptin NNP O
ELISA NNP O
, , O
BioVendor NNP O
Laboratory NNP O
Medicine NNP O
, , O
Inc NNP O
, , O
Czech NNP O
Republic NNP O
) -RRB- O
. . O

Its PRP$ O
sensitivity NN O
limit NN O
was VBD O
0 CD O
. . O
2 CD O
ng CD O
/ SYM O
ml NN O
, , O
intraassay NN O
CV NN O
6 CD O
. . O
1 CD O
% NN O
at IN O
the DT O
level NN O
of IN O
7 CD O
. . O
5 CD O
ng CD O
/ SYM O
m CD O
, , O
inter JJ O
- HYPH O
assay NN O
CV NN O
8 CD O
. . O
5 CD O
% NN O
at IN O
the DT O
level NN O
of IN O
4 CD O
. . O
8 CD O
ng CD O
/ SYM O
ml NN O
. . O

Tetramethylbenzidine NNP O
was VBD O
used VBN O
as IN O
a DT O
substrate NN O
; : O
quality NN O
controls NNS O
were VBD O
human NN B-Species
based VBN O
. . O

Several JJ O
other JJ O
hormones NNS O
and CC O
peptides NNS O
were VBD O
estimated VBN O
by IN O
routine JJ O
immunochemical JJ O
tests NNS O
: : O
insulin NN O
, , O
C NN O
- HYPH O
peptide NN O
, , O
TNF NNP O
alpha NN O
( , O
IMMULITE NNP O
, , O
Diagnostic NNP O
Products NNPS O
Corporation NNP O
, , O
Los NNP O
Angeles NNP O
, , O
CA NNP O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
) -RRB- O
, , O
proinsulin NN O
intact JJ O
( , O
DAKO NNP O
, , O
Denmark NNP O
) -RRB- O
, , O
IgG NNP O
anticardiolipin NN O
( , O
ACL NNP O
- HYPH O
IgG NNP O
, , O
IMMCO NNP O
Diagnostics NNP O
, , O
Buffalo NNP O
, , O
NY NNP O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
) -RRB- O
and CC O
heart NN O
fatty NN O
acid NN O
binding NN O
protein NN O
( , O
hFABP NNP O
, , O
Hbt NNP O
HUMAN NNP O
H NNP O
- HYPH O
FABP NNP O
, , O
HyCult NNP O
Biotechnology NNP O
, , O
Uden NNP O
, , O
the DT O
Netherlands NNP O
) -RRB- O
. . O

Serum JJ O
concentration NN O
of IN O
glucose NN O
, , O
total JJ O
cholesterol NN O
, , O
triglycerides NNS O
, , O
HDL NN O
- HYPH O
cholesterol NN O
, , O
LDL NN O
- HYPH O
cholesterol NN O
, , O
Apoprotein NN O
B NN O
and CC O
uric NN O
acid NN O
were VBD O
measured VBN O
on IN O
a DT O
ILAB NNP O
- HYPH O
600 CD O
biochemical JJ O
analyzer NN O
( -LRB- O
Instrumentation NNP O
Laboratory NNP O
, , O
Lexington NNP O
, , O
Ma NNP O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
) -RRB- O
using VBG O
BioVendor NNP O
sets NNS O
. . O

All DT O
samples NNS O
were VBD O
processed VBN O
and CC O
examined VBN O
according VBG O
to IN O
principles NNS O
of IN O
good JJ O
laboratory NN O
practice NN O
and CC O
under IN O
constant JJ O
intralaboratory JJ O
and CC O
external JJ O
quality NN O
control NN O
. . O

The DT O
homeostatic JJ O
indexes NNS O
of IN O
insulin NN O
resistance NN O
( -LRB- O
HOMA NNP O
IR NNP O
and CC O
QUICKI NNP O
) -RRB- O
were VBD O
calculated VBN O
according VBG O
to IN O
the DT O
homeostasis NN O
model NN O
of IN O
assessment NN O
[ -LRB- O
33 CD O
- SYM O
35 CD O
] -RRB- O
as IN O
follows VBZ O
: : O

HOMA NNP O
IR NNP O
= : O
fasting VBG O
insulin NN O
( : O
mu NN O
U NN O
/ , O
ml NN O
) NFP O
* NFP O
fasting VBG O
glucose NN O
( : O
mmol NN O
/ : O
l NN O
) NFP O
/ SYM O
22 CD O
. . O
5 CD O
; : O

QUICKI NNP O
= SYM O
1 CD O
/ SYM O
[ -LRB- O
log NN O
fasting VBG O
insulin NN O
( HYPH O
mu NN O
U NN O
/ SYM O
ml NN O
) NFP O
+ SYM O
log NN O
fasting VBG O
glucose NN O
( -LRB- O
mg NN O
/ SYM O
100 CD O
ml NNS O
) -RRB- O
] -RRB- O
. . O

Statistics NNS O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
using VBG O
the DT O
Version NNP O
6 CD O
SAS NNP O
/ SYM O
STAT NNP O
software NN O
( : O
SAS NNP O
Institute NNP O
, , O
Inc NNP O
. . O
, , O
Cary NNP O
, , O
NC NNP O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
) -RRB- O
. . O

The DT O
Shapiro NNP O
- HYPH O
Wilks NNP O
tests NNS O
were VBD O
used VBN O
in IN O
testing VBG O
the DT O
normality NN O
of IN O
distribution NN O
. . O

Some DT O
of IN O
the DT O
data NNS O
obtained VBN O
were VBD O
not RB O
normally RB O
distributed VBN O
. . O

The DT O
statistical JJ O
significance NN O
of IN O
differences NNS O
between IN O
the DT O
means NNS O
in IN O
the DT O
hyperlipemic JJ O
and CC O
control NN O
groups NNS O
were VBD O
evaluated VBN O
using VBG O
the DT O
unpaired JJ O
Student NNP O
' '' O
s POS O
T NN O
- HYPH O
test NN O
in IN O
the DT O
case NN O
of IN O
normal JJ O
distribution NN O
of IN O
data NNS O
sets NNS O
, , O
and CC O
using VBG O
the DT O
Kolmogorov NNP O
- HYPH O
Smirnov NNP O
test NN O
when WRB O
at IN O
least JJS O
in IN O
one CD O
of IN O
the DT O
data NNS O
sets NNS O
the DT O
normal JJ O
distribution NN O
was VBD O
excluded VBN O
. . O

Spearman NNP O
' POS O
s NNS O
rank NN O
- HYPH O
order NN O
correlation NN O
was VBD O
used VBN O
for IN O
correlation NN O
analysis NN O
. . O

Multiple JJ O
regression NN O
analysis NN O
was VBD O
performed VBN O
using VBG O
HOMA NNP O
IR NNP O
indexes NNS O
of IN O
insulin NN O
resistance NN O
as IN O
dependent JJ O
variables NNS O
, , O
and CC O
other JJ O
metabolic JJ O
and CC O
hormonal JJ O
factors NNS O
( , O
lipid NN O
parameters NNS O
, , O
BMI NNP O
, , O
leptin NN O
, , O
TNF NNP O
alpha NN O
, , O
hFABP NNP O
, , O
ACL NNP O
- HYPH O
IgG NNP O
) -RRB- O
as IN O
independent JJ O
variables NNS O
. . O

The DT O
so RB O
- HYPH O
called VBN O
step NN O
- HYPH O
down RP O
regression NN O
model NN O
was VBD O
used VBN O
to TO O
select VB O
dominant JJ O
independent JJ O
variables NNS O
. . O

Various JJ O
four CD O
- HYPH O
member NN O
groups NNS O
of IN O
independent JJ O
( , O
explanatory JJ O
) -RRB- O
variables NNS O
were VBD O
used VBN O
for IN O
the DT O
analysis NN O
and CC O
the DT O
non AFX O
- HYPH O
zero CD O
intercept NN O
was VBD O
taken VBN O
into IN O
account NN O
. . O

The DT O
independent JJ O
variables NNS O
were VBD O
then RB O
dropped VBN O
, , O
one CD O
at IN O
a DT O
time NN O
; , O
at IN O
each DT O
stage NN O
one CD O
variable NN O
making VBG O
the DT O
least JJS O
contribution NN O
to IN O
the DT O
dependent JJ O
variable NN O
( : O
i LS O
. . O
e -RRB- O
. . O
that WDT O
showed VBD O
the DT O
least JJS O
p NN O
- HYPH O
value NN O
in IN O
the DT O
test NN O
of IN O
the DT O
regression NN O
coefficient JJ O
being VBG O
zero CD O
) -RRB- O
was VBD O
excluded VBN O
. . O

The DT O
coefficient NN O
of IN O
determination NN O
R2 NN O
, , O
which WDT O
can MD O
be VB O
viewed VBN O
as IN O
a DT O
percentage NN O
explaining VBG O
the DT O
total JJ O
variance NN O
, , O
was VBD O
simultaneously RB O
monitored VBN O
. . O

A DT O
great JJ O
drop NN O
in IN O
R2 NN O
after IN O
excluding VBG O
some DT O
independent JJ O
variable JJ O
enabled VBN O
selection NN O
of IN O
those DT O
independent JJ O
variables NNS O
that WDT O
could MD O
be VB O
thought VBN O
to TO O
be VB O
the DT O
most RBS O
important JJ O
determinants NNS O
of IN O
the DT O
dependent JJ O
variable NN O
. . O

Results NNS O

Table NN O
1 CD O
demonstrates VBZ O
mean JJ O
parameters NNS O
in IN O
individual JJ O
groups NNS O
of IN O
subjects NNS O
matched VBN O
according VBG O
to IN O
sex NN O
, , O
lipid NN O
parameters NNS O
and CC O
age NN O
. . O

While IN O
the DT O
age NN O
of IN O
all DT O
four CD O
groups NNS O
did VBD O
not RB O
differ VB O
substantially RB O
, , O
the DT O
concentrations NNS O
of IN O
total JJ O
serum NN O
cholesterol NN O
, , O
triglycerides NNS O
, , O
HDL NN O
- HYPH O
cholesterol NN O
and CC O
LDL NN O
- HYPH O
cholesterol NN O
differ VBP O
very RB O
significantly RB O
in IN O
both CC O
male JJ O
and CC O
female JJ O
hyperlipemic JJ O
groups NNS O
as IN O
compared VBN O
with IN O
controls NNS O
. . O

In IN O
addition NN O
, , O
the DT O
concentration NN O
of IN O
triglycerides NNS O
in IN O
control NN O
women NNS B-Species
was VBD O
significantly RB O
higher JJR O
than IN O
in IN O
control NN O
men NNS B-Species
, , O
the DT O
concentration NN O
of IN O
triglycerides NNS O
in IN O
hyperlipemic JJ O
women NNS B-Species
was VBD O
lower JJR O
than IN O
in IN O
hyperlipemic JJ O
men NNS B-Species
, , O
and CC O
the DT O
concentration NN O
of IN O
HDL NNP O
- HYPH O
cholesterol NN O
in IN O
hyperlipemic JJ O
women NNS B-Species
was VBD O
very RB O
significantly RB O
higher JJR O
when WRB O
compared VBN O
with IN O
hyperlipemic JJ O
men NNS B-Species
. . O

Table NNP O
2 CD O
shows VBZ O
the DT O
values NNS O
of IN O
other JJ O
metabolic JJ O
and CC O
insulin NN O
parameters NNS O
, , O
factors NNS O
related VBN O
to IN O
insulin NN O
resistance NN O
and CC O
indexes NNS O
of IN O
insulin NN O
resistance NN O
, , O
respectively RB O
. . O

Body NN O
mass NN O
indexes NNS O
and CC O
uric JJ O
acid NN O
concentration NN O
were VBD O
significantly RB O
higher JJR O
in IN O
hyperlipemic JJ O
men NNS B-Species
as IN O
compared VBN O
to IN O
controls NNS O
, , O
but CC O
not RB O
in IN O
hyperlipemic JJ O
women NNS B-Species
. . O

Uric JJ O
acid NN O
concentration NN O
was VBD O
substantially RB O
lower JJR O
in IN O
hyperlipemic JJ O
women NNS B-Species
than IN O
in IN O
hyperlipemic JJ O
men NNS B-Species
. . O

Plasma NN O
concentrations NNS O
of IN O
glycemia NN O
, , O
insulin NN O
and CC O
intact JJ O
proinsulin NN O
were VBD O
significantly RB O
higher JJR O
in IN O
both CC O
hyperlipemic JJ O
men NNS B-Species
and CC O
women NNS B-Species
as IN O
compared VBN O
with IN O
controls NNS O
of IN O
identical JJ O
gender NN O
, , O
while IN O
the DT O
concentration NN O
of IN O
leptin NN O
increased VBD O
only RB O
in IN O
hyperlipemic JJ O
men NNS B-Species
. . O

However RB O
, , O
serum NN O
leptin NN O
concentrations NNS O
of IN O
both CC O
control NN O
and CC O
hyperlipemic JJ O
women NNS B-Species
were VBD O
significantly RB O
higher JJR O
than IN O
in IN O
corresponding VBG O
groups NNS O
of IN O
men NNS B-Species
. . O

Serum NN O
concentrations NNS O
of IN O
TNF NNP O
alpha NN O
, , O
hFABP NNP O
and CC O
ACL NNP O
- HYPH O
IgG NNP O
in IN O
hyperlipemic JJ O
groups NNS O
of IN O
both DT O
men NNS B-Species
and CC O
women NNS B-Species
were VBD O
not RB O
significantly RB O
different JJ O
from IN O
control NN O
groups NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
indexes NNS O
of IN O
insulin NN O
resistance NN O
HOMA NNP O
IR NNP O
and CC O
QUICKI NNP O
differed VBD O
very RB O
significantly RB O
in IN O
hyperlipemic JJ O
groups NNS O
of IN O
both DT O
men NNS B-Species
and CC O
women NNS B-Species
as IN O
compared VBN O
with IN O
corresponding VBG O
control NN O
groups NNS O
, , O
more RBR O
distinctly RB O
in IN O
women NNS B-Species
. . O

From IN O
Fig NNP O
. . O

1 CD O
, , O
presenting VBG O
95 CD O
% NN O
confidence NN O
limits NNS O
of IN O
insulin NN O
resistance NN O
indexes NNS O
HOMA NNP O
IR NNP O
and CC O
QUICKI NNP O
, , O
we PRP O
concluded VBD O
that IN O
in IN O
groups NNS O
of IN O
hyperlipemic JJ O
patients NNS B-Species
of IN O
both DT O
genders NNS O
the DT O
insulin NN O
resistance NN O
was VBD O
substantially RB O
higher JJR O
than IN O
in IN O
control NN O
groups NNS O
; : O
the DT O
groups NNS O
did VBD O
not RB O
overlap VB O
each DT O
other JJ O
. . O

In IN O
Table NNP O
3 CD O
the DT O
results NNS O
of IN O
Spearman NNP O
' POS O
s POS O
correlations NNS O
between IN O
insulin NN O
resistance NN O
index NN O
HOMA NN O
IR NN O
and CC O
various JJ O
metabolic JJ O
parameters NNS O
are VBP O
presented VBN O
. . O

In IN O
the DT O
control NN O
group NN O
of IN O
men NNS B-Species
, , O
positive JJ O
significant JJ O
correlation NN O
between IN O
HOMA NN O
IR NN O
and CC O
serum NN O
leptin NN O
concentration NN O
, , O
and CC O
inverse JJ O
significant JJ O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
and CC O
ACL NNP O
IgG NNP O
, , O
respectively RB O
, , O
were VBD O
found VBN O
. . O

In IN O
the DT O
control NN O
group NN O
of IN O
women NNS B-Species
, , O
the DT O
significance NN O
of IN O
Spearman NNP O
' POS O
s POS O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
and CC O
leptin NN O
was VBD O
more RBR O
expressive JJ O
; : O
inverse JJ O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
and CC O
HDL NNP O
- HYPH O
cholesterol NN O
was VBD O
also RB O
present JJ O
. . O

In IN O
the DT O
hyperlipemic JJ O
group NN O
of IN O
men NNS B-Species
, , O
the DT O
significance NN O
of IN O
the DT O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
was VBD O
more RBR O
expressive JJ O
in IN O
relation NN O
to IN O
the DT O
control NN O
group NN O
, , O
and CC O
no DT O
significant JJ O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
and CC O
ACL NNP O
IgG NNP O
was VBD O
found VBN O
. . O

In IN O
the DT O
hyperlipemic JJ O
group NN O
of IN O
women NNS B-Species
, , O
however RB O
, , O
the DT O
significance NN O
of IN O
Spearman NNP O
' POS O
s POS O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
and CC O
serum NN O
leptin NN O
concentration NN O
weakened VBD O
, , O
the DT O
inverse JJ O
correlation NN O
between IN O
HOMA NNP O
IR NNP O
and CC O
HDL NNP O
- HYPH O
cholesterol NN O
remained VBD O
approximately RB O
unchanged JJ O
, , O
and CC O
a DT O
positive JJ O
correlation NN O
between IN O
HOMA NN O
IR NN O
and CC O
serum JJ O
concentration NN O
of IN O
TNF NNP O
alpha NN O
appeared VBD O
. . O

Table NN O
4 CD O
shows VBZ O
results NNS O
of IN O
multiple JJ O
regression NN O
analysis NN O
, , O
when WRB O
data NNS O
from IN O
both CC O
control NN O
and CC O
hyperlipemic JJ O
groups NNS O
of IN O
each DT O
gender NN O
were VBD O
judged VBN O
together RB O
. . O

HOMA NNP O
IR NNP O
was VBD O
considered VBN O
as IN O
a DT O
dependent JJ O
variable NN O
and CC O
differently RB O
changed VBN O
constellations NNS O
of IN O
metabolic JJ O
and CC O
other JJ O
factors NNS O
were VBD O
taken VBN O
as IN O
independent JJ O
variables NNS O
. . O

In IN O
men NNS B-Species
, , O
BMI NNP O
and CC O
leptin NN O
seemed VBD O
to TO O
play VB O
a DT O
main JJ O
role NN O
in IN O
influencing VBG O
the DT O
insulin NN O
resistance NN O
index NN O
HOMA NNP O
IR NNP O
, , O
while IN O
TGL NNP O
, , O
ACL NNP O
IgG NNP O
and CC O
LDL NN O
- HYPH O
cholesterol NN O
didn VBD O
' '' O
t RB O
play VB O
any DT O
significant JJ O
role NN O
( : O
see VB O
left VBN O
columns NNS O
of IN O
Table NNP O
4 CD O
) -RRB- O
. . O

The DT O
decreasing NN O
of IN O
HDL NNP O
- HYPH O
cholesterol NN O
concentration NN O
may MD O
also RB O
have VB O
some DT O
influence NN O
( , O
see VB O
a DT O
significant JJ O
drop NN O
of IN O
R2 NN O
after IN O
exclusion NN O
of IN O
this DT O
factor NN O
in IN O
Table NNP O
4A NNP O
, , O
4B NNP O
) -RRB- O
. . O

But CC O
in IN O
the DT O
presence NN O
of IN O
leptin NN O
in IN O
the DT O
group NN O
of IN O
independent JJ O
factors NNS O
, , O
the DT O
drop NN O
of IN O
R2 NN O
after IN O
exclusion NN O
of IN O
HDL NNP O
- HYPH O
cholesterol NN O
from IN O
these DT O
factors NNS O
was VBD O
minimal JJ O
( : O
see VB O
Table NNP O
4C NNP O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
after IN O
the DT O
exclusion NN O
of IN O
TNF NNP O
alpha NN O
from IN O
the DT O
group NN O
of IN O
independent JJ O
variables NNS O
( , O
see VB O
Table NNP O
4B NNP O
, , O
4D CD O
) -RRB- O
the DT O
value NN O
of IN O
R2 NNP O
has VBZ O
unexpectedly RB O
risen VBN O
, , O
which WDT O
could MD O
reflect VB O
the DT O
interference NN O
of IN O
TNF NNP O
alpha NN O
with IN O
factors NNS O
increasing VBG O
the DT O
insulin NN O
resistance NN O
. . O

In IN O
women NNS B-Species
( , O
see VB O
right JJ O
columns NNS O
of IN O
Table NNP O
4 CD O
) -RRB- O
, , O
the DT O
maximal JJ O
values NNS O
of IN O
R2 NNP O
were VBD O
achieved VBN O
with IN O
combination NN O
of IN O
independent JJ O
variables NNS O
containing VBG O
TGL NNP O
, , O
leptin NN O
and CC O
HDL NN O
- HYPH O
cholesterol NN O
( : O
about RB O
60 CD O
% NN O
influence NN O
on IN O
HOMA NNP O
IR NNP O
! . O
- : O
see VB O
Table NNP O
4A NNP O
, , O
4B NNP O
, , O
4C CD O
) -RRB- O
. . O

TNF NNP O
alpha NN O
seemed VBD O
to TO O
play VB O
quite PDT O
a DT O
different JJ O
role NN O
than IN O
in IN O
men NNS B-Species
: : O
after IN O
exclusion NN O
of IN O
this DT O
factor NN O
from IN O
the DT O
group NN O
of IN O
independent JJ O
factors NNS O
R2significantly RB O
decreased VBD O
( : O
see VB O
Table NNP O
4B NNP O
, , O
4D CD O
) -RRB- O
. . O

In IN O
contrast NN O
to IN O
men NNS B-Species
, , O
the DT O
role NN O
of IN O
BMI NNP O
seemed VBD O
to TO O
be VB O
minimal JJ O
. . O

As IN O
in IN O
men NNS B-Species
, , O
the DT O
role NN O
of IN O
ACL NNP O
IgG NNP O
and CC O
LDL NN O
- HYPH O
cholesterol NN O
in IN O
influencing VBG O
HOMA NNP O
IR NNP O
was VBD O
negligible JJ O
, , O
but CC O
in IN O
contrast NN O
to IN O
men NNS B-Species
, , O
hFABP NNP O
might MD O
play VB O
a DT O
certain JJ O
role NN O
in IN O
this DT O
process NN O
( , O
see VB O
Table NNP O
4D NNP O
) -RRB- O
. . O

Generally RB O
, , O
the DT O
insulin NN O
resistance NN O
( , O
represented VBN O
by IN O
HOMA NNP O
IR NNP O
) -RRB- O
was VBD O
in IN O
men NNS B-Species
much RB O
less RBR O
influenced VBN O
by IN O
metabolic JJ O
variables NNS O
than IN O
in IN O
women NNS B-Species
; , O
while IN O
in IN O
women NNS B-Species
in IN O
some DT O
combinations NNS O
of IN O
dependent JJ O
variables NNS O
R2 NNP O
reached VBD O
64 CD O
% NN O
, , O
in IN O
men NNS B-Species
the DT O
maximal JJ O
value NN O
of IN O
R2 NNP O
was VBD O
only RB O
39 CD O
% NN O
. . O

Discussion NN O

In IN O
our PRP$ O
previous JJ O
paper NN O
[ -LRB- O
36 CD O
] -RRB- O
, , O
the DT O
mean JJ O
value NN O
of IN O
HOMA NN O
IR NN O
in IN O
healthy JJ O
subjects NNS O
of IN O
both DT O
genders NNS O
and CC O
of IN O
age NN O
comparable JJ O
with IN O
our PRP$ O
controls NNS O
was VBD O
1 CD O
. . O
57 CD O
+ CD O
/ SYM O
- SYM O
0 CD O
. . O
87 CD O
, , O
and CC O
the DT O
mean JJ O
value NN O
of IN O
index NN O
QUICKI NNP O
0 CD O
. . O
366 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
29 CD O
, , O
respectively RB O
. . O

These DT O
values NNS O
, , O
as RB O
well RB O
as IN O
the DT O
95 CD O
% NN O
confidence NN O
limits NNS O
, , O
correspond VBP O
to IN O
values NNS O
found VBN O
in IN O
controls NNS O
in IN O
this DT O
study NN O
. . O

In IN O
accordance NN O
with IN O
many JJ O
previous JJ O
papers NNS O
, , O
serum JJ O
concentrations NNS O
of IN O
leptin NN O
in IN O
women NNS B-Species
( , O
both CC O
control NN O
and CC O
hyperlipemic NN O
) -RRB- O
were VBD O
substantially RB O
higher JJR O
than IN O
in IN O
men NNS B-Species
. . O

In IN O
the DT O
control NN O
group NN O
of IN O
women NNS B-Species
the DT O
correlation NN O
between IN O
leptin NN O
and CC O
HOMA NNP O
IR NNP O
was VBD O
highly RB O
significant JJ O
. . O

However RB O
, , O
in IN O
hyperlipemic JJ O
women NNS B-Species
the DT O
significance NN O
of IN O
this DT O
correlation NN O
lessened VBD O
, , O
because IN O
HOMA NNP O
IR NNP O
increased VBD O
considerably RB O
( , O
and CC O
significantly RB O
) , O
but CC O
serum JJ O
concentration NN O
of IN O
leptin NN O
only RB O
slightly RB O
( : O
insignificantly RB O
) RB O
. . O

In IN O
men NNS B-Species
the DT O
significance NN O
of IN O
correlations NNS O
between IN O
serum NN O
leptin NN O
and CC O
HOMA NNP O
IR NNP O
was VBD O
high JJ O
and CC O
approximately RB O
the DT O
same JJ O
in IN O
both CC O
the DT O
control NN O
and CC O
hyperlipemic JJ O
groups NNS O
, , O
because IN O
the DT O
values NNS O
of IN O
HOMA NNP O
IR NNP O
as RB O
well RB O
as IN O
serum NN O
leptin NN O
have VBP O
nearly RB O
doubled VBN O
in IN O
hyperlipemic JJ O
in IN O
relation NN O
to IN O
control NN O
groups NNS O
. . O

In IN O
non JJ O
- HYPH O
hyperlipemic JJ O
postmenopausal JJ O
women NNS B-Species
the DT O
high JJ O
concentration NN O
of IN O
serum NN O
leptin NN O
was VBD O
not RB O
associated VBN O
with IN O
higher JJR O
insulin NN O
resistance NN O
: : O
HOMA NNP O
IR NNP O
did VBD O
not RB O
differ VB O
substantially RB O
from IN O
men NNS B-Species
. . O

A DT O
significant JJ O
increase NN O
of IN O
insulin NN O
resistance NN O
in IN O
hyperlipemic JJ O
women NNS B-Species
was VBD O
associated VBN O
by IN O
only RB O
slight JJ O
and CC O
insignificant JJ O
increase NN O
of IN O
leptin NN O
concentration NN O
. . O

According VBG O
to IN O
Spearman NNP O
' POS O
s POS O
correlations NNS O
, , O
an DT O
increase NN O
of IN O
serum NN O
TNF NNP O
alpha NN O
and CC O
/ SYM O
or CC O
a DT O
decrease NN O
of IN O
HDL NNP O
- HYPH O
cholesterol NN O
might MD O
also RB O
play VB O
a DT O
distinct JJ O
role NN O
in IN O
this DT O
respect NN O
. . O

( : O
see VB O
Table NNP O
3 CD O
) -RRB- O
. . O

In IN O
contrast NN O
to IN O
women NNS B-Species
, , O
in IN O
hyperlipemic JJ O
men NNS B-Species
the DT O
increase NN O
of IN O
insulin NN O
resistance NN O
index NN O
was VBD O
approximately RB O
proportional JJ O
with IN O
the DT O
increase NN O
of IN O
leptin NN O
concentration NN O
. . O

Multiple JJ O
regression NN O
analysis NN O
affirmed VBD O
the DT O
importance NN O
of IN O
leptin NN O
serum NN O
in IN O
increasing VBG O
of IN O
insulin NN O
resistance NN O
in IN O
both DT O
genders NNS O
. . O

In IN O
men NNS B-Species
, , O
only RB O
BMI NNP O
and CC O
HDL NNP O
- HYPH O
cholesterol NN O
from IN O
other JJ O
factors NNS O
studied VBN O
seemed VBD O
to TO O
play VB O
a DT O
certain JJ O
role NN O
, , O
but CC O
the DT O
maximal JJ O
values NNS O
of IN O
influencing VBG O
HOMA NNP O
IR NNP O
reached VBD O
only RB O
39 CD O
% NN O
, , O
with IN O
leptin NN O
and CC O
BMI NNP O
being VBG O
the DT O
more RBR O
important JJ O
factors NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
in IN O
women NNS B-Species
the DT O
maximal JJ O
determination NN O
of IN O
HOMA NNP O
IR NNP O
as RB O
high JJ O
as IN O
60 CD O
% NN O
was VBD O
registered VBN O
in IN O
combination NN O
of IN O
serum NN O
leptin NN O
, , O
TGL NN O
and CC O
decreased VBN O
HDL NNP O
- HYPH O
cholesterol NN O
as IN O
independent JJ O
factors NNS O
; : O
the DT O
role NN O
of IN O
BMI NNP O
was VBD O
insignificant JJ O
. . O

It PRP O
is VBZ O
not RB O
known VBN O
how WRB O
leptin NN O
is VBZ O
regulated VBN O
. . O

A DT O
strong JJ O
correlation NN O
between IN O
plasma NN O
leptin NN O
and CC O
fasting VBG O
insulin NN O
undoubtedly RB O
exists VBZ O
, , O
but CC O
hyperleptinemia NN O
in IN O
both CC O
obese JJ O
and CC O
lean JJ O
humans NNS B-Species
is VBZ O
not RB O
likely RB O
the DT O
result NN O
of IN O
hyperinsulinemia NN O
[ -LRB- O
37 CD O
] -RRB- O
. . O

A DT O
relationship NN O
between IN O
leptin NN O
and CC O
insulin NN O
dependent JJ O
on IN O
sex NN O
or CC O
BMI NNP O
was VBD O
reported VBN O
, , O
but CC O
relationship NN O
between IN O
triglyceride NN O
concentrations NNS O
and CC O
leptin NN O
was VBD O
independent JJ O
of IN O
sex NN O
, , O
BMI NNP O
, , O
and CC O
insulin NN O
[ -LRB- O
18 CD O
, , O
24 CD O
] -RRB- O
. . O

Hyperleptinemia NN O
, , O
as IN O
an DT O
early JJ O
sign NN O
of IN O
obesity NN O
, , O
was VBD O
closely RB O
linked VBN O
to IN O
subcutaneous JJ O
fat JJ O
mass NN O
[ -LRB- O
39 CD O
, , O
40 CD O
] -RRB- O
. . O

Percentage NN O
of IN O
body NN O
fat NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
the DT O
strongest JJS O
predictor NN O
of IN O
leptin NN O
levels NNS O
even RB O
in IN O
lean JJ O
women NNS B-Species
[ -LRB- O
41 CD O
] -RRB- O
. . O

Leptin NN O
was VBD O
highly RB O
correlated VBN O
with IN O
percentage NN O
of IN O
body NN O
fat NN O
and CC O
with IN O
fat JJ O
mass NN O
in IN O
adults NNS O
irrespective JJ O
of IN O
gender NN O
and CC O
age NN O
; : O
however RB O
, , O
the DT O
mean JJ O
determinant NN O
of IN O
leptin NN O
plasma NN O
concentration NN O
in IN O
men NNS B-Species
and CC O
postmenopausal JJ O
women NNS B-Species
was VBD O
BMI NNP O
, , O
while IN O
in IN O
premenopausal JJ O
women NNS B-Species
it PRP O
was VBD O
only RB O
the DT O
fat JJ O
mass NN O
[ -LRB- O
42 CD O
] -RRB- O
. . O

These DT O
findings NNS O
contrast VBP O
with IN O
our PRP$ O
results NNS O
showing VBG O
minimal JJ O
influence NN O
of IN O
BMI NNP O
on IN O
HOMA NNP O
IR NN O
in IN O
postmenopausal JJ O
women NNS B-Species
. . O

All DT O
factors NNS O
mentioned VBN O
are VBP O
connected VBN O
with IN O
fat JJ O
tissue NN O
: : O
leptin NN O
and CC O
TNF NNP O
alpha NN O
are VBP O
directly RB O
produced VBN O
chiefly RB O
by IN O
adipocytes NNS O
, , O
BMI NN O
growth NN O
is VBZ O
obviously RB O
accompanied VBN O
by IN O
fat JJ O
mass NN O
increase NN O
, , O
and CC O
the DT O
typical JJ O
hypertriglyceridemia NN O
associated VBN O
with IN O
a DT O
decrease NN O
of IN O
HDL NNP O
- HYPH O
cholesterol NN O
goes VBZ O
along IN O
with IN O
obesity NN O
and CC O
fat JJ O
mass NN O
growth NN O
. . O

The DT O
gender NN O
differences NNS O
in IN O
circulating VBG O
leptin NN O
were VBD O
best RBS O
explained VBN O
by IN O
percentage NN O
of IN O
body NN O
fat NN O
and CC O
- HYPH O
inversely RB O
- HYPH O
by IN O
lean JJ O
body NN O
mass NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

In IN O
both DT O
genders NNS O
the DT O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
correlated VBN O
with IN O
insulin NN O
resistance NN O
, , O
while IN O
the DT O
subcutaneous JJ O
fat NN O
correlated VBD O
with IN O
circulating VBG O
leptin NN O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
. . O

In IN O
men NNS B-Species
obesity NN O
led VBD O
to IN O
a DT O
prevalent JJ O
increase NN O
of IN O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
, , O
while IN O
in IN O
women NNS B-Species
of IN O
subcutaneous JJ O
fat NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Influences NNS O
of IN O
different JJ O
compartments NNS O
of IN O
adipose JJ O
tissues NNS O
could MD O
elucidate VB O
the DT O
variability NN O
of IN O
correlations NNS O
between IN O
insulin NN O
resistance NN O
and CC O
high JJ O
leptin NN O
concentrations NNS O
in IN O
lean JJ O
and CC O
obese JJ O
subjects NNS O
of IN O
both DT O
genders NNS O
[ -LRB- O
43 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
non JJ O
- HYPH O
hyperlipemic JJ O
postmenopausal JJ O
women NNS B-Species
the DT O
content NN O
of IN O
subcutaneous JJ O
fat NN O
mass NN O
might MD O
be VB O
higher JJR O
than IN O
in IN O
non JJ O
- HYPH O
hyperlipemic JJ O
men NNS B-Species
of IN O
appropriate JJ O
age NN O
, , O
which WDT O
indicated VBD O
a DT O
higher JJR O
serum JJ O
concentration NN O
of IN O
leptin NN O
. . O

However RB O
, , O
the DT O
insulin NN O
resistance NN O
- HYPH O
related VBN O
to IN O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
mass NN O
- , O
did VBD O
not RB O
differ VB O
from IN O
men NNS B-Species
. . O

The DT O
significant JJ O
increase NN O
of IN O
insulin NN O
resistance NN O
and CC O
leptin NN O
concentration NN O
in IN O
hyperlipemic JJ O
men NNS B-Species
might MD O
reflect VB O
the DT O
growing VBG O
content NN O
of IN O
both CC O
subcutaneous JJ O
and CC O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
mass NN O
( , O
see VB O
the DT O
significant JJ O
increase NN O
of IN O
BMI NNP O
) -RRB- O
. . O

In IN O
hyperlipemic JJ O
women NNS B-Species
the DT O
significant JJ O
increase NN O
of IN O
insulin NN O
resistance NN O
accompanying VBG O
only RB O
minimal JJ O
insignificant JJ O
increase NN O
of IN O
leptin NN O
could MD O
be VB O
caused VBN O
by IN O
prevalent JJ O
growing NN O
of IN O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
mass NN O
. . O

In IN O
elderly JJ O
postmenopausal JJ O
women NNS B-Species
, , O
an DT O
association NN O
between IN O
leptin NN O
and CC O
plasma NN O
lipoprotein NN O
concentration NN O
was VBD O
found VBN O
which WDT O
depended VBD O
on IN O
adiposity NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
and CC O
inverse JJ O
correlations NNS O
between IN O
serum NN O
leptin NN O
and CC O
HDL NNP O
- HYPH O
cholesterol NN O
were VBD O
described VBN O
[ -LRB- O
44 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
study NN O
, , O
insulin NN O
resistance NN O
in IN O
women NNS B-Species
seemed VBD O
to TO O
be VB O
more RBR O
notably RB O
than IN O
in IN O
men NNS B-Species
influenced VBN O
by IN O
lipid NN O
disorders NNS O
, , O
i PRP O
. . O
e LS O
. . O
positively RB O
by IN O
serum NN O
triglycerides NNS O
and CC O
inversely RB O
by IN O
HDL NNP O
- HYPH O
cholesterol NN O
. . O

These DT O
findings NNS O
might MD O
be VB O
important JJ O
in IN O
considering VBG O
the DT O
concept NN O
of IN O
treatment NN O
of IN O
insulin NN O
resistance NN O
- HYPH O
related VBN O
disorders NNS O
in IN O
postmenopausal JJ O
women NNS B-Species
. . O

The DT O
significant JJ O
role NN O
of IN O
TNF NNP O
alpha NN O
in IN O
insulin NN O
resistance NN O
, , O
caused VBN O
by IN O
inhibiting VBG O
the DT O
transduction NN O
of IN O
insulin NN O
signaling NN O
and CC O
by IN O
down RB O
- HYPH O
regulation NN O
of IN O
glucose NN O
transporter NN O
GLUT NNP O
- HYPH O
4 CD O
and CC O
insulin NN O
receptor NN O
substrate NN O
- HYPH O
1 CD O
, , O
has VBZ O
been VBN O
repeatedly RB O
confirmed VBN O
[ -LRB- O
45 CD O
- HYPH O
48 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
supported VBD O
these DT O
findings NNS O
unambiguously RB O
only RB O
in IN O
women NNS B-Species
, , O
while IN O
in IN O
men NNS B-Species
TNF NNP O
alpha NN O
seemed VBD O
paradoxically RB O
to TO O
interfere VB O
with IN O
other JJ O
factors NNS O
- : O
mainly RB O
BMI NNP O
and CC O
leptin NN O
- : O
in IN O
influencing VBG O
insulin NN O
resistance NN O
, , O
thus RB O
playing VBG O
a DT O
quite RB O
different JJ O
role NN O
. . O

Previously RB O
it PRP O
was VBD O
found VBN O
[ -LRB- O
46 CD O
] -RRB- O
that IN O
correlation NN O
between IN O
serum NN O
TNF NNP O
alpha NN O
on IN O
the DT O
one CD O
side NN O
, , O
and CC O
insulin NN O
, , O
HOMA NNP O
IR NNP O
, , O
serum NN O
triglycerids NNS O
, , O
respectively RB O
, , O
on IN O
the DT O
other JJ O
side NN O
, , O
was VBD O
substantially RB O
more RBR O
significant JJ O
in IN O
women NNS B-Species
than IN O
in IN O
men NNS B-Species
. . O

Serum JJ O
concentration NN O
of IN O
TNF NNP O
alpha NN O
in IN O
patients NNS B-Species
with IN O
type NN O
2 CD O
diabetes NNS O
of IN O
both DT O
genders NNS O
correlated VBD O
only RB O
with IN O
the DT O
quantity NN O
of IN O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
compartment NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Visceral JJ O
obesity NN O
correlated VBD O
with IN O
plasmatic JJ O
aldosterone NN O
and CC O
with IN O
insulin NN O
resistance NN O
only RB O
in IN O
premenopausal JJ O
women NNS B-Species
, , O
but CC O
not RB O
in IN O
men NNS B-Species
[ -LRB- O
51 CD O
] -RRB- O
. . O

From IN O
all PDT O
these DT O
data NNS O
we PRP O
might MD O
support VB O
our PRP$ O
above JJ O
mentioned VBN O
conclusion NN O
- : O
that IN O
rising VBG O
of IN O
insulin NN O
resistance NN O
in IN O
hyperlipemic JJ O
women NNS B-Species
was VBD O
associated VBN O
with IN O
an DT O
increase NN O
of IN O
intra JJ O
- HYPH O
abdominal JJ O
fat NN O
, , O
because IN O
this DT O
fat NN O
mass NN O
in IN O
particular JJ O
is VBZ O
a DT O
source NN O
of IN O
TNF NNP O
alpha NN O
, , O
which WDT O
interfered VBD O
with IN O
insulin NN O
sensitivity NN O
only RB O
in IN O
women NNS B-Species
. . O

We PRP O
came VBD O
to IN O
this DT O
conclusion NN O
irrespective RB O
of IN O
the DT O
finding NN O
that IN O
the DT O
increase NN O
of IN O
serum NN O
TNF NNP O
alpha NN O
in IN O
hyperlipemic JJ O
women NNS B-Species
was VBD O
statistically RB O
insignificant JJ O
; : O
results NNS O
of IN O
Spearman NNP O
' POS O
s NN O
correlation NN O
( -LRB- O
Table NN O
3 CD O
) -RRB- O
and CC O
multiple JJ O
regression NN O
analysis NN O
confirm VBP O
a DT O
distinct JJ O
role NN O
of IN O
this DT O
factor NN O
. . O

In IN O
hyperlipemic JJ O
men NNS B-Species
not RB O
only RB O
the DT O
serum JJ O
concentration NN O
of IN O
TNF NNP O
alpha NN O
has VBZ O
decreased VBN O
instead RB O
of IN O
increasing VBG O
, , O
but CC O
according VBG O
to IN O
multiple JJ O
regression NN O
analysis NN O
it PRP O
played VBD O
a DT O
quite RB O
different JJ O
role NN O
in IN O
influencing VBG O
insulin NN O
sensitivity NN O
, , O
interfering VBG O
with IN O
factors NNS O
that WDT O
determined VBD O
insulin NN O
resistance NN O
( , O
leptin NN O
and CC O
BMI NNP O
) -RRB- O
. . O

In IN O
the DT O
control NN O
group NN O
of IN O
men NNS B-Species
IgG NN O
anticardiolipin NN O
was VBD O
inversely RB O
correlated VBN O
to IN O
HOMA NNP O
IR NNP O
. . O

The DT O
significance NN O
of IN O
this DT O
finding NN O
is VBZ O
not RB O
clear JJ O
. . O

These DT O
antibodies NNS O
indicate VBP O
vascular JJ O
and CC O
thrombotic JJ O
complications NNS O
and CC O
oxidative JJ O
modification NN O
of IN O
lipoproteins NNS O
[ -LRB- O
52 CD O
, , O
53 CD O
] -RRB- O
and CC O
may MD O
represent VB O
an DT O
increased VBN O
risk NN O
of IN O
atherogenic JJ O
and CC O
inflammatory JJ O
complications NNS O
. . O

In IN O
this DT O
case NN O
, , O
however RB O
, , O
their PRP$ O
growing VBG O
might MD O
be VB O
connected VBN O
with IN O
an DT O
increase NN O
in IN O
insulin NN O
sensitivity NN O
. . O

Anyway RB O
, , O
ACL NNP O
IgG NNP O
evidently RB O
did VBD O
not RB O
participate VB O
significantly RB O
in IN O
influencing VBG O
the DT O
increase NN O
of IN O
insulin NN O
resistance NN O
associated VBN O
with IN O
hyperlipidemia NN O
, , O
although IN O
other JJ O
anti JJ O
- HYPH O
cardiolipin NN O
correlations NNS O
could MD O
be VB O
masked VBN O
by IN O
the DT O
relatively RB O
large JJ O
inter JJ O
- HYPH O
individual JJ O
variations NNS O
in IN O
this DT O
parameter NN O
. . O

Neither DT O
serum JJ O
concentration NN O
of IN O
hFABP NNP O
, , O
a DT O
factor NN O
ensuring VBG O
transmembrane NN O
transport NN O
and CC O
oxidative JJ O
metabolisation NN O
of IN O
long JJ O
- HYPH O
chain NN O
fatty NN O
acids NNS O
[ -LRB- O
54 CD O
, , O
55 CD O
] -RRB- O
, , O
was VBD O
significantly RB O
changed VBN O
in IN O
hyperlipemic JJ O
and CC O
insulin NN O
resistant JJ O
subjects NNS O
of IN O
both DT O
genders NNS O
. . O

This DT O
factor NN O
was VBD O
very RB O
weakly RB O
associated VBN O
only RB O
with IN O
HOMA NNP O
IR NNP O
in IN O
women NNS B-Species
( , O
see VB O
Table NNP O
4D NNP O
) -RRB- O
, , O
indicating VBG O
that IN O
enhanced JJ O
metabolisation NN O
of IN O
fatty NN O
acids NNS O
in IN O
cells NNS O
might MD O
to IN O
some DT O
degree NN O
contribute VB O
to IN O
insulin JJ O
resistance NN O
. . O

Conclusions NNS O

In IN O
postmenopausal JJ O
women NNS B-Species
as RB O
well RB O
as IN O
in IN O
men NNS B-Species
of IN O
approximately RB O
equal JJ O
age NN O
serum NN O
leptin NN O
plays VBZ O
a DT O
significant JJ O
role NN O
as IN O
an DT O
important JJ O
determinant NN O
of IN O
insulin NN O
resistance NN O
. . O

In IN O
addition NN O
to IN O
this DT O
factor NN O
, , O
in IN O
women NNS B-Species
the DT O
grade NN O
of IN O
insulin NN O
resistance NN O
is VBZ O
very RB O
considerably RB O
influenced VBN O
by IN O
serum NN O
triglycerides NNS O
, , O
tumor NN O
necrosis NN O
factor NN O
alpha NN O
, , O
and CC O
by IN O
decreased VBN O
concentration NN O
of IN O
HDL NN O
- HYPH O
cholesterol NN O
, , O
while IN O
in IN O
men NNS B-Species
only RB O
a DT O
mild JJ O
influence NN O
of IN O
BMI NN O
and CC O
decreased VBN O
HDL NNP O
- HYPH O
cholesterol NN O
is VBZ O
observed VBN O
. . O

These DT O
findings NNS O
are VBP O
explained VBN O
as IN O
a DT O
consequence NN O
of IN O
gender NN O
- HYPH O
related VBN O
differences NNS O
in IN O
adipose NN O
tissue NN O
composition NN O
and CC O
/ SYM O
or CC O
distribution NN O
in IN O
both DT O
normal JJ O
- HYPH O
weight NN O
and CC O
over IN O
- HYPH O
weight NN O
subjects NNS O
and CC O
should MD O
be VB O
taken VBN O
into IN O
account NN O
in IN O
treatment NN O
of IN O
patients NNS B-Species
with IN O
metabolic JJ O
risk NN O
factors NNS O
of IN O
cardiovascular JJ O
diseases NNS O
. . O

List NN O
of IN O
abbreviations NNS O

HDL NNP O
- HYPH O
Cholesterol NN O
= : O
high JJ O
- HYPH O
density NN O
cholesterol NN O

LDL NNP O
- HYPH O
cholesterol NN O
= : O
low JJ O
- HYPH O
density NN O
cholesterol NN O

HOMA NNP O
IR NNP O
= : O
Homeostasis NN O
Assessment NN O
of IN O
Insulin NNP O
Resistance NNP O

= NFP O
fasting VBG O
insulin NN O
( : O
mu NN O
U NN O
/ , O
ml NN O
) NFP O
* NFP O
fasting VBG O
glucose NN O
( , O
mmol NN O
/ : O
l NN O
) NFP O
/ SYM O
22 CD O
, , O
5 CD O

QUICKI NNP O
= SYM O
1 CD O
/ SYM O
[ -LRB- O
log NN O
fasting VBG O
insulin NN O
( HYPH O
mu NN O
U NN O
/ HYPH O
ml NN O
) NFP O
+ SYM O
log NN O
fasting VBG O
glucose NN O
( -LRB- O
mg NN O
/ SYM O
100 CD O
ml NN O
) -RRB- O
] -RRB- O

TNF NNP O
alpha NN O
= HYPH O
tumor NN O
necrosis NN O
factor NN O
alpha NN O

BMI NNP O
= : O
body NN O
mass NN O
index NN O

R2 CD O
= SYM O
coefficient JJ O
of IN O
determination NN O

hFABP NN O
= SYM O
heart NN O
fatty JJ O
acid NN O
binding NN O
protein NN O

ACL NNP O
- HYPH O
IgG NN O
= : O
IgG NN O
fraction NN O
of IN O
anticardiolipin NN O

TGL NNP O
= SYM O
triglycerides NNS O

GLUT NNP O
- HYPH O
4 CD O
= HYPH O
glucose NN O
transporter NN O
- HYPH O
4 CD O

PPAR NN O
gamma NN O
= : O
Peroxisome NN O
Proliferator NN O
- HYPH O
Associated JJ O
Receptor NN O
gamma NN O

CV NN O
= : O
coefficient JJ O
of IN O
variation NN O

Authors NNS O
' POS O
contributions NNS O

Dr NNP O
. , O
Radka NNP O
Lichnovsk NNP O
a DT O
collected VBD O
the DT O
clinical JJ O
material NN O
, , O
performed VBD O
analysis NN O
of IN O
biochemical JJ O
values NNS O
and CC O
edited VBD O
the DT O
manuscript NN O
. . O

Dr NNP O
. , O
Simona NNP O
Gwozdziewiczov NNP O
a DT O
performed VBN O
analysis NN O
of IN O
clinical JJ O
and CC O
biochemical JJ O
data NNS O
and CC O
edited VBD O
the DT O
manuscript NN O
. . O

Prof NNP O
. . O

Jir NNP O
i NNP O
Hreb NNP O
i NNP O
cek NNP O
initiated VBD O
the DT O
study NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
, , O
and CC O
wrote VBD O
and CC O
edited VBD O
the DT O
manuscript NN O
. . O

Alexithymia NN O
and CC O
anxiety NN O
in IN O
female JJ O
chronic JJ O
pain NN O
patients NNS B-Species

Abstract JJ O

Objectives NNS O

Alexithymia NNP O
is VBZ O
highly RB O
prevalent JJ O
among IN O
chronic JJ O
pain NN O
patients NNS B-Species
. . O

Pain NN O
is VBZ O
a DT O
remarkable JJ O
cause NN O
for IN O
high JJ O
levels NNS O
of IN O
chronic JJ O
anxiety NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
prevalence NN O
of IN O
alexithymia NN O
and CC O
to TO O
determine VB O
anxiety NN O
levels NNS O
among IN O
DSM NN O
- HYPH O
IV NN O
somatoform NN O
pain NN O
disorder NN O
( , O
chronic JJ O
pain NN O
) , O
female JJ O
patients NNS B-Species
and CC O
to TO O
examine VB O
the DT O
relationship NN O
between IN O
alexithymia NN O
and CC O
the DT O
self NN O
- HYPH O
reporting NN O
of IN O
pain NN O
. . O

Methods NNS O

Thirty CD O
adult NN O
females NNS O
( , O
mean JJ O
age NN O
: : O
34 CD O
, , O
63 CD O
+ NN O
/ SYM O
- HYPH O
10 CD O
, , O
62 CD O
years NNS O
) -RRB- O
, , O
who WP O
applied VBD O
to IN O
the DT O
outpatient JJ O
psychiatry NN O
clinic NN O
at IN O
a DT O
public JJ O
hospital NN O
with IN O
the DT O
diagnosis NN O
of IN O
chronic JJ O
pain NN O
disorder NN O
( , O
DSM NNP O
- HYPH O
IV NNP O
) -RRB- O
, , O
were VBD O
included VBN O
in IN O
the DT O
study NN O
. . O

Thirty CD O
seven CD O
healthy JJ O
females NNS O
( , O
mean JJ O
age NN O
: : O
34 CD O
, , O
46 CD O
+ NN O
/ SYM O
- HYPH O
7 CD O
, , O
43 CD O
years NNS O
) -RRB- O
, , O
who WP O
matched VBD O
for IN O
sociodemographic JJ O
features NNS O
with IN O
the DT O
patient JJ B-Species
group NN O
, , O
consisted VBD O
the DT O
control NN O
group NN O
. . O

A DT O
sociodemographic JJ O
data NN O
form NN O
, , O
26 CD O
- HYPH O
item NN O
Toronto NNP O
Alexithymia NNP O
Scale NNP O
( : O
TAS NNP O
- HYPH O
26 CD O
) -RRB- O
, , O
Spielberger NNP O
Trait NNP O
Anxiety NNP O
Inventory NNP O
( , O
STAI NNP O
) -RRB- O
were VBD O
administered VBN O
to IN O
each DT O
subject NN O
and CC O
information NN O
was VBD O
obtained VBN O
on IN O
several JJ O
aspects NNS O
of IN O
the DT O
patients NNS B-Species
' POS O
pain NN O
, , O
including VBG O
intensity NN O
( , O
measured VBN O
by IN O
VAS NNP O
) -RRB- O
, , O
and CC O
duration NN O
. . O

Results NNS O

Chronic JJ O
pain NN O
patients NNS B-Species
were VBD O
found VBN O
significantly RB O
more RBR O
alexithymic JJ O
than IN O
controls NNS O
. . O

There EX O
was VBD O
a DT O
positive JJ O
correlation NN O
between IN O
TAS NNP O
- HYPH O
26 CD O
scores NNS O
and CC O
the DT O
duration NN O
of IN O
pain NN O
. . O

The DT O
alexithymic JJ O
and CC O
nonalexithymic JJ O
group NN O
did VBD O
not RB O
differ VB O
in IN O
their PRP$ O
perception NN O
of IN O
pain NN O
. . O

Neither CC O
positive JJ O
correlation NN O
nor CC O
significant JJ O
difference NN O
was VBD O
found VBN O
between IN O
alexithymia NN O
and CC O
trait NN O
anxiety NN O
in IN O
pain NN O
patients NNS B-Species
. . O

Discussion NN O

Alexithymia NNP O
may MD O
be VB O
important JJ O
in IN O
addressing VBG O
the DT O
diversity NN O
of IN O
subjective JJ O
factors NNS O
involved VBN O
in IN O
pain NN O
. . O

The DT O
conceptualization NN O
of IN O
alexithymia NN O
as IN O
a DT O
personality NN O
trait NN O
as RB O
well RB O
as IN O
a DT O
secondary JJ O
state NN O
reaction NN O
is VBZ O
underlined VBN O
by IN O
our PRP$ O
data NNS O
. . O

Background NN O

The DT O
original JJ O
definition NN O
of IN O
alexithymia NN O
is VBZ O
the DT O
inability NN O
to TO O
identify VB O
and CC O
use VB O
verbal JJ O
language NN O
to TO O
describe VB O
feelings NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

Alexithymia NNP O
has VBZ O
been VBN O
associated VBN O
with IN O
a DT O
variety NN O
of IN O
psychiatric JJ O
disorders NNS O
as RB O
well RB O
as IN O
physical JJ O
illness NN O
[ -LRB- O
3 CD O
- SYM O
10 CD O
] -RRB- O
. . O

As IN O
a DT O
measure NN O
, , O
Toronto NNP O
Alexithymia NNP O
Scale NNP O
was VBD O
significantly RB O
correlated VBN O
with IN O
the DT O
measures NNS O
of IN O
the DT O
tendency NN O
to TO O
experience VB O
and CC O
report VB O
physical JJ O
signs NNS O
and CC O
symptoms NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Several JJ O
studies NNS O
have VBP O
found VBN O
a DT O
high JJ O
prevalence NN O
of IN O
alexithymia NN O
in IN O
pain NN O
patients NNS B-Species
. . O

Chronic JJ O
pain NN O
patients NNS B-Species
frequently RB O
exhibit VBP O
many JJ O
of IN O
the DT O
core NN O
features NNS O
of IN O
alexithymia NN O
, , O
such JJ O
as IN O
problems NNS O
in IN O
identifying VBG O
and CC O
describing VBG O
subjective JJ O
feelings NNS O
, , O
impoverished JJ O
imaginative JJ O
abilities NNS O
, , O
and CC O
excessive JJ O
preoccupation NN O
with IN O
physical JJ O
symptoms NNS O
and CC O
external JJ O
events NNS O
. . O

Although IN O
several JJ O
studies NNS O
have VBP O
found VBN O
a DT O
high JJ O
prevalence NN O
of IN O
alexithymia NN O
in IN O
pain NN O
patients NNS B-Species
, , O
the DT O
way NN O
alexithymia NN O
may MD O
possibly RB O
influence VB O
pain NN O
experience NN O
is VBZ O
still RB O
unclear JJ O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
. . O

DSM NNP O
- HYPH O
IV NN O
- HYPH O
TR NNP O
defines VBZ O
pain NN O
disorder NN O
as IN O
the DT O
presence NN O
of IN O
pain NN O
that WDT O
is VBZ O
"""" `` O
the DT O
predominant JJ O
focus NN O
of IN O
clinical JJ O
attention NN O
"""" '' O
[ -LRB- O
14 CD O
] -RRB- O
. . O

In IN O
chronic JJ O
pain NN O
disorder NN O
, , O
patients NNS B-Species
complain VBP O
of IN O
chronic JJ O
pain NN O
, , O
for IN O
which WDT O
no DT O
physical JJ O
etiology NN O
could MD O
be VB O
found VBN O
or CC O
the DT O
underlying VBG O
disorder NN O
is VBZ O
insufficient JJ O
in IN O
explaining VBG O
the DT O
symptoms NNS O
. . O

The DT O
pain NN O
causes VBZ O
clinically RB O
significant JJ O
distress NN O
or CC O
impairment NN O
in IN O
social JJ O
, , O
occupational JJ O
, , O
or CC O
other JJ O
important JJ O
areas NNS O
of IN O
functioning VBG O
. . O

Psychological JJ O
factors NNS O
are VBP O
judged VBN O
to TO O
have VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
onset NN O
, , O
severity NN O
, , O
exacerbation NN O
, , O
or CC O
maintenance NN O
of IN O
the DT O
pain NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

The DT O
alexithymic JJ O
person NN B-Species
' POS O
s POS O
difficulty NN O
in IN O
identifying VBG O
and CC O
describing VBG O
feelings NNS O
may MD O
increase VB O
symptom NN O
reporting NN O
by IN O
several JJ O
mechanisms NNS O
. . O

Consequently RB O
, , O
due IN O
to IN O
the DT O
difficulty NN O
to TO O
experience VB O
and CC O
express VB O
emotions NNS O
, , O
alexithymia NN O
has VBZ O
been VBN O
linked VBN O
with IN O
somatosensory JJ O
amplification NN O
, , O
which WDT O
is VBZ O
the DT O
tendency NN O
to TO O
focus VB O
on IN O
benign JJ O
somatic JJ O
sensations NNS O
. . O

Alexithymic JJ O
subjects NNS O
are VBP O
considered VBN O
to TO O
focus VB O
on IN O
somatic JJ O
manifestations NNS O
of IN O
emotional JJ O
arousal NN O
, , O
resulting VBG O
in IN O
misinterpretation NN O
of IN O
somatic JJ O
sensations NNS O
as IN O
signs NNS O
of IN O
physical JJ O
illness NN O
[ -LRB- O
12 CD O
, , O
13 CD O
, , O
16 CD O
] -RRB- O
. . O

Accordingly RB O
, , O
previous JJ O
studies NNS O
have VBP O
found VBN O
evidence NN O
of IN O
an DT O
association NN O
between IN O
alexithymia NN O
and CC O
the DT O
development NN O
of IN O
functional JJ O
somatic JJ O
symptoms NNS O
, , O
as IN O
seen VBN O
in IN O
patients NNS B-Species
with IN O
somatoform NN O
disorders NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
alexithymia NN O
may MD O
also RB O
occur VB O
as IN O
a DT O
secondary JJ O
state NN O
reaction NN O
in IN O
response NN O
to IN O
severe JJ O
and CC O
chronic JJ O
medical JJ O
illness NN O
[ -LRB- O
17 CD O
- SYM O
21 CD O
] -RRB- O
. . O

Based VBN O
on IN O
previous JJ O
findings NNS O
, , O
these DT O
factors NNS O
are VBP O
worth JJ O
receiving VBG O
more JJR O
attention NN O
in IN O
terms NNS O
of IN O
clinical JJ O
research NN O
. . O

The DT O
purpose NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
prevalence NN O
of IN O
alexithymia NN O
among IN O
DSM NNP O
- HYPH O
IV NN O
somatoform NN O
pain NN O
disorder NN O
( , O
chronic JJ O
pain NN O
) , O
female JJ O
patients NNS B-Species
and CC O
to TO O
examine VB O
the DT O
relationship NN O
between IN O
alexithymia NN O
and CC O
the DT O
self NN O
- HYPH O
reporting NN O
of IN O
pain NN O
in IN O
this DT O
group NN O
of IN O
patients NNS B-Species
. . O

Besides IN O
, , O
the DT O
study NN O
searched VBD O
for IN O
the DT O
anxiety NN O
levels NNS O
of IN O
chronic JJ O
pain NN O
patients NNS B-Species
with IN O
or CC O
without IN O
alexithymia NN O
. . O

Materials NNS O
and CC O
methods NNS O

Sample NN O

The DT O
sample NN O
consisted VBD O
of IN O
30 CD O
females NNS O
who WP O
applied VBD O
to IN O
the DT O
outpatient JJ O
psychiatry NN O
clinic NN O
at IN O
a DT O
public JJ O
hospital NN O
and CC O
who WP O
met VBD O
DSM NNP O
- HYPH O
IV NN O
diagnostic JJ O
criteria NNS O
for IN O
chronic JJ O
pain NN O
disorder NN O
. . O

Patients NNS B-Species
with IN O
concomitant JJ O
psychiatric JJ O
disorders NNS O
, , O
such JJ O
as IN O
major JJ O
depression NN O
, , O
anxiety NN O
disorders NNS O
and CC O
somatoform NN O
disorders NNS O
other JJ O
than IN O
pain NN O
disorder NN O
were VBD O
excluded VBN O
. . O

Patients NNS B-Species
either CC O
directly RB O
applied VBD O
to IN O
the DT O
psychiatry NN O
clinic NN O
themselves PRP O
or CC O
were VBD O
referred VBN O
for IN O
psychiatric JJ O
assessment NN O
from IN O
another DT O
outpatient JJ O
clinic NN O
, , O
mainly RB O
physical JJ O
medicine NN O
and CC O
rehabilitation NN O
. . O

After IN O
complete JJ O
description NN O
of IN O
the DT O
study NN O
, , O
written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
each DT O
subject NN O
. . O

The DT O
control NN O
group NN O
was VBD O
37 CD O
healthy JJ O
females NNS O
, , O
who WP O
matched VBD O
for IN O
age NN O
, , O
and CC O
education NN O
with IN O
the DT O
subjects NNS O
. . O

All DT O
subjects NNS O
participated VBD O
voluntarily RB O
in IN O
the DT O
study NN O
and CC O
gave VBD O
consent NN O
after IN O
the DT O
procedure NN O
had VBD O
been VBN O
fully RB O
explained VBN O
to IN O
them PRP O
. . O

The DT O
mean JJ O
age NN O
of IN O
the DT O
patients NNS B-Species
and CC O
the DT O
healthy JJ O
controls NNS O
was VBD O
34 CD O
, , O
63 CD O
+ CD O
/ SYM O
- HYPH O
10 CD O
, , O
62 CD O
( , O
range NN O
: : O
16 CD O
- SYM O
62 CD O
) CD O
and CC O
34 CD O
, , O
46 CD O
+ SYM O
/ SYM O
- HYPH O
7 CD O
, , O
43 CD O
( , O
range NN O
: : O
22 CD O
- SYM O
57 CD O
) -RRB- O
years NNS O
and CC O
the DT O
educational JJ O
level NN O
was VBD O
6 CD O
, , O
13 CD O
+ CD O
/ SYM O
- HYPH O
3 CD O
, , O
3 CD O
( HYPH O
range NN O
: : O
5 CD O
- HYPH O
11 CD O
) -RRB- O
and CC O
6 CD O
, , O
59 CD O
+ SYM O
/ SYM O
- HYPH O
2 CD O
, , O
9 CD O
( HYPH O
range NN O
: : O
5 CD O
- HYPH O
14 CD O
) -RRB- O
years NNS O
, , O
respectively RB O
. . O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
between IN O
the DT O
two CD O
groups NNS O
with IN O
respect NN O
to IN O
age NN O
( , O
t CD O
= SYM O
0 CD O
, , O
79 CD O
, , O
df IN O
= SYM O
65 CD O
, , O
P NN O
> SYM O
0 CD O
, , O
5 CD O
) -RRB- O
, , O
educational JJ O
level NN O
( , O
t CD O
= SYM O
1 CD O
, , O
2 CD O
, , O
df IN O
= SYM O
65 CD O
, , O
P NN O
> SYM O
0 CD O
, , O
5 CD O
) -RRB- O
, , O
and CC O
marital JJ O
status NN O
( : O
x2 CD O
= SYM O
0 CD O
, , O
51 CD O
, , O
df IN O
= SYM O
1 CD O
, , O
P NN O
> SYM O
0 CD O
, , O
5 CD O
) -RRB- O
. . O

Measures NNS O

A DT O
detailed JJ O
sociodemographic JJ O
data NN O
form NN O
was VBD O
used VBN O
for IN O
all DT O
subjects NNS O
. . O

All DT O
participants NNS B-Species
were VBD O
applied VBN O
Structured NNP O
Clinical NNP O
Interview NNP O
for IN O
DSM NNP O
- HYPH O
IV NNP O
( -LRB- O
SCID NNP O
- HYPH O
I NNP O
) -RRB- O
[ -LRB- O
22 CD O
] -RRB- O
, , O
Turkish JJ O
version NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Regarding VBG O
the DT O
pain NN O
assessment NN O
, , O
information NN O
was VBD O
first RB O
obtained VBN O
on IN O
several JJ O
aspects NNS O
of IN O
the DT O
patients NNS B-Species
' POS O
pain NN O
, , O
such JJ O
as IN O
intensity NN O
, , O
and CC O
duration NN O
. . O

Pain NN O
intensity NN O
was VBD O
measured VBN O
by IN O
Visual NNP O
Analogue NNP O
Scale NNP O
( , O
VAS NNP O
) -RRB- O
, , O
using VBG O
a DT O
horizontal JJ O
10 CD O
- HYPH O
cm NN O
line NN O
with IN O
the DT O
statement NN O
' `` O
no DT O
pain NN O
at RB O
all RB O
' '' O
at IN O
the DT O
extreme JJ O
left JJ O
- HYPH O
hand NN O
end NN O
and CC O
' `` O
the DT O
worst JJS O
possible JJ O
pain NN O
' '' O
or CC O
' `` O
unbearable JJ O
' '' O
at IN O
the DT O
right JJ O
- HYPH O
hand NN O
extreme NN O
. . O

VAS NNP O
is VBZ O
scored VBN O
by IN O
measuring VBG O
the DT O
distance NN O
from IN O
the DT O
end NN O
of IN O
the DT O
scale NN O
indicating VBG O
absence NN O
of IN O
pain NN O
( , O
or CC O
no DT O
distress NN O
or CC O
no DT O
pain NN O
relief NN O
) , O
to IN O
the DT O
place NN O
marked VBN O
by IN O
the DT O
patient NN B-Species
[ -LRB- O
24 CD O
] -RRB- O
. . O

The DT O
psychometric JJ O
scales NNS O
used VBN O
in IN O
the DT O
study NN O
were VBD O
the DT O
26 CD O
- HYPH O
item NN O
Toronto NNP O
Alexithymia NNP O
Scale NNP O
( -LRB- O
TAS NNP O
- HYPH O
26 CD O
] -RRB- O
and CC O
the DT O
Trait NNP O
Anxiety NNP O
Inventory NNP O
( -LRB- O
STAI NNP O
) -RRB- O
, , O
which WDT O
were VBD O
both DT O
validated VBN O
in IN O
Turkish JJ O
population NN O
studies NNS O
[ -LRB- O
25 CD O
- SYM O
28 CD O
] -RRB- O
. . O

TAS NNP O
is VBZ O
a DT O
psychometrically RB O
well RB O
validated VBN O
and CC O
reliable JJ O
instrument NN O
in IN O
the DT O
assessment NN O
of IN O
alexithymia NN O
. . O
TAS NNP O
has VBZ O
been VBN O
validated VBN O
in IN O
Turkish JJ O
studies NNS O
as IN O
a DT O
true JJ O
or CC O
false JJ O
scale NN O
. . O

Twenty CD O
- HYPH O
six CD O
items NNS O
are VBP O
scored VBN O
either CC O
as IN O
1 CD O
or CC O
0 CD O
and CC O
the DT O
higher JJR O
scores NNS O
indicate VBP O
higher JJR O
degrees NNS O
of IN O
alexithymia NN O
. . O

TAS NNP O
has VBZ O
an DT O
interval JJ O
consistency NN O
of IN O
0 CD O
. . O
65 CD O
[ -LRB- O
Kuder NNP O
- HYPH O
Richardson NNP O
) -RRB- O
and CC O
test NN O
- HYPH O
retest NN O
reliability NN O
is VBZ O
r NN O
= SYM O
0 CD O
. . O
71 CD O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
in IN O
Turkish JJ O
reliability NN O
and CC O
validity NN O
study NN O
. . O

The DT O
sample NN O
was VBD O
divided VBN O
into IN O
nonalexithymic JJ O
and CC O
alexityhmic JJ O
groups NNS O
, , O
with IN O
the DT O
recommended VBN O
cut VBN O
- HYPH O
off RP O
score NN O
of IN O
11 CD O
[ -LRB- O
27 CD O
] -RRB- O
. . O

Spielberger NNP O
Trait NNP O
Anxiety NNP O
Inventory NNP O
( : O
STAI NNP O
) -RRB- O
is VBZ O
one CD O
of IN O
the DT O
two CD O
sections NNS O
of IN O
the DT O
Spielberger NNP O
Anxiety NNP O
Inventory NNP O
( , O
the DT O
other JJ O
, , O
measuring VBG O
state NN O
anxiety NN O
) -RRB- O
. . O

' `` O
Trait NN O
anxiety NN O
' '' O
has VBZ O
been VBN O
defined VBN O
as IN O
anxiety NN O
proneness NN O
, , O
that RB O
is RB O
, , O
the DT O
tendency NN O
to TO O
respond VB O
to IN O
situations NNS O
perceived VBN O
as IN O
threatening VBG O
with IN O
elevations NNS O
in IN O
the DT O
intensity NN O
of IN O
state NN O
anxiety NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Statistical JJ O
analysis NN O

In IN O
order NN O
to TO O
determine VB O
the DT O
relative JJ O
importance NN O
of IN O
a DT O
number NN O
of IN O
factors NNS O
in IN O
pain NN O
disorders NNS O
, , O
we PRP O
used VBD O
both DT O
correlation NN O
analyses NNS O
. . O

The DT O
alexithymic JJ O
and CC O
nonalexithymic JJ O
groups NNS O
were VBD O
compared VBN O
using VBG O
the DT O
independent JJ O
sample NN O
t NN O
- HYPH O
tests NNS O
on IN O
scores NNS O
of IN O
psychological JJ O
tests NNS O
. . O

The DT O
statistical JJ O
procedure NN O
, , O
which WDT O
was VBD O
carried VBN O
out RP O
by IN O
a DT O
SPSS NNP O
package NN O
program NN O
for IN O
Windows NNP O
using VBG O
Chi NNP O
- HYPH O
square NNP O
, , O
Fisher NNP O
' POS O
s POS O
exact JJ O
test NN O
, , O
two CD O
tailed JJ O
t NN O
test NN O
and CC O
Pearson NNP O
correlation NN O
coefficients NNS O
, , O
was VBD O
also RB O
used VBN O
to TO O
determine VB O
group NN O
differences NNS O
( , O
alexithymics NNS O
versus IN O
nonalexithymics NN O
) -RRB- O
in IN O
sociodemographic JJ O
variables NNS O
and CC O
various JJ O
aspects NNS O
of IN O
pain NN O
. . O

Results NNS O

In IN O
the DT O
chronic JJ O
pain NN O
group NN O
, , O
56 CD O
. . O
7 CD O
% NN O
of IN O
patients NNS B-Species
( , O
n CD O
= SYM O
17 CD O
) -RRB- O
had VBD O
a DT O
score NN O
greater JJR O
than IN O
11 CD O
on IN O
the DT O
TAS NN O
- HYPH O
26 CD O
, , O
and CC O
were VBD O
considered VBN O
alexithymic JJ O
. . O

The DT O
mean JJ O
TAS NNP O
- HYPH O
26 CD O
score NN O
of IN O
the DT O
alexithymic JJ O
group NN O
( , O
n CD O
= SYM O
17 CD O
) -RRB- O
was VBD O
17 CD O
. . O
88 CD O
+ NN O
/ SYM O
- HYPH O
3 CD O
. . O
43 CD O
and CC O
the DT O
nonalexithymic JJ O
group NN O
( : O
n CD O
= SYM O
13 CD O
) -RRB- O
was VBD O
8 CD O
. . O
39 CD O
+ NN O
/ SYM O
- SYM O
2 CD O
. . O
2 CD O
. . O

Age NN O
( : O
t NN O
= SYM O
1 CD O
, , O
38 CD O
, , O
df IN O
= SYM O
28 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
18 CD O
) -RRB- O
, , O
education NN O
( , O
t CD O
= SYM O
- HYPH O
0 CD O
, , O
21 CD O
, , O
df IN O
= SYM O
28 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
16 CD O
) -RRB- O
and CC O
marital JJ O
status NN O
( : O
x2 CD O
= SYM O
0 CD O
, , O
27 CD O
, , O
df IN O
= SYM O
1 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
87 CD O
) -RRB- O
were VBD O
not RB O
associated VBN O
with IN O
alexithymia NN O
( : O
Table NN O
1 CD O
) -RRB- O
. . O

In IN O
the DT O
control NN O
group NN O
, , O
24 CD O
, , O
3 CD O
% NN O
of IN O
patients NNS B-Species
( , O
n CD O
= SYM O
9 CD O
) -RRB- O
were VBD O
alexithymic JJ O
according VBG O
to IN O
TAS NNP O
- HYPH O
26 CD O
. . O

The DT O
mean JJ O
TAS NNP O
- HYPH O
26 CD O
score NN O
of IN O
the DT O
alexithymic JJ O
group NN O
( : O
n NN O
= SYM O
9 CD O
) -RRB- O
was VBD O
13 CD O
, , O
82 CD O
+ CD O
/ SYM O
- HYPH O
1 CD O
, , O
93 CD O
and CC O
the DT O
nonalexithymic JJ O
group NN O
( : O
n CD O
= SYM O
28 CD O
) -RRB- O
was VBD O
10 CD O
, , O
33 CD O
+ CD O
/ SYM O
- HYPH O
0 CD O
, , O
86 CD O
. . O

Alexithymia NNP O
was VBD O
not RB O
associated VBN O
with IN O
age NN O
( : O
t CD O
= SYM O
- HYPH O
1 CD O
, , O
8 CD O
, , O
df IN O
= SYM O
35 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
29 CD O
) -RRB- O
, , O
educational JJ O
level NN O
( , O
t CD O
= SYM O
1 CD O
, , O
1 CD O
, , O
df IN O
= SYM O
35 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
28 CD O
) -RRB- O
, , O
or CC O
marital JJ O
status NN O
( , O
x2 CD O
= SYM O
0 CD O
, , O
74 CD O
, , O
df IN O
= SYM O
1 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
79 CD O
) -RRB- O
or CC O
anxiety NN O
levels NNS O
in IN O
the DT O
control NN O
subjects NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

The DT O
duration NN O
and CC O
severity NN O
of IN O
pain NN O
, , O
TAS NNP O
- HYPH O
26 CD O
scores NNS O
, , O
and CC O
STAI NNP O
scores NNS O
of IN O
the DT O
female JJ O
pain NN O
patients NNS B-Species
are VBP O
shown VBN O
in IN O
Table NNP O
2 CD O
. . O

Comparison NN O
of IN O
the DT O
alexithymics NNS O
with IN O
nonalexithymics NNS O
on IN O
either CC O
the DT O
severity NN O
of IN O
pain NN O
or CC O
pain NN O
duration NN O
showed VBD O
no DT O
statistical JJ O
significance NN O
( : O
t CD O
= SYM O
0 CD O
, , O
64 CD O
, , O
df IN O
= SYM O
28 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
52 CD O
, , O
t CD O
= SYM O
2 CD O
, , O
5 CD O
, , O
df IN O
= SYM O
28 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
5 CD O
, , O
respectively RB O
) -RRB- O
. . O

TAS NNP O
- HYPH O
26 CD O
score NN O
and CC O
duration NN O
of IN O
pain NN O
were VBD O
found VBN O
positively RB O
correlated VBN O
( : O
r NFP O
= SYM O
0 CD O
, , O
50 CD O
, , O
n CD O
= SYM O
30 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
5 CD O
) -RRB- O
. . O

STAI NNP O
( -LRB- O
trait NN O
) -RRB- O
scores NNS O
of IN O
the DT O
alexithymics NNS O
in IN O
the DT O
pain NN O
group NN O
did VBD O
not RB O
significantly RB O
differ VB O
from IN O
the DT O
nonlalexithymics NNS O
( , O
t CD O
= SYM O
0 CD O
, , O
6 CD O
, , O
df IN O
= SYM O
28 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
95 CD O
) -RRB- O
and CC O
besides RB O
, , O
TAS NNP O
- HYPH O
26 CD O
and CC O
STAI NNP O
scores NNS O
were VBD O
not RB O
correlated VBN O
( , O
r NFP O
= SYM O
0 CD O
, , O
6 CD O
, , O
p NN O
> SYM O
0 CD O
, , O
72 CD O
) -RRB- O
. . O

In IN O
summary NN O
, , O
there EX O
are VBP O
three CD O
points NNS O
to TO O
be VB O
emphasized VBN O
. . O

First RB O
, , O
chronic JJ O
pain NN O
patients NNS B-Species
were VBD O
found VBN O
significantly RB O
more RBR O
alexithymic JJ O
than IN O
controls NNS O
( : O
56 CD O
, , O
7 CD O
% NN O
to TO O
24 CD O
, , O
3 CD O
% NN O
) -RRB- O
. . O

Second RB O
, , O
a DT O
positive JJ O
correlation NN O
was VBD O
observed VBN O
between IN O
TAS NNP O
- HYPH O
26 CD O
scores NNS O
and CC O
duration NN O
of IN O
pain NN O
. . O

Third RB O
, , O
neither CC O
positive JJ O
correlation NN O
nor CC O
significant JJ O
difference NN O
was VBD O
found VBN O
between IN O
alexithymia NN O
and CC O
trait NN O
anxiety NN O
in IN O
pain NN O
patients NNS B-Species
. . O

Discussion NN O

The DT O
results NNS O
of IN O
the DT O
present JJ O
study NN O
suggest VBP O
that IN O
patients NNS B-Species
with IN O
chronic JJ O
pain NN O
disorder NN O
are VBP O
more RBR O
alexithymic JJ O
than IN O
individuals NNS O
with IN O
no DT O
pain NN O
. . O

This DT O
finding NN O
is VBZ O
consistent JJ O
with IN O
results NNS O
obtained VBN O
with IN O
earlier JJR O
measures NNS O
of IN O
alexithymia NN O
[ -LRB- O
11 CD O
- HYPH O
13 CD O
] -RRB- O
. . O

Although IN O
they PRP O
may MD O
share VB O
common JJ O
clinical JJ O
features NNS O
, , O
alexithymia NN O
and CC O
somatoform NN O
pain NN O
are VBP O
independent JJ O
constructs NNS O
. . O

Alexithymia NNP O
may MD O
be VB O
a DT O
consequence NN O
to IN O
the DT O
effects NNS O
of IN O
severe JJ O
physical JJ O
symptoms NNS O
, , O
such JJ O
as IN O
a DT O
reduced VBN O
quality NN O
of IN O
life NN O
and CC O
limitations NNS O
in IN O
daily JJ O
activities NNS O
. . O

Besides IN O
, , O
alexithymia NN O
may MD O
be VB O
conceptualized VBN O
as IN O
a DT O
personality NN O
trait NN O
as RB O
well RB O
as IN O
a DT O
secondary JJ O
state NN O
reaction NN O
[ -LRB- O
2 CD O
, , O
3 CD O
, , O
15 CD O
- HYPH O
17 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
question NN O
investigated VBN O
was VBD O
whether IN O
alexithymia NN O
has VBZ O
any DT O
correlation NN O
with IN O
the DT O
duration NN O
or CC O
severity NN O
of IN O
the DT O
pain NN O
itself PRP O
. . O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
between IN O
alexithymic JJ O
and CC O
nonalexitymic JJ O
patients NNS B-Species
on IN O
self NN O
reports NNS O
of IN O
current JJ O
pain NN O
severity NN O
. . O

This DT O
is VBZ O
in IN O
accordance NN O
with IN O
Cox NNP O
' POS O
s POS O
study NN O
[ -LRB- O
1994 CD O
] -RRB- O
in IN O
which WDT O
it PRP O
was VBD O
further RB O
pointed VBN O
out RP O
that IN O
alexithymic JJ O
patients NNS B-Species
were VBD O
found VBN O
to TO O
use VB O
significantly RB O
more JJR O
verbal JJ O
descriptors NNS O
of IN O
pain NN O
compared VBN O
to IN O
nonalexithymic JJ O
patients NNS B-Species
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
study NN O
, , O
pain NN O
intensity NN O
was VBD O
only RB O
evaluated VBN O
by IN O
using VBG O
VAS NNP O
. . O

One CD O
problem NN O
in IN O
trying VBG O
to TO O
measure VB O
the DT O
intensity NN O
of IN O
pain NN O
is VBZ O
the DT O
lack NN O
of IN O
an DT O
objective JJ O
way NN O
. . O

Pain NN O
is VBZ O
a DT O
subjective JJ O
experience NN O
and CC O
each DT O
patient NN B-Species
may MD O
communicate VB O
in IN O
a DT O
different JJ O
way NN O
, , O
verbally RB O
or CC O
nonverbally RB O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Patients NNS B-Species
in IN O
this DT O
sample NN O
were VBD O
sufferers NNS O
of IN O
chronic JJ O
pain NN O
, , O
who WP O
had VBD O
already RB O
chosen VBN O
an DT O
approved VBN O
way NN O
of IN O
expressing VBG O
their PRP$ O
distress NN O
. . O

Since IN O
this DT O
is VBZ O
true JJ O
regardless RB O
of IN O
alexithymia NN O
, , O
alexithymic JJ O
groups NNS O
and CC O
nonalexithymic JJ O
groups NNS O
in IN O
this DT O
sample NN O
showed VBD O
no DT O
difference NN O
on IN O
pain NN O
severity NN O
. . O

The DT O
positive JJ O
correlation NN O
between IN O
alexithymia NN O
and CC O
the DT O
duration NN O
of IN O
pain NN O
in IN O
this DT O
sample NN O
supports VBZ O
the DT O
assumption NN O
of IN O
a DT O
two CD O
- HYPH O
way NN O
hypothesis NN O
. . O

It PRP O
is VBZ O
often RB O
assumed VBN O
that IN O
pain NN O
can MD O
be VB O
caused VBN O
by IN O
alexithymic JJ O
personality NN O
traits NNS O
and CC O
also RB O
that IN O
severe JJ O
and CC O
chronic JJ O
pain NN O
may MD O
cause VB O
emotional JJ O
change NN O
. . O

One CD O
of IN O
the DT O
limitations NNS O
of IN O
this DT O
study NN O
is VBZ O
that IN O
because IN O
of IN O
the DT O
cross JJ O
- HYPH O
sectional JJ O
design NN O
, , O
we PRP O
are VBP O
unable JJ O
to TO O
draw VB O
conclusions NNS O
about IN O
the DT O
direction NN O
of IN O
causality NN O
between IN O
alexithymia NN O
and CC O
pain NN O
. . O

The DT O
duration NN O
of IN O
the DT O
patients NNS B-Species
' POS O
pain NN O
could MD O
approximately RB O
be VB O
determined VBN O
, , O
yet CC O
the DT O
preexisting VBG O
level NN O
of IN O
alexithymia NN O
was VBD O
not RB O
known VBN O
. . O

In IN O
the DT O
usual JJ O
absence NN O
of IN O
internal JJ O
stimuli NN O
, , O
alexithymic JJ O
person NN B-Species
may MD O
be VB O
expected VBN O
to TO O
maintain VB O
an DT O
external JJ O
focus NN O
of IN O
attention NN O
, , O
such JJ O
as IN O
pain NN O
. . O

Symptom NN O
chronicity NN O
may MD O
force VB O
the DT O
alexithymic JJ O
person NN B-Species
to TO O
attent VB O
to IN O
and CC O
amplify VB O
this DT O
somatic JJ O
sensation NN O
. . O

Difficulties NNS O
in IN O
the DT O
ability NN O
to TO O
identify VB O
and CC O
differentiate VB O
emotions NNS O
and CC O
somatic JJ O
experiences NNS O
are VBP O
core JJ O
features NNS O
of IN O
the DT O
alexithymic JJ O
construct NN O
. . O

Therefore RB O
, , O
alexithymic JJ O
patients NNS B-Species
might MD O
be VB O
expected VBN O
to TO O
differ VB O
from IN O
nonalexithymic JJ O
ones NNS O
in IN O
their PRP$ O
anxiety NN O
levels NNS O
. . O

Yet CC O
, , O
in IN O
our PRP$ O
pain NN O
group NN O
alexithymic JJ O
patients NNS B-Species
showed VBD O
no DT O
significant JJ O
difference NN O
from IN O
the DT O
nonalexithymics NNS O
on IN O
trait NN O
anxiety NN O
. . O

Besides IN O
, , O
alexithymia NN O
and CC O
anxiety NN O
were VBD O
not RB O
correlated VBN O
at RB O
all RB O
. . O

The DT O
reasons NNS O
may MD O
be VB O
lying VBG O
in IN O
the DT O
specific JJ O
characteristics NNS O
of IN O
this DT O
patient JJ B-Species
group NN O
itself PRP O
. . O

The DT O
study NN O
included VBD O
patients NNS B-Species
suffering VBG O
from IN O
chronic JJ O
symptoms NNS O
; : O
with IN O
an DT O
average NN O
of IN O
7 CD O
, , O
44 CD O
+ NN O
/ SYM O
- HYPH O
6 CD O
, , O
82 CD O
years NNS O
of IN O
pain NN O
in IN O
the DT O
alexithymic NN O
and CC O
3 CD O
, , O
31 CD O
+ NN O
/ SYM O
- HYPH O
2 CD O
, , O
79 CD O
years NNS O
in IN O
the DT O
nonalexithymic JJ O
groups NNS O
. . O

Persistency NN O
of IN O
any DT O
physical JJ O
symptom NN O
may MD O
bring VB O
along RP O
alexithymia NN O
as IN O
a DT O
coping NN O
strategy NN O
. . O

In IN O
their PRP$ O
paper NN O
, , O
Crook NNP O
and CC O
Tunks NNP O
( , O
1988 CD O
) -RRB- O
examined VBD O
the DT O
types NNS O
of IN O
coping NN O
strategies NNS O
used VBN O
by IN O
persistent JJ O
pain NN O
sufferers NNS O
and CC O
addressed VBN O
to IN O
the DT O
importance NN O
to TO O
alter VB O
their PRP$ O
attitudes NNS O
and CC O
behavior NN O
that WDT O
tend VBP O
toward IN O
catastrophizing NN O
, , O
avoidance NN O
and CC O
withdrawal NN O
, , O
rather RB O
than IN O
simply RB O
concentrate VB O
on IN O
trying VBG O
to TO O
teach VB O
them PRP O
techniques NNS O
for IN O
' `` O
coping VBG O
with IN O
stress NN O
' '' O
to TO O
help VB O
persistent JJ O
pain NN O
sufferers NNS O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Sufferers NNS O
of IN O
chronic JJ O
symptoms NNS O
in IN O
this DT O
sample NN O
were VBD O
members NNS O
of IN O
a DT O
subgroup NN O
who WP O
have VBP O
been VBN O
seeking VBG O
medical JJ O
care NN O
for IN O
a DT O
long JJ O
time NN O
and CC O
besides IN O
given VBN O
the DT O
chance NN O
of IN O
being VBG O
referred VBN O
to IN O
a DT O
psychiatrist NN O
. . O

Therefore RB O
, , O
alexithymic JJ O
or CC O
not RB O
, , O
their PRP$ O
anxiety NN O
might MD O
have VB O
induced VBN O
unique JJ O
coping NN O
strategies NNS O
and CC O
illness NN O
behavior NN O
. . O

Alexithymia NNP O
may MD O
be VB O
important JJ O
in IN O
addressing VBG O
the DT O
diversity NN O
of IN O
subjective JJ O
factors NNS O
involved VBN O
in IN O
pain NN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
not RB O
known VBN O
whether IN O
it PRP O
should MD O
be VB O
addressed VBN O
in IN O
the DT O
treatment NN O
of IN O
pain NN O
patients NNS B-Species
, , O
but CC O
a DT O
high JJ O
level NN O
of IN O
alexithymia NN O
may MD O
effect VB O
the DT O
nature NN O
of IN O
assessment NN O
. . O

In IN O
summary NN O
, , O
the DT O
conceptualization NN O
of IN O
alexithymia NN O
as IN O
a DT O
personality NN O
trait NN O
as RB O
well RB O
as IN O
a DT O
secondary JJ O
state NN O
reaction NN O
is VBZ O
underlined VBN O
by IN O
our PRP$ O
data NNS O
. . O

However RB O
, , O
regarding VBG O
the DT O
cross JJ O
- HYPH O
sectional JJ O
design NN O
of IN O
this DT O
study NN O
, , O
only RB O
limited JJ O
conclusions NNS O
can MD O
be VB O
drawn VBN O
about IN O
the DT O
nature NN O
of IN O
the DT O
causal JJ O
relationship NN O
between IN O
alexithymia NN O
and CC O
chronic JJ O
pain NN O
. . O

Therefore RB O
, , O
future JJ O
longitudinal JJ O
studies NNS O
assessing VBG O
the DT O
cause NN O
of IN O
alexithymic JJ O
characteristics NNS O
are VBP O
required VBN O
to TO O
fully RB O
elucidate VB O
the DT O
concepts NNS O
of IN O
primary JJ O
and CC O
secondary JJ O
alexithymia NN O
. . O

Molecular JJ O
polymorphism NN O
, , O
differentiation NN O
and CC O
introgression NN O
in IN O
the DT O
period NN O
gene NN O
between IN O
Lutzomyia NNP B-Species
intermedia NN I-Species
and CC O
Lutzomyia NNP B-Species
whitmani NNP I-Species

Abstract JJ O

Background NN O

Lutzomyia NNP B-Species
intermedia NN I-Species
and CC O
Lutzomyia NNP B-Species
whitmani NNP I-Species
( , O
Diptera NNP O
: : O
Psychodidae NNP O
) -RRB- O
are VBP O
important JJ O
and CC O
very RB O
closely RB O
related JJ O
vector NN O
species NNS O
of IN O
cutaneous JJ O
leishmaniasis NN O
in IN O
Brazil NNP O
, , O
which WDT O
are VBP O
distinguishable JJ O
by IN O
a DT O
few JJ O
morphological JJ O
differences NNS O
. . O

There EX O
is VBZ O
evidence NN O
of IN O
mitochondrial JJ O
introgression NN O
between IN O
the DT O
two CD O
species NNS O
but CC O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
gene NN O
flow NN O
also RB O
occurs VBZ O
in IN O
nuclear JJ O
genes NNS O
. . O

Results NNS O

We PRP O
analyzed VBD O
the DT O
molecular JJ O
variation NN O
within IN O
the DT O
clock NN O
gene NN O
period NN O
( , O
per IN O
) -RRB- O
of IN O
these DT O
two CD O
species NNS O
in IN O
five CD O
different JJ O
localities NNS O
in IN O
Eastern NNP O
Brazil NNP O
. . O

AMOVA NNP O
and CC O
Fst NNP O
estimates NNS O
showed VBD O
no DT O
evidence NN O
for IN O
geographical JJ O
differentiation NN O
within IN O
species NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
values NNS O
were VBD O
highly RB O
significant JJ O
for IN O
both DT O
analyses NNS O
between IN O
species NNS O
. . O

The DT O
two CD O
species NNS O
show VBP O
no DT O
fixed JJ O
differences NNS O
and CC O
a DT O
higher JJR O
number NN O
of IN O
shared VBN O
polymorphisms NNS O
compared VBN O
to IN O
exclusive JJ O
mutations NNS O
. . O

In IN O
addition NN O
, , O
some DT O
haplotypes NNS O
that WDT O
are VBP O
"""" `` O
typical JJ O
"""" '' O
of IN O
one CD O
species NNS O
were VBD O
found VBN O
in IN O
some DT O
individuals NNS O
of IN O
the DT O
other JJ O
species NNS O
suggesting VBG O
either CC O
the DT O
persistence NN O
of IN O
old JJ O
polymorphisms NNS O
or CC O
the DT O
occurrence NN O
of IN O
introgression NN O
. . O

Two CD O
tests NNS O
of IN O
gene NN O
flow NN O
, , O
one CD O
based VBN O
on IN O
linkage NN O
disequilibrium NN O
and CC O
a DT O
MCMC NNP O
analysis NN O
based VBN O
on IN O
coalescence NN O
, , O
suggest VBP O
that IN O
the DT O
two CD O
species NNS O
might MD O
be VB O
exchanging VBG O
alleles NNS O
at IN O
the DT O
per IN O
locus NN O
. . O

Conclusion NN O

Introgression NN O
might MD O
be VB O
occurring VBG O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NN B-Species
. . I-Species
whitmani NNP I-Species
in IN O
period NN O
, , O
a DT O
gene NN O
controlling VBG O
behavioral JJ O
rhythms NNS O
in IN O
Drosophila NNP O
. . O

This DT O
result NN O
raises VBZ O
the DT O
question NN O
of IN O
whether IN O
similar JJ O
phenomena NNS O
are VBP O
occurring VBG O
at IN O
other JJ O
loci NN O
controlling VBG O
important JJ O
aspects NNS O
of IN O
behavior NN O
and CC O
vectorial JJ O
capacity NN O
. . O

Background NN O

The DT O
Phlebotominae NNP O
sand NN O
flies VBZ O
Lutzomyia NNP B-Species
intermedia NN I-Species
Lutz NNP O
& CC O
Neiva NNP O
1912 CD O
and CC O
Lutzomyia NNP B-Species
whitmani NNP I-Species
Antunes NNP O
& CC O
Coutinho NNP O
1912 CD O
are VBP O
vectors NNS O
of IN O
cutaneous JJ O
leishmaniasis NN O
in IN O
Brazil NNP O
. . O

These DT O
are VBP O
closely RB O
related JJ O
species NNS O
that WDT O
can MD O
be VB O
only RB O
distinguished VBN O
by IN O
a DT O
few JJ O
morphological JJ O
differences NNS O
[ -LRB- O
1 CD O
] -RRB- O
and CC O
both DT O
show VBP O
high JJ O
anthropophily JJ O
and CC O
reported VBN O
natural JJ O
infections NNS O
with IN O
Leishmania NNP O
in IN O
different JJ O
regions NNS O
of IN O
Brazil NNP O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Despite IN O
their PRP$ O
importance NN O
as IN O
vectors NNS O
, , O
only RB O
a DT O
handful NN O
of IN O
studies NNS O
have VBP O
been VBN O
carried VBN O
out RP O
in IN O
these DT O
two CD O
species NNS O
using VBG O
molecular JJ O
techniques NNS O
[ -LRB- O
3 CD O
- SYM O
6 CD O
] -RRB- O
. . O

One CD O
of IN O
the DT O
most RBS O
important JJ O
findings NNS O
from IN O
an DT O
epidemiological JJ O
perspective NN O
is VBZ O
the DT O
evidence NN O
obtained VBN O
for IN O
introgression NN O
between IN O
the DT O
two CD O
species NNS O
using VBG O
mitochondrial JJ O
DNA NNP O
[ -LRB- O
4 CD O
] -RRB- O
. . O

This DT O
was VBD O
particularly RB O
interesting JJ O
because IN O
apparently RB O
, , O
only RB O
lineages NNS O
of IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
sympatric JJ O
with IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
have VBP O
been VBN O
involved VBN O
in IN O
cutaneous JJ O
leishmaniasis NN O
transmission NN O
in IN O
the DT O
peridomestic JJ O
environment NN O
[ -LRB- O
4 CD O
] -RRB- O
, , O
which WDT O
suggests VBZ O
that IN O
genes NNS O
controlling VBG O
aspects NNS O
of IN O
vectorial JJ O
capacity NN O
could MD O
be VB O
passing VBG O
from IN O
one CD O
species NNS O
to IN O
the DT O
other JJ O
. . O

In IN O
fact NN O
, , O
mitochondrial JJ O
introgression NN O
has VBZ O
been VBN O
reported VBN O
in IN O
other JJ O
sand NN O
fly NN O
species NNS O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
suggesting VBG O
that DT O
might MD O
be VB O
a DT O
common JJ O
phenomenon NN O
in IN O
these DT O
insect NN O
vectors NNS O
. . O

However RB O
, , O
because IN O
mitochondrial JJ O
genes NNS O
can MD O
introgress VB O
relatively RB O
easily RB O
between IN O
closely RB O
related VBN O
species NNS O
[ -LRB- O
9 CD O
] -RRB- O
, , O
it PRP O
becomes VBZ O
important JJ O
to TO O
examine VB O
whether IN O
introgression NN O
can MD O
occur VB O
with IN O
nuclear JJ O
genes NNS O
. . O

The DT O
Drosophila NNP O
period NN O
( : O
per IN O
) -RRB- O
gene NN O
homologue NN O
was VBD O
isolated VBN O
in IN O
sand NN O
flies NNS O
by IN O
Peixoto NNP O
et FW O
al NNP O
. . O

[ -LRB- O
10 CD O
] -RRB- O
. . O

This DT O
circadian JJ O
clock NN O
gene NN O
was VBD O
originally RB O
identified VBN O
using VBG O
mutagenesis NN O
by IN O
Konopka NNP O
and CC O
Benzer NNP O
[ -LRB- O
11 CD O
] -RRB- O
, , O
but CC O
is VBZ O
also RB O
known VBN O
to TO O
control VB O
the DT O
differences NNS O
in IN O
the DT O
"""" `` O
lovesong JJ O
"""" '' O
rhythms NNS O
between IN O
D NNP B-Species
. , I-Species
melanogaster NN I-Species
and CC O
D NN B-Species
. , I-Species
simulans NNS I-Species
[ -LRB- O
12 CD O
] -RRB- O
, , O
that WDT O
are VBP O
important JJ O
to IN O
the DT O
sexual JJ O
isolation NN O
between IN O
these DT O
two CD O
species NNS O
[ -LRB- O
13 CD O
- SYM O
15 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
per IN O
was VBD O
implicated VBN O
in IN O
the DT O
control NN O
of IN O
species NNS O
- HYPH O
specific JJ O
circadian JJ O
mating NN O
rhythms NNS O
in IN O
Drosophila NNP O
and CC O
Bractocera NNP O
, , O
which WDT O
might MD O
also RB O
constitute VB O
a DT O
reproductive JJ O
isolation NN O
mechanism NN O
[ -LRB- O
16 CD O
- HYPH O
18 CD O
] -RRB- O
. . O

Thus RB O
per IN O
may MD O
possibly RB O
represent VB O
an DT O
example NN O
of IN O
a DT O
Drosophila NNP O
speciation NN O
gene NN O
[ -LRB- O
19 CD O
] -RRB- O
, , O
and CC O
in IN O
fact NN O
it PRP O
has VBZ O
been VBN O
used VBN O
as IN O
a DT O
molecular JJ O
marker NN O
in IN O
a DT O
number NN O
of IN O
speciation NN O
and CC O
evolutionary JJ O
studies NNS O
, , O
not RB O
only RB O
in IN O
Drosophila NNP O
( , O
reviewed VBN O
in IN O
[ -LRB- O
20 CD O
] -RRB- O
) , O
but CC O
also RB O
in IN O
other JJ O
insects NNS O
( , O
e LS O
. . O
g LS O
. . O
[ -LRB- O
21 CD O
] -RRB- O
) -RRB- O
including VBG O
sand NN O
flies NNS O
[ -LRB- O
22 CD O
- SYM O
24 CD O
] -RRB- O
. . O

Because IN O
per IN O
controls VBZ O
the DT O
circadian JJ O
clock NN O
in IN O
different JJ O
insects NNS O
[ -LRB- O
25 CD O
] -RRB- O
, , O
it PRP O
is VBZ O
almost RB O
certainly RB O
involved JJ O
in IN O
the DT O
rhythms NNS O
of IN O
activity NN O
and CC O
biting NN O
of IN O
sand NN O
flies NNS O
[ -LRB- O
26 CD O
] -RRB- O
, , O
which WDT O
are VBP O
very RB O
important JJ O
to IN O
leishmaniasis NN O
transmission NN O
. . O

In IN O
addition NN O
, , O
per FW O
might MD O
be VB O
involved VBN O
in IN O
reproductive JJ O
isolation NN O
in IN O
sand NN O
flies NNS O
, , O
via IN O
mating NN O
rhythms NNS O
, , O
or CC O
via IN O
their PRP$ O
"""" `` O
lovesongs NNS O
"""" '' O
[ -LRB- O
2 CD O
, , O
27 CD O
] -RRB- O
. , O
per FW O
is VBZ O
thus RB O
a DT O
particularly RB O
interesting JJ O
marker NN O
, , O
among IN O
the DT O
few JJ O
available JJ O
, , O
for IN O
an DT O
introgression NN O
analysis NN O
in IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
. . O

Evidence NN O
for IN O
introgression NN O
in IN O
per FW O
might MD O
suggest VB O
that IN O
gene NN O
flow NN O
between IN O
these DT O
two CD O
vector NN O
species NNS O
is VBZ O
occurring VBG O
at IN O
other JJ O
genes NNS O
controlling VBG O
important JJ O
aspects NNS O
of IN O
behavior NN O
and CC O
vectorial JJ O
capacity NN O
. . O

It PRP O
might MD O
also RB O
suggest VB O
that IN O
per IN O
does VBZ O
not RB O
have VB O
a DT O
strong JJ O
role NN O
in IN O
their PRP$ O
reproductive JJ O
isolation NN O
. . O

In IN O
the DT O
current JJ O
study NN O
, , O
we PRP O
analyzed VBD O
the DT O
molecular JJ O
variation NN O
within IN O
the DT O
per IN O
gene NN O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
in IN O
five CD O
different JJ O
localities NNS O
in IN O
Eastern NNP O
Brazil NNP O
. . O

Results NNS O

Polymorphism NN O
and CC O
divergence NN O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species

A DT O
total NN O
of IN O
68 CD O
sequences NNS O
from IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
53 CD O
from IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
homologue NN O
to IN O
a DT O
fragment NN O
of IN O
the DT O
period NN O
gene NN O
were VBD O
analyzed VBN O
from IN O
populations NNS O
of IN O
five CD O
localities NNS O
in IN O
Eastern NNP O
Brazil NNP O
( -LRB- O
Fig NNP O
1 CD O
) -RRB- O
. . O

The DT O
alignment NN O
of IN O
72 CD O
variable JJ O
sites NNS O
is VBZ O
shown VBN O
in IN O
Fig NNP O
2 CD O
. . O

Although IN O
most JJS O
of IN O
the DT O
changes NNS O
are VBP O
either CC O
synonymous JJ O
or CC O
occur VBP O
within IN O
the DT O
58 CD O
bp IN O
intron NN O
, , O
non JJ O
- HYPH O
synonymous JJ O
substitutions NNS O
are VBP O
observed VBN O
causing VBG O
9 CD O
amino JJ O
acid NN O
differences NNS O
among IN O
the DT O
sequences NNS O
( -LRB- O
Fig NNP O
2 CD O
) -RRB- O
. . O

Table NN O
1 CD O
shows VBZ O
the DT O
number NN O
of IN O
sequences NNS O
of IN O
each DT O
population NN O
of IN O
the DT O
two CD O
species NNS O
, , O
the DT O
number NN O
of IN O
polymorphic JJ O
sites NNS O
( , O
S NNP O
) -RRB- O
and CC O
the DT O
estimates NNS O
of IN O
molecular JJ O
polymorphism NN O
theta NN O
( , O
based VBN O
on IN O
the DT O
total JJ O
number NN O
of IN O
mutations NNS O
) , O
and CC O
pi NN O
. . O

Table NN O
1 CD O
also RB O
shows VBZ O
the DT O
Tajima NNP O
' POS O
s NNS O
[ -LRB- O
28 CD O
] -RRB- O
and CC O
Fu NNP O
& CC O
Li NNP O
' POS O
s NNS O
[ -LRB- O
29 CD O
] -RRB- O
statistics NNS O
. . O

Within IN O
each DT O
species NN O
, , O
all DT O
populations NNS O
present VBP O
similar JJ O
levels NNS O
of IN O
polymorphism NN O
with IN O
the DT O
exception NN O
of IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
from IN O
Ilh NNP O
e NNP O
us PRP O
, , O
which WDT O
seems VBZ O
to TO O
be VB O
less RBR O
polymorphic JJ O
than IN O
the DT O
others NNS O
. . O

This DT O
population NN O
was VBD O
also RB O
the DT O
only RB O
one CD O
presenting VBG O
a DT O
significant JJ O
value NN O
in IN O
the DT O
Fu NNP O
& CC O
Li NNP O
test NN O
but CC O
only RB O
at IN O
the DT O
5 CD O
% NN O
level NN O
. . O

Finally RB O
, , O
the DT O
last JJ O
column NN O
of IN O
Table NNP O
1 CD O
presents VBZ O
the DT O
recombination NN O
estimator NN O
gamma NN O
[ -LRB- O
30 CD O
] -RRB- O
indicating VBG O
that IN O
both DT O
species NNS O
show VBP O
evidence NN O
of IN O
intragenic JJ O
recombination NN O
in IN O
the DT O
per IN O
gene NN O
. . O

To TO O
investigate VB O
the DT O
level NN O
of IN O
intra JJ O
and CC O
interspecific JJ O
differences NNS O
, , O
initially RB O
an DT O
AMOVA NNP O
was VBD O
carried VBN O
out RP O
as IN O
shown VBN O
in IN O
Table NNP O
2 CD O
. . O

The DT O
results NNS O
show VBP O
a DT O
non NN O
- HYPH O
significant JJ O
within IN O
species NNS O
and CC O
a DT O
significant JJ O
between IN O
species NNS O
molecular JJ O
variation NN O
at IN O
the DT O
per IN O
locus NN O
. . O

Table NN O
3 CD O
shows VBZ O
a DT O
more RBR O
detailed JJ O
analysis NN O
of IN O
the DT O
intraspecific JJ O
differentiation NN O
among IN O
populations NNS O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
. . O

None NN O
of IN O
the DT O
pairwise JJ O
and CC O
overall JJ O
fixation NN O
indexes NNS O
( -LRB- O
Fst NNP O
) -RRB- O
are VBP O
significant JJ O
in IN O
the DT O
case NN O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
only RB O
one CD O
( HYPH O
Posse NNP O
x SYM O
Ilh NNP O
e NNP O
us PRP O
) -RRB- O
has VBZ O
a DT O
borderline JJ O
significant JJ O
value NN O
in IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
. . O

The DT O
results NNS O
therefore RB O
show VBP O
that IN O
no DT O
significant JJ O
geographical JJ O
heterogeneity NN O
was VBD O
detected VBN O
among IN O
the DT O
populations NNS O
of IN O
the DT O
two CD O
species NNS O
. . O

The DT O
estimated VBN O
number NN O
of IN O
migrants NNS O
per IN O
generation NN O
, , O
based VBN O
on IN O
the DT O
overall JJ O
Fst NNP O
values NNS O
, , O
is VBZ O
20 CD O
. . O
683 CD O
for IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
23 CD O
. . O
125 CD O
for IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
. . O

Table NNP O
4 CD O
shows VBZ O
measures NNS O
for IN O
DNA NN O
divergence NN O
between IN O
species NNS O
( , O
Dxy NNP O
and CC O
Da NNP O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
Fst NNP O
and CC O
Nm NNP O
values NNS O
considering VBG O
each DT O
species NN O
as IN O
a DT O
unique JJ O
population NN O
. . O

Dxy NNP O
is VBZ O
the DT O
average JJ O
number NN O
of IN O
nucleotide JJ O
substitutions NNS O
per IN O
site NN O
between IN O
alleles NNS O
from IN O
two CD O
different JJ O
populations NNS O
and CC O
Da NNP O
is VBZ O
the DT O
number NN O
of IN O
net JJ O
nucleotide NN O
substitutions NNS O
between IN O
two CD O
populations NNS O
. . O

Table NN O
4 CD O
also RB O
shows VBZ O
the DT O
number NN O
of IN O
polymorphisms NNS O
exclusive JJ O
for IN O
each DT O
species NNS O
( , O
Sint NNP O
and CC O
Swhit NNP O
) -RRB- O
, , O
the DT O
number NN O
of IN O
shared VBN O
polymorphisms NNS O
( , O
Ss NNS O
) -RRB- O
and CC O
the DT O
number NN O
of IN O
fixed VBN O
differences NNS O
( -LRB- O
Sf NNP O
) -RRB- O
between IN O
species NNS O
. . O

As IN O
one PRP O
can MD O
note VB O
, , O
there EX O
is VBZ O
a DT O
high JJ O
number NN O
of IN O
shared VBN O
polymorphisms NNS O
between IN O
species NNS O
, , O
and CC O
no DT O
fixed VBN O
differences NNS O
between IN O
them PRP O
suggesting VBG O
either CC O
the DT O
persistence NN O
of IN O
ancestral JJ O
polymorphisms NNS O
or CC O
the DT O
occurrence NN O
of IN O
introgression NN O
. . O

In IN O
fact NN O
, , O
there EX O
is VBZ O
one CD O
shared VBN O
haplotype NN O
between IN O
the DT O
two CD O
species NNS O
( , O
IPO13 NNP O
, , O
WPO10 NNP O
and CC O
WPO19 NNP O
) -RRB- O
and CC O
three CD O
L NNP B-Species
. , I-Species
whitmani NNP I-Species
sequences NNS O
( , O
WAC02 NNP O
, , O
WPO13 NNP O
and CC O
WPO14 NN O
) -RRB- O
which WDT O
show VBP O
only RB O
one CD O
nucleotide NN O
difference NN O
to IN O
"""" `` O
typical JJ O
"""" '' O
L NN B-Species
. . I-Species
intermedia NN I-Species
haplotypes NNS O
( , O
see VB O
also RB O
below RB O
) -RRB- O
. . O

Genealogy NN O
of IN O
period NN O
sequences NNS O

A DT O
phylogenetic JJ O
analysis NN O
of IN O
the DT O
period NN O
gene NN O
sequences NNS O
from IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
was VBD O
carried VBN O
out RP O
with IN O
the DT O
Minimum NNP O
Evolution NNP O
method NN O
using VBG O
the DT O
Kimura NNP O
2 CD O
- HYPH O
parameter NN O
distance NN O
( -LRB- O
Fig NNP O
3 CD O
) -RRB- O
. . O

A DT O
sequence NN O
from IN O
L NNP B-Species
. . I-Species
umbratilis NN I-Species
, , O
a DT O
related VBN O
species NN O
from IN O
the DT O
same JJ O
subgenus NN O
Nyssomyia NNP O
, , O
was VBD O
used VBN O
as IN O
outgroup NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

The DT O
tree NN O
shows VBZ O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
as IN O
non NN O
- HYPH O
monophyletic JJ O
. . O

However RB O
, , O
despite IN O
the DT O
low JJ O
bootstrap NN O
values NNS O
, , O
which WDT O
are VBP O
below IN O
50 CD O
% NN O
in IN O
most JJS O
cases NNS O
, , O
there EX O
is VBZ O
a DT O
large JJ O
group NN O
that WDT O
contains VBZ O
most JJS O
L NN B-Species
. . I-Species
intermedia NN I-Species
sequences NNS O
and CC O
a DT O
second JJ O
large JJ O
group NN O
with IN O
most JJS O
L NN B-Species
. . I-Species
whitmani NNP I-Species
sequences NNS O
. . O

A DT O
few JJ O
other JJ O
sequences NNS O
are VBP O
clustered VBN O
outside IN O
these DT O
two CD O
main JJ O
groups NNS O
. . O

It PRP O
is VBZ O
interesting JJ O
to TO O
note VB O
that IN O
there EX O
are VBP O
three CD O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
alleles NNS O
( , O
WAC2 NNP O
, , O
WPO13 NNP O
and CC O
WPO14 NN O
) -RRB- O
inside IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
main JJ O
group NN O
, , O
as RB O
well RB O
as IN O
one CD O
L NNP B-Species
. . I-Species
intermedia NN I-Species
allele NN O
( , O
ICP16 NNP O
) -RRB- O
inside IN O
the DT O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
main JJ O
group NN O
. . O

In IN O
addition NN O
, , O
a DT O
second JJ O
L NNP B-Species
. . I-Species
intermedia NN I-Species
allele NN O
( -LRB- O
IPO13 NNP O
) -RRB- O
is VBZ O
a DT O
shared VBN O
haplotype NN O
between IN O
the DT O
two CD O
species NNS O
as IN O
mentioned VBN O
above RB O
. . O

Again RB O
, , O
the DT O
results NNS O
suggest VBP O
either CC O
the DT O
persistence NN O
of IN O
ancestral JJ O
polymorphisms NNS O
or CC O
the DT O
occurrence NN O
of IN O
introgression NN O
between IN O
the DT O
two CD O
species NNS O
. . O

Very RB O
similar JJ O
results NNS O
were VBD O
obtained VBN O
using VBG O
the DT O
maximum JJ O
likelihood NN O
algorithm NN O
as IN O
implemented VBN O
in IN O
PAUP NNP O
4 CD O
. . O
0b10 CD O
software NN O
[ -LRB- O
31 CD O
] -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

As IN O
mentioned VBN O
before RB O
, , O
there EX O
is VBZ O
evidence NN O
of IN O
intragenic JJ O
recombination NN O
in IN O
the DT O
per IN O
gene NN O
fragment NN O
of IN O
both DT O
species NNS O
( , O
see VB O
Table NNP O
1 CD O
) -RRB- O
and CC O
for IN O
that DT O
reason NN O
the DT O
bifurcating VBG O
tree NN O
shown VBN O
in IN O
Fig NNP O
3 CD O
has VBZ O
to TO O
be VB O
viewed VBN O
with IN O
caution NN O
, , O
as IN O
different JJ O
regions NNS O
of IN O
the DT O
gene NN O
might MD O
have VB O
different JJ O
phylogenetic JJ O
histories NNS O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
constructed VBD O
Minimum NNP O
Evolution NNP O
trees NNS O
with IN O
the DT O
two CD O
most RBS O
polymorphic JJ O
non NN O
- HYPH O
recombining VBG O
blocks NNS O
of IN O
the DT O
per IN O
gene NN O
fragment NN O
identified VBN O
using VBG O
the DT O
Hudson NNP O
and CC O
Kaplan NNP O
[ -LRB- O
33 CD O
] -RRB- O
method NN O
available JJ O
in IN O
the DT O
DNAsp NNP O
4 CD O
. . O
1 CD O
program NN O
[ -LRB- O
34 CD O
] -RRB- O
. . O

We PRP O
did VBD O
not RB O
observed VBN O
major JJ O
changes NNS O
in IN O
the DT O
genealogy NN O
of IN O
the DT O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
per IN O
sequences NNS O
, , O
especially RB O
regarding VBG O
the DT O
five CD O
haplotypes NNS O
( , O
ICP16 NNP O
, , O
IPO13 NNP O
, , O
WAC2 NNP O
, , O
WPO13 NNP O
and CC O
WPO14 NNP O
) -RRB- O
that WDT O
clearly RB O
cluster VBP O
with IN O
sequences NNS O
of IN O
the DT O
other JJ O
species NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Finally RB O
, , O
a DT O
haplotype NN O
network NN O
was VBD O
estimated VBN O
from IN O
per IN O
sequences NNS O
using VBG O
statistical JJ O
parsimony NN O
, , O
as IN O
described VBN O
by IN O
Templeton NNP O
et FW O
al NNP O
. . O

[ -LRB- O
35 CD O
] -RRB- O
and CC O
implemented VBN O
in IN O
the DT O
TCS1 NNP O
. . O
21 CD O
software NN O
[ -LRB- O
36 CD O
] -RRB- O
( -LRB- O
Fig NNP O
4 CD O
) -RRB- O
. . O

A DT O
small JJ O
number NN O
of IN O
ambiguities NNS O
were VBD O
resolved VBN O
as IN O
suggested VBN O
by IN O
Crandall NNP O
and CC O
Templeton NNP O
[ -LRB- O
37 CD O
] -RRB- O
. . O

The DT O
haplotype NN O
network NN O
shows VBZ O
connections NNS O
between IN O
sequences NNS O
from IN O
each DT O
species NNS O
, , O
separating VBG O
most JJS O
of IN O
the DT O
sequences NNS O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
in IN O
two CD O
groups NNS O
. . O

No DT O
intraspecific JJ O
geographical JJ O
structuring NN O
was VBD O
found VBN O
. . O

Once RB O
again RB O
, , O
some DT O
of IN O
the DT O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
sequences NNS O
( , O
WAC2 NNP O
, , O
WAC10 NNP O
, , O
WPO13 NNP O
and CC O
WPO14 NNP O
) -RRB- O
appear VBP O
more RBR O
closely RB O
related VBN O
to IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
haplotypes NNS O
. . O

In IN O
addition NN O
, , O
one CD O
L NNP B-Species
. . I-Species
intermedia NN I-Species
allele NN O
( , O
ICP16 NNP O
) -RRB- O
is VBZ O
connected VBN O
by IN O
a DT O
small JJ O
number NN O
of IN O
mutations NNS O
to IN O
some DT O
of IN O
the DT O
main JJ O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
haplotypes NNS O
and CC O
IPO13 NNP O
is VBZ O
a DT O
shared VBN O
haplotype NN O
between IN O
the DT O
two CD O
species NNS O
. . O

These DT O
results NNS O
confirm VBP O
the DT O
same JJ O
putative JJ O
introgressed JJ O
sequences NNS O
indicated VBN O
by IN O
the DT O
phylogenetic JJ O
reconstructions NNS O
. . O

LD NN O
test NN O
of IN O
introgression NN O

We PRP O
tested VBD O
the DT O
hypothesis NN O
of IN O
gene NN O
flow NN O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. , I-Species
whitmani NNP I-Species
using VBG O
a DT O
method NN O
based VBN O
on IN O
linkage NN O
disequilibrium NN O
( -LRB- O
LD NNP O
) -RRB- O
developed VBN O
by IN O
Machado NNP O
et FW O
al FW O
. . O

[ -LRB- O
38 CD O
] -RRB- O
. . O

In IN O
this DT O
test NN O
, , O
x NN O
is VBZ O
the DT O
difference NN O
between IN O
the DT O
average JJ O
LD NNP O
found VBN O
among IN O
all DT O
pairs NNS O
of IN O
shared VBN O
polymorphisms NNS O
( -LRB- O
DSS NNP O
) , O
between IN O
the DT O
two CD O
species NNS O
and CC O
the DT O
average JJ O
LD NN O
among IN O
all DT O
pairs NNS O
of IN O
sites NNS O
for IN O
which WDT O
one CD O
member NN O
is VBZ O
a DT O
shared VBN O
polymorphism NN O
and CC O
the DT O
other JJ O
is VBZ O
an DT O
exclusive JJ O
polymorphism NN O
( , O
DSX NNP O
) -RRB- O
. . O

In IN O
case NN O
of IN O
gene NN O
flow NN O
x NN O
should MD O
tend VB O
to TO O
be VB O
positive JJ O
[ -LRB- O
see VB O
[ -LRB- O
38 CD O
] -RRB- O
for IN O
more JJR O
details NNS O
] -RRB- O
. . O

Because IN O
of IN O
limitations NNS O
on IN O
the DT O
total JJ O
number NN O
of IN O
sequences NNS O
that WDT O
could MD O
be VB O
handled VBN O
by IN O
the DT O
WH NNP O
program NN O
we PRP O
could MD O
not RB O
perform VB O
the DT O
simulations NNS O
with IN O
all DT O
sequences NNS O
. . O

Therefore RB O
, , O
we PRP O
carried VBD O
out RP O
the DT O
LD NNP O
test NN O
of IN O
introgression NN O
between IN O
each DT O
pair NN O
of IN O
sympatric JJ O
populations NNS O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
from IN O
the DT O
localities NNS O
of IN O
Posse NNP O
, , O
Afonso NNP O
Claudio NNP O
and CC O
Corte NNP O
de NNP O
Pedra NNP O
. . O

The DT O
input NN O
files NNS O
were VBD O
prepared VBN O
using VBG O
the DT O
values NNS O
of IN O
recombination NN O
and CC O
linkage NN O
disequilibrium NN O
calculated VBN O
by IN O
the DT O
SITES NNP O
program NN O
[ -LRB- O
30 CD O
] -RRB- O
for IN O
each DT O
population NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Although IN O
no DT O
significant JJ O
values NNS O
were VBD O
found VBN O
for IN O
the DT O
smaller JJR O
samples NNS O
of IN O
Afonso NNP O
Claudio NNP O
and CC O
Corte NNP O
de NNP O
Pedra NNP O
, , O
the DT O
results NNS O
( -LRB- O
Table NNP O
5 CD O
) -RRB- O
present VBP O
evidence NN O
for IN O
introgression NN O
in IN O
the DT O
period NN O
gene NN O
in IN O
both DT O
directions NNS O
( , O
from IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
to IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
and CC O
vice NN O
- HYPH O
versa NN O
) -RRB- O
in IN O
the DT O
locality NN O
of IN O
Posse NNP O
. . O

Isolation NN O
with IN O
Migration NN O
model NN O

To TO O
further RB O
examine VB O
the DT O
gene NN O
flow NN O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
we PRP O
used VBD O
the DT O
IM NNP O
software NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

The DT O
Isolation NNP O
with IN O
Migration NN O
model NN O
has VBZ O
six CD O
demographic JJ O
parameters NNS O
that WDT O
include VBP O
two CD O
migration NN O
rates NNS O
, , O
one CD O
for IN O
each DT O
population NN O
. . O

The DT O
IM NNP O
software NN O
estimates VBZ O
the DT O
posterior JJ O
probability NN O
for IN O
each DT O
of IN O
the DT O
model NN O
parameters NNS O
, , O
fitting VBG O
the DT O
Isolation NNP O
with IN O
Migration NNP O
model NN O
to IN O
the DT O
data NNS O
. . O

One CD O
of IN O
the DT O
assumptions NNS O
of IN O
this DT O
model NN O
is VBZ O
that IN O
the DT O
loci NN O
studied VBN O
do VBP O
not RB O
have VB O
internal JJ O
recombination NN O
. . O

Therefore RB O
, , O
we PRP O
identified VBD O
four CD O
different JJ O
non AFX O
- HYPH O
recombining VBG O
blocks NNS O
of IN O
our PRP$ O
fragment NN O
of IN O
per FW O
, , O
which WDT O
were VBD O
then RB O
treated VBN O
as IN O
different JJ O
loci NN O
in IN O
the DT O
analysis NN O
. . O

The DT O
four CD O
- HYPH O
gametes NNS O
test NN O
[ -LRB- O
33 CD O
] -RRB- O
implemented VBN O
in IN O
DnaSP4 NNP O
. . O
1 CD O
was VBD O
used VBN O
for IN O
the DT O
identification NN O
of IN O
possible JJ O
recombination NN O
events NNS O
. . O

Since IN O
the DT O
program NN O
estimates VBZ O
parameters NNS O
for IN O
a DT O
pair NN O
of IN O
closely RB O
related VBN O
populations NNS O
or CC O
species NNS O
, , O
all DT O
sequences NNS O
of IN O
each DT O
species NNS O
were VBD O
used VBN O
in IN O
the DT O
analysis NN O
as IN O
a DT O
single JJ O
population NN O
. . O

We PRP O
performed VBD O
MCMC NNP O
runs NNS O
using VBG O
the DT O
IM NNP O
software NN O
with IN O
different JJ O
seed NN O
numbers NNS O
, , O
in IN O
order NN O
to TO O
guarantee VB O
convergence NN O
of IN O
the DT O
sample NN O
. . O

Maximum JJ O
likelihood NN O
estimates NNS O
of IN O
migration NN O
parameters NNS O
revealed VBD O
a DT O
non AFX O
- HYPH O
zero CD O
value NN O
for IN O
both DT O
species NNS O
, , O
m1 CD O
= SYM O
1 CD O
. . O
398 CD O
and CC O
m2 CD O
= SYM O
1 CD O
. . O
14 CD O
( SYM O
m1 CD O
- HYPH O
from IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
towards IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
; : O
m2 NNP O
- : O
from IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
towards IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
) -RRB- O
. . O

Fig NNP O
5 CD O
shows VBZ O
the DT O
posterior NN O
distributions NNS O
for IN O
migration NN O
rates NNS O
and CC O
reveals VBZ O
a DT O
null JJ O
probability NN O
for IN O
the DT O
absence NN O
of IN O
migration NN O
from IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
towards IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
. . O

In IN O
addition NN O
, , O
the DT O
absence NN O
of IN O
migration NN O
in IN O
the DT O
opposite JJ O
direction NN O
is VBZ O
not RB O
included VBN O
in IN O
the DT O
95 CD O
% NN O
confidence NN O
interval NN O
( , O
values NNS O
range VBP O
from IN O
0 CD O
. . O
222 CD O
to IN O
8 CD O
. SYM O
898 CD O
) -RRB- O
, , O
thus RB O
supporting VBG O
the DT O
presence NN O
of IN O
migration NN O
in IN O
both DT O
directions NNS O
. . O

The DT O
conversion NN O
of IN O
the DT O
migration NN O
rate NN O
estimate NN O
to IN O
population NN O
migration NN O
rate NN O
per IN O
generation NN O
( , O
m1 CD O
and CC O
m2 CD O
) -RRB- O
is VBZ O
not RB O
accurate JJ O
when WRB O
the DT O
population NN O
size NN O
is VBZ O
based VBN O
on IN O
a DT O
single JJ O
locus NN O
. . O

However RB O
, , O
the DT O
average NN O
of IN O
the DT O
migrant NN O
number NN O
per IN O
generation NN O
for IN O
both DT O
species NNS O
was VBD O
very RB O
close JJ O
to IN O
the DT O
Nm NNP O
estimate NN O
based VBN O
on IN O
Fst NNP O
values NNS O
( , O
Nm NNP O
~ $ O
0 CD O
. . O
49 CD O
in IN O
Table NNP O
4 CD O
, , O
m1 CD O
~ SYM O
0 CD O
. . O
52 CD O
and CC O
m2 CD O
~ SYM O
0 CD O
. . O
34 CD O
) -RRB- O
. . O

Discussion NN O

There EX O
is VBZ O
some DT O
evidence NN O
that IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
might MD O
represent VB O
sibling NN O
- HYPH O
species NNS O
complexes NNS O
in IN O
Brazil NNP O
. . O

Lutzomyia NNP B-Species
neivai NNP I-Species
Pinto NNP O
1926 CD O
, , O
a DT O
sibling NN O
of IN O
L NNP B-Species
. , I-Species
intermedia NN I-Species
is VBZ O
found VBN O
in IN O
parts NNS O
of IN O
Southern NNP O
and CC O
Western NNP O
Brazil NNP O
and CC O
some DT O
other JJ O
countries NNS O
of IN O
South NNP O
America NNP O
[ -LRB- O
40 CD O
] -RRB- O
. . O

The DT O
present JJ O
study NN O
did VBD O
not RB O
include VB O
populations NNS O
of IN O
this DT O
species NNS O
. . O

In IN O
the DT O
case NN O
of IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
, , O
mitochondrial JJ O
data NNS O
[ -LRB- O
3 CD O
, , O
6 CD O
] -RRB- O
indicates VBZ O
three CD O
main JJ O
lineages NNS O
in IN O
Brazil NNP O
: : O
an DT O
Amazonian JJ O
group NN O
, , O
a DT O
North NNP O
- HYPH O
South NNP O
group NN O
and CC O
a DT O
Northeast NNP O
group NN O
. . O

We PRP O
did VBD O
not RB O
find VB O
strong JJ O
evidence NN O
of IN O
a DT O
geographical JJ O
differentiation NN O
in IN O
the DT O
period NN O
gene NN O
among IN O
populations NNS O
of IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
although IN O
one CD O
of IN O
the DT O
pairwise JJ O
Fst NNP O
comparisons NNS O
( : O
Posse NNP O
x FW O
Ilh NNP O
e '' O
us PRP O
) -RRB- O
was VBD O
significant JJ O
at IN O
the DT O
5 CD O
% NN O
level NN O
. . O

When WRB O
we PRP O
compare VBP O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
, , O
we PRP O
find VBP O
a DT O
highly RB O
significant JJ O
Fst NNP O
value NN O
( , O
0 CD O
. . O
3373 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
however RB O
smaller JJR O
than IN O
that DT O
observed VBN O
for IN O
the DT O
period NN O
gene NN O
between IN O
sympatric JJ O
siblings NNS O
of IN O
Lutzomyia NNP B-Species
longipalpis NNP I-Species
( , O
Fst NNP O
= SYM O
0 CD O
. . O
3952 CD O
) -RRB- O
[ -LRB- O
23 CD O
] -RRB- O
, , O
a DT O
complex NN O
of IN O
cryptic JJ O
species NNS O
that WDT O
are VBP O
vectors NNS O
of IN O
American JJ O
visceral JJ O
leishmaniasis NN O
. . O

Therefore RB O
, , O
despite IN O
the DT O
presence NN O
of IN O
diagnostic JJ O
morphological JJ O
characters NNS O
to TO O
identify VB O
L NN B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
[ -LRB- O
1 CD O
] -RRB- O
the DT O
level NN O
of IN O
molecular JJ O
divergence NN O
in IN O
period NN O
is VBZ O
not RB O
as RB O
high JJ O
as IN O
the DT O
cryptic JJ O
L NN B-Species
. . I-Species
longipalpis NN I-Species
siblings NNS O
. . O

Even RB O
though IN O
it PRP O
is VBZ O
hard JJ O
to TO O
distinguish VB O
introgression NN O
from IN O
the DT O
persistence NN O
of IN O
ancestral JJ O
polymorphisms NNS O
, , O
a DT O
test NN O
of IN O
gene NN O
flow NN O
based VBN O
on IN O
the DT O
signature JJ O
introgression NN O
leaves NNS O
on IN O
the DT O
patterns NNS O
of IN O
linkage NN O
disequilibrium NN O
[ -LRB- O
38 CD O
] -RRB- O
as RB O
well RB O
as IN O
simulations NNS O
that WDT O
fit VBP O
the DT O
"""" `` O
Isolation NNP O
with IN O
Migration NNP O
"""" '' O
model NN O
to IN O
the DT O
data NNS O
suggest VBP O
that IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
might MD O
be VB O
exchanging VBG O
alleles NNS O
at IN O
the DT O
per IN O
locus NN O
. . O

This DT O
is VBZ O
further RB O
supported VBN O
by IN O
the DT O
presence NN O
of IN O
shared VBN O
haplotypes NNS O
between IN O
the DT O
two CD O
species NNS O
in IN O
Posse NNP O
and CC O
very RB O
similar JJ O
sequences NNS O
in IN O
all DT O
sympatric JJ O
populations NNS O
. . O

There EX O
is VBZ O
mounting VBG O
evidence NN O
that IN O
introgression NN O
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
the DT O
evolution NN O
of IN O
closely RB O
related JJ O
insect NN O
vector NN O
species NNS O
. . O

Introgression NN O
among IN O
vectors NNS O
may MD O
have VB O
important JJ O
epidemiological JJ O
consequences NNS O
. . O

Gene NN O
flow NN O
in IN O
loci NN O
that WDT O
affect VBP O
vectorial JJ O
capacity NN O
, , O
such JJ O
as IN O
those DT O
controlling VBG O
host NN O
preference NN O
and CC O
susceptibility NN O
to IN O
parasite NN O
infection NN O
, , O
can MD O
change VB O
the DT O
transmission NN O
patterns NNS O
and CC O
consequently RB O
make VB O
the DT O
disease NN O
control VB O
a DT O
harder JJR O
task NN O
. . O

Introgression NN O
of IN O
genes NNS O
that WDT O
control VBP O
adaptation NN O
to IN O
particular JJ O
types NNS O
of IN O
environment NN O
can MD O
also RB O
have VB O
a DT O
major JJ O
impact NN O
on IN O
the DT O
spread NN O
of IN O
vector NN O
- HYPH O
borne VBN O
diseases NNS O
as IN O
was VBD O
proposed VBN O
for IN O
the DT O
major JJ O
African JJ O
malaria NN O
vector NN O
Anopheles NNP B-Species
gambiae NN I-Species
[ -LRB- O
41 CD O
] -RRB- O
. . O

The DT O
same JJ O
can MD O
be VB O
said VBN O
about IN O
genes NNS O
controlling VBG O
insecticide NN O
resistance NN O
. . O

For IN O
example NN O
, , O
Weill NNP O
et FW O
al NNP O
. . O

[ -LRB- O
42 CD O
] -RRB- O
found VBD O
a DT O
kdr NN O
mutation NN O
responsible JJ O
for IN O
pyrethroid NN O
resistance NN O
in IN O
the DT O
Mopti NNP O
form NN O
of IN O
Anopheles NNP B-Species
gambiae NN I-Species
, , O
a DT O
normally RB O
susceptible JJ O
taxon NN O
of IN O
this DT O
species NN O
complex NN O
. . O

Sequence NN O
analysis NN O
reveals VBZ O
that IN O
this DT O
resistant JJ O
allele NN O
probably RB O
originates VBZ O
through IN O
introgression NN O
from IN O
the DT O
Savanna NNP O
form NN O
. . O

Although IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
are VBP O
closely RB O
related JJ O
and CC O
only RB O
distinguished VBN O
by IN O
a DT O
few JJ O
morphological JJ O
differences NNS O
, , O
they PRP O
do VBP O
show VB O
differentiation NN O
in IN O
some DT O
other JJ O
important JJ O
traits NNS O
. . O

For IN O
example NN O
, , O
in IN O
Posse NNP O
, , O
one CD O
of IN O
the DT O
localities NNS O
we PRP O
studied VBD O
, , O
the DT O
two CD O
species NNS O
show VBP O
differences NNS O
in IN O
abundance NN O
during IN O
the DT O
year NN O
. . O

L NN B-Species
. . I-Species
intermedia NN I-Species
is VBZ O
more RBR O
abundant JJ O
in IN O
the DT O
summer NN O
while IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
is VBZ O
more RBR O
frequent JJ O
in IN O
the DT O
winter NN O
months NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

They PRP O
also RB O
show VBP O
differences NNS O
in IN O
microhabitat NN O
preferences NNS O
, , O
L NNP B-Species
. . I-Species
intermedia NN I-Species
being VBG O
more RBR O
common JJ O
in IN O
the DT O
peridomestic JJ O
area NN O
while IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
is VBZ O
found VBN O
mainly RB O
in IN O
the DT O
surrounding VBG O
forest NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
two CD O
species NNS O
show VBP O
marked JJ O
differences NNS O
in IN O
their PRP$ O
tendencies NNS O
to TO O
bite VB O
humans NNS B-Species
in IN O
the DT O
early JJ O
morning NN O
, , O
with IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
showing VBG O
higher JJR O
feeding NN O
rates NNS O
than IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
[ -LRB- O
26 CD O
] -RRB- O
. . O

Therefore RB O
, , O
despite IN O
the DT O
evidence NN O
of IN O
introgression NN O
in IN O
the DT O
period NN O
gene NN O
in IN O
this DT O
locality NN O
, , O
there EX O
are VBP O
important JJ O
ecological JJ O
and CC O
behavioral JJ O
differences NNS O
between IN O
the DT O
two CD O
species NNS O
in IN O
Posse NNP O
suggesting VBG O
that IN O
gene NN O
flow NN O
is VBZ O
probably RB O
rather RB O
limited VBN O
in IN O
loci NN O
controlling VBG O
these DT O
traits NNS O
. . O

Hence RB O
, , O
it PRP O
is VBZ O
yet RB O
not RB O
clear JJ O
whether IN O
introgression NN O
has VBZ O
played VBN O
an DT O
important JJ O
role NN O
in IN O
the DT O
evolution NN O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
. . O

Further JJ O
work NN O
with IN O
other JJ O
genes NNS O
might MD O
help VB O
clarify VB O
the DT O
issue NN O
. . O

Conclusion NN O

Evidence NN O
for IN O
introgression NN O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. , I-Species
whitmani NNP I-Species
obtained VBD O
using VBG O
mitochondrial JJ O
DNA NNP O
[ -LRB- O
4 CD O
] -RRB- O
seems VBZ O
to TO O
be VB O
corroborated VBN O
by IN O
our PRP$ O
data NNS O
on IN O
the DT O
period NN O
gene NN O
, , O
a DT O
nuclear JJ O
marker NN O
. . O

Nevertheless RB O
, , O
considering VBG O
that IN O
period NN O
is VBZ O
potentially RB O
involved VBN O
in IN O
reproductive JJ O
isolation NN O
and CC O
might MD O
be VB O
, , O
therefore RB O
, , O
less RBR O
prone JJ O
to IN O
introgression NN O
than IN O
the DT O
"""" `` O
average JJ O
"""" '' O
gene NN O
[ -LRB- O
43 CD O
] -RRB- O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
much RB O
higher JJR O
levels NNS O
of IN O
gene NN O
flow NN O
between IN O
the DT O
two CD O
species NNS O
occur VBP O
at IN O
other JJ O
genes NNS O
. . O

It PRP O
might MD O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
suggest VB O
that IN O
this DT O
behavioral JJ O
gene NN O
, , O
or CC O
at IN O
least JJS O
the DT O
fragment NN O
we PRP O
analyzed VBD O
, , O
did VBD O
not RB O
play VB O
a DT O
role NN O
in IN O
speciation NN O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
. . O

In IN O
fact NN O
the DT O
same JJ O
has VBZ O
been VBN O
suggested VBN O
for IN O
some DT O
Drosophila NNP O
species NNS O
[ -LRB- O
44 CD O
] -RRB- O
despite IN O
per IN O
' '' O
s NN O
role NN O
controlling VBG O
lovesong NN O
and CC O
mating NN O
rhythm NN O
differences NNS O
between IN O
D NNP B-Species
. . I-Species
melanogaster NN I-Species
and CC O
D NN B-Species
. . I-Species
simulans NNS I-Species
[ -LRB- O
13 CD O
- HYPH O
16 CD O
] -RRB- O
. . O

Although IN O
the DT O
evidence NN O
for IN O
introgression NN O
in IN O
the DT O
per IN O
gene NN O
between IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
is VBZ O
not RB O
overwhelming JJ O
, , O
it PRP O
does VBZ O
indicate VB O
the DT O
need NN O
to TO O
extend VB O
this DT O
analysis NN O
to IN O
other JJ O
loci NN O
in IN O
the DT O
future NN O
. . O

We PRP O
are VBP O
currently RB O
isolating VBG O
new JJ O
molecular JJ O
markers NNS O
in IN O
the DT O
two CD O
species NNS O
to TO O
carry VB O
out RP O
a DT O
multi JJ O
- HYPH O
locus NN O
approach NN O
[ -LRB- O
39 CD O
] -RRB- O
that WDT O
might MD O
help VB O
determining VBG O
how WRB O
much JJ O
variation NN O
in IN O
gene NN O
flow NN O
and CC O
differentiation NN O
there RB O
is VBZ O
across IN O
the DT O
genome NN O
of IN O
these DT O
two CD O
very RB O
important JJ O
leishmaniasis NN O
vectors NNS O
. . O

Methods NNS O

Sand NN O
fly NN O
samples NNS O

Sand NN O
fly NN O
samples NNS O
used VBN O
in IN O
this DT O
work NN O
were VBD O
all PDT O
the DT O
F1 NN O
generation NN O
from IN O
wild JJ O
collected VBN O
females NNS O
from IN O
the DT O
Brazilian JJ O
localities NNS O
of IN O
Posse NNP O
( , O
Petr NNP O
o FW O
polis FW O
, , O
Rio NNP O
de FW O
Janeiro NNP O
State NNP O
, , O
22 CD O
degrees NNS O
30 CD O
' '' O
S NN O
43 CD O
degrees NNS O
10 CD O
' '' O
W NNP O
) -RRB- O
, , O
Jacarepagu NNP O
a NNP O
( , O
Rio NNP O
de NNP O
Janeiro NNP O
, , O
Rio NNP O
de FW O
Janeiro NNP O
State NNP O
, , O
22 CD O
degrees NNS O
55 CD O
' '' O
S NN O
43 CD O
degrees NNS O
21 CD O
' '' O
W NN O
) -RRB- O
, , O
Afonso NNP O
Claudio NNP O
( , O
Esp NNP O
i HYPH O
rito NNP O
Santo NNP O
State NNP O
, , O
20 CD O
degrees NNS O
4 CD O
' POS O
S NN O
41 CD O
degrees NNS O
7 CD O
' '' O
W NNP O
) -RRB- O
, , O
Corte NNP O
de FW O
Pedra NNP O
( , O
Presidente NNP O
Tancredo NNP O
Neves NNP O
, , O
Bahia NNP O
State NNP O
, , O
13 CD O
degrees NNS O
27 CD O
' POS O
S NN O
39 CD O
degrees NNS O
25 CD O
' '' O
W NNP O
) -RRB- O
and CC O
Ilh NNP O
e NNP O
us PRP O
( , O
Bahia NNP O
State NNP O
, , O
14 CD O
degrees NNS O
50 CD O
' POS O
S NN O
39 CD O
degrees NNS O
6 CD O
' '' O
W NN O
) -RRB- O
. . O

L NNP B-Species
. . I-Species
intermedia NN I-Species
and CC O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
were VBD O
identified VBN O
according VBG O
to IN O
Young NNP O
and CC O
Duncan NNP O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
progeny NN O
of IN O
each DT O
wild JJ O
caught VBN O
female NN O
was VBD O
raised VBN O
separately RB O
according VBG O
to IN O
Souza NNP O
et NN O
al NN O
. . O

[ -LRB- O
45 CD O
] -RRB- O
and CC O
only RB O
one CD O
F1 CD O
male NN O
of IN O
each DT O
female NN O
was VBD O
used VBN O
for IN O
the DT O
molecular JJ O
analysis NN O
, , O
which WDT O
included VBD O
68 CD O
individuals NNS O
of IN O
L NNP B-Species
. . I-Species
intermedia NN I-Species
( , O
12 CD O
from IN O
Afonso NNP O
Claudio NNP O
, , O
18 CD O
from IN O
Posse NNP O
, , O
20 CD O
from IN O
Corte NNP O
de NNP O
Pedra NNP O
and CC O
18 CD O
from IN O
Jacarepagu NNP O
a DT O
) -RRB- O
and CC O
51 CD O
individuals NNS O
of IN O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
( , O
12 CD O
from IN O
Afonso NNP O
Claudio NNP O
, , O
17 CD O
from IN O
Posse NNP O
, , O
3 CD O
from IN O
Corte NNP O
de NNP O
Pedra NNP O
and CC O
19 CD O
from IN O
Ilh NNP O
e NNP O
us PRP O
) -RRB- O
. . O

Note VB O
that IN O
, , O
although IN O
the DT O
distribution NN O
of IN O
the DT O
two CD O
species NNS O
shows VBZ O
considerable JJ O
overlap NN O
in IN O
Eastern NNP O
Brazil NNP O
, , O
in IN O
many JJ O
localities NNS O
only RB O
one CD O
species NN O
is VBZ O
found VBN O
or CC O
is VBZ O
far RB O
more RBR O
abundant JJ O
than IN O
the DT O
other JJ O
. . O

There EX O
are VBP O
also RB O
seasonal JJ O
and CC O
microhabitat JJ O
differences NNS O
in IN O
abundance NN O
between IN O
them PRP O
in IN O
areas NNS O
of IN O
sympatry NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

DNA NNP O
methods NNS O

Genomic JJ O
DNA NNP O
was VBD O
prepared VBN O
according VBG O
to IN O
Jowett NNP O
[ -LRB- O
46 CD O
] -RRB- O
with IN O
slight JJ O
modifications NNS O
and CC O
the DT O
PCR NNP O
was VBD O
carried VBN O
out RP O
for IN O
30 CD O
cycles NNS O
at IN O
95 CD O
degrees NNS O
C NN O
for IN O
30 CD O
sec NN O
, , O
60 CD O
degrees NNS O
C NN O
for IN O
30 CD O
sec NN O
and CC O
72 CD O
degrees NNS O
C NN O
for IN O
30 CD O
sec NN O
, , O
using VBG O
Abgene NNP O
, , O
Amersham NNP O
Biosciences NNPS O
or CC O
Biotools NNP O
reagents NNS O
according VBG O
to IN O
manufacturers NNS O
directions NNS O
. . O

The DT O
per IN O
primer JJ O
sequences NNS O
are VBP O
: : O
5llper2 NN O
: : O
5 CD O
' '' O
- HYPH O
AGCATCCTTTTGTAGCAAAC NNP O
- HYPH O
3 CD O
' '' O
( : O
forward RB O
) -RRB- O
and CC O
3llper2 NN O
: : O
5 CD O
' '' O
- HYPH O
TCAGATGAACTCTTGCTGTC NNP O
- HYPH O
3 CD O
' '' O
( : O
reverse NN O
) -RRB- O
. . O

These DT O
primers NNS O
amplify VBP O
a DT O
486 CD O
bp NN O
fragment NN O
of IN O
the DT O
sand NN O
fly NN O
per IN O
gene NN O
homologue NN O
that WDT O
includes VBZ O
part NN O
of IN O
the DT O
PAS NNP O
/ SYM O
CLD NNP O
domain NN O
, , O
an DT O
intron NN O
( , O
58 CD O
bp NN O
) -RRB- O
and CC O
the DT O
beginning NN O
of IN O
the DT O
perS NN O
domain NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

The DT O
amplified VBN O
fragments NNS O
were VBD O
cloned VBN O
using VBG O
the DT O
pMOSBlue JJ O
blunt NN O
ended VBN O
cloning NN O
kit NN O
( , O
Amersham NNP O
Biosciences NNPS O
) , O
and CC O
plasmid JJ O
DNA NN O
preparation NN O
was VBD O
carried VBN O
out RP O
using VBG O
the DT O
"""" `` O
Flexiprep NNP O
"""" '' O
Kit NN O
( -LRB- O
Amersham NNP O
Biosciences NNPS O
) -RRB- O
. . O

Cloned JJ O
PCR NN O
fragments NNS O
were VBD O
sequenced VBN O
at IN O
Funda NNP O
c NN O
a DT O
o FW O
Oswaldo NNP O
Cruz NNP O
and CC O
at IN O
University NNP O
of IN O
Leicester NNP O
using VBG O
ABI NNP O
377 CD O
sequencers NNS O
. . O

With IN O
the DT O
exception NN O
of IN O
two CD O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
individuals NNS O
from IN O
Corte NNP O
de NNP O
Pedra NNP O
( , O
see VB O
below RB O
) -RRB- O
, , O
only RB O
one CD O
sequence NN O
of IN O
each DT O
sand NN O
fly NN O
( , O
representing VBG O
one CD O
of IN O
the DT O
two CD O
possible JJ O
alleles NNS O
) -RRB- O
was VBD O
used VBN O
in IN O
the DT O
analysis NN O
but CC O
an DT O
average NN O
of IN O
three CD O
sequences NNS O
per IN O
individual NN O
were VBD O
obtained VBN O
in IN O
order NN O
to TO O
check VB O
possible JJ O
PCR NNP O
induced VBN O
mutations NNS O
. . O

In IN O
addition NN O
, , O
PCR NNP O
fragments NNS O
were VBD O
also RB O
sequenced VBN O
directly RB O
in IN O
some DT O
cases NNS O
for IN O
the DT O
same JJ O
reason NN O
. . O

In IN O
the DT O
case NN O
of IN O
the DT O
two CD O
L NNP B-Species
. . I-Species
whitmani NNP I-Species
mentioned VBN O
above IN O
6 CD O
and CC O
9 CD O
clones NNS O
were VBD O
sequenced VBN O
respectively RB O
from IN O
specimens NNS O
WCP01 NNP O
and CC O
WCP03 NNP O
to TO O
determine VB O
both DT O
alleles NNS O
simply RB O
to TO O
increase VB O
the DT O
size NN O
of IN O
this DT O
small JJ O
sample NN O
. . O

Negative JJ O
controls NNS O
were VBD O
performed VBN O
for IN O
all DT O
amplification NN O
reactions NNS O
. . O

In IN O
addition NN O
, , O
PCR NNP O
, , O
cloning NN O
and CC O
sequencing NN O
were VBD O
repeated VBN O
for IN O
two CD O
individuals NNS O
to TO O
confirm VB O
putative JJ O
introgressed JJ O
sequences NNS O
and CC O
to TO O
exclude VB O
the DT O
possibility NN O
that IN O
they PRP O
were VBD O
the DT O
result NN O
of IN O
PCR NN O
contamination NN O
. . O

Finally RB O
, , O
for IN O
at RB O
least RBS O
two CD O
individuals NNS O
with IN O
putative JJ O
introgressed JJ O
sequences NNS O
, , O
we PRP O
could MD O
define VB O
the DT O
other JJ O
allele NN O
from IN O
additional JJ O
clones NNS O
( , O
not RB O
included VBN O
in IN O
the DT O
analysis NN O
) , O
, , O
which WDT O
showed VBD O
to TO O
be VB O
typical JJ O
of IN O
the DT O
species NNS O
, , O
indicating VBG O
no DT O
identification NN O
problems NNS O
. . O

The DT O
sequences NNS O
were VBD O
submitted VBN O
to IN O
GenBank NNP O
( : O
accession NN O
numbers NNS O
AY927062 CD O
to IN O
AY927182 CD O
) -RRB- O
. . O

Sequence NN O
analyses NNS O

The DT O
preliminary JJ O
sequence NN O
editing NN O
was VBD O
carried VBN O
out RP O
using VBG O
the DT O
Wisconsin NNP O
Package NNP O
Version NNP O
9 CD O
. . O
1 CD O
, , O
Genetics NNP O
Computer NNP O
Group NNP O
( , O
GCG NNP O
) -RRB- O
, , O
Madison NNP O
, , O
and CC O
ClustalX NNP O
[ -LRB- O
47 CD O
] -RRB- O
was VBD O
used VBN O
to TO O
perform VB O
the DT O
multiple JJ O
alignment NN O
. . O

Analyses NNS O
of IN O
population NN O
polymorphisms NNS O
and CC O
differentiation NN O
between IN O
populations NNS O
were VBD O
carried VBN O
out RP O
using VBG O
DNAsp4 NNP O
. . O
1 CD O
[ -LRB- O
34 CD O
] -RRB- O
and CC O
ProSeq NNP O
[ -LRB- O
48 CD O
] -RRB- O
softwares NNS O
, , O
while IN O
Arlequin NNP O
v NN O
. . O

2 LS O
. . O
0 CD O
[ -LRB- O
49 CD O
] -RRB- O
was VBD O
used VBN O
for IN O
an DT O
analysis NN O
of IN O
molecular JJ O
variance NN O
( , O
AMOVA NNP O
) , O
between IN O
populations NNS O
. . O

The DT O
Minimum NNP O
Evolution NNP O
phylogenetic JJ O
tree NN O
was VBD O
constructed VBN O
using VBG O
MEGA NNP O
3 CD O
. . O
1 CD O
software NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

The DT O
haplotype NN O
network NN O
was VBD O
estimated VBN O
using VBG O
TCS1 NNP O
. . O
21 CD O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Recombination NN O
and CC O
linkage NN O
disequilibrium NN O
analyses NNS O
were VBD O
performed VBN O
using VBG O
the DT O
DNAsp4 NNP O
. . O
1 CD O
and CC O
SITES NNP O
program NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Linkage NN O
disequilibrium NN O
simulations NNS O
were VBD O
carried VBN O
out RP O
by IN O
the DT O
WH NNP O
program NN O
[ -LRB- O
51 CD O
, , O
52 CD O
] -RRB- O
and CC O
Markov NNP O
Chain NNP O
Monte NNP O
Carlo NNP O
( , O
MCMC NNP O
) -RRB- O
simulations NNS O
of IN O
the DT O
isolation NN O
with IN O
migration NN O
model NN O
were VBD O
performed VBN O
using VBG O
the DT O
algorithm NN O
implemented VBN O
in IN O
the DT O
IM NNP O
program NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

Authors NNS O
' POS O
contributions NNS O

CJM NNP O
generate VBP O
and CC O
analyzed VBD O
all PDT O
the DT O
data NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

NAS NNP O
and CC O
CAC NNP O
collected VBD O
and CC O
maintained VBD O
sand NN O
fly NN O
samples NNS O
. . O

CPK NNP O
helped VBD O
to TO O
write VB O
the DT O
manuscript NN O
and CC O
supervised VBD O
CJM NNP O
during IN O
her PRP$ O
stay NN O
in IN O
Leicester NNP O
. . O

AAP NNP O
is VBZ O
the DT O
principal JJ O
investigator NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
, , O
and CC O
helped VBD O
to TO O
write VB O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Presence NN O
of IN O
antibodies NNS O
against IN O
cyclic JJ O
citrullinated VBN O
peptides NNS O
in IN O
patients NNS B-Species
with IN O
' `` O
rhupus NN O
' '' O
: : O
a DT O
cross JJ O
- HYPH O
sectional JJ O
study NN O

Abstract JJ O

' `` O
Rhupus NNP O
' '' O
is VBZ O
a DT O
rare JJ O
condition NN O
sharing VBG O
features NNS O
of IN O
rheumatoid JJ O
arthritis NN O
( , O
RA NN O
) -RRB- O
and CC O
systemic JJ O
lupus NN O
erythematosus NN O
( , O
SLE NNP O
) -RRB- O
. . O

If IN O
rhupus NNS O
is VBZ O
a DT O
distinctive JJ O
entity NN O
, , O
an DT O
overlap NN O
between IN O
RA NNP O
and CC O
SLE NNP O
or CC O
a DT O
subset NN O
of IN O
SLE NNP O
is VBZ O
currently RB O
debated VBN O
. . O

This DT O
study NN O
was VBD O
performed VBN O
to TO O
explore VB O
the DT O
prevalence NN O
of IN O
antibodies NNS O
against IN O
cyclic JJ O
citrullinated VBN O
peptides NNS O
( , O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
) -RRB- O
in IN O
rhupus NN O
. . O

Patients NNS B-Species
meeting VBG O
American NNP O
College NNP O
of IN O
Rheumatology NNP O
criteria NNS O
for IN O
RA NNP O
, , O
SLE NNP O
, , O
or CC O
both DT O
were VBD O
included VBN O
. . O

Clinical JJ O
and CC O
radiographic JJ O
features NNS O
were VBD O
recorded VBN O
and CC O
sera NN O
were VBD O
searched VBN O
for IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
, , O
rheumatoid NN O
factor NN O
, , O
antinuclear JJ O
antibodies NNS O
, , O
anti JJ O
- HYPH O
extractable JJ O
nuclear JJ O
antigens NNS O
, , O
and CC O
antibodies NNS O
against IN O
double JJ O
- HYPH O
stranded VBN O
DNA NNP O
( , O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
) -RRB- O
. . O

Seven CD O
patients NNS B-Species
for IN O
each DT O
group NN O
were VBD O
included VBN O
. . O

Clinical JJ O
and CC O
serological JJ O
features NNS O
for IN O
RA NNP O
or CC O
SLE NNP O
were VBD O
similar JJ O
between IN O
rhupus NN O
and CC O
RA NN O
patients NNS B-Species
, , O
and CC O
between IN O
rhupus NN O
and CC O
SLE NNP O
patients NNS B-Species
, , O
respectively RB O
. . O

Values NNS O
for IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
obtained VBN O
were VBD O
significantly RB O
( : O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
higher JJR O
in IN O
RA NNP O
( , O
6 CD O
/ SYM O
7 CD O
) , O
and CC O
rhupus NN O
( , O
4 CD O
/ SYM O
7 CD O
) -RRB- O
than IN O
in IN O
SLE NNP O
patients NNS B-Species
( , O
0 CD O
/ SYM O
7 CD O
) -RRB- O
and CC O
healthy JJ O
subjects NNS O
( , O
0 CD O
/ SYM O
7 CD O
) -RRB- O
. . O

Our PRP$ O
data NNS O
support VBP O
the DT O
possibility NN O
that IN O
rhupus NN O
is VBZ O
an DT O
overlap NN O
between IN O
RA NNP O
and CC O
SLE NNP O
, , O
because IN O
highly RB O
specific JJ O
autoantibodies NNS O
for IN O
RA NNP O
( , O
anti JJ O
- HYPH O
CCP NNP O
) -RRB- O
and CC O
for IN O
SLE NNP O
( , O
anti JJ O
- HYPH O
dsDNA NN O
and CC O
anti JJ O
- HYPH O
Sm NN O
) -RRB- O
are VBP O
detected VBN O
in IN O
coexistence NN O
. . O

Introduction NN O

The DT O
clinical JJ O
coexistence NN O
of IN O
rheumatoid JJ O
arthritis NN O
( -LRB- O
RA NN O
) -RRB- O
and CC O
systemic JJ O
lupus NN O
erythematosus NN O
( -LRB- O
SLE NNP O
) -RRB- O
was VBD O
first RB O
described VBN O
in IN O
1969 CD O
by IN O
Kantor NNP O
and CC O
was VBD O
termed VBN O
' `` O
rhupus JJ O
syndrome NN O
' '' O
by IN O
Schur NNP O
( , O
both DT O
cited VBN O
in IN O
[ -LRB- O
1 CD O
] -RRB- O
) -RRB- O
. . O

Since IN O
then RB O
, , O
fewer JJR O
than IN O
100 CD O
cases NNS O
of IN O
rhupus NN O
have VBP O
been VBN O
published VBN O
[ -LRB- O
1 CD O
- SYM O
3 CD O
] -RRB- O
. . O

In IN O
an DT O
epidemiological JJ O
study NN O
including VBG O
about RB O
7 CD O
, , O
0 CD O
new JJ O
patients NNS B-Species
, , O
the DT O
prevalence NN O
of IN O
RA NN O
was VBD O
15 CD O
% NN O
and CC O
for IN O
SLE NNP O
it PRP O
was VBD O
8 CD O
. . O
9 CD O
% NN O
. . O

The DT O
expected VBN O
coincidence NN O
of IN O
RA NNP O
and CC O
SLE NNP O
by IN O
chance NN O
would MD O
therefore RB O
be VB O
1 CD O
. . O
2 CD O
% NN O
. . O

However RB O
, , O
the DT O
observed JJ O
prevalence NN O
of IN O
rhupus NN O
was VBD O
0 CD O
. . O
9 CD O
% NN O
, , O
less JJR O
than IN O
one CD O
- HYPH O
tenth NN O
of IN O
that DT O
expected VBN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Previous JJ O
reports NNS O
have VBP O
shown VBN O
that IN O
the DT O
patients NNS B-Species
with IN O
rhupus NNS O
display VBP O
an DT O
array NN O
of IN O
autoantibodies NNS O
including VBG O
anti JJ O
- HYPH O
double JJ O
- HYPH O
stranded VBN O
DNA NNP O
( , O
anti JJ O
- HYPH O
dsDNA NNP O
) -RRB- O
, , O
anti JJ O
- HYPH O
Sm NN O
( , O
both CC O
highly RB O
specific JJ O
for IN O
SLE NNP O
) -RRB- O
, , O
anti CC O
- HYPH O
SSA NN O
, , O
anti JJ O
- HYPH O
SSB NN O
, , O
anti JJ O
- HYPH O
ribonucleoprotein NN O
, , O
antinuclear JJ O
antibodies NNS O
( , O
ANA NNP O
) -RRB- O
, , O
anti JJ O
- HYPH O
cardiolipins NN O
, , O
and CC O
rheumatoid JJ O
factor NN O
( -LRB- O
RF NNP O
) -RRB- O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

However RB O
, , O
no DT O
study NN O
has VBZ O
yet RB O
been VBN O
performed VBN O
to TO O
investigate VB O
the DT O
presence NN O
of IN O
antibodies NNS O
against IN O
cyclic JJ O
citrullinated VBN O
peptides NNS O
( , O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
) -RRB- O
, , O
which WDT O
have VBP O
a DT O
specificity NN O
for IN O
RA NNP O
of IN O
96 CD O
to TO O
98 CD O
% NN O
( , O
for IN O
second JJ O
- HYPH O
generation NN O
assays NNS O
( -LRB- O
anti JJ O
- HYPH O
CCP2 NNP O
) -RRB- O
) -RRB- O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
. . O

Recent JJ O
data NNS O
have VBP O
confirmed VBN O
that IN O
these DT O
antibodies NNS O
are VBP O
rarely RB O
if IN O
ever RB O
present JJ O
in IN O
other JJ O
autoimmune JJ O
diseases NNS O
such JJ O
as IN O
SLE NNP O
, , O
Sj NNP O
o , O
gren NNP O
' POS O
s NN O
syndrome NN O
( , O
SS NN O
) -RRB- O
, , O
scleroderma NN O
and CC O
myositis NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Nowadays RB O
, , O
it PRP O
is VBZ O
a DT O
matter NN O
of IN O
debate NN O
whether IN O
rhupus NNP O
is VBZ O
a DT O
clinically RB O
and CC O
immunologically RB O
distinctive JJ O
entity NN O
[ -LRB- O
2 CD O
] -RRB- O
, , O
a DT O
true JJ O
overlap NN O
between IN O
SLE NNP O
and CC O
RA NNP O
[ -LRB- O
7 CD O
] -RRB- O
, , O
or CC O
a DT O
subgroup NN O
of IN O
patients NNS B-Species
with IN O
lupus NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

This DT O
descriptive JJ O
, , O
cross JJ O
- HYPH O
sectional JJ O
study NN O
was VBD O
performed VBN O
to TO O
investigate VB O
the DT O
frequency NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
in IN O
a DT O
cohort NN O
of IN O
patients NNS B-Species
with IN O
rhupus NN O
. . O

Materials NNS O
and CC O
methods NNS O

We PRP O
included VBD O
all DT O
patients NNS B-Species
fulfilling VBG O
American NNP O
College NNP O
of IN O
Rheumatology NNP O
( -LRB- O
ACR NNP O
) -RRB- O
classification NN O
criteria NNS O
for IN O
both DT O
RA NNP O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
SLE NNP O
[ -LRB- O
10 CD O
] -RRB- O
who WP O
belonged VBD O
to IN O
our PRP$ O
cohorts NNS O
of IN O
patients NNS B-Species
with IN O
RA NNP O
and CC O
with IN O
SLE NNP O
. . O

Comparisons NNS O
were VBD O
made VBN O
with IN O
age NN O
- HYPH O
and CC O
gender NN O
- HYPH O
matched VBN O
patients NNS B-Species
with IN O
RA NNP O
and CC O
with IN O
SLE NNP O
, , O
and CC O
healthy JJ O
subjects NNS O
. . O

The DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
local JJ O
ethics NNS O
committee NN O
, , O
and CC O
informed VBN O
consent NN O
was VBD O
obtained VBN O
. . O

Serum NN O
samples NNS O
were VBD O
obtained VBN O
and CC O
stored VBN O
at IN O
- SYM O
75 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

Sera NNP O
were VBD O
analyzed VBN O
for IN O
anti JJ O
- HYPH O
CCP2 NN O
antibodies NNS O
by IN O
ELISA NNP O
( : O
Inova NNP O
Diagnostics NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
with IN O
a DT O
cutoff NN O
value NN O
of IN O
60 CD O
U NN O
/ SYM O
ml NN O
. . O

Fine JJ O
antinuclear JJ O
reactivities NNS O
( , O
ELISA NNP O
; , O
Inova NNP O
Diagnostics NNP O
) -RRB- O
, , O
RF NNP O
( , O
nephelometry NN O
) -RRB- O
, , O
ANA NNP O
( , O
indirect JJ O
immunofluorescence NN O
on IN O
HEp NNP O
- HYPH O
2 CD O
slides NNS O
) -RRB- O
, , O
and CC O
anti NN O
- HYPH O
dsDNA NN O
( , O
indirect JJ O
immunofluorescence NN O
on IN O
Crithidia NNP O
luciliae NN O
substrate NN O
) -RRB- O
antibodies NNS O
were VBD O
also RB O
determined VBN O
. . O

Except IN O
for IN O
healthy JJ O
individuals NNS O
, , O
standard JJ O
radiographs NNS O
of IN O
hands NNS O
were VBD O
available JJ O
. . O

For IN O
statistical JJ O
analysis NN O
, , O
ANOVA NNP O
and CC O
the DT O
Mann NNP O
- HYPH O
Whitney NNP O
U NNP O
test NN O
were VBD O
performed VBN O
as IN O
appropriate JJ O
with IN O
GraphPad NNP O
Prism NNP O
4 CD O
. . O
0 CD O
software NN O
( : O
GraphPad NNP O
Inc NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Results NNS O

Seven CD O
female JJ O
patients NNS B-Species
with IN O
a DT O
median JJ O
age NN O
of IN O
44 CD O
years NNS O
( -LRB- O
range NN O
25 CD O
to TO O
64 CD O
) CD O
met VBD O
our PRP$ O
inclusion NN O
criteria NNS O
. . O

The DT O
major JJ O
clinical JJ O
and CC O
laboratory NN O
findings NNS O
are VBP O
presented VBN O
in IN O
Table NNP O
1 CD O
. . O

Healthy JJ O
individuals NNS O
and CC O
all DT O
patients NNS B-Species
belonged VBD O
to IN O
cohorts NNS O
from IN O
the DT O
same JJ O
ethnic JJ O
group NN O
( : O
Hispanic JJ O
mestizo NN O
) -RRB- O
. . O

No DT O
differences NNS O
in IN O
demographic JJ O
data NNS O
were VBD O
found VBN O
between IN O
groups NNS O
. . O

Mean JJ O
ACR NN O
criteria NNS O
for IN O
SLE NNP O
were VBD O
5 CD O
. . O
57 CD O
( HYPH O
range NN O
4 CD O
to TO O
8 CD O
) CD O
in IN O
the DT O
SLE NNP O
group NN O
, , O
and CC O
5 CD O
. . O
57 CD O
( SYM O
4 CD O
to TO O
8 CD O
) -RRB- O
in IN O
the DT O
rhupus NN O
group NN O
. . O

In IN O
the DT O
same JJ O
way NN O
, , O
mean JJ O
ACR NN O
criteria NNS O
for IN O
RA NNP O
were VBD O
6 CD O
( SYM O
4 CD O
to TO O
7 CD O
) CD O
in IN O
the DT O
RA NNP O
group NN O
, , O
and CC O
5 CD O
. . O
14 CD O
( SYM O
4 CD O
to TO O
6 CD O
) -RRB- O
for IN O
the DT O
patients NNS B-Species
with IN O
rhupus NN O
. . O

In IN O
all DT O
patients NNS B-Species
with IN O
rhupus NN O
, , O
RA NNP O
was VBD O
presented VBN O
as IN O
the DT O
initial JJ O
disease NN O
, , O
as IN O
has VBZ O
been VBN O
described VBN O
previously RB O
[ -LRB- O
2 CD O
] -RRB- O
. . O

In IN O
accordance NN O
with IN O
another DT O
report NN O
, , O
in IN O
two CD O
patients NNS B-Species
the DT O
disease NN O
started VBD O
during IN O
their PRP$ O
childhood NN O
as IN O
juvenile NN O
chronic JJ O
arthritis NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Anti JJ O
- HYPH O
CCP NNP O
antibodies NNS O
were VBD O
found VBN O
in IN O
four CD O
of IN O
seven CD O
( SYM O
57 CD O
% NN O
) , O
patients NNS B-Species
with IN O
rhupus NN O
, , O
and CC O
in IN O
six CD O
of IN O
seven CD O
( SYM O
86 CD O
% NN O
) SYM O
patients NNS B-Species
with IN O
RA NNP O
, , O
whereas IN O
neither CC O
patients NNS B-Species
with IN O
SLE NNP O
nor CC O
healthy JJ O
individuals NNS O
showed VBD O
reactivity NN O
. . O

When WRB O
the DT O
concentrations NNS O
in IN O
each DT O
group NN O
were VBD O
compared VBN O
, , O
a DT O
statistical JJ O
significant JJ O
difference NN O
between IN O
groups NNS O
was VBD O
found VBN O
( , O
ANOVA NNP O
, , O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

The DT O
mean JJ O
concentration NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
was VBD O
584 CD O
U NN O
/ SYM O
ml NNS O
( , O
range NN O
0 CD O
to IN O
1 CD O
, , O
237 CD O
) -RRB- O
in IN O
patients NNS B-Species
with IN O
rhupus NN O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
, , O
875 CD O
U NN O
/ SYM O
ml CD O
( , O
0 CD O
to TO O
1 CD O
, , O
178 CD O
) -RRB- O
in IN O
the DT O
RA NN O
group NN O
( : O
not RB O
significant JJ O
compared VBN O
with IN O
rhupus NN O
) -RRB- O
, , O
1 CD O
U NN O
/ SYM O
ml NN O
( , O
0 CD O
to TO O
10 CD O
) CD O
for IN O
SLE NNP O
individuals NNS O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
compared VBN O
with IN O
rhupus NN O
) -RRB- O
, , O
and CC O
0 CD O
U NN O
/ SYM O
ml NN O
( , O
0 CD O
to IN O
2 CD O
) -RRB- O
for IN O
healthy JJ O
controls NNS O
( : O
p NN O
< SYM O
0 CD O
. . O
5 CD O
compared VBN O
with IN O
rhupus NN O
) -RRB- O
. . O

Two CD O
of IN O
three CD O
patients NNS B-Species
with IN O
rhupus NNS O
who WP O
were VBD O
negative JJ O
for IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
were VBD O
also RB O
negative JJ O
for IN O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
, , O
RF NN O
and CC O
anti AFX O
- HYPH O
extractable JJ O
nuclear JJ O
antigen NN O
antibodies NNS O
, , O
although IN O
both DT O
patients NNS B-Species
met VBD O
RA NNP O
and CC O
SLE NNP O
classification NN O
criteria NNS O
, , O
including VBG O
ANA NN O
and CC O
erosive JJ O
arthritis NN O
. . O

Differences NNS O
in IN O
ANA NNP O
, , O
anti CC O
- HYPH O
dsDNA NN O
and CC O
anti JJ O
- HYPH O
extractable JJ O
nuclear JJ O
antigen NN O
autoantibodies NNS O
between IN O
patients NNS B-Species
with IN O
rhupus NN O
and CC O
those DT O
with IN O
SLE NNP O
were VBD O
not RB O
found VBN O
. . O

We PRP O
also RB O
found VBD O
no DT O
difference NN O
in IN O
the DT O
prevalence NN O
of IN O
RF NNP O
between IN O
patients NNS B-Species
with IN O
rhupus NN O
and CC O
those DT O
with IN O
RA NNP O
. . O

Surprisingly RB O
, , O
one CD O
healthy JJ O
subject NN O
was VBD O
positive JJ O
for IN O
RF NNP O
, , O
ANA NNP O
and CC O
anti JJ O
- HYPH O
SSA NNP O
antibodies NNS O
, , O
although IN O
she PRP O
was VBD O
asymptomatic JJ O
and CC O
no DT O
features NNS O
of IN O
any DT O
disease NN O
were VBD O
found VBN O
. . O

Discussion NN O

The DT O
close JJ O
association NN O
between IN O
different JJ O
type NN O
II NN O
human JJ B-Species
leukocyte NN O
antigen NN O
( , O
HLA NNP O
) -RRB- O
molecules NNS O
and CC O
the DT O
risk NN O
of IN O
RA NNP O
is VBZ O
well RB O
established VBN O
. . O

These DT O
major JJ O
histocompatibility NN O
complex NN O
( -LRB- O
MHC NNP O
) -RRB- O
class NN O
II NN O
molecules NNS O
share VBP O
the DT O
same JJ O
amino NN O
acid NN O
sequence NN O
( , O
QKRAA NNP O
or CC O
QRRAA NNP O
) -RRB- O
in IN O
positions NNS O
69 CD O
to TO O
74 CD O
of IN O
the DT O
beta NN O
- HYPH O
chain NN O
, , O
namely RB O
the DT O
' `` O
shared VBN O
epitope NN O
' '' O
. . O

Recent JJ O
works NNS O
have VBP O
demonstrated VBN O
that IN O
this DT O
' `` O
shared VBN O
epitope NN O
' '' O
preferentially RB O
binds VBZ O
peptides NNS O
containing VBG O
the DT O
non AFX O
- HYPH O
standard JJ O
amino NN O
acid NN O
citrulline NN O
( -LRB- O
deiminated VBN O
arginine NN O
) -RRB- O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
an DT O
abnormally RB O
increased VBN O
function NN O
of IN O
the DT O
enzyme NN O
peptidylarginine NN O
deiminase NN O
4 CD O
( , O
PAD4 NN O
; , O
responsible JJ O
for IN O
the DT O
deimination NN O
of IN O
arginine NN O
) -RRB- O
and CC O
an DT O
elevated JJ O
anti JJ O
- HYPH O
CCP NN O
autoantibody NN O
production NN O
in IN O
patients NNS B-Species
with IN O
RA NNP O
have VBP O
been VBN O
demonstrated VBN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

These DT O
facts NNS O
have VBP O
built VBN O
the DT O
first JJ O
bridge NN O
between IN O
cellular JJ O
and CC O
humoral JJ O
autoimmunity NN O
in IN O
a DT O
major JJ O
rheumatic JJ O
disease NN O
, , O
supporting VBG O
a DT O
pathogenetic JJ O
role NN O
for IN O
an DT O
abnormal JJ O
metabolism NN O
of IN O
citrulline NN O
in IN O
the DT O
development NN O
of IN O
RA NNP O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

Patients NNS B-Species
with IN O
SLE NNP O
are VBP O
often RB O
part NN O
of IN O
the DT O
control NN O
group NN O
when WRB O
determining VBG O
the DT O
specificity NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
for IN O
RA NNP O
[ -LRB- O
15 CD O
] -RRB- O
, , O
although IN O
some DT O
studies NNS O
have VBP O
been VBN O
performed VBN O
specifically RB O
on IN O
patients NNS B-Species
with IN O
SLE NNP O
. . O

These DT O
studies NNS O
contribute VBP O
some DT O
clues NNS O
to IN O
the DT O
role NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
in IN O
rhupus NN O
. . O

Mediwake NNP O
and CC O
colleagues NNS O
[ -LRB- O
16 CD O
] -RRB- O
, , O
in IN O
a DT O
study NN O
exploring VBG O
the DT O
predictive JJ O
value NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
to TO O
distinguish VB O
erosive JJ O
arthritis NN O
in IN O
SLE NNP O
, , O
found VBD O
ten CD O
patients NNS B-Species
( , O
out IN O
of IN O
231 CD O
) , O
with IN O
erosive JJ O
arthritis NN O
, , O
two CD O
of IN O
whom WP O
had VBD O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
. . O

In IN O
concord NN O
with IN O
this DT O
, , O
Hoffman NNP O
and CC O
colleagues NNS O
[ -LRB- O
15 CD O
] -RRB- O
demonstrate VBP O
that IN O
three CD O
patients NNS B-Species
with IN O
erosive JJ O
arthritis NN O
, , O
included VBN O
in IN O
a DT O
cohort NN O
of IN O
235 CD O
patients NNS B-Species
with IN O
SLE NNP O
, , O
were VBD O
positive JJ O
for IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
. . O

These DT O
authors NNS O
suggest VBP O
that IN O
the DT O
presence NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
can MD O
predispose VB O
for IN O
a DT O
chronic JJ O
RA NN O
- HYPH O
like JJ O
arthritis NN O
in IN O
patients NNS B-Species
with IN O
SLE NNP O
. . O

Additionally RB O
Weissman NNP O
and CC O
colleagues NNS O
[ -LRB- O
17 CD O
] -RRB- O
demonstrated VBD O
that IN O
patients NNS B-Species
with IN O
SLE NNP O
can MD O
display VB O
radiographic JJ O
abnormalities NNS O
similar JJ O
to IN O
those DT O
of IN O
RA NNP O
, , O
although IN O
the DT O
presence NN O
of IN O
marginal JJ O
erosions NNS O
is VBZ O
a DT O
rare JJ O
finding NN O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
demonstrate VBP O
that IN O
the DT O
patients NNS B-Species
with IN O
rhupus NN O
show VBP O
a DT O
very RB O
similar JJ O
arthritis NN O
pattern NN O
( , O
including VBG O
erosive JJ O
disease NN O
) , O
and CC O
similar JJ O
autoantibody NN O
production NN O
( , O
RF NN O
and CC O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
) -RRB- O
to IN O
those DT O
in IN O
patients NNS B-Species
with IN O
RA NNP O
. . O

In IN O
addition NN O
, , O
patients NNS B-Species
with IN O
rhupus NNS O
display VBP O
a DT O
clinical JJ O
and CC O
serological JJ O
profile NN O
indistinguishable JJ O
from IN O
patients NNS B-Species
with IN O
SLE NNP O
. . O

Moreover RB O
, , O
the DT O
presence NN O
of IN O
other JJ O
coexistent JJ O
autoimmune JJ O
diseases NNS O
was VBD O
similar JJ O
in IN O
all DT O
groups NNS O
of IN O
patients NNS B-Species
( , O
two CD O
patients NNS B-Species
with IN O
rhupus NN O
, , O
three CD O
patients NNS B-Species
with IN O
RA NNP O
, , O
and CC O
three CD O
patients NNS B-Species
with IN O
SLE NNP O
also RB O
had VBD O
SS NN O
) -RRB- O
. . O

We PRP O
found VBD O
high JJ O
titers NNS O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
in IN O
four CD O
of IN O
seven CD O
( SYM O
57 CD O
% NN O
) SYM O
patients NNS B-Species
with IN O
rhupus NN O
, , O
a DT O
frequency NN O
similar JJ O
to IN O
that DT O
reported VBN O
for IN O
RA NNP O
[ -LRB- O
4 CD O
] -RRB- O
. . O

This DT O
finding NN O
, , O
together RB O
with IN O
the DT O
clinical JJ O
similarity NN O
, , O
supports VBZ O
the DT O
contention NN O
that IN O
rhupus NNS O
belongs VBZ O
to IN O
the DT O
RA NNP O
spectrum NN O
. . O

The DT O
high JJ O
prevalence NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
in IN O
RA NNP O
found VBN O
in IN O
our PRP$ O
study NN O
could MD O
be VB O
explained VBN O
by IN O
a DT O
selection NN O
bias NN O
because IN O
only RB O
patients NNS B-Species
with IN O
RA NN O
with IN O
an DT O
aggressive JJ O
disease NN O
( , O
namely RB O
erosive JJ O
arthritis NN O
and CC O
RF NN O
+ CC O
) -RRB- O
were VBD O
included VBN O
. . O

In IN O
contrast NN O
, , O
the DT O
mean JJ O
ACR NN O
criterion NN O
for IN O
SLE NNP O
was VBD O
similar JJ O
between IN O
patients NNS B-Species
with IN O
rhupus NN O
and CC O
those DT O
with IN O
SLE NNP O
, , O
including VBG O
the DT O
' `` O
robust JJ O
' '' O
features NNS O
of IN O
SLE NNP O
such JJ O
as IN O
renal JJ O
and CC O
neurological JJ O
involvement NN O
, , O
and CC O
anti JJ O
- HYPH O
dsDNA NN O
and CC O
anti JJ O
- HYPH O
Sm NN O
antibodies NNS O
. . O

These DT O
clinical JJ O
and CC O
serological JJ O
features NNS O
shared VBN O
between IN O
patients NNS B-Species
with IN O
rhupus NN O
and CC O
those DT O
with IN O
SLE NNP O
also RB O
place VBP O
rhupus NN O
in IN O
the DT O
SLE NNP O
spectrum NN O
. . O

Titration NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
in IN O
the DT O
rhupus NN O
group NN O
clearly RB O
shows VBZ O
a DT O
bimodal JJ O
distribution NN O
, , O
suggesting VBG O
the DT O
existence NN O
of IN O
two CD O
different JJ O
subpopulations NNS O
. . O

Because IN O
of IN O
the DT O
small JJ O
number NN O
of IN O
patients NNS B-Species
, , O
we PRP O
are VBP O
unable JJ O
to TO O
define VB O
the DT O
differential JJ O
features NNS O
underlying VBG O
each DT O
subset NN O
. . O

However RB O
, , O
two CD O
of IN O
three CD O
patients NNS B-Species
negative JJ O
for IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
were VBD O
also RB O
negative JJ O
for IN O
both CC O
RF NNP O
and CC O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
. . O

Conclusion NN O

On IN O
the DT O
basis NN O
of IN O
the DT O
presence NN O
of IN O
shared VBN O
clinical JJ O
features NNS O
of IN O
RA NN O
( , O
mainly RB O
erosive JJ O
arthritis NN O
) , O
and CC O
SLE NNP O
( , O
including VBG O
renal JJ O
and CC O
neurological JJ O
involvement NN O
) , O
along IN O
with IN O
the DT O
presence NN O
of IN O
anti JJ O
- HYPH O
dsDNA NN O
and CC O
anti JJ O
- HYPH O
CCP NN O
autoantibodies NNS O
in IN O
our PRP$ O
patients NNS B-Species
with IN O
rhupus NN O
, , O
our PRP$ O
findings NNS O
strongly RB O
support VBP O
the DT O
contention NN O
that IN O
rhupus NN O
is VBZ O
a DT O
true JJ O
overlap NN O
between IN O
RA NNP O
and CC O
SLE NNP O
, , O
not RB O
merely RB O
a DT O
part NN O
of IN O
the DT O
clinical JJ O
spectrum NN O
of IN O
the DT O
articular JJ O
involvement NN O
seen VBN O
in IN O
SLE NNP O
. . O

Moreover RB O
, , O
on IN O
the DT O
basis NN O
of IN O
the DT O
mean JJ O
ACR NN O
criteria NNS O
for IN O
both DT O
diseases NNS O
, , O
we PRP O
have VBP O
confirmed VBN O
that IN O
patients NNS B-Species
with IN O
rhupus NN O
have VBP O
more JJR O
RA NN O
- HYPH O
associated VBN O
and CC O
less JJR O
SLE NN O
- HYPH O
associated VBN O
damage NN O
, , O
an DT O
issue NN O
that WDT O
has VBZ O
been VBN O
suggested VBN O
previously RB O
[ -LRB- O
2 CD O
] -RRB- O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
exploring VBG O
the DT O
prevalence NN O
of IN O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
specifically RB O
in IN O
patients NNS B-Species
with IN O
rhupus NN O
. . O

More JJR O
studies NNS O
are VBP O
needed VBN O
to TO O
expand VB O
the DT O
pathogenetic JJ O
knowledge NN O
of IN O
this DT O
overlap NN O
syndrome NN O
. . O

Abbreviations NNS O

ANA NN O
= : O
antinuclear JJ O
antibodies NNS O
; : O
anti JJ O
- HYPH O
CCP NN O
antibodies NNS O
= , O
antibodies NNS O
against IN O
cyclic JJ O
citrullinated VBN O
peptides NNS O
; : O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
= SYM O
antibodies NNS O
against IN O
double JJ O
- HYPH O
stranded VBN O
DNA NNP O
; : O
ELISA NNP O
= , O
enzyme NN O
- HYPH O
linked VBN O
immunosorbent JJ O
assay NN O
; : O
RA NN O
= : O
rheumatoid JJ O
arthritis NN O
; : O
RF NN O
= , O
rheumatoid JJ O
factor NN O
; : O
SLE NN O
= : O
systemic JJ O
lupus NN O
erythematosus NN O
; : O
SS NNP O
= : O
Sj NNP O
o FW O
gren FW O
' '' O
s NN O
syndrome NN O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

LA NNP O
- HYPH O
G NNP O
participated VBD O
in IN O
the DT O
conception NN O
and CC O
design NN O
of IN O
the DT O
experiments NNS O
, , O
in IN O
the DT O
acquisition NN O
, , O
analysis NN O
and CC O
interpretation NN O
of IN O
data NNS O
, , O
and CC O
was VBD O
involved VBN O
in IN O
drafting VBG O
the DT O
manuscript NN O
. . O

RS NNP O
performed VBD O
the DT O
immunoassays NNS O
. . O

RM NN O
- HYPH O
V NNP O
participated VBD O
in IN O
the DT O
analysis NN O
and CC O
interpretation NN O
of IN O
data NNS O
and CC O
performed VBD O
the DT O
statistical JJ O
analysis NN O
. . O

LG NNP O
- HYPH O
G NNP O
participated VBD O
in IN O
the DT O
analysis NN O
and CC O
interpretation NN O
of IN O
data NNS O
. . O

AV NN O
participated VBD O
in IN O
the DT O
recruitment NN O
of IN O
patients NNS B-Species
and CC O
the DT O
acquisition NN O
of IN O
data NNS O
. . O

RB NNP O
participated VBD O
in IN O
the DT O
interpretation NN O
of IN O
data NNS O
, , O
revising VBG O
the DT O
manuscript NN O
for IN O
intellectual JJ O
content NN O
and CC O
giving VBG O
the DT O
final JJ O
approval NN O
of IN O
the DT O
version NN O
to TO O
be VB O
published VBN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Identification NN O
of IN O
a DT O
human JJ B-Species
peripheral JJ O
blood NN O
monocyte NN O
subset NN O
that WDT O
differentiates VBZ O
into IN O
osteoclasts NNS O

Abstract JJ O

Increased VBN O
bone NN O
resorption NN O
mediated VBN O
by IN O
osteoclasts NNS O
causes VBZ O
various JJ O
diseases NNS O
such JJ O
as IN O
osteoporosis NN O
and CC O
bone NN O
erosion NN O
in IN O
rheumatoid JJ O
arthritis NN O
( : O
RA NNP O
) -RRB- O
. . O

Osteoclasts NNS O
are VBP O
derived VBN O
from IN O
the DT O
monocyte NN O
/ SYM O
macrophage NN O
lineage NN O
, , O
but CC O
the DT O
precise JJ O
origin NN O
remains VBZ O
unclear JJ O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
purified JJ O
CD16 NNP O
- HYPH O
human JJ B-Species
peripheral JJ O
blood NN O
monocyte NN O
subset NN O
, , O
but CC O
not RB O
the DT O
CD16 NN O
+ CC O
monocyte NN O
subset NN O
, , O
differentiates VBZ O
into IN O
osteoclast NN O
by IN O
stimulation NN O
with IN O
receptor NN O
activator NN O
of IN O
NF NNP O
- HYPH O
kappa NN O
B NNP O
ligand NN O
( -LRB- O
RANKL NNP O
) -RRB- O
in IN O
combination NN O
with IN O
macrophage NN O
colony NN O
- HYPH O
stimulating VBG O
factor NN O
( -LRB- O
M NNP O
- HYPH O
CSF NNP O
) -RRB- O
. . O

Integrin NNP O
- HYPH O
beta NN O
3 CD O
mRNA NNP O
and CC O
the DT O
integrin NN O
- HYPH O
alpha NN O
v IN O
beta NN O
3 CD O
heterodimer NN O
were VBD O
only RB O
expressed VBN O
on IN O
CD16 NNP O
- HYPH O
monocytes NNS O
, , O
when WRB O
they PRP O
were VBD O
stimulated VBN O
with IN O
RANKL NNP O
+ CC O
M NNP O
- HYPH O
CSF NNP O
. . O

Downregulation NN O
of IN O
beta JJ O
3 CD O
- HYPH O
subunit NN O
expression NN O
by IN O
small JJ O
interfering VBG O
RNA NNP O
targeting VBG O
beta NN O
3 CD O
abrogated VBD O
osteoclastogenesis NN O
from IN O
the DT O
CD16 NNP O
- HYPH O
monocyte NN O
subset NN O
. . O

In IN O
contrast NN O
, , O
the DT O
CD16 NNP O
+ CC O
monocyte NN O
subset NN O
expressed VBD O
larger JJR O
amounts NNS O
of IN O
tumor NN O
necrosis NN O
factor NN O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
than IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
, , O
which WDT O
was VBD O
further RBR O
enhanced VBN O
by IN O
RANKL NNP O
stimulation NN O
. . O

Examination NN O
of IN O
RA NN O
synovial NN O
tissue NN O
showed VBD O
accumulation NN O
of IN O
both DT O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
macrophages NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
peripheral JJ O
blood NN O
monocytes NNS O
consist VBP O
of IN O
two CD O
functionally RB O
heterogeneous JJ O
subsets NNS O
with IN O
distinct JJ O
responses NNS O
to IN O
RANKL NNP O
. . O

Osteoclasts NNS O
seem VBP O
to TO O
originate VB O
from IN O
CD16 NN O
- HYPH O
monocytes NNS O
, , O
and CC O
integrin NN O
beta NN O
3 CD O
is VBZ O
necessary JJ O
for IN O
osteoclastogenesis NN O
. . O

Blockade NN O
of IN O
accumulation NN O
and CC O
activation NN O
of IN O
CD16 NN O
- HYPH O
monocytes NNS O
could MD O
therefore RB O
be VB O
a DT O
beneficial JJ O
approach NN O
as IN O
an DT O
anti JJ O
- HYPH O
bone NN O
resorptive JJ O
therapy NN O
, , O
especially RB O
for IN O
RA NNP O
. . O

Introduction NN O

Rheumatoid NN O
arthritis NN O
( , O
RA NNP O
) -RRB- O
is VBZ O
an DT O
autoimmune JJ O
disease NN O
characterized VBN O
by IN O
chronic JJ O
inflammation NN O
and CC O
proliferation NN O
of IN O
the DT O
synovium NN O
in IN O
multiple JJ O
joints NNS O
. . O

A DT O
large JJ O
number NN O
of IN O
inflammatory JJ O
cells NNS O
, , O
including VBG O
T NN O
cells NNS O
, , O
B NN O
cells NNS O
, , O
macrophages NNS O
and CC O
dendritic JJ O
cells NNS O
, , O
accumulate VBP O
in IN O
the DT O
affected VBN O
synovium NN O
, , O
and CC O
these DT O
inflammatory JJ O
cells NNS O
, , O
together RB O
with IN O
fibroblast NN O
- HYPH O
like JJ O
synoviocytes NNS O
, , O
express VBP O
various JJ O
cytokines NNS O
, , O
such JJ O
as IN O
tumor NN O
necrosis NN O
factor NN O
alpha NN O
( , O
TNF NNP O
alpha NN O
) -RRB- O
, , O
IL NN O
- HYPH O
6 CD O
and CC O
receptor NN O
activator NN O
of IN O
NF NNP O
- HYPH O
kappa NN O
B NNP O
ligand NN O
( : O
RANKL NNP O
) -RRB- O
, , O
which WDT O
are VBP O
known VBN O
to TO O
induce VB O
differentiation NN O
and CC O
activation NN O
of IN O
osteoclasts NNS O
. . O

The DT O
inflammatory JJ O
synovial JJ O
tissue NN O
, , O
known VBN O
as IN O
pannus NN O
, , O
invades VBZ O
the DT O
articular JJ O
bone NN O
and CC O
causes VBZ O
focal JJ O
bone NN O
erosion NN O
, , O
which WDT O
is VBZ O
the DT O
hallmark NN O
of IN O
RA NNP O
. . O

Histopathologically RB O
, , O
osteoclasts NNS O
are VBP O
present JJ O
at IN O
the DT O
interface NN O
of IN O
the DT O
pannus NN O
and CC O
bone NN O
. . O

Interestingly RB O
, , O
the DT O
deletion NN O
of IN O
RANKL NN O
or CC O
c NN O
- HYPH O
Fos NN O
gene NN O
, , O
which WDT O
is VBZ O
important JJ O
for IN O
osteoclastogenesis NN O
, , O
results VBZ O
in IN O
minimal JJ O
bone NN O
destruction NN O
in IN O
mouse NN B-Species
models NNS O
of IN O
arthritis NN O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
other JJ O
studies NNS O
indicated VBD O
that IN O
inhibition NN O
of IN O
osteoclastogenesis NN O
by IN O
osteoprotegerin NN O
, , O
a DT O
decoy NN O
receptor NN O
for IN O
RANKL NNP O
, , O
limits VBZ O
bone NN O
destruction NN O
in IN O
experimental JJ O
models NNS O
of IN O
arthritis NN O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
osteoclasts NNS O
are VBP O
involved VBN O
in IN O
focal JJ O
bone NN O
erosion NN O
in IN O
RA NNP O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Osteoclasts NNS O
are VBP O
derived VBN O
from IN O
the DT O
monocyte NN O
/ SYM O
macrophage NN O
lineage NN O
. . O

It PRP O
is VBZ O
reported VBN O
that IN O
osteoclast NN O
precursors NNS O
reside VBP O
in IN O
human JJ B-Species
peripheral JJ O
blood NN O
monocytes NNS O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
. . O

A DT O
marked JJ O
increase NN O
of IN O
the DT O
circulating VBG O
osteoclast NN O
precursors NNS O
was VBD O
demonstrated VBN O
in IN O
patients NNS B-Species
with IN O
erosive JJ O
psoriatic JJ O
arthritis NN O
as RB O
well RB O
as IN O
in IN O
arthritic JJ O
TNF NNP O
alpha NN O
transgenic JJ O
mice NNS B-Species
[ -LRB- O
6 CD O
, , O
7 CD O
] -RRB- O
. . O

It PRP O
was VBD O
also RB O
shown VBN O
that IN O
peripheral JJ O
monocytes NNS O
differentiate VBP O
into IN O
osteoclasts NNS O
when WRB O
seeded VBN O
on IN O
RANKL NNP O
/ SYM O
osteoclast NN O
differentiation NN O
factor NN O
- HYPH O
producing VBG O
RA NN O
synovial NN O
fibroblasts NNS O
[ -LRB- O
8 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
RA NNP O
synovial JJ O
macrophages NNS O
thought VBD O
to TO O
originate VB O
from IN O
peripheral JJ O
blood NN O
monocytes NNS O
were VBD O
shown VBN O
to TO O
differentiate VB O
into IN O
osteoclasts NNS O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

Monocytes NNS O
are VBP O
therefore RB O
involved VBN O
not RB O
only RB O
in IN O
synovial JJ O
inflammation NN O
, , O
but CC O
also RB O
in IN O
bone NN O
remodeling NN O
as IN O
potential JJ O
precursors NNS O
for IN O
synovial JJ O
macrophages NNS O
and CC O
osteoclasts NNS O
. . O

Human JJ B-Species
peripheral JJ O
blood NN O
monocytes NNS O
consist VBP O
of IN O
two CD O
major JJ O
subsets NNS O
, , O
CD16 NNP O
+ CC O
and CC O
CD16 NN O
- HYPH O
, , O
comprising VBG O
5 CD O
- SYM O
10 CD O
% NN O
and CC O
90 CD O
- SYM O
95 CD O
% NN O
of IN O
the DT O
monocytes NNS O
, , O
respectively RB O
. . O

These DT O
two CD O
subsets NNS O
exhibit VBP O
different JJ O
chemotaxis NN O
activities NNS O
and CC O
potential NN O
of IN O
cytokine NN O
production NN O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
. . O

Moreover RB O
, , O
activation NN O
of IN O
the DT O
Toll NN O
- HYPH O
like JJ O
receptor NN O
induces VBZ O
distinct JJ O
subsets NNS O
, , O
CD1b NN O
+ CC O
dendritic JJ O
cells NNS O
and CC O
DC NNP O
- HYPH O
SIGN NNP O
+ CC O
( -RRB- O
dendritic JJ O
cell NN O
- HYPH O
specific JJ O
C NN O
- HYPH O
type NN O
lectin NN O
ICAM NNP O
- HYPH O
3 CD O
- HYPH O
grabbing VBG O
nonintegrin NN O
) -RRB- O
macrophages NNS O
from IN O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O
, , O
respectively RB O
[ -LRB- O
13 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
not RB O
been VBN O
revealed VBN O
, , O
however RB O
, , O
which WDT O
monocyte NN O
subset NN O
develops VBZ O
into IN O
osteoclasts NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
determined VBD O
the DT O
human JJ B-Species
peripheral JJ O
blood NN O
monocyte NN O
subset NN O
that WDT O
differentiates VBZ O
into IN O
osteoclasts NNS O
, , O
and CC O
revealed VBD O
that IN O
each DT O
subset NN O
exhibits VBZ O
a DT O
different JJ O
response NN O
for IN O
osteoclastogenic JJ O
stimuli NNS O
. . O

Materials NNS O
and CC O
methods NNS O

Purification NN O
of IN O
peripheral JJ O
blood NN O
monocytes NNS O

Peripheral JJ O
blood NN O
monocytes NNS O
from IN O
healthy JJ O
donors NNS O
were VBD O
collected VBN O
using VBG O
Ficoll NNP O
- HYPH O
Conray NNP O
( : O
Imuuno NNP O
- HYPH O
Biological NNP O
Laboratories NNPS O
, , O
Gunma NNP O
, , O
Japan NNP O
) -RRB- O
gradient NN O
centrifugation NN O
. . O

Negative JJ O
selection NN O
of IN O
monocytes NNS O
was VBD O
performed VBN O
using VBG O
MACS NNP O
microbeads NNS O
( , O
Miltenyi NNP O
Biotec NNP O
, , O
Auburn NNP O
, , O
CA NNP O
, , O
USA NNP O
) , O
according VBG O
to IN O
the DT O
protocol NN O
supplied VBN O
by IN O
the DT O
manufacturer NN O
. . O

The DT O
purified JJ O
monocytes NNS O
were VBD O
separated VBN O
into IN O
two CD O
subsets NNS O
, , O
CD16 NN O
+ , O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O
, , O
using VBG O
CD16 NNP O
MicroBeads NNP O
( : O
Miltenyi NNP O
Biotec NNP O
) -RRB- O
. . O

Flow NN O
cytometry NN O
analysis NN O
using VBG O
FITC NNP O
- HYPH O
conjugated VBN O
mouse NN B-Species
anti JJ O
- HYPH O
CD14 NNP O
mAb NNP O
( , O
MY4 NNP O
; : O
Bechman NNP O
Coulter NNP O
, , O
Fullerton NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
and CC O
phycoerythin NN O
- HYPH O
conjugated VBN O
mouse NN B-Species
anti AFX O
- HYPH O
CD16 NNP O
mAb NNP O
( , O
3G8 CD O
; : O
BD NNP O
Biosciences NNP O
, , O
San NNP O
Jose NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
showed VBD O
that IN O
the DT O
purities NNS O
of IN O
the DT O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O
were VBD O
more JJR O
than IN O
90 CD O
% NN O
and CC O
92 CD O
% NN O
, , O
respectively RB O
. . O

For IN O
the DT O
other JJ O
experiment NN O
, , O
monocytes NNS O
were VBD O
purified VBN O
using VBG O
CD14 NNP O
MicroBeads NNP O
( , O
Miltenyi NNP O
Biotec NNP O
) -RRB- O
, , O
and CC O
then RB O
stained VBN O
either CC O
with IN O
FITC NNP O
- HYPH O
conjugated VBN O
mouse NN B-Species
anti JJ O
- HYPH O
CD33 NN O
mAb NN O
( : O
MY9 NNP O
; : O
Bechman NNP O
Coulter NNP O
) -RRB- O
or CC O
phycoerythin NN O
- HYPH O
conjugated VBN O
mouse NN B-Species
anti AFX O
- HYPH O
CD16 NN O
mAb NN O
( , O
3G8 CD O
) -RRB- O
. . O

Cell NN O
sorting NN O
of IN O
the DT O
stained VBN O
cells NNS O
was VBD O
performed VBN O
using VBG O
a DT O
FACS NNP O
Vantage NNP O
cytometer NN O
( , O
BD NNP O
Biosciences NNP O
) -RRB- O
or CC O
a DT O
MoFlo NNP O
cell NN O
sorter NN O
( : O
Dako NNP O
, , O
Glostrup NNP O
, , O
Denmark NNP O
) -RRB- O
. . O

Osteoclast NN O
differentiation NN O

Purified VBN O
CD16 NN O
+ CC O
and CC O
CD16 CD O
- HYPH O
monocytes NNS O
( , O
5 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
well NN O
) -RRB- O
were VBD O
incubated VBN O
in IN O
96 CD O
- HYPH O
well NN O
plates NNS O
in IN O
alpha NN O
MEM NNP O
( , O
Sigma NNP O
, , O
St NNP O
Louis NNP O
, , O
MO NNP O
, , O
USA NNP O
) -RRB- O
with IN O
heat NN O
- HYPH O
inactivated VBN O
10 CD O
% NN O
fetal JJ O
bovine NN B-Species
serum NN O
( , O
FBS NNP O
) -RRB- O
( , O
Sigma NNP O
) -RRB- O
or CC O
with IN O
Ultra NNP O
- HYPH O
Low NNP O
IgG NNP O
FBS NNP O
( , O
IgG NNP O
< , O
5 CD O
mu NNS O
g NN O
/ : O
ml NNP O
; : O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
, , O
and CC O
where WRB O
indicated VBN O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
( , O
Peprotech NNP O
, , O
Rocky NNP O
Hill NNP O
, , O
NJ NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
the DT O
other JJ O
experiments NNS O
, , O
varied JJ O
numbers NNS O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
( , O
1 CD O
x SYM O
103 CD O
, , O
2 CD O
. . O
5 CD O
x SYM O
103 CD O
, , O
5 CD O
x SYM O
103 CD O
) -RRB- O
were VBD O
mixed VBN O
with IN O
CD16 NNP O
- HYPH O
monocytes NNS O
( , O
5 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
well NN O
) -RRB- O
, , O
and CC O
were VBD O
cultured VBN O
in IN O
96 CD O
- HYPH O
well NN O
plates NNS O
in IN O
alpha NN O
MEM NNP O
with IN O
heat NN O
- HYPH O
inactivated VBN O
10 CD O
% NN O
FBS NNP O
. . O

The DT O
medium NN O
was VBD O
replaced VBN O
with IN O
fresh JJ O
medium NN O
3 CD O
days NNS O
later RB O
, , O
and CC O
after IN O
incubation NN O
for IN O
7 CD O
days NNS O
the DT O
cells NNS O
were VBD O
stained VBN O
for IN O
tartrate NN O
- HYPH O
resistant JJ O
acid NN O
phosphatase NN O
( -LRB- O
TRAP NN O
) -RRB- O
expression NN O
using VBG O
a DT O
commercial JJ O
kit NN O
( , O
Hokudo NNP O
, , O
Sapporo NNP O
, , O
Japan NNP O
) -RRB- O
. . O

The DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
multinucleated JJ O
cells NNS O
( -LRB- O
MNC NNP O
) -RRB- O
in IN O
three CD O
randomly RB O
selected VBN O
fields NNS O
examined VBN O
at IN O
100 CD O
x NN O
magnification NN O
or CC O
the DT O
total JJ O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
per IN O
well NN O
was VBD O
counted VBN O
under IN O
light JJ O
microscopy NN O
. . O

Resorption NN O
assay NN O

Monocytes NNS O
were VBD O
seeded VBN O
onto IN O
plates NNS O
coated VBN O
with IN O
calcium NN O
phosphate NN O
thin JJ O
films NNS O
( , O
Biocoat NNP O
Osteologic NNP O
; : O
BD NNP O
Biosciences NNPS O
) -RRB- O
and CC O
were VBD O
incubated VBN O
with IN O
RANKL NNP O
( : O
40 CD O
ng CD O
/ SYM O
ml CD O
) SYM O
+ SYM O
M NNP O
- HYPH O
CSF NNP O
( : O
25 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
for IN O
7 CD O
days NNS O
. . O

The DT O
cells NNS O
were VBD O
then RB O
lysed VBN O
in IN O
bleach NN O
solution NN O
( : O
6 CD O
% NN O
NaOCl NNP O
, , O
5 CD O
. . O
2 CD O
% NN O
NaCl NNP O
) -RRB- O
. . O

The DT O
resorption NN O
lacunae NN O
were VBD O
examined VBN O
under IN O
light JJ O
microscopy NN O
. . O

Enzyme NN O
- HYPH O
linked VBN O
immunosorbent JJ O
assay NN O

Purified JJ O
monocytes NNS O
were VBD O
cultured VBN O
in IN O
96 CD O
- HYPH O
well NN O
plates NNS O
where WRB O
indicated VBN O
either CC O
with IN O
RANKL NNP O
or CC O
M NNP O
- HYPH O
CSF NNP O
for IN O
24 CD O
hours NNS O
. . O

Concentrations NNS O
of IN O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
in IN O
the DT O
culture NN O
supernatant NN O
were VBD O
measured VBN O
with IN O
an DT O
ELISA NNP O
kit NN O
( , O
BioSourse NNP O
International NNP O
, , O
Camarillo NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
experiments NNS O
of IN O
matrix NN O
metalloproteinase NN O
( , O
MMP NNP O
) -RRB- O
- : O
9 CD O
and CC O
TRAP NNP O
- HYPH O
5b CD O
, , O
culture NN O
supernatants NNS O
were VBD O
collected VBN O
on IN O
day NN O
7 CD O
and CC O
the DT O
concentrations NNS O
of IN O
these DT O
enzymes NNS O
were VBD O
measured VBN O
using VBG O
an DT O
MMP NNP O
- HYPH O
9 CD O
ELISA NNP O
kit NN O
( : O
Amersham NNP O
Biosciences NNP O
, , O
Piscataway NNP O
, , O
NJ NNP O
, , O
USA NNP O
) -RRB- O
or CC O
a DT O
TRAP NNP O
- HYPH O
5b NNP O
ELISA NNP O
kit NN O
( , O
Suomen NNP O
, , O
Turku NNP O
, , O
Finland NNP O
) -RRB- O
. . O

Reverse JJ O
transcriptase NN O
- HYPH O
polymerase NN O
chain NN O
reaction NN O

Monocytes NNS O
( , O
1 CD O
x SYM O
106 CD O
cells NNS O
/ SYM O
well NN O
) -RRB- O
were VBD O
cultured VBN O
in IN O
six CD O
- HYPH O
well NN O
plates NNS O
with IN O
M NNP O
- HYPH O
CSF NNP O
alone RB O
or CC O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
for IN O
3 CD O
days NNS O
. . O

Total JJ O
RNA NNP O
was VBD O
extracted VBN O
using VBG O
RNeasy NNP O
Micro NNP O
( , O
Qiagen NNP O
, , O
Valencia NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
RNA NNP O
was VBD O
then RB O
treated VBN O
with IN O
DNase NNP O
I NNP O
( , O
Qiagen NNP O
) -RRB- O
. . O

The DT O
oligo NN O
( HYPH O
dT NNP O
) NFP O
- HYPH O
primed VBN O
cDNA NNP O
was VBD O
synthesized VBN O
using VBG O
Superscript NNP O
II NNP O
reverse JJ O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
. . O

The DT O
amount NN O
of IN O
cDNA NN O
for IN O
amplification NN O
was VBD O
adjusted VBN O
by IN O
the DT O
amount NN O
of IN O
RNA NNP O
measured VBN O
by IN O
an DT O
optical JJ O
density NN O
meter NN O
and CC O
also RB O
by IN O
beta NN O
- HYPH O
actin NN O
or CC O
GAPDH NNP O
PCR NNP O
products NNS O
. . O

One CD O
microliter NN O
of IN O
cDNA NNP O
was VBD O
amplified VBN O
in IN O
a DT O
50 CD O
mu NN O
l CC O
final JJ O
volume NN O
containing VBG O
25 CD O
pmol NN O
appropriate JJ O
primer NN O
pair NN O
, , O
10 CD O
pmol NN O
each DT O
of IN O
the DT O
four CD O
deoxynucleotide NN O
triphosphates NNS O
, , O
and CC O
5 CD O
units NNS O
FastStart NNP O
Taq NNP O
DNA NNP O
Polymerase NNP O
( : O
Roche NNP O
, , O
Manheim NNP O
, , O
Germany NNP O
) , O
in IN O
a DT O
thermal JJ O
cycler NN O
( , O
PTC NNP O
- HYPH O
200 CD O
; : O
MJ NNP O
GeneWorks NNPS O
, , O
Waltham NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
PCR NNP O
conditions NNS O
were VBD O
25 CD O
- SYM O
40 CD O
cycles NNS O
of IN O
denaturation NN O
( : O
95 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
) -RRB- O
, , O
annealing VBG O
( , O
60 CD O
- SYM O
62 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
) -RRB- O
and CC O
extension NN O
( : O
72 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
) -RRB- O
. . O

The DT O
sequences NNS O
of IN O
the DT O
primers NNS O
are VBP O
presented VBN O
in IN O
Table NNP O
1 CD O
. . O

The DT O
PCR NNP O
products NNS O
were VBD O
separated VBN O
by IN O
electrophoresis NN O
through IN O
2 CD O
% NN O
agarose JJ O
gel NN O
. . O

Western JJ O
immunoblot NN O
analysis NN O

Purified JJ O
monocytes NNS O
were VBD O
cultured VBN O
for IN O
3 CD O
days NNS O
in IN O
the DT O
presence NN O
of IN O
40 CD O
ng CD O
/ SYM O
ml NNP O
M NNP O
- HYPH O
CSF NNP O
with IN O
or CC O
without IN O
25 CD O
ng CD O
/ SYM O
ml NNP O
RANKL NNP O
. . O

Cells NNS O
were VBD O
lysed VBN O
in IN O
RIPA NNP O
Lysis NNP O
buffer NN O
( HYPH O
upstate JJ O
, , O
Lake NNP O
Placid NNP O
, , O
NY NNP O
, , O
USA NNP O
) , O
containing VBG O
protease NN O
inhibitors NNS O
( -LRB- O
Roche NNP O
) -RRB- O
for IN O
15 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

A DT O
total NN O
of IN O
20 CD O
mu NNS O
g NN O
protein NN O
was VBD O
boiled VBN O
in IN O
the DT O
presence NN O
of IN O
6 CD O
x NN O
sodium NN O
dodecyl NN O
sulfate NN O
sample NN O
buffer NN O
, , O
and CC O
was VBD O
separated VBN O
on IN O
7 CD O
. . O
5 CD O
% NN O
or CC O
10 CD O
% NN O
sodium NN O
dodecyl NN O
sulfate NN O
- HYPH O
polyacrylamide NN O
gel NN O
( , O
ATTO NNP O
, , O
Tokyo NNP O
, , O
Japan NNP O
) -RRB- O
. . O

Proteins NNS O
were VBD O
then RB O
electrotransferred VBN O
to IN O
a DT O
polyvinylidene NN O
fluoride NN O
microporous JJ O
membrane NN O
( , O
Millipore NNP O
, , O
Billerica NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
in IN O
a DT O
semidry JJ O
system NN O
. . O

Membranes NNS O
were VBD O
incubated VBN O
in IN O
10 CD O
% NN O
skim NN O
milk NN O
prepared VBN O
in IN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
) -RRB- O
containing VBG O
0 CD O
. . O
1 CD O
% NN O
Tween NNP O
20 CD O
, , O
and CC O
were VBD O
subjected VBN O
to IN O
immunoblotting NN O
. . O

Antibodies NNS O
used VBN O
were VBD O
goat JJ B-Species
anti JJ O
- HYPH O
RANK NN O
antibody NN O
( , O
Techne NNP O
Corporation NNP O
, , O
Minneapolis NNP O
, , O
MN NNP O
, , O
USA NNP O
) -RRB- O
, , O
goat NN B-Species
anti AFX O
- HYPH O
c NN O
- HYPH O
fms NN O
antibody NN O
( -LRB- O
R NNP O
& CC O
D NNP O
systems NNS O
, , O
Minneapolis NNP O
, , O
MN NNP O
, , O
USA NNP O
) -RRB- O
, , O
and CC O
mouse NN B-Species
anti AFX O
- HYPH O
beta NN O
- HYPH O
actin NN O
mAb NNP O
( , O
AC NNP O
- HYPH O
15 CD O
; : O
Sigma NNP O
) -RRB- O
. . O

Peroxidase NN O
- HYPH O
conjugated VBN O
rabbit NN B-Species
anti JJ O
- HYPH O
goat NN B-Species
IgG NNP O
antibody NN O
( , O
Dako NNP O
) -RRB- O
or CC O
peroxidase NN O
- HYPH O
conjugated VBN O
rabbit NN B-Species
anti JJ O
- HYPH O
mouse NN B-Species
IgG NN O
antibody NN O
( , O
Dako NNP O
) -RRB- O
was VBD O
used VBN O
as IN O
the DT O
second JJ O
antibody NN O
. . O

The DT O
signals NNS O
were VBD O
visualized VBN O
by IN O
chemiluminescence NN O
reagent NN O
( , O
ECL NNP O
; : O
Amersham NNP O
Biocsiences NNP O
, , O
Little NNP O
Chalfont NNP O
, , O
UK NNP O
) -RRB- O
. . O

Cell NN O
surface NN O
expression NN O
of IN O
c NN O
- HYPH O
fms NN O

The DT O
following VBG O
mAbs NNS O
were VBD O
used VBN O
for IN O
analysis NN O
of IN O
c NN O
- HYPH O
fms NN O
expression NN O
: : O
Alexa NNP O
647 CD O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
CD14 NNP O
mAb NNP O
( , O
UCHM1 NNP O
; : O
Serotec NNP O
, , O
Oxford NNP O
, , O
UK NNP O
) -RRB- O
, , O
FITC NNP O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
CD16 NNP O
mAb NNP O
( , O
3G8 CD O
; : O
Bechman NNP O
Coulter NNP O
) -RRB- O
and CC O
phycoerythin NN O
- HYPH O
conjugated VBN O
anti NN O
- HYPH O
c NN O
- HYPH O
fms NN O
mAb NN O
( , O
61708 CD O
; : O
R NNP O
& CC O
D NNP O
systems NNS O
) -RRB- O
. . O

Alexa NNP O
647 CD O
- HYPH O
conjugated VBN O
mouse NNP B-Species
IgG2a NNP O
( , O
Serotec NNP O
) -RRB- O
, , O
FITC NNP O
- HYPH O
conjugated VBN O
mouse NNP B-Species
IgG1 NNP O
( -LRB- O
BD NNP O
Biosciences NNP O
) -RRB- O
and CC O
phycoerythin NN O
- HYPH O
conjugated VBN O
mouse NNP B-Species
IgG1 NNP O
( -LRB- O
Bechman NNP O
Coulter NNP O
) -RRB- O
were VBD O
used VBN O
as IN O
isotype NN O
controls NNS O
. . O

Peripheral JJ O
blood NN O
monocytes NNS O
( , O
1 CD O
x SYM O
105 CD O
cells NNS O
) -RRB- O
were VBD O
incubated VBN O
with IN O
1 CD O
mu NNS O
g VBN O
human JJ B-Species
IgG NN O
for IN O
15 CD O
minutes NNS O
, , O
and CC O
were VBD O
then RB O
stained VBN O
with IN O
three CD O
fluorochrome NN O
- HYPH O
labeled VBN O
mAbs NNS O
for IN O
45 CD O
minutes NNS O
on IN O
ice NN O
. . O

The DT O
stained VBN O
cells NNS O
were VBD O
analyzed VBN O
with IN O
a DT O
FACS NNP O
Calibur NNP O
( , O
BD NNP O
Biosciences NNPS O
) -RRB- O
. . O

Immunofluorescent JJ O
staining NN O

Monocytes NNS O
( : O
8 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
well NN O
) -RRB- O
were VBD O
allowed VBN O
to TO O
adhere VB O
on IN O
96 CD O
- HYPH O
well NN O
plates NNS O
overnight RB O
or CC O
were VBD O
cultured VBN O
with IN O
M NNP O
- HYPH O
CSF NNP O
and CC O
RANKL NNP O
for IN O
2 CD O
- SYM O
4 CD O
days NNS O
. . O

The DT O
cells NNS O
were VBD O
fixed VBN O
in IN O
acetone NN O
and CC O
then RB O
stained VBN O
with IN O
anti JJ O
- HYPH O
alpha NN O
v NN O
beta NN O
3 CD O
mAb NN O
( , O
LM609 NNP O
; : O
Chemicon NNP O
, , O
Temecula NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
or CC O
mouse NNP B-Species
IgG1 NNP O
( , O
11711 CD O
; : O
R NNP O
& CC O
D NNP O
Systems NNPS O
) -RRB- O
as IN O
an DT O
isotype NN O
- HYPH O
matched VBN O
control NN O
. . O

Alexa NNP O
fluor546 NN O
- HYPH O
conjugated JJ O
goat NN B-Species
anti JJ O
- HYPH O
mouse NN B-Species
IgG1 NNP O
antibody NN O
( , O
Molecular NNP O
Probes NNP O
, , O
Eugene NNP O
, , O
OR NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
used VBN O
as IN O
the DT O
second JJ O
antibody NN O
. . O

TOTO NNP O
- HYPH O
3 CD O
( , O
Molecular NNP O
Probes NNPS O
) -RRB- O
was VBD O
used VBN O
for IN O
nuclear JJ O
staining NN O
. . O

Flow NN O
cytometric JJ O
analysis NN O
of IN O
p38 NN O
MAPK NNP O
and CC O
ERK1 NNP O
/ SYM O
2 CD O
phosphorylation NN O

Purified JJ O
monocytes NNS O
were VBD O
cultured VBN O
in IN O
the DT O
presence NN O
of IN O
25 CD O
ng CD O
/ SYM O
ml NNP O
M NNP O
- HYPH O
CSF NNP O
for IN O
3 CD O
days NNS O
, , O
and CC O
were VBD O
either CC O
left VBN O
unstimulated JJ O
or CC O
were VBD O
stimulated VBN O
with IN O
40 CD O
ng CD O
/ SYM O
ml NNS O
RANKL NNP O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Stimulations NNS O
were VBD O
stopped VBN O
by IN O
adding VBG O
an DT O
equal JJ O
volume NN O
of IN O
PhosFlow NNP O
Fix NNP O
Buffer NNP O
I NNP O
solution NN O
( , O
BD NNP O
Biosciences NNP O
) -RRB- O
to IN O
the DT O
cell NN O
culture NN O
. . O

After IN O
incubation NN O
for IN O
10 CD O
minutes NNS O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
the DT O
cells NNS O
were VBD O
permeabilized VBN O
by IN O
washing NN O
twice RB O
at IN O
room NN O
temperature NN O
in IN O
PhosFlow NNP O
Perm NNP O
/ SYM O
Wash NNP O
Buffer NNP O
I NNP O
( , O
BD NNP O
Biosciences NNPS O
) -RRB- O
. . O

A DT O
total NN O
of IN O
1 CD O
x SYM O
105 CD O
cells NNS O
was VBD O
then RB O
Fc NNP O
blocked VBN O
with IN O
1 CD O
mu NN O
g NN O
human JJ B-Species
IgG NN O
for IN O
15 CD O
minutes NNS O
, , O
and CC O
was VBD O
stained VBN O
with IN O
Alexa NNP O
Fluor NNP O
647 CD O
- HYPH O
conjugated VBN O
mAb NN O
either CC O
to IN O
phospho NN O
- HYPH O
p38 CD O
MAPK NNP O
( , O
T180 CD O
/ SYM O
Y182 CD O
) -RRB- O
or CC O
to IN O
phospho NN O
- HYPH O
ERK1 NNP O
/ SYM O
2 CD O
( SYM O
T202 CD O
/ SYM O
Y204 CD O
) -RRB- O
( , O
BD NNP O
Biosciences NNPS O
) -RRB- O
for IN O
30 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
. . O

Alexa NNP O
Fluor NNP O
647 CD O
- HYPH O
conjugated VBN O
mouse NNP B-Species
IgG1 NNP O
( , O
BD NNP O
Biosciences NNP O
) -RRB- O
was VBD O
used VBN O
as IN O
an DT O
isotype NN O
control NN O
. . O

The DT O
cells NNS O
were VBD O
washed VBN O
in IN O
PhosFlow NNP O
Perm NNP O
/ SYM O
Wash NNP O
Buffer NNP O
I NNP O
, , O
and CC O
were VBD O
analyzed VBN O
by IN O
flow NN O
cytometry NN O
, , O
as IN O
already RB O
described VBN O
. . O

RNA NNP O
interference NN O

RNA NNP O
oligonucleotides NNS O
( -LRB- O
iGENE NNP O
, , O
Tsukuba NNP O
, , O
Japan NNP O
) -RRB- O
were VBD O
designed VBN O
based VBN O
on IN O
the DT O
algorithm NN O
that WDT O
incorporates VBZ O
single JJ O
nucleotide NN O
polymorphism NN O
and CC O
homology NN O
screening NN O
to TO O
ensure VB O
a DT O
target NN O
- HYPH O
specific JJ O
RNA NNP O
interference NN O
effect NN O
. . O

The DT O
following JJ O
sense NN O
and CC O
antisense JJ O
oligonucleotides NNS O
were VBD O
used VBN O
: : O
integrin NN O
beta NN O
3 CD O
, , O
5 CD O
' '' O
- HYPH O
GCU NN O
UCA NNP O
AUG NNP O
AGG NNP O
AAG NNP O
UGA NNP O
AGA NNP O
AGC NNP O
A NNP O
- HYPH O
AG NNP O
and CC O
3 CD O
' '' O
- HYPH O
UA NNP O
- HYPH O
CGA NNP O
AGU NNP O
UAC NNP O
UCC NNP O
UUC NNP O
ACU NNP O
UCU NNP O
UCG NNP O
U NNP O
; , O
randomized VBN O
control NN O
, , O
5 CD O
' '' O
- HYPH O
CGA NNP O
UUC NNP O
GCU NNP O
AGA NNP O
CCG NNP O
GCU NNP O
UCA NNP O
UUG NNP O
C NNP O
- HYPH O
AG NNP O
and CC O
3 CD O
' '' O
- HYPH O
UA NNP O
- HYPH O
GCU NNP O
AAG NNP O
CGA NNP O
UCU NNP O
GGC NNP O
CGA NNP O
AGU NNP O
AAC NNP O
G NNP O
; : O
and CC O
lamin NN O
, , O
5 CD O
' '' O
- HYPH O
GAG NNP O
GAA NNP O
CUG NNP O
GAC NNP O
UUC NNP O
CAG NNP O
AAG NNP O
AAC NNP O
A NN O
- HYPH O
AG NNP O
and CC O
3 CD O
' '' O
- HYPH O
UA NN O
- HYPH O
CUC NNP O
CUU NNP O
GAC NNP O
CUG NNP O
AAG NNP O
GUC NNP O
UUC NNP O
UUG NNP O
U NNP O
. . O

CD16 NNP O
- HYPH O
monocytes NNS O
( , O
8 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
well NN O
) -RRB- O
were VBD O
incubated VBN O
in IN O
96 CD O
- HYPH O
well NN O
plates NNS O
in IN O
optimem NN O
( : O
Invitrogen NNP O
) -RRB- O
. . O

After IN O
1 CD O
hour NN O
, , O
siRNAs NNS O
were VBD O
transfected VBN O
into IN O
the DT O
cells NNS O
using VBG O
oligofectamine NN O
( , O
Qiagen NNP O
) -RRB- O
based VBN O
on IN O
the DT O
method NN O
recommended VBN O
by IN O
the DT O
manufacturer NN O
. . O

After IN O
2 CD O
hours NNS O
, , O
the DT O
cells NNS O
were VBD O
washed VBN O
once RB O
with IN O
PBS NNP O
, , O
followed VBN O
by IN O
the DT O
addition NN O
of IN O
alpha NN O
MEM NNP O
supplemented VBN O
with IN O
10 CD O
% NN O
FBS NNP O
, , O
M NNP O
- HYPH O
CSF NNP O
and CC O
RANKL NNP O
. . O

After IN O
a DT O
2 CD O
- HYPH O
day NN O
incubation NN O
, , O
the DT O
beta NN O
3 CD O
mRNA NNP O
expression NN O
was VBD O
analyzed VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
with IN O
different JJ O
PCR NNP O
cycles NNS O
, , O
as IN O
described VBN O
earlier RBR O
. . O

Immunofluorescent NN O
staining NN O
for IN O
the DT O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimer NN O
was VBD O
also RB O
performed VBN O
as IN O
described VBN O
above RB O
, , O
and CC O
numbers NNS O
of IN O
alpha NN O
v NN O
beta NN O
3 CD O
- HYPH O
positive JJ O
cells NNS O
were VBD O
counted VBN O
in IN O
randomly RB O
selected VBN O
three CD O
fields NNS O
at IN O
100 CD O
x SYM O
magnification NN O
. . O

Seven CD O
days NNS O
after IN O
the DT O
transfection NN O
of IN O
siRNAs NNS O
, , O
the DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
in IN O
five CD O
fields NNS O
examined VBN O
at IN O
100 CD O
x NN O
magnification NN O
was VBD O
counted VBN O
under IN O
light JJ O
microscopy NN O
. . O

Inhibition NN O
of IN O
osteoclastogenesis NN O
with IN O
cyclic JJ O
RGDfV NN O
peptide NN O

CD16 NN O
- HYPH O
monocytes NNS O
were VBD O
incubated VBN O
in IN O
96 CD O
- HYPH O
well NN O
plates NNS O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
for IN O
2 CD O
days NNS O
. . O

A DT O
medium NN O
containing VBG O
either CC O
cyclic JJ O
RGDfV NNP O
peptide NN O
( , O
Arg NNP O
- HYPH O
Gly NNP O
- HYPH O
Asp NNP O
- HYPH O
D NNP O
- HYPH O
Phe NNP O
- HYPH O
Val NNP O
) -RRB- O
( : O
Calbiochem NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
or CC O
dimethyl NN O
sulfoxide NN O
was VBD O
then RB O
added VBN O
. . O

After IN O
incubation NN O
for IN O
a DT O
further JJ O
5 CD O
days NNS O
, , O
the DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
in IN O
five CD O
fields NNS O
examined VBN O
at IN O
100 CD O
x NN O
magnification NN O
was VBD O
counted VBN O
under IN O
light JJ O
microscopy NN O
. . O

Immunohistochemistry NN O

Synovial JJ O
tissue NN O
samples NNS O
were VBD O
obtained VBN O
during IN O
total JJ O
knee NN O
joint NN O
replacement NN O
surgery NN O
from IN O
four CD O
RA NNP O
patients NNS B-Species
. . O

Signed VBN O
consent NN O
forms NNS O
were VBD O
obtained VBN O
before IN O
the DT O
operation NN O
. . O

The DT O
experimental JJ O
protocol NN O
was VBD O
approved VBN O
by IN O
the DT O
ethics NNS O
committee NN O
of IN O
the DT O
Tokyo NNP O
Medical NNP O
and CC O
Dental NNP O
University NNP O
. . O

RA NNP O
was VBD O
diagnosed VBN O
according VBG O
to IN O
the DT O
American NNP O
College NNP O
of IN O
Rheumatology NNP O
criteria NNS O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Double JJ O
immunofluorescent NN O
staining NN O
for IN O
CD68 NN O
and CC O
CD16 NN O
antigens NNS O
was VBD O
conducted VBN O
on IN O
optimal JJ O
cutting NN O
temperature NN O
- HYPH O
embedded VBN O
sections NNS O
of IN O
frozen JJ O
synovial NN O
samples NNS O
. . O

Eight CD O
- HYPH O
micrometer NN O
- HYPH O
thick JJ O
cryostat NN O
sections NNS O
of IN O
RA NNP O
synovium NN O
were VBD O
fixed VBN O
in IN O
acetone NN O
for IN O
3 CD O
minutes NNS O
and CC O
were VBD O
then RB O
rehydrated VBN O
in IN O
PBS NNP O
for IN O
5 CD O
minutes NNS O
. . O

The DT O
samples NNS O
were VBD O
incubated VBN O
in IN O
5 CD O
mu NNS O
g NN O
/ SYM O
ml NNP O
proteinase NN O
K NNP O
( -LRB- O
Roche NNP O
) -RRB- O
, , O
50 CD O
mM NN O
ethylenediamine NN O
tetraacetic NN O
acid NN O
, , O
100 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
for IN O
15 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
followed VBN O
by IN O
a DT O
wash NN O
in IN O
PBS NNP O
. . O

The DT O
samples NNS O
were VBD O
then RB O
blocked VBN O
with IN O
10 CD O
% NN O
goat NN B-Species
serum NN O
in IN O
PBS NNP O
for IN O
60 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
, , O
and CC O
were VBD O
incubated VBN O
with IN O
anti AFX O
- HYPH O
CD16 NN O
mAb NN O
( , O
3G8 CD O
; : O
Immunotech NNP O
, , O
Marseille NNP O
, , O
France NNP O
) , O
or CC O
mouse NNP B-Species
IgG1 NNP O
( SYM O
11711 CD O
) -RRB- O
as IN O
an DT O
isotype NN O
- HYPH O
matched VBN O
control NN O
in IN O
1 CD O
% NN O
bovine JJ B-Species
serum NN O
albumin NN O
/ SYM O
PBS NN O
for IN O
60 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
. . O

The DT O
samples NNS O
were VBD O
then RB O
washed VBN O
three CD O
times NNS O
in IN O
PBS NNP O
, , O
for IN O
5 CD O
minutes NNS O
each DT O
, , O
and CC O
incubated VBN O
with IN O
Alexa NNP O
fluor546 NN O
- HYPH O
conjugated VBN O
goat NN B-Species
anti AFX O
- HYPH O
mouse NN B-Species
IgG1 NNP O
antibody NN O
( -LRB- O
Molecular NNP O
Probes NNP O
) -RRB- O
in IN O
1 CD O
% NN O
bovine JJ B-Species
serum NN O
albumin NN O
/ SYM O
PBS NN O
for IN O
60 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
. . O

The DT O
samples NNS O
were VBD O
then RB O
sequentially RB O
stained VBN O
for IN O
CD68 NNP O
antigen NN O
in IN O
a DT O
manner NN O
similar JJ O
to IN O
that DT O
used VBN O
for IN O
CD16 NN O
staining NN O
. . O

The DT O
samples NNS O
were VBD O
stained VBN O
with IN O
anti JJ O
- HYPH O
CD68 NN O
mAb NN O
( , O
PGM1 NNP O
; : O
Immunotech NNP O
) -RRB- O
or CC O
mouse NNP B-Species
IgG3 NNP O
( -LRB- O
6A3 CD O
; : O
MBL NNP O
, , O
Nagoya NNP O
, , O
Japan NNP O
) , O
followed VBN O
by IN O
labeling NN O
with IN O
Alexa NNP O
fluor488 NN O
- HYPH O
conjugated VBN O
goat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
IgG3 NNP O
antibody NN O
( , O
Molecular NNP O
Probes NNP O
) -RRB- O
. . O

The DT O
samples NNS O
were VBD O
examined VBN O
by IN O
confocal JJ O
laser NN O
scanning NN O
microscope NN O
( , O
Olympus NNP O
, , O
Tokyo NNP O
, , O
Japan NNP O
) -RRB- O
. . O

Statistical JJ O
analysis NN O

Data NNS O
are VBP O
expressed VBN O
as IN O
the DT O
mean JJ O
+ SYM O
/ SYM O
- HYPH O
standard JJ O
error NN O
of IN O
the DT O
mean NN O
. . O

A DT O
nonpaired JJ O
Student NNP O
' '' O
s POS O
t NN O
test NN O
was VBD O
used VBN O
for IN O
comparison NN O
, , O
using VBG O
the DT O
StatView NNP O
program NN O
( , O
Abacus NNP O
Concepts NNP O
, , O
Berkeley NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

P NN O
< NN O
0 CD O
. . O
5 CD O
was VBD O
considered VBN O
statistically RB O
significant JJ O
. . O

Results NNS O

Induction NN O
of IN O
osteoclasts NNS O
from IN O
CD16 NN O
- HYPH O
peripheral JJ O
blood NN O
monocytes NNS O

To TO O
identify VB O
the DT O
monocyte NN O
subset NN O
that WDT O
differentiates VBZ O
into IN O
osteoclasts NNS O
, , O
we PRP O
examined VBD O
osteoclast JJ O
formation NN O
from IN O
CD16 NNP O
+ CC O
and CC O
CD16 CD O
- HYPH O
human JJ B-Species
peripheral JJ O
blood NN O
monocytes NNS O
. . O

The DT O
monocyte NN O
subsets NNS O
were VBD O
purified VBN O
using VBG O
magnetic JJ O
beads NNS O
. . O

Incubation NN O
with IN O
M NNP O
- HYPH O
CSF NNP O
alone RB O
did VBD O
not RB O
induce VB O
osteoclast NN O
formation NN O
from IN O
either DT O
subset NN O
( , O
Figure NNP O
1a CD O
) -RRB- O
. . O

Culture NN O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
induced VBD O
a DT O
significant JJ O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
from IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
, , O
whereas IN O
only RB O
few JJ O
CD16 NN O
+ CC O
monocytes NNS O
differentiated VBN O
into IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
( -LRB- O
Figure NN O
1a NN O
, , O
b NN O
) -RRB- O
. . O

We PRP O
then RB O
assessed VBD O
the DT O
bone NN O
resorptive JJ O
ability NN O
by IN O
culturing VBG O
cells NNS O
on IN O
calcium NN O
phosphate NN O
- HYPH O
coated VBN O
plates NNS O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
. . O

Resorption NN O
lacunae NN O
were VBD O
detected VBN O
only RB O
in IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
( : O
Figure NNP O
1c NNP O
) -RRB- O
, , O
indicating VBG O
the DT O
TRAP NNP O
- HYPH O
positive JJ O
CD16 NNP O
- HYPH O
- HYPH O
derived VBN O
MNC NNP O
possessed VBD O
the DT O
osteoclast JJ O
phenotype NN O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
using VBG O
purified VBN O
monocytes NNS O
by IN O
FACS NNP O
sorting NN O
( : O
purities NNS O
: : O
CD16 NNP O
+ CC O
, , O
96 CD O
% NN O
; : O
CD16 CD O
- : O
, , O
97 CD O
% NN O
) -RRB- O
. . O

The DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
induced VBN O
were VBD O
36 CD O
+ SYM O
/ SYM O
- HYPH O
3 CD O
cells NNS O
/ SYM O
well NN O
and CC O
348 CD O
+ NN O
/ SYM O
- HYPH O
13 CD O
cells NNS O
/ SYM O
well RB O
from IN O
CD16 NNP O
+ CC O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O
, , O
respectively RB O
. . O

To TO O
exclude VB O
the DT O
possibility NN O
that IN O
the DT O
anti AFX O
- HYPH O
CD16 NN O
antibody NN O
used VBN O
for IN O
isolation NN O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
inhibits VBZ O
osteoclast NN O
formation NN O
, , O
we PRP O
separated VBD O
the DT O
two CD O
subsets NNS O
, , O
CD33low JJ O
monocytes NNS O
and CC O
CD33high NNP O
monocytes NNS O
, , O
using VBG O
anti JJ O
- HYPH O
CD33 NN O
mAb NN O
and CC O
a DT O
fluorescent JJ O
cell NN O
sorter NN O
, , O
since IN O
it PRP O
was VBD O
reported VBN O
that IN O
CD33low NNP O
monocytes NNS O
correspond VBP O
to IN O
CD16 NN O
+ NFP O
, , O
and CC O
that IN O
CD33high NNP O
correspond VBP O
to IN O
CD16 CD O
- HYPH O
monocytes NNS O
[ -LRB- O
15 CD O
] -RRB- O
. . O

On IN O
average JJ O
, , O
the DT O
CD33low NNP O
population NN O
contained VBD O
CD16 NN O
- HYPH O
( : O
10 CD O
. . O
2 CD O
% NN O
) NFP O
/ SYM O
CD16 CD O
+ SYM O
( SYM O
89 CD O
. . O
8 CD O
% NN O
) -RRB- O
monocytes NNS O
, , O
and CC O
the DT O
CD33high NNP O
population NN O
contained VBD O
CD16 NN O
- : O
( : O
86 CD O
. . O
3 CD O
% NN O
) NFP O
/ SYM O
CD16 CD O
+ NN O
( SYM O
13 CD O
. . O
7 CD O
% NN O
) -RRB- O
monocytes NNS O
. . O

Culture NN O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ SYM O
RANKL NNP O
induced VBN O
TRAP NN O
- HYPH O
positive JJ O
MNC NNP O
from IN O
CD33high NNP O
monocytes NNS O
, , O
whereas IN O
no DT O
or CC O
few JJ O
CD33low JJ O
monocytes NNS O
differentiated VBN O
into IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
( , O
CD33low NNP O
vs IN O
CD33high NN O
, , O
2 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
vs IN O
192 CD O
+ SYM O
/ SYM O
- HYPH O
71 CD O
cells NNS O
/ SYM O
well NN O
; : O
n CD O
= SYM O
3 CD O
) -RRB- O
. . O

TRAP NNP O
- HYPH O
5b CD O
and CC O
MMP NNP O
- HYPH O
9 CD O
in IN O
the DT O
culture NN O
supernatants NNS O
, , O
both DT O
of IN O
which WDT O
are VBP O
known VBN O
to TO O
be VB O
produced VBN O
by IN O
osteoclasts NNS O
, , O
were VBD O
measured VBN O
by IN O
ELISA NNP O
. . O

The DT O
concentrations NNS O
of IN O
both DT O
enzymes NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
culture NN O
supernatant NN O
of IN O
CD16 NN O
- HYPH O
monocytes NNS O
than IN O
in IN O
that DT O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
( -LRB- O
Figure NNP O
1d NN O
) -RRB- O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
CD16 NNP O
- HYPH O
peripheral JJ O
blood NN O
monocyte NN O
subset NN O
, , O
but CC O
not RB O
the DT O
CD16 NN O
+ SYM O
subset NN O
, , O
differentiate VBP O
into IN O
osteoclasts NNS O
by IN O
incubation NN O
with IN O
RANKL NNP O
+ CC O
M NNP O
- HYPH O
CSF NNP O
. . O

CD16 NN O
+ CC O
monocytes NNS O
do VBP O
not RB O
affect VB O
the DT O
osteoclastogenesis NN O
from IN O
CD16 NNP O
- : O
monocytes NNS O

To TO O
examine VB O
whether IN O
CD16 NN O
+ CC O
monocytes NNS O
affect VBP O
osteoclastogenesis NN O
from IN O
CD16 NNP O
- HYPH O
monocytes NNS O
, , O
varied JJ O
numbers NNS O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
were VBD O
mixed VBN O
with IN O
CD16 NNP O
- HYPH O
monocytes NNS O
( , O
5 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
well NN O
) -RRB- O
, , O
and CC O
were VBD O
cultured VBN O
for IN O
7 CD O
days NNS O
in IN O
the DT O
presence NN O
of IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
. . O

The DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
was VBD O
not RB O
altered VBN O
by IN O
the DT O
presence NN O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

The DT O
results NNS O
indicated VBD O
that IN O
CD16 NN O
+ CC O
monocytes NNS O
did VBD O
not RB O
hamper VB O
or CC O
enhance VB O
the DT O
osteoclastogenesis NN O
from IN O
CD16 NNP O
- HYPH O
monocytes NNS O
. . O

Differences NNS O
in IN O
cytokine NN O
production NN O
by IN O
RANKL NNP O
- HYPH O
stimulated VBN O
or CC O
M NNP O
- HYPH O
CSF NNP O
- HYPH O
stimulated VBN O
CD16 NNP O
+ CC O
and CC O
CD16 NNP O
- HYPH O
monocytes NNS O

To TO O
compare VB O
the DT O
biological JJ O
response NN O
of IN O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
subsets NNS O
with IN O
either CC O
RANKL NNP O
or CC O
M NNP O
- HYPH O
CSF NNP O
stimulation NN O
, , O
we PRP O
measured VBD O
the DT O
amount NN O
of IN O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
production NN O
after IN O
exposure NN O
of IN O
cells NNS O
to IN O
various JJ O
concentrations NNS O
of IN O
RANKL NNP O
or CC O
M NNP O
- HYPH O
CSF NNP O
with IN O
an DT O
ELISA NNP O
. . O

Without IN O
RANKL NNP O
the DT O
CD16 NNP O
+ CC O
subset NN O
produced VBD O
a DT O
significant JJ O
amount NN O
of IN O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
, , O
whereas IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
produced VBD O
undetectable JJ O
levels NNS O
( -LRB- O
Figure NNP O
3a CD O
) -RRB- O
. . O

RANKL NNP O
stimulation NN O
increased VBD O
TNF NNP O
alpha NN O
production NN O
from IN O
both DT O
subsets NNS O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
, , O
although IN O
the DT O
CD16 NNP O
+ CC O
subset NN O
produced VBD O
more JJR O
TNF NNP O
alpha NN O
than IN O
did VBD O
the DT O
CD16 NNP O
- HYPH O
subset NN O
. . O

RANKL NNP O
stimulation NN O
also RB O
enhanced VBD O
IL NN O
- HYPH O
6 CD O
production NN O
from IN O
the DT O
CD16 NNP O
+ SYM O
subset NN O
, , O
but CC O
not RB O
from IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
. . O

M NNP O
- HYPH O
CSF NNP O
stimulation NN O
increased VBD O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
production NN O
from IN O
both DT O
subsets NNS O
, , O
although IN O
the DT O
CD16 NNP O
+ CC O
subset NN O
produced VBN O
more JJR O
than IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
( -LRB- O
Figure NNP O
3b NN O
) -RRB- O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
CD16 NN O
+ CC O
monocytes NNS O
also RB O
respond VBP O
both DT O
to IN O
RANKL NNP O
and CC O
M NNP O
- HYPH O
CSF NNP O
stimulation NN O
, , O
although IN O
such JJ O
stimulation NN O
does VBZ O
not RB O
result VB O
in IN O
differentiation NN O
into IN O
osteoclasts NNS O
. . O

CD16 NN O
+ CC O
monocytes NNS O
were VBD O
also RB O
noted VBN O
to TO O
express VB O
higher JJR O
amounts NNS O
of IN O
inflammatory JJ O
cytokines NNS O
compared VBN O
with IN O
CD16 NN O
- : O
monocytes NNS O
with IN O
or CC O
without IN O
RANKL NNP O
or CC O
M NNP O
- HYPH O
CSF NNP O
stimulation NN O
. . O

Comparison NN O
of IN O
expression NN O
levels NNS O
of IN O
molecules NNS O
involved VBN O
in IN O
osteoclastogenesis NN O
between IN O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O

Diverse JJ O
molecules NNS O
are VBP O
involved VBN O
in IN O
RANKL NNP O
/ SYM O
RANK NNP O
and CC O
its PRP$ O
costimulatory JJ O
signal NN O
transduction NN O
pathways NNS O
[ -LRB- O
16 CD O
] -RRB- O
. . O

The DT O
different JJ O
response NN O
to IN O
RANKL NNP O
+ CC O
M NNP O
- HYPH O
CSF NNP O
stimulation NN O
between IN O
the DT O
CD16 NN O
+ CC O
monocyte NN O
subset NN O
and CC O
the DT O
CD16 NNP O
- HYPH O
monocytes NN O
subset NN O
might MD O
be VB O
explained VBN O
by IN O
the DT O
expression NN O
profiles NNS O
of IN O
these DT O
molecules NNS O
. . O

We PRP O
therefore RB O
examined VBD O
the DT O
mRNA NNP O
levels NNS O
of IN O
the DT O
following VBG O
molecules NNS O
: : O
receptor NN O
activator NN O
of IN O
NF NNP O
- HYPH O
kappa NNP O
B NNP O
( -LRB- O
RANK NNP O
) -RRB- O
, , O
the DT O
receptor NN O
for IN O
RANKL NNP O
; : O
c NN O
- HYPH O
fms NNP O
, , O
the DT O
receptor NN O
for IN O
M NNP O
- HYPH O
CSF NNP O
; , O
tumor NN O
necrosis NN O
factor NN O
receptor NN O
- HYPH O
associated VBN O
factor NN O
6 CD O
( , O
TRAF NNP O
- HYPH O
6 CD O
) -RRB- O
, , O
the DT O
adaptor NN O
protein NN O
for IN O
RANK NNP O
; : O
c NN O
- HYPH O
Fos NNS O
and CC O
nuclear JJ O
factor NN O
of IN O
activated VBN O
T NNP O
cells NNS O
c1 NN O
( -LRB- O
NFATc1 NNP O
) -RRB- O
, , O
transcription NN O
factors NNS O
that WDT O
are VBP O
essential JJ O
for IN O
osteoclastogenesis NN O
; : O
DNAX NNP O
- HYPH O
activation NN O
protein NN O
12 CD O
( , O
DAP12 NN O
) -RRB- O
and CC O
Fc NN O
receptor NN O
gamma NN O
chain NN O
( -LRB- O
FcR NNP O
gamma NN O
) -RRB- O
, , O
adaptor NN O
proteins NNS O
known VBN O
to TO O
deliver VB O
costimulatory JJ O
signals NNS O
in IN O
RANKL NNP O
- HYPH O
induced VBN O
osteoclastogenesis NN O
; : O
signal NN O
regulatory JJ O
protein NN O
beta NN O
1 CD O
( , O
SIRP NNP O
- HYPH O
beta NN O
1 CD O
) -RRB- O
, , O
triggering VBG O
receptor NN O
expressed VBN O
on IN O
myeloid NN O
cells NNS O
2 CD O
( , O
TREM NN O
- HYPH O
2 CD O
) -RRB- O
and CC O
osteoclast NN O
- HYPH O
associated VBN O
receptor NN O
( , O
OSCAR NNP O
) -RRB- O
, , O
transmembrane NN O
receptors NNS O
that WDT O
associate VBP O
with IN O
either CC O
DAP12 NNP O
or CC O
FcR NN O
gamma NN O
; : O
and CC O
alpha NN O
v NN O
and CC O
beta NN O
3 CD O
, , O
integrins NNS O
known VBN O
to TO O
be VB O
expressed VBN O
as IN O
the DT O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimer NN O
on IN O
osteoclasts NNS O
. . O

The DT O
mRNA NNP O
levels NNS O
of IN O
RANK NNP O
, , O
c NN O
- HYPH O
fms NNP O
, , O
TRAF NNP O
- HYPH O
6 CD O
, , O
DAP12 NNP O
and CC O
SIRP NNP O
- HYPH O
beta NN O
1 CD O
under IN O
the DT O
baseline JJ O
condition NN O
( , O
no DT O
stimulation NN O
) , O
varied VBN O
between IN O
the DT O
donors NNS O
; : O
however RB O
, , O
we PRP O
did VBD O
not RB O
find VB O
consistent JJ O
differences NNS O
in IN O
the DT O
mRNA NNP O
levels NNS O
of IN O
these DT O
molecules NNS O
between IN O
the DT O
CD16 NN O
+ CC O
monocyte NN O
subset NN O
and CC O
the DT O
CD16 NNP O
- HYPH O
monocyte NN O
subset NN O
among IN O
three CD O
to TO O
six CD O
donors NNS O
( -LRB- O
Figure NNP O
4a CD O
) -RRB- O
. . O

The DT O
mRNA NNP O
levels NNS O
of IN O
other JJ O
molecules NNS O
, , O
apart RB O
from IN O
integrin NN O
beta NN O
3 CD O
, , O
were VBD O
similar JJ O
between IN O
the DT O
two CD O
subsets NNS O
under IN O
the DT O
no DT O
- HYPH O
stimulation NN O
condition NN O
. . O

Although IN O
the DT O
mRNA NNP O
levels NNS O
of IN O
RANK NNP O
, , O
c NN O
- HYPH O
fms NNP O
, , O
DAP12 NNP O
, , O
FcR NNP O
gamma NN O
, , O
TREM NN O
- HYPH O
2 CD O
and CC O
OSCAR NNP O
increased VBD O
in IN O
response NN O
to IN O
M NNP O
- HYPH O
CSF NNP O
alone RB O
or CC O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
in IN O
both DT O
subsets NNS O
, , O
the DT O
expression NN O
levels NNS O
were VBD O
not RB O
significantly RB O
different JJ O
between IN O
the DT O
two CD O
subsets NNS O
. . O

Expressions NNS O
of IN O
TRAF NNP O
- HYPH O
6 CD O
, , O
c NN O
- HYPH O
Fos NNP O
and CC O
SIRP NNP O
- HYPH O
beta NN O
1 CD O
mRNA NNP O
did VBD O
not RB O
change VB O
following VBG O
stimulation NN O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
. . O

Of IN O
note NN O
, , O
the DT O
expression NN O
of IN O
NFATc1 NNP O
mRNA NNP O
was VBD O
enhanced VBN O
by IN O
M NNP O
- HYPH O
CSF NNP O
+ SYM O
RANKL NNP O
treatment NN O
only RB O
in IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
. . O

Furthermore RB O
, , O
expression NN O
of IN O
integrin NN O
alpha NN O
v NN O
in IN O
both DT O
subsets NNS O
was VBD O
enhanced VBN O
by IN O
M NNP O
- HYPH O
CSF NNP O
with IN O
or CC O
without IN O
RANKL NNP O
; : O
however RB O
, , O
the DT O
expression NN O
level NN O
was VBD O
greater JJR O
in IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
. . O

It PRP O
was VBD O
noted VBN O
that IN O
integrin NN O
- HYPH O
beta NN O
3 CD O
mRNA NNP O
was VBD O
detected VBN O
only RB O
in IN O
the DT O
CD16 NN O
- HYPH O
subset NN O
and CC O
was VBD O
increased VBN O
by IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
stimulation NN O
, , O
but CC O
not RB O
by IN O
M NNP O
- HYPH O
CSF NNP O
alone RB O
. . O

The DT O
protein NN O
expression NN O
of IN O
RANK NNP O
under IN O
the DT O
baseline NN O
condition NN O
was VBD O
weakly RB O
detected VBN O
in IN O
both DT O
subsets NNS O
, , O
and CC O
the DT O
levels NNS O
were VBD O
varied VBN O
between IN O
donors NNS O
by IN O
western JJ O
immunoblotting NN O
. . O

The DT O
protein NN O
expression NN O
of IN O
c NN O
- HYPH O
fms NN O
was VBD O
weakly RB O
detected VBN O
in IN O
unstimulated JJ O
CD16 NN O
+ CC O
monocytes NNS O
, , O
but CC O
not RB O
in IN O
CD16 NN O
- HYPH O
monocytes NN O
( -LRB- O
Figure NN O
4b NN O
) -RRB- O
. . O

Flow NN O
cytometry NN O
analysis NN O
of IN O
c NN O
- HYPH O
fms NNS O
in IN O
fresh JJ O
monocytes NNS O
, , O
however RB O
, , O
showed VBD O
that IN O
both DT O
subsets NNS O
express VBP O
the DT O
molecule NN O
on IN O
the DT O
cell NN O
surface NN O
( -LRB- O
Figure NNP O
4c NNP O
) -RRB- O
. . O

Expressions NNS O
of IN O
both CC O
RANK NNP O
and CC O
c NN O
- HYPH O
fms NNS O
were VBD O
upregulated VBN O
by IN O
M NNP O
- HYPH O
CSF NNP O
alone RB O
and CC O
by IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
, , O
and CC O
we PRP O
did VBD O
not RB O
find VB O
consistent JJ O
differences NNS O
in IN O
the DT O
protein NN O
levels NNS O
of IN O
these DT O
molecules NNS O
between IN O
the DT O
two CD O
monocyte NN O
subsets NNS O
. . O

The DT O
profiles NNS O
of IN O
expression NN O
levels NNS O
of IN O
molecules NNS O
involved VBN O
in IN O
RANKL NNP O
/ SYM O
RANK NNP O
and CC O
its PRP$ O
costimulatory JJ O
pathways NNS O
are VBP O
similar JJ O
between IN O
the DT O
two CD O
subsets NNS O
, , O
except IN O
for IN O
NFATc1 NNP O
, , O
integrin NN O
alpha NN O
v NN O
and CC O
integrin NN O
beta NN O
3 CD O
. . O

We PRP O
therefore RB O
assumed VBD O
that IN O
the DT O
distinct JJ O
induction NN O
of IN O
NFATc1 NNP O
, , O
integrin NN O
alpha NN O
v NN O
and CC O
integrin NN O
beta NN O
3 CD O
in IN O
response NN O
to IN O
RANKL NNP O
stimulation NN O
among IN O
the DT O
two CD O
monocyte NN O
subsets NNS O
might MD O
explain VB O
the DT O
differences NNS O
in IN O
their PRP$ O
abilities NNS O
to TO O
differentiate VB O
into IN O
osteoclasts NNS O
. . O

RANKL NNP O
stimulation NN O
induces VBZ O
alpha NN O
v IN O
beta NN O
3 CD O
expression NN O
on IN O
CD16 NNP O
- HYPH O
monocytes NNS O

The DT O
integrin NN O
- HYPH O
beta NN O
3 CD O
subunit NN O
binds VBZ O
to IN O
integrin NN O
alpha NN O
v NN O
only RB O
and CC O
is VBZ O
expressed VBN O
as IN O
the DT O
heterodimeric JJ O
protein NN O
alpha NN O
v NN O
beta NN O
3 CD O
on IN O
monocytes NNS O
and CC O
osteoclasts NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

We PRP O
examined VBD O
the DT O
expression NN O
of IN O
alpha NN O
v IN O
beta NN O
3 CD O
on IN O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O
by IN O
immunofluorescent JJ O
staining NN O
. . O

Neither CC O
unstimulated JJ O
nor CC O
M NNP O
- HYPH O
CSF NNP O
- HYPH O
stimulated VBN O
monocyte NN O
subsets NNS O
expressed VBN O
alpha NN O
v IN O
beta NN O
3 CD O
( HYPH O
Figure NN O
4d NN O
and CC O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

After IN O
48 CD O
and CC O
72 CD O
hours NNS O
of IN O
treatment NN O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
, , O
alpha NN O
v IN O
beta NN O
3 CD O
- HYPH O
positive JJ O
mononuclear JJ O
cells NNS O
were VBD O
observed VBN O
in IN O
CD16 NN O
- HYPH O
monocyte NN O
cultures NNS O
but CC O
not RB O
in IN O
CD16 NN O
+ CC O
monocyte NN O
cultures NNS O
. . O

At IN O
96 CD O
hours NNS O
, , O
both DT O
alpha NN O
v IN O
beta NN O
3 CD O
- HYPH O
positive JJ O
mononuclear JJ O
cells NNS O
and CC O
multinucleated JJ O
cells NNS O
were VBD O
present JJ O
in IN O
the DT O
CD16 NNP O
- HYPH O
monocyte NN O
culture NN O
. . O

The DT O
results NNS O
indicated VBD O
that IN O
alpha NN O
v IN O
beta NN O
3 CD O
was VBD O
selectively RB O
expressed VBN O
on IN O
CD16 NNP O
- HYPH O
monocytes NNS O
in IN O
the DT O
presence NN O
of IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
, , O
and CC O
the DT O
expression NN O
was VBD O
revealed VBN O
before IN O
the DT O
cells NNS O
differentiate VBP O
into IN O
typical JJ O
multinucleated JJ O
osteoclasts NNS O
. . O

RANKL NNP O
activates VBZ O
ERK NNP O
and CC O
p38 NN O
kinases NNS O
only RB O
in IN O
CD16 NNP O
- HYPH O
monocytes NNS O

Since IN O
ERK NNP O
and CC O
p38 NN O
MAPK NNP O
are VBP O
essential JJ O
in IN O
RANKL NNP O
- HYPH O
induced VBN O
osteoclastogenesis NN O
[ -LRB- O
18 CD O
- HYPH O
20 CD O
] -RRB- O
, , O
we PRP O
next RB O
examined VBD O
whether IN O
these DT O
kinases NNS O
were VBD O
activated VBN O
differently RB O
in IN O
CD16 NN O
+ CC O
monocytes NNS O
and CC O
in IN O
CD16 NN O
- HYPH O
monocytes NNS O
. . O

Purified JJ O
monocytes NNS O
were VBD O
precultured VBN O
with IN O
25 CD O
ng CD O
/ SYM O
ml NN O
M NN O
- HYPH O
CSF NNP O
for IN O
3 CD O
days NNS O
to TO O
enhance VB O
RANK NN O
expression NN O
, , O
and CC O
were VBD O
then RB O
treated VBN O
with IN O
RANKL NNP O
. . O

The DT O
RANKL NNP O
treatment NN O
induced VBD O
phosphorylation NN O
of IN O
both CC O
ERK NNP O
and CC O
p38 NN O
MAPK NNP O
in IN O
CD16 NN O
- HYPH O
monocytes NNS O
at IN O
5 CD O
minutes NNS O
postexposure NN O
, , O
although IN O
the DT O
p38 NN O
MAPK NNP O
phosphorylation NN O
was VBD O
weak JJ O
. . O

Both DT O
phosphorylations NNS O
declined VBD O
to IN O
a DT O
basal JJ O
level NN O
within IN O
20 CD O
minutes NNS O
( -LRB- O
Figure NNP O
5 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
ERK NNP O
and CC O
p38 NN O
MAPK NNP O
were VBD O
not RB O
detectably RB O
phosphorylated VBN O
in IN O
CD16 NN O
+ CC O
monocytes NNS O
with IN O
RANKL NNP O
. . O

siRNA NNP O
targeting VBG O
integrin NN O
beta NN O
3 CD O
inhibits VBZ O
osteoclastogenesis NN O
from IN O
CD16 NNP O
- : O
monocytes NNS O

The DT O
integrin JJ O
- HYPH O
beta NN O
3 CD O
cytoplasmic JJ O
domain NN O
is VBZ O
essential JJ O
for IN O
activation NN O
of IN O
intracellular JJ O
signals NNS O
from IN O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimers NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

We PRP O
therefore RB O
examined VBD O
the DT O
involvement NN O
of IN O
alpha NN O
v NN O
beta NN O
3 CD O
in IN O
RANKL NNP O
+ CC O
M NNP O
- HYPH O
CSF NNP O
- HYPH O
induced VBN O
osteoclastogenesis NN O
in IN O
human JJ B-Species
CD16 NN O
- HYPH O
monocytes NNS O
using VBG O
siRNA NN O
targeting VBG O
the DT O
integrin NN O
- HYPH O
beta NN O
3 CD O
subunit NN O
. . O

The DT O
integrin NN O
- HYPH O
beta NN O
3 CD O
siRNA NNP O
or CC O
control NN O
randomized VBN O
siRNA NNP O
were VBD O
transfected VBN O
into IN O
CD16 NNP O
- HYPH O
monocytes NNS O
. . O

At IN O
48 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
, , O
we PRP O
determined VBD O
the DT O
integrin NN O
- HYPH O
beta NN O
3 CD O
mRNA NN O
level NN O
and CC O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimer NN O
protein NN O
expression NN O
. . O

The DT O
integrin NN O
- HYPH O
beta NN O
3 CD O
mRNA NN O
level NN O
was VBD O
reduced VBN O
in IN O
the DT O
integrin NN O
- HYPH O
beta NN O
3 CD O
siRNA NN O
- HYPH O
transfected VBN O
monocytes NNS O
compared VBN O
with IN O
control NN O
siRNA NN O
- HYPH O
transfected VBN O
monocytes NNS O
( -LRB- O
Figure NNP O
6a CD O
) -RRB- O
. . O

The DT O
alpha NN O
v IN O
beta NN O
3 CD O
heterodimer NN O
expression NN O
was VBD O
evaluated VBN O
by IN O
immunofluorescent JJ O
staining NN O
. . O

The DT O
number NN O
of IN O
alpha NN O
v NN O
beta NN O
3 CD O
- HYPH O
positive JJ O
cells NNS O
was VBD O
significantly RB O
decreased VBN O
in IN O
integrin NN O
- HYPH O
beta NN O
3 CD O
siRNA NN O
- HYPH O
transfected VBN O
monocytes NNS O
compared VBN O
with IN O
that DT O
in IN O
control NN O
siRNA NN O
( -LRB- O
Figure NN O
6b NN O
) -RRB- O
. . O

After IN O
7 CD O
days NNS O
of IN O
incubation NN O
, , O
the DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
was VBD O
counted VBN O
. . O

Transfection NN O
with IN O
integrin NN O
- HYPH O
beta NN O
3 CD O
siRNA NNP O
significantly RB O
reduced VBD O
the DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
compared VBN O
with IN O
control NN O
siRNA NN O
transfection NN O
( -LRB- O
Figure NNP O
6c NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
use NN O
of IN O
siRNA NNP O
directed VBN O
toward IN O
a DT O
different JJ O
site NN O
of IN O
integrin NN O
- HYPH O
beta NN O
3 CD O
mRNA NNP O
also RB O
inhibited VBD O
osteoclast NN O
formation NN O
from IN O
CD16 NNP O
- HYPH O
monocytes NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
siRNA NNP O
that WDT O
targeted VBD O
lamin NN O
, , O
which WDT O
was VBD O
used VBN O
as IN O
a DT O
negative JJ O
control NN O
, , O
did VBD O
not RB O
inhibit VB O
the DT O
induction NN O
of IN O
osteoclasts NNS O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

These DT O
results NNS O
indicate VBP O
the DT O
importance NN O
of IN O
integrin NN O
beta NN O
3 CD O
in IN O
RANKL NNP O
- HYPH O
induced VBN O
osteoclast NN O
formation NN O
from IN O
CD16 NNP O
- HYPH O
peripheral JJ O
blood NN O
monocytes NNS O
. . O

Cyclic JJ O
RGDfV NN O
peptide NN O
inhibits VBZ O
the DT O
osteoclastogenesis NN O
from IN O
CD16 NNP O
- HYPH O
monocytes NNS O

Integrin NN O
alpha NN O
v IN O
beta NN O
3 CD O
recognizes VBZ O
a DT O
common JJ O
tripeptide NN O
sequence NN O
, , O
RGD NNP O
( , O
Arg NNP O
- HYPH O
Gly NNP O
- HYPH O
Asp NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
present JJ O
in IN O
bone NN O
matrix NN O
proteins NNS O
such JJ O
as IN O
vitronectin NN O
and CC O
fibronectin NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Cyclic JJ O
RGDfV NNP O
peptide NN O
( : O
Arg NNP O
- HYPH O
Gly NNP O
- HYPH O
Asp NNP O
- HYPH O
D NNP O
- HYPH O
Phe NNP O
- HYPH O
Val NNP O
) -RRB- O
inhibits VBZ O
binding NN O
of IN O
the DT O
RGD NNP O
- HYPH O
containing VBG O
molecules NNS O
to IN O
alpha NN O
v NN O
beta NN O
3 CD O
[ -LRB- O
22 CD O
] -RRB- O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
ligand JJ O
binding NN O
to IN O
the DT O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimer NN O
in IN O
the DT O
osteoclastogenesis NN O
, , O
we PRP O
examined VBD O
whether IN O
cyclic JJ O
RGDfV NN O
peptide NN O
inhibits VBZ O
the DT O
formation NN O
of IN O
osteoclasts NNS O
. . O

Cyclic JJ O
RGDfV NNP O
peptide NN O
significantly RB O
reduced VBD O
the DT O
number NN O
of IN O
TRAP NNP O
- HYPH O
positive JJ O
MNC NNP O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
6d CD O
) -RRB- O
. . O

The DT O
results NNS O
imply VBP O
possible JJ O
involvement NN O
of IN O
ligand JJ O
bindings NNS O
to IN O
alpha NN O
v NN O
beta NN O
3 CD O
in IN O
the DT O
osteoclastogenesis NN O
. . O

Knockdown NN O
of IN O
integrin NN O
beta NN O
3 CD O
did VBD O
not RB O
affect VB O
the DT O
expression NN O
of IN O
NFATc1 NNP O
mRNA NNP O

In IN O
the DT O
next JJ O
step NN O
, , O
we PRP O
determined VBD O
whether IN O
integrin JJ O
- HYPH O
beta NN O
3 CD O
- HYPH O
siRNA NNP O
- HYPH O
induced VBN O
inhibition NN O
of IN O
the DT O
osteoclastogenesis NN O
reflects VBZ O
downregulation NN O
of IN O
NFATc1 NNP O
, , O
which WDT O
is VBZ O
a DT O
key JJ O
transcription NN O
factor NN O
in IN O
osteoclastogenesis NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

For IN O
this DT O
purpose NN O
, , O
we PRP O
compared VBD O
NFATc1 NNP O
mRNA NNP O
levels NNS O
between IN O
integrin NN O
beta NN O
3 CD O
and CC O
control NN O
siRNA NN O
- HYPH O
transfected VBN O
monocytes NNS O
. . O

Interestingly RB O
, , O
integrin JJ O
- HYPH O
beta NN O
3 CD O
knockdown NN O
did VBD O
not RB O
alter VB O
the DT O
NFATc1 NNP O
mRNA NNP O
level NN O
( -LRB- O
Figure NNP O
7 CD O
) -RRB- O
, , O
suggesting VBG O
that IN O
signal NN O
transduction NN O
mediated VBN O
by IN O
integrin NN O
beta NN O
3 CD O
does VBZ O
not RB O
affect VB O
the DT O
expression NN O
of IN O
NFATc1 NNP O
. . O

Detection NN O
of IN O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
macrophages NNS O
in IN O
synovium NN O
of IN O
RA NNP O
patients NNS B-Species

RA NNP O
synovial JJ O
macrophages NNS O
are VBP O
derived VBN O
from IN O
peripheral JJ O
blood NN O
monocytes NNS O
, , O
and CC O
their PRP$ O
recruitment NN O
into IN O
the DT O
synovium NN O
is VBZ O
facilitated VBN O
by IN O
various JJ O
adhesion NN O
molecules NNS O
and CC O
chemokines NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

To TO O
analyze VB O
CD16 NN O
expression NN O
on IN O
synovial JJ O
macrophages NNS O
, , O
RA NNP O
synovial JJ O
tissues NNS O
were VBD O
double RB O
- HYPH O
stained VBN O
for IN O
CD16 NNP O
and CC O
a DT O
macrophage NN O
marker NN O
, , O
CD68 NNP O
. . O

CD16 NN O
- HYPH O
/ SYM O
CD68 CD O
+ SYM O
macrophages NNS O
were VBD O
widespread JJ O
in IN O
the DT O
synovium NN O
. . O

Although IN O
less RBR O
frequent JJ O
, , O
CD16 NNP O
+ CC O
/ SYM O
CD68 CD O
+ CC O
macrophages NNS O
were VBD O
also RB O
observed VBN O
both CC O
in IN O
the DT O
synovial JJ O
intima NN O
and CC O
subintima NN O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

The DT O
presence NN O
of IN O
two CD O
subsets NNS O
of IN O
macrophages NNS O
, , O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
, , O
in IN O
RA NN O
synovium NN O
indicates VBZ O
that IN O
both CC O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
peripheral JJ O
blood NN O
monocytes NNS O
are VBP O
recruited VBN O
into IN O
the DT O
synovium NN O
. . O

Discussion NN O

Human JJ B-Species
peripheral JJ O
blood NN O
monocytes NNS O
are VBP O
a DT O
heterogeneous JJ O
population NN O
, , O
and CC O
they PRP O
are VBP O
divided VBN O
into IN O
two CD O
subsets NNS O
based VBN O
on IN O
the DT O
expression NN O
of IN O
CD16 NNP O
. . O

The DT O
CD16 NN O
+ CC O
and CC O
CD16 CD O
- HYPH O
monocyte NN O
subsets NNS O
show VBP O
functional JJ O
differences NNS O
in IN O
migration NN O
, , O
cytokine NN O
production NN O
and CC O
differentiation NN O
into IN O
macrophages NNS O
or CC O
dendritic JJ O
cells NNS O
[ -LRB- O
11 CD O
- SYM O
13 CD O
, , O
15 CD O
] -RRB- O
. . O

We PRP O
focused VBD O
on IN O
the DT O
heterogeneity NN O
of IN O
the DT O
monocytes NNS O
, , O
and CC O
the DT O
primary JJ O
question NN O
addressed VBN O
in IN O
this DT O
study NN O
was VBD O
which WDT O
monocyte NN O
subset NN O
could MD O
be VB O
the DT O
source NN O
of IN O
osteoclasts NNS O
. . O

The DT O
results NNS O
demonstrated VBD O
that IN O
CD16 NN O
- HYPH O
peripheral JJ O
blood NN O
monocytes NNS O
, , O
but CC O
not RB O
CD16 NN O
+ CC O
monocytes NNS O
, , O
differentiated VBN O
in IN O
vitro FW O
into IN O
osteoclasts NNS O
by IN O
treatment NN O
with IN O
RANKL NNP O
+ CC O
M NNP O
- HYPH O
CSF NNP O
. . O

To TO O
investigate VB O
the DT O
molecular JJ O
mechanisms NNS O
of IN O
the DT O
different JJ O
response NN O
to IN O
RANKL NNP O
and CC O
the DT O
differentiation NN O
into IN O
osteoclasts NNS O
between IN O
CD16 NN O
+ CC O
and CC O
CD16 NNP O
- HYPH O
monocytes NNS O
, , O
we PRP O
examined VBD O
the DT O
expression NN O
of IN O
molecules NNS O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
osteoclastogenesis NN O
. . O

The DT O
expression NN O
profiles VBZ O
of IN O
integrin NN O
alpha NN O
v NN O
, , O
integrin NN O
beta NN O
3 CD O
and CC O
NFATc1 NNP O
were VBD O
different JJ O
between IN O
the DT O
two CD O
subsets NNS O
. . O

Integrin NN O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimer NN O
was VBD O
expressed VBN O
only RB O
on IN O
RANKL NNP O
and CC O
M NNP O
- HYPH O
CSF NNP O
- HYPH O
stimulated VBN O
CD16 NNP O
- HYPH O
monocytes NNS O
. . O

It PRP O
is VBZ O
known VBN O
that IN O
alpha NN O
v NN O
beta NN O
3 CD O
expressed VBN O
on IN O
osteoclasts NNS O
is VBZ O
important JJ O
in IN O
bone NN O
resorption NN O
as RB O
well RB O
as IN O
in IN O
attachment NN O
of IN O
osteoclasts NNS O
to IN O
the DT O
bone NN O
matrix NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

It PRP O
was VBD O
recently RB O
reported VBN O
that IN O
bone NN O
marrow NN O
macrophages NNS O
of IN O
integrin NN O
- HYPH O
beta NN O
3 CD O
- HYPH O
deficient JJ O
mice NN B-Species
could MD O
not RB O
differentiate VB O
into IN O
mature JJ O
osteoclasts NNS O
in IN O
vitro NN O
, , O
suggesting VBG O
that IN O
alpha NN O
v IN O
beta NN O
3 CD O
is VBZ O
involved VBN O
not RB O
only RB O
in IN O
activation NN O
, , O
but CC O
also RB O
in IN O
differentiation NN O
, , O
of IN O
osteoclasts NNS O
in IN O
mice NNS B-Species
[ -LRB- O
26 CD O
, , O
27 CD O
] -RRB- O
. . O

The DT O
authors NNS O
also RB O
showed VBD O
that IN O
alpha NN O
v NN O
beta NN O
3 CD O
and CC O
c NN O
- HYPH O
fms NNS O
share VBP O
a DT O
common JJ O
intracellular JJ O
signaling NN O
pathway NN O
, , O
including VBG O
the DT O
activation NN O
of IN O
ERK NNP O
and CC O
the DT O
induction NN O
of IN O
c NN O
- HYPH O
Fos NNP O
[ -LRB- O
27 CD O
] -RRB- O
, , O
both DT O
of IN O
which WDT O
are VBP O
essential JJ O
for IN O
osteoclastogenesis NN O
[ -LRB- O
28 CD O
, , O
29 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
it PRP O
was VBD O
reported VBN O
that IN O
echistatin NN O
, , O
an DT O
alpha NN O
v NN O
beta NN O
3 CD O
antagonist NN O
, , O
inhibited VBD O
osteoclast JJ O
formation NN O
of IN O
mouse NN B-Species
bone NN O
marrow NN O
cells NNS O
[ -LRB- O
30 CD O
] -RRB- O
. . O

In IN O
accordance NN O
with IN O
these DT O
reports NNS O
, , O
our PRP$ O
data NNS O
showed VBD O
that IN O
knockdown NN O
of IN O
integrin JJ O
- HYPH O
beta NN O
3 CD O
expression NN O
resulted VBD O
in IN O
downregulation NN O
of IN O
the DT O
alpha NN O
v NN O
beta NN O
3 CD O
heterodimer NN O
, , O
and CC O
abrogated VBD O
osteoclastogenesis NN O
from IN O
human JJ B-Species
peripheral JJ O
blood NN O
CD16 NN O
- HYPH O
monocytes NNS O
. . O

We PRP O
also RB O
showed VBD O
that IN O
blocking NN O
of IN O
adhesive JJ O
ligands NNS O
to TO O
bind VB O
to IN O
alpha NN O
v IN O
beta NN O
3 CD O
by IN O
RGDfV NN O
peptide NN O
inhibited VBN O
osteoclast NN O
formation NN O
from IN O
CD16 NNP O
- HYPH O
monocytes NNS O
. . O

Taken VBN O
together RB O
, , O
the DT O
process NN O
of IN O
ligand JJ O
binding NN O
to IN O
alpha NN O
v NN O
beta NN O
3 CD O
may MD O
be VB O
involved VBN O
in IN O
the DT O
osteoclastogenesis NN O
. . O

Blockade NN O
of IN O
alpha NN O
v IN O
beta NN O
3 CD O
could MD O
therefore RB O
be VB O
a DT O
therapeutically RB O
beneficial JJ O
approach NN O
to TO O
modulate VB O
osteoclastogenesis NN O
. . O

Indeed RB O
, , O
integrin NN O
alpha NN O
v IN O
beta NN O
3 CD O
antagonists NNS O
effectively RB O
treated VBD O
osteoporosis NN O
in IN O
mice NNS B-Species
, , O
rats NNS B-Species
and CC O
humans NNS B-Species
, , O
and CC O
protected VBN O
bone NN O
destruction NN O
in IN O
rat NN O
adjuvant NN O
- HYPH O
induced VBN O
arthritis NN O
in IN O
vivo NN O
[ -LRB- O
31 CD O
- HYPH O
34 CD O
] -RRB- O
. . O

Of IN O
note NN O
, , O
it PRP O
is VBZ O
reported VBN O
that IN O
patients NNS B-Species
with IN O
Iraqi JJ O
- HYPH O
Jewish JJ O
- HYPH O
type NN O
Glanzmann NNP O
thrombasthenia NN O
who WP O
are VBP O
deficient JJ O
in IN O
integrin NN O
beta NN O
3 CD O
do VBP O
not RB O
develop VB O
osteopetrosis NN O
because IN O
of IN O
the DT O
upregulation NN O
of IN O
alpha NN O
2 CD O
beta NN O
1 CD O
expression NN O
on IN O
osteoclasts NNS O
, , O
although IN O
the DT O
bone NN O
- HYPH O
resorptive JJ O
ability NN O
of IN O
the DT O
osteoclasts NNS O
was VBD O
decreased VBN O
in IN O
vitro FW O
[ -LRB- O
35 CD O
] -RRB- O
. . O

The DT O
function NN O
of IN O
alpha NN O
v NN O
beta NN O
3 CD O
in IN O
vivo NN O
in IN O
osteoclast NN O
formation NN O
and CC O
resorptive JJ O
function NN O
could MD O
therefore RB O
be VB O
partially RB O
compensated VBN O
by IN O
other JJ O
integrins NNS O
. . O

Although IN O
all PDT O
the DT O
multinucleated JJ O
osteoclasts NNS O
expressed VBD O
alpha NN O
v IN O
beta NN O
3 CD O
( SYM O
Figure NNP O
4d CD O
) -RRB- O
[ -LRB- O
36 CD O
] -RRB- O
, , O
a DT O
small JJ O
number NN O
of IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
- HYPH O
stimulated VBN O
mononuclear JJ O
CD16 NNP O
- HYPH O
monocytes NNS O
expressed VBN O
alpha NN O
v NN O
beta NN O
3 CD O
( HYPH O
Figure NN O
4d NN O
) -RRB- O
. . O

Multinucleated JJ O
osteoclasts NNS O
are VBP O
formed VBN O
by IN O
fusion NN O
of IN O
osteoclast JJ O
precursor NN O
cells NNS O
[ -LRB- O
37 CD O
] -RRB- O
. . O

It PRP O
was VBD O
reported VBN O
that IN O
alpha NN O
v NN O
beta NN O
3 CD O
is VBZ O
involved VBN O
in IN O
the DT O
migration NN O
of IN O
osteoclast NN O
precursors NNS O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
alpha NN O
v IN O
beta NN O
3 CD O
- HYPH O
positive JJ O
cells NNS O
could MD O
therefore RB O
be VB O
forced VBN O
to TO O
migrate VB O
by IN O
the DT O
ligands NNS O
and CC O
may MD O
fuse VB O
with IN O
closed JJ O
alpha NN O
v NN O
beta NN O
3 CD O
- HYPH O
negative JJ O
cells NNS O
. . O

Alternatively RB O
, , O
only RB O
alpha NN O
v IN O
beta NN O
3 CD O
- HYPH O
positive JJ O
cells NNS O
may MD O
be VB O
fused VBN O
with IN O
each DT O
other JJ O
. . O

It PRP O
is VBZ O
possible JJ O
to TO O
consider VB O
that IN O
signaling VBG O
from IN O
CD16 NNP O
by IN O
anti JJ O
- HYPH O
CD16 NN O
mAb NN O
- HYPH O
coated VBN O
magnetic JJ O
beads NNS O
, , O
which WDT O
were VBD O
used VBN O
for IN O
the DT O
cell NN O
separation NN O
, , O
or CC O
by IN O
IgG NN O
contained VBN O
in IN O
FBS NNP O
might MD O
inhibit VB O
osteoclastogenesis NN O
from IN O
CD16 NN O
+ CC O
monocytes NNS O
. . O

We PRP O
therefore RB O
separated VBD O
the DT O
two CD O
subsets NNS O
using VBG O
anti JJ O
- HYPH O
CD33 NN O
mAb NN O
and CC O
a DT O
fluorescent JJ O
cell NN O
sorter NN O
, , O
and CC O
stimulated VBD O
the DT O
cells NNS O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
. . O

The DT O
results NNS O
showed VBD O
that IN O
CD33low NNP O
monocytes NNS O
, , O
which WDT O
correspond VBP O
to IN O
CD16 NN O
+ CC O
monocytes NNS O
, , O
still RB O
could MD O
not RB O
differentiate VB O
into IN O
osteoclasts NNS O
. . O

CD16 NNP O
is VBZ O
a DT O
heterodimer NN O
consisting VBG O
of IN O
Fc NNP O
gamma NN O
IIIa NNP O
and CC O
Fc NNP O
gamma NN O
, , O
and CC O
has VBZ O
low JJ O
affinity NN O
for IN O
the DT O
Fc NNP O
region NN O
of IN O
IgG NNP O
. . O

Aggregation NN O
of IN O
CD16 NNP O
by IN O
immune JJ O
complexes NNS O
leads VBZ O
to IN O
transmission NN O
of IN O
activating VBG O
signals NNS O
via IN O
the DT O
immunoreceptor NN O
tyrosine NN O
- HYPH O
based VBN O
activation NN O
motif NN O
in IN O
the DT O
gamma NN O
chain NN O
[ -LRB- O
38 CD O
] -RRB- O
. . O

We PRP O
also RB O
assessed VBD O
osteoclastogenesis NN O
from IN O
the DT O
two CD O
monocyte NN O
subsets NNS O
using VBG O
IgG NN O
- HYPH O
depleted VBN O
bovine JJ B-Species
serum NN O
. . O

Even RB O
in IN O
the DT O
IgG NNP O
- HYPH O
free JJ O
medium NN O
, , O
CD16 NNP O
- HYPH O
monocytes NNS O
but CC O
not RB O
CD16 NN O
+ CC O
monocytes NNS O
differentiated VBN O
into IN O
osteoclasts NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

We PRP O
could MD O
therefore RB O
exclude VB O
the DT O
possibility NN O
that IN O
signal NN O
transduction NN O
through IN O
CD16 NN O
inhibits VBZ O
osteoclastogenesis NN O
from IN O
CD16 NNP O
+ CC O
monocytes NNS O
. . O

NFATc1 NNP O
is VBZ O
a DT O
key JJ O
transcription NN O
factor NN O
in IN O
osteoclastogenesis NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
stimulation NN O
with IN O
M NNP O
- HYPH O
CSF NNP O
+ CC O
RANKL NNP O
increased VBD O
the DT O
NFATc1 NNP O
mRNA NNP O
expression NN O
in IN O
the DT O
CD16 NNP O
- HYPH O
subset NN O
only RB O
, , O
similar JJ O
to IN O
integrin JJ O
alpha NN O
v NN O
and CC O
integrin NN O
beta NN O
3 CD O
. . O

The DT O
differences NNS O
in IN O
NFATc1 NNP O
induction NN O
might MD O
therefore RB O
also RB O
explain VB O
the DT O
difference NN O
in IN O
osteoclastogenesis NN O
between IN O
the DT O
two CD O
monocyte NN O
subsets NNS O
. . O

It PRP O
is VBZ O
of IN O
interest NN O
that IN O
knockdown NN O
of IN O
integrin NN O
beta NN O
3 CD O
did VBD O
not RB O
lower VB O
the DT O
mRNA NNP O
level NN O
of IN O
NFATc1 NNP O
. . O

This DT O
result NN O
supports VBZ O
the DT O
notion NN O
that IN O
NFATc1 NNP O
is VBZ O
located VBN O
upstream JJ O
of IN O
integrin JJ O
- HYPH O
beta NN O
3 CD O
expression NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
parallel JJ O
activation NN O
of IN O
two CD O
signaling VBG O
pathways NNS O
mediated VBN O
by IN O
integrin NN O
beta NN O
3 CD O
and CC O
NFATc1 NNP O
contributes VBZ O
to IN O
osteoclastogenesis NN O
independently RB O
or CC O
cooperatively RB O
. . O

Further JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
determine VB O
the DT O
mechanisms NNS O
of IN O
integrin JJ O
beta NN O
3 CD O
involvement NN O
in IN O
RANKL NNP O
/ SYM O
RANK NNP O
- HYPH O
mediated VBN O
osteoclast NN O
differentiation NN O
. . O

It PRP O
has VBZ O
been VBN O
demonstrated VBN O
that IN O
MAPK NNP O
families NNS O
, , O
ERK NNP O
and CC O
p38 NN O
MAPK NNP O
, , O
were VBD O
activated VBN O
by IN O
RANKL NNP O
- HYPH O
induced VBN O
intracellular JJ O
signalings NNS O
in IN O
osteoclasts NNS O
and CC O
osteoclast NN O
precursors NNS O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
these DT O
kinases NNS O
are VBP O
involved VBN O
in IN O
the DT O
differentiation NN O
of IN O
osteoclasts NNS O
[ -LRB- O
20 CD O
] -RRB- O
. . O

We PRP O
showed VBD O
that IN O
RANKL NNP O
stimulation NN O
induced VBD O
phosphorylation NN O
of IN O
ERK NNP O
and CC O
p38 NN O
MAPK NNP O
only RB O
in IN O
CD16 NNP O
- HYPH O
monocytes NNS O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
differential JJ O
activation NN O
of IN O
these DT O
kinases NNS O
may MD O
partially RB O
explain VB O
the DT O
distinct JJ O
properties NNS O
of IN O
the DT O
two CD O
monocyte NN O
subsets NNS O
upon IN O
RANKL NNP O
stimulation NN O
. . O

Our PRP$ O
results NNS O
showed VBD O
that IN O
CD16 NN O
+ CC O
monocytes NNS O
produce VBP O
higher JJR O
levels NNS O
of IN O
inflammatory JJ O
cytokines NNS O
including VBG O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
compared VBN O
with IN O
CD16 NNP O
- HYPH O
monocytes NNS O
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
previous JJ O
report NN O
showing VBG O
that IN O
CD16 NN O
+ CC O
monocytes NNS O
produced VBD O
larger JJR O
amounts NNS O
of IN O
TNF NNP O
alpha NN O
upon IN O
lipopolysaccharide NN O
or CC O
lipopeptide NN O
stimulation NN O
than IN O
did VBD O
CD16 NNP O
- HYPH O
monocytes NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
we PRP O
showed VBD O
that IN O
stimulation NN O
either CC O
with IN O
RANKL NNP O
or CC O
M NNP O
- HYPH O
CSF NNP O
upregulated VBD O
the DT O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
production NN O
by IN O
CD16 NNP O
+ CC O
monocytes NNS O
. . O

A DT O
marked JJ O
increase NN O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
in IN O
peripheral JJ O
blood NN O
is VBZ O
reported VBN O
in IN O
inflammatory JJ O
diseases NNS O
, , O
such JJ O
as IN O
infection NN O
, , O
malignancy NN O
, , O
Kawasaki NNP O
disease NN O
and CC O
RA NNP O
[ -LRB- O
41 CD O
- SYM O
44 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
, , O
CD16 NN O
+ CC O
monocytes NNS O
may MD O
be VB O
an DT O
important JJ O
source NN O
of IN O
inflammatory JJ O
cytokines NNS O
. . O

In IN O
mice NNS B-Species
, , O
peripheral JJ O
blood NN O
Ly NNP O
- HYPH O
6Chigh NNP O
monocytes NNS O
, , O
which WDT O
are VBP O
thought VBN O
to TO O
correspond VB O
to IN O
human JJ B-Species
CD16 NN O
- HYPH O
monocytes NNS O
, , O
increase NN O
in IN O
inflammatory JJ O
conditions NNS O
, , O
and CC O
these DT O
cells NNS O
are VBP O
recruited VBN O
into IN O
sites NNS O
of IN O
inflammation NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
Ly NNP O
- HYPH O
6Clow NNP O
monocytes NNS O
, , O
which WDT O
are VBP O
thought VBN O
to TO O
correspond VB O
to IN O
human JJ B-Species
CD16 NN O
+ NFP O
, , O
migrate VB O
into IN O
noninflamed JJ O
tissues NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

These DT O
data NNS O
on IN O
mouse NN B-Species
monocytes NNS O
seem VBP O
to TO O
be VB O
in IN O
contrast NN O
to IN O
the DT O
data NNS O
on IN O
human JJ B-Species
monocytes NNS O
, , O
which WDT O
show VBP O
expansion NN O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
in IN O
inflammatory JJ O
conditions NNS O
where WRB O
they PRP O
produce VBP O
larger JJR O
amounts NNS O
of IN O
inflammatory JJ O
cytokines NNS O
. . O

At IN O
present NN O
, , O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
mouse NN B-Species
monocyte NN O
subsets NNS O
, , O
Ly NNP O
- HYPH O
6Clow NNP O
/ : O
Ly NNP O
- HYPH O
6Chigh NNP O
, , O
represent VBP O
human JJ B-Species
monocyte NN O
subsets NNS O
, , O
CD16 NN O
+ NFP O
/ SYM O
CD16 CD O
- HYPH O
monocytes NNS O
, , O
and CC O
whether IN O
the DT O
biologic JJ O
functions NNS O
of IN O
mouse NN B-Species
monocytes NNS O
are VBP O
analogous JJ O
to IN O
those DT O
of IN O
human JJ B-Species
monocytes NNS O
. . O

In IN O
mice NNS B-Species
, , O
blood NN O
monocytes NNS O
newly RB O
released VBN O
from IN O
the DT O
bone NN O
marrow NN O
are VBP O
exclusively RB O
Ly NNP O
- HYPH O
6Chigh NNP O
and CC O
the DT O
level NN O
of IN O
Ly NNP O
- HYPH O
6C NNP O
is VBZ O
downregulated VBN O
while IN O
in IN O
circulation NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
thus RB O
suggested VBN O
that IN O
in IN O
mice NNS B-Species
the DT O
two CD O
monocyte NN O
subsets NNS O
differing VBG O
in IN O
Ly NNP O
- HYPH O
6C NNP O
expression NN O
represent VBP O
different JJ O
stages NNS O
in IN O
the DT O
maturation NN O
pathway NN O
. . O

In IN O
the DT O
human JJ B-Species
, , O
transition NN O
from IN O
CD16 NN O
- HYPH O
monocytes NNS O
to IN O
CD16 NN O
+ CC O
monocytes NNS O
is VBZ O
observed VBN O
upon IN O
culture NN O
with IN O
IL NN O
- HYPH O
10 CD O
, , O
M NNP O
- HYPH O
CSF NNP O
and CC O
transforming VBG O
growth NN O
factor NN O
beta NN O
in IN O
vitro FW O
[ -LRB- O
42 CD O
, , O
46 CD O
] -RRB- O
. . O

Similar JJ O
to IN O
mouse NN B-Species
monocytes NNS O
, , O
therefore RB O
, , O
human JJ B-Species
peripheral JJ O
blood NN O
CD16 NN O
- HYPH O
monocytes NNS O
may MD O
also RB O
maturate VB O
into IN O
CD16 NNP O
+ CC O
monocytes NNS O
. . O

It PRP O
is VBZ O
reported VBN O
that IN O
a DT O
significant JJ O
number NN O
of IN O
RA NNP O
synovial JJ O
cells NNS O
in IN O
the DT O
intima NN O
express VBP O
CD16 NNP O
, , O
suggesting VBG O
that IN O
CD16 NN O
+ CC O
cells NNS O
are VBP O
synovial JJ O
macrophages NNS O
[ -LRB- O
47 CD O
] -RRB- O
. . O

We PRP O
confirmed VBD O
that IN O
both CC O
CD16 NNP O
+ CC O
and CC O
CD16 NN O
- HYPH O
macrophages NNS O
accumulate VBP O
in IN O
the DT O
RA NN O
synovium NN O
by IN O
double JJ O
- HYPH O
color NN O
immunohistochemical JJ O
staining NN O
for IN O
CD68 NNP O
and CC O
CD16 NNP O
. . O

A DT O
number NN O
of IN O
chemokines NNS O
are VBP O
abundantly RB O
expressed VBN O
in IN O
the DT O
RA NNP O
synovium NN O
[ -LRB- O
24 CD O
, , O
48 CD O
] -RRB- O
. . O

Among IN O
these DT O
cytokines NNS O
, , O
MCP NNP O
- HYPH O
1 CD O
, , O
MIP NNP O
- HYPH O
1 CD O
alpha NN O
, , O
SDF NNP O
- HYPH O
1 CD O
, , O
RANTES NN O
and CC O
fractalkine NN O
can MD O
induce VB O
migration NN O
of IN O
CD16 NN O
- HYPH O
monocytes NNS O
in IN O
vitro FW O
( , O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
and CC O
unpublished JJ O
data NNS O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
migration NN O
of IN O
CD16 NN O
+ CC O
monocytes NNS O
is VBZ O
induced VBN O
only RB O
by IN O
fractalkine NN O
. . O

These DT O
chemokines NNS O
therefore RB O
seem VBP O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
recruitment NN O
of IN O
CD16 NN O
+ CC O
and CC O
CD16 NN O
- HYPH O
monocytes NNS O
from IN O
the DT O
circulating VBG O
pool NN O
into IN O
the DT O
RA NNP O
synovium NN O
. . O

The DT O
osteoclast NN O
inducers NNS O
are VBP O
also RB O
produced VBN O
in IN O
the DT O
RA NNP O
synovium NN O
. . O

RANKL NNP O
is VBZ O
expressed VBN O
by IN O
synovial JJ O
fibroblasts NNS O
and CC O
activated VBN O
T NNP O
cells NNS O
[ -LRB- O
49 CD O
- HYPH O
51 CD O
] -RRB- O
, , O
while IN O
M NNP O
- HYPH O
CSF NNP O
is VBZ O
expressed VBN O
on IN O
RA NN O
synovial NN O
macrophages NNS O
and CC O
fibroblasts NNS O
[ -LRB- O
52 CD O
, , O
53 CD O
] -RRB- O
. . O

TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
, , O
which WDT O
are VBP O
mainly RB O
expressed VBN O
on IN O
RA NN O
synovial NN O
macrophages NNS O
and CC O
fibroblasts NNS O
, , O
respectively RB O
, , O
could MD O
also RB O
enhance VB O
osteoclast NN O
differentiation NN O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Collectively RB O
, , O
it PRP O
is VBZ O
probable JJ O
that IN O
the DT O
recruited VBN O
CD16 NN O
- HYPH O
monocytes NNS O
/ SYM O
macrophages NNS O
differentiate VBP O
into IN O
osteoclasts NNS O
in IN O
the DT O
RA NN O
synovium NN O
, , O
and CC O
contribute VBP O
to IN O
bone NN O
destruction NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
CD16 NN O
+ CC O
monocytes NNS O
/ SYM O
macrophages NNS O
might MD O
also RB O
be VB O
involved VBN O
in IN O
RA NN O
pathogenesis NN O
by IN O
producing VBG O
inflammatory JJ O
cytokines NNS O
including VBG O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
. . O

Since IN O
TNF NNP O
alpha NN O
and CC O
IL NN O
- HYPH O
6 CD O
enhance VBP O
osteoclast NN O
formation NN O
[ -LRB- O
54 CD O
, , O
55 CD O
] -RRB- O
, , O
CD16 NN O
+ CC O
monocytes NNS O
/ SYM O
macrophages NNS O
may MD O
also RB O
contribute VB O
to IN O
osteoclastogenesis NN O
in IN O
RA NN O
synovium NN O
. . O

Conclusion NN O

We PRP O
have VBP O
shown VBN O
that IN O
human JJ B-Species
peripheral JJ O
blood NN O
monocytes NNS O
consist VBP O
of IN O
two CD O
functionally RB O
heterogeneous JJ O
subsets NNS O
with IN O
distinct JJ O
response NN O
to IN O
osteoclastogenic JJ O
stimuli NNS O
. . O

Osteoclasts NNS O
seem VBP O
to TO O
originate VB O
from IN O
CD16 NN O
- HYPH O
monocytes NNS O
, , O
and CC O
integrin NN O
beta NN O
3 CD O
is VBZ O
necessary JJ O
for IN O
the DT O
osteoclastogenesis NN O
. . O

The DT O
blockade NN O
of IN O
accumulation NN O
and CC O
activation NN O
of IN O
CD16 NN O
- HYPH O
monocytes NNS O
could MD O
therefore RB O
be VB O
a DT O
beneficial JJ O
approach NN O
as IN O
an DT O
anti JJ O
- HYPH O
bone NN O
resorptive JJ O
therapy NN O
, , O
especially RB O
for IN O
RA NNP O
. . O

Abbreviations NNS O

DAP NNP O
= : O
DNAX NNP O
- HYPH O
activation NN O
protein NN O
; : O
ELISA NNP O
= : O
enzyme NN O
- HYPH O
linked VBN O
immunosorbent JJ O
assay NN O
; : O
FBS NNP O
= : O
fetal JJ O
bovine NN B-Species
serum NN O
; : O
FcR NN O
gamma NN O
= : O
Fc NN O
receptor NN O
gamma NN O
chain NN O
; : O
IL NN O
= : O
interleukin NN O
; : O
FITC NNP O
= : O
fluorescein NN O
isothiocianate NN O
; , O
mAb NN O
, , O
monoclonal JJ O
antibody NN O
; : O
M NNP O
- HYPH O
CSF NNP O
= : O
macrophage NN O
colony NN O
- HYPH O
stimulating VBG O
factor NN O
; : O
MEM NNP O
= , O
modified VBN O
Eagle NNP O
' '' O
s NNS O
medium NN O
; : O
MMP NNP O
= : O
matrix NN O
metalloproteinase NN O
; : O
MNC NNP O
= , O
multinucleated JJ O
cells NNS O
; : O
NF NNP O
= , O
nuclear JJ O
factor NN O
; : O
OSCAR NNP O
= , O
osteoclast NN O
- HYPH O
associated VBN O
receptor NN O
; : O
PBS NN O
= : O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
; : O
PCR NN O
= : O
polymerase NN O
chain NN O
reaction NN O
; , O
RA NN O
= : O
rheumatoid JJ O
arthritis NN O
; : O
RANK NN O
= , O
receptor NN O
activator NN O
of IN O
NF NNP O
- HYPH O
kappa NNP O
B NNP O
; : O
RANKL NNP O
= , O
receptor NN O
activator NN O
of IN O
NF NNP O
- HYPH O
kappa NN O
B NN O
ligand NN O
; : O
RT NN O
= SYM O
reverse JJ O
transcriptase NN O
; : O
siRNA NNP O
= SYM O
small JJ O
interfering NN O
RNA NN O
; : O
SIRP NN O
- HYPH O
beta NN O
1 CD O
= SYM O
signal NN O
regulatory JJ O
protein NN O
- HYPH O
beta NN O
1 CD O
; : O
TNF NN O
alpha NN O
= : O
tumor NN O
necrosis NN O
factor NN O
alpha NN O
; : O
TRAF NN O
= : O
tumor NN O
necrosis NN O
factor NN O
receptor NN O
- HYPH O
associated VBN O
factor NN O
; : O
TRAP NN O
= : O
tartrate NN O
- HYPH O
resistant JJ O
acid NN O
phosphatase NN O
; : O
TREM NN O
= , O
triggering VBG O
receptor NN O
expressed VBN O
on IN O
myeloid NN O
cells NNS O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

YK NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
, , O
carried VBD O
out RP O
the DT O
experiments NNS O
and CC O
statistical JJ O
analysis NN O
, , O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

KH NNP O
and CC O
KT NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
and CC O
its PRP$ O
coordination NN O
. . O

TN NNP O
and CC O
NM NNP O
conceived VBD O
of IN O
the DT O
study NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
, , O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Embryonic JJ O
sympathoblasts NNS O
transiently RB O
express VBP O
TrkB NNP O
in IN O
vivo NN O
and CC O
proliferate VBP O
in IN O
response NN O
to IN O
brain NN O
- HYPH O
derived VBN O
neurotrophic JJ O
factor NN O
in IN O
vitro FW O

Abstract JJ O

Background NN O

Nerve JJ O
growth NN O
factor NN O
and CC O
neurotrophin NN O
- HYPH O
3 CD O
are VBP O
involved VBN O
in IN O
the DT O
development NN O
of IN O
sympathetic JJ O
neurons NNS O
; : O
however RB O
, , O
whether IN O
brain NN O
derived VBN O
neurotrophic JJ O
factor NN O
also RB O
plays VBZ O
a DT O
role NN O
is VBZ O
not RB O
known VBN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
whether IN O
BDNF NNP O
and CC O
its PRP$ O
receptor NN O
, , O
TrkB NNP O
, , O
are VBP O
expressed VBN O
during IN O
the DT O
development NN O
of IN O
paravertebral JJ O
sympathetic JJ O
ganglia NN O
in IN O
vivo NN O
and CC O
to TO O
determine VB O
the DT O
effect NN O
of IN O
BDNF NNP O
in IN O
vitro NN O
. . O

Results NNS O

As IN O
neural JJ O
crest NN O
cells NNS O
coalesce VBP O
to TO O
form VB O
sympathetic JJ O
ganglia NN O
, , O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
are VBP O
seen VBN O
in IN O
both CC O
chicken NN B-Species
and CC O
mouse NN B-Species
embryos NNS O
. . O

In IN O
chicken NN B-Species
embryos NNS O
, , O
TrkB NNP O
- HYPH O
expressing VBG O
cells NNS O
first RB O
appear VBP O
at IN O
Hamburger NNP O
- HYPH O
Hamilton NNP O
Stage NNP O
( : O
St NNP O
) -RRB- O
27 CD O
and CC O
they PRP O
co VBP O
- HYPH O
express VBP O
HNK NNP O
- HYPH O
1 CD O
, , O
confirming VBG O
that IN O
they PRP O
are VBP O
migrating VBG O
neural JJ O
crest NN O
cells NNS O
. . O

The DT O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
lack VBP O
neural JJ O
markers NNS O
at IN O
this DT O
stage NN O
; : O
however RB O
, , O
they PRP O
migrate VBP O
with IN O
other JJ O
neurally RB O
differentiating VBG O
cells NNS O
that WDT O
are VBP O
TrkA NNP O
and CC O
TrkC NNP O
- HYPH O
positive JJ O
. . O

By IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
, , O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
begin VBP O
to TO O
express VB O
the DT O
neural JJ O
specific JJ O
markers NNS O
Hu NNP O
C NNP O
/ SYM O
D NNP O
and CC O
Islet NNP O
- HYPH O
1 CD O
; : O
eventually RB O
, , O
all DT O
TrkB NNP O
positive JJ O
cells NNS O
commence VBP O
neural JJ O
differentiation NN O
. . O

By IN O
St NNP O
. . O

34 CD O
, , O
TrkB NNP O
and CC O
TrkC NNP O
staining NN O
are VBP O
lost VBN O
. . O

BDNF NNP O
transcript NN O
expression NN O
parallels VBZ O
that DT O
of IN O
TrkB NNP O
. . O

In IN O
the DT O
mouse NN B-Species
, , O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
surround VBP O
newly RB O
formed VBN O
sympathetic JJ O
ganglia NN O
and CC O
a DT O
small JJ O
number NN O
of IN O
TrkB NNP O
positive JJ O
cells NNS O
that WDT O
co VBP O
- HYPH O
express VBP O
tyrosine NN O
hydroxylase NN O
are VBP O
seen VBN O
within IN O
ganglia NN O
between IN O
E13 NNP O
. . O
5 CD O
- SYM O
15 CD O
. . O

In IN O
cell NN O
culture NN O
, , O
many JJ O
cells NNS O
from IN O
St NNP O
. . O

29 CD O
- SYM O
30 CD O
chicken NN B-Species
lumbar NN O
sympathetic JJ O
ganglia NN O
express VBP O
neural JJ O
markers NNS O
and CC O
are VBP O
dividing VBG O
, , O
indicating VBG O
that IN O
they PRP O
are VBP O
sympathoblasts NNS O
. . O

Sympathoblasts NNS O
and CC O
neurons NNS O
require VBP O
both CC O
nerve JJ O
growth NN O
factor NN O
and CC O
neurotrophin NN O
- HYPH O
3 CD O
for IN O
survival NN O
. . O

BDNF NNP O
increases VBZ O
the DT O
number NN O
of IN O
cells NNS O
expressing VBG O
neural JJ O
markers NNS O
in IN O
culture NN O
by IN O
increasing VBG O
number NN O
of IN O
cells NNS O
that WDT O
incorporate VBP O
bromodeoxyuridine NN O
. . O

In IN O
contrast NN O
, , O
most JJS O
TrkB NNP O
- HYPH O
positive JJ O
sympathetic JJ O
cells NNS O
in IN O
vivo NN O
are VBP O
not RB O
actively RB O
proliferating VBG O
between IN O
E6 NNP O
- HYPH O
E8 NNP O
. . O

Conclusion NN O

Developing VBG O
paravertebral JJ O
sympathetic JJ O
ganglia NN O
in IN O
avian JJ O
and CC O
murine JJ O
embryos NNS O
contain VBP O
a DT O
subpopulation NN O
of IN O
sympathoblasts NNS O
that WDT O
transiently RB O
express VBP O
TrkB NNP O
and CC O
ultimately RB O
commence VBP O
neuronal JJ O
differentiation NN O
. . O

These DT O
TrkB NNP O
expressing VBG O
sympathoblasts NNS O
are VBP O
not RB O
actively RB O
dividing VBG O
in IN O
vivo NN O
; : O
yet CC O
, , O
when WRB O
placed VBN O
in IN O
vitro NN O
, , O
will MD O
divide VB O
in IN O
response NN O
to IN O
BDNF NNP O
. . O

This DT O
suggests VBZ O
that IN O
the DT O
availability NN O
of IN O
BDNF NNP O
in IN O
vivo NN O
fails VBZ O
to TO O
reach VB O
a DT O
threshold NN O
necessary JJ O
to TO O
induce VB O
proliferation NN O
. . O

We PRP O
suggest VBP O
that IN O
excess JJ O
TrkB NN O
stimulation NN O
of IN O
sympathoblasts NNS O
in IN O
vivo NN O
may MD O
lead VB O
to IN O
the DT O
genesis NN O
of IN O
neuroblastoma NN O
. . O

Background NN O

Neural JJ O
crest NN O
cells NNS O
destined VBN O
to TO O
become VB O
paravertebral JJ O
sympathetic JJ O
neurons NNS O
proliferate VBP O
and CC O
differentiate VBP O
during IN O
migration NN O
and CC O
gangliogenesis NN O
. . O

In IN O
chicken NN B-Species
embryos NNS O
, , O
migrating VBG O
neural JJ O
crest NN O
cells NNS O
express VBP O
catecholamines NNS O
at IN O
Hamburger NNP O
/ SYM O
Hamilton NNP O
Stage NNP O
( , O
St NNP O
. . O
) -RRB- O
19 CD O
, , O
and CC O
these DT O
cells NNS O
form VBP O
the DT O
primary JJ O
sympathetic JJ O
chain NN O
dorsolateral NN O
to IN O
the DT O
aorta NN O
at IN O
St NNP O
. . O

22 CD O
( : O
E3 NNP O
. . O
5 CD O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Between IN O
St NNP O
. . O

23 CD O
( : O
E4 NNP O
) -RRB- O
and CC O
St NNP O
. . O

28 CD O
( , O
E6 NNP O
) -RRB- O
, , O
these DT O
cells NNS O
disperse VBP O
and CC O
undergo VBP O
a DT O
secondary JJ O
migration NN O
to TO O
form VB O
the DT O
paravertebral JJ O
sympathetic JJ O
chain NN O
that WDT O
resides VBZ O
ventral JJ O
to IN O
the DT O
spinal JJ O
cord NN O
and CC O
dorsal JJ O
root NN O
ganglion NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

After IN O
ganglia NN O
coalesce NN O
, , O
sympathoblasts NNS O
express VBP O
markers NNS O
of IN O
neuronal JJ O
differentiation NN O
, , O
such JJ O
as IN O
Q211 NN O
and CC O
tyrosine NN O
hydroxylase NN O
( -LRB- O
TH NN O
) -RRB- O
, , O
at IN O
a DT O
time NN O
when WRB O
they PRP O
also RB O
incorporate VBP O
[ -LRB- O
3H CD O
] -RRB- O
- HYPH O
thymidine NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Time NN O
lapse NN O
photography NN O
has VBZ O
shown VBN O
that IN O
cultured JJ O
E15 NN O
. . O
5 CD O
- SYM O
E16 CD O
. . O
5 CD O
sympathetic JJ O
neurons NNS O
from IN O
rat JJ B-Species
embryos NNS O
extend VBP O
axons NNS O
while IN O
they PRP O
divide VBP O
[ -LRB- O
3 CD O
- SYM O
5 CD O
] -RRB- O
. . O

Although IN O
proliferation NN O
appears VBZ O
to TO O
be VB O
an DT O
important JJ O
process NN O
to TO O
expand VB O
the DT O
sympathetic JJ O
neuron NN O
population NN O
during IN O
differentiation NN O
, , O
the DT O
mechanisms NNS O
that WDT O
guide VBP O
sympathoblast NN O
proliferation NN O
have VBP O
not RB O
been VBN O
identified VBN O
. . O

The DT O
development NN O
of IN O
sympathetic JJ O
neurons NNS O
is VBZ O
guided VBN O
by IN O
neurotrophins NNS O
. . O

Neurotrophin NNP O
- HYPH O
3 CD O
( , O
NT NNP O
- HYPH O
3 CD O
) -RRB- O
binds VBZ O
to IN O
its PRP$ O
receptor NN O
, , O
TrkC NNP O
, , O
to TO O
promote VB O
the DT O
survival NN O
of IN O
cultured VBN O
sympathoblasts NNS O
from IN O
early JJ O
lumbar NN O
paravertebral JJ O
ganglia NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Nerve JJ O
growth NN O
factor NN O
( , O
NGF NNP O
) -RRB- O
signals NNS O
through IN O
its PRP$ O
receptor NN O
, , O
TrkA NNP O
, , O
to TO O
promote VB O
the DT O
survival NN O
of IN O
sympathetic JJ O
neurons NNS O
upon IN O
target NN O
innervation NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

There EX O
are VBP O
severe JJ O
sympathetic JJ O
defects NNS O
in IN O
the DT O
superior JJ O
cervical JJ O
ganglion NN O
of IN O
individual JJ O
NT NNP O
- HYPH O
3 CD O
and CC O
NGF NNP O
knockout NN O
mice NNS B-Species
[ -LRB- O
8 CD O
- SYM O
10 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
there EX O
is VBZ O
no DT O
additional JJ O
cell NN O
death NN O
in IN O
the DT O
superior JJ O
cervical JJ O
ganglion NN O
of IN O
NT NNP O
- HYPH O
3 CD O
and CC O
NGF NNP O
double JJ O
knockout NN O
mouse NN B-Species
embryos NNS O
, , O
suggesting VBG O
that IN O
all DT O
of IN O
the DT O
neurons NNS O
are VBP O
dependent JJ O
on IN O
both DT O
neurotrophins NNS O
for IN O
survival NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

There EX O
is VBZ O
also RB O
an DT O
increase NN O
in IN O
sympathetic JJ O
neuron NN O
cell NN O
death NN O
in IN O
TrkA NNP O
knockout NN O
mice NNS B-Species
[ -LRB- O
12 CD O
] -RRB- O
. . O

However RB O
, , O
in IN O
TrkB NNP O
and CC O
BDNF NNP O
knockout NN O
mice NNS B-Species
, , O
there EX O
is VBZ O
no DT O
apparent JJ O
phenotype NN O
in IN O
the DT O
superior JJ O
cervical JJ O
ganglion NN O
, , O
and CC O
there EX O
is VBZ O
little JJ O
evidence NN O
that IN O
TrkB NNP O
or CC O
BDNF NNP O
is VBZ O
expressed VBN O
in IN O
sympathetic JJ O
ganglia NN O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
generally RB O
thought VBN O
that IN O
TrkB NNP O
and CC O
BDNF NNP O
have VBP O
little JJ O
or CC O
no DT O
roles NNS O
in IN O
guiding VBG O
the DT O
development NN O
of IN O
sympathetic JJ O
neurons NNS O
. . O

In IN O
addition NN O
to IN O
their PRP$ O
developmental JJ O
functions NNS O
, , O
neurotrophin NN O
receptors NNS O
regulate VBP O
cell NN O
behavior NN O
in IN O
neuroblastoma NN O
, , O
a DT O
tumor NN O
found VBN O
in IN O
sympathetic JJ O
ganglia NN O
and CC O
adrenal JJ O
medulla NN O
. . O

Tumors NNS O
that WDT O
express VBP O
TrkA NNP O
often RB O
spontaneously RB O
regress VBP O
, , O
while IN O
those DT O
that WDT O
express VBP O
TrkB NNP O
and CC O
its PRP$ O
ligand NN O
, , O
brain NN O
- HYPH O
derived VBN O
neurotrophic JJ O
factor NN O
( , O
BDNF NNP O
) -RRB- O
, , O
grow VBP O
aggressively RB O
, , O
are VBP O
invasive JJ O
, , O
and CC O
fail VBP O
to TO O
respond VB O
to IN O
chemotherapeutic JJ O
agents NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
presence NN O
of IN O
TrkA NNP O
in IN O
neuroblastoma NN O
tumors NNS O
is VBZ O
consistent JJ O
with IN O
its PRP$ O
expression NN O
in IN O
developing VBG O
sympathetic JJ O
neurons NNS O
, , O
and CC O
suggests VBZ O
that IN O
regressive JJ O
neuroblastoma NN O
tumors NNS O
arise VBP O
from IN O
early JJ O
sympathetic JJ O
neurons NNS O
that WDT O
express VBP O
TrkA NNP O
. . O

The DT O
function NN O
of IN O
TrkB NNP O
in IN O
early JJ O
sympathetic JJ O
development NN O
is VBZ O
unknown JJ O
, , O
which WDT O
makes VBZ O
understanding VBG O
the DT O
etiology NN O
of IN O
aggressive JJ O
neuroblastoma NN O
tumors NNS O
difficult JJ O
. . O

Based VBN O
on IN O
its PRP$ O
function NN O
in IN O
neuroblastoma NN O
tumors NNS O
, , O
we PRP O
hypothesize VBP O
that IN O
BDNF NNP O
and CC O
TrkB NNP O
expression NN O
in IN O
differentiating VBG O
sympathoblasts NNS O
is VBZ O
responsible JJ O
for IN O
expanding VBG O
the DT O
neuronal JJ O
population NN O
through IN O
proliferation NN O
. . O

We PRP O
sought VBD O
to TO O
determine VB O
whether IN O
BDNF NNP O
and CC O
TrkB NNP O
are VBP O
involved VBN O
in IN O
sympathetic JJ O
development NN O
. . O

We PRP O
report VBP O
that IN O
during IN O
early JJ O
embryonic JJ O
development NN O
, , O
TrkB NNP O
is VBZ O
expressed VBN O
in IN O
a DT O
subset NN O
of IN O
differentiating VBG O
sympathoblasts NNS O
in IN O
both CC O
avian JJ O
and CC O
murine JJ O
embryos NNS O
. . O

We PRP O
also RB O
find VBP O
that IN O
BDNF NNP O
promotes VBZ O
the DT O
proliferation NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
sympathoblasts NNS O
in IN O
cell NN O
culture NN O
. . O

However RB O
, , O
the DT O
majority NN O
of IN O
TrkB NNP O
positive JJ O
cells NNS O
in IN O
vivo NN O
fail VBP O
to TO O
take VB O
up RP O
bromodeoxyuridine NN O
( , O
BrdU NNP O
) -RRB- O
over IN O
a DT O
24 CD O
hr NN O
period NN O
, , O
suggesting VBG O
that IN O
endogenous JJ O
BDNF NNP O
concentrations NNS O
do VBP O
not RB O
reach VB O
a DT O
threshold NN O
necessary JJ O
to TO O
stimulate VB O
proliferation NN O
of IN O
sympathoblasts NNS O
. . O

Shortly RB O
after IN O
all DT O
of IN O
the DT O
TrkB NNP O
positive JJ O
cells NNS O
commence VBP O
neuronal JJ O
differentiation NN O
, , O
TrkB NNP O
immunoreactivity NN O
is VBZ O
lost VBN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
prolonged VBN O
expression NN O
and CC O
/ SYM O
or CC O
activation NN O
of IN O
TrkB NNP O
signaling NN O
at IN O
these DT O
early JJ O
stages NNS O
may MD O
be VB O
an DT O
early JJ O
event NN O
triggering VBG O
the DT O
formation NN O
of IN O
neuroblastoma NN O
. . O

Results NNS O

TrkB NNP O
is VBZ O
expressed VBN O
during IN O
migration NN O
of IN O
neural JJ O
crest NN O
cells NNS O
to IN O
sympathetic JJ O
ganglia NN O

We PRP O
first RB O
determined VBD O
whether IN O
TrkB NNP O
is VBZ O
expressed VBN O
in IN O
neural JJ O
crest NN O
- HYPH O
derived VBN O
cells NNS O
in IN O
the DT O
region NN O
ventral JJ O
to IN O
the DT O
spinal JJ O
cord NN O
and CC O
dorsal JJ O
root NN O
ganglia NN O
where WRB O
sympathetic JJ O
ganglia NN O
coalesce VBP O
between IN O
Hamburger NNP O
/ SYM O
Hamilton NNP O
Stages NNPS O
( : O
St NNP O
. . O
) SYM O
25 CD O
- SYM O
28 CD O
/ SYM O
29 CD O
. . O

To TO O
identify VB O
cells NNS O
that WDT O
have VBP O
commenced VBN O
neuronal JJ O
differentiation NN O
, , O
transverse JJ O
sections NNS O
of IN O
the DT O
lumbar JJ O
spinal JJ O
column NN O
region NN O
were VBD O
stained VBN O
with IN O
antibodies NNS O
against IN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
[ -LRB- O
14 CD O
] -RRB- O
, , O
a DT O
neuronal JJ O
- HYPH O
specific JJ O
RNA NN O
- HYPH O
binding VBG O
protein NN O
, , O
or CC O
Islet NNP O
- HYPH O
1 CD O
, , O
a DT O
transcription NN O
factor NN O
found VBN O
in IN O
sympathetic JJ O
neurons NNS O
[ -LRB- O
15 CD O
] -RRB- O
. . O

We PRP O
found VBD O
that IN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
and CC O
Islet NNP O
- HYPH O
1 CD O
are VBP O
expressed VBN O
in IN O
the DT O
same JJ O
cells NNS O
both CC O
in IN O
vivo NN O
and CC O
in IN O
vitro FW O
throughout IN O
sympathetic JJ O
development NN O
. . O

In IN O
experiments NNS O
done VBN O
between IN O
St NNP O
. . O

25 CD O
and CC O
28 CD O
, , O
Islet NNP O
- HYPH O
1 CD O
staining NN O
appeared VBD O
weaker JJR O
than IN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
staining NN O
, , O
and CC O
thus RB O
we PRP O
used VBD O
Hu NNP O
C NNP O
/ SYM O
D NNP O
to TO O
identify VB O
differentiating VBG O
neurons NNS O
at IN O
these DT O
stages NNS O
. . O

At IN O
later JJR O
stages NNS O
, , O
Islet NNP O
- HYPH O
1 CD O
was VBD O
used VBN O
to TO O
facilitate VB O
the DT O
identification NN O
of IN O
neurons NNS O
because IN O
of IN O
the DT O
nuclear JJ O
location NN O
of IN O
its PRP$ O
immunoreactivity NN O
. . O

Cells NNS O
expressing VBG O
Hu NNP O
C NNP O
/ SYM O
D NNP O
are VBP O
first RB O
detected VBN O
at IN O
St NNP O
. . O

25 CD O
ventral JJ O
to IN O
the DT O
spinal JJ O
cord NN O
and CC O
dorsal JJ O
root NN O
ganglion NN O
and CC O
lateral JJ O
to IN O
the DT O
dorsal JJ O
aorta NN O
( -LRB- O
Figure NNP O
1A NNP O
, , O
1B NN O
) -RRB- O
. . O

By IN O
St NNP O
. . O

26 CD O
, , O
the DT O
number NN O
of IN O
cells NNS O
that WDT O
express VBP O
Hu NNP O
C NNP O
/ SYM O
D NNP O
in IN O
this DT O
region NN O
increases VBZ O
dramatically RB O
( : O
Figure NNP O
1C NNP O
) -RRB- O
. . O

TrkB NNP O
- HYPH O
expressing VBG O
cells NNS O
first RB O
appear VBP O
at IN O
St NNP O
. . O

27 CD O
in IN O
the DT O
same JJ O
region NN O
and CC O
are VBP O
adjacent JJ O
to IN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
- HYPH O
positive JJ O
cells NNS O
( -LRB- O
Figure NNP O
1D NNP O
, , O
2A NNP O
, , O
2H CD O
) -RRB- O
. . O

TrkB NN O
- HYPH O
positive JJ O
cells NNS O
co NN O
- HYPH O
localize VBP O
with IN O
a DT O
neural JJ O
crest NN O
marker NN O
, , O
HNK NNP O
- HYPH O
1 CD O
( , O
Figures NNS O
2B NN O
, , O
2C NN O
, , O
2D CD O
) -RRB- O
. . O

The DT O
Hu NNP O
C NNP O
/ SYM O
D NN O
- HYPH O
positive JJ O
cells NNS O
in IN O
this DT O
region NN O
are VBP O
likely JJ O
to TO O
be VB O
sympathetic JJ O
neurons NNS O
, , O
since IN O
they PRP O
appear VBP O
in IN O
the DT O
region NN O
where WRB O
sympathetic JJ O
ganglia NN O
form NN O
and CC O
express VBP O
tyrosine NN O
hydroxylase NN O
, , O
a DT O
rate NN O
- HYPH O
limiting VBG O
enzyme NN O
in IN O
the DT O
synthesis NN O
of IN O
catecholamines NNS O
( -LRB- O
Figures NNS O
2E CD O
, , O
2F CD O
, , O
2G NNP O
) -RRB- O
. . O

At IN O
St NNP O
. . O

28 CD O
/ SYM O
29 CD O
, , O
the DT O
cells NNS O
begin VBP O
to TO O
coalesce VB O
ventral JJ O
to IN O
the DT O
dorsal JJ O
root NN O
ganglion NN O
and CC O
the DT O
Hu NNP O
C NNP O
/ SYM O
D NN O
- HYPH O
positive JJ O
cells NNS O
and CC O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
remain VBP O
as IN O
two CD O
separate JJ O
cell NN O
populations NNS O
( -LRB- O
Figure NNP O
1E CD O
) -RRB- O
; : O
however RB O
, , O
shortly RB O
afterwards RB O
, , O
all DT O
of IN O
the DT O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
begin VBP O
to TO O
express VB O
Islet NNP O
- HYPH O
1 CD O
( HYPH O
Figure NNP O
3B NNP O
) -RRB- O
and CC O
Hu NNP O
C NNP O
/ SYM O
D NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Developmental JJ O
regulation NN O
of IN O
TrkA NNP O
, , O
TrkB NNP O
, , O
TrkC NNP O
, , O
and CC O
BDNF NNP O
expression NN O

In IN O
contrast NN O
to IN O
TrkB NNP O
, , O
the DT O
other JJ O
neurotrophin NN O
receptors NNS O
, , O
TrkA NNP O
and CC O
TrkC NNP O
, , O
are VBP O
co NN O
- HYPH O
expressed VBN O
in IN O
both CC O
Hu NNP O
C NNP O
/ SYM O
D NNP O
- HYPH O
positive JJ O
and CC O
Hu NNP O
C NNP O
/ SYM O
D NNP O
- HYPH O
negative JJ O
cells NNS O
at IN O
St NNP O
. . O

27 CD O
( HYPH O
Figures NNS O
2I CD O
, , O
2J CD O
) -RRB- O
. . O

We PRP O
find VBP O
that IN O
approximately RB O
30 CD O
% NN O
of IN O
the DT O
Islet NNP O
- HYPH O
1 CD O
- HYPH O
positive JJ O
cells NNS O
express VBP O
TrkA NNP O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
, , O
while IN O
50 CD O
% NN O
express VBP O
TrkB NNP O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
and CC O
100 CD O
% NN O
express JJ O
TrkC NNP O
( -LRB- O
Figure NNP O
3C NNP O
) -RRB- O
at IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( : O
E6 NNP O
. . O
5 CD O
) -RRB- O
. . O

Thus RB O
, , O
all DT O
developing VBG O
neurons NNS O
express VBP O
TrkC NNP O
in IN O
combination NN O
with IN O
either CC O
TrkA NNP O
or CC O
TrkB NNP O
. . O

By IN O
St NNP O
. . O

31 CD O
( SYM O
E7 CD O
) -RRB- O
, , O
the DT O
number NN O
of IN O
TrkA NNP O
- HYPH O
positive JJ O
, , O
Islet NNP O
- HYPH O
1 CD O
- HYPH O
positive JJ O
cells NNS O
increases VBZ O
to IN O
100 CD O
% NN O
( -LRB- O
Figure NNP O
3D NN O
) -RRB- O
and CC O
immunoreactivities NNS O
for IN O
both DT O
TrkB NNP O
and CC O
TrkC NNP O
appear VBP O
dispersed VBN O
( -LRB- O
Figure NNP O
3E CD O
, , O
3F CD O
) -RRB- O
. . O

By IN O
St NNP O
. . O

34 CD O
( : O
E8 NNP O
) -RRB- O
, , O
TrkA NNP O
expression NN O
is VBZ O
well RB O
- HYPH O
sustained VBN O
( : O
Figure NNP O
3G NNP O
) -RRB- O
and CC O
TrkB NNP O
and CC O
TrkC NNP O
immunoreactivities NNS O
are VBP O
lost VBN O
( -LRB- O
Figure NNP O
3H CD O
, , O
3I CD O
) -RRB- O
. . O

We PRP O
also RB O
examined VBD O
the DT O
early JJ O
development NN O
of IN O
murine NN O
sympathetic JJ O
ganglia NN O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
. . O

At IN O
E13 CD O
, , O
the DT O
newly RB O
formed VBN O
lumbar NN O
sympathetic JJ O
ganglia NN O
can MD O
be VB O
observed VBN O
ventral JJ O
to IN O
the DT O
spinal JJ O
cord NN O
and CC O
notochord NN O
by IN O
their PRP$ O
staining NN O
for IN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
and CC O
TH NNP O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

TrkB NN O
- HYPH O
positive JJ O
cells NNS O
can MD O
be VB O
seen VBN O
surrounding VBG O
developing VBG O
ganglia NN O
, , O
as RB O
well RB O
as IN O
in IN O
occasional JJ O
cells NNS O
within IN O
the DT O
ganglia NN O
( -LRB- O
Figure NNP O
4C NNP O
, , O
D NNP O
) -RRB- O
. . O

These DT O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
within IN O
the DT O
ganglia NN O
co NN O
- HYPH O
express VBP O
TH NNP O
and CC O
are VBP O
seen VBN O
at IN O
a DT O
frequency NN O
of IN O
1 CD O
- HYPH O
2 CD O
cells NNS O
per IN O
section NN O
starting VBG O
at IN O
E13 NNP O
( -LRB- O
Figure NNP O
4A NN O
- HYPH O
D NN O
) -RRB- O
and CC O
are VBP O
still RB O
present JJ O
at IN O
E15 CD O
. . O
5 CD O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

In IN O
neuroblastoma NN O
cells NNS O
, , O
BDNF NNP O
is VBZ O
co NN O
- HYPH O
expressed VBN O
with IN O
TrkB NNP O
, , O
suggesting VBG O
that IN O
autocrine NN O
stimulation NN O
is VBZ O
a DT O
means NN O
by IN O
which WDT O
proliferation NN O
is VBZ O
sustained VBN O
in IN O
the DT O
transformed VBN O
cells NNS O
. . O

To TO O
test VB O
whether IN O
BDNF NNP O
, , O
the DT O
ligand NN O
for IN O
TrkB NNP O
, , O
was VBD O
present JJ O
in IN O
embryonic JJ O
chick NN B-Species
sympathetic JJ O
ganglia NN O
, , O
we PRP O
used VBD O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NNP O
with IN O
TaqMan NNP O
probes NNS O
to TO O
determine VB O
the DT O
relative JJ O
abundance NN O
of IN O
BDNF NNP O
transcripts NNS O
in IN O
total JJ O
RNA NNP O
extracted VBN O
from IN O
lumbar NN O
sympathetic JJ O
ganglia NN O
at IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( : O
E6 NNP O
. . O
5 CD O
) -RRB- O
, , O
St NNP O
. . O

31 CD O
( : O
E7 NNP O
) -RRB- O
, , O
St NNP O
. . O

34 CD O
( SYM O
E8 NNP O
) -RRB- O
, , O
and CC O
E9 NNP O
. . O

BDNF NNP O
expression NN O
within IN O
the DT O
ganglia NN O
parallels VBZ O
that DT O
of IN O
TrkB NNP O
: : O
BDNF NNP O
mRNA NNP O
expression NN O
levels NNS O
are VBP O
highest JJS O
at IN O
St NNP O
29 CD O
/ SYM O
30 CD O
( , O
E6 CD O
. . O
5 CD O
) -RRB- O
, , O
and CC O
these DT O
levels NNS O
decrease VBP O
2 CD O
- HYPH O
fold NN O
at IN O
St NNP O
. . O

31 CD O
( : O
E7 NNP O
) -RRB- O
and CC O
St NNP O
. . O

34 CD O
( : O
E8 NNP O
; : O
Figure NN O
5 CD O
) -RRB- O
. . O

By IN O
E9 NNP O
, , O
BDNF NNP O
levels NNS O
are VBP O
7 CD O
times NNS O
lower JJR O
than IN O
at IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( : O
E6 NNP O
. . O
5 CD O
; : O
Figure NN O
5 CD O
) -RRB- O
. . O

NT3 NNP O
and CC O
NGF NNP O
promote VBP O
survival NN O
of IN O
differentiating VBG O
sympathetic JJ O
neurons NNS O
in IN O
culture NN O

To TO O
determine VB O
the DT O
effect NN O
of IN O
neurotrophins NNS O
, , O
we PRP O
cultured VBD O
cells NNS O
dispersed VBN O
from IN O
lumbar JJ O
sympathetic JJ O
ganglia NN O
at IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( : O
E6 NNP O
. . O
5 CD O
) -RRB- O
because IN O
, , O
at IN O
this DT O
stage NN O
, , O
ganglion NN O
formation NN O
is VBZ O
complete JJ O
, , O
the DT O
number NN O
of IN O
TrkA NNP O
- HYPH O
, , O
TrkB NNP O
- HYPH O
, , O
and CC O
TrkC NNP O
- HYPH O
positive JJ O
cells NNS O
have VBP O
peaked VBN O
, , O
and CC O
all DT O
Trk NNP O
- HYPH O
expressing VBG O
cells NNS O
have VBP O
initiated VBN O
neural JJ O
differentiation NN O
. . O

First RB O
, , O
we PRP O
identified VBD O
markers NNS O
expressed VBN O
by IN O
acutely RB O
isolated VBN O
cells NNS O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
1 CD O
, , O
80 CD O
- SYM O
91 CD O
% NN O
of IN O
the DT O
cells NNS O
are VBP O
p75 NN O
neurotrophin NN O
receptor NN O
( -LRB- O
NTR NNP O
) -RRB- O
- HYPH O
positive JJ O
, , O
indicating VBG O
that IN O
most JJS O
of IN O
the DT O
cells NNS O
are VBP O
neural JJ O
crest NN O
- HYPH O
derived VBN O
and CC O
little JJ O
mesenchymal JJ O
contamination NN O
is VBZ O
introduced VBN O
by IN O
the DT O
isolation NN O
procedure NN O
. . O

In IN O
addition NN O
, , O
28 CD O
- SYM O
33 CD O
% NN O
of IN O
the DT O
cultured JJ O
cells NNS O
express VBP O
the DT O
neural JJ O
marker NN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
. . O

Approximately RB O
half NN O
of IN O
these DT O
Hu NNP O
C NNP O
/ SYM O
D NNP O
- HYPH O
positive JJ O
cells NNS O
express VBP O
TrkB NNP O
. . O

Conversely RB O
, , O
all DT O
of IN O
the DT O
TrkB NNP O
positive JJ O
cells NNS O
express VBP O
Hu NNP O
C NNP O
/ SYM O
D NNP O
. . O

These DT O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
comprise VBP O
approximately RB O
14 CD O
- SYM O
17 CD O
% NN O
of IN O
the DT O
total JJ O
cell NN O
population NN O
. . O

We PRP O
then RB O
determined VBD O
how WRB O
many JJ O
of IN O
the DT O
acutely RB O
isolated VBN O
cells NNS O
were VBD O
proliferating VBG O
by IN O
incubating VBG O
them PRP O
for IN O
12 CD O
hrs NNS O
in IN O
BrdU NNP O
- HYPH O
containing VBG O
medium NN O
. . O

For IN O
these DT O
experiments NNS O
, , O
we PRP O
identified VBD O
differentiating VBG O
neurons NNS O
with IN O
the DT O
transcription NN O
factor NN O
Islet NNP O
- HYPH O
1 CD O
because IN O
this DT O
marker NN O
labels VBZ O
nuclei NNS O
, , O
thus RB O
it PRP O
co VBZ O
localizes VBZ O
with IN O
any DT O
BrdU NNP O
that WDT O
has VBZ O
been VBN O
incorporated VBN O
into IN O
the DT O
DNA NN O
, , O
allowing VBG O
us PRP O
to TO O
determine VB O
whether IN O
the DT O
cell NN O
had VBD O
undergone VBN O
S NN O
- HYPH O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
. . O

After IN O
12 CD O
hrs NNS O
in IN O
BrdU NNP O
, , O
59 CD O
% NN O
of IN O
Islet NNP O
- HYPH O
1 CD O
- HYPH O
positive JJ O
nuclei NNS O
stain NN O
for IN O
BrdU NNP O
immunoreactivity NN O
. . O

Thus RB O
, , O
cultures NNS O
of IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
sympathetic JJ O
ganglia NN O
contain VBP O
many JJ O
cells NNS O
that WDT O
proliferate VBP O
while IN O
exhibiting VBG O
markers NNS O
of IN O
neuronal JJ O
differentiation NN O
, , O
confirming VBG O
previous JJ O
observations NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

We PRP O
call VBP O
these DT O
dividing VBG O
neuronal JJ O
precursors NNS O
sympathoblasts NNS O
. . O

The DT O
remaining VBG O
non AFX O
- HYPH O
BrdU NNP O
incorporating VBG O
, , O
Islet NNP O
- HYPH O
1 CD O
positive JJ O
cells NNS O
are VBP O
likely JJ O
to TO O
be VB O
post NN O
mitotic JJ O
neurons NNS O
. . O

Finally RB O
, , O
we PRP O
determined VBD O
the DT O
trophic JJ O
requirements NNS O
of IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( , O
E6 NNP O
. . O
5 CD O
) -RRB- O
sympathetic JJ O
neurons NNS O
and CC O
sympathoblasts NNS O
. . O

We PRP O
monitored VBD O
cultures NNS O
over IN O
a DT O
three CD O
day NN O
period NN O
after IN O
plating VBG O
and CC O
counted VBD O
the DT O
number NN O
of IN O
phase NN O
bright JJ O
cells NNS O
with IN O
neurites NNS O
, , O
a DT O
morphological JJ O
feature NN O
of IN O
both DT O
neurons NNS O
and CC O
sympathoblasts NNS O
. . O

In IN O
the DT O
absence NN O
of IN O
trophic JJ O
factors NNS O
, , O
more JJR O
than IN O
2 CD O
/ SYM O
3 CD O
of IN O
the DT O
cells NNS O
die VBP O
by IN O
24 CD O
hours NNS O
in IN O
culture NN O
and CC O
BDNF NNP O
, , O
NT NNP O
- HYPH O
3 CD O
, , O
or CC O
NGF NNP O
alone RB O
is VBZ O
not RB O
sufficient JJ O
to TO O
promote VB O
survival NN O
( : O
Figure NN O
6 CD O
) -RRB- O
. . O

However RB O
, , O
NGF NNP O
together RB O
with IN O
NT NNP O
- HYPH O
3 CD O
supports VBZ O
the DT O
survival NN O
of IN O
a DT O
significantly RB O
larger JJR O
number NN O
of IN O
cells NNS O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

For IN O
the DT O
subsequent JJ O
experiments NNS O
, , O
all DT O
neurons NNS O
were VBD O
cultured VBN O
with IN O
25 CD O
ng CD O
/ SYM O
ml NN O
NT NNP O
- HYPH O
3 CD O
and CC O
1 CD O
mu NN O
g NN O
/ SYM O
ml NN O
7S NN O
NGF NNP O
to TO O
optimize VB O
survival NN O
. . O

BDNF NNP O
promotes VBZ O
proliferation NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
sympathetic JJ O
neurons NNS O
in IN O
culture NN O

To TO O
determine VB O
the DT O
effects NNS O
of IN O
BDNF NNP O
, , O
cultures NNS O
of IN O
cells NNS O
from IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( SYM O
E6 CD O
. . O
5 CD O
) -RRB- O
sympathetic JJ O
ganglia NN O
were VBD O
supplemented VBN O
with IN O
200 CD O
ng NNS O
/ SYM O
ml NNP O
BDNF NNP O
and CC O
the DT O
number NN O
of IN O
neurons NNS O
and CC O
sympathoblasts NNS O
were VBD O
counted VBN O
at IN O
24 CD O
, , O
48 CD O
, , O
and CC O
72 CD O
hours NNS O
using VBG O
phase NN O
microscopy NN O
( -LRB- O
Figure NNP O
7A NNP O
) -RRB- O
. . O

A DT O
1 CD O
. . O
6 CD O
- HYPH O
fold NN O
increase NN O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
due IN O
to IN O
BDNF NNP O
is VBZ O
observed VBN O
by IN O
24 CD O
hours NNS O
and CC O
this DT O
number NN O
does VBZ O
not RB O
increase VB O
further RBR O
at IN O
48 CD O
or CC O
72 CD O
hours NNS O
. . O

This DT O
effect NN O
of IN O
BDNF NNP O
is VBZ O
concentration NN O
- HYPH O
dependent JJ O
with IN O
an DT O
EC50 NN O
of IN O
75 CD O
ng CD O
/ SYM O
ml NNS O
( -LRB- O
Figure NNP O
7B NN O
) -RRB- O
. . O

To TO O
test VB O
whether IN O
the DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
and CC O
sympathoblasts NNS O
caused VBN O
by IN O
BDNF NNP O
is VBZ O
due JJ O
to IN O
the DT O
differentiation NN O
of IN O
pluripotent JJ O
neural JJ O
crest NN O
cells NNS O
, , O
we PRP O
quantified VBD O
the DT O
effects NNS O
of IN O
BDNF NNP O
on IN O
the DT O
number NN O
of IN O
neurally RB O
differentiating VBG O
cells NNS O
( , O
Hu NNP O
C NNP O
/ SYM O
D NNP O
- HYPH O
positive JJ O
) -RRB- O
versus IN O
the DT O
number NN O
of IN O
non JJ O
- HYPH O
neuronal JJ O
cells NNS O
( , O
Hu NNP O
C NNP O
/ SYM O
D NN O
- HYPH O
negative JJ O
) -RRB- O
after IN O
identifying VBG O
all DT O
neural JJ O
crest NN O
- HYPH O
derived VBN O
cells NNS O
by IN O
staining VBG O
for IN O
p75NTR NN O
in IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( SYM O
E6 CD O
. . O
5 CD O
) -RRB- O
cultures NNS O
. . O

If IN O
BDNF NNP O
increases VBZ O
the DT O
number NN O
of IN O
neurons NNS O
and CC O
sympathoblasts NNS O
by IN O
inducing VBG O
a DT O
non AFX O
- HYPH O
neuronal JJ O
cell NN O
to TO O
express VB O
Hu NNP O
C NNP O
/ SYM O
D NNP O
, , O
then RB O
we PRP O
expected VBD O
that IN O
the DT O
total JJ O
cell NN O
number NN O
would MD O
remain VB O
the DT O
same JJ O
and CC O
that IN O
there EX O
would MD O
be VB O
a DT O
decrease NN O
in IN O
the DT O
number NN O
of IN O
non JJ O
- HYPH O
neuronal JJ O
cells NNS O
as RB O
well RB O
as IN O
a DT O
corresponding VBG O
increase NN O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
. . O

After IN O
24 CD O
hours NNS O
, , O
BDNF NNP O
significantly RB O
increases VBZ O
the DT O
number NN O
of IN O
p75NTR NN O
- HYPH O
positive JJ O
cells NNS O
as RB O
well RB O
as IN O
the DT O
number NN O
of IN O
Hu NNP O
C NNP O
/ SYM O
D NNP O
- HYPH O
positive JJ O
cells NNS O
( -LRB- O
Figure NNP O
8A NNP O
) -RRB- O
. . O

However RB O
, , O
there EX O
was VBD O
no DT O
statistically RB O
significant JJ O
change NN O
in IN O
the DT O
number NN O
of IN O
non JJ O
- HYPH O
neuronal JJ O
cells NNS O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
unlikely JJ O
that IN O
BDNF NNP O
increases VBZ O
the DT O
number NN O
of IN O
neurons NNS O
and CC O
sympathoblasts NNS O
by IN O
inducing VBG O
differentiation NN O
of IN O
non JJ O
- HYPH O
neuronal JJ O
cells NNS O
. . O

To TO O
determine VB O
whether IN O
the DT O
increase NN O
in IN O
the DT O
total JJ O
number NN O
of IN O
neurons NNS O
and CC O
sympathoblasts NNS O
is VBZ O
caused VBN O
by IN O
BDNF NNP O
- HYPH O
induced VBN O
proliferation NN O
, , O
control NN O
and CC O
BDNF NNP O
- HYPH O
treated VBN O
sympathetic JJ O
cultures NNS O
were VBD O
exposed VBN O
to IN O
BrdU NNP O
for IN O
12 CD O
hours NNS O
after IN O
plating NN O
, , O
and CC O
the DT O
number NN O
of IN O
cells NNS O
that WDT O
incorporated VBD O
BrdU NNP O
into IN O
their PRP$ O
DNA NNP O
was VBD O
determined VBN O
after IN O
24 CD O
hours NNS O
in IN O
culture NN O
. . O

Even RB O
in IN O
the DT O
control NN O
condition NN O
, , O
a DT O
number NN O
of IN O
cells NNS O
in IN O
the DT O
culture NN O
are VBP O
dividing VBG O
, , O
giving VBG O
a DT O
high JJ O
baseline NN O
of IN O
BrdU NNP O
incorporation NN O
( -LRB- O
Figure NNP O
8B NNP O
) -RRB- O
. . O

When WRB O
BDNF NNP O
is VBZ O
added VBN O
, , O
the DT O
total JJ O
number NN O
of IN O
BrdU NNP O
positive JJ O
cells NNS O
increases VBZ O
approximately RB O
1 CD O
. . O
6 CD O
- HYPH O
fold NN O
( -LRB- O
Figure NN O
8B NN O
) -RRB- O
. . O

This DT O
BDNF NNP O
- HYPH O
induced VBN O
increase NN O
in IN O
the DT O
total JJ O
number NN O
of IN O
BrdU NNP O
positive JJ O
cells NNS O
occurs VBZ O
in IN O
sympathoblasts NNS O
because IN O
the DT O
number NN O
of IN O
Islet NNP O
- HYPH O
1 CD O
- HYPH O
positive JJ O
nuclei NNS O
from IN O
control NN O
cultures NNS O
that WDT O
label VBP O
with IN O
BrdU NNP O
is VBZ O
268 CD O
+ SYM O
/ SYM O
- HYPH O
59 CD O
and CC O
BDNF NNP O
treatment NN O
raises VBZ O
this DT O
number NN O
to IN O
424 CD O
+ SYM O
/ SYM O
- HYPH O
80 CD O
, , O
which WDT O
corresponds VBZ O
to IN O
an DT O
increase NN O
of IN O
1 CD O
. . O
6 CD O
- HYPH O
fold NN O
. . O

This DT O
accounts VBZ O
for IN O
the DT O
1 CD O
. . O
6 CD O
- HYPH O
fold NN O
increase NN O
in IN O
total JJ O
neuron NN O
number NN O
and CC O
total JJ O
BrdU NNP O
- HYPH O
positive JJ O
cells NNS O
described VBN O
above RB O
. . O

We PRP O
then RB O
confirmed VBD O
that IN O
BDNF NNP O
acts VBZ O
on IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
: : O
BDNF NNP O
increases VBZ O
the DT O
number NN O
of IN O
TrkB NNP O
- HYPH O
expressing VBG O
cells NNS O
that WDT O
incorporate VBP O
BrdU NNP O
2 CD O
. . O
6 CD O
- SYM O
4 CD O
- HYPH O
fold NN O
over IN O
control NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
and CC O
it PRP O
also RB O
increases VBZ O
the DT O
overall JJ O
number NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
2 CD O
- SYM O
2 CD O
. . O
5 CD O
- HYPH O
fold NN O
over IN O
control NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

BDNF NNP O
does VBZ O
not RB O
increase VB O
the DT O
number NN O
of IN O
BrdU NNP O
- HYPH O
positive JJ O
, , O
TrkB NNP O
- HYPH O
negative JJ O
cells NNS O
or CC O
the DT O
overall JJ O
number NN O
of IN O
TrkB NNP O
- HYPH O
negative JJ O
cells NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

In IN O
further JJ O
support NN O
that IN O
BDNF NNP O
acts VBZ O
directly RB O
on IN O
TrkB NNP O
- HYPH O
expressing VBG O
cells NNS O
, , O
an DT O
antibody NN O
directed VBN O
against IN O
the DT O
extracellular JJ O
domain NN O
of IN O
TrkB NNP O
completely RB O
prevents VBZ O
the DT O
effect NN O
of IN O
BDNF NNP O
in IN O
promoting VBG O
proliferation NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
, , O
but CC O
not RB O
TrkB NNP O
- HYPH O
negative JJ O
cells NNS O
( -LRB- O
compare VBP O
Figure NN O
9A NN O
to IN O
9B NN O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
effect NN O
of IN O
BDNF NNP O
is VBZ O
restricted VBN O
to IN O
the DT O
population NN O
that WDT O
expresses VBZ O
TrkB NNP O
, , O
which WDT O
are VBP O
developing VBG O
sympathoblasts NNS O
. . O

To TO O
determine VB O
whether IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
are VBP O
actively RB O
proliferating VBG O
in IN O
vivo NN O
, , O
embryos NNS O
were VBD O
injected VBN O
with IN O
BrdU NNP O
at IN O
St NNP O
. . O

27 CD O
and CC O
harvested VBD O
at IN O
St NNP O
. . O

29 CD O
, , O
approximately RB O
24 CD O
hrs NNS O
later RB O
. . O

The DT O
majority NN O
( : O
85 CD O
- SYM O
90 CD O
% NN O
) -RRB- O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
do VBP O
not RB O
incorporate VB O
BrdU NNP O
into IN O
their PRP$ O
nuclei NNS O
under IN O
basal JJ O
conditions NNS O
in IN O
vivo NN O
( -LRB- O
Figure NNP O
10 CD O
) -RRB- O
, , O
although IN O
a DT O
few JJ O
TrkB NNP O
positive JJ O
cells NNS O
with IN O
labeled VBN O
nuclei NNS O
could MD O
be VB O
observed VBN O
( , O
arrows NNS O
) -RRB- O
. . O

This DT O
contrasts VBZ O
with IN O
our PRP$ O
observation NN O
that IN O
71 CD O
- SYM O
76 CD O
% NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
incorporate VBP O
BrdU NNP O
in IN O
culture NN O
after IN O
treatment NN O
with IN O
BDNF NNP O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
, , O
suggesting VBG O
that IN O
endogenous JJ O
BDNF NNP O
does VBZ O
not RB O
achieve VB O
a DT O
threshold NN O
sufficient JJ O
to TO O
support VB O
a DT O
high JJ O
level NN O
of IN O
sympathoblast NN O
proliferation NN O
in IN O
vivo NN O
. . O

Discussion NN O

We PRP O
report VBP O
that IN O
the DT O
neurotrophin NN O
receptor NN O
TrkB NNP O
is VBZ O
expressed VBN O
in IN O
a DT O
subset NN O
of IN O
embryonic JJ O
sympathoblasts NNS O
during IN O
the DT O
early JJ O
development NN O
of IN O
lumbar NN O
paravertebral JJ O
sympathetic JJ O
ganglia NN O
in IN O
chicken NN B-Species
and CC O
mouse NN B-Species
embryos NNS O
. . O

In IN O
the DT O
chicken NN B-Species
, , O
TrkB NNP O
expression NN O
is VBZ O
transient JJ O
, , O
and CC O
completely RB O
lost VBN O
by IN O
St NNP O
34 CD O
( , O
E8 NNP O
) -RRB- O
. . O

Since IN O
BDNF NNP O
induces VBZ O
the DT O
proliferation NN O
of IN O
sympathoblasts NNS O
in IN O
cell NN O
culture NN O
, , O
yet CC O
in IN O
vivo NN O
there EX O
is VBZ O
little JJ O
proliferation NN O
observed VBN O
in IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
in IN O
nascent JJ O
ganglia NN O
, , O
we PRP O
propose VBP O
that IN O
if IN O
TrkB NNP O
activation NN O
becomes VBZ O
unregulated JJ O
by IN O
excess JJ O
BDNF NNP O
or CC O
constitutive JJ O
phosphorylation NN O
of IN O
TrkB NNP O
[ -LRB- O
16 CD O
] -RRB- O
, , O
this DT O
transient JJ O
population NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
sympathoblasts NNS O
may MD O
trigger VB O
the DT O
genesis NN O
of IN O
neuroblastoma NN O
, , O
a DT O
childhood NN O
tumor NN O
found VBN O
in IN O
the DT O
paravertebral JJ O
chain NN O
and CC O
adrenal JJ O
medulla NN O
. . O

The DT O
two CD O
populations NNS O
of IN O
sympathoblasts NNS O
that WDT O
we PRP O
observe VBP O
support VBP O
previous JJ O
findings NNS O
of IN O
heterogeneity NN O
among IN O
developing VBG O
sympathetic JJ O
neurons NNS O
and CC O
neural JJ O
crest NN O
cells NNS O
. . O

Early RB O
sympathetic JJ O
ganglia NN O
contain VBP O
at IN O
least JJS O
two CD O
subpopulations NNS O
: : O
early JJ O
differentiating VBG O
neurons NNS O
that WDT O
lack VBP O
TrkB NNP O
expression NN O
and CC O
express VBP O
TrkA NNP O
and CC O
TrkC NNP O
, , O
and CC O
late RB O
differentiating VBG O
sympathoblasts NNS O
that WDT O
express VBP O
TrkB NNP O
. . O

Explant NN O
cultures NNS O
of IN O
sympathetic JJ O
ganglia NN O
from IN O
E16 NNP O
chick NN B-Species
embryos NNS O
give VBP O
rise NN O
to IN O
two CD O
neuronal JJ O
populations NNS O
: : O
one CD O
that WDT O
remains VBZ O
close JJ O
to IN O
the DT O
explant NN O
, , O
and CC O
one CD O
that WDT O
migrates VBZ O
away RB O
from IN O
the DT O
explant NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
early JJ O
neuronal JJ O
subpopulations NNS O
have VBP O
been VBN O
observed VBN O
in IN O
cultures NNS O
of IN O
neural JJ O
crest NN O
cells NNS O
from IN O
St NNP O
. . O

13 CD O
/ SYM O
14 CD O
quail NN O
embryos NNS O
as IN O
evidenced VBN O
by IN O
the DT O
expression NN O
of IN O
neuronal JJ O
cell NN O
type NN O
- HYPH O
specific JJ O
gangliosides NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Perhaps RB O
these DT O
different JJ O
subpopulations NNS O
will MD O
ultimately RB O
give VB O
rise NN O
to IN O
the DT O
two CD O
neurochemically RB O
distinct JJ O
populations NNS O
found VBN O
in IN O
lumbar JJ O
sympathetic JJ O
ganglia NN O
: : O
the DT O
noradrenergic JJ O
, , O
NPY NNP O
- HYPH O
containing VBG O
neurons NNS O
that WDT O
innervate VBP O
internal JJ O
organs NNS O
and CC O
enteric JJ O
ganglia NN O
and CC O
the DT O
cholinergic JJ O
, , O
VIP NN O
- HYPH O
containing VBG O
neurons NNS O
that WDT O
innervate VBP O
vasculature NN O
in IN O
the DT O
hind NN O
limbs NNS O
. . O

The DT O
effects NNS O
of IN O
BDNF NNP O
and CC O
TrkB NNP O
deletion NN O
and CC O
over IN O
expression NN O
have VBP O
been VBN O
studied VBN O
on IN O
superior JJ O
cervical JJ O
ganglion NN O
and CC O
preganglionic JJ O
neurons NNS O
in IN O
thoracic JJ O
segments NNS O
of IN O
the DT O
spinal JJ O
column NN O
, , O
but CC O
not RB O
on IN O
paravertebral JJ O
sympathetic JJ O
neurons NNS O
. . O

In IN O
the DT O
superior JJ O
cervical JJ O
ganglion NN O
, , O
an DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
of IN O
BDNF NNP O
null JJ O
mice NN B-Species
is VBZ O
likely JJ O
due JJ O
to IN O
apoptosis NN O
induced VBN O
by IN O
BDNF NNP O
via IN O
p75NTR NNP O
[ -LRB- O
18 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
responses NNS O
of IN O
paravertebral JJ O
sympathetic JJ O
neurons NNS O
to IN O
BDNF NNP O
are VBP O
complex JJ O
and CC O
subtype NN O
dependent JJ O
. . O

Over IN O
expression NN O
of IN O
BDNF NNP O
leads VBZ O
to IN O
an DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
noradrenergic JJ O
fibers NNS O
innervating VBG O
the DT O
erector NN O
pilli NN O
muscles NNS O
of IN O
hair NN O
follicles NNS O
, , O
while IN O
noradrenergic JJ O
fibers NNS O
innervating VBG O
blood NN O
vessels NNS O
were VBD O
unaffected JJ O
[ -LRB- O
19 CD O
] -RRB- O
. . O

If IN O
our PRP$ O
results NNS O
indicating VBG O
that IN O
BDNF NNP O
promotes VBZ O
proliferation NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
sympathoblasts NNS O
in IN O
the DT O
chicken NN B-Species
embryo NN O
can MD O
be VB O
extrapolated VBN O
to IN O
the DT O
subset NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
sympathoblasts NNS O
in IN O
murine NN O
ganglia NN O
, , O
then RB O
these DT O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
may MD O
be VB O
neurons NNS O
destined VBN O
to TO O
innervate VB O
the DT O
erector NN O
pilli NN O
. . O

In IN O
other JJ O
studies NNS O
, , O
TrkB NNP O
null NN O
mice NN B-Species
showed VBD O
no DT O
changes NNS O
in IN O
morphology NN O
or CC O
cell NN O
number NN O
in IN O
superior JJ O
cervical JJ O
ganglia NN O
[ -LRB- O
12 CD O
] -RRB- O
or CC O
in IN O
the DT O
intermediolateral JJ O
column NN O
[ -LRB- O
20 CD O
] -RRB- O
; , O
but CC O
this DT O
may MD O
not RB O
be VB O
predictive JJ O
of IN O
a DT O
phenotype NN O
in IN O
the DT O
lumbar JJ O
paravertebral JJ O
chain NN O
. . O

It PRP O
is VBZ O
thus RB O
possible JJ O
that IN O
BDNF NNP O
/ SYM O
TrkB NNP O
signaling NN O
could MD O
play VB O
a DT O
specific JJ O
role NN O
in IN O
other JJ O
regions NNS O
of IN O
the DT O
paravertebral JJ O
sympathetic JJ O
chain NN O
, , O
such JJ O
as IN O
the DT O
lumbar JJ O
region NN O
. . O

However RB O
, , O
if IN O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
are VBP O
not RB O
normally RB O
actively RB O
proliferating VBG O
in IN O
vivo NN O
, , O
then RB O
it PRP O
would MD O
not RB O
be VB O
surprising JJ O
that IN O
the DT O
development NN O
of IN O
the DT O
paravertebral JJ O
sympathetic JJ O
chain NN O
is VBZ O
not RB O
disrupted VBN O
in IN O
TrkB NNP O
or CC O
BDNF NNP O
null JJ O
mice NNS B-Species
. . O

It PRP O
may MD O
be VB O
more RBR O
informative JJ O
to TO O
examine VB O
mice NNS B-Species
that IN O
over RB O
express VBP O
BDNF NNP O
on IN O
a DT O
promoter NN O
that WDT O
targets VBZ O
expression NN O
to IN O
embryonic JJ O
lumbar NN O
ganglia NN O
. . O

Unfortunately RB O
, , O
such JJ O
mice NNS B-Species
do VBP O
not RB O
exist VB O
. . O

Our PRP$ O
findings NNS O
that WDT O
the DT O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( , O
E6 CD O
. . O
5 CD O
) -RRB- O
sympathoblasts NNS O
are VBP O
dependent JJ O
on IN O
both CC O
NT NNP O
- HYPH O
3 CD O
and CC O
NGF NNP O
for IN O
survival NN O
in IN O
culture NN O
are VBP O
consistent JJ O
with IN O
previous JJ O
work NN O
on IN O
mouse NN B-Species
sympathoblasts NNS O
from IN O
the DT O
superior JJ O
cervical JJ O
ganglion NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
these DT O
studies NNS O
, , O
NT NNP O
- HYPH O
3 CD O
and CC O
NGF NNP O
deletion NN O
separately RB O
led VBD O
to IN O
a DT O
decrease NN O
in IN O
the DT O
number NN O
of IN O
sympathetic JJ O
neurons NNS O
at IN O
E17 NNP O
. . O
5 CD O
compared VBN O
to IN O
control NN O
. . O

Deletion NN O
of IN O
both CC O
NT NNP O
- HYPH O
3 CD O
and CC O
NGF NNP O
together RB O
did VBD O
not RB O
enhance VB O
cell NN O
death NN O
. . O

In IN O
contrast NN O
, , O
cultured JJ O
rat JJ B-Species
superior JJ O
cervical JJ O
ganglion NN O
sympathetic JJ O
neurons NNS O
respond VBP O
to IN O
NT NNP O
- HYPH O
3 CD O
at IN O
E14 CD O
. . O
5 CD O
and CC O
then RB O
to IN O
NGF NNP O
at IN O
E19 CD O
. . O
5 CD O
, , O
although IN O
time NN O
points NNS O
in IN O
between IN O
were VBD O
not RB O
analyzed VBN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

In IN O
addition NN O
to IN O
promoting VBG O
survival NN O
, , O
NT NNP O
- HYPH O
3 CD O
, , O
NGF NNP O
, , O
and CC O
BDNF NNP O
also RB O
induce VBP O
proliferation NN O
of IN O
various JJ O
neuronal JJ O
precursors NNS O
at IN O
different JJ O
stages NNS O
of IN O
development NN O
. . O

NT NNP O
- HYPH O
3 CD O
can MD O
promote VB O
the DT O
incorporation NN O
of IN O
[ -LRB- O
3H NN O
] -RRB- O
- HYPH O
thymidine NN O
into IN O
cultured JJ O
quail NN O
neural JJ O
crest NN O
cells NNS O
from IN O
the DT O
trunk NN O
region NN O
[ -LRB- O
21 CD O
, , O
22 CD O
] -RRB- O
, , O
Later RB O
in IN O
rat JJ B-Species
sympathetic JJ O
development NN O
, , O
NT NNP O
- HYPH O
3 CD O
supports VBZ O
survival NN O
of IN O
neurons NNS O
, , O
but CC O
does VBZ O
not RB O
promote VB O
proliferation NN O
[ -LRB- O
6 CD O
] -RRB- O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
our PRP$ O
results NNS O
. . O

NGF NNP O
promotes VBZ O
an DT O
increase NN O
in IN O
BrdU NNP O
incorporation NN O
from IN O
25 CD O
% NN O
to IN O
35 CD O
% NN O
in IN O
the DT O
DRG NNP O
cervical JJ O
segment NN O
2 CD O
in IN O
the DT O
chick NN B-Species
embryo NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

In IN O
chicken NN B-Species
embryos NNS O
that WDT O
are VBP O
treated VBN O
with IN O
NGF NNP O
in IN O
ovo NN O
at IN O
St NNP O
. . O

18 CD O
and CC O
21 CD O
, , O
there EX O
is VBZ O
an DT O
increase NN O
in IN O
BrdU NNP O
uptake NN O
after IN O
formation NN O
of IN O
the DT O
primary JJ O
sympathetic JJ O
chain NN O
at IN O
St NNP O
. . O

23 CD O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Since IN O
NGF NNP O
does VBZ O
not RB O
appear VB O
to TO O
affect VB O
proliferation NN O
of IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( , O
E6 NNP O
. . O
5 CD O
) -RRB- O
chick NN B-Species
sympathoblasts NNS O
, , O
NGF NNP O
may MD O
only RB O
promote VB O
proliferation NN O
in IN O
primary JJ O
, , O
but CC O
not RB O
secondary JJ O
chain NN O
sympathoblasts NNS O
. . O

Motor NN O
neuron NN O
progenitors NNS O
in IN O
the DT O
ventral JJ O
neural JJ O
tube NN O
from IN O
the DT O
chick NN B-Species
embryo NN O
express VBP O
TrkB NNP O
and CC O
when WRB O
ventral JJ O
neural JJ O
tube NN O
explants NNS O
are VBP O
treated VBN O
with IN O
BDNF NNP O
, , O
there EX O
is VBZ O
an DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
motor NN O
neurons NNS O
produced VBN O
and CC O
BrdU NNP O
incorporation NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

BDNF NNP O
also RB O
promotes VBZ O
the DT O
proliferation NN O
of IN O
cultured VBN O
neuroblastoma NN O
cells NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
are VBP O
consistent JJ O
with IN O
our PRP$ O
findings NNS O
that IN O
NT NNP O
- HYPH O
3 CD O
and CC O
NGF NNP O
do VBP O
not RB O
promote VB O
proliferation NN O
of IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( , O
E6 NNP O
. . O
5 CD O
) -RRB- O
sympathoblasts NNS O
, , O
and CC O
support VBP O
the DT O
assertion NN O
that IN O
BDNF NNP O
promotes VBZ O
proliferation NN O
of IN O
TrkB NNP O
- HYPH O
positive JJ O
sympathoblasts NNS O
in IN O
culture NN O
. . O

Our PRP$ O
observations NNS O
suggest VBP O
a DT O
transient JJ O
function NN O
of IN O
TrkB NNP O
during IN O
early JJ O
sympathetic JJ O
development NN O
in IN O
supporting VBG O
proliferation NN O
of IN O
this DT O
early JJ O
subpopulation NN O
of IN O
sympathoblasts NNS O
. . O

However RB O
, , O
the DT O
in IN O
vivo NN O
labeling NN O
suggests VBZ O
that IN O
only RB O
a DT O
minority NN O
( -LRB- O
10 CD O
- SYM O
20 CD O
% NN O
) -RRB- O
of IN O
this DT O
population NN O
is VBZ O
dividing VBG O
during IN O
the DT O
window NN O
that WDT O
TrkB NNP O
is VBZ O
expressed VBN O
. . O

In IN O
light NN O
of IN O
the DT O
very RB O
strong JJ O
proliferative JJ O
effect NN O
produced VBN O
in IN O
cell NN O
culture NN O
, , O
these DT O
TrkB NNP O
expressing VBG O
cells NNS O
could MD O
respond VB O
more RBR O
strongly RB O
if IN O
endogenous JJ O
BDNF NNP O
rises VBZ O
to IN O
higher JJR O
levels NNS O
, , O
or CC O
if IN O
the DT O
mechanism NN O
that WDT O
down RB O
regulates VBZ O
TrkB NNP O
expression NN O
becomes VBZ O
nonfunctional JJ O
. . O

Such JJ O
events NNS O
could MD O
trigger VB O
an DT O
early JJ O
proliferative JJ O
event NN O
that WDT O
leads VBZ O
to IN O
a DT O
cascade NN O
of IN O
changes NNS O
that WDT O
initiates VBZ O
transformation NN O
of IN O
cells NNS O
to IN O
neuroblastoma NN O
. . O

Thus RB O
, , O
these DT O
early JJ O
TrkB NNP O
expressing VBG O
cells NNS O
help VBP O
solve VB O
the DT O
puzzle NN O
as IN O
to IN O
why WRB O
TrkB NNP O
is VBZ O
expressed VBN O
in IN O
aggressive JJ O
and CC O
invasive JJ O
forms NNS O
of IN O
neuroblastoma NN O
, , O
particularly RB O
because IN O
BDNF NNP O
induces VBZ O
cultured JJ O
neuroblastoma NN O
cells NNS O
to TO O
become VB O
more RBR O
proliferative JJ O
, , O
invasive JJ O
, , O
angiogenic JJ O
, , O
and CC O
resistant JJ O
to IN O
chemotherapeutic JJ O
reagents NNS O
than IN O
untreated JJ O
cultures NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Future JJ O
studies NNS O
will MD O
determine VB O
whether IN O
constitutive JJ O
expression NN O
of IN O
BDNF NNP O
and CC O
TrkB NNP O
in IN O
the DT O
chick NN B-Species
embryo NN O
sustains VBZ O
proliferation NN O
of IN O
differentiating VBG O
sympathoblasts NNS O
. . O

Conclusion NN O

We PRP O
have VBP O
identified VBN O
a DT O
time NN O
point NN O
during IN O
development NN O
when WRB O
differentiating VBG O
lumbar NN O
sympathetic JJ O
neurons NNS O
transiently RB O
express VBP O
TrkB NNP O
and CC O
proliferate VBP O
in IN O
response NN O
to IN O
high JJ O
concentrations NNS O
of IN O
BDNF NNP O
in IN O
culture NN O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
elevated JJ O
BDNF NNP O
expression NN O
above IN O
basal JJ O
levels NNS O
and CC O
signaling NN O
through IN O
TrkB NNP O
may MD O
be VB O
a DT O
mechanism NN O
that WDT O
contributes VBZ O
to IN O
the DT O
onset NN O
of IN O
neuroblastoma NN O
. . O

A DT O
further JJ O
understanding NN O
of IN O
the DT O
two CD O
populations NNS O
of IN O
sympathetic JJ O
neurons NNS O
and CC O
the DT O
fate NN O
of IN O
the DT O
TrkB NNP O
- HYPH O
positive JJ O
cells NNS O
will MD O
provide VB O
additional JJ O
insight NN O
into IN O
the DT O
development NN O
of IN O
paravertebral JJ O
sympathetic JJ O
ganglia NN O
and CC O
the DT O
genesis NN O
of IN O
neuroblastoma NN O
. . O

Methods NNS O

Preparation NN O
of IN O
tissue NN O
for IN O
immunohistochemistry NN O

The DT O
lumbar JJ O
spinal JJ O
column NN O
and CC O
surrounding VBG O
tissues NNS O
were VBD O
dissected VBN O
from IN O
chicken NN B-Species
embryos NNS O
at IN O
the DT O
indicated VBN O
stages NNS O
and CC O
placed VBN O
in IN O
Zamboni NNP O
' POS O
s NNS O
fixative JJ O
( , O
4 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) SYM O
paraformaldehyde NN O
, , O
15 CD O
% NN O
( , O
v NN O
/ SYM O
v NN O
) , O
picric NN O
acid NN O
in IN O
0 CD O
. . O
1 CD O
M NN O
sodium NN O
phosphate NN O
buffer NN O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
for IN O
two CD O
hours NNS O
at IN O
room NN O
temperature NN O
. . O

Mouse NNP B-Species
embryos NNS O
at IN O
13 CD O
- SYM O
15 CD O
days NNS O
post NN O
- HYPH O
coitus NN O
were VBD O
collected VBN O
according VBG O
to IN O
an DT O
IACUC NNP O
- HYPH O
approved VBN O
protocol NN O
to IN O
Dr NNP O
. . O
L NNP O
. . O

Sherman NNP O
at IN O
the DT O
Oregon NNP O
Health NNP O
and CC O
Science NNP O
University NNP O
. . O

The DT O
mouse NN B-Species
embryos NNS O
were VBD O
immersion NN O
- HYPH O
fixed VBN O
in IN O
Zamboni NNP O
' POS O
s NNS O
fixative JJ O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
then RB O
washed VBN O
with IN O
phosphate NN O
buffered VBN O
saline NN O
( , O
PBS NNP O
; : O
130 CD O
mM NN O
NaCl NNP O
, , O
20 CD O
mM NN O
sodium NN O
phosphate NN O
buffer NN O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
. . O

Fixed VBN O
tissues NNS O
were VBD O
equilibrated VBN O
in IN O
30 CD O
% NN O
sucrose NN O
in IN O
1 CD O
x NN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
) -RRB- O
. . O

Fixed VBN O
mouse NN B-Species
embryos NNS O
were VBD O
shipped VBN O
to IN O
Vermont NNP O
in IN O
sucrose NN O
. . O

Transverse NN O
30 CD O
mu NNS O
M NN O
sections NNS O
of IN O
the DT O
spinal JJ O
columns NNS O
were VBD O
cut VBN O
at IN O
on IN O
a DT O
Microm NNP O
HM NNP O
cryostat NN O
( , O
knife NN O
temperature NN O
: : O
16 CD O
degrees NNS O
C NN O
; : O
object NN O
temperature NN O
: : O
23 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
collected VBN O
on IN O
Superfrost NNP O
Plus NNP O
slides NNS O
( , O
Fisher NNP O
) -RRB- O
. . O

Sections NNS O
were VBD O
dried VBN O
at IN O
room NN O
temperature NN O
, , O
washed VBN O
in IN O
1 CD O
x SYM O
PBS NN O
and CC O
incubated VBN O
overnight RB O
in IN O
blocking NN O
buffer NN O
( , O
1 CD O
x SYM O
PBS NN O
consisting VBG O
of IN O
10 CD O
% NN O
( HYPH O
v NN O
/ SYM O
v NN O
) SYM O
heat NN O
- HYPH O
inactivated VBN O
horse NN B-Species
serum NN O
( , O
Invitrogen NNP O
/ SYM O
Gibco NNP O
) -RRB- O
, , O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
X NNP O
- SYM O
100 CD O
( , O
Sigma NNP O
) -RRB- O
, , O
and CC O
0 CD O
. . O
1 CD O
% NN O
sodium NN O
azide NN O
( -LRB- O
Fisher NNP O
) -RRB- O
) -RRB- O
. . O

Immunohistochemistry NN O

Sections NNS O
were VBD O
incubated VBN O
with IN O
primary JJ O
antibodies NNS O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
, , O
followed VBN O
by IN O
incubation NN O
with IN O
secondary JJ O
antibodies NNS O
for IN O
2 CD O
hours NNS O
at IN O
room NN O
temperature NN O
. . O

Primary JJ O
antibodies NNS O
used VBN O
were VBD O
: : O
rabbit NN B-Species
anti JJ O
- HYPH O
p75 NN O
( , O
1 CD O
: : O
1500 CD O
, , O
generous JJ O
gift NN O
from IN O
Louis NNP O
Reichardt NNP O
, , O
UCSF NNP O
[ -LRB- O
26 CD O
] -RRB- O
) -RRB- O
, , O
mouse NN B-Species
IgG2b NNP O
anti AFX O
- HYPH O
Hu NNP O
C NNP O
/ SYM O
D NNP O
, , O
( , O
1 CD O
: : O
250 CD O
, , O
Molecular NNP O
Probes NNPS O
) -RRB- O
; : O
mouse NNP B-Species
IgG1 NNP O
anti NNP O
- HYPH O
Islet NNP O
- HYPH O
1 CD O
, , O
( , O
1 CD O
: SYM O
10 CD O
, , O
Developmental NNP O
Studies NNPS O
Hybridoma NNP O
Bank NNP O
) : O
; : O
rabbit NN B-Species
anti JJ O
- HYPH O
chicken NN B-Species
TrkA NNP O
( : O
1 CD O
: SYM O
500 CD O
) -RRB- O
; : O
rabbit NN B-Species
anti JJ O
- HYPH O
chicken NN B-Species
TrkB NNP O
( : O
1 CD O
: SYM O
500 CD O
) -RRB- O
; : O
rabbit NN B-Species
anti JJ O
- HYPH O
chicken NN B-Species
TrkC NNP O
( , O
1 CD O
: SYM O
500 CD O
) -RRB- O
( , O
all DT O
Trk NN O
antibodies NNS O
were VBD O
generous JJ O
gifts NNS O
of IN O
Dr NNP O
. . O
Louis NNP O
Reichardt NNP O
, , O
UCSF NNP O
[ -LRB- O
26 CD O
- HYPH O
28 CD O
] -RRB- O
) -RRB- O
; : O
mouse NN B-Species
anti JJ O
- HYPH O
HNK NNP O
- HYPH O
1 CD O
( , O
1 CD O
: SYM O
50 CD O
, , O
Developmental NNP O
Studies NNPS O
Hybridoma NNP O
Bank NNP O
) -RRB- O
; : O
mouse NNP B-Species
IgG2a NNP O
anti JJ O
- HYPH O
tyrosine NN O
hydroxylase NN O
( , O
1 CD O
: SYM O
10 CD O
, , O
Developmental NNP O
Studies NNPS O
Hybridoma NNP O
Bank NNP O
) -RRB- O
, , O
sheep NN B-Species
anti AFX O
- HYPH O
BrdU NNP O
( , O
1 CD O
: : O
100 CD O
, , O
Biodesign NNP O
International NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti JJ O
- HYPH O
tyrosine NN O
hydroxylase NN O
( , O
1 CD O
: : O
100 CD O
, , O
Chemicon NNP O
) -RRB- O
, , O
and CC O
goat NN B-Species
anti AFX O
- HYPH O
TrkB NN O
( SYM O
1 CD O
: SYM O
1000 CD O
, , O
R NNP O
& CC O
D NNP O
Systems NNPS O
) -RRB- O
. . O

Immunofluorescence NN O
was VBD O
imaged VBN O
using VBG O
a DT O
Nikon NNP O
C1 NNP O
confocal NN O
mounted VBN O
on IN O
a DT O
Nikon NNP O
Eclipse NNP O
E800 NNP O
microscope NN O
with IN O
a DT O
10 CD O
x SYM O
Plan NNP O
Apo NNP O
( -LRB- O
null NNP O
0 CD O
. . O
785 CD O
) -RRB- O
air NN O
objective NN O
or CC O
a DT O
60 CD O
x SYM O
Plan NNP O
Apo NNP O
( -LRB- O
null NN O
1 CD O
. . O
4 CD O
) -RRB- O
oil NN O
objective JJ O
lens NN O
, , O
E7 NNP O
- HYPH O
C1 NN O
software NN O
, , O
and CC O
UV NN O
, , O
Argon NNP O
, , O
and CC O
He NNP O
/ SYM O
Ne NNP O
lasers NNS O
exciting JJ O
at IN O
408 CD O
, , O
488 CD O
, , O
and CC O
543 CD O
nm NN O
and CC O
emitting VBG O
at IN O
404 CD O
500 CD O
- SYM O
530 CD O
, , O
and CC O
555 CD O
- SYM O
615 CD O
nm NN O
, , O
respectively RB O
. . O

A DT O
Nikon NNP O
Eclipse NNP O
E800 NNP O
microscope NN O
in IN O
the DT O
nearby JJ O
COBRE NNP O
Molecular NNP O
/ SYM O
Cellular NNP O
Core NNP O
Facility NNP O
was VBD O
used VBN O
for IN O
counting VBG O
immunofluorescent JJ O
cells NNS O
at IN O
200 CD O
x SYM O
using VBG O
epifluorescence NN O
optics NNS O
. . O

RNA NNP O
Extraction NNP O
/ SYM O
cDNA NNP O
synthesis NN O

Sympathetic JJ O
ganglia NN O
were VBD O
removed VBN O
from IN O
chick NN B-Species
embryos NNS O
and CC O
RNA NNP O
was VBD O
isolated VBN O
using VBG O
TriReagent NNP O
( -LRB- O
Molecular NNP O
Research NNP O
Center NNP O
) -RRB- O
, , O
an DT O
acidified VBN O
guanidinium NN O
with IN O
phenol NN O
extraction NN O
method NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

RNA NNP O
was VBD O
transcribed VBN O
to IN O
cDNA NNP O
using VBG O
oligo NN O
- HYPH O
dT NN O
with IN O
Superscript NNP O
II NNP O
Reverse NNP O
Transcriptase NNP O
( , O
Invitrogen NNP O
) -RRB- O
at IN O
42 CD O
degrees NNS O
C NN O
for IN O
1 CD O
hour NN O
. . O

Real JJ O
- HYPH O
time NN O
PCR NNP O

Relative JJ O
RNA NNP O
levels NNS O
were VBD O
determined VBN O
using VBG O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
with IN O
an DT O
ABI NNP O
7500 CD O
Fast NNP O
Real NNP O
Time NNP O
PCR NNP O
System NNP O
. . O

TaqMan NNP O
probes NNS O
were VBD O
used VBN O
to TO O
quantify VB O
the DT O
progression NN O
of IN O
the DT O
PCR NNP O
reaction NN O
and CC O
reactions NNS O
were VBD O
normalized VBN O
using VBG O
the DT O
constitutively RB O
expressed VBN O
gene NN O
chick NN B-Species
ribosomal NN O
binding NN O
protein NN O
s17 NN O
( -LRB- O
CHRPS NNP O
) -RRB- O
. . O

The DT O
sequences NNS O
were VBD O
used VBN O
for IN O
primer NN O
/ SYM O
probes NNS O
sets NNS O
: : O
for IN O
BDNF NNP O
: : O
forward RB O
: : O
5 CD O
' '' O
- HYPH O
AGCCCAGTGAGGAAAACAAG NNP O
- HYPH O
3 CD O
' '' O
, , O
reverse NN O
: : O
5 CD O
' '' O
- HYPH O
ACTCCTCGAGCAGAAAGAGC NNP O
- HYPH O
3 CD O
' '' O
, , O
probe NN O
: : O
5 CD O
' '' O
- HYPH O
[ -LRB- O
6 CD O
- HYPH O
FAM NNP O
] -RRB- O
- : O
TACACATCCCGAGTCATGCT NNP O
- HYPH O
[ -LRB- O
BHQ NNP O
] -RRB- O
- : O
3 CD O
' '' O
; : O
for IN O
CHRPS NNP O
( : O
chick NN B-Species
ribosomal NN O
binding NN O
protein NN O
S NN O
- HYPH O
17 CD O
) : O
: : O
5 CD O
' '' O
AACGACTTCCACACCAACAA NN O
' '' O
, , O
reverse NN O
: : O
5 CD O
' '' O
CTTCATCAGGTGGGTGACAT NNP O
' '' O
, , O
probe NN O
: : O
5 CD O
' '' O
- : O
[ -LRB- O
6 CD O
- HYPH O
FAM NN O
] -RRB- O
- : O
CGCCATCATCCCCAGCAAGA NN O
[ -LRB- O
BHQ NN O
] -RRB- O
- : O
3 CD O
' '' O
. . O

Primers NNS O
and CC O
probes NNS O
were VBD O
synthesized VBN O
by IN O
Operon NNP O
Technologies NNP O
, , O
Inc NNP O
( , O
Alameda NNP O
, , O
CA NNP O
) -RRB- O
. . O

The DT O
primers NNS O
for IN O
BDNF NNP O
were VBD O
validated VBN O
against IN O
primers NNS O
for IN O
CHRPS NNP O
according VBG O
to IN O
an DT O
Applied NNP O
BioSystems NNP O
protocol NN O
by IN O
serially RB O
diluting VBG O
the DT O
target NN O
cDNA NN O
1 CD O
: : O
10 CD O
, , O
determining VBG O
the DT O
cycle NN O
threshold NN O
( , O
Ct NNP O
) -RRB- O
for IN O
each DT O
reaction NN O
, , O
and CC O
plotting VBG O
the DT O
Ct NNP O
versus IN O
log NN O
concentration NN O
. . O

Slopes NNS O
of IN O
the DT O
resulting VBG O
lines NNS O
were VBD O
calculated VBN O
and CC O
primers NNS O
were VBD O
accepted VBN O
if IN O
their PRP$ O
Ct NNP O
slopes NNS O
were VBD O
between IN O
- HYPH O
3 CD O
. . O
2 CD O
and CC O
- HYPH O
3 CD O
. . O
4 CD O
( , O
a DT O
perfect JJ O
efficiency NN O
of IN O
1 CD O
. . O
0 CD O
yields VBZ O
a DT O
slope NN O
of IN O
- HYPH O
3 CD O
. . O
3 CD O
) -RRB- O
. . O

To TO O
analyze VB O
the DT O
data NNS O
, , O
the DT O
delta NN O
Ct NNP O
method NN O
of IN O
relative JJ O
quantification NN O
was VBD O
used VBN O
, , O
where WRB O
the DT O
Ct NNP O
of IN O
Chrps NNP O
was VBD O
subtracted VBN O
from IN O
the DT O
Ct NNP O
of IN O
the DT O
gene NN O
of IN O
interest NN O
( , O
Delta NNP O
Ct NNP O
) -RRB- O
and CC O
the DT O
arbitrary JJ O
units NNS O
of IN O
mRNA NNP O
were VBD O
expressed VBN O
as IN O
10000 CD O
/ SYM O
2 CD O
^ SYM O
( : O
Delta NNP O
Ct NNP O
) -RRB- O
. . O

Cell NN O
culture NN O

Sympathetic JJ O
neurons NNS O
were VBD O
cultured VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
30 CD O
] -RRB- O
with IN O
a DT O
few JJ O
modifications NNS O
. . O

Sympathetic JJ O
ganglia NN O
were VBD O
removed VBN O
from IN O
the DT O
lumbar JJ O
region NN O
of IN O
the DT O
paravertebral JJ O
chain NN O
of IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( SYM O
E6 CD O
. . O
5 CD O
) -RRB- O
chick NN B-Species
embryos NNS O
and CC O
placed VBN O
in IN O
Modified NNP O
Puck NNP O
' POS O
s NN O
solution NN O
with IN O
glucose NN O
( -LRB- O
MPG NN O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
dissociated VBN O
by IN O
incubation NN O
of IN O
sympathetic JJ O
ganglia NN O
with IN O
0 CD O
. . O
1 CD O
% NN O
trypsin NN O
in IN O
MPG NN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
10 CD O
minutes NNS O
followed VBN O
by IN O
triturating VBG O
with IN O
a DT O
fire NN O
polished VBN O
9 CD O
"""" '' O
Pasteur NN O
pipette NN O
. . O

Cells NNS O
were VBD O
then RB O
resuspended VBN O
in IN O
Dulbecco NNP O
' POS O
s POS O
Modified NNP O
Eagle NNP O
Medium NNP O
( , O
DMEM NNP O
) -RRB- O
consisting VBG O
of IN O
10 CD O
% NN O
horse NN B-Species
serum NN O
, , O
2 CD O
% NN O
fetal JJ O
calf NN O
serum NN O
, , O
and CC O
10 CD O
mg NN O
/ SYM O
ml NN O
penicillin NN O
/ SYM O
streptomycin NN O
. . O

For IN O
neurotrophin NN O
studies NNS O
, , O
the DT O
culture NN O
medium NN O
was VBD O
supplemented VBN O
with IN O
25 CD O
ng CD O
/ SYM O
ml NNP O
NT NNP O
- HYPH O
3 CD O
( , O
R NN O
& CC O
D NNP O
Systems NNP O
) -RRB- O
and CC O
1 CD O
mu NN O
g NN O
/ SYM O
ml NNP O
7S NNP O
NGF NNP O
( -LRB- O
Alomone NNP O
Labs NNPS O
) -RRB- O
upon IN O
plating NN O
, , O
and CC O
50 CD O
ng NN O
/ SYM O
ml NN O
, , O
100 CD O
ng NNS O
/ SYM O
ml NN O
, , O
or CC O
200 CD O
ng NNS O
/ SYM O
ml NNP O
BDNF NNP O
( -LRB- O
R NNP O
& CC O
D NNP O
Systems NNP O
) -RRB- O
once IN O
the DT O
cells NNS O
adhered VBD O
to IN O
the DT O
wells NNS O
. . O

Cells NNS O
were VBD O
plated VBN O
on IN O
poly JJ O
- HYPH O
D NN O
- HYPH O
lysine NN O
/ SYM O
laminin NN O
coated VBN O
wells NNS O
or CC O
cover NN O
slips NNS O
( -LRB- O
Fisher NNP O
) -RRB- O
as IN O
previously RB O
described VBN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Quantification NN O
of IN O
neurons NNS O
and CC O
sympathoblasts NNS O
using VBG O
phase NN O
microscopy NN O

Embryonic JJ O
sympathoblasts NNS O
and CC O
neurons NNS O
are VBP O
small JJ O
, , O
phase NN O
bright JJ O
cells NNS O
with IN O
neurites NNS O
. . O

The DT O
total JJ O
number NN O
of IN O
cells NNS O
with IN O
neurites NNS O
the DT O
length NN O
of IN O
two CD O
cell NN O
bodies NNS O
were VBD O
counted VBN O
in IN O
10 CD O
non AFX O
- HYPH O
overlapping VBG O
fields NNS O
of IN O
view NN O
evenly RB O
spaced VBN O
in IN O
a DT O
grid NN O
- HYPH O
like JJ O
pattern NN O
across IN O
the DT O
bottom NN O
of IN O
a DT O
well NN O
from IN O
a DT O
24 CD O
well NN O
plate NN O
at IN O
200 CD O
x NNS O
using VBG O
a DT O
Nikon NNP O
Eclipse NNP O
TE200 NNP O
microscope NN O
. . O

BrdU NNP O
labeling NN O

For IN O
in FW O
vitro FW O
studies NNS O
, , O
approximately RB O
2 CD O
hours NNS O
after IN O
plating VBG O
cells NNS O
from IN O
St NNP O
. . O

29 CD O
/ SYM O
30 CD O
( , O
E6 NNP O
. . O
5 CD O
) -RRB- O
sympathetic JJ O
ganglia NN O
, , O
cells NNS O
were VBD O
labeled VBN O
with IN O
10 CD O
mu NN O
M NNP O
bromodeoxyuridine NN O
( , O
BrdU NNP O
, , O
Sigma NNP O
) -RRB- O
for IN O
12 CD O
hours NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Following VBG O
this DT O
labeling NN O
period NN O
, , O
cells NNS O
were VBD O
incubated VBN O
in IN O
complete JJ O
medium NN O
without IN O
BrdU NNP O
for IN O
an DT O
additional JJ O
10 CD O
hrs NNS O
. . O

Cells NNS O
were VBD O
then RB O
fixed VBN O
in IN O
Zamboni NNP O
' POS O
s NNS O
fixative JJ O
for IN O
30 CD O
min NN O
at IN O
room NN O
temperature NN O
and CC O
rinsed VBN O
with IN O
1 CD O
x SYM O
PBS NNP O
. . O

For IN O
in IN O
vivo NN O
studies NNS O
, , O
25 CD O
mu NNS O
g VBD O
BrdU NNP O
was VBD O
injected VBN O
into IN O
the DT O
amnion NN O
of IN O
chick NN B-Species
embryos NNS O
at IN O
St NNP O
. . O

27 CD O
. . O

The DT O
cells NNS O
and CC O
sections NNS O
were VBD O
denatured VBN O
with IN O
2 CD O
N NNP O
HCl NNP O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
1 CD O
hr NN O
, , O
and CC O
were VBD O
then RB O
neutralized VBN O
with IN O
0 CD O
. . O
1 CD O
M NN O
borate NN O
buffer NN O
, , O
pH NN O
8 CD O
. . O
5 CD O
, , O
for IN O
10 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

Immunochemistry NN O
was VBD O
performed VBN O
as IN O
described VBN O
above RB O
. . O

Abbreviations NNS O

BDNF NNP O
, , O
brain NN O
- HYPH O
derived VBN O
neurotrophic JJ O
factor NN O
; : O
BrdU NNP O
, , O
Bromodeoxyuridine NNP O
; : O
DA NN O
, , O
dorsal JJ O
aorta NN O
; : O
DMEM NNP O
, , O
Dulbecco NNP O
' POS O
s NNP O
Modified NNP O
Eagle NNP O
' '' O
s NNPS O
Medium NNP O
; , O
DRG NNP O
, , O
dorsal JJ O
root NN O
ganglion NN O
; : O
E NN O
, , O
embryonic JJ O
day NN O
; : O
HS NN O
, , O
horse NN B-Species
serum NN O
; , O
MPG NNP O
, , O
Modified NNP O
Puck NNP O
' POS O
s NN O
solution NN O
with IN O
glucose NN O
; , O
NGF NNP O
, , O
nerve JJ O
growth NN O
factor NN O
; , O
NC NNP O
, , O
notochord NN O
; , O
NT NNP O
, , O
neural JJ O
tube NN O
; : O
NT NNP O
- HYPH O
3 CD O
, , O
neurotrophin NN O
- HYPH O
3 CD O
; : O
NTR NNP O
, , O
neurotrophin NN O
receptor NN O
; : O
PBS NNP O
, , O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
; : O
SC NN O
, , O
spinal JJ O
cord NN O
; , O
SCG NNP O
, , O
superior JJ O
cervical JJ O
ganglion NN O
; : O
SEM NN O
, , O
standard JJ O
error NN O
of IN O
the DT O
mean NN O
; : O
SG NN O
, , O
sympathetic JJ O
ganglion NN O
; : O
St NNP O
. . O
, , O
stage NN O
; : O
w NN O
/ SYM O
v NN O
, , O
weight NN O
/ SYM O
volume NN O
; : O
v NN O
/ SYM O
v NN O
, , O
volume NN O
/ SYM O
volume NN O
. . O

Authors NNS O
' POS O
contributions NNS O

JAS NNP O
designed VBD O
the DT O
experiments NNS O
, , O
performed VBD O
the DT O
experiments NNS O
, , O
analyzed VBD O
the DT O
data NNS O
, , O
and CC O
wrote VBD O
the DT O
manuscript NN O
. . O

GLSS NNP O
contributed VBD O
intellectually RB O
to IN O
the DT O
conception NN O
and CC O
design NN O
of IN O
this DT O
study NN O
, , O
and CC O
assisted VBN O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
. . O

RN NNP O
supervised VBD O
the DT O
study NN O
, , O
participated VBD O
in IN O
the DT O
design NN O
of IN O
experiments NNS O
, , O
edited VBD O
the DT O
manuscript NN O
, , O
and CC O
obtained VBD O
funding NN O
for IN O
the DT O
project NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Video NNP O
analysis NN O
of IN O
the DT O
escape NN O
flight NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
Dryocopus NNP B-Species
pileatus NN I-Species
: : O
does VBZ O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
Campephilus NNP B-Species
principalis NN I-Species
persist VB O
in IN O
continental JJ O
North NNP O
America NNP O
? . O

Abstract JJ O

Background NN O

The DT O
apparent JJ O
rediscovery NN O
of IN O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
Campephilus NNP B-Species
principalis NN I-Species
in IN O
Arkansas NNP O
, , O
USA NNP O
, , O
previously RB O
feared VBN O
extinct JJ O
, , O
was VBD O
supported VBN O
by IN O
video NN O
evidence NN O
of IN O
a DT O
single JJ O
bird NN O
in IN O
flight NN O
( : O
Fitzpatrick NNP O
et FW O
al NNP O
, , O
Science NNP O
2005 CD O
, , O
308 CD O
: : O
1460 CD O
- HYPH O
1462 CD O
) -RRB- O
. . O

Plumage NN O
patterns NNS O
and CC O
wingbeat NN O
frequency NN O
of IN O
the DT O
putative JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
were VBD O
said VBN O
to TO O
be VB O
incompatible JJ O
with IN O
the DT O
only JJ O
possible JJ O
confusion NN O
species NNS O
native JJ O
to IN O
the DT O
area NN O
, , O
the DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
Dryocopus NNP B-Species
pileatus NN I-Species
. . O

Results NNS O

New JJ O
video NN O
analysis NN O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
in IN O
escape NN O
flights NNS O
comparable JJ O
to IN O
that DT O
of IN O
the DT O
putative JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
filmed VBN O
in IN O
Arkansas NNP O
shows VBZ O
that IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
can MD O
display VB O
a DT O
wingbeat NN O
frequency NN O
equivalent JJ O
to IN O
that DT O
of IN O
the DT O
Arkansas NNP O
bird NN O
during IN O
escape NN O
flight NN O
. . O

The DT O
critical JJ O
frames NNS O
from IN O
the DT O
Arkansas NNP O
video NN O
that WDT O
were VBD O
used VBN O
to TO O
identify VB O
the DT O
bird NN O
as IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
are VBP O
shown VBN O
to TO O
be VB O
equally RB O
, , O
or CC O
more RBR O
, , O
compatible JJ O
with IN O
the DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Conclusion NN O

The DT O
identification NN O
of IN O
the DT O
bird NN O
filmed VBN O
in IN O
Arkansas NNP O
in IN O
April NNP O
2004 CD O
as IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
is VBZ O
best RBS O
regarded VBN O
as IN O
unsafe JJ O
. . O

The DT O
similarities NNS O
between IN O
the DT O
Arkansas NNP O
bird NN O
and CC O
known VBN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
suggest VBP O
that IN O
it PRP O
was VBD O
most RBS O
likely JJ O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Background NN O

The DT O
reported JJ O
rediscovery NN O
of IN O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
in IN O
2004 CD O
- SYM O
5 CD O
in IN O
the DT O
Big NNP O
Woods NNPS O
of IN O
Arkansas NNP O
gave VBD O
new JJ O
impetus NN O
to IN O
efforts NNS O
to TO O
conserve VB O
the DT O
mature JJ O
bottomland NN O
woodlands NNS O
of IN O
the DT O
south JJ O
- HYPH O
eastern JJ O
USA NNP O
. . O

Several JJ O
sightings NNS O
have VBP O
been VBN O
reported VBN O
without IN O
photographic JJ O
evidence NN O
being VBG O
obtained VBN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Unless IN O
sightings NNS O
are VBP O
, , O
however RB O
, , O
independently RB O
verifiable JJ O
on IN O
the DT O
basis NN O
of IN O
photographic JJ O
or CC O
other JJ O
recorded VBN O
evidence NN O
, , O
the DT O
possibility NN O
that IN O
mistakes NNS O
have VBP O
been VBN O
made VBN O
cannot MD O
be VB O
eliminated VBN O
. . O

Crucial JJ O
to IN O
the DT O
scientific JJ O
case NN O
for IN O
the DT O
persistence NN O
of IN O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
was VBD O
a DT O
4 CD O
s NN O
video NN O
of IN O
a DT O
large JJ O
woodpecker NN O
in IN O
flight NN O
recorded VBN O
by IN O
M NNP O
. . O
D NNP O
. . O

Luneau NNP O
on IN O
25 CD O
April NNP O
2004 CD O
( , O
henceforth RB O
referred VBN O
to IN O
as IN O
the DT O
' `` O
Luneau NNP O
video NN O
' '' O
) -RRB- O
and CC O
published VBN O
in IN O
2005 CD O
[ -LRB- O
1 CD O
] -RRB- O
, , O
which WDT O
was VBD O
claimed VBN O
to TO O
be VB O
inconsistent JJ O
with IN O
the DT O
plumage NN O
patterns NNS O
of IN O
the DT O
superficially RB O
similar JJ O
Pileated NNP B-Species
Woodpecker NNP I-Species
( , O
a DT O
common JJ O
resident JJ O
bird NN O
of IN O
the DT O
area NN O
) -RRB- O
. . O

Both DT O
species NNS O
are VBP O
large JJ O
, , O
black JJ O
- HYPH O
and CC O
- HYPH O
white JJ O
woodpeckers NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
upperwing NN O
of IN O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
is VBZ O
black JJ O
, , O
with IN O
white JJ O
secondary JJ O
feathers NNS O
and CC O
white JJ O
on IN O
some DT O
inner JJ O
primary JJ O
feathers NNS O
. . O

Pileated VBN B-Species
Woodpeckers NNPS I-Species
have VBP O
a DT O
largely RB O
black JJ O
upperwing NN O
, , O
with IN O
white JJ O
restricted VBN O
to IN O
the DT O
' `` O
wrist NN O
' '' O
due JJ O
to IN O
white JJ O
bases NNS O
to IN O
the DT O
primary JJ O
feathers NNS O
. . O

The DT O
underwing NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
has VBZ O
all RB O
- HYPH O
white JJ O
underwing JJ O
coverts NNS O
, , O
giving VBG O
an DT O
appearance NN O
of IN O
a DT O
white JJ O
underwing NN O
with IN O
a DT O
broad JJ O
black JJ O
outline NN O
( , O
the DT O
black JJ O
flight NN O
feathers NNS O
) -RRB- O
. . O

These DT O
plumage NN O
differences NNS O
result VBP O
in IN O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
having VBG O
a DT O
white JJ O
trailing VBG O
edge NN O
to IN O
the DT O
wings NNS O
( , O
upper JJ O
and CC O
lower JJ O
sides NNS O
) -RRB- O
, , O
whereas IN O
the DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
has VBZ O
a DT O
black JJ O
trailing VBG O
edge NN O
to IN O
the DT O
wings NNS O
. . O

Both DT O
species NNS O
have VBP O
black JJ O
wing NN O
- HYPH O
tips NNS O
. . O

These DT O
and CC O
other JJ O
plumage NN O
characteristics NNS O
are VBP O
shown VBN O
in IN O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

The DT O
wingbeat NN O
frequency NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
was VBD O
measured VBN O
at IN O
8 CD O
. . O
6 CD O
beats NNS O
s NN O
- HYPH O
1 CD O
, , O
similar JJ O
to IN O
that DT O
inferred VBN O
from IN O
archival JJ O
sound NN O
recording NN O
of IN O
a DT O
single JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
, , O
but CC O
claimed VBD O
to TO O
be VB O
outside IN O
the DT O
range NN O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
( : O
which WDT O
generally RB O
have VBP O
slower JJR O
wingbeats NNS O
) -RRB- O
[ -LRB- O
1 CD O
, , O
3 CD O
] -RRB- O
. . O

Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
questioned VBD O
the DT O
video NN O
evidence NN O
, , O
in IN O
particular JJ O
providing VBG O
alternative JJ O
explanations NNS O
for IN O
the DT O
plumage NN O
patterns NNS O
of IN O
the DT O
Luneau NNP O
bird NN O
in IN O
flight NN O
and CC O
at IN O
rest NN O
. . O

They PRP O
pointed VBD O
out RP O
individual JJ O
frames NNS O
of IN O
the DT O
Luneau NNP O
video NN O
that WDT O
appear VBP O
to TO O
show VB O
three CD O
features NNS O
that WDT O
are VBP O
each DT O
inconsistent JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
: : O
( : O
1 CD O
) SYM O
apparently RB O
black JJ O
secondary JJ O
feathers NNS O
on IN O
the DT O
upper JJ O
surface NN O
of IN O
the DT O
left JJ O
wing NN O
, , O
( , O
2 CD O
) SYM O
particularly RB O
bright JJ O
white JJ O
primary JJ O
bases NNS O
, , O
and CC O
( , O
3 CD O
) , O
a DT O
black JJ O
band NN O
curving VBG O
smoothly RB O
round IN O
the DT O
wing NN O
tip NN O
( , O
see VB O
Figure NN O
3 CD O
in IN O
[ -LRB- O
4 CD O
] -RRB- O
) -RRB- O
. . O

They PRP O
hypothesized VBD O
that IN O
flexing VBG O
of IN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
' '' O
s POS O
wings NNS O
during IN O
flight NN O
could MD O
produce VB O
the DT O
appearance NN O
of IN O
white JJ O
trailing VBG O
edges NNS O
on IN O
both DT O
wings NNS O
in IN O
low JJ O
- HYPH O
quality NN O
videos NNS O
[ -LRB- O
4 CD O
] -RRB- O
. . O

They PRP O
offered VBD O
, , O
however RB O
, , O
no DT O
direct JJ O
evidence NN O
to TO O
show VB O
that IN O
this DT O
could MD O
cause VB O
a DT O
video NN O
of IN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
to TO O
look VB O
like IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
. . O

Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
5 CD O
] -RRB- O
in IN O
turn NN O
rebutted VBD O
some DT O
aspects NNS O
of IN O
the DT O
hypothesis NN O
of IN O
Sibley NNP O
et NN O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
, , O
publishing VBG O
video NN O
stills NNS O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
, , O
and CC O
a DT O
model NN O
of IN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
that WDT O
appeared VBD O
to TO O
show VB O
a DT O
black JJ O
trailing VBG O
edge NN O
to IN O
the DT O
wings NNS O
inconsistent JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
and CC O
the DT O
Luneau NNP O
video NN O
. . O

Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
5 CD O
] -RRB- O
neither CC O
rebutted VBN O
nor CC O
discussed VBD O
the DT O
three CD O
key JJ O
inconsistencies NNS O
described VBN O
above RB O
. . O

Without IN O
further JJ O
evidence NN O
, , O
this DT O
became VBD O
largely RB O
a DT O
theoretical JJ O
debate NN O
over IN O
interpretation NN O
of IN O
field NN O
characters NNS O
that WDT O
were VBD O
barely RB O
visible JJ O
in IN O
the DT O
very RB O
small JJ O
images NNS O
originally RB O
obtained VBN O
. . O

On IN O
one CD O
hand NN O
, , O
as IN O
pointed VBN O
out RP O
in IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
, , O
some DT O
of IN O
the DT O
frames NNS O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
do VBP O
appear VB O
to TO O
be VB O
inconsistent JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
flight NN O
pattern NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
is VBZ O
asserted VBN O
to TO O
be VB O
atypical JJ O
for IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
( , O
but CC O
matching VBG O
anecdotal JJ O
descriptions NNS O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
) -RRB- O
. . O

Furthermore RB O
, , O
the DT O
general JJ O
impression NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
was VBD O
that IN O
there EX O
is VBZ O
far RB O
too RB O
much JJ O
white JJ O
in IN O
the DT O
wings NNS O
for IN O
it PRP O
to TO O
be VB O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
and CC O
that IN O
if IN O
it PRP O
was VBD O
a DT O
Pileated JJ O
, , O
then RB O
it PRP O
must MD O
be VB O
an DT O
aberrant JJ O
one NN O
with IN O
abnormally RB O
extensive JJ O
white JJ O
plumage NN O
. . O

Such JJ O
birds NNS O
occasionally RB O
occur VBP O
, , O
and CC O
have VBP O
been VBN O
observed VBN O
in IN O
the DT O
Arkansas NNP O
study NN O
area NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
determine VB O
whether IN O
the DT O
flight NN O
and CC O
plumage NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
really RB O
was VBD O
inconsistent JJ O
with IN O
either CC O
a DT O
normal JJ O
or CC O
partial JJ O
albino NN O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Independent JJ O
analyses NNS O
of IN O
the DT O
plumage NN O
patterns NNS O
and CC O
wingbeat NN O
frequencies NNS O
observable JJ O
in IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
are VBP O
presented VBN O
, , O
and CC O
it PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
identification NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
as IN O
definite JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
is VBZ O
probably RB O
unsafe JJ O
. . O

Results NNS O

On IN O
January NNP O
28 CD O
and CC O
February NNP O
5 CD O
, , O
2006 CD O
, , O
David NNP O
Nolin NNP O
( : O
DN NNP O
) -RRB- O
video NN O
- HYPH O
recorded VBN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
Dryocopus NNP B-Species
pileatus NN I-Species
at IN O
a DT O
bird NN O
- HYPH O
feeder NN O
in IN O
Dayton NNP O
, , O
Ohio NNP O
, , O
USA NNP O
. . O

A DT O
Hi NNP O
- HYPH O
8 CD O
Sony NNP O
Handycam NNP O
was VBD O
used VBN O
, , O
hand NN O
- HYPH O
held VBN O
, , O
at IN O
approximately RB O
5 CD O
m NN O
from IN O
the DT O
feeder NN O
. . O

Birds NNS O
on IN O
the DT O
tree NN O
trunk NN O
were VBD O
alarmed VBN O
by IN O
movement NN O
, , O
and CC O
their PRP$ O
escape NN O
flights NNS O
recorded VBN O
. . O

Four CD O
escape NN O
flights NNS O
were VBD O
captured VBN O
that DT O
approximate JJ O
to IN O
that DT O
recorded VBN O
for IN O
the DT O
putative JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
Campephilus NNP B-Species
principalis NN I-Species
by IN O
Luneau NNP O
in IN O
April NNP O
2004 CD O
and CC O
published VBN O
in IN O
Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
videos NNS O
are VBP O
not RB O
directly RB O
equivalent JJ O
because IN O
the DT O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
made VBD O
only RB O
short JJ O
escape NN O
flights NNS O
to IN O
nearby JJ O
trees NNS O
, , O
whereas IN O
the DT O
putative JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
in IN O
the DT O
Luneau NNP O
video NN O
showed VBD O
little JJ O
sign NN O
of IN O
coming VBG O
to IN O
rest NN O
before IN O
being VBG O
lost VBN O
from IN O
view NN O
. . O

Nevertheless RB O
, , O
interesting JJ O
comparisons NNS O
can MD O
be VB O
made VBN O
. . O

Wingbeat NN O
frequency NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species

The DT O
woodpecker NN O
in IN O
the DT O
Luneau NNP O
video NN O
maintains VBZ O
a DT O
steady JJ O
rapid JJ O
wingbeat NN O
rate NN O
of IN O
8 CD O
. . O
6 CD O
beats NNS O
s VBZ O
- HYPH O
1 CD O
for IN O
at RB O
least RBS O
8 CD O
wingbeats NNS O
[ -LRB- O
1 CD O
] -RRB- O
, , O
a DT O
figure NN O
that WDT O
was VBD O
confirmed VBN O
by IN O
independent JJ O
analysis NN O
during IN O
preparation NN O
of IN O
this DT O
paper NN O
. . O

The DT O
Pileated JJ B-Species
woodpeckers NNS I-Species
in IN O
DN NNP O
' '' O
s POS O
video NN O
do VBP O
not RB O
do VB O
this DT O
- , O
after IN O
initial JJ O
rapid JJ O
flapping NN O
immediately RB O
after IN O
take NN O
- HYPH O
off NN O
, , O
they PRP O
settle VBP O
into IN O
a DT O
more RBR O
relaxed JJ O
level NN O
flight NN O
. . O

As IN O
shown VBN O
in IN O
Tables NNP O
1 CD O
and CC O
2 CD O
, , O
although IN O
the DT O
mean JJ O
wingbeat NN O
frequencies NNS O
of IN O
the DT O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
in IN O
DN NNP O
' '' O
s POS O
video NN O
are VBP O
slower JJR O
than IN O
the DT O
8 CD O
. . O
6 CD O
s NN O
- HYPH O
1 CD O
recorded VBN O
for IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
[ -LRB- O
1 CD O
, , O
3 CD O
, , O
5 CD O
] -RRB- O
the DT O
first JJ O
four CD O
wingbeats NNS O
, , O
the DT O
initial JJ O
escape NN O
response NN O
, , O
are VBP O
faster RBR O
than IN O
those DT O
claimed VBN O
for IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
in IN O
the DT O
literature NN O
[ -LRB- O
1 CD O
, , O
3 CD O
, , O
5 CD O
] -RRB- O
. . O

For IN O
the DT O
four CD O
escape NN O
flights NNS O
, , O
the DT O
mean JJ O
frequency NN O
values NNS O
for IN O
the DT O
first JJ O
four CD O
wingbeats NNS O
are VBP O
7 CD O
. . O
1 CD O
, , O
6 CD O
. . O
7 CD O
, , O
8 CD O
. . O
6 CD O
, , O
and CC O
8 CD O
. . O
0 CD O
s NN O
- HYPH O
1 CD O
, , O
respectively RB O
. . O

The DT O
8 CD O
. . O
6 CD O
beats NNS O
s VBZ O
- HYPH O
1 CD O
of IN O
the DT O
bird NN O
identified VBN O
in IN O
the DT O
Luneau NNP O
video NN O
, , O
while IN O
consistent JJ O
with IN O
the DT O
limited JJ O
data NN O
( : O
n CD O
= SYM O
1 CD O
; : O
see VB O
Discussion NNP O
) -RRB- O
for IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
, , O
is VBZ O
equally RB O
consistent JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
in IN O
its PRP$ O
initial JJ O
escape NN O
flight NN O
. . O

The DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
maintains VBZ O
a DT O
frequency NN O
of IN O
8 CD O
. . O
6 CD O
s NN O
- HYPH O
1 CD O
for IN O
the DT O
next JJ O
four CD O
wingbeats NNS O
too RB O
, , O
whereas IN O
the DT O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
recorded VBN O
here RB O
all DT O
slowed VBD O
their PRP$ O
flight NN O
as IN O
they PRP O
prepared VBD O
to TO O
land VB O
in IN O
nearby JJ O
trees NNS O
. . O

There EX O
are VBP O
no DT O
data NNS O
to TO O
suggest VB O
whether IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
can MD O
maintain VB O
a DT O
wingbeat NN O
frequency NN O
approaching VBG O
8 CD O
. . O
6 CD O
s NNS O
- HYPH O
1 CD O
for IN O
eight CD O
or CC O
more JJR O
wingbeats NNS O
, , O
like IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
. . O

It PRP O
remains VBZ O
possible JJ O
that IN O
the DT O
flight NN O
pattern NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
is VBZ O
unusual JJ O
for IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
but CC O
a DT O
frequency NN O
of IN O
8 CD O
. . O
6 CD O
s NN O
- HYPH O
1 CD O
is VBZ O
consistent JJ O
with IN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
gaining VBG O
initial JJ O
speed NN O
and CC O
height NN O
in IN O
escape NN O
flight NN O
, , O
and CC O
by IN O
itself PRP O
cannot MD O
be VB O
taken VBN O
as IN O
strong JJ O
evidence NN O
that IN O
the DT O
Luneau NNP O
video NN O
bird NN O
was VBD O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

This DT O
is VBZ O
discussed VBN O
further RB O
below RB O
. . O

Plumage NN O
pattern NN O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
in IN O
flight NN O

The DT O
video NN O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
in IN O
flight NN O
was VBD O
obtained VBN O
in IN O
avi NN O
format NN O
, , O
decompiled VBN O
and CC O
examined VBN O
frame NN O
by IN O
frame NN O
. . O

Comparisons NNS O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
images NNS O
with IN O
key JJ O
images NNS O
of IN O
Luneau NNP O
video NN O
are VBP O
shown VBN O
in IN O
Figures NNPS O
1 CD O
and CC O
2 CD O
, , O
and CC O
suggest VBP O
a DT O
genuine JJ O
resemblance NN O
between IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
and CC O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Analysis NN O
is VBZ O
complicated VBN O
by IN O
the DT O
different JJ O
digital JJ O
processing NN O
of IN O
the DT O
two CD O
videos NNS O
, , O
and CC O
in IN O
the DT O
case NN O
of IN O
the DT O
Nolin NNP O
videos NNS O
it PRP O
is VBZ O
important JJ O
to TO O
concentrate VB O
only RB O
on IN O
those DT O
frames NNS O
or CC O
part NN O
- HYPH O
frames NNS O
where WRB O
apparent JJ O
plumage NN O
features VBZ O
are VBP O
not RB O
an DT O
artifact NN O
of IN O
blurred VBN O
images NNS O
. . O

Thirty CD O
- HYPH O
six CD O
frames NNS O
from IN O
the DT O
fourth JJ O
example NN O
of IN O
Pileated JJ O
escape NN O
flight NN O
, , O
which WDT O
most RBS O
resembled VBD O
the DT O
flight NN O
path NN O
of IN O
the DT O
Luneau NNP O
video NN O
bird NN O
, , O
were VBD O
analysed VBN O
systematically RB O
frame NN O
by IN O
frame NN O
. . O

They PRP O
represent VBP O
seven CD O
complete JJ O
wingbeats NNS O
( , O
1 CD O
. . O
20 CD O
s NNS O
from IN O
the DT O
middle NN O
of IN O
the DT O
second JJ O
wingbeat NN O
to IN O
middle NN O
of IN O
wingbeat NN O
9 CD O
) -RRB- O
and CC O
were VBD O
directly RB O
compared VBN O
frame NN O
- HYPH O
by IN O
- HYPH O
frame NN O
with IN O
the DT O
equivalent JJ O
fields NNS O
( , O
middle JJ O
wingbeat NN O
2 CD O
- HYPH O
middle JJ O
wingbeat NN O
9 CD O
) -RRB- O
of IN O
the DT O
Luneau NNP O
video NN O
. . O

This DT O
comparison NN O
is VBZ O
shown VBN O
in IN O
Figure NNP O
3 CD O
. . O

The DT O
images NNS O
of IN O
the DT O
birds NNS O
are VBP O
not RB O
identical JJ O
, , O
but CC O
in IN O
every DT O
frame NN O
of IN O
the DT O
36 CD O
frames NNS O
available JJ O
, , O
there EX O
are VBP O
sufficient JJ O
similarities NNS O
to TO O
suggest VB O
that IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
is VBZ O
consistent JJ O
with IN O
the DT O
known VBN O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Further JJ O
comparisons NNS O
of IN O
the DT O
Luneau NNP O
bird NN O
with IN O
the DT O
other JJ O
three CD O
Pileated JJ B-Species
escape NN O
flights NNS O
recorded VBN O
are VBP O
presented VBN O
in IN O
the DT O
supplementary JJ O
material NN O
( , O
see VB O
Additional JJ O
file NN O
1 CD O
) -RRB- O
. . O

Key JJ O
findings NNS O
of IN O
the DT O
video NN O
analysis NN O
are VBP O
: : O

1 LS O
. . O

Pileated VBN B-Species
Woodpeckers NNPS I-Species
flying VBG O
near RB O
- HYPH O
horizontally RB O
away RB O
from IN O
the DT O
observer NN O
show VBP O
much RB O
more RBR O
white JJ O
in IN O
poor JJ O
- HYPH O
quality NN O
video NN O
than IN O
would MD O
be VB O
expected VBN O
from IN O
their PRP$ O
general JJ O
plumage NN O
pattern NN O
. . O

They PRP O
present VBP O
an DT O
appearance NN O
of IN O
a DT O
black JJ O
- HYPH O
bodied JJ O
bird NN O
with IN O
largely RB O
white JJ O
wings NNS O
and CC O
black JJ O
wingtips NNS O
, , O
very RB O
similar JJ O
to IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
; , O
compare VBP O
in IN O
particular JJ O
Figure NNP O
1B NNP O
, , O
frame NN O
758 CD O
, , O
with IN O
Figure NNP O
1A NNP O
, , O
frame NN O
283 CD O
. . O
3 CD O
. . O

The DT O
expected VBN O
appearance NN O
of IN O
the DT O
upperwing NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
- , O
mostly RB O
black JJ O
with IN O
a DT O
small JJ O
white JJ O
patch NN O
at IN O
the DT O
base NN O
of IN O
the DT O
primaries NNS O
- , O
is VBZ O
often RB O
not RB O
seen VBN O
, , O
and CC O
is VBZ O
only RB O
clearly RB O
resolvable JJ O
when WRB O
birds NNS O
are VBP O
flying VBG O
near RB O
- HYPH O
vertically RB O
before IN O
landing VBG O
on IN O
a DT O
tree NN O
trunk NN O
; : O
something NN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
did VBD O
not RB O
do VB O
. . O

2 LS O
. . O

The DT O
black JJ O
trailing VBG O
edge NN O
to IN O
the DT O
underwing NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
is VBZ O
often RB O
very RB O
inconspicuous JJ O
and CC O
may MD O
disappear VB O
completely RB O
. . O

Due IN O
to IN O
motion NN O
and CC O
flexion NN O
of IN O
the DT O
wing NN O
, , O
the DT O
black JJ O
trailing VBG O
edge NN O
is VBZ O
much RB O
more RBR O
obvious JJ O
towards IN O
the DT O
wingtips NNS O
. . O

This DT O
produces VBZ O
an DT O
apparent JJ O
plumage NN O
pattern NN O
that WDT O
matches VBZ O
the DT O
patterns NNS O
shown VBN O
by IN O
the DT O
Luneau NNP O
video NN O
bird NN O
( , O
compare VBP O
Figure NNP O
1B NNP O
, , O
frames NNS O
175 CD O
and CC O
457 CD O
with IN O
Figure NNP O
1A NNP O
, , O
frames NNS O
300 CD O
and CC O
416 CD O
. . O
7 CD O
) -RRB- O
. . O

In IN O
many JJ O
frames NNS O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
a DT O
black JJ O
trailing VBG O
edge NN O
to IN O
the DT O
wing NN O
is VBZ O
discernable JJ O
( , O
though IN O
due IN O
to IN O
bleeding NN O
of IN O
white JJ O
as IN O
a DT O
video NN O
artifact NN O
, , O
it PRP O
appears VBZ O
narrower JJR O
than IN O
it PRP O
really RB O
is VBZ O
) -RRB- O
. . O

However RB O
, , O
analysis NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
in IN O
light NN O
of IN O
images NNS O
of IN O
known VBN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
confirms VBZ O
that IN O
a DT O
similar JJ O
black JJ O
trailing VBG O
edge NN O
to IN O
the DT O
wing NN O
is VBZ O
discernable JJ O
in IN O
some DT O
frames NNS O
of IN O
the DT O
Luneau NNP O
video NN O
( , O
compare VBP O
Figure NNP O
1B NNP O
, , O
frame NN O
775 CD O
with IN O
Figure NNP O
1A NNP O
, , O
frame NN O
366 CD O
. . O
7 CD O
: : O
the DT O
apparent JJ O
plumage NN O
patterns NNS O
are VBP O
similar JJ O
, , O
and CC O
inconsistent JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
) -RRB- O
. . O

It PRP O
is VBZ O
argued VBN O
here RB O
that IN O
the DT O
hypothesis NN O
put VBN O
forward RB O
in IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
is VBZ O
correct JJ O
, , O
and CC O
that IN O
the DT O
black JJ O
trailing VBG O
edge NN O
of IN O
the DT O
underwing NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
can MD O
indeed RB O
, , O
due IN O
to IN O
flexion NN O
of IN O
the DT O
wings NNS O
during IN O
the DT O
downstroke NN O
, , O
be VB O
misinterpreted VBN O
as IN O
the DT O
black JJ O
leading VBG O
edge NN O
and CC O
wingtips NNS O
of IN O
the DT O
upperwing NN O
of IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

3 LS O
. . O

Figure NN O
3 CD O
shows VBZ O
that IN O
the DT O
plumage NN O
patterns NNS O
shown VBN O
by IN O
the DT O
Luneau NNP O
bird NN O
, , O
throughout IN O
several JJ O
wingbeat NN O
cycles NNS O
, , O
are VBP O
compatible JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

The DT O
three CD O
plumage NN O
features NNS O
described VBN O
in IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
that WDT O
are VBP O
incompatible JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
( , O
black JJ O
secondary JJ O
feathers NNS O
on IN O
upper JJ O
surface NN O
of IN O
left JJ O
wing NN O
, , O
brighter JJR O
white JJ O
primary JJ O
bases NNS O
, , O
and CC O
a DT O
black JJ O
band NN O
curling VBG O
round IN O
the DT O
wing NN O
tip NN O
) , O
are VBP O
seen VBN O
consistently RB O
in IN O
the DT O
Luneau NNP O
video NN O
and CC O
are VBP O
recapitulated VBN O
throughout IN O
the DT O
video NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Discussion NN O

Evidence NN O
is VBZ O
presented VBN O
here RB O
to TO O
show VB O
that IN O
the DT O
distinctive JJ O
plumage NN O
features NNS O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
are VBP O
surprisingly RB O
difficult JJ O
to TO O
resolve VB O
in IN O
poor JJ O
- HYPH O
quality NN O
video NN O
of IN O
birds NNS O
in IN O
escape NN O
flight NN O
away RB O
from IN O
the DT O
camera NN O
, , O
and CC O
that IN O
they PRP O
can MD O
show VB O
apparent JJ O
plumage NN O
patterns NNS O
that WDT O
might MD O
more RBR O
readily RB O
be VB O
associated VBN O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

Irrespective RB O
of IN O
the DT O
identity NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
, , O
this DT O
knowledge NN O
will MD O
be VB O
critical JJ O
to IN O
assessment NN O
of IN O
further JJ O
claims NNS O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpeckers NNPS I-Species
during IN O
the DT O
current JJ O
intensive JJ O
search NN O
effort NN O
. . O

It PRP O
is VBZ O
, , O
however RB O
, , O
suggested VBN O
here RB O
that IN O
critical JJ O
frames NNS O
used VBN O
for IN O
identification NN O
of IN O
the DT O
Luneau NNP O
video NN O
woodpecker NN O
as IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
are VBP O
also RB O
consistent JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

The DT O
wingbeat NN O
frequency NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
is VBZ O
also RB O
perhaps RB O
consistent JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
at IN O
least JJS O
for IN O
short JJ O
periods NNS O
of IN O
flight NN O
. . O

Analysis NN O
of IN O
the DT O
videos NNS O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
has VBZ O
supported VBN O
the DT O
hypothesised JJ O
interpretations NNS O
of IN O
key JJ O
frames NNS O
of IN O
the DT O
Luneau NNP O
video NN O
by IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Although IN O
the DT O
rebuttal NN O
of IN O
that DT O
comment NN O
in IN O
Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
5 CD O
] -RRB- O
asserted VBD O
that IN O
flexion NN O
and CC O
motion NN O
of IN O
wings NNS O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
could MD O
not RB O
produce VB O
the DT O
images NNS O
seen VBN O
in IN O
the DT O
Luneau NNP O
video NN O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
here RB O
that WDT O
they PRP O
can MD O
. . O

The DT O
Luneau NNP O
video NN O
as IN O
presented VBN O
in IN O
Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
1 CD O
] -RRB- O
, , O
shows VBZ O
features NNS O
that WDT O
are VBP O
consistent JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
and CC O
inconsistent JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

It PRP O
is VBZ O
argued VBN O
in IN O
this DT O
paper NN O
that IN O
, , O
in IN O
fact NN O
, , O
the DT O
black JJ O
trailing VBG O
edge NN O
of IN O
the DT O
wing NN O
of IN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
is VBZ O
seen VBN O
clearly RB O
in IN O
the DT O
Luneau NNP O
video NN O
, , O
during IN O
the DT O
downstroke NN O
of IN O
the DT O
wingbeat NN O
cycle NN O
, , O
but CC O
that IN O
it PRP O
has VBZ O
been VBN O
misinterpreted VBN O
as IN O
black JJ O
wingtips NNS O
( -LRB- O
Figure NNP O
1 CD O
, , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

A DT O
fuller JJR O
analysis NN O
of IN O
the DT O
Luneau NNP O
video NN O
by IN O
the DT O
Cornell NNP O
University NNP O
team NN O
is VBZ O
presented VBN O
online RB O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Although IN O
it PRP O
is VBZ O
not RB O
peer NN O
- HYPH O
reviewed VBN O
, , O
the DT O
points NNS O
this DT O
article NN O
makes VBZ O
should MD O
be VB O
taken VBN O
into IN O
account NN O
. . O

The DT O
authors NNS O
summarise VBP O
nine CD O
diagnostic JJ O
traits NNS O
from IN O
their PRP$ O
analysis NN O
of IN O
the DT O
Luneau NNP O
video NN O
that WDT O
identify VBP O
the DT O
bird NN O
as IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

These DT O
are VBP O
listed VBN O
and CC O
discussed VBN O
point NN O
- HYPH O
by IN O
point NN O
below RB O
. . O

1 LS O
. . O

' '' O
The DT O
underwing JJ O
pattern NN O
in IN O
flight NN O
consistently RB O
appears VBZ O
largely RB O
white JJ O
, , O
giving VBG O
the DT O
appearance NN O
of IN O
having VBG O
black JJ O
wingtips NNS O
but CC O
lacking VBG O
any DT O
black NN O
along IN O
the DT O
rear NN O
, , O
or CC O
trailing VBG O
edge NN O
. . O
' '' O

Data NNS O
presented VBN O
in IN O
this DT O
paper NN O
show VBP O
that IN O
this DT O
statement NN O
is VBZ O
not RB O
wholly RB O
supported VBN O
, , O
and CC O
in IN O
any DT O
case NN O
the DT O
underwing NN O
of IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
can MD O
present VB O
the DT O
same JJ O
appearance NN O
. . O

2 LS O
. . O

' '' O
The DT O
upperwing JJ O
pattern NN O
in IN O
flight NN O
consistently RB O
shows VBZ O
a DT O
broad JJ O
, , O
white JJ O
trailing VBG O
edge NN O
, , O
with IN O
no DT O
frames NNS O
demonstrating VBG O
the DT O
conspicuous JJ O
dark JJ O
rear JJ O
border NN O
to TO O
be VB O
expected VBN O
of IN O
normal JJ O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
. . O
' '' O

Notwithstanding IN O
that DT O
certain JJ O
frames NNS O
of IN O
the DT O
Luneau NNP O
video NN O
( : O
e ADD O
. . O
g LS O
. . O
frame NN O
350 CD O
) -RRB- O
do VBP O
appear VB O
to TO O
show VB O
a DT O
black JJ O
trailing VBG O
edge NN O
to IN O
the DT O
upperwing NN O
, , O
data NNS O
presented VBN O
in IN O
this DT O
paper NN O
shows VBZ O
that IN O
, , O
at IN O
this DT O
angle NN O
of IN O
view NN O
and CC O
resolution NN O
of IN O
video NN O
, , O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
also RB O
may MD O
fail VB O
to TO O
show VB O
this DT O
feature NN O
. . O

This DT O
analysis NN O
has VBZ O
shown VBN O
that IN O
the DT O
hypothesis NN O
presented VBN O
in IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
is VBZ O
plausible JJ O
, , O
i PRP O
. . O
e UH O
. . O
that IN O
some DT O
of IN O
the DT O
frames NNS O
interpreted VBN O
by IN O
[ -LRB- O
1 CD O
] -RRB- O
to TO O
show VB O
the DT O
upperwing NN O
of IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
may MD O
in IN O
fact NN O
show VB O
large JJ O
amounts NNS O
of IN O
white JJ O
and CC O
the DT O
black JJ O
trailing VBG O
edge NN O
from IN O
the DT O
underwing NN O
of IN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

3 LS O
. . O

' '' O
The DT O
wings NNS O
are VBP O
longer JJR O
relative JJ O
to IN O
the DT O
body NN O
diameter NN O
than IN O
in IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
and CC O
consistent JJ O
with IN O
the DT O
wing NN O
shape NN O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O
' '' O

Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
5 CD O
] -RRB- O
agreed VBD O
that IN O
accurate JJ O
measurements NNS O
were VBD O
not RB O
possible JJ O
from IN O
the DT O
video NN O
images NNS O
presented VBN O
in IN O
their PRP$ O
original JJ O
paper NN O
[ -LRB- O
1 CD O
] -RRB- O
, , O
and CC O
it PRP O
seems VBZ O
unlikely JJ O
that IN O
much JJ O
confidence NN O
can MD O
be VB O
placed VBN O
in IN O
the DT O
wing NN O
- HYPH O
length NN O
measurements NNS O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
. . O

Comparison NN O
of IN O
, , O
for IN O
example NN O
, , O
Figure NNP O
1A NNP O
, , O
frame NN O
283 CD O
. . O
3 CD O
with IN O
Figure NNP O
1B NNP O
, , O
frame NN O
578 CD O
suggests VBZ O
that IN O
any DT O
differences NNS O
will MD O
be VB O
very RB O
difficult JJ O
to TO O
prove VB O
. . O

4 LS O
. . O

' '' O
Reenactment NN O
of IN O
the DT O
scene NN O
using VBG O
life NN O
- HYPH O
sized JJ O
, , O
realistically RB O
painted JJ O
, , O
dynamically RB O
flapping VBG O
models NNS O
produced VBD O
images NNS O
remarkably RB O
similar JJ O
to IN O
those DT O
of IN O
the DT O
Luneau NNP O
video NN O
using VBG O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
model NN O
, , O
and CC O
images NNS O
clearly RB O
identifiable JJ O
as IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
using VBG O
a DT O
model NN O
of IN O
that DT O
species NN O
. . O
' '' O

Interpretation NN O
of IN O
model NN O
re IN O
- HYPH O
enactments NNS O
is VBZ O
hampered VBN O
by IN O
the DT O
fact NN O
that IN O
the DT O
stiff JJ O
, , O
flat JJ O
- HYPH O
winged JJ O
models NNS O
cannot MD O
reflect VB O
the DT O
wing NN O
flexion NN O
and CC O
curvature NN O
of IN O
real JJ O
birds NNS O
. . O

Reenactment NN O
of IN O
the DT O
scene NN O
using VBG O
real JJ O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
has VBZ O
produced VBN O
images NNS O
remarkably RB O
similar JJ O
to IN O
the DT O
Luneau NNP O
video NN O
. . O

5 LS O
. . O

' '' O
The DT O
wingbeat NN O
frequency NN O
is VBZ O
8 CD O
. . O
6 CD O
beats NNS O
per IN O
second NN O
, , O
which WDT O
is VBZ O
almost RB O
identical JJ O
to IN O
that DT O
recorded VBN O
for IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
( , O
as IN O
documented VBN O
by IN O
one CD O
acoustic JJ O
record NN O
from IN O
1935 CD O
) -RRB- O
. . O

The DT O
wing NN O
- HYPH O
beat NN O
frequencies NNS O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
are VBP O
not RB O
known VBN O
to TO O
exceed VB O
7 CD O
. . O
5 CD O
beats NNS O
per IN O
second NN O
, , O
and CC O
more RBR O
typically RB O
range VBP O
between IN O
3 CD O
and CC O
6 CD O
beats NNS O
per IN O
second NN O
. . O
' '' O

The DT O
fact NN O
that IN O
in IN O
only RB O
four CD O
recorded VBN O
escape NN O
flights NNS O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
two CD O
were VBD O
recorded VBN O
for IN O
which WDT O
the DT O
initial JJ O
escape NN O
flight NN O
wingbeat NN O
frequency NN O
( , O
8 CD O
. . O
0 CD O
s NN O
- HYPH O
1 CD O
and CC O
8 CD O
. . O
6 CD O
s NN O
- HYPH O
1 CD O
) -RRB- O
exceeded VBD O
that DT O
previously RB O
recorded VBN O
for IN O
this DT O
species NN O
shows VBZ O
that IN O
previous JJ O
datasets NNS O
were VBD O
too RB O
limited JJ O
to TO O
make VB O
this DT O
conclusion NN O
. . O

Birds NNS O
flap VBP O
more RBR O
rapidly RB O
at IN O
take VBP O
off RP O
to TO O
gain VB O
altitude NN O
and CC O
speed NN O
than IN O
they PRP O
do VBP O
in IN O
sustained JJ O
level NN O
flight NN O
: : O
Pileated NNP B-Species
Woodpecker NNP I-Species
flight NN O
data NNS O
in IN O
the DT O
literature NN O
[ -LRB- O
1 CD O
, , O
4 CD O
, , O
5 CD O
] -RRB- O
was VBD O
derived VBN O
from IN O
the DT O
work NN O
of IN O
Tobalske NNP O
[ -LRB- O
8 CD O
] -RRB- O
, , O
which WDT O
explicitly RB O
excluded VBD O
the DT O
initial JJ O
take NN O
- HYPH O
off NN O
period NN O
, , O
and CC O
therefore RB O
cannot MD O
be VB O
used VBN O
to TO O
support VB O
the DT O
elimination NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
in IN O
the DT O
Luneau NNP O
video NN O
. . O

Furthermore RB O
, , O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
is VBZ O
consistently RB O
gaining VBG O
height NN O
from IN O
a DT O
low JJ O
position NN O
above IN O
water NN O
and CC O
, , O
whatever WDT O
its PRP$ O
species NN O
, , O
might MD O
be VB O
expected VBN O
to TO O
flap VB O
more RBR O
rapidly RB O
than IN O
if IN O
it PRP O
were VBD O
in IN O
level JJ O
flight NN O
. . O

Tanner NNP O
[ -LRB- O
9 CD O
] -RRB- O
noted VBD O
that IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
can MD O
maintain VB O
extended JJ O
fast JJ O
direct JJ O
flight NN O
. . O

He PRP O
was VBD O
of IN O
the DT O
opinion NN O
that IN O
flight NN O
pattern NN O
was VBD O
not RB O
a DT O
useful JJ O
character NN O
for IN O
separating VBG O
the DT O
two CD O
species NNS O
in IN O
the DT O
field NN O
, , O
and CC O
that IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
frequently RB O
fly VBP O
in IN O
a DT O
manner NN O
that WDT O
was VBD O
in IN O
no DT O
way NN O
different JJ O
to IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpeckers NNPS I-Species
. . O

The DT O
figure NN O
of IN O
8 CD O
. . O
6 CD O
wingbeats NNS O
per IN O
second NN O
for IN O
the DT O
Luneau NNP O
bird NN O
( , O
data NNS O
reanalysed VBN O
here RB O
) -RRB- O
is VBZ O
taken VBN O
as IN O
consistent JJ O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
on IN O
the DT O
basis NN O
of IN O
analysis NN O
of IN O
a DT O
single JJ O
archival JJ O
audio JJ O
recording NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

The DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
in IN O
that DT O
audio JJ O
tape NN O
is VBZ O
clearly RB O
flapping VBG O
its PRP$ O
wings NNS O
, , O
but CC O
without IN O
accompanying VBG O
visual JJ O
confirmation NN O
it PRP O
is VBZ O
not RB O
clear JJ O
that IN O
it PRP O
is VBZ O
in IN O
flight NN O
. . O

In IN O
general JJ O
, , O
larger JJR O
birds NNS O
are VBP O
expected VBN O
to TO O
flap VB O
their PRP$ O
wings NNS O
more RBR O
slowly RB O
than IN O
smaller JJR O
birds NNS O
of IN O
comparable JJ O
wing NN O
morphology NN O
. . O

Tobalske NNP O
[ -LRB- O
8 CD O
] -RRB- O
showed VBD O
that IN O
, , O
across IN O
species NNS O
, , O
smaller JJR O
woodpeckers NNS O
tend VBP O
to TO O
flap VB O
more RBR O
quickly RB O
than IN O
larger JJR O
ones NNS O
, , O
and CC O
that IN O
there EX O
was VBD O
considerable JJ O
intraspecific JJ O
variation NN O
. . O

The DT O
assertion NN O
that IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpeckers NNPS I-Species
flap VBP O
their PRP$ O
wings NNS O
more RBR O
quickly RB O
than IN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
is VBZ O
therefore RB O
counterintuitive JJ O
. . O

Further JJ O
comment NN O
is VBZ O
conjecture NN O
: : O
while IN O
the DT O
flight NN O
pattern NN O
and CC O
wing NN O
posture NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
may MD O
be VB O
unusual JJ O
, , O
it PRP O
has VBZ O
not RB O
been VBN O
shown VBN O
that IN O
it PRP O
is VBZ O
outside IN O
the DT O
range NN O
of IN O
variability NN O
of IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
and CC O
cannot MD O
therefore RB O
be VB O
used VBN O
to TO O
eliminate VB O
the DT O
possibility NN O
that IN O
it PRP O
was VBD O
the DT O
commoner NN O
species NN O
. . O

6 LS O
. . O

' `` O
White JJ O
plumage NN O
on IN O
the DT O
back NN O
is VBZ O
visible JJ O
on IN O
the DT O
retreating VBG O
bird NN O
as IN O
it PRP O
begins VBZ O
to TO O
gain VB O
altitude NN O
. . O

Ivory NN B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
has VBZ O
white JJ O
on IN O
the DT O
back NN O
; : O
Pileated NNP B-Species
Woodpecker NNP I-Species
has VBZ O
entirely RB O
black JJ O
back NN O
. . O
' '' O

This DT O
was VBD O
discussed VBN O
by IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
, , O
who WP O
argued VBD O
that IN O
the DT O
images NNS O
thought VBD O
to TO O
show VB O
white JJ O
on IN O
the DT O
dorsum NN O
were VBD O
too RB O
small JJ O
to TO O
be VB O
accepted VBN O
uncritically RB O
. . O

In IN O
all PDT O
the DT O
frames NNS O
of IN O
the DT O
Luneau NNP O
video NN O
that WDT O
appear VBP O
to TO O
show VB O
white JJ O
on IN O
the DT O
dorsum NN O
, , O
the DT O
bird NN O
is VBZ O
distant JJ O
( , O
dorsal JJ O
white JJ O
is VBZ O
not RB O
visible JJ O
on IN O
the DT O
higher JJR O
resolution NN O
images NNS O
earlier RBR O
in IN O
the DT O
video NN O
) , O
and CC O
partially RB O
obscured VBN O
, , O
making VBG O
it PRP O
difficult JJ O
to TO O
distinguish VB O
dorsum NN O
from IN O
wing NN O
. . O

Spurious JJ O
areas NNS O
of IN O
white JJ O
pixels NNS O
appear VBP O
as IN O
artifacts NNS O
in IN O
both DT O
videos NNS O
. . O

Nevertheless RB O
, , O
this DT O
remains VBZ O
the DT O
best JJS O
evidence NN O
that IN O
the DT O
Luneau NNP O
bird NN O
was VBD O
not RB O
a DT O
standard NN O
Pileated VBN B-Species
Woodpecker NNP I-Species
. . O

7 LS O
. . O

' '' O
The DT O
dorsal JJ O
view NN O
of IN O
the DT O
right JJ O
wing NN O
as IN O
it PRP O
begins VBZ O
to TO O
unfold VB O
shows VBZ O
a DT O
triangle NN O
of IN O
white JJ O
that WDT O
matches VBZ O
in IN O
size NN O
and CC O
position VB O
the DT O
white JJ O
on IN O
the DT O
folded VBN O
wing NN O
of IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
beginning VBG O
to TO O
launch VB O
into IN O
flight NN O
. . O
' '' O

No DT O
further JJ O
comment NN O
is VBZ O
provided VBN O
here RB O
. . O

An DT O
alternative JJ O
explanation NN O
was VBD O
offered VBN O
by IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
and CC O
rebutted VBN O
by IN O
Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
statement NN O
requires VBZ O
a DT O
degree NN O
of IN O
certainty NN O
about IN O
the DT O
position NN O
of IN O
the DT O
wing NN O
. . O

( : O
8 CD O
) , O
' '' O
The DT O
distance NN O
between IN O
the DT O
wrist NN O
area NN O
and CC O
the DT O
tip NN O
of IN O
the DT O
tail NN O
( : O
32 CD O
- SYM O
36 CD O
cm NNS O
, , O
as IN O
measured VBN O
when WRB O
the DT O
bird NN O
begins VBZ O
to TO O
take VB O
flight NN O
) -RRB- O
is VBZ O
comparable JJ O
to IN O
known VBN O
measurements NNS O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
and CC O
considerably RB O
larger JJR O
than IN O
even RB O
the DT O
largest JJS O
Pileated NNP B-Species
Woodpecker NNP I-Species
we PRP O
measured VBD O
. . O
' '' O

As IN O
stated VBN O
under IN O
( : O
3 CD O
) -RRB- O
, , O
above RB O
, , O
there EX O
is VBZ O
general JJ O
agreement NN O
that IN O
accurate JJ O
measurements NNS O
are VBP O
not RB O
possible JJ O
from IN O
the DT O
Luneau NNP O
video NN O
because IN O
too RB O
many JJ O
uncontrolled JJ O
variables NNS O
are VBP O
involved VBN O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
. . O

9 LS O
. . O

' '' O
Only RB O
20 CD O
seconds NNS O
before IN O
the DT O
woodpecker NN O
flees VBZ O
, , O
a DT O
bird NN O
with IN O
the DT O
size NN O
and CC O
color NN O
pattern NN O
of IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
was VBD O
perched VBN O
within IN O
3 CD O
m NN O
of IN O
the DT O
site NN O
from IN O
which WDT O
the DT O
woodpecker NN O
took VBD O
flight NN O
. . O
' '' O

This DT O
would MD O
be VB O
a DT O
strong JJ O
argument NN O
if IN O
it PRP O
could MD O
be VB O
shown VBN O
that IN O
the DT O
object NN O
in IN O
question NN O
was VBD O
a DT O
bird NN O
and CC O
not RB O
, , O
as IN O
is VBZ O
now RB O
apparently RB O
thought VBN O
likely JJ O
, , O
a DT O
section NN O
of IN O
branch NN O
or CC O
tree NN O
stump NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
Luneau NNP O
video NN O
reveals VBZ O
several JJ O
white JJ O
triangular JJ O
patches NNS O
apparently RB O
visible JJ O
on IN O
or CC O
around IN O
tree NN O
trunks NNS O
, , O
most JJS O
or CC O
all DT O
of IN O
which WDT O
must MD O
therefore RB O
be VB O
images NNS O
of IN O
tree NN O
topography NN O
or CC O
video NN O
artifacts NNS O
. . O

This DT O
was VBD O
discussed VBN O
in IN O
the DT O
literature NN O
( , O
see VB O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
) -RRB- O
. . O

Central JJ O
to IN O
the DT O
identification NN O
of IN O
the DT O
flying VBG O
bird NN O
seen VBN O
in IN O
the DT O
Luneau NNP O
video NN O
was VBD O
the DT O
evidence NN O
that IN O
plumage NN O
and CC O
flight NN O
patterns NNS O
were VBD O
inconsistent JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

A DT O
very RB O
basic JJ O
video NN O
analysis NN O
presented VBN O
here RB O
has VBZ O
suggested VBN O
that IN O
this DT O
may MD O
not RB O
be VB O
the DT O
case NN O
, , O
and CC O
that IN O
further JJ O
research NN O
is VBZ O
needed VBN O
. . O

Any DT O
identification NN O
of IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
as IN O
an DT O
Ivory NNP B-Species
- HYPH I-Species
bill NN I-Species
must MD O
take VB O
into IN O
account NN O
the DT O
data NNS O
presented VBN O
here RB O
and CC O
in IN O
Sibley NNP O
et FW O
al NNP O
[ -LRB- O
4 CD O
] -RRB- O
, , O
which WDT O
shows VBZ O
it PRP O
is VBZ O
largely RB O
consistent JJ O
with IN O
Pileated NNP B-Species
Woodpecker NNP I-Species
and CC O
points VBZ O
out RP O
apparent JJ O
inconsistencies NNS O
with IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
. . O

This DT O
does VBZ O
not RB O
of IN O
course NN O
necessarily RB O
imply VB O
that IN O
the DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
is VBZ O
extinct JJ O
, , O
nor CC O
indeed RB O
entirely RB O
rule VB O
out RP O
the DT O
possibility NN O
that IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
was VBD O
one CD O
. . O

There EX O
appears VBZ O
to TO O
be VB O
no DT O
reason NN O
to TO O
question VB O
the DT O
anecdotal JJ O
sight NN O
records NNS O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
presented VBN O
in IN O
Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
1 CD O
] -RRB- O
( , O
or CC O
in IN O
many JJ O
online JJ O
sources NNS O
) -RRB- O
, , O
because IN O
some DT O
of IN O
them PRP O
appear VBP O
credible JJ O
, , O
albeit IN O
brief JJ O
. . O

Audio JJ O
evidence NN O
has VBZ O
since RB O
been VBN O
published VBN O
[ -LRB- O
11 CD O
] -RRB- O
although IN O
this DT O
too RB O
is VBZ O
far RB O
from IN O
conclusive JJ O
. . O

However RB O
, , O
to TO O
regard VB O
the DT O
Luneau NNP O
video NN O
by IN O
itself PRP O
as IN O
presenting VBG O
anything NN O
other JJ O
than IN O
an DT O
unidentified JJ O
woodpecker NN O
falls VBZ O
below IN O
the DT O
standards NNS O
of IN O
proof NN O
normally RB O
required VBN O
for IN O
scientific JJ O
publication NN O
: : O
the DT O
images NNS O
are VBP O
not RB O
good JJ O
enough RB O
. . O

The DT O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
may MD O
persist VB O
in IN O
continental JJ O
North NNP O
America NNP O
, , O
and CC O
there EX O
is VBZ O
enough JJ O
anecdotal JJ O
evidence NN O
to TO O
make VB O
this DT O
a DT O
possibility NN O
, , O
but CC O
the DT O
Luneau NNP O
video NN O
does VBZ O
not RB O
support VB O
the DT O
case NN O
. . O

The DT O
balance NN O
of IN O
evidence NN O
would MD O
suggest VB O
that IN O
the DT O
bird NN O
in IN O
the DT O
Luneau NNP O
video NN O
is VBZ O
more RBR O
likely JJ O
to TO O
have VB O
been VBN O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
, , O
but CC O
the DT O
search NN O
for IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
should MD O
continue VB O
. . O

While IN O
this DT O
paper NN O
was VBD O
under IN O
review NN O
, , O
a DT O
report NN O
of IN O
sight NN O
records NNS O
and CC O
sound NN O
recordings NNS O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpeckers NNPS I-Species
was VBD O
published VBN O
from IN O
a DT O
location NN O
in IN O
Florida NNP O
[ -LRB- O
12 CD O
] -RRB- O
. . O

This DT O
very RB O
exciting JJ O
claim NN O
is VBZ O
strengthened VBN O
by IN O
reports NNS O
of IN O
sighting NN O
of IN O
the DT O
white JJ O
dorsal JJ O
stripes NNS O
on IN O
one CD O
bird NN O
in IN O
flight NN O
. . O

Unfortunately RB O
, , O
several JJ O
sightings NNS O
were VBD O
made VBN O
without IN O
optical JJ O
aids NNS O
and CC O
cannot MD O
be VB O
considered VBN O
proven VBN O
. . O

The DT O
' `` O
kent NN O
' '' O
calls VBZ O
recorded VBN O
from IN O
the DT O
Florida NNP O
location NN O
are VBP O
spectrographically RB O
similar JJ O
to IN O
the DT O
' `` O
bleat NN O
' '' O
calls NNS O
of IN O
young JJ O
White NNP B-Species
- HYPH I-Species
tailed JJ I-Species
Deer NNP I-Species
, , O
as IN O
described VBN O
in IN O
Richardson NNP O
et FW O
al NNP O
[ -LRB- O
13 CD O
] -RRB- O
. . O

A DT O
clear JJ O
photograph NN O
will MD O
be VB O
required VBN O
from IN O
this DT O
location NN O
too RB O
before IN O
the DT O
presence NN O
of IN O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpeckers NNPS I-Species
can MD O
be VB O
considered VBN O
confirmed VBN O
. . O

It PRP O
is VBZ O
hoped VBN O
that IN O
this DT O
paper NN O
will MD O
help VB O
with IN O
assessment NN O
of IN O
any DT O
further JJ O
low JJ O
quality NN O
photographs NNS O
or CC O
videos NNS O
. . O

Conclusion NN O

Flight NN O
and CC O
plumage NN O
patterns NNS O
of IN O
the DT O
putative JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
recorded VBN O
in IN O
Arkansas NNP O
in IN O
2005 CD O
are VBP O
recapitulated VBN O
by IN O
confirmed VBN O
Pileated NNP B-Species
Woodpeckers NNPS I-Species
. . O

The DT O
bird NN O
in IN O
the DT O
Arkansas NNP O
video NN O
is VBZ O
best RBS O
regarded VBN O
as IN O
not RB O
fully RB O
identified VBN O
, , O
and CC O
is VBZ O
probably RB O
a DT O
Pileated NNP B-Species
Woodpecker NNP I-Species
. . O

Methods NNS O

Video NNP O
recording NN O

Pileated VBN B-Species
Woodpeckers NNPS I-Species
were VBD O
attracted VBN O
to IN O
a DT O
bird NN O
feeder NN O
containing VBG O
suet NN O
at IN O
Grants NNP O
Trail NNP O
, , O
Dayton NNP O
, , O
OH NNP O
45459 CD O
. . O

The DT O
suet NN O
feeder NN O
was VBD O
placed VBN O
approximately RB O
2 CD O
. . O
1 CD O
m NN O
high RB O
on IN O
a DT O
tree NN O
trunk NN O
, , O
and CC O
the DT O
distance NN O
to IN O
the DT O
suet NN O
feeder NN O
from IN O
the DT O
observation NN O
point NN O
was VBD O
approximately RB O
5 CD O
m NN O
. . O

Birds NNS O
on IN O
the DT O
feeder NN O
were VBD O
startled VBN O
by IN O
movement NN O
of IN O
window NN O
blinds NNS O
on IN O
January NNP O
28 CD O
and CC O
February NNP O
5 CD O
, , O
2006 CD O
, , O
and CC O
their PRP$ O
escape NN O
flights NNS O
were VBD O
filmed VBN O
using VBG O
a DT O
Sony NNP O
Hi NNP O
- HYPH O
8 CD O
SteadyShot NNP O
video NN O
camera NN O
at IN O
29 CD O
. . O
97 CD O
frames NNS O
s SYM O
- HYPH O
1 CD O
. . O

At IN O
least JJS O
two CD O
birds NNS O
feature VBP O
in IN O
the DT O
videos NNS O
, , O
male JJ O
and CC O
female JJ O
. . O

Analogue NN O
tape NN O
was VBD O
converted VBN O
to IN O
digital JJ O
by IN O
connecting VBG O
the DT O
Hi NNP O
- HYPH O
8 CD O
camera NN O
directly RB O
to IN O
a DT O
Sony NNP O
DCR NNP O
- HYPH O
HC30 NNP O
digital JJ O
video NN O
camera NN O
and CC O
recording NN O
onto IN O
that DT O
camera NN O
' POS O
s POS O
mini JJ O
dv NN O
cassette NN O
. . O

The DT O
resulting VBG O
images NNS O
were VBD O
converted VBN O
to IN O
an DT O
avi NN O
file NN O
using VBG O
Windows NNP O
Movie NNP O
Maker NNP O
on IN O
a DT O
Windows NNP O
XP NNP O
PC NNP O
. . O

The DT O
video NN O
is VBZ O
freely RB O
available JJ O
in IN O
wmv NNP O
format NN O
[ -LRB- O
14 CD O
] -RRB- O
and CC O
in IN O
avi NN O
format NN O
from IN O
the DT O
author NN O
or CC O
David NNP O
Nolin NNP O
( : O
via IN O
the DT O
author NN O
) -RRB- O
. . O

The DT O
video NN O
was VBD O
decompiled VBN O
using VBG O
Blaze NNP O
Media NNP O
Pro NNP O
( : O
Mystik NNP O
Media NNP O
, , O
Hampstead NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
for IN O
a DT O
detailed JJ O
analysis NN O
. . O

Import NN O
into IN O
Avid NNP O
( , O
R NNP O
) -RRB- O
Xpress NNP O
Pro NNP O
HD NN O
for IN O
deinterlacing NN O
did VBD O
not RB O
reduce VB O
the DT O
wing NN O
flicker NN O
seen VBN O
in IN O
the DT O
images NNS O
, , O
and CC O
further JJ O
professional JJ O
processing NN O
could MD O
not RB O
improve VB O
the DT O
resolution NN O
, , O
so IN O
the DT O
original JJ O
decompiled VBN O
file NN O
was VBD O
used VBN O
for IN O
analysis NN O
. . O

Hence RB O
some DT O
frames NNS O
contain VBP O
two CD O
overlaid JJ O
images NNS O
, , O
which WDT O
may MD O
lower VB O
the DT O
resolution NN O
in IN O
some DT O
cases NNS O
. . O

The DT O
decompiled VBN O
file NN O
was VBD O
examined VBN O
frame NN O
by IN O
frame NN O
and CC O
compared VBN O
to IN O
the DT O
decompiled VBN O
images NNS O
of IN O
the DT O
putative JJ O
Ivory NNP B-Species
- HYPH I-Species
billed VBN I-Species
Woodpecker NNP I-Species
presented VBN O
in IN O
Fitzpatrick NNP O
et FW O
al NNP O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Wingbeat NNP O
frequencies NNS O
were VBD O
calculated VBN O
by IN O
noting VBG O
the DT O
frame NN O
number NN O
of IN O
the DT O
midpoint NN O
of IN O
the DT O
downstroke NN O
of IN O
each DT O
wingbeat NN O
( , O
e LS O
. . O
g LS O
. . O
Figure NNP O
1B NN O
, , O
frame NN O
758 CD O
) -RRB- O
and CC O
calculating VBG O
the DT O
length NN O
of IN O
time NN O
taken VBN O
per IN O
wingbeat NN O
as IN O
( , O
number NN O
of IN O
frames NNS O
between IN O
downstroke NN O
midpoints NNS O
) SYM O
/ SYM O
29 CD O
. . O
97 CD O
. . O

Authors NNS O
' POS O
contributions NNS O

JMC NNP O
performed VBD O
the DT O
data NNS O
analysis NN O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

Supplementary JJ O
Material NN O

A DT O
global JJ O
gene NN O
evolution NN O
analysis NN O
on IN O
Vibrionaceae NNP O
family NN O
using VBG O
phylogenetic JJ O
profile NN O

Abstract JJ O

Background NN O

Vibrionaceae NNP O
represent VBP O
a DT O
significant JJ O
portion NN O
of IN O
the DT O
cultivable JJ O
heterotrophic JJ O
sea NN O
bacteria NNS O
; , O
they PRP O
strongly RB O
affect VBP O
nutrient JJ O
cycling NN O
and CC O
some DT O
species NNS O
are VBP O
devastating JJ O
pathogens NNS O
. . O

In IN O
this DT O
work NN O
we PRP O
propose VBP O
an DT O
improved JJ O
phylogenetic JJ O
profile NN O
analysis NN O
on IN O
14 CD O
Vibrionaceae NNP O
genomes NNS O
, , O
to TO O
study VB O
the DT O
evolution NN O
of IN O
this DT O
family NN O
on IN O
the DT O
basis NN O
of IN O
gene NN O
content NN O
. . O

The DT O
phylogenetic JJ O
profile NN O
is VBZ O
based VBN O
on IN O
the DT O
observation NN O
that IN O
genes NNS O
involved VBN O
in IN O
the DT O
same JJ O
process NN O
( , O
e LS O
. . O
g LS O
. . O
metabolic JJ O
pathway NN O
or CC O
structural JJ O
complex NN O
) -RRB- O
tend VBP O
to TO O
be VB O
concurrently RB O
present JJ O
or CC O
absent JJ O
within IN O
different JJ O
genomes NNS O
. . O

This DT O
allows VBZ O
the DT O
prediction NN O
of IN O
hypothetical JJ O
functions NNS O
on IN O
the DT O
basis NN O
of IN O
a DT O
shared VBN O
phylogenetic JJ O
profiles NNS O
. . O

Moreover RB O
this DT O
approach NN O
is VBZ O
useful JJ O
to TO O
identify VB O
putative JJ O
laterally RB O
transferred VBN O
elements NNS O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
presence NN O
on IN O
distantly RB O
phylogenetically RB O
related VBN O
bacteria NNS O
. . O

Results NNS O

Vibrionaceae NN O
ORFs NNS O
were VBD O
aligned VBN O
against IN O
all PDT O
the DT O
available JJ O
bacterial JJ O
proteomes NNS O
. . O

Phylogenetic JJ O
profile NN O
is VBZ O
defined VBN O
as IN O
an DT O
array NN O
of IN O
distances NNS O
, , O
based VBN O
on IN O
aminoacid JJ O
substitution NN O
matrixes NNS O
, , O
from IN O
single JJ O
genes NNS O
to IN O
all DT O
their PRP$ O
orthologues NNS O
. . O

Final JJ O
phylogenetic JJ O
profiles NNS O
, , O
derived VBN O
from IN O
non AFX O
- HYPH O
redundant JJ O
list NN O
of IN O
all DT O
ORFs NNS O
, , O
was VBD O
defined VBN O
as IN O
the DT O
median NN O
of IN O
all PDT O
the DT O
profiles NNS O
belonging VBG O
to IN O
the DT O
cluster NN O
. . O

The DT O
resulting VBG O
phylogenetic JJ O
profiles NNS O
matrix NN O
contains VBZ O
gene NN O
clusters NNS O
on IN O
the DT O
rows NNS O
and CC O
organisms NNS O
on IN O
the DT O
columns NNS O
. . O

Cluster NN O
analysis NN O
identified VBD O
groups NNS O
of IN O
"""" `` O
core JJ O
genes NNS O
"""" '' O
with IN O
a DT O
widespread JJ O
high JJ O
similarity NN O
across IN O
all PDT O
the DT O
organisms NNS O
and CC O
several JJ O
clusters NNS O
that WDT O
contain VBP O
genes NNS O
homologous JJ O
only RB O
to IN O
a DT O
limited JJ O
set NN O
of IN O
organisms NNS O
. . O

On IN O
each DT O
of IN O
these DT O
clusters NNS O
, , O
COG NNP O
class NN O
enrichment NN O
has VBZ O
been VBN O
calculated VBN O
. . O

The DT O
analysis NN O
reveals VBZ O
that IN O
clusters NNS O
of IN O
core NN O
genes NNS O
have VBP O
the DT O
highest JJS O
number NN O
of IN O
enriched VBN O
classes NNS O
, , O
while IN O
the DT O
others NNS O
are VBP O
enriched VBN O
just RB O
for IN O
few JJ O
of IN O
them PRP O
like IN O
DNA NN O
replication NN O
, , O
recombination NN O
and CC O
repair NN O
. . O

Conclusion NN O

We PRP O
found VBD O
that IN O
mobile JJ O
elements NNS O
have VBP O
heterogeneous JJ O
profiles NNS O
not RB O
only RB O
across IN O
the DT O
entire JJ O
set NN O
of IN O
organisms NNS O
, , O
but CC O
also RB O
within IN O
Vibrionaceae NNP O
; , O
this DT O
confirms VBZ O
their PRP$ O
great JJ O
influence NN O
on IN O
bacteria NNS O
evolution NN O
even RB O
inside IN O
the DT O
same JJ O
family NN O
. . O

Furthermore RB O
, , O
several JJ O
hypothetical JJ O
proteins NNS O
highly RB O
correlate VBP O
with IN O
mobile JJ O
elements NNS O
profiles NNS O
suggesting VBG O
a DT O
possible JJ O
horizontal JJ O
transfer NN O
mechanism NN O
for IN O
the DT O
evolution NN O
of IN O
these DT O
genes NNS O
. . O

Finally RB O
, , O
we PRP O
suggested VBD O
the DT O
putative JJ O
role NN O
of IN O
some DT O
ORFs NNS O
having VBG O
an DT O
unknown JJ O
function NN O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
phylogenetic JJ O
profile NN O
similarity NN O
to IN O
well RB O
characterized VBN O
genes NNS O
. . O

Background NN O

Over IN O
the DT O
past JJ O
ten CD O
years NNS O
, , O
a DT O
great JJ O
number NN O
of IN O
microbial JJ O
genomes NNS O
have VBP O
been VBN O
sequenced VBN O
covering VBG O
a DT O
wide JJ O
representation NN O
of IN O
prokaryots NNS O
as RB O
well RB O
as IN O
multiple JJ O
strains NNS O
of IN O
some DT O
species NNS O
. . O

The DT O
study NN O
of IN O
these DT O
genomes NNS O
both CC O
by IN O
computational JJ O
and CC O
experimental JJ O
approaches NNS O
has VBZ O
highly RB O
improved VBN O
our PRP$ O
understanding NN O
on IN O
physiology NN O
, , O
phylogenetic JJ O
relationship NN O
and CC O
pathogenicity NN O
of IN O
many JJ O
organisms NNS O
. . O

Furthermore RB O
, , O
it PRP O
has VBZ O
provided VBN O
new JJ O
knowledge NN O
on IN O
microbial JJ O
genome NN O
evolution NN O
, , O
revealing VBG O
a DT O
gene NN O
core NN O
shared VBN O
by IN O
the DT O
great JJ O
majority NN O
of IN O
bacteria NNS O
, , O
genes NNS O
characteristic JJ O
of IN O
particular JJ O
groups NNS O
and CC O
"""" `` O
novel NN O
"""" '' O
genes NNS O
that WDT O
possibly RB O
originated VBD O
by IN O
lateral JJ O
gene NN O
transfer NN O
from IN O
some DT O
unknown JJ O
source NN O
. . O

Analysis NN O
performed VBN O
on IN O
closely RB O
related VBN O
genomes NNS O
revealed VBD O
that IN O
a DT O
substantial JJ O
fraction NN O
of IN O
genes NNS O
in IN O
any DT O
genome NN O
seem VBP O
to TO O
be VB O
strain NN O
specific JJ O
. . O

These DT O
genes NNS O
might MD O
sometime RB O
arise VB O
by IN O
gene NN O
duplication NN O
followed VBN O
by IN O
a DT O
rapid JJ O
divergence NN O
, , O
or CC O
by IN O
lineage NN O
- HYPH O
specific JJ O
loss NN O
of IN O
genes NNS O
in IN O
one CD O
strain NN O
, , O
resulting VBG O
in IN O
a DT O
unique JJ O
gene NN O
in IN O
other JJ O
strains NNS O
. . O

However RB O
, , O
there EX O
are VBP O
several JJ O
lines NNS O
of IN O
evidence NN O
indicating VBG O
that IN O
lateral JJ O
gene NN O
transfer NN O
may MD O
be VB O
the DT O
main JJ O
mechanism NN O
to TO O
acquire VB O
novel JJ O
genes NNS O
. . O

Indeed RB O
, , O
this DT O
could MD O
be VB O
one CD O
of IN O
the DT O
main JJ O
forces NNS O
driving VBG O
bacterial JJ O
adaptation NN O
and CC O
evolution NN O
. . O

Phage NNP O
DNA NNP O
is VBZ O
thought VBN O
to TO O
be VB O
one CD O
of IN O
the DT O
main JJ O
vectors NNS O
for IN O
lateral JJ O
gene NN O
transfer NN O
among IN O
bacteria NNS O
[ -LRB- O
1 CD O
] -RRB- O
and CC O
many JJ O
virulence NN O
factors NNS O
from IN O
bacterial JJ O
pathogen NN O
are VBP O
phage NN O
encoded VBN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

For IN O
example NN O
, , O
the DT O
genes NNS O
for IN O
CT NNP O
, , O
the DT O
most RBS O
important JJ O
virulence NN O
factor NN O
of IN O
V NN B-Species
. . I-Species
cholerae NN I-Species
, , O
are VBP O
encoded VBN O
in IN O
the DT O
genome NN O
of IN O
phage NN O
CTX NN O
phi NN O
, , O
integrated VBN O
in IN O
the DT O
bacterial JJ O
chromosome NN O
1 CD O
. . O

Since IN O
lateral JJ O
gene NN O
transfer NN O
plays VBZ O
a DT O
relevant JJ O
role NN O
in IN O
bacterial JJ O
evolution NN O
, , O
the DT O
reconstruction NN O
of IN O
phylogeny NN O
is VBZ O
very RB O
complex JJ O
and CC O
phylogenetic JJ O
trees NNS O
built VBN O
by IN O
standard JJ O
sequence NN O
analysis NN O
may MD O
not RB O
lead VB O
to IN O
a DT O
reliable JJ O
picture NN O
of IN O
the DT O
evolutionary JJ O
history NN O
. . O

In IN O
fact NN O
, , O
alternative JJ O
trees NNS O
can MD O
be VB O
obtained VBN O
when WRB O
different JJ O
proteins NNS O
are VBP O
considered VBN O
. . O

For IN O
many JJ O
aspects NNS O
the DT O
classification NN O
of IN O
bacteria NNS O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
global JJ O
gene NN O
content NN O
may MD O
give VB O
a DT O
better JJR O
description NN O
of IN O
their PRP$ O
evolutionary JJ O
history NN O
. . O

This DT O
may MD O
be VB O
particularly RB O
important JJ O
when WRB O
bacteria NNS O
of IN O
the DT O
same JJ O
group NN O
are VBP O
compared VBN O
, , O
since IN O
newly RB O
acquired VBN O
genes NNS O
could MD O
be VB O
relevant JJ O
to TO O
confer VB O
peculiar JJ O
features NNS O
that WDT O
allows VBZ O
the DT O
exploitation NN O
of IN O
different JJ O
ecological JJ O
niches NNS O
. . O

In IN O
this DT O
study NN O
we PRP O
propose VBP O
a DT O
bioinformatic JJ O
procedure NN O
to TO O
investigate VB O
bacterial JJ O
genome NN O
evolution NN O
, , O
taking VBG O
into IN O
account NN O
the DT O
global JJ O
gene NN O
content NN O
, , O
as RB O
well RB O
as IN O
sequence NN O
similarity NN O
. . O

We PRP O
based VBD O
our PRP$ O
analysis NN O
on IN O
modified VBN O
phylogenetic JJ O
profiles NNS O
[ -LRB- O
3 CD O
] -RRB- O
; , O
however RB O
, , O
we PRP O
do VBP O
not RB O
consider VB O
only RB O
the DT O
presence NN O
/ SYM O
absence NN O
of IN O
orthologue NN O
genes NNS O
, , O
but CC O
also RB O
their PRP$ O
distance NN O
, , O
based VBN O
on IN O
a DT O
substitution NN O
matrix NN O
. . O

A DT O
phylogenetic JJ O
profile NN O
is VBZ O
a DT O
non AFX O
- HYPH O
sequence NN O
- HYPH O
homology NN O
- HYPH O
based VBN O
method NN O
developed VBN O
to TO O
infer VB O
a DT O
possible JJ O
functional JJ O
relationship NN O
between IN O
genes NNS O
. . O

It PRP O
is VBZ O
based VBN O
on IN O
the DT O
idea NN O
that IN O
proteins NNS O
that WDT O
are VBP O
involved VBN O
in IN O
the DT O
same JJ O
metabolic JJ O
pathway NN O
or CC O
structural JJ O
complex NN O
are VBP O
likely JJ O
to TO O
evolve VB O
in IN O
a DT O
correlate JJ O
fashion NN O
and CC O
during IN O
evolution NN O
appear VBP O
phylogenetically RB O
linked VBN O
, , O
showing VBG O
a DT O
tendency NN O
to TO O
be VB O
either CC O
preserved VBN O
or CC O
eliminated VBN O
as IN O
a DT O
whole NN O
. . O

Therefore RB O
, , O
genes NNS O
showing VBG O
similar JJ O
phylogenetic JJ O
profiles NNS O
are VBP O
likely JJ O
to TO O
be VB O
functionally RB O
related VBN O
. . O

We PRP O
extended VBD O
the DT O
use NN O
of IN O
phylogenetic JJ O
profiles NNS O
to TO O
produce VB O
an DT O
evolutionary JJ O
tree NN O
based VBN O
on IN O
a DT O
hierarchical JJ O
clusterization NN O
of IN O
organisms NNS O
with IN O
similar JJ O
phylogenetic JJ O
profiles NNS O
. . O

For IN O
this DT O
study NN O
we PRP O
took VBD O
the DT O
whole JJ O
gene NN O
dataset NN O
of IN O
320 CD O
prokaryotic JJ O
genomes NNS O
, , O
however RB O
, , O
we PRP O
limited VBD O
the DT O
analysis NN O
to IN O
the DT O
orthologous JJ O
groups NNS O
that WDT O
are VBP O
present JJ O
in IN O
at IN O
least JJS O
one CD O
of IN O
the DT O
14 CD O
considered VBN O
species NNS O
of IN O
the DT O
Vibrionaceae NNP O
family NN O
. . O

These DT O
bacteria NNS O
belong VBP O
to IN O
the DT O
Gammaproteobacteria NNP O
group NN O
and CC O
are VBP O
highly RB O
abundant JJ O
in IN O
aquatic JJ O
environment NN O
, , O
they PRP O
strongly RB O
influence VBP O
nutrient NN O
cycling NN O
and CC O
various JJ O
species NNS O
are VBP O
also RB O
devastating VBG O
pathogens NNS O
. . O

Since IN O
we PRP O
focused VBD O
our PRP$ O
analysis NN O
on IN O
this DT O
particular JJ O
group NN O
, , O
the DT O
aim NN O
of IN O
this DT O
study NN O
is VBZ O
not RB O
the DT O
construction NN O
of IN O
a DT O
global JJ O
evolutionary JJ O
tree NN O
, , O
but CC O
rather RB O
a DT O
Vibrionaceae NNP O
perspective NN O
of IN O
bacterial JJ O
diversity NN O
, , O
based VBN O
on IN O
phylogenetic JJ O
profiles NNS O
. . O

Results NNS O
and CC O
discussion NN O

Phylogenetic JJ O
matrix NN O

The DT O
analysis NN O
was VBD O
performed VBN O
on IN O
14 CD O
bacteria NNS O
belonging VBG O
to IN O
the DT O
Vibrionaceae NNP O
family NN O
( , O
Table NNP O
1 CD O
) -RRB- O
. . O

The DT O
redundant JJ O
list NN O
of IN O
Vibrionaceae NNP O
ORFs NNP O
was VBD O
clustered VBN O
to TO O
reduce VB O
the DT O
number NN O
of IN O
proteins NNS O
to TO O
analyze VB O
and CC O
the DT O
phylogenetic JJ O
profile NN O
for IN O
each DT O
cluster NN O
was VBD O
calculated VBN O
as IN O
described VBN O
in IN O
the DT O
Method NNP O
section NN O
. . O

Many JJ O
authors NNS O
proposed VBD O
and CC O
successfully RB O
applied VBD O
different JJ O
measure NN O
methods NNS O
to TO O
calculate VB O
the DT O
phylogenetic JJ O
profile NN O
values NNS O
. . O

Pellegrini NNP O
et FW O
al NNP O
. . O

[ -LRB- O
3 CD O
] -RRB- O
firstly RB O
proposed VBD O
a DT O
phylogenetic JJ O
profile NN O
described VBN O
as IN O
a DT O
string NN O
of IN O
bits NNS O
, , O
each DT O
bit NN O
representing VBG O
the DT O
absence NN O
or CC O
presence NN O
of IN O
an DT O
homologous JJ O
gene NN O
in IN O
a DT O
given VBN O
genome NN O
. . O

This DT O
method NN O
lacks VBZ O
a DT O
weighting NN O
procedure NN O
, , O
giving VBG O
the DT O
same JJ O
weight NN O
( , O
value NN O
1 CD O
) -RRB- O
to IN O
all PDT O
the DT O
sequences NNS O
that WDT O
are VBP O
considered VBN O
homologous JJ O
given VBN O
a DT O
similarity NN O
threshold NN O
. . O

Enault NN O
and CC O
colleagues NNS O
proposed VBD O
an DT O
improved JJ O
phylogenetic JJ O
profile NN O
based VBN O
on IN O
a DT O
normalized JJ O
Blastp NNP O
bit NN O
score NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

This DT O
method NN O
, , O
compared VBN O
to IN O
the DT O
approach NN O
implemented VBN O
by IN O
Pellegrini NNP O
, , O
allows VBZ O
weighting VBG O
each DT O
point NN O
of IN O
the DT O
profile NN O
proportionally RB O
to IN O
the DT O
length NN O
and CC O
the DT O
quality NN O
of IN O
the DT O
alignment NN O
. . O

Jingchun NNP O
and CC O
colleagues NNS O
optimized VBD O
the DT O
phylogenetic JJ O
profiles NNS O
method NN O
by IN O
integrating VBG O
phylogenetic JJ O
relationships NNS O
among IN O
reference NN O
organisms NNS O
and CC O
sequence NN O
homology NN O
information NN O
, , O
based VBN O
on IN O
E NN O
- HYPH O
value NN O
score NN O
, , O
to TO O
improve VB O
prediction NN O
accuracy NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
measure NN O
index NN O
I PRP O
proposed VBD O
in IN O
this DT O
work NN O
is VBZ O
similar JJ O
to IN O
the DT O
others NNS O
described VBN O
above RB O
, , O
taking VBG O
into IN O
account NN O
both CC O
the DT O
quality NN O
and CC O
the DT O
length NN O
of IN O
the DT O
alignment NN O
using VBG O
a DT O
substitution NN O
matrix NN O
. . O

Moreover RB O
our PRP$ O
approach NN O
considers VBZ O
also RB O
the DT O
total JJ O
length NN O
of IN O
the DT O
sequences NNS O
, , O
penalizing VBG O
good JJ O
alignments NNS O
occurring VBG O
between IN O
ORFs NNS O
having VBG O
different JJ O
lengths NNS O
and CC O
taking VBG O
into IN O
consideration NN O
that IN O
ORFs NNPS O
could MD O
differentiate VB O
mainly RB O
for IN O
the DT O
presence NN O
of IN O
functional JJ O
domains NNS O
. . O

The DT O
final JJ O
phylogenetic JJ O
profile NN O
for IN O
each DT O
cluster NN O
was VBD O
defined VBN O
as IN O
the DT O
median NN O
of IN O
all PDT O
the DT O
profiles NNS O
belonging VBG O
to IN O
the DT O
cluster NN O
, , O
named VBN O
"""" `` O
meta JJ O
- HYPH O
profile NN O
"""" '' O
, , O
which WDT O
describes VBZ O
the DT O
profile NN O
of IN O
conserved VBN O
ORFs NNS O
belonging VBG O
to IN O
an DT O
entire JJ O
family NN O
. . O

Hierarchical JJ O
cluster NN O
analysis NN O

A DT O
hierarchical JJ O
cluster NN O
analysis NN O
was VBD O
performed VBN O
on IN O
the DT O
entire JJ O
phylogenetic JJ O
profile NN O
matrix NN O
and CC O
it PRP O
was VBD O
calculated VBN O
a DT O
statistical JJ O
support NN O
based VBN O
on IN O
bootstrap NN O
method NN O
for IN O
the DT O
nodes NNS O
of IN O
the DT O
columns NNS O
tree NN O
( -LRB- O
Fig NNP O
1 CD O
) -RRB- O
. . O

The DT O
branch NN O
tree NN O
colors NNS O
represent VBP O
the DT O
bootstrap NN O
percentage NN O
support NN O
. . O

This DT O
constitutes VBZ O
a DT O
phylogenetic JJ O
tree NN O
based VBN O
on IN O
gene NN O
content NN O
using VBG O
Vibrionaceae NNP O
ORFs NNPS O
as IN O
a DT O
reference NN O
. . O

Genomes NNS O
belonging VBG O
to IN O
the DT O
same JJ O
taxonomic JJ O
group NN O
tend VBP O
to TO O
cluster VB O
together RB O
and CC O
the DT O
Vibrionaceae NNP O
species NNS O
are VBP O
closely RB O
related VBN O
. . O

As IN O
expected VBN O
, , O
according VBG O
to IN O
the DT O
Vibrionaceae NNP O
branch NN O
lengths NNS O
it PRP O
is VBZ O
evident JJ O
that IN O
variability NN O
within IN O
this DT O
group NN O
is VBZ O
higher JJR O
compared VBN O
to IN O
the DT O
other JJ O
groups NNS O
. . O

The DT O
dataset NN O
used VBN O
for IN O
phylogenetic JJ O
matrix NN O
calculation NN O
is VBZ O
indeed RB O
composed VBN O
by IN O
Vibrionaceae NNP O
ORFs NNPS O
. . O

This DT O
implies VBZ O
that IN O
the DT O
similarity NN O
measures NNS O
between IN O
these DT O
ORFs NNPS O
and CC O
the DT O
corresponding VBG O
orthologues NNS O
will MD O
be VB O
nearly RB O
zero CD O
in IN O
most JJS O
of IN O
the DT O
other JJ O
species NNS O
and CC O
significantly RB O
higher JJR O
in IN O
the DT O
Vibrionaceae NNP O
family NN O
, , O
increasing VBG O
the DT O
variability NN O
into IN O
this DT O
group NN O
. . O

Moreover RB O
the DT O
average JJ O
percentage NN O
of IN O
clusters NNS O
shared VBN O
by IN O
the DT O
Vibrionaceae NNP O
members NNS O
is VBZ O
only RB O
47 CD O
. . O
5 CD O
% NN O
( , O
average JJ O
number NN O
of IN O
shared VBN O
clusters NNS O
divided VBN O
by IN O
the DT O
total JJ O
number NN O
of IN O
clusters NNS O
) , O
that WDT O
again RB O
indicates VBZ O
a DT O
high JJ O
variability NN O
inside IN O
this DT O
family NN O
. . O

It PRP O
is VBZ O
also RB O
interesting JJ O
to TO O
note VB O
that IN O
organisms NNS O
belonging VBG O
to IN O
the DT O
same JJ O
or CC O
closely RB O
related VBN O
taxa NN O
split VBP O
into IN O
different JJ O
subgroups NNS O
. . O

This DT O
highlights VBZ O
the DT O
existence NN O
of IN O
a DT O
high JJ O
variability NN O
among IN O
lineages NNS O
, , O
due IN O
to IN O
genetic JJ O
and CC O
evolutionary JJ O
processes NNS O
such JJ O
as IN O
lateral JJ O
gene NN O
transfer NN O
, , O
concerted JJ O
evolution NN O
and CC O
gene NN O
duplication NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

In IN O
terms NNS O
of IN O
gene NN O
content NN O
, , O
the DT O
organisms NNS O
more RBR O
related JJ O
to IN O
the DT O
Vibrionaceae NNP O
belong VBP O
to IN O
the DT O
gamma NN O
and CC O
beta NN O
proteobacteria NN O
. . O

In IN O
particular JJ O
Altermonadales NNP O
, , O
Enterobacteriales NNPS O
and CC O
Burkholderiales NNPS O
are VBP O
closely RB O
related JJ O
to IN O
Vibrionaceae NNP O
, , O
and CC O
share VBP O
the DT O
higher JJR O
number NN O
of IN O
cluster NN O
of IN O
genes NNS O
( , O
average JJ O
percentage NN O
of IN O
20 CD O
% NN O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
Archea NNP O
are VBP O
the DT O
most RBS O
distant JJ O
group NN O
sharing VBG O
just RB O
3 CD O
. . O
8 CD O
% NN O
of IN O
clusters NNS O
. . O

Clusters NNS O
and CC O
genes NNS O
distribution NN O
, , O
as IN O
shown VBN O
in IN O
Fig NNP O
2 CD O
, , O
reveals VBZ O
that IN O
the DT O
number NN O
of IN O
clusters NNS O
and CC O
genes NNS O
shared VBN O
by IN O
the DT O
organisms NNS O
decreases VBZ O
as IN O
the DT O
number NN O
of IN O
organisms NNS O
considered VBN O
increases VBZ O
. . O

The DT O
analysis NN O
was VBD O
performed VBN O
considering VBG O
for IN O
each DT O
cluster NN O
profile VB O
the DT O
number NN O
of IN O
organisms NNS O
sharing VBG O
the DT O
same JJ O
numbers NNS O
of IN O
clusters NNS O
( , O
and CC O
genes NNS O
) -RRB- O
. . O

The DT O
majority NN O
of IN O
gene NN O
cluster NN O
groups NNS O
no DT O
more JJR O
than IN O
21 CD O
species NNS O
on IN O
a DT O
total NN O
of IN O
320 CD O
. . O

The DT O
highest JJS O
blue JJ O
spike NN O
corresponds VBZ O
to IN O
the DT O
higher JJR O
number NN O
of IN O
genes NNS O
shared VBN O
by IN O
105 CD O
groups NNS O
of IN O
14 CD O
organisms NNS O
. . O

Among IN O
these DT O
groups NNS O
, , O
as IN O
expected VBN O
, , O
Vibrionaceae NNP O
are VBP O
highly RB O
represented VBN O
. . O

Other JJ O
species NNS O
represented VBN O
are VBP O
Colwellia NNP B-Species
psychrerythraea NN I-Species
34H CD I-Species
and CC O
Shewanella NNP B-Species
oneidensis NN I-Species
, , O
that WDT O
belong VBP O
to IN O
the DT O
Alteromonadales NNP O
family NN O
. . O

The DT O
cluster NN O
analysis NN O
performed VBN O
on IN O
genes NNS O
is VBZ O
shown VBN O
in IN O
Fig NNP O
. . O

3 LS O
. . O

From IN O
now RB O
on RB O
, , O
to TO O
avoid VB O
confusing VBG O
interpretation NN O
between IN O
clusters NNS O
derived VBN O
from IN O
the DT O
cluster NN O
analysis NN O
and CC O
cluster NN O
derived VBN O
from IN O
the DT O
ORFs NNS O
clustering VBG O
we PRP O
will MD O
use VB O
the DT O
term NN O
"""" `` O
gene NN O
"""" '' O
in IN O
place NN O
of IN O
cluster NN O
of IN O
ORFs NNS O
. . O

The DT O
different JJ O
gradient NN O
of IN O
color NN O
, , O
from IN O
bright JJ O
to IN O
dark JJ O
red NN O
, , O
represents VBZ O
decreasing VBG O
similarity NN O
values NNS O
. . O

The DT O
cluster NN O
analysis NN O
allows VBZ O
the DT O
detection NN O
of IN O
three CD O
main JJ O
groups NNS O
of IN O
genes NNS O
. . O

The DT O
first JJ O
one CD O
( , O
Fig NNP O
3 CD O
, , O
panel NN O
B NN O
) -RRB- O
contains VBZ O
the DT O
most RBS O
conserved VBN O
and CC O
established VBN O
genes NNS O
shared VBN O
almost RB O
by IN O
all PDT O
the DT O
organisms NNS O
. . O

These DT O
core NN O
genes NNS O
can MD O
be VB O
defined VBN O
as IN O
the DT O
set NN O
of IN O
all DT O
genes NNS O
shared VBN O
as IN O
orthologous JJ O
by IN O
all DT O
members NNS O
of IN O
an DT O
evolutionary JJ O
coherent JJ O
group NN O
. . O

In IN O
our PRP$ O
analysis NN O
we PRP O
identify VBP O
four CD O
clusters NNS O
, , O
for IN O
a DT O
total NN O
of IN O
145 CD O
genes NNS O
, , O
shared VBN O
by IN O
all PDT O
the DT O
320 CD O
organisms NNS O
. . O

The DT O
ORFs NNS O
belonging VBG O
to IN O
these DT O
clusters NNS O
are VBP O
predicted VBN O
to TO O
codify VB O
for IN O
the DT O
ATP NNP O
binding VBG O
subunit NN O
of IN O
ABC NNP O
transporters NNS O
( , O
annotated VBN O
as IN O
ABC NNP O
- HYPH O
type NN O
polar JJ O
amino NN O
acid NN O
transport NN O
system NN O
, , O
ABC NNP O
- HYPH O
type NN O
antimicrobial JJ O
peptide NN O
transport NN O
system NN O
, , O
ABC NNP O
- HYPH O
type NN O
histidine NN O
transport NN O
system NN O
and CC O
ABC NNP O
- HYPH O
type NN O
transport NN O
system NN O
involved VBN O
in IN O
lysophospholipase NN O
L1 NN O
biosynthesis NN O
) -RRB- O
. . O

This DT O
finding NN O
is VBZ O
surprising JJ O
since IN O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
where WRB O
these DT O
ORFs NNS O
are VBP O
assigned VBN O
to IN O
the DT O
core NN O
genes NNS O
. . O

Anyway RB O
two CD O
different JJ O
explanations NNS O
can MD O
be VB O
traced VBN O
. . O

First RB O
, , O
it PRP O
is VBZ O
known VBN O
that IN O
the DT O
ABC NNP O
transporters NNS O
represent VBP O
an DT O
essential JJ O
transport NN O
system NN O
in IN O
the DT O
prokaryotes NNS O
and CC O
that IN O
their PRP$ O
ATP NNP O
binding NN O
subunits NNS O
are VBP O
apparently RB O
overrepresented JJ O
compared VBN O
to IN O
the DT O
other JJ O
two CD O
subunits NNS O
( -LRB- O
ligand NN O
binding NN O
and CC O
permease NN O
subunit NN O
) -RRB- O
in IN O
all DT O
genomes NNS O
sequenced VBN O
thus RB O
far RB O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Second RB O
, , O
one CD O
organism NN O
, , O
Buchnera NNP B-Species
aphidicola NNP I-Species
, , O
presents VBZ O
these DT O
genes NNS O
with IN O
a DT O
similarity NN O
just RB O
below IN O
the DT O
cut NN O
- HYPH O
off NN O
used VBN O
for IN O
the DT O
analysis NN O
, , O
but CC O
they PRP O
have VBP O
been VBN O
considered VBN O
since IN O
it PRP O
is VBZ O
well RB O
known VBN O
that IN O
in IN O
this DT O
mutualistic JJ O
endosymbiont NN O
the DT O
accelerated JJ O
evolution NN O
and CC O
AT NN O
bias NN O
affect VBP O
all PDT O
its PRP$ O
genes NNS O
, , O
including VBG O
the DT O
16S NNP O
rRNA NNP O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

The DT O
dataset NN O
used VBN O
for IN O
the DT O
analysis NN O
includes VBZ O
genomes NNS O
in IN O
draft NN O
quality NN O
( , O
Vibrio NNP B-Species
cholerae NN I-Species
395 CD I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
MO10 NNP I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
RC385 NN I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
V51 NN I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
V52 NN I-Species
, , O
Photobacterium NN B-Species
profundum NN I-Species
3TCK NN I-Species
, , O
Vibrio NNP B-Species
MED222 NNP I-Species
, , O
Vibrio NNP B-Species
splendidus12B01 NN I-Species
) -RRB- O
. . O

Wrong JJ O
ORFs NNS O
prediction NN O
or CC O
missing VBG O
genes NNS O
due JJ O
to IN O
incomplete JJ O
genome NN O
sequences NNS O
can MD O
explain VB O
the DT O
low JJ O
number NN O
of IN O
core NN O
genes NNS O
identified VBN O
. . O

To TO O
avoid VB O
such JJ O
problems NNS O
we PRP O
repeated VBD O
the DT O
analysis NN O
excluding VBG O
the DT O
draft NN O
genomes NNS O
and CC O
thus RB O
considering VBG O
312 CD O
genomes NNS O
. . O

The DT O
results NNS O
, , O
reported VBN O
in IN O
Table NNP O
2 CD O
, , O
show VBP O
an DT O
increased JJ O
number NN O
of IN O
the DT O
core NN O
genes NNS O
and CC O
in IN O
particular JJ O
ribosomal JJ O
proteins NNS O
and CC O
tRNA NNP O
synthetase NN O
, , O
as IN O
reported VBN O
by IN O
Charlesbois NNP O
and CC O
Doolittle NNP O
[ -LRB- O
10 CD O
] -RRB- O
. . O

This DT O
could MD O
be VB O
considered VBN O
as IN O
a DT O
sort NN O
of IN O
"""" `` O
minimal JJ O
genome NN O
"""" '' O
containing VBG O
the DT O
group NN O
of IN O
genes NNS O
that WDT O
are VBP O
necessary JJ O
to TO O
maintain VB O
a DT O
free RB O
- HYPH O
living VBG O
organism NN O
. . O

The DT O
low JJ O
number NN O
of IN O
genes NNS O
shared VBN O
by IN O
all PDT O
the DT O
organisms NNS O
can MD O
be VB O
due IN O
to IN O
many JJ O
factors NNS O
. . O

First RB O
of IN O
all DT O
we PRP O
used VBD O
the DT O
Vibrionaceae NNP O
ORFs NNPS O
as IN O
a DT O
reference NN O
, , O
limiting VBG O
the DT O
number NN O
of IN O
genes NNS O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
. . O

It PRP O
was VBD O
further RB O
demonstrated VBN O
that IN O
the DT O
core NN O
gene NN O
size NN O
decreases VBZ O
as IN O
more JJR O
genome NN O
sequences NNS O
are VBP O
analyzed VBN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Genes NNS O
that WDT O
are VBP O
considered VBN O
to TO O
belong VB O
to IN O
the DT O
core NN O
set NN O
when WRB O
close JJ O
organisms NNS O
are VBP O
compared VBN O
, , O
are VBP O
classified VBN O
as IN O
flexible JJ O
genes NNS O
when WRB O
distantly RB O
related VBN O
genomes NNS O
are VBP O
analyzed VBN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Finally RB O
, , O
genes NNS O
within IN O
core NN O
genomes NNS O
might MD O
be VB O
transferred VBN O
or CC O
replaced VBN O
, , O
introducing VBG O
new JJ O
versions NNS O
of IN O
existing VBG O
genes NNS O
into IN O
genomes NNS O
. . O

Such JJ O
transfers NNS O
can MD O
replace VB O
even RB O
highly RB O
conserved VBN O
genes NNS O
by IN O
non JJ O
- HYPH O
homologous JJ O
counterparts NNS O
but CC O
the DT O
advantages NNS O
provided VBN O
are VBP O
difficult JJ O
to TO O
explain VB O
. . O

It PRP O
is VBZ O
also RB O
to TO O
take VB O
into IN O
consideration NN O
that IN O
many JJ O
symbiotic JJ O
and CC O
parasitic JJ O
bacteria NNS O
undergo VBP O
a DT O
reduction NN O
of IN O
their PRP$ O
genomes NNS O
, , O
loosing VBG O
many JJ O
genes NNS O
required VBN O
by IN O
free RB O
- HYPH O
living NN O
cell NN O
. . O

The DT O
second JJ O
group NN O
( , O
Fig NNP O
3 CD O
, , O
panel NN O
C NNP O
) -RRB- O
represents VBZ O
genes NNS O
shared VBN O
mainly RB O
among IN O
Vibrionaceae NNP O
and CC O
other JJ O
gamma NN O
proteobacteria NN O
( , O
as IN O
Altermonadales NNP O
, , O
Burkholderiales NNPS O
and CC O
Enterobactidiales NNP O
) -RRB- O
. . O

Finally RB O
, , O
the DT O
third JJ O
group NN O
( , O
Fig NNP O
. . O
3 CD O
, , O
panel NN O
D NN O
) -RRB- O
is VBZ O
composed VBN O
by IN O
genes NNS O
that WDT O
are VBP O
mainly RB O
specific JJ O
to IN O
the DT O
Vibrionaceae NNP O
. . O

k XX O
- HYPH O
mean VB O
cluster NN O
analysis NN O
and CC O
cluster NN O
enrichment NN O

We PRP O
performed VBD O
a DT O
k NN O
- HYPH O
means VBZ O
cluster NN O
analysis NN O
, , O
setting VBG O
the DT O
k NN O
value NN O
to IN O
14 CD O
. . O

As IN O
shown VBN O
in IN O
Fig NNP O
. . O

4 CD O
, , O
the DT O
clusters NNS O
3 CD O
, , O
4 CD O
, , O
11 CD O
, , O
13 CD O
and CC O
14 CD O
contain VBP O
the DT O
higher JJR O
percentage NN O
of IN O
genes NNS O
, , O
accounting VBG O
for IN O
more JJR O
that IN O
50 CD O
% NN O
of IN O
the DT O
total JJ O
genes NNS O
, , O
while IN O
clusters NNS O
9 CD O
and CC O
10 CD O
contain VBP O
the DT O
lower JJR O
number NN O
of IN O
ORFs NNS O
( : O
3 CD O
% NN O
of IN O
genes NNS O
) -RRB- O
. . O

The DT O
variance NN O
in IN O
each DT O
k NN O
- HYPH O
means VBZ O
cluster NN O
is VBZ O
very RB O
low JJ O
( , O
Fig NNP O
. . O
4 CD O
) -RRB- O
, , O
meaning VBG O
that IN O
the DT O
clusters NNS O
contain VBP O
genes NNS O
with IN O
compact JJ O
and CC O
similar JJ O
profiles NNS O
. . O

As IN O
described VBN O
in IN O
Fig NNP O
. . O

4 CD O
, , O
the DT O
majority NN O
of IN O
the DT O
clusters NNS O
( , O
1 CD O
, , O
2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
, , O
6 CD O
, , O
7 CD O
, , O
9 CD O
, , O
12 CD O
, , O
13 CD O
) -RRB- O
contains VBZ O
genes NNS O
with IN O
a DT O
similar JJ O
profile NN O
, , O
with IN O
the DT O
average JJ O
values NNS O
( , O
red JJ O
line NN O
) -RRB- O
near IN O
zero CD O
, , O
except IN O
for IN O
the DT O
presence NN O
of IN O
some DT O
spikes NNS O
correspondent NN O
to IN O
an DT O
increasing VBG O
similarity NN O
with IN O
some DT O
isolated VBN O
organisms NNS O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
3 CD O
, , O
clusters NNS O
1 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
, , O
and CC O
9 CD O
contains VBZ O
genes NNS O
that WDT O
have VBP O
a DT O
high JJ O
similarity NN O
in IN O
a DT O
small JJ O
subset NN O
of IN O
organisms NNS O
. . O

The DT O
majority NN O
of IN O
these DT O
ORFs NNS O
are VBP O
annotated VBN O
as IN O
hypothetical JJ O
proteins NNS O
or CC O
phage NN O
related VBN O
proteins NNS O
. . O

Clusters NNS O
8 CD O
, , O
10 CD O
and CC O
14 CD O
present JJ O
genes NNS O
shared VBN O
among IN O
almost RB O
all PDT O
the DT O
organisms NNS O
. . O

In IN O
particular JJ O
cluster NN O
10 CD O
is VBZ O
composed VBN O
by IN O
the DT O
core NN O
genes NNS O
described VBN O
before IN O
having VBG O
an DT O
high JJ O
value NN O
of IN O
similarity NN O
widespread JJ O
among IN O
all PDT O
the DT O
organisms NNS O
; , O
cluster NN O
8 CD O
contains VBZ O
genes NNS O
shared VBN O
mainly RB O
by IN O
gamma NN O
proteobacteria NN O
and CC O
cluster NN O
14 CD O
is VBZ O
composed VBN O
of IN O
genes NNS O
in IN O
common JJ O
between IN O
Vibrionaceae NNP O
and CC O
Enterobacteriaceae NNP O
. . O

A DT O
functional JJ O
annotation NN O
has VBZ O
been VBN O
performed VBN O
on IN O
each DT O
gene NN O
cluster NN O
using VBG O
COG NNP O
( , O
Cluster NNP O
of IN O
Orthologous NNP O
Genes NNPS O
) -RRB- O
, , O
KEGG NNP O
pathway NN O
map NN O
and CC O
GO NNP O
databases NNS O
. . O

For IN O
each DT O
k NN O
- HYPH O
mean JJ O
cluster NN O
the DT O
enrichment NN O
probability NN O
with IN O
respect NN O
to IN O
the DT O
total JJ O
number NN O
of IN O
clusters NNS O
has VBZ O
been VBN O
obtained VBN O
with IN O
the DT O
hypergeometric JJ O
distribution NN O
. . O

Fig NN O
. . O

5 CD O
shows VBZ O
COG NNP O
enrichment NN O
results NNS O
for IN O
each DT O
cluster NN O
. . O

As IN O
expected VBN O
clusters NNS O
represented VBN O
by IN O
conserved VBN O
genes NNS O
( -LRB- O
cluster NN O
8 CD O
, , O
10 CD O
and CC O
14 CD O
) , O
have VBP O
the DT O
higher JJR O
number NN O
of IN O
enriched VBN O
COG NNP O
codes NNS O
, , O
while IN O
cluster NN O
specific JJ O
of IN O
few JJ O
organisms NNS O
are VBP O
characterized VBN O
by IN O
a DT O
small JJ O
number NN O
of IN O
enriched VBN O
COGs NNS O
. . O

The DT O
majority NN O
of IN O
clusters NNS O
presents VBZ O
COG NNP O
codes NNS O
enrichment NN O
for IN O
S NNP O
( HYPH O
function NN O
unknown JJ O
) -RRB- O
, , O
R NNP O
( , O
poorly RB O
characterized VBN O
) -RRB- O
and CC O
- HYPH O
( , O
absence NN O
of IN O
COG NNP O
code NN O
) -RRB- O
categories NNS O
. . O

This DT O
is VBZ O
due JJ O
to IN O
the DT O
large JJ O
abundance NN O
of IN O
unknown JJ O
and CC O
hypothetical JJ O
proteins NNS O
presents VBZ O
in IN O
the DT O
Vibrionaceae NNP O
proteomes NNS O
. . O

It PRP O
is VBZ O
worth JJ O
noting VBG O
that IN O
cluster NN O
3 CD O
, , O
mainly RB O
represented VBN O
by IN O
Photobacterium NN B-Species
profundum NN I-Species
SS9 NNP I-Species
ORFs NNP O
, , O
is VBZ O
enriched VBN O
only RB O
by IN O
C NNP O
( , O
Energy NN O
production NN O
and CC O
conversion NN O
) -RRB- O
, , O
L NNP O
( , O
DNA NN O
replication NN O
, , O
recombination NN O
and CC O
repair NN O
) , O
and CC O
M NN O
( HYPH O
Cell NN O
envelope NN O
biogenesis NN O
, , O
outer JJ O
membrane NN O
) -RRB- O
. . O

Probably RB O
the DT O
L NNP O
class NN O
overrepresentation NN O
is VBZ O
determined VBN O
by IN O
the DT O
high JJ O
number NN O
of IN O
transposons NNS O
that WDT O
are VBP O
present JJ O
in IN O
the DT O
SS9 NNP O
genome NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

The DT O
role NN O
played VBN O
by IN O
these DT O
transposable JJ O
elements NNS O
in IN O
the DT O
survival NN O
of IN O
this DT O
deep JJ O
- HYPH O
sea NN O
bacterium NN O
it PRP O
is VBZ O
still RB O
a DT O
matter NN O
of IN O
debate NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

In IN O
addition NN O
V NN B-Species
. . I-Species
vulnificus NNP I-Species
YJ016 NNP I-Species
and CC O
V NN B-Species
. . I-Species
vulnificus NNP I-Species
CMCP6 NNP I-Species
( -LRB- O
cluster NN O
13 CD O
) -RRB- O
seem VBP O
to TO O
share VB O
genes NNS O
belonging VBG O
to IN O
the DT O
enriched VBN O
COG NNP O
classes NNS O
K NNP O
( -LRB- O
Transcription NNP O
) -RRB- O
, , O
L NNP O
and CC O
T NNP O
( , O
Signal NNP O
transduction NN O
mechanisms NNS O
) -RRB- O
. . O

It PRP O
was VBD O
previously RB O
reported VBN O
an DT O
enrichment NN O
in IN O
genes NNS O
belonging VBG O
to IN O
the DT O
transcription NN O
class NN O
in IN O
the DT O
genome NN O
of IN O
V NN B-Species
. . I-Species
vulnificus NN I-Species
respect NN O
to IN O
the DT O
V NN B-Species
. . I-Species
cholerae NN I-Species
genome NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

This DT O
class NN O
is VBZ O
clearly RB O
related VBN O
to IN O
the DT O
T NNP O
class NN O
and CC O
seems VBZ O
to TO O
indicate VB O
that IN O
this DT O
organism NN O
is VBZ O
able JJ O
to TO O
receive VB O
and CC O
translate VB O
in IN O
a DT O
transcriptional JJ O
response NN O
specific JJ O
environmental JJ O
signals NNS O
. . O

Despite IN O
this DT O
, , O
the DT O
large JJ O
majority NN O
of IN O
the DT O
genes NNS O
in IN O
clusters NNS O
3 CD O
and CC O
13 CD O
lacks VBZ O
COG NNP O
annotation NN O
. . O

Cluster NN O
7 CD O
, , O
as IN O
shown VBN O
in IN O
Table NNP O
3 CD O
, , O
accounts VBZ O
organisms NNS O
with IN O
large JJ O
genome NN O
size NN O
( , O
see VB O
Table NNP O
1 CD O
) -RRB- O
. . O

This DT O
can MD O
explain VB O
the DT O
fact NN O
the DT O
this DT O
cluster NN O
contains VBZ O
almost RB O
all PDT O
the DT O
COG NNP O
class NN O
enriched VBN O
and CC O
suggests VBZ O
a DT O
more RBR O
complex JJ O
and CC O
flexible JJ O
life NN O
- HYPH O
style NN O
of IN O
these DT O
organisms NNS O
compared VBN O
to IN O
the DT O
other JJ O
Vibrionaceae NNP O
members NNS O
. . O

KEGG NNP O
annotation NN O
is VBZ O
limited JJ O
to IN O
metabolic JJ O
or CC O
structural JJ O
complex JJ O
network NN O
and CC O
so IN O
a DT O
reduced VBN O
number NN O
of IN O
genes NNS O
have VBP O
a DT O
KEGG NNP O
entry NN O
. . O

This DT O
causes VBZ O
the DT O
presence NN O
of IN O
clusters NNS O
without IN O
enriched VBN O
map NN O
( , O
cluster NN O
2 CD O
- HYPH O
5 CD O
, , O
7 CD O
, , O
13 CD O
, , O
see VB O
Fig NNP O
5 CD O
) -RRB- O
. . O

Also RB O
in IN O
this DT O
case NN O
, , O
the DT O
clusters NNS O
presenting VBG O
the DT O
higher JJR O
number NN O
of IN O
significant JJ O
KEGG NNP O
map NN O
are VBP O
those DT O
containing VBG O
the DT O
conserved VBN O
genes NNS O
. . O

The DT O
most RBS O
enriched VBN O
KEGG NNP O
clusters NNS O
are VBP O
cluster NN O
14 CD O
, , O
10 CD O
and CC O
8 CD O
accounting VBG O
for IN O
the DT O
majority NN O
of IN O
the DT O
metabolic JJ O
pathways NNS O
. . O

Cluster NN O
1 CD O
is VBZ O
enriched VBN O
for IN O
map3080 CD O
( HYPH O
type NN O
IV NN O
secretion NN O
system NN O
) -RRB- O
. . O

In IN O
fact NN O
V NN B-Species
. . I-Species
fischeri NNP I-Species
genome NN O
contains VBZ O
10 CD O
separate JJ O
pilus NN O
gene NN O
clusters NNS O
, , O
including VBG O
eight CD O
type NN O
- HYPH O
IV NN O
pilus NN O
loci NN O
. . O

The DT O
presence NN O
of IN O
multiple JJ O
pilus NN O
gene NN O
clusters NNS O
suggests VBZ O
that IN O
different JJ O
pili NN O
may MD O
be VB O
expressed VBN O
in IN O
different JJ O
environments NNS O
or CC O
during IN O
multiple JJ O
stages NNS O
of IN O
its PRP$ O
development NN O
as IN O
a DT O
symbiont NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Cluster NN O
11 CD O
is VBZ O
enriched VBN O
for IN O
map3090 CD O
( HYPH O
type NN O
II NN O
secretion NN O
system NN O
) -RRB- O
. . O

The DT O
type NN O
II NN O
pathway NN O
is VBZ O
conserved VBN O
among IN O
gram NN O
- HYPH O
negative JJ O
bacteria NNS O
, , O
including VBG O
many JJ O
pathogens NNS O
, , O
and CC O
secretes VBZ O
a DT O
variety NN O
of IN O
virulence NN O
factors NNS O
and CC O
degradative JJ O
enzymes NNS O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Cluster NN O
9 CD O
is VBZ O
enriched VBN O
for IN O
map NN O
860 CD O
( HYPH O
Porphyrin NNP O
and CC O
chlorophyll NN O
metabolism NN O
) -RRB- O
. . O

These DT O
genes NNS O
are VBP O
involved VBN O
in IN O
the DT O
cobalamin NN O
( , O
coenzyme NN O
B12 NN O
) -RRB- O
biosynthetic JJ O
pathway NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Some DT O
organisms NNS O
, , O
such JJ O
as IN O
Salmonella NNP B-Species
typhimurium NN I-Species
and CC O
Klebsiella NNP B-Species
pneumoniae NN I-Species
, , O
can MD O
synthesize VB O
cobalamin NN O
de FW O
novo FW O
[ -LRB- O
17 CD O
] -RRB- O
, , O
while IN O
E NN B-Species
. . I-Species
coli NN I-Species
and CC O
large JJ O
part NN O
of IN O
the DT O
Vibrionaceae NNP O
perform VBP O
cobalamin NN O
biosynthesis NN O
only RB O
when WRB O
provided VBN O
with IN O
cobinamide NN O
. . O

It PRP O
is VBZ O
interesting JJ O
to TO O
observe VB O
that IN O
the DT O
genes NNS O
belonging VBG O
to IN O
the DT O
de FW O
novo FW O
pathway NN O
are VBP O
only RB O
shared VBN O
by IN O
Archea NNP O
, , O
some DT O
other JJ O
organisms NNS O
like IN O
Salmonella NNP O
, , O
Pseudomonas NNP O
and CC O
Vibrio NNP B-Species
MED222 NNP I-Species
. . O

Finally RB O
cluster NN O
6 CD O
is VBZ O
enriched VBN O
by IN O
map2010 NNP O
( , O
ABC NNP O
transporter NN O
) -RRB- O
, , O
map2020 NN O
( , O
two CD O
- HYPH O
component NN O
system NN O
) -RRB- O
, , O
map2030 NN O
and CC O
map2031 NN O
( , O
bacterial JJ O
chemotaxis NN O
) -RRB- O
, , O
map2040 NN O
( , O
Flagellar NNP O
assembly NN O
) , O
and CC O
map3090 NN O
( HYPH O
type NN O
II NN O
secretion NN O
system NN O
) -RRB- O
. . O

This DT O
cluster NN O
contains VBZ O
genes NNS O
shared VBN O
with IN O
a DT O
high JJ O
similarity NN O
by IN O
all DT O
Vibrio NNP O
and CC O
with IN O
a DT O
lower JJR O
similarity NN O
with IN O
Photobacterium NN B-Species
profundum NN I-Species
species NNS O
. . O

Among IN O
the DT O
Vibrio NNP O
species NNS O
the DT O
organisms NNS O
showing VBG O
the DT O
highest JJS O
similarity NN O
( , O
Tab NNP O
. . O
3 CD O
) -RRB- O
are VBP O
V NN B-Species
. . I-Species
cholerae NN I-Species
strains NNS O
. . O

Vibrionaceae NNP O
specific JJ O
genes NNS O

We PRP O
identify VBP O
1940 CD O
clusters NNS O
specific JJ O
to IN O
the DT O
Vibrionaceae NNP O
. . O

All PDT O
the DT O
Vibrionaceae NNP O
considered VBN O
in IN O
the DT O
analysis NN O
share VBP O
108 CD O
clusters NNS O
. . O

Among IN O
these DT O
genes NNS O
we PRP O
identify VBP O
ToxR NNP O
and CC O
ToxS NNP O
genes NNS O
. . O

ToxR NN O
gene NN O
encodes VBZ O
a DT O
transmembrane NN O
regulatory JJ O
protein NN O
firstly RB O
identified VBN O
in IN O
V NN B-Species
. . I-Species
cholerae NN I-Species
, , O
in IN O
which WDT O
it PRP O
co VBZ O
- HYPH O
ordinates VBZ O
many JJ O
virulence NN O
factors NNS O
in IN O
response NN O
to IN O
several JJ O
environmental JJ O
parameters NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

V NN B-Species
. . I-Species
cholerae NN I-Species
ToxR NN O
activity NN O
is VBZ O
enhanced VBN O
by IN O
a DT O
second JJ O
transmembrane NN O
protein NN O
, , O
ToxS NNP O
, , O
encoded VBN O
downstream NN O
toxR NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

This DT O
family NN O
of IN O
proteins NNS O
is VBZ O
involved VBN O
in IN O
response NN O
to IN O
temperature NN O
, , O
pH NN O
, , O
osmolarity NN O
and CC O
in IN O
Photobacterium NN B-Species
profundum NN I-Species
SS9 NNP I-Species
, , O
a DT O
piezophilic JJ O
bacterium NN O
, , O
to IN O
hydrostatic JJ O
pressure NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

The DT O
widespread JJ O
presence NN O
of IN O
these DT O
genes NNS O
among IN O
the DT O
Vibrionaceae NNP O
suggests VBZ O
their PRP$ O
importance NN O
in IN O
regulatory JJ O
mechanisms NNS O
. . O

We PRP O
identify VBP O
two CD O
other JJ O
noteworthy JJ O
groups NNS O
of IN O
genes NNS O
composed VBN O
by IN O
257 CD O
and CC O
160 CD O
genes NNS O
respectively RB O
shared VBN O
just RB O
by IN O
two CD O
strains NNS O
, , O
mainly RB O
annotated VBN O
as IN O
"""" `` O
hypothetical JJ O
protein NN O
"""" '' O
. . O

The DT O
first JJ O
group NN O
of IN O
genes NNS O
is VBZ O
shared VBN O
between IN O
Photobacterium NN B-Species
profundum NN I-Species
SS9 NNP I-Species
and CC O
Photobacterium NNP B-Species
profundum NN I-Species
3TCK NNP I-Species
, , O
while IN O
the DT O
second JJ O
is VBZ O
shared VBN O
between IN O
V NN B-Species
. . I-Species
vulnificus NN I-Species
CMCP6 NNP I-Species
and CC O
YJ016 NNP B-Species
. . O

These DT O
strains NNS O
are VBP O
closely RB O
related JJ O
and CC O
this DT O
explains VBZ O
the DT O
high JJ O
number NN O
of IN O
shared VBN O
genes NNS O
; : O
while IN O
, , O
inside IN O
the DT O
Vibrionaceae NNP O
family NN O
, , O
the DT O
number NN O
of IN O
specific JJ O
shared VBN O
genes NNS O
highly RB O
decreases VBZ O
, , O
showing VBG O
a DT O
high JJ O
inter JJ O
- HYPH O
species NN O
variability NN O
( , O
Fig NNP O
. . O
6 CD O
) -RRB- O

Prophages NNS O
and CC O
transposases NNS O

Prophages NNS O
recover VBP O
different JJ O
biological JJ O
roles NNS O
both CC O
as IN O
quantitatively RB O
important JJ O
genetic JJ O
elements NNS O
of IN O
the DT O
bacterial JJ O
chromosome NN O
, , O
and CC O
as IN O
vectors NNS O
of IN O
lateral JJ O
gene NN O
transfer NN O
among IN O
bacteria NNS O
, , O
due IN O
to IN O
their PRP$ O
characters NNS O
of IN O
mobile JJ O
DNA NN O
elements NNS O
. . O

Indeed RB O
, , O
numerous JJ O
virulence NN O
factors NNS O
from IN O
bacterial JJ O
pathogens NNS O
are VBP O
phage NN O
encoded VBN O
. . O

It PRP O
was VBD O
postulated VBN O
that IN O
this DT O
role NN O
of IN O
prophages NNS O
is VBZ O
not RB O
limited VBN O
to IN O
pathogenic JJ O
bacteria NNS O
but CC O
some DT O
adaptations NNS O
of IN O
nonpathogenic JJ O
strains NNS O
to IN O
their PRP$ O
ecological JJ O
niche NN O
might MD O
also RB O
be VB O
mediated VBN O
by IN O
prophages NNS O
acquisition NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

To TO O
better RBR O
understand VB O
the DT O
importance NN O
of IN O
mobile JJ O
elements NNS O
within IN O
Vibrionaceae NNP O
family NN O
, , O
we PRP O
performed VBD O
a DT O
hierarchical JJ O
cluster NN O
analysis NN O
using VBG O
gene NN O
profiles NNS O
annotated VBN O
as IN O
"""" `` O
phage NN O
protein NN O
"""" '' O
and CC O
"""" `` O
transposase NN O
"""" '' O
, , O
for IN O
a DT O
total NN O
of IN O
172 CD O
clusters NNS O
of IN O
genes NNS O
( -LRB- O
Fig NNP O
7 CD O
) -RRB- O
. . O

We PRP O
found VBD O
that IN O
a DT O
high JJ O
inter JJ O
- HYPH O
strain NN O
genetic JJ O
variability NN O
exists VBZ O
and CC O
phages NNS O
and CC O
transposases NNS O
are VBP O
both DT O
shared VBN O
by IN O
almost RB O
all DT O
Vibrionaceae NNP O
, , O
and CC O
specific JJ O
to IN O
just RB O
some DT O
organisms NNS O
. . O

We PRP O
identified VBD O
five CD O
major JJ O
clusters NNS O
of IN O
mobile JJ O
elements NNS O
that WDT O
are VBP O
specific JJ O
to IN O
a DT O
single JJ O
organism NN O
. . O

A DT O
group NN O
composed VBN O
by IN O
26 CD O
clusters NNS O
containing VBG O
both CC O
transposase NN O
and CC O
phage NN O
proteins NNS O
seem VBP O
to TO O
be VB O
unique JJ O
to IN O
V NN B-Species
. . I-Species
splendiduds NN I-Species
12B01 CD I-Species
( SYM O
Fig NNP O
7 CD O
) -RRB- O
. . O

Another DT O
one NN O
composed VBN O
by IN O
16 CD O
clusters NNS O
is VBZ O
specific JJ O
of IN O
V NN B-Species
. . I-Species
vulnificus NN I-Species
CMCP6 NNP I-Species
( -LRB- O
Fig NNP O
7 CD O
) -RRB- O
while IN O
V NN B-Species
. . I-Species
parahaemoliticus NN I-Species
has VBZ O
a DT O
cluster NN O
of IN O
11 CD O
genes NNS O
( -LRB- O
Fig NNP O
7 CD O
) -RRB- O
. . O

Moreover RB O
there EX O
is VBZ O
another DT O
group NN O
of IN O
transposases NNS O
and CC O
phage NN O
genes NNS O
shared VBN O
mainly RB O
by IN O
V NN B-Species
. . I-Species
cholerae NN I-Species
395 CD O
, , O
Shewanella NN B-Species
oneidensis NN I-Species
and CC O
V NN B-Species
. . I-Species
cholerae NN I-Species
V51 NNP O
( , O
Fig NNP O
7 CD O
) -RRB- O
. . O

Finally RB O
a DT O
big JJ O
cluster NN O
of IN O
almost RB O
30 CD O
genes NNS O
, , O
all DT O
predicted VBN O
to TO O
codify VB O
for IN O
transposases NNS O
, , O
was VBD O
found VBN O
in IN O
P NN B-Species
. . I-Species
profundum NN I-Species
SS9 NN I-Species
genome NN O
( , O
Fig NNP O
. . O
7 CD O
) -RRB- O
. . O

The DT O
high JJ O
presence NN O
of IN O
transposases NNS O
in IN O
this DT O
bacterium NN O
seems VBZ O
to TO O
correlate VB O
with IN O
its PRP$ O
deep JJ O
- HYPH O
sea NN O
habitat NN O
, , O
a DT O
feature NN O
presumably RB O
shared VBN O
with IN O
other JJ O
deep JJ O
- HYPH O
sea NN O
microorganisms NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

As IN O
shown VBN O
in IN O
Fig NNP O
7 CD O
, , O
many JJ O
of IN O
the DT O
clusters NNS O
well RB O
conserved VBN O
in IN O
an DT O
organism NN O
, , O
are VBP O
partially RB O
shared VBN O
with IN O
a DT O
low JJ O
similarity NN O
by IN O
other JJ O
organisms NNS O
. . O

This DT O
agrees VBZ O
with IN O
the DT O
idea NN O
that IN O
prophages NNS O
are VBP O
not RB O
maintained VBN O
in IN O
the DT O
genome NN O
over IN O
a DT O
long JJ O
period NN O
of IN O
time NN O
and CC O
part NN O
of IN O
their PRP$ O
genes NNS O
may MD O
be VB O
deleted VBN O
from IN O
the DT O
chromosome NN O
. . O

Moreover RB O
, , O
microarray NN O
analysis NN O
and CC O
PCR NN O
scanning NN O
demonstrated VBD O
that IN O
prophages NNS O
are VBP O
frequently RB O
strain VBP O
specific JJ O
within IN O
a DT O
given VBN O
bacterial JJ O
species NN O
[ -LRB- O
22 CD O
- SYM O
24 CD O
] -RRB- O
. . O

According VBG O
to IN O
the DT O
modular JJ O
theory NN O
of IN O
phage NN O
evolution NN O
, , O
phage NN O
genomes NNS O
are VBP O
mosaics NNS O
of IN O
modules NNS O
, , O
groups NNS O
of IN O
genes NNS O
functionally RB O
related VBN O
, , O
that WDT O
are VBP O
free JJ O
to TO O
recombine VB O
in IN O
genetic JJ O
exchanges NNS O
between IN O
distinct JJ O
phages NNS O
infecting VBG O
the DT O
same JJ O
cell NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

This DT O
can MD O
result VB O
in IN O
the DT O
occurrences NNS O
of IN O
different JJ O
part NN O
of IN O
phage NN O
distributed VBN O
in IN O
far RB O
related JJ O
genomes NNS O
. . O

Phylogenetic JJ O
profile NN O
of IN O
some DT O
transposases NNS O
is VBZ O
similar JJ O
to IN O
the DT O
phage NN O
ones NNS O
, , O
suggesting VBG O
a DT O
possible JJ O
transfer NN O
mechanism NN O
phage NN O
- HYPH O
mediated VBN O
for IN O
such JJ O
mobile JJ O
elements NNS O
. . O

Conclusion NN O

In IN O
this DT O
work NN O
we PRP O
propose VBP O
an DT O
improved JJ O
phylogenetic JJ O
profile NN O
analysis NN O
on IN O
14 CD O
Vibrionaceae NNP O
genomes NNS O
, , O
to TO O
study VB O
this DT O
family NN O
on IN O
the DT O
basis NN O
of IN O
gene NN O
content NN O
. . O

Using VBG O
a DT O
phylogenetic JJ O
profile NN O
for IN O
each DT O
cluster NN O
of IN O
genes NNS O
defined VBN O
as IN O
the DT O
median NN O
of IN O
all PDT O
the DT O
profiles NNS O
belonging VBG O
to IN O
the DT O
cluster NN O
( , O
meta JJ O
- HYPH O
profile NN O
) -RRB- O
we PRP O
investigate VBP O
the DT O
evolution NN O
of IN O
groups NNS O
of IN O
ORFs NNS O
belonging VBG O
to IN O
the DT O
entire JJ O
family NN O
. . O

A DT O
two CD O
- HYPH O
way NN O
cluster NN O
analysis NN O
allows VBZ O
us PRP O
to TO O
identify VB O
similarity NN O
structures NNS O
on IN O
the DT O
entire JJ O
phylogenetic JJ O
matrix NN O
composed VBN O
by IN O
8 CD O
, , O
239 CD O
clusters NNS O
of IN O
genes NNS O
and CC O
320 CD O
organisms NNS O
. . O

The DT O
phylogenetic JJ O
tree NN O
obtained VBN O
with IN O
the DT O
cluster NN O
analysis NN O
does VBZ O
not RB O
reflect VB O
the DT O
global JJ O
evolutionary JJ O
tree NN O
because IN O
of IN O
the DT O
Vibrionaceae NNP O
ORFs NNP O
dataset NN O
used VBN O
for IN O
the DT O
analysis NN O
, , O
but CC O
rather RB O
can MD O
be VB O
considered VBN O
as IN O
the DT O
Vibrionaceae NNP O
perspective NN O
of IN O
bacterial JJ O
diversity NN O
. . O

The DT O
phylogenetic JJ O
tree NN O
reflects VBZ O
the DT O
evolutionary JJ O
processes NNS O
that WDT O
shape VBP O
genomes NNS O
, , O
as IN O
lateral JJ O
gene NN O
transfer NN O
, , O
genes NNS O
genesis NN O
and CC O
loss NN O
. . O

In IN O
this DT O
context NN O
, , O
the DT O
tree NN O
allows VBZ O
to TO O
group VB O
together RB O
genomes NNS O
on IN O
the DT O
base NN O
of IN O
their PRP$ O
global JJ O
gene NN O
content NN O
. . O

We PRP O
found VBD O
that IN O
genomes NNS O
belonging VBG O
to IN O
the DT O
same JJ O
taxonomic JJ O
group NN O
tend VBP O
to TO O
cluster VB O
together RB O
and CC O
that IN O
Vibrionaceae NNP O
species NNS O
are VBP O
closely RB O
related VBN O
. . O

Moreover RB O
organisms NNS O
belonging VBG O
to IN O
the DT O
same JJ O
or CC O
closely RB O
related VBN O
taxa NN O
split VBP O
into IN O
different JJ O
subgroups NNS O
, , O
confirming VBG O
the DT O
existence NN O
of IN O
a DT O
high JJ O
variability NN O
among IN O
lineages NNS O
, , O
due IN O
to IN O
genetic JJ O
and CC O
evolutionary JJ O
process NN O
such JJ O
as IN O
lateral JJ O
gene NN O
transfer NN O
, , O
concerted JJ O
evolution NN O
and CC O
genes NNS O
duplication NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
several JJ O
groups NNS O
of IN O
genes NNS O
characterised VBN O
by IN O
different JJ O
homogeneous JJ O
profiles NNS O
have VBP O
been VBN O
identified VBN O
. . O

In IN O
particular JJ O
we PRP O
found VBD O
, , O
1 CD O
) , O
a DT O
set NN O
of IN O
conserved VBN O
genes NNS O
( , O
with IN O
a DT O
high JJ O
similarity NN O
values NNS O
across IN O
all DT O
organisms NNS O
) , O
that WDT O
reflects VBZ O
the DT O
"""" `` O
minimal JJ O
genome NN O
"""" '' O
composition NN O
defined VBN O
in IN O
other JJ O
previous JJ O
works NNS O
; : O
2 CD O
) -RRB- O
a DT O
set NN O
of IN O
genes NNS O
mainly RB O
shared VBN O
by IN O
Vibrionaceae NNP O
and CC O
other JJ O
Gamma NNP O
proteobacteria NN O
and CC O
3 CD O
) SYM O
genes NNS O
specific JJ O
to IN O
different JJ O
sets NNS O
of IN O
Vibrionaceae NNP O
. . O

Finally RB O
a DT O
further JJ O
analysis NN O
on IN O
prophage NN O
and CC O
transposase NN O
has VBZ O
confirmed VBN O
the DT O
high JJ O
inter JJ O
- HYPH O
strain NN O
genetic JJ O
variability NN O
even RB O
among IN O
closely RB O
related VBN O
species NNS O
. . O

The DT O
increasing VBG O
number NN O
of IN O
genomes NNS O
included VBN O
in IN O
this DT O
type NN O
of IN O
analysis NN O
surely RB O
add VBP O
new JJ O
sorces NNS O
of IN O
variability NN O
and CC O
noise NN O
, , O
anyway UH O
we PRP O
think VBP O
that IN O
the DT O
use NN O
of IN O
meta NN O
- HYPH O
profiles NNS O
can MD O
be VB O
useful JJ O
for IN O
complexity NN O
reduction NN O
and CC O
data NN O
analysis NN O
to TO O
study VB O
global JJ O
gene NN O
evolution NN O
. . O

Methods NNS O

Datasets NNS O

The DT O
Vibrionaceae NNP O
species NNS O
used VBN O
in IN O
this DT O
analysis NN O
were VBD O
selected VBN O
among IN O
the DT O
freely RB O
available JJ O
complete JJ O
and CC O
draft NN O
genome NN O
sequences NNS O
. . O

The DT O
proteomes NNS O
of IN O
V NN B-Species
. . I-Species
cholerae NN I-Species
N16961 CD I-Species
, , O
V NN B-Species
. . I-Species
parahaemolyticus NN I-Species
, , O
V NN B-Species
. . I-Species
vulnificus NN I-Species
YJ016 NN I-Species
, , O
V NN B-Species
. . I-Species
vulnificus NNP I-Species
CMCP6 NNP I-Species
, , O
V NNP B-Species
. , I-Species
fischeri NNP I-Species
ES114 NNP I-Species
, , O
Photobacterium NN B-Species
profundum NN I-Species
SS9 NN I-Species
were VBD O
downloaded VBN O
from IN O
the DT O
NCBI NNP O
ftp NN O
site NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Protein NN O
sequences NNS O
of IN O
Vibrio NNP B-Species
cholerae NN I-Species
MO10 NNP I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
395 CD I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
RC385 NNP I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
V51 NN I-Species
, , O
Vibrio NNP B-Species
cholerae NN I-Species
V52 NN I-Species
were VBD O
downloaded VBN O
from IN O
the DT O
NCBI NNP O
genome NN O
database NN O
, , O
while IN O
sequences NNS O
of IN O
Vibrio NNP B-Species
MED222 NNP I-Species
, , O
Vibrio NNP B-Species
splendidus NN I-Species
12B01 CD I-Species
, , O
Photobacterium NN B-Species
profundum NN I-Species
3TCK NN I-Species
from IN O
the DT O
J NNP O
. . O

Craig NNP O
Venter NNP O
Institute NNP O
web NN O
site NN O
. . O

The DT O
320 CD O
complete JJ O
genomes NNS O
update VBP O
at IN O
3 CD O
/ SYM O
6 CD O
were VBD O
downloaded VBN O
from IN O
the DT O
NCBI NNP O
ftp NN O
site NN O
. . O

Similarity NN O
search NN O
and CC O
phylogenetic JJ O
profile NN O
construction NN O

All PDT O
the DT O
Vibrionaceae NNP O
ORFs NNPS O
were VBD O
merged VBN O
generating VBG O
a DT O
redundant JJ O
list NN O
of IN O
59 CD O
, , O
669 CD O
proteins NNS O
and CC O
were VBD O
compared VBN O
to IN O
all DT O
open JJ O
reading NN O
frame NN O
from IN O
320 CD O
bacterial JJ O
and CC O
archeal JJ O
genomes NNS O
using VBG O
Blastp NNP O
. . O

To TO O
determine VB O
the DT O
presence NN O
of IN O
an DT O
orthologous JJ O
we PRP O
used VBD O
a DT O
combination NN O
of IN O
three CD O
different JJ O
thresholds NNS O
; : O
a DT O
similarity NN O
value NN O
equal JJ O
to IN O
or CC O
higher JJR O
than IN O
30 CD O
% NN O
, , O
an DT O
alignment NN O
length NN O
equal JJ O
or CC O
higher JJR O
than IN O
70 CD O
% NN O
and CC O
an DT O
Evalue JJ O
score NN O
lower JJR O
than IN O
or CC O
equal JJ O
to IN O
e CD O
- HYPH O
6 CD O
. . O

After IN O
determining VBG O
the DT O
presence NN O
of IN O
an DT O
orthologous JJ O
gene NN O
, , O
we PRP O
computed VBD O
a DT O
similarity NN O
index NN O
I PRP O
for IN O
each DT O
pair NN O
of IN O
orthologous JJ O
( , O
a DT O
point NN O
of IN O
the DT O
phylogenetic JJ O
profile NN O
) -RRB- O
as IN O
follow VBP O
: : O

I PRP O
= NFP O
SqsSqq NNP O
. . O
min NN O
( : O
lq NNS O
, , O
ls NNS O
) -RRB- O
max NN O
( , O
lq NNS O
, , O
ls FW O
) -RRB- O

MathType NNP O
@ CC O
MTEF NNP O
@ : O
5 CD O
@ SYM O
5 CD O
@ CC O
+ NFP O
= NFP O
feaafiart1ev1aaatCvA NN O
= : O
wiFfYdH8Gipec8Eeeu0x ADD O
= NFP O
OqFfea0dXdd9vqai NN O
= NFP O
hGuQ8kuc9pgc9s8qqaq NN O
= NFP O
dirpe0xb9q8qiLsFr0 NN O
= NFP O
vr0 NN O
= NFP O
vr0dc8meaabaqaciaaca NN O
@ IN O
532D CD O
@ SYM O

where WRB O
lq NNS O
and CC O
ls NNS O
are VBP O
the DT O
query NN O
and CC O
subject NN O
length NN O
sequence NN O
respectively RB O
and CC O
Sqs NNP O
is VBZ O
the DT O
similarity NN O
score NN O
between IN O
the DT O
query NN O
and CC O
the DT O
subject NN O
sequence NN O
. . O

Sqs NNP O
is VBZ O
defined VBN O
as IN O
follow NN O
: : O

Sqs NNS O
= : O
sum NN O
i NN O
= NFP O
1M CD O
alpha NN O
Aqi NNP O
, , O
Asi NNP O
+ CC O
GP NN O

MathType NNP O
@ CC O
MTEF NNP O
@ : O
5 CD O
@ SYM O
5 CD O
@ CC O
+ NFP O
= NFP O
feaafiart1ev1aaatCvA NN O
= : O
wiFfYdH8Gipec8Eeeu0x ADD O
= NFP O
OqFfea0dXdd9vqai NN O
= NFP O
hGuQ8kuc9pgc9s8qqaq NN O
= NFP O
dirpe0xb9q8qiLsFr0 NN O
= NFP O
vr0 NN O
= NFP O
vr0dc8meaabaqaciaaca NN O
@ SYM O
4620 CD O
@ SYM O

where WRB O
M NNP O
is VBZ O
the DT O
match NN O
length NN O
between IN O
the DT O
query NN O
and CC O
subject NN O
sequence NN O
; : O
Aqi NNP O
and CC O
Asi NNP O
respectively RB O
the DT O
query NN O
and CC O
subject NN O
amino NN O
acid NN O
in IN O
position NN O
i PRP O
; : O
alpha NN O
the DT O
BLOSUM NNP O
substitution NN O
matrix NN O
value NN O
for IN O
amino NN O
acid NN O
pair NN O
Aqi NNP O
, , O
Asi NNP O
and CC O
GP NNP O
the DT O
gap NN O
penalty NN O
. . O

GP NNP O
is VBZ O
defined VBN O
as IN O
follow NN O
: : O

GP NNP O
= SYM O
GOP NNP O
+ SYM O
GEP NNP O
( : O
k NN O
- HYPH O
1 CD O
) : O

where WRB O
GOP NNP O
is VBZ O
the DT O
Gap NNP O
Open JJ O
Penalty NN O
set VBN O
to IN O
- HYPH O
11 CD O
, , O
GEP NNP O
the DT O
Gap NN O
Extension NN O
Penalty NN O
set VBN O
to IN O
- HYPH O
1 CD O
and CC O
k VB O
the DT O
gap NN O
length NN O
. . O

Sqq NNP O
represents VBZ O
the DT O
score NN O
of IN O
the DT O
self NN O
- HYPH O
aligned VBN O
query NN O
sequence NN O
. . O

Sqs NNP O
is VBZ O
always RB O
smaller JJR O
than IN O
Sqq NNP O
and CC O
the DT O
score NN O
S NN O
range VBP O
between IN O
0 CD O
and CC O
1 CD O
. . O

In IN O
order NN O
to TO O
take VB O
into IN O
account NN O
also RB O
the DT O
different JJ O
sequence NN O
lengths NNS O
, , O
we PRP O
multiplied VBD O
the DT O
score NN O
S NN O
by IN O
the DT O
ratio NN O
between IN O
the DT O
minimum JJ O
length NN O
between IN O
query NN O
and CC O
subject NN O
and CC O
the DT O
maximum JJ O
length NN O
between IN O
query NN O
and CC O
subjects NNS O
. . O

In IN O
this DT O
way NN O
the DT O
total JJ O
score NN O
is VBZ O
weighted VBN O
on IN O
the DT O
base NN O
of IN O
the DT O
length NN O
, , O
resulting VBG O
in IN O
a DT O
lower JJR O
similarity NN O
value NN O
if IN O
the DT O
lengths NNS O
of IN O
the DT O
sequences NNS O
are VBP O
different JJ O
. . O

The DT O
phylogenetic JJ O
profile NN O
for IN O
each DT O
ORF NNP O
is VBZ O
an DT O
array NN O
of IN O
index NN O
I PRP O
with IN O
length NN O
equal JJ O
to IN O
the DT O
number NN O
of IN O
genomes NNS O
considered VBN O
( $ O
320 CD O
) -RRB- O
. . O

ORFs NNS O
clustering VBG O

The DT O
redundant JJ O
list NN O
of IN O
59 CD O
, , O
669 CD O
Vibrionaceae NNP O
ORFs NNPS O
contained VBD O
multiple JJ O
copies NNS O
of IN O
the DT O
same JJ O
genes NNS O
due JJ O
to IN O
the DT O
presence NN O
of IN O
conserved VBN O
genes NNS O
in IN O
the DT O
considered VBN O
genomes NNS O
. . O

In IN O
order NN O
to TO O
reduce VB O
the DT O
redundancy NN O
, , O
we PRP O
clustered VBD O
proteins NNS O
using VBG O
a DT O
two CD O
- HYPH O
step NN O
approach NN O
. . O

The DT O
first JJ O
step NN O
is VBZ O
based VBN O
on IN O
COG NNP O
( -LRB- O
Cluster NNP O
of IN O
Othologous NNP O
Genes NNPS O
) -RRB- O
annotation NN O
. . O

COG NNP O
classifies VBZ O
conserved VBN O
genes NNS O
according VBG O
to IN O
their PRP$ O
homologous JJ O
relationships NNS O
. . O

All PDT O
the DT O
Vibrionaceae NNP O
ORFs NNS O
were VBD O
annotated VBN O
using VBG O
COG NNP O
clusters NNS O
and CC O
proteins NNS O
sharing VBG O
the DT O
same JJ O
COG NNP O
code NN O
were VBD O
considered VBN O
belonging VBG O
to IN O
the DT O
same JJ O
cluster NN O
. . O

In IN O
particular JJ O
, , O
the DT O
annotation NN O
process NN O
consists VBZ O
of IN O
a DT O
similarity NN O
search NN O
of IN O
all PDT O
the DT O
ORFs NNS O
against IN O
the DT O
COG NNP O
proteins NNS O
using VBG O
blast NN O
and CC O
considering VBG O
the DT O
best JJS O
hit NN O
for IN O
each DT O
protein NN O
. . O

43 CD O
, , O
24 CD O
ORFs NNS O
presented VBD O
a DT O
similarity NN O
with IN O
a DT O
COG NNP O
entry NN O
, , O
producing VBG O
2 CD O
, , O
463 CD O
different JJ O
clusters NNS O
. . O

In IN O
the DT O
second JJ O
step NN O
, , O
the DT O
remaining VBG O
16 CD O
, , O
645 CD O
ORFs NNS O
without IN O
similarity NN O
with IN O
any DT O
COG NNP O
entry NN O
were VBD O
clustered VBN O
using VBG O
CD NN O
- HYPH O
HIT NNP O
software NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

CD NN O
- HYPH O
HIT NN O
program NN O
clusters NNS O
protein NN O
sequence NN O
database NN O
at IN O
high JJ O
sequence NN O
identity NN O
threshold NN O
and CC O
efficiently RB O
removes VBZ O
high JJ O
sequence NN O
redundancy NN O
. . O

This DT O
last JJ O
clustering NN O
process NN O
produced VBD O
9 CD O
, , O
613 CD O
different JJ O
groups NNS O
of IN O
similar JJ O
proteins NNS O
. . O

Finally RB O
from IN O
the DT O
12 CD O
, , O
76 CD O
total JJ O
clusters NNS O
obtained VBN O
by IN O
this DT O
methodology NN O
, , O
those DT O
composed VBN O
by IN O
ORFs NNS O
that WDT O
do VBP O
not RB O
have VB O
any DT O
ortologous JJ O
genes NNS O
( , O
with IN O
a DT O
phylogenetic JJ O
profile NN O
composed VBN O
by IN O
an DT O
array NN O
with IN O
all DT O
zero CD O
values NNS O
except IN O
for IN O
one CD O
position NN O
match NN O
with IN O
itself PRP O
) -RRB- O
were VBD O
eliminated VBN O
, , O
resulting VBG O
in IN O
a DT O
dataset NN O
composed VBN O
by IN O
8 CD O
, , O
239 CD O
distinct JJ O
clusters NNS O
. . O

The DT O
final JJ O
phylogenetic JJ O
profile NN O
for IN O
each DT O
cluster NN O
( , O
meta JJ O
- HYPH O
profile NN O
) -RRB- O
was VBD O
defined VBN O
as IN O
the DT O
median NN O
of IN O
all PDT O
the DT O
profiles NNS O
belonging VBG O
to IN O
the DT O
cluster NN O
. . O

At IN O
the DT O
end NN O
of IN O
these DT O
procedures NNS O
the DT O
final JJ O
phylogenetic JJ O
matrix NN O
was VBD O
composed VBN O
by IN O
8 CD O
, , O
239 CD O
rows NNS O
( , O
cluster NN O
of IN O
genes NNS O
) -RRB- O
and CC O
320 CD O
columns NNS O
( , O
organisms NNS O
) -RRB- O
. . O

In IN O
each DT O
cell NN O
the DT O
median NN O
of IN O
the DT O
index NN O
in IN O
the DT O
cluster NN O
was VBD O
reported VBN O
. . O

Cluster NN O
analysis NN O

Several JJ O
clustering JJ O
techniques NNS O
have VBP O
been VBN O
used VBN O
to TO O
identify VB O
the DT O
similarity NN O
structure NN O
underneath IN O
our PRP$ O
data NNS O
. . O

A DT O
k NN O
- HYPH O
means VBZ O
and CC O
a DT O
two CD O
- HYPH O
way NN O
hierarchical JJ O
cluster NN O
analysis NN O
with IN O
Euclidean JJ O
distance NN O
and CC O
complete JJ O
linkage NN O
were VBD O
performed VBN O
on IN O
the DT O
phylogenetic JJ O
matrix NN O
. . O

The DT O
goal NN O
of IN O
a DT O
cluster NN O
analysis NN O
is VBZ O
to TO O
partition VB O
the DT O
elements NNS O
into IN O
subsets NNS O
without IN O
any DT O
constrains NNS O
or CC O
a DT O
priori JJ O
information NN O
, , O
so IN O
that IN O
two CD O
criteria NNS O
are VBP O
satisfied JJ O
: : O
homogeneity NN O
, , O
elements NNS O
inside IN O
a DT O
cluster NN O
are VBP O
highly RB O
similar JJ O
to IN O
each DT O
other JJ O
; , O
and CC O
separation NN O
, , O
elements NNS O
from IN O
different JJ O
clusters NNS O
have VBP O
low JJ O
similarity NN O
to IN O
each DT O
other JJ O
. . O

The DT O
Figure NNP O
of IN O
Merit NNP O
( : O
FOM NNP O
) -RRB- O
is VBZ O
a DT O
measure NN O
of IN O
fit NN O
of IN O
the DT O
expression NN O
patterns NNS O
for IN O
the DT O
clusters NNS O
produced VBN O
by IN O
a DT O
particular JJ O
algorithm NN O
that WDT O
estimates VBZ O
the DT O
predictive JJ O
power NN O
of IN O
a DT O
clustering VBG O
algorithm NN O
. . O

It PRP O
is VBZ O
computed VBN O
by IN O
removing VBG O
each DT O
sample NN O
in IN O
turn NN O
from IN O
the DT O
data NNS O
set NN O
, , O
clustering VBG O
genes NNS O
based VBN O
on IN O
the DT O
remaining VBG O
data NNS O
, , O
and CC O
calculating VBG O
the DT O
fit NN O
of IN O
the DT O
withheld VBN O
sample NN O
to IN O
the DT O
clustering VBG O
pattern NN O
obtained VBN O
from IN O
the DT O
other JJ O
samples NNS O
. . O

On IN O
our PRP$ O
data NN O
FOM NN O
analysis NN O
identified VBD O
the DT O
best JJS O
number NN O
of IN O
k NN O
- HYPH O
means VBZ O
clusters NNS O
between IN O
10 CD O
and CC O
15 CD O
. . O

We PRP O
decided VBD O
to TO O
set VB O
k NN O
( , O
in IN O
the DT O
k NN O
- HYPH O
means NN O
analysis NN O
) -RRB- O
equal JJ O
to IN O
14 CD O
. . O

In IN O
each DT O
of IN O
these DT O
14 CD O
clusters NNS O
subsequent JJ O
hierarchical JJ O
cluster NN O
analysis NN O
was VBD O
performed VBN O
with IN O
bootstrap NN O
cluster NN O
assessment NN O
. . O

All PDT O
the DT O
previous JJ O
analyses NNS O
were VBD O
performed VBN O
with IN O
TMEV NNP O
software NN O
[ -LRB- O
27 CD O
] -RRB- O
, , O
freely RB O
available JJ O
at IN O
[ $ O
28 CD O
] -RRB- O
. . O

Enrichment NN O
categories NNS O

Each DT O
cluster NN O
of IN O
genes NNS O
has VBZ O
been VBN O
annotated VBN O
according VBG O
to IN O
COG NNP O
code NN O
, , O
GO NNP O
terms NNS O
and CC O
KEGG NNP O
pathway NN O
maps NNS O
. . O

Class NN O
enrichment NN O
( , O
with IN O
respect NN O
to IN O
the DT O
entire JJ O
matrix NN O
) , O
has VBZ O
been VBN O
calculated VBN O
according VBG O
to IN O
the DT O
hypergeometric JJ O
distribution NN O
that WDT O
was VBD O
used VBN O
to TO O
obtain VB O
the DT O
chance NN O
probability NN O
of IN O
observing VBG O
the DT O
number NN O
of IN O
genes NNS O
annotated VBN O
with IN O
a DT O
particular JJ O
COG NNP O
, , O
GO NNP O
and CC O
KEGG NNP O
category NN O
among IN O
the DT O
selected VBN O
cluster NN O
. . O

The DT O
probability NN O
P NN O
of IN O
observing VBG O
at IN O
least JJS O
k NN O
genes NNS O
of IN O
a DT O
functional JJ O
category NN O
within IN O
a DT O
group NN O
of IN O
n CD O
genes NNS O
is VBZ O
given VBN O
by IN O
: : O

P NN O
= SYM O
sum NN O
i NN O
= SYM O
kn FW O
( : O
fi FW O
) -RRB- O
( : O
g CD O
- HYPH O
fn NN O
- HYPH O
i PRP O
) -RRB- O
( : O
gn NN O
) -RRB- O

MathType NNP O
@ CC O
MTEF NNP O
@ : O
5 CD O
@ SYM O
5 CD O
@ CC O
+ NFP O
= NFP O
feaafiart1ev1aaatCvA NN O
= : O
wiFfYdH8Gipec8Eeeu0x ADD O
= NFP O
OqFfea0dXdd9vqai NN O
= NFP O
hGuQ8kuc9pgc9s8qqaq NN O
= NFP O
dirpe0xb9q8qiLsFr0 NN O
= NFP O
vr0 NN O
= NFP O
vr0dc8meaabaqaciaaca NN O
@ IN O
47C6 CD O
@ SYM O

where WRB O
f XX O
is VBZ O
the DT O
total JJ O
number NN O
of IN O
genes NNS O
with IN O
the DT O
same JJ O
category NN O
( , O
in IN O
the DT O
matrix NN O
) -RRB- O
and CC O
g NN O
is VBZ O
the DT O
total JJ O
number NN O
of IN O
genes NNS O
in IN O
our PRP$ O
matrix NN O
. . O

A DT O
secondary JJ O
structural JJ O
common JJ O
core NN O
in IN O
the DT O
ribosomal JJ O
ITS2 NN O
( , O
internal JJ O
transcribed VBN O
spacer NN O
) -RRB- O
of IN O

Culexspecies NNS O
from IN O
diverse JJ O
geographical JJ O
locations NNS O

Abstract JJ O

In IN O
the DT O
present JJ O
study NN O
, , O
sequence NN O
and CC O
structural JJ O
analysis NN O
of IN O
ITS2 NNP O
region NN O
( , O
the DT O
spacer NN O
segment NN O
between IN O
5 CD O
. . O
8S CD O
and CC O
28S CD O
rRNA NN O
of IN O

mature JJ O
rRNA NNP O
sequences NNS O
) -RRB- O
of IN O
7 CD O
Culex NNP O
species NNS O
belonging VBG O
to IN O
5 CD O
different JJ O
geographical JJ O
locations NNS O
was VBD O
carried VBN O
out RP O
. . O

Alignment NN O
of IN O
the DT O

ITS2 NNP O
sequence NN O
from IN O
the DT O
7 CD O
species NNS O
revealed VBD O
8 CD O
homologous JJ O
domains NNS O
. . O

Four CD O
species NNS O
namely RB O
C NNP B-Species
. . I-Species
vishnui NN I-Species
, , O
C NN B-Species
. . I-Species
annulus NN I-Species
, , O
C NN B-Species
. . I-Species
pipiens NNS I-Species
, , O

C NN B-Species
. . I-Species
quiquefasciatusshowe NN I-Species
high JJ O
sequence NN O
( : O
98 CD O
- SYM O
100 CD O
% NN O
) -RRB- O
and CC O
RNA NNP O
secondary JJ O
structure NN O
similarity NN O
. . O

The DT O
ITS2 NNP O
similarity NN O
among IN O
different JJ O

species NNS O
is VBZ O
high JJ O
despite IN O
their PRP$ O
varying VBG O
geographical JJ O
locations NNS O
. . O

Several JJ O
common JJ O
features NNS O
of IN O
secondary JJ O
structure NN O
are VBP O
shared VBN O
among IN O

these DT O
species NNS O
, , O
with IN O
some DT O
of IN O
them PRP O
supported VBN O
by IN O
compensatory JJ O
changes NNS O
, , O
suggesting VBG O
the DT O
significant JJ O
role NN O
by IN O
ITS2 NNP O
as IN O
an DT O
RNA NNP O
domain NN O

during IN O
ribosome NN O
biogenesis NN O
. . O

Background NN O

Culex NNP O
mosquito NN O
species NNS O
have VBP O
been VBN O
described VBN O
from IN O
a DT O
wide JJ O
range NN O
of IN O
environments NNS O
and CC O
are VBP O
involved VBN O
in IN O
pathogen NN O
transmission NN O
from IN O

human JJ B-Species
to IN O
reservoirs NNS O
and CC O
vice NN O
- HYPH O
versa NN O
. . O

[ -LRB- O
1 LS O
] -RRB- O
Sequence NN O
similarity NN O
have VBP O
been VBN O

reported VBN O
for IN O
ITS2 NNP O
( : O
the DT O
spacer NN O
segments NNS O
between IN O
5 CD O
. . O
8S NNS O
and CC O
28S CD O
rRNA NN O
of IN O
mature JJ O
rRNA NNP O
sequences NNS O
) -RRB- O
from IN O
5 CD O
Culex NNP O
species NNS O
of IN O
diverse JJ O

geographic JJ O
locations NNS O
. . O

[ -LRB- O
3 CD O
- SYM O
4 CD O
- : O

5 CD O
- SYM O
9 CD O
- : O

20 CD O
] -RRB- O
The DT O
ITS NNP O
spacers NNS O
are VBP O
versatile JJ O
as IN O
genetic JJ O
markers NNS O
and CC O
have VBP O
been VBN O
used VBN O
for IN O
the DT O
determination NN O
of IN O
taxonomic JJ O

classification NN O
. . O

[ -LRB- O
17 CD O
] -RRB- O
Recent JJ O
functional JJ O
analyses NNS O
performed VBN O
on IN O
yeast NN B-Species
ribosomal JJ O

RNA NNP O
genes NNS O
clearly RB O
show VBP O
that IN O
the DT O
structural JJ O
integrity NN O
of IN O
the DT O
transcribed VBN O
spacer NN O
regions NNS O
is VBZ O
an DT O
essential JJ O
prerequisite NN O
for IN O
the DT O
correct JJ O

processing NN O
of IN O
mature JJ O
rRNA NN O
and CC O
for IN O
the DT O
biogenesis NN O
of IN O
active JJ O
ribosomal JJ O
subunits NNS O
. . O

[ -LRB- O
2 LS O
- . O

3 LS O
] -RRB- O
The DT O
derivation NN O
of IN O
reliable JJ O
secondary JJ O
structure NN O
models NNS O
for IN O
each DT O
transcribed VBN O
spacer NN O

region NN O
would MD O
represent VB O
a DT O
major JJ O
step NN O
towards IN O
a DT O
detailed JJ O
understanding NN O
of IN O
their PRP$ O
biological JJ O
roles NNS O
. . O

Comparative JJ O
sequence NN O
analysis NN O
provides VBZ O
a DT O
powerful JJ O
tool NN O
for IN O
identifying VBG O
biologically RB O
relevant JJ O
folding VBG O
patterns NNS O
in IN O
RNA NNP O
molecules NNS O
. . O

[ -LRB- O
4 LS O
] -RRB- O
This DT O
involves VBZ O
collection NN O
of IN O
sequences NNS O
exhibiting VBG O
substantial JJ O
nucleotide NN O

differences NNS O
while IN O
retaining VBG O
unequivocal JJ O
sequence NN O
similarity NN O
. . O

However RB O
, , O
a DT O
high JJ O
degree NN O
of IN O
sequence NN O
variation NN O
in IN O
the DT O
transcribed VBN O

spacers NNS O
is VBZ O
known VBN O
even RB O
among IN O
closely RB O
related VBN O
species NNS O
. . O

[ -LRB- O
5 CD O
- SYM O
6 CD O
- SYM O
7 CD O
] -RRB- O
Here RB O
, , O
we PRP O
analyze VBP O
ITS2 NNP O
from IN O
7 CD O

Culex NNP O
species NNS O
characteristic JJ O
of IN O
5 CD O
different JJ O
geographical JJ O
locations NNS O
to TO O
assemble VB O
common JJ O
RNA NNP O
structural JJ O
features NNS O
. . O

Methodology NN O

Dataset NNP O

ITS2 NNP O
nucleotide NN O
sequences NNS O
from IN O
7 CD O
Culex NNP O
mosquitoes NNS O
characteristic JJ O
of IN O
5 CD O
geographical JJ O
locations NNS O
( , O
Italy NNP O
, , O
China NNP O
, , O
Africa NNP O
, , O

America NNP O
, , O
and CC O
Japan NNP O
) , O
were VBD O
downloaded VBN O
from IN O
GenBank NNP O
( : O
www ADD O
. . O
ncbi ADD O
. . O
nlm UH O
. . O
nih UH O
. . O
gov NN O
/ SYM O
genbank NNP O

) -RRB- O
. , O
The DT O
GenBank NNP O
accession NN O
numbers NNS O
for IN O
ITS2 NNP O
sequences NNS O

from IN O
C NNP B-Species
. . I-Species
pipens NNS I-Species
( : O
North NNP O
America NNP O
) -RRB- O
, , O
C NNP B-Species
. . I-Species
tritaeniorhynchus NN I-Species
( : O
China NNP O
) -RRB- O
, , O
C NN B-Species
. . I-Species
quinquefasciatus NN I-Species

( : O
Africa NNP O
) -RRB- O
, , O
C NNP B-Species
. . I-Species
tarsalis NNP I-Species
( , O
Italy NNP O
) -RRB- O
, , O
C NNP B-Species
. . I-Species
annulus NNP I-Species
( , O
China NNP O
) -RRB- O
, , O
C NN B-Species
. . I-Species
pseudovishnui NN I-Species

( -LRB- O
China NNP O
) -RRB- O
, , O
and CC O
C NNP B-Species
. . I-Species
vishnui NNP I-Species
( , O
Japan NNP O
) -RRB- O
were VBD O
X75817 CD O
, , O
AF305558 NNP O
, , O
Z48468 CD O
, , O
U33031 NNP O
, , O
AF453488 NNP O
, , O
AF453498 NNP O
and CC O
AF165900 NN O
, . O

respectively RB O
. . O

Sequence NN O
alignments NNS O

Multiple JJ O
sequence NN O
alignments NNS O
were VBD O
performed VBN O
using VBG O
CLUSTALW NNP O
with IN O
a DT O
gap NN O
opening VBG O
penalty NN O
of IN O
15 CD O
and CC O
gap NN O
extension NN O
penalty NN O
of IN O
6 CD O
. . O
66 CD O
. . O

[ -LRB- O
8 CD O
] -RRB- O

Secondary JJ O
structure NN O
prediction NN O

The DT O
RNA NNP O
secondary JJ O
structures NNS O
for IN O
ITS2 NNP O
were VBD O
predicted VBN O
using VBG O
RNADRAW NNP O
. . O

[ -LRB- O
21 CD O
] -RRB- O

RNADRAW NNP O
predicts VBZ O
RNA NNP O
structures NNS O
by IN O
identifying VBG O
suboptimal JJ O
structures NNS O
using VBG O
the DT O
free JJ O
energy NN O
optimization NN O
methodology NN O
at IN O
a DT O
default NN O

temperature NN O
of IN O
370 CD O
degrees NNS O
C NN O
. . O

In IN O
the DT O
current JJ O
study NN O
, , O
ITS2 NNP O
and CC O
5 CD O
. . O
8S NNP O
regions NNS O
( , O
the DT O
first JJ O
170 CD O
nucleotides NNS O
) -RRB- O
were VBD O
used VBN O
for IN O
RNA NNP O
structure NN O

prediction NN O
. . O

The DT O
minimum JJ O
energy NN O
structure NN O
prediction NN O
algorithm NN O
in IN O
RNADRAW NNP O
was VBD O
ported VBN O
from IN O
the DT O
RNAFOLD NNP O
program NN O
included VBN O
in IN O
the DT O

Vienna NNP O
RNA NNP O
package NN O
. . O

[ -LRB- O
24 CD O
] -RRB- O
The DT O
dynamic JJ O
programming NN O
algorithm NN O
employed VBN O
in IN O

RNADRAW NNP O
was VBD O
based VBN O
on IN O
the DT O
work NN O
of IN O
Zuker NNP O
and CC O
Stiegler NNP O
[ -LRB- O
25 CD O
] -RRB- O
and CC O
uses VBZ O
energy NN O

parameters NNS O
taken VBN O
from IN O
Turner NNP O
[ -LRB- O
26 CD O
] -RRB- O
, , O
Freier NNP O
[ -LRB- O
27 CD O
] -RRB- O
and CC O
Jaeger NNP O
. . O

[ -LRB- O
28 CD O
] -RRB- O

Phylogenetic JJ O
analysis NN O

The DT O
phylogenetic JJ O
Genebee NNP O
service NN O
was VBD O
used VBN O
for IN O
phylogenetic JJ O
tree NN O
construction NN O
. . O

[ -LRB- O
22 CD O

] -RRB- O

RNA NNP O
fold NN O

The DT O
Sribo NNP O
program NN O
in IN O
Sfold NNP O
( : O
Statistical NNP O
Folding NNP O
and CC O
Rational NNP O
Design NNP O
of IN O
Nucleic NNP O
Acids NNPS O
) -RRB- O
was VBD O

used VBN O
to TO O
predict VB O
the DT O
probable JJ O
target NN O
accessibility NN O
sites NNS O
( -LRB- O
loops NNS O
) -RRB- O
for IN O
trans NNS O
- HYPH O
cleaving VBG O
ribozymes NNS O
in IN O
ITS2 NNP O
. . O

[ -LRB- O
24 CD O
] -RRB- O
The DT O
prediction NN O
of IN O
accessibility NN O
is VBZ O
based VBN O
on IN O
a DT O
statistical JJ O
sample NN O
of IN O
the DT O
Boltzmann NNP O

ensemble NN O
for IN O
secondary JJ O
structures NNS O
. . O

Here RB O
, , O
we PRP O
assessed VBD O
the DT O
likelihood NN O
of IN O
unpaired JJ O
sites NNS O
for IN O
potential JJ O
ribozyme NN O
target NN O
. . O

Each DT O
mRNA NNP O

exists VBZ O
as IN O
a DT O
population NN O
of IN O
different JJ O
structures NNS O
. . O

Hence RB O
, , O
stochastic JJ O
approach NN O
to IN O
the DT O
evaluation NN O
of IN O
accessible JJ O
sites NNS O
was VBD O
found VBN O

appropriate JJ O
. . O

[ -LRB- O
29 CD O
] -RRB- O
The DT O
probability NN O
profiling NN O
approach NN O
by IN O
Ding NNP O
and CC O
Lawrence NNP O

[ -LRB- O
30 CD O
] -RRB- O
reveals VBZ O
target NN O
sites NNS O
that WDT O
are VBP O
commonly RB O
accessible JJ O
for IN O

a DT O
large JJ O
number NN O
of IN O
statistically RB O
representative JJ O
structures NNS O
in IN O
the DT O
target NN O
RNA NNP O
. . O

This DT O
novel JJ O
approach NN O
bypasses VBZ O
the DT O
long RB O
- HYPH O
standing VBG O

difficulty NN O
in IN O
accessibility NN O
evaluation NN O
due IN O
to IN O
limited JJ O
representation NN O
of IN O
probable JJ O
structures NNS O
due IN O
to IN O
high JJ O
statistical JJ O
confidence NN O

in IN O
predictions NNS O
. . O

The DT O
probability NN O
profile NN O
for IN O
individual JJ O
bases NNS O
( -LRB- O
W NNP O
= SYM O
1 CD O
) -RRB- O
is VBZ O
produced VBN O
for IN O
the DT O
region NN O
that WDT O

includes VBZ O
a DT O
triplet NN O
and CC O
two CD O
flanking JJ O
sequences NNS O
of IN O
15 CD O
bases NNS O
each DT O
in IN O
every DT O
site NN O
of IN O
the DT O
selected VBN O
cleavage NN O
triplet NN O
( : O
e FW O
. . O
g NN O
. . O
, , O
GUC NNP O
) -RRB- O
. . O

Results NNS O
and CC O
Discussion NN O

ITS2 NNP O
sequences NNS O
showed VBD O
a DT O
taxonomic JJ O
trend NN O
similar JJ O
to IN O
that DT O
in IN O
phylogeny NN O
construction NN O
( -LRB- O
Figure NN O
1A NN O

) -RRB- O
. . O

A DT O
multiple JJ O
sequence NN O
alignment NN O

of IN O
5 CD O
. . O
8S NNP O
rDNA NNP O
and CC O
ITS2 NNP O
showed VBD O
in IN O
Figure NN O
1B NN O
indicated VBD O
that IN O
more RBR O
distantly RB O
related VBN O
species NNS O
have VBP O

lower JJR O
sequence NN O
similarity NN O
in IN O
the DT O

ITS2 NNP O
region NN O
. . O

The DT O
predicted VBN O
features NNS O
of IN O
ITS2 NNP O
using VBG O
RNADRAW NNP O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
. . O

The DT O
stems NNS O

( , O
double RB O
stranded VBN O
paired VBN O
regions NNS O
) -RRB- O

stabilize VB O
RNA NNP O
secondary JJ O
structures NNS O
and CC O
the DT O
number NN O
of IN O
stems NNS O
present JJ O
in IN O
each DT O
ITS2 NNP O
is VBZ O
given VBN O
( : O
Table NNP O
1 CD O
) -RRB- O
. . O

ITS2 NNP O
RNA NNP O
structures NNS O
from IN O

C NN B-Species
. . I-Species
pipiens NNS I-Species
and CC O
C NN B-Species
. . I-Species
quinquefasciatus NN I-Species
have VBP O
the DT O
highest JJS O
negative JJ O
free JJ O
energy NN O
( : O
- : O
149 CD O
. . O
38 CD O
Kcal NNP O
and CC O

- : O
148 CD O
. . O
23 CD O
Kcal NNP O
) , O
followed VBN O
by IN O
C NNP B-Species
. . I-Species
tarsalis NNP I-Species
( : O
- HYPH O
129 CD O
. . O
2 CD O
) -RRB- O
, , O
C NN B-Species
. . I-Species
annulus NN I-Species
and CC O
then RB O
by IN O
C NN B-Species
. . I-Species
vishnui NNP I-Species

( NFP O
- HYPH O
115 CD O
. . O
3 CD O
) -RRB- O
, , O
C NN B-Species
. . I-Species
pseudovishnui NN I-Species
( : O
- HYPH O
105 CD O
. . O
66 CD O
) -RRB- O
and CC O
C NN B-Species
. . I-Species
tritaeniorhyncus NN I-Species
( : O
- HYPH O
82 CD O
. . O
57 CD O
) -RRB- O
. . O

Visual JJ O
comparison NN O
shows NNS O

that IN O
this DT O
is VBZ O
related JJ O
to IN O
the DT O
trend NN O
in IN O
the DT O
cladogram NN O
given VBN O
in IN O
Figure NNP O
1A NNP O
. . O

A DT O
high JJ O
degree NN O
of IN O
sequence NN O
similarity NN O
is VBZ O
observed VBN O
at IN O
the DT O

5 CD O
' POS O
end NN O
compared VBN O
to IN O
the DT O
3 CD O
' '' O
end NN O
( : O
Figure NNP O
1A NN O
) -RRB- O
. . O

This DT O
is VBZ O
due JJ O
to IN O
factors NNS O
such JJ O
as IN O
genetic JJ O
drift NN O
, , O
the DT O
relative JJ O
number NN O
and CC O
size NN O
of IN O
repeats NNS O
, , O

rates NNS O
of IN O
unequal JJ O
crossover NN O
, , O
gene NN O
conversion NN O
, , O
immigration NN O
and CC O
the DT O
number NN O
of IN O
the DT O
loci NN O
influencing VBG O
the DT O
length NN O
. . O

[ -LRB- O
10 CD O
] -RRB- O
Furthermore RB O
, , O
a DT O
high JJ O
level NN O
of IN O
sequence NN O
similarity NN O
is VBZ O
found VBN O
between IN O
C NNP O
. . O

annulus NN O
and CC O
C NN B-Species
. . I-Species
vishnui NN I-Species
as RB O
well RB O
as IN O
C NN B-Species
. . I-Species
quinquefasciatus NN I-Species
and CC O
C NN B-Species
. . I-Species

pipiens NNS B-Species
. . O

The DT O
simple JJ O
tandem NN O
repeats VBZ O
shown VBN O
in IN O
Figure NNP O
1B NNP O
as IN O
bolded JJ O
regions NNS O
are VBP O
found VBN O
to TO O
be VB O
similar JJ O
. . O

This DT O
similarity NN O
is VBZ O
seen VBN O
in IN O
corresponding VBG O

RNA NNP O
structures NNS O
and CC O
computed VBN O
energies NNS O
. . O

The DT O
Culex NNP O
species NNS O
considered VBN O
in IN O
this DT O
study NN O
were VBD O
then RB O
grouped VBN O
into IN O
three CD O
classes NNS O
based VBN O
on IN O
the DT O
similarity NN O
of IN O

RNA NNP O
stems NNS O
and CC O
loops NNS O
. . O

Despite IN O
their PRP$ O
different JJ O
geographic JJ O
locations NNS O
with IN O
varying VBG O
eco JJ O
- HYPH O
climatic JJ O
conditions NNS O
, , O
class NN O
I PRP O

( -LRB- O
C NN B-Species
. . I-Species
annulus NNP I-Species
, , O
C NNP B-Species
. . I-Species
pseudovishnui NN I-Species
and CC O
C NNP B-Species
. . I-Species
vishnui NNP I-Species
) -RRB- O
isolates NNS O
( , O
China NNP O
and CC O
Japan NNP O
) -RRB- O
showed VBD O
high JJ O
similarity NN O

in IN O
secondary JJ O
structural JJ O
features NNS O
. . O

Similar JJ O
observations NNS O
were VBD O
seen VBN O
in IN O
class NN O
II NN O
( , O
C NNP B-Species
. . I-Species
pipiens NNS I-Species
, , O
C NNP B-Species
. . I-Species
quinquefasciatus NNP I-Species
and CC O

C NN B-Species
. . I-Species
tarsalis NNP I-Species
) -RRB- O
isolates VBZ O
from IN O
North NNP O
America NNP O
and CC O
Africa NNP O
. . O

[ -LRB- O
19 CD O
] -RRB- O

A DT O
high JJ O
degree NN O
of IN O
similarity NN O
in IN O
the DT O
5 CD O
. . O
8S NNP O
region NN O
unlike IN O
the DT O
ITS2 NNP O
is VBZ O
shown VBN O
for IN O
different JJ O
isolates NNS O
due IN O
to IN O
relative JJ O
evolutionary JJ O

selection NN O
. . O

[ -LRB- O
9 LS O
] -RRB- O
The DT O
loops NNS O
11 CD O
and CC O
12 CD O
having VBG O
sequences NNS O
UGUCG NNP O
and CC O
CUUCGGUG NNP O
, , O

respectively RB O
are VBP O
highly RB O
conserved VBN O
in IN O
all DT O
classes NNS O
. . O

Figure NN O
1C NNP O
shows VBZ O
the DT O
distribution NN O
of IN O
different JJ O
types NNS O
of IN O
loops NNS O
( , O
hairpin NN O
, , O
bulge NN O
, , O
multi NN O
branched VBN O
, , O
interior NN O
and CC O
exterior NN O
) , O
among IN O

different JJ O
isolates NNS O
. . O

The DT O
segments NNS O
of IN O
the DT O
ITS2 NNP O
having VBG O
score NN O
> SYM O
= SYM O
50 CD O
are VBP O
further RB O
probed VBN O
carefully RB O
for IN O
target NN O
site NN O
to TO O
assess VB O
the DT O

likelihood NN O
of IN O
unpaired JJ O
segments NNS O
. . O

Interestingly RB O
, , O
the DT O
observed JJ O
phylogenetic JJ O
trend NN O
was VBD O
identified VBN O
with IN O
respect NN O
to IN O
the DT O
target NN O

accessibility NN O
sites NNS O
for IN O
the DT O
seven CD O
Culex NNP O
isolates NNS O
. . O

The DT O
order NN O
of IN O
preference NN O
is VBZ O
interior JJ O
loop NN O
, , O
bulge NN O
loop NN O
, , O
multiple JJ O

branched VBN O
loop NN O
, , O
hairpin NN O
loop NN O
and CC O
exterior NN O
loops NNS O
in IN O
all PDT O
the DT O
isolates NNS O
. . O

Several JJ O
homologous JJ O
domains NNS O
were VBD O
observed VBN O
in IN O
the DT O
ITS NNP O
regions NNS O
of IN O
Aedes NNP O
mosquito NN O
species NNS O
by IN O
Wesson NNP O

et FW O
al NNP O
[ -LRB- O
11 CD O
] -RRB- O
and CC O
was VBD O
shown VBN O
that IN O
these DT O
domains NNS O
base NN O
pair NN O
to IN O

form VB O
a DT O
core NN O
region NN O
central JJ O
to IN O

several JJ O
stem NN O
features NNS O
. . O

This DT O
suggested VBD O
that IN O
conserved JJ O
core NN O
region NN O
of IN O
rDNA NNP O
is VBZ O
more RBR O
important JJ O
for IN O
a DT O
functional JJ O
rRNA NNP O
folding NN O

pattern NN O
. . O

Barker NNP O
found VBD O
that IN O
ITS2 NNP O
is VBZ O
unique JJ O
in IN O
the DT O
16 CD O
populations NNS O
of IN O
Boophilus NNP B-Species
microplus NN I-Species
, , O
Boophilus NNP B-Species
decoloratus NN I-Species
, , O

Rhipicephalus NNP B-Species
appendiculatus NN I-Species
, , O
Rhipicephalus NNP B-Species
zambesiensis NNP I-Species
, , O
Rhipicephalus NNP B-Species
evertsi NN I-Species
, , O
Rhipicephalus NNP B-Species
sanguineus NN I-Species
, , O
Rhipicephalus NNP O

turanicus NNP O
, , O
Rhipicephalus NNP B-Species
pumilio NN I-Species
and CC O
Rhipicephalus NNP B-Species
camicasi NN I-Species
from IN O
different JJ O
geographical JJ O
locations NNS O
. . O

[ -LRB- O
12 CD O
] -RRB- O
These DT O
results NNS O
suggest VBP O
that IN O
the DT O
differences NNS O
and CC O
similarity NN O
observed VBN O

in IN O
the DT O
ITS2 NNP O
of IN O
different JJ O
species NNS O
are VBP O
not RB O
simply RB O
accumulated VBN O
due IN O
to IN O
random JJ O
mutation NN O
and CC O
have VBP O
evolved VBN O
for IN O
functional JJ O
selection NN O

in IN O
ribosome NN O
biogenesis NN O
. . O

However RB O
, , O
it PRP O
was VBD O
shown VBN O
in IN O
three CD O
related JJ O
mosquito NN O
genera NN O
( , O
Aedes NNP O
, , O
Psorophora NNP O
and CC O
Haemogogus NNP B-Species
) . O

that IN O
the DT O
intra JJ O
- HYPH O
spacer NN O
variable JJ O
regions NNS O
appear VBP O
to TO O
co VB O
- HYPH O
evolve VB O
and CC O
that IN O
ITS2 NNP O
variation NN O
is VBZ O
constrained VBN O
by IN O
its PRP$ O
secondary JJ O
structure NN O
. . O

[ -LRB- O
11 CD O
] -RRB- O
Further JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
ITS2 NNP O
is VBZ O
essential JJ O

for IN O
the DT O
correct JJ O
and CC O
efficient JJ O
processing NN O
and CC O
maturation NN O
of IN O
26S NNP O
rRNA NNP O
ribosomal JJ O
units NNS O
. . O

[ -LRB- O

13 CD O
] -RRB- O
Furthermore RB O
, , O
the DT O
information NN O
required VBN O
for IN O
the DT O
efficient JJ O
removal NN O
of IN O
ITS2 NNP O
from IN O
its PRP$ O
RNA NNP O
precursor NN O
is VBZ O
not RB O

localized VBN O
but CC O
dispersed VBN O
throughout IN O
the DT O
ITS2 NNP O
region NN O
. . O

Thus RB O
, , O
insertions NNS O
and CC O
deletions NNS O
( , O
indels NNS O
) -RRB- O
that WDT O
affect VBP O
secondary JJ O
structures NNS O

alter NN O
rRNA NNP O
processing NN O
. . O

Critical JJ O
changes NNS O
in IN O
the DT O
rRNA NNP O
folding VBG O
pattern NN O
due IN O
to IN O
evolutionary JJ O
sequence NN O
variation NN O
in IN O
the DT O
ITS NNP O
spacer NN O

regions NNS O
may MD O
thus RB O
have VB O
an DT O
important JJ O
role NN O
on IN O
the DT O
kinetics NNS O
of IN O
precursor NN O
rRNA NN O
formation NN O
for IN O
the DT O
efficient JJ O
functioning NN O
of IN O
rDNA NNP O
clusters NNS O
. . O

Conclusion NN O

Comparison NN O
of IN O
ITS2 NNP O
sequences NNS O
from IN O
different JJ O
isolates NNS O
of IN O
Culex NNP O
show VBP O
similarity NN O
and CC O
variations NNS O
. . O

Surprisingly RB O
, , O
species NNS O
displaying VBG O

sequence NN O
similarity NN O
belong VBP O
to IN O
different JJ O
geographical JJ O
locations NNS O
with IN O
diverse JJ O
climatic JJ O
and CC O
ecological JJ O
conditions NNS O
. . O

This DT O
implies VBZ O
that DT O

the DT O
ITS2 NNP O
regions NNS O
have VBP O
less JJR O
selective JJ O
pressure NN O
than IN O
the DT O
ribosomal JJ O
regions NNS O
. . O

Several JJ O
common JJ O
structural JJ O
folds NNS O
were VBD O
shared VBN O
among IN O
the DT O

selected VBN O
mosquitoes NNS O
for IN O
maintaining VBG O
functional JJ O
equivalents NNS O
. . O

Construction NN O
of IN O
an DT O
evolutionary JJ O
tree NN O
using VBG O
more JJR O
isolates NNS O
of IN O

Culex NNP O
will MD O
provide VB O
an DT O
understanding NN O
for IN O
their PRP$ O
functional JJ O
selection NN O
. . O

Integration NN O
in IN O
primary JJ O
community NN O
care NN O
networks NNS O
( , O
PCCNs NNP O
) -RRB- O
: : O
examination NN O
of IN O
governance NN O
, , O
clinical JJ O
, , O
marketing NN O
, , O
financial JJ O
, , O
and CC O
information NN O
infrastructures NNS O
in IN O
a DT O
national JJ O
demonstration NN O
project NN O
in IN O
Taiwan NNP O

Abstract JJ O

Background NN O

Taiwan NNP O
' POS O
s POS O
primary JJ O
community NN O
care NN O
network NN O
( : O
PCCN NNP O
) -RRB- O
demonstration NN O
project NN O
, , O
funded VBN O
by IN O
the DT O
Bureau NNP O
of IN O
National NNP O
Health NNP O
Insurance NNP O
on IN O
March NNP O
2003 CD O
, , O
was VBD O
established VBN O
to TO O
discourage VB O
hospital NN O
shopping NN O
behavior NN O
of IN O
people NNS B-Species
and CC O
drive VB O
the DT O
traditional JJ O
fragmented JJ O
health NN O
care NN O
providers NNS O
into IN O
cooperate NN O
care NN O
models NNS O
. . O

Between IN O
2003 CD O
and CC O
2005 CD O
, , O
268 CD O
PCCNs NNS O
were VBD O
established VBN O
. . O

This DT O
study NN O
profiled VBD O
the DT O
individual JJ O
members NNS O
in IN O
the DT O
PCCNs NNS O
to TO O
study VB O
the DT O
nature NN O
and CC O
extent NN O
to IN O
which WDT O
their PRP$ O
network NN O
infrastructures NNS O
have VBP O
been VBN O
integrated VBN O
among IN O
the DT O
members NNS O
( , O
clinics NNS O
and CC O
hospitals NNS O
) -RRB- O
within IN O
individual JJ O
PCCNs NNS O
. . O

Methods NNS O

The DT O
thorough JJ O
questionnaire NN O
items NNS O
, , O
covering VBG O
the DT O
network NN O
working VBG O
infrastructures NNS O
- : O
governance NN O
, , O
clinical JJ O
, , O
marketing NN O
, , O
financial JJ O
, , O
and CC O
information NN O
integration NN O
in IN O
PCCNs NNPS O
, , O
were VBD O
developed VBN O
with IN O
validity NN O
and CC O
reliability NN O
confirmed VBN O
. . O

One CD O
thousand CD O
five CD O
hundred CD O
and CC O
fifty CD O
- HYPH O
seven CD O
clinics NNS O
that WDT O
had VBD O
belonged VBN O
to IN O
PCCNs NNPS O
for IN O
more JJR O
than IN O
one CD O
year NN O
, , O
based VBN O
on IN O
the DT O
2003 CD O
- SYM O
2005 CD O
Taiwan NNP O
Primary NNP O
Community NNP O
Care NNP O
Network NNP O
List NNP O
, , O
were VBD O
surveyed VBN O
by IN O
mail NN O
. . O

Nine CD O
hundred CD O
and CC O
twenty CD O
- HYPH O
eight CD O
clinic NN O
members NNS O
responded VBD O
to IN O
the DT O
surveys NNS O
giving VBG O
a DT O
59 CD O
. . O
6 CD O
% NN O
response NN O
rate NN O
. . O

Results NNS O

Overall RB O
, , O
the DT O
PCCNs NNPS O
' POS O
members NNS O
had VBD O
higher JJR O
involvement NN O
in IN O
the DT O
governance NN O
infrastructure NN O
, , O
which WDT O
was VBD O
usually RB O
viewed VBN O
as IN O
the DT O
most RBS O
important JJ O
for IN O
establishment NN O
of IN O
core NN O
values NNS O
in IN O
PCCNs NNP O
' POS O
organization NN O
design NN O
and CC O
management NN O
at IN O
the DT O
early JJ O
integration NN O
stage NN O
. . O

In IN O
addition NN O
, , O
it PRP O
found VBD O
that IN O
there EX O
existed VBD O
a DT O
higher JJR O
extent NN O
of IN O
integration NN O
of IN O
clinical JJ O
, , O
marketing NN O
, , O
and CC O
information NN O
infrastructures NNS O
among IN O
the DT O
hospital NN O
- HYPH O
clinic NN O
member NN O
relationship NN O
than IN O
those DT O
among IN O
clinic NN O
members NNS O
within IN O
individual JJ O
PCCNs NNS O
. . O

The DT O
financial JJ O
infrastructure NN O
was VBD O
shown VBN O
the DT O
least RBS O
integrated JJ O
relative JJ O
to IN O
other JJ O
functional JJ O
infrastructures NNS O
at IN O
the DT O
early JJ O
stage NN O
of IN O
PCCN NNP O
formation NN O
. . O

Conclusion NN O

There EX O
was VBD O
still RB O
room NN O
for IN O
better JJR O
integrated VBN O
partnerships NNS O
, , O
as IN O
evidenced VBN O
by IN O
the DT O
great JJ O
variety NN O
of IN O
relationships NNS O
and CC O
differences NNS O
in IN O
extent NN O
of IN O
integration NN O
in IN O
this DT O
study NN O
. . O

In IN O
addition NN O
to TO O
provide VB O
how WRB O
the DT O
network NN O
members NNS O
have VBP O
done VBN O
for IN O
their PRP$ O
initial JJ O
work NN O
at IN O
the DT O
early JJ O
stage NN O
of IN O
network NN O
forming VBG O
in IN O
this DT O
study NN O
, , O
the DT O
detailed VBN O
surveyed VBN O
items NNS O
, , O
the DT O
concepts NNS O
proposed VBN O
by IN O
the DT O
managerial JJ O
and CC O
theoretical JJ O
professionals NNS O
, , O
could MD O
be VB O
a DT O
guide NN O
for IN O
those DT O
health NN O
care NN O
providers NNS O
who WP O
have VBP O
willingness NN O
to TO O
turn VB O
their PRP$ O
business NN O
into IN O
multi JJ O
- HYPH O
organizations NNS O
. . O

Background NN O

Taiwan NNP O
' POS O
s POS O
National NNP O
Health NNP O
Insurance NNP O
( -LRB- O
NHI NNP O
) -RRB- O
under IN O
the DT O
control NN O
of IN O
the DT O
Bureau NNP O
of IN O
National NNP O
Health NNP O
Insurance NNP O
( -LRB- O
BNHI NNP O
) -RRB- O
, , O
was VBD O
launched VBN O
in IN O
March NNP O
1995 CD O
to TO O
replace VB O
its PRP$ O
social JJ O
insurance NN O
system NN O
that WDT O
was VBD O
covering VBG O
59 CD O
% NN O
of IN O
its PRP$ O
population NN O
: : O
government NN O
employees NNS O
, , O
labourers NNS O
, , O
farmers NNS O
and CC O
servicemen NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

By IN O
June NNP O
2003 CD O
the DT O
number NN O
of IN O
people NNS B-Species
insured VBN O
had VBD O
reached VBN O
21 CD O
, , O
956 CD O
, , O
729 CD O
( SYM O
99 CD O
% NN O
) -RRB- O
. . O

There EX O
were VBD O
17 CD O
, , O
259 CD O
medical JJ O
providers NNS O
( : O
92 CD O
% NN O
) -RRB- O
, , O
including VBG O
575 CD O
hospitals NNS O
and CC O
16 CD O
, , O
684 CD O
clinics NNS O
contracted VBN O
with IN O
the DT O
BNHI NNP O
for IN O
serving VBG O
the DT O
enrolled VBN O
population NN O
. . O

The DT O
unique JJ O
phenomenon NN O
characterized VBN O
in IN O
Taiwan NNP O
health NN O
care NN O
industry NN O
different JJ O
from IN O
those DT O
in IN O
the DT O
western JJ O
countries NNS O
is VBZ O
the DT O
freedom NN O
of IN O
patients NNS B-Species
to TO O
choose VB O
the DT O
health NN O
care NN O
providers NNS O
they PRP O
want VBP O
, , O
no RB O
matter RB O
what WP O
their PRP$ O
disease NN O
severity NN O
is VBZ O
. . O

Furthermore RB O
, , O
Taiwan NNP O
people NNS B-Species
favor VBP O
the DT O
larger JJR O
scales NNS O
of IN O
facilities NNS O
and CC O
this DT O
fallacy NN O
leads VBZ O
to IN O
the DT O
phenomenon NN O
of IN O
big JJ O
- HYPH O
hospital NN O
shopping NN O
. . O

For IN O
example NN O
, , O
people NNS B-Species
choose VBP O
the DT O
medical JJ O
centers NNS O
which WDT O
are VBP O
accredited VBN O
as IN O
the DT O
highest JJS O
level NN O
of IN O
medical JJ O
science NN O
in IN O
Taiwan NNP O
when WRB O
they PRP O
only RB O
suffer VBP O
from IN O
a DT O
common JJ O
cold NN O
. . O

In IN O
the DT O
spring NN O
of IN O
2003 CD O
, , O
the DT O
SARS NNP O
epidemic NN O
viciously RB O
attacked VBD O
the DT O
health NN O
of IN O
Taiwan NNP O
' POS O
s POS O
people NNS B-Species
. . O

The DT O
people NNS B-Species
' POS O
s POS O
freedom NN O
to TO O
choose VB O
medical JJ O
providers NNS O
caused VBD O
the DT O
national JJ O
health NN O
authority NN O
to TO O
barely RB O
control VB O
and CC O
traced VBD O
the DT O
flow NN O
of IN O
epidemic NN O
. . O

This DT O
event NN O
made VBD O
Taiwan NNP O
national JJ O
health NN O
authorities NNS O
rethink VB O
what WP O
happened VBD O
and CC O
how WRB O
it PRP O
damaged VBD O
under IN O
the DT O
traditional JJ O
fragmented JJ O
health NN O
care NN O
providers NNS O
in IN O
Taiwan NNP O
. . O

One CD O
health NN O
reform NN O
launched VBN O
was VBD O
named VBN O
the DT O
"""" `` O
Primary NNP O
Community NNP O
Care NNP O
Network NNP O
( -LRB- O
PCCN NNP O
) -RRB- O
demonstration NN O
project NN O
"""" '' O
, , O
a DT O
nationwide JJ O
health NN O
care NN O
financing NN O
program NN O
funded VBN O
by IN O
the DT O
Bureau NNP O
of IN O
National NNP O
Health NNP O
Insurance NNP O
( -LRB- O
BNHI NNP O
) -RRB- O
in IN O
March NNP O
2003 CD O
and CC O
it PRP O
was VBD O
a DT O
new JJ O
model NN O
for IN O
the DT O
Taiwan NNP O
government NN O
to TO O
redefine VB O
the DT O
role NN O
of IN O
family NN O
physicians NNS O
in IN O
the DT O
health NN O
care NN O
delivery NN O
system NN O
. . O

A DT O
PCCN NNP O
in IN O
Taiwan NNP O
consists VBZ O
of IN O
a DT O
group NN O
of IN O
clinic JJ O
physicians NNS O
whose WP$ O
medical JJ O
jobs NNS O
are VBP O
viewed VBN O
as IN O
family NN O
care NN O
and CC O
at RB O
least RBS O
one CD O
hospital NN O
for IN O
secondary JJ O
or CC O
tertiary JJ O
care NN O
. . O

The DT O
idea NN O
of IN O
member NN O
component NN O
design NN O
in IN O
PCCNs NNPS O
was VBD O
aimed VBN O
to TO O
lead VB O
the DT O
Taiwan NNP O
citizens NNS O
to TO O
choose VB O
one CD O
clinic NN O
physician NN O
as IN O
their PRP$ O
personal JJ O
family NN O
physician NN O
for IN O
health NN O
maintenance NN O
and CC O
this DT O
family NN O
physician NN O
also RB O
would MD O
have VB O
the DT O
responsibility NN O
of IN O
referring VBG O
the DT O
patients NNS B-Species
to IN O
specialty NN O
care NN O
if IN O
necessary JJ O
. . O

From IN O
a DT O
national JJ O
health NN O
authority NN O
perspective NN O
, , O
they PRP O
expected VBD O
the DT O
Taiwan NNP O
people NNS B-Species
to TO O
put VB O
an DT O
end NN O
to IN O
their PRP$ O
fallacy NN O
that IN O
"""" `` O
bigger JJR O
is VBZ O
better JJR O
"""" '' O
for IN O
health NN O
care NN O
organizations NNS O
and CC O
establish VB O
the DT O
idea NN O
of IN O
"""" `` O
human JJ B-Species
health NN O
"""" '' O
, , O
starting VBG O
with IN O
prevention NN O
and CC O
primary JJ O
care NN O
, , O
followed VBN O
by IN O
secondary JJ O
or CC O
tertiary JJ O
care NN O
, , O
emphasizing VBG O
health NN O
promotion NN O
and CC O
maintenance NN O
instead RB O
of IN O
disease NN O
curing NN O
. . O

Furthermore RB O
, , O
it PRP O
could MD O
decrease VB O
the DT O
inappropriateness NN O
of IN O
medical JJ O
usage NN O
, , O
i PRP O
. . O
e LS O
. . O
, , O
over IN O
- HYPH O
uses NNS O
of IN O
secondary JJ O
and CC O
tertiary JJ O
medical JJ O
services NNS O
in IN O
the DT O
high JJ O
- HYPH O
tech NN O
hospitals NNS O
. . O

In IN O
addition NN O
, , O
the DT O
national JJ O
health NN O
authority NN O
was VBD O
expected VBN O
to TO O
drive VB O
the DT O
traditional JJ O
fragmented JJ O
heath NN O
care NN O
providers NNS O
into IN O
coordinated JJ O
medical JJ O
multidisciplinary JJ O
teams NNS O
and CC O
share VB O
the DT O
limited JJ O
medical JJ O
resources NNS O
through IN O
the DT O
PCCN NNP O
demonstration NN O
project NN O
. . O

In IN O
summary NN O
, , O
the DT O
PCCN NNP O
demonstration NN O
project NN O
was VBD O
aimed VBN O
to IN O
: : O
1 LS O
) -RRB- O
change VB O
the DT O
traditional JJ O
patients NNS B-Species
' POS O
customs NNS O
of IN O
freely RB O
choosing VBG O
health NN O
care NN O
organizations NNS O
and CC O
establish VB O
referral NN O
channels NNS O
along IN O
the DT O
continuum NN O
of IN O
care NN O
, , O
and CC O
2 LS O
) -RRB- O
establish VB O
partnerships NNS O
among IN O
the DT O
primary JJ O
care NN O
clinics NNS O
and CC O
hospitals NNS O
to TO O
provide VB O
a DT O
continuum NN O
of IN O
health NN O
care NN O
services NNS O
. . O

It PRP O
was VBD O
also RB O
expected VBN O
to TO O
establish VB O
the DT O
primary JJ O
care NN O
system NN O
of IN O
family NN O
physicians NNS O
to TO O
provide VB O
whole JJ O
- HYPH O
people NNS B-Species
health NN O
care NN O
and CC O
improve VB O
care NN O
quality NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Partnership NN O
structures NNS O
in IN O
the DT O
PCCNs NNPS O
represent VBP O
the DT O
virtual JJ O
vertical JJ O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
between IN O
the DT O
member NN O
clinics NNS O
and CC O
hospitals NNS O
) -RRB- O
and CC O
virtual JJ O
horizontal JJ O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
among IN O
the DT O
member NN O
clinics NNS O
) -RRB- O
aspects NNS O
of IN O
organizing NN O
, , O
which WDT O
designate VBP O
the DT O
formal JJ O
relationships NNS O
between IN O
individuals NNS O
and CC O
the DT O
total JJ O
network NN O
and CC O
include VBP O
organizational JJ O
design NN O
to TO O
ensure VB O
effective JJ O
communication NN O
, , O
coordination NN O
, , O
and CC O
integration NN O
across IN O
the DT O
total JJ O
network NN O
. . O

Each DT O
PCCN NNP O
consists VBZ O
of IN O
five CD O
to TO O
ten CD O
clinics NNS O
: : O
half NN O
of IN O
them PRP O
should MD O
offer VB O
the DT O
services NNS O
of IN O
general JJ O
medicine NN O
, , O
internal JJ O
medicine NN O
, , O
surgery NN O
, , O
obstetrics NNS O
and CC O
gynecology NN O
, , O
pediatric JJ O
, , O
or CC O
family NN O
medicine NN O
. . O

And CC O
each DT O
PCCN NNP O
has VBZ O
a DT O
central JJ O
headquarters NN O
, , O
usually RB O
in IN O
one CD O
of IN O
the DT O
clinic NN O
facilities NNS O
, , O
to TO O
coordinate VB O
and CC O
integrate VB O
the DT O
network NN O
. . O

All PDT O
the DT O
clinic NN O
physicians NNS O
in IN O
a DT O
PCCN NNP O
are VBP O
assigned VBN O
the DT O
roles NNS O
of IN O
"""" `` O
family NN O
physicians NNS O
"""" '' O
or CC O
"""" `` O
gatekeepers NNS O
"""" '' O
who WP O
recruit VBP O
people NNS B-Species
from IN O
the DT O
local JJ O
community NN O
, , O
keep VBP O
background NN O
and CC O
medical JJ O
files NNS O
on IN O
them PRP O
, , O
certify VBP O
family NN O
physician NN O
education NN O
training NN O
programs NNS O
, , O
and CC O
hold VBP O
office NN O
hours NNS O
in IN O
the DT O
member NN O
hospital NN O
, , O
where WRB O
they PRP O
serve VBP O
as IN O
joint JJ O
faculty NN O
members NNS O
for IN O
further JJ O
medical JJ O
consultations NNS O
or CC O
medical JJ O
utilizations NNS O
of IN O
labs NNS O
and CC O
tests NNS O
, , O
if IN O
necessary JJ O
. . O

In IN O
addition NN O
, , O
the DT O
hospital NN O
member NN O
is VBZ O
asked VBN O
to TO O
help VB O
clinic NN O
physicians NNS O
in IN O
their PRP$ O
network NN O
to TO O
set VB O
up RP O
a DT O
medical JJ O
information NN O
system NN O
, , O
share VB O
hospital NN O
resources NNS O
( , O
medical JJ O
equipment NN O
and CC O
library NN O
literature NN O
) -RRB- O
with IN O
the DT O
clinic NN O
physicians NNS O
in IN O
their PRP$ O
network NN O
and CC O
establish VB O
referral NN O
channels NNS O
among IN O
the DT O
network NN O
members NNS O
. . O

Furthermore RB O
, , O
this DT O
new JJ O
demonstration NN O
model NN O
tries VBZ O
to TO O
minimize VB O
the DT O
barriers NNS O
to IN O
patient JJ B-Species
access NN O
by IN O
setting VBG O
up RP O
24 CD O
- HYPH O
hour NN O
a DT O
day NN O
, , O
7 CD O
- HYPH O
day NN O
a DT O
week NN O
medical JJ O
consultation NN O
telephone NN O
lines NNS O
for IN O
providing VBG O
urgent JJ O
services NNS O
onsite RB O
and CC O
for IN O
taking VBG O
care NN O
of IN O
the DT O
patients NNS B-Species
whose WP$ O
family NN O
physicians NNS O
' POS O
practices NNS O
are VBP O
closed VBN O
to TO O
assure VB O
seamless JJ O
care NN O
channels NNS O
. . O

The DT O
BNHI NNP O
funded VBD O
these DT O
extra JJ O
demonstration NN O
actions NNS O
, , O
at IN O
around RB O
one CD O
hundred CD O
thousand CD O
US NNP O
dollars NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
NT NNP O
$ $ O
3 CD O
, , O
500 CD O
, , O
0 CD O
) -RRB- O
for IN O
each DT O
PCCN NNP O
under IN O
the DT O
current JJ O
fee NN O
- HYPH O
for IN O
- HYPH O
service NN O
payment NN O
system NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Figure NN O
1 CD O
describes VBZ O
the DT O
organizational JJ O
structure NN O
of IN O
individual JJ O
PCCNs NNPS O
introduced VBN O
in IN O
the DT O
demonstration NN O
project NN O
in IN O
Taiwan NNP O
. . O

To IN O
date NN O
, , O
the DT O
PCCN NNP O
demonstration NN O
project NN O
has VBZ O
been VBN O
in IN O
operation NN O
for IN O
more JJR O
than IN O
three CD O
years NNS O
. . O

There EX O
have VBP O
been VBN O
268 CD O
PCCNs NNS O
formed VBN O
in IN O
the DT O
period NN O
of IN O
2003 CD O
to IN O
2005 CD O
around IN O
Taiwan NNP O
. . O

The DT O
geographical JJ O
distributions NNS O
of IN O
PCCNs NNPS O
and CC O
their PRP$ O
members NNS O
were VBD O
described VBN O
in IN O
Table NNP O
1 CD O
. . O

Analyzing VBG O
all DT O
1 CD O
, , O
557 CD O
participating VBG O
clinic NN O
members NNS O
in IN O
the DT O
demonstration NN O
project NN O
in IN O
terms NNS O
of IN O
medical JJ O
specialties NNS O
, , O
they PRP O
cover VBP O
general JJ O
medicine NN O
, , O
internal JJ O
medicine NN O
, , O
surgeries NNS O
, , O
obstetrics NNS O
and CC O
gynecology NN O
, , O
pediatrics NN O
, , O
family NN O
medicines NNS O
, , O
otolaryngology NN O
, , O
ophthalmology NN O
, , O
rehabilitation NN O
medicine NN O
, , O
dermatology NN O
, , O
and CC O
psychiatry NN O
, , O
with IN O
237 CD O
clinics NNS O
providing VBG O
more JJR O
than IN O
two CD O
specialties NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
each DT O
PCCN NNP O
recruits VBZ O
at RB O
least RBS O
one CD O
district NN O
or CC O
regional JJ O
accredited VBN O
hospital NN O
for IN O
acute JJ O
care NN O
demands NNS O
( , O
required VBN O
for IN O
network NN O
members NNS O
) -RRB- O
and CC O
a DT O
medical JJ O
center NN O
for IN O
tertiary JJ O
care NN O
support NN O
( , O
not RB O
required VBN O
for IN O
network NN O
members NNS O
) -RRB- O
. . O

There EX O
are VBP O
6 CD O
medical JJ O
centers NNS O
, , O
52 CD O
regional JJ O
hospitals NNS O
, , O
and CC O
71 CD O
district NN O
hospitals NNS O
joining VBG O
in IN O
the DT O
demonstration NN O
project NN O
. . O

See VB O
Table NNP O
1 CD O
for IN O
more RBR O
detailed JJ O
information NN O
about IN O
the DT O
PCCN NNP O
members NNS O
. . O

To IN O
date NN O
, , O
there EX O
have VBP O
been VBN O
few JJ O
empirical JJ O
studies NNS O
of IN O
the DT O
working VBG O
relationships NNS O
that WDT O
have VBP O
developed VBN O
between IN O
members NNS O
of IN O
the DT O
PCCN NNP O
program NN O
. . O

Partnership NN O
needs VBZ O
a DT O
method NN O
to TO O
determine VB O
at IN O
an DT O
early JJ O
stage NN O
, , O
to TO O
make VB O
sure JJ O
whether IN O
they PRP O
are VBP O
making VBG O
the DT O
most JJS O
of IN O
collaboration NN O
[ -LRB- O
2 CD O
] -RRB- O
and CC O
the DT O
acceptance NN O
of IN O
the DT O
contracting VBG O
networks NNS O
in IN O
Taiwan NNP O
as IN O
an DT O
organizational JJ O
innovation NN O
worthy JJ O
of IN O
greater JJR O
diffusion NN O
deserves VBZ O
to TO O
be VB O
explored VBN O
. . O

Therefore RB O
, , O
this DT O
study NN O
used VBD O
a DT O
structured VBN O
questionnaire NN O
to TO O
characterize VB O
the DT O
relationship NN O
among IN O
the DT O
members NNS O
in IN O
the DT O
individual JJ O
PCCNs NNPS O
, , O
with IN O
regard NN O
to IN O
governance NN O
, , O
clinical JJ O
, , O
marketing NN O
, , O
financing NN O
, , O
as RB O
well RB O
as IN O
information NN O
integration NN O
infrastructures NNS O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
provide VBP O
descriptive JJ O
analyses NNS O
in IN O
detail NN O
to TO O
map VB O
the DT O
partnership NN O
developments NNS O
, , O
to TO O
enrich VB O
the DT O
body NN O
of IN O
knowledge NN O
of IN O
the DT O
partner NN O
relationships NNS O
and CC O
to TO O
help VB O
policy NN O
makers NNS O
understand VB O
the DT O
coordinated VBN O
efforts NNS O
of IN O
these DT O
health NN O
care NN O
providers NNS O
which WDT O
have VBP O
developed VBN O
under IN O
this DT O
system NN O
. . O

It PRP O
also RB O
provides VBZ O
the DT O
recommendations NNS O
for IN O
heath NN O
policy NN O
decision NN O
- HYPH O
making NN O
and CC O
management NN O
of IN O
networks NNS O
of IN O
health NN O
care NN O
providers NNS O
for IN O
the DT O
future JJ O
involvement NN O
. . O

Methods NNS O

This DT O
study NN O
was VBD O
aimed VBN O
at IN O
providing VBG O
descriptive JJ O
analyses NNS O
to TO O
map VB O
the DT O
partnership NN O
development NN O
. . O

To TO O
understand VB O
the DT O
actual JJ O
integration NN O
actions NNS O
done VBN O
by IN O
network NN O
members NNS O
, , O
the DT O
theoretical JJ O
concept NN O
employed VBN O
by IN O
network NN O
partnerships NNS O
were VBD O
described VBN O
and CC O
then RB O
the DT O
derived VBN O
survey NN O
instrument NN O
was VBD O
developed VBN O
. . O

Theoretical JJ O
framework NN O
for IN O
organization NN O
design NN O
of IN O
network NN O
integration NN O

The DT O
rapid JJ O
organizational JJ O
changes NNS O
in IN O
the DT O
health NN O
care NN O
industry NN O
have VBP O
driven VBN O
theorists NNS O
from IN O
every DT O
discipline NN O
and CC O
across IN O
the DT O
world NN O
to TO O
seek VB O
an DT O
approach NN O
that WDT O
allows VBZ O
organizations NNS O
to TO O
flourish VB O
. . O

Organization NN O
theory NN O
allows VBZ O
investigators NNS O
to TO O
profile VB O
an DT O
organization NN O
from IN O
the DT O
aspect NN O
of IN O
patterns NNS O
and CC O
regularities NNS O
in IN O
organizational JJ O
design NN O
and CC O
behavior NN O
. . O

In IN O
the DT O
early JJ O
20th JJ O
century NN O
, , O
classical JJ O
management NN O
theorists NNS O
claimed VBD O
that IN O
an DT O
organization NN O
has VBZ O
"""" `` O
a DT O
best JJS O
way NN O
"""" '' O
to TO O
be VB O
organized VBN O
and CC O
managed VBN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

That DT O
implied VBD O
that IN O
all DT O
organizations NNS O
would MD O
own VB O
the DT O
"""" `` O
same JJ O
"""" '' O
organizational JJ O
styles NNS O
or CC O
structures NNS O
. . O

In IN O
the DT O
1960s NNS O
, , O
several JJ O
theorists NNS O
[ -LRB- O
4 CD O
- SYM O
8 CD O
] -RRB- O
challenged VBD O
this DT O
assumption NN O
by IN O
applying VBG O
a DT O
"""" `` O
contingency NN O
approach NN O
"""" '' O
to TO O
propose VB O
that IN O
there EX O
is VBZ O
no DT O
best JJS O
way NN O
to TO O
organize VB O
an DT O
organization NN O
, , O
and CC O
that IN O
the DT O
effectiveness NN O
of IN O
an DT O
organizational JJ O
structure NN O
varies VBZ O
with IN O
the DT O
situation NN O
of IN O
an DT O
organization NN O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
proposed VBN O
that IN O
the DT O
best JJS O
way NN O
to TO O
organize VB O
an DT O
organization NN O
depends VBZ O
on IN O
the DT O
nature NN O
of IN O
the DT O
environment NN O
to TO O
which WDT O
the DT O
organization NN O
relates VBZ O
. . O

Contingency NN O
theory NN O
delineates VBZ O
the DT O
concepts NNS O
"""" `` O
organization NN O
' '' O
s `` O
internal JJ O
features NNS O
, , O
"""" '' O
"""" `` O
the DT O
demands NNS O
of IN O
organizational JJ O
environments NNS O
, , O
"""" '' O
"""" `` O
best JJS O
adaptation NN O
, , O
"""" '' O
and CC O
, , O
the DT O
most RBS O
important JJ O
and CC O
difficult JJ O
of IN O
all DT O
, , O
"""" `` O
best JJS O
match NN O
"""" '' O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Lawrence NNP O
& CC O
Lorsch NNP O
[ -LRB- O
7 CD O
] -RRB- O
argued VBD O
that IN O
environments NNS O
characterized VBN O
by IN O
uncertainty NN O
and CC O
rapid JJ O
rates NNS O
of IN O
change NN O
in IN O
market NN O
conditions NNS O
or CC O
technology NN O
impose VBP O
different JJ O
demands NNS O
, , O
including VBG O
constraints NNS O
and CC O
opportunities NNS O
, , O
on IN O
organizations NNS O
than IN O
do VBP O
placid JJ O
and CC O
stable JJ O
environments NNS O
. . O

Similarly RB O
to IN O
Lawrence NNP O
and CC O
Lorsch NNP O
' POS O
s POS O
views NNS O
mentioned VBN O
above RB O
, , O
Galbraith NNP O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
stressed VBD O
the DT O
contingency NN O
perspective NN O
on IN O
information NN O
processing NN O
. . O

The DT O
information NN O
- HYPH O
processing NN O
approach NN O
emphasizes VBZ O
that IN O
environment NN O
, , O
size NN O
, , O
and CC O
technology NN O
impose VBP O
different JJ O
information NN O
- HYPH O
processing NN O
requirements NNS O
on IN O
organizations NNS O
, , O
and CC O
thus RB O
an DT O
organization NN O
must MD O
be VB O
designed VBN O
to TO O
encourage VB O
information NN O
flow NN O
in IN O
both CC O
vertical JJ O
and CC O
horizontal JJ O
directions NNS O
to TO O
achieve VB O
the DT O
overall JJ O
tasks NNS O
of IN O
the DT O
organization NN O
and CC O
, , O
finally RB O
, , O
organizational JJ O
effectiveness NN O
[ -LRB- O
11 CD O
- SYM O
14 CD O
] -RRB- O
. . O

Some DT O
theorists NNS O
have VBP O
criticized VBN O
conventional JJ O
contingency NN O
theorists NNS O
who WP O
presume VBP O
that IN O
organizational JJ O
structure NN O
is VBZ O
driven VBN O
by IN O
the DT O
environment NN O
. . O

Child NN O
[ -LRB- O
15 CD O
] -RRB- O
, , O
Miller NNP O
[ -LRB- O
16 CD O
] -RRB- O
, , O
Van NNP O
de NNP O
Ven NNP O
and CC O
Drazin NNP O
[ -LRB- O
17 CD O
] -RRB- O
, , O
and CC O
Tushman NNP O
and CC O
Romanelli NNP O
[ -LRB- O
18 CD O
] -RRB- O
raised VBD O
such JJ O
criticisms NNS O
; : O
they PRP O
argued VBD O
that IN O
organizations NNS O
become VBP O
what WP O
they PRP O
are VBP O
not RB O
only RB O
because IN O
of IN O
the DT O
environment NN O
, , O
but CC O
also RB O
because IN O
of IN O
choices NNS O
made VBN O
by IN O
members NNS O
, , O
especially RB O
choices NNS O
about IN O
strategy NN O
and CC O
organizational JJ O
design NN O
. . O

As IN O
Thompson NNP O
' POS O
s POS O
words NNS O
in IN O
the DT O
book NN O
Organizations NNS O
in IN O
Action NNP O
[ -LRB- O
8 CD O
] -RRB- O
put VBD O
it PRP O
, , O
"""" `` O
organizations NNS O
are VBP O
not RB O
determined VBN O
simply RB O
by IN O
their PRP$ O
environments NNS O
( , O
p NN O
. . O
27 CD O
) -RRB- O
. , O
"""" `` O
He PRP O
also RB O
pointed VBD O
out RP O
that IN O
"""" `` O
administration NN O
may MD O
innovate VB O
on IN O
any DT O
or CC O
all DT O
of IN O
the DT O
necessary JJ O
dimensions NNS O
, , O
but CC O
only RB O
to IN O
the DT O
extent NN O
that IN O
innovations NNS O
are VBP O
acceptable JJ O
to IN O
those DT O
on IN O
whom WP O
the DT O
organization NN O
can MD O
and CC O
must MD O
depend VB O
. , O
"""" '' O
Instead RB O
of IN O
assuming VBG O
that IN O
administrators NNS O
are VBP O
highly RB O
constrained JJ O
in IN O
their PRP$ O
decisions NNS O
, , O
strategic JJ O
contingency NN O
theorists NNS O
emphasized VBD O
"""" `` O
the DT O
importance NN O
of IN O
choice NN O
, , O
"""" '' O
that RB O
is RB O
, , O
"""" `` O
the DT O
freedom NN O
of IN O
agency NN O
"""" '' O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
Pfeffer NNP O
[ -LRB- O
19 CD O
] -RRB- O
explicitly RB O
pointed VBD O
out RP O
that IN O
"""" `` O
organizational JJ O
structures NNS O
are VBP O
the DT O
outcomes NNS O
of IN O
political JJ O
contests NNS O
within IN O
organizations NNS O
( , O
p NN O
. . O
38 CD O
) -RRB- O
. . O
"""" '' O

Daft NNP O
[ -LRB- O
14 CD O
] -RRB- O
proposed VBD O
a DT O
top JJ O
management NN O
model NN O
to TO O
delineate VB O
how WRB O
"""" `` O
a DT O
strategy NN O
is VBZ O
a DT O
plan NN O
for IN O
interacting VBG O
with IN O
the DT O
competitive JJ O
environment NN O
to TO O
achieve VB O
organizational JJ O
goals NNS O
. , O
"""" '' O
He PRP O
stated VBD O
that IN O
the DT O
major JJ O
responsibility NN O
of IN O
top JJ O
management NN O
is VBZ O
to TO O
determine VB O
the DT O
goals NNS O
, , O
strategy NN O
, , O
and CC O
design NN O
of IN O
an DT O
organization NN O
to TO O
adapt VB O
to IN O
a DT O
changing VBG O
environment NN O
. . O

To TO O
assess VB O
the DT O
external JJ O
and CC O
internal JJ O
environments NNS O
of IN O
an DT O
organization NN O
seems VBZ O
to TO O
be VB O
the DT O
first JJ O
task NN O
for IN O
top JJ O
managers NNS O
in IN O
defining VBG O
an DT O
organization NN O
' POS O
s POS O
goals NNS O
and CC O
missions NNS O
. . O

Then RB O
, , O
guided VBN O
by IN O
the DT O
goals NNS O
and CC O
missions NNS O
of IN O
the DT O
organization NN O
, , O
top JJ O
managers NNS O
shape VBP O
the DT O
design NN O
of IN O
the DT O
organization NN O
, , O
including VBG O
structural JJ O
forms NNS O
, , O
information NN O
system NN O
, , O
technology NN O
, , O
human JJ B-Species
resources NNS O
, , O
organizational JJ O
culture NN O
, , O
and CC O
inter JJ O
- HYPH O
organizational JJ O
linkages NNS O
, , O
to TO O
achieve VB O
the DT O
final JJ O
organizational JJ O
performance NN O
. . O

Integration NN O
refers VBZ O
to IN O
the DT O
mechanisms NNS O
of IN O
coordination NN O
, , O
the DT O
ways NNS O
guided VBN O
to IN O
partnership NN O
goals NNS O
to TO O
fit VB O
internal JJ O
and CC O
external JJ O
conditions NNS O
[ -LRB- O
7 CD O
, , O
20 CD O
, , O
21 CD O
] -RRB- O
. . O

In IN O
the DT O
early JJ O
1990s CD O
, , O
proposals NNS O
for IN O
US NNP O
national JJ O
health NN O
care NN O
reform NN O
recognized VBD O
the DT O
need NN O
for IN O
integrating VBG O
mechanisms NNS O
to TO O
achieve VB O
both CC O
financial JJ O
success NN O
and CC O
quality NN O
of IN O
care NN O
of IN O
a DT O
well RB O
- HYPH O
organized VBN O
system NN O
of IN O
care NN O
[ -LRB- O
22 CD O
, , O
23 CD O
] -RRB- O
. . O

Several JJ O
researchers NNS O
also RB O
viewed VBD O
inter JJ O
- HYPH O
organizational JJ O
cooperation NN O
as IN O
resource NN O
exchanges NNS O
, , O
including VBG O
client NN O
referrals NNS O
, , O
money NN O
, , O
and CC O
staff NN O
[ -LRB- O
24 CD O
- SYM O
27 CD O
] -RRB- O
. . O

From IN O
practical JJ O
ways NNS O
of IN O
viewing VBG O
integration NN O
, , O
the DT O
success NN O
of IN O
integration NN O
lies VBZ O
in IN O
the DT O
coordinative JJ O
mechanisms NNS O
and CC O
partnership NN O
working NN O
that WDT O
support VBP O
it PRP O
[ -LRB- O
28 CD O
] -RRB- O
, , O
including VBG O
an DT O
administrative JJ O
organization NN O
that WDT O
coordinates VBZ O
the DT O
operations NNS O
of IN O
various JJ O
health NN O
care NN O
services NNS O
; , O
a DT O
management NN O
information NN O
system NN O
that WDT O
integrates VBZ O
clinical JJ O
, , O
utilization NN O
, , O
and CC O
financial JJ O
data NNS O
and CC O
follows VBZ O
clients NNS O
across IN O
different JJ O
settings NNS O
; : O
a DT O
care NN O
coordination NN O
program NN O
such JJ O
as IN O
case NN O
management NN O
or CC O
disease NN O
management NN O
that WDT O
works VBZ O
with IN O
clients NNS O
to TO O
arrange VB O
health NN O
care NN O
services NNS O
; : O
and CC O
a DT O
financial JJ O
mechanism NN O
that WDT O
enables VBZ O
pooling NN O
of IN O
funds NNS O
across IN O
services NNS O
[ -LRB- O
29 CD O
- SYM O
35 CD O
] -RRB- O
. . O

Fox NNP O
[ -LRB- O
36 CD O
] -RRB- O
suggested VBD O
the DT O
success NN O
of IN O
integrated JJ O
health NN O
networks NNS O
should MD O
ensure VB O
that IN O
the DT O
new JJ O
business NN O
link NN O
such JJ O
aspects NNS O
as IN O
technology NN O
, , O
functional JJ O
skills NNS O
, , O
customer NN O
access NN O
, , O
management NN O
, , O
or CC O
products NNS O
that WDT O
can MD O
be VB O
shared VBN O
across IN O
both CC O
the DT O
core NN O
and CC O
the DT O
new JJ O
business NN O
; : O
to TO O
conduct VB O
market NN O
financial JJ O
evaluation NN O
; , O
to TO O
share VB O
the DT O
risk NN O
of IN O
vertical JJ O
integration NN O
with IN O
outside JJ O
entities NNS O
, , O
to TO O
develop VB O
the DT O
management NN O
structure NN O
that WDT O
can MD O
reflect VB O
the DT O
degree NN O
of IN O
coordination NN O
necessary JJ O
to TO O
support VB O
the DT O
core NN O
business NN O
activities NNS O
; : O
to TO O
ensure VB O
that IN O
the DT O
integration NN O
strategy NN O
meets VBZ O
the DT O
needs NNS O
of IN O
customers NNS O
, , O
including VBG O
medical JJ O
treatment NN O
, , O
the DT O
use NN O
of IN O
medical JJ O
technology NN O
, , O
and CC O
the DT O
preferred JJ O
methods NNS O
of IN O
purchase NN O
; , O
and CC O
to TO O
measure VB O
the DT O
new JJ O
business NN O
by IN O
its PRP$ O
value NN O
to IN O
the DT O
enterprise NN O
as IN O
a DT O
whole NN O
, , O
rather RB O
than IN O
by IN O
its PRP$ O
profitability NN O
as IN O
a DT O
stand VB O
- HYPH O
alone RB O
entity NN O
. . O

In IN O
summary NN O
, , O
the DT O
effects NNS O
that IN O
integration NN O
in IN O
inter JJ O
- HYPH O
organizational JJ O
designs NNS O
has VBZ O
on IN O
network NN O
management NN O
were VBD O
substantial JJ O
from IN O
a DT O
managerial JJ O
perspective NN O
. . O

Borrowing VBG O
the DT O
ideas NNS O
of IN O
strategic JJ O
contingency NN O
perspective NN O
[ -LRB- O
8 CD O
, , O
15 CD O
, , O
19 CD O
] -RRB- O
and CC O
top JJ O
management NN O
model NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
it PRP O
could MD O
be VB O
imply JJ O
that IN O
success NN O
( , O
organization NN O
performance NN O
) , O
in IN O
reengineering VBG O
a DT O
network NN O
lies VBZ O
in IN O
the DT O
integration NN O
of IN O
process NN O
and CC O
services NNS O
( , O
see VB O
Figure NNP O
1 CD O
) -RRB- O
, , O
including VBG O
leadership NN O
/ SYM O
governing NN O
structure NN O
, , O
teamwork NN O
between IN O
disciplines NNS O
and CC O
patient NN B-Species
care NN O
, , O
financial JJ O
planning NN O
, , O
and CC O
information NN O
systems NNS O
, , O
characterized VBN O
as IN O
the DT O
constructs NNS O
of IN O
governance NN O
, , O
clinical JJ O
, , O
financial JJ O
, , O
and CC O
information NN O
infrastructures NNS O
, , O
respectively RB O
, , O
in IN O
this DT O
study NN O
. . O

In IN O
addition NN O
, , O
another DT O
construct NN O
, , O
marketing NN O
infrastructure NN O
, , O
was VBD O
especially RB O
important JJ O
and CC O
designed VBN O
to TO O
explore VB O
for IN O
PCCNs NNS O
in IN O
this DT O
study NN O
because IN O
of IN O
patients NNS B-Species
' POS O
freedom NN O
of IN O
making VBG O
healthcare NN O
choice NN O
and CC O
the DT O
traditional JJ O
fragmented JJ O
health NN O
care NN O
systems NNS O
by IN O
individual JJ O
health NN O
care NN O
organizations NNS O
in IN O
Taiwan NNP O
. . O

One CD O
major JJ O
reason NN O
for IN O
Taiwan NNP O
people NNS B-Species
' POS O
s POS O
hospital NN O
shopping NN O
preferences NNS O
was VBD O
that IN O
Taiwan NNP O
people NNS B-Species
usually RB O
believe VBP O
the DT O
bigger JJR O
the DT O
facility NN O
, , O
the DT O
better JJR O
capacities NNS O
a DT O
facility NN O
has VBZ O
no RB O
matter RB O
on IN O
any DT O
aspect NN O
from IN O
medical JJ O
professionals NNS O
to IN O
tangible JJ O
medical JJ O
equipment NN O
and CC O
plants NNS O
. . O

And CC O
this DT O
fallacy NN O
made VBD O
the DT O
public NN O
want VB O
to TO O
overuse VB O
the DT O
facility NN O
with IN O
high JJ O
- HYPH O
tech NN O
medical JJ O
services NNS O
no RB O
matter RB O
if IN O
it PRP O
fits VBZ O
their PRP$ O
needs NNS O
. . O

From IN O
the DT O
health NN O
policy NN O
and CC O
management NN O
perspectives NNS O
, , O
therefore RB O
, , O
the DT O
health NN O
care NN O
providers NNS O
were VBD O
encouraged VBN O
to TO O
market VB O
their PRP$ O
services NNS O
as IN O
a DT O
new JJ O
corporate JJ O
identity NN O
and CC O
brand NN O
strategy NN O
[ -LRB- O
37 CD O
] -RRB- O
, , O
including VBG O
offering VBG O
tangible JJ O
resources NNS O
such JJ O
as IN O
books NNS O
, , O
libraries NNS O
, , O
medical JJ O
equipment NN O
, , O
and CC O
intangible JJ O
resources NNS O
such JJ O
as IN O
knowledge NN O
and CC O
information NN O
exchanges NNS O
( , O
education NN O
) -RRB- O
and CC O
reputation NN O
sharing VBG O
one NN O
another DT O
among IN O
PCCN NNP O
members NNS O
. . O

Furthermore RB O
, , O
through IN O
the DT O
process NN O
of IN O
marketing VBG O
resource NN O
exchanges NNS O
, , O
therefore RB O
, , O
each DT O
PCCN NNP O
could MD O
establish VB O
the DT O
images NNS O
of IN O
"""" `` O
one CD O
system NN O
, , O
one CD O
brand NN O
and CC O
quality NN O
"""" '' O
for IN O
the DT O
public NN O
and CC O
for IN O
the DT O
health NN O
care NN O
providers NNS O
. . O

It PRP O
also RB O
makes VBZ O
it PRP O
be VB O
more RBR O
visible JJ O
to IN O
the DT O
public NN O
. . O

The DT O
five CD O
integration NN O
infrastructures NNS O
of IN O
network NN O
management NN O
were VBD O
constructed VBN O
as IN O
a DT O
conceptual JJ O
framework NN O
in IN O
this DT O
study NN O
to TO O
help VB O
to TO O
portray VB O
how WRB O
the DT O
PCCN NNP O
members NNS O
have VBP O
done VBN O
. . O

The DT O
survey NN O
instrument NN O
development NN O
was VBD O
described VBN O
in IN O
the DT O
following VBG O
. . O

Survey NN O
instrument NN O
development NN O
: : O
integration NN O
infrastructures NNS O
and CC O
measurements NNS O
of IN O
partnerships NNS O

Based VBN O
on IN O
the DT O
five CD O
integration NN O
infrastructures NNS O
of IN O
network NN O
management NN O
, , O
the DT O
structured VBN O
questionnaire NN O
were VBD O
derived VBN O
from IN O
extensive JJ O
literature NN O
reviews NNS O
. . O

Governance NN O
infrastructure NN O

Governance NN O
assumes VBZ O
the DT O
broad JJ O
responsibility NN O
for IN O
organizational JJ O
goals NNS O
and CC O
survival NN O
and CC O
involves VBZ O
the DT O
series NN O
process NN O
of IN O
setting VBG O
and CC O
monitoring VBG O
organizational JJ O
goals NNS O
and CC O
strategy NN O
development NN O
through IN O
a DT O
board NN O
of IN O
representatives NNS O
[ -LRB- O
38 CD O
] -RRB- O
. . O

Governance NN O
or CC O
administrative JJ O
integration NN O
infrastructure NN O
in IN O
establishing VBG O
network NN O
partnerships NNS O
refers VBZ O
to IN O
administrative JJ O
structures NNS O
( , O
or CC O
responsibilities NNS O
) -RRB- O
created VBN O
to TO O
facilitate VB O
communication NN O
, , O
clear JJ O
lines NNS O
of IN O
authority NN O
, , O
accountability NN O
, , O
and CC O
responsibility NN O
for IN O
patient NN B-Species
care NN O
services NNS O
; : O
to TO O
negotiate VB O
budgets NNS O
and CC O
financial JJ O
trade NN O
- HYPH O
offs NNS O
; : O
and CC O
to TO O
present VB O
a DT O
cohesive JJ O
, , O
consistent JJ O
message NN O
in IN O
interactions NNS O
with IN O
external JJ O
agencies NNS O
and CC O
the DT O
community NN O
[ -LRB- O
29 CD O
, , O
39 CD O
- HYPH O
41 CD O
] -RRB- O
and CC O
most RBS O
important JJ O
for IN O
members NNS O
in IN O
contract NN O
agreements NNS O
, , O
to TO O
manage VB O
participation NN O
[ -LRB- O
33 CD O
] -RRB- O
. . O

From IN O
a DT O
multidisciplinary JJ O
perspective NN O
, , O
Mitchell NNP O
and CC O
Shortell NNP O
[ -LRB- O
42 CD O
] -RRB- O
applied VBD O
the DT O
concepts NNS O
of IN O
governance NN O
and CC O
management NN O
characteristics NNS O
in IN O
effective JJ O
community NN O
health NN O
partnerships NNS O
. . O

The DT O
construct NN O
of IN O
governance NN O
involved VBD O
several JJ O
tasks NNS O
, , O
including VBG O
setting VBG O
priorities NNS O
for IN O
strategic JJ O
goals NNS O
, , O
choosing VBG O
the DT O
membership NN O
composition NN O
, , O
obtaining VBG O
the DT O
necessary JJ O
financial JJ O
resources NNS O
, , O
and CC O
setting VBG O
up RP O
the DT O
accountability NN O
systems NNS O
, , O
and CC O
so RB O
on RB O
. . O

The DT O
construct NN O
of IN O
the DT O
management NN O
refers VBZ O
to IN O
the DT O
tasks NNS O
of IN O
engaging VBG O
and CC O
maintaining VBG O
organizational JJ O
members NNS O
' POS O
interest NN O
in IN O
a DT O
shared VBN O
vision NN O
and CC O
mission NN O
, , O
providing VBG O
appropriate JJ O
structures NNS O
and CC O
coordination NN O
mechanisms NNS O
for IN O
the DT O
specified VBN O
strategies NNS O
, , O
promoting VBG O
constructive JJ O
conflicts NNS O
and CC O
managing VBG O
destructive JJ O
conflicts NNS O
, , O
implementing VBG O
information NN O
systems NNS O
to TO O
monitor VB O
the DT O
dynamics NNS O
, , O
adjusting VBG O
the DT O
leadership NN O
in IN O
the DT O
overall JJ O
membership NN O
, , O
and CC O
so RB O
on RB O
. . O

The DT O
issues NNS O
of IN O
governance NN O
and CC O
administrative JJ O
integration NN O
in IN O
the DT O
PCCNs NNPS O
could MD O
include VB O
[ -LRB- O
2 CD O
, , O
38 CD O
, , O
40 CD O
, , O
41 CD O
, , O
43 CD O
- HYPH O
47 CD O
] -RRB- O
: : O

* NFP O
planning VBG O
the DT O
shared VBN O
visions NNS O
and CC O
missions NNS O

* NFP O
determining VBG O
the DT O
shared VBN O
service NN O
strategies NNS O
, , O
cooperation NN O
priorities NNS O
, , O
policies NNS O
and CC O
principles NNS O

* NFP O
identifying VBG O
the DT O
information NN O
needed VBN O
and CC O
how WRB O
to TO O
get VB O
it PRP O

* NFP O
organizing VBG O
the DT O
network NN O
dynamics NNS O
and CC O
member NN O
roles NNS O

* NFP O
leading VBG O
and CC O
managing VBG O
the DT O
conflicts NNS O
and CC O
communication NN O

* NFP O
designing VBG O
and CC O
controlling VBG O
the DT O
shared VBN O
network NN O
performance NN O
systems NNS O
, , O
including VBG O
indicator NN O
settings NNS O
, , O
feedbacks NNS O
, , O
and CC O
accountability NN O
. . O

Clinical JJ O
infrastructure NN O

The DT O
idea NN O
of IN O
care NN O
integration NN O
begins VBZ O
through IN O
such JJ O
public JJ O
programs NNS O
that WDT O
include VBP O
social JJ O
workers NNS O
in IN O
public JJ O
welfare NN O
departments NNS O
, , O
caseworkers NNS O
in IN O
mental JJ O
health NN O
, , O
or CC O
nurses NNS O
in IN O
public JJ O
health NN O
departments NNS O
. . O

In IN O
the DT O
late JJ O
1980s NNS O
, , O
care NN O
integration NN O
was VBD O
deemed VBN O
necessary JJ O
for IN O
the DT O
streamlining NN O
of IN O
care NN O
and CC O
negotiating VBG O
the DT O
maze NN O
of IN O
long JJ O
- HYPH O
term NN O
care NN O
services NNS O
. . O

At IN O
that DT O
time NN O
, , O
it PRP O
was VBD O
referred VBN O
to IN O
as IN O
service NN O
coordination NN O
or CC O
case NN O
management NN O
, , O
or CC O
in IN O
other JJ O
related JJ O
terms NNS O
[ -LRB- O
29 CD O
] -RRB- O
. . O

The DT O
purpose NN O
of IN O
care NN O
integration NN O
is VBZ O
to TO O
work VB O
directly RB O
with IN O
patients NNS B-Species
and CC O
their PRP$ O
families NNS O
over IN O
time NN O
to TO O
help VB O
them PRP O
arrange VB O
and CC O
manage VB O
the DT O
complex JJ O
resources NNS O
that IN O
patients NNS B-Species
may MD O
need VB O
to TO O
maintain VB O
health NN O
and CC O
independent JJ O
functioning NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
care NN O
integration NN O
is VBZ O
used VBN O
to TO O
achieve VB O
the DT O
most JJS O
cost NN O
- HYPH O
effective JJ O
use NN O
possible JJ O
of IN O
scarce JJ O
resources NNS O
, , O
by IN O
steering VBG O
patients NNS B-Species
to IN O
the DT O
health NN O
, , O
social JJ O
, , O
and CC O
support NN O
services NNS O
most RBS O
appropriate JJ O
for IN O
them PRP O
at IN O
a DT O
given VBN O
time NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Conrad NNP O
and CC O
Dowling NNP O
[ -LRB- O
33 CD O
] -RRB- O
pointed VBD O
out RP O
that IN O
to TO O
coordinate VB O
and CC O
integrate VB O
patient NN B-Species
care NN O
relies VBZ O
on IN O
connecting VBG O
patient NN B-Species
services NNS O
at IN O
the DT O
different JJ O
stages NNS O
of IN O
the DT O
patient NN B-Species
care NN O
processes NNS O
. . O

Care NN O
coordination NN O
in IN O
integrated VBN O
networks NNS O
can MD O
be VB O
achieved VBN O
through IN O
integration NN O
of IN O
training NN O
programs NNS O
and CC O
some DT O
clinical JJ O
services NNS O
, , O
provision NN O
of IN O
complementary JJ O
clinical JJ O
capabilities NNS O
, , O
clinical JJ O
geographic JJ O
proximity NN O
design NN O
, , O
clear JJ O
role NN O
definition NN O
of IN O
each DT O
institution NN O
, , O
commitment NN O
and CC O
flexibility NN O
of IN O
leaderships NNS O
and CC O
medical JJ O
staffs NNS O
, , O
and CC O
the DT O
support NN O
of IN O
a DT O
large JJ O
referring VBG O
physician NN O
groups NNS O
embracing VBG O
the DT O
affiliation NN O
concepts NNS O
[ -LRB- O
48 CD O
] -RRB- O
. . O

The DT O
issues NNS O
of IN O
clinical JJ O
integration NN O
in IN O
the DT O
PCCNs NNPS O
could MD O
include VB O
[ -LRB- O
48 CD O
- SYM O
50 CD O
] -RRB- O
: : O

* NFP O
planning NN O
and CC O
differentiating NN O
target NN O
markets NNS O
based VBN O
on IN O
the DT O
clinical JJ O
services NNS O
of IN O
the DT O
network NN O
members NNS O

* NFP O
uniting VBG O
individual JJ O
clinical JJ O
professionals NNS O
for IN O
clinical JJ O
project NN O
planning NN O

* NFP O
designing VBG O
patient NN B-Species
- HYPH O
centered VBN O
care NN O
or CC O
case NN O
management NN O
teams NNS O

* NFP O
establishing VBG O
committees NNS O
responsible JJ O
for IN O
patient NN B-Species
- HYPH O
centered VBN O
case NN O
report NN O
meetings NNS O
, , O
case NN O
referral NN O
, , O
transfer NN O
, , O
and CC O
tracing NN O
, , O
file NN O
management NN O
( , O
record NN O
and CC O
information NN O
exchanges NNS O
) -RRB- O
, , O
clinical JJ O
quality NN O
management NN O
( , O
quality NN O
assurance NN O
, , O
improvement NN O
, , O
risk NN O
and CC O
malpractice NN O
management NN O
, , O
and CC O
utilization NN O
review NN O
) -RRB- O
, , O
and CC O
medical JJ O
continuing VBG O
education NN O
and CC O
on IN O
- HYPH O
job NN O
education NN O
. . O

Marketing NN O
infrastructure NN O

Marketing NN O
integration NN O
refers VBZ O
to IN O
how WRB O
to TO O
work VB O
together RB O
as IN O
a DT O
whole NN O
both CC O
from IN O
the DT O
provider NN O
and CC O
patient JJ B-Species
perspectives NNS O
. . O

One CD O
of IN O
the DT O
case NN O
reports NNS O
interviewing VBG O
developing VBG O
integrated VBN O
delivery NN O
system NN O
or CC O
networks NNS O
realized VBD O
that IN O
the DT O
most RBS O
important JJ O
thing NN O
is VBZ O
how WRB O
an DT O
integrated JJ O
system NN O
or CC O
network NN O
is VBZ O
promoted VBN O
and CC O
what WP O
is VBZ O
promoted VBN O
for IN O
the DT O
consumers NNS O
[ -LRB- O
51 CD O
] -RRB- O
, , O
including VBG O
focusing VBG O
on IN O
product NN O
development NN O
, , O
making VBG O
sure JJ O
the DT O
branding NN O
holds VBZ O
together RB O
, , O
marketing NN O
directly RB O
to IN O
consumers NNS O
, , O
demonstrating VBG O
values NNS O
to IN O
consumers NNS O
, , O
and CC O
even RB O
conducting VBG O
marketing NN O
research NN O
to TO O
make VB O
efforts NNS O
for IN O
the DT O
long JJ O
term NN O
. . O

In IN O
a DT O
health NN O
care NN O
network NN O
with IN O
several JJ O
organizational JJ O
members NNS O
and CC O
target NN O
patients NNS B-Species
, , O
the DT O
marketing NN O
infrastructure NN O
in IN O
PCCNs NNPS O
here RB O
refers VBZ O
to IN O
provider NN O
members NNS O
' POS O
marketing NN O
, , O
meaning VBG O
the DT O
resource NN O
sharing NN O
and CC O
market NN O
development NN O
in IN O
a DT O
PCCN NNP O
as IN O
a DT O
whole NN O
. . O

The DT O
issues NNS O
of IN O
the DT O
marketing NN O
integration NN O
in IN O
the DT O
PCCNs NNPS O
could MD O
include VB O
[ -LRB- O
37 CD O
, , O
52 CD O
- HYPH O
54 CD O
] -RRB- O
: : O

* NFP O
sharing VBG O
the DT O
literature NN O
and CC O
facility NN O
publications NNS O
among IN O
the DT O
network NN O
members NNS O

* NFP O
uniting VBG O
public JJ O
promotions NNS O
such JJ O
as IN O
united JJ O
activities NNS O
, , O
electronic JJ O
and CC O
paper NN O
media NNS O
for IN O
enhancing VBG O
the DT O
network NN O
reputation NN O
as IN O
"""" `` O
one CD O
system NN O
, , O
one CD O
brand NN O
and CC O
quality NN O
"""" '' O

* NFP O
differentiating VBG O
target NN O
markets NNS O
of IN O
the DT O
network NN O
for IN O
competing VBG O
in IN O
the DT O
medical JJ O
industry NN O
. . O

Financial JJ O
infrastructure NN O

Comprehensive JJ O
, , O
flexible JJ O
, , O
and CC O
adequate JJ O
financing NN O
is VBZ O
a DT O
goal NN O
of IN O
the DT O
ideal JJ O
continuum NN O
of IN O
care NN O
. . O

That DT O
component NN O
is VBZ O
the DT O
most RBS O
critical JJ O
and CC O
challenging JJ O
to TO O
manage VB O
under IN O
the DT O
changes NNS O
in IN O
the DT O
health NN O
care NN O
delivery NN O
environment NN O
. . O

Gillies NNP O
et FW O
al NN O
. . O

[ -LRB- O
30 CD O
] -RRB- O
suggested VBD O
that IN O
integrating VBG O
financial JJ O
management NN O
across IN O
operating VBG O
units NNS O
adds VBZ O
the DT O
greatest JJS O
value NN O
to IN O
systems NNS O
or CC O
organizations NNS O
. . O

In IN O
one CD O
case NN O
study NN O
, , O
Bramson NNP O
et FW O
al NNP O
. . O

[ -LRB- O
55 CD O
] -RRB- O
also RB O
showed VBD O
that IN O
reducing VBG O
costs NNS O
through IN O
joint JJ O
purchasing NN O
by IN O
the DT O
radiology NN O
departments NNS O
of IN O
a DT O
vertically RB O
integrated VBN O
health NN O
system NN O
could MD O
yield VB O
substantial JJ O
savings NNS O
. . O

The DT O
issues NNS O
of IN O
the DT O
financial JJ O
integration NN O
in IN O
the DT O
PCCNs NNPS O
could MD O
include VB O
: : O

* NFP O
budgeting NN O

* NFP O
uniting VBG O
equipment NN O
, , O
medical JJ O
materials NNS O
, , O
and CC O
drug NN O
purchasing NN O
and CC O
routine JJ O
administrative JJ O
stuff NN O
management NN O

* NFP O
pooling VBG O
recruitment NN O
funds NNS O

* NFP O
designing VBG O
a DT O
financial JJ O
risk NN O
and CC O
sharing NN O
mechanism NN O
. . O

Information NN O
infrastructure NN O

Information NN O
is VBZ O
an DT O
essential JJ O
component NN O
of IN O
an DT O
organization NN O
. . O

A DT O
complete JJ O
information NN O
system NN O
can MD O
help VB O
an DT O
organization NN O
to TO O
integrate VB O
its PRP$ O
individual JJ O
units NNS O
and CC O
efficiently RB O
manage VB O
the DT O
continuum NN O
. . O

The DT O
ideal JJ O
information NN O
system NN O
for IN O
a DT O
continuum NN O
of IN O
care NN O
was VBD O
conceived VBN O
of IN O
and CC O
formed VBN O
in IN O
the DT O
mid JJ O
- HYPH O
1980s NNS O
[ -LRB- O
56 CD O
] -RRB- O
. . O

During IN O
the DT O
late JJ O
1980s NNS O
, , O
computer NN O
technology NN O
began VBD O
to TO O
make VB O
an DT O
information NN O
system NN O
feasible JJ O
and CC O
affordable JJ O
through IN O
new JJ O
computer NN O
chips NNS O
with IN O
expanded VBN O
capability NN O
and CC O
networking NN O
technology NN O
. . O

In IN O
the DT O
1990s CD O
, , O
the DT O
individual JJ O
services NNS O
of IN O
the DT O
continuum NN O
upgraded VBD O
their PRP$ O
information NN O
systems NNS O
to TO O
combine VB O
clinical JJ O
, , O
financial JJ O
, , O
and CC O
utilization NN O
data NNS O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Some DT O
studies NNS O
have VBP O
argued VBN O
that IN O
the DT O
quality NN O
of IN O
information NN O
systems NNS O
can MD O
drive VB O
costs NNS O
down IN O
, , O
because IN O
a DT O
good JJ O
information NN O
system NN O
can MD O
give VB O
physicians NNS O
easy JJ O
electronic JJ O
access NN O
to TO O
complete VB O
the DT O
documentation NN O
of IN O
the DT O
patients NNS B-Species
' POS O
clinical JJ O
records NNS O
, , O
better RBR O
inform VB O
them PRP O
about IN O
reimbursement NN O
and CC O
capitation NN O
issues NNS O
, , O
help VB O
them PRP O
easily RB O
associate VB O
and CC O
manage VB O
cases NNS O
together RB O
, , O
and CC O
achieve VB O
a DT O
higher JJR O
level NN O
of IN O
professional JJ O
satisfaction NN O
[ -LRB- O
57 CD O
, , O
58 CD O
] -RRB- O
. . O

Using VBG O
Inova NNP O
Health NNP O
System NNP O
, , O
an DT O
integrated VBN O
delivery NN O
system NN O
in IN O
northern JJ O
Virginia NNP O
, , O
as IN O
an DT O
example NN O
, , O
Wager NNP O
, , O
Heda NNP O
, , O
and CC O
Austin NNP O
[ -LRB- O
59 CD O
] -RRB- O
showed VBD O
that IN O
by IN O
developing VBG O
a DT O
health NN O
information NN O
network NN O
within IN O
an DT O
integrated JJ O
delivery NN O
system NN O
, , O
Inova NNP O
can MD O
have VB O
a DT O
clinical JJ O
transaction NN O
system NN O
for IN O
hospitals NNS O
and CC O
other JJ O
entities NNS O
, , O
a DT O
data NN O
repository NN O
for IN O
decision NN O
support NN O
and CC O
outcome NN O
management NN O
, , O
a DT O
managed VBN O
care NN O
information NN O
system NN O
to TO O
support VB O
managed VBN O
care NN O
and CC O
capitation NN O
contracts NNS O
, , O
and CC O
greater JJR O
capability NN O
to TO O
acquire VB O
physicians NNS O
. . O

The DT O
issues NNS O
of IN O
information NN O
coordination NN O
include VBP O
[ -LRB- O
60 CD O
- HYPH O
68 CD O
] -RRB- O
: : O

* NFP O
establishing VBG O
an DT O
electronic JJ O
medical JJ O
record NN O
system NN O
, , O
regional JJ O
information NN O
network NN O
for IN O
patient JJ B-Species
clinical JJ O
and CC O
administrative JJ O
data NNS O
, , O
clinical JJ O
service NN O
arrangements NNS O
and CC O
administrative JJ O
work NN O

* NFP O
uniting VBG O
the DT O
system NN O
information NN O
management NN O
and CC O
web NN O
pages NNS O
. . O

The DT O
structured VBN O
questionnaire NN O
was VBD O
developed VBN O
with IN O
the DT O
wording NN O
of IN O
practical JJ O
managerial JJ O
actions NNS O
based VBN O
on IN O
the DT O
five CD O
concepts NNS O
just RB O
mentioned VBN O
. . O

There EX O
were VBD O
19 CD O
survey NN O
items NNS O
on IN O
governance NN O
infrastructure NN O
, , O
25 CD O
on IN O
clinical JJ O
infrastructure NN O
, , O
13 CD O
on IN O
marketing NN O
infrastructure NN O
, , O
20 CD O
on IN O
financial JJ O
infrastructure NN O
, , O
and CC O
7 CD O
on IN O
information NN O
infrastructure NN O
. . O

All DT O
84 CD O
items NNS O
were VBD O
, , O
simultaneously RB O
, , O
applied VBD O
to TO O
examine VB O
the DT O
relationships NNS O
of IN O
the DT O
clinic NN O
' POS O
s POS O
peer NN O
members NNS O
and CC O
the DT O
relationship NN O
of IN O
clinic NN O
and CC O
hospital NN O
members NNS O
in IN O
a DT O
PCCN NNP O
, , O
and CC O
it PRP O
resulted VBD O
in IN O
a DT O
total NN O
of IN O
168 CD O
survey NN O
questions NNS O
. . O

The DT O
detailed JJ O
information NN O
of IN O
the DT O
item NN O
questions NNS O
was VBD O
listed VBN O
in IN O
Table NNP O
2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
, , O
6 CD O
. . O

The DT O
structured VBN O
questionnaires NNS O
were VBD O
drafted VBN O
from IN O
previous JJ O
literatures NNS O
and CC O
then RB O
examined VBN O
by IN O
two CD O
academic JJ O
professors NNS O
for IN O
theoretical JJ O
accuracy NN O
. . O

Then RB O
one CD O
pilot NN O
study NN O
was VBD O
pre NN O
- HYPH O
tested VBN O
for IN O
the DT O
PCCN NNP O
pioneers NNS O
( : O
i LS O
. . O
e CD O
. . O
, , O
92 CD O
network NN O
clinic NN O
members NNS O
) -RRB- O
and CC O
116 CD O
hospital NN O
providers NNS O
which WDT O
have VBP O
partner NN O
relationships NNS O
with IN O
other JJ O
health NN O
care NN O
organizations NNS O
( : O
i LS O
. . O
e LS O
. . O
, , O
hospitals NNS O
, , O
clinics NNS O
, , O
long JJ O
- HYPH O
term NN O
care NN O
facilities NNS O
) -RRB- O
. . O

The DT O
wordings NNS O
and CC O
meanings NNS O
of IN O
each DT O
question NN O
item NN O
were VBD O
revised VBN O
to TO O
assure VB O
content NN O
validity NN O
. . O

The DT O
Cronbach NNP O
alpha NN O
values NNS O
for IN O
the DT O
five CD O
integration NN O
constructs NNS O
- : O
governance NN O
, , O
clinical JJ O
, , O
marketing NN O
, , O
finance NN O
, , O
and CC O
information NN O
infrastructure NN O
were VBD O
0 CD O
. . O
946 CD O
, , O
0 CD O
. . O
958 CD O
, , O
0 CD O
. . O
932 CD O
, , O
0 CD O
. . O
944 CD O
, , O
and CC O
0 CD O
. . O
898 CD O
for IN O
the DT O
measures NNS O
of IN O
clinic NN O
- HYPH O
clinic NN O
member NN O
relationships NNS O
; : O
and CC O
0 CD O
. . O
945 CD O
, , O
0 CD O
. . O
949 CD O
, , O
0 CD O
. . O
916 CD O
, , O
0 CD O
. . O
948 CD O
, , O
and CC O
0 CD O
. . O
896 CD O
for IN O
the DT O
measures NNS O
of IN O
clinic NN O
- HYPH O
hospital NN O
member NN O
relationships NNS O
. . O

Study NN O
subjects NNS O

To TO O
find VB O
the DT O
member NN O
partnership NN O
, , O
we PRP O
sent VBD O
questionnaires NNS O
to IN O
1 CD O
, , O
557 CD O
individual JJ O
clinics NNS O
which WDT O
had VBD O
belonged VBN O
to IN O
PCCNs NNPS O
for IN O
at RB O
least RBS O
one CD O
year NN O
, , O
based VBN O
on IN O
information NN O
contained VBN O
in IN O
the DT O
Taiwan NNP O
Primary NNP O
Community NNP O
Care NNP O
Network NNP O
List NNP O
( -LRB- O
Bureau NNP O
of IN O
National NNP O
Health NNP O
Insurance NNP O
2003 CD O
, , O
2004 CD O
and CC O
2005 CD O
) -RRB- O
. . O

We PRP O
let VBP O
clinic NN O
members NNS O
in IN O
all DT O
PCCNs NNS O
point VB O
out RP O
how WRB O
they PRP O
coordinate VBP O
with IN O
their PRP$ O
peer NN O
clinic NN O
members NNS O
and CC O
hospital NN O
members NNS O
within IN O
a DT O
PCCN NNP O
because IN O
individual JJ O
clinic NN O
members NNS O
could MD O
be VB O
better JJR O
informants NNS O
than IN O
hospital NN O
members NNS O
, , O
which WDT O
need VBP O
to TO O
deal VB O
with IN O
multiple JJ O
clinic JJ O
relationships NNS O
and CC O
therefore RB O
might MD O
find VB O
it PRP O
hard JJ O
to TO O
describe VB O
the DT O
coordination NN O
involvement NN O
one CD O
by IN O
one CD O
with IN O
clinic NN O
members NNS O
. . O

Moreover RB O
, , O
networks NNS O
form VBP O
for IN O
various JJ O
reasons NNS O
and CC O
it PRP O
might MD O
lead VB O
to IN O
the DT O
various JJ O
involvements NNS O
by IN O
individual JJ O
network NN O
members NNS O
( : O
i LS O
. . O
e LS O
. . O
, , O
hospital NN O
and CC O
clinic NN O
members NNS O
) -RRB- O
. . O

Therefore RB O
, , O
using VBG O
the DT O
participating VBG O
clinics NNS O
as IN O
individual JJ O
survey NN O
units NNS O
, , O
the DT O
results NNS O
could MD O
portray VB O
the DT O
overall JJ O
dynamics NNS O
and CC O
processes NNS O
more RBR O
authentically RB O
and CC O
detailed VBN O
throughout IN O
all DT O
PCCNs NNPS O
in IN O
the DT O
demonstration NN O
project NN O
. . O

Nine CD O
hundred CD O
and CC O
twenty CD O
- HYPH O
eight CD O
clinics NNS O
responded VBD O
( : O
59 CD O
. . O
6 CD O
% NN O
) -RRB- O
, , O
with IN O
239 CD O
clinics NNS O
in IN O
the DT O
Taipei NNP O
region NN O
, , O
165 CD O
in IN O
the DT O
northern JJ O
region NN O
, , O
241 CD O
in IN O
the DT O
central JJ O
region NN O
, , O
108 CD O
in IN O
the DT O
southern JJ O
region NN O
, , O
150 CD O
in IN O
the DT O
Kao NNP O
- HYPH O
Ping NNP O
region NN O
, , O
and CC O
15 CD O
in IN O
the DT O
eastern JJ O
region NN O
of IN O
Taiwan NNP O
. . O

Ten CD O
clinics NNS O
had VBD O
not RB O
mentioned VBN O
their PRP$ O
practicing VBG O
locations NNS O
. . O

There EX O
is VBZ O
no DT O
statistically RB O
significant JJ O
difference NN O
in IN O
geographical JJ O
distribution NN O
between IN O
the DT O
respondents NNS O
and CC O
the DT O
study NN O
population NN O
( : O
chi NN O
2 CD O
= SYM O
4 CD O
. . O
208 CD O
, , O
p NN O
> SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Analytical JJ O
techniques NNS O

The DT O
data NNS O
was VBD O
first RB O
analyzed VBN O
descriptively RB O
with IN O
frequency NN O
counts NNS O
( : O
percentage NN O
) -RRB- O
for IN O
each DT O
survey NN O
item NN O
, , O
instead RB O
of IN O
using VBG O
mean JJ O
as IN O
a DT O
statistical JJ O
method NN O
, , O
because IN O
the DT O
variation NN O
among IN O
the DT O
respondents NNS O
may MD O
not RB O
represent VB O
the DT O
normal JJ O
distribution NN O
and CC O
it PRP O
might MD O
ignore VB O
the DT O
extreme JJ O
values NNS O
for IN O
the DT O
respondents NNS O
' POS O
answers NNS O
. . O

To TO O
compare VB O
how WRB O
the DT O
respondents NNS O
perceived VBD O
the DT O
strength NN O
of IN O
integration NN O
existing VBG O
in IN O
clinic NN O
- HYPH O
clinic NN O
and CC O
clinic NN O
- HYPH O
hospital NN O
relationships NNS O
, , O
paired VBN O
t NN O
- HYPH O
tests NNS O
were VBD O
performed VBN O
for IN O
individual JJ O
survey NN O
items NNS O
, , O
using VBG O
the DT O
original JJ O
numerical JJ O
scores NNS O
. . O

Results NNS O

Profiling VBG O
the DT O
partnerships NNS O
in IN O
Taiwan NNP O
PCCNs NNPS O
: : O
governance NN O
infrastructure NN O

With IN O
regard NN O
to IN O
the DT O
governance NN O
infrastructures NNS O
, , O
the DT O
frequency NN O
was VBD O
counted VBN O
for IN O
each DT O
survey NN O
item NN O
with IN O
recalculated VBN O
scales NNS O
: : O
disagree VB O
( : O
Likert NNP O
scale NN O
1 CD O
and CC O
2 CD O
) -RRB- O
, , O
fair JJ O
( HYPH O
Likert NNP O
scale NN O
3 CD O
) -RRB- O
, , O
and CC O
agree VB O
( : O
Likert NNP O
scale NN O
4 CD O
and CC O
5 CD O
) -RRB- O
with IN O
individual JJ O
items NNS O
. . O

In IN O
clinic NN O
- HYPH O
clinic NN O
relationship NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
, , O
the DT O
majority NN O
of IN O
clinic NN O
members NNS O
agree VBP O
that IN O
the DT O
determined VBN O
deals NNS O
were VBD O
obeyed VBN O
( : O
Table NNP O
2 CD O
, , O
item NN O
1 CD O
: : O
88 CD O
. . O
69 CD O
% NN O
) -RRB- O
, , O
the DT O
goals NNS O
and CC O
strategies NNS O
of IN O
members NNS O
were VBD O
well RB O
- HYPH O
understood VBN O
( : O
Table NNP O
2 CD O
, , O
item NN O
16 CD O
: : O
79 CD O
. . O
74 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
united JJ O
principals NNS O
for IN O
individual JJ O
members NNS O
were VBD O
developed VBN O
( : O
Table NNP O
2 CD O
, , O
item NN O
15 CD O
: : O
79 CD O
. . O
42 CD O
% NN O
) -RRB- O
. . O

The DT O
higher JJR O
percentages NNS O
were VBD O
also RB O
found VBN O
in IN O
clinic NN O
- HYPH O
hospital NN O
relationship NN O
in IN O
the DT O
same JJ O
items NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
establishing VBG O
fair JJ O
coordination NN O
mechanism NN O
( , O
Table NNP O
2 CD O
, , O
item NN O
11 CD O
: : O
27 CD O
. . O
91 CD O
% NN O
) -RRB- O
, , O
designing VBG O
and CC O
employing VBG O
the DT O
network NN O
performance NN O
indicators NNS O
( -LRB- O
Table NNP O
2 CD O
, , O
item NN O
3 CD O
: : O
21 CD O
. . O
23 CD O
% NN O
) -RRB- O
, , O
and CC O
establishing VBG O
communication NN O
models NNS O
and CC O
channels NNS O
( -LRB- O
Table NNP O
2 CD O
, , O
item NN O
12 CD O
: : O
19 CD O
. . O
94 CD O
% NN O
) -RRB- O
still RB O
occupied VBD O
higher JJR O
percentages NNS O
not RB O
developed VBN O
and CC O
deserved VBN O
to TO O
been VBN O
made VBN O
the DT O
focus NN O
of IN O
more JJR O
efforts NNS O
in IN O
the DT O
future NN O
. . O

Paired VBN O
t NN O
- HYPH O
test NN O
analyses NNS O
for IN O
all DT O
individual JJ O
survey NN O
items NNS O
of IN O
governance NN O
infrastructure NN O
showed VBD O
that IN O
the DT O
deals NNS O
obeyed VBD O
( -LRB- O
Table NNP O
2 CD O
, , O
item1 CD O
) -RRB- O
and CC O
plans NNS O
and CC O
goals NNS O
controlled VBN O
( -LRB- O
Table NNP O
2 CD O
, , O
item NN O
2 CD O
) -RRB- O
were VBD O
achieved VBN O
more JJR O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
than IN O
those DT O
in IN O
clinic NN O
- HYPH O
hospital NN O
relationships NNS O
; , O
however RB O
, , O
the DT O
design NN O
of IN O
network NN O
performance NN O
indicators NNS O
( -LRB- O
Table NNP O
2 CD O
, , O
item NN O
3 CD O
) -RRB- O
, , O
development NN O
of IN O
disintegration NN O
policy NN O
and CC O
principals NNS O
( -LRB- O
Table NNP O
2 CD O
, , O
item NN O
8 CD O
) -RRB- O
, , O
and CC O
the DT O
establishment NN O
of IN O
fair JJ O
coordination NN O
mechanism NN O
( -LRB- O
Table NNP O
2 CD O
, , O
item NN O
11 CD O
) -RRB- O
were VBD O
reached VBN O
more RBR O
in IN O
clinic NN O
- HYPH O
hospital NN O
relationships NNS O
than IN O
those DT O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
. . O

Profiling VBG O
the DT O
partnerships NNS O
in IN O
Taiwan NNP O
PCCNs NNPS O
: : O
clinical JJ O
infrastructure NN O

Examining VBG O
the DT O
extent NN O
of IN O
clinical JJ O
infrastructure NN O
for IN O
network NN O
members NNS O
, , O
establishing VBG O
two CD O
- HYPH O
directed VBN O
patient JJ B-Species
referral NN O
systems NNS O
and CC O
patient JJ B-Species
referral NN O
information NN O
files NNS O
( -LRB- O
Table NNP O
3 CD O
, , O
items NNS O
35 CD O
& CC O
37 CD O
) -RRB- O
and CC O
uniting VBG O
medical JJ O
continuing VBG O
education NN O
and CC O
on IN O
- HYPH O
job NN O
education NN O
( -LRB- O
Table NNP O
3 CD O
, , O
item NN O
34 CD O
) -RRB- O
were VBD O
shown VBN O
at IN O
a DT O
highly RB O
implemented VBN O
rate NN O
in IN O
clinic NN O
- HYPH O
clinic NN O
( : O
more JJR O
than IN O
70 CD O
% NN O
) -RRB- O
and CC O
clinic NN O
- HYPH O
hospital NN O
( , O
more JJR O
than IN O
80 CD O
% NN O
) -RRB- O
relationships NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
network NN O
members NNS O
had VBD O
higher JJR O
percentages NNS O
( : O
more JJR O
than IN O
40 CD O
% NN O
) : O
not RB O
to TO O
think VB O
about IN O
the DT O
possible JJ O
integration NN O
mechanisms NNS O
including VBG O
establishing VBG O
committees NNS O
to TO O
deal VB O
with IN O
medical JJ O
malpractice NN O
( : O
Table NNP O
3 CD O
, , O
item NN O
44 CD O
) -RRB- O
, , O
planning NN O
and CC O
differentiating VBG O
clinical JJ O
market NN O
areas NNS O
( : O
Table NNP O
3 CD O
, , O
item NN O
20 CD O
) -RRB- O
, , O
and CC O
designing VBG O
patient NN B-Species
- HYPH O
centered VBN O
case NN O
management NN O
teams NNS O
( -LRB- O
Table NNP O
3 CD O
, , O
item NN O
22 CD O
) -RRB- O
. . O

Overall RB O
, , O
there EX O
was VBD O
better JJR O
clinical JJ O
integration NN O
involvement NN O
for IN O
all PDT O
the DT O
described VBN O
items NNS O
in IN O
clinic NN O
- HYPH O
hospital NN O
relationships NNS O
than IN O
those DT O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
within IN O
a DT O
network NN O
in IN O
this DT O
study NN O
( , O
see VB O
Table NNP O
3 CD O
, , O
paired VBN O
t NN O
- HYPH O
tests NNS O
, , O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Profiling VBG O
the DT O
partnerships NNS O
in IN O
Taiwan NNP O
PCCNs NNPS O
: : O
marketing NN O
infrastructure NN O

For IN O
marketing NN O
planning NN O
, , O
the DT O
clinics NNS O
had VBD O
better JJR O
integrated VBN O
marketing NN O
activities NNS O
with IN O
their PRP$ O
respective JJ O
hospitals NNS O
than IN O
with IN O
peer NN O
clinic NN O
members NNS O
within IN O
PCCNs NNP O
for IN O
all DT O
studied VBN O
items NNS O
( -LRB- O
Table NN O
4 CD O
, , O
paired VBN O
t NN O
- HYPH O
test NN O
, , O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Examining VBG O
the DT O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
, , O
uniting VBG O
social JJ O
activities NNS O
( , O
Table NNP O
4 CD O
, , O
item NN O
53 CD O
) -RRB- O
, , O
sharing VBG O
the DT O
individual JJ O
facility NN O
reports NNS O
for IN O
updated VBN O
services NNS O
( -LRB- O
Table NNP O
4 CD O
, , O
item NN O
46 CD O
) -RRB- O
, , O
public JJ O
promotion NN O
( , O
Table NNP O
4 CD O
, , O
item NN O
54 CD O
) -RRB- O
, , O
and CC O
uniting VBG O
and CC O
joining VBG O
the DT O
facility NN O
activities NNS O
( -LRB- O
Table NNP O
4 CD O
, , O
item NN O
51 CD O
) -RRB- O
were VBD O
the DT O
top JJ O
four CD O
marketing NN O
works NNS O
done VBN O
among IN O
clinic NN O
members NNS O
( , O
more JJR O
than IN O
60 CD O
% NN O
implemented VBN O
rate NN O
) -RRB- O
; , O
and CC O
those DT O
items NNS O
also RB O
showed VBD O
a DT O
higher JJR O
implemented VBN O
rate NN O
( , O
more JJR O
than IN O
70 CD O
% NN O
) -RRB- O
between IN O
clinic NN O
and CC O
hospital NN O
members NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
facility NN O
assets NNS O
such JJ O
as IN O
reports NNS O
( , O
Table NNP O
4 CD O
, , O
item NN O
49 CD O
) -RRB- O
, , O
and CC O
professional JJ O
literatures NNS O
and CC O
books NNS O
( -LRB- O
Table NNP O
4 CD O
, , O
item NN O
45 CD O
) -RRB- O
were VBD O
not RB O
well RB O
- HYPH O
shared VBN O
among IN O
clinic NN O
members NNS O
( , O
"""" `` O
never RB O
- HYPH O
thinking VBG O
"""" '' O
rate NN O
: : O
42 CD O
. . O
13 CD O
% NN O
) -RRB- O
. . O

In IN O
addition NN O
, , O
uniting VBG O
the DT O
network NN O
publication NN O
could MD O
make VB O
more JJR O
efforts NNS O
in IN O
the DT O
future NN O
( : O
"""" `` O
never RB O
- HYPH O
thinking VBG O
"""" '' O
rate NN O
in IN O
item NN O
50 CD O
: : O
39 CD O
. . O
98 CD O
% NN O
) -RRB- O
. . O

The DT O
room NN O
for IN O
clinic NN O
- HYPH O
hospital NN O
partnership NN O
to TO O
think VB O
about IN O
acting NN O
was VBD O
kind RB O
of RB O
different JJ O
from IN O
those DT O
in IN O
the DT O
clinic NN O
- HYPH O
clinic NN O
relationship NN O
. . O

In IN O
addition NN O
to IN O
the DT O
uniting VBG O
publication NN O
that WDT O
can MD O
be VB O
encouraged VBN O
to TO O
improve VB O
the DT O
clinic NN O
- HYPH O
hospital NN O
relationship NN O
( : O
Table NNP O
4 CD O
, , O
item NN O
50 CD O
: : O
27 CD O
. . O
48 CD O
% NN O
) -RRB- O
, , O
cooperating VBG O
in IN O
research NN O
projects NNS O
( -LRB- O
Table NNP O
4 CD O
, , O
item NN O
52 CD O
: : O
25 CD O
. . O
0 CD O
% NN O
) -RRB- O
and CC O
identifying VBG O
and CC O
differentiating VBG O
target NN O
markets NNS O
( -LRB- O
Table NN O
4 CD O
, , O
item NN O
57 CD O
: : O
24 CD O
. . O
57 CD O
% NN O
) -RRB- O
had VBD O
still RB O
more JJR O
opportunities NNS O
to TO O
be VB O
focused VBN O
on IN O
in IN O
the DT O
future NN O
. . O

Profiling VBG O
the DT O
partnerships NNS O
in IN O
Taiwan NNP O
PCCNs NNPS O
: : O
financial JJ O
infrastructure NN O

The DT O
PCCN NNP O
members NNS O
were VBD O
found VBN O
to TO O
have VB O
a DT O
lower JJR O
extent NN O
of IN O
financial JJ O
integration NN O
as IN O
evidenced VBN O
by IN O
higher JJR O
percentage NN O
of IN O
' `` O
' `` O
never RB O
thinking VBG O
' '' O
' '' O
scale NN O
about IN O
the DT O
survey NN O
items NNS O
on IN O
almost RB O
all DT O
items NNS O
( , O
see VB O
Table NNP O
5 CD O
) -RRB- O
. . O

Slightly RB O
more JJR O
integration NN O
( : O
that RB O
is RB O
, , O
' '' O
' `` O
acting NN O
' '' O
' '' O
rate NN O
) , O
was VBD O
found VBN O
in IN O
only RB O
four CD O
items NNS O
both CC O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
and CC O
in IN O
clinic NN O
- HYPH O
hospital NN O
relationships NNS O
, , O
including VBG O
uniting VBG O
budget NN O
planning NN O
( : O
Table NNP O
5 CD O
: : O
item NN O
58 CD O
) -RRB- O
, , O
sharing VBG O
places NNS O
, , O
materials NNS O
, , O
and CC O
equipment NN O
( , O
Table NNP O
5 CD O
: : O
item NN O
68 CD O
) -RRB- O
, , O
uniting VBG O
budgeting NN O
for IN O
certain JJ O
services NNS O
( -LRB- O
Table NNP O
5 CD O
: : O
items NNS O
72 CD O
) -RRB- O
, , O
and CC O
designing VBG O
the DT O
resource NN O
distribution NN O
principals NNS O
based VBN O
on IN O
the DT O
whole JJ O
network NN O
goals NNS O
( -LRB- O
Table NNP O
5 CD O
: : O
item NN O
77 CD O
) -RRB- O
. . O

Further RB O
examining VBG O
the DT O
financial JJ O
infrastructure NN O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationship NN O
and CC O
clinic NN O
- HYPH O
hospital NN O
relationship NN O
, , O
paired VBN O
- HYPH O
t NN O
tests NNS O
revealed VBD O
that IN O
clinic NN O
- HYPH O
hospital NN O
partnerships NNS O
were VBD O
involved VBN O
more RBR O
in IN O
places NNS O
, , O
materials NNS O
, , O
and CC O
equipment NN O
sharing NN O
and CC O
maintenance NN O
( , O
Table NNP O
5 CD O
, , O
items NNS O
62 CD O
and CC O
68 CD O
) -RRB- O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
and CC O
higher JJR O
financial JJ O
infrastructure NN O
coordination NN O
exists VBZ O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
( -LRB- O
Table NNP O
5 CD O
, , O
items NNS O
58 CD O
, , O
59 CD O
, , O
63 CD O
- HYPH O
65 CD O
, , O
72 CD O
, , O
74 CD O
, , O
75 CD O
, , O
and CC O
77 CD O
) -RRB- O
( : O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Profiling VBG O
the DT O
partnerships NNS O
in IN O
Taiwan NNP O
PCCNs NNPS O
: : O
information NN O
infrastructure NN O

There EX O
was VBD O
significantly RB O
greater JJR O
integration NN O
of IN O
information NN O
in IN O
clinic NN O
- HYPH O
hospital NN O
than IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
in IN O
all DT O
items NNS O
in IN O
this DT O
category NN O
( -LRB- O
Table NNP O
6 CD O
, , O
paired VBN O
t NN O
- HYPH O
tests NNS O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

The DT O
greatest JJS O
integration NN O
was VBD O
found VBN O
in IN O
electronic JJ O
patient NN B-Species
records NNS O
( -LRB- O
Table NNP O
6 CD O
: : O
item NN O
78 CD O
) -RRB- O
, , O
followed VBN O
by IN O
information NN O
integration NN O
for IN O
patient NN B-Species
data NNS O
( -LRB- O
Table NNP O
6 CD O
: : O
item NN O
79 CD O
) -RRB- O
and CC O
clinical JJ O
service NN O
arrangements NNS O
( -LRB- O
Table NN O
6 CD O
: : O
item NN O
81 CD O
) -RRB- O
. . O

The DT O
lowest JJS O
level NN O
of IN O
integration NN O
in IN O
information NN O
infrastructure NN O
was VBD O
found VBN O
in IN O
administrative JJ O
works NNS O
such JJ O
as IN O
registration NN O
, , O
billing NN O
and CC O
so RB O
on RB O
( -LRB- O
Table NN O
6 CD O
: : O
item NN O
82 CD O
, , O
' '' O
' `` O
never RB O
- HYPH O
thinking VBG O
' '' O
' '' O
rate NN O
more JJR O
than IN O
50 CD O
% NN O
) -RRB- O
within IN O
network NN O
members NNS O
. . O

Discussion NN O

In IN O
this DT O
study NN O
, , O
we PRP O
surveyed VBD O
943 CD O
clinics NNS O
that WDT O
had VBD O
belonged VBN O
to IN O
Taiwan NNP O
PCCNs NNPS O
for IN O
more JJR O
than IN O
a DT O
year NN O
to TO O
understand VB O
the DT O
nature NN O
and CC O
extent NN O
of IN O
integration NN O
to IN O
which WDT O
they PRP O
and CC O
their PRP$ O
associated JJ O
PCCN NNP O
members NNS O
( , O
clinics NNS O
and CC O
hospitals NNS O
) , O
had VBD O
in IN O
governance NN O
, , O
clinical JJ O
, , O
marketing NN O
, , O
financial JJ O
, , O
and CC O
information NN O
infrastructures NNS O
. . O

It PRP O
was VBD O
found VBN O
a DT O
wide JJ O
variance NN O
in IN O
the DT O
kind NN O
and CC O
degree NN O
of IN O
integration NN O
among IN O
them PRP O
and CC O
a DT O
lot NN O
of IN O
room NN O
for IN O
better JJR O
integration NN O
( , O
Table NNP O
2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
, , O
6 CD O
) -RRB- O
. . O

From IN O
the DT O
governance NN O
perspective NN O
, , O
we PRP O
found VBD O
lower JJR O
integration NN O
was VBD O
found VBN O
in IN O
the DT O
establishment NN O
of IN O
fair JJ O
coordination NN O
mechanism NN O
( -LRB- O
Table NNP O
2 CD O
: : O
item NN O
11 CD O
) -RRB- O
among IN O
member NN O
clinics NNS O
and CC O
member NN O
hospitals NNS O
. . O

Coordination NN O
could MD O
be VB O
viewed VBN O
from IN O
different JJ O
perspectives NNS O
, , O
including VBG O
the DT O
use NN O
of IN O
standardized VBN O
languages NNS O
and CC O
forms NNS O
, , O
organizational JJ O
rules NNS O
and CC O
procedures NNS O
, , O
the DT O
establishment NN O
of IN O
common JJ O
rules NNS O
, , O
policies NNS O
, , O
and CC O
procedures NNS O
, , O
and CC O
the DT O
monitoring NN O
through IN O
memos NNS O
, , O
reports NNS O
, , O
and CC O
a DT O
computerized JJ O
information NN O
system NN O
[ -LRB- O
69 CD O
, , O
70 CD O
] -RRB- O
. . O

Facing VBG O
the DT O
cumbersome JJ O
integration NN O
processes NNS O
, , O
it PRP O
suggests VBZ O
that IN O
each DT O
PCCN NNP O
' POS O
s NN O
headquarters NN O
should MD O
become VB O
actively RB O
involved VBN O
and CC O
clarify VB O
the DT O
authority NN O
, , O
responsibility NN O
and CC O
accountability NN O
of IN O
individual JJ O
members NNS O
, , O
identify VB O
the DT O
potential JJ O
conflict NN O
sources NNS O
, , O
and CC O
publicize VB O
the DT O
rules NNS O
and CC O
regulation NN O
of IN O
network NN O
integration NN O
dynamics NNS O
covering VBG O
decision NN O
making NN O
processes NNS O
, , O
market NN O
planning NN O
, , O
clinical JJ O
teamwork NN O
designs NNS O
, , O
and CC O
financial JJ O
reports NNS O
of IN O
individual JJ O
network NN O
members NNS O
. . O

These DT O
actions NNS O
could MD O
enhance VB O
the DT O
trust NN O
and CC O
respect NN O
of IN O
network NN O
members NNS O
one CD O
another DT O
and CC O
could MD O
improve VB O
the DT O
small JJ O
extent NN O
of IN O
integration NN O
found VBN O
in IN O
this DT O
study NN O
about IN O
the DT O
mechanisms NNS O
for IN O
communication NN O
models NNS O
and CC O
channels NNS O
in IN O
the DT O
PCCNs NNPS O
( -LRB- O
Table NNP O
2 CD O
: : O
item NN O
12 CD O
) -RRB- O
. . O

From IN O
the DT O
network NN O
management NN O
perspective NN O
, , O
communication NN O
could MD O
occur VB O
between IN O
the DT O
various JJ O
entities NNS O
such JJ O
as IN O
between IN O
hospital NN O
and CC O
clinics NNS O
, , O
primary JJ O
care NN O
physicians NNS O
and CC O
specialists NNS O
, , O
managers NNS O
and CC O
clinical JJ O
professionals NNS O
, , O
and CC O
even RB O
among IN O
the DT O
clinical JJ O
professionals NNS O
in IN O
the DT O
network NN O
. . O

To TO O
develop VB O
effective JJ O
and CC O
timely JJ O
communication NN O
channels NNS O
was VBD O
the DT O
key NN O
for IN O
the DT O
management NN O
of IN O
integrated JJ O
organizations NNS O
[ -LRB- O
30 CD O
- SYM O
32 CD O
] -RRB- O
and CC O
could MD O
alleviate VB O
the DT O
tensions NNS O
that WDT O
sometimes RB O
occur VBP O
in IN O
the DT O
dynamics NNS O
of IN O
the DT O
multi JJ O
- HYPH O
organizations NNS O
. . O

In IN O
this DT O
study NN O
, , O
it PRP O
was VBD O
found VBN O
a DT O
low JJ O
level NN O
of IN O
involvement NN O
of IN O
medical JJ O
teams NNS O
in IN O
medical JJ O
projects NNS O
, , O
patient NN B-Species
- HYPH O
centered VBN O
case NN O
management NN O
, , O
and CC O
case NN O
report NN O
meetings NNS O
among IN O
the DT O
network NN O
members NNS O
( -LRB- O
Table NNP O
3 CD O
: : O
item NN O
21 CD O
, , O
22 CD O
, , O
and CC O
23 CD O
) -RRB- O
from IN O
a DT O
clinical JJ O
integration NN O
perspective NN O
. . O

Several JJ O
researchers NNS O
have VBP O
addressed VBN O
that DT O
clinical JJ O
integration NN O
providing VBG O
a DT O
process NN O
of IN O
medical JJ O
management NN O
, , O
care NN O
management NN O
, , O
case NN O
management NN O
, , O
and CC O
patient JJ B-Species
management NN O
designed VBN O
to TO O
transform VB O
the DT O
traditionally RB O
fragmented JJ O
delivery NN O
system NN O
into IN O
a DT O
more RBR O
cohesive JJ O
system NN O
[ -LRB- O
71 CD O
] -RRB- O
, , O
and CC O
lead VB O
to IN O
higher JJR O
service NN O
quality NN O
and CC O
assure VB O
financial JJ O
objectives NNS O
[ -LRB- O
72 CD O
, , O
73 CD O
] -RRB- O
. . O

More JJR O
attention NN O
could MD O
be VB O
paid VBN O
to IN O
these DT O
activities NNS O
in IN O
the DT O
future NN O
. . O

In IN O
addition NN O
, , O
it PRP O
was VBD O
also RB O
found VBN O
less JJR O
integration NN O
in IN O
planning NN O
and CC O
differentiating VBG O
clinical JJ O
market NN O
areas NNS O
( -LRB- O
Table NNP O
3 CD O
, , O
item NN O
20 CD O
) -RRB- O
among IN O
the DT O
network NN O
members NNS O
in IN O
the DT O
category NN O
of IN O
clinical JJ O
infrastructure NN O
. . O

This DT O
may MD O
result VB O
from IN O
the DT O
existing VBG O
specialty NN O
diversities NNS O
in IN O
individual JJ O
PCCNs NNS O
, , O
which WDT O
might MD O
not RB O
need VB O
to TO O
involve VB O
planning NN O
and CC O
differentiating VBG O
market NN O
area NN O
based VBN O
on IN O
the DT O
members NNS O
' POS O
clinical JJ O
services NNS O
at IN O
the DT O
early JJ O
stage NN O
of IN O
network NN O
development NN O
. . O

There EX O
was VBD O
more JJR O
involvement NN O
in IN O
marketing VBG O
efforts NNS O
in IN O
clinic NN O
- HYPH O
hospital NN O
relationships NNS O
than IN O
in IN O
clinic NN O
- HYPH O
clinic NN O
relationships NNS O
. . O

Generally RB O
speaking VBG O
, , O
hospitals NNS O
have VBP O
more JJR O
resources NNS O
( : O
i LS O
. . O
e LS O
. . O
, , O
money NN O
, , O
human JJ B-Species
resources NNS O
, , O
materials NNS O
, , O
and CC O
physical JJ O
assets NNS O
) -RRB- O
than IN O
clinics NNS O
, , O
which WDT O
might MD O
explain VB O
the DT O
stronger JJR O
marketing VBG O
involvements NNS O
between IN O
the DT O
clinic NN O
and CC O
hospital NN O
members NNS O
, , O
including VBG O
the DT O
library NN O
sharing NN O
( , O
books NNS O
and CC O
literatures NNS O
) -RRB- O
, , O
facility NN O
brochure NN O
dissemination NN O
, , O
public JJ O
promoting NN O
, , O
and CC O
medical JJ O
research NN O
cooperation NN O
. . O

These DT O
integration NN O
efforts NNS O
also RB O
meet VBP O
the DT O
expectation NN O
of IN O
the DT O
national JJ O
health NN O
authority NN O
for IN O
resource NN O
sharing NN O
and CC O
medical JJ O
quality NN O
image NN O
enhancement NN O
among IN O
the DT O
health NN O
care NN O
providers NNS O
. . O

Financial JJ O
infrastructure NN O
was VBD O
found VBN O
to TO O
be VB O
the DT O
least RBS O
integrated VBN O
, , O
with IN O
most JJS O
items NNS O
never RB O
considered VBN O
. . O

Perhaps RB O
the DT O
only JJ O
reason NN O
for IN O
the DT O
higher JJR O
score NN O
of IN O
budget NN O
planning NN O
activities NNS O
( -LRB- O
Table NNP O
5 CD O
: : O
items NNS O
58 CD O
and CC O
77 CD O
) -RRB- O
was VBD O
that IN O
BHNI NNP O
required VBD O
each DT O
PCCN NNP O
to TO O
design VB O
and CC O
determine VB O
its PRP$ O
budgeting NN O
arrangement NN O
in IN O
advance NN O
before IN O
joining VBG O
the DT O
demonstration NN O
project NN O
. . O

While IN O
slightly RB O
more JJR O
financial JJ O
involvement NN O
was VBD O
made VBN O
among IN O
network NN O
members NNS O
( -LRB- O
Table NNP O
5 CD O
: : O
items NNS O
68 CD O
, , O
72 CD O
& CC O
73 CD O
) -RRB- O
, , O
possibly RB O
due JJ O
to IN O
similar JJ O
needs NNS O
, , O
there EX O
remains VBZ O
a DT O
lot NN O
of IN O
room NN O
for IN O
financial JJ O
integration NN O
in IN O
the DT O
future NN O
. . O

There EX O
was VBD O
a DT O
need NN O
for IN O
networks NNS O
to TO O
develop VB O
electronic JJ O
information NN O
systems NNS O
, , O
though IN O
creating VBG O
and CC O
managing VBG O
an DT O
integrated JJ O
information NN O
system NN O
involves VBZ O
very RB O
detailed JJ O
work NN O
. . O

Most JJS O
of IN O
the DT O
clinics NNS O
surveyed VBN O
have VBP O
focused VBN O
more RBR O
on IN O
the DT O
individual JJ O
public JJ O
members NNS O
' POS O
administrative JJ O
works NNS O
such JJ O
as IN O
filing VBG O
patient JJ B-Species
medical JJ O
records NNS O
, , O
collecting VBG O
and CC O
managing VBG O
network NN O
patient JJ B-Species
clinical JJ O
data NNS O
, , O
and CC O
scheduling VBG O
clinical JJ O
services NNS O
, , O
which WDT O
were VBD O
required VBN O
by IN O
the DT O
BNHI NNP O
. . O

The DT O
factors NNS O
for IN O
the DT O
health NN O
care NN O
managers NNS O
to TO O
adopt VB O
the DT O
integrated VBN O
clinical JJ O
information NN O
systems NNS O
include VBP O
the DT O
decision NN O
of IN O
make NN O
or CC O
buy VB O
, , O
adoption NN O
leadership NN O
, , O
adoption NN O
objectives NNS O
, , O
implementation NN O
leadership NN O
, , O
phased VBN O
versus IN O
simultaneous JJ O
implementation NN O
, , O
parallel JJ O
systems NNS O
, , O
information NN O
technology NN O
implementation NN O
policies NNS O
and CC O
practices NNS O
, , O
use NN O
levels NNS O
and CC O
resistance NN O
, , O
and CC O
realized VBN O
benefits NNS O
and CC O
return NN O
on IN O
investment NN O
calculation NN O
[ -LRB- O
66 CD O
] -RRB- O
, , O
which WDT O
might MD O
be VB O
very RB O
cumbersome JJ O
and CC O
time NN O
- HYPH O
consuming VBG O
. . O

It PRP O
suggests VBZ O
that IN O
the DT O
network NN O
partners NNS O
might MD O
be VB O
engaged VBN O
, , O
firstly RB O
, , O
more RBR O
in IN O
simpler JJR O
network NN O
cooperation NN O
such JJ O
as IN O
the DT O
administrative JJ O
systems NNS O
for IN O
patient JJ B-Species
admission NN O
to IN O
the DT O
network NN O
members NNS O
and CC O
establishing VBG O
united JJ O
web NN O
pages NNS O
for IN O
patients NNS B-Species
to TO O
access VB O
their PRP$ O
family NN O
physicians NNS O
and CC O
network NN O
members NNS O
for IN O
medical JJ O
and CC O
public JJ O
promotion NN O
purposes NNS O
. . O

And CC O
for IN O
further JJ O
integrated JJ O
information NN O
investments NNS O
, , O
efforts NNS O
must MD O
be VB O
redirected VBN O
for IN O
network NN O
members NNS O
to TO O
work VB O
together RB O
to TO O
define VB O
the DT O
approach NN O
to IN O
specific JJ O
classes NNS O
of IN O
integration NN O
for IN O
the DT O
long JJ O
term NN O
[ -LRB- O
74 CD O
] -RRB- O
. . O

Conclusion NN O

This DT O
study NN O
tried VBD O
to TO O
portray VB O
and CC O
trace VB O
how WRB O
the DT O
facility NN O
participants NNS B-Species
were VBD O
involved VBN O
in IN O
the DT O
Taiwan NNP O
PCCNs NNPS O
. . O

It PRP O
was VBD O
found VBN O
that IN O
Taiwan NNP O
PCCNs NNPS O
' POS O
members NNS O
had VBD O
higher JJR O
involvement NN O
in IN O
the DT O
governance NN O
infrastructure NN O
, , O
which WDT O
was VBD O
usually RB O
viewed VBN O
as IN O
the DT O
most RBS O
important JJ O
for IN O
establishment NN O
of IN O
core NN O
values NNS O
in IN O
PCCNs NNP O
' POS O
organization NN O
design NN O
and CC O
management NN O
. . O

There EX O
existed VBD O
a DT O
higher JJR O
extent NN O
of IN O
integration NN O
of IN O
clinical JJ O
, , O
marketing NN O
, , O
and CC O
information NN O
infrastructures NNS O
among IN O
the DT O
hospital NN O
- HYPH O
clinic NN O
member NN O
relationship NN O
than IN O
those DT O
among IN O
clinic NN O
members NNS O
within IN O
individual JJ O
PCCNs NNS O
. . O

The DT O
financial JJ O
infrastructure NN O
was VBD O
shown VBN O
the DT O
least RBS O
integrated JJ O
relative JJ O
to IN O
other JJ O
functional JJ O
infrastructures NNS O
at IN O
the DT O
early JJ O
stage NN O
of IN O
PCCN NNP O
formation NN O
. . O

Page NNP O
[ -LRB- O
43 CD O
] -RRB- O
argued VBD O
that IN O
networks NNS O
form VBP O
and CC O
grow VBP O
for IN O
various JJ O
reasons NNS O
, , O
however RB O
, , O
only RB O
some DT O
of IN O
them PRP O
could MD O
be VB O
compatible JJ O
with IN O
the DT O
iterative JJ O
processes NNS O
of IN O
collaboration NN O
. . O

Some DT O
participants NNS B-Species
in IN O
the DT O
PCCNs NNPS O
may MD O
simply RB O
seek VB O
short JJ O
- HYPH O
term NN O
economic JJ O
gains NNS O
and CC O
have VBP O
little JJ O
interest NN O
in IN O
joint JJ O
learning NN O
and CC O
continuous JJ O
improvement NN O
. . O

From IN O
an DT O
organizational JJ O
design NN O
perspective NN O
, , O
the DT O
old JJ O
phrase NN O
proposed VBN O
by IN O
the DT O
wisdom NN O
of IN O
the DT O
saying NN O
about IN O
developing VBG O
the DT O
integrated JJ O
organizations NNS O
( , O
networks NNS O
) -RRB- O
should MD O
be VB O
- : O
"""" `` O
coming VBG O
together RB O
is VBZ O
the DT O
beginning NN O
, , O
and CC O
working VBG O
together RB O
is VBZ O
the DT O
success NN O
. , O
"""" `` O
Page NNP O
[ -LRB- O
43 CD O
] -RRB- O
examined VBD O
the DT O
virtual JJ O
provider NN O
organizations NNS O
such JJ O
as IN O
physician NN O
- HYPH O
hospital NN O
organizations NNS O
and CC O
pointed VBN O
out RP O
the DT O
issue NN O
of IN O
the DT O
provider NN O
attitudes NNS O
and CC O
behaviors NNS O
as IN O
the DT O
critically RB O
successful JJ O
continuous JJ O
improvements NNS O
in IN O
the DT O
health NN O
care NN O
environments NNS O
. . O

A DT O
wide JJ O
variance NN O
of IN O
degree NN O
of IN O
network NN O
integration NN O
in IN O
Taiwan NNP O
PCCNs NNPS O
still RB O
leaves VBZ O
room NN O
to TO O
improve VB O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
thoroughly RB O
surveyed VBN O
items NNS O
, , O
that RB O
is RB O
, , O
the DT O
potential JJ O
network NN O
design NN O
content NN O
, , O
were VBD O
employed VBN O
. . O

In IN O
addition NN O
to TO O
provide VB O
how WRB O
the DT O
network NN O
members NNS O
have VBP O
done VBN O
their PRP$ O
initial JJ O
work NN O
at IN O
the DT O
early JJ O
stage NN O
of IN O
network NN O
forming VBG O
in IN O
this DT O
study NN O
, , O
the DT O
detailed VBN O
surveyed VBN O
items NNS O
, , O
the DT O
concepts NNS O
proposed VBN O
by IN O
the DT O
managerial JJ O
and CC O
theoretical JJ O
professionals NNS O
, , O
could MD O
be VB O
also RB O
a DT O
guide NN O
for IN O
those DT O
health NN O
care NN O
providers NNS O
who WP O
have VBP O
a DT O
willingness NN O
to TO O
join VB O
multi JJ O
- HYPH O
organizations NNS O
. . O

It PRP O
suggests VBZ O
that IN O
health NN O
care NN O
providers NNS O
could MD O
take VB O
more RBR O
detailed JJ O
looks NNS O
about IN O
those DT O
surveyed VBN O
items NNS O
and CC O
give VB O
some DT O
possible JJ O
opportunities NNS O
to TO O
create VB O
the DT O
potential JJ O
actions NNS O
. . O

Further JJ O
research NN O
could MD O
be VB O
empirically RB O
done VBN O
to TO O
explore VB O
the DT O
relative JJ O
influence NN O
of IN O
these DT O
integration NN O
mechanisms NNS O
on IN O
the DT O
effectiveness NN O
of IN O
organizational JJ O
partnerships NNS O
. . O

The DT O
partnerships NNS O
within IN O
each DT O
PCCN NNP O
represent VBP O
various JJ O
relationships NNS O
that WDT O
depend VBP O
on IN O
how WRB O
much RB O
the DT O
members NNS O
are VBP O
engaged VBN O
in IN O
the DT O
projects NNS O
. . O

In IN O
addition NN O
to IN O
the DT O
macro JJ O
concepts NNS O
including VBG O
governance NN O
, , O
clinical JJ O
, , O
marketing NN O
, , O
financial JJ O
, , O
and CC O
information NN O
infrastructures NNS O
explored VBN O
in IN O
this DT O
study NN O
, , O
other JJ O
managerial JJ O
issues NNS O
for IN O
integrated JJ O
organizations NNS O
were VBD O
also RB O
suggested VBN O
such JJ O
as IN O
formation NN O
of IN O
an DT O
integrated VBN O
cultural JJ O
atmosphere NN O
, , O
human JJ B-Species
resources NNS O
management NN O
, , O
physician NN O
involvement NN O
, , O
mission NN O
and CC O
commitment NN O
establishment NN O
, , O
from IN O
micro JJ O
organizational JJ O
behavior NN O
perspective NN O
[ -LRB- O
30 CD O
- HYPH O
32 CD O
, , O
34 CD O
, , O
36 CD O
, , O
75 CD O
, , O
76 CD O
] -RRB- O
. . O

Micro JJ O
managerial JJ O
and CC O
longitudinal JJ O
research NN O
designs NNS O
could MD O
be VB O
employed VBN O
to TO O
more RBR O
precisely RB O
catch VB O
the DT O
never RB O
completing VBG O
integration NN O
efforts NNS O
in IN O
the DT O
future NN O
. . O

Abbreviations NNS O

primary JJ O
community NN O
care NN O
network NN O
( : O
PCCN NNP O
) -RRB- O
; : O
Bureau NNP O
of IN O
National NNP O
Health NNP O
Insurance NNP O
( : O
BNHI NNP O
) -RRB- O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

BYJL NNP O
independently RB O
designed VBD O
and CC O
conducted VBD O
this DT O
study NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Recombinant JJ O
activated VBN O
protein NN O
C NN O
in IN O
sepsis NN O
: : O
endothelium NN O
protection NN O
or CC O
endothelium NN O
therapy NN O
? . O

Abstract JJ O

Endothelium NN O
dysfunction NN O
is VBZ O
one CD O
of IN O
the DT O
hallmarks NNS O
of IN O
sepsis NNS O
. . O

Looney NNP O
and CC O
Mattay NNP O
, , O
in IN O
the DT O
previous JJ O
issue NN O
of IN O
Critical NNP O
Care NNP O
, , O
highlight VBP O
the DT O
role NN O
of IN O
activated VBN O
protein NN O
C NNP O
( -LRB- O
APC NNP O
) -RRB- O
as IN O
a DT O
protective JJ O
endothelial JJ O
drug NN O
in IN O
septic JJ O
situations NNS O
. . O

Nevertheless RB O
, , O
the DT O
results NNS O
of IN O
in IN O
vivo NN O
studies NNS O
are VBP O
less RBR O
explicit JJ O
and CC O
it PRP O
remains VBZ O
uncertain JJ O
whether IN O
these DT O
properties NNS O
are VBP O
relevant JJ O
in IN O
human JJ B-Species
septic NN O
shock NN O
. . O

Before IN O
considering VBG O
recombinant JJ O
APC NNP O
( , O
rAPC NNP O
) -RRB- O
as IN O
a DT O
therapeutic JJ O
drug NN O
for IN O
the DT O
endothelium NN O
, , O
we PRP O
have VBP O
to TO O
demonstrate VB O
its PRP$ O
efficiency NN O
to TO O
protect VB O
or CC O
to TO O
reduce VB O
endothelium NN O
injury NN O
when WRB O
infused VBN O
a DT O
long JJ O
time NN O
after IN O
the DT O
septic NN O
challenge NN O
. . O

Nevertheless RB O
, , O
if IN O
rAPC NNP O
is VBZ O
efficient JJ O
when WRB O
infused VBN O
in IN O
the DT O
early JJ O
phase NN O
of IN O
septic NN O
challenge NN O
, , O
we PRP O
thus RB O
need VBP O
to TO O
treat VB O
our PRP$ O
patients NNS B-Species
earlier RBR O
. . O

At IN O
the DT O
least JJS O
, , O
genetically RB O
engineered VBN O
variants NNS O
have VBP O
been VBN O
designed VBN O
with IN O
greater JJR O
anti JJ O
- HYPH O
apoptotic JJ O
activity NN O
and CC O
reduced VBN O
anticoagulant JJ O
activity NN O
relative JJ O
to IN O
wild JJ O
- HYPH O
type NN O
APC NNP O
. . O

Further JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
demonstrate VB O
the DT O
usefulness NN O
of IN O
these DT O
variants NNS O
in IN O
septic NN O
shock NN O
therapy NN O
. . O

The DT O
use NN O
of IN O
recombinant JJ O
activated VBN O
protein NN O
C NNP O
( -LRB- O
rAPC NNP O
) -RRB- O
is VBZ O
one CD O
of IN O
the DT O
hottest JJS O
topics NNS O
in IN O
septic NN O
shock NN O
therapy NN O
. . O

The DT O
pivotal JJ O
phase NN O
3 CD O
placebo NN O
- HYPH O
controlled VBN O
Protein NNP O
C NNP O
Worldwide NNP O
Evaluation NNP O
in IN O
Severe NNP O
Sepsis NNP O
( -LRB- O
PROWESS NNP O
) -RRB- O
clinical JJ O
trial NN O
demonstrated VBD O
a DT O
19 CD O
. . O
4 CD O
% NN O
relative JJ O
risk NN O
reduction NN O
in IN O
28 CD O
- HYPH O
day NN O
mortality NN O
( : O
6 CD O
. . O
1 CD O
% NN O
absolute JJ O
risk NN O
reduction NN O
) -RRB- O
with IN O
an DT O
increased JJ O
risk NN O
( , O
3 CD O
. . O
5 CD O
% NN O
versus IN O
2 CD O
. . O
0 CD O
% NN O
) -RRB- O
of IN O
serious JJ O
bleeding NN O
events NNS O
compared VBN O
with IN O
placebo NN O
. . O

Two CD O
recent JJ O
and CC O
important JJ O
articles NNS O
have VBP O
highlighted VBN O
the DT O
role NN O
of IN O
APC NNP O
as IN O
a DT O
protective JJ O
endothelial JJ O
drug NN O
[ -LRB- O
1 CD O
] -RRB- O
and CC O
as IN O
a DT O
cyto NN O
- HYPH O
protective JJ O
drug NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Beneficial JJ O
effects NNS O
of IN O
rAPC NNP O
in IN O
the DT O
PROWESS NNP O
study NN O
were VBD O
thought VBN O
to TO O
be VB O
related VBN O
to IN O
a DT O
reduction NN O
in IN O
coagulation NN O
and CC O
, , O
to IN O
a DT O
lesser JJR O
extent NN O
, , O
to IN O
a DT O
reduction NN O
in IN O
inflammatory JJ O
response NN O
to IN O
sepsis NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Post NN O
- HYPH O
PROWESS NN O
investigations NNS O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
myriad NN O
of IN O
cellular JJ O
or CC O
animal NN O
studies NNS O
demonstrating VBG O
that IN O
rAPC NNP O
, , O
through IN O
reactions NNS O
mediated VBN O
by IN O
endothelial JJ O
protein NN O
C NN O
receptor NN O
and CC O
the DT O
effector NN O
receptor NN O
, , O
protease VBP O
activated VBN O
receptor NN O
- HYPH O
1 CD O
, , O
acts VBZ O
directly RB O
on IN O
cells NNS O
to TO O
exert VB O
multiple JJ O
cytoprotective JJ O
effects NNS O
including VBG O
: : O
down RB O
regulation NN O
of IN O
pro JJ O
- HYPH O
inflammatory JJ O
gene NN O
expression NN O
[ -LRB- O
4 CD O
] -RRB- O
; , O
anti JJ O
- HYPH O
inflammatory JJ O
activities NNS O
[ -LRB- O
5 CD O
] -RRB- O
; , O
anti JJ O
- HYPH O
apoptotic JJ O
activity NN O
[ -LRB- O
6 CD O
] -RRB- O
; , O
and CC O
protection NN O
of IN O
endothelial JJ O
barrier NN O
function NN O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

Endothelium NN O
dysfunction NN O
is VBZ O
one CD O
of IN O
the DT O
hallmarks NNS O
of IN O
sepsis NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Sepsis NNS O
, , O
per FW O
se FW O
, , O
may MD O
induce VB O
phenotypic JJ O
modulations NNS O
of IN O
the DT O
endothelium NN O
through IN O
direct JJ O
or CC O
indirect JJ O
interaction NN O
of IN O
the DT O
endothelial JJ O
layer NN O
with IN O
components NNS O
of IN O
the DT O
bacterial JJ O
wall NN O
, , O
inducing VBG O
a DT O
myriad NN O
of IN O
host NN O
- HYPH O
derived VBN O
factors NNS O
from IN O
endothelial JJ O
cells NNS O
. . O

Phenotypic JJ O
modifications NNS O
include VBP O
changes NNS O
in IN O
pro JJ O
- HYPH O
coagulant JJ O
and CC O
proadhesive JJ O
properties NNS O
, , O
increased VBN O
endothelial JJ O
permeability NN O
, , O
endothelial JJ O
cell NN O
apoptosis NN O
and CC O
changes NNS O
in IN O
vasomotor NN O
properties NNS O
; : O
the DT O
last JJ O
of IN O
these DT O
is VBZ O
crucial JJ O
since IN O
vasoplegia NN O
is VBZ O
directly RB O
related VBN O
to IN O
septic JJ O
shock NN O
mortality NN O
. . O

Recent JJ O
animal NN O
and CC O
human JJ B-Species
data NNS O
have VBP O
suggested VBN O
that IN O
rAPC NNP O
may MD O
improve VB O
both CC O
vascular JJ O
and CC O
myocardial JJ O
dysfunction NN O
and CC O
vascular JJ O
reactivity NN O
to IN O
catecholamine NN O
during IN O
endotoxin NN O
and CC O
/ SYM O
or CC O
septic NN O
challenge NN O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

From IN O
bench NN O
to IN O
bedside NN O

Experimental JJ O
evidence NN O
supports VBZ O
a DT O
role NN O
of IN O
APC NNP O
in IN O
maintaining VBG O
the DT O
integrity NN O
of IN O
the DT O
endothelium NN O
through IN O
both CC O
direct JJ O
and CC O
indirect JJ O
mechanisms NNS O
. . O

Nevertheless RB O
, , O
the DT O
results NNS O
of IN O
in IN O
vivo NN O
studies NNS O
are VBP O
less RBR O
explicit JJ O
. . O

In IN O
a DT O
retrospective JJ O
study NN O
of IN O
septic JJ O
shock NN O
in IN O
humans NNS B-Species
, , O
Monnet NNP O
and CC O
colleagues NNS O
[ -LRB- O
9 CD O
] -RRB- O
demonstrated VBD O
that IN O
APC NNP O
infusion NN O
was VBD O
associated VBN O
with IN O
a DT O
decrease NN O
in IN O
the DT O
amount NN O
of IN O
delivered VBN O
norepinephrine NN O
. . O

Wiel NNP O
and CC O
colleagues NNS O
[ -LRB- O
10 CD O
] -RRB- O
demonstrated VBD O
in IN O
a DT O
rabbit NN B-Species
model NN O
of IN O
endotoxin NN O
induced VBN O
shock NN O
that IN O
APC NNP O
decreased VBD O
aorta JJ O
endothelial JJ O
injury NN O
. . O

By IN O
contrast NN O
, , O
in IN O
a DT O
lung NN O
model NN O
of IN O
endotoxin NN O
induced VBN O
inflammation NN O
, , O
Robriquet NNP O
and CC O
colleagues NNS O
[ -LRB- O
11 CD O
] -RRB- O
demonstrated VBD O
a DT O
trend NN O
to IN O
an DT O
increased VBN O
vascular JJ O
permeability NN O
using VBG O
high JJ O
doses NNS O
of IN O
human JJ B-Species
APC NNP O
. . O

This DT O
last JJ O
result NN O
was VBD O
in IN O
sharp JJ O
contrast NN O
with IN O
the DT O
results NNS O
obtained VBN O
by IN O
Nick NNP O
and CC O
colleagues NNS O
[ -LRB- O
12 CD O
] -RRB- O
in IN O
a DT O
human JJ B-Species
model NN O
of IN O
pulmonary JJ O
endotoxin NN O
administration NN O
. . O

APC NNP O
appears VBZ O
to TO O
improve VB O
mortality NN O
in IN O
septic JJ O
shock NN O
with IN O
a DT O
high JJ O
APACHE NNP O
2 CD O
score NN O
and CC O
is VBZ O
potentially RB O
detrimental JJ O
in IN O
severe JJ O
sepsis NNS O
. . O

In IN O
rats NNS O
, , O
APC NNP O
markedly RB O
decreased VBD O
tumour NN O
necrosis NN O
factor NN O
concentrations NNS O
whereas IN O
they PRP O
remained VBD O
unchanged JJ O
in IN O
either CC O
human JJ B-Species
septic NN O
shock NN O
or CC O
endotoxemia NN O
. . O

The DT O
question NN O
arises VBZ O
, , O
therefore RB O
, , O
as IN O
to IN O
whether IN O
it PRP O
is VBZ O
truly RB O
possible JJ O
to TO O
reconcile VB O
all PDT O
these DT O
discrepancies NNS O
? . O

Moreover RB O
, , O
can MD O
these DT O
stirring VBG O
laboratory NN O
data NNS O
be VB O
translated VBN O
into IN O
clinical JJ O
practice NN O
? . O

Limitations NNS O
of IN O
experimental JJ O
studies NNS O
: : O
endothelium NN O
protection NN O
versus IN O
endothelium NN O
therapy NN O

Clearly RB O
, , O
in IN O
cellular JJ O
and CC O
animal NN O
models NNS O
, , O
rAPC NNP O
has VBZ O
been VBN O
given VBN O
either CC O
as IN O
a DT O
pre JJ O
- HYPH O
treatment NN O
or CC O
concurrent JJ O
with IN O
septic NN O
challenge NN O
. . O

This DT O
mode NN O
of IN O
administration NN O
favours VBZ O
the DT O
anti JJ O
- HYPH O
inflammatory JJ O
effects NNS O
of IN O
rAPC NNP O
, , O
which WDT O
are VBP O
particularly RB O
efficient JJ O
in IN O
murine NN B-Species
models NNS O
in IN O
protecting VBG O
the DT O
endothelium NN O
from IN O
cytokine NN O
- HYPH O
mediated VBN O
apoptosis NN O
or CC O
upregulation NN O
of IN O
endothelial JJ O
adhesion NN O
molecules NNS O
. . O

Thus RB O
, , O
studies NNS O
using VBG O
post NN O
- HYPH O
injury NN O
treatment NN O
are VBP O
needed VBN O
in IN O
models NNS O
that WDT O
mimic VBP O
septic JJ O
shock NN O
, , O
such JJ O
as IN O
experimental JJ O
pneumonia NN O
or CC O
peritonitis NN O
treated VBN O
by IN O
antibiotics NNS O
and CC O
volume NN O
resuscitation NN O
, , O
and CC O
where WRB O
the DT O
effects NNS O
of IN O
rAPC NNP O
would MD O
be VB O
investigated VBN O
16 CD O
to TO O
24 CD O
hours NNS O
after IN O
septic NN O
challenge NN O
. . O

If IN O
we PRP O
can MD O
demonstrate VB O
the DT O
efficiency NN O
of IN O
rAPC NNP O
to TO O
protect VB O
or CC O
to TO O
reduce VB O
endothelium NN O
injury NN O
in IN O
these DT O
conditions NNS O
, , O
we PRP O
can MD O
ultimately RB O
postulate VB O
that IN O
rAPC NNP O
is VBZ O
also RB O
a DT O
therapeutic JJ O
drug NN O
for IN O
the DT O
endothelium NN O
. . O

The DT O
earlier JJR O
the DT O
better JJR O

If IN O
rAPC NNP O
is VBZ O
efficient JJ O
when WRB O
infused VBN O
in IN O
the DT O
early JJ O
phase NN O
of IN O
septic NN O
challenge NN O
, , O
we PRP O
thus RB O
need VBP O
to TO O
treat VB O
our PRP$ O
patients NNS B-Species
earlier RBR O
. . O

At RB O
least RBS O
two CD O
studies NNS O
suggest VBP O
that IN O
treatment NN O
with IN O
rAPC NNP O
within IN O
24 CD O
hours NNS O
may MD O
carry VB O
a DT O
larger JJR O
survival NN O
advantage NN O
for IN O
patients NNS B-Species
with IN O
severe JJ O
sepsis NNS O
, , O
compared VBN O
with IN O
those DT O
treated VBN O
more JJR O
than IN O
24 CD O
hours NNS O
after IN O
organ NN O
dysfunction NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Interventions NNS O
directed VBN O
at IN O
specific JJ O
endpoints NNS O
, , O
when WRB O
initiated VBN O
early RB O
in IN O
the DT O
' `` O
golden JJ O
hours NNS O
' '' O
of IN O
a DT O
patient NN O
' POS O
s NN O
condition NN O
, , O
seem VBP O
to TO O
be VB O
promising JJ O
[ -LRB- O
14 CD O
] -RRB- O
. . O

The DT O
beneficial JJ O
effects NNS O
of IN O
earlier JJR O
administration NN O
of IN O
rAPC NNP O
to IN O
appropriate JJ O
patients NNS B-Species
may MD O
fit VB O
into IN O
this DT O
paradigm NN O
. . O

The DT O
future NN O

Extensive JJ O
in IN O
vivo NN O
and CC O
in FW O
vitro FW O
studies NNS O
have VBP O
focused VBN O
on IN O
the DT O
cytoprotective JJ O
effects NNS O
of IN O
APC NNP O
and CC O
most JJS O
authors NNS O
agree VBP O
that IN O
its PRP$ O
anticoagulant JJ O
and CC O
cytoprotective JJ O
effects NNS O
are VBP O
mediated VBN O
by IN O
distinct JJ O
APC NNP O
structural JJ O
features NNS O
. . O

Positively RB O
charged VBN O
residues NNS O
in IN O
surface NN O
loops NNS O
in IN O
the DT O
APC NNP O
protease NN O
domain NN O
have VBP O
been VBN O
identified VBN O
as IN O
participating VBG O
in IN O
the DT O
anticoagulant JJ O
activity NN O
but CC O
not RB O
in IN O
cellular JJ O
effects NNS O
. . O

Hence RB O
, , O
variants NNS O
have VBP O
been VBN O
designed VBN O
with IN O
greater JJR O
anti JJ O
- HYPH O
apoptotic JJ O
activity NN O
and CC O
reduced VBN O
anticoagulant JJ O
activity NN O
relative JJ O
to IN O
wild JJ O
- HYPH O
type NN O
APC NNP O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Whether IN O
these DT O
genetically RB O
engineered VBN O
variants NNS O
actually RB O
provide VBP O
superior JJ O
pharmacological JJ O
properties NNS O
remains VBZ O
to TO O
be VB O
elucidated VBN O
in IN O
vivo NN O
. . O

Such JJ O
investigations NNS O
may MD O
allow VB O
the DT O
design NN O
of IN O
therapeutic JJ O
APC NNP O
variants NNS O
with IN O
decreased VBN O
anticoagulant JJ O
activity NN O
to TO O
reduce VB O
the DT O
risk NN O
of IN O
bleeding NN O
on IN O
the DT O
one CD O
hand NN O
, , O
but CC O
also RB O
with IN O
normal JJ O
cytoprotective JJ O
properties NNS O
in IN O
order NN O
to TO O
retain VB O
full JJ O
beneficial JJ O
effects NNS O
on IN O
sepsis NN O
outcome NN O
. . O

Abbreviations NNS O

PROWESS NN O
= : O
Protein NN O
C NN O
Worldwide NN O
Evaluation NN O
in IN O
Severe JJ O
Sepsis NN O
; : O
rAPC NNP O
= SYM O
recombinant JJ O
activated VBN O
protein NN O
C NN O
. . O

Competing VBG O
interests NNS O

BL NNP O
has VBZ O
received VBN O
reimbursements NNS O
and CC O
funding NN O
from IN O
Eli NNP O
Lilly NNP O
, , O
France NNP O
. . O

Carbonic NNP O
Anhydrase NNP O
Inhibitors NNPS O
. . O

Part NN O
541 CD O
: : O
Metal NN O
Complexes NNS O
of IN O
Heterocyclic JJ O
Sulfonamides NN O
: : O
A DT O
New JJ O
Class NN O
of IN O
Antiglaucoma NNP O
Agents NNPS O

Abstract JJ O

Metal NN O
complexes NNS O
of IN O
heterocyclic JJ O
sulfonamides NNS O
possessing VBG O
carbonic JJ O
anhydrase NN O
( , O
CA NN O
) -RRB- O
inhibitory NN O
properties NNS O
were VBD O
recently RB O
shown VBN O
to TO O
be VB O
useful JJ O
as IN O
intraocular JJ O
pressure NN O
( -LRB- O
IOP NN O
) , O
lowering VBG O
agents NNS O
in IN O
experimental JJ O
animals NNS O
, , O
and CC O
might MD O
be VB O
developed VBN O
as IN O
a DT O
novel JJ O
class NN O
of IN O
antiglaucoma NN O
drugs NNS O
. . O

Here RB O
we PRP O
report VBP O
the DT O
synthesis NN O
of IN O
a DT O
heterocyclic JJ O
sulfonamide NN O
CA NN O
inhibitor NN O
and CC O
of IN O
the DT O
metal NN O
complexes NNS O
containing VBG O
main JJ O
group NN O
metal NN O
ions NNS O
, , O
such JJ O
as IN O
Be NNP O
( , O
II NNP O
) -RRB- O
, , O
Mg NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
Al NNP O
( , O
III NNP O
) -RRB- O
, , O
Zn NNP O
( , O
II NNP O
) -RRB- O
, , O
Cd NNP O
( , O
II NNP O
) -RRB- O
and CC O
Hg NNP O
( , O
II NNP O
) -RRB- O
and CC O
the DT O
new JJ O
sulfonamide NN O
as RB O
well RB O
as IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
as IN O
ligands NNS O
. . O

The DT O
new JJ O
complexes NNS O
were VBD O
characterized VBN O
by IN O
standard JJ O
physico NN O
- HYPH O
chemical NN O
procedures NNS O
, , O
and CC O
assayed VBN O
as IN O
inhibitors NNS O
of IN O
three CD O
CA NN O
isozymes NNS O
, , O
CA NN O
I NN O
, , O
II NNP O
and CC O
IV NN O
. . O

Some DT O
of IN O
them PRP O
( , O
but CC O
not RB O
the DT O
parent NN O
sulfonamides NNS O
) , O
strongly RB O
lowered VBD O
IOP NNP O
in IN O
rabbits NNS B-Species
when WRB O
administered VBN O
as IN O
a DT O
2 CD O
% NN O
solution NN O
into IN O
the DT O
eye NN O
. . O

CARBONIC NNP O
ANHYDRASE NNP O
INHIBITORS NNS O
. . O

Part NN O
54 CD O
METAL NN O
COMPLEXES NNS O
OF IN O
HETEROCYCLIC JJ O
SULFONAMIDES NNS O
: : O
A DT O
NEW JJ O
CLASS NN O
OF IN O
ANTIGLAUCOMA NNP O
AGENTS NNS O
Claudiu NNP O
T NNP O
. . O

Supuran NNP O
* NFP O
, , O
Andrea NNP O
Scozzafava NNP O

and CC O
Andrei NNP O
Jitianu NNP O
2 CD O

Universit NNP O
& CC O
degli NN O
Studi NNP O
, , O
Dipartimento NNP O
di FW O
Chimica NNP O
, , O
Laboratorio NNP O
di FW O
Chimica NNP O
Inorganica NNP O
e , O
Bioinorganica NNP O
, , O
Via NNP O
Gino NNP O
Capponi NNP O
7 CD O
, , O
1 CD O
- HYPH O
50121 CD O
, , O
Florence NNP O
, , O
Italy NNP O
2 CD O
"""" '' O
I PRP O
. . O
G NNP O
. . O

Murgulescu NNP O
"""" `` O
Institute NNP O
of IN O
Physical NNP O
Chemistry NNP O
, , O
Academia NNP O
Romana NNP O
, , O
Spl NNP O
. . O

Independentei NNP O
202 CD O
, , O
R NNP O
- HYPH O
77208 CD O
Bucharest NNP O
, , O
Roumania NNP O
Abstract NNP O
: : O
Metal JJ O
complexes NNS O
of IN O
heterocyclic JJ O
sulfonamides NNS O
possessing VBG O
carbonic JJ O
anhydrase NN O
( , O
CA NN O
) , O
inhibitory NN O
properties NNS O
were VBD O
recently RB O
shown VBN O
to TO O
be VB O
useful JJ O
as IN O
intraocular JJ O
pressure NN O
( -LRB- O
IOP NN O
) , O
lowering VBG O
agents NNS O
in IN O
experimental JJ O
animals NNS O
, , O
and CC O
might MD O
be VB O
developed VBN O
as IN O
a DT O
novel JJ O
class NN O
of IN O
antiglaucoma NN O
drugs NNS O
. . O

Here RB O
we PRP O
report VBP O
the DT O
synthesis NN O
of IN O
a DT O
heterocyclic JJ O
sulfonamide NN O
CA NN O
inhibitor NN O
and CC O
of IN O
the DT O
metal NN O
complexes NNS O
containing VBG O
main JJ O
group NN O
metal NN O
ions NNS O
, , O
such JJ O
as IN O
Be NNP O
( , O
II NNP O
) -RRB- O
, , O
Mg NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
AI NNP O
( , O
III NNP O
) -RRB- O
, , O
Zn NNP O
( , O
II NNP O
) -RRB- O
, , O
Cd NNP O
( , O
II NNP O
) -RRB- O
and CC O
Hg NNP O
( , O
II NNP O
) -RRB- O
and CC O
the DT O
new JJ O
sulfonamide NN O
as RB O
well RB O
as IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
l NN O
, , O
3 CD O
, , O
4thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
as IN O
ligands NNS O
. . O

The DT O
new JJ O
complexes NNS O
were VBD O
characterized VBN O
by IN O
standard JJ O
physico NN O
- HYPH O
chemical NN O
procedures NNS O
, , O
and CC O
assayed VBN O
as IN O
inhibitors NNS O
of IN O
three CD O
CA NN O
isozymes NNS O
, , O
CA NN O
I NN O
, , O
II NNP O
and CC O
IV NN O
. . O

Some DT O
of IN O
them PRP O
( , O
but CC O
not RB O
the DT O
parent NN O
sulfonamides NNS O
) , O
strongly RB O
lowered VBD O
IOP NNP O
in IN O
rabbits NNS B-Species
when WRB O
administered VBN O
as IN O
a DT O
2 CD O
% NN O
solution NN O
into IN O
the DT O
eye NN O
. . O

Introduction NN O
Sulfonamides NNS O
possessing VBG O
carbonic JJ O
anhydrase NN O
( , O
CA NN O
, , O
EC NN O
4 CD O
. . O
2 CD O
. . O
1 CD O
. . O
1 CD O
) -RRB- O
inhibitory JJ O
properties NNS O
[ -LRB- O
2 CD O
] -RRB- O
such JJ O
as IN O
acetazolamide NN O
1 CD O
, , O
methazolamide NN O
2 CD O
, , O
ethoxzolamide NN O
3 CD O
and CC O
dichlorophenamide NN O
4 CD O
have VBP O
been VBN O
used VBN O
for IN O
more JJR O
than IN O
40 CD O
years NNS O
as IN O
pressure NN O
lowering VBG O
systemic JJ O
drugs NNS O
in IN O
the DT O
treatment NN O
of IN O
open JJ O
- HYPH O
angle NN O
glaucoma NN O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

Their PRP$ O
effect NN O
is VBZ O
due JJ O
to IN O
inhibition NN O
of IN O
at RB O
least RBS O
two CD O
CA NN O
isozymes NNS O
present JJ O
within IN O
cilliary JJ O
processes NNS O
of IN O
the DT O
eye NN O
, , O
ie NN O
, , O
CA NN O
II NN O
and CC O
CA NN O
IV NN O
, , O
which WDT O
is VBZ O
followed VBN O
by IN O
lowered VBN O
bicarbonate NN O
formation NN O
and CC O
reduction NN O
of IN O
aqueous JJ O
humor NN O
secretion NN O
[ -LRB- O
5 CD O
- SYM O
7 CD O
] -RRB- O
. . O

Their PRP$ O
main JJ O
drawback NN O
is VBZ O
constituted VBN O
by IN O
side NN O
effects NNS O
such JJ O
as IN O
fatigue NN O
, , O
augmented VBN O
diuresis NN O
, , O
or CC O
paresthesias NNS O
, , O
due IN O
to IN O
CA NN O
inhibition NN O
in IN O
other JJ O
tissues NNS O
/ SYM O
organs NNS O
than IN O
the DT O
target NN O
one CD O
, , O
ie RB O
, , O
the DT O
eye NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

N NFP O
- HYPH O
- HYPH O
N NN O

XN NNP O
- HYPH O
- HYPH O
N NNP O
EtO NNP O
S NN O

NH NN O
2 CD O

O UH O

NH NN O
O NN O
: : O
S NFP O
- HYPH O
- : O
- : O
- HYPH O
O NN O

NHEt NNP O

The DT O
above RB O
- HYPH O
mentioned VBN O
side NN O
effects NNS O
are VBP O
absent JJ O
in IN O
the DT O
case NN O
in IN O
which WDT O
the DT O
inhibitor NN O
has VBZ O
topical JJ O
activity NN O
, , O
and CC O
is VBZ O
applied VBN O
directly RB O
into IN O
the DT O
eye NN O
. . O

This DT O
route NN O
has VBZ O
been VBN O
demonstrated VBN O
only RB O
in IN O
1983 CD O
by IN O
Maren NNP O
' POS O
s NNP O
group NN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
was VBD O
followed VBN O
by IN O
the DT O
development NN O
of IN O
the DT O
first JJ O
clinical JJ O
agent NN O
of IN O
this DT O
type NN O
, , O
dorzolamide NN O
5 CD O
[ SYM O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Dorzolamide NNP O
( : O
Trusopt NNP O
) -RRB- O
has VBZ O
been VBN O
introduced VBN O
in IN O
clinical JJ O
use NN O
in IN O
1995 CD O
in IN O
USA NNP O
and CC O
Europe NNP O
and CC O
it PRP O
constituted VBD O
the DT O
beginning NN O
of IN O
a DT O
radically RB O
new JJ O
treatment NN O
of IN O
glaucoma NN O
, , O
devoid JJ O
of IN O
the DT O
severe JJ O
side NN O
effects NNS O
observed VBN O
with IN O
the DT O
systemic JJ O
inhibitors NNS O
[ -LRB- O
4 CD O
- SYM O
6 CD O
] -RRB- O
. . O

The DT O
success NN O
of IN O
topical JJ O
antiglaucoma NN O
CA NN O
inhibitors NNS O
fostered VBD O
much JJ O
research NN O
in IN O
the DT O
synthesis NN O
and CC O
clinical JJ O
evaluation NN O
of IN O
other JJ O
types NNS O
of IN O
such JJ O
compounds NNS O
[ -LRB- O
12 CD O
- SYM O
15 CD O
] -RRB- O
. . O

307 CD O

Vol NNP O
. . O

4 CD O
, , O
No UH O
. . O
6 CD O
, , O
1997 CD O

Metal NN O
Complexes NNS O
of IN O
Heterocyclic JJ O
Sulfonamides NN O
: : O
A DT O
New JJ O
Class NN O
ofAntiglaucoma NN O
Agents NNS O

On IN O
the DT O
other JJ O
hand NN O
, , O
metal NN O
complexes NNS O
of IN O
heterocyclic JJ O
sulfonamides NNS O
of IN O
type NN O
1 CD O
- HYPH O
5 CD O
have VBP O
been VBN O
recently RB O
prepared VBN O
by IN O
two CD O
groups NNS O
16 CD O
- SYM O
20 CD O
] -RRB- O
, , O
and CC O
it PRP O
was VBD O
proved VBN O
that IN O
they PRP O
possess VBP O
much RB O
stronger JJR O
CA NN O
inhibitory JJ O
properties NNS O
than IN O
the DT O
sulfonamides NNS O
from IN O
which WDT O
they PRP O
were VBD O
prepared VBN O
18 CD O
- SYM O
22 CD O
] -RRB- O
. . O

Although IN O
the DT O
mechanism NN O
of IN O
CA NN O
inhibition NN O
of IN O
the DT O
metal NN O
complexes NNS O
is VBZ O
presently RB O
unknown JJ O
, , O
it PRP O
was VBD O
hypothesized VBN O
that IN O
their PRP$ O
increased VBN O
inhibitory JJ O
power NN O
might MD O
be VB O
due IN O
to IN O
two CD O
processes NNS O
, , O
occurring VBG O
separately RB O
or CC O
in IN O
concert NN O
, , O
ie FW O
, , O
( , O
i PRP O
) -RRB- O
dissociation NN O
of IN O
the DT O
complex JJ O
inhibitor NN O
in IN O
sulfonamide NN O
anions NNS O
and CC O
metal NN O
ions NNS O
( , O
in IN O
diluted VBN O
solution NN O
) -RRB- O
, , O
which WDT O
in IN O
turn NN O
both DT O
interact VBP O
thereafter RB O
with IN O
the DT O
enzyme NN O
, , O
at IN O
different JJ O
binding NN O
sites NNS O
, , O
and CC O
( , O
ii FW O
) -RRB- O
direct JJ O
interaction NN O
of IN O
the DT O
undissociated JJ O
complex NN O
with IN O
the DT O
enzyme NN O
, , O
and CC O
more RBR O
specifically RB O
with IN O
the DT O
hydrophilic JJ O
patch NN O
at IN O
the DT O
entrance NN O
of IN O
CA NN O
II NN O
active JJ O
site NN O
[ -LRB- O
23 CD O
] -RRB- O
, , O
this DT O
being VBG O
the DT O
isozyme NN O
most RBS O
susceptible JJ O
to IN O
inhibition NN O
with IN O
this DT O
class NN O
of IN O
compounds NNS O
[ -LRB- O
2 CD O
, , O
22 CD O
] -RRB- O
. . O

Whether IN O
initially RB O
the DT O
first JJ O
mechanism NN O
of IN O
action NN O
mentioned VBN O
above RB O
was VBD O
favored VBN O
by IN O
us PRP O
[ -LRB- O
22 CD O
] -RRB- O
, , O
recent JJ O
evidences NNS O
suggested VBD O
that IN O
the DT O
undissociated JJ O
complex NN O
might MD O
be VB O
the DT O
inhibitory JJ O
species NN O
, , O
at IN O
least JJS O
for IN O
some DT O
isozymes NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Since IN O
metal NN O
complexes NNS O
are VBP O
much RB O
more RBR O
inhibitory JJ O
than IN O
the DT O
parent NN O
sulfonamide NN O
from IN O
which WDT O
they PRP O
were VBD O
prepared VBN O
, , O
it PRP O
appeared VBD O
of IN O
interest NN O
to TO O
test VB O
whether IN O
this DT O
property NN O
might MD O
be VB O
useful JJ O
for IN O
their PRP$ O
use NN O
in IN O
lowering VBG O
IOP NN O
in IN O
experimental JJ O
animals NNS O
and CC O
whence RB O
as IN O
a DT O
possible JJ O
glaucoma NN O
therapy NN O
. . O

Recently RB O
we PRP O
proved VBD O
[ -LRB- O
25 CD O
, , O
26 CD O
] -RRB- O
that IN O
some DT O
metal NN O
complexes NNS O
of IN O
heterocyclic JJ O
sulfonamides NNS O
( , O
which WDT O
themselves PRP O
do VBP O
not RB O
possess VB O
IOP NNP O
lowering VBG O
properties NNS O
) -RRB- O
act VBP O
as IN O
very RB O
powerful JJ O
such JJ O
agents NNS O
when WRB O
administered VBN O
as IN O
diluted VBN O
solutions NNS O
directly RB O
into IN O
the DT O
eye NN O
of IN O
experimental JJ O
animals NNS O
, , O
and CC O
would MD O
thus RB O
offer VB O
the DT O
possibility NN O
of IN O
developing VBG O
such JJ O
totally RB O
novel JJ O
drugs NNS O
. . O

Here RB O
we PRP O
report VBP O
the DT O
synthesis NN O
of IN O
a DT O
heterocyclic JJ O
sulfonamide NN O
possessing VBG O
strong JJ O
CA NN O
inhibitory NN O
properties NNS O
, , O
ie IN O
, , O
5 CD O
- HYPH O
( , O
chloroacetamido NN O
) NFP O
- HYPH O
l NN O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
, , O
and CC O
of IN O
the DT O
metal NN O
complexes NNS O
of IN O
this DT O
sulfonamide NN O
and CC O
of IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
, , O
containing VBG O
some DT O
main JJ O
group NN O
metal NN O
ions NNS O
. . O

The DT O
new JJ O
compounds NNS O
have VBP O
been VBN O
characterized VBN O
by IN O
standard JJ O
physico NN O
- HYPH O
chemical NN O
procedures NNS O
, , O
and CC O
were VBD O
assayed VBN O
as IN O
inhibitors NNS O
of IN O
three CD O
CA NN O
isozymes NNS O
, , O
hCA NNP O
I NNP O
, , O
hCA NN O
II NN O
and CC O
bCA NN O
IV NN O
( , O
h CD O
human NN B-Species
; : O
b NN O
bovine NN B-Species
; : O
these DT O
are VBP O
the DT O
isozymes NNS O
considered VBN O
to TO O
play VB O
a DT O
critical JJ O
role NN O
in IN O
aqueous JJ O
humour NN O
secretion NN O
within IN O
the DT O
eye NN O
of IN O
higher JJR O
vertebrates NNS O
[ -LRB- O
2 CD O
- SYM O
5 CD O
] -RRB- O
) -RRB- O
. . O

Materials NNS O
and CC O
Methods NNS O

Melting NN O
points NNS O
were VBD O
recorded VBN O
with IN O
a DT O
heating NN O
plate NN O
microscope NN O
and CC O
are VBP O
not RB O
corrected VBN O
. . O

IR NNP O
spectra NN O
were VBD O
recorded VBN O
in IN O
KBr NNP O
pellets NNS O
with IN O
a DT O
Carl NNP O
Zeiss NNP O
IR NNP O
- HYPH O
80 CD O
instrument NN O
. . O

1H NN O
- HYPH O
NMR NNP O
spectra NN O
were VBD O
recorded VBN O
in IN O
DMSO NNP O
- HYPH O
d6 CD O
as IN O
solvent JJ O
, , O
with IN O
a DT O
Bruker NNP O
CPX200 NNP O
instrument NN O
. . O

Chemical JJ O
shifts NNS O
are VBP O
reported VBN O
as IN O
values NNS O
, , O
relative JJ O
to IN O
Me4Si NNP O
as IN O
internal JJ O
standard NN O
. . O

Conductimetric JJ O
measurements NNS O
were VBD O
done VBN O
at IN O
room NN O
temperature NN O
( : O
1 CD O
mM NN O
concentration NN O
of IN O
complex NN O
) , O
in IN O
DMSO NNP O
solution NN O
with IN O
a DT O
Fisher NNP O
conductimeter NN O
. . O

Elemental JJ O
analyses NNS O
were VBD O
done VBN O
by IN O
combustion NN O
for IN O
C NNP O
, , O
H NNP O
, , O
N NNP O
with IN O
an DT O
automated JJ O
Carlo NNP O
Erba NNP O
analyzer NN O
, , O
and CC O
gravimetrically RB O
for IN O
the DT O
metal NN O
ions NNS O
, , O
and CC O
were VBD O
0 CD O
. . O
4 CD O
% NN O
of IN O
the DT O
theoretical JJ O
values NNS O
. . O

Thermogravimetric JJ O
measurements NNS O
were VBD O
done VBN O
in IN O
air NN O
, , O
at IN O
a DT O
heating NN O
rate NN O
of IN O
10C CD O
/ SYM O
min NN O
. . O
, , O
with IN O
a DT O
Perkin NNP O
Elmer NNP O
3600 CD O
thermobalance NN O
. . O

Sulfonamides NNP O
used VBD O
as IN O
standards NNS O
in IN O
the DT O
enzymatic JJ O
assay NN O
( , O
except IN O
for IN O
5 CD O
) -RRB- O
, , O
acetazolamide NN O
, , O
pyridine NN O
, , O
and CC O
chloroacetyl NN O
chloride NN O
used VBN O
for IN O
the DT O
preparation NN O
of IN O
compound NN O
7 CD O
, , O
solvents NNS O
as RB O
well RB O
as IN O
inorganic JJ O
reagents NNS O
were VBD O
from IN O
Sigma NNP O
, , O
Merck NNP O
and CC O
Carlo NNP O
Erba NNP O
. . O

5 NNP O
- HYPH O
Amino NNP O
- HYPH O
l NNP O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
6 CD O
was VBD O
prepared VBN O
from IN O
acetazolamide NN O
by IN O
literature NN O
procedures NNS O
[ -LRB- O
27 CD O
] -RRB- O
, , O
by IN O
desacetylation NN O
with IN O
concentrated VBN O
hydrochloric JJ O
acid NN O
, , O
followed VBN O
by IN O
neutralization NN O
with IN O
sodium NN O
bicarbonate NN O
of IN O
the DT O
corresponding VBG O
hydrochloride NN O
( -LRB- O
Scheme NN O
1 CD O
) -RRB- O
. . O

Dorzolamide NNP O
hydrochloride NN O
5 CD O
was VBD O
from IN O
Merck NNP O
, , O
Sharp NNP O
and CC O
Dohme NNP O
or CC O
was VBD O
prepared VBN O
as IN O
described VBN O
by IN O
Ponticello NNP O
et FW O
al NNP O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Human JJ B-Species
CA NN O
and CC O
CA NN O
II NN O
cDNAs NNS O
were VBD O
expressed VBN O
in IN O
Escherichia NNP O
coli NN O
strain NN O
BL21 NNP O
( -LRB- O
DE3 NN O
) -RRB- O
from IN O
the DT O
plasmids NNS O
pACA NNP O
/ SYM O
hCA NNP O
I NNP O
and CC O
pACAdaCA NNP O
II NNP O
described VBN O
by IN O
Forsman NNP O
et FW O
al NNP O
. . O

[ -LRB- O
28 CD O
] -RRB- O
( , O
the DT O
two CD O
plasmids NNS O
were VBD O
a DT O
gift NN O
from IN O
Prof NNP O
. . O
Sven NNP O
Lindskog NNP O
, , O
Umea NNP O
University NNP O
, , O
Sweden NNP O
) -RRB- O
. . O

Cell NN O
growth NN O
conditions NNS O
were VBD O
those DT O
described VBN O
by IN O
Lindskog NNP O
' POS O
s NN O
group NN O
[ -LRB- O
29 CD O
] -RRB- O
, , O
and CC O
enzymes NNS O
were VBD O
purified VBN O
by IN O
affinity NN O
chromatography NN O
according VBG O
to IN O
the DT O
method NN O
of IN O
Khalifah NNP O
et FW O
al NNP O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Enzyme NN O
concentrations NNS O
were VBD O
determined VBN O
spectrophotometrical JJ O
at IN O
280 CD O
nm NN O
, , O
utilizing VBG O
a DT O
molar JJ O
absorptivity NN O
of IN O
49 CD O
mM NN O
- HYPH O
l NN O
. . O
cm NN O
- HYPH O
1 CD O
for IN O
hCA NN O
and CC O
54 CD O
mM NN O
- HYPH O
l NN O
. . O
cm NN O
- HYPH O
1 CD O
for IN O
hCA NN O
II CD O
, , O
respectively RB O
, , O
based VBN O
on IN O
M NNP O
28 CD O
. . O
85 CD O
kDa NN O
for IN O
hCA NNP O
I NNP O
, , O
and CC O
29 CD O
. . O
3 CD O
kDa NN O
for IN O
hCA NNP O
II CD O
, , O
respectively RB O
[ -LRB- O
31 CD O
, , O
32 CD O
] -RRB- O
. . O

bCA NNP O
IV NNP O
was VBD O
isolated VBN O
from IN O
bovine JJ B-Species
lung NN O
microsomes NNS O
as IN O
described VBN O
by IN O
Maren NNP O
et FW O
al NNP O
, , O
and CC O
its PRP$ O
concentration NN O
has VBZ O
been VBN O
determined VBN O
by IN O
titration NN O
with IN O
ethoxzolamide NN O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Synthesis NN O
of IN O
5 CD O
- HYPH O
( , O
chloroacetamido NN O
) NFP O
- HYPH O
l NN O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
7 CD O
An DT O
amount NN O
of IN O
1 CD O
. . O
80 CD O
g NN O
( SYM O
10 CD O
mmol NN O
) -RRB- O
of IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
6 CD O
was VBD O
suspended VBN O
in IN O
20 CD O
mL NN O
of IN O
anhydrous JJ O
acetonitrile NN O
and CC O
0 CD O
. . O
9 CD O
mL CD O
( SYM O
0 CD O
. . O
87g CD O
, , O
11 CD O
mmol NN O
) -RRB- O
of IN O
pyridine NN O
added VBN O
. . O

The DT O
mixture NN O
was VBD O
magnetically RB O
stirred VBN O
at IN O
4 CD O
C NN O
for IN O
10 CD O
minutes NNS O
, , O
then RB O
10 CD O
. . O
5 CD O
mmol NN O
of IN O
monochloroacetyl NN O
chloride NN O
, , O
dissolved VBN O
in IN O
3 CD O
mL NN O
acetonitrile NN O
, , O
were VBD O
added VBN O
dropwise JJ O
for IN O
5 CD O
min NN O
, , O
and CC O
stirring NN O
was VBD O
continued VBN O
for IN O
other JJ O
2 CD O
hours NNS O
at IN O
room NN O
temperature NN O
. . O

After IN O
an DT O
additional JJ O
30 CD O
min NN O
of IN O
refluxation NN O
, , O
followed VBN O
by IN O
cooling NN O
, , O
the DT O
precipitated VBN O
crystals NNS O
were VBD O
filtered VBN O
and CC O
recrystallized VBN O
from IN O
ethanol NN O
. . O

Yield NN O
of IN O
62 CD O
% NN O
white JJ O
crystals NNS O
, , O
mp FW O
246 CD O
- HYPH O
248 CD O
o CD O
lit NN O
[ -LRB- O
34 CD O
] -RRB- O
mp NN O
IR NN O
( , O
KBr NNP O
) -RRB- O
, , O
cm NN O
- HYPH O
l NN O
: : O
590 CD O
, , O
610 CD O
, , O
660 CD O
, , O
790 CD O
, , O
935 CD O
, , O
1090 CD O
, , O
1115 CD O
, , O
1170 CD O
, , O
1350 CD O
, , O
1400 CD O
, , O
1550 CD O
, , O
1650 CD O
, , O
1720 CD O
, , O
2870 CD O
, , O
3280 CD O
3370 CD O
( , O
broad JJ O
) -RRB- O
; : O
UV NN O
spectrum NN O
, , O
, , O
max NN O
, , O
nm NN O
( , O
lg NNP O
) -RRB- O
: : O
255 CD O
( SYM O
3 CD O
. . O
50 CD O
) -RRB- O
; : O
288 CD O
( SYM O
4 CD O
. . O
37 CD O
) SYM O
H NNP O
- HYPH O
NMR NNP O
( : O
DMSO NNP O
- HYPH O
d6 CD O
) -RRB- O
, , O
i CD O
, , O
ppm NN O
: : O
2 CD O
. . O
96 CD O
( , O
s NNS O
, , O
2H CD O
, , O
CH2 NNP O
) -RRB- O
; : O
8 CD O
. . O
20 CD O
( HYPH O
s NN O
, , O
2H CD O
, , O
SOzNH2 NNP O
) -RRB- O
; : O
12 CD O
. . O
22 CD O
( , O
s NN O
, , O
1H CD O
, , O
CONH NNP O
) -RRB- O
. . O

Analysis NN O
, , O
found VBN O
: : O
C NNP O
, , O
18 CD O
. . O
56 CD O
; : O
H NN O
, , O
1 CD O
. . O
88 CD O
; : O
N CD O
, , O
21 CD O
. . O
76 CD O
; : O
S NN O
, , O
24 CD O
. . O
62 CD O
% NN O
; : O
C4HsC1N403S2 NN O
requires VBZ O
"""" `` O
C NNP O
, , O
18 CD O
. . O
72 CD O
; : O
H NN O
, , O
1 CD O
. . O
96 CD O
; : O
N CD O
, , O
21 CD O
. . O
83 CD O
; : O
S NNP O
, , O
24 CD O
. . O
98 CD O
% NN O
. . O

General JJ O
procedure NN O
for IN O
the DT O
preparation NN O
of IN O
compounds NNS O
8 CD O
- SYM O
20 CD O
An DT O
amount NN O
of IN O
6 CD O
mmol NN O
of IN O
sodium NN O
salt NN O
of IN O
sulfonamides NN O
6 CD O
or CC O
7 CD O
was VBD O
prepared VBN O
by IN O
reacting VBG O
the DT O
corresponding VBG O
sulfonamide NN O
with IN O
the DT O
required VBN O
amount NN O
of IN O
an DT O
alcoholic JJ O
1N CD O
NaOH NNP O
solution NN O
, , O
in IN O
ethanol NN O
as IN O
solvent JJ O
. . O

To IN O
this DT O
308 CD O

Claudiu NNP O
T NNP O
. . O
Supuran NNP O
et FW O
al NNP O
. . O

Metal NN O
- HYPH O
Based VBN O
Drugs NNS O

solution NN O
was VBD O
added VBN O
the DT O
aqueous JJ O
metal NN O
salt NN O
( , O
Zn NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
Mg NNP O
( , O
II NNP O
) -RRB- O
, , O
AI NNP O
( , O
III NNP O
) -RRB- O
, , O
Cd NNP O
( , O
II NNP O
) -RRB- O
chlorides NNS O
, , O
and CC O
Be NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
Pb NN O
( , O
II NNP O
) -RRB- O
and CC O
Hg NNP O
( , O
II NNP O
) -RRB- O
nitrate NN O
) -RRB- O
solution NN O
, , O
working VBG O
in IN O
molar NN O
ratios NNS O
RSOzNH NNP O
- HYPH O
Mn NNP O
+ SYM O
of IN O
2 CD O
: : O
1 CD O
for IN O
the DT O
divalent JJ O
cations NNS O
and CC O
3 CD O
: SYM O
1 CD O
for IN O
the DT O
trivalent JJ O
cation NN O
, , O
respectively RB O
. . O

The DT O
aqueous JJ O
- HYPH O
alcoholic JJ O
reaction NN O
mixture NN O
was VBD O
heated VBN O
on IN O
a DT O
steam NN O
bath NN O
for IN O
one CD O
hour NN O
, , O
adjusting VBG O
the DT O
pH NN O
at IN O
7 CD O
if IN O
necessary JJ O
, , O
and CC O
after IN O
being VBG O
cooled VBN O
at IN O
0 CD O
C NN O
the DT O
precipitated JJ O
complexes NNS O
were VBD O
filtered VBN O
and CC O
thoroughly RB O
washed VBN O
with IN O
alcohol NN O
- HYPH O
water NN O
1 CD O
: SYM O
1 CD O
( HYPH O
v NN O
/ SYM O
v NN O
) -RRB- O
and CC O
air NN O
dried VBN O
. . O

Yields NNS O
were VBD O
in IN O
the DT O
range NN O
of IN O
85 CD O
- SYM O
90 CD O
% NN O
. . O

The DT O
obtained VBN O
white JJ O
powders NNS O
of IN O
compounds NNS O
8 CD O
- SYM O
20 CD O
melted VBD O
with IN O
decomposition NN O
at IN O
temperatures NNS O
higher JJR O
than IN O
350 CD O
C NNS O
, , O
and CC O
were VBD O
poorly RB O
soluble JJ O
in IN O
water NN O
and CC O
alcohol NN O
, , O
but CC O
had VBD O
good JJ O
solubilities NNS O
in IN O
DMSO NNP O
, , O
DMF NNP O
as RB O
well RB O
as IN O
mixtures NNS O
of IN O
DMSO NNP O
- HYPH O
water NN O
, , O
DMF NNP O
- HYPH O
water NN O
. . O

Pharmacology NN O
Carbonic JJ O
anhydrase NN O
inhibition NN O
Initial JJ O
rates NNS O
of IN O
4 CD O
- HYPH O
nitrophenyl NN O
acetate NN O
hydrolysis NN O
catalysed VBN O
by IN O
different JJ O
CA NN O
isozymes NNS O
were VBD O
monitored VBN O
spectrophotometrical JJ O
, , O
at IN O
400 CD O
rim NN O
, , O
with IN O
a DT O
Cary NNP O
3 CD O
instrument NN O
interfaced VBN O
with IN O
an DT O
IBM NNP O
compatible JJ O
PC NN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Solutions NNS O
of IN O
substrate NN O
were VBD O
prepared VBN O
in IN O
anhydrous JJ O
acetonitrile NN O
; : O
the DT O
substrate NN O
concentrations NNS O
varied VBD O
between IN O
2 CD O
. . O
10 CD O
- SYM O
2 CD O
and CC O
1 CD O
. . O
10 CD O
- SYM O
6 CD O
M NN O
, , O
working VBG O
at IN O
25C CD O
. . O

A DT O
molar NN O
absorption NN O
coefficient NN O
of IN O
18 CD O
, , O
400 CD O
M NN O
- HYPH O
l NN O
. . O
cm NN O
- HYPH O
1 CD O
was VBD O
used VBN O
for IN O
the DT O
4 CD O
- HYPH O
nitrophenolate NN O
formed VBN O
by IN O
hydrolysis NN O
, , O
in IN O
the DT O
conditions NNS O
of IN O
the DT O
experiments NNS O
( , O
pH NN O
7 CD O
. . O
40 CD O
) -RRB- O
, , O
as IN O
reported VBN O
in IN O
the DT O
literature NN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Non NN O
- HYPH O
enzymatic JJ O
hydrolysis NN O
rates NNS O
were VBD O
always RB O
subtracted VBN O
from IN O
the DT O
observed VBN O
rates NNS O
. . O

Duplicate NN O
experiments NNS O
were VBD O
done VBN O
for IN O
each DT O
inhibitor NN O
concentration NN O
, , O
and CC O
the DT O
values NNS O
reported VBN O
throughout IN O
the DT O
paper NN O
are VBP O
the DT O
mean NN O
of IN O
such JJ O
results NNS O
. . O

Stock NN O
solutions NNS O
of IN O
inhibitor NN O
( -LRB- O
1 CD O
mM NN O
) -RRB- O
were VBD O
prepared VBN O
in IN O
distilled VBN O
- HYPH O
deionized VBN O
water NN O
with IN O
1020 CD O
% NN O
( , O
v NN O
/ SYM O
v NN O
) SYM O
DMSO NNP O
( , O
which WDT O
is VBZ O
not RB O
inhibitory JJ O
at IN O
these DT O
concentrations NNS O
[ -LRB- O
2 CD O
] -RRB- O
) -RRB- O
and CC O
dilutions NNS O
up IN O
to IN O
0 CD O
. . O
1 CD O
nM CD O
were VBD O
done VBN O
thereafter RB O
with IN O
distilled VBN O
- HYPH O
deionized VBN O
water NN O
. . O

Inhibitor NN O
and CC O
enzyme NN O
solutions NNS O
were VBD O
preincubated VBN O
together RB O
for IN O
10 CD O
min NN O
at IN O
room NN O
temperature NN O
prior RB O
to IN O
assay NN O
, , O
in IN O
order NN O
to TO O
allow VB O
for IN O
the DT O
formation NN O
of IN O
the DT O
E NN O
- HYPH O
I NNP O
complex NN O
. . O

The DT O
inhibition NN O
constant JJ O
KI NNP O
was VBD O
determined VBN O
as IN O
described VBN O
by IN O
Pocket NNP O
and CC O
Stone NNP O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Enzyme NN O
concentrations NNS O
were VBD O
3 CD O
. . O
3 CD O
nM NN O
for IN O
hCA NNP O
II NNP O
, , O
l0 CD O
nM NN O
for IN O
hCA NN O
and CC O
34 CD O
nM NN O
for IN O
bCA NN O
IV NN O
( , O
this DT O
isozyme NN O
has VBZ O
a DT O
decreased VBN O
esterase NN O
activity NN O
[ -LRB- O
36 CD O
] -RRB- O
and CC O
higher JJR O
concentrations NNS O
had VBD O
to TO O
be VB O
used VBN O
for IN O
the DT O
- HYPH O
measurements NNS O
) -RRB- O
. . O

Measurement NN O
of IN O
tonometric JJ O
lOP NN O
Adult NN O
male JJ O
New NNP O
Zealand NNP O
albino NN O
rabbits NNS B-Species
weighing VBG O
2 CD O
- SYM O
3 CD O
kg NNS O
were VBD O
used VBN O
in IN O
the DT O
experiments NNS O
( , O
three CD O
animals NNS O
were VBD O
used VBN O
for IN O
each DT O
inhibitor NN O
studied VBN O
) -RRB- O
. . O

The DT O
experimental JJ O
procedures NNS O
conform VBP O
to IN O
the DT O
Association NNP O
for IN O
Research NNP O
in IN O
Vision NNP O
and CC O
Ophthalmology NNP O
Resolution NNP O
on IN O
the DT O
use NN O
of IN O
animals NNS O
. . O

The DT O
rabbits NNS B-Species
were VBD O
kept VBN O
in IN O
individual JJ O
cages NNS O
with IN O
food NN O
and CC O
water NN O
provided VBN O
ad NN O
libitum NN O
. . O

The DT O
animals NNS O
were VBD O
maintained VBN O
on IN O
a DT O
12 CD O
h NN O
: SYM O
12 CD O
h CD O
light NN O
/ SYM O
dark JJ O
cycle NN O
in IN O
a DT O
temperature NN O
controlled VBN O
room NN O
, , O
at IN O
22 CD O
- SYM O
26 CD O
C NN O
. . O

Solutions NNS O
of IN O
inhibitors NNS O
( : O
2 CD O
% NN O
, , O
by IN O
weight NN O
) -RRB- O
were VBD O
obtained VBN O
in IN O
DMSOwater NNP O
( : O
2 CD O
: SYM O
3 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
due IN O
to IN O
the DT O
low JJ O
water NN O
solubility NN O
of IN O
some DT O
of IN O
these DT O
derivatives NNS O
. . O

Control NN O
experiments NNS O
with IN O
DMSO NNP O
( , O
at IN O
the DT O
same JJ O
concentration NN O
as IN O
that DT O
used VBN O
for IN O
obtaining VBG O
the DT O
inhibitors NNS O
solutions NNS O
showed VBD O
that IN O
it PRP O
does VBZ O
not RB O
possess VB O
IOP NN O
lowering NN O
or CC O
increasing VBG O
effects NNS O
. . O

IOP NNP O
was VBD O
measured VBN O
using VBG O
a DT O
Digilab NNP O
30R NNP O
pneumatonometer NN O
( , O
BioRad NNP O
, , O
Cambridge NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
as IN O
described VBN O
by IN O
Maren NNP O
' POS O
s NNS O
group NN O
[ -LRB- O
37 CD O
- HYPH O
39 CD O
] -RRB- O
. . O

The DT O
pressure NN O
readings NNS O
were VBD O
matched VBN O
with IN O
two CD O
- HYPH O
point NN O
standard JJ O
pressure NN O
measurements NNS O
at IN O
least JJS O
twice RB O
each DT O
day NN O
using VBG O
a DT O
Digilab NNP O
Calibration NNP O
verifier NN O
. . O

All DT O
IOP NNP O
measurements NNS O
were VBD O
done VBN O
by IN O
the DT O
same JJ O
investigator NN O
with IN O
the DT O
same JJ O
tonometer NN O
. . O

One CD O
drop NN O
of IN O
0 CD O
. . O
2 CD O
% NN O
oxybuprocaine NN O
hydrochloride NN O
( HYPH O
novesine NN O
, , O
Sandoz NNP O
) -RRB- O
diluted VBN O
1 CD O
"""" '' O
1 CD O
with IN O
saline NN O
was VBD O
instilled VBN O
in IN O
each DT O
eye NN O
immediately RB O
before IN O
each DT O
set NN O
of IN O
pressure NN O
measurements NNS O
. . O

IOP NNP O
was VBD O
measured VBN O
three CD O
times NNS O
at IN O
each DT O
time NN O
interval NN O
, , O
and CC O
the DT O
means NNS O
reported VBN O
. . O

IOP NNP O
was VBD O
measured VBN O
first RB O
immediately RB O
before IN O
drug NN O
administration NN O
, , O
then RB O
at IN O
30 CD O
min NN O
after IN O
the DT O
instillation NN O
of IN O
the DT O
pharmacological JJ O
agent NN O
, , O
and CC O
then RB O
each DT O
30 CD O
minutes NNS O
for IN O
a DT O
period NN O
of IN O
several JJ O
hours NNS O
. . O

For IN O
all DT O
IOP NNP O
experiments NNS O
drug NN O
was VBD O
administered VBN O
to IN O
only RB O
one CD O
eye NN O
, , O
leaving VBG O
the DT O
contralateral JJ O
eye NN O
as IN O
an DT O
untreated JJ O
control NN O
. . O

The DT O
ocular JJ O
hypotensive JJ O
activity NN O
is VBZ O
expressed VBN O
as IN O
the DT O
average JJ O
difference NN O
in IN O
IOP NN O
between IN O
the DT O
treated VBN O
and CC O
control NN O
eye NN O
, , O
in IN O
this DT O
way NN O
minimizing VBG O
the DT O
diurnal JJ O
, , O
seasonal JJ O
and CC O
interindividual JJ O
variations NNS O
commonly RB O
observed VBN O
in IN O
the DT O
rabbit NN B-Species
[ -LRB- O
37 CD O
- SYM O
39 CD O
] -RRB- O
. . O

All DT O
data NNS O
are VBP O
expressed VBN O
as IN O
mean JJ O
SE NNP O
, , O
using VBG O
a DT O
one CD O
- HYPH O
tailed JJ O
test NN O
. . O

Results NNS O
and CC O
Discussion NN O
Reaction NN O
of IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
l NN O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
6 CD O
[ -LRB- O
19b NN O
] -RRB- O
with IN O
chloroacteyl NN O
chloride NN O
in IN O
the DT O
presence NN O
of IN O
pyridine NN O
afforded VBN O
5 CD O
- HYPH O
( , O
chloroacetamido NN O
) SYM O
- HYPH O
l NN O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
7 CD O
, , O
by IN O
the DT O
procedure NN O
already RB O
reported VBN O
by IN O
Young NNP O
et FW O
al JJ O
. . O

[ -LRB- O
34 CD O
] -RRB- O
( : O
Scheme NN O
1 CD O
) -RRB- O
. . O

The DT O
sulfonamide NN O
7 CD O
has VBZ O
been VBN O
characterized VBN O
by IN O
elemental JJ O
analysis NN O
and CC O
spectroscopic JJ O
methods NNS O
which WDT O
confirmed VBD O
its PRP$ O
structure NN O
( , O
only RB O
its PRP$ O
m UH O
. . O
p LS O
. . O
has VBZ O
been VBN O
reported VBN O
in IN O
ref NN O
. . O
[ -LRB- O
34 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
sodium NN O
salt NN O
of IN O
sulfonamides NNS O
6 CD O
and CC O
7 CD O
, , O
obtained VBN O
in IN O
situ NN O
from IN O
the DT O
corresponding VBG O
sulfonamide NN O
and CC O
sodium NN O
hydroxide NN O
, , O
were VBD O
then RB O
used VBN O
for IN O
the DT O
preparation NN O
of IN O
coordination NN O
compounds NNS O
, , O
containing VBG O
the DT O
following VBG O
metal NN O
ions NNS O
: : O
Be NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
Mg NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
Al NNP O
( , O
III NNP O
) -RRB- O
, , O
Zn NNP O
( -LRB- O
II NNP O
) -RRB- O
, , O
Cd NNP O
( , O
II NNP O
) -RRB- O
and CC O
Hg NNP O
( , O
II CD O
) -RRB- O
. . O

Mention NN O
should MD O
be VB O
made VBN O
that IN O
although IN O
5 CD O
- HYPH O
amino JJ O
- HYPH O
l JJ O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
6 CD O
is VBZ O
the DT O
parent NN O
compound NN O
of IN O
important JJ O
sulfonamide NN O
CA NN O
inhibitors NNS O
, , O
such JJ O
as IN O
acetazolamide NN O
, , O
benzolamide NN O
, , O
methazolamide NN O
, , O
etc FW O
. . O
, , O
its PRP$ O
coordination NN O
chemistry NN O
has VBZ O
been VBN O
scarcely RB O
investigated VBN O
up IN O
to IN O
now RB O
[ -LRB- O
22 CD O
, , O
40 CD O
] -RRB- O
. . O

The DT O
new JJ O
complexes NNS O
prepared VBN O
in IN O
this DT O
work NN O
are VBP O
shown VBN O
in IN O
Table NNP O
I NNP O
. , O
Both DT O
compounds NNS O
containing VBG O
the DT O
sulfonamide NN O
- HYPH O
deprotonated VBN O
species NNS O
of IN O
sulfonamide NN O
7 CD O
( , O
LH NNP O
) -RRB- O
, , O
as RB O
well RB O
as IN O
complexes NNS O
in IN O
which WDT O
the DT O
anion NN O
of IN O
5amino NNP O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
( : O
tda NN O
) -RRB- O
act VBP O
as IN O
ligands NNS O
, , O
have VBP O
been VBN O
prepared VBN O
. . O

In IN O
fact NN O
in IN O
another DT O
work NN O
[ -LRB- O
40 CD O
] -RRB- O
it PRP O
was VBD O
documented VBN O
that IN O
in IN O
some DT O
cases NNS O
, , O
sulfonamides NNS O
derived VBN O
from IN O
this DT O
ring NN O
system NN O
may MD O
undergo VB O
hydrolysis NN O
to IN O

309 CD O

Vol NNP O
. . O

4 CD O
, , O
No UH O
. . O
6 CD O
, , O
1997 CD O

Metal NN O
Complexes NNS O
of IN O
Heterocyclic NNP O
Sulfonamides NNP O
. . O
"""" '' O
A DT O
New NNP O
Class NNP O
ofAntiglaucoma NNP O
Agents NNPS O

the DT O
moiety NN O
substituting VBG O
the DT O
5 CD O
position NN O
, , O
with IN O
the DT O
formation NN O
of IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
l NN O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
6 CD O
, , O
which WDT O
thereafter RB O
coordinates VBZ O
metal NN O
ions NNS O
present JJ O
in IN O
solution NN O
. . O

N NN O
CIH NNP O
N NNP O

I PRP O

N NN O
+ SYM O
NaHCO NNP O
2 CD O

N NN O
2 CD O

S NNP O
' POS O

- : O
NaCl NNP O

I PRP O
S NN O

N NN O

II NNP O

SO2NH NNP O

1 CD O
_ SYM O
12 CD O
O NN O
Py NN O
/ SYM O
MeCN NNP O

6Htda NNP O
+ CC O
CIOCCH2CI NNP O

0 NFP O
Cl NN O
CH NN O
2 CD O
Scheme NN O
1 CD O

HN NNP O

. . O
I PRP O

N NN O

N NN O

S NN O
7 CD O
: : O
LH NNP O

II NNP O

SqNH NNP O

Thus RB O
, , O
the DT O
X NNP O
- HYPH O
ray NN O
crystal NN O
structure NN O
of IN O
the DT O
complex NN O
[ -LRB- O
Zn NNP O
( : O
tda NNP O
) -RRB- O
2 CD O
( , O
NH3 CD O
) -RRB- O
] -RRB- O
. , O
H20 CD O
prepared VBN O
in IN O
this DT O
way NN O
has VBZ O
recently RB O
been VBN O
reported VBN O
by IN O
this DT O
group NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
when WRB O
the DT O
ligand NN O
7 CD O
has VBZ O
not RB O
been VBN O
hydrolyzed VBN O
( , O
during IN O
the DT O
preparation NN O
of IN O
the DT O
coordination NN O
compounds NNS O
) , O
in IN O
the DT O
presence NN O
of IN O
the DT O
metal NN O
ion NN O
to IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
l NN O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2sulfonamide NN O
and CC O
chloroacetate NN O
, , O
the DT O
metal NN O
complexes NNS O
contining VBG O
6 CD O
as IN O
ligand NN O
have VBP O
been VBN O
prepared VBN O
from IN O
the DT O
last JJ O
( , O
pure JJ O
) , O
compound NN O
( , O
as IN O
sodium NN O
salt NN O
) -RRB- O
and CC O
the DT O
corresponding VBG O
metal NN O
salt NN O
, , O
by IN O
the DT O
general JJ O
procedure NN O
described VBN O
in IN O
the DT O
Experimental JJ O
part NN O
. . O

Table NNP O
I NNP O
: : O
Prepared JJ O
complexes NNS O
8 CD O
- HYPH O
20 CD O
, , O
containing VBG O
the DT O
conjugate JJ O
bases NNS O
of IN O
sulfonamides NNS O
6 CD O
and CC O
7 CD O
as IN O
ligands NNS O
and CC O
their PRP$ O
elemental JJ O
analysis NN O
data NNS O
. . O

L NNP O
stands VBZ O
for IN O
the DT O
sulfonamide NN O
deprotonated VBN O
species NN O
of IN O
7 CD O
, , O
whereas IN O
tda NN O
for IN O
the DT O
sulfonamide NN O
deprotonated VBN O
species NNS O
of IN O
5 CD O
- HYPH O
amino NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
6 CD O
. . O

No UH O
. . O
8 CD O
9 CD O
10 CD O
11 CD O
12 CD O
13 CD O
14 CD O
15 CD O
16 CD O
17 CD O
18 CD O
19 CD O
20 CD O

Complex NN O

Yield NN O

( : O
% NN O
) -RRB- O

% UH O
Ma NNP O

Analysis NN O
( , O
calculated VBN O
/ SYM O
found VBN O
) NFP O
% NN O
H NN O
b NN O
% NN O
C NN O
b NN O
13 CD O
. . O
0 CD O
/ SYM O
13 CD O
. . O
1 CD O
11 CD O
. . O
0 CD O
/ SYM O
10 CD O
. . O
8 CD O
11 CD O
. . O
3 CD O
/ SYM O
11 CD O
. . O
4 CD O
10 CD O
. . O
2 CD O
/ SYM O
10 CD O
. . O
1 CD O
8 CD O
. . O
5 CD O
/ SYM O
8 CD O
. . O
1 CD O
7 CD O
. . O
9 CD O
/ SYM O
7 CD O
. . O
9 CD O
12 CD O
. . O
7 CD O
/ SYM O
12 CD O
. . O
8 CD O
18 CD O
. . O
4 CD O
/ SYM O
18 CD O
. . O
1 CD O
18 CD O
. . O
1 CD O
/ SYM O
17 CD O
. . O
9 CD O
16 CD O
. . O
6 CD O
/ SYM O
16 CD O
. . O
2 CD O
15 CD O
. . O
3 CD O
/ SYM O
14 CD O
. . O
9 CD O
13 CD O
. . O
4 CD O
/ SYM O
13 CD O
. . O
3 CD O
12 CD O
. . O
7 CD O
/ SYM O
12 CD O
. . O
5 CD O
1 CD O
. . O
6 CD O
/ SYM O
1 CD O
. . O
3 CD O
2 CD O
. . O
7 CD O
/ SYM O
2 CD O
. . O
3 CD O
1 CD O
. . O
4 CD O
/ SYM O
1 CD O
. . O
1 CD O
1 CD O
. . O
2 CD O
/ SYM O
1 CD O
. . O
2 CD O
1 CD O
. . O
0 CD O
/ SYM O
1 CD O
. . O
2 CD O
1 CD O
. . O
6 CD O
/ SYM O
1 CD O
. . O
3 CD O
1 CD O
. . O
6 CD O
/ SYM O
1 CD O
. . O
6 CD O
1 CD O
. . O
5 CD O
/ SYM O
1 CD O
. . O
5 CD O
1 CD O
. . O
5 CD O
/ SYM O
1 CD O
. . O
3 CD O
1 CD O
. . O
3 CD O
/ SYM O
1 CD O
. . O
4 CD O
1 CD O
. . O
2 CD O
/ SYM O
1 CD O
. . O
1 CD O
1 CD O
. . O
1 CD O
/ SYM O
1 CD O
. . O
2 CD O
1 CD O
. . O
0 CD O
/ SYM O
1 CD O
. . O
0 NFP O

% NN O
N NN O
b NN O
30 CD O
. . O
4 CD O
/ SYM O
30 CD O
. . O
2 CD O
25 CD O
. . O
6 CD O
/ SYM O
25 CD O
. . O
5 CD O
26 CD O
. . O
4 CD O
/ SYM O
26 CD O
. . O
4 CD O
13 CD O
. . O
7 CD O
/ SYM O
23 CD O
. . O
3 CD O
20 CD O
. . O
0 CD O
/ SYM O
19 CD O
. . O
8 CD O
18 CD O
. . O
6 CD O
/ SYM O
18 CD O
. . O
5 CD O
29 CD O
. . O
7 CD O
/ SYM O
29 CD O
. . O
6 CD O
21 CD O
. . O
5 CD O
/ SYM O
21 CD O
. . O
3 CD O
21 CD O
. . O
1 CD O
/ SYM O
20 CD O
. . O
8 CD O
19 CD O
. . O
4 CD O
/ SYM O
19 CD O
. . O
3 CD O
17 CD O
. . O
9 CD O
/ SYM O
17 CD O
. . O
8 CD O
15 CD O
. . O
7 CD O
/ SYM O
15 CD O
. . O
6 CD O
14 CD O
. . O
8 CD O
/ SYM O
14 CD O
. . O
6 CD O

[ -LRB- O
Be VB O
( : O
tda NNP O
) SYM O
2 CD O
] -RRB- O
[ -LRB- O
Mg NNP O
( HYPH O
tda NNP O
) SYM O
2 CD O
] -RRB- O
. . O
3 CD O
H20 CD O
[ -LRB- O
Zn NNP O
( : O
tda NNP O
) SYM O
2 CD O
] -RRB- O
[ -LRB- O
Cd NN O
( : O
tda NNP O
) SYM O
2 CD O
] -RRB- O
[ -LRB- O
Hg NNP O
( , O
tda CD O
) SYM O
2 CD O
] -RRB- O
[ -LRB- O
Pb NN O
( : O
tda NNP O
) -RRB- O
z NNP O
( : O
OH2 CD O
) SYM O
2 CD O
] -RRB- O
[ -LRB- O
Al NNP O
( HYPH O
tda NNP O
) SYM O
3 CD O
] -RRB- O
[ -LRB- O
BeL2 NNP O
] -RRB- O
[ -LRB- O
ALL3 NNP O
] -RRB- O
[ -LRB- O
ZnL2 NNP O
] -RRB- O
[ -LRB- O
CdL2 NNP O
] -RRB- O
[ -LRB- O
HgL2 NNP O
] -RRB- O
[ -LRB- O
PbLz NNP O
( , O
OH2 NNP O
) -RRB- O
2 CD O
] -RRB- O

78 CD O
76 CD O
83 CD O
90 CD O
95 CD O
84 CD O
72 CD O
75 CD O
59 CD O
87 CD O
88 CD O
92 CD O
95 CD O

2 LS O
. . O
4 CD O
/ SYM O
2 CD O
. . O
5 CD O
5 CD O
. . O
5 CD O
/ SYM O
5 CD O
. . O
1 CD O
15 CD O
. . O
4 CD O
/ SYM O
15 CD O
. . O
0 CD O
23 CD O
. . O
8 CD O
/ SYM O
24 CD O
. . O
1 CD O
35 CD O
. . O
8 CD O
/ SYM O
35 CD O
. . O
7 CD O
34 CD O
. . O
4 CD O
/ SYM O
34 CD O
. . O
7 CD O
4 CD O
. . O
7 CD O
/ SYM O
4 CD O
. . O
4 CD O
1 CD O
. . O
7 CD O
/ SYM O
1 CD O
. . O
6 CD O
3 CD O
. . O
4 CD O
/ SYM O
3 CD O
. . O
5 CD O
11 CD O
. . O
3 CD O
/ SYM O
11 CD O
. . O
5 CD O
18 CD O
. . O
0 CD O
/ SYM O
18 CD O
. . O
1 CD O
28 CD O
. . O
1 CD O
/ SYM O
28 CD O
. . O
3 CD O
27 CD O
. . O
4 CD O
/ SYM O
27 CD O
. . O
2 CD O

aBy IN O
gravimetry NN O
; : O
bBy NN O
combustion NN O
. . O

The DT O
new JJ O
complexes NNS O
have VBP O
also RB O
been VBN O
characterized VBN O
by IN O
spectroscopic JJ O
, , O
conductimetric JJ O
and CC O
thermogravimetric JJ O
measurements NNS O
( -LRB- O
Table NNP O
II NNP O
) -RRB- O
. . O

By IN O
comparing VBG O
the DT O
IR NN O
spectra NN O
of IN O
the DT O
complexes NNS O
and CC O
the DT O
corresponding VBG O
ligands NNS O
, , O
the DT O
following VBG O
observations NNS O
should MD O
be VB O
made VBN O
: : O
( : O
i PRP O
) -RRB- O
the DT O
shift NN O
of IN O
the DT O
two CD O
sulfonamido NN O
vibrations NNS O
( , O
both CC O
the DT O
symmetric JJ O
as RB O
well RB O
as IN O
the DT O
the DT O
assymetric JJ O
one NN O
) -RRB- O
, , O
towards IN O
lower JJR O
wavenumbers NNS O
in IN O
the DT O
spectra NN O
of IN O
the DT O
complexes NNS O
, , O
as IN O
compared VBN O
to IN O
the DT O
spectra NN O
of IN O
the DT O
corresponding JJ O
ligand NN O
( -LRB- O
Table NNP O
II NNP O
) -RRB- O
, , O
as IN O
already RB O
documented VBN O
previously RB O
for IN O
similar JJ O
complexes NNS O
[ -LRB- O
13 CD O
- SYM O
22 CD O
] -RRB- O
. . O

This DT O
is VBZ O
a DT O
direct JJ O
indication NN O
that IN O
the DT O
deprotonated JJ O
sulfonamido NN O
310 CD O

Claudiu NNP O
T NNP O
. . O
Supuran NNP O
et FW O
al NNP O
. . O

Metal NN O
- HYPH O
Based VBN O
Drugs NNS O

moieties NNS O
of IN O
the DT O
ligands NNS O
interacts VBZ O
with IN O
the DT O
metal NN O
ions NNS O
in IN O
the DT O
newly RB O
prepared VBN O
coordination NN O
compounds NNS O
; : O
( , O
ii FW O
) -RRB- O
the DT O
amide JJ O
vibrations NNS O
( , O
the DT O
most RBS O
intense JJ O
such JJ O
bands NNS O
at IN O
1670 CD O
- SYM O
1680 CD O
cm NNS O
- SYM O
1 CD O
) -RRB- O
of IN O
ligand NN O
7 CD O
appear VBP O
unchanged JJ O
in IN O
the DT O
IR NN O
spectra NN O
of IN O
complexes NNS O
15 CD O
- SYM O
20 CD O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
suggesting VBG O
that IN O
these DT O
moieties NNS O
do VBP O
not RB O
participate VB O
in IN O
coordination NN O
of IN O
the DT O
metal NN O
ions NNS O
; : O
( , O
iii FW O
) : O
the DT O
C NN O
- HYPH O
N NN O
stretching VBG O
vibration NN O
in IN O
the DT O
spectra NN O
of IN O
the DT O
prepared VBN O
complexes NNS O
is VBZ O
shifted VBN O
with IN O
5 CD O
- SYM O
20 CD O
cm NN O
- HYPH O
1 CD O
towards IN O
lower JJR O
wavenumbers NNS O
, , O
as IN O
compared VBN O
to IN O
the DT O
same JJ O
vibration NN O
in IN O
the DT O
spectra NN O
of IN O
sulfonamides NNS O
6 CD O
and CC O
7 CD O
, , O
indicating VBG O
that IN O
one CD O
of IN O
the DT O
endocyclic JJ O
nitrogens NNS O
of IN O
the DT O
thiadiazolic JJ O
ring NN O
( , O
presumably RB O
N3 NNP O
) -RRB- O
acts VBZ O
as IN O
donor NN O
atom NN O
, , O
as IN O
already RB O
documented VBN O
by IN O
X NN O
- HYPH O
ray NN O
crystallographic JJ O
and CC O
spectroscopic JJ O
determinations NNS O
on IN O
complexes NNS O
of IN O
other JJ O
sulfonamides NNS O
( , O
such JJ O
as IN O
1 CD O
- SYM O
3 CD O
) -RRB- O
with IN O
divalent JJ O
metal NN O
ions NNS O
[ -LRB- O
13 CD O
- HYPH O
22 CD O
] -RRB- O
( -LRB- O
Table NN O
II CD O
) -RRB- O
; : O
( , O
iv FW O
) -RRB- O
changes NNS O
in IN O
the DT O
region NN O
3100 CD O
- SYM O
3160 CD O
cm NN O
- , O
, , O
as IN O
the DT O
bands NNS O
present JJ O
in IN O
the DT O
spectra NN O
of IN O
sulfonamides NNS O
6 CD O
, , O
7 CD O
are VBP O
present JJ O
in IN O
the DT O
spectra NN O
of IN O
complexes NNS O
8 CD O
- SYM O
20 CD O
too RB O
, , O
but CC O
they PRP O
are VBP O
not RB O
well RB O
resolved VBN O
, , O
and CC O
have VBP O
a DT O
smaller JJR O
intensity NN O
. . O

This DT O
is VBZ O
probably RB O
due JJ O
to IN O
deprotonation NN O
of IN O
the DT O
SO2NH2 NN O
moiety NN O
and CC O
participation NN O
in IN O
the DT O
binding NN O
of IN O
cations NNS O
; : O
( : O
v NN O
) : O
the DT O
amino NN O
vibrations NNS O
from IN O
3320 CD O
cm NNS O
- HYPH O
in IN O
the DT O
spectra NN O
of IN O
6 CD O
appear VBP O
unchanged JJ O
in IN O
the DT O
spectra NN O
of IN O
its PRP$ O
complexes NNS O
8 CD O
- SYM O
14 CD O
( HYPH O
data NN O
not RB O
s VBZ O
. . O
hown NN O
) -RRB- O
. . O

In IN O
the DT O
1H CD O
- HYPH O
NMR NNP O
spectra NN O
of IN O
compound NN O
6 CD O
and CC O
its PRP$ O
metal NN O
complexes NNS O
, , O
the DT O
signal NN O
of IN O
the DT O
amino NN O
group NN O
has VBZ O
been VBN O
evidenced VBN O
as IN O
a DT O
broad JJ O
singlet NN O
centered VBN O
at IN O
4 CD O
. . O
54 CD O
ppm NN O
( -LRB- O
Table NNP O
II NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
not RB O
exchangeable JJ O
by IN O
addition NN O
of IN O
D20 NNP O
into IN O
the DT O
NMR NNP O
tube NN O
, , O
in IN O
contrast NN O
to IN O
the DT O
sulfonamido NN O
NH2 NNP O
protons NNS O
( , O
which WDT O
readily RB O
exchange NN O
) -RRB- O
. . O

This DT O
proves VBZ O
that IN O
the DT O
5 CD O
- HYPH O
amino JJ O
moiety NN O
is VBZ O
not RB O
involved VBN O
in IN O
binding VBG O
the DT O
metal NN O
ions NNS O
, , O
as IN O
already RB O
shown VBN O
in IN O
the DT O
X NNP O
- HYPH O
ray NN O
crystallographic JJ O
work NN O
of IN O
the DT O
complex NN O
[ -LRB- O
Zn NNP O
( : O
tda NNP O
) -RRB- O
z NN O
( , O
NH3 NNP O
) -RRB- O
] -RRB- O
. , O
H20 CD O
previously RB O
reported VBN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

For IN O
sulfonamide NN O
7 CD O
the DT O
CONH NNP O
proton NN O
resonates VBZ O
as IN O
a DT O
singlet NN O
at IN O
12 CD O
. . O
22 CD O
ppm NN O
. . O

In IN O
complexes NNS O
15 CD O
- SYM O
20 CD O
only RB O
very RB O
minor JJ O
shifts NNS O
of IN O
this DT O
signal NN O
were VBD O
evidenced VBN O
( -LRB- O
Table NNP O
II NNP O
) -RRB- O
, , O
proving VBG O
basically RB O
that IN O
the DT O
CONH NNP O
moiety NN O
does VBZ O
not RB O
interact VB O
with IN O
the DT O
metal NN O
ions NNS O
in IN O
these DT O
complexes NNS O
. . O

Table NN O
II NN O
: : O
Spectroscopic JJ O
, , O
thermogravimetric JJ O
and CC O
conductimetric JJ O
data NNS O
for IN O
compounds NNS O
6 CD O
- SYM O
20 CD O
. . O

1H NN O
- HYPH O
NMR NNP O
Spectrab NNP O
Comp NNP O
. . O

IR NNP O
Spectraa NNP O
, , O
cm NN O
- HYPH O
1 CD O
as IN O
v NN O
( : O
C NN O
= : O
N NNP O
) NFP O
CONH NNP O
, , O
i NN O
( HYPH O
ppm NN O
) -RRB- O
v NN O
( : O
SO2 NN O
) : O
S NN O
; : O
v NN O
( -LRB- O
SO2 NNP O
) SYM O
6 CD O
8 CD O
9 CD O
10 CD O
11 CD O

TG NNP O
analysisc NN O
calc NN O
. . O
/ SYM O
found VBD O

Conductimetryd NN O
AM NN O
( : O
- HYPH O
1 CD O
x SYM O
cm2x CD O
mol NN O
- HYPH O
) SYM O
2 CD O
7 CD O
4 CD O
5 CD O
3 CD O
2 CD O
2 CD O
6 CD O
3 CD O
4 CD O
2 CD O
9 CD O
3 CD O
2 CD O
8 CD O

12 CD O
13 CD O
14 CD O
7 CD O
15 CD O
16 CD O
17 CD O
18 CD O
19 CD O
20 CD O

1170 CD O
; : O
1150 CD O
; : O
1150 CD O
; : O
1145 CD O
; : O
1145 CD O
; : O
1140 CD O
; : O
1145 CD O
; : O
1150 CD O
; : O
1170 CD O
; : O
1130 CD O
; : O
1140 CD O
; : O
1140 CD O
; : O
1150 CD O
; : O
1140 CD O
; : O
1145 CD O
; : O

1350 CD O
1300 CD O
1305 CD O
1300 CD O
1305 CD O
1300 CD O
1300 CD O
1300 CD O
1350 CD O
1335 CD O
1330 CD O
1330 CD O
1330 CD O
1335 CD O
1330 CD O

1610 CD O
1600 CD O
1600 CD O
1600 CD O
1600 CD O
1590 CD O
1605 CD O
1605 CD O
1610 CD O
1605 CD O
1610 CD O
1610 CD O
1605 CD O
1600 CD O
1600 CD O

A DT O
A NN O
A NN O
A NN O
A NN O
A NN O
A NN O

e NFP O
e XX O

12 CD O
. . O
3 CD O
/ SYM O
12 CD O
. . O
1f CD O
e NN O
e NN O
e NN O
5 CD O
. . O
9 CD O
/ SYM O
5 CD O
. . O
7g CD O

A DT O
12 CD O
. . O
22 CD O
( SYM O
1H CD O
) SYM O
12 CD O
. . O
19 CD O
( SYM O
2H CD O
) SYM O
12 CD O
. . O
18 CD O
( SYM O
3H CD O
) SYM O
12 CD O
. . O
20 CD O
( SYM O
2H CD O
) SYM O
12 CD O
. . O
18 CD O
( SYM O
2H CD O
) SYM O
12 CD O
. . O
19 CD O
( SYM O
2H CD O
) SYM O
12 CD O
. . O
21 CD O
( SYM O
2H CD O
) -RRB- O

e NN O
e NN O
e NN O
e NN O
e NN O
e NN O
e NN O
4 CD O
. . O
7 CD O
/ SYM O
4 CD O
. . O
8g CD O

a LS O
In IN O
KBr NNP O
; : O
bin NNP O
DMSO NNP O
- HYPH O
d6 CD O
; : O
A DT O
the DT O
signal NN O
of IN O
the DT O
5 CD O
- HYPH O
amino NN O
group NN O
of IN O
6 CD O
( , O
appearing VBG O
in IN O
the DT O
ligand NN O
at IN O
4 CD O
. . O
54 CD O
ppm NN O
as IN O
a DT O
broad JJ O
singlet NN O
) -RRB- O
appears VBZ O
at IN O
the DT O
same JJ O
chemical JJ O
shift NN O
( , O
4 CD O
. . O
50 CD O
4 CD O
. . O
55 CD O
ppm NN O
) -RRB- O
in IN O
complexes NNS O
8 CD O
- SYM O
14 CD O
; : O
cWeight NN O
loss NN O
between IN O
70 CD O
- SYM O
250 CD O
C NN O
; : O
d NN O
mM NN O
solution NN O
, , O
in IN O
DMF NNP O
, , O
at IN O
25C CD O
; : O
e LS O
No DT O
weight NN O
loss NN O
seen VBN O
under IN O
250 CD O
C NN O
; : O
fCorresponding VBG O
to IN O
three CD O
lattice NN O
water NN O
molecules NNS O
lost VBN O
at IN O
70 CD O
- HYPH O
110C NN O
, , O
and CC O
gCorresponding VBG O
to IN O
two CD O
coordinated JJ O
water NN O
molecules NNS O
, , O
lost VBN O
at IN O
160 CD O
- SYM O
180 CD O
C NN O
. . O

Thermogravimetric JJ O
analysis NN O
showed VBD O
the DT O
presence NN O
of IN O
uncoordinated JJ O
water NN O
molecules NNS O
in IN O
the DT O
molecule NN O
of IN O
complex JJ O
9 CD O
( , O
the DT O
three CD O
waters NNS O
were VBD O
lost VBN O
in IN O
a DT O
single JJ O
step NN O
, , O
between IN O
70 CD O
- SYM O
110 CD O
C NN O
) , O
and CC O
of IN O
coordinated JJ O
water NN O
in IN O
the DT O
molecules NNS O
of IN O
the DT O
lead NN O
( , O
II NNP O
) -RRB- O
derivatives NNS O
13 CD O
and CC O
20 CD O
. . O

All PDT O
these DT O
compounds NNS O
behaved VBD O
as IN O
non AFX O
- HYPH O
electrolytes NNS O
in IN O
DMF NNP O
as IN O
solvent JJ O
( -LRB- O
Table NNP O
II NNP O
) -RRB- O
. . O

Mention NN O
should MD O
be VB O
made VBN O
that IN O
the DT O
Mg NNP O
( -LRB- O
II NNP O
) -RRB- O
complex NN O
of IN O
sulfonamide NN O
7 CD O
could MD O
not RB O
be VB O
isolated VBN O
. . O

Instead RB O
, , O
only RB O
the DT O
correponding JJ O
complex NN O
of IN O
5 CD O
- HYPH O
amino JJ O
- HYPH O
l JJ O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
has VBZ O
been VBN O
obtained VBN O
from IN O
reaction NN O
mixtures NNS O
containing VBG O
magnesium NN O
salts NNS O
and CC O
the DT O
sodium NN O
salt NN O
of IN O
7 CD O
, , O
probably RB O
due JJ O
to IN O
a DT O
metal NN O
ion NN O
assisted VBN O
hydrolysis NN O
of IN O
7 CD O
to IN O
6 CD O
and CC O
chloroacetate NN O
. . O

Generally RB O
such JJ O
hydrolytic JJ O
processes NNS O
involve VBP O
highly RB O
acidic JJ O
conditions NNS O
and CC O
prolonged JJ O
heating NN O
of IN O
the DT O
5 CD O
- HYPH O
alkylamido NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
- HYPH O
thiadiazole NN O
- HYPH O
2 CD O
- HYPH O
sulfonamide NN O
derivatives NNS O
[ -LRB- O
41 CD O
] -RRB- O
, , O
but CC O
they PRP O
might MD O
become VB O
milder JJR O
by IN O
taking VBG O
into IN O
account NN O
the DT O
putative JJ O
catalytic JJ O
effect NN O
of IN O
Mg2 NNP O
+ SYM O
ions NNS O
reported VBN O
here RB O
. . O

The DT O
data NNS O
shown VBN O
above RB O
lead VBP O
to IN O
the DT O
conclusion NN O
that IN O
ligand NN O
7 CD O
shares VBZ O
a DT O
common JJ O
coordination NN O
chemistry NN O
with IN O
acetazolamide NN O
1 CD O
with IN O
which WDT O
it PRP O
is VBZ O
structurally RB O
related VBN O
, , O
whereas IN O
6 CD O
probably RB O
also RB O
behaves VBZ O
similarly RB O
to IN O
acetazolamide NN O
in IN O
the DT O
sense NN O
that IN O
the DT O
5 CD O
- HYPH O
amino NN O
group NN O
seems VBZ O
not RB O
to TO O
be VB O
involved VBN O
in IN O
coordinating VBG O
metal NN O
ions NNS O
, , O
at IN O
311 CD O

Vol NNP O
. . O

4 CD O
, , O
No UH O
. . O
6 CD O
, , O
1997 CD O

Metal NN O
Complexes NNS O
of IN O
Heterocyclic JJ O
Sulfonamides NN O
: : O
A DT O
New JJ O
Class NN O
ofAntiglaucoma NN O
Agents NNS O

least JJS O
in IN O
the DT O
complexes NNS O
reported VBN O
by IN O
us PRP O
here RB O
( , O
and CC O
also RB O
in IN O
the DT O
compound NN O
characterized VBN O
by IN O
X NN O
- HYPH O
ray NN O
crystallography NN O
mentioned VBN O
above RB O
[ -LRB- O
40 CD O
] -RRB- O
) -RRB- O
. . O

Thus RB O
, , O
in IN O
all DT O
complexes NNS O
reported VBN O
here RB O
these DT O
sulfonamides NNS O
( , O
as IN O
monodeprotonated JJ O
species NNS O
at IN O
the DT O
SO2NH NNP O
2 CD O
moieties NNS O
) -RRB- O
act VBP O
as IN O
bidentate NN O
ligands NNS O
, , O
through IN O
the DT O
endocyclic JJ O
N NNP O
- HYPH O
3 CD O
and CC O
the DT O
NH NNP O
- HYPH O
groups NNS O
. . O

The DT O
proposed VBN O
formulae NN O
of IN O
the DT O
new JJ O
complxes NNS O
are VBP O
shown VBN O
below RB O
. . O

Except IN O
for IN O
the DT O
two CD O
Pb NNP O
( HYPH O
II NNP O
) -RRB- O
complexes NNS O
13 CD O
and CC O
20 CD O
, , O
as RB O
well RB O
as IN O
the DT O
AI NNP O
( , O
III NNP O
) -RRB- O
derivatives NNS O
14 CD O
and CC O
16 CD O
, , O
which WDT O
presumably RB O
are VBP O
pseudo NN O
- HYPH O
octahedral NN O
, , O
the DT O
other JJ O
derivatives NNS O
are VBP O
supposed VBN O
to TO O
contain VB O
tetrahedral NN O
M NNP O
( -LRB- O
II NNP O
) -RRB- O
ions NNS O
. . O

R NN O

R NN O
13 CD O
"""" '' O
R NN O
= SYM O
20 CD O
"""" '' O
R NN O
= . O

H2N NNP O

CICH2CONH NNP O

14 CD O
: : O
R NN O
= SYM O
16 CD O
: : O
R NN O
= . O

H2N NNP O
CICH2CONH NNP O

The DT O
compounds NNS O
6 CD O
- SYM O
20 CD O
together RB O
with IN O
the DT O
standard JJ O
CA NN O
inhibitors NNS O
1 CD O
- HYPH O
5 CD O
were VBD O
assayed VBN O
for IN O
inhibition NN O
against IN O
three CD O
isozymes NNS O
, , O
hCA NNP O
I NNP O
, , O
hCA NNP O
II NNP O
and CC O
bCA NN O
IV NN O
( HYPH O
Table NNP O
III NNP O
) -RRB- O
. . O

As IN O
seen VBN O
from IN O
the DT O
above JJ O
data NN O
, , O
the DT O
chloracetamido NN O
derivative NN O
is VBZ O
more RBR O
inhibitory JJ O
than IN O
acetazolamide NN O
, , O
methazolamide NN O
and CC O
dichlorophenamide NN O
, , O
whereas IN O
the DT O
unacylated JJ O
compound NN O
6 CD O
is VBZ O
less RBR O
inhibitory JJ O
than IN O
the DT O
above JJ O
sulfonamides NNS O
. . O

The DT O
metal NN O
complexes NNS O
820 CD O
are VBP O
much RB O
more RBR O
inhibitory JJ O
than IN O
the DT O
sulfonamides NNS O
from IN O
which WDT O
they PRP O
derive VBP O
6 CD O
, , O
7 CD O
and CC O
than IN O
all DT O
other JJ O
simple JJ O
sulfonamides NNS O
assayed VBD O
. . O

They PRP O
behave VBP O
similarly RB O
to IN O
the DT O
metal NN O
complexes NNS O
of IN O
acetazolamide NN O
, , O
methazolamide NN O
or CC O
dorzolamide NN O
previously RB O
reported VBN O
by IN O
this DT O
group NN O
, , O
which WDT O
were VBD O
all DT O
more RBR O
inhibitory JJ O
than IN O
the DT O
parent NN O
sulfonamide NN O
from IN O
which WDT O
were VBD O
prepared VBN O
[ -LRB- O
16 CD O
- SYM O
22 CD O
, , O
40 CD O
] -RRB- O
. . O

Particularly RB O
strong JJ O
inhibition NN O
was VBD O
observed VBN O
for IN O
the DT O
Zn NNP O
( , O
II NNP O
) -RRB- O
, , O
Hg NNP O
( , O
II NNP O
) -RRB- O
, , O
Pb NN O
( , O
II NNP O
) -RRB- O
and CC O
Cd NNP O
( -LRB- O
II NNP O
) -RRB- O
complexes NNS O
, , O
especially RB O
against IN O
CA NN O
II NN O
and CC O
CA NN O
IV NN O
, , O
the DT O
isozymes NNS O
critical JJ O
for IN O
aqueous JJ O
humor NN O
formation NN O
. . O

In IN O
vivo NN O
IOP NNP O
lowering NN O
experiments NNS O
were VBD O
done VBN O
in IN O
rabbits NNS B-Species
with IN O
some DT O
of IN O
the DT O
new JJ O
compounds NNS O
prepared VBN O
in IN O
the DT O
present JJ O
work NN O
, , O
such JJ O
as IN O
the DT O
sulfonamides NNS O
6 CD O
and CC O
7 CD O
, , O
and CC O
their PRP$ O
Zn NNP O
( HYPH O
II NNP O
) -RRB- O
complexes NNS O
, , O
which WDT O
were VBD O
among IN O
the DT O
strong JJ O
CA NN O
II NN O
and CC O
CA NN O
IV NN O
inhibitors NNS O
in IN O
the DT O
obtained VBN O
series NN O
. . O

Some DT O
of IN O
the DT O
IOP NNP O
lowering VBG O
data NNS O
at IN O
half PDT O
an DT O
hour NN O
and CC O
one CD O
hour NN O
after IN O
the DT O
instillation NN O
of IN O
one CD O
drop NN O
of IN O
2 CD O
% NN O
solution NN O
of IN O
inhibitor NN O
within IN O
the DT O
rabbit NN B-Species
eye NN O
are VBP O
shown VBN O
in IN O
312 CD O

Claudiu NNP O
T NNP O
. . O
Supuran NNP O
et FW O
al NNP O
. . O

Metal NN O
- HYPH O
Based VBN O
Drugs NNS O

Table NN O
IV NN O
, , O
with IN O
dorzolamide NN O
( , O
at IN O
the DT O
same JJ O
concentration NN O
) -RRB- O
as IN O
standard NN O
. . O

In IN O
Fig NN O
. . O
the DT O
time NN O
dependence NN O
of IN O
IOP NNP O
lowering VBG O
with IN O
dorzolamide NN O
5 CD O
and CC O
the DT O
two CD O
Zn NNP O
( HYPH O
II NN O
) -RRB- O
complexes NNS O
10 CD O
and CC O
17 CD O
is VBZ O
presented VBN O
. . O

Table NNP O
III NNP O
. . O

CA NN O
inhibition NN O
data NNS O
with IN O
the DT O
standard JJ O
inhibitors NNS O
1 CD O
- SYM O
5 CD O
, , O
the DT O
sulfonamides NNS O
6 CD O
and CC O
7 CD O
, , O
and CC O
their PRP$ O
metal NN O
complexes NNS O
8 CD O
- SYM O
20 CD O
. . O

No UH O
1 CD O
2 CD O
3 CD O
4 CD O
5 CD O
6 CD O
7 CD O
8 CD O
9 CD O
10 CD O
11 CD O
12 CD O
13 CD O
14 CD O
15 CD O
16 CD O
17 CD O
18 CD O
19 CD O
20 CD O
a NN O

Inhibitor NN O

KI NNP O
hCA NNP O
Ia NNP O
900 CD O
780 CD O
25 CD O
1200 CD O
> SYM O
50 CD O
, , O
0 CD O
1550 CD O
640 CD O
1050 CD O
350 CD O
50 CD O
40 CD O
12 CD O
80 CD O
240 CD O
120 CD O
80 CD O
40 CD O
40 CD O
9 CD O
15 CD O

( -LRB- O
nM NN O
) NFP O
bCA NNP O
IVb NNP O
220 CD O
240 CD O
13 CD O
380 CD O
43 CD O
780 CD O
24 CD O
540 CD O
220 CD O
25 CD O
19 CD O
10 CD O
26 CD O
110 CD O
12 CD O
16 CD O
9 CD O
10 CD O
5 CD O
10 CD O

hCA NNP O
IIa NNP O
12 CD O
14 CD O
8 CD O
38 CD O
9 CD O
230 CD O
5 CD O
190 CD O
110 CD O
15 CD O
14 CD O
7 CD O
10 CD O
76 CD O
5 CD O
4 CD O
3 CD O
3 CD O
2 CD O
5 CD O

Acetazolamide NN O
Methazolamide NN O
Ethoxzolamide NN O

Dichlorophenamide NNP O
Dorzolamide NNP O

Human JJ B-Species
( HYPH O
cloned JJ O
) -RRB- O
isozymes NNS O
; : O
b LS O
From IN O
bovine JJ B-Species
lung NN O
microsomes NNS O
. . O

Table NN O
IV NN O
: : O
IOP NNP O
lowering NN O
following VBG O
topical JJ O
application NN O
of IN O
CA NN O
inhibitors NNS O
, , O
half PDT O
an DT O
hour NN O
and CC O
one CD O
hour NN O
after IN O
instillation NN O
into IN O
the DT O
eye NN O
of IN O
a DT O
drop NN O
( : O
50 CD O
L NN O
) -RRB- O
of IN O
2 CD O
% NN O
solution NN O
of IN O
inhibitor NN O
. . O

Inhibitor NN O

lOP NNP O
SE NNP O
1 CD O
/ SYM O
2 CD O
h NN O

a LS O

( NFP O
mm NNP O
Hg NNP O
) , O
lh UH O
4 CD O
. . O
1 CD O
0 CD O
. . O
15 CD O
0 CD O
0 CD O
. . O
9 CD O
0 CD O
0 CD O
. . O
9 CD O
5 CD O
. . O
0 CD O
0 CD O
. . O
12 CD O
8 CD O
. . O
1 CD O
0 CD O
. . O
21 CD O
Dorzolamide NNP O
5 CD O
6 CD O
7 CD O
10 CD O
17 CD O
a NN O

2 CD O
. . O
2 CD O
0 CD O
. . O
10 CD O
0 CD O
0 CD O
. . O
10 CD O
0 CD O
0 CD O
. . O
10 CD O
2 CD O
. . O
0 CD O
. . O
9 CD O
8 CD O
. . O
0 CD O
0 CD O
. . O
14 CD O

IOP NNP O

IOP NNP O
control NN O
eye NN O
"""" `` O
IOP NNP O
treated VBN O
eye NN O
( HYPH O
N NN O
3 CD O
) -RRB- O
. . O

As IN O
seen VBN O
from IN O
the DT O
above JJ O
data NN O
, , O
the DT O
sulfonamides NNS O
6 CD O
and CC O
7 CD O
are VBP O
totally RB O
ineffective JJ O
as IN O
lOP NNP O
lowering VBG O
agents NNS O
, , O
similarly RB O
to IN O
the DT O
classical JJ O
clinically RB O
used VBN O
inhibitors NNS O
of IN O
type NN O
1 CD O
- HYPH O
5 CD O
[ SYM O
2 CD O
, , O
3 CD O
] -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
dorzolamide NN O
, , O
the DT O
first JJ O
topical JJ O
sulfonamide NN O
used VBN O
clinically RB O
in IN O
the DT O
treatment NN O
of IN O
glaucoma NN O
is VBZ O
an DT O
effective JJ O
such JJ O
agent NN O
, , O
with IN O
a DT O
decrease NN O
of IN O
lOP NN O
of IN O
around IN O
4 CD O
mm NN O
Hg NNP O
, , O
one CD O
hour NN O
after IN O
administration NN O
directly RB O
into IN O
the DT O
eye NN O
( , O
Table NNP O
IV NNP O
) -RRB- O
. . O

From IN O
the DT O
data NNS O
of IN O
this DT O
table NN O
, , O
it PRP O
is VBZ O
obvious JJ O
that IN O
the DT O
metal NN O
complexes NNS O
of IN O
heterocyclic JJ O
sulfonamides NNS O
investigated VBN O
by IN O
us PRP O
behave VBP O
as IN O
much RB O
more RBR O
effective JJ O
IOP NNP O
lowering VBG O
agents NNS O
than IN O
dorzolamide NN O
, , O
and CC O
their PRP$ O
effect NN O
is VBZ O
generally RB O
longerlasting VBG O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

A DT O
last JJ O
remark NN O
should MD O
be VB O
made VBN O
about IN O
the DT O
possible JJ O
mechanism NN O
of IN O
action NN O
of IN O
the DT O
new JJ O
class NN O
of IN O
IOP NNP O
lowering VBG O
agents NNS O
. . O

Obviously RB O
, , O
their PRP$ O
activity NN O
is VBZ O
due JJ O
to IN O
inhibition NN O
of IN O
CA NN O
isozymes NNS O
present JJ O
in IN O
the DT O
cilliary NN O
processes NNS O
within IN O
the DT O
eye NN O
, , O
similarly RB O
to IN O
other JJ O
topically RB O
active JJ O
sulfonamides NNS O
[ -LRB- O
2 CD O
- SYM O
6 CD O
] -RRB- O
. . O

The DT O
fact NN O
that IN O
the DT O
sulfonamide NN O
per FW O
se FW O
is VBZ O
inactive JJ O
via IN O
the DT O
topical JJ O
route NN O
, , O
whereas IN O
the DT O
metal NN O
complexes NNS O
result VBP O
much RB O
better RBR O
than IN O
the DT O
drug NN O

313 CD O

Vol NNP O
. . O

4 CD O
, , O
No UH O
. . O
6 CD O
, , O
1997 CD O

Metal NN O
Complexes NNS O
of IN O
Heterocyclic NNP O
Sulfonamides NNP O
. . O
"""" '' O
A DT O
New NNP O
Class NNP O
ofAntiglaucoma NNP O
Agents NNPS O

dorzolamide NNP O
, , O
indicates VBZ O
that IN O
the DT O
presence NN O
of IN O
metal NN O
ions NNS O
in IN O
the DT O
molecules NNS O
of IN O
these DT O
CA NNP O
inhibitors NNS O
is VBZ O
essential JJ O
and CC O
confers VBZ O
them PRP O
completely RB O
new JJ O
properties NNS O
. . O

Lowering VBG O
of IN O
IOP NNP O
( : O
ram NN O
Hg NNP O
) . O

"""" `` O
| NFP O
| NFP O
, , O

/ NFP O

"""" '' O
, , O
, , O

' '' O
"""" '' O
, , O
. . O
, , O

, , O
< NFP O

. . O
7 CD O
, , O
/ , O

/ NFP O

. . O
6 CD O

- : O
0 NFP O

- : O
10 CD O
0 CD O

2 LS O

Time NN O
( : O
hours NNS O
) -RRB- O

Fig NN O
l -LRB- O
"""" `` O
Time NN O
dependence NN O
of IN O
IOP NNP O
lowering VBG O
with IN O
dorzolamide NN O
( -LRB- O
curve NN O
1 CD O
) -RRB- O
; , O
the DT O
zinc NN O
complex NN O
10 CD O
( , O
curve NN O
3 CD O
) -RRB- O
and CC O
the DT O
zinc NN O
complex NN O
17 CD O
( , O
curve NN O
3 CD O
) -RRB- O
, , O
after IN O
topical JJ O
administration NN O
of IN O
one CD O
drop NN O
of IN O
2 CD O
% NN O
solution NN O
of IN O
inhibitor NN O
in IN O
rabbit NN B-Species
. . O

Preliminary JJ O
results NNS O
from IN O
this DT O
laboratory NN O
indicate VBP O
that IN O
the DT O
metal NN O
complexes NNS O
of IN O
topically RB O
active JJ O
sulfonamides NNS O
show VBP O
also RB O
increased VBN O
lOP NN O
lowering VBG O
effects NNS O
with IN O
respect NN O
to IN O
the DT O
complexes NNS O
prepared VBN O
in IN O
the DT O
present JJ O
study NN O
[ -LRB- O
42 CD O
] -RRB- O
. . O

Our PRP$ O
hypothesis NN O
is VBZ O
that IN O
the DT O
presence NN O
of IN O
the DT O
metal NN O
ion NN O
in IN O
the DT O
molecules NNS O
of IN O
these DT O
complex JJ O
inhibitors NNS O
induces VBZ O
a DT O
dramatic JJ O
change NN O
in IN O
their PRP$ O
physico NN O
- HYPH O
chemical NN O
properties NNS O
as IN O
compared VBN O
to IN O
those DT O
of IN O
the DT O
parent NN O
sulfonamide NN O
. . O

This DT O
phenomenon NN O
is VBZ O
certainly RB O
governed VBN O
by IN O
the DT O
strong JJ O
polarization NN O
induced VBN O
by IN O
the DT O
metal NN O
ions NNS O
. . O

In IN O
this DT O
way NN O
, , O
it PRP O
is VBZ O
quite RB O
probable JJ O
that IN O
the DT O
right JJ O
balance NN O
between IN O
the DT O
lipo NN O
- HYPH O
and CC O
hydrosolubility NN O
of IN O
these DT O
compounds NNS O
is VBZ O
achieved VBN O
, , O
which WDT O
has VBZ O
been VBN O
considered VBN O
to TO O
be VB O
the DT O
critical JJ O
factor NN O
for IN O
not RB O
observing VBG O
topical JJ O
activity NN O
in IN O
the DT O
classical JJ O
CA NN O
inhibitors NNS O
, , O
such JJ O
as IN O
acetazolamide NN O
, , O
methazolamide NN O
and CC O
ethoxzolamide NN O
, , O
which WDT O
were VBD O
either CC O
too RB O
lipophilic JJ O
or CC O
too RB O
hy JJ O
. . O
drosoluble NN O
[ -LRB- O
2 CD O
, , O
3 CD O
] -RRB- O
. . O

So CC O
, , O
by IN O
choosing VBG O
different JJ O
metal NN O
ions NNS O
and CC O
diverse JJ O
sulfonamides NNS O
, , O
much RB O
larger JJR O
possibilities NNS O
arise VBP O
to TO O
finely RB O
tune VB O
the DT O
pharmacological JJ O
properties NNS O
which WDT O
strongly RB O
influence VBP O
the DT O
value NN O
of IN O
a DT O
drug NN O
. . O

In IN O
conclusion NN O
we PRP O
describe VBP O
here RB O
a DT O
novel JJ O
class NN O
of IN O
lOP NNP O
lowering VBG O
agents NNS O
, , O
ie RB O
, , O
the DT O
metal NN O
complexes NNS O
of IN O
sulfonamide NN O
CA NN O
inhibitors NNS O
. . O

These DT O
derivatives NNS O
appear VBP O
to TO O
be VB O
very RB O
active JJ O
and CC O
longer RBR O
lasting VBG O
than IN O
the DT O
drug NN O
dorzolamide NN O
, , O
and CC O
might MD O
constitute VB O
the DT O
premises NNS O
for IN O
a DT O
new JJ O
generation NN O
of IN O
antiglaucoma NN O
drugs NNS O
. . O

Acknowledgments NNS O
. . O

We PRP O
are VBP O
grateful JJ O
to IN O
Prof NNP O
. . O

S UH O
. . O

Lindskog NNP O
( , O
Umea NNP O
Univ NNP O
. . O
, , O
Sweden NNP O
) , O
for IN O
the DT O
gift NN O
of IN O
the DT O
hCA NNP O
and CC O
II NNP O
plasmids NNS O
. . O

References NNS O
Preceding VBG O
part NN O
of IN O
this DT O
series NN O
"""" `` O
Supuran NNP O
CT NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Ilies NNP O
MA NNP O
, , O
Iorga NNP O
B NNP O
, , O
Cristea NNP O
T NNP O
, , O
Chiraleu NNP O
F NNP O
, , O
Banciu NNP O
MD NNP O
( , O
1997 CD O
) -RRB- O
Eur NNP O
J NNP O
Med NNP O
Chem NNP O
, , O
submitted VBD O
. . O

2 LS O
Supuran NNP O
CT NNP O
( SYM O
1994 CD O
) -RRB- O
"""" `` O
Carbonic JJ O
anhydrase NN O
inhibitors NNS O
"""" '' O
In IN O
Carbonic NNP O
Anhydrase NNP O
and CC O
Modulation NNP O
of IN O
Physiologic NNP O
and CC O
Pathologic NNP O
Processes NNPS O
in IN O
the DT O
Organism NNP O
, , O
( , O
Puscas NNP O
I NNP O
, , O
Ed NNP O
) , O
Helicon NNP O
, , O
Timisoara NNP O
, , O
pp NN O
. . O

29 CD O
- SYM O
111 CD O
. . O

3 LS O
Maren NNP O
TH NNP O
( : O
1991 CD O
) -RRB- O
"""" `` O
The DT O
links NNS O
among IN O
biochemistry NN O
, , O
physiology NN O
and CC O
pharmacology NN O
in IN O
carbonic JJ O
anhydrase NN O
mediated VBN O
systems NNS O
"""" '' O
. . O

In IN O
Carbonic NNP O
Anhydrase NNP O
From IN O
Biochemistry NNP O
and CC O
Genetics NNP O
to IN O
Physiology NNP O
and CC O
Clinical NNP O
Medicine NNP O
, , O
( , O
Botr6 NNP O
F NNP O
, , O
Gros NNP O
G NNP O
, , O
Storey NNP O
BT NNP O
Eds NNP O
) , O
VCH NNP O
, , O
Weinheim NNP O
, , O
pp UH O
. . O

186 CD O
- SYM O
207 CD O
. . O

4 CD O
Bayer NNP O
A NNP O
, , O
Ferrari NNP O
F NNP O
, , O
Maren NNP O
TH NNP O
, , O
Erb NNP O
C NNP O
( , O
1996 CD O
) -RRB- O
dFr NNP O
Ophtalrnol NNP O
19 CD O
, , O
3 CD O
: SYM O
57 CD O
- HYPH O
362 CD O
. . O

: : O
5 CD O
Maren NNP O
TH NNP O
, , O
Conroy NNP O
CW NNP O
, , O
Wynns NNP O
GC NNP O
, , O
Levy NNP O
NS NNP O
( , O
1997 CD O
) , O
d NN O
Ocul NNP O
Pharrnacol NNP O
Therapeut NNP O
13 CD O
, , O
23 CD O
- HYPH O
30 CD O
. . O

6 CD O
Sugrue NNP O
MF NNP O
( : O
1996 CD O
) -RRB- O
d , O
Ocul NNP O
Pharmacol NNP O
Ther NNP O
12 CD O
, , O
363 CD O
- HYPH O
376 CD O
. . O

7 CD O
Bartlett NNP O
JD NNP O
, , O
Jaanus NNP O
SD NNP O
( : O
1989 CD O
) -RRB- O
"""" `` O
Carbonic JJ O
anhydrase NN O
inhibitors NNS O
"""" '' O
. . O

In IN O
Clinical NNP O
Ocular NNP O
Pharmacology NNP O
, , O
Second NNP O
Edition NNP O
, , O
Butterworths NNP O
Publishers NNPS O
, , O
Boston NNP O
, , O
pp NN O
. . O

2 CD O
: : O
54 CD O
- HYPH O
263 CD O
. . O

8 CD O
Alward NNP O
PD NN O
, , O
Wilensky NNP O
JT NNP O
( : O
1981 CD O
) -RRB- O
Arch NNP O
Ophthalmo199 NNP O
, , O
1973 CD O
- SYM O
1976 CD O
. . O

314 CD O

Claudiu NNP O
T NNP O
. . O
Supuran NNP O
et FW O
al NNP O
. . O

Metal NN O
- HYPH O
Based VBN O
Drugs NNS O

9 CD O
Maren NNP O
TH NNP O
, , O
Jankowska NNP O
L NNP O
, , O
Sanyal NNP O
G NNP O
, , O
Edelhauser NNP O
HF NNP O
( , O
1983 CD O
) -RRB- O
Exp NNP O
Eye NNP O
Res NNP O
36 CD O
, , O
457 CD O
- HYPH O
480 CD O
. . O

10 CD O
a DT O
) : O
Ponticello NNP O
GS NNP O
, , O
Freedman NNP O
MB NNP O
, , O
Habecker NNP O
CN NNP O
, , O
Lyle NNP O
PA NNP O
, , O
Schwam NNP O
H NNP O
, , O
Varga NNP O
SL NNP O
, , O
Christy NNP O
ME NNP O
, , O
Randall NNP O
WC NNP O
, , O
Baldwin NNP O
JJ NNP O
( : O
1987 CD O
) SYM O
J NNP O
Med NNP O
Chem NNP O
30 CD O
, , O
591 CD O
- HYPH O
597 CD O
; : O
b NN O
) : O
Greer NNP O
J NNP O
, , O
Erickson NNP O
JW NNP O
, , O
Baldwin NNP O
JJ NNP O
, , O
Varney NNP O
MD NNP O
( , O
1994 CD O
) , O
J NNP O
Med NNP O
Chem NNP O
37 CD O
, , O
1035 CD O
- HYPH O
1054 CD O
. . O

11 CD O
Baldwin NNP O
JJ NNP O
, , O
Ponticello NNP O
GS NNP O
, , O
Anderson NNP O
GS NNP O
, , O
Christy NNP O
ME NNP O
, , O
Murcko NNP O
MA NNP O
, , O
Randall NNP O
WC NNP O
, , O
Schwam NNP O
H NNP O
, , O
Sugrue NNP O
MF NNP O
, , O
Springer NNP O
JP NNP O
, , O
Gautheron NNP O
P NNP O
, , O
Grove NNP O
J NNP O
, , O
Mallorga NNP O
P NNP O
, , O
Viader NNP O
MP NNP O
, , O
McKeever NNP O
BM NNP O
, , O
Navia NNP O
MA NNP O
( , O
1989 CD O
) SYM O
J NNP O
Med NNP O
Chem NNP O
32 CD O
, , O
2510 CD O
- HYPH O
2513 CD O
. . O

12 CD O
Chow NNP O
K NNP O
, , O
Lai NNP O
R NNP O
, , O
Holmes NNP O
JM NNP O
, , O
Wijono NNP O
M NNP O
, , O
Wheeler NNP O
LA NNP O
, , O
Garst NNP O
ME NNP O
( , O
1996 CD O
) -RRB- O
EurJMed NNP O
Chem NNP O
31 CD O
, , O
175 CD O
- HYPH O
186 CD O
. . O

13 CD O
Supuran NNP O
CT NNP O
, , O
Nicolae NNP O
A NNP O
, , O
Popescu NNP O
A NNP O
( , O
1996 CD O
) -RRB- O
Eur NNP O
JMed NNP O
Chem NNP O
31 CD O
, , O
431 CD O
- HYPH O
438 CD O
. . O

14 CD O
Supuran NNP O
CT NNP O
, , O
Popescu NNP O
A NNP O
, , O
Ilisiu NNP O
M NNP O
, , O
Costandache NNP O
A NNP O
, , O
Banciu NNP O
MD NNP O
( , O
1996 CD O
) -RRB- O
Eur NNP O
JMed NNP O
Chem NNP O
31 CD O
, , O
439 CD O
- HYPH O
448 CD O
. . O

15 CD O
Supuran NNP O
CT NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Popescu NNP O
A NNP O
, , O
Bobes NNP O
- HYPH O
Tureac NNP O
R NNP O
, , O
Banciu NNP O
A NNP O
, , O
Creanga NNP O
A NNP O
, , O
Bobes NNP O
- HYPH O
Tureac NNP O
G NNP O
, , O
Banciu NNP O
MD NNP O
( , O
1997 CD O
) -RRB- O
Eur NNP O
JMed NNP O
Chem NNP O
32 CD O
, , O
445 CD O
- HYPH O
452 CD O
. . O

16 CD O
Alzuet NNP O
G NNP O
, , O
Casanova NNP O
J NNP O
, , O
Ramirez NNP O
JA NNP O
, , O
Borras NNP O
J NNP O
, , O
Carugo NNP O
O NNP O
( , O
1995 CD O
) , O
J NNP O
Inorg NNP O
Bioehem NNP O
57 CD O
, , O
219 CD O
- HYPH O
234 CD O
. . O

17 CD O
Sumalan NNP O
SL NNP O
, , O
Casanova NNP O
J NNP O
, , O
Alzuet NNP O
G NNP O
, , O
Borras NNP O
J NNP O
, , O
Castifieiras NNP O
A NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1996 CD O
) , O
J NNP O
Inorg NNP O
Biochem NNP O
62 CD O
, , O
3139 CD O
. . O

18 CD O
a DT O
) : O
Supuran NNP O
CT NNP O
( : O
1995 CD O
) -RRB- O
Metal NNP O
Based NNP O
Drugs NNPS O
2 CD O
, , O
327 CD O
- HYPH O
330 CD O
; : O
b NN O
) : O
Scozzafava NNP O
A NNP O
, , O
Supuran NNP O
CT NNP O
( SYM O
1997 CD O
) -RRB- O
Metal NNP O
Based NNP O
Drugs NNPS O
4 CD O
, , O
19 CD O
- SYM O
26 CD O
. . O

19 CD O
a DT O
) : O
Borras NNP O
J NNP O
, , O
Cristea NNP O
T NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1996 CD O
) -RRB- O
, , O
Main NNP O
Group NNP O
Met NNP O
Chem NNP O
19 CD O
, , O
339 CD O
- HYPH O
346 CD O
; : O
b NN O
) : O
Jitianu NNP O
A NNP O
, , O
Ilies NNP O
MA NNP O
, , O
Briganti NNP O
F NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1997 CD O
) -RRB- O
Metal NNP O
Based NNP O
Drugs NNPS O
4 CD O
, , O
1 CD O
- SYM O
7 CD O
. . O

20 CD O
a DT O
) : O
Supuran NNP O
CT NNP O
, , O
Scozzafava NNP O
A NNP O
( , O
1997 CD O
) , O
J NNP O
Enzyme NNP O
Inhibition NNP O
12 CD O
, , O
37 CD O
- HYPH O
51 CD O
; : O
b NN O
) , O
Supuran NNP O
CT NNP O
, , O
Briganti NNP O
F NNP O
, , O
Scozzafava NNP O
A NNP O
( , O
1997 CD O
) -RRB- O
J NNP O
Enzyme NNP O
Inhibition NNP O
12 CD O
, , O
175 CD O
- HYPH O
190 CD O
. . O

21 CD O
Mincione NNP O
G NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1997 CD O
) -RRB- O
Metal NNP O
Based NNP O
Drugs NNPS O
4 CD O
, , O
27 CD O
- SYM O
34 CD O
. . O

22 CD O
Alzuet NNP O
G NNP O
, , O
Ferrer NNP O
S NNP O
, , O
Borras NNP O
J NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1994 CD O
) -RRB- O
Roum NNP O
Chem NNP O
Quart NNP O
Rev NNP O
2 CD O
, , O
283 CD O
- HYPH O
300 CD O
. . O

23 CD O
Briganti NNP O
F NNP O
, , O
Mangani NNP O
S NNP O
, , O
Orioli NNP O
P NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Vernaglione NNP O
G NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1997 CD O
) -RRB- O
Biochemistry NNP O
36 CD O
, , O
10384 CD O
- HYPH O
10392 CD O
. . O

24 CD O
Borras NNP O
J NNP O
, , O
Casanova NNP O
J NNP O
, , O
Cristea NNP O
T NNP O
, , O
Gheorghe NNP O
A NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Supuran NNP O
CT NNP O
, , O
Tudor NNP O
V NNP O
( , O
1996 CD O
) -RRB- O
Metal NNP O
Based NNP O
Drugs NNPS O
3 CD O
, , O
143 CD O
- HYPH O
148 CD O
. . O

25 CD O
Supuran NNP O
CT NNP O
, , O
Mincione NNP O
F NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Briganti NNP O
F NNP O
, , O
Mincione NNP O
G NNP O
, , O
Ilies NNP O
MA NNP O
( , O
1997 CD O
) SYM O
Eur NNP O
J NNP O
Med NNP O
Chem NNP O
, , O
in IN O

press NN O
. . O

26 CD O
Supuran NNP O
CT NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Saramet NNP O
I NNP O
, , O
Banciu NNP O
MD NNP O
( , O
1997 CD O
) -RRB- O
J NNP O
Enzyme NNP O
Inhibition NNP O
, , O
in IN O
press NN O
. . O

27 CD O
Jitianu NNP O
A NNP O
, , O
Ilies NNP O
MA NNP O
, , O
Scozzafava NNP O
A NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1997 CD O
) : O
Main NNP O
Group NNP O
Met NNP O
Chem NNP O
20 CD O
, , O
151 CD O
- HYPH O
156 CD O
. . O

28 CD O
Forsman NNP O
C NNP O
, , O
Behravan NNP O
G NNP O
, , O
Osterman NNP O
A NNP O
, , O
Jonsson NNP O
BH NNP O
( , O
1988 CD O
) -RRB- O
Acta NNP O
Chem NNP O
Scand NNP O
B42 CD O
, , O
314 CD O
- HYPH O
318 CD O
. . O

29 CD O
Behravan NNP O
G NNP O
, , O
Jonasson NNP O
P NNP O
, , O
Jonsson NNP O
BH NNP O
, , O
Lindskog NNP O
S NNP O
( , O
1991 CD O
) SYM O
Eur NNP O
JBiochem NNP O
198 CD O
, , O
589 CD O
- HYPH O
592 CD O
. . O

30 CD O
Khalifah NNP O
RG NNP O
, , O
Strader NNP O
DJ NNP O
, , O
Bryant NNP O
SH NNP O
, , O
Gibson NNP O
SM NNP O
( , O
1977 CD O
) -RRB- O
Biochemistry NNP O
16 CD O
, , O
2241 CD O
- HYPH O
2247 CD O
. . O

31 CD O
Nyman NNP O
PO NNP O
, , O
Lindskog NNP O
S NNP O
( , O
1964 CD O
) SYM O
Biochim NNP O
Biophys NNP O
Acta NNP O
85 CD O
, , O
141 CD O
- HYPH O
151 CD O
. . O

32 CD O
Henderson NNP O
LE NNP O
, , O
Henriksson NNP O
D NNP O
, , O
Nyman NNP O
PO NNP O
( , O
1976 CD O
) SYM O
JBiol NNP O
Chem NNP O
251 CD O
, , O
5457 CD O
- HYPH O
5463 CD O
. . O

33 CD O
Maren NNP O
TH NNP O
, , O
Wynns NNP O
GC NNP O
, , O
Wistrand NNP O
PJ NNP O
( , O
1993 CD O
) -RRB- O
Mol NNP O
Pharmaco144 NNP O
, , O
901 CD O
- HYPH O
906 CD O
. . O

34 CD O
Young JJ O
RW NNP O
, , O
Wood NNP O
KH NNP O
, , O
Vaughan NNP O
JR NNP O
, , O
Anderson NNP O
GW NNP O
( : O
1956 CD O
) -RRB- O
J NNP O
Am NNP O
Chem NNP O
Soc NNP O
78 CD O
, , O
4649 CD O
- HYPH O
4654 CD O
. . O

35 CD O
Pocker NNP O
Y NNP O
, , O
Stone NNP O
JT NNP O
( , O
1967 CD O
) -RRB- O
Biochemistry NNP O
6 CD O
, , O
668 CD O
- HYPH O
678 CD O
. . O

36 CD O
Baird NNP O
TT NNP O
, , O
Waheed NNP O
A NNP O
, , O
Okuyama NNP O
T NNP O
, , O
Sly NNP O
WS NNP O
, , O
Fierke NNP O
CA NNP O
( , O
1997 CD O
) -RRB- O
Biochemistry NNP O
36 CD O
, , O
2669 CD O
- HYPH O
2678 CD O
. . O

37 CD O
Maren NNP O
TH NNP O
, , O
Bar NNP O
- HYPH O
Ilan NNP O
A NNP O
, , O
Conroy NNP O
CW NNP O
, , O
Brechue NNP O
WF NNP O
( , O
1990 CD O
) -RRB- O
Exp NNP O
Eye NNP O
Res NNP O
50 CD O
, , O
27 CD O
- HYPH O
36 CD O
. . O

38 CD O
Maren NNP O
TH NNP O
, , O
Brechue NNP O
WF NNP O
, , O
Bar NNP O
- HYPH O
Ilan NNP O
A NNP O
( , O
1992 CD O
) SYM O
Exp NNP O
Eye NNP O
Res NNP O
55 CD O
, , O
73 CD O
- HYPH O
79 CD O
. . O

39 CD O
Brechue NNP O
WF NNP O
, , O
Maren NNP O
TH NNP O
( , O
1993 CD O
) -RRB- O
Invest NNP O
Ophthalmol NNP O
Vis NNP O
Sci NNP O
34 CD O
, , O
2581 CD O
- HYPH O
2587 CD O
. . O

40 CD O
Borja NNP O
P NNP O
, , O
Alzuet NNP O
G NNP O
, , O
Server NNP O
- HYPH O
Carri6 NNP O
J NNP O
, , O
Borras NNP O
J NNP O
, , O
Supuran NNP O
CT NNP O
( , O
1997 CD O
) -RRB- O
J NNP O
Biol NNP O
Inorg NNP O
Chem NNP O
( : O
JBIC NNP O
) -RRB- O
, , O
in IN O
press NN O
. . O

41 CD O
Supuran NNP O
CT NNP O
, , O
Balaban NNP O
AT NNP O
, , O
Gheorghiu NNP O
MD NNP O
, , O
Schiketanz NNP O
A NNP O
, , O
Dinculescu NNP O
A NNP O
, , O
Puscas NNP O
I NNP O
( , O
1990 CD O
) -RRB- O
Rev NNP O
Roum NNP O
Chim NNP O
35 CD O
, , O
399 CD O
- HYPH O
405 CD O
. . O

42 CD O
Supuran NNP O
CT NNP O
, , O
Scozzafava NNP O
A NNP O
( , O
1997 CD O
) -RRB- O
unpublished JJ O
results NNS O
. . O

Received VBN O
: : O
September NNP O
24 CD O
, , O
1997 CD O
Accepted VBN O
: : O
October NNP O
17 CD O
, , O
1997 CD O
Received VBN O
in IN O
revised JJ O
camera NN O
- HYPH O
ready JJ O
format NN O
"""" '' O
October NNP O
23 CD O
, , O
1997 CD O

315 CD O

Synthesis NN O
, , O
Characterization NN O
and CC O
Antitumour NN O
Activity NN O
of IN O
Some DT O
Butyltin NNP O
( , O
IV NN O
) -RRB- O
Cysteaminates NNS O
and CC O
N NN O
, , O
N CC O
- HYPH O
Dimethylcysteaminate NN O

Abstract JJ O

The DT O
synthesis NN O
and CC O
characterization NN O
of IN O
four CD O
di NN O
- HYPH O
and CC O
tri NN O
- HYPH O
n CC O
- HYPH O
butyltin NN O
cysteaminates NNS O
and CC O
N NNP O
, , O
N NNP O
- HYPH O
dimethylcysteaminate NN O
and CC O
three CD O
protonated VBN O
/ SYM O
quaternized JJ O
derivatives NNS O
are VBP O
reported VBN O
. . O

They PRP O
all DT O
exhibit VBP O
moderate JJ O
or CC O
high JJ O
in IN O
vitro FW O
cytotoxic JJ O
activity NN O
. . O

Six CD O
of IN O
seven CD O
compounds NNS O
presented VBN O
in IN O
this DT O
work NN O
are VBP O
more RBR O
active JJ O
than IN O
cisplatin NN O
, , O
etoposide NN O
and CC O
5 CD O
- HYPH O
fluorouracil NN O
, , O
but CC O
less RBR O
active JJ O
than IN O
methotrexate NN O
and CC O
doxorubicin NN O
. . O

Metal NN O
Based VBN O
Drugs NNS O

Vol NNP O
. . O

7 CD O
, , O
Nr NNP O
. . O

5 CD O
, , O
2000 CD O

SYNTHESIS NNP O
, , O
CHARACTERIZATION NN O
AND CC O
ANTITUMOUR NN O
ACTITY NN O
OF IN O
SOME DT O
BUTYLTIN NNP O
( , O
IV FW O
) -RRB- O
CYSTEAMINATES NNP O
AND CC O
N NNP O
, , O
N NNP O
- HYPH O
DIMETHYLCYSTEAMINATE NNP O
Marcel NNP O
Gielen NNP O
Karel NNP O
Handlir NNP O
. . O
2 CD O
, , O
Martin NNP O
Hollein NNP O
and CC O
Dick NNP O
de NNP O
Vos NNP O
2 CD O
3 CD O

Departement NNP O
of IN O
General NNP O
and CC O
Organic NNP O
Chemistry NNP O
AOSC NNP O
, , O
Faculty NNP O
of IN O
Applied NNP O
Sciences NNPS O
, , O
Free NNP O
University NNP O
of IN O
Brussels NNP O
VUV NNP O
, , O
Pleinlaan NNP O
2 CD O
, , O
B NNP O
- HYPH O
1050 CD O
Brussels NNP O
, , O
Belgium NNP O
Departement NNP O
of IN O
General NNP O
and CC O
Inorganic NNP O
Chemistry NNP O
, , O
Faculty NNP O
of IN O
Chemical NNP O
Technology NNP O
, , O
University NNP O
of IN O
Pafdubice NNP O
, , O
Nam NNP O
. . O

Cs NNS O
. . O
legii NNP O
565 CD O
, , O
53210 CD O
Pardubice NNP O
, , O
Czech NNP O
Republic NNP O
Pharmachemie NNP O
B NNP O
. . O

V NNP O
. . O
, , O
Haarlem NNP O
, , O
the DT O
Netherlands NNP O
Abstract NNP O
. . O

The DT O
synthesis NN O
and CC O
characterization NN O
of IN O
four CD O
di NN O
- HYPH O
and CC O
tri NN O
- HYPH O
n CC O
- HYPH O
butyltin NN O
cysteaminates NNS O
and CC O
_ HYPH O
N NN O
, , O
N NNP O
- HYPH O
dimethylcysteaminate NN O
and CC O
three CD O
protonated VBN O
/ SYM O
quaternized JJ O
derivatives NNS O
are VBP O
reported VBN O
. . O

They PRP O
all DT O
exhibit VBP O
moderate JJ O
or CC O
high JJ O
in IN O
vitro FW O
cytotoxic JJ O
activity NN O
. . O

Six CD O
of IN O
seven CD O
compounds NNS O
presented VBN O
in IN O
this DT O
work NN O
are VBP O
more RBR O
active JJ O
than IN O
cisplatin NN O
, , O
etoposide NN O
and CC O
5 CD O
- HYPH O
fluorouracil NN O
, , O
but CC O
less RBR O
active JJ O
than IN O
methotrexate NN O
and CC O
doxorubiein NN O
. . O

Introduction NN O
. . O

Several JJ O
organotin NN O
cysteaminates NNS O
( , O
aminoethylthiolates NNS O
) , O
have VBP O
been VBN O
studied VBN O
1 CD O
- SYM O
4 CD O
as IN O
compounds NNS O
with IN O
potentially RB O
high JJ O
biological JJ O
activity NN O
, , O
but CC O
little JJ O
is VBZ O
known VBN O
about IN O
their PRP$ O
cytotoxic JJ O
effect NN O
. . O

The DT O
present JJ O
paper NN O
reports VBZ O
the DT O
synthesis NN O
and CC O
characterization NN O
of IN O
di NN O
- HYPH O
and CC O
tri NN O
- HYPH O
n NN O
- HYPH O
butyltin NN O
cysteaminates NNS O
and CC O
their PRP$ O
N NN O
, , O
N NNP O
- HYPH O
dimethyl NN O
analogues NNS O
and CC O
their PRP$ O
in FW O
vitro FW O
cytotoxicity NN O
. . O

It PRP O
is VBZ O
shown VBN O
that IN O
a DT O
correct JJ O
evaluation NN O
of IN O
the DT O
biological JJ O
activity NN O
of IN O
organotin NN O
compounds NNS O
remains VBZ O
5 CD O
often RB O
hampered VBN O
by IN O
their PRP$ O
low JJ O
water NN O
solubility NN O
. . O

Therefore RB O
, , O
we PRP O
focused VBD O
on IN O
the DT O
synthesis NN O
of IN O
derivatives NNS O
with IN O
potentially RB O
higher JJR O
water NN O
solubility NN O
by IN O
introducing VBG O
ionic JJ O
groups NNS O
into IN O
the DT O
molecule NN O
by IN O
protonation NN O
or CC O
quatemization NN O
of IN O
a DT O
nitrogen NN O
atom NN O
. . O

Results NNS O
and CC O
discussion NN O
. . O

3 LS O

2 LS O

4 LS O

( : O
n NNP O
- HYPH O
Bu NNP O
) : O
n -LRB- O
Sn NN O
[ -LRB- O
SCH2 NN O
- HYPH O
CH2 NN O
- HYPH O
NHm NN O
( : O
CH3 NN O
) -RRB- O
2 CD O
- HYPH O
m NN O
] -RRB- O
4 CD O
- HYPH O
n NN O

n NFP O
= SYM O
3 CD O
, , O
n CD O
= SYM O
3 CD O
, , O
n CD O
= SYM O
2 CD O
, , O
n CD O
= SYM O
2 CD O
, , O

m NN O
= SYM O
2 CD O
m NN O
= NFP O
O NN O
m NN O
= SYM O
2 CD O
m NN O
= SYM O
O NN O

( : O
1 CD O
) SYM O
( : O
2 CD O
) SYM O
( : O
3 CD O
) NFP O
( : O
4 CD O
) NFP O

3 LS O

2 LS O

4 LS O

( NFP O
n NFP O
- HYPH O
Bu NN O
) : O
3 CD O
Sn NN O
S NN O
- HYPH O
CH2 NN O
- HYPH O
CH2 NN O
- HYPH O
NHm NN O
( : O
CH3 NN O
) : O
3 CD O
. . O
m NN O
X NN O

m NN O
= SYM O
3 CD O
, , O
x CD O
= SYM O
cn3so3 CD O
( SYM O
5 CD O
) NFP O
m SYM O
1 CD O
, , O
X NN O
= SYM O
CH3SO3 CD O
( SYM O
6 CD O
) SYM O
m NN O
0 CD O
, , O
X NN O
I CD O
( SYM O
7 CD O
) NN O

n LS O
- : O
Bu NNP O
CH3 NNP O
- HYPH O
CH2 NNP O
- HYPH O
CH2 NNP O
- HYPH O
CH2 NN O

( : O
2 CD O
) NFP O
, , O
di FW O
- HYPH O
nTri NNP O
- HYPH O
n NNP O
- HYPH O
butyltin NN O
cysteaminate NN O
( , O
1 CD O
) -RRB- O
, , O
tri NN O
- HYPH O
n NN O
- HYPH O
butyltin NN O
N NN O
, , O
N NN O
- HYPH O
dimethylcysteaminate NN O
butyltin NN O
bis NN O
( , O
cysteaminate NN O
) -RRB- O
( , O
3 CD O
) -RRB- O
and CC O
di NN O
- HYPH O
n NN O
- HYPH O
butyltin NN O
bis NN O
( , O
N NNP O
, , O
N NNP O
- HYPH O
dimethylcysteaminate NN O
) -RRB- O
( , O
4 CD O
) -RRB- O
were VBD O
prepared VBN O
by IN O
the DT O
reaction NN O
of IN O
the DT O
sodium NN O
cysteaminate NN O
( , O
prepared VBN O
in IN O
situ NN O
by IN O
the DT O
reaction NN O
of IN O
sodium NN O
methylate NN O
with IN O
the DT O
hydrochloride NN O
of IN O
eysteamine NN O
) , O
with IN O
the DT O
suitable JJ O
di NN O
- HYPH O
or CC O
tri NN O
- HYPH O
n NN O
- HYPH O
butyltin NN O
chloride NN O
in IN O
chloroform NN O
following VBG O
reference NN O
by IN O
the DT O
reactions NNS O
of IN O
the DT O
The DT O
methanesulphonates NNS O
5 CD O
and CC O
6 CD O
were VBD O
respectively RB O
synthesized VBN O
equimolar JJ O
amount NN O
of IN O
methane NN O
sulphonic NN O
acid NN O
in IN O
unprotonated JJ O
analogs NNS O
1 CD O
and CC O
2 CD O
with IN O
an DT O
chloroform NN O
. . O

After IN O
purification NN O
on IN O
a DT O
short JJ O
column NN O
of IN O
alumina NN O
and CC O
evaporation NN O
of IN O
the DT O
solvent NN O
, , O
colourless JJ O
viscous JJ O
oils NNS O
were VBD O
obtained VBN O
. . O

The DT O
quaternized JJ O
methyl NN O
derivative NN O
of IN O
2 CD O
, , O
the DT O
methiodide NN O
( , O
7 CD O
) -RRB- O
, , O
was VBD O
prepared VBN O
by IN O
its PRP$ O
reaction NN O
with IN O
methyl NN O
iodide NN O
in IN O
benzene NN O
and CC O
purified VBN O
by IN O
recrystalization NN O
from IN O
chloroform NN O
. . O

233 CD O

M UH O
. . O

Gielen NNP O
, , O
K UH O
. . O

Handlir NNP O
, , O
M NNP O
. . O

Hollein NNP O
and CC O
D NNP O
. . O

de FW O
Vos NNP O
Synthesis NNP O
, , O
Characterization NN O
and CC O
Antitumor NN O
Activity NN O
ofSome IN O
Butyltin NNP O
( , O
IV NN O
) -RRB- O
Cysteaminates NNS O
and CC O
N NN O
, , O
N NNP O
- HYPH O
Dimethylcysteaminate NN O

86 CD O
77 CD O
85 CD O
3 CD O
( SYM O
C4H9 CD O
) SYM O
2Sn CD O
( : O
SCH2CH2NH2 NN O
) SYM O
2 CD O
90 CD O
4 CD O
( SYM O
C4Hg NN O
) : O
zSn NN O
( : O
SCH2CHzN NNP O
( -LRB- O
CH3 NN O
) SYM O
2 CD O
) SYM O
2 CD O
92 CD O
oil NN O
5 CD O
( SYM O
C4H9 CD O
) SYM O
3 CD O
SnSCH2CH2NH3 NN O
CH3SO3 NN O
94 CD O
6 CD O
oil NN O
( SYM O
C4H9 CD O
) SYM O
3 CD O
SnSCH2CH2NH NN O
( -LRB- O
CH3 NN O
) SYM O
2 CD O
CH3SO3 NN O
118 CD O
- HYPH O
120 CD O
74 CD O
7 CD O
( SYM O
C4H9 CD O
) -RRB- O
. , O
SnSCH NNP O
. . O
CH NNP O
. . O
N NN O
( , O
CH3 NNP O
) -RRB- O
31 CD O
The DT O
elemental JJ O
analyses NNS O
( , O
C NNP O
, , O
H NNP O
, , O
N NNP O
, , O
Sn NNP O
) -RRB- O
agree VBP O
satisfactorily RB O
with IN O
the DT O
proposed VBN O
formul NN O

Table NN O
1 CD O
. . O

Melting NN O
points NNS O
and CC O
yields NNS O
for IN O
. . O
. . O
c0mP0unds NNS O
1 CD O
( SYM O
) NFP O
rmula NN O
, , O
2 CD O
comp NN O
. . O

1 CD O
( SYM O
C4H9 NNP O
) -RRB- O
3SnSCHzCH2NH2 CD O
2 CD O
( SYM O
C4H9 CD O
) SYM O
3SnSCHzCH2N NN O
( : O
CH3 NN O
) -RRB- O
2 CD O

7 LS O
. . O

m UH O
. . O
p UH O
. . O
, , O
. . O
. . O
b LS O
. . O
p LS O
. . O
. . O
, , O
. . O
C NNP O
120 CD O
- HYPH O
123 CD O
/ SYM O
40 CD O
Pa NN O
129 CD O
- HYPH O
131 CD O
/ SYM O
35 CD O
Pa NNP O
167 CD O
- HYPH O
169 CD O
/ SYM O
35 CD O
Pa NNP O
172 CD O
- HYPH O
174 CD O
/ SYM O
40 CD O
Pa NN O

' '' O
o XX O
' '' O

yield NN O
, , O
. . O
% NN O

Compounds NNS O
1 CD O
- SYM O
4 CD O
, , O
and CC O
7 CD O
, , O
are VBP O
poorly RB O
soluble JJ O
in IN O
aqueous JJ O
solutions NNS O
( : O
< : O
mg NN O
/ SYM O
mL NNP O
) -RRB- O
. . O

Compounds NNS O
5 CD O
and CC O
6 CD O
exhibit VBP O
higher JJR O
water NN O
solubilities NNS O
( , O
ca FW O
. . O
2 CD O
mg NN O
/ SYM O
mL NN O
) -RRB- O
. . O

Compounds NNS O
1 CD O
7 CD O
are VBP O
soluble JJ O
in IN O
a DT O
therapeutic JJ O
solution NN O
( , O
0 CD O
, , O
103 CD O
M NN O
solution NN O
of IN O
NaCl NNP O
in IN O
water NN O
/ SYM O
DMSO NNP O
1 CD O
/ SYM O
9 CD O
) -RRB- O
. . O

A DT O
white JJ O
turbidity NN O
appears VBZ O
in IN O
these DT O
solutions NNS O
only RB O
after IN O
several JJ O
hours NNS O
due JJ O
to IN O
slow JJ O
hydrolysis NN O
. . O

Compounds NNS O
1 CD O
7 CD O
were VBD O
characterized VBN O
by IN O
multinuclear JJ O
NMR NNP O
spectroscopy NN O
. . O

The DT O
NMR NNP O
parameters NNS O
are VBP O
given VBN O
in IN O
Table NNP O
2 CD O
. . O

Table NN O
2 CD O
. . O

Resonances NNS O
of IN O
13C CD O
, , O
( , O
ca MD O
20 CD O
% NN O
sol NN O
. . O
v NN O
/ SYM O
v NN O
) SYM O
1 CD O
' '' O
compound NN O

SN NNP O
and CC O
ll9Sn NN O
NMR NNP O
spectra NN O
of IN O
2 CD O

the DT O
compounds NNS O
1 CD O
- HYPH O
7 CD O
in IN O
CDCI3 NN O
5 CD O
86 CD O
. . O
3 CD O
13 CD O
. . O
45 CD O

6 CD O
' '' O
' '' O
S NN O
' '' O
n NN O
) -RRB- O
, , O
"""" `` O
ppm NN O
6 CD O
( SYM O
3c CD O
) SYM O
a DT O
, , O
ppm NN O

x LS O

77 CD O
. . O
6 CD O
12 CD O
. . O
3 CD O

77 CD O
. . O
5 CD O
12 CD O
. . O
75 CD O

3 CD O
- SYM O
28 CD O
. . O
9 CD O
22 CD O
. . O
38 CD O

38 CD O
. . O
' '' O
18 CD O
. . O
78 CD O

4 LS O

6 CD O
' '' O
' '' O
89 CD O
. . O
5 CD O
13 CD O
. . O
45 CD O

7 CD O
93 CD O
. . O
2 CD O
13 CD O
. . O
60 CD O

( : O
332 CD O
) SYM O
27 CD O
. . O
93 CD O

( : O
331 CD O
) SYM O
27 CD O
. . O
97 CD O

( : O
495 CD O
) SYM O
28 CD O
. . O
27 CD O

( : O
438 CD O
) SYM O
27 CD O
. . O
51 CD O

( : O
322 CD O
) SYM O
28 CD O
. . O
30 CD O

( : O
350 CD O
) SYM O
28 CD O
. . O
34 CD O

( : O
339 CD O
) SYM O
28 CD O
. . O
47 CD O

( : O
21 CD O
. . O
3 CD O
) SYM O
26 CD O
. . O
32 CD O

( : O
21 CD O
. . O
1 CD O
) SYM O
26 CD O
. . O
38 CD O

( : O
28 CD O
. . O
4 CD O
) SYM O
26 CD O
. . O
42 CD O

( : O
26 CD O
. . O
4 CD O
) SYM O
25 CD O
. . O
90 CD O

( : O
21 CD O
. . O
4 CD O
) SYM O
26 CD O
. . O
85 CD O

( : O
21 CD O
. . O
3 CD O
) SYM O
26 CD O
. . O
81 CD O

( : O
22 CD O
. . O
0 CD O
) SYM O
26 CD O
. . O
91 CD O

( : O
59 CD O
. . O
6 CD O
) SYM O
12 CD O
. . O
89 CD O

( : O
59 CD O
. . O
8 CD O
) SYM O
12 CD O
. . O
95 CD O

( : O
87 CD O
. . O
1 CD O
) SYM O
13 CD O
. . O
35 CD O

( : O
83 CD O
. . O
8 CD O
) SYM O
12 CD O
. . O
82 CD O

( : O
62 CD O
. . O
7 CD O
) SYM O
13 CD O
. . O
45 CD O

( : O
61 CD O
. . O
4 CD O
) SYM O
13 CD O
. . O
58 CD O

62 CD O
. . O
2 CD O
) SYM O
14 CD O
. . O
0 NFP O

( NFP O
- : O
) SYM O
30 CD O
. . O
31 CD O
45 CD O
. . O
2 CD O

( : O
- : O
) SYM O
23 CD O
. . O
59 CD O
63 CD O
. . O
12 CD O
44 CD O
. . O
71 CD O

( NFP O
- : O
) SYM O
30 CD O
. . O
4 CD O
44 CD O
. . O
44 CD O

( NFP O
- : O
) SYM O
23 CD O
. . O
84 CD O
61 CD O
. . O
84 CD O
44 CD O
. . O
46 CD O

( NFP O
- : O
) SYM O
23 CD O
. . O
92 CD O
43 CD O
. . O
8 CD O

( : O
- : O
; : O

( NFP O
- : O
) -RRB- O

20 CD O
. . O
94 CD O
19 CD O
. . O
70 CD O
60 CD O
. . O
94 CD O
69 CD O
. . O
49 CD O
43 CD O
. . O
42 CD O
54 CD O
. . O
18 CD O
39 CD O
. . O
15 CD O
39 CD O
. . O
16 CD O
- HYPH O
360 CD O
. . O
4 CD O
- HYPH O
354 CD O
. . O
0 CD O
- HYPH O
355 CD O
. . O
3 CD O
- HYPH O
354 CD O
. . O
4 CD O
- HYPH O
349 CD O
. . O
4 CD O
- HYPH O
344 CD O
. . O
2 CD O
- HYPH O
325 CD O
. . O
8 CD O
1 CD O
. . O
1 CD O
6 CD O
. . O
2 CD O
1 CD O
. . O
5 CD O
1 CD O
. . O
5 CD O
12 CD O
. . O
7 CD O
11 CD O
. . O
7 CD O
30 CD O
. . O
1 CD O
13 CD O
a NN O
' IN O
values NNS O
of IN O
nJ NN O
( : O
n NN O
J NN O
9 CD O
Sn NN O
, , O
, , O
C NN O
) , O
c0uplihg NN O
constants NNS O
in IN O
Hz NN O
' '' O
for IN O
Carbon NN O
ato NN O
] -RRB- O
ns VBZ O
in IN O
parentlee NN O
' '' O
s NN O
difference NN O
btween NN O
( , O
N NN O
) -RRB- O
for IN O
the DT O
organo NN O
. . O
i PRP O
compound VBP O
and CC O
free JJ O
cysteamine NN O
, , O
6 CD O
( SYM O
N CD O
) SYM O
361 CD O
. . O
5 CD O
ppm NN O
; : O
N NNP O
, , O
N NNP O
- HYPH O
dimethylcysteamine NN O
, , O
5 CD O
( HYPH O
N NNP O
) -RRB- O
- : O
355 CD O
. . O
9 CD O
ppm NN O
) -RRB- O
not RB O
observed VBN O

C NN O
resonances NNS O
were VBD O
assigned VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
values NNS O
of IN O
n NNP O
J NNP O
( SYM O
119 CD O
Sn NNP O
, , O
13 CD O
C NN O
) -RRB- O
coupling NN O
constants NNS O
and CC O
standard JJ O
13 CD O
C NN O
- HYPH O
APT NN O
techniques NNS O
utilization NN O
in IN O
agreement NN O
with IN O
ref NN O
. . O
. . O

The DT O
values NNS O
of IN O
119 CD O
Sn JJ O
chemical NN O
shifts NNS O
are VBP O
found VBN O
in IN O
the DT O
interval NN O
characteristic JJ O
for IN O
fourcoordinated VBN O
tin NN O
6 CD O
, , O
7 CD O
. . O

The DT O
values NNS O
of IN O
the DT O
coupling NN O
constants NNS O
j JJ O
( -LRB- O
1 CD O
lqSn NNP O
, , O
13C CD O
) -RRB- O
agree VBP O
with IN O
the DT O
structure NN O
proposed VBN O
. . O

Compound NN O
3 CD O
is VBZ O
characterized VBN O
by IN O
a DT O
somewhat RB O
larger JJR O
upfield JJ O
shift NN O
, , O
close RB O
to IN O
the DT O
upper JJ O
limit NN O
of IN O
the DT O
above JJ O
mentioned VBN O
interval NN O
, , O
together RB O
with IN O
a DT O
high JJ O
value NN O
of IN O
1j CD O
( HYPH O
l FW O
lqSn FW O
, , O
13C CD O
) -RRB- O
( : O
495 CD O
Hz NN O
) -RRB- O
. . O

67 CD O
The DT O
C NNP O
- HYPH O
Sn NNP O
- HYPH O
C NNP O
angle NN O
, , O
est NN O
' '' O
mated VBN O
, , O
from IN O
this DT O
value NN O
of IN O
coupling NN O
constant JJ O
is VBZ O
124 CD O
According VBG O
to IN O
ref NN O
. . O
this DT O
behaviour NN O
can MD O
be VB O
due JJ O
to IN O
intermolecular JJ O
association NN O
increasing VBG O
the DT O
coordinatitn JJ O
number NN O
of IN O
tin NN O
in IN O
concentrated JJ O
solutions NNS O
, , O
as IN O
suggested VBN O
by IN O
the DT O
concentration NN O
dependence NN O
of IN O
tS NN O
( : O
Sn NN O
) -RRB- O
and CC O
cryoscopic JJ O
measurements NNS O
in IN O
benzene NN O
. . O

The DT O
values NNS O
of IN O
the DT O
6 CD O
( , O
SN NNP O
) -RRB- O
chemical NN O
shifts NNS O
of IN O
compounds NNS O
1 CD O
, , O
2 CD O
and CC O
4 CD O
only RB O
slightly RB O
differ VBP O
from IN O
the DT O
( -LRB- O
15N CD O
) -RRB- O
values NNS O
of IN O
the DT O
free JJ O
cysteamine NN O
. . O

The DT O
significantly RB O
larger JJR O
i NN O
( -LRB- O
15N CD O
) -RRB- O
chemical NN O
shift NN O
of IN O
compound NN O
3 CD O
is VBZ O
however RB O
much RB O
lower JJR O
than IN O
those DT O
of IN O
compounds NNS O
5 CD O
, , O
6 CD O
and CC O
7 CD O
containing VBG O
a DT O
N NN O
interaction NN O
in IN O
compounds NNS O
1 CD O
tetracoordinated JJ O
nitrogen NN O
atom NN O
. . O

It PRP O
can MD O
be VB O
stated VBN O
that IN O
the DT O
Sn NNP O
4 CD O
is VBZ O
negligible JJ O
or CC O
only RB O
very RB O
weak JJ O
in IN O
chlorofom NN O
solutions NNS O
. . O

This DT O
conclusion NN O
is VBZ O
not RB O
in IN O
contradiction NN O
with IN O
the DT O
proved VBN O
Sn NNP O
N NNP O
interaction NN O
found VBN O
in IN O
the DT O
solid JJ O
state NN O
8 CD O
. . O

13 CD O

. . O

, , O

234 CD O

Metal NN O
Based VBN O
Drugs NNS O

Vol NNP O
. . O

7 CD O
, , O
Nr NNP O
. . O

5 CD O
, , O
2000 CD O

Antitumour NN O
activity NN O
. . O

The DT O
results NNS O
of IN O
the DT O
in FW O
vitro FW O
antitumour NN O
tests NNS O
of IN O
compounds NNS O
1 CD O
7 CD O
are VBP O
given VBN O
in IN O
Table NNP O
3 CD O
as IN O
the DT O
inhibition NN O
doses NNS O
IDs0 NN O
observed VBD O
against IN O
a DT O
panel NN O
of IN O
seven CD O
human JJ O
tumour NN O
cell NN O
lines NNS O
, , O
MCF NNP O
- HYPH O
7 CD O
and CC O
EVSA NNP O
- HYPH O
T NNP O
, , O
two CD O
breast NN O
cancers NNS O
, , O
WiDr NNP O
, , O
a DT O
colon NN O
cancer NN O
, , O
IGROV NNP O
, , O
an DT O
ovarian JJ O
cancer NN O
, , O
M19 NNP O
MEL NNP O
, , O
a DT O
melanoma NN O
, , O
A248 CD O
, , O
a DT O
renal JJ O
cancer NN O
, , O
and CC O
H226 CD O
, , O
a DT O
non NN O
- HYPH O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

The DT O
antitumour NN O
tests NNS O
results NNS O
are VBP O
compared VBN O
with IN O
those DT O
obtained VBN O
for IN O
clinically RB O
used VBN O
reference NN O
compounds9 NN O
like IN O
cisplatin NN O
, , O
doxorubicin NN O
, , O
etoposide NN O
, , O
5 CD O
- HYPH O
fluorouracil NN O
and CC O
methotrexate NN O
. . O

Table NN O
3 CD O
. . O

Inhibition NN O
doses NNS O

comp NN O
. . O

1 CD O
2 CD O
3 CD O
4 CD O
5 CD O
6 CD O
7 CD O

MF NNP O
- HYPH O
7 CD O
41 CD O
41 CD O
51 CD O
78 CD O
30 CD O
90 CD O
385 CD O
699 CD O
10 CD O
2 CD O
594 CD O
750 CD O
18 CD O

EVSA NNP O
- HYPH O
T NNP O
33 CD O
35 CD O
45 CD O
65 CD O
< CD O
3 CD O
57 CD O
367 CD O

IDs0 NN O
of IN O
compounds NNS O
WiDr NNP O
39 CD O
39 CD O
211 CD O
331 CD O
19 CD O
40 CD O
339 CD O

1 CD O
- SYM O
7 CD O
and CC O
of IN O
five CD O
reference NN O
compounds NNS O
. . O

IGROV NNP O
M19MEL NNP O
A498 CD O
H226 CD O
67 CD O
44 CD O
85 CD O
39 CD O
46 CD O
78 CD O
88 CD O
39 CD O
68 CD O
70 CD O
118 CD O
72 CD O
110 CD O
129 CD O
108 CD O
112 CD O
31 CD O
29 CD O
36 CD O
42 CD O
83 CD O
133 CD O
77 CD O
111 CD O
327 CD O
758 CD O
576 CD O
411 CD O
169 CD O
60 CD O
580 CD O
297 CD O
7 CD O
558 CD O
16 CD O
505 CD O
442 CD O
23 CD O

cisplatin NN O
doxorubicin NN O

etoposide NN O
5 CD O
- HYPH O
fluorouracil NN O

422 CD O
8 CD O
317 CD O
475 CD O
5 CD O

methotrexate NN O

967 CD O
11 CD O
150 CD O
225 CD O
< CD O
3 CD O

2 CD O
253 CD O
90 CD O
314 CD O
143 CD O
37 CD O

3 CD O
369 CD O
199 CD O
3 CD O
934 CD O
340 CD O
2 CD O
287 CD O

It PRP O
is VBZ O
evident JJ O
from IN O
Table NNP O
3 CD O
that IN O
all DT O
studied VBN O
compounds NNS O
exhibit VBP O
excellent JJ O
cytostatic JJ O
activities NNS O
, , O
except IN O
compound NN O
7 CD O
showing VBG O
only RB O
moderate JJ O
activity NN O
. . O

Compounds NNS O
1 CD O
6 CD O
are VBP O
more RBR O
active JJ O
than IN O
cisplatin NN O
and CC O
, , O
in IN O
most JJS O
cases NNS O
, , O
than IN O
etoposide NN O
and CC O
5 CD O
- HYPH O
fluorouracil NN O
. . O

Their PRP$ O
activity NN O
is VBZ O
lower JJR O
than IN O
that DT O
of IN O
doxorubicin NN O
and CC O
methotrexate NN O
in IN O
most JJS O
cases NNS O
for IN O
the DT O
studied VBN O
cancer NN O
cell NN O
lines NNS O
. . O

The DT O
very RB O
limited JJ O
set NN O
of IN O
acquired VBN O
activity NN O
values NNS O
show VBP O
that IN O
the DT O
activity NN O
of IN O
tri NN O
- HYPH O
n NN O
- HYPH O
butyltin NN O
are VBP O
higher JJR O
than IN O
those DT O
of IN O
di NN O
- HYPH O
n NN O
- HYPH O
butyl NN O
analogues NNS O
( , O
1 CD O
> SYM O
3 CD O
, , O
2 CD O
> SYM O
4 CD O
) -RRB- O
for IN O
all DT O
cell NN O
lines NNS O
, , O
especially RB O
compounds NNS O
against IN O
WiDr NNP O
. . O

The DT O
N NNP O
, , O
N CD O
- HYPH O
dimethyl NN O
derivatives NNS O
exhibit VBP O
an DT O
activity NN O
comparable JJ O
to IN O
or CC O
somewhat RB O
higher JJR O
than IN O
that DT O
of IN O
unmethylated JJ O
compounds NNS O
. . O

Compound NN O
8 CD O
, , O
with IN O
a DT O
quaternized JJ O
nitrogen NN O
, , O
exhibits VBZ O
the DT O
lowest JJS O
cytotoxic JJ O
activities NNS O
, , O
approximatively RB O
9 CD O
times NNS O
lower JJR O
than IN O
compound NN O
2 CD O
. . O

It PRP O
might MD O
be VB O
underlined VBN O
that IN O
the DT O
ionic JJ O
more JJR O
water NN O
- HYPH O
soluble JJ O
compounds NNS O
5 CD O
and CC O
6 CD O
are VBP O
not RB O
more RBR O
active JJ O
than IN O
the DT O
uncharged JJ O
analogs NNS O
1 CD O
- HYPH O
4 CD O
, , O
whereas IN O
the DT O
hydrophilic JJ O
organotin NN O
polyoxacarboxylates NNS O
exhibit VBP O
much RB O
higher JJR O
in IN O
vitro FW O
activities NNS O
than IN O
other JJ O
organotin NN O
carxylates NNS O
51 CD O
Compounds NNS O
5 CD O
and CC O
6 CD O
( , O
with IN O
a DT O
protonated VBN O
nitrogen NN O
) , O
exhibit NN O
activities NNS O
comparable JJ O
or CC O
even RB O
considerably RB O
higher JJR O
( , O
compound NN O
5 CD O
) -RRB- O
against IN O
EVSA NNP O
- HYPH O
T NNP O
than IN O
the DT O
corresponding VBG O
unprotonated JJ O
compounds NNS O
. . O

Compound NN O
7 CD O
( , O
with IN O
a DT O
quaternized JJ O
nitrogen NN O
) , O
exhibits VBZ O
the DT O
lowest JJS O
cytostatic JJ O
activities NNS O
, , O
approximately RB O
9 CD O
times NNS O
should MD O
however RB O
be VB O
mentioned VBN O
that IN O
another DT O
ionic JJ O
organotin NN O
lower JJR O
than IN O
compound NN O
2 CD O
. . O

It PRP O
compound VBP O
, , O
bis NN O
( , O
dicyclohexyl NN O
) , O
ammonium NN O
bis NN O
( , O
2 CD O
, , O
6 CD O
- HYPH O
pyridinecarboxyla NN O
, , O
to IN O
) NFP O
di FW O
- HYPH O
n CC O
- HYPH O
butylstannate NN O
, , O
where WRB O
the DT O
organotin NN O
moiety NN O
is VBZ O
this DT O
time NN O
anionic JJ O
, , O
is VBZ O
also RB O
as RB O
active JJ O
as IN O
the DT O
uncharged JJ O
analog NN O
l NN O
. . O

All DT O
NMR NNP O
spectra NN O
were VBD O
recorded VBN O
on IN O
a DT O
Bruker NNP O
AMX NNP O
360 CD O
instrument NN O
using VBG O
a DT O
5 CD O
mm NN O
multinuclear JJ O
tuneable JJ O
probe NN O
. . O

The DT O
residual JJ O
CHCI3 NNP O
resonance NN O
at IN O
7 CD O
. . O
24 CD O
ppm NN O
was VBD O
used VBN O
as IN O
reference NN O
for IN O
the DT O
H NN O
soectra NN O
and CC O
the DT O
central JJ O
13CDCI3 CD O
resonance NN O
at IN O
77 CD O
. . O
0 CD O
ppm NN O
, , O
for IN O
the DT O
13C CD O
spectra NN O
. . O

The DT O
119 CD O
Sn JJ O
chemical NN O
shifts NNS O
were VBD O
refered VBN O
to IN O
the DT O
external JJ O
tetramethyltin NN O
[ -LRB- O
6 CD O
( SYM O
119 CD O
Sn CD O
) SYM O
0 CD O
. . O
0 CD O
] -RRB- O
. . O

The DT O
15N CD O
NMR NNP O
spectra NN O
were VBD O
measur NN O
; : O
l DT O
using VBG O
the DT O
INEPT NNP O
technique NN O
or CC O
in IN O
inverse JJ O
- HYPH O
gated VBN O
mode NN O
. . O

( : O
reference NN O
: : O
Instrumentation NN O
. . O

external JJ O
nitromethane NN O
, , O
[ -LRB- O
5 CD O
( , O
' '' O
N NN O
) SYM O
0 CD O
. . O
0 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
protocol NN O
followed VBD O
for IN O
the DT O
in FW O
vitro FW O
antitumour NN O
screenings NNS O
has VBZ O
been VBN O
already RB O
reported VBN O
10 CD O
. . O

Acknowledgements NNS O
. . O

K UH O
. . O

H UH O
. . O
and CC O
M NNP O
H NNP O
. . O
thank VBP O
the DT O
Grant NNP O
Agency NNP O
of IN O
the DT O
Czech NNP O
Republic NNP O
( , O
Grant NNP O
No NNP O
. . O
203 CD O
/ SYM O
0 CD O
/ SYM O
920 CD O
) -RRB- O
and CC O
the DT O
Ministry NNP O
o '' O
"""" `` O
Education NNP O
, , O
Youth NNP O
and CC O
Sport NNP O
of IN O
the DT O
Czech NNP O
republic NNP O
, , O
associated VBN O
with IN O
EU NNP O
in IN O
the DT O
COST NNP O
8 CD O
. . O
20 CD O
program NN O
for IN O
financial JJ O
support NN O
of IN O
this DT O
work NN O
. . O

We PRP O
are VBP O
grateful JJ O
to IN O
Mr NNP O
. . O
R NNP O
. . O

G NNP O
. . O

Experimental NNP O
Oostrum NNP O
, , O
Dr NNP O
. . O
J NNP O
. . O
verweij NNP O
, , O
Prof NNP O
. . O

Dr NNP O
. . O
G NNP O
. . O

Stoter NNP O
, , O
r UH O
. . O
K UH O
. . O

Nooter NNP O
, , O
Laboratory NNP O
of IN O
Chemotherapy NNP O
and CC O
Pharmacology NNP O
, , O
Department NNP O
of IN O
Medical NNP O
Oncology NNP O
, , O
Rotterdam NNP O
Cancer NNP O
235 CD O

M UH O
. . O

Gielen NNP O
, , O
K UH O
. . O

Handlir NNP O
, , O
M NNP O
. . O

HoHein NNP O
and CC O
D NNP O
. . O

de FW O
Vos NNP O
Synthesis NNP O
, , O
Characterization NN O
and CC O
Antitumor NN O
Activity NN O
ofSome IN O
Butyltin NNP O
( , O
IV NN O
) -RRB- O
Cysteaminates NNS O
and CC O
N NN O
, , O
N NNP O
- HYPH O
Dimethylcysteaminate NN O

Institute NNP O
, , O
NL NNP O
3008 CD O
AE NNP O
, , O
Rotterdam NNP O
, , O
The DT O
Netherlands NNP O
, , O
for IN O
performing VBG O
the DT O
in FW O
vitro FW O
tests NNS O
. . O

This DT O
research NN O
was VBD O
supported VBN O
by IN O
the DT O
Fund NNP O
for IN O
Scientific NNP O
Research NNP O
Flanders NNP O
( -LRB- O
Belgium NNP O
) -RRB- O
, , O
grant NN O
nr NNP O
G NNP O
. . O
74 CD O
. . O
0 NFP O
, , O
M NNP O
. . O

G NNP O
. . O
) -RRB- O
. . O

References NNS O
. . O

1 LS O
. . O

B NN O
. . O
S NN O
. . O

Saraswat NNP O
, , O
J NNP O
. . O

Mason NNP O
, , O
Polyhedron NNP O
( , O
9 CD O
) -RRB- O
, , O
5 CD O
( SYM O
1986 CD O
) -RRB- O
, , O
1449 CD O
. . O

2 LS O
. . O

G NNP O
. . O

Domazetis NNP O
, , O
R NNP O
. . O

J NNP O
. . O

Magee NNP O
, , O
B NNP O
. . O

D NNP O
. . O

James NNP O
, , O
J NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
, , O
162 CD O
( , O
1978 CD O
) -RRB- O
, , O
239 CD O
. . O

3 LS O
. . O

J NNP O
. . O
D NN O
. . O

Cashion NNP O
, , O
G NNP O
. . O

Domazetis NNP O
, , O
B NNP O
. . O

D NNP O
. . O

James NNP O
, , O
J NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
, , O
185 CD O
( , O
1980 CD O
) -RRB- O
, , O
433 CD O
. . O

4 LS O
. . O

G NNP O
. . O

Domazetis NNP O
, , O
R NNP O
. . O

J NNP O
. . O

Magee NNP O
, , O
B NNP O
. . O

D NNP O
. . O

James NNP O
, , O
J NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
, , O
148 CD O
( , O
1978 CD O
) -RRB- O
, , O
339 CD O
. . O

5 LS O
. . O

G NNP O
. . O

Atassi NNP O
, , O
Rev NNP O
. . O

Si NNP O
Ge NNP O
Sn NNP O
Pb NNP O
Cpds NNP O
, , O
8 CD O
( , O
1985 CD O
) -RRB- O
, , O
219 CD O
; : O
M NN O
. . O

Kemmer NNP O
, , O
M NNP O
. . O

Gielen NNP O
, , O
M NNP O
. . O

Biesemans NNP O
, , O
D NNP O
. . O

de FW O
Vos NNP O
, , O
R NN O
. . O

Willem NNP O
, , O
Metal NNP O
- HYPH O
Based NNP O
Drugs NNPS O
5 CD O
( SYM O
1998 CD O
) -RRB- O
, , O
189 CD O
; : O
M NN O
. . O

Gielen NNP O
, , O
M NNP O
. . O

Biesemans NNP O
, , O
D NNP O
. . O

de FW O
Vos NNP O
, , O
R NN O
. . O

Willem NNP O
, , O
J NNP O
. . O

Inorg NNP O
. . O

Biochem NNP O
. . O
, , O
79 CD O
( , O
2000 CD O
) -RRB- O
, , O
139 CD O
. . O

6 LS O
. . O

J NNP O
. . O

Holecek NNP O
, , O
A NNP O
. . O

Lycka NNP O
, , O
Inorg NNP O
. . O

Chim NNP O
. . O

Acta NNP O
, , O
118 CD O
( , O
1986 CD O
) -RRB- O
, , O
L NN O
15 CD O
. . O

7 LS O
. . O

J NNP O
. . O

Holecek NNP O
, , O
M NNP O
. . O

Nadvomik NNP O
, , O
K UH O
. . O

Handlir NNP O
, , O
A NNP O
. . O

Lycka NNP O
, , O
J NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
. . O
, , O
315 CD O
( , O
1986 CD O
) -RRB- O
, , O
299 CD O
. . O

8 LS O
. . O

B NN O
. . O
D NN O
. . O

James NNP O
, , O
R NNP O
. . O

J NNP O
. . O

Magee NNP O
, , O
W NNP O
. . O

C NN O
. . O

Patalinghug NNP O
, , O
B NNP O
. . O

W UH O
. . O

Skelton NNP O
, , O
A NNP O
. . O

H NN O
. . O

White JJ O
, , O
J NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
, , O
467 CD O
( , O
1994 CD O
) CD O
, , O
51 CD O
9 CD O
. . O

P NN O
. . O

Skehan NNP O
, , O
R NNP O
. . O

Storeng NNP O
, , O
D NNP O
. . O

Scudiero NNP O
, , O
A NNP O
. . O

Monks NNS O
, , O
J NNP O
. . O

McMahon NNP O
, , O
D NNP O
. . O

Vistica NNP O
, , O
J NNP O
. . O

T NNP O
. . O

Warren NNP O
, , O
H NNP O
. . O

Bokesh NNP O
, , O
S NNP O
. . O

Kenney NNP O
, , O
M NNP O
. . O

R NN O
. . O

Boyd NNP O
, , O
J NNP O
. . O
. . O

Natl NNP O
. . O

Cancer NN O
lnst NN O
. . O
, , O
82 CD O
( , O
1990 CD O
) -RRB- O
, , O
1107 CD O
. . O

10 CD O
. . O

Y UH O
. . O

P NN O
. . O

Kepers NNP O
, , O
G NNP O
. . O

J NNP O
. . O

Peters NNP O
, , O
J NNP O
. . O

Van NNP O
Ark NNP O
- HYPH O
Otte NNP O
, , O
B NNP O
. . O

Winograd NNP O
, , O
H NNP O
. . O

M UH O
. . O

Pinedo NNP O
, , O
Eur NNP O
. . O

J NNP O
. . O

Cancer NNP O
, , O
27 CD O
( , O
1991 CD O
) -RRB- O
, , O
897 CD O
. . O

11 CD O
. . O

M UH O
. . O

Kemmer NNP O
, , O
L NNP O
. . O

Ghys NNP O
, , O
M NNP O
. . O

Gielen NNP O
, , O
M NNP O
. . O

Biesemans NNP O
, , O
E NNP O
. . O

R NN O
. . O

T NNP O
. . O

Tiekink NNP O
, , O
R NNP O
. . O

Willem NNP O
, , O
J NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
. . O

582 CD O
( SYM O
1999 CD O
) -RRB- O
, , O
195 CD O
. . O

12 CD O
. . O

S UH O
. . O

W UH O
. . O

Ng UH O
, , O
V NN O
. . O

G NNP O
. . O

Kumar NNP O
Das NNP O
, , O
J NNP O
. . O

Holecek NNP O
, , O
A NNP O
. . O

Lycka NNP O
, , O
M NNP O
. . O

Gielen NNP O
, , O
M NNP O
. . O

G NNP O
. . O

B NN O
. . O

Drew NNP O
, , O
Appl NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
. . O

11 CD O
( SYM O
1997 CD O
) NN O
, , O
3 CD O
9 CD O
. . O

Received VBN O
"""" `` O
September NNP O
22 CD O
, , O
2000 CD O
Accepted VBN O
- : O
October NNP O
19 CD O
, , O
2000 CD O
Received VBN O
in IN O
revised JJ O
camera NN O
- HYPH O
ready JJ O
format NN O
- : O
October NNP O
20 CD O
, , O
2000 CD O

236 CD O

Genomic JJ O
- HYPH O
Bioinformatic JJ O
Analysis NN O
of IN O
Transcripts NNS O
Enriched VBN O
in IN O
the DT O
Third JJ O
- HYPH O
Stage NN O
Larva NN O
of IN O
the DT O
Parasitic JJ O
Nematode NN O
Ascaris NN B-Species
suum NN I-Species

Abstract JJ O

Differential JJ O
transcription NN O
in IN O
Ascaris NNP B-Species
suum NN I-Species
was VBD O
investigated VBN O
using VBG O
a DT O
genomic JJ O
- HYPH O
bioinformatic JJ O
approach NN O
. . O

A DT O
cDNA NNP O
archive NN O
enriched VBN O
for IN O
molecules NNS O
in IN O
the DT O
infective JJ O
third JJ O
- HYPH O
stage NN O
larva NN O
( , O
L3 NNP O
) -RRB- O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
was VBD O
constructed VBN O
by IN O
suppressive JJ O
- HYPH O
subtractive JJ O
hybridization NN O
( , O
SSH NNP O
) -RRB- O
, , O
and CC O
a DT O
subset NN O
of IN O
cDNAs NNS O
from IN O
3075 CD O
clones NNS O
subjected VBN O
to IN O
microarray JJ O
analysis NN O
using VBG O
cDNA NN O
probes NNS O
derived VBN O
from IN O
RNA NNP O
from IN O
different JJ O
developmental JJ O
stages NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
. . O

The DT O
cDNAs NNS O
( -LRB- O
n CD O
= SYM O
498 CD O
) -RRB- O
shown VBN O
by IN O
microarray NN O
analysis NN O
to TO O
be VB O
enriched VBN O
in IN O
the DT O
L3 NNP O
were VBD O
sequenced VBN O
and CC O
subjected VBN O
to IN O
bioinformatic JJ O
analyses NNS O
using VBG O
a DT O
semi NN O
- HYPH O
automated VBN O
pipeline NN O
( , O
ESTExplorer NNP O
) -RRB- O
. . O

Using VBG O
gene NN O
ontology NN O
( -LRB- O
GO NNP O
) -RRB- O
, , O
235 CD O
of IN O
these DT O
molecules NNS O
were VBD O
assigned VBN O
to IN O
' `` O
biological JJ O
process NN O
' '' O
( , O
n CD O
= SYM O
68 CD O
) -RRB- O
, , O
' `` O
cellular JJ O
component NN O
' '' O
( , O
n NN O
= SYM O
50 CD O
) -RRB- O
, , O
or CC O
' `` O
molecular JJ O
function NN O
' '' O
( : O
n CD O
= SYM O
117 CD O
) -RRB- O
. . O

Of IN O
the DT O
91 CD O
clusters NNS O
assembled VBN O
, , O
56 CD O
molecules NNS O
( , O
61 CD O
. . O
5 CD O
% NN O
) -RRB- O
had VBD O
homologues NNS O
/ SYM O
orthologues NNS O
in IN O
the DT O
free RB O
- HYPH O
living VBG O
nematodes NNS O
Caenorhabditis NNP B-Species
elegans NNS I-Species
and CC O
C NN B-Species
. . I-Species
briggsae NNP I-Species
and CC O
/ SYM O
or CC O
other JJ O
organisms NNS O
, , O
whereas IN O
35 CD O
( SYM O
38 CD O
. . O
5 CD O
% NN O
) -RRB- O
had VBD O
no DT O
significant JJ O
similarity NN O
to IN O
any DT O
sequences NNS O
available JJ O
in IN O
current JJ O
gene NN O
databases NNS O
. . O

Transcripts NNS O
encoding VBG O
protein NN O
kinases NNS O
, , O
protein NN O
phosphatases NNS O
( , O
and CC O
their PRP$ O
precursors NNS O
) -RRB- O
, , O
and CC O
enolases NNS O
were VBD O
abundantly RB O
represented VBN O
in IN O
the DT O
L3 NNP O
of IN O
A NN B-Species
. . I-Species
suum NNP I-Species
, , O
as IN O
were VBD O
molecules NNS O
involved VBN O
in IN O
cellular JJ O
processes NNS O
, , O
such JJ O
as IN O
ubiquitination NN O
and CC O
proteasome NN O
function NN O
, , O
gene NN O
transcription NN O
, , O
protein NN O
- HYPH O
protein NN O
interactions NNS O
, , O
and CC O
function NN O
. . O

In IN O
silico NN O
analyses NNS O
inferred VBN O
the DT O
C NN B-Species
. . I-Species
elegans NN I-Species
orthologues NNS O
/ SYM O
homologues NNS O
( , O
n CD O
= SYM O
50 CD O
) -RRB- O
to TO O
be VB O
involved VBN O
in IN O
apoptosis NN O
and CC O
insulin NN O
signaling NN O
( : O
2 CD O
% NN O
) -RRB- O
, , O
ATP NNP O
synthesis NN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
carbon NN O
metabolism NN O
( , O
6 CD O
% NN O
) -RRB- O
, , O
fatty JJ O
acid NN O
biosynthesis NN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
gap NN O
junction NN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
glucose NN O
metabolism NN O
( , O
6 CD O
% NN O
) -RRB- O
, , O
or CC O
porphyrin NN O
metabolism NN O
( : O
2 CD O
% NN O
) -RRB- O
, , O
although IN O
34 CD O
( SYM O
68 CD O
% NN O
) -RRB- O
of IN O
them PRP O
could MD O
not RB O
be VB O
mapped VBN O
to IN O
a DT O
specific JJ O
metabolic JJ O
pathway NN O
. . O

Small JJ O
numbers NNS O
of IN O
these DT O
50 CD O
molecules NNS O
were VBD O
predicted VBN O
to TO O
be VB O
secreted VBN O
( : O
10 CD O
% NN O
) -RRB- O
, , O
anchored VBN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
and CC O
/ SYM O
or CC O
transmembrane NN O
( , O
12 CD O
% NN O
) . O
proteins NNS O
. . O

Functionally RB O
, , O
17 CD O
( SYM O
34 CD O
% NN O
) -RRB- O
of IN O
them PRP O
were VBD O
predicted VBN O
to TO O
be VB O
associated VBN O
with IN O
( : O
non JJ O
- HYPH O
wild JJ O
- HYPH O
type NN O
) SYM O
RNAi NNP O
phenotypes NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
the DT O
majority NN O
being VBG O
embryonic JJ O
lethality NN O
( , O
Emb NNP O
) -RRB- O
( , O
13 CD O
types NNS O
; : O
58 CD O
. . O
8 CD O
% NN O
) -RRB- O
, , O
larval JJ O
arrest NN O
( , O
Lva NNP O
) -RRB- O
( , O
23 CD O
. . O
5 CD O
% NN O
) -RRB- O
and CC O
larval JJ O
lethality NN O
( : O
Lvl NNP O
) -RRB- O
( : O
47 CD O
% NN O
) -RRB- O
. . O

A DT O
genetic JJ O
interaction NN O
network NN O
was VBD O
predicted VBN O
for IN O
these DT O
17 CD O
C NN B-Species
. , I-Species
elegans NNS I-Species
orthologues NNS O
, , O
revealing VBG O
highly RB O
significant JJ O
interactions NNS O
for IN O
nine CD O
molecules NNS O
associated VBN O
with IN O
embryonic JJ O
and CC O
larval JJ O
development NN O
( : O
66 CD O
. . O
9 CD O
% NN O
) -RRB- O
, , O
information NN O
storage NN O
and CC O
processing NN O
( , O
5 CD O
. . O
1 CD O
% NN O
) -RRB- O
, , O
cellular JJ O
processing NN O
and CC O
signaling NN O
( , O
15 CD O
. . O
2 CD O
% NN O
) -RRB- O
, , O
metabolism NN O
( , O
6 CD O
. . O
1 CD O
% NN O
) -RRB- O
, , O
and CC O
unknown JJ O
function NN O
( : O
6 CD O
. . O
7 CD O
% NN O
) -RRB- O
. . O

The DT O
potential JJ O
roles NNS O
of IN O
these DT O
molecules NNS O
in IN O
development NN O
are VBP O
discussed VBN O
in IN O
relation NN O
to IN O
the DT O
known VBN O
roles NNS O
of IN O
their PRP$ O
homologues NNS O
/ SYM O
orthologues NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
and CC O
some DT O
other JJ O
nematodes NNS O
. . O

The DT O
results NNS O
of IN O
the DT O
present JJ O
study NN O
provide VBP O
a DT O
basis NN O
for IN O
future JJ O
functional JJ O
genomic JJ O
studies NNS O
to TO O
elucidate VB O
molecular JJ O
aspects NNS O
governing VBG O
larval JJ O
developmental JJ O
processes NNS O
in IN O
A NN B-Species
. . I-Species
suum NN I-Species
and CC O
/ SYM O
or CC O
the DT O
transition NN O
to IN O
parasitism NN O
. . O

Introduction NN O

Parasitic JJ O
nematodes NNS O
are VBP O
of IN O
major JJ O
socio JJ O
- HYPH O
economic JJ O
importance NN O
in IN O
animals NNS O
. . O

For IN O
example NN O
, , O
hundreds NNS O
of IN O
millions NNS O
of IN O
people NNS B-Species
are VBP O
infected VBN O
with IN O
geohelminths NNS O
( , O
soil NN O
- HYPH O
transmitted VBN O
worms NNS O
) -RRB- O
, , O
such JJ O
as IN O
blood NN O
- HYPH O
feeding VBG O
hookworms NNS O
Ancylostoma NNP B-Species
duodenale NN I-Species
and CC O
/ SYM O
or CC O
Necator NNP B-Species
americanus NN I-Species
, , O
Trichuris NNP B-Species
trichiura NNP I-Species
and CC O
Ascaris NNP O
spp NN O
. . O

[ -LRB- O
1 LS O
] -RRB- O
, , O
causing VBG O
serious JJ O
adverse JJ O
effects NNS O
on IN O
human JJ B-Species
health NN O
, , O
particularly RB O
in IN O
children NNS B-Species
. . O

Similarly RB O
, , O
parasitic JJ O
nematodes NNS O
of IN O
livestock NN O
, , O
such JJ O
as IN O
pigs NNS B-Species
, , O
also RB O
cause VBP O
substantial JJ O
economic JJ O
losses NNS O
due IN O
to IN O
subclinical JJ O
and CC O
clinical JJ O
diseases NNS O
, , O
with IN O
billions NNS O
of IN O
dollars NNS O
spent VBN O
annually RB O
on IN O
the DT O
treatment NN O
and CC O
control NN O
of IN O
gastro JJ O
- HYPH O
intestinal JJ O
nematodes NNS O
. . O

In IN O
addition NN O
to IN O
the DT O
socioeconomic JJ O
impact NN O
that WDT O
these DT O
parasites NNS O
have VBP O
, , O
there EX O
is VBZ O
potential NN O
for IN O
the DT O
emergence NN O
of IN O
resistance NN O
in IN O
them PRP O
against IN O
all DT O
of IN O
the DT O
main JJ O
classes NNS O
of IN O
( : O
nematocidal JJ O
) , O
compounds NNS O
used VBN O
to TO O
treat VB O
the DT O
diseases NNS O
they PRP O
cause VBP O
[ -LRB- O
2 CD O
] -RRB- O
- : O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Therefore RB O
, , O
there EX O
is VBZ O
a DT O
significant JJ O
need NN O
to TO O
work VB O
toward IN O
discovering VBG O
new JJ O
compounds NNS O
to TO O
control VB O
these DT O
parasites NNS O
. . O

Gaining VBG O
an DT O
improved JJ O
understanding NN O
of IN O
the DT O
molecular JJ O
basis NN O
of IN O
parasite NN O
development NN O
provides VBZ O
such PDT O
an DT O
avenue NN O
. . O

Compared VBN O
with IN O
the DT O
free RB O
- HYPH O
living VBG O
nematode NN O
Caenorhabditis NNP B-Species
elegans NNS I-Species
, , O
there EX O
is VBZ O
very RB O
little JJ O
information NN O
on IN O
fundamental JJ O
molecular JJ O
aspects NNS O
of IN O
development NN O
in IN O
parasitic JJ O
nematodes NNS O
[ -LRB- O
6 CD O
] -RRB- O
- : O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Since IN O
the DT O
genome NN O
sequence NN O
of IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
was VBD O
published VBN O
in IN O
1998 CD O
[ -LRB- O
9 CD O
] -RRB- O
, , O
many JJ O
aspects NNS O
of IN O
the DT O
molecular JJ O
biology NN O
of IN O
this DT O
nematode NN O
have VBP O
been VBN O
elucidated VBN O
. . O

For IN O
instance NN O
, , O
microarray NN O
analyses NNS O
have VBP O
been VBN O
used VBN O
to TO O
examine VB O
developmental JJ O
and CC O
gender NN O
- HYPH O
enriched VBN O
gene NN O
expression NN O
[ -LRB- O
10 CD O
] -RRB- O
, , O
[ -LRB- O
11 CD O
] -RRB- O
, , O
and CC O
the DT O
functions NNS O
of IN O
more JJR O
than IN O
96 CD O
% NN O
of IN O
the DT O
C NNP B-Species
. , I-Species
elegans NNS I-Species
genes NNS O
have VBP O
been VBN O
assessed VBN O
by IN O
double JJ O
- HYPH O
stranded VBN O
RNA NNP O
interference NN O
( , O
RNAi NNP O
, , O
or CC O
gene NN O
silencing NN O
; : O
[ -LRB- O
12 CD O
] -RRB- O
) -RRB- O
[ -LRB- O
13 CD O
] -RRB- O
- : O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Comparative JJ O
analyses NNS O
of IN O
genetic JJ O
data NNS O
sets NNS O
have VBP O
shown VBN O
that IN O
parasitic JJ O
nematodes NNS O
usually RB O
share VBP O
~ : O
50 CD O
- SYM O
70 CD O
% NN O
of IN O
genes NNS O
with IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
( : O
e LS O
. . O
g LS O
. . O
, , O
[ -LRB- O
19 CD O
] -RRB- O
, , O
[ -LRB- O
20 CD O
] -RRB- O
) -RRB- O
. . O

There EX O
is VBZ O
similarity NN O
in IN O
other JJ O
features NNS O
( , O
such JJ O
as IN O
basic JJ O
body NN O
plan NN O
and CC O
moulting NN O
) , O
between IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
and CC O
parasitic JJ O
nematodes NNS O
, , O
suggesting VBG O
that IN O
some DT O
molecular JJ O
pathways NNS O
are VBP O
relatively RB O
conserved VBN O
[ -LRB- O
8 CD O
] -RRB- O
, , O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Understanding VBG O
the DT O
pathways NNS O
linked VBN O
to IN O
basic JJ O
nematode NN O
biology NN O
and CC O
development NN O
could MD O
have VB O
important JJ O
implications NNS O
for IN O
finding VBG O
new JJ O
ways NNS O
of IN O
disrupting VBG O
these DT O
pathways NNS O
and CC O
thus RB O
facilitate VB O
the DT O
identification NN O
of IN O
new JJ O
drug NN O
targets NNS O
. . O

Despite IN O
the DT O
advances NNS O
in IN O
genomic JJ O
technologies NNS O
[ -LRB- O
7 CD O
] -RRB- O
, , O
[ -LRB- O
22 CD O
] -RRB- O
- : O
[ -LRB- O
29 CD O
] -RRB- O
and CC O
the DT O
study NN O
of IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
, , O
there EX O
is VBZ O
a DT O
paucity NN O
of IN O
information NN O
on IN O
the DT O
genomics NNS O
of IN O
parasitic JJ O
nematodes NNS O
of IN O
animals NNS O
, , O
particularly RB O
in IN O
relation NN O
to IN O
development NN O
. . O

Also RB O
considering VBG O
the DT O
major JJ O
socioeconomic JJ O
impact NN O
of IN O
Ascaris NNP O
and CC O
ascariasis NN O
in IN O
humans NNS B-Species
and CC O
pigs NNS B-Species
[ -LRB- O
30 CD O
] -RRB- O
- : O
[ -LRB- O
32 CD O
] -RRB- O
, , O
several JJ O
characteristics NNS O
, , O
including VBG O
the DT O
large JJ O
size NN O
of IN O
the DT O
adult NN O
worm NN O
( , O
providing VBG O
the DT O
opportunity NN O
of IN O
investigating VBG O
individual JJ O
organ NN O
systems NNS O
and CC O
tissues NNS O
) -RRB- O
, , O
the DT O
ability NN O
to TO O
maintain VB O
Ascaris NNP O
in IN O
the DT O
pig NN B-Species
, , O
store NN O
eggs NNS O
and CC O
culture NN O
larvae NN O
in IN O
vitro FW O
for IN O
relatively RB O
long JJ O
periods NNS O
of IN O
time NN O
( , O
months NNS O
to IN O
years NNS O
) -RRB- O
[ -LRB- O
32 CD O
] -RRB- O
as RB O
well RB O
as IN O
the DT O
discovery NN O
that IN O
RNAi NNP O
achieves VBZ O
"""" `` O
cross JJ O
- HYPH O
species NNS O
"""" '' O
gene NN O
silencing NN O
for IN O
a DT O
selected VBN O
number NN O
of IN O
genes NNS O
[ -LRB- O
33 CD O
] -RRB- O
, , O
[ -LRB- O
34 CD O
] -RRB- O
and CC O
the DT O
imminent JJ O
genome NN O
sequence NN O
( , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
sanger NN O
. . O
ac ADD O
. , O
uk IN O
/ SYM O
Projects NNS O
/ SYM O
Helminths NNP O
/ , O
) -RRB- O
all DT O
indicate VBP O
that IN O
Ascaris NNP O
could MD O
serve VB O
as IN O
a DT O
powerful JJ O
model NN O
system NN O
for IN O
investigating VBG O
reproductive JJ O
and CC O
developmental JJ O
processes NNS O
in IN O
nematodes NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
Ascaris NNP O
from IN O
pigs NNS B-Species
was VBD O
used VBN O
to TO O
study VB O
molecules NNS O
abundantly RB O
transcribed VBN O
in IN O
the DT O
infective JJ O
third JJ O
- HYPH O
stage NN O
larva NN O
( -LRB- O
L3 NNP O
) -RRB- O
. . O

Following VBG O
the DT O
oral JJ O
ingestion NN O
of IN O
Ascaris NNP O
eggs NNS O
by IN O
the DT O
host NN O
( , O
human JJ B-Species
or CC O
pig NN B-Species
) -RRB- O
, , O
L3s NNS O
are VBP O
released VBN O
and CC O
then RB O
invade VBP O
/ SYM O
penetrate VBP O
predominantly RB O
the DT O
caecal JJ O
wall NN O
[ -LRB- O
35 CD O
] -RRB- O
to TO O
then RB O
undergo VB O
hepato JJ O
- HYPH O
pulmonary JJ O
migration NN O
, , O
after IN O
which WDT O
ultimately RB O
the DT O
adult NN O
females NNS O
and CC O
males NNS O
establish VBP O
and CC O
develop VBP O
in IN O
the DT O
small JJ O
intestine NN O
[ -LRB- O
36 CD O
] -RRB- O
, , O
[ -LRB- O
37 CD O
] -RRB- O
. . O

The DT O
molecular JJ O
mechanisms NNS O
linked VBN O
to IN O
host NN O
invasion NN O
and CC O
parasite NN O
development NN O
are VBP O
largely RB O
unknown JJ O
. . O

Here RB O
, , O
we PRP O
constructed VBD O
an DT O
L3 NNP O
- HYPH O
enriched VBN O
cDNA NNP O
library NN O
using VBG O
the DT O
method NN O
of IN O
suppressive JJ O
- HYPH O
subtractive JJ O
hybridization NN O
( , O
SSH NNP O
) -RRB- O
, , O
explored VBD O
transcription NN O
of IN O
a DT O
representative JJ O
subset NN O
of IN O
molecules NNS O
by IN O
microarray NN O
analysis NN O
and CC O
conducted VBN O
bioinformatic JJ O
analyses NNS O
to TO O
characterize VB O
these DT O
molecules NNS O
, , O
map VB O
them PRP O
to IN O
biochemical JJ O
pathways NNS O
and CC O
predict VB O
genetic JJ O
interactions NNS O
based VBN O
on IN O
comparisons NNS O
with IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
and CC O
/ SYM O
or CC O
other JJ O
organisms NNS O
. . O

Materials NNS O
and CC O
Methods NNS O

Production NN O
of IN O
Different JJ O
Developmental JJ O
Stages NNS O
of IN O
Ascaris NNP O

Experimental JJ O
pigs NNS B-Species
( , O
8 CD O
- SYM O
12 CD O
weeks NNS O
of IN O
age NN O
) , O
were VBD O
purchased VBN O
from IN O
and CC O
maintained VBN O
in IN O
the DT O
Experimental NNP O
Animal NNP O
Center NNP O
of IN O
South NNP O
China NNP O
Agricultural NNP O
University NNP O
. . O

These DT O
pigs NNS B-Species
were VBD O
treated VBN O
humanely RB O
, , O
according VBG O
to IN O
the DT O
Animal NNP O
Ethics NNP O
procedures NNS O
and CC O
guidelines NNS O
of IN O
the DT O
People NNPS O
' POS O
s POS O
Republic NNP O
of IN O
China NNP O
. . O

Adult NN O
worms NNS O
( , O
males NNS O
and CC O
females NNS O
) , O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
were VBD O
collected VBN O
from IN O
the DT O
small JJ O
intestines NNS O
of IN O
pigs NNS B-Species
from IN O
an DT O
abattoir NN O
in IN O
Shenzhen NNP O
, , O
China NNP O
. . O

Infective JJ O
eggs NNS O
and CC O
infective JJ O
L3s NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
were VBD O
produced VBN O
according VBG O
to IN O
the DT O
methods NNS O
described VBN O
previously RB O
[ -LRB- O
38 CD O
] -RRB- O
. . O

In IN O
brief JJ O
, , O
eggs NNS O
from IN O
the DT O
uteri NN O
of IN O
adult NN O
females NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
were VBD O
collected VBN O
and CC O
incubated VBN O
at IN O
28 CD O
degrees NNS O
C NN O
for IN O
28 CD O
days NNS O
to TO O
allow VB O
them PRP O
to TO O
develop VB O
to IN O
infective JJ O
eggs NNS O
( , O
containing VBG O
infective JJ O
L3s NNS O
) -RRB- O
. . O

To TO O
obtain VB O
pure JJ O
infective JJ O
L3s NNS O
, , O
7 CD O
. . O
5 CD O
% NN O
v NN O
/ SYM O
v NN O
sodium NN O
hypochlorite NN O
was VBD O
used VBN O
to TO O
treat VB O
the DT O
larvated JJ O
eggs NNS O
at IN O
37 CD O
degrees NNS O
C NN O
overnight RB O
and CC O
then RB O
the DT O
eggs NNS O
were VBD O
shaken VBN O
with IN O
glass NN O
- HYPH O
beads NNS O
; : O
then RB O
, , O
the DT O
exsheathed VBN O
L3s NNS O
and CC O
shells NNS O
were VBD O
separated VBN O
by IN O
density NN O
gradient NN O
centrifugation NN O
using VBG O
lymphocyte NN O
separating VBG O
medium NN O
( , O
LSM NNP O
) -RRB- O
[ -LRB- O
38 CD O
] -RRB- O
. . O

Following VBG O
the DT O
experimental JJ O
infection NN O
of IN O
helminth NN O
- HYPH O
free JJ O
pigs NNS B-Species
with IN O
infective JJ O
Ascaris NNP O
eggs NNS O
as IN O
described VBN O
previously RB O
[ -LRB- O
39 CD O
] -RRB- O
, , O
the DT O
L3s NNS O
from IN O
livers NNS O
and CC O
in IN O
lungs NNS O
as RB O
well RB O
as IN O
L4s NNS O
in IN O
intestines NNS O
were VBD O
isolated VBN O
according VBG O
to IN O
an DT O
established VBN O
method NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

All DT O
parasite NN O
materials NNS O
were VBD O
snap NN O
- HYPH O
frozen VBN O
in IN O
liquid NN O
nitrogen NN O
prior RB O
to IN O
storage NN O
at IN O
- SYM O
70 CD O
degrees NNS O
C NN O
. . O

Construction NN O
of IN O
the DT O
cDNA NNP O
Library NNP O
by IN O
Subtractive NNP O
- HYPH O
Suppressive NNP O
Hybridization NNP O
( , O
SSH NNP O
) -RRB- O

Total JJ O
RNA NNP O
was VBD O
isolated VBN O
from IN O
adult NN O
females NNS O
and CC O
males NNS O
, , O
different JJ O
larval JJ O
stages NNS O
or CC O
eggs NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
using VBG O
TriPure NNP O
reagent NN O
( , O
Roche NNP O
) -RRB- O
as IN O
recommended VBN O
by IN O
the DT O
manufacturer NN O
. . O

Equal JJ O
amounts NNS O
of IN O
total JJ O
RNA NNP O
from IN O
each DT O
stage NN O
or CC O
sex NN O
were VBD O
pooled VBN O
. . O

The DT O
mRNA NNP O
was VBD O
isolated VBN O
using VBG O
the DT O
Oligotex NNP O
mRNA NNP O
Kit NNP O
( : O
Qiagen NNP O
) -RRB- O
, , O
following VBG O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
. . O

SSH NNP O
was VBD O
carried VBN O
out RP O
using VBG O
the DT O
PCR NNP O
- HYPH O
Select NNP O
cDNA NNP O
Subtraction NNP O
kit NN O
( : O
Clontech NNP O
) -RRB- O
, , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

In IN O
brief JJ O
, , O
cDNA NNP O
synthesized VBN O
from IN O
mRNAs NNS O
from IN O
infective JJ O
L3s NNP O
was VBD O
subtracted VBN O
against IN O
cDNA NNP O
synthesized VBN O
from IN O
the DT O
pooled VBN O
mRNA NNP O
from IN O
all DT O
other JJ O
stages NNS O
included VBN O
herein RB O
. . O

The DT O
SSH NNP O
library NN O
was VBD O
constructed VBN O
using VBG O
infective JJ O
L3s NNS O
as IN O
the DT O
tester NN O
and CC O
pooled VBD O
cDNAs NNS O
from IN O
all DT O
other JJ O
stages NNS O
as IN O
the DT O
driver NN O
. . O

The DT O
effectiveness NN O
of IN O
this DT O
subtraction NN O
process NN O
has VBZ O
already RB O
been VBN O
demonstrated VBN O
in IN O
previous JJ O
studies NNS O
[ -LRB- O
41 CD O
] -RRB- O
, , O
[ -LRB- O
42 CD O
] -RRB- O
. . O

The DT O
cDNA NNP O
obtained VBN O
following VBG O
SSH NNP O
was VBD O
cloned VBN O
into IN O
the DT O
pGEM NNP O
- HYPH O
T NNP O
Easy NNP O
plasmid NN O
vector NN O
( -LRB- O
Promega NNP O
) -RRB- O
and CC O
competent JJ O
Escherichia NNP B-Species
coli NN I-Species
( -LRB- O
JM109 NNP O
) -RRB- O
transformed VBN O
. . O

Positive JJ O
clones NNS O
, , O
picked VBN O
randomly RB O
( , O
based VBN O
on IN O
blue JJ O
/ SYM O
white JJ O
selection NN O
) -RRB- O
, , O
were VBD O
grown VBN O
overnight RB O
in IN O
Luria NNP O
Bertani NNP O
( , O
LB NNP O
) -RRB- O
medium NN O
( , O
shaking NN O
, , O
37 CD O
degrees NNS O
C NN O
) -RRB- O
. . O

Individual JJ O
inserts NNS O
were VBD O
PCR NN O
- HYPH O
amplified VBN O
using VBG O
"""" `` O
nested JJ O
primers NNS O
"""" '' O
1 CD O
and CC O
2R CD O
from IN O
the DT O
Subtraction NNP O
kit NN O
( , O
Clontech NNP O
) -RRB- O
and CC O
examined VBN O
by IN O
agarose JJ O
electrophoresis NN O
. . O

Preparation NN O
of IN O
Microarray NN O
Slides NNS O

Clones NNS O
( : O
n CD O
= SYM O
3075 CD O
) -RRB- O
from IN O
the DT O
subtracted JJ O
library NN O
were VBD O
picked VBN O
and CC O
cultured VBN O
overnight RB O
in IN O
LB NNP O
containing VBG O
ampicillin NN O
( , O
1000 CD O
IU NN O
/ SYM O
ml NN O
) -RRB- O
in IN O
sealed VBN O
96 CD O
- HYPH O
well NN O
blocks NNS O
. . O

Five CD O
micro JJ O
l NN O
of IN O
culture NN O
suspension NN O
from IN O
each DT O
well NN O
were VBD O
transferred VBN O
into IN O
individual JJ O
wells NNS O
thermocycling VBG O
( , O
96 CD O
- HYPH O
well NN O
) NFP O
plates NNS O
and CC O
the DT O
inserts NNS O
PCR NN O
- HYPH O
amplified VBN O
using VBG O
primers NNS O
1 CD O
and CC O
2R CD O
. . O

Following VBG O
a DT O
10 CD O
min NN O
denaturation NN O
step NN O
at IN O
94 CD O
degrees NNS O
C NN O
, , O
the DT O
amplification NN O
proceeded VBD O
for IN O
25 CD O
cycles NNS O
of IN O
10 CD O
s NNS O
at IN O
94 CD O
degrees NNS O
C NNP O
, , O
30 CD O
s NNS O
at IN O
68 CD O
degrees NNS O
C NN O
and CC O
1 CD O
. . O
5 CD O
min NN O
at IN O
72 CD O
degrees NNS O
C NN O
, , O
with IN O
a DT O
final JJ O
extension NN O
for IN O
5 CD O
min NN O
at IN O
72 CD O
degrees NNS O
C NN O
. . O

Products NNS O
were VBD O
resolved VBN O
in IN O
agarose JJ O
gels NNS O
, , O
ethanol NN O
precipitated VBN O
, , O
re NN O
- HYPH O
suspended VBN O
in IN O
16 CD O
micro NN O
l NN O
of IN O
"""" `` O
spotting NN O
solution NN O
"""" '' O
( , O
Shanghai NNP O
BioStar NNP O
Genechip NNP O
, , O
Inc NNP O
) -RRB- O
to IN O
a DT O
final JJ O
concentration NN O
of IN O
~ $ O
500 CD O
ng NN O
per IN O
micro NN O
l CC O
, , O
before IN O
being VBG O
printed VBN O
on IN O
to IN O
glass NN O
slides NNS O
( , O
in IN O
duplicate NN O
) , O
using VBG O
a DT O
robotic JJ O
arrayer NN O
. . O

Sixteen CD O
blanks NNS O
( , O
using VBG O
spotting NN O
solution NN O
only RB O
) -RRB- O
and CC O
the DT O
same JJ O
number NN O
of IN O
negative JJ O
( -LRB- O
irrelevant JJ O
cDNAs NNS O
with IN O
no DT O
relationship NN O
to IN O
Ascaris NNP O
) -RRB- O
were VBD O
also RB O
printed VBN O
on IN O
to IN O
slides NNS O
and CC O
served VBN O
as IN O
negative JJ O
controls NNS O
; : O
beta NN O
- HYPH O
actin NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
served VBD O
as IN O
a DT O
positive JJ O
control NN O
to TO O
assess VB O
the DT O
efficiency NN O
of IN O
labeling NN O
and CC O
hybridization NN O
. . O

The DT O
slides NNS O
were VBD O
air NN O
- HYPH O
dried VBN O
for IN O
2 CD O
h NN O
, , O
and CC O
cDNA NN O
in IN O
the DT O
spots NNS O
were VBD O
cross NN O
- HYPH O
linked VBN O
at IN O
254 CD O
mJ NNS O
. . O

The DT O
printed VBN O
slides NNS O
were VBD O
stored VBN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

Labeling VBG O
of IN O
cDNA NNP O
Probes NNS O
with IN O
Fluorescent NNP O
Dyes NNPS O
, , O
and CC O
Microarray NNP O
Analysis NNP O

The DT O
cDNAs NNS O
produced VBN O
from IN O
total JJ O
RNA NNP O
from IN O
A NN B-Species
. . I-Species
suum NN I-Species
eggs NNS O
, , O
infective JJ O
L3s NNS O
, , O
L3s NNS O
isolated VBN O
from IN O
pig NN B-Species
liver NN O
or CC O
lung NN O
, , O
fourth JJ O
- HYPH O
stage NN O
larvae NN O
( , O
L4s NNS O
) -RRB- O
, , O
adult NN O
males NNS O
or CC O
females NNS O
[ -LRB- O
as IN O
described VBN O
in IN O
the DT O
section NN O
' '' O
Construction NNP O
of IN O
the DT O
cDNA NNP O
Library NNP O
by IN O
Subtractive NNP O
- HYPH O
Suppressive NNP O
Hybridization NNP O
( -LRB- O
SSH NNP O
) -RRB- O
' '' O
] -RRB- O
were VBD O
labeled VBN O
with IN O
cyanine NN O
dyes NNS O
. . O

Cy3 NNP O
or CC O
Cy5 NNP O
- HYPH O
dCTP NNP O
was VBD O
incorporated VBN O
into IN O
cDNA NNP O
produced VBN O
from IN O
30 CD O
micro JJ O
g NN O
of IN O
total JJ O
RNA NN O
by IN O
direct JJ O
labeling NN O
in IN O
a DT O
reverse JJ O
transcription NN O
reaction NN O
using VBG O
an DT O
oligo NN O
( , O
dT NN O
) -RRB- O
primer NN O
. . O

Labeled VBN O
cDNA NNP O
was VBD O
purified VBN O
using VBG O
DyeEx NNP O
columns NNS O
( , O
Qiagen NNP O
) -RRB- O
. . O

Microarray NNP O
slides NNS O
were VBD O
incubated VBN O
with IN O
a DT O
pre JJ O
- HYPH O
hybridization NN O
solution NN O
[ -LRB- O
5 CD O
x SYM O
SSC NNP O
, , O
1 CD O
% NN O
bovine NN B-Species
serum NN O
albumin NN O
( , O
BSA NNP O
) -RRB- O
, , O
0 CD O
. . O
1 CD O
% NN O
sodium NN O
dodecyl NN O
- HYPH O
sulphate NN O
( -LRB- O
SDS NNP O
) -RRB- O
] -RRB- O
for IN O
6 CD O
h NNS O
at IN O
42 CD O
degrees NNS O
C NN O
. . O

After IN O
pre NN O
- HYPH O
hybridization NN O
, , O
the DT O
microarray NN O
slides NNS O
were VBD O
incubated VBN O
with IN O
' `` O
pooled VBN O
' '' O
Cy3 NNP O
and CC O
Cy5 NNP O
- HYPH O
labeled VBN O
probes NNS O
in IN O
hybridization NN O
solution NN O
( , O
5 CD O
x SYM O
SSC NNP O
, , O
1 CD O
% NN O
BSA NNP O
, , O
0 CD O
. . O
1 CD O
% NN O
SDS NN O
) -RRB- O
, , O
in IN O
the DT O
dark NN O
at IN O
42 CD O
degrees NNS O
C NN O
for IN O
18 CD O
h NNS O
, , O
and CC O
then RB O
washed VBN O
in IN O
solution NN O
I PRP O
( : O
1 CD O
x SYM O
SSC NNP O
, , O
0 CD O
. . O
2 CD O
% NN O
SDS NN O
) -RRB- O
for IN O
10 CD O
min NN O
, , O
followed VBN O
by IN O
solution NN O
II NNP O
( : O
0 CD O
. . O
1 CD O
x SYM O
SSC NNP O
, , O
0 CD O
. . O
2 CD O
% NN O
SDS NN O
) -RRB- O
for IN O
10 CD O
min NN O
at IN O
60 CD O
degrees NNS O
C NNS O
, , O
according VBG O
to IN O
the DT O
protocols NNS O
provided VBN O
by IN O
Shanghai NNP O
BioStar NNP O
Genechip NNP O
, , O
Inc NNP O
. . O

A DT O
"""" `` O
dye NN O
flip NN O
"""" '' O
was VBD O
carried VBN O
out RP O
to TO O
control VB O
for IN O
any DT O
bias NN O
in IN O
hybridization NN O
signal NN O
between IN O
the DT O
Cy NNP O
- HYPH O
labeled VBN O
cDNA NNP O
probes NNS O
( , O
produced VBN O
for IN O
two CD O
distinct JJ O
mRNA NNP O
populations NNS O
) -RRB- O
. . O

The DT O
slides NNS O
were VBD O
dried VBN O
and CC O
scanned VBN O
( : O
ScanArray NNP O
4000 CD O
scanner NN O
) -RRB- O
using VBG O
image NN O
acquisition NN O
software NN O
( , O
Shanghai NNP O
BioStar NNP O
Genechip NNP O
Inc NNP O
. . O
) -RRB- O
and CC O
a DT O
range NN O
of IN O
laser NN O
power NN O
and CC O
photo NN O
- HYPH O
multiplier NN O
tube NN O
intensities NNS O
. . O

The DT O
mean JJ O
hybridization NN O
signal NN O
( -LRB- O
derived VBN O
from IN O
four CD O
replicates NNS O
of IN O
the DT O
same JJ O
array NN O
) -RRB- O
were VBD O
corrected VBN O
for IN O
background NN O
, , O
normalized VBN O
[ -LRB- O
43 CD O
] -RRB- O
, , O
log2 NN O
- HYPH O
transformed VBN O
and CC O
then RB O
subjected VBN O
to IN O
statistical JJ O
analysis NN O
employing VBG O
the DT O
students NNS O
t NN O
- HYPH O
test NN O
in IN O
a DT O
spreadsheet NN O
( , O
Excel NNP O
, , O
Microsoft NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
microarray NN O
data NNS O
were VBD O
analysed VBN O
for IN O
differential JJ O
cDNA NN O
hybridization NN O
( : O
> SYM O
2 CD O
. . O
0 CD O
- HYPH O
fold NN O
to IN O
114 CD O
. . O
3 CD O
- HYPH O
fold NN O
) -RRB- O
between IN O
L3 NNP O
and CC O
each DT O
of IN O
the DT O
other JJ O
stages NNS O
( , O
eggs NNS O
, , O
lung NN O
and CC O
liver NN O
L3s NNS O
, , O
L4 NNP O
, , O
adult NN O
female NN O
and CC O
adult NN O
male NN O
) -RRB- O
. . O

Verification NN O
of IN O
Differential NNP O
Hybridization NNP O
by IN O
Reverse NNP O
Transcription NNP O
- HYPH O
Coupled NNP O
Polymerase NNP O
Chain NNP O
Reaction NNP O
( : O
RT NNP O
- HYPH O
PCR NNP O
) -RRB- O
Analysis NN O

For IN O
a DT O
subset NN O
( , O
n CD O
= SYM O
17 CD O
) -RRB- O
of IN O
representative JJ O
ESTs NNS O
( : O
rESTs NNS O
) -RRB- O
, , O
RT NNP O
- HYPH O
PCR NNP O
was VBD O
used VBN O
to TO O
verify VB O
the DT O
differential JJ O
transcription NN O
recorded VBN O
by IN O
microarray NN O
analysis NN O
. . O

Double JJ O
- HYPH O
stranded VBN O
cDNA NNP O
was VBD O
synthesized VBN O
from IN O
total JJ O
RNA NNP O
( , O
separately RB O
) -RRB- O
from IN O
each DT O
stage NN O
or CC O
sex NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
using VBG O
reverse JJ O
transcriptase NN O
( -LRB- O
Superscript NNP O
III NNP O
, , O
Invitrogen NNP O
) -RRB- O
. . O

Briefly RB O
, , O
5 CD O
micro NN O
g NN O
of IN O
total JJ O
RNA NNP O
were VBD O
added VBN O
to IN O
14 CD O
micro NN O
l NN O
of IN O
H2O NN O
and CC O
1 CD O
micro NN O
l NN O
of IN O
oligo NN O
d NN O
( HYPH O
T NNP O
) SYM O
n CD O
= SYM O
12 CD O
- HYPH O
18 CD O
primer NN O
( : O
0 CD O
. . O
5 CD O
micro NN O
g NN O
/ SYM O
micro NN O
l NN O
) -RRB- O
, , O
heated VBN O
to IN O
70 CD O
degrees NNS O
C NN O
for IN O
10 CD O
min NN O
and CC O
chilled VBN O
on IN O
ice NN O
. . O

First JJ O
- HYPH O
and CC O
second JJ O
- HYPH O
strand NN O
cDNAs NNS O
were VBD O
synthesized VBN O
via IN O
the DT O
addition NN O
of IN O
4 CD O
micro NN O
l NN O
of IN O
first JJ O
- HYPH O
strand NN O
cDNA NN O
buffer NN O
( , O
250 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH NN O
8 CD O
. . O
3 CD O
, , O
375 CD O
mM NN O
KCl NN O
and CC O
15 CD O
mM NN O
MgCl2 NN O
) -RRB- O
, , O
2 CD O
micro NN O
l NN O
of IN O
0 CD O
. . O
1 CD O
M NN O
dithiothreitol NN O
, , O
and CC O
1 CD O
micro NN O
l NN O
of IN O
10 CD O
mM NN O
of IN O
each DT O
dNTP NN O
, , O
followed VBN O
by IN O
an DT O
incubation NN O
at IN O
25 CD O
degrees NNS O
C NN O
( : O
10 CD O
min NN O
) CD O
, , O
42 CD O
degrees NNS O
C NN O
( , O
50 CD O
min NN O
) CD O
and CC O
70 CD O
degrees NNS O
C NN O
( , O
15 CD O
min NN O
) -RRB- O
. . O

One CD O
- HYPH O
tenth NN O
of IN O
each DT O
double JJ O
- HYPH O
stranded VBN O
cDNA NNP O
produced VBN O
was VBD O
then RB O
used VBN O
as IN O
a DT O
template NN O
in IN O
the DT O
PCR NNP O
. . O

The DT O
transcripts NNS O
were VBD O
amplified VBN O
from IN O
individual JJ O
cDNAs NNS O
by IN O
PCR NNP O
using VBG O
oligonucleotide NN O
primers NNS O
( , O
sequences NNS O
available JJ O
upon IN O
request NN O
) -RRB- O
designed VBN O
to IN O
each DT O
EST NNP O
. . O

The DT O
PCR NNP O
amplification NN O
of IN O
a DT O
portion NN O
( , O
209 CD O
bp NN O
) -RRB- O
of IN O
the DT O
beta NN O
- HYPH O
actin NN O
gene NN O
( , O
accession NN O
no UH O
. , O
BI594141 CD O
) -RRB- O
using VBG O
forward JJ O
primer NN O
( -LRB- O
5 CD O
' '' O
- HYPH O
CTCGAAACAAGAATACGATG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
reverse JJ O
primer NN O
( -LRB- O
5 CD O
' '' O
- HYPH O
ACATGTGCCGTTGTATGATG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
, , O
previously RB O
determined VBN O
to TO O
be VB O
present JJ O
in IN O
all DT O
developmental JJ O
stages NNS O
and CC O
both DT O
sexes NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
[ -LRB- O
44 CD O
] -RRB- O
, , O
served VBD O
as IN O
a DT O
positive JJ O
control NN O
. . O

Samples NNS O
without IN O
template NN O
( , O
no DT O
- HYPH O
DNA NN O
controls NNS O
) , O
were VBD O
included VBN O
in IN O
each DT O
PCR NNP O
run NN O
. . O

The DT O
following VBG O
cycling NN O
conditions NNS O
were VBD O
employed VBN O
: : O
one CD O
cycle NN O
at IN O
94 CD O
degrees NNS O
C NN O
( : O
5 CD O
min NN O
) CD O
, , O
94 CD O
degrees NNS O
C NN O
( , O
30 CD O
s NNS O
) -RRB- O
, , O
60 CD O
degrees NNS O
C NN O
( : O
30 CD O
s NNS O
) -RRB- O
and CC O
72 CD O
degrees NNS O
C NN O
( : O
30 CD O
s NNS O
) -RRB- O
for IN O
30 CD O
cycles NNS O
, , O
followed VBN O
by IN O
a DT O
final JJ O
extension NN O
of IN O
70 CD O
degrees NNS O
C NN O
( , O
7 CD O
min NN O
) -RRB- O
. . O

Following VBG O
the DT O
PCR NNP O
, , O
5 CD O
micro NN O
l NN O
of IN O
individual JJ O
amplicons NNS O
were VBD O
resolved VBN O
in IN O
ethidium NN O
bromide NN O
- HYPH O
stained VBN O
agarose NN O
gels NNS O
( : O
2 CD O
% NN O
) -RRB- O
and CC O
then RB O
photographed VBN O
upon IN O
transillumination NN O
. . O

The DT O
relative JJ O
band NN O
intensities NNS O
were VBD O
analyzed VBN O
using VBG O
UVIsoft NNP O
Image NNP O
Acquisition NNP O
and CC O
Analysis NNP O
software NN O
( , O
UVITEC NNP O
) -RRB- O
. . O

The DT O
specificity NN O
and CC O
identity NN O
of IN O
individual JJ O
amplicons NNS O
were VBD O
confirmed VBN O
by IN O
direct JJ O
sequencing NN O
using VBG O
the DT O
same JJ O
primers NNS O
( -LRB- O
separately RB O
) -RRB- O
as IN O
employed VBN O
for IN O
their PRP$ O
amplification NN O
. . O

Sequencing NN O
and CC O
Bioinformatics NNP O
Analyses NNS O

Clones NNS O
from IN O
the DT O
SSH NNP O
cDNA NNP O
library NN O
with IN O
increased VBN O
hybridization NN O
in IN O
microarray NN O
analysis NN O
to IN O
the DT O
infective JJ O
L3 NNP O
compared VBN O
with IN O
other JJ O
stages NNS O
were VBD O
sequenced VBN O
using VBG O
standard JJ O
technology NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

The DT O
nucleotide NN O
sequences NNS O
have VBP O
been VBN O
deposited VBN O
in IN O
the DT O
GenBank NNP O
database NN O
under IN O
accession NN O
numbers NNS O
ES290984 CD O
- HYPH O
ES291074 NN O
. . O

Following VBG O
the DT O
processing NN O
of IN O
the DT O
sequences NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
removal NN O
of IN O
vector NN O
sequences NNS O
, , O
quality NN O
assurance NN O
and CC O
clustering NN O
) -RRB- O
, , O
contigs NNS O
or CC O
singletons NNS O
from IN O
individual JJ O
clusters NNS O
were VBD O
subjected VBN O
to IN O
BLASTx NNP O
( : O
NCBI NNP O
: : O
www NN O
. . O
ncbi ADD O
. . O
nlm UH O
. . O
nih NN O
. . O
gov NN O
) -RRB- O
and CC O
BLASTn NNP O
( : O
EMBL NN O
- HYPH O
EBI NNP O
Parasite NN O
Genome NN O
Blast NN O
Server NN O
: : O
www NN O
. . O
ebi NNP O
. . O
ac ADD O
. . O
uk NN O
) -RRB- O
analysis NN O
to TO O
identify VB O
putative JJ O
homologues NNS O
in IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
, , O
other JJ O
nematodes NNS O
and CC O
other JJ O
organisms NNS O
( , O
e LS O
- HYPH O
value NN O
of IN O
< : O
= SYM O
1e CD O
- HYPH O
5 CD O
) -RRB- O
. . O

Peptides NNS O
inferred VBD O
from IN O
ESTs NNS O
were VBD O
classified VBN O
functionally RB O
using VBG O
Interproscan NNP O
( -LRB- O
available JJ O
at IN O
http NN O
: : O
/ SYM O
/ SYM O
www ADD O
. . O
ebi NNP O
. . O
ac ADD O
. . O
uk IN O
/ SYM O
InterProScan NNP O
/ SYM O
) -RRB- O
employing VBG O
the DT O
default JJ O
search NN O
parameters NNS O
. . O

WormBase NNP O
( : O
www NN O
. . O
wormbase NN O
. . O
org NN O
) -RRB- O
was VBD O
interrogated VBN O
extensively RB O
for IN O
relevant JJ O
information NN O
on IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
homologues NNS O
/ , O
orthologues NNS O
, , O
including VBG O
RNAi NNP O
phenotypic JJ O
, , O
transcriptomic JJ O
, , O
proteomic JJ O
and CC O
interactomic JJ O
data NNS O
. . O

ESTs NNS O
with IN O
homologues NNS O
/ SYM O
orthologues NNS O
in IN O
C NN B-Species
. , I-Species
elegans NNS I-Species
and CC O
other JJ O
nematodes NNS O
were VBD O
also RB O
subjected VBN O
to IN O
analysis NN O
employing VBG O
the DT O
KEGG NNP O
Orthology NNP O
- HYPH O
Based NNP O
Annotation NNP O
System NNP O
( : O
KOBAS NNP O
) -RRB- O
( : O
www ADD O
. . O
kobas NN O
. . O
cbi ADD O
. . O
pku NNP O
. . O
edu NNP O
. . O
cn NN O
) -RRB- O
, , O
which WDT O
predicts VBZ O
the DT O
biochemical JJ O
pathways NNS O
in IN O
which WDT O
molecules NNS O
are VBP O
involved VBN O
. . O

The DT O
open JJ O
reading NN O
frames NNS O
( , O
ORFs NNS O
) -RRB- O
inferred VBN O
from IN O
selected VBN O
ESTs NNS O
with IN O
orthologues NNS O
in IN O
C NNP B-Species
. , I-Species
elegans NNS I-Species
were VBD O
also RB O
subjected VBN O
to IN O
"""" `` O
secretome NN O
analysis NN O
"""" '' O
using VBG O
the DT O
program NN O
SignalP NN O
v NN O
. . O
2 CD O
. . O
0 NFP O
www NN O
. . O
cbs NN O
. . O
dtu NNP O
. . O
dk NN O
/ SYM O
services NNS O
/ SYM O
SignalP NNP O
/ , O
) -RRB- O
, , O
employing VBG O
both CC O
the DT O
neural JJ O
network NN O
and CC O
hidden VBN O
Markov NNP O
models NNS O
to TO O
predict VB O
signal NN O
peptides NNS O
and CC O
/ SYM O
or CC O
anchors NNS O
[ -LRB- O
46 CD O
] -RRB- O
- : O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Also RB O
, , O
transmembrane NN O
domains NNS O
were VBD O
predicted VBN O
using VBG O
the DT O
program NN O
TMHMM NNP O
( : O
www NN O
. . O
cbs NNP O
. . O
dtu NNP O
. . O
dk NN O
/ SYM O
services NNS O
/ SYM O
TMHMM NNP O
/ : O
; : O
[ -LRB- O
49 CD O
] -RRB- O
- HYPH O
[ -LRB- O
51 CD O
] -RRB- O
) -RRB- O
, , O
and CC O
subcellular JJ O
localization NN O
inferred VBN O
employing VBG O
the DT O
program NN O
WoLF NNP O
PSORT NNP O
( : O
http NN O
: : O
/ NFP O
/ SYM O
wolfpsort ADD O
. . O
org NN O
/ : O
; : O
[ -LRB- O
52 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
method NN O
established VBN O
by IN O
Zhong NNP O
and CC O
Sternberg NNP O
[ -LRB- O
53 CD O
] -RRB- O
was VBD O
used VBN O
to TO O
predict VB O
the DT O
interactions NNS O
for IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
orthologues NNS O
of IN O
the DT O
L3 NNP O
- HYPH O
enriched VBN O
molecules NNS O
from IN O
Ascaris NNP O
. . O

In IN O
brief JJ O
, , O
interaction NN O
, , O
phenotypic JJ O
, , O
expression NN O
and CC O
gene NN O
ontology NN O
data NNS O
from IN O
fruitfly NN B-Species
, , O
yeast NN B-Species
, , O
mouse NN B-Species
and CC O
human NN B-Species
were VBD O
integrated VBN O
using VBG O
a DT O
na FW O
i FW O
ve FW O
Bayesian JJ O
model NN O
to TO O
predict VB O
genetic JJ O
interactions NNS O
among IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
genes NNS O
( -LRB- O
[ -LRB- O
45 CD O
] -RRB- O
, , O
[ -LRB- O
53 CD O
] -RRB- O
; , O
Zhong NNP O
and CC O
Sternberg NNP O
, , O
unpublished JJ O
) -RRB- O
. . O

The DT O
predicted VBN O
networks NNS O
resulting VBG O
from IN O
the DT O
analyses NNS O
were VBD O
saved VBN O
in IN O
a DT O
graphic JJ O
display NN O
file NN O
( , O
gdf NN O
) , O
format NN O
and CC O
examined VBN O
using VBG O
the DT O
graph NN O
exploration NN O
system NN O
available JJ O
at IN O
http NN O
: : O
/ NFP O
/ SYM O
graphexploration NN O
. . O
cond NN O
. . O
org NN O
/ SYM O
. . O

Images NNS O
were VBD O
labeled VBN O
and CC O
saved VBN O
in IN O
the DT O
joint JJ O
photographic JJ O
experts NNS O
group NN O
( , O
jpeg NN O
) -RRB- O
format NN O
. . O

Results NNS O

To TO O
identify VB O
molecules NNS O
transcribed VBN O
abundantly RB O
in IN O
the DT O
L3 NNP O
of IN O
A NNP B-Species
. . I-Species
suum NNP I-Species
, , O
an DT O
enriched VBN O
cDNA NNP O
library NN O
was VBD O
constructed VBN O
by IN O
SSH NNP O
. . O

From IN O
a DT O
total NN O
of IN O
3075 CD O
clones NNS O
from IN O
this DT O
library NN O
, , O
2921 CD O
( SYM O
95 CD O
% NN O
) -RRB- O
were VBD O
shown VBN O
to TO O
contain VB O
an DT O
insert NN O
( , O
which WDT O
could MD O
be VB O
amplified VBN O
by IN O
PCR NNP O
) -RRB- O
. . O

From IN O
2671 CD O
( : O
92 CD O
% NN O
) -RRB- O
of IN O
these DT O
clones NNS O
, , O
amplicons NNS O
representing VBG O
single JJ O
bands NNS O
of IN O
~ $ O
400 CD O
to TO O
600 CD O
bp NN O
in IN O
size NN O
were VBD O
produced VBN O
. . O

These DT O
latter JJ O
amplicons NNS O
were VBD O
arrayed VBN O
( , O
in IN O
duplicate NN O
) , O
on IN O
to IN O
slides NNS O
and CC O
then RB O
hybridized VBN O
with IN O
Cy3 NNP O
- HYPH O
labeled VBN O
L3 NNP O
- HYPH O
cDNA NNP O
or CC O
with IN O
Cy5 NNP O
- HYPH O
labeled VBN O
cDNA NNP O
from IN O
eggs NNS O
, , O
liver NN O
/ SYM O
lung NN O
L3s NNS O
, , O
L4s NNS O
, , O
adult NN O
female JJ O
or CC O
adult NN O
male NN O
of IN O
Ascaris NNP O
. . O

Dye NN O
flip NN O
was VBD O
conducted VBN O
to TO O
verify VB O
the DT O
hybridization NN O
data NNS O
. . O

Of IN O
the DT O
2671 CD O
( SYM O
duplicate JJ O
) -RRB- O
spots NNS O
, , O
1526 CD O
had VBD O
a DT O
significant JJ O
difference NN O
in IN O
hybridization NN O
between IN O
infective JJ O
L3 NNP O
cDNA NNP O
and CC O
cDNAs NNS O
from IN O
all DT O
other JJ O
stages NNS O
or CC O
sexes NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
, , O
of IN O
which WDT O
515 CD O
had VBD O
a DT O
> SYM O
2 CD O
. . O
0 CD O
- HYPH O
fold NN O
increased VBN O
hybridization NN O
for IN O
the DT O
L3 NNP O
. . O

In IN O
order NN O
to TO O
independently RB O
verify VB O
the DT O
hybridization NN O
results NNS O
in IN O
the DT O
microarray NN O
, , O
a DT O
PCR NN O
- HYPH O
based VBN O
analysis NN O
of IN O
a DT O
selected VBN O
subset NN O
( HYPH O
n NN O
= SYM O
17 CD O
) -RRB- O
clones NNS O
was VBD O
conducted VBN O
using VBG O
specific JJ O
primer NN O
pairs NNS O
. . O

Having VBG O
verified VBN O
the DT O
specificity NN O
and CC O
identity NN O
of IN O
individual JJ O
amplicons NNS O
by IN O
sequencing NN O
, , O
PCR NNP O
results NNS O
were VBD O
reproducible JJ O
( , O
based VBN O
on IN O
multiple JJ O
runs NNS O
on IN O
different JJ O
days NNS O
) -RRB- O
and CC O
~ $ O
94 CD O
% NN O
( , O
16 CD O
of IN O
17 CD O
) -RRB- O
concordant JJ O
with IN O
those DT O
of IN O
the DT O
microarray NN O
analysis NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

There EX O
was VBD O
complete JJ O
concordance NN O
for IN O
representative JJ O
clones NNS O
associated VBN O
with IN O
a DT O
differential JJ O
signal NN O
of IN O
> NFP O
= SYM O
3 CD O
. . O
0 NFP O
- HYPH O
fold NN O
in IN O
the DT O
microarray NN O
. . O

The DT O
clones NNS O
linked VBN O
to IN O
the DT O
515 CD O
spots NNS O
representing VBG O
increased VBN O
transcription NN O
( , O
> SYM O
2 CD O
. . O
0 CD O
- HYPH O
fold NN O
) -RRB- O
in IN O
infective JJ O
L3 NNP O
compared VBN O
with IN O
the DT O
other JJ O
developmental JJ O
stages NNS O
or CC O
sexes NNS O
included VBN O
were VBD O
subjected VBN O
to IN O
sequencing NN O
. . O

The DT O
498 CD O
sequences NNS O
( -LRB- O
length NN O
: : O
550 CD O
+ SYM O
/ SYM O
- HYPH O
115 CD O
bp NN O
) -RRB- O
determined VBN O
were VBD O
then RB O
subjected VBN O
to IN O
detailed JJ O
bioinformatic JJ O
analyses NNS O
. . O

There EX O
were VBD O
91 CD O
unique JJ O
clusters NNS O
( , O
accession NN O
numbers NNS O
ES290984 CD O
- HYPH O
ES291074 CD O
) -RRB- O
, , O
of IN O
which WDT O
55 CD O
were VBD O
singletons NNS O
( , O
sequences NNS O
determined VBN O
once RB O
) -RRB- O
. . O

Of IN O
56 CD O
molecules NNS O
( : O
61 CD O
. . O
5 CD O
% NN O
) -RRB- O
with IN O
significant JJ O
similarity NN O
to IN O
sequences NNS O
other JJ O
than IN O
A NN B-Species
. . I-Species
suum NN I-Species
in IN O
the DT O
databases NNS O
interrogated VBN O
, , O
50 CD O
( SYM O
54 CD O
. . O
9 CD O
% NN O
) -RRB- O
had VBD O
C NN B-Species
. . I-Species
elegans NNS I-Species
or CC O
C NN B-Species
. . I-Species
briggsae NN I-Species
homologues NNS O
, , O
and CC O
six CD O
had VBD O
similarity NN O
to IN O
ESTs NNS O
already RB O
sequenced VBN O
from IN O
ascaridoid NN O
and CC O
/ SYM O
or CC O
other JJ O
parasitic JJ O
nematodes NNS O
, , O
and CC O
/ SYM O
or CC O
other JJ O
organisms NNS O
( , O
Table NN O
1 CD O
) -RRB- O
. . O

A DT O
significant JJ O
proportion NN O
( : O
38 CD O
. . O
4 CD O
% NN O
) -RRB- O
did VBD O
not RB O
have VB O
any DT O
similarity NN O
in IN O
sequence NN O
to IN O
any DT O
organisms NNS O
for IN O
which WDT O
data NNS O
are VBP O
presently RB O
available JJ O
. . O

Comparative JJ O
analysis NN O
specifically RB O
against IN O
A NNP B-Species
. . I-Species
suum NNP I-Species
EST NNP O
data NN O
sets NNS O
( : O
n : O
~ $ O
42 CD O
, , O
0 CD O
) -RRB- O
available JJ O
in IN O
public JJ O
databases NNS O
confirmed VBN O
independently RB O
that IN O
the DT O
majority NN O
of IN O
molecules NNS O
( : O
> : O
60 CD O
% NN O
) -RRB- O
were VBD O
present JJ O
exclusively RB O
in IN O
the DT O
infective JJ O
L3 NN O
stage NN O
or CC O
were VBD O
orphans NNS O
. . O

As IN O
gene NN O
ontology NN O
( -LRB- O
GO NNP O
) -RRB- O
provides VBZ O
a DT O
hierarchy NN O
that WDT O
unifies VBZ O
the DT O
descriptions NNS O
of IN O
biological JJ O
, , O
cellular JJ O
and CC O
molecular JJ O
functions NNS O
[ -LRB- O
54 CD O
] -RRB- O
, , O
this DT O
approach NN O
was VBD O
employed VBN O
to TO O
predict VB O
the DT O
classification NN O
and CC O
gene NN O
function NN O
of IN O
molecules NNS O
enriched VBN O
in IN O
infective JJ O
L3 NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
. . O

A DT O
summary NN O
of IN O
the DT O
GO NNP O
categories NNS O
of IN O
these DT O
molecules NNS O
is VBZ O
displayed VBN O
in IN O
Fig NNP O
. . O

1 LS O
. . O

Of IN O
the DT O
91 CD O
contigs NNS O
, , O
32 CD O
( SYM O
35 CD O
% NN O
) -RRB- O
could MD O
be VB O
functionally RB O
assigned VBN O
to IN O
' `` O
biological JJ O
process NN O
' '' O
( : O
n CD O
= SYM O
38 CD O
) -RRB- O
, , O
' `` O
cellular JJ O
component NN O
' '' O
( , O
n NN O
= SYM O
17 CD O
) -RRB- O
and CC O
' `` O
molecular JJ O
function NN O
' '' O
( : O
n CD O
= SYM O
64 CD O
) -RRB- O
. . O

The DT O
most RBS O
common JJ O
subcategories NNS O
were VBD O
gluconeogenesis NN O
( , O
13 CD O
% NN O
) -RRB- O
and CC O
metabolic JJ O
process NN O
( , O
13 CD O
% NN O
) -RRB- O
within IN O
' `` O
biological JJ O
process NN O
' '' O
, , O
extracellular JJ O
region NN O
( : O
24 CD O
% NN O
) -RRB- O
within IN O
' `` O
cellular JJ O
component NN O
' '' O
, , O
and CC O
catalytic JJ O
activity NN O
( , O
11 CD O
% NN O
) -RRB- O
and CC O
phosphoenolpyruvate NN O
carboxykinase NN O
activity NN O
( : O
8 CD O
% NN O
) -RRB- O
within IN O
' `` O
molecular JJ O
function NN O
' '' O
( -LRB- O
Table NNP O
S1 NNP O
) -RRB- O
. . O

A DT O
focused VBN O
KOBAS NNP O
analysis NN O
inferred VBD O
the DT O
50 CD O
C NN B-Species
. . I-Species
elegans NNS I-Species
orthologues NNS O
/ SYM O
homologues NNS O
to TO O
be VB O
involved VBN O
in IN O
apoptosis NN O
and CC O
insulin NN O
signaling NN O
( : O
2 CD O
% NN O
) -RRB- O
, , O
ATP NNP O
synthesis NN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
carbon NN O
metabolism NN O
( , O
6 CD O
% NN O
) -RRB- O
, , O
fatty JJ O
acid NN O
biosynthesis NN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
gap NN O
junction NN O
( , O
2 CD O
% NN O
) -RRB- O
, , O
glucose NN O
metabolism NN O
( , O
6 CD O
% NN O
) , O
or CC O
porphyrin NN O
metabolism NN O
( : O
2 CD O
% NN O
) -RRB- O
, , O
although IN O
34 CD O
( SYM O
68 CD O
% NN O
) -RRB- O
of IN O
them PRP O
could MD O
not RB O
be VB O
mapped VBN O
to IN O
a DT O
specific JJ O
metabolic JJ O
pathway NN O
( : O
Table NN O
2 CD O
) -RRB- O
. . O

Of IN O
these DT O
50 CD O
molecules NNS O
, , O
small JJ O
numbers NNS O
were VBD O
predicted VBN O
to TO O
be VB O
secreted VBN O
( : O
10 CD O
% NN O
) -RRB- O
, , O
anchored VBN O
( , O
2 CD O
% NN O
) -RRB- O
and CC O
/ SYM O
or CC O
transmembrane NN O
( , O
12 CD O
% NN O
) , O
proteins NNS O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

Functionally RB O
, , O
17 CD O
( SYM O
34 CD O
% NN O
) -RRB- O
of IN O
the DT O
50 CD O
molecules NNS O
were VBD O
associated VBN O
with IN O
( , O
non JJ O
- HYPH O
wild JJ O
- HYPH O
type NN O
) SYM O
RNAi NNP O
phenotypes NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
the DT O
majority NN O
displaying VBG O
embryonic JJ O
lethality NN O
( , O
Emb NNP O
) -RRB- O
( , O
13 CD O
types NNS O
; : O
58 CD O
. . O
8 CD O
% NN O
) -RRB- O
, , O
larval JJ O
arrest NN O
( , O
Lva NNP O
) -RRB- O
( , O
23 CD O
. . O
5 CD O
% NN O
) -RRB- O
and CC O
larval JJ O
lethality NN O
( : O
Lvl NNP O
) -RRB- O
( : O
47 CD O
% NN O
) -RRB- O
( , O
Table NN O
2 CD O
) -RRB- O
. . O

Extending VBG O
this DT O
analysis NN O
, , O
a DT O
relatively RB O
complex JJ O
genetic JJ O
interaction NN O
network NN O
was VBD O
predicted VBN O
for IN O
the DT O
17 CD O
C NN B-Species
. . I-Species
elegans NNS I-Species
orthologues NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
with IN O
non JJ O
- HYPH O
wild JJ O
- HYPH O
type NN O
RNAi NNP O
phenotypes NNS O
) -RRB- O
( , O
see VB O
Table NNP O
S2 NNP O
) -RRB- O
. . O

Statistically RB O
highly RB O
significant JJ O
interactions NNS O
were VBD O
predicted VBN O
for IN O
nine CD O
of IN O
the DT O
C NNP B-Species
. . I-Species
elegans NNS I-Species
genes NNS O
; : O
the DT O
top JJ O
five CD O
interactors NNS O
are VBP O
displayed VBN O
in IN O
Fig NNP O
. . O

2 LS O
. . O

The DT O
gene NN O
ontology NN O
categories NNS O
for IN O
eight CD O
selected VBN O
C NN B-Species
. . I-Species
elegans NNS I-Species
genes NNS O
( -LRB- O
F33D11 CD O
. . O
10 CD O
, , O
F55A12 CD O
. . O
8 CD O
, , O
kin NN O
- HYPH O
2 CD O
, , O
mec NN O
- HYPH O
12 CD O
, , O
mup NN O
- HYPH O
2 CD O
, , O
pab NN O
- HYPH O
1 CD O
, , O
rpl NN O
- HYPH O
22 CD O
and CC O
T21B10 CD O
. . O
2 CD O
) -RRB- O
included VBN O
: : O
embryonic JJ O
development NN O
, , O
egg NN O
hatching NN O
, , O
larval JJ O
development NN O
and CC O
/ SYM O
or CC O
growth NN O
. . O

The DT O
other JJ O
categories NNS O
included VBD O
: : O
positive JJ O
regulation NN O
of IN O
growth NN O
rate NN O
( , O
F55A12 CD O
. . O
8 CD O
, , O
kin NN O
- HYPH O
2 CD O
, , O
mup NN O
- HYPH O
2 CD O
, , O
pab NN O
- HYPH O
1 CD O
, , O
rpl NN O
- HYPH O
22 CD O
and CC O
T21B10 CD O
. . O
2 CD O
) -RRB- O
and CC O
gamete NN O
generation NN O
and CC O
locomotory NN O
behaviour NN O
( HYPH O
kin NN O
- HYPH O
2 CD O
, , O
mup NN O
- HYPH O
2 CD O
, , O
pab NN O
- HYPH O
1 CD O
and CC O
F55A12 CD O
. . O
8 CD O
, , O
kin NN O
- HYPH O
2 CD O
, , O
mup NN O
- HYPH O
2 CD O
, , O
respectively RB O
) -RRB- O
. . O

The DT O
C NNP B-Species
. , I-Species
elegans NN I-Species
homologue NN O
egl NN O
- HYPH O
3 CD O
was VBD O
predicted VBN O
to TO O
be VB O
involved VBN O
in IN O
proteolysis NN O
( , O
see VB O
www NN O
. . O
wormbase NN O
. . O
org NN O
) -RRB- O
. . O

All DT O
nine CD O
C NN B-Species
. . I-Species
elegans NNS I-Species
orthologues NNS O
were VBD O
predicted VBN O
to TO O
interact VB O
directly RB O
with IN O
a DT O
total NN O
of IN O
296 CD O
( , O
range NN O
: : O
5 CD O
- HYPH O
75 CD O
) SYM O
other JJ O
genes NNS O
and CC O
, , O
in IN O
particular JJ O
, , O
a DT O
direct JJ O
genetic JJ O
interaction NN O
was VBD O
predicted VBN O
between IN O
pab NN O
- HYPH O
1 CD O
and CC O
T21B10 CD O
. . O
2 CD O
( SYM O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

The DT O
296 CD O
interactors NNS O
were VBD O
associated VBN O
with IN O
embryonic JJ O
and CC O
larval JJ O
development NN O
( : O
n CD O
= SYM O
198 CD O
; : O
66 CD O
. . O
9 CD O
% NN O
) -RRB- O
, , O
information NN O
storage NN O
and CC O
processing NN O
( : O
n NN O
= SYM O
15 CD O
; : O
5 CD O
. . O
1 CD O
% NN O
) -RRB- O
, , O
cellular JJ O
processes NNS O
and CC O
signalling NN O
( : O
n NN O
= SYM O
45 CD O
; : O
15 CD O
. . O
2 CD O
% NN O
) -RRB- O
and CC O
metabolism NN O
( : O
n CD O
= SYM O
18 CD O
; : O
6 CD O
. . O
1 CD O
% NN O
) -RRB- O
; : O
the DT O
precise JJ O
function NN O
of IN O
some DT O
of IN O
the DT O
interactors NNS O
( : O
n CD O
= SYM O
20 CD O
; : O
6 CD O
. . O
7 CD O
% NN O
) -RRB- O
is VBZ O
presently RB O
unknown JJ O
( : O
Table NNP O
S2 NNP O
) -RRB- O
. . O

Discussion NN O

The DT O
present JJ O
study NN O
investigated VBD O
transcripts NNS O
in IN O
infective JJ O
L3s NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
using VBG O
a DT O
genomic JJ O
- HYPH O
bioinformatic JJ O
platform NN O
. . O

The DT O
focus NN O
was VBD O
on IN O
comparisons NNS O
with IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
homologues NNS O
/ , O
orthologues NNS O
, , O
because IN O
the DT O
entire JJ O
genome NN O
sequence NN O
of IN O
this DT O
nematode NN O
is VBZ O
known VBN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
because IN O
there EX O
is VBZ O
a DT O
wealth NN O
of IN O
information NN O
on IN O
the DT O
localization NN O
and CC O
functionality NN O
of IN O
its PRP$ O
molecules NNS O
( , O
www NN O
. . O
wormbase NN O
. . O
org NN O
; : O
http NN O
: : O
/ : O
/ : O
elegans NNS O
. . O
bcgsc ADD O
. . O
bc ADD O
. . O
ca NN O
/ SYM O
knockout NN O
. . O
shtml NN O
) -RRB- O
. . O

The DT O
functions NNS O
of IN O
most JJS O
genes NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
have VBP O
been VBN O
assessed VBN O
using VBG O
RNAi NNP O
( , O
e LS O
. . O
g LS O
. . O
, , O
[ -LRB- O
14 CD O
] -RRB- O
, , O
[ -LRB- O
15 CD O
] -RRB- O
, , O
[ -LRB- O
17 CD O
] -RRB- O
, , O
[ -LRB- O
55 CD O
] -RRB- O
, , O
[ -LRB- O
56 CD O
] -RRB- O
) -RRB- O
in IN O
the DT O
hermaphroditic JJ O
stage NN O
, , O
whereas IN O
there EX O
is VBZ O
a DT O
paucity NN O
of IN O
functional JJ O
information NN O
available JJ O
for IN O
Ascaris NNP O
and CC O
other JJ O
parasitic JJ O
nematodes NNS O
of IN O
animals NNS O
[ -LRB- O
57 CD O
] -RRB- O
, , O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Following VBG O
the DT O
microarray NN O
analysis NN O
of IN O
> SYM O
2500 CD O
ESTs NNS O
from IN O
the DT O
SSH NNP O
library NN O
, , O
498 CD O
cDNAs NNS O
inferred VBN O
to TO O
be VB O
enriched VBN O
in IN O
the DT O
L3 NNP O
, , O
based VBN O
on IN O
hybridization NN O
signal NN O
, , O
were VBD O
sequenced VBN O
and CC O
subjected VBN O
to IN O
comprehensive JJ O
in IN O
silico NN O
analyses NNS O
. . O

Of IN O
the DT O
91 CD O
clusters NNS O
of IN O
molecules NNS O
categorized VBN O
, , O
50 CD O
( SYM O
54 CD O
. . O
9 CD O
% NN O
) -RRB- O
had VBD O
C NN B-Species
. . I-Species
elegans NNS I-Species
homologues NNS O
/ SYM O
orthologues NNS O
with IN O
loss NN O
- HYPH O
of IN O
- HYPH O
function NN O
phenotypes NNS O
could MD O
be VB O
mapped VBN O
to IN O
key JJ O
pathways NNS O
. . O

The DT O
statistically RB O
significant JJ O
genetic JJ O
interactions NNS O
predicted VBN O
for IN O
9 CD O
of IN O
the DT O
50 CD O
C NN B-Species
. , I-Species
elegans FW I-Species
orthologues NNS O
[ -LRB- O
namely RB O
egl NN O
- HYPH O
3 CD O
, , O
F33D11 CD O
. . O
10 CD O
, , O
F55A12 CD O
. . O
8 CD O
, , O
kin NN O
- HYPH O
2 CD O
, , O
mec NN O
- HYPH O
12 CD O
, , O
mup NN O
- HYPH O
2 CD O
, , O
pab NN O
- HYPH O
1 CD O
, , O
rpl NN O
- HYPH O
22 CD O
and CC O
T21B10 CD O
. . O
2 CD O
( , O
= SYM O
enol NN O
- HYPH O
1 CD O
) -RRB- O
] -RRB- O
and CC O
the DT O
interaction NN O
network NN O
included VBD O
genes NNS O
encoding VBG O
kinases NNS O
, , O
alpha NN O
- HYPH O
tubulins NNS O
, , O
enolases NNS O
, , O
troponin NN O
and CC O
other JJ O
named VBN O
and CC O
unnamed JJ O
proteins NNS O
. . O

Eight CD O
of IN O
these DT O
molecules NNS O
( , O
enol NN O
- HYPH O
1 CD O
, , O
pab NN O
- HYPH O
1 CD O
, , O
F33D11 CD O
. . O
10 CD O
, , O
rpl NN O
- HYPH O
22 CD O
, , O
F55A12 CD O
. . O
8 CD O
mec NN O
- HYPH O
12 CD O
, , O
mup NN O
- HYPH O
2 CD O
and CC O
kin NN O
- HYPH O
2 CD O
) , O
have VBP O
known VBN O
or CC O
predicted VBN O
roles NNS O
in IN O
embryonic JJ O
and CC O
larval JJ O
growth NN O
and CC O
development NN O
, , O
gamete NN O
generation NN O
, , O
locomotory NN O
behaviour NN O
or CC O
other JJ O
biological JJ O
processes NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
( , O
see VB O
www NN O
. . O
wormbase NN O
. . O
org NN O
) -RRB- O
. . O

The DT O
enolase NN O
encoded VBN O
by IN O
enol NN O
- HYPH O
1 CD O
is VBZ O
predicted VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
glycolysis NN O
, , O
gluconeogenesis NN O
, , O
phenylalanine NN O
, , O
tyrosine NN O
and CC O
tryptophan NN O
biosynthesis NN O
( , O
cf NN O
. . O
[ -LRB- O
59 CD O
] -RRB- O
) -RRB- O
. . O

Since IN O
glucose NN O
is VBZ O
the DT O
main JJ O
source NN O
for IN O
ATP NNP O
production NN O
, , O
the DT O
alteration NN O
in IN O
these DT O
key JJ O
glycolytic JJ O
enzymes NNS O
may MD O
lead VB O
to IN O
cellular JJ O
dysfunction NN O
, , O
such JJ O
as IN O
impaired JJ O
ion NN O
- HYPH O
motive NN O
ATPase NN O
required VBN O
to TO O
maintain VB O
potential JJ O
gradients NNS O
, , O
operate VB O
pumps NNS O
and CC O
maintain VB O
membrane NN O
lipid NN O
asymmetry NN O
[ -LRB- O
60 CD O
] -RRB- O
. . O

Bioinformatic JJ O
analysis NN O
for IN O
transmembrane NN O
helices NNS O
( -LRB- O
TMHMM NNP O
) -RRB- O
and CC O
peptide NN O
signal NN O
sequences NNS O
( , O
SignalP NNP O
) -RRB- O
predicted VBD O
ENOL NNP O
- HYPH O
1 CD O
to TO O
be VB O
a DT O
non NN O
- HYPH O
secreted VBN O
protein NN O
localized VBN O
to IN O
the DT O
cytoplasm NN O
( , O
cf NN O
. . O
Table NN O
2 CD O
) -RRB- O
. . O

Nonetheless RB O
, , O
enolases NNS O
are VBP O
often RB O
detected VBN O
in IN O
the DT O
excretory NN O
/ SYM O
secretory NN O
( , O
ES NNP O
) , O
products NNS O
of IN O
parasitic JJ O
helminths NNS O
, , O
including VBG O
adult NN O
A NN B-Species
. . I-Species
suum NN I-Species
[ -LRB- O
61 CD O
] -RRB- O
, , O
and CC O
appear VBP O
to TO O
play VB O
a DT O
role NN O
in IN O
the DT O
triggering NN O
of IN O
nitric JJ O
oxide NN O
production NN O
by IN O
host NN O
cells NNS O
. . O

The DT O
enol NN O
- HYPH O
1 CD O
orthologue NN O
of IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
has VBZ O
been VBN O
predicted VBN O
to TO O
interact VB O
specifically RB O
with IN O
the DT O
polyadenylate NN O
binding VBG O
protein NN O
gene NN O
, , O
pab NN O
- HYPH O
1 CD O
, , O
inferred VBN O
to TO O
be VB O
involved VBN O
in IN O
coordinated VBN O
gene NN O
transcription NN O
and CC O
expression NN O
during IN O
normal JJ O
larval JJ O
development NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Poly NNP O
( -LRB- O
A NN O
) NFP O
- HYPH O
binding VBG O
proteins NNS O
( , O
PABPs NNS O
) -RRB- O
are VBP O
recognized VBN O
to TO O
be VB O
central JJ O
to IN O
the DT O
regulation NN O
of IN O
mRNA NN O
translation NN O
and CC O
stability NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

Present JJ O
evidence NN O
suggests VBZ O
that IN O
the DT O
expression NN O
of IN O
PAB NNP O
- HYPH O
1 CD O
is VBZ O
regulated VBN O
by IN O
an DT O
oligo JJ O
- HYPH O
pyrimidine NN O
tract NN O
in IN O
response NN O
to IN O
cell NN O
growth NN O
and CC O
relates VBZ O
to IN O
coordinated VBN O
growth NN O
regulation NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
[ -LRB- O
62 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
gene NN O
silencing NN O
of IN O
pab NN O
- HYPH O
1 CD O
and CC O
its PRP$ O
selected VBN O
interactors NNS O
( , O
see VB O
Fig NNP O
. . O
2 CD O
) -RRB- O
leads VBZ O
to IN O
embryonic JJ O
lethal NN O
( , O
Emb NNP O
) -RRB- O
, , O
slow JJ O
growth NN O
( , O
Slo NNP O
) -RRB- O
and CC O
sterile JJ O
progeny NN O
( -LRB- O
Stp NN O
) -RRB- O
phenotypes NNS O
( , O
see VB O
www NN O
. . O
wormbase NN O
. . O
org NN O
) -RRB- O
. . O

Another DT O
gene NN O
( : O
F33D11 CD O
. . O
10 CD O
; : O
EST NN O
code NN O
4F10 CD O
; : O
see VB O
Table NN O
2 CD O
) -RRB- O
which WDT O
encodes VBZ O
an DT O
ATP NN O
- HYPH O
dependent JJ O
RNA NN O
helicase NN O
and CC O
is VBZ O
associated VBN O
with IN O
embryonic JJ O
lethal JJ O
( , O
Emb NNP O
) -RRB- O
and CC O
larval JJ O
lethal JJ O
( , O
Lvl NNP O
) -RRB- O
RNAi NNP O
phenotypes NNS O
, , O
was VBD O
shown VBN O
to TO O
be VB O
highly RB O
transcribed VBN O
in IN O
infective JJ O
L3s NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
. . O

Helicases NNS O
are VBP O
involved VBN O
in IN O
a DT O
variety NN O
of IN O
RNA NNP O
metabolic JJ O
processes NNS O
, , O
including VBG O
translation NN O
initiation NN O
, , O
pre NN O
- HYPH O
mRNA NN O
splicing NN O
, , O
pre NN O
- HYPH O
rRNA NN O
processing NN O
, , O
rRNA NNP O
maturation NN O
and CC O
RNA NN O
degradation NN O
[ -LRB- O
63 CD O
] -RRB- O
, , O
and CC O
are VBP O
crucial JJ O
for IN O
life NN O
cycle NN O
progression NN O
, , O
sex NN O
determination NN O
and CC O
early JJ O
embryogenesis NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
[ -LRB- O
60 CD O
] -RRB- O
. . O

The DT O
high JJ O
transcription NN O
levels NNS O
of IN O
a DT O
homologue NN O
/ SYM O
orthologue NN O
in IN O
the DT O
L3 NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
might MD O
suggest VB O
a DT O
similar JJ O
role NN O
in IN O
this DT O
ascaridoid NN O
. . O

Similarly RB O
, , O
the DT O
coordination NN O
of IN O
the DT O
expression NN O
of IN O
a DT O
large JJ O
number NN O
of IN O
genes NNS O
is VBZ O
required VBN O
for IN O
normal JJ O
growth NN O
and CC O
cell NN O
proliferation NN O
during IN O
larval JJ O
development NN O
. . O

The DT O
high JJ O
transcription NN O
level NN O
for IN O
the DT O
ribosomal JJ O
protein NN O
gene NN O
homologue NN O
rpl NN O
- HYPH O
22 CD O
( , O
large JJ O
subunit NN O
family NN O
member NN O
; , O
EST NNP O
code NN O
26G12 CD O
, , O
see VB O
Table NN O
2 CD O
) -RRB- O
in IN O
the DT O
infective JJ O
L3 NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
compared VBN O
with IN O
other JJ O
developmental JJ O
stages NNS O
is VBZ O
likely JJ O
to TO O
reflect VB O
the DT O
substantial JJ O
rate NN O
of IN O
cell NN O
growth NN O
in IN O
this DT O
stage NN O
[ -LRB- O
64 CD O
] -RRB- O
. . O

The DT O
gene NN O
( , O
F55A12 CD O
. . O
8 CD O
, , O
EST NN O
code NN O
4G11 CD O
; : O
see VB O
Table NN O
2 CD O
) -RRB- O
encoding VBG O
an DT O
acetyl NN O
- HYPH O
transferase NN O
with IN O
a DT O
putative JJ O
ATPase NNP O
domain NN O
, , O
shown VBN O
to TO O
be VB O
enriched VBN O
in IN O
the DT O
L3 NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
, , O
was VBD O
predicted VBN O
to TO O
interact VB O
with IN O
75 CD O
other JJ O
genes NNS O
all DT O
involved VBN O
in IN O
energy NN O
production NN O
and CC O
/ SYM O
or CC O
RNA NN O
processing NN O
( , O
see VB O
Table NNP O
S2 NNP O
) -RRB- O
. . O

Several JJ O
molecules NNS O
involved VBN O
in IN O
ATP NNP O
synthesis NN O
and CC O
mitochondrial JJ O
pathways NNS O
( , O
e LS O
. . O
g LS O
. . O
, , O
cytochrome NN O
oxidase NN O
c NN O
subunits NN O
1 CD O
, , O
2 CD O
and CC O
3 CD O
, , O
ADP NNP O
/ SYM O
ATP NNP O
translocases NNS O
, , O
NADH NNP O
dehydrogenases NNS O
, , O
ATPases NNP O
and CC O
ATP NNP O
synthetases NNS O
) -RRB- O
have VBP O
been VBN O
reported VBN O
previously RB O
to TO O
be VB O
highly RB O
represented VBN O
in IN O
the DT O
L3 NNP O
stage NN O
of IN O
Anisakis NNP B-Species
simplex NN I-Species
[ -LRB- O
65 CD O
] -RRB- O
, , O
thus RB O
supporting VBG O
the DT O
proposal NN O
that IN O
substantial JJ O
energy NN O
is VBZ O
required VBN O
for IN O
larval JJ O
development NN O
as RB O
well RB O
as IN O
the DT O
transition NN O
from IN O
the DT O
free RB O
- HYPH O
living NN O
to IN O
the DT O
parasitic JJ O
stage NN O
and CC O
the DT O
invasion NN O
of IN O
the DT O
host NN O
. . O

There EX O
is VBZ O
also RB O
likely JJ O
to TO O
be VB O
a DT O
substantial JJ O
energy NN O
requirement NN O
for IN O
muscle NN O
contraction NN O
linked VBN O
to IN O
larval JJ O
motility NN O
in IN O
A NN B-Species
. . I-Species
suum NNP I-Species
, , O
as IN O
the DT O
L3s NNS O
penetrate VBP O
the DT O
caecal JJ O
wall NN O
in IN O
the DT O
porcine NN O
host NN O
, , O
before IN O
undergoing VBG O
hepato JJ O
- HYPH O
pulmonary JJ O
migration NN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Accordingly RB O
, , O
genes NNS O
encoding VBG O
a DT O
specialized JJ O
tubulin NN O
expressed VBN O
in IN O
mechanoreceptors NNS O
( , O
mec NN O
- HYPH O
12 CD O
, , O
EST NNP O
code NN O
13000000000 CD O
) -RRB- O
and CC O
a DT O
troponin NN O
( , O
mup NN O
- HYPH O
2 CD O
, , O
EST NNP O
code NN O
01G03 CD O
; : O
see VB O
Table NNP O
2 CD O
) -RRB- O
, , O
both DT O
predicted VBN O
to TO O
interact VB O
with IN O
a DT O
total JJ O
number NN O
of IN O
32 CD O
tubulin NN O
- HYPH O
and CC O
myosin NN O
- HYPH O
encoding VBG O
genes NNS O
, , O
also RB O
supported VBD O
a DT O
link NN O
to IN O
extensive JJ O
muscle NN O
contraction NN O
and CC O
motility NN O
in IN O
A NN B-Species
. . I-Species
suum NN I-Species
L3s NNS O
. . O

Also RB O
, , O
neuroactive JJ O
peptides NNS O
are VBP O
required VBN O
to TO O
regulate VB O
the DT O
responsiveness NN O
of IN O
nematode NN O
larvae NN O
to IN O
mechanical JJ O
stimuli NNS O
[ -LRB- O
66 CD O
] -RRB- O
. . O

A DT O
homologue NN O
encoded VBN O
by IN O
egl NN O
- HYPH O
3 CD O
was VBD O
shown VBN O
to TO O
be VB O
highly RB O
transcribed VBN O
in IN O
the DT O
L3 NNP O
of IN O
A NNP B-Species
. . I-Species
suum NN I-Species
; : O
EGL NNP O
- HYPH O
3 CD O
is VBZ O
predicted VBN O
to TO O
be VB O
a DT O
pro JJ O
- HYPH O
hormone NN O
convertase NN O
involved VBN O
in IN O
the DT O
maturation NN O
of IN O
neuropeptides NNS O
and CC O
could MD O
be VB O
associated VBN O
with IN O
mechano NN O
- HYPH O
sensory NN O
responses NNS O
and CC O
touch NN O
sensitivity NN O
linked VBN O
to IN O
the DT O
host NN O
invasion NN O
. . O

A DT O
regulatory JJ O
subunit NN O
of IN O
a DT O
cAMP NN O
- HYPH O
dependent JJ O
protein NN O
kinase NN O
( , O
kin NN O
- HYPH O
2 CD O
, , O
EST NN O
code NN O
22H01 CD O
; : O
see VB O
Table NN O
2 CD O
) -RRB- O
was VBD O
predicted VBN O
to TO O
interact VB O
with IN O
72 CD O
other JJ O
genes NNS O
all DT O
involved VBN O
in IN O
diverse JJ O
cellular JJ O
processes NNS O
, , O
such JJ O
as IN O
nuclear JJ O
trafficking NN O
, , O
and CC O
DNA NN O
replication NN O
and CC O
repair NN O
( , O
see VB O
Table NNP O
S2 NNP O
) -RRB- O
. . O

Based VBN O
on IN O
gene NN O
ontology NN O
terms NNS O
, , O
kin NN O
- HYPH O
2 CD O
is VBZ O
implicated VBN O
in IN O
gamete NN O
generation NN O
, , O
growth NN O
, , O
larval JJ O
development NN O
, , O
post NN O
- HYPH O
embryonic JJ O
body NN O
morphogenesis NN O
, , O
signal NN O
transduction NN O
and CC O
/ SYM O
or CC O
protein NN O
amino NN O
acid NN O
phosphorylation NN O
( , O
see VB O
Table NNP O
S2 NNP O
) -RRB- O
. . O

Gene NN O
silencing NN O
of IN O
kin NN O
- HYPH O
2 CD O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
leads VBZ O
to IN O
phenotypes NNS O
, , O
such JJ O
as IN O
larval NN O
lethal JJ O
( , O
Lvl NNP O
) -RRB- O
, , O
larval JJ O
arrest NN O
( , O
Lva NNP O
) -RRB- O
, , O
body NN O
morphology NN O
defect NN O
( , O
Bmd NNP O
) -RRB- O
, , O
dumpy JJ O
( , O
Dpy JJ O
) -RRB- O
, , O
uncoordinated JJ O
( , O
Unc NNP O
) -RRB- O
and CC O
sterile JJ O
progeny NN O
( -LRB- O
Stp NN O
) -RRB- O
( , O
www NN O
. . O
wormbase NN O
. . O
org NN O
) -RRB- O
, , O
suggesting VBG O
that IN O
its PRP$ O
homologue NN O
in IN O
A NN B-Species
. . I-Species
suum NN I-Species
is VBZ O
central JJ O
to IN O
larval JJ O
maturation NN O
. . O

The DT O
KOBAS NNP O
analysis NN O
predicted VBD O
the DT O
protein NN O
KIN NN O
- HYPH O
2 CD O
to TO O
be VB O
involved VBN O
in IN O
the DT O
insulin NN O
- HYPH O
signaling VBG O
pathway NN O
, , O
previously RB O
implicated VBN O
in IN O
controlling VBG O
the DT O
exit NN O
from IN O
dauer NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
and CC O
the DT O
activation NN O
of IN O
L3s NNS O
of IN O
the DT O
canine NN B-Species
hookworm NN I-Species
, , O
Ancylostoma NNP B-Species
caninum NN I-Species
, , O
following VBG O
exsheathment NN O
[ -LRB- O
67 CD O
] -RRB- O
. . O

In IN O
a DT O
recent JJ O
study NN O
, , O
Brand NNP O
and CC O
Hawdon NNP O
[ -LRB- O
68 CD O
] -RRB- O
were VBD O
able JJ O
to TO O
inhibit VB O
( , O
with IN O
a DT O
phosphoinositide NN O
- HYPH O
3 CD O
- HYPH O
OH NN O
- HYPH O
kinase NN O
inhibitor NN O
) , O
the DT O
activation NN O
of IN O
infective JJ O
L3s NNS O
of IN O
both DT O
of IN O
the DT O
hookworms NNS O
Ancylostoma NN B-Species
caninum NN I-Species
and CC O
Ancylostoma NN B-Species
ceylanicum NN I-Species
via IN O
the DT O
insulin NN O
signaling NN O
pathway NN O
, , O
thus RB O
lending VBG O
some DT O
credence NN O
to IN O
the DT O
hypothesis NN O
that IN O
this DT O
pathway NN O
plays VBZ O
an DT O
critical JJ O
role NN O
in IN O
regulating VBG O
the DT O
transition NN O
from IN O
the DT O
free RB O
- HYPH O
living VBG O
to IN O
the DT O
parasitic JJ O
stage NN O
[ -LRB- O
68 CD O
] -RRB- O
. . O

Recently RB O
, , O
it PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
transcriptional JJ O
and CC O
feeding NN O
responses NNS O
to IN O
serum NN O
- HYPH O
stimulation NN O
in IN O
Ancylostoma NNP B-Species
caninum NN I-Species
are VBP O
regulated VBN O
by IN O
parallel JJ O
systems NNS O
, , O
with IN O
the DT O
insulin NN O
signaling NN O
pathway NN O
playing VBG O
a DT O
significant JJ O
role NN O
in IN O
the DT O
' `` O
resumption NN O
of IN O
feeding NN O
' '' O
in IN O
activated JJ O
larvae NN O
[ -LRB- O
69 CD O
] -RRB- O
. . O

Protein NN O
kinases NNS O
are VBP O
also RB O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
pathways NNS O
linked VBN O
to IN O
sexual JJ O
maturation NN O
in IN O
developing VBG O
larvae NN O
. . O

As IN O
already RB O
proposed VBN O
for IN O
adult NN O
stages NNS O
of IN O
H NN B-Species
. , I-Species
contortus NN I-Species
[ -LRB- O
45 CD O
] -RRB- O
, , O
the DT O
protein NN O
kinase NN O
gene NN O
cdk NN O
- HYPH O
1 CD O
is VBZ O
predicted VBN O
to TO O
play VB O
a DT O
pivotal JJ O
role NN O
in IN O
the DT O
germline NN O
, , O
oogenesis NN O
and CC O
spermiogenesis NN O
pathways NNS O
of IN O
this DT O
parasitic JJ O
nematode NN O
. . O

Other JJ O
protein NN O
kinases NNS O
, , O
such JJ O
as IN O
PEPCK NNP O
, , O
and CC O
phosphatases NNS O
, , O
were VBD O
shown VBN O
herein RB O
to TO O
be VB O
transcribed VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
L3 NNP O
stage NN O
compared VBN O
with IN O
other JJ O
developmental JJ O
stages NNS O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
( , O
see VB O
Table NNP O
2 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
in IN O
accordance NN O
to IN O
findings NNS O
reported VBN O
recently RB O
for IN O
Anisakis NNP B-Species
simplex NN I-Species
[ -LRB- O
65 CD O
] -RRB- O
. . O

Due IN O
to IN O
their PRP$ O
major JJ O
regulatory JJ O
effects NNS O
in IN O
eukaryotic JJ O
signaling NN O
events NNS O
and CC O
regulatory JJ O
and CC O
sensory JJ O
functions NNS O
, , O
protein NN O
kinases NNS O
have VBP O
been VBN O
considered VBN O
interesting JJ O
targets NNS O
for IN O
anti JJ O
- HYPH O
parasitic JJ O
drugs NNS O
[ -LRB- O
70 CD O
] -RRB- O
. . O

In IN O
conclusion NN O
, , O
this DT O
study NN O
has VBZ O
given VBN O
some DT O
interesting JJ O
insights NNS O
into IN O
early JJ O
molecular JJ O
processes NNS O
in IN O
the DT O
L3 NNP O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
. . O

Approximately RB O
60 CD O
% NN O
of IN O
the DT O
transcripts NNS O
enriched VBN O
in IN O
the DT O
L3 NNP O
stage NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
have VBP O
homologues NNS O
/ SYM O
orthologues NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
. . O

The DT O
bioinformatic JJ O
analyses NNS O
of IN O
selected VBN O
molecules NNS O
suggest VBP O
that IN O
a DT O
complex JJ O
genetic JJ O
network NN O
regulates VBZ O
or CC O
controls VBZ O
larval JJ O
growth NN O
and CC O
development NN O
in IN O
A NN B-Species
. . I-Species
suum NN I-Species
L3s NNS O
, , O
and CC O
some DT O
of IN O
these DT O
might MD O
be VB O
involved VBN O
in IN O
or CC O
regulate VB O
the DT O
switch NN O
from IN O
the DT O
free RB O
- HYPH O
living VBG O
to IN O
the DT O
parasitic JJ O
stage NN O
. . O

Some DT O
caution NN O
is VBZ O
warranted VBN O
in IN O
drawing VBG O
conclusions NNS O
regarding VBG O
molecular JJ O
mechanisms NNS O
regulating VBG O
the DT O
transition NN O
to IN O
parasitism NN O
in IN O
parasitic JJ O
nematodes NNS O
from IN O
information NN O
on IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
as IN O
latter JJ O
is VBZ O
a DT O
free RB O
- HYPH O
living VBG O
nematode NN O
. . O

Also RB O
, , O
while IN O
the DT O
method NN O
of IN O
data NN O
integration NN O
is VBZ O
essential JJ O
for IN O
the DT O
reliable JJ O
prediction NN O
of IN O
genetic JJ O
interactions NNS O
, , O
it PRP O
might MD O
limit VB O
the DT O
capacity NN O
of IN O
the DT O
approach NN O
somewhat RB O
to TO O
infer VB O
nematode NN O
- HYPH O
specific JJ O
interactions NNS O
. . O

As IN O
additional JJ O
datasets NNS O
of IN O
genes NNS O
and CC O
gene NN O
functions NNS O
become VBP O
available JJ O
for IN O
various JJ O
parasitic JJ O
nematodes NNS O
, , O
more RBR O
informed JJ O
inferences NNS O
can MD O
be VB O
made VBN O
regarding VBG O
the DT O
functions NNS O
of IN O
nematode NN O
- HYPH O
specific JJ O
genes NNS O
, , O
particularly RB O
those DT O
involved VBN O
in IN O
the DT O
transition NN O
to IN O
parasitism NN O
. . O

The DT O
imminent JJ O
genome NN O
sequence NN O
of IN O
A NN B-Species
. . I-Species
suum NN I-Species
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
sanger NN O
. . O
ac ADD O
. . O
uk IN O
/ SYM O
Projects NNS O
/ SYM O
Helminths NNP O
/ , O
) -RRB- O
should MD O
all RB O
assist VB O
in IN O
this DT O
endeavour NN O
. . O

Also RB O
, , O
functional JJ O
analysis NN O
of IN O
selected VBN O
molecules NNS O
representing VBG O
selected VBN O
ESTs NNS O
identified VBN O
herein RB O
, , O
utilizing VBG O
gene NN O
silencing NN O
approaches NNS O
established VBN O
recently RB O
[ -LRB- O
33 CD O
] -RRB- O
, , O
[ -LRB- O
34 CD O
] -RRB- O
, , O
could MD O
provide VB O
some DT O
insights NNS O
into IN O
developmental JJ O
processes NNS O
in IN O
Ascaris NNP O
and CC O
related JJ O
ascaridoid NN O
nematodes NNS O
and CC O
provide VB O
avenues NNS O
for IN O
the DT O
development NN O
of IN O
novel JJ O
approaches NNS O
for IN O
their PRP$ O
control NN O
. . O

Supporting VBG O
Information NN O

Minocycline NN O
attenuates VBZ O
lipopolysaccharide NN O
( -LRB- O
LPS NNP O
) -RRB- O
- HYPH O
induced VBN O
neuroinflammation NN O
, , O
sickness NN O
behavior NN O
, , O
and CC O
anhedonia NN O

Abstract JJ O

Background NN O

Activation NN O
of IN O
the DT O
peripheral JJ O
innate JJ O
immune JJ O
system NN O
stimulates VBZ O
the DT O
secretion NN O
of IN O
CNS NNP O
cytokines NNS O
that WDT O
modulate VBP O
the DT O
behavioral JJ O
symptoms NNS O
of IN O
sickness NN O
. . O

Excessive JJ O
production NN O
of IN O
cytokines NNS O
by IN O
microglia NN O
, , O
however RB O
, , O
may MD O
cause VB O
long RB O
- HYPH O
lasting VBG O
behavioral JJ O
and CC O
cognitive JJ O
complications NNS O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
if IN O
minocycline NN O
, , O
an DT O
anti JJ O
- HYPH O
inflammatory JJ O
agent NN O
and CC O
purported VBN O
microglial JJ O
inhibitor NN O
, , O
attenuates VBZ O
lipopolysaccharide NN O
( , O
LPS NNP O
) -RRB- O
- HYPH O
induced VBN O
neuroinflammation NN O
, , O
sickness NN O
behavior NN O
, , O
and CC O
anhedonia NN O
. . O

Methods NNS O

In IN O
the DT O
first JJ O
set NN O
of IN O
experiments NNS O
the DT O
effect NN O
of IN O
minocycline NN O
pretreatment NN O
on IN O
LPS NNP O
- HYPH O
induced VBN O
microglia NN O
activation NN O
was VBD O
assessed VBN O
in IN O
BV NNP O
- HYPH O
2 CD O
microglia NN O
cell NN O
cultures NNS O
. . O

In IN O
the DT O
second JJ O
study NN O
, , O
adult NN O
( , O
3 CD O
- SYM O
6 CD O
m NN O
) SYM O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
received VBD O
an DT O
intraperitoneal JJ O
( , O
i CD O
. . O
p NN O
. . O
) -RRB- O
injection NN O
of IN O
vehicle NN O
or CC O
minocycline NN O
( , O
50 CD O
mg NNS O
/ SYM O
kg NNS O
) -RRB- O
for IN O
three CD O
consecutive JJ O
days NNS O
. . O

On IN O
the DT O
third JJ O
day NN O
, , O
mice NNS B-Species
were VBD O
also RB O
injected VBN O
( : O
i PRP O
. . O
p NN O
. . O
) -RRB- O
with IN O
saline NN O
or CC O
Escherichia NN B-Species
coli NN I-Species
LPS NN O
( : O
0 CD O
. . O
33 CD O
mg NN O
/ SYM O
kg NN O
) -RRB- O
and CC O
behavior NN O
( : O
i LS O
. . O
e LS O
. . O
, , O
sickness NN O
and CC O
anhedonia NN O
) -RRB- O
and CC O
markers NNS O
of IN O
neuroinflammation NN O
( , O
i LS O
. . O
e LS O
. . O
, , O
microglia NN O
activation NN O
and CC O
inflammatory JJ O
cytokines NNS O
) -RRB- O
were VBD O
determined VBN O
. . O

In IN O
the DT O
final JJ O
study NN O
, , O
adult NN O
and CC O
aged JJ O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
were VBD O
treated VBN O
with IN O
the DT O
same JJ O
minocycline NN O
and CC O
LPS NN O
injection NN O
regimen NN O
and CC O
markers NNS O
of IN O
neuroinflammation NN O
were VBD O
determined VBN O
. . O

All DT O
data NNS O
were VBD O
analyzed VBN O
using VBG O
Statistical NNP O
Analysis NNP O
Systems NNP O
General NNP O
Linear NNP O
Model NNP O
procedures NNS O
and CC O
were VBD O
subjected VBN O
to IN O
one CD O
- HYPH O
, , O
two CD O
- HYPH O
, , O
or CC O
three CD O
- HYPH O
way NN O
ANOVA NNP O
to TO O
determine VB O
significant JJ O
main JJ O
effects NNS O
and CC O
interactions NNS O
. . O

Results NNS O

Minocycline NN O
blocked VBD O
LPS NNP O
- HYPH O
stimulated VBN O
inflammatory JJ O
cytokine NN O
secretion NN O
in IN O
the DT O
BV NNP O
- HYPH O
2 CD O
microglia NN O
- HYPH O
derived VBN O
cell NN O
line NN O
and CC O
reduced VBN O
LPS NNP O
- HYPH O
induced VBN O
Toll NNP O
- HYPH O
like NNP O
- HYPH O
receptor NN O
- HYPH O
2 CD O
( SYM O
TLR2 NNP O
) -RRB- O
surface NN O
expression NN O
on IN O
brain NN O
microglia NN O
. . O

Moreover RB O
, , O
minocycline NN O
facilitated VBD O
the DT O
recovery NN O
from IN O
sickness NN O
behavior NN O
( : O
i LS O
. . O
e LS O
. . O
, , O
anorexia NN O
, , O
weight NN O
loss NN O
, , O
and CC O
social JJ O
withdrawal NN O
) -RRB- O
and CC O
prevented VBD O
anhedonia NN O
in IN O
adult NN O
mice NNS B-Species
challenged VBN O
with IN O
LPS NNP O
. . O

Furthermore RB O
, , O
the DT O
minocycline NN O
associated VBN O
recovery NN O
from IN O
LPS NNP O
- HYPH O
induced VBN O
sickness NN O
behavior NN O
was VBD O
paralleled VBN O
by IN O
reduced VBN O
mRNA NNP O
levels NNS O
of IN O
Interleukin NNP O
( , O
IL NNP O
) SYM O
- HYPH O
1 CD O
beta NN O
, , O
IL NN O
- HYPH O
6 CD O
, , O
and CC O
indoleamine NN O
2 CD O
, , O
3 CD O
dioxygenase NN O
( , O
IDO NN O
) -RRB- O
in IN O
the DT O
cortex NN O
and CC O
hippocampus NN O
. . O

Finally RB O
, , O
in IN O
aged JJ O
mice NNS B-Species
, , O
where WRB O
exaggerated JJ O
neuroinflammation NN O
was VBD O
elicited VBN O
by IN O
LPS NNP O
, , O
minocycline NN O
pretreatment NN O
was VBD O
still RB O
effective JJ O
in IN O
markedly RB O
reducing VBG O
mRNA NN O
levels NNS O
of IN O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
TLR2 NNP O
and CC O
IDO NN O
in IN O
the DT O
hippocampus NN O
. . O

Conclusion NN O

These DT O
data NNS O
indicate VBP O
that IN O
minocycline NN O
mitigates VBZ O
neuroinflammation NN O
in IN O
the DT O
adult NN O
and CC O
aged JJ O
brain NN O
and CC O
modulates VBZ O
the DT O
cytokine NN O
- HYPH O
associated VBN O
changes NNS O
in IN O
motivation NN O
and CC O
behavior NN O
. . O

Background NN O

The DT O
bi JJ O
- HYPH O
directional JJ O
communication NN O
between IN O
the DT O
immune JJ O
system NN O
and CC O
the DT O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
is VBZ O
necessary JJ O
for IN O
mounting VBG O
the DT O
appropriate JJ O
immunological JJ O
, , O
physiological JJ O
, , O
and CC O
behavioral JJ O
responses NNS O
to IN O
immune JJ O
stimulation NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

CNS NNP O
innate JJ O
immune JJ O
cells NNS O
including VBG O
microglia NN O
and CC O
macrophages NNS O
play VBP O
integral JJ O
roles NNS O
in IN O
receiving VBG O
and CC O
propagating VBG O
inflammatory JJ O
signals NNS O
that WDT O
are VBP O
initiated VBN O
at IN O
the DT O
periphery NN O
. . O

Activation NN O
of IN O
peripheral JJ O
innate JJ O
immune JJ O
cells NNS O
elicits VBZ O
the DT O
secretion NN O
of IN O
inflammatory JJ O
cytokines NNS O
, , O
including VBG O
interleukin NN O
( , O
IL NN O
) -RRB- O
- HYPH O
1 CD O
, , O
IL NN O
- HYPH O
6 CD O
, , O
and CC O
tumor NN O
necrosis NN O
factor NN O
- HYPH O
alpha NN O
( , O
TNF NNP O
alpha NN O
. . O
) -RRB- O
, , O
that WDT O
use VBP O
neural JJ O
[ -LRB- O
2 CD O
, , O
3 CD O
] -RRB- O
, , O
humoral JJ O
[ -LRB- O
4 CD O
] -RRB- O
and CC O
blood NN O
brain NN O
barrier NN O
pathways NNS O
[ -LRB- O
5 CD O
] -RRB- O
to TO O
relay VB O
this DT O
signal NN O
to IN O
the DT O
CNS NNP O
. . O

This DT O
inflammatory JJ O
signal NN O
, , O
in IN O
turn NN O
, , O
induces VBZ O
CNS NNP O
macrophages NNS O
and CC O
microglia NN O
to TO O
produce VB O
the DT O
same JJ O
cytokines NNS O
[ -LRB- O
6 CD O
] -RRB- O
, , O
which WDT O
target VBP O
neuronal JJ O
substrates NNS O
and CC O
elicit VBP O
a DT O
sickness NN O
behavior NN O
syndrome NN O
that WDT O
is VBZ O
normally RB O
adaptive JJ O
and CC O
beneficial JJ O
to IN O
the DT O
host NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

An DT O
amplified JJ O
or CC O
excessive JJ O
inflammatory JJ O
cytokine NN O
response NN O
in IN O
the DT O
brain NN O
, , O
however RB O
, , O
is VBZ O
associated VBN O
with IN O
a DT O
myriad NN O
of IN O
complications NNS O
including VBG O
cognitive JJ O
dysfunction NN O
[ -LRB- O
7 CD O
- SYM O
10 CD O
] -RRB- O
, , O
prolonged VBN O
sickness NN O
behavior NN O
[ -LRB- O
11 CD O
- SYM O
14 CD O
] -RRB- O
, , O
and CC O
depressive JJ O
- HYPH O
like JJ O
behavior NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Microglia NNP O
are VBP O
primarily RB O
involved VBN O
in IN O
immune JJ O
surveillance NN O
[ -LRB- O
16 CD O
, , O
17 CD O
] -RRB- O
, , O
but CC O
when WRB O
activated VBN O
have VBP O
macrophage NN O
- HYPH O
like JJ O
capabilities NNS O
including VBG O
phagocytosis NN O
, , O
inflammatory JJ O
cytokine NN O
production NN O
, , O
and CC O
antigen NN O
presentation NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Normally RB O
these DT O
neuroinflammatory JJ O
changes NNS O
are VBP O
transient JJ O
with IN O
microglia NN O
returning VBG O
to IN O
a DT O
resting VBG O
state NN O
as IN O
the DT O
immune JJ O
stimulus NN O
is VBZ O
resolved VBN O
. . O

Aging NN O
or CC O
neurological JJ O
disease NN O
, , O
however RB O
, , O
may MD O
provide VB O
a DT O
brain NN O
environment NN O
where WRB O
microglia NN O
are VBP O
more RBR O
"""" `` O
reactive JJ O
or CC O
primed VBN O
"""" '' O
to IN O
a DT O
peripheral JJ O
immune JJ O
challenge NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Recent JJ O
findings NNS O
indicate VBP O
that IN O
several JJ O
markers NNS O
of IN O
glial NN O
activation NN O
such JJ O
as IN O
major JJ O
histocompatibility NN O
complex NN O
( , O
MHC NNP O
) -RRB- O
class NN O
II NN O
, , O
complement NN O
receptors NNS O
, , O
and CC O
scavenger NN O
receptors NNS O
are VBP O
increased VBN O
in IN O
brain NN O
during IN O
normal JJ O
aging NN O
[ -LRB- O
13 CD O
, , O
20 CD O
- SYM O
26 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
we PRP O
and CC O
others NNS O
have VBP O
reported VBN O
that IN O
a DT O
biological JJ O
consequence NN O
of IN O
this DT O
reactive JJ O
glial NN O
profile NN O
is VBZ O
an DT O
exaggerated JJ O
neuroinflammatory JJ O
response NN O
to IN O
innate JJ O
immune JJ O
challenge NN O
[ -LRB- O
9 CD O
, , O
10 CD O
, , O
12 CD O
- SYM O
14 CD O
, , O
27 CD O
, , O
28 CD O
] -RRB- O
. . O

Active JJ O
microglia NN O
and CC O
CNS NNP O
macrophages NNS O
also RB O
contribute VBP O
to IN O
the DT O
production NN O
of IN O
oxidative JJ O
and CC O
neuroactive JJ O
mediators NNS O
that WDT O
may MD O
influence VB O
behavior NN O
. . O

For IN O
instance NN O
, , O
inflammatory JJ O
cytokines NNS O
in IN O
the DT O
CNS NNP O
upregulate VBP O
the DT O
enzyme NN O
IDO NNP O
[ -LRB- O
29 CD O
, , O
30 CD O
] -RRB- O
, , O
which WDT O
metabolizes VBZ O
tryptophan NN O
( -LRB- O
TRP NNP O
) -RRB- O
into IN O
L NNP O
- HYPH O
kynurenine NN O
( : O
KYN NNP O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
. . O

TRP NN O
degradation NN O
to IN O
KYN NNP O
can MD O
reduce VB O
TRP NNP O
levels NNS O
that WDT O
are VBP O
required VBN O
for IN O
serotonin NN O
synthesis NN O
[ -LRB- O
32 CD O
] -RRB- O
and CC O
can MD O
lead VB O
to IN O
the DT O
production NN O
of IN O
neuroactive JJ O
mediators NNS O
including VBG O
3 CD O
- HYPH O
hydroxykynurenine NN O
( , O
3HK NN O
) -RRB- O
and CC O
quinolinic NN O
acid NN O
( -LRB- O
QUIN NNP O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
. . O

High JJ O
levels NNS O
of IN O
3HK NN O
and CC O
QUIN NNP O
induce VBP O
neuronal JJ O
damage NN O
through IN O
oxidative JJ O
stress NN O
[ -LRB- O
33 CD O
] -RRB- O
and CC O
over IN O
stimulation NN O
of IN O
N NNP O
- HYPH O
methyl NN O
- HYPH O
D NNP O
- HYPH O
aspartate NN O
( -LRB- O
NMDA NNP O
) -RRB- O
receptors NNS O
[ -LRB- O
34 CD O
, , O
35 CD O
] -RRB- O
. . O

A DT O
recent JJ O
study NN O
indicates VBZ O
that IN O
while IN O
several JJ O
cell NN O
types NNS O
in IN O
the DT O
CNS NNP O
express VBP O
IDO NNP O
, , O
only RB O
microglia NN O
maintain VBP O
all PDT O
the DT O
enzymes NNS O
required VBN O
to TO O
produce VB O
3HK NNP O
and CC O
QUIN NNP O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Because IN O
IDO NNP O
mediated VBN O
TRP NNP O
degradation NN O
impacts VBZ O
both CC O
serotonergic JJ O
and CC O
glutamatergic JJ O
pathways NNS O
, , O
this DT O
may MD O
be VB O
an DT O
important JJ O
mechanism NN O
underlying VBG O
mood NN O
and CC O
behavior NN O
complications NNS O
concomitant JJ O
with IN O
inflammation NN O
[ -LRB- O
37 CD O
- SYM O
39 CD O
] -RRB- O
. . O

Because IN O
activated JJ O
microglia NN O
are VBP O
suspected VBN O
to TO O
cause VB O
or CC O
exacerbate VB O
several JJ O
neurodegenerative JJ O
diseases NNS O
, , O
pharmacological JJ O
strategies NNS O
to TO O
suppress VB O
microglial JJ O
activity NN O
are VBP O
being VBG O
explored VBN O
as IN O
therapies NNS O
. . O

Minocycline NN O
is VBZ O
a DT O
tetracycline NN O
derived VBN O
antibiotic NN O
that WDT O
has VBZ O
anti JJ O
- HYPH O
inflammatory JJ O
properties NNS O
in IN O
the DT O
CNS NNP O
that WDT O
are VBP O
separate JJ O
from IN O
its PRP$ O
antimicrobial JJ O
action NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Minocycline NN O
readily RB O
crosses VBZ O
the DT O
blood NN O
brain NN O
barrier NN O
and CC O
attenuates VBZ O
inflammation NN O
associated VBN O
with IN O
microglial JJ O
activation NN O
. . O

For IN O
example NN O
, , O
minocycline NN O
blocks VBZ O
the DT O
deleterious JJ O
effects NNS O
of IN O
neuroinflammation NN O
on IN O
neurogenesis NN O
, , O
long JJ O
- HYPH O
term NN O
potentiation NN O
, , O
and CC O
neuronal JJ O
survival NN O
[ -LRB- O
41 CD O
- HYPH O
43 CD O
] -RRB- O
. . O

The DT O
mechanism NN O
of IN O
action NN O
is VBZ O
unclear JJ O
, , O
but CC O
recent JJ O
studies NNS O
indicate VBP O
that IN O
minocycline NN O
abrogates VBZ O
MAPkinase NNP O
and CC O
NF NNP O
kappa NN O
B NNP O
dependent JJ O
signaling NN O
pathways NNS O
in IN O
primary JJ O
microglia NN O
and CC O
microglia NN O
cell NN O
cultures NNS O
[ -LRB- O
44 CD O
] -RRB- O
. . O

Moreover RB O
, , O
in IN O
the DT O
brain NN O
of IN O
rats NNS B-Species
, , O
minocycline NN O
abrogates VBZ O
microglial JJ O
expression NN O
of IN O
CD11b NNP O
and CC O
MHC NNP O
II NNP O
through IN O
a DT O
protein NN O
kinase NN O
- HYPH O
c NN O
dependent JJ O
mechanism NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

This DT O
is VBZ O
relevant JJ O
because IN O
minocycline NN O
attenuates VBZ O
neuroinflammation NN O
in IN O
several JJ O
rodent JJ O
models NNS O
of IN O
disease NN O
including VBG O
Amyotrophic NNP O
Lateral NNP O
Sclerosis NNP O
[ -LRB- O
46 CD O
] -RRB- O
, , O
Experimental NNP O
Autoimmune NNP O
Encephalomyelitis NNP O
( , O
EAE NNP O
) -RRB- O
[ -LRB- O
45 CD O
] -RRB- O
and CC O
MPTP NNP O
- HYPH O
induced VBN O
Parkinson NNP O
' POS O
s NNS O
disease NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
extent NN O
to IN O
which WDT O
minocycline NN O
facilitates VBZ O
the DT O
recovery NN O
from IN O
cytokine NN O
- HYPH O
mediated VBN O
sickness NN O
behavior NN O
is VBZ O
unknown JJ O
. . O

The DT O
present JJ O
study NN O
investigated VBD O
the DT O
degree NN O
to IN O
which WDT O
minocycline NN O
- : O
an DT O
anti JJ O
- HYPH O
inflammatory JJ O
agent NN O
and CC O
purported VBN O
microglial JJ O
inhibitor NN O
- , O
reduced VBD O
LPS NNP O
- HYPH O
induced VBN O
neuroinflammation NN O
and CC O
sickness NN O
behavior NN O
. . O

We PRP O
show VBP O
that IN O
minocycline NN O
blocked VBD O
LPS NNP O
- HYPH O
stimulated VBN O
inflammatory JJ O
cytokine NN O
secretion NN O
in IN O
the DT O
BV NNP O
- HYPH O
2 CD O
microglia NN O
- HYPH O
derived VBN O
cell NN O
line NN O
and CC O
reduced VBN O
LPS NNP O
- HYPH O
induced VBN O
Toll NNP O
- HYPH O
like NNP O
- HYPH O
receptor NN O
- HYPH O
2 CD O
( SYM O
TLR2 NNP O
) -RRB- O
surface NN O
expression NN O
on IN O
brain NN O
microglia NN O
. . O

Moreover RB O
, , O
our PRP$ O
data NNS O
show VBP O
that IN O
minocycline NN O
pretreatment NN O
attenuated VBN O
LPS NNP O
- HYPH O
induced VBN O
weight NN O
loss NN O
, , O
social JJ O
withdrawal NN O
, , O
and CC O
anhedonia NN O
in IN O
adult NN O
mice NNS B-Species
. . O

The DT O
attenuation NN O
of IN O
sickness NN O
behavior NN O
was VBD O
paralleled VBN O
with IN O
minocycline NN O
dependent JJ O
decrease NN O
in IN O
markers NNS O
of IN O
neuroinflammation NN O
( , O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
TLR2 NNP O
, , O
and CC O
IDO NNP O
) -RRB- O
in IN O
adult NN O
and CC O
aged JJ O
mice NNS B-Species
. . O

These DT O
findings NNS O
support VBP O
our PRP$ O
hypothesis NN O
that IN O
the DT O
ability NN O
to TO O
mitigate VB O
cytokine NN O
expression NN O
in IN O
the DT O
brain NN O
during IN O
systemic JJ O
inflammatory JJ O
events NNS O
may MD O
be VB O
useful JJ O
in IN O
preventing VBG O
cognitive JJ O
and CC O
behavioral JJ O
deficits NNS O
. . O

Methods NNS O

Animals NNS O

Male JJ O
BALB NNP O
/ SYM O
c NNS O
mice NNS B-Species
, , O
adults NNS O
( , O
3 CD O
month NN O
old JJ O
) -RRB- O
and CC O
juvenile NN O
( , O
3 CD O
- SYM O
4 CD O
week NN O
old JJ O
) -RRB- O
were VBD O
purchased VBN O
from IN O
Harlan NNP O
( : O
Indianapolis NNP O
, , O
IN NNP O
) -RRB- O
. . O

For IN O
age NN O
comparisons NNS O
, , O
male JJ O
BALB NNP O
/ SYM O
c NNS O
mice NNS B-Species
( , O
3 CD O
- SYM O
4 CD O
and CC O
20 CD O
- SYM O
22 CD O
month NN O
old JJ O
) -RRB- O
were VBD O
purchased VBN O
from IN O
the DT O
National NNP O
Institute NNP O
on IN O
Aging NNP O
specific JJ O
pathogen NN O
free JJ O
colony NN O
. . O

Upon IN O
arrival NN O
, , O
mice NNS B-Species
were VBD O
individually RB O
housed VBN O
in IN O
polypropylene NN O
cages NNS O
and CC O
maintained VBN O
at IN O
21 CD O
degrees NNS O
C NN O
under IN O
a DT O
12 CD O
h NN O
light NN O
: : O
12 CD O
h NN O
dark JJ O
cycle NN O
with IN O
ad NN O
libitum NN O
access NN O
to IN O
water NN O
and CC O
rodent NN O
chow NN O
. . O

At IN O
the DT O
end NN O
of IN O
each DT O
study NN O
, , O
mice NNS B-Species
were VBD O
examined VBN O
postmortem NN O
for IN O
gross JJ O
signs NNS O
of IN O
disease NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
splenomeglia NN O
or CC O
tumors NNS O
) -RRB- O
. . O

Data NNS O
from IN O
mice NNS B-Species
determined VBD O
to TO O
be VB O
unhealthy JJ O
were VBD O
excluded VBN O
from IN O
analysis NN O
( : O
< : O
5 CD O
% NN O
) -RRB- O
. . O

All DT O
procedures NNS O
were VBD O
in IN O
accordance NN O
with IN O
the DT O
National NNP O
Institute NNP O
of IN O
Health NNP O
Guidelines NNPS O
for IN O
the DT O
Care NNP O
and CC O
Use NNP O
of IN O
Laboratory NNP O
Animals NNPS O
and CC O
were VBD O
approved VBN O
by IN O
The DT O
Ohio NNP O
State NNP O
University NNP O
Institutional NNP O
Laboratory NNP O
Animal NNP O
Care NNP O
and CC O
Use NNP O
Committee NNP O
. . O

Cell NN O
culture NN O

BV NN O
- HYPH O
2 CD O
microglia NN O
cell NN O
lines NNS O
were VBD O
cultured VBN O
in IN O
growth NN O
medium NN O
( , O
DMEM NNP O
supplemented VBN O
with IN O
10 CD O
% NN O
FBS NNP O
, , O
sodium NN O
bicarbonate NN O
3 CD O
. . O
7 CD O
g NNS O
/ SYM O
l NN O
, , O
200 CD O
mM NN O
glutamine NN O
, , O
100 CD O
U NN O
/ SYM O
ml NN O
penicillin NN O
G NNP O
, , O
100 CD O
mu NN O
g NN O
/ SYM O
ml NN O
streptomycin NN O
, , O
0 CD O
. . O
25 CD O
mu NN O
g NN O
/ SYM O
ml NN O
fungizone NN O
) -RRB- O
as IN O
previously RB O
described VBN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Cultures NNS O
were VBD O
maintained VBN O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
95 CD O
% NN O
humidity NN O
and CC O
5 CD O
% NN O
CO2 NN O
and CC O
growth NN O
medium NN O
was VBD O
replenished VBN O
every DT O
third JJ O
day NN O
until IN O
confluence NN O
. . O

Cultures NNS O
were VBD O
washed VBN O
twice RB O
and CC O
supplemented VBN O
with IN O
warm JJ O
growth NN O
medium NN O
containing VBG O
experimental JJ O
treatments NNS O
. . O

Cell NN O
viability NN O
was VBD O
measured VBN O
by IN O
the DT O
MTS NNP O
cell NN O
proliferation NN O
assay NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
( , O
Promega NNP O
, , O
Madison NNP O
, , O
WI NNP O
) -RRB- O
. . O

CNS NNP O
macrophage NN O
/ SYM O
microglia NN O
isolation NN O

CNS NNP O
macrophages NNS O
and CC O
microglia NN O
were VBD O
collected VBN O
from IN O
whole JJ O
brain NN O
homogenates NNS O
as IN O
described VBN O
previously RB O
[ -LRB- O
48 CD O
] -RRB- O
, , O
but CC O
with IN O
several JJ O
modifications NNS O
. . O

Mice NNS B-Species
were VBD O
euthanized VBN O
by IN O
CO2 NNP O
asphyxiation NN O
and CC O
whole JJ O
brains NNS O
were VBD O
collected VBN O
. . O

Brains NNS O
were VBD O
homogenized VBN O
in IN O
Hank NNP O
' POS O
s NNS O
balanced VBN O
salt NN O
solution NN O
( , O
HBSS NNP O
) : O
pH NN O
7 CD O
. . O
4 CD O
. . O

Brain NN O
homogenates NNS O
were VBD O
passed VBN O
through IN O
a DT O
70 CD O
mu NN O
m NN O
nylon NN O
cell NN O
strainer NN O
and CC O
centrifuged VBN O
at IN O
400 CD O
x SYM O
g NN O
for IN O
10 CD O
min NN O
. . O

Supernatants NNS O
were VBD O
removed VBN O
and CC O
cell NN O
pellets NNS O
were VBD O
re RB O
- HYPH O
suspended VBN O
in IN O
70 CD O
% NN O
isotonic JJ O
Percoll NNP O
( , O
GE NNP O
- HYPH O
healthcare NN O
, , O
Uppsala NNP O
, , O
Sweden NNP O
) -RRB- O
at IN O
room NN O
temperature NN O
. . O

A DT O
discontinuous JJ O
Percoll NNP O
density NN O
gradient NN O
was VBD O
set VBN O
up RP O
as IN O
follows VBZ O
: : O
70 CD O
% NN O
, , O
35 CD O
% NN O
, , O
and CC O
0 CD O
% NN O
isotonic JJ O
Percoll NNP O
. . O

This DT O
suspension NN O
was VBD O
centrifuged VBN O
for IN O
30 CD O
minutes NNS O
at IN O
400 CD O
x SYM O
g NN O
. . O

A DT O
mixed JJ O
population NN O
of IN O
CNS NNP O
macrophages NNS O
and CC O
microglia NN O
was VBD O
collected VBN O
from IN O
the DT O
interphase NN O
between IN O
the DT O
70 CD O
% NN O
and CC O
35 CD O
% NN O
Percoll NN O
layers NNS O
. . O

Cells NNS O
were VBD O
washed VBN O
and CC O
then RB O
re RB O
- HYPH O
suspended VBN O
in IN O
sterile JJ O
HBSS NNP O
. . O

The DT O
number NN O
of IN O
viable JJ O
cells NNS O
was VBD O
determined VBN O
using VBG O
a DT O
hemacytometer NN O
and CC O
0 CD O
. . O
2 CD O
% NN O
trypan NN O
blue JJ O
staining NN O
. . O

Flow NN O
cytometry NN O

Flow JJ O
cytometric JJ O
analysis NN O
of IN O
microglial JJ O
cell NN O
surface NN O
markers NNS O
was VBD O
performed VBN O
as IN O
described VBN O
previously RB O
, , O
but CC O
with IN O
a DT O
few JJ O
modifications NNS O
[ -LRB- O
48 CD O
] -RRB- O
. . O

In IN O
brief JJ O
, , O
Fc NNP O
receptors NNS O
on IN O
macrophages NNS O
and CC O
microglia NN O
were VBD O
blocked VBN O
with IN O
anti JJ O
- HYPH O
CD16 NN O
/ SYM O
CD32 NN O
antibody NN O
( , O
eBiosciences NNS O
, , O
CA NNP O
) -RRB- O
. . O

Next RB O
, , O
cells NNS O
were VBD O
incubated VBN O
with IN O
either CC O
Panel NNP O
- HYPH O
1 CD O
( , O
anti JJ O
- HYPH O
CD11b NNP O
APC NNP O
, , O
anti JJ O
- HYPH O
CD45 NN O
FITC NN O
, , O
and CC O
anti JJ O
- HYPH O
MHC NNP O
II NN O
PE NN O
from IN O
eBiosciences NNP O
, , O
CA NNP O
) -RRB- O
or CC O
Panel NNP O
- HYPH O
2 CD O
antibodies NNS O
( , O
anti JJ O
- HYPH O
CD11b NN O
APC NN O
, , O
anti JJ O
- HYPH O
CD45 NN O
FITC NN O
, , O
and CC O
anti JJ O
- HYPH O
TLR2 NN O
PE NN O
from IN O
eBiosciences NNPS O
, , O
CA NNP O
) -RRB- O
. . O

Expression NN O
of IN O
these DT O
surface NN O
receptors NNS O
was VBD O
determined VBN O
by IN O
flow NN O
cytometry NN O
using VBG O
a DT O
Becton NNP O
- HYPH O
Dickinson NNP O
FACSCaliber NNP O
four CD O
color NN O
Cytometer NN O
. . O

Thirty CD O
thousand CD O
events NNS O
were VBD O
collected VBN O
and CC O
microglia NN O
were VBD O
differentiated VBN O
from IN O
macrophages NNS O
based VBN O
on IN O
the DT O
levels NNS O
of IN O
CD11b NN O
and CC O
CD45 NN O
surface NN O
expression NN O
. . O

Microglia NN O
stain NN O
CD11b NN O
+ CC O
/ SYM O
CD45low NN O
and CC O
macrophages NNS O
stain VBP O
CD11b NN O
+ SYM O
/ SYM O
CD45high NNP O
[ -LRB- O
48 CD O
, , O
49 CD O
] -RRB- O
. . O

Flow NN O
data NNS O
were VBD O
analyzed VBN O
using VBG O
FlowJo NNP O
software NN O
( : O
Tree NNP O
Star NNP O
, , O
San NNP O
Carlos NNP O
, , O
CA NNP O
) -RRB- O
. . O

Behavior NN O
tests NNS O

Social JJ O
exploratory JJ O
behavior NN O

To TO O
assess VB O
the DT O
motivation NN O
to TO O
engage VB O
in IN O
social JJ O
exploratory JJ O
behavior NN O
, , O
a DT O
novel JJ O
juvenile JJ O
conspecific NN O
was VBD O
introduced VBN O
into IN O
the DT O
test NN O
subject NN O
' POS O
s POS O
home NN O
cage NN O
for IN O
a DT O
10 CD O
- HYPH O
min NN O
period NN O
. . O

Behavior NN O
was VBD O
video NN O
taped VBN O
and CC O
the DT O
cumulative JJ O
amount NN O
of IN O
time NN O
the DT O
subject NN O
engaged VBD O
in IN O
social JJ O
investigation NN O
was VBD O
determined VBN O
from IN O
the DT O
video NN O
records NNS O
by IN O
a DT O
trained VBN O
observer NN O
who WP O
was VBD O
blind JJ O
to IN O
the DT O
experimental JJ O
treatments NNS O
. . O

Baseline JJ O
social JJ O
behavior NN O
was VBD O
measured VBN O
at IN O
time NN O
0 CD O
for IN O
all DT O
experimental JJ O
treatments NNS O
. . O

Social JJ O
behavior NN O
was VBD O
determined VBN O
as IN O
the DT O
amount NN O
of IN O
time NN O
that WDT O
the DT O
experimental JJ O
subject NN O
spent VBD O
investigating VBG O
( : O
e LS O
. . O
g LS O
. . O
, , O
anogenital JJ O
sniffing NN O
, , O
trailing VBG O
) , O
the DT O
juvenile NN O
. . O

Results NNS O
are VBP O
expressed VBN O
as IN O
percent NN O
decrease NN O
in IN O
time NN O
engaged VBN O
in IN O
social JJ O
behavior NN O
compared VBN O
to IN O
respective JJ O
baseline NN O
measures NNS O
. . O

Sucrose JJ O
preference NN O

To TO O
assess VB O
sucrose NN O
preference NN O
, , O
mice NNS B-Species
were VBD O
provided VBN O
two CD O
solutions NNS O
, , O
water NN O
or CC O
water NN O
supplemented VBN O
with IN O
2 CD O
% NN O
sucrose NN O
, , O
in IN O
50 CD O
ml NNS O
conical JJ O
tubes NNS O
with IN O
stoppers NNS O
fitted VBN O
with IN O
ball NN O
- HYPH O
type NN O
sipper NN O
tubes NNS O
. . O

Prior RB O
to IN O
testing NN O
conditions NNS O
, , O
all DT O
mice NNS B-Species
were VBD O
acclimated VBN O
to IN O
the DT O
two CD O
bottle NN O
test NN O
choice NN O
. . O

All DT O
mice NNS B-Species
drank VBD O
both CC O
the DT O
water NN O
and CC O
the DT O
2 CD O
% NN O
sucrose NN O
solution NN O
, , O
but CC O
preferred VBD O
drinking VBG O
the DT O
sucrose NN O
over IN O
the DT O
water NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

On IN O
the DT O
day NN O
of IN O
testing NN O
, , O
mice NNS B-Species
were VBD O
fluid JJ O
and CC O
food NN O
deprived VBN O
for IN O
2 CD O
h NNS O
prior RB O
to IN O
testing NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

At IN O
the DT O
start NN O
of IN O
the DT O
dark JJ O
phase NN O
of IN O
the DT O
photoperiod NN O
, , O
drinking NN O
water NN O
and CC O
the DT O
2 CD O
% NN O
sucrose NN O
solution NN O
were VBD O
placed VBN O
in IN O
the DT O
home NN O
cage NN O
overnight RB O
( : O
15 CD O
h NN O
) -RRB- O
. . O

At IN O
the DT O
end NN O
of IN O
each DT O
testing NN O
period NN O
the DT O
fluid JJ O
content NN O
of IN O
the DT O
conical JJ O
tubes NNS O
was VBD O
measured VBN O
and CC O
sucrose JJ O
preference NN O
was VBD O
determined VBN O
using VBG O
the DT O
equation NN O
: : O
Sucrose JJ O
intake NN O
/ SYM O
Total JJ O
fluid NN O
intake NN O
( , O
water NN O
+ CC O
sucrose NN O
intake NN O
) SYM O
x SYM O
100 CD O
[ SYM O
51 CD O
] -RRB- O
. . O

Plasma NN O
cytokine NN O
measurement NN O

IL NN O
- HYPH O
6 CD O
and CC O
IL NN O
- HYPH O
1 CD O
beta NN O
were VBD O
measured VBN O
in IN O
the DT O
plasma NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

In IN O
brief JJ O
, , O
mice NNS B-Species
were VBD O
euthanized VBN O
by IN O
CO2 NN O
asphyxiation NN O
and CC O
blood NN O
was VBD O
collected VBN O
by IN O
cardiac JJ O
puncture NN O
into IN O
EDTA NNP O
coated VBN O
syringes NNS O
. . O

Samples NNS O
were VBD O
centrifuged VBN O
( : O
6000 CD O
x SYM O
g NN O
for IN O
15 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
) , O
and CC O
plasma NN O
was VBD O
collected VBN O
and CC O
stored VBN O
frozen VBN O
( , O
- SYM O
80 CD O
degrees NNS O
C NN O
) -RRB- O
until IN O
assaying VBG O
. . O

Plasma NN O
samples NNS O
were VBD O
assayed VBN O
for IN O
IL NN O
- HYPH O
6 CD O
using VBG O
a DT O
customized VBN O
ELISA NNP O
that WDT O
we PRP O
have VBP O
described VBN O
in IN O
detail NN O
[ -LRB- O
52 CD O
] -RRB- O
and CC O
for IN O
IL NN O
- HYPH O
1 CD O
beta NN O
using VBG O
a DT O
commercial JJ O
ELISA NNP O
kit NN O
( -LRB- O
R NNP O
& CC O
D NNP O
Systems NNPS O
, , O
Minneapolis NNP O
, , O
MN NNP O
) -RRB- O
. . O

Assays NNS O
were VBD O
sensitive JJ O
to IN O
8 CD O
pg NN O
/ SYM O
ml NNS O
of IN O
IL NN O
- HYPH O
6 CD O
and CC O
1 CD O
. . O
5 CD O
pg NN O
/ SYM O
ml NNS O
of IN O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
and CC O
inter NN O
- HYPH O
and CC O
intra JJ O
- HYPH O
assay NN O
coefficients NNS O
of IN O
variation NN O
were VBD O
less JJR O
than IN O
10 CD O
% NN O
. . O

Real JJ O
time NN O
PCR NNP O

Total JJ O
RNA NNP O
was VBD O
isolated VBN O
from IN O
brain NN O
using VBG O
the DT O
Tri NNP O
Reagent NNP O
protocol NN O
( , O
Sigma NNP O
, , O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
) -RRB- O
. . O

RNA NNP O
samples NNS O
were VBD O
subjected VBN O
to IN O
a DT O
DNase NNP O
I NNP O
digestion NN O
procedure NN O
and CC O
then RB O
reverse RB O
transcribed VBN O
to IN O
cDNA NNP O
using VBG O
a DT O
RT NNP O
RETROscript NNP O
kit NN O
( : O
Ambion NNP O
, , O
Austin NNP O
, , O
TX NNP O
) -RRB- O
. . O

Quantitative JJ O
real JJ O
time NN O
PCR NNP O
was VBD O
performed VBN O
using VBG O
the DT O
Applied NNP O
Biosystems NNPS O
( -LRB- O
Foster NNP O
, , O
CA NNP O
) -RRB- O
Assay NNP O
- HYPH O
on IN O
Demand NNP O
Gene NNP O
Expression NNP O
protocol NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
brief JJ O
, , O
cDNA NNP O
was VBD O
amplified VBN O
by IN O
real JJ O
time NN O
PCR NNP O
where WRB O
a DT O
target NN O
cDNA NN O
( , O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
IL NN O
- HYPH O
6 CD O
, , O
MHC NNP O
II NNP O
, , O
TLR2 NNP O
, , O
or CC O
IDO NNP O
) -RRB- O
and CC O
a DT O
reference NN O
cDNA NN O
( -LRB- O
glyceraldehyde NN O
- HYPH O
3 CD O
- HYPH O
phosphate NN O
dehydrogenase NN O
) -RRB- O
were VBD O
amplified VBN O
simultaneously RB O
using VBG O
an DT O
oligonucleotide NN O
probe NN O
with IN O
a DT O
5 CD O
' '' O
fluorescent NN O
reporter NN O
dye NN O
( , O
6 CD O
- HYPH O
FAM NN O
) -RRB- O
and CC O
a DT O
3 CD O
' '' O
quencher NN O
dye NN O
( , O
NFQ NNP O
) -RRB- O
. . O

Fluorescence NN O
was VBD O
determined VBN O
on IN O
an DT O
ABI NNP O
PRISM NNP O
7300 CD O
- HYPH O
sequence NN O
detection NN O
system NN O
( : O
Applied NNP O
Biosystems NNP O
, , O
CA NNP O
) -RRB- O
. . O

Data NNS O
were VBD O
analyzed VBN O
using VBG O
the DT O
comparative JJ O
threshold NN O
cycle NN O
( -LRB- O
Ct NNP O
) -RRB- O
method NN O
and CC O
results NNS O
are VBP O
expressed VBN O
as IN O
fold VBN O
difference NN O
. . O

Experimental JJ O
protocols NNS O

For IN O
the DT O
cell NN O
culture NN O
studies NNS O
, , O
minocycline NN O
was VBD O
prepared VBN O
in IN O
dimethyl NN O
sulfoxide NN O
( , O
DMSO NNP O
) -RRB- O
and CC O
BV NN O
- HYPH O
2 CD O
cells NNS O
were VBD O
washed VBN O
and CC O
replenished VBN O
with IN O
growth NN O
mediumsupplemented VBN O
with IN O
0 CD O
, , O
25 CD O
, , O
50 CD O
, , O
100 CD O
, , O
200 CD O
, , O
or CC O
400 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
minocycline NN O
. . O

After IN O
30 CD O
min NN O
, , O
LPS NNP O
at IN O
10 CD O
ng CD O
/ SYM O
ml NNS O
was VBD O
added VBN O
to IN O
the DT O
culture NN O
medium NN O
. . O

Supernatants NNS O
were VBD O
collected VBN O
4 CD O
h NN O
later RB O
and CC O
IL NN O
- HYPH O
6 CD O
and CC O
IL NN O
- HYPH O
1 CD O
beta JJ O
concentrations NNS O
were VBD O
determined VBN O
by IN O
ELISA NNP O
. . O

Total JJ O
proteins NNS O
were VBD O
determined VBN O
from IN O
cell NN O
culture NN O
homogenates NNS O
by IN O
the DT O
Bio NNP O
- HYPH O
Rad NNP O
Dc NNP O
protein NN O
assay NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
Lboratories NNP O
, , O
Hercules NNP O
, , O
CA NNP O
) -RRB- O
. . O

Each DT O
treatment NN O
was VBD O
replicated VBN O
a DT O
minimum NN O
of IN O
four CD O
times NNS O
. . O

Cell NN O
viability NN O
was VBD O
confirmed VBN O
by IN O
the DT O
MTS NNP O
cell NN O
proliferation NN O
assay NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
( , O
Promega NNP O
, , O
Madison NNP O
, , O
WI NNP O
) -RRB- O
. . O

For IN O
all DT O
mouse NN B-Species
studies NNS O
, , O
minocycline NN O
( , O
Sigma NNP O
, , O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
) -RRB- O
was VBD O
dissolved VBN O
in IN O
sterile JJ O
water NN O
and CC O
sonicated VBN O
to TO O
ensure VB O
complete JJ O
solubilization NN O
. . O

In IN O
the DT O
first JJ O
mouse NN B-Species
study NN O
, , O
adult NN O
male NN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
received VBD O
an DT O
intraperitoneal JJ O
( , O
i CD O
. . O
p NN O
. . O
) -RRB- O
injection NN O
of IN O
vehicle NN O
or CC O
minocycline NN O
( , O
50 CD O
mg NNS O
/ SYM O
kg NNS O
) -RRB- O
for IN O
three CD O
consecutive JJ O
days NNS O
. . O

On IN O
the DT O
3rd JJ O
day NN O
, , O
mice NNS B-Species
were VBD O
also RB O
injected VBN O
i PRP O
. . O
p UH O
. . O
with IN O
saline NN O
or CC O
Escherichia NNP B-Species
coli NN I-Species
LPS NNP O
( : O
0 CD O
. . O
33 CD O
mg CD O
/ SYM O
kg NN O
; : O
serotype NN O
127 CD O
: : O
B8 CD O
, , O
Sigma NNP O
, , O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
) -RRB- O
and CC O
were VBD O
euthanized VBN O
by IN O
CO2 NN O
asphyxiation NN O
24 CD O
h NN O
later RB O
( : O
n CD O
= SYM O
6 CD O
) -RRB- O
. . O

The DT O
LPS NNP O
dosage NN O
was VBD O
selected VBN O
because IN O
it PRP O
elicits VBZ O
a DT O
proinflammatory JJ O
cytokine NN O
response NN O
in IN O
the DT O
brain NN O
resulting VBG O
in IN O
mild JJ O
transient JJ O
sickness NN O
behavior NN O
in IN O
adult NN O
mice NNS B-Species
[ -LRB- O
13 CD O
, , O
53 CD O
] -RRB- O
. . O

Macrophage NN O
/ SYM O
microglial JJ O
cells NNS O
were VBD O
isolated VBN O
from IN O
whole JJ O
brain NN O
homogenates NNS O
and CC O
TLR2 NN O
and CC O
MHC NNP O
II NNP O
surface NN O
expression NN O
were VBD O
determined VBN O
by IN O
flow NN O
cytometry NN O
. . O

The DT O
minocycline NN O
injection NN O
regimen NN O
and CC O
dosage NN O
was VBD O
selected VBN O
because IN O
a DT O
repeated VBN O
pretreatment NN O
course NN O
with IN O
minocycline NN O
is VBZ O
necessary JJ O
to TO O
attenuate VB O
neuroinflammation NN O
[ -LRB- O
41 CD O
- HYPH O
43 CD O
, , O
45 CD O
] -RRB- O
. . O

In IN O
the DT O
second JJ O
study NN O
, , O
adult NN O
male NN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
received VBD O
an DT O
i CD O
. . O
p NN O
. . O
injection NN O
with IN O
vehicle NN O
or CC O
minocycline NN O
for IN O
three CD O
consecutive JJ O
days NNS O
. . O

On IN O
the DT O
third JJ O
day NN O
, , O
motivation NN O
to TO O
engage VB O
in IN O
social JJ O
behavior NN O
was VBD O
determined VBN O
immediately RB O
before IN O
i PRP O
. . O
p UH O
. . O
injection NN O
of IN O
saline NN O
or CC O
LPS NNP O
( : O
0 CD O
. . O
33 CD O
mg NN O
/ SYM O
kg NN O
) -RRB- O
and CC O
again RB O
2 CD O
, , O
4 CD O
, , O
8 CD O
, , O
12 CD O
, , O
and CC O
24 CD O
h NN O
later RB O
( , O
n CD O
= SYM O
8 CD O
) -RRB- O
. . O

Body NN O
weight NN O
and CC O
food NN O
intake NN O
were VBD O
measured VBN O
at IN O
each DT O
time NN O
point NN O
over IN O
the DT O
24 CD O
h NN O
period NN O
. . O

In IN O
a DT O
related JJ O
, , O
but CC O
separate JJ O
study NN O
, , O
adult NN O
mice NNS B-Species
were VBD O
treated VBN O
with IN O
minocycline NN O
and CC O
LPS NN O
as IN O
described VBN O
and CC O
anhedonia NN O
was VBD O
assessed VBN O
24 CD O
- SYM O
39 CD O
h NN O
following VBG O
i CD O
. . O
p NN O
. . O
injection NN O
of IN O
saline NN O
or CC O
LPS NN O
( : O
0 CD O
. . O
33 CD O
mg CD O
/ SYM O
kg NNS O
) -RRB- O
( : O
n CD O
= SYM O
15 CD O
) -RRB- O
. . O

Body NN O
weight NN O
, , O
food NN O
intake NN O
, , O
water NN O
intake NN O
, , O
and CC O
sucrose NN O
intake NN O
were VBD O
determined VBN O
over IN O
the DT O
testing NN O
period NN O
. . O

In IN O
the DT O
third JJ O
study NN O
, , O
adult NN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
were VBD O
treated VBN O
with IN O
minocycline NN O
and CC O
then RB O
LPS NNP O
as IN O
described VBN O
. . O

Mice NNS B-Species
were VBD O
euthanized VBN O
by IN O
CO2 NN O
asphyxiation NN O
4 CD O
later RB O
. . O

Brains NNS O
were VBD O
removed VBN O
and CC O
dissected VBN O
to TO O
collect VB O
different JJ O
brain NN O
regions NNS O
. . O

Brain NN O
regions NNS O
were VBD O
stored VBN O
at IN O
- SYM O
20 CD O
degrees NNS O
C NN O
in IN O
RNAlater NNP O
( , O
Qiagen NNP O
, , O
CA NNP O
) -RRB- O
. . O

Total JJ O
RNA NNP O
was VBD O
isolated VBN O
from IN O
brain NN O
samples NNS O
and CC O
assayed VBN O
using VBG O
quantitative JJ O
PCR NN O
( : O
n NN O
= SYM O
8 CD O
) -RRB- O
. . O

Plasma NN O
was VBD O
also RB O
collected VBN O
and CC O
stored VBN O
( : O
- : O
80 CD O
degrees NNS O
C NN O
) -RRB- O
until IN O
assaying VBG O
. . O

In IN O
a DT O
final JJ O
study NN O
, , O
adult NN O
( , O
3 CD O
- SYM O
4 CD O
month NN O
old JJ O
) -RRB- O
or CC O
aged VBN O
( , O
20 CD O
- SYM O
22 CD O
month NN O
old JJ O
) -RRB- O
male JJ O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
were VBD O
treated VBN O
with IN O
minocycline NN O
and CC O
LPS NNP O
as IN O
described VBN O
and CC O
euthanized VBN O
4 CD O
h NN O
later RBR O
. . O

Brains NNS O
were VBD O
dissected VBN O
to TO O
collect VB O
different JJ O
brain NN O
regions NNS O
and CC O
were VBD O
stored VBN O
at IN O
- SYM O
20 CD O
degrees NNS O
C NN O
in IN O
RNAlater NNP O
( , O
Qiagen NNP O
, , O
CA NNP O
) -RRB- O
. . O

Total JJ O
RNA NNP O
was VBD O
isolated VBN O
from IN O
the DT O
hippocampus NN O
and CC O
assayed VBD O
using VBG O
quantitative JJ O
PCR NN O
( : O
n NN O
= SYM O
8 CD O
) -RRB- O
. . O

Statistical JJ O
analysis NN O

All DT O
data NNS O
were VBD O
analyzed VBN O
using VBG O
Statistical NNP O
Analysis NNP O
Systems NNPS O
( -LRB- O
SAS NNP O
) -RRB- O
General NNP O
Linear NNP O
Model NNP O
procedures NNS O
. . O

Data NNS O
were VBD O
subjected VBN O
to IN O
one CD O
, , O
two CD O
- HYPH O
( , O
Mino NNP O
x CC O
LPS NNP O
, , O
Age NNP O
x NNP O
LPS NNP O
, , O
Mino NNP O
x SYM O
Age NNP O
) , O
or CC O
three CD O
- HYPH O
way NN O
( , O
Mino NNP O
x SYM O
LPS NNP O
x SYM O
Time NNP O
, , O
Mino NNP O
x NNP O
LPS NNP O
x SYM O
Age NNP O
) , O
ANOVA NNP O
to TO O
determine VB O
significant JJ O
main JJ O
effects NNS O
and CC O
interactions NNS O
between IN O
main JJ O
factors NNS O
. . O

When WRB O
appropriate JJ O
, , O
differences NNS O
between IN O
treatment NN O
means NNS O
were VBD O
evaluated VBN O
by IN O
an DT O
F NN O
- HYPH O
protected VBN O
t NN O
- HYPH O
test NN O
using VBG O
the DT O
Least JJS O
- HYPH O
Significant NNP O
Difference NNP O
procedure NN O
of IN O
SAS NNP O
. . O

All DT O
data NNS O
are VBP O
expressed VBN O
as IN O
treatment NN O
means NNS O
+ SYM O
/ SYM O
- HYPH O
standard JJ O
error NN O
of IN O
the DT O
mean NN O
( -LRB- O
SEM NN O
) -RRB- O
. . O

Results NNS O

Minocycline NN O
attenuates VBZ O
LPS NNP O
- HYPH O
induced VBN O
cytokine NN O
production NN O
in IN O
BV NN O
- HYPH O
2 CD O
microglia NN O

Minocycline NN O
is VBZ O
a DT O
tetracycline NN O
- HYPH O
type NN O
antibiotic NN O
that WDT O
has VBZ O
anti JJ O
- HYPH O
inflammatory JJ O
properties NNS O
in IN O
the DT O
CNS NNP O
[ -LRB- O
41 CD O
- HYPH O
43 CD O
, , O
45 CD O
] -RRB- O
. . O

To TO O
determine VB O
the DT O
degree NN O
to IN O
which WDT O
minocycline NN O
suppresses VBZ O
microglia NN O
activation NN O
, , O
BV NN O
- HYPH O
2 CD O
microglia NN O
- HYPH O
derived VBN O
cell NN O
lines NNS O
were VBD O
used VBN O
. . O

In IN O
the DT O
first JJ O
experiment NN O
, , O
BV NNP O
- HYPH O
2 CD O
cells NNS O
were VBD O
treated VBN O
with IN O
LPS NNP O
and CC O
IL NN O
- HYPH O
6 CD O
production NN O
was VBD O
determined VBN O
4 CD O
h NN O
later RB O
. . O

Fig NN O
. . O

1A NN O
shows VBZ O
that IN O
LPS NNP O
increased VBD O
IL NN O
- HYPH O
6 CD O
production NN O
in IN O
a DT O
dose NN O
dependent JJ O
manner NN O
F NNP O
( , O
5 CD O
, , O
23 CD O
) SYM O
= SYM O
101 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

In IN O
the DT O
second JJ O
experiment NN O
, , O
BV NNP O
- HYPH O
2 CD O
cells NNS O
were VBD O
incubated VBN O
with IN O
DMSO NNP O
or CC O
minocycline NN O
and CC O
then RB O
stimulated VBN O
with IN O
LPS NNP O
. . O

Minocycline NN O
reduced VBD O
LPS NNP O
- HYPH O
induced VBN O
IL NN O
- HYPH O
6 CD O
secretion NN O
in IN O
a DT O
dose NN O
dependent JJ O
manner NN O
( , O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
4 CD O
, , O
23 CD O
) SYM O
= SYM O
16 CD O
. . O
87 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
, , O
Fig NNP O
. . O
1B NN O
) -RRB- O
. . O

Minocycline NN O
pretreatment NN O
had VBD O
a DT O
similar JJ O
anti JJ O
- HYPH O
inflammatory JJ O
effect NN O
on IN O
LPS NNP O
- HYPH O
stimulated VBN O
IL NN O
- HYPH O
1 CD O
beta NN O
secretion NN O
( -LRB- O
Fig NNP O
. . O
1C NN O
) -RRB- O
. . O

In IN O
a DT O
third JJ O
experiment NN O
, , O
minocycline NN O
suppressed VBN O
LPS NNP O
- HYPH O
induced VBN O
MHC NNP O
II NNP O
, , O
TLR2 NNP O
, , O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
and CC O
IL NN O
- HYPH O
6 CD O
mRNA NN O
levels NNS O
( : O
P NN O
< SYM O
0 CD O
. . O
5 CD O
, , O
for IN O
each DT O
, , O
Fig NNP O
. . O
1D CD O
) -RRB- O
. . O

The DT O
MTS NNP O
assay NN O
verified VBD O
that IN O
neither DT O
cell NN O
survival NN O
nor CC O
proliferation NN O
was VBD O
affected VBN O
by IN O
the DT O
experimental JJ O
treatments NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

LPS NNP O
- HYPH O
induced VBN O
TLR2 NNP O
surface NN O
expression NN O
on IN O
microglia NN O
is VBZ O
reduced VBN O
by IN O
minocycline NN O

Because IN O
minocycline NN O
attenuated VBD O
LPS NNP O
- HYPH O
induced VBN O
cytokine NN O
secretion NN O
and CC O
TLR2 NNP O
mRNA NNP O
expression NN O
in IN O
BV NNP O
- HYPH O
2 CD O
cells NNS O
we PRP O
next RB O
sought VBD O
to TO O
determine VB O
if IN O
minocycline NN O
suppresses VBZ O
markers NNS O
of IN O
microglial JJ O
activation NN O
in IN O
the DT O
brain NN O
of IN O
mice NNS B-Species
. . O

Mice NNS B-Species
were VBD O
injected VBN O
i PRP O
. . O
p UH O
. . O
with IN O
vehicle NN O
or CC O
minocycline NN O
for IN O
3 CD O
consecutive JJ O
days NNS O
then RB O
challenged VBN O
with IN O
saline NN O
or CC O
LPS NN O
i CD O
. . O
p LS O
. . O

Markers NNS O
of IN O
activation NN O
, , O
TLR2 NNP O
and CC O
MHC NNP O
II NNP O
, , O
were VBD O
determined VBN O
on IN O
microglia NN O
collected VBN O
24 CD O
h NN O
later RBR O
. . O

The DT O
representative JJ O
bivariate NN O
density NN O
plot NN O
in IN O
Fig NNP O
. . O

2A NNP O
shows VBZ O
that IN O
there EX O
were VBD O
two CD O
populations NNS O
of IN O
CD11b NN O
/ SYM O
CD45 NN O
positive JJ O
cells NNS O
and CC O
that IN O
more JJR O
cells NNS O
stained VBD O
CD11b NNP O
+ CC O
/ SYM O
CD45low NNP O
( HYPH O
microglia NN O
) -RRB- O
than IN O
CD11b NN O
+ CC O
/ SYM O
CD45high NNP O
( -LRB- O
CNS NNP O
macrophages NNS O
) -RRB- O
. . O

ANOVA NNP O
revealed VBD O
that IN O
LPS NNP O
injection NN O
increased VBD O
TLR2 NN O
surface NN O
expression NN O
on IN O
microglia NN O
( , O
F NNP O
( , O
1 CD O
, , O
20 CD O
) SYM O
= SYM O
17 CD O
. . O
6 CD O
, , O
P NN O
< NN O
0 CD O
. . O
4 CD O
, , O
Fig NNP O
. . O
2B NN O
& CC O
D NN O
) -RRB- O
, , O
but CC O
this DT O
induction NN O
was VBD O
abrogated VBN O
by IN O
minocycline NN O
pretreatment NN O
( , O
Tendency NN O
for IN O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
20 CD O
) SYM O
= SYM O
2 CD O
. . O
66 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
10 CD O
, , O
Fig NNP O
. . O
2C NN O
& CC O
D NNP O
) -RRB- O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
note VB O
that IN O
because IN O
minocycline NN O
and CC O
saline NN O
controls NNS O
did VBD O
not RB O
differ VB O
in IN O
their PRP$ O
TLR2 NNP O
expression NN O
, , O
these DT O
data NNS O
were VBD O
grouped VBN O
together RB O
as IN O
the DT O
Control NNP O
group NN O
( , O
Fig NNP O
. . O
2B NN O
& CC O
C NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
neither CC O
minocycline NN O
nor CC O
LPS NNP O
treatment NN O
had VBD O
a DT O
significant JJ O
main JJ O
effect NN O
on IN O
MHC NNP O
class NN O
II NN O
surface NN O
expression NN O
on IN O
microglia NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
minocycline NN O
attenuated VBN O
LPS NNP O
- HYPH O
induced VBN O
TLR2 NNP O
expression NN O
on IN O
microglia NN O
. . O

Minocycline NN O
facilitates VBZ O
the DT O
recovery NN O
from IN O
LPS NNP O
- HYPH O
induced VBN O
sickness NN O
behavior NN O

CNS NNP O
macrophages NNS O
and CC O
microglia NN O
produce VBP O
inflammatory JJ O
cytokines NNS O
and CC O
secondary JJ O
messengers NNS O
that WDT O
modulate VBP O
behavioral JJ O
responses NNS O
. . O

Therefore RB O
, , O
we PRP O
next RB O
investigated VBD O
if IN O
minocycline NN O
reduced VBD O
the DT O
sickness NN O
response NN O
associated VBN O
with IN O
peripheral JJ O
LPS NNP O
injection NN O
. . O

In IN O
this DT O
experiment NN O
, , O
adult NN O
mice NNS B-Species
were VBD O
treated VBN O
with IN O
minocycline NN O
and CC O
LPS NNP O
as IN O
described VBN O
. . O

Social JJ O
exploratory JJ O
behavior NN O
was VBD O
measured VBN O
before IN O
i PRP O
. . O
p LS O
. . O

LPS NNP O
injection NN O
and CC O
again RB O
2 CD O
, , O
4 CD O
, , O
8 CD O
, , O
and CC O
24 CD O
h NN O
later RBR O
. . O

Fig NN O
. . O

3A NNP O
shows VBZ O
that IN O
LPS NNP O
injection NN O
caused VBD O
a DT O
reduction NN O
in IN O
social JJ O
exploratory JJ O
behavior NN O
( , O
F NNP O
( , O
1 CD O
, , O
57 CD O
) SYM O
= SYM O
218 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
that WDT O
was VBD O
time NN O
dependent JJ O
( , O
F NNP O
( , O
4 CD O
, , O
57 CD O
) SYM O
= SYM O
66 CD O
. . O
5 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Moreover RB O
, , O
the DT O
LPS NNP O
- HYPH O
associated VBN O
reduction NN O
in IN O
social JJ O
exploration NN O
was VBD O
attenuated VBN O
by IN O
minocycline NN O
( , O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
57 CD O
) SYM O
= SYM O
7 CD O
. . O
5 CD O
, , O
P NN O
< NN O
0 CD O
. . O
7 CD O
) -RRB- O
. . O

For IN O
example NN O
, , O
at IN O
8 CD O
h CD O
post NN O
LPS NNP O
, , O
social JJ O
exploration NN O
was VBD O
reduced VBN O
by IN O
35 CD O
% NN O
in IN O
minocycline NN O
pretreated VBN O
mice NNS B-Species
given VBN O
LPS NNP O
compared VBN O
to IN O
a DT O
67 CD O
% NN O
reduction NN O
in IN O
vehicle NN O
pretreated VBN O
mice NNS B-Species
given VBN O
LPS NNP O
( : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

While IN O
minocycline NN O
administration NN O
alone RB O
reduced VBD O
food NN O
intake NN O
and CC O
body NN O
weight NN O
in IN O
control NN O
mice NNS B-Species
( , O
P NN O
< SYM O
0 CD O
. . O
5 CD O
, , O
for IN O
each DT O
) -RRB- O
, , O
it PRP O
also RB O
protected VBD O
against IN O
LPS NNP O
- HYPH O
associated VBN O
anorexia NN O
( , O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
60 CD O
) SYM O
= SYM O
70 CD O
. . O
0 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
, , O
Fig NNP O
. . O
3B NN O
) -RRB- O
and CC O
weight NN O
loss NN O
( , O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
60 CD O
) SYM O
= SYM O
29 CD O
. . O
7 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
, , O
Fig NNP O
. . O
3C NN O
) -RRB- O
. . O

Because IN O
sickness NN O
can MD O
also RB O
be VB O
associated VBN O
with IN O
longer JJR O
lasting VBG O
changes NNS O
in IN O
motivation NN O
[ -LRB- O
38 CD O
] -RRB- O
, , O
we PRP O
next RB O
sought VBD O
to TO O
determine VB O
if IN O
minocycline NN O
abrogated VBD O
LPS NNP O
- HYPH O
induced VBN O
anhedonia NN O
[ -LRB- O
54 CD O
, , O
55 CD O
] -RRB- O
. . O

In IN O
this DT O
experiment NN O
, , O
mice NNS B-Species
were VBD O
subjected VBN O
to IN O
the DT O
same JJ O
minocycline NN O
injection NN O
regimen NN O
and CC O
LPS NN O
challenge NN O
as IN O
above IN O
and CC O
sucrose JJ O
preference NN O
was VBD O
assessed VBN O
24 CD O
- SYM O
39 CD O
h NN O
post NN O
LPS NNP O
injection NN O
. . O

By IN O
24 CD O
h CD O
post NN O
LPS NNP O
injection NN O
, , O
food NN O
and CC O
water NN O
intake NN O
returned VBD O
to IN O
baseline NN O
and CC O
LPS NNP O
treated VBN O
mice NNS B-Species
still RB O
exhibited VBD O
a DT O
marked JJ O
reduction NN O
in IN O
sucrose NN O
preference NN O
from IN O
24 CD O
- SYM O
39 CD O
h NN O
( , O
F NN O
( , O
1 CD O
, , O
59 CD O
) SYM O
= SYM O
14 CD O
. . O
3 CD O
, , O
P NN O
< NN O
0 CD O
. . O
3 CD O
) -RRB- O
. . O

Moreover RB O
, , O
this DT O
LPS NN O
- HYPH O
dependent JJ O
reduction NN O
in IN O
sucrose NN O
preference NN O
was VBD O
prevented VBN O
by IN O
minocycline NN O
pretreatment NN O
( , O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
59 CD O
) SYM O
= SYM O
9 CD O
. . O
9 CD O
, , O
P NN O
< SYM O
0 CD O
. . O
4 CD O
, , O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

For IN O
example NN O
, , O
minocycline NN O
pretreated VBN O
mice NNS B-Species
injected VBN O
with IN O
LPS NNP O
maintained VBD O
the DT O
same JJ O
strong JJ O
preference NN O
for IN O
sucrose NN O
as IN O
saline NN O
and CC O
minocycline NN O
controls NNS O
( , O
i LS O
. . O
e -RRB- O
. . O
, , O
approximately RB O
85 CD O
% NN O
preference NN O
) -RRB- O
. . O

These DT O
data NNS O
can MD O
be VB O
interpreted VBN O
to TO O
indicate VB O
that IN O
minocycline NN O
blocks VBZ O
anhedonia NN O
associated VBN O
with IN O
peripheral JJ O
LPS NNP O
challenge NN O
. . O

Minocycline NN O
reduces VBZ O
LPS NNP O
- HYPH O
induced VBN O
neuroinflammation NN O

Pro JJ O
- HYPH O
inflammatory JJ O
cytokines NNS O
in IN O
the DT O
CNS NNP O
are VBP O
partially RB O
responsible JJ O
for IN O
the DT O
behavioral JJ O
symptoms NNS O
of IN O
sickness NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
anorexia NN O
, , O
social JJ O
withdrawal NN O
, , O
and CC O
anhedonia NN O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
investigated VBD O
the DT O
degree NN O
to IN O
which WDT O
minocycline NN O
reduces VBZ O
neuroinflammation NN O
( , O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
IL NN O
- HYPH O
6 CD O
, , O
and CC O
IDO NNP O
) -RRB- O
after IN O
peripheral JJ O
injection NN O
of IN O
LPS NNP O
. . O

In IN O
this DT O
experiment NN O
, , O
mice NNS B-Species
were VBD O
subjected VBN O
to IN O
the DT O
minocycline NN O
injection NN O
regimen NN O
and CC O
LPS NN O
challenge NN O
as IN O
above RB O
and CC O
cytokine NN O
mRNA NN O
levels NNS O
were VBD O
determined VBN O
in IN O
the DT O
cortex NN O
and CC O
hippocampus NN O
4 CD O
h NN O
after IN O
LPS NNP O
injection NN O
. . O

In IN O
mice NNS B-Species
pretreated VBN O
with IN O
vehicle NN O
, , O
LPS NNP O
markedly RB O
increased VBD O
IL NN O
- HYPH O
1 CD O
beta NN O
mRNA NN O
levels NNS O
in IN O
the DT O
hippocampus NN O
( , O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
62 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
cortex NN O
( HYPH O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
17 CD O
. . O
25 CD O
, , O
P NN O
< NN O
0 CD O
. . O
3 CD O
) -RRB- O
. . O

The DT O
LPS NNP O
- HYPH O
induced VBN O
IL NN O
- HYPH O
1 CD O
beta NN O
mRNA NNP O
expression NN O
was VBD O
reduced VBN O
in IN O
both CC O
brain NN O
regions NNS O
in IN O
mice NNS B-Species
receiving VBG O
minocycline NN O
prior RB O
to IN O
LPS NNP O
injection NN O
: : O
( : O
hippocampus NN O
, , O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
9 CD O
. . O
63 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
cortex NN O
, , O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
7 CD O
. . O
23 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
8 CD O
, , O
Fig NNP O
. . O

5A NN O
) -RRB- O
. . O

LPS NNP O
caused VBD O
a DT O
similar JJ O
induction NN O
of IN O
IL NN O
- HYPH O
6 CD O
mRNA NN O
levels NNS O
in IN O
the DT O
hippocampus NN O
( , O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
37 CD O
. . O
2 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
cortex NN O
( HYPH O
F NNP O
( , O
1 CD O
, , O
31 CD O
) CD O
= SYM O
22 CD O
. . O
5 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
, , O
but CC O
minocycline NN O
pretreatment NN O
only RB O
significantly RB O
attenuated VBN O
LPS NNP O
- HYPH O
induced VBN O
IL NN O
- HYPH O
6 CD O
mRNA NN O
levels NNS O
in IN O
the DT O
hippocampus NN O
( : O
F NNP O
( , O
1 CD O
, , O
31 CD O
) CD O
= SYM O
10 CD O
. . O
27 CD O
, , O
P NN O
< NN O
0 CD O
. . O
4 CD O
, , O
Fig NNP O
. . O
5B NN O
) -RRB- O
. . O

IDO NNP O
mRNA NNP O
levels NNS O
were VBD O
determined VBN O
from IN O
the DT O
same JJ O
RNA NNP O
pool NN O
. . O

Fig NN O
. . O

6D NN O
shows VBZ O
that IN O
LPS NNP O
injection NN O
increased VBD O
IDO NNP O
mRNA NNP O
expression NN O
in IN O
the DT O
hippocampus NN O
( , O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
11 CD O
. . O
69 CD O
, , O
P NN O
< NN O
0 CD O
. . O
2 CD O
) -RRB- O
and CC O
cortex NN O
( : O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
5 CD O
. . O
26 CD O
, , O
P NN O
< NN O
0 CD O
. . O
3 CD O
) -RRB- O
. . O

This DT O
LPS NNP O
- HYPH O
induced VBN O
IDO NNP O
mRNA NNP O
expression NN O
was VBD O
attenuated VBN O
by IN O
minocycline NN O
in IN O
the DT O
hippocampus NN O
( , O
F NNP O
( , O
1 CD O
, , O
31 CD O
) SYM O
= SYM O
11 CD O
. . O
69 CD O
, , O
P NN O
< NN O
0 CD O
. . O
2 CD O
) -RRB- O
and CC O
cortex NN O
( : O
F NNP O
( , O
1 CD O
, , O
31 CD O
) NFP O
= SYM O
5 CD O
. . O
26 CD O
, , O
P NN O
< NN O
0 CD O
. . O
3 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
note VB O
that IN O
IDO NNP O
mRNA NNP O
was VBD O
undetected JJ O
in IN O
saline NN O
treated VBN O
mice NNS B-Species
. . O

Therefore RB O
, , O
the DT O
fold NN O
IDO NNP O
change NN O
was VBD O
relative JJ O
to IN O
the DT O
IDO NNP O
mRNA NNP O
levels NNS O
in IN O
mice NNS B-Species
receiving VBG O
minocycline NN O
prior RB O
to IN O
LPS NNP O
. . O

Minocycline NN O
reduces VBZ O
LPS NNP O
- HYPH O
induced VBN O
IL NN O
- HYPH O
6 CD O
, , O
but CC O
not RB O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
in IN O
the DT O
plasma NN O

Because IN O
cytokine NN O
signals NNS O
can MD O
be VB O
relayed VBN O
from IN O
the DT O
periphery NN O
to IN O
the DT O
brain NN O
by IN O
humoral JJ O
pathways NNS O
[ -LRB- O
56 CD O
] -RRB- O
, , O
plasma NN O
cytokine NN O
levels NNS O
of IN O
IL NN O
- HYPH O
6 CD O
and CC O
IL NN O
- HYPH O
1 CD O
beta NN O
were VBD O
determined VBN O
4 CD O
h NN O
post NN O
LPS NNP O
injection NN O
. . O

As IN O
expected VBN O
, , O
LPS NNP O
injection NN O
caused VBD O
a DT O
marked JJ O
increase NN O
in IN O
plasma NN O
IL NN O
- HYPH O
1 CD O
beta NN O
( HYPH O
F NNP O
( SYM O
1 CD O
, , O
36 CD O
) SYM O
= SYM O
52 CD O
. . O
5 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
IL NN O
- HYPH O
6 CD O
levels NNS O
( : O
F NNP O
( , O
1 CD O
, , O
36 CD O
) SYM O
34 CD O
. . O
1 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Minocycline NN O
pretreatment NN O
reduced VBD O
LPS NNP O
- HYPH O
induced VBN O
IL NN O
- HYPH O
6 CD O
levels NNS O
in IN O
the DT O
plasma NN O
( , O
F NNP O
( , O
1 CD O
, , O
36 CD O
) SYM O
6 CD O
. . O
68 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
but CC O
had VBD O
no DT O
significant JJ O
main JJ O
effect NN O
on IN O
LPS NNP O
- HYPH O
induced VBN O
IL NN O
- HYPH O
1 CD O
beta NN O
levels NNS O
( : O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

Minocycline NN O
attenuates VBZ O
LPS NNP O
- HYPH O
induced VBN O
exaggerated VBN O
neuroinflammation NN O
in IN O
aged JJ O
mice NNS B-Species

Aged JJ O
BALB NNP O
/ SYM O
c NNP O
mice NNS B-Species
( : O
22 CD O
- SYM O
24 CD O
m NN O
) , O
have VBP O
an DT O
exaggerated JJ O
neuroinflammatory JJ O
response NN O
to IN O
LPS NNP O
injection NN O
[ -LRB- O
10 CD O
, , O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
next RB O
sought VBD O
to TO O
determine VB O
if IN O
the DT O
heightened VBN O
inflammatory JJ O
response NN O
in IN O
the DT O
brain NN O
of IN O
aged JJ O
mice NNS B-Species
was VBD O
reduced VBN O
by IN O
minocycline NN O
. . O

In IN O
this DT O
experiment NN O
, , O
adult NN O
and CC O
aged JJ O
mice NNS B-Species
were VBD O
subjected VBN O
to IN O
the DT O
minocycline NN O
injection NN O
regimen NN O
and CC O
LPS NNP O
challenge NN O
as IN O
above RB O
. . O

As IN O
we PRP O
have VBP O
reported VBN O
previously RB O
, , O
MHC NNP O
II NNP O
mRNA NNP O
expression NN O
was VBD O
increased VBN O
by IN O
age NN O
( : O
P NN O
< SYM O
0 CD O
. . O
3 CD O
, , O
Fig NNP O
. . O
7A NNP O
) -RRB- O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
, , O
but CC O
MHC NNP O
II NNP O
levels NNS O
were VBD O
unaffected JJ O
by IN O
either CC O
LPS NNP O
or CC O
minocycline NN O
treatment NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

Consistent JJ O
with IN O
the DT O
data NNS O
presented VBN O
in IN O
Fig NNP O
. . O

2 LS O
, , O
ANOVA NNP O
revealed VBD O
a DT O
significant JJ O
main JJ O
effect NN O
of IN O
LPS NNP O
injection NN O
on IN O
TLR2 NNP O
mRNA NNP O
expression NN O
in IN O
the DT O
hippocampus NN O
( , O
F NNP O
( , O
1 CD O
, , O
63 CD O
) SYM O
= SYM O
85 CD O
. . O
5 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Moreover RB O
, , O
LPS NNP O
caused VBD O
a DT O
greater JJR O
increase NN O
in IN O
TLR2 NNP O
mRNA NNP O
in IN O
the DT O
hippocampus NN O
of IN O
aged VBN O
mice NNS B-Species
compared VBN O
to IN O
adults NNS O
( , O
LPS NNP O
x CC O
Age NN O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
63 CD O
) SYM O
= SYM O
12 CD O
. . O
70 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
minocycline NN O
pretreatment NN O
attenuated VBD O
LPS NNP O
- HYPH O
induced VBN O
TLR2 NNP O
mRNA NNP O
levels NNS O
in IN O
both CC O
adult NN O
and CC O
aged JJ O
mice NN B-Species
( , O
Mino NNP O
x NNP O
LPS NNP O
interaction NN O
, , O
F NNP O
( , O
1 CD O
, , O
63 CD O
) SYM O
= SYM O
9 CD O
. . O
2 CD O
, , O
P NN O
< NN O
0 CD O
. . O
4 CD O
) -RRB- O
. . O

Parallel JJ O
to IN O
the DT O
results NNS O
for IN O
TLR2 NNP O
, , O
LPS NNP O
caused VBD O
a DT O
greater JJR O
increase NN O
in IN O
IL NN O
- HYPH O
1 CD O
beta NN O
and CC O
IDO NNP O
mRNA NNP O
levels NNS O
in IN O
hippocampus NN O
of IN O
aged JJ O
mice NNS B-Species
compared VBN O
to IN O
adults NNS O
( , O
Age NN O
x SYM O
LPS NNP O
, , O
F NNP O
( , O
1 CD O
, , O
60 CD O
) SYM O
= SYM O
8 CD O
. . O
64 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
for IN O
IL NN O
- HYPH O
1 CD O
beta NN O
and CC O
F NN O
( HYPH O
1 CD O
, , O
60 CD O
) SYM O
= SYM O
4 CD O
. . O
0 CD O
, , O
P NN O
< NN O
0 CD O
. . O
5 CD O
for IN O
IDO NNP O
) -RRB- O
. . O

Minocycline NN O
pretreatment NN O
attenuated VBN O
LPS NNP O
- HYPH O
induced VBN O
mRNA NNP O
levels NNS O
of IN O
IL NN O
- HYPH O
1 CD O
beta NN O
( : O
Mino NNP O
x NNP O
LPS NNP O
, , O
F NNP O
( , O
1 CD O
, , O
60 CD O
) SYM O
= SYM O
8 CD O
. . O
76 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
, , O
Fig NNP O
. . O
7C NNP O
) -RRB- O
and CC O
IDO NNP O
( : O
Mino NNP O
x SYM O
LPS NNP O
, , O
F NNP O
( , O
1 CD O
, , O
60 CD O
) SYM O
= SYM O
9 CD O
. . O
7 CD O
, , O
P NN O
< NN O
0 CD O
. . O
3 CD O
, , O
Fig NNP O
. . O
7D CD O
) -RRB- O
. . O

While IN O
LPS NNP O
induced VBD O
higher JJR O
IL NN O
- HYPH O
6 CD O
mRNA NN O
levels NNS O
in IN O
the DT O
hippocampus NN O
of IN O
both CC O
adult NN O
and CC O
aged JJ O
mice NNS B-Species
( , O
F NNP O
( , O
1 CD O
, , O
59 CD O
) SYM O
= SYM O
44 CD O
. . O
5 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
, , O
there EX O
was VBD O
not RB O
an DT O
Age NN O
x NN O
LPS NNP O
interaction NN O
. . O

Minocycline NN O
pretreatment NN O
attenuated VBD O
the DT O
LPS NN O
- HYPH O
induced VBN O
increase NN O
in IN O
hippocampal JJ O
IL NNP O
- HYPH O
6 CD O
mRNA NNP O
( , O
Mino NNP O
x NNP O
LPS NNP O
, , O
F NNP O
( , O
1 CD O
, , O
59 CD O
) SYM O
= SYM O
5 CD O
. . O
4 CD O
, , O
P NN O
< NN O
0 CD O
. . O
2 CD O
, , O
Fig NNP O
. . O
7E CD O
) -RRB- O
. . O

Taken VBN O
together RB O
these DT O
data NNS O
indicate VBP O
that IN O
minocycline NN O
pretreatment NN O
was VBD O
effective JJ O
in IN O
attenuating VBG O
the DT O
exaggerated VBN O
neuroinflammation NN O
in IN O
aged JJ O
mice NNS B-Species
. . O

Discussion NN O

In IN O
the DT O
elderly JJ O
, , O
systemic JJ O
infection NN O
is VBZ O
associated VBN O
with IN O
an DT O
increased VBN O
frequency NN O
of IN O
behavioral JJ O
and CC O
cognitive JJ O
complications NNS O
[ -LRB- O
57 CD O
, , O
58 CD O
] -RRB- O
. . O

We PRP O
have VBP O
reported VBN O
that IN O
stimulation NN O
of IN O
the DT O
peripheral JJ O
immune JJ O
system NN O
in IN O
older JJR O
( , O
20 CD O
- SYM O
24 CD O
m NN O
) SYM O
BALB NN O
/ SYM O
c NN O
mice NN B-Species
causes VBZ O
exaggerated VBN O
neuroinflammation NN O
that WDT O
is VBZ O
paralleled VBN O
by IN O
prolonged VBN O
sickness NN O
[ -LRB- O
13 CD O
] -RRB- O
, , O
impaired VBN O
working VBG O
memory NN O
[ -LRB- O
10 CD O
] -RRB- O
, , O
and CC O
depressive JJ O
- HYPH O
like JJ O
behaviors NNS O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
understand VB O
the DT O
mechanisms NNS O
that WDT O
can MD O
modulate VB O
cytokine NN O
- HYPH O
mediated VBN O
pathways NNS O
in IN O
the DT O
brain NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
minocycline NN O
treatment NN O
reduced VBD O
LPS NNP O
- HYPH O
induced VBN O
TLR2 NNP O
expression NN O
in IN O
BV NNP O
- HYPH O
2 CD O
cells NNS O
and CC O
on IN O
microglia NN O
isolated VBN O
from IN O
adult NN O
mice NNS B-Species
. . O

Moreover RB O
, , O
we PRP O
demonstrate VBP O
that IN O
minocycline NN O
was VBD O
effective JJ O
in IN O
facilitating VBG O
the DT O
recovery NN O
from IN O
LPS NNP O
- HYPH O
induced VBN O
sickness NN O
and CC O
preventing VBG O
anhedonia NN O
in IN O
adult NN O
mice NNS B-Species
. . O

Furthermore RB O
, , O
we PRP O
show VBP O
that IN O
minocycline NN O
attenuated VBN O
LPS NNP O
- HYPH O
induced VBN O
neuroinflammation NN O
in IN O
adults NNS O
and CC O
normalized VBD O
the DT O
exaggerated VBN O
neuroinflammation NN O
in IN O
aged JJ O
mice NNS B-Species
. . O

Our PRP$ O
findings NNS O
, , O
using VBG O
cell NN O
culture NN O
and CC O
animal NN O
experiments NNS O
, , O
support VBP O
the DT O
notion NN O
that IN O
minocycline NN O
attenuates VBZ O
microglial JJ O
activation NN O
and CC O
limits VBZ O
production NN O
of IN O
inflammatory JJ O
mediators NNS O
. . O

For IN O
instance NN O
, , O
minocycline NN O
pretreatment NN O
of IN O
BV NN O
- HYPH O
2 CD O
cultures NNS O
decreased VBD O
LPS NNP O
- HYPH O
stimulated VBN O
cytokine NN O
production NN O
in IN O
a DT O
dose NN O
dependent JJ O
manner NN O
( , O
Fig NNP O
. . O
1A NN O
) -RRB- O
. . O

In IN O
BV NN O
- HYPH O
2 CD O
cells NNS O
, , O
minocycline NN O
also RB O
attenuated VBD O
mRNA NN O
expression NN O
of IN O
inflammatory JJ O
genes NNS O
including VBG O
IL NN O
- HYPH O
6 CD O
, , O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
MHC NNP O
II NNP O
, , O
and CC O
TLR2 NNP O
( , O
Fig NNP O
. . O
1D NN O
) -RRB- O
. . O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
other JJ O
studies NNS O
using VBG O
minocycline NN O
and CC O
LPS NNP O
in IN O
BV NNP O
- HYPH O
2 CD O
cells NNS O
[ -LRB- O
44 CD O
, , O
59 CD O
] -RRB- O
. . O

Based VBN O
on IN O
these DT O
data NNS O
we PRP O
next RB O
investigated VBD O
if IN O
microglial JJ O
activation NN O
could MD O
be VB O
attenuated VBN O
in IN O
the DT O
brain NN O
. . O

Because IN O
LPS NNP O
increases VBZ O
brain NN O
cytokine NN O
production NN O
we PRP O
expected VBD O
that IN O
MHC NNP O
II NNP O
expression NN O
would MD O
also RB O
be VB O
increased VBN O
. . O

Contrary JJ O
to IN O
our PRP$ O
predictions NNS O
, , O
neither CC O
MHC NNP O
II NNP O
mRNA NNP O
levels NNS O
( -LRB- O
Fig NNP O
. . O
7 CD O
) -RRB- O
in IN O
the DT O
brain NN O
nor CC O
MHC NNP O
II NNP O
surface NN O
expression NN O
on IN O
microglia NN O
( -LRB- O
CD11b NNP O
+ SYM O
/ SYM O
CD45low NNP O
) -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) , O
were VBD O
increased VBN O
by IN O
LPS NNP O
injection NN O
. . O

In IN O
an DT O
EAE NNP O
model NN O
, , O
minocycline NN O
reduced VBD O
microglial JJ O
expression NN O
of IN O
MHC NNP O
II NNP O
[ -LRB- O
45 CD O
] -RRB- O
, , O
but CC O
one CD O
key JJ O
difference NN O
from IN O
our PRP$ O
study NN O
is VBZ O
that IN O
the DT O
induction NN O
of IN O
EAE NNP O
pathology NN O
requires VBZ O
functional JJ O
antigen NN O
presentation NN O
on IN O
MHC NNP O
II NNP O
[ -LRB- O
60 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
postulated VBN O
that IN O
microglia NN O
have VBP O
several JJ O
activation NN O
states NNS O
that WDT O
depend VBP O
on IN O
the DT O
specific JJ O
inflammatory JJ O
stimulus NN O
[ -LRB- O
61 CD O
] -RRB- O
. . O

Thus RB O
, , O
in IN O
situations NNS O
of IN O
transient JJ O
peripheral JJ O
innate JJ O
immune JJ O
stimulation NN O
, , O
markers NNS O
in IN O
the DT O
CNS NNP O
such JJ O
as IN O
Toll NN O
- HYPH O
Like JJ O
receptors NNS O
[ -LRB- O
6 CD O
] -RRB- O
may MD O
be VB O
indicative JJ O
of IN O
microglia NN O
activation NN O
. . O

In IN O
support NN O
of IN O
this DT O
premise NN O
, , O
our PRP$ O
data NNS O
show VBP O
that IN O
LPS NNP O
injection NN O
increases VBZ O
TLR2 NN O
surface NN O
expression NN O
on IN O
microglia NN O
( , O
CD11b NN O
+ CC O
/ SYM O
CD45low NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
inhibited VBN O
by IN O
minocycline NN O
pretreatment NN O
( , O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
other JJ O
studies NNS O
showing VBG O
that IN O
central JJ O
or CC O
peripheral JJ O
LPS NN O
challenge NN O
increases VBZ O
TLR2 NNP O
mRNA NNP O
in IN O
the DT O
brain NN O
[ -LRB- O
6 CD O
, , O
14 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
our PRP$ O
findings NNS O
can MD O
be VB O
interpreted VBN O
to TO O
suggest VB O
that IN O
minocycline NN O
attenuates VBZ O
pathways NNS O
associated VBN O
with IN O
microglia NN O
activation NN O
following VBG O
peripheral JJ O
LPS NNP O
challenge NN O
. . O

One CD O
of IN O
the DT O
important JJ O
findings NNS O
of IN O
this DT O
study NN O
was VBD O
that IN O
reduction NN O
of IN O
neuroinflammation NN O
by IN O
minocycline NN O
was VBD O
associated VBN O
with IN O
facilitated VBN O
recovery NN O
from IN O
LPS NNP O
- HYPH O
induced VBN O
sickness NN O
behavior NN O
. . O

These DT O
results NNS O
are VBP O
akin JJ O
to IN O
our PRP$ O
previous JJ O
work NN O
with IN O
the DT O
anti AFX O
- HYPH O
oxidant NN O
, , O
alpha NN O
- HYPH O
tocopherol NN O
[ -LRB- O
52 CD O
] -RRB- O
, , O
and CC O
an DT O
NFKB NNP O
decoy NN O
inhibitor NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

Consistent JJ O
with IN O
our PRP$ O
previous JJ O
studies NNS O
[ -LRB- O
52 CD O
, , O
53 CD O
, , O
62 CD O
, , O
63 CD O
] -RRB- O
, , O
reductions NNS O
in IN O
neuroinflammatory JJ O
cytokines NNS O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
did VBD O
not RB O
prevent VB O
the DT O
induction NN O
of IN O
the DT O
LPS NNP O
- HYPH O
induced VBN O
sickness NN O
response NN O
( : O
2 CD O
- SYM O
4 CD O
h NN O
) -RRB- O
, , O
but CC O
rather RB O
facilitated VBD O
the DT O
recovery NN O
from IN O
sickness NN O
( : O
8 CD O
- SYM O
24 CD O
h NN O
) -RRB- O
( : O
Fig NNP O
. . O
3A CD O
) -RRB- O
. . O

Recovery NN O
may MD O
be VB O
a DT O
critical JJ O
issue NN O
because IN O
brain NN O
cytokines NNS O
and CC O
the DT O
corresponding VBG O
physiological JJ O
and CC O
behavioral JJ O
responses NNS O
are VBP O
beneficial JJ O
to IN O
the DT O
host NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
potential JJ O
risk NN O
for IN O
a DT O
maladaptive JJ O
response NN O
occurs VBZ O
when WRB O
the DT O
normally RB O
transient JJ O
neuroinflammatory JJ O
response NN O
is VBZ O
amplified VBN O
or CC O
protracted VBN O
[ -LRB- O
64 CD O
] -RRB- O
. . O

Therefore RB O
pharmacological JJ O
agents NNS O
, , O
similar JJ O
to IN O
minocycline NN O
, , O
that WDT O
attenuate VBP O
neuroinflammatory JJ O
responses NNS O
, , O
but CC O
do VBP O
not RB O
completely RB O
inhibit VB O
them PRP O
, , O
may MD O
be VB O
important JJ O
in IN O
preventing VBG O
the DT O
development NN O
of IN O
more RBR O
severe JJ O
and CC O
long RB O
- HYPH O
lasting VBG O
cognitive JJ O
and CC O
behavioral JJ O
complications NNS O
. . O

The DT O
results NNS O
of IN O
the DT O
sucrose JJ O
preference NN O
experiments NNS O
support VBP O
the DT O
idea NN O
that IN O
limiting VBG O
exposure NN O
to IN O
neuroinflammation NN O
decreases VBZ O
the DT O
duration NN O
of IN O
behavioral JJ O
responses NNS O
. . O

For IN O
example NN O
, , O
while IN O
minocycline NN O
did VBD O
not RB O
inhibit VB O
cytokine NN O
expression NN O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
or CC O
the DT O
induction NN O
of IN O
sickness NN O
( : O
Fig NNP O
. . O
3A NN O
) -RRB- O
, , O
minocycline NN O
pretreatment NN O
completely RB O
reversed VBD O
the DT O
reduction NN O
in IN O
sucrose NN O
preference NN O
( : O
i LS O
. . O
e LS O
. . O
, , O
anhedonia NN O
) , O
associated VBN O
with IN O
LPS NNP O
injection NN O
( , O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
also RB O
important JJ O
to TO O
mention VB O
that IN O
while IN O
LPS NN O
- HYPH O
associated VBN O
sickness NN O
and CC O
anhedonia NN O
are VBP O
interrelated JJ O
, , O
these DT O
behaviors NNS O
can MD O
be VB O
differentiated VBN O
from IN O
one CD O
another DT O
. . O

For IN O
instance NN O
, , O
reduced VBN O
social JJ O
exploration NN O
was VBD O
evident JJ O
2 CD O
- SYM O
24 CD O
h NN O
post NN O
injection NN O
( -LRB- O
Fig NNP O
. . O
3A NN O
) -RRB- O
, , O
but CC O
only RB O
decreased VBN O
sucrose NN O
preference NN O
was VBD O
exhibited VBN O
24 CD O
to TO O
39 CD O
h NNS O
later RB O
( : O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

This DT O
separation NN O
between IN O
behaviors NNS O
is VBZ O
consistent JJ O
with IN O
other JJ O
studies NNS O
investigating VBG O
sickness NN O
and CC O
longer RBR O
- HYPH O
lasting VBG O
changes NNS O
in IN O
motivation NN O
[ -LRB- O
15 CD O
, , O
65 CD O
, , O
66 CD O
] -RRB- O
. . O

IDO NNP O
mediated VBN O
TRP NNP O
metabolism NN O
represents VBZ O
a DT O
potential JJ O
connection NN O
between IN O
activation NN O
of IN O
CNS NNP O
innate JJ O
immune JJ O
cells NNS O
and CC O
longer JJR O
lasting VBG O
behavioral JJ O
responses NNS O
. . O

IDO NNP O
mediated VBN O
TRP NNP O
metabolism NN O
in IN O
the DT O
brain NN O
may MD O
affect VB O
behavior NN O
by IN O
impacting VBG O
both CC O
serotonin NN O
and CC O
glutamate NN O
pathways NNS O
[ -LRB- O
39 CD O
] -RRB- O
. . O

We PRP O
have VBP O
reported VBN O
that IN O
IDO NNP O
induction NN O
and CC O
activity NN O
is VBZ O
amplified VBN O
in IN O
the DT O
brain NN O
of IN O
aged JJ O
mice NNS B-Species
and CC O
is VBZ O
associated VBN O
with IN O
prolonged VBN O
depressive JJ O
- HYPH O
like JJ O
behavior NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Here RB O
we PRP O
show VBP O
that IN O
IDO NNP O
mRNA NNP O
induction NN O
is VBZ O
blocked VBN O
by IN O
minocycline NN O
in IN O
the DT O
brain NN O
of IN O
both CC O
adult NN O
and CC O
aged JJ O
mice NNS B-Species
( , O
Figs NNPS O
. . O
5 CD O
& SYM O
7 CD O
) -RRB- O
. . O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
a DT O
recent JJ O
report NN O
showing VBG O
a DT O
causal JJ O
relationship NN O
between IN O
IDO NNP O
activity NN O
and CC O
acute JJ O
depressive JJ O
effects NNS O
in IN O
adult NN O
CD NN O
- HYPH O
1 CD O
mice NNS B-Species
. . O

In IN O
this DT O
study NN O
, , O
O UH O
' '' O
Connor NNP O
et FW O
al JJ O
. . O
report VB O
that IN O
both CC O
1 CD O
- HYPH O
methyl NN O
tryptophan NN O
( , O
a DT O
competitive JJ O
inhibitor NN O
of IN O
IDO NNP O
) -RRB- O
and CC O
minocycline NN O
blocked VBD O
IDO NNP O
induction NN O
and CC O
prevented VBD O
depressive JJ O
- HYPH O
like JJ O
immobility NN O
in IN O
the DT O
tail NN O
suspension NN O
and CC O
forced VBN O
swimming NN O
tests NNS O
[ -LRB- O
66 CD O
] -RRB- O
. . O

Thus RB O
, , O
in IN O
the DT O
present JJ O
study NN O
, , O
the DT O
minocycline NN O
blockade NN O
of IN O
IDO NNP O
induction NN O
may MD O
explain VB O
the DT O
abrogation NN O
of IN O
LPS NNP O
- HYPH O
induced VBN O
anhedonia NN O
. . O

Another DT O
interesting JJ O
finding NN O
was VBD O
that IN O
while IN O
minocycline NN O
pretreatment NN O
in IN O
adult NN O
mice NN B-Species
attenuated VBD O
LPS NNP O
- HYPH O
induced VBN O
brain NN O
IL NN O
- HYPH O
1 CD O
beta NN O
at IN O
4 CD O
h NN O
( SYM O
Fig NNP O
. . O
5 CD O
) -RRB- O
, , O
it PRP O
had VBD O
no DT O
effect NN O
on IN O
plasma NN O
IL NN O
- HYPH O
1 CD O
beta NN O
levels NNS O
( : O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

Because IN O
IL NN O
- HYPH O
1 CD O
beta JJ O
signals NNS O
can MD O
be VB O
relayed VBN O
from IN O
the DT O
periphery NN O
to IN O
the DT O
brain NN O
by IN O
humoral JJ O
pathways NNS O
[ -LRB- O
5 CD O
] -RRB- O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
minocycline NN O
has VBZ O
anti JJ O
- HYPH O
inflammatory JJ O
properties NNS O
within IN O
the DT O
brain NN O
. . O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
related JJ O
findings NNS O
that IN O
minocycline NN O
readily RB O
crosses VBZ O
the DT O
blood NN O
brain NN O
barrier NN O
to TO O
elicit VB O
an DT O
anti JJ O
- HYPH O
inflammatory JJ O
effect NN O
[ -LRB- O
41 CD O
- HYPH O
43 CD O
] -RRB- O
. . O

With IN O
regard NN O
to IN O
IL NN O
- HYPH O
6 CD O
, , O
minocycline NN O
pretreatment NN O
attenuated VBD O
both CC O
brain NN O
and CC O
plasma NN O
levels NNS O
at IN O
4 CD O
h CD O
post NN O
LPS NNP O
injection NN O
. . O

Because IN O
circulating VBG O
IL NN O
- HYPH O
6 CD O
levels NNS O
can MD O
be VB O
increased VBN O
by IN O
CNS NNP O
mediated VBN O
pathways NNS O
including VBG O
activation NN O
of IN O
the DT O
hypothalamus NN O
- HYPH O
pituitary NN O
- HYPH O
adrenal JJ O
( -LRB- O
HPA NN O
) , O
axis NN O
[ -LRB- O
67 CD O
] -RRB- O
and CC O
the DT O
sympathetic JJ O
nervous JJ O
system NN O
[ -LRB- O
68 CD O
] -RRB- O
, , O
the DT O
specific JJ O
reduction NN O
in IN O
plasma NN O
IL NN O
- HYPH O
6 CD O
by IN O
minocycline NN O
may MD O
reflect VB O
the DT O
reduction NN O
in IN O
brain NN O
inflammation NN O
at IN O
4 CD O
h NN O
( SYM O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

In IN O
support NN O
of IN O
this DT O
notion NN O
, , O
we PRP O
and CC O
others NNS O
have VBP O
reported VBN O
that IN O
i PRP O
. . O
c NN O
. . O
v NN O
. . O
injection NN O
of IN O
LPS NN O
or CC O
IL NN O
- HYPH O
1 CD O
beta NN O
increase NN O
plasma NN O
IL NN O
- HYPH O
6 CD O
levels NNS O
, , O
but CC O
not RB O
IL NN O
- HYPH O
1 CD O
beta NN O
levels NNS O
[ -LRB- O
14 CD O
, , O
68 CD O
, , O
69 CD O
] -RRB- O
. . O

The DT O
final JJ O
critical JJ O
finding NN O
of IN O
this DT O
study NN O
was VBD O
that IN O
minocycline NN O
was VBD O
effective JJ O
in IN O
attenuating VBG O
neuroinflammation NN O
independent JJ O
of IN O
age NN O
. . O

Consistent JJ O
with IN O
other JJ O
aging NN O
and CC O
neuroinflammation NN O
studies NNS O
, , O
our PRP$ O
data NNS O
show VBP O
that IN O
LPS NNP O
caused VBD O
exaggerated VBN O
neuroinflammation NN O
in IN O
aged JJ O
mice NNS B-Species
compared VBN O
to IN O
adults NNS O
[ -LRB- O
10 CD O
, , O
13 CD O
- SYM O
15 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
mention VB O
that IN O
while IN O
there EX O
was VBD O
an DT O
age NN O
- HYPH O
related VBN O
difference NN O
in IN O
MHC NNP O
II NNP O
expression NN O
in IN O
the DT O
hippocampus NN O
of IN O
saline NN O
treated VBN O
mice NN B-Species
( , O
Fig NNP O
. . O
7A CD O
) -RRB- O
there EX O
was VBD O
not RB O
an DT O
age NN O
- HYPH O
related VBN O
difference NN O
in IN O
IL NN O
- HYPH O
1 CD O
beta NN O
and CC O
IL NN O
- HYPH O
6 CD O
mRNA NN O
levels NNS O
. . O

These DT O
data NNS O
differ VBP O
from IN O
a DT O
previous JJ O
report NN O
using VBG O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
showing VBG O
an DT O
increase NN O
in IN O
IL NN O
- HYPH O
6 CD O
in IN O
older JJR O
mice NNS B-Species
[ -LRB- O
70 CD O
] -RRB- O
. . O

This DT O
may MD O
be VB O
because IN O
the DT O
mice NNS B-Species
used VBN O
in IN O
the DT O
present JJ O
study NN O
were VBD O
approximately RB O
4 CD O
months NNS O
younger JJR O
than IN O
the DT O
mice NNS B-Species
used VBN O
previously RB O
. . O

Nonetheless RB O
, , O
microglia NN O
can MD O
be VB O
primed VBN O
or CC O
reactive JJ O
with IN O
increased JJ O
MHC NNP O
II NNP O
expression NN O
, , O
but CC O
do VBP O
not RB O
necessarily RB O
produce VB O
inflammatory JJ O
cytokines NNS O
in IN O
this DT O
state NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

The DT O
key JJ O
results NNS O
are VBP O
that IN O
peripheral JJ O
LPS NNP O
injection NN O
causes VBZ O
a DT O
greater JJR O
induction NN O
of IN O
TLR2 NNP O
, , O
IL NN O
- HYPH O
1 CD O
beta NN O
, , O
and CC O
IDO NNP O
mRNA NNP O
in IN O
the DT O
aged VBN O
brain NN O
than IN O
in IN O
the DT O
adult NN O
brain NN O
and CC O
that IN O
minocycline NN O
pretreatment NN O
normalizes VBZ O
this DT O
age NN O
- HYPH O
related VBN O
exaggerated VBN O
neuroinflammation NN O
( , O
Fig NNP O
. . O
7 CD O
) -RRB- O
. . O

These DT O
findings NNS O
are VBP O
also RB O
important JJ O
because IN O
an DT O
amplified JJ O
neuroinflammatory JJ O
response NN O
in IN O
the DT O
aged VBN O
brain NN O
is VBZ O
a DT O
precursor NN O
to IN O
complications NNS O
including VBG O
deficits NNS O
in IN O
working VBG O
memory NN O
, , O
memory NN O
consolidation NN O
, , O
and CC O
depressive JJ O
- HYPH O
like JJ O
behavior NN O
[ -LRB- O
9 CD O
, , O
10 CD O
, , O
15 CD O
] -RRB- O
. . O

Based VBN O
on IN O
the DT O
biochemical JJ O
and CC O
behavioral JJ O
data NNS O
obtained VBN O
from IN O
this DT O
study NN O
, , O
we PRP O
predict VBP O
that IN O
minocycline NN O
will MD O
abrogate VB O
the DT O
prolonged VBN O
LPS NNP O
- HYPH O
induced VBN O
sickness NN O
[ -LRB- O
13 CD O
] -RRB- O
and CC O
depressive JJ O
- HYPH O
like JJ O
behavior NN O
exhibited VBN O
by IN O
aged VBN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
[ -LRB- O
15 CD O
] -RRB- O
. . O

We PRP O
acknowledge VBP O
, , O
however RB O
, , O
that IN O
future JJ O
studies NNS O
are VBP O
necessary JJ O
to TO O
test VB O
these DT O
predictions NNS O
. . O

Conclusion NN O

The DT O
present JJ O
study NN O
demonstrates VBZ O
that IN O
minocycline NN O
reduces VBZ O
LPS NNP O
- HYPH O
induced VBN O
microglial JJ O
activation NN O
, , O
CNS NNP O
cytokine NN O
production NN O
, , O
and CC O
behavioral JJ O
symptoms NNS O
of IN O
sickness NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
social JJ O
withdrawal NN O
and CC O
anhedonia NN O
) -RRB- O
. . O

These DT O
findings NNS O
are VBP O
potentially RB O
important JJ O
because IN O
they PRP O
indicate VBP O
that IN O
minocycline NN O
can MD O
be VB O
used VBN O
to TO O
mitigate VB O
cytokine NN O
expression NN O
in IN O
the DT O
brain NN O
and CC O
have VB O
a DT O
beneficial JJ O
affect NN O
on IN O
behavioral JJ O
responses NNS O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
support VBP O
the DT O
idea NN O
that IN O
pharmacological JJ O
strategies NNS O
aimed VBN O
at IN O
decreasing VBG O
neuroinflammation NN O
associated VBN O
with IN O
microglial JJ O
activation NN O
are VBP O
important JJ O
for IN O
improving VBG O
recovery NN O
from IN O
sickness NN O
and CC O
reducing VBG O
the DT O
frequency NN O
of IN O
neurobehavioral JJ O
complications NNS O
. . O

List NN O
of IN O
abbreviations NNS O

3 NNP O
- HYPH O
Hydroxy NNP O
- HYPH O
L NNP O
- HYPH O
Kynuriene NNP O
( : O
3HK NNP O
) -RRB- O
, , O
Allophycocyanin NNP O
( , O
APC NNP O
) -RRB- O
, , O
Analysis NNP O
of IN O
variance NN O
( , O
ANOVA NNP O
) -RRB- O
, , O
Central NNP O
Nervous NNP O
System NNP O
( , O
CNS NNP O
) -RRB- O
, , O
Dulbecco NNP O
' POS O
s NNP O
Modified NNP O
Eagle NNP O
' POS O
s NNP O
Medium NNP O
( , O
DMEM NNP O
) -RRB- O
, , O
Dimethyl NNP O
Sulfoxide NNP O
( , O
DMSO NNP O
) -RRB- O
, , O
Experimental NNP O
Autoimmune NNP O
Encephalomyelitis NNP O
( , O
EAE NNP O
) -RRB- O
, , O
Enzyme NNP O
Linked NNP O
Immmunosorbent NNP O
Assay NNP O
( -LRB- O
ELISA NNP O
) -RRB- O
, , O
Fluorescein NNP O
Isothiocyanate NNP O
( , O
FITC NNP O
) -RRB- O
, , O
Fetal NNP O
Bovine NNP B-Species
Serum NNP O
( , O
FBS NNP O
) -RRB- O
, , O
Hank NNP O
' POS O
s NNP O
Balanced NNP O
Salt NNP O
Solution NNP O
( , O
HBSS NNP O
) -RRB- O
, , O
Indoleamine NNP O
2 CD O
, , O
3 CD O
dioxygenase NN O
( , O
IDO NN O
) -RRB- O
, , O
Intraperitoneal NNP O
( : O
i ADD O
. . O
p NN O
. . O
) -RRB- O
, , O
Intracerebroventricu NNP O
( : O
i ADD O
. . O
c NN O
. . O
v NN O
. . O
) -RRB- O
, , O
Interleukin NNP O
( , O
IL NNP O
) -RRB- O
, , O
Kynurenine NNP O
( , O
KYN NNP O
) -RRB- O
, , O
Lipopolysaccharide NNP O
( , O
LPS NNP O
) -RRB- O
, , O
Major NNP O
Histocompatibility NNP O
Complex NNP O
class NN O
II NNP O
( , O
MHC NNP O
II NNP O
) -RRB- O
, , O
Mitogen NNP O
Activated NNP O
Protein NNP O
Kinase NNP O
( , O
MAP NNP O
- HYPH O
kinase NN O
) -RRB- O
, , O
Nuclear JJ O
factor NN O
kappa NN O
B NNP O
( , O
NF NNP O
kappa NN O
B NNP O
) -RRB- O
, , O
N NNP O
- HYPH O
methyl NN O
- HYPH O
D NNP O
- HYPH O
aspartate NN O
( , O
NMDA NNP O
) -RRB- O
, , O
R NNP O
- HYPH O
Phycoerthrin NNP O
( -LRB- O
PE NN O
) -RRB- O
, , O
Quinolinic NNP O
acid NN O
( , O
QUIN NNP O
) -RRB- O
, , O
Statistical NNP O
Analysis NNP O
Systems NNPS O
( : O
SAS NNP O
) -RRB- O
, , O
Standard NNP O
Error NNP O
of IN O
the DT O
Mean NNP O
( , O
SEM NNP O
) -RRB- O
, , O
Toll NN O
- HYPH O
like NNP O
Receptor NNP O
- HYPH O
2 CD O
( , O
TLR2 NNP O
) -RRB- O
, , O
and CC O
Tryptophan NNP O
( -LRB- O
TRP NNP O
) -RRB- O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
of IN O
this DT O
manuscript NN O
declare VBP O
that IN O
there EX O
are VBP O
no DT O
actual JJ O
or CC O
potential JJ O
conflicts NNS O
of IN O
interest NN O
. . O

The DT O
authors NNS O
affirm VBP O
that IN O
there EX O
are VBP O
no DT O
financial JJ O
, , O
personal JJ O
or CC O
other JJ O
relationships NNS O
with IN O
other JJ O
people NNS B-Species
or CC O
organizations NNS O
that WDT O
have VBP O
inappropriately RB O
influenced VBN O
or CC O
biased VBN O
their PRP$ O
research NN O
. . O

Authors NNS O
' POS O
contributions NNS O

CJH NNP O
was VBD O
involved VBN O
in IN O
research NN O
experimentation NN O
, , O
completion NN O
of IN O
statistical JJ O
analysis NN O
, , O
and CC O
writing NN O
of IN O
the DT O
manuscript NN O
. . O

YH NNP O
, , O
AW NNP O
, , O
MH NNP O
and CC O
JH NNP O
assisted VBN O
with IN O
experimentation NN O
and CC O
data NNS O
analysis NN O
. . O

MB NNP O
and CC O
JFS NNP O
contributed VBD O
to IN O
the DT O
design NN O
of IN O
the DT O
experiments NNS O
and CC O
assisted VBD O
in IN O
editing VBG O
the DT O
manuscript NN O
. . O

JPG NNP O
directed VBD O
all DT O
aspects NNS O
of IN O
this DT O
research NN O
project NN O
including VBG O
the DT O
experimental JJ O
design NN O
, , O
research NN O
experimentation NN O
, , O
completion NN O
of IN O
statistical JJ O
analysis NN O
, , O
and CC O
writing NN O
of IN O
the DT O
manuscript NN O
. . O

A DT O
case NN O
of IN O
demand NN O
ischemia NN O
from IN O
phendimetrazine NN O

Abstract JJ O

Introduction NN O

Phendimetrazine NN O
is VBZ O
a DT O
medication NN O
currently RB O
being VBG O
used VBN O
to TO O
help VB O
patients NNS B-Species
with IN O
weight NN O
loss NN O
. . O

It PRP O
shares VBZ O
a DT O
chemical JJ O
structure NN O
with IN O
amphetamines NNS O
. . O

As IN O
such JJ O
, , O
it PRP O
shares VBZ O
some DT O
of IN O
the DT O
same JJ O
toxicities NNS O
, , O
which WDT O
can MD O
include VB O
cardiac JJ O
toxicity NN O
. . O

This DT O
case NN O
highlights VBZ O
this DT O
principle NN O
. . O

Case NN O
presentation NN O

a DT O
54 CD O
year NN O
old JJ O
Caucasian JJ O
female NN O
presented VBN O
to IN O
our PRP$ O
urgent JJ O
care NN O
facility NN O
with IN O
complaints NNS O
of IN O
chest NN O
pains NNS O
and CC O
other JJ O
symptoms NNS O
suggestive JJ O
of IN O
acute JJ O
coronary JJ O
syndrome NN O
. . O

Ultimately RB O
, , O
she PRP O
was VBD O
transferred VBN O
to IN O
the DT O
emergency NN O
room NN O
. . O

After IN O
evaluation NN O
there RB O
, , O
it PRP O
appeared VBD O
she PRP O
was VBD O
having VBG O
demand NN O
ischemia NN O
from IN O
prescription NN O
diet NN O
pills NNS O

Conclusion NN O

This DT O
case NN O
report NN O
demonstrates VBZ O
the DT O
potential JJ O
dangers NNS O
of IN O
amphetamine NN O
based VBN O
diet NN O
pills NNS O
. . O

There EX O
have VBP O
been VBN O
other JJ O
cases NNS O
of IN O
cardiomyopathies NNS O
related VBN O
to IN O
phendimetrazine NN O
, , O
but CC O
it PRP O
is VBZ O
something NN O
that WDT O
is VBZ O
rarely RB O
recognized VBN O
in IN O
an DT O
outpatient JJ O
setting NN O
. . O

A DT O
case NN O
such JJ O
as IN O
this DT O
demonstrates VBZ O
the DT O
importance NN O
of IN O
obtaining VBG O
a DT O
careful JJ O
medication NN O
history NN O
in IN O
all DT O
patients NNS B-Species
and CC O
in IN O
recognizing VBG O
diet NN O
pills NNS O
with IN O
an DT O
amphetamine NN O
base NN O
can MD O
cause VB O
cardiac JJ O
toxicity NN O
. . O

Case NN O
presentation NN O

A DT O
54 CD O
year NN O
- HYPH O
old JJ O
Caucasian JJ O
female NN O
presented VBD O
to IN O
our PRP$ O
urgent JJ O
care NN O
facility NN O
complaining VBG O
of IN O
nausea NN O
and CC O
vomiting NN O
, , O
sense NN O
of IN O
impending JJ O
doom NN O
and CC O
vague JJ O
chest NN O
pain NN O
radiating VBG O
toward IN O
her PRP$ O
left JJ O
side NN O
for IN O
about RB O
five CD O
hours NNS O
. . O

She PRP O
never RB O
had VBD O
similar JJ O
symptoms NNS O
in IN O
the DT O
past NN O
. . O

She PRP O
also RB O
denied VBD O
anything NN O
that WDT O
could MD O
have VB O
precipitated VBN O
these DT O
symptoms NNS O
. . O

Her PRP$ O
only JJ O
past JJ O
medical JJ O
history NN O
was VBD O
significant JJ O
for IN O
spina NN O
bifida NN O
. . O

Her PRP$ O
medications NNS O
included VBD O
occasional JJ O
Fiorinal NNP O
( , O
unknown JJ O
dose NN O
) -RRB- O
, , O
Xanax NNP O
0 CD O
. . O
5 CD O
mg NN O
as IN O
needed VBN O
, , O
and CC O
Phendimetrazine NNP O
( , O
unclear JJ O
dose NN O
) -RRB- O
. . O

Her PRP$ O
social JJ O
history NN O
was VBD O
significant JJ O
for IN O
smoking NN O
1 CD O
/ SYM O
2 CD O
pack NN O
per IN O
day NN O
cigarette NN O
use NN O
. . O

She PRP O
denied VBD O
alcohol NN O
use NN O
. . O

Family NN O
history NN O
was VBD O
non RB O
contributory JJ O
. . O

She PRP O
worked VBD O
from IN O
home NN O
. . O

Her PRP$ O
physical JJ O
exam NN O
showed VBD O
a DT O
tachycardia NN O
of IN O
around RB O
100 CD O
beats NNS O
per IN O
minute NN O
, , O
respiratory JJ O
rate NN O
of IN O
16 CD O
, , O
temperature NN O
of IN O
98 CD O
. . O
1 CD O
, , O
and CC O
O2 NN O
saturation NN O
of IN O
100 CD O
% NN O
on IN O
room NN O
air NN O
. . O

She PRP O
was VBD O
approximately RB O
5 CD O
' NN O
7 CD O
"""" '' O
and CC O
145 CD O
pounds NNS O
. . O

In IN O
general JJ O
, , O
she PRP O
was VBD O
an DT O
anxious JJ O
appearing VBG O
, , O
diaphoretic JJ O
woman NN B-Species
in IN O
moderate JJ O
distress NN O
, , O
she PRP O
had VBD O
no DT O
elevated JJ O
JVD NN O
at IN O
30 CD O
degrees NNS O
, , O
her PRP$ O
heart NN O
was VBD O
tachycardic JJ O
, , O
but CC O
otherwise RB O
without IN O
murmur NN O
, , O
gallops NNS O
, , O
or CC O
rubs NNS O
, , O
her PRP$ O
lungs NNS O
were VBD O
clear JJ O
, , O
abdomen NN O
soft JJ O
, , O
and CC O
she PRP O
had VBD O
no DT O
peripheral JJ O
edema NN O
. . O

An DT O
EKG NNP O
was VBD O
checked VBN O
which WDT O
appears VBZ O
below IN O
( -LRB- O
figure NN O
1 CD O
) -RRB- O
. . O

After IN O
examination NN O
, , O
there EX O
was VBD O
concern NN O
for IN O
acute JJ O
coronary JJ O
syndrome NN O
( -LRB- O
ACS NNP O
) -RRB- O
. . O

She PRP O
was VBD O
given VBN O
nitroglycerin NN O
with IN O
relief NN O
of IN O
her PRP$ O
chest NN O
discomfort NN O
. . O

She PRP O
was VBD O
also RB O
given VBN O
aspirin NN O
to TO O
chew VB O
. . O

EMS NNP O
was VBD O
called VBN O
and CC O
she PRP O
was VBD O
transferred VBN O
to IN O
a DT O
local JJ O
emergency NN O
room NN O
. . O

She PRP O
was VBD O
hospitalized VBN O
there RB O
for IN O
three CD O
days NNS O
and CC O
after IN O
her PRP$ O
discharge NN O
, , O
we PRP O
got VBD O
permission NN O
from IN O
her PRP O
to TO O
request VB O
records NNS O
. . O

While IN O
hospitalized VBN O
, , O
she PRP O
was VBD O
ruled VBN O
out RP O
for IN O
ACS NNP O
with IN O
negative JJ O
troponins NNS O
. . O

She PRP O
was VBD O
also RB O
given VBN O
beta JJ O
blockade NN O
which WDT O
resolved VBD O
her PRP$ O
tachycardia NN O
and CC O
her PRP$ O
T NN O
wave NN O
changes NNS O
on IN O
EKG NNP O
. . O

The DT O
next JJ O
morning NN O
, , O
she PRP O
had VBD O
an DT O
adenosine JJ O
stress NN O
test NN O
which WDT O
revealed VBD O
normal JJ O
uptake NN O
with IN O
no DT O
areas NNS O
of IN O
ischemia NN O
and CC O
an DT O
ejection NN O
fraction NN O
of IN O
55 CD O
% NN O
. . O

She PRP O
was VBD O
monitored VBN O
for IN O
one CD O
more JJR O
day NN O
and CC O
then RB O
discharged VBN O
with IN O
instructions NNS O
to TO O
discontinue VB O
her PRP$ O
diet NN O
pills NNS O
. . O

Discussion NN O

Phendimetrazine NN O
is VBZ O
a DT O
medication NN O
currently RB O
being VBG O
used VBN O
for IN O
weight NN O
loss NN O
, , O
with IN O
potential JJ O
for IN O
illicit JJ O
use NN O
. . O

It PRP O
has VBZ O
a DT O
similar JJ O
chemical JJ O
composition NN O
of IN O
amphetamines NNS O
, , O
which WDT O
is VBZ O
thought VBN O
to TO O
account VB O
for IN O
its PRP$ O
clinical JJ O
actions NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Amphetamines NNS O
are VBP O
well RB O
recognized VBN O
as IN O
an DT O
etiology NN O
of IN O
cardiac JJ O
ischemia NN O
, , O
however WRB O
phendimetrazine NN O
is VBZ O
more RBR O
rarely RB O
described VBN O
in IN O
the DT O
literature NN O
as IN O
causing VBG O
cardiac JJ O
events NNS O
. . O

[ -LRB- O
2 CD O
, , O
3 CD O
] -RRB- O
. . O

Acute JJ O
effects NNS O
include VBP O
hyperpyrexia NN O
, , O
mydriasis NN O
, , O
chest NN O
pain NN O
, , O
arrhytmias NN O
, , O
delirium NN O
, , O
and CC O
, , O
rhabdomylosis NN O
, , O
among IN O
others NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Long JJ O
term NN O
use NN O
has VBZ O
been VBN O
associated VBN O
with IN O
dilated VBN O
cardiomyopathies NNS O
, , O
some DT O
of IN O
which WDT O
have VBP O
resolved VBN O
with IN O
discontinuation NN O
of IN O
the DT O
medication NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

In IN O
this DT O
particular JJ O
case NN O
, , O
it PRP O
appears VBZ O
she PRP O
may MD O
have VB O
developed VBN O
a DT O
demand NN O
ischemia NN O
from IN O
the DT O
medication NN O
. . O

It PRP O
is VBZ O
not RB O
known VBN O
how WRB O
much JJ O
of IN O
the DT O
drug NN O
she PRP O
was VBD O
taking VBG O
. . O

Initially RB O
, , O
she PRP O
was VBD O
resistant JJ O
to IN O
accepting VBG O
that IN O
phendimetrazine NN O
could MD O
induce VB O
side NN O
effects NNS O
, , O
and CC O
there EX O
was VBD O
suspicion NN O
that IN O
she PRP O
could MD O
have VB O
been VBN O
taking VBG O
more JJR O
of IN O
the DT O
drug NN O
that WDT O
recommended VBD O
. . O

In IN O
addition NN O
, , O
she PRP O
was VBD O
not RB O
prescribed VBN O
the DT O
medication NN O
and CC O
would MD O
not RB O
admit VB O
to IN O
where WRB O
she PRP O
obtained VBD O
it PRP O
. . O

As IN O
the DT O
public NN O
seems VBZ O
to TO O
have VB O
more JJR O
focus NN O
on IN O
using VBG O
medications NNS O
to TO O
induce VB O
weight NN O
loss NN O
, , O
this DT O
may MD O
be VB O
a DT O
more RBR O
recognized VBN O
complication NN O
and CC O
heart NN O
conditions NNS O
should MD O
likely RB O
be VB O
monitored VBN O
prior RB O
to IN O
starting VBG O
amphetamine NN O
based VBN O
weight NN O
loss NN O
pills NNS O
. . O

Conclusion NN O

Due IN O
to IN O
potentially RB O
detrimental JJ O
effects NNS O
of IN O
this DT O
medication NN O
, , O
phendimetrazine NN O
should MD O
be VB O
used VBN O
cautiously RB O
in IN O
many JJ O
situations NNS O
. . O

As IN O
it PRP O
shares VBZ O
its PRP$ O
chemical JJ O
structure NN O
with IN O
amphetamines NNS O
, , O
it PRP O
also RB O
shares VBZ O
many JJ O
of IN O
the DT O
side NN O
effects NNS O
and CC O
the DT O
potential NN O
for IN O
abuse NN O
/ SYM O
addiction NN O
. . O

There EX O
have VBP O
been VBN O
other JJ O
reports NNS O
in IN O
literature NN O
describing VBG O
adverse JJ O
outcomes NNS O
from IN O
phendimetrazine NN O
as RB O
well RB O
as IN O
other JJ O
weight NN O
loss NN O
medications NNS O
. . O

Therefore RB O
, , O
cautious JJ O
use NN O
is VBZ O
warranted VBN O
. . O

Abbreviations NNS O

ACS NNP O
: : O
Acute NNP O
Coronary NNP O
Syndrome NNP O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

DL NNP O
, , O
JJ NNP O
, , O
GG NNP O
have VBP O
all RB O
been VBN O
involved VBN O
in IN O
and CC O
approve VB O
of IN O
the DT O
writing NN O
of IN O
this DT O
case NN O
presentation NN O
. . O

Consent NN O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN O
for IN O
publication NN O
purposes NNS O
. . O

A DT O
copy NN O
can MD O
be VB O
obtained VBN O
if IN O
requested VBN O
by IN O
the DT O
Editor NNP O
in IN O
Chief NNP O
of IN O
this DT O
journal NN O
. . O

Advanced JJ O
software NN O
concepts NNS O
for IN O
employing VBG O
microcomputers NNS O
in IN O
the DT O

laboratory NN O

Abstract JJ O

IIII NNP O

II NNP O

, , O
Advanced JJ O
software NN O
concepts NNS O
for IN O

employing VBG O
microcomputers NNS O
in IN O
the DT O
laboratory NN O
Scott NNP O
B NNP O
. . O
Tilden NNP O
and CC O
M NNP O
. . O
Bonner NNP O
Denton NNP O
, , O
Department NNP O
of IN O
Chemistry NNP O
, , O
University NNP O
of IN O
Arizona NNP O
, , O
Tucson NNP O
, , O
Arizona NNP O
85721 CD O
, , O
USA NNP O
. . O

Introduction NN O
While IN O
a DT O
proliferation NN O
of IN O
commercial JJ O
chemical NN O
instrumentation NN O
is VBZ O
appearing VBG O
today NN O
employing VBG O
microprocessors NNS O
for IN O
a DT O
variety NN O
of IN O
control NN O
and CC O
data NN O
reduction NN O
applications NNS O
, , O
the DT O
great JJ O
potential NN O
of IN O
microprocessors NNS O
has VBZ O
not RB O
been VBN O
exploited VBN O
extensively RB O
for IN O
individual JJ O
custom NN O
applications NNS O
. . O

The DT O
primary JJ O
reason NN O
for IN O
this DT O
phenomenon NN O
is VBZ O
altogether RB O
too RB O
clear JJ O
microprocessor NN O
software NN O
is VBZ O
either CC O
difficult JJ O
to TO O
develop VB O
or CC O
inefficient JJ O
in IN O
memory NN O
requirements NNS O
and CC O
speed NN O
. . O

This DT O
problem NN O
is VBZ O
even RB O
more RBR O
important JJ O
in IN O
situations NNS O
requiring VBG O
constant JJ O
software NN O

modification NN O
. . O

Initially RB O
, , O
most JJS O
instrument NN O
manufacturers NNS O
utilized VBD O
cross NN O
assemblers NNS O
supported VBN O
on IN O
large JJ O
"""" `` O
number NN O
cruncher NN O
"""" '' O
computers NNS O
to TO O
generate VB O
the DT O
required VBN O
machine NN O
code NN O
binary NN O
program NN O
. . O

More RBR O
recently RB O
, , O
the DT O
trend NN O
has VBZ O
been VBN O
toward IN O
the DT O
use NN O
of IN O
a DT O
"""" `` O
developmental JJ O
system NN O
"""" '' O
( , O
at IN O
a DT O
cost NN O
comparable JJ O
to IN O
a DT O
moderate JJ O
minicomputer NN O
- , O
the DT O
authors NNS O
use VBP O
the DT O
term NN O
"""" `` O
mini NN O
"""" '' O
in IN O
contrast NN O
to IN O
"""" `` O
micro NN O
"""" '' O
reluctantly RB O
because IN O
of IN O
the DT O
ever RB O
increasing VBG O
overlap NN O
in IN O
computing NN O
capability NN O
) , O
to TO O
write VB O
and CC O
debug VB O
assembly NN O
level NN O
porgrams NNS O
which WDT O
are VBP O
subsequently RB O
converted VBN O
to IN O
binary JJ O
and CC O
incorporated VBN O
into IN O
an DT O
instrument NN O
in IN O
the DT O
form NN O
of IN O
"""" `` O
read VB O
only RB O
memory NN O
"""" '' O
( , O
ROM NNP O
) -RRB- O
. . O

While IN O
this DT O
approach NN O

Interpretative JJ O
Machine NNP O
Code NNP O

Source NN O
Code NN O
File NN O

to TO O
Execute VB O
Command NN O
A DT O
Hachine NN O
Code NN O
Various JJ O

to TO O
Execute VB O
Comma NN O
nd NN O
B NN O
ne NN O
Code NN O

' '' O
commands NNS O
making VBG O
up RP O

, , O
lachi NNP O

to TO O
Execute VB O
Command NN O
C NN O

users NNS O
source NN O
program NN O

i PRP O

Machine NNP O
Code NNP O

to TO O
Execute VB O
Command NN O
D NN O

etc FW O
. . O

Figure NN O
1 CD O
. . O

The DT O
interpretative JJ O
cycle NN O
of IN O
common JJ O
types NNS O
of IN O
languages NNS O
such JJ O
as IN O
BASIC NNP O
. . O

After IN O
examining VBG O
each DT O
command NN O
in IN O
the DT O
source NN O
file NN O
, , O
the DT O
interpreter NN O
searches VBZ O
for IN O
and CC O
branches NNS O
to IN O
the DT O
corresponding VBG O
block NN O
of IN O
machine NN O
code NN O
; : O
thus RB O
, , O
program NN O
execution NN O
always RB O
remains VBZ O
within IN O
the DT O
interpreter NN O
. . O

128 CD O

The DT O
Journal NNP O
of IN O
Automatic NNP O
Chemistry NNP O

Tilden NNP O
& CC O
Denton NNP O
IIII NNP O

Advanced JJ O
software NN O
concepts NNS O

III NNP O

Users NNS O
Source NN O
File NN O

The DT O
Compiler NNP O

Command VB O
A NN O

Comma NNP O
nd NN O
B NN O
Command NNP O
C NNP O
Command NNP O
D NNP O
etc FW O
. . O

/ SYM O
z XX O
/ SYM O
li NNP O
i PRP O

II NNP O

. . O
Machine NNP O
Code NNP O

etc FW O
. . O

. . O
lachi NNP O
ne NNP O
Code NNP O

to TO O
Execute VB O
Command NN O
A NN O

etc FW O
. . O
to TO O
Execute VB O

Machine NNP O
Code NNP O

to TO O
Execute VB O
Command NN O
C NN O

Machine NNP O
Code NNP O

etc FW O
. . O

Figure NN O
2 CD O
. . O

Note VB O
that IN O
the DT O
compiler NN O
transforms VBZ O
each DT O
source NN O
"""" `` O
command NN O
"""" '' O
into IN O
executable JJ O
machine NN O
code NN O
. . O

This DT O
code NN O
will MD O
, , O
subsequently RB O
, , O
be VB O
loaded VBN O
and CC O
executed VBN O
independently RB O
of IN O
the DT O
compiler NN O
. . O

has VBZ O
proven VBN O
cost NN O
effective JJ O
for IN O
high JJ O
volume NN O
mass NN O
produced VBN O
applications NNS O
, , O
it PRP O
possesses VBZ O
serious JJ O
limitations NNS O
for IN O
system NN O
updates NNS O
and CC O
custom NN O
applications NNS O
. . O

Additionally RB O
, , O
the DT O
ability NN O
to TO O
program VB O
efficiently RB O
at IN O
the DT O
assembly NN O
level NN O
is VBZ O
a DT O
talent NN O
requiring VBG O
a DT O
significant JJ O
expenditure NN O
of IN O
time NN O
to TO O
develop VB O
. . O

During IN O
the DT O
past JJ O
several JJ O
years NNS O
, , O
a DT O
virtual JJ O
deluge NN O
of IN O
sophisticated JJ O
, , O
flexible JJ O
, , O
high JJ O
performance NN O
computer NN O
hardware NN O
has VBZ O
been VBN O
introduced VBN O
primarily RB O
aimed VBN O
at IN O
a DT O
rapidly RB O
growing VBG O
"""" `` O
hobbyist NN O
"""" '' O
market NN O
. . O

Manufacturers NNS O
quickly RB O
realilsed VBD O
that IN O
to TO O
sell VB O
the DT O
public JJ O
hardware NN O
, , O
some DT O
form NN O
of IN O
reasonably RB O
high JJ O
level NN O
software NN O
must MD O
be VB O
made VBN O
available JJ O
. . O

A DT O
variety NN O
of IN O
BASIC NNP O
interpreters NNS O
, , O
ranging VBG O
from IN O
rather RB O
"""" `` O
dumb JJ O
"""" '' O
to IN O
"""" `` O
quite RB O
intelligent JJ O
"""" '' O
have VBP O
since RB O
evolved VBN O
. . O

The DT O
more RBR O
intelligent JJ O
BASIC NNP O
interpreters NNS O
have VBP O
several JJ O
highly RB O
attractive JJ O
attributes NNS O
for IN O
"""" `` O
hobbyist JJ O
"""" '' O
applications NNS O
. . O

The DT O
language NN O
is VBZ O
both DT O
easy JJ O
to TO O
master VB O
and CC O
conversational JJ O
. . O

Error NN O
and CC O
caution NN O
messages NNS O
are VBP O
provided VBN O
as IN O
aids NNS O
during IN O
programming NN O
. . O

Why WRB O
not RB O
apply VB O
the DT O
"""" `` O
hobbyist NN O
"""" '' O
technology NN O
toward IN O
the DT O
implementation NN O
of IN O
custom JJ O
laboratory NN O
systems NNS O
? . O

Many JJ O
investigators NNS O
have VBP O
and CC O
, , O
no DT O
doubt NN O
, , O
many JJ O
more JJR O
will MD O
take VB O
this DT O
approach NN O
. . O

However RB O
, , O
BASIC NNP O
interpreters NNS O
possess VBP O
serious JJ O
limitations NNS O
in IN O
terms NNS O
of IN O
system NN O
speed NN O
, , O
flexibility NN O
and CC O
input NN O
/ SYM O
output NN O
( -LRB- O
I NNP O
/ SYM O
O NN O
) -RRB- O
capabilities NNS O
. . O

In IN O
BASIC NNP O
, , O
each DT O
command NN O
must MD O
first RB O
be VB O
interpreted VBN O
and CC O
then RB O
executed VBN O
( , O
see VB O
Figure NNP O
1 CD O
) -RRB- O
. . O

In IN O
many JJ O
cases NNS O
, , O
the DT O
interpretation NN O
process NN O
takes VBZ O
much RB O
more JJR O
time NN O
than IN O
the DT O
actual JJ O
execution NN O
. . O

This DT O
problem NN O
is VBZ O
compounded VBN O
by IN O
the DT O
fact NN O
that IN O
commands NNS O
interpreted VBN O
in IN O
the DT O
past NN O
must MD O
be VB O
re RB O
- HYPH O
interpreted VBN O
each DT O
time NN O
they PRP O
are VBP O
used VBN O
causing VBG O
iterative JJ O
programs NNS O
to TO O
be VB O
very RB O
slow JJ O
. . O

While IN O
speed NN O
is VBZ O
often RB O
not RB O
a DT O
serious JJ O
limitation NN O
in IN O
playing VBG O
computer NN O
games NNS O
, , O
laboratory NN O
application NN O
requiring VBG O
high JJ O
speed NN O
data NN O
acquisition NN O
and CC O
/ SYM O
or CC O
data NN O
manipulation NN O
are VBP O
common JJ O
. . O

Additionally RB O
, , O
the DT O
more RBR O
intelligent JJ O
BASICs NNPS O
make VBP O
very RB O
inefficient JJ O
use NN O
of IN O
memory NN O
often RB O
requiring VBG O
minimum NN O
of IN O
12 CD O
or CC O
16 CD O
K NN O
bytes NNS O
( : O
twelve CD O
or CC O
sixteen CD O
thousand CD O
eight CD O
bit NN O
words NNS O
) : O
' '' O
Volume NN O

cS NN O

H NN O

A DT O

D NN O

H NN O
Figure NN O
3 CD O
. . O

The DT O
' `` O
threaded JJ O
' '' O
code NN O
approach NN O
used VBN O
in IN O
CONVERS NNP O
. . O

In IN O
' `` O
threaded VBN O
' '' O
code NN O
programming NN O
modules NNS O
for IN O
sub NN O
- HYPH O
routines NNS O
are VBP O
used VBN O
repetitively RB O
in IN O
a DT O
variety NN O
of IN O
combinations NNS O
to TO O
allow VB O
implementation NN O
of IN O
an DT O
infinite JJ O
number NN O
of IN O
functions NNS O
. . O

Note VB O
that IN O
the DT O
flow NN O
of IN O
logic NN O
threads VBZ O
its PRP$ O
way NN O
in IN O
a DT O
very RB O
non JJ O
. . O
linear JJ O
fashion NN O
through IN O
these DT O
modules NNS O
. . O

No UH O
. . O
3 CD O
April NNP O
1979 CD O

129 CD O

Tilden NNP O

& CC O
Denton NNP O

Advanced JJ O
software NN O
concepts NNS O
| : O
I PRP O

Stack NN O

Upper JJ O
Memory NN O
Bound VBN O

User NN O
' '' O
s NNS O
Application NN O
Dictionaries NNS O

4 LS O
. . O
5k NFP O
Octal NNP O
CONVERS NNP O
- HYPH O
Di NN O
sk NN O
Operating NN O
System NN O

3 LS O
. . O
7k CD O
Octal NNP O
Standard NN O
High JJ O

Level NN O
Dictionary NN O
1 CD O
. . O
2k CD O
Octal NNP O
Initial NNP O
Machine NNP O

Code NNP O
Dictionary NNP O

I PRP O
@ NFP O
@ CC O
Octal NNP O

Figure NN O
4 CD O
. . O

Memory NN O
map NN O
of IN O
the DT O
CON NNP O
VERS NNP O
dictionary NN O
. . O

The DT O
stack NN O
which WDT O
is VBZ O
composed VBN O
of IN O
data NN O
parameters NNS O
etc FW O
. , O
acts VBZ O
as IN O
a DT O
constantly RB O
expanding VBG O
or CC O
contracting VBG O
memory NN O
buffer NN O
which WDT O
allows VBZ O
one CD O
subroutine NN O
to TO O
communicate VB O
with IN O
another DT O
without IN O
either CC O
needing VBG O
to TO O
know VB O
the DT O
other JJ O
' '' O
s NNS O
location NN O
. . O

In IN O
contrast NN O
to IN O
interpreters NNS O
, , O
high JJ O
level NN O
compilers NNS O
, , O
such JJ O
as IN O
FORTRAN NNP O
, , O
offer VBP O
a DT O
much RB O
faster JJR O
"""" `` O
run NN O
time NN O
"""" '' O
execution NN O
speed NN O
. . O

This DT O
is VBZ O
accomplished VBN O
through IN O
generation NN O
of IN O
the DT O
required VBN O
machine NN O
code NN O
during IN O
a DT O
series NN O
of IN O
programming NN O
operations NNS O
. . O

Compilers NNS O
using VBG O
FORTRAN NNP O
, , O
which WDT O
are VBP O
designed VBN O
to TO O
run VB O
on IN O
many JJ O
minicomputers NNS O
and CC O
some DT O
micros NNS O
, , O
often RB O
first RB O
transform VBP O
user NN O
symbolic JJ O
source NN O
code NN O
into IN O
assembly NN O
code NN O
. . O

An DT O
assembler NN O
program NN O
, , O
subsequently RB O
, , O
transforms VBZ O
this DT O
into IN O
the DT O
required VBN O
machine NN O
code NN O
. . O

This DT O
ready JJ O
- HYPH O
to IN O
- HYPH O
run VB O
machine NN O
code NN O
is VBZ O
often RB O
loaded VBN O
along IN O
with IN O
a DT O
run NN O
time NN O
package NN O
which WDT O
executes VBZ O
in IN O
the DT O
manner NN O
shown VBN O
in IN O
Figure NN O
2 CD O
. . O

While IN O
this DT O
approach NN O
greatly RB O
improves VBZ O
execution NN O
speed NN O
, , O
the DT O
need NN O
for IN O
loading VBG O
several JJ O
different JJ O
soft JJ O
- HYPH O
ware NN O
routines NNS O
increases VBZ O
the DT O
"""" `` O
hassle NN O
"""" '' O
associated VBN O
with IN O
editing NN O
and CC O
debugging NN O
. . O

Thus RB O
, , O
this DT O
makes VBZ O
some DT O
form NN O
of IN O
mass NN O
memory NN O
, , O
such JJ O
as IN O
a DT O
disk NN O
or CC O
magnetic JJ O
tape NN O
, , O
almost RB O
mandatory JJ O
. . O

Additionally RB O
, , O
I NNP O
/ SYM O
O NN O
algorithms NNS O
generally RB O
must MD O
be VB O
implemented VBN O
in IN O
assembly NN O
level NN O
code NN O
! . O

One CD O
obvious JJ O
question NN O
immediately RB O
arises VBZ O
- : O
why WRB O
not RB O
incorporate VB O
the DT O
most RBS O
desirable JJ O
characteristics NNS O
of IN O
both DT O
interpreters NNS O
and CC O
compilers NNS O
into IN O
a DT O
single JJ O
language NN O
? . O

Additionally RB O
, , O
due IN O
to IN O
the DT O
unique JJ O
requirements NNS O
found VBN O
in IN O
many JJ O
applications NNS O
, , O
why WRB O
not RB O
allow VB O
the DT O
programmer NN O
additional JJ O
flexibility NN O
by IN O
providing VBG O
him PRP O
with IN O
the DT O
ability NN O
to TO O
actually RB O
develop VB O
his PRP$ O
own JJ O
individual JJ O
modifications NNS O
and CC O
additions NNS O
to IN O
the DT O
language NN O
itself PRP O
? . O

Other JJ O
desirable JJ O
features NNS O
would MD O
include VB O
high JJ O
memory NN O
efficiency NN O
, , O
high JJ O
level NN O
I NN O
] -RRB- O
O NN O
programming NN O
, , O
ease NN O
of IN O
understanding VBG O
the DT O
language NN O
' '' O
s POS O
"""" `` O
inter NN O
- HYPH O
working VBG O
"""" '' O
and CC O
the DT O
ability NN O
to TO O
be VB O
transferred VBN O
from IN O
one CD O
CPU NN O
to IN O
another DT O
with IN O
minimum JJ O
effort NN O
. . O

Type VB O
"""" `` O
ACQUIRE VB O
"""" '' O

ACQUIRE VB O

# NFP O
of IN O
characters NNS O

A DT O
G NN O

FORMAT NN O
T NNP O
PLOT NNP O

START NN O
SCAN NNP O
GALC NNP O
% NN O
T NN O

DISPLAY NN O
RETURN NN O

EXECUTIVE NN O

Figure NN O
5 CD O
. . O

If IN O
a DT O
previously RB O
defined VBN O
program NN O
name NN O
( , O
A NN O
CO NNP O
U NNP O
R NNP O
tQ NNP O
is VBZ O
entered VBN O
when WRB O
in IN O
EXECUTE NNP O
mode NN O
, , O
a DT O
dictionary JJ O
search NN O
takes VBZ O
place NN O
locating VBG O
the DT O
ACQUIRE NNP O
entry NN O
. . O

Once RB O
found VBN O
, , O
this DT O
entry NN O
contains VBZ O
all PDT O
the DT O
required JJ O
machine NN O
code NN O
and CC O
/ SYM O
or CC O
calls NNS O
to IN O
addresses NNS O
of IN O
other JJ O
previously RB O
compiled VBN O
machine NN O
code NN O
modules NNS O
to TO O
completely RB O
execute VB O
the DT O
desired VBN O
function NN O
. . O

130 CD O

The DT O
Journal NNP O
of IN O
Automatic NNP O
Chemistry NNP O

Tilden NNP O
& CC O
Denton NNP O

Advanced JJ O
software NN O
concepts NNS O

2000 CD O

VARIABLE JJ O
VARIABLE JJ O

START VB O
STOP NN O

5000 CD O
20 CD O

VARIABLE JJ O
VARIABLE JJ O
7 CD O

INCREMENT NN O

0 NFP O

LOCATION NN O

A DT O
/ SYM O
D7 NN O

INDEVICE NNP O
START NNP O

INITIALIZE VB O
STEP NNP O

@ NFP O

LOCATION NN O

LOCATION NN O

@ NFP O

INCREMENT NN O
5 CD O
INDEVICE NN O

@ NFP O

+ NFP O
10 CD O

LOCATION NN O

DELAY NN O
MOVE VBP O
SCAN NNP O

BEGIN VB O
- : O
HERE RB O
LOCATION NN O

AND CC O

IF IN O
DELAY NNP O

A DT O
/ SYM O
D7 NN O

ELSE RB O

BEGIN NNP O

THEN RB O

@ NFP O

5 CD O

OUTDEVICE NNP O

STEP NNP O

INITIALIZE VBP O

BEGIN VB O
- : O
HERE RB O

MOVE NNP O

LOCATION NN O

@ NFP O

STOP NN O

@ NFP O

> XX O

IF IN O

END NN O

ELSE RB O

BEGIN NNP O

THEN RB O

3000 CD O
6500 CD O
10 CD O

START VB O
START NN O

INCREMENT NN O

SCAN NNP O

Figure NN O
6 CD O
. . O

Ten CD O
lines NNS O
of IN O
typical JJ O
CONVERS NNP O
code NN O
to TO O
scan VB O
wavelengths NNS O
between IN O
two CD O
easily RB O
changed VBN O
limits NNS O
and CC O
acquire VB O
data NNS O
. . O

By IN O
reference NN O
to IN O
notes NNS O
in IN O
the DT O
text NN O
it PRP O
can MD O
be VB O
easily RB O
understood VBN O
. . O

NOTE NN O
: : O
a DT O
number NN O
or CC O
name NN O
pushes VBZ O
the DT O
number NN O
of IN O
address NN O
occupied VBN O
by IN O
the DT O
name NN O
on IN O
the DT O
stack NN O
. . O

The DT O
symbol NN O
@ , O
, , O
pips VBZ O
the DT O
top JJ O
number NN O
from IN O
the DT O
stack NN O
uses VBZ O
it PRP O
as IN O
the DT O
address NN O
from IN O
which WDT O
to TO O
obtain VB O
a DT O
number NN O
and CC O
pushes VBZ O
that DT O
number NN O
on IN O
the DT O
stack NN O
. . O

Development NN O
of IN O
CONVERS NNS O
During IN O
the DT O
past JJ O
two CD O
years NNS O
, , O
a DT O
different JJ O
approach NN O
to IN O
software NN O
has VBZ O
been VBN O
taking VBG O
place NN O
at IN O
the DT O
University NNP O
of IN O
Arizona NNP O
referred VBD O
to IN O
as IN O
an DT O
"""" `` O
Interpretive NNP O
Compiler NNP O
"""" '' O
called VBN O
CONVERS NNP O
. . O

This DT O
package NN O
, , O
which WDT O
is VBZ O
conceptually RB O
similar JJ O
to IN O
the DT O
FORTH NNP O
language NN O
currently RB O
being VBG O
used VBN O
in IN O
several JJ O
minicomputerastronom NN O
applications NNS O
] -RRB- O
, , O
is VBZ O
able JJ O
to TO O
provide VB O
many JJ O
of IN O
the DT O
desirable JJ O
features NNS O
found VBN O
in IN O
both CC O
interpreters NNS O
and CC O
compilers NNS O
by IN O
separating VBG O
the DT O
compile NN O
and CC O
execute VB O
states NNS O
( , O
as IN O
a DT O
compiler NN O
does VBZ O
) -RRB- O
while IN O
maintaining VBG O
a DT O
resident JJ O
user NN O
interactive JJ O
and CC O
conversational JJ O
executive NN O
which WDT O
oversees VBZ O
system NN O
operation NN O
. . O

The DT O
ability NN O
to TO O
realise VB O
such JJ O
advanced JJ O
software NN O
capabilities NNS O
in IN O
a DT O
very RB O
modest JJ O
amount NN O
of IN O
memory NN O
( : O
less JJR O
than IN O
4 CD O
K NN O
bytes NNS O
on IN O
an DT O
8080 CD O
based VBN O
micro NN O
) -RRB- O
is VBZ O
the DT O
direct JJ O
result NN O
of IN O
exploiting VBG O
threaded VBN O
code NN O
programming NN O
techniques NNS O
( , O
see VB O
Figure NNP O
3 CD O
) -RRB- O
. . O

The DT O
approach NN O
involves VBZ O
highly RB O
efficient JJ O
use NN O
of IN O
simple JJ O
macroinstructions NNS O
to TO O
build VB O
more RBR O
complex JJ O
subroutines NNS O
which WDT O
are VBP O
recombined VBN O
with IN O
additional JJ O
macroinstructions NNS O
to TO O
form VB O
super JJ O
subroutines NNS O
. . O

This DT O
process NN O
of IN O
combining VBG O
previously RB O
defined VBN O
modules NNS O
to TO O
form VB O
ever RB O
increasingly RB O
sophisticated JJ O
routines NNS O
for IN O
performing VBG O
the DT O
task NN O
at IN O
hand NN O
is VBZ O
the DT O
essence NN O
of IN O
threaded JJ O
code NN O
programming NN O
. . O

When WRB O
initially RB O
loaded VBN O
and CC O
running VBG O
, , O
CONVERS NNP O
acts VBZ O
much RB O
like IN O
an DT O
interpreter NN O
, , O
i PRP O
. . O
e NFP O
. . O
it PRP O
is VBZ O
conversational JJ O
, , O
ready JJ O
to TO O
either CC O
execute VB O
a DT O
previously RB O
programmed VBN O
algorithm NN O
or CC O
accept VB O
a DT O
new JJ O
one NN O
. . O

However RB O
, , O
in IN O
contrast NN O
to IN O
BASIC NNP O
, , O
when WRB O
a DT O
new JJ O
program NN O
is VBZ O
being VBG O
entered VBN O
under IN O
CONVERS NNP O
, , O
it PRP O
is VBZ O
immediately RB O
transformed VBN O
into IN O
binary JJ O
machine NN O
code NN O
or CC O
to IN O
the DT O
binary JJ O
starting VBG O
addresses NNS O
of IN O
other JJ O
previously RB O
entered VBN O
and CC O
compiled VBN O
machine NN O
code NN O
programs NNS O
. . O

During IN O
this DT O
process NN O
, , O
the DT O
operator NN O
is VBZ O
kept VBN O
informed VBN O
of IN O
the DT O
status NN O
of IN O
the DT O
program NN O
by IN O
a DT O
series NN O
of IN O
error NN O
and CC O
diagnostic JJ O
Volume NN O

messages NNS O
. . O

When WRB O
the DT O
new JJ O
program NN O
has VBZ O
been VBN O
completed VBN O
, , O
it PRP O
is VBZ O
entered VBN O
in IN O
a DT O
program NN O
library NN O
or CC O
dictionary NN O
, , O
which WDT O
is VBZ O
constantly RB O
building VBG O
up RP O
from IN O
low JJ O
memory NN O
( , O
see VB O
Figure NNP O
4 CD O
) -RRB- O
. . O

If IN O
the DT O
operator NN O
now RB O
wants VBZ O
to TO O
execute VB O
this DT O
program NN O
, , O
he PRP O
can MD O
request VB O
it PRP O
from IN O
his PRP$ O
terminal NN O
. . O

A DT O
dictionary JJ O
search NN O
will MD O
begin VB O
at IN O
the DT O
last JJ O
entry NN O
and CC O
progress NN O
until IN O
the DT O
requested VBN O
program NN O
is VBZ O
located VBN O
. . O

Once RB O
located VBN O
, , O
the DT O
requested VBN O
program NN O
will MD O
run VB O
in IN O
its PRP$ O
entirety NN O
without IN O
need NN O
for IN O
any DT O
additional JJ O
dictionary JJ O
searches NNS O
. . O

For IN O
example NN O
, , O
let VB O
us PRP O
assume VB O
an DT O
algorithm NN O
, , O
called VBN O
ACQUIRE NNP O
, , O
has VBZ O
been VBN O
programmed VBN O
to TO O
take VB O
data NNS O
from IN O
some DT O
hypothetical JJ O
experimental JJ O
system NN O
. . O

When WRB O
ACQUIRE NNP O
is VBZ O
requested VBN O
from IN O
the DT O
terminal NN O
, , O
a DT O
dictionary JJ O
search NN O
is VBZ O
initiated VBN O
. . O

The DT O
program NN O
names NNS O
ACQUIRE VBP O
( , O
see VB O
Figure NNP O
5 CD O
) -RRB- O
, , O
once RB O
located VBN O
, , O
contains VBZ O
the DT O
starting VBG O
addresses NNS O
of IN O
a DT O
series NN O
of IN O
previously RB O
defined VBN O
modules NNS O
which WDT O
implement VBP O
the DT O
various JJ O
steps NNS O
necessary JJ O
to TO O
perform VB O
the DT O
desired VBN O
experiment NN O
. . O

For IN O
example NN O
, , O
the DT O
module NN O
SCAN NNP O
which WDT O
might MD O
be VB O
intended VBN O
to TO O
scan VB O
a DT O
monochromator NN O
' '' O
s POS O
wavelength NN O
in IN O
some DT O
desired VBN O
manner NN O
has VBZ O
been VBN O
previously RB O
defined VBN O
and CC O
tested VBN O
. . O

This DT O
ability NN O
to TO O
easily RB O
test VB O
each DT O
module NN O
separately RB O
and CC O
then RB O
efficiently RB O
combine VB O
a DT O
series NN O
of IN O
modules NNS O
to TO O
perform VB O
a DT O
more RBR O
complex JJ O
function NN O
, , O
test VB O
this DT O
function NN O
, , O
and CC O
then RB O
employ VB O
. , O
it PRP O
in IN O
a DT O
vastly RB O
more RBR O
complex JJ O
function NN O
, , O
etc FW O
. . O
, , O
i LS O
. . O
e LS O
. . O
testing VBG O
each DT O
step NN O
as IN O
the DT O
threaded VBN O
code NN O
is VBZ O
made VBN O
increasingly RB O
complex JJ O
, , O
is VBZ O
a DT O
major JJ O
factor NN O
contributing VBG O
to IN O
the DT O
speed NN O
with IN O
which WDT O
software NN O
can MD O
be VB O
developed VBN O
using VBG O
CONVERS NNS O
. . O

Use NN O
of IN O
a DT O
software NN O
stack NN O
also RB O
contributes VBZ O
toward IN O
improved VBN O
memory NN O
efficiency NN O
and CC O
simplified JJ O
programming NN O
. . O

The DT O
stack NN O
is VBZ O
an DT O
area NN O
of IN O
memory NN O
set VBN O
aside RB O
to TO O
handle VB O
parameters NNS O
, , O
data NN O
numbers NNS O
, , O
etc FW O
. . O

One CD O
of IN O
the DT O
primary JJ O
advantages NNS O
of IN O
the DT O
stack NN O
is VBZ O
that IN O
entries NNS O
can MD O
leave VB O
temporary JJ O
parameters NNS O
on IN O
the DT O
stack NN O
without IN O
having VBG O
to TO O
assign VB O
specific JJ O
131 CD O

No UH O
. . O
3 CD O
April NNP O
1979 CD O

Tilden NNP O
& CC O
Denton NNP O

Advanced JJ O
software NN O
concepts NNS O

DUAL JJ O
REGULATED VBN O
POWER NN O
SUPPLY NNP O
I0 NNP O
KV NNP O
I00 CD O

GRATING NN O

PIEZOELECTRIC NNP O
TRANSLATOR NNP O

OP UH O
TOACOUS NNP O
TIC NNP O
CELL NNP O

, , O
. . O
. . O

C02He NNP O
, , O
N2 NNP O

MIRROR NN O
TRANSLATOR NN O

CHOPPER NN O

POWER NN O
DE NNP O
TECTOR NNP O

STEPPER NN O
MOTOR NNP O

DRIVER NN O

ADC NNP O

LOCK NN O
- HYPH O
IN IN O
AMP NN O

CONTROLLER NN O

LOCK NN O
- HYPH O
IN NN O

AMP NNP O

MICROFLOPPY NNP O

DISK NN O
24K CD O
RAM NNP O

1 NFP O

Figure NN O
7 CD O
. . O

The DT O
optoacoustic JJ O
experiment NN O
in IN O
which WDT O
a DT O
microcomputer NN O
is VBZ O
used VBN O
to TO O
control VB O
laser NN O
wavelength NN O
and CC O
to TO O
monitor VB O
laser NN O
power NN O
and CC O
optoacoustic JJ O
signal NN O
. . O

memory NN O
locations NNS O
to TO O
store VB O
them PRP O
. . O

This DT O
not RB O
only RB O
can MD O
save VB O
considerable JJ O
memory NN O
, , O
but CC O
also RB O
allows VBZ O
programs NNS O
to TO O
be VB O
easily RB O
relocatable JJ O
since IN O
one CD O
algorithm NN O
need MD O
only RB O
know VB O
that IN O
a DT O
previous JJ O
routine NN O
left VBD O
so RB O
many JJ O
words NNS O
of IN O
data NNS O
, , O
etc FW O
. . O
on IN O
the DT O
stack NN O
. . O

It PRP O
need VBP O
not RB O
know VB O
where WRB O
the DT O
previous JJ O
routine NN O
is VBZ O
nor CC O
even RB O
where WRB O
the DT O
stack NN O
is VBZ O
located VBN O
. . O

A DT O
series NN O
of IN O
stack NN O
handling NN O
routines NNS O
, , O
which WDT O
should MD O
appear VB O
quite RB O
familiar JJ O
to IN O
many JJ O
small JJ O
calculator NN O
users NNS O
, , O
provide VB O
an DT O
array NN O
of IN O
capabilities NNS O
, , O
including VBG O
the DT O
ability NN O
to TO O
PUSH VB O
a DT O
number NN O
on IN O
the DT O
stack NN O
, , O
POP NN O
, , O
it PRP O
off RB O
, , O
duplicate VB O
it PRP O
, , O
SWAP VB O
the DT O
top JJ O
two CD O
numbers NNS O
, , O
locate VB O
a DT O
number NN O
some DT O
distance NN O
into IN O
the DT O
stack NN O
, , O
and CC O
copy VB O
it PRP O
on IN O
top NN O
of IN O
the DT O
stack NN O
, , O
etc FW O
. . O

Additionally RB O
, , O
a DT O
variety NN O
of IN O
logic JJ O
functions NNS O
familiar JJ O
to IN O
the DT O
minicomputer NN O
user NN O
are VBP O
provided VBN O
including VBG O
OR NNP O
, , O
AND CC O
, , O
shift NN O
left VBN O
, , O
shift NN O
right NN O
, , O
greater JJR O
than IN O
, , O
less JJR O
than IN O
, , O
etc FW O
. . O

Input NN O
/ SYM O
output NN O
( : O
I NNP O
/ SYM O
O NN O
) -RRB- O
is VBZ O
normally RB O
accomplished VBN O
using VBG O
the DT O
stack NN O
in IN O
conjunction NN O
with IN O
the DT O
INDEVICE NN O
or CC O
OUTDEVICE NN O
commands NNS O
. . O

For IN O
example NN O
, , O
to TO O
take VB O
data NNS O
from IN O
a DT O
device NN O
located VBN O
at IN O
I NNP O
/ SYM O
O NNP O
, , O
port NN O
7 CD O
, , O
the DT O
number NN O
seven CD O
is VBZ O
"""" `` O
pushed VBN O
"""" '' O
onto IN O
the DT O
stack NN O
( , O
7 CD O
) -RRB- O
, , O
goes VBZ O
to IN O
this DT O
I NNP O
/ SYM O
O NNP O
port NN O
, , O
takes VBZ O
in RP O
a DT O
number NN O
and CC O
"""" `` O
pushes VBZ O
"""" '' O
the DT O
number NN O
on IN O
the DT O
stack NN O
. . O

OUTDEVICE NNP O
functions NNS O
in IN O
a DT O
similar JJ O
manner NN O
, , O
requiring VBG O
the DT O
number NN O
to TO O
be VB O
sent VBN O
to IN O
the DT O
desired VBN O
device NN O
to TO O
be VB O
"""" `` O
pushed VBN O
"""" '' O
onto IN O
the DT O
stack NN O
followed VBN O
by IN O
the DT O
device NN O
' POS O
s NN O
I NNP O
/ SYM O
O NN O
port NN O
address NN O
. . O

Hence RB O
, , O
to TO O
send VB O
the DT O
number NN O
131 CD O
to IN O
device NN O
11 CD O
, , O
the DT O
number NN O
131 CD O
is VBZ O
pushed VBN O
on IN O
the DT O
stack NN O
followed VBN O
by IN O
11 CD O
and CC O
then RB O
OUTDEVICE NNP O
. . O

This DT O
"""" `` O
pops VBZ O
"""" '' O
the DT O
top JJ O
number NN O
( $ O
11 CD O
) -RRB- O
from IN O
the DT O
stack NN O
, , O
uses VBZ O
it PRP O
as IN O
the DT O
output NN O
port NN O
and CC O
then RB O
sends VBZ O
the DT O
number NN O
131 CD O
to IN O
that DT O
location NN O
. . O

SOUND NN O

BELL NNP O

BELL NNP O

BELL NNP O

The DT O
colon NN O
denotes VBZ O
changing VBG O
from IN O
EXECUTE NN O
to IN O
COMPILE NNP O
mode NN O
. . O

After IN O
typing VBG O
the DT O
name NN O
of IN O
the DT O
new JJ O
routine NN O
, , O
in IN O
this DT O
case NN O
to TO O
be VB O
called VBN O
SOUND NN O
, , O
typing VBG O
the DT O
name NN O
of IN O
the DT O
earlier JJR O
defined VBN O
routine NN O
( : O
BELL NNP O
a DT O
previously RB O
defined VBN O
simple JJ O
program NN O
to TO O
rng VB O
the DT O
terminal NN O
bell NN O
) -RRB- O
initiates VBZ O
a DT O
dictionary JJ O
search NN O
to TO O
locate VB O
this DT O
routine NN O
' '' O
s POS O
starting VBG O
address NN O
which WDT O
subsequentially RB O
is VBZ O
entered VBN O
three CD O
times NNS O
. . O

The DT O
resulting VBG O
SOUND NNP O
routine NN O
contains VBZ O
machine NN O
code NN O
calls NNS O
to IN O
the DT O
BE NNP O
LL NNP O
routine NN O
which WDT O
, , O
itself PRP O
, , O
is VBZ O
composed VBN O
of IN O
machine NN O
code NN O
. . O

Of RB O
course RB O
, , O
SOUND NN O
could MD O
also RB O
have VB O
been VBN O
defined VBN O
using VBG O
a DT O
DO VB O
- HYPH O
LOOP NN O
, , O
i PRP O
. . O
e LS O
. . O
SOUND NN O
3 CD O

DO VB O

BELL NNP O

LOOP VB O

where WRB O
the DT O
numbers NNS O
three CD O
and CC O
one CD O
set VBD O
the DT O
upper JJ O
and CC O
lower JJR O
indices NNS O
. . O

If IN O
it PRP O
were VBD O
desirable JJ O
to TO O
change VB O
the DT O
actual JJ O
number NN O
of IN O
bell NN O
rings NNS O
from IN O
some DT O
other JJ O
program NN O
, , O
this DT O
value NN O
could MD O
be VB O
defined VBN O
as IN O
a DT O
VARIABLE JJ O
let NN O
' '' O
s PRP O
call VB O
it PRP O
NOISE NN O
. . O

3 LS O

VARIABLE JJ O
NOISE NN O

In IN O
this DT O
case NN O
, , O
the DT O
number NN O
three CD O
is VBZ O
first RB O
pushed VBN O
on IN O
the DT O
stack NN O
, , O
VARIABLE NN O
transfers VBZ O
the DT O
top JJ O
number NN O
on IN O
the DT O
stack NN O
( , O
the DT O
three CD O
) -RRB- O
to IN O
a DT O
dictionary JJ O
location NN O
named VBN O
NOISE NNP O
. . O

If IN O
SOUND NNP O
were VBD O
now RB O
defined VBN O
as IN O
: : O
SOUND NN O

NOISE NNP O

@ NFP O

DO VB O

BELL NNP O

LOOP VB O

Applications NNS O
of IN O
CONVERS NNP O
To TO O
appreciate VB O
the DT O
ease NN O
with IN O
which WDT O
real JJ O
programs NNS O
can MD O
be VB O
written VBN O
, , O
a DT O
few JJ O
examples NNS O
will MD O
be VB O
considered VBN O
. . O

A DT O
trivial JJ O
program NN O
, , O
called VBN O
SOUND NNP O
, , O
which WDT O
rings VBZ O
the DT O
terminal JJ O
bell NN O
three CD O
times NNS O
, , O
might MD O
be VB O
written VBN O
: : O
132 CD O

the DT O
bell NN O
would MD O
again RB O
ring VB O
three CD O
times NNS O
. . O

In IN O
this DT O
case NN O
, , O
when WRB O
the DT O
word NN O
NOISE NN O
iS VBZ O
encountered VBN O
, , O
its PRP$ O
address NN O
is VBZ O
pushed VBN O
on IN O
the DT O
stack NN O
, , O
the DT O
@ , O
is VBZ O
a DT O
simple JJ O
program NN O
which WDT O
goes VBZ O
to IN O
the DT O
address NN O
indicated VBN O
on IN O
the DT O
top NN O
of IN O
the DT O
stack NN O
( : O
that DT O
of IN O
NOISE NNP O
) -RRB- O
and CC O
replaces VBZ O
it PRP O
with IN O
the DT O
actual JJ O
value NN O
located VBN O
at IN O
that DT O
address NN O
( , O
the DT O
number NN O
three CD O
) -RRB- O
. . O

At IN O
any DT O
future JJ O
time NN O
, , O
the DT O
value NN O
of IN O
VARIABLE NN O
can MD O
be VB O
changed VBN O
by IN O
"""" `` O
pushing VBG O
"""" '' O
the DT O
new JJ O
value NN O
onto IN O
the DT O
stack NN O
, , O
followed VBN O
by IN O
the DT O
address NN O
of IN O
the DT O
variable NN O
to TO O
be VB O
changed VBN O
, , O
generated VBN O
by IN O
its PRP$ O
name NN O
and CC O
an DT O
exclamation NN O
mark NN O
. . O

To TO O
change VB O
N NN O
O NN O
IS NN O
E NN O
to IN O
5 CD O
, , O
The DT O
Journal NNP O
of IN O
Automatic JJ O
Chemistry NN O

Tilden NNP O
& CC O
Denton NNP O

Advanced JJ O
software NN O
concepts NNS O

5 LS O
NOISE NN O
a DT O
number NN O
five CD O
is VBZ O
pushed VBN O
onto IN O
the DT O
stack NN O
, , O
NOISE NNP O
pushes VBZ O
its PRP$ O
address NN O
on IN O
the DT O
stack NN O
, , O
and CC O
goes VBZ O
to IN O
the DT O
address NN O
indicated VBN O
by IN O
the DT O
"""" `` O
top JJ O
"""" '' O
number NN O
on IN O
the DT O
stack NN O
and CC O
deposits VBZ O
the DT O
next JJ O
number NN O
. . O

Now UH O
sound NN O
would MD O
ring VB O
the DT O
terminal JJ O
bell NN O
five CD O
times NNS O
. . O

A DT O
much RB O
less RBR O
trivial JJ O
program NN O
which WDT O
could MD O
be VB O
written VBN O
to TO O
scan VB O
and CC O
take VB O
data NNS O
from IN O
a DT O
monochromator NN O
equipped VBN O
with IN O
a DT O

DENCO NNP O
SM2A NNP O
stepper NN O
motor NN O
controller NN O
[ -LRB- O
2 CD O
] -RRB- O
( , O
the DT O
SM2A NNP O
takes VBZ O
a DT O
parallel JJ O
number NN O
as IN O
an DT O
address NN O
, , O
sends VBZ O
one CD O
of IN O
two CD O
stepper NN O
motors NNS O
to IN O
this DT O
location NN O
and CC O
outputs VBZ O
an DT O
arrival NN O
flag NN O
when WRB O
the DT O
address NN O
is VBZ O
reached VBN O
) -RRB- O
is VBZ O
given VBN O
in IN O
Figure NNP O
6 CD O
. . O

Assume VB O
that IN O
the DT O
experimental JJ O
system NN O
is VBZ O
configured VBN O
so IN O
the DT O
SM2A NNP O
is VBZ O
at IN O
I NNP O
/ SYM O
O NNP O
, , O
port NN O
5 CD O
and CC O
an DT O
analog NN O
to IN O
digital JJ O
converter NN O
to TO O
acquire VB O
data NNS O
is VBZ O
at IN O
I NNP O
/ SYM O
O NNP O
, , O
port NN O
7 CD O
. . O

Let VB O
us PRP O
assume VB O
that IN O
, , O
initially RB O
, , O
a DT O
scan NN O
is VBZ O
designed VBN O
from IN O
a DT O
starting VBG O
stepper NN O
motor NN O
location NN O
of IN O
2000 CD O
to IN O
a DT O
final JJ O
location NN O
of IN O
5000 CD O
, , O
taking VBG O
data NNS O
every DT O
20 CD O
steps NNS O
. . O

The DT O
program NN O
illustrated VBD O
in IN O
figure NN O
6 CD O
acts NNS O
in IN O
the DT O
following JJ O
manner NN O
. . O

Line NN O
defines VBZ O
a DT O
variable NN O
called VBN O
START NN O
to TO O
be VB O
2000 CD O
, , O
which WDT O
is VBZ O
the DT O
starting VBG O
location NN O
of IN O
fhe DT O
scan NN O
. . O

The DT O
end NN O
of IN O
the DT O
scan NN O
is VBZ O
defined VBN O
as IN O
5000 CD O
in IN O
the DT O
next JJ O
line NN O
. . O

Line NN O
3 CD O
defines VBZ O
the DT O
increment NN O
between IN O
data NNS O
points NNS O
. . O

A DT O
variable NN O
called VBN O
LOCATION NN O
where WRB O
the DT O
. , O
next JJ O
address NN O
is VBZ O
stored VBN O
is VBZ O
defined VBN O
in IN O
line NN O
4 CD O
. . O
. . O

Colon NNP O
, , O
in IN O
line NN O
5 CD O
, , O
puts VBZ O
the DT O
system NN O
in IN O
the DT O
compile NN O
mode NN O
, , O
A NNP O
/ SYM O
D7 NNP O
will MD O
be VB O
the DT O
name NN O
of IN O
the DT O
module NN O
which WDT O
when WRB O
called VBN O
will MD O
cause VB O
a DT O
7 CD O
to TO O
be VB O
pushed VBN O
onto IN O
the DT O
stack NN O
. . O

INDEVICE NN O
will MD O
' `` O
pop VB O
' '' O
it PRP O
back RB O
off RB O
and CC O
use VB O
it PRP O
as IN O
a DT O
device NN O
address NN O
to TO O
go VB O
and CC O
take VB O
a DT O
data NN O
point NN O
and CC O
push VB O
the DT O
data NNS O
onto IN O
the DT O
stack NN O
. . O

Line NN O
6 CD O
defines VBZ O
a DT O
module NN O
INITIALIZE VB O
, , O
START NNP O
puts VBZ O
its PRP$ O
address NN O
on IN O
the DT O
stack NN O
, , O
@ CC O
replaces VBZ O
the DT O
address NN O
with IN O
the DT O
value NN O
at IN O
that DT O
address NN O
, , O
LOCATION NN O
puts VBZ O
its PRP$ O
address NN O
on IN O
the DT O
stack NN O
, , O
' '' O
! . O
' '' O
goes VBZ O
to IN O
the DT O
address NN O
specified VBN O
by IN O
the DT O
number NN O
on IN O
the DT O
stack NN O
and CC O
deposits NNS O
the DT O
second JJ O
number NN O
and CC O
the DT O
net JJ O
result NN O
value NN O
at IN O
START NNP O
is VBZ O
put VBN O
into IN O
LOCATION NNP O
. . O

Line NN O
7 CD O
defines VBZ O
STEP NNP O
to TO O
take VB O
values NNS O
from IN O

LOCATION NN O
and CC O
INCREMENT NNP O
adds VBZ O
them PRP O
together RB O
and CC O
puts VBZ O
the DT O
result NN O
into IN O
LOCATION NN O
, , O
i PRP O
. . O
e ADD O
. . O
LOCATION NN O
puts VBZ O
its PRP$ O
address NN O
on IN O
the DT O
stack NN O
, , O
@ CC O
replaces VBZ O
the DT O
top JJ O
value NN O
on IN O
the DT O
stack NN O
with IN O
the DT O
number NN O
stored VBN O
at IN O
the DT O
address NN O
, , O
INCREMENT NN O
@ CC O
gets VBZ O
the DT O
value NN O
at IN O
INCREMENT NNP O
and CC O
puts VBZ O
it PRP O
in RP O
to IN O
the DT O
stack NN O
, , O
and CC O
adds VBZ O
the DT O
top JJ O
two CD O
stack NN O
numbers NNS O
and CC O
pushes VBZ O
the DT O
result NN O
on IN O
the DT O
stack NN O
. . O

LOCATION NN O
puts VBZ O
its PRP$ O
address NN O
on IN O
the DT O
stack NN O
and CC O
goes VBZ O
to IN O
the DT O
address NN O
specified VBN O
by IN O
the DT O
top JJ O
number NN O
on IN O
the DT O
stack NN O
and CC O
deposits VBZ O
the DT O
second JJ O
number NN O
. . O

Themodule NN O
defined VBN O
in IN O
line NN O
8 CD O
takes VBZ O
a DT O
number NN O
from IN O
the DT O
stepper NN O
motor NN O
controller NN O
( , O
assume NN O
device NN O
numbered VBN O
5 CD O
) -RRB- O
pushes VBZ O
on IN O
the DT O
stack NN O
, , O
and CC O
pushes VBZ O
the DT O
value NN O
10 CD O
on IN O
the DT O
stack NN O
and CC O
does VBZ O
a DT O
logical JJ O
AND CC O
to TO O
see VB O
if IN O
the DT O
controllers NNS O
flag VBP O
is VBZ O
set VBN O
, , O
if IN O
this DT O
is VBZ O
true JJ O
the DT O
A NNP O
/ SYM O
D7 NNP O
module NN O
will MD O
be VB O
called VBN O
to TO O
input VB O
data NNS O
, , O
if IN O
the DT O
flag NN O
is VBZ O
not RB O
set VBN O
, , O
the DT O
program NN O
is VBZ O
returned VBN O
to TO O
BEGIN VB O
- : O
HERE RB O
. . O

Therefore RB O
the DT O
DELAY NNP O
module NN O
is VBZ O
a DT O
loop NN O
waiting VBG O
for IN O
the DT O
stepper NN O
motor NN O
to TO O
arrive VB O
at IN O
its PRP$ O
new JJ O
location NN O
followed VBN O
by IN O
a DT O
call NN O
to IN O
A NNP O
/ SYM O
D7 NNP O
data NN O
acquisition NN O
module NN O
. . O

MOVE NN O
defined VBN O
in IN O
line NN O
9 CD O
gets VBZ O
the DT O
value NN O
stored VBN O
at IN O
LOCATION NN O
pushes VBZ O
the DT O
device NN O
code NN O
onto IN O
the DT O
stack NN O
performs VBZ O
an DT O
outdevice NN O
( : O
which WDT O
uses VBZ O
the DT O
top JJ O
stack NN O
number NN O
as IN O
a DT O
1 CD O
/ SYM O
0 CD O
port NN O
address NN O
to TO O
send VB O
the DT O
next JJ O
value NN O
to TO O
call VB O
the DT O
STEP NNP O
module NN O
( : O
ie IN O
the DT O
value NN O
at IN O
LOCATION NN O
) -RRB- O
, , O
this DT O
increments NNS O
LOCATION NN O
by IN O
the DT O
INCREM NN O
E NN O
N NN O
T NN O
value NN O
and CC O
finally RB O
calls VBZ O
D NNP O
E NNP O
L NNP O
A NNP O
Y NNP O
and CC O
waits VBZ O
for IN O
a DT O
flag NN O
from IN O
the DT O
stepper NN O
motor NN O
controller NN O
to TO O
signal VB O
its PRP$ O
arrival NN O
at IN O
the DT O
desired VBN O
address NN O
and CC O
then RB O
takes VBZ O
a DT O
data NN O
point NN O
. . O

The DT O
final JJ O
line NN O
shown VBN O
in IN O
the DT O
example NN O
Called VBN O
SCAN NNP O
itself PRP O
calls VBZ O
the DT O
INITIALIZE NN O
module NN O
( : O
which WDT O
sets VBZ O
LOCATION NN O
to IN O
the DT O
START NNP O
location NN O
for IN O
the DT O
Scan NNP O
) -RRB- O
it PRP O
also RB O
calls VBZ O
MOVE NNP O
( : O
which WDT O
sends VBZ O
this DT O
value NN O
to IN O
the DT O
motor NN O
LOCATION NN O
controller NN O
, , O
increments NNS O
the DT O
value NN O
stored VBN O
in IN O
LOCATION NN O
by IN O
INCREMENT NNP O
and CC O
calls VBZ O
DELAY NNP O
which WDT O
waits VBZ O
for IN O
the DT O
motor NN O
to TO O
arrive VB O
and CC O
then RB O
takes VBZ O
a DT O
data NN O
point NN O
) NFP O
. . O

Next RB O
the DT O
incremented JJ O
value NN O
from IN O
LOCATION NNP O
is VBZ O
placed VBN O
on IN O
the DT O
stack NN O
( , O
LOCATION NN O
) -RRB- O
followed VBN O
by IN O
the DT O
STOP NNP O

I0 NN O
KW NN O
AMPLIFIER NN O
MATCHING NN O

, , O
NETWORKIS NNP O
PREAMP NNP O

MOTOR NN O
CON NN O
TROL NN O
ER NNP O

MICRODISK NNP O
90K CD O
byte NN O

INTEL NNP O
8080 CD O
based VBN O
MICROCOMPUTER NN O
16K CD O

RAM NNP O

Figure NN O
8 CD O
. . O

A DT O
schematic NN O
of IN O
the DT O
inductively RB O
coupled VBN O
plasma NN O
emission NN O
spectrometer NN O
in IN O
which WDT O
the DT O
microcomputer NN O
is VBZ O
used VBN O
to TO O
control VB O
radio NN O
frequency JJ O
power NN O
and CC O
' `` O
flame NN O
' '' O
positioning NN O
as RB O
well RB O
as IN O
to TO O
monitor VB O
light JJ O
intensity NN O
. . O

Volume NN O

No UH O
. . O
3 CD O
April NNP O
1979 CD O

133 CD O

Tilden NNP O
& CC O
Denton NNP O

Advanced JJ O
software NN O
concepts NNS O

value NN O
( -LRB- O
STOP NNP O
@ CC O
) -RRB- O
, , O
the DT O
two CD O
are VBP O
compared VBN O
to IN O
to TO O
see VB O
if IN O
the DT O
incremented JJ O
value NN O
at IN O
LOCATION NNP O
is VBZ O
larger JJR O
then IN O
the DT O
STOP NNP O
value NN O
, , O
if IN O
it PRP O
is VBZ O
the DT O
program NN O
ends VBZ O
, , O
if IN O
not RB O
, , O
it PRP O
repeats VBZ O
the DT O
process NN O
starting VBG O
at IN O
BEGIN NNP O
- : O
- : O
HERE RB O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
whilst IN O
many JJ O
variables NNS O
have VBP O
been VBN O
pushed VBN O
on IN O
the DT O
stack NN O
, , O
only RB O
the DT O
data NNS O
will MD O
remain VB O
, , O
since IN O
each DT O
time NN O
a DT O
value NN O
is VBZ O
used VBN O
it PRP O
is VBZ O
' `` O
popped VBN O
' '' O
( , O
removed VBN O
) -RRB- O
from IN O
the DT O
stack NN O
. . O

If IN O
a DT O
different JJ O
spectra NN O
region NN O
is VBZ O
to TO O
be VB O
scanned VBN O
i : O
. . O
e LS O
. . O
from IN O
3000 CD O
to IN O
6500 CD O
with IN O
10 CD O
increments NNS O
the DT O
variables NNS O
need MD O
only RB O
be VB O

> XX O

data NN O
acquisition NN O
programs NNS O
have VBP O
been VBN O
easily RB O
implemented VBN O
. . O

Memory NN O
requirements NNS O
and CC O
operating NN O
speed NN O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
far RB O
superior JJ O
to IN O
conventional JJ O
approaches NNS O
. . O

Additionally RB O
, , O
new JJ O
system NN O
users NNS O
have VBP O
encountered VBN O
a DT O
difficulty NN O
in IN O
utilising VBG O
previously RB O
developed VBN O
custom NN O
software NN O
for IN O
a DT O
particular JJ O
experiment NN O
even RB O
when WRB O
documentation NN O
was VBD O
vague JJ O
. . O

Discussion NN O
The DT O
authors NNS O
hope VBP O
that IN O
this DT O
short JJ O
introduction NN O
to IN O
only RB O
a DT O
few JJ O
of IN O
the DT O
concepts NNS O
employed VBN O
in IN O
CONVERS NNP O
will MD O
generate VB O
interest NN O
in IN O
its PRP$ O
capabilities NNS O
. . O

A DT O
much RB O
more RBR O
complete JJ O
discussion NN O
is VBZ O
available JJ O
in IN O
the DT O
form NN O
of IN O
a DT O
user NN O
' '' O
s NNS O
manual JJ O
[ -LRB- O
3 CD O
] -RRB- O
available JJ O
from IN O
the DT O
authors NNS O
. . O

changed VBN O
thus RB O
3000 CD O
START NN O
! . O

6500 CD O
STOP NNP O
10 CD O
INCREMENT NNP O
and CC O
type NN O
SCAN NNP O
, , O
system NN O
will MD O
now RB O
scan VB O
from IN O
3000 CD O
to IN O
6500 CD O
taking VBG O
data NNS O
every DT O
10 CD O
steps NNS O
. . O

While IN O
the DT O
code NN O
might MD O
look VB O
a DT O
little RB O
strange JJ O
at IN O
first RB O
, , O
it PRP O
quickly RB O
becomes VBZ O
very RB O
easy JJ O
to TO O
work VB O
with IN O
. . O

The DT O
SCAN NNP O
program NN O
of IN O
Figure NN O
6 CD O
could MD O
be VB O
combined VBN O
with IN O
other JJ O
modules NNS O
as IN O
shown VBN O
in IN O
Figure NN O
5 CD O
to TO O
perform VB O
some DT O
more RBR O
complex JJ O
experimental JJ O
function NN O
. . O

Each DT O
module NN O
of IN O
the DT O
program NN O
can MD O
be VB O
easily RB O
tried VBN O
out RP O
to TO O
ensure VB O
that IN O
it PRP O
is VBZ O
operational JJ O
before IN O
proceeding VBG O
with IN O
the DT O
next JJ O
. . O

Presently RB O
, , O
CONVERS NNP O
is VBZ O
being VBG O
used VBN O
in IN O
the DT O
authors NNS O
' POS O
laboratories NNS O
for IN O
a DT O
variety NN O
of IN O
spectrochemical JJ O
investigations NNS O
, , O
including VBG O
laser NN O
excited VBN O
optoacoustic JJ O
spectroscopy NN O
( , O
Figure NNP O
7 CD O
) -RRB- O
and CC O
inductively RB O
coupled VBN O
plasma NN O
optical JJ O
emission NN O
spectroscopy NN O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

Rather RB O
complex JJ O
interactive JJ O
control NN O
and CC O

ACKNOWLEDGEMENTS NNS O
The DT O
development NN O
of IN O
the DT O
CONVERS NNP O
system NN O
was VBD O
partially RB O
supported VBN O
by IN O
the DT O
Office NNP O
of IN O
Naval NNP O
Research NNP O
and CC O
a DT O
Alfred NNP O
P NNP O
. . O
Cloan NNP O
Foundation NNP O
Research NNP O
Fellowship NNP O
to IN O
M NNP O
. . O

Bonnet NNP O
Denton NNP O
. . O

REFERENCES NNS O
C VBZ O
. . O

Moore NNP O
, , O
Astronomical NNP O
Astrophysics NNP O
Supplemental NNP O
, , O
15 CD O
, , O
( , O
1974 CD O
) SYM O
497 CD O
. . O

[ -LRB- O
2 LS O
] -RRB- O
M NN O
. . O
B NN O
. . O

Denton NNP O
, , O
J NNP O
. . O
D NNP O
. . O

Mack NNP O
, , O
M NNP O
. . O
W NNP O
. . O

Routh NNP O
and CC O
D NNP O
. . O
B NN O
. . O

SwartzClmerican JJ O

[ -LRB- O
3 LS O
] -RRB- O

Laboratory NN O
, , O
8 CD O
, , O
69 CD O
( SYM O
1976 CD O
) -RRB- O
. . O

CONVERS VBZ O
An DT O
Interpretive NNP O
Compiler NNP O
, , O
developed VBN O
by IN O
Scott NNP O
B NNP O
. . O
Tilden NNP O
and CC O
M NNP O
. . O

Bonner NNP O
Denton NNP O
, , O
Department NNP O
of IN O
Chemistry NNP O
, , O
University NNP O
of IN O
Arizona NNP O
, , O
Tucson NNP O
, , O
Arizona NNP O
85721 CD O
, , O
USA NNP O
. . O

The DT O
use NN O
of IN O
a DT O
microcomputer NN O
for IN O
flexible JJ O
automation NN O
of IN O
a DT O
liquid NN O

chromatograph NN O
A NN O
. . O
D NN O
. . O

Mills NNP O
, , O
i PRP O
. . O

Mackenzie NNP O
and CC O
R NNP O
. . O
J NNP O
. . O

Dolphin NNP O
* CC O
Philips NNP O
Research NNP O
Laboratories NNP O
, , O
Redhill NNP O
, , O
Surrey NNP O
, , O
RH1 NNP O
5HA NNP O
, , O
U NNP O
. . O
K NNP O
. . O

Introduction NN O
Microprocessors NNS O
are VBP O
being VBG O
used VBN O
to TO O
add VB O
inexpensive JJ O
automatic JJ O
control NN O
and CC O
data NNS O
handling NN O
facilities NNS O
to IN O
a DT O
variety NN O
of IN O
chemical JJ O
instruments NNS O
. . O

With IN O
a DT O
microcomputer NN O
it PRP O
is VBZ O
now RB O
possible JJ O
to TO O
realise VB O
the DT O
flexibility NN O
formerly RB O
available JJ O
only RB O
with IN O
a DT O
relatively RB O
large JJ O
and CC O
expensive JJ O
minicomputer NN O
in IN O
an DT O
instrument NN O
little JJ O
different JJ O
in IN O
size NN O
and CC O
cost NN O
from IN O
one CD O
controlled VBN O
by IN O
inflexible JJ O
hardware NN O
. . O

In IN O
many JJ O
ways NNS O
chromatography NN O
is VBZ O
an DT O
ideal JJ O
process NN O
for IN O
such JJ O
automation NN O
. . O

Most JJS O
instruments NNS O
are VBP O
given VBN O
a DT O
high JJ O
workload NN O
and CC O
, , O
although IN O
many JJ O
applications NNS O
may MD O
be VB O
routine JJ O
and CC O
repetitive JJ O
, , O
the DT O
versatility NN O
of IN O
the DT O
technique NN O
requires VBZ O
an DT O
instrument NN O
which WDT O
can MD O
easily RB O
be VB O
used VBN O
in IN O
a DT O
variety NN O
of IN O
modes NNS O
. . O

In IN O
addition NN O
to IN O
improving VBG O
the DT O
convenience NN O
to IN O
the DT O
user NN O
, , O
automation NN O
of IN O
a DT O
liquid JJ O
chromatrograph NN O
should MD O
enhance VB O
the DT O
performance NN O
of IN O
the DT O
instrument NN O
. . O

Some DT O
aspects NNS O
of IN O
high JJ O
performance NN O
liquid NN O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
which WDT O
can MD O
benefit VB O
in IN O
this DT O
way NN O
are VBP O
as IN O
follows VBZ O
: : O
( : O
1 LS O
) -RRB- O
Accurate JJ O
control NN O
of IN O
solvent JJ O
flow NN O
rate NN O
will MD O
compensate VB O
for IN O
changes NNS O
in IN O
pressure NN O
drop NN O
and CC O
lead VB O
to IN O
more RBR O
reliable JJ O
retention NN O
times NNS O
. . O

( : O
2 LS O
) , O
The DT O
composition NN O
of IN O
the DT O
mobile JJ O
phase NN O
can MD O
be VB O
accurately RB O
controlled VBN O
in IN O
either CC O
isocratic JJ O
or CC O
gradient JJ O
elution NN O
chromatography NN O
using VBG O
, , O
for IN O
example NN O
, , O
a DT O
proportioning VBG O
valve NN O
on IN O
the DT O
low JJ O
pressure NN O
side NN O
of IN O
the DT O
pump NN O
. . O

( : O
3 CD O
) SYM O
Automatic JJ O
sampling NN O
can MD O
be VB O
operated VBN O
in IN O
a DT O
variety NN O
of IN O
modes NNS O
to TO O
process VB O
a DT O
number NN O
of IN O
samples NNS O
without IN O
supervision NN O
. . O

It PRP O
is VBZ O
also RB O
more RBR O
precise JJ O
than IN O
manual JJ O
injection NN O
. . O

( : O
4 CD O
) SYM O
A DT O
built VBN O
- HYPH O
in RP O
data NN O
handling NN O
facility NN O
can MD O
present VB O
the DT O
analyst NN O
with IN O
an DT O
easily RB O
read VBN O
post NN O
- HYPH O
run VBN O
report NN O
of IN O
the DT O
analytical JJ O
results NNS O
with IN O
accurate JJ O
peak NN O
area NN O
measurements NNS O
even RB O
for IN O
peaks NNS O
which WDT O
are VBP O
poorly RB O
resolved VBN O
. . O

Although IN O
liquid JJ O
chromatographs NNS O
incorporating VBG O
microprocessors NNS O
for IN O
control NN O
and CC O
data NN O
handling NN O
purposes NNS O
are VBP O
commercially RB O
available JJ O
, , O
these DT O
instruments NNS O
are VBP O
, , O
so RB O
far RB O
, , O
This DT O
paper NN O
describes VBZ O
, , O
in IN O
detail NN O
, , O
the DT O
relatively RB O
inflexible JJ O
. , O
automation NN O
of IN O
a DT O
liquid JJ O
chromatograph NN O
using VBG O
an DT O
inexpensive JJ O
general JJ O
purpose NN O
microcomputer NN O
, , O
which WDT O
has VBZ O
previously RB O
been VBN O
applied VBN O
in IN O
atomic JJ O
absorption NN O
spectrophotometry NN O
[ -LRB- O
1 CD O
] -RRB- O
and CC O
for IN O
column NN O
switching NN O
in IN O
HPLC NNP O
2 CD O
] -RRB- O
. . O

Figure NN O
illustrates VBZ O
the DT O
interconnection NN O
of IN O
the DT O
chromatograph NN O
and CC O
the DT O
microcomputer NN O
which WDT O
controls VBZ O
the DT O
mobile JJ O
phase NN O
flow NN O
rate NN O
, , O
operates VBZ O
an DT O
automatic JJ O
sampler NN O
and CC O
analyses VBZ O
data NNS O
from IN O
the DT O
detector NN O
. . O

The DT O
control NN O
and CC O
data NN O
handling NN O
functions NNS O
are VBP O
integrated VBN O
in IN O
a DT O
program NN O
which WDT O
enables VBZ O
the DT O
user NN O
to TO O
communicate VB O
with IN O
the DT O
instrument NN O
, , O
in IN O
plain JJ O
English NNP O
, , O
via IN O
a DT O
visual JJ O
display NN O
unit NN O
( : O
VDU NNP O
) -RRB- O
or CC O
teletypewriter NN O
keyboard NN O
. . O

A DT O
variety NN O
of IN O
operational JJ O
modes NNS O
is VBZ O
offered VBN O
, , O
giving VBG O
the DT O
analyst NN O
an DT O
opportunity NN O
to TO O
establish VB O
the DT O
best JJS O
conditions NNS O
for IN O
a DT O
particular JJ O
separation NN O
before IN O
leaving VBG O
the DT O
instrument NN O
to TO O
perform VB O
its PRP$ O
given VBN O
tasks NNS O
without IN O
further JJ O
interaction NN O
. . O

The DT O
microcomputer NN O
Hardware NNP O
The DT O
computer NN O
is VBZ O
a DT O
general JJ O
purpose NN O
instrument NN O
constructed VBN O
using VBG O
a DT O
set NN O
of IN O
ready JJ O
made VBN O
circuit NN O
cards NNS O
( , O
Philips NNP O
, , O
Science NNP O
and CC O
The DT O
Journal NNP O
of IN O
Automatic NNP O
Chemistry NNP O

* NFP O
Present JJ O
address NN O
: : O
lye NNP O
Unicam NNP O
Ltd NNP O
. . O
, , O
York NNP O
Street NNP O
, , O
Cambridge NNP O
, , O
CB1 NNP O
2PX NNP O
, , O
U NNP O
. . O
K NNP O
. . O

134 CD O

TOPS NNS O
+ CC O
+ NFP O
FATCAT NN O
: : O
Fast JJ O
flexible JJ O
structural JJ O
alignment NN O
using VBG O
constraints NNS O
derived VBN O
from IN O
TOPS NNS O
+ SYM O
Strings NNS O
Model NNP O

Abstract JJ O

Background NN O

Protein NN O
structure NN O
analysis NN O
and CC O
comparison NN O
are VBP O
major JJ O
challenges NNS O
in IN O
structural JJ O
bioinformatics NNS O
. . O

Despite IN O
the DT O
existence NN O
of IN O
many JJ O
tools NNS O
and CC O
algorithms NNS O
, , O
very RB O
few JJ O
of IN O
them PRP O
have VBP O
managed VBN O
to TO O
capture VB O
the DT O
intuitive JJ O
understanding NN O
of IN O
protein NN O
structures NNS O
developed VBN O
in IN O
structural JJ O
biology NN O
, , O
especially RB O
in IN O
the DT O
context NN O
of IN O
rapid JJ O
database NN O
searches NNS O
. . O

Such JJ O
intuitions NNS O
could MD O
help VB O
speed VB O
up RP O
similarity NN O
searches NNS O
and CC O
make VB O
it PRP O
easier JJR O
to TO O
understand VB O
the DT O
results NNS O
of IN O
such JJ O
analyses NNS O
. . O

Results NNS O

We PRP O
developed VBD O
a DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
algorithm NN O
that WDT O
uses VBZ O
an DT O
intuitive JJ O
description NN O
of IN O
the DT O
proteins NNS O
' POS O
structures NNS O
as IN O
captured VBN O
in IN O
the DT O
popular JJ O
TOPS NNP O
diagrams NNS O
to TO O
limit VB O
the DT O
search NN O
space NN O
of IN O
the DT O
aligned VBN O
fragment NN O
pairs NNS O
( , O
AFPs NNS O
) -RRB- O
in IN O
the DT O
flexible JJ O
alignment NN O
of IN O
protein NN O
structures NNS O
performed VBN O
by IN O
the DT O
FATCAT NNP O
algorithm NN O
. . O

The DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
algorithm NN O
is VBZ O
faster JJR O
than IN O
FATCAT NNP O
by IN O
more JJR O
than IN O
an DT O
order NN O
of IN O
magnitude NN O
with IN O
a DT O
minimal JJ O
cost NN O
in IN O
classification NN O
and CC O
alignment NN O
accuracy NN O
. . O

For IN O
beta JJ O
- HYPH O
rich JJ O
proteins NNS O
its PRP$ O
accuracy NN O
is VBZ O
better JJR O
than IN O
FATCAT NNP O
, , O
because IN O
the DT O
TOPS NNS O
+ CC O
strings NNS O
models NNS O
contains VBZ O
important JJ O
information NN O
of IN O
the DT O
parallel JJ O
and CC O
anti JJ O
- HYPH O
parallel JJ O
hydrogen NN O
- HYPH O
bond NN O
patterns NNS O
between IN O
the DT O
beta NN O
- HYPH O
strand NN O
SSEs NNPS O
( -LRB- O
Secondary NNP O
Structural NNP O
Elements NNPS O
) -RRB- O
. . O

We PRP O
show VBP O
that IN O
the DT O
TOPS NNS O
+ SYM O
+ SYM O
FATCAT NNP O
errors NNS O
, , O
rare JJ O
as IN O
they PRP O
are VBP O
, , O
can MD O
be VB O
clearly RB O
linked VBN O
to IN O
oversimplifications NNS O
of IN O
the DT O
TOPS NNP O
diagrams NNS O
and CC O
can MD O
be VB O
corrected VBN O
by IN O
the DT O
development NN O
of IN O
more RBR O
precise JJ O
secondary JJ O
structure NN O
element NN O
definitions NNS O
. . O

Software NNP O
Availability NNP O

The DT O
benchmark JJ O
analysis NN O
results NNS O
and CC O
the DT O
compressed JJ O
archive NN O
of IN O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
program NN O
for IN O
Linux NNP O
platform NN O
can MD O
be VB O
downloaded VBN O
from IN O
the DT O
following VBG O
web NN O
site NN O
: : O

Conclusion NN O

TOPS NNS O
+ CC O
+ NFP O
FATCAT NNP O
provides VBZ O
FATCAT NNP O
accuracy NN O
and CC O
insights NNS O
into IN O
protein NN O
structural JJ O
changes NNS O
at IN O
a DT O
speed NN O
comparable JJ O
to IN O
sequence NN O
alignments NNS O
, , O
opening VBG O
up RP O
a DT O
possibility NN O
of IN O
interactive JJ O
protein NN O
structure NN O
similarity NN O
searches NNS O
. . O

Background NN O

Structural JJ O
biology NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
successful JJ O
fields NNS O
of IN O
modern JJ O
biology NN O
. . O

Over IN O
50 CD O
, , O
0 CD O
solved VBN O
protein NN O
structures NNS O
illustrate VBP O
details NNS O
of IN O
many JJ O
specific JJ O
biological JJ O
processes NNS O
. . O

The DT O
same JJ O
data NNS O
also RB O
provide VBP O
us PRP O
with IN O
information NN O
about IN O
the DT O
global JJ O
features NNS O
of IN O
protein NN O
structure NN O
space NN O
and CC O
can MD O
be VB O
studied VBN O
to TO O
discover VB O
the DT O
evolutionary JJ O
, , O
physical JJ O
, , O
and CC O
mathematical JJ O
rules NNS O
governing VBG O
them PRP O
. . O

How WRB O
many JJ O
fundamentally RB O
different JJ O
protein NN O
shapes NNS O
( -LRB- O
folds NNS O
) -RRB- O
are VBP O
there RB O
? . O

How WRB O
do VBP O
protein NN O
structures NNS O
evolve VB O
? . O

How WRB O
do VBP O
new JJ O
structural JJ O
features NNS O
appear VB O
, , O
and CC O
if IN O
they PRP O
are VBP O
coupled VBN O
with IN O
changes NNS O
in IN O
function NN O
, , O
how WRB O
does VBZ O
this DT O
process NN O
occur VB O
? . O

Such JJ O
questions NNS O
can MD O
be VB O
studied VBN O
by IN O
classifying VBG O
, , O
comparing VBG O
and CC O
analyzing VBG O
known VBN O
protein NN O
structures NNS O
. . O

Two CD O
different JJ O
, , O
but CC O
synergistic JJ O
strategies NNS O
are VBP O
typically RB O
used VBN O
for IN O
this DT O
purpose NN O
. . O

In IN O
classification NN O
systems NNS O
such JJ O
as IN O
SCOP NNP O
[ -LRB- O
1 CD O
] -RRB- O
or CC O
CATH NN O
[ -LRB- O
2 CD O
] -RRB- O
, , O
human JJ B-Species
intuition NN O
is VBZ O
used VBN O
to TO O
simplify VB O
the DT O
description NN O
of IN O
protein NN O
structures NNS O
to IN O
a DT O
manageable JJ O
size NN O
, , O
and CC O
a DT O
human JJ B-Species
eye NN O
, , O
sometimes RB O
supported VBN O
by IN O
automated JJ O
analysis NN O
, , O
can MD O
recognize VB O
patterns NNS O
and CC O
types NNS O
of IN O
structures NNS O
. . O

In IN O
the DT O
second JJ O
approach NN O
, , O
specialized JJ O
comparison NN O
algorithms NNS O
, , O
such JJ O
as IN O
DALI NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
CE NNP O
[ -LRB- O
4 CD O
] -RRB- O
, , O
or CC O
FATCAT NNP O
[ -LRB- O
5 CD O
] -RRB- O
can MD O
be VB O
used VBN O
to TO O
calculate VB O
a DT O
distance NN O
- HYPH O
like JJ O
metric NN O
in IN O
the DT O
protein NN O
structure NN O
space NN O
. . O

This DT O
in IN O
turn NN O
can MD O
be VB O
used VBN O
to TO O
cluster VB O
proteins NNS O
into IN O
groups NNS O
. . O

Many JJ O
such JJ O
algorithms NNS O
have VBP O
been VBN O
developed VBN O
over IN O
the DT O
past JJ O
few JJ O
decades NNS O
and CC O
have VBP O
been VBN O
mostly RB O
used VBN O
for IN O
the DT O
classification NN O
of IN O
protein NN O
structures NNS O
into IN O
families NNS O
. . O

An DT O
exact JJ O
solution NN O
of IN O
an DT O
alignment NN O
between IN O
two CD O
structures NNS O
is VBZ O
formally RB O
equivalent JJ O
to IN O
a DT O
threading NN O
problem NN O
and CC O
is VBZ O
therefore RB O
NP NNP O
- HYPH O
complete JJ O
[ -LRB- O
6 CD O
] -RRB- O
. . O

However RB O
, , O
a DT O
practical JJ O
solution NN O
can MD O
be VB O
obtained VBN O
by IN O
heuristics NNS O
reducing VBG O
the DT O
problem NN O
to IN O
a DT O
manageable JJ O
size NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
human JJ B-Species
classification NN O
systems NNS O
, , O
the DT O
protein NN O
is VBZ O
usually RB O
reduced VBN O
to IN O
a DT O
set NN O
of IN O
several JJ O
structural JJ O
elements NNS O
, , O
which WDT O
obviously RB O
involve VBP O
many JJ O
arbitrary JJ O
thresholds NNS O
. . O

Automated JJ O
algorithms NNS O
have VBP O
the DT O
same JJ O
problem NN O
and CC O
also RB O
suffer VBP O
from IN O
inconsistencies NNS O
between IN O
different JJ O
numerical JJ O
measures NNS O
of IN O
protein NN O
structure NN O
similarity NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
despite IN O
these DT O
problems NNS O
, , O
results NNS O
of IN O
different JJ O
approaches NNS O
are VBP O
broadly RB O
similar JJ O
. . O

They PRP O
all DT O
identify VBP O
approximately RB O
a DT O
few JJ O
hundred CD O
general JJ O
classes NNS O
of IN O
protein NN O
structures NNS O
, , O
usually RB O
called VBN O
folds NNS O
[ -LRB- O
1 CD O
] -RRB- O
or CC O
topologies NNS O
[ -LRB- O
2 CD O
] -RRB- O
, , O
distinguished VBN O
by IN O
how WRB O
the DT O
main JJ O
chain NN O
of IN O
the DT O
protein NN O
folds VBZ O
around IN O
itself PRP O
in IN O
the DT O
three CD O
- HYPH O
dimensional JJ O
space NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
the DT O
comparison NN O
of IN O
different JJ O
approaches NNS O
, , O
both CC O
between IN O
and CC O
within IN O
the DT O
two CD O
classes NNS O
, , O
shows VBZ O
that IN O
fold NN O
/ SYM O
topologies NNS O
( , O
or CC O
cluster NN O
) -RRB- O
definitions NNS O
are VBP O
somewhat RB O
fuzzy JJ O
, , O
with IN O
some DT O
proteins NNS O
being VBG O
occasionally RB O
difficult JJ O
to TO O
classify VB O
and CC O
joining VBG O
different JJ O
groups NNS O
depending VBG O
on IN O
various JJ O
assumptions NNS O
. . O

This DT O
lead VBP O
some DT O
to TO O
question VB O
the DT O
concept NN O
of IN O
the DT O
fold NN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
but CC O
practical JJ O
application NN O
of IN O
protein NN O
structure NN O
comparison NN O
leaves VBZ O
little JJ O
doubt NN O
that IN O
protein NN O
structure NN O
space NN O
has VBZ O
some DT O
natural JJ O
granularity NN O
that WDT O
overlaps VBZ O
well RB O
with IN O
the DT O
traditional JJ O
fold NN O
classification NN O
. . O

Comparison NN O
and CC O
classification NN O
of IN O
protein NN O
structures NNS O
is VBZ O
significantly RB O
simplified VBN O
by IN O
the DT O
fact NN O
that IN O
proteins NNS O
have VBP O
naturally RB O
modular JJ O
structures NNS O
, , O
being VBG O
mostly RB O
composed VBN O
of IN O
locally RB O
regular JJ O
structures NNS O
: : O
alpha NN O
helices NNS O
and CC O
beta NN O
strands NNS O
. . O

These DT O
two CD O
types NNS O
of IN O
secondary JJ O
structures NNS O
constitute VBP O
a DT O
little JJ O
over IN O
50 CD O
% NN O
of IN O
an DT O
average JJ O
protein NN O
' '' O
s NN O
length NN O
. . O

With IN O
the DT O
average JJ O
length NN O
of IN O
a DT O
secondary JJ O
structure NN O
being VBG O
around RB O
10 CD O
amino NN O
acids NNS O
, , O
this DT O
makes VBZ O
it PRP O
possible JJ O
to TO O
describe VB O
protein NN O
structure NN O
as IN O
an DT O
arrangement NN O
of IN O
a DT O
much RB O
smaller JJR O
number NN O
of IN O
elements NNS O
. . O

Protein NN O
structures NNS O
are VBP O
often RB O
visualized VBN O
in IN O
a DT O
simplified JJ O
form NN O
, , O
with IN O
the DT O
so RB O
- HYPH O
called VBN O
ribbon NN O
diagram NN O
with IN O
secondary JJ O
structures NNS O
shown VBN O
as IN O
helices NNS O
and CC O
arrows NNS O
being VBG O
the DT O
most RBS O
popular JJ O
( , O
see VB O
Figure NNP O
1 CD O
) -RRB- O
. . O

This DT O
picture NN O
can MD O
be VB O
simplified VBN O
further RBR O
by IN O
showing VBG O
individual JJ O
secondary JJ O
structure NN O
elements NNS O
as IN O
simple JJ O
symbols NNS O
( , O
circles NNS O
or CC O
boxes NNS O
/ SYM O
triangles NNS O
) -RRB- O
. . O

These DT O
depictions NNS O
, , O
called VBN O
fold NN O
diagrams NNS O
, , O
originally RB O
proposed VBN O
in IN O
the DT O
70s NNS O
[ -LRB- O
10 CD O
- HYPH O
12 CD O
] -RRB- O
are VBP O
best RBS O
captured VBN O
by IN O
a DT O
TOPS NNP O
( , O
Topology NNP O
of IN O
Protein NNP O
Structures NNPS O
) , O
algorithm NN O
, , O
which WDT O
attempts VBZ O
to TO O
automate VB O
the DT O
process NN O
of IN O
creation NN O
of IN O
the DT O
topology NN O
cartoon NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

While IN O
useful JJ O
in IN O
protein NN O
classification NN O
, , O
such JJ O
simplified JJ O
descriptions NNS O
are VBP O
not RB O
used VBN O
in IN O
the DT O
most RBS O
popular JJ O
automated JJ O
protein NN O
structure NN O
comparison NN O
algorithms NNS O
such JJ O
as IN O
DALI NNP O
[ -LRB- O
3 CD O
] -RRB- O
or CC O
CE NNP O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Kleywegt NNP O
and CC O
Jones NNP O
developed VBD O
a DT O
method NN O
for IN O
finding VBG O
similar JJ O
motifs NNS O
based VBN O
on IN O
comparing VBG O
distance NN O
matrices NNS O
that WDT O
are VBP O
constructed VBN O
by IN O
representing VBG O
protein NN O
as IN O
a DT O
set NN O
of IN O
SSEs NNPS O
with IN O
their PRP$ O
directional JJ O
vectors NNS O
and CC O
angle NN O
between IN O
those DT O
vectors NNS O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Programs NNS O
that WDT O
used VBD O
SSEs NNS O
either CC O
for IN O
structure NN O
comparison NN O
based VBN O
on IN O
hierarchical JJ O
superposition NN O
of IN O
both CC O
SSEs NNS O
and CC O
atomic JJ O
representation NN O
[ -LRB- O
15 CD O
] -RRB- O
or CC O
for IN O
finding VBG O
common JJ O
substructures NNS O
in IN O
the DT O
comparison NN O
process NN O
based VBN O
on IN O
subgraph NN O
isomorphism NN O
, , O
such JJ O
as IN O
[ -LRB- O
16 CD O
, , O
17 CD O
] -RRB- O
and CC O
recent JJ O
applications NNS O
of IN O
the DT O
TOPS NNP O
diagram NN O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
, , O
usually RB O
struggle VBP O
with IN O
translating VBG O
the DT O
comparison NN O
results NNS O
from IN O
the DT O
secondary JJ O
structure NN O
to IN O
the DT O
individual JJ O
residue NN O
level NN O
. . O

Although IN O
the DT O
SSM NNP O
method NN O
uses VBZ O
graph NN O
- HYPH O
matching VBG O
procedures NNS O
at IN O
the DT O
SSE NNP O
level NN O
followed VBN O
by IN O
an DT O
interactive JJ O
3D JJ O
alignment NN O
of IN O
the DT O
protein NN O
C NN O
- HYPH O
alpha NN O
atom NN O
[ -LRB- O
20 CD O
] -RRB- O
, , O
it PRP O
lacks VBZ O
the DT O
topological JJ O
relationships NNS O
between IN O
the DT O
SSEs NNS O
, , O
which WDT O
are VBP O
essential JJ O
features NNS O
in IN O
identifying VBG O
common JJ O
scaffolds NNS O
in IN O
distantly RB O
related VBN O
proteins NNS O
. . O

A DT O
TOPS NNP O
pattern NN O
was VBD O
used VBN O
to TO O
guide VB O
the DT O
sequence NN O
alignment NN O
, , O
for IN O
instance NN O
, , O
to TO O
build VB O
multiple JJ O
structural JJ O
alignments NNS O
of IN O
the DT O
distantly RB O
related VBN O
family NN O
of IN O
beta JJ O
- HYPH O
rich JJ O
protein NN O
domains NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

The DT O
Multiple NNP O
Sequence NNP O
Alignment NNP O
Tool NNP O
( : O
MSAT NNP O
) -RRB- O
automates VBZ O
this DT O
approach NN O
, , O
merging VBG O
it PRP O
with IN O
a DT O
popular JJ O
ClustalW NNP O
program NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

DALI NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
CE NNP O
[ -LRB- O
4 CD O
] -RRB- O
or CC O
FATCAT NNP O
[ -LRB- O
5 CD O
] -RRB- O
introduce VBP O
their PRP$ O
own JJ O
methods NNS O
of IN O
decomposing VBG O
the DT O
protein NN O
structure NN O
into IN O
smaller JJR O
units NNS O
, , O
such JJ O
as IN O
7 CD O
x SYM O
7 CD O
dense JJ O
distance NN O
map NN O
fragments NNS O
( , O
DALIs NNP O
) -RRB- O
or CC O
aligned VBN O
fragment NN O
pairs NNS O
( , O
AFPs NNS O
) -RRB- O
( , O
CE NN O
and CC O
FATCAT NNP O
) -RRB- O
. . O

The DT O
large JJ O
number NN O
of IN O
such JJ O
fragments NNS O
and CC O
the DT O
combinations NNS O
of IN O
the DT O
fragments NNS O
that WDT O
need VBP O
to TO O
be VB O
evaluated VBN O
by IN O
structure NN O
comparison NN O
programs NNS O
is VBZ O
the DT O
main JJ O
reason NN O
for IN O
the DT O
significant JJ O
computational JJ O
requirements NNS O
of IN O
such JJ O
algorithms NNS O
. . O

However RB O
, , O
more RBR O
importantly RB O
, , O
TOPS NNP O
+ CC O
method NN O
is VBZ O
used VBN O
here RB O
to TO O
enable VB O
a DT O
structural JJ O
comparison NN O
that WDT O
takes VBZ O
into IN O
account NN O
flexibility NN O
in IN O
protein NN O
structures NNS O
and CC O
not RB O
only RB O
classifies VBZ O
the DT O
differences NNS O
, , O
but CC O
also RB O
can MD O
recognize VB O
such JJ O
rearrangements NNS O
- , O
which WDT O
is VBZ O
a DT O
first JJ O
such JJ O
application NN O
using VBG O
the DT O
SSEs NNP O
language NN O
. . O

In IN O
this DT O
contribution NN O
, , O
we PRP O
explore VBP O
the DT O
question NN O
of IN O
whether IN O
it PRP O
would MD O
be VB O
possible JJ O
to TO O
combine VB O
insights NNS O
provided VBN O
by IN O
topology NN O
diagrams NNS O
into IN O
automated JJ O
protein NN O
structure NN O
alignment NN O
algorithms NNS O
, , O
focusing VBG O
on IN O
the DT O
FATCAT NNP O
program NN O
developed VBN O
previously RB O
in IN O
our PRP$ O
group NN O
. . O

Methods NNS O

Flexible JJ O
structure NN O
alignment NN O
method NN O
FATCAT NNP O

FATCAT NNP O
[ -LRB- O
5 CD O
] -RRB- O
is VBZ O
a DT O
unique JJ O
structure NN O
alignment NN O
method NN O
that WDT O
allows VBZ O
for IN O
flexibility NN O
in IN O
the DT O
structures NNS O
being VBG O
compared VBN O
. . O

It PRP O
builds VBZ O
the DT O
alignment NN O
by IN O
chaining VBG O
aligned VBN O
fragment NN O
pairs NNS O
( , O
AFPs NNS O
) -RRB- O
[ -LRB- O
23 CD O
] -RRB- O
together RB O
using VBG O
a DT O
unified JJ O
scoring NN O
function NN O
where WRB O
AFP NNP O
extensions NNS O
, , O
gaps NNS O
, , O
and CC O
twists NNS O
each DT O
have VBP O
their PRP$ O
specific JJ O
scores NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Introducing VBG O
a DT O
twist NN O
into IN O
the DT O
alignment NN O
is VBZ O
penalized VBN O
, , O
but CC O
this DT O
penalty NN O
may MD O
be VB O
compensated VBN O
for IN O
by IN O
the DT O
gain NN O
in IN O
the DT O
score NN O
of IN O
the DT O
resulting VBG O
alignment NN O
( : O
i LS O
. . O
e LS O
. . O
, , O
longer JJR O
alignment NN O
and CC O
/ SYM O
or CC O
better JJR O
RMSD NN O
) -RRB- O
. . O

Rigid JJ O
alignment NN O
can MD O
be VB O
treated VBN O
as IN O
a DT O
special JJ O
case NN O
, , O
in IN O
which WDT O
no DT O
twist NN O
is VBZ O
allowed VBN O
in IN O
chaining VBG O
AFPs NNS O
. . O

FATCAT NNP O
program NN O
provides VBZ O
alignment NN O
in IN O
both DT O
, , O
"""" `` O
rigid JJ O
"""" '' O
mode NN O
and CC O
"""" `` O
flexible JJ O
"""" '' O
( , O
default NN O
) -RRB- O
mode NN O
. . O

FATCAT NNP O
, , O
as RB O
well RB O
as IN O
most JJS O
other JJ O
protein NN O
structure NN O
comparison NN O
programs NNS O
, , O
is VBZ O
very RB O
slow JJ O
when WRB O
compared VBN O
to IN O
sequence NN O
alignments NNS O
. . O

The DT O
computing NN O
time NN O
of IN O
FATCAT NNP O
is VBZ O
determined VBN O
by IN O
the DT O
size NN O
of IN O
the DT O
collection NN O
of IN O
AFPs NNS O
detected VBN O
between IN O
the DT O
two CD O
structures NNS O
being VBG O
compared VBN O
. . O

FATCAT NNP O
is VBZ O
available JJ O
from IN O
a DT O
server NN O
with IN O
an DT O
option NN O
to TO O
search VB O
in IN O
SCOP NNP O
or CC O
PDB NNP O
databases NNS O
for IN O
similar JJ O
structures NNS O
. . O

This DT O
search NN O
typically RB O
takes VBZ O
between IN O
8 CD O
to TO O
16 CD O
hours NNS O
of IN O
CPU NN O
time NN O
, , O
and CC O
this DT O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
broader JJR O
use NN O
of IN O
this DT O
option NN O
. . O

FATCAT NNP O
has VBZ O
been VBN O
used VBN O
to TO O
construct VB O
a DT O
Flexible NNP O
Structure NNP O
Neighborhood NNP O
( , O
FSN NNP O
) -RRB- O
database NN O
that WDT O
contains VBZ O
pre NN O
- HYPH O
computed VBN O
results NNS O
of IN O
structure NN O
similarity NN O
searches NNS O
and CC O
it PRP O
takes VBZ O
several JJ O
weeks NNS O
of IN O
CPU NN O
time NN O
to TO O
update VB O
the DT O
FSN NNP O
database NN O
. . O

Other JJ O
protein NN O
structure NN O
comparison NN O
resources NNS O
, , O
such JJ O
as IN O
DALI NNP O
or CC O
CE NNP O
have VBP O
very RB O
similar JJ O
problems NNS O
. . O

TOPS NNP O
cartoons NNS O
and CC O
TOPS NNP O
graph NN O
models NNS O

As IN O
discussed VBN O
in IN O
the DT O
Background NNP O
, , O
TOPS NNP O
cartoons NNS O
capture VBP O
the DT O
simplified JJ O
, , O
fold JJ O
- HYPH O
level NN O
description NN O
of IN O
protein NN O
structure NN O
and CC O
at IN O
the DT O
same JJ O
time NN O
can MD O
be VB O
automated VBN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

The DT O
TOPS NNP O
algorithm NN O
uses VBZ O
structural JJ O
features NNS O
such JJ O
as IN O
hydrogen NN O
bonds NNS O
and CC O
chirality NN O
of IN O
the DT O
beta NN O
strands NNS O
to TO O
provide VB O
a DT O
scoring NN O
function NN O
to TO O
optimize VB O
the DT O
cartoon NN O
( , O
see VB O
Figure NN O
1 CD O
( SYM O
b LS O
) -RRB- O
) -RRB- O
. . O

In IN O
TOPS NNP O
, , O
the DT O
secondary JJ O
structural JJ O
elements NNS O
( , O
SSEs NNPS O
) -RRB- O
are VBP O
derived VBN O
from IN O
the DT O
DSSP NNP O
program NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Based VBN O
on IN O
TOPS NNP O
cartoons NNS O
, , O
a DT O
formal JJ O
graph NN O
model NN O
and CC O
graph NN O
- HYPH O
based VBN O
definitions NNS O
of IN O
protein NN O
topology NN O
and CC O
pattern NN O
discovery NN O
and CC O
comparison NN O
methods NNS O
were VBD O
developed VBN O
[ -LRB- O
26 CD O
, , O
27 CD O
] -RRB- O
. . O

The DT O
TOPS NNP O
database NN O
and CC O
comparison NN O
, , O
pattern NN O
discovery NN O
and CC O
matching NN O
programs NNS O
are VBP O
accessible JJ O
from IN O
. . O

Novel NNP O
TOPS NNP O
+ SYM O
and CC O
TOPS NNS O
+ SYM O
strings NNS O
models NNS O

The DT O
TOPS NNP O
model NN O
was VBD O
further RBR O
enhanced VBN O
to TO O
incorporate VB O
features NNS O
such JJ O
as IN O
protein NN O
- HYPH O
ligand NN O
interaction NN O
information NN O
and CC O
more RBR O
detailed JJ O
secondary JJ O
structural JJ O
segment NN O
information NN O
. . O

This DT O
enhanced VBN O
model NN O
is VBZ O
called VBN O
TOPS NNP O
+ SYM O
model NN O
( , O
see VB O
Figure NNP O
3a CD O
) -RRB- O
. . O

This DT O
TOPS NNP O
+ NN O
model NN O
can MD O
be VB O
described VBN O
formally RB O
in IN O
a DT O
TOPS NNP O
+ SYM O
strings NNS O
language NN O
( -LRB- O
Figure NNP O
3b NN O
) -RRB- O
at IN O
a DT O
reduced VBN O
linear JJ O
level NN O
. . O

The DT O
enhanced JJ O
TOPS NNS O
+ SYM O
strings NNS O
models NNS O
can MD O
be VB O
used VBN O
in IN O
fast JJ O
string NN O
- HYPH O
based VBN O
structure NN O
matching NN O
and CC O
comparison NN O
, , O
at IN O
the DT O
same JJ O
time NN O
avoiding VBG O
issues NNS O
of IN O
NP NNP O
- HYPH O
completeness NN O
associated VBN O
with IN O
graph NN O
alignments NNS O
. . O

In IN O
detail NN O
, , O
each DT O
node NN O
( -LRB- O
SSE NNP O
segment NN O
) -RRB- O
of IN O
the DT O
TOPS NNP O
+ CC O
strings NNS O
is VBZ O
described VBN O
by IN O
its PRP$ O
type NN O
, , O
orientation NN O
, , O
PDB NN O
start NN O
number NN O
, , O
segment NN O
length NN O
, , O
total JJ O
number NN O
of IN O
incoming JJ O
( , O
InArc NNP O
) -RRB- O
and CC O
outgoing NN O
( -LRB- O
OutArc NNP O
) -RRB- O
arcs NNS O
( , O
edges NNS O
) -RRB- O
, , O
total JJ O
number NN O
of IN O
ArcTypes NNPS O
, , O
and CC O
total JJ O
number NN O
of IN O
ligand JJ O
arcs NNS O
( , O
LigArc NNP O
) -RRB- O
. . O

The DT O
type NN O
of IN O
the DT O
segment NN O
( -LRB- O
SSEType NNP O
) -RRB- O
could MD O
be VB O
one CD O
of IN O
[ -LRB- O
E NNP O
, , O
e FW O
, , O
H NNP O
, , O
h UH O
, , O
U NNP O
, , O
u NNP O
] -RRB- O
, , O
where WRB O
, , O
"""" `` O
E NN O
"""" '' O
and CC O
"""" `` O
e NN O
"""" '' O
represent VBP O
the DT O
"""" `` O
up NN O
"""" '' O
- HYPH O
and CC O
"""" `` O
down RB O
"""" '' O
- HYPH O
oriented VBN O
beta JJ O
strands NNS O
; : O
"""" `` O
H NN O
"""" '' O
and CC O
"""" `` O
h NN O
"""" '' O
indicate VBP O
the DT O
"""" `` O
up RB O
"""" '' O
- HYPH O
and CC O
"""" `` O
down RB O
"""" '' O
- HYPH O
oriented VBN O
alpha NN O
helices NNS O
; , O
and CC O
"""" `` O
U NNP O
"""" '' O
and CC O
"""" `` O
u NNP O
"""" '' O
represent VBP O
ligand NN O
- HYPH O
bound JJ O
and CC O
ligand NN O
- HYPH O
free JJ O
loops NNS O
. . O

The DT O
InArcType NNP O
can MD O
be VB O
classified VBN O
as IN O
an DT O
/ , O
a DT O
[ -LRB- O
R NNP O
, , O
L NNP O
, , O
P NNP O
, , O
A NNP O
] -RRB- O
, , O
where WRB O
"""" `` O
R NN O
"""" '' O
and CC O
"""" `` O
L NNP O
"""" '' O
represent VBP O
right NN O
and CC O
left JJ O
chiralities NNS O
; : O
and CC O
"""" `` O
P NN O
"""" '' O
and CC O
"""" `` O
A NN O
"""" '' O
represent VBP O
parallel JJ O
and CC O
anti JJ O
- HYPH O
parallel JJ O
hydrogen NN O
bonds NNS O
, , O
respectively RB O
. . O

The DT O
OutArcType NNP O
is VBZ O
represented VBN O
in IN O
a DT O
similar JJ O
manner NN O
by IN O
[ -LRB- O
R NNP O
' '' O
, , O
L NNP O
' '' O
, , O
P NNP O
' '' O
, , O
A NNP O
' '' O
] -RRB- O
. . O

Ligand NNP O
arcs NNS O
are VBP O
indicated VBN O
by IN O
LT NNP O
= SYM O
AA NNP O
, , O
where WRB O
LT NNP O
is VBZ O
the DT O
ligand JJ O
type NN O
and CC O
AA NN O
is VBZ O
the DT O
PDB NNP O
number NN O
. . O

For IN O
example NN O
, , O
Figure NNP O
3 CD O
( : O
a DT O
) -RRB- O
and CC O
3 CD O
( HYPH O
b NN O
) -RRB- O
contain VB O
visual JJ O
representations NNS O
of IN O
TOPS NNS O
+ SYM O
and CC O
TOPS NNS O
+ SYM O
strings NNS O
models NNS O
, , O
respectively RB O
, , O
for IN O
the DT O
protein NN O
domain NN O
d1fnb NN O
_ : O
1 CD O
. . O

Here RB O
the DT O
triangles NNS O
represent VBP O
the DT O
beta JJ O
strands NNS O
; : O
the DT O
red JJ O
curve NN O
represents VBZ O
the DT O
alpha NN O
helix NN O
; , O
gray JJ O
ellipsoids NNS O
indicate VBP O
loops NNS O
; , O
and CC O
green JJ O
arcs NNS O
indicate VBP O
hydrogen NN O
bonds NNS O
between IN O
two CD O
beta JJ O
strands NNS O
, , O
called VBN O
anti JJ O
- HYPH O
parallel JJ O
beta NN O
sheets NNS O
. . O

The DT O
length NN O
of IN O
a DT O
TOPS NNS O
+ SYM O
strings NNS O
model NN O
is VBZ O
defined VBN O
by IN O
number NN O
of IN O
SSEs NNS O
; : O
thus RB O
, , O
the DT O
length NN O
of IN O
d1fnb NN O
_ HYPH O
1 CD O
is VBZ O
19 CD O
. . O

For IN O
further JJ O
details NNS O
, , O
see VB O
[ -LRB- O
28 CD O
] -RRB- O
. . O

TOPS NNS O
+ CC O
strings NNS O
comparison NN O
method NN O

TOPS NNS O
+ CC O
is VBZ O
a DT O
comparison NN O
method NN O
that WDT O
computes VBZ O
a DT O
distance NN O
between IN O
TOPS NNS O
+ CC O
strings NNS O
models NNS O
of IN O
two CD O
proteins NNS O
based VBN O
on IN O
a DT O
dynamic JJ O
programming NN O
approach NN O
and CC O
identifies VBZ O
the DT O
longest JJS O
common JJ O
subsequence NN O
( , O
LCS NNP O
) -RRB- O
, , O
consisting VBG O
of IN O
the DT O
list NN O
of IN O
the DT O
topologically RB O
equivalent JJ O
SSEs NNPS O
between IN O
two CD O
proteins NNS O
. . O

For IN O
example NN O
, , O
Figure NNP O
3 CD O
( SYM O
c NN O
) -RRB- O
shows VBZ O
the DT O
TOPS NNS O
+ SYM O
strings NNS O
alignment NN O
between IN O
Dihydropteridine NNP O
reductase NN O
proteins NNS O
from IN O
rat NN O
( , O
1dhr NN O
) -RRB- O
and CC O
human JJ B-Species
( , O
1hdr CD O
) -RRB- O
. . O

The DT O
TOPS NNP O
+ CC O
strings NNS O
models NNS O
for IN O
1dhr NNP O
and CC O
1hdr NNP O
are VBP O
represented VBN O
by IN O
a DT O
linear JJ O
string NN O
- HYPH O
model NN O
, , O
where WRB O
a DT O
yellow JJ O
triangle NN O
and CC O
red JJ O
curves NNS O
indicate VBP O
the DT O
beta JJ O
strands NNS O
and CC O
alpha NN O
helices NNS O
in IN O
their PRP$ O
"""" `` O
up RP O
"""" '' O
or CC O
"""" `` O
down RB O
"""" '' O
orientations NNS O
, , O
respectively RB O
. . O

The DT O
grey JJ O
line NN O
and CC O
purple JJ O
stubs NNS O
represent VBP O
the DT O
loop NN O
regions NNS O
and CC O
the DT O
NAD NNP O
ligand NN O
interactions NNS O
, , O
respectively RB O
. . O

Note VB O
that IN O
the DT O
ligand JJ O
- HYPH O
interaction NN O
information NN O
is VBZ O
optional JJ O
and CC O
in IN O
this DT O
work NN O
we PRP O
have VBP O
not RB O
used VBN O
it PRP O
. . O

The DT O
incoming JJ O
and CC O
outgoing JJ O
arcs NNS O
are VBP O
depicted VBN O
in IN O
the DT O
SSEs NNS O
( , O
top NN O
and CC O
bottom NN O
of IN O
the DT O
beta NN O
strands NNS O
) -RRB- O
, , O
where WRB O
red JJ O
and CC O
green JJ O
arcs NNS O
represent VBP O
the DT O
parallel JJ O
and CC O
anti JJ O
- HYPH O
parallel JJ O
hydrogen NN O
- HYPH O
bond NN O
interactions NNS O
that WDT O
show VBP O
beta JJ O
- HYPH O
sheet NN O
information NN O
, , O
while IN O
yellow JJ O
and CC O
blue JJ O
arcs NNS O
indicate VBP O
the DT O
right JJ O
and CC O
left JJ O
chirality NN O
relationships NNS O
between IN O
the DT O
SSEs NNPS O
. . O

A DT O
pink JJ O
arrow NN O
between IN O
the DT O
TOPS NNS O
+ SYM O
strings NNS O
elements NNS O
indicates VBZ O
the DT O
conserved VBN O
SSE NNP O
. . O

The DT O
dotted JJ O
arrows NNS O
indicate VBP O
the DT O
conserved JJ O
alpha NN O
helices NNS O
and CC O
beta JJ O
strands NNS O
, , O
while IN O
the DT O
plain JJ O
arrows NNS O
indicate VBP O
the DT O
conserved JJ O
loop NN O
regions NNS O
. . O

TOPS NNS O
+ NFP O
+ SYM O
FATCAT JJ O
method NN O

In IN O
this DT O
work NN O
, , O
we PRP O
want VBP O
to TO O
test VB O
the DT O
general JJ O
idea NN O
of IN O
pruning VBG O
the DT O
search NN O
space NN O
of IN O
the DT O
FATCAT NNP O
comparison NN O
process NN O
using VBG O
topological JJ O
constraints NNS O
derived VBN O
from IN O
the DT O
TOPS NNP O
+ SYM O
strings NNS O
alignment NN O
. . O

Many JJ O
of IN O
the DT O
AFPs NNPS O
considered VBN O
in IN O
the DT O
FATCAT NNP O
alignment NN O
could MD O
be VB O
easily RB O
eliminated VBN O
from IN O
the DT O
comparison NN O
by IN O
constraining VBG O
the DT O
alignment NN O
region NN O
. . O

Here RB O
we PRP O
explore VBP O
constraints NNS O
obtained VBN O
from IN O
the DT O
TOPS NNP O
+ SYM O
strings NNS O
alignment NN O
, , O
which WDT O
identifies VBZ O
topologically RB O
equivalent JJ O
secondary JJ O
structure NN O
elements NNS O
( , O
alpha NN O
helices NNS O
, , O
beta NN O
strands NNS O
, , O
and CC O
loops NNS O
) -RRB- O
for IN O
this DT O
purpose NN O
. . O

Such JJ O
equivalences NNS O
define VBP O
blocks NNS O
that WDT O
restrict VBP O
the DT O
alignment NN O
region NN O
; : O
AFPs NNS O
that WDT O
fall VBP O
outside IN O
these DT O
regions NNS O
are VBP O
simply RB O
not RB O
considered VBN O
( , O
see VB O
Figure NNP O
4 CD O
( , O
b LS O
) -RRB- O
) -RRB- O
. . O

We PRP O
introduce VBP O
a DT O
parameter NN O
r NN O
to TO O
control VB O
the DT O
strictness NN O
of IN O
constraints NNS O
by IN O
TOPS NNS O
+ SYM O
strings NNS O
alignments NNS O
; : O
r CC O
equals VBZ O
0 NFP O
if IN O
the DT O
alignment NN O
region NN O
is VBZ O
strictly RB O
restrained VBN O
by IN O
TOPS NNS O
+ CC O
strings NNS O
alignment NN O
, , O
and CC O
r NN O
is VBZ O
set VBN O
to IN O
1 CD O
by IN O
default NN O
in IN O
our PRP$ O
program NN O
to TO O
allow VB O
certain JJ O
flexibility NN O
to IN O
the DT O
constrained JJ O
alignment NN O
region NN O
( -LRB- O
Figure NNP O
4 CD O
( -LRB- O
c NN O
) -RRB- O
) -RRB- O
. . O

We PRP O
then RB O
can MD O
speed VB O
up RP O
the DT O
FATCAT NNP O
alignment NN O
by IN O
considering VBG O
only RB O
the DT O
AFPs NNPS O
within IN O
the DT O
constrained VBN O
alignment NN O
area NN O
( -LRB- O
Figure NNP O
4 CD O
( SYM O
d CD O
) -RRB- O
) -RRB- O
. . O

The DT O
rigid JJ O
structural JJ O
alignment NN O
can MD O
be VB O
treated VBN O
as IN O
a DT O
special JJ O
case NN O
of IN O
TOPS NNP O
+ CC O
+ SYM O
FATCAT NNP O
, , O
in IN O
which WDT O
no DT O
twist NN O
is VBZ O
allowed VBN O
in IN O
chaining VBG O
AFPs NNS O
. . O

However RB O
, , O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
program NN O
provides VBZ O
alignment NN O
in IN O
both DT O
, , O
"""" `` O
rigid JJ O
"""" '' O
mode NN O
and CC O
"""" `` O
flexible JJ O
"""" '' O
mode NN O
( , O
default NN O
) -RRB- O
. . O

Benchmarking NN O

For IN O
benchmarking NN O
and CC O
comparison NN O
, , O
we PRP O
have VBP O
used VBN O
the DT O
PDB40 NNP O
dataset NN O
of IN O
1 CD O
, , O
901 CD O
protein NN O
domain NN O
pairs NNS O
( -LRB- O
DP NNP O
) -RRB- O
corresponding VBG O
to IN O
SCOP NNP O
version NN O
1 CD O
. . O
61 CD O
from IN O
the DT O
ASTRAL NNP O
database NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Table NNP O
1 CD O
provides VBZ O
the DT O
SCOP NNP O
superfamily NN O
level NN O
homolog NN O
versus IN O
non JJ O
- HYPH O
homolog NN O
statistics NNS O
for IN O
the DT O
four CD O
main JJ O
SCOP NNP O
classes NNS O
i : O
. . O
e LS O
. . O
, , O
all DT O
- HYPH O
alpha NN O
, , O
all DT O
- HYPH O
beta NN O
, , O
alpha NN O
/ SYM O
beta NN O
, , O
alpha NN O
+ CC O
beta NN O
, , O
and CC O
all DT O
proteins NNS O
regardless RB O
of IN O
their PRP$ O
structural JJ O
classes NNS O
. . O

Evaluation NN O
Analyses NNS O

We PRP O
performed VBD O
the DT O
Receiver NNP O
Operating NNP O
Characteristics NNP O
( -LRB- O
ROC NNP O
) -RRB- O
curve NN O
and CC O
the DT O
AUC NNP O
( , O
Area NN O
Under IN O
the DT O
ROC NNP O
Curve NNP O
) -RRB- O
analyses NNS O
to TO O
compare VB O
the DT O
performance NN O
of IN O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
with IN O
the DT O
original JJ O
FATCAT NNP O
method NN O
, , O
using VBG O
SCOP NNP O
classification NN O
at IN O
the DT O
superfamily JJ O
level NN O
as IN O
a DT O
standard NN O
of IN O
comparison NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Results NNS O

ROC NNP O
and CC O
AUC NNP O
Analyses NNS O

We PRP O
have VBP O
compared VBN O
the DT O
performance NN O
of IN O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
against IN O
the DT O
original JJ O
FATCAT NNP O
method NN O
using VBG O
the DT O
SCOP NNP O
classification NN O
information NN O
at IN O
the DT O
superfamily JJ O
level NN O
. . O

We PRP O
have VBP O
plotted VBN O
the DT O
ROC NNP O
curves NNS O
based VBN O
on IN O
P NN O
- HYPH O
values NNS O
obtained VBN O
from IN O
the DT O
FATCAT NNP O
and CC O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
. . O

We PRP O
have VBP O
plotted VBN O
the DT O
ROC NNP O
curves NNS O
separately RB O
for IN O
the DT O
main JJ O
SCOP NNP O
classes NNS O
, , O
i PRP O
. . O
e UH O
. . O
, , O
all DT O
- HYPH O
alpha NN O
, , O
all DT O
- HYPH O
beta NN O
, , O
alpha NN O
/ , O
beta NN O
, , O
alpha NN O
+ CC O
beta NN O
, , O
and CC O
all DT O
proteins NNS O
regardless RB O
of IN O
the DT O
class NN O
they PRP O
belong VBP O
to IN O
( , O
see VB O
Figure NNP O
5 CD O
( : O
a DT O
) -RRB- O
to IN O
5 CD O
( HYPH O
e NN O
) -RRB- O
) -RRB- O
. . O

In IN O
the DT O
graph NN O
, , O
the DT O
x NN O
- HYPH O
and CC O
y NN O
- HYPH O
axes NNS O
represent VBP O
the DT O
false JJ O
positive JJ O
and CC O
true JJ O
positive JJ O
rates NNS O
of IN O
the DT O
performance NN O
of IN O
the DT O
comparison NN O
methods NNS O
respectively RB O
. . O

In IN O
the DT O
legend NN O
, , O
rF NN O
- HYPH O
pvalue NN O
and CC O
fF NN O
- HYPH O
pvalue NN O
indicate VBP O
results NNS O
from IN O
the DT O
rigid JJ O
and CC O
flexible JJ O
FATCAT NNP O
methods NNS O
, , O
respectively RB O
; , O
similarly RB O
, , O
rT2F NN O
- HYPH O
pvalue NN O
and CC O
fT2F NN O
- HYPH O
pvalue NN O
represent VBP O
the DT O
rigid JJ O
and CC O
flexible JJ O
TOPS NN O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
, , O
respectively RB O
. . O

We PRP O
have VBP O
calculated VBN O
the DT O
AUC NNP O
values NNS O
for IN O
all PDT O
the DT O
SCOP NNP O
classes NNS O
based VBN O
on IN O
ROC NNP O
curves NNS O
obtained VBN O
from IN O
the DT O
FATCAT NNP O
and CC O
TOPS NNS O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
with IN O
the DT O
flexible JJ O
/ SYM O
rigid JJ O
options NNS O
( -LRB- O
see VB O
Table NNP O
2 CD O
) -RRB- O
. . O

For IN O
all DT O
protein NN O
classes NNS O
, , O
the DT O
rigid JJ O
FATCAT NNP O
performs VBZ O
best RBS O
, , O
usually RB O
followed VBN O
by IN O
the DT O
flexible JJ O
FATCAT NNP O
, , O
the DT O
rigid JJ O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
, , O
and CC O
the DT O
flexible JJ O
TOPS NN O
+ SYM O
+ SYM O
FATCAT NN O
. . O

The DT O
performance NN O
of IN O
all DT O
four CD O
methods NNS O
is VBZ O
best JJS O
for IN O
all DT O
alpha NN O
and CC O
all DT O
beta JJ O
proteins NNS O
, , O
and CC O
all DT O
four CD O
perform VBP O
markedly RB O
worse JJR O
( , O
but CC O
similar JJ O
to IN O
each DT O
other JJ O
) , O
for IN O
alpha NN O
/ SYM O
beta NN O
proteins NNS O
. . O

Only RB O
alpha NN O
+ CC O
beta NN O
proteins NNS O
show VBP O
a DT O
clear JJ O
difference NN O
between IN O
the DT O
FATCAT NNP O
and CC O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
note VB O
that IN O
the DT O
TOPS NNS O
+ SYM O
strings NNS O
models NNS O
consider VBP O
the DT O
parallel JJ O
and CC O
anti JJ O
- HYPH O
parallel JJ O
properties NNS O
of IN O
the DT O
beta JJ O
- HYPH O
sheet NN O
information NN O
in IN O
the DT O
form NN O
of IN O
total JJ O
number NN O
of IN O
incoming JJ O
and CC O
outgoing JJ O
arcs NNS O
with IN O
their PRP$ O
ArcTypes NNS O
. . O

Thus RB O
, , O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
discriminates VBZ O
the DT O
protein NN O
domain NN O
pairs NNS O
more RBR O
efficiently RB O
compared VBN O
to IN O
the DT O
original JJ O
FATCAT NNP O
method NN O
. . O

For IN O
example NN O
, , O
in IN O
the DT O
all DT O
- HYPH O
beta JJ O
protein NN O
domain NN O
pairs NNS O
, , O
both CC O
the DT O
flexible JJ O
and CC O
the DT O
rigid JJ O
TOPS NNS O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
perform VBP O
well RB O
. . O

The DT O
flexible JJ O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
covers VBZ O
nearly RB O
84 CD O
% NN O
of IN O
protein NN O
domains NNS O
with IN O
0 CD O
% NN O
false JJ O
positives NNS O
, , O
but CC O
the DT O
flexible JJ O
and CC O
rigid JJ O
FATCAT NNP O
methods NNS O
cover VBP O
only RB O
76 CD O
% NN O
and CC O
49 CD O
% NN O
of IN O
the DT O
true JJ O
positives NNS O
, , O
respectively RB O
, , O
with IN O
0 CD O
% NN O
false JJ O
positives NNS O
. . O

The DT O
zoomed VBN O
- HYPH O
in RP O
version NN O
of IN O
the DT O
ROC NNP O
curves NNS O
with IN O
up IN O
to TO O
10 CD O
% NN O
false JJ O
positives NNS O
for IN O
all DT O
- HYPH O
beta JJ O
rich JJ O
protein NN O
families NNS O
is VBZ O
shown VBN O
in IN O
Figure NNP O
5 CD O
( SYM O
f CD O
) -RRB- O
; : O
where WRB O
both CC O
the DT O
rigid JJ O
TOPS NNS O
+ SYM O
+ SYM O
FATCAT NNP O
( , O
green JJ O
) -RRB- O
and CC O
flexible JJ O
( , O
red JJ O
) -RRB- O
TOPS NNS O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
have VBP O
coverage NN O
rates NNS O
of IN O
82 CD O
% NN O
and CC O
84 CD O
% NN O
true JJ O
positives NNS O
respectively RB O
with IN O
0 CD O
% NN O
false JJ O
positives NNS O
. . O

The DT O
overall JJ O
results NNS O
for IN O
all DT O
protein NN O
classes NNS O
show VBP O
that IN O
TOPS NNS O
+ CC O
+ SYM O
FATCAT NNP O
performance NN O
is VBZ O
only RB O
slightly RB O
lower JJR O
( : O
3 CD O
% NN O
- SYM O
7 CD O
% NN O
AUC NNP O
value NN O
difference NN O
( , O
see VB O
Table NNP O
2 CD O
) -RRB- O
) , O
as IN O
compared VBN O
to IN O
FATCAT NNP O
while IN O
providing VBG O
a DT O
significant JJ O
, , O
more JJR O
than IN O
10 CD O
- HYPH O
fold NN O
speedup NN O
( , O
see VB O
next JJ O
section NN O
) -RRB- O
. . O

AFP NNP O
and CC O
Runtime NNP O
Analyses NNPS O

We PRP O
tested VBD O
both CC O
the DT O
FATCAT NNP O
and CC O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
using VBG O
the DT O
Mac NNP O
OS NNP O
X NNP O
version NN O
10 CD O
. . O
4 CD O
. . O
10 CD O
computer NN O
system NN O
with IN O
a DT O
2 CD O
x SYM O
2 CD O
. . O
66 CD O
- HYPH O
GHz NN O
Dual NNP O
- HYPH O
Core NNP O
Intel NNP O
Xeon NNP O
processor NN O
and CC O
1 CD O
- HYPH O
GB NN O
667 CD O
MHz NN O
memory NN O
. . O

We PRP O
have VBP O
performed VBN O
runtime JJ O
analysis NN O
on IN O
1 CD O
, , O
901 CD O
protein NN O
domain NN O
pairs NNS O
and CC O
counted VBN O
the DT O
total JJ O
number NN O
of IN O
AFPs NNS O
and CC O
the DT O
corresponding VBG O
runtime NN O
from IN O
both CC O
the DT O
FATCAT NNP O
and CC O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
. . O

The DT O
results NNS O
show VBP O
an DT O
exponential JJ O
increase NN O
in IN O
AFPs NNP O
( -LRB- O
Figure NNP O
6 CD O
( , O
b NN O
) -RRB- O
) -RRB- O
and CC O
corresponding VBG O
runtime NN O
( , O
Figure NNP O
6 CD O
( , O
a DT O
) -RRB- O
) -RRB- O
for IN O
the DT O
FATCAT NNP O
method NN O
as IN O
compared VBN O
to IN O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
( , O
see VB O
Table NNP O
3 CD O
) , O
For IN O
example NN O
, , O
the DT O
average JJ O
number NN O
of IN O
AFPs NNS O
for IN O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
is VBZ O
530 CD O
, , O
but CC O
the DT O
average JJ O
number NN O
of IN O
AFPs NNPS O
for IN O
the DT O
FATCAT NNP O
method NN O
is VBZ O
15 CD O
, , O
19 CD O
. . O

This DT O
represents VBZ O
the DT O
number NN O
of IN O
average JJ O
AFPs NNPS O
used VBN O
by IN O
the DT O
FATCAT NNP O
method NN O
is VBZ O
increased VBN O
by IN O
a DT O
factor NN O
of IN O
28 CD O
( , O
see VB O
Table NNP O
3 CD O
) -RRB- O
. . O

This DT O
result NN O
leads VBZ O
to IN O
the DT O
conclusion NN O
that IN O
TOPS NNP O
+ CC O
+ SYM O
FATCAT NNP O
is VBZ O
22 CD O
times NNS O
faster RBR O
compared VBN O
to IN O
the DT O
FATCAT NNP O
because IN O
this DT O
method NN O
must MD O
take VB O
into IN O
account NN O
more JJR O
number NN O
of IN O
AFPs NNS O
in IN O
the DT O
comparison NN O
process NN O
( , O
see VB O
Table NNP O
3 CD O
) -RRB- O
. . O

Case NNP O
Studies NNP O

While IN O
the DT O
overall JJ O
accuracy NN O
of IN O
both CC O
rigid JJ O
and CC O
flexible JJ O
FATCAT NNP O
methods NNS O
is VBZ O
better JJR O
than IN O
their PRP$ O
TOPS NNS O
+ SYM O
+ SYM O
FATCAT NNP O
equivalents NNS O
, , O
an DT O
interesting JJ O
example NN O
where WRB O
the DT O
opposite NN O
is VBZ O
true JJ O
lies VBZ O
in IN O
the DT O
comparison NN O
of IN O
two CD O
proteins NNS O
, , O
d2trxa NN O
_ : O
( : O
108 CD O
aa NN O
) -RRB- O
from IN O
Escherichia NNP B-Species
coli NN I-Species
and CC O
d1kte NN O
_ : O
_ : O
( : O
105 CD O
aa NN O
) -RRB- O
from IN O
Sus NNP B-Species
scrofa NN I-Species
( , O
pig NN B-Species
) -RRB- O
from IN O
the DT O
thioredoxin NN O
- HYPH O
like JJ O
superfamily NN O
. . O

For IN O
this DT O
pair NN O
, , O
the DT O
flexible NN O
_ : O
TOPS NN O
+ NFP O
+ SYM O
FATCAT NNP O
method NN O
provides VBZ O
an DT O
alignment NN O
with IN O
88 CD O
equivalent JJ O
positions NNS O
with IN O
1 CD O
. . O
67 CD O
A NN O
chain NN O
RMSD NN O
and CC O
3 CD O
. . O
6 CD O
A NN O
of IN O
optimal JJ O
RMSD NN O
without IN O
any DT O
twist NN O
, , O
giving VBG O
the DT O
alignment NN O
with IN O
10 CD O
% NN O
sequence NN O
identity NN O
( , O
see VB O
Table NN O
4 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
flexible JJ O
_ : O
FATCAT NNP O
method NN O
provides VBZ O
an DT O
alignment NN O
with IN O
86 CD O
aligned VBN O
positions NNS O
using VBG O
a DT O
twist NN O
in IN O
the DT O
C NNP O
- HYPH O
terminal NN O
region NN O
; : O
it PRP O
has VBZ O
a DT O
higher JJR O
chain NN O
RMSD NN O
of IN O
5 CD O
. . O
14 CD O
A NN O
, , O
and CC O
its PRP$ O
optimal JJ O
RMSD NN O
is VBZ O
3 CD O
. . O
48 CD O
A NN O
. . O

For IN O
more JJR O
information NN O
regarding VBG O
the DT O
chain NN O
and CC O
optimal JJ O
RMSDs NNS O
refer VBP O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
flexible JJ O
_ : O
FATCAT NNP O
method NN O
uses VBZ O
the DT O
twist NN O
to TO O
align VB O
a DT O
helix NN O
in IN O
the DT O
C NNP O
- HYPH O
terminal NN O
region NN O
, , O
which WDT O
is VBZ O
positioned VBN O
incorrectly RB O
with IN O
a DT O
beta JJ O
- HYPH O
sheet NN O
core NN O
( , O
see VB O
Table NNP O
4 CD O
) -RRB- O
. . O

Figure NN O
7 CD O
( : O
a DT O
) -RRB- O
shows VBZ O
the DT O
superposition NN O
of IN O
d2trxa NN O
_ : O
( : O
gray JJ O
) , O
and CC O
d1kte NN O
_ NFP O
_ NFP O
( HYPH O
orange NN O
) -RRB- O
domains NNS O
from IN O
the DT O
flexible JJ O
_ : O
FATCAT NNP O
method NN O
, , O
where WRB O
the DT O
blue JJ O
color NN O
indicates VBZ O
the DT O
d1kte NN O
_ NFP O
_ NFP O
protein NN O
domain NN O
from IN O
the DT O
flexible NN O
_ : O
TOPS NN O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
. . O

The DT O
incorrect JJ O
alignment NN O
of IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
domain NN O
alpha NN O
helix NN O
of IN O
the DT O
d1kte NN O
_ : O
_ : O
domain NN O
( -LRB- O
orange NN O
) -RRB- O
is VBZ O
visible JJ O
in IN O
the DT O
core NN O
of IN O
the DT O
beta JJ O
- HYPH O
sheet NN O
region NN O
. . O

Figure NN O
7 CD O
( , O
b NN O
) -RRB- O
and CC O
7 CD O
( HYPH O
c NN O
) -RRB- O
shows VBZ O
the DT O
AFPs NNS O
from IN O
the DT O
flexible NN O
_ : O
FATCAT NN O
and CC O
flexible NN O
_ : O
TOPS NN O
+ SYM O
+ SYM O
FATCAT NNP O
methods NNS O
, , O
respectively RB O
. . O

The DT O
hinge NN O
region NN O
provides VBZ O
a DT O
twist NN O
in IN O
the DT O
flexible JJ O
_ HYPH O
FATCAT NNP O
method NN O
indicated VBN O
by IN O
an DT O
arrow NN O
and CC O
the DT O
AFPs NNS O
represented VBN O
by IN O
a DT O
different JJ O
color NN O
( , O
see VB O
Figure NNP O
7 CD O
( : O
b LS O
) -RRB- O
) -RRB- O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
alignment NN O
constraints NNS O
from IN O
the DT O
TOPS NNS O
+ SYM O
strings NNS O
alignment NN O
allow VBP O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
to TO O
avoid VB O
a DT O
spurious JJ O
alignment NN O
. . O

The DT O
Erythrocruorin NNP O
protein NN O
domain NN O
d1eca NN O
_ : O
_ NFP O
( : O
136 CD O
aa NN O
) -RRB- O
from IN O
Chironomus NNP B-Species
thummi NNP I-Species
and CC O
the DT O
Phycocyanin NN O
alpha NN O
subunit NN O
protein NN O
domain NN O
d1cpca NN O
_ : O
( -LRB- O
162 CD O
aa NN O
) -RRB- O
from IN O
Fremyella NNP B-Species
diplosiphon NN I-Species
( -LRB- O
Cyanobacterium NN O
) -RRB- O
belong VBP O
to IN O
the DT O
Globin NNP O
- HYPH O
like JJ O
superfamily NN O
. . O

For IN O
these DT O
protein NN O
domain NN O
pairs NNS O
, , O
the DT O
FATCAT NNP O
method NN O
provides VBZ O
a DT O
better JJR O
alignment NN O
with IN O
120 CD O
and CC O
118 CD O
aligned VBN O
positions NNS O
with IN O
the DT O
chain NN O
RMSD NN O
of IN O
4 CD O
. . O
2 CD O
A NN O
based VBN O
on IN O
the DT O
flexible JJ O
and CC O
rigid JJ O
options NNS O
, , O
respectively RB O
. . O

The DT O
flexible JJ O
_ : O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
gives VBZ O
an DT O
alignment NN O
of IN O
63 CD O
aligned VBN O
positions NNS O
with IN O
the DT O
3 CD O
. . O
23 CD O
A NN O
optimal JJ O
RMSD NN O
and CC O
the DT O
6 CD O
. . O
28 CD O
A NN O
chain NN O
RMSD NN O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
flexible JJ O
_ : O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
misses VBZ O
the DT O
N NNP O
- HYPH O
terminal JJ O
region NN O
helix NN O
and CC O
misaligns VBZ O
some DT O
helices NNS O
. . O

For IN O
example NN O
, , O
Figure NNP O
8 CD O
( , O
a DT O
) -RRB- O
shows VBZ O
the DT O
superposition NN O
of IN O
d1eca NN O
_ NFP O
_ NFP O
( : O
gray JJ O
) -RRB- O
and CC O
d1cpca NN O
_ SYM O
( HYPH O
orange NN O
) -RRB- O
domains NNS O
from IN O
the DT O
flexible JJ O
_ : O
FATCAT NNP O
method NN O
, , O
while IN O
d1cpca NN O
_ : O
( : O
blue JJ O
) -RRB- O
domain NN O
is VBZ O
from IN O
the DT O
flexible NN O
_ : O
TOPS NN O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
. . O

The DT O
AFP NNP O
chaining VBG O
alignment NN O
and CC O
the DT O
actual JJ O
alignment NN O
from IN O
FATCAT NNP O
are VBP O
shown VBN O
in IN O
Figure NNP O
8 CD O
( SYM O
b LS O
) -RRB- O
and CC O
8 CD O
( SYM O
e CD O
) -RRB- O
, , O
respectively RB O
. . O

Figure NN O
8 CD O
( SYM O
c NN O
) -RRB- O
shows VBZ O
the DT O
AFP NNP O
alignment NN O
from IN O
TOPS NNP O
+ CC O
+ SYM O
FATCAT NNP O
, , O
in IN O
which WDT O
this DT O
method NN O
misses VBZ O
the DT O
N NNP O
- HYPH O
terminal NN O
region NN O
and CC O
incorrectly RB O
aligns VBZ O
some DT O
of IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
regions NNS O
( , O
see VB O
Figure NNP O
8 CD O
( : O
d LS O
) -RRB- O
) -RRB- O
. . O

However RB O
, , O
the DT O
rigid JJ O
_ : O
TOPS NNP O
+ NFP O
+ SYM O
FATCAT NNP O
method NN O
produces VBZ O
an DT O
alignment NN O
of IN O
108 CD O
aligned VBN O
positions NNS O
with IN O
optimal JJ O
and CC O
chain NN O
RMSDs NNS O
of IN O
3 CD O
. . O
22 CD O
A NN O
and CC O
6 CD O
. . O
28 CD O
A NN O
respectively RB O
. . O

In IN O
general JJ O
, , O
TOPS NNP O
comparison NN O
does VBZ O
not RB O
work VB O
well RB O
for IN O
alpha JJ O
- HYPH O
rich JJ O
proteins NNS O
due IN O
to IN O
the DT O
lack NN O
of IN O
hydrogen NN O
bonds NNS O
between IN O
SSEs NNPS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

The DT O
same JJ O
is VBZ O
true JJ O
for IN O
TOPS NNS O
+ SYM O
strings NNS O
comparison NN O
to IN O
some DT O
extent NN O
; : O
however RB O
, , O
this DT O
method NN O
takes VBZ O
advantage NN O
of IN O
ligand JJ O
- HYPH O
interaction NN O
information NN O
to TO O
compare VB O
protein NN O
domains NNS O
more RBR O
efficiently RB O
; , O
for IN O
example NN O
the DT O
DNA NN O
binding VBG O
motifs NNS O
such JJ O
as IN O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
and CC O
helix NN O
- HYPH O
loop NN O
- HYPH O
helix NN O
can MD O
be VB O
easily RB O
recognized VBN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

However RB O
, , O
we PRP O
have VBP O
not RB O
explored VBN O
that DT O
ligand JJ O
pattern NN O
discovery NN O
option NN O
within IN O
the DT O
TOPS NNP O
+ SYM O
strings NNS O
comparison NN O
in IN O
this DT O
paper NN O
. . O

In IN O
addition NN O
, , O
the DT O
TOPS NNP O
+ CC O
strings NNS O
alignment NN O
provides VBZ O
only RB O
a DT O
basic JJ O
alignment NN O
; : O
the DT O
scoring NN O
function NN O
to TO O
find VB O
the DT O
best JJS O
alignment NN O
has VBZ O
not RB O
been VBN O
optimized VBN O
. . O

These DT O
problems NNS O
can MD O
be VB O
addressed VBN O
in IN O
future JJ O
development NN O
by IN O
considering VBG O
the DT O
advanced JJ O
TOPS NNP O
+ SYM O
and CC O
TOPS NNP O
+ SYM O
strings NNS O
models NNS O
based VBN O
on IN O
helix NN O
- HYPH O
helix NN O
packing NN O
relationships NNS O
and CC O
SSE NNP O
- HYPH O
ligand NN O
interaction NN O
properties NNS O
together RB O
with IN O
the DT O
right JJ O
and CC O
left JJ O
chiralities NNS O
. . O

Furthermore RB O
, , O
the DT O
TOPS NNP O
+ CC O
strings NNS O
comparison NN O
can MD O
be VB O
optimized VBN O
in IN O
both CC O
the DT O
comparison NN O
process NN O
as RB O
well RB O
as IN O
in IN O
the DT O
alignment NN O
process NN O
in IN O
order NN O
to TO O
take VB O
into IN O
account NN O
indels NNS O
( , O
insertion NN O
/ SYM O
deletion NN O
) -RRB- O
of IN O
SSEs NNS O
which WDT O
exist VBP O
in IN O
nature NN O
across IN O
the DT O
different JJ O
members NNS O
of IN O
the DT O
protein NN O
superfamilies NNS O
[ -LRB- O
31 CD O
] -RRB- O
. . O

Discussion NN O
and CC O
conclusion NN O

The DT O
overall JJ O
results NNS O
for IN O
all DT O
protein NN O
classes NNS O
show VBP O
that IN O
TOPS NNS O
+ CC O
+ SYM O
FATCAT NNP O
performance NN O
is VBZ O
only RB O
slightly RB O
lower JJR O
( : O
3 CD O
% NN O
- SYM O
7 CD O
% NN O
AUC NNP O
value NN O
difference NN O
) , O
as IN O
compared VBN O
to IN O
FATCAT NNP O
while IN O
providing VBG O
a DT O
significant JJ O
, , O
more JJR O
than IN O
10 CD O
- HYPH O
fold NN O
speedup NN O
. . O

The DT O
main JJ O
reason NN O
for IN O
the DT O
discrepancies NNS O
is VBZ O
that IN O
TOPS NNS O
+ CC O
strings NNS O
alignments NNS O
occasionally RB O
misalign VBP O
the DT O
secondary JJ O
structure NN O
elements NNS O
and CC O
subsequent JJ O
FATCAT NNP O
alignment NN O
, , O
constrained VBN O
by IN O
the DT O
TOPS NNP O
+ SYM O
strings NNS O
alignment NN O
, , O
cannot MD O
overcome VB O
the DT O
earlier JJR O
errors NNS O
. . O

There EX O
is VBZ O
a DT O
clear JJ O
trade NN O
- HYPH O
off NN O
between IN O
the DT O
runtime NN O
and CC O
the DT O
accuracy NN O
; , O
limiting VBG O
the DT O
pool NN O
of IN O
fragments NNS O
being VBG O
compared VBN O
speeds VBZ O
up RP O
the DT O
algorithm NN O
but CC O
results VBZ O
in IN O
( : O
slightly RB O
) , O
lower JJR O
accuracy NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
these DT O
results NNS O
offer VBP O
clear JJ O
suggestions NNS O
for IN O
future JJ O
development NN O
. . O

Using VBG O
a DT O
more RBR O
advanced JJ O
version NN O
of IN O
the DT O
TOPS NNP O
+ NN O
strings NNS O
comparison NN O
method NN O
would MD O
remove VB O
some DT O
of IN O
the DT O
false JJ O
positives NNS O
might MD O
be VB O
at IN O
a DT O
cost NN O
of IN O
significantly RB O
slowing VBG O
the DT O
total JJ O
performance NN O
of IN O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
method NN O
. . O

Authors NNS O
' POS O
contributions NNS O

MV NNP O
developed VBD O
the DT O
TOPS NNP O
+ SYM O
+ SYM O
FATCAT NNP O
algorithm NN O
, , O
performed VBD O
the DT O
calculations NNS O
and CC O
prepared VBD O
the DT O
figures NNS O
, , O
YY NNP O
provided VBD O
advice NN O
and CC O
oversight NN O
in IN O
the DT O
project NN O
, , O
verified VBD O
the DT O
code NN O
and CC O
provided VBD O
FATCAT NNP O
results NNS O
for IN O
comparison NN O
, , O
AG NNP O
contributed VBD O
to IN O
the DT O
original JJ O
idea NN O
and CC O
to IN O
writing NN O
of IN O
the DT O
manuscript NN O
. . O

Are VBP O
there EX O
sensitive JJ O
subgroups NNS O
for IN O
the DT O
effects NNS O
of IN O
airborne JJ O
particles NNS O
? . O

Abstract JJ O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
particulate JJ O
air NN O
pollution NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
hospitalization NN O
for IN O
heart NN O
and CC O
lung NN O
disease NN O
; : O
however RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
what WDT O
subpopulations NNS O
are VBP O
most RBS O
sensitive JJ O
to IN O
this DT O
pollutant NN O
. . O

We PRP O
analyzed VBD O
Medicare NNP O
hospital NN O
admissions NNS O
for IN O
heart NN O
disease NN O
, , O
chronic JJ O
obstructive JJ O
pulmonary NN O
disorders NNS O
( , O
COPD NNP O
) -RRB- O
and CC O
pneumonia NN O
in IN O
Chicago NNP O
, , O
Cook NNP O
County NNP O
, , O
Illinois NNP O
, , O
between IN O
1985 CD O
and CC O
1994 CD O
. . O

We PRP O
examined VBD O
whether IN O
previous JJ O
admissions NNS O
or CC O
secondary JJ O
diagnoses NNS O
for IN O
selected VBN O
conditions NNS O
predisposed VBN O
persons NNS B-Species
to IN O
having VBG O
a DT O
greater JJR O
risk NN O
from IN O
air NN O
pollution NN O
. . O

We PRP O
also RB O
considered VBD O
effect NN O
modification NN O
by IN O
age NN O
, , O
sex NN O
, , O
and CC O
race NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
air NN O
- HYPH O
pollution NN O
- HYPH O
associated VBN O
increase NN O
in IN O
hospital NN O
admissions NNS O
for IN O
cardiovascular JJ O
diseases NNS O
was VBD O
almost RB O
doubled VBN O
in IN O
subjects NNS O
with IN O
concurrent JJ O
respiratory JJ O
infections NNS O
. . O

The DT O
risk NN O
was VBD O
also RB O
increased VBN O
by IN O
a DT O
previous JJ O
admission NN O
for IN O
conduction NN O
disorders NNS O
. . O

For IN O
COPD NN O
and CC O
pneumonia NN O
admissions NNS O
, , O
diagnosis NN O
of IN O
conduction NN O
disorders NNS O
or CC O
dysrhythmias NNS O
increased VBD O
the DT O
risk NN O
of IN O
particulate NN O
matter NN O
< SYM O
10 CD O
microm NN O
in IN O
aerodynamic JJ O
diameter NN O
( , O
PM NN O
( SYM O
10 CD O
) -RRB- O
) -RRB- O
- HYPH O
associated VBN O
admissions NNS O
. . O

Persons NNS B-Species
with IN O
asthma NN O
had VBD O
twice PDT O
the DT O
risk NN O
of IN O
a DT O
PM NN O
( SYM O
10 CD O
) NN O
- HYPH O
associated VBN O
pneumonia NN O
admission NN O
and CC O
persons NNS B-Species
with IN O
heart NN O
failure NN O
had VBD O
twice PDT O
the DT O
risk NN O
of IN O
PM NNP O
( SYM O
10 CD O
) SYM O
- HYPH O
induced VBN O
COPD NNP O
admissions NNS O
. . O

The DT O
PM NNP O
( SYM O
10 CD O
) -RRB- O
effect NN O
did VBD O
not RB O
vary VB O
by IN O
sex NN O
, , O
age NN O
, , O
and CC O
race NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
patients NNS B-Species
with IN O
acute JJ O
respiratory JJ O
infections NNS O
or CC O
defects NNS O
in IN O
the DT O
electrical JJ O
control NN O
of IN O
the DT O
heart NN O
are VBP O
a DT O
risk NN O
group NN O
for IN O
particulate NN O
matter NN O
effects NNS O
. . O

Articles NNS O

Are VBP O
There EX O
Sensitive JJ O
Subgroups NNS O
for IN O
the DT O
Effects NNS O
of IN O
Airborne JJ O
Particles NNS O
? . O

Antonella NNP O
Zanobetti NNP O
, , O
1 CD O
Joel NNP O
Schwartz NNP O
, , O
1 CD O
, , O
2 CD O
and CC O
Diane NNP O
Gold1 NNP O
, , O
2 CD O
1Environmental JJ O

Epidemiology NNP O
Program NNP O
, , O
Department NNP O
of IN O
Environmental NNP O
Health NNP O
, , O
Harvard NNP O
School NNP O
of IN O
Public NNP O
Health NNP O
, , O
Boston NNP O
, , O
Massachusetts NNP O
, , O
USA NNP O
; : O
2Channing NNP O
Laboratory NNP O
, , O
Department NNP O
of IN O
Medicine NNP O
, , O
Harvard NNP O
Medical NNP O
School NNP O
and CC O
Brigham NNP O
and CC O
Women NNPS B-Species
' POS O
s NNPS O
Hospital NNP O
, , O
Boston NNP O
, , O
Massachusetts NNP O
, , O
USA NNP O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
particulate JJ O
air NN O
pollution NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
hospitalization NN O
for IN O
heart NN O
and CC O
lung NN O
disease NN O
; : O
however RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
what WDT O
subpopulations NNS O
are VBP O
most RBS O
sensitive JJ O
to IN O
this DT O
pollutant NN O
. . O

We PRP O
analyzed VBD O
Medicare NNP O
hospital NN O
admissions NNS O
for IN O
heart NN O
disease NN O
, , O
chronic JJ O
obstructive JJ O
pulmonary NN O
disorders NNS O
( , O
COPD NNP O
) -RRB- O
and CC O
pneumonia NN O
in IN O
Chicago NNP O
, , O
Cook NNP O
County NNP O
, , O
Illinois NNP O
, , O
between IN O
1985 CD O
and CC O
1994 CD O
. . O

We PRP O
examined VBD O
whether IN O
previous JJ O
admissions NNS O
or CC O
secondary JJ O
diagnoses NNS O
for IN O
selected VBN O
conditions NNS O
predisposed VBN O
persons NNS B-Species
to IN O
having VBG O
a DT O
greater JJR O
risk NN O
from IN O
air NN O
pollution NN O
. . O

We PRP O
also RB O
considered VBD O
effect NN O
modification NN O
by IN O
age NN O
, , O
sex NN O
, , O
and CC O
race NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
air NN O
- HYPH O
pollution NN O
- HYPH O
associated VBN O
increase NN O
in IN O
hospital NN O
admissions NNS O
for IN O
cardiovascular JJ O
diseases NNS O
was VBD O
almost RB O
doubled VBN O
in IN O
subjects NNS O
with IN O
concurrent JJ O
respiratory JJ O
infections NNS O
. . O

The DT O
risk NN O
was VBD O
also RB O
increased VBN O
by IN O
a DT O
previous JJ O
admission NN O
for IN O
conduction NN O
disorders NNS O
. . O

For IN O
COPD NN O
and CC O
pneumonia NN O
admissions NNS O
, , O
diagnosis NN O
of IN O
conduction NN O
disorders NNS O
or CC O
dysrhythmias NNS O
increased VBD O
the DT O
risk NN O
of IN O
particulate NN O
matter NN O
< SYM O
10 CD O
< SYM O
FFFD NN O
> SYM O
m NN O
in IN O
aerodynamic JJ O
diameter NN O
( HYPH O
PM10 NN O
) -RRB- O
- HYPH O
associated VBN O
admissions NNS O
. . O

Persons NNS B-Species
with IN O
asthma NN O
had VBD O
twice PDT O
the DT O
risk NN O
of IN O
a DT O
PM10 NN O
- HYPH O
associated VBN O
pneumonia NN O
admission NN O
and CC O
persons NNS B-Species
with IN O
heart NN O
failure NN O
had VBD O
twice PDT O
the DT O
risk NN O
of IN O
PM10 NNP O
- HYPH O
induced VBN O
COPD NNP O
admissions NNS O
. . O

The DT O
PM10 NNP O
effect NN O
did VBD O
not RB O
vary VB O
by IN O
sex NN O
, , O
age NN O
, , O
and CC O
race NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
patients NNS B-Species
with IN O
acute JJ O
respiratory JJ O
infections NNS O
or CC O
defects NNS O
in IN O
the DT O
electrical JJ O
control NN O
of IN O
the DT O
heart NN O
are VBP O
a DT O
risk NN O
group NN O
for IN O
particulate NN O
matter NN O
effects NNS O
. . O

Key JJ O
words NNS O
: : O
effect NN O
modification NN O
, , O
hospital NN O
admissions NNS O
, , O
particulate NN O
air NN O
pollution NN O
. . O

Environ NNP O
Health NNP O
Perspect NNP O
108 CD O
: : O
841 CD O
< SYM O
FFFD NNP O
> SYM O
845 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

[ -LRB- O
Online NN O
28 CD O
July NNP O
2000 CD O
] -RRB- O
http NN O
: : O
/ : O
/ : O
ehpnet1 ADD O
. . O
niehs ADD O
. . O
nih UH O
. . O
gov NN O
/ : O
docs NN O
/ SYM O
2000 CD O
/ SYM O
108p841 CD O
- HYPH O
845zanobetti NN O
/ : O
abstract NN O
. . O
html ADD O

Particulate JJ O
air NN O
pollution NN O
has VBZ O
been VBN O
associated VBN O
with IN O
increases NNS O
in IN O
daily JJ O
deaths NNS O
and CC O
hospital NN O
admissions NNS O
in IN O
studies NNS O
all RB O
over IN O
the DT O
world NN O
( , O
1 CD O
< SYM O
FFFD NNP O
> SYM O
15 CD O
) -RRB- O
. . O

These DT O
associations NNS O
are VBP O
now RB O
well RB O
documented VBN O
but CC O
little JJ O
is VBZ O
known VBN O
, , O
as IN O
yet RB O
, , O
of IN O
the DT O
characteristics NNS O
of IN O
persons NNS B-Species
that WDT O
put VBD O
them PRP O
at IN O
increased VBN O
risk NN O
of IN O
adverse JJ O
events NNS O
related VBN O
to IN O
particulate JJ O
air NN O
pollution NN O
. . O

This DT O
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
key JJ O
data NN O
gap NN O
( SYM O
16 CD O
) -RRB- O
. . O

Schwartz NNP O
and CC O
Dockery NNP O
( SYM O
17 CD O
) -RRB- O
reported VBD O
that IN O
persons NNS B-Species
older JJR O
than IN O
65 CD O
years NNS O
of IN O
age NN O
had VBD O
a DT O
somewhat RB O
increased VBN O
risk NN O
of IN O
death NN O
, , O
and CC O
this DT O
has VBZ O
been VBN O
confirmed VBN O
in IN O
other JJ O
studies NNS O
( SYM O
18 CD O
) -RRB- O
. . O

A DT O
more RBR O
detailed JJ O
examination NN O
of IN O
particulate NN O
matter NN O
- HYPH O
related VBN O
risk NN O
by IN O
deciles NNS O
of IN O
age NN O
( : O
19 CD O
) -RRB- O
showed VBD O
the DT O
risk NN O
beginning VBG O
to TO O
increase VB O
at IN O
approximately RB O
40 CD O
years NNS O
of IN O
age NN O
and CC O
reaching VBG O
its PRP$ O
maximum NN O
for IN O
those DT O
75 CD O
years NNS O
of IN O
age NN O
and CC O
older JJR O
. . O

In IN O
addition NN O
to IN O
age NN O
, , O
several JJ O
studies NNS O
suggest VBP O
that IN O
persons NNS B-Species
with IN O
respiratory JJ O
illness NN O
are VBP O
at IN O
increased VBN O
risk NN O
for IN O
cardiovascular JJ O
effects NNS O
associated VBN O
with IN O
air NN O
pollution NN O
. . O

An DT O
examination NN O
of IN O
death NN O
certificates NNS O
on IN O
high JJ O
- HYPH O
and CC O
low JJ O
- HYPH O
air NN O
pollution NN O
days NNS O
reported VBD O
a DT O
substantial JJ O
difference NN O
in IN O
the DT O
proportion NN O
of IN O
deaths NNS O
from IN O
cardiovascular JJ O
causes NNS O
that WDT O
had VBD O
respiratory JJ O
disease NN O
as IN O
a DT O
contributing VBG O
cause NN O
of IN O
death NN O
( SYM O
19 CD O
) -RRB- O
. . O

A DT O
recent JJ O
follow NN O
- HYPH O
up NN O
study NN O
of IN O
a DT O
cohort NN O
of IN O
persons NNS B-Species
with IN O
chronic JJ O
obstructive JJ O
pulmonary JJ O
disease NN O
( , O
COPD NNP O
) -RRB- O
in IN O
Barcelona NNP O
, , O
Spain NNP O
, , O
found VBD O
an DT O
association NN O
between IN O
particulate JJ O
air NN O
pollution NN O
and CC O
all DT O
- HYPH O
cause NN O
mortality NN O
in IN O
the DT O
cohort NN O
( SYM O
20 CD O
) -RRB- O
. . O

The DT O
magnitude NN O
of IN O
the DT O
risk NN O
per IN O
microgram NN O
per IN O
cubic JJ O
meter NN O
of IN O
exposure NN O
was VBD O
substantially RB O
greater JJR O
than IN O
that DT O
for IN O
the DT O
general JJ O
population NN O
. . O

Environmental NNP O
Health NNP O
Perspectives NNPS O

Controlled VBN O
exposure NN O
of IN O
animals NNS O
with IN O
chronic JJ O
bronchitis NN O
and CC O
control NN O
animals NNS O
to IN O
concentrated VBN O
air NN O
particles NNS O
also RB O
demonstrated VBD O
a DT O
potentiating VBG O
effect NN O
of IN O
chronic JJ O
lung NN O
disease NN O
in IN O
the DT O
response NN O
to IN O
airborne JJ O
particles NNS O
( SYM O
21 CD O
) -RRB- O
. . O

This DT O
has VBZ O
led VBN O
to IN O
the DT O
hypothesis NN O
that IN O
the DT O
cardiovascular JJ O
effects NNS O
of IN O
air NN O
pollution NN O
are VBP O
predominantly RB O
in IN O
persons NNS B-Species
with IN O
chronic JJ O
lung NN O
disease NN O
. . O

There EX O
has VBZ O
been VBN O
even RB O
less RBR O
done VBN O
to TO O
examine VB O
potential JJ O
modifiers NNS O
of IN O
the DT O
effects NNS O
of IN O
airborne JJ O
particles NNS O
on IN O
hospital NN O
admissions NNS O
. . O

The DT O
existing VBG O
literature NN O
on IN O
comorbidity NN O
shows VBZ O
that IN O
comorbidity NN O
per IN O
se FW O
seems VBZ O
to TO O
increase VB O
the DT O
risk NN O
of IN O
adverse JJ O
outcomes NNS O
( : O
22 CD O
< SYM O
FFFD NN O
> SYM O
30 CD O
) -RRB- O
. . O

Little RB O
is VBZ O
known VBN O
about IN O
the DT O
role NN O
of IN O
these DT O
comorbidities NNS O
as IN O
effect NN O
modifiers NNS O
for IN O
the DT O
effects NNS O
of IN O
air NN O
pollution NN O
. . O

This DT O
study NN O
uses VBZ O
data NNS O
from IN O
the DT O
Medicare NNP O
system NN O
to TO O
examine VB O
potential JJ O
short JJ O
- HYPH O
term NN O
and CC O
long JJ O
- HYPH O
term NN O
medical JJ O
conditions NNS O
that WDT O
may MD O
increase VB O
a DT O
person NN B-Species
' POS O
s NNS O
risk NN O
of IN O
hospital NN O
admissions NNS O
associated VBN O
with IN O
particulate JJ O
air NN O
pollution NN O
. . O

In IN O
addition NN O
, , O
we PRP O
examine VBP O
potential JJ O
effect NN O
modification NN O
by IN O
age NN O
, , O
race NN O
, , O
and CC O
sex NN O
. . O

Materials NNPS O
and CC O
Methods NNP O
Health NNP O
data NNS O
. . O

The DT O
Health NNP O
Care NNP O
Financing NNP O
Administration NNP O
( : O
Baltimore NNP O
, , O
MD NNP O
) -RRB- O
maintains VBZ O
records NNS O
of IN O
every DT O
hospital NN O
admission NN O
for IN O
Medicare NNP O
participants NNS B-Species
in IN O
the DT O
United NNP O
States NNP O
. . O

Persons NNS B-Species
in IN O
this DT O
database NN O
have VBP O
a DT O
unique JJ O
identifier NN O
. . O

Using VBG O
this DT O
identifier NN O
, , O
we PRP O
traced VBD O
every DT O
hospital NN O
admission NN O
for IN O
heart NN O
and CC O
lung NN O
disease NN O
for IN O
each DT O
person NN B-Species
in IN O
Cook NNP O
County NNP O
, , O
Illinois NNP O
, , O
between IN O
1985 CD O
and CC O
1994 CD O
. . O

We PRP O
chose VBD O
Cook NNP O
County NNP O
because IN O
it PRP O
is VBZ O
the DT O
most RBS O
populous JJ O

county NN O
in IN O
the DT O
United NNP O
States NNP O
with IN O
daily JJ O
monitoring NN O
for IN O
particulate NN O
matter NN O
with IN O
aerodynamic JJ O
diameter NN O
< SYM O
10 CD O
< SYM O
FFFD NN O
> SYM O
m NN O
( -LRB- O
PM10 NN O
) -RRB- O
. . O

The DT O
data NNS O
were VBD O
then RB O
analyzed VBN O
to TO O
look VB O
at IN O
effect NN O
modification NN O
by IN O
concurrent JJ O
and CC O
preexisting JJ O
conditions NNS O
as RB O
well RB O
as IN O
by IN O
age NN O
, , O
race NN O
, , O
and CC O
sex NN O
. . O

To TO O
establish VB O
a DT O
baseline NN O
risk NN O
, , O
we PRP O
computed VBD O
daily JJ O
counts NNS O
of IN O
hospital NN O
admissions NNS O
for IN O
cardiovascular JJ O
disease NN O
( -LRB- O
CVD NNP O
) -RRB- O
[ -LRB- O
International NNP O
Classification NNP O
of IN O
Disease NNP O
, , O
9th JJ O
edition NN O
, , O
World NNP O
Health NNP O
Organization NNP O
, , O
Geneva NNP O
( , O
ICD NNP O
- HYPH O
9 CD O
) -RRB- O
code NN O
390 CD O
< SYM O
FFFD NNP O
> SYM O
429 CD O
] -RRB- O
, , O
pneumonia NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
480 CD O
< SYM O
FFFD NNP O
> SYM O
487 CD O
) -RRB- O
, , O
and CC O
COPD NNP O
( , O
ICD NNP O
- HYPH O
9 CD O
code NN O
490 CD O
< SYM O
FFFD NN O
> SYM O
496 CD O
, , O
excluding VBG O
493 CD O
) -RRB- O
. . O

The DT O
association NN O
between IN O
these DT O
daily JJ O
counts NNS O
and CC O
PM10 NNP O
was VBD O
examined VBN O
for IN O
the DT O
years NNS O
1988 CD O
< SYM O
FFFD NNP O
> SYM O
1994 CD O
, , O
when WRB O
daily JJ O
PM10 NNP O
monitoring NN O
data NNS O
were VBD O
available JJ O
in IN O
Chicago NNP O
. . O

Once IN O
our PRP$ O
baseline NN O
risks NNS O
were VBD O
established VBN O
, , O
we PRP O
examined VBD O
three CD O
classes NNS O
of IN O
potential JJ O
effect NN O
modifiers NNS O
. . O

First RB O
, , O
we PRP O
looked VBD O
at IN O
whether IN O
previous JJ O
admissions NNS O
for IN O
selected VBN O
conditions NNS O
predisposed VBD O
persons NNS B-Species
to IN O
having VBG O
a DT O
greater JJR O
risk NN O
from IN O
air NN O
pollution NN O
. . O

For IN O
each DT O
of IN O
the DT O
three CD O
admission NN O
categories NNS O
( , O
CVD NNP O
, , O
pneumonia NN O
, , O
and CC O
COPD NNP O
) -RRB- O
, , O
we PRP O
considered VBD O
10 CD O
causes NNS O
( , O
defined VBN O
by IN O
a DT O
previous JJ O
admission NN O
) -RRB- O
as IN O
effect NN O
modifiers NNS O
: : O
COPD NNP O
( , O
ICD NNP O
- HYPH O
9 CD O
code NN O
490 CD O
< SYM O
FFFD NN O
> SYM O
496 CD O
except IN O
493 CD O
) -RRB- O
, , O
asthma NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
493 CD O
) -RRB- O
, , O
acute JJ O
bronchitis NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
466 CD O
) -RRB- O
, , O
acute JJ O
respiratory JJ O
illness NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
460 CD O
< SYM O
FFFD NNP O
> SYM O
466 CD O
) -RRB- O
, , O
pneumonia NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
480 CD O
< SYM O
FFFD NNP O
> SYM O
487 CD O
) -RRB- O
, , O
CVD NN O
( , O
ICD NNP O
- HYPH O
9 CD O
code NN O
390 CD O
< SYM O
FFFD NNP O
> SYM O
429 CD O
) -RRB- O
, , O
myocardial JJ O
infarction NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
410 CD O
) -RRB- O
, , O
congestive JJ O
heart NN O
failure NN O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
428 CD O
) -RRB- O
, , O
conduction NN O
disorders NNS O
( , O
ICD NN O
- HYPH O
9 CD O
code NN O
426 CD O
) -RRB- O
, , O
and CC O
dysrhythmias NN O
( , O
ICD9 NN O
code NN O
427 CD O
) -RRB- O
. . O

To TO O
test VB O
the DT O
hypothesis NN O
that IN O
persons NNS B-Species
with IN O
these DT O
conditions NNS O
had VBD O
higher JJR O
risks NNS O
of IN O
subsequent JJ O
PM10 NN O
- HYPH O
related VBN O
admissions NNS O
, , O
we PRP O
computed VBD O
separate JJ O
daily JJ O
counts NNS O
of IN O
admissions NNS O
for IN O
our PRP$ O
three CD O
target NN O
causes NNS O
, , O
stratified VBN O
by IN O
whether IN O
or CC O
not RB O
the DT O
person NN B-Species
admitted VBN O
had VBD O
been VBN O
previously RB O
admitted VBN O
for IN O
the DT O
hypothesized VBN O
predisposing VBG O
condition NN O
. . O

Separate JJ O
analyses NNS O
were VBD O
then RB O
performed VBN O
within IN O
each DT O
strata NN O
to TO O
see VB O
if IN O
the DT O
effects NNS O
of IN O
PM10 NN O
differed VBN O
by IN O
strata NN O
. . O

Address NN O
correspondence NN O
to IN O
A NN O
. . O

Zanobetti NNP O
, , O
Department NNP O
of IN O
Environmental NNP O
Health NNP O
, , O
Environmental NNP O
Epidemiology NNP O
Program NNP O
, , O
Harvard NNP O
School NNP O
of IN O
Public NNP O
Health NNP O
, , O
665 CD O
Huntington NNP O
Avenue NNP O
, , O
Boston NNP O
, , O
MA NNP O
2115 CD O
USA NNP O
. . O

Telephone NN O
: : O
( : O
617 CD O
) SYM O
4324642 CD O
. . O

Fax NN O
: : O
( : O
617 CD O
) SYM O
277 CD O
- HYPH O
2382 CD O
. . O

E NN O
- HYPH O
mail NN O
: : O
azanob NN O
@ IN O
sparc6a ADD O
. . O
harvard NN O
. . O
edu NNP O
Supported VBN O
by IN O
NIEHS NNP O
grant NN O
ES07937 CD O
. . O

Received VBN O
18 CD O
January NNP O
2000 CD O
; : O
accepted VBN O
18 CD O
April NNP O
2000 CD O
. . O

< NFP O
FFFD NNP O
> : O
VOLUME NN O
108 CD O
| : O
NUMBER NN O
9 CD O
| SYM O
September NNP O
2000 CD O

841 CD O

Articles NNS O

< NFP O
FFFD NNP O
> NFP O

Zanobetti NNP O
et FW O
al FW O
. . O

The DT O
second JJ O
set NN O
of IN O
potential JJ O
predisposing VBG O
conditions NNS O
included VBD O
secondary JJ O
diagnoses NNS O
associated VBN O
with IN O
the DT O
index NN O
admission NN O
. . O

These DT O
could MD O
represent VB O
the DT O
presence NN O
of IN O
a DT O
chronic JJ O
condition NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
COPD NNP O
) -RRB- O
that WDT O
has VBZ O
not RB O
resulted VBN O
in IN O
a DT O
previous JJ O
hospital NN O
admission NN O
. . O

They PRP O
could MD O
also RB O
represent VB O
acute JJ O
conditions NNS O
that WDT O
may MD O
have VB O
increased VBN O
the DT O
subjects NNS O
' POS O
sensitivity NN O
to IN O
air NN O
pollution NN O
. . O

For IN O
example NN O
, , O
if IN O
respiratory JJ O
infections NNS O
modified VBD O
the DT O
effect NN O
of IN O
particulate NN O
matter NN O
on IN O
the DT O
cardiovascular JJ O
health NN O
of IN O
persons NNS B-Species
with IN O
underlying VBG O
heart NN O
disease NN O
, , O
then RB O
the DT O
risk NN O
of IN O
a DT O
hospital NN O
admission NN O
for IN O
heart NN O
disease NN O
might MD O
be VB O
different JJ O
in IN O
persons NNS B-Species
with IN O
infections NNS O
. . O

If IN O
this DT O
were VBD O
true JJ O
, , O
then RB O
the DT O
risk NN O
ratio NN O
of IN O
a DT O
10 CD O
- HYPH O
< SYM O
FFFD NN O
> SYM O
g NN O
/ SYM O
m3 CD O
increase NN O
of IN O
PM10 NN O
on IN O
cardiovascular JJ O
admissions NNS O
of IN O
persons NNS B-Species
with IN O
a DT O
concurrent JJ O
respiratory JJ O
infection NN O
would MD O
be VB O
different JJ O
from IN O
the DT O
ratio NN O
in IN O
persons NNS B-Species
without IN O
respiratory JJ O
infection NN O
. . O

To TO O
test VB O
these DT O
hypotheses NNS O
, , O
we PRP O
computed VBD O
separate JJ O
daily JJ O
counts NNS O
of IN O
admissions NNS O
for IN O
events NNS O
with IN O
and CC O
without IN O
the DT O
concurrent JJ O
conditions NNS O
hypothesized VBN O
to TO O
increase VB O
sensitivity NN O
to IN O
air NN O
pollution NN O
. . O

These DT O
were VBD O
taken VBN O
as IN O
the DT O
same JJ O
10 CD O
conditions NNS O
in IN O
the DT O
first JJ O
analysis NN O
with IN O
certain JJ O
exclusions NNS O
for IN O
pairing VBG O
that DT O
would MD O
be VB O
illogical JJ O
. . O

That RB O
is RB O
, , O
the DT O
concurrent JJ O
diagnosis NN O
of IN O
a DT O
specific JJ O
cardiac JJ O
condition NN O
was VBD O
not RB O
treated VBN O
as IN O
an DT O
effect NN O
modifier NN O
for IN O
admissions NNS O
for IN O
any DT O
cardiovascular JJ O
condition NN O
. . O

Likewise RB O
, , O
pneumonia NN O
and CC O
COPD NNP O
were VBD O
not RB O
possible JJ O
concurrent JJ O
conditions NNS O
for IN O
each DT O
other JJ O
. . O

The DT O
third JJ O
set NN O
of IN O
predisposing VBG O
conditions NNS O
considered VBD O
was VBD O
being VBG O
older JJR O
than IN O
75 CD O
years NNS O
of IN O
age NN O
, , O
nonwhite JJ O
, , O
and CC O
female JJ O
. . O

These DT O
were VBD O
examined VBN O
for IN O
all DT O
three CD O
outcomes NNS O
. . O

We PRP O
obtained VBD O
weather NN O
data NNS O
for IN O
O NNP O
' '' O
Hare NNP O
Airport NNP O
from IN O
the DT O
EarthInfo NNP O
CD NNP O
- HYPH O
ROM NNP O
( : O
EarthInfo NNP O
CD NNP O
NCDC NNP O
Surface NNP O
Airways NNPS O
, , O
EarthInfo NNP O
Inc NNP O
. . O
, , O
Boulder NNP O
, , O
CO NNP O
) -RRB- O
, , O
and CC O
we PRP O
obtained VBD O
air NN O
pollution NN O
data NNS O
from IN O
the DT O
U NNP O
. . O
S NNP O
. . O

Environmental NNP O
Protection NNP O
Agency NNP O
Aerometric NNP O
Information NNP O
Retrieval NNP O
System NNP O
network NN O
( : O
31 CD O
) -RRB- O
. . O

running VBG O
- HYPH O
line NN O
smoother JJR O
, , O
loess NN O
( HYPH O
35 CD O
) -RRB- O
, , O
was VBD O
chosen VBN O
to TO O
estimate VB O
the DT O
smooth JJ O
function NN O
. . O

To TO O
control VB O
for IN O
weather NN O
variables NNS O
and CC O
day NN O
of IN O
the DT O
week NN O
, , O
we PRP O
chose VBD O
the DT O
smoothing VBG O
parameter NN O
that WDT O
minimized VBD O
the DT O
Akaike NNP O
' '' O
s POS O
information NN O
criterion NN O
( SYM O
36 CD O
) -RRB- O
. . O

To TO O
model VB O
seasonality NN O
we PRP O
chose VBD O
the DT O
smoothing VBG O
parameter NN O
that WDT O
minimized VBD O
the DT O
sum NN O
of IN O
the DT O
autocorrelation NN O
of IN O
the DT O
residuals NNS O
while IN O
removing VBG O
seasonal JJ O
patterns NNS O
. . O

Two CD O
autoregressive JJ O
terms NNS O
( SYM O
37 CD O
) -RRB- O
were VBD O
added VBN O
in IN O
the DT O
model NN O
to TO O
eliminate VB O
the DT O
remaining VBG O
serial JJ O
correlation NN O
from IN O
the DT O
residuals NNS O
. . O

We PRP O
used VBD O
the DT O
mean NN O
of IN O
PM10 NN O
on IN O
the DT O
day NN O
of IN O
the DT O
admission NN O
and CC O
the DT O
day NN O
before IN O
the DT O
admission NN O
as IN O
our PRP$ O
exposure NN O
variable JJ O
. . O

This DT O
gives VBZ O
results NNS O
that WDT O
are VBP O
similar JJ O
to IN O
those DT O
obtained VBN O
fitting VBG O
a DT O
full JJ O
distributed VBN O
lag NN O
model NN O
( SYM O
38 CD O
) -RRB- O
. . O

PM10 NNP O
was VBD O
treated VBN O
linearly RB O
. . O

Our PRP$ O
baseline NN O
models NNS O
used VBD O
the DT O
daily JJ O
counts NNS O
of IN O
CVD NN O
, , O
pneumonia NN O
, , O
and CC O
COPD NNP O
admissions NNS O
as IN O
outcomes NNS O
. . O

We PRP O
then RB O
subdivided VBD O
those DT O
counts NNS O
by IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
the DT O
potential JJ O
effect NN O
modifier NN O
and CC O
reestimated VBD O
our PRP$ O
regressions NNS O
on IN O
those DT O
subgroups NNS O
. . O

We PRP O
considered VBD O
effect NN O
modification NN O
to TO O
be VB O
indicated VBN O
when WRB O
the DT O
estimates NNS O
of IN O
PM10 NNP O
in IN O
the DT O
group NN O
with IN O
the DT O
condition NN O
was VBD O
outside IN O
of IN O
the DT O
95 CD O
% NN O
confidence NN O
interval NN O
( , O
CI NNP O
) -RRB- O
of IN O
the DT O
effect NN O
estimate NN O
in IN O
persons NNS B-Species
without IN O
the DT O
condition NN O
. . O

Results NNS O
Table NNP O
1 CD O
shows VBZ O
the DT O
mean JJ O
daily JJ O
admissions NNS O
for IN O
COPD NNP O
, , O
cardiovascular JJ O
, , O
and CC O
pneumonia NN O
both CC O
overall RB O
and CC O
in IN O
the DT O
presence NN O
of IN O
the DT O
potential JJ O
effect NN O
modifiers NNS O
. . O

For IN O
some DT O
effect NN O
modifiers NNS O
such JJ O
as IN O
conduction NN O
disorders NNS O
or CC O
myocardial JJ O
infarctions NNS O
, , O
the DT O
counts NNS O
in IN O
conjunction NN O
with IN O
our PRP$ O
respiratory JJ O
outcomes NNS O
are VBP O

low JJ O
, , O
which WDT O
limits VBZ O
power NN O
. . O

In IN O
general JJ O
, , O
the DT O
numbers NNS O
are VBP O
lower JJR O
for IN O
examining VBG O
effect NN O
modification NN O
by IN O
previous JJ O
admissions NNS O
than IN O
for IN O
effect NN O
modification NN O
by IN O
concurrent JJ O
diagnosis NN O
. . O

This DT O
is VBZ O
as IN O
expected VBN O
because IN O
many JJ O
clinically RB O
relevant JJ O
comorbidities NNS O
may MD O
never RB O
have VB O
resulted VBN O
in IN O
a DT O
hospital NN O
admission NN O
. . O

Table NNP O
2 CD O
shows VBZ O
the DT O
25th JJ O
, , O
50th JJ O
, , O
and CC O
75th JJ O
percentile NN O
values NNS O
for IN O
the DT O
environmental JJ O
variables NNS O
. . O

The DT O
mean JJ O
value NN O
for IN O
PM10 NNP O
is VBZ O
33 CD O
< SYM O
FFFD NNP O
> SYM O
g NNP O
/ SYM O
m3 CD O
. . O

The DT O
daily JJ O
values NNS O
for IN O
PM10 NNP O
were VBD O
computed VBN O
as IN O
the DT O
average NN O
of IN O
10 CD O
monitors NNS O
, , O
two CD O
of IN O
which WDT O
measured VBD O
PM10 NNP O
almost RB O
every DT O
day NN O
and CC O
the DT O
others NNS O
less RBR O
frequently RB O
( : O
38 CD O
) -RRB- O
. . O

Table NN O
3 CD O
shows VBZ O
the DT O
mean JJ O
daily JJ O
counts NNS O
of IN O
CVD NN O
, , O
COPD NNP O
, , O
and CC O
pneumonia NN O
by IN O
sex NN O
, , O
age NN O
groups NNS O
, , O
and CC O
race NN O
. . O

The DT O
distribution NN O
by IN O
sex NN O
is VBZ O
almost RB O
even JJ O
, , O
although IN O
the DT O
counts NNS O
of IN O
admissions NNS O
for IN O
males NNS O
are VBP O
generally RB O
lower JJR O
( : O
approximately RB O
10 CD O
% NN O
) -RRB- O
than IN O
for IN O
females NNS O
, , O
particularly RB O
for IN O
cardiovascular JJ O
diseases NNS O
. . O

The DT O
counts NNS O
of IN O
CVD NNP O
, , O
COPD NNP O
, , O
and CC O
pneumonia NN O
admissions NNS O
were VBD O
similar JJ O
for IN O
people NNS B-Species
65 CD O
< SYM O
FFFD NNP O
> SYM O
75 CD O
or CC O
75 CD O
years NNS O
of IN O
age NN O
and CC O
older JJR O
. . O

Tables NNS O
4 CD O
< SYM O
FFFD NN O
> SYM O
6 CD O
show VBP O
the DT O
results NNS O
for IN O
the DT O
effect NN O
PM10 NN O
overall RB O
and CC O
stratifying VBG O
by IN O
concurrent JJ O
diagnosis NN O
and CC O
previous JJ O
admissions NNS O
. . O

These DT O
are VBP O
expressed VBN O
as IN O
the DT O
percentage NN O
increase NN O
for IN O
10 CD O
< SYM O
FFFD NNP O
> SYM O
g NNP O
/ SYM O
m3 CD O
PM10 NN O
. . O

Table NN O
4 CD O
shows VBZ O
the DT O
results NNS O
for IN O
CVD NNP O
. . O

A DT O
10 CD O
- HYPH O
< NN O
FFFD NN O
> SYM O
g NN O
/ SYM O
m3 CD O
increase NN O
in IN O
PM10 NN O
was VBD O
associated VBN O
with IN O
a DT O
1 CD O
. . O
31 CD O
% NN O
( SYM O
5 CD O
% NN O
CI NN O
, , O
0 CD O
. . O
97 CD O
% NN O
; : O
95 CD O
% NN O
CI NN O
, , O
1 CD O
. . O
66 CD O
% NN O
) -RRB- O
increase NN O
in IN O
hospital NN O
admissions NNS O
for IN O
heart NN O
disease NN O
in IN O
all DT O
elderly JJ O
persons NNS B-Species
. . O

A DT O
concurrent JJ O
( , O
not RB O
previous JJ O
) -RRB- O
diagnosis NN O
of IN O
COPD NNP O
modified VBD O
the DT O
risk NN O
of IN O
PM10 NN O
- HYPH O
associated VBN O
admissions NNS O
for IN O
heart NN O
disease NN O
. . O

However RB O
, , O
significant JJ O
associations NNS O
were VBD O
still RB O
seen VBN O
between IN O
PM10 NNP O

Table NN O
1 CD O
. . O

Mean JJ O
daily JJ O
counts NNS O
of IN O
admissions NNS O
, , O
Chicago NNP O
1986 CD O
< SYM O
FFFD NNP O
> SYM O
1994 CD O
, , O
for IN O
COPD NNP O
, , O
CVD NNP O
, , O
and CC O
pneumonia NN O
overall RB O
and CC O
by IN O
concurrent JJ O
diagnosis NN O
and CC O
by IN O
previous JJ O
admissions NNS O
. . O

By IN O
concurrent JJ O
diagnosis NN O
COPD NN O
CVD NN O
Pneumonia NN O
Overall JJ O
Respiratory JJ O
disease NN O
Acute JJ O
bronchitis NN O
Acute JJ O
respiratory JJ O
infections NNS O
Pneumonia NNP O
Asthma NNP O
COPD NNP O
Cardiovascular JJ O
disease NN O
CVD NN O
Conduction NN O
disorders NNS O
Cardiac JJ O
dysrhythmias NNS O
Congestive JJ O
heart NN O
failure NN O
Myocardial JJ O
infarction NN O
null NNP O
, , O
not RB O
applicable JJ O
. . O

By IN O
previous JJ O
admissions NNS O
COPD NNP O
CVD NNP O
Pneumonia NNP O
7 CD O
. . O
8 CD O
0 CD O
. . O
8 CD O
0 CD O
. . O
9 CD O
1 CD O
. . O
6 CD O
0 CD O
. . O
9 CD O
2 CD O
. . O
7 CD O
2 CD O
. . O
1 CD O
0 CD O
. . O
0 CD O
0 CD O
. . O
4 CD O
0 CD O
. . O
9 CD O
0 CD O
. . O
3 CD O
102 CD O
. . O
1 CD O
1 CD O
. . O
6 CD O
1 CD O
. . O
8 CD O
7 CD O
. . O
3 CD O
1 CD O
. . O
5 CD O
2 CD O
. . O
0 CD O
54 CD O
. . O
7 CD O
1 CD O
. . O
0 CD O
9 CD O
. . O
9 CD O
24 CD O
. . O
2 CD O
11 CD O
. . O
4 CD O
26 CD O
. . O
5 CD O
0 CD O
. . O
9 CD O
1 CD O
. . O
0 CD O
6 CD O
. . O
4 CD O
0 CD O
. . O
7 CD O
1 CD O
. . O
4 CD O
7 CD O
. . O
2 CD O
0 CD O
. . O
2 CD O
1 CD O
. . O
5 CD O
3 CD O
. . O
1 CD O
1 CD O
. . O
0 NFP O

Methods NNS O
We PRP O
analyzed VBD O
the DT O
data NNS O
with IN O
a DT O
generalized VBN O
additive JJ O
robust JJ O
Poisson NNP O
regression NN O
model NN O
( SYM O
32 CD O
) -RRB- O
. . O

This DT O
approach NN O
has VBZ O
become VBN O
the DT O
norm NN O
in IN O
such JJ O
studies NNS O
( , O
14 CD O
, , O
33 CD O
, , O
34 CD O
) -RRB- O
. . O

In IN O
the DT O
generalized VBN O
additive JJ O
model NN O
the DT O
outcome NN O
is VBZ O
assumed VBN O
to TO O
depend VB O
on IN O
a DT O
sum NN O
of IN O
nonparametric JJ O
smooth JJ O
functions NNS O
for IN O
each DT O
variable NN O
that WDT O
models VBZ O
the DT O
potential JJ O
nonlinear JJ O
dependence NN O
of IN O
daily JJ O
admission NN O
on IN O
weather NN O
and CC O
season NN O
. . O

The DT O
model NN O
is VBZ O
of IN O
the DT O
form NN O
: : O
log NN O
[ -LRB- O
E NN O
( -LRB- O
Yt NNP O
) -RRB- O
] -RRB- O
= SYM O
0 CD O
+ SYM O
S1 CD O
( SYM O
X1 CD O
) -RRB- O
+ NFP O
. . O
. . O
. . O

+ NFP O
Sp NNP O
( : O
Xp NNP O
) -RRB- O
where WRB O
E NNP O
( , O
Yt NNP O
) -RRB- O
is VBZ O
the DT O
expected VBN O
value NN O
of IN O
the DT O
daily JJ O
count NN O
of IN O
admissions NNS O
Yt NNP O
and CC O
Si NNP O
are VBP O
the DT O
smooth JJ O
functions NNS O
of IN O
the DT O
covariates NNS O
Xi NNP O
. . O

We PRP O
examined VBD O
temperature NN O
, , O
previous JJ O
day NN O
' '' O
s , O
temperature NN O
, , O
relative JJ O
humidity NN O
, , O
barometric JJ O
pressure NN O
, , O
and CC O
day NN O
of IN O
week NN O
covariates NNS O
. . O

The DT O
locally RB O
weighted VBN O

7 CD O
. . O
8 CD O
0 CD O
. . O
1 CD O
0 CD O
. . O
3 CD O
0 CD O
. . O
4 CD O
0 CD O
. . O
1 CD O
null NN O
4 CD O
. . O
7 CD O
0 CD O
. . O
2 CD O
1 CD O
. . O
4 CD O
1 CD O
. . O
8 CD O
0 CD O
. . O
1 CD O

102 CD O
. . O
1 CD O
0 CD O
. . O
9 CD O
1 CD O
. . O
3 CD O
4 CD O
. . O
0 CD O
1 CD O
. . O
8 CD O
13 CD O
. . O
4 CD O
null NN O
null NN O
null NN O
null NN O
null NN O

26 CD O
. . O
5 CD O
0 CD O
. . O
3 CD O
0 CD O
. . O
3 CD O
null NN O
0 CD O
. . O
9 CD O
6 CD O
. . O
9 CD O
14 CD O
. . O
7 CD O
0 CD O
. . O
6 CD O
4 CD O
. . O
6 CD O
7 CD O
. . O
3 CD O
0 CD O
. . O
4 CD O

Table NN O
2 CD O
. . O

25th JJ O
, , O
50th JJ O
, , O
and CC O
75th JJ O
percentile NN O
values NNS O
for IN O
the DT O
environmental JJ O
variables NNS O
in IN O
Chicago NNP O
, , O
1988 CD O
< SYM O
FFFD NNP O
> SYM O
1994 CD O
. . O

Temperature NN O
( : O
< : O
FFFD NN O
> : O
F NN O
) SYM O
35 CD O
51 CD O
67 CD O
Relative JJ O
humidity NN O
62 CD O
70 CD O
79 CD O
Barometric NN O
pressure NN O
29 CD O
. . O
2 CD O
29 CD O
. . O
3 CD O
29 CD O
. . O
4 CD O
PM10 CD O
( SYM O
< NN O
FFFD NN O
> NFP O
g NN O
/ SYM O
m3 CD O
) SYM O
23 CD O
33 CD O
46 CD O

Table NN O
3 CD O
. . O

Mean VB O
daily JJ O
counts NNS O
of IN O
admissions NNS O
by IN O
sex NN O
, , O
race NN O
, , O
and CC O
age NN O
groups NNS O
, , O
Chicago NNP O
, , O
1986 CD O
< SYM O
FFFD NNP O
> SYM O
1994 CD O
. . O

Group NN O
Overall JJ O
Female JJ O
Nonwhite JJ O
Age NN O
> : O
75 CD O
years NNS O
COPD NN O
7 CD O
. . O
8 CD O
4 CD O
. . O
2 CD O
1 CD O
. . O
6 CD O
3 CD O
. . O
7 CD O
CVD NN O
102 CD O
. . O
1 CD O
59 CD O
. . O
4 CD O
21 CD O
. . O
0 CD O
55 CD O
. . O
1 CD O
Pneumonia NN O
26 CD O
. . O
5 CD O
14 CD O
. . O
7 CD O
5 CD O
. . O
2 CD O
17 CD O
. . O
4 CD O

842 CD O

VOLUME NN O

108 CD O
| SYM O
NUMBER NNP O
9 CD O
| SYM O
September NNP O
2000 CD O
< SYM O
FFFD NNP O
> SYM O
Environmental NNP O
Health NNP O
Perspectives NNPS O

Articles NNS O

< NFP O
FFFD NNP O
> NFP O

Effects NNS O
of IN O
particles NNS O
on IN O
sensitive JJ O
subgroups NNS O

and CC O
heart NN O
disease NN O
admissions NNS O
in IN O
persons NNS B-Species
without IN O
COPD NNP O
listed VBN O
as IN O
either CC O
a DT O
comorbidity NN O
or CC O
a DT O
cause NN O
of IN O
previous JJ O
admission NN O
( : O
Table NNP O
4 CD O
) -RRB- O
. . O

A DT O
significant JJ O
association NN O
was VBD O
also RB O
seen VBN O
in IN O
persons NNS B-Species
without IN O
any DT O
respiratory JJ O
disease NN O
as IN O
a DT O
concurrent JJ O
diagnosis NN O
, , O
although IN O
the DT O
risk NN O
is VBZ O
much RB O
lower JJR O
than IN O
in IN O
persons NNS B-Species
with IN O
respiratory JJ O
disease NN O
. . O

However RB O
, , O
the DT O
risk NN O
associated VBN O
with IN O
PM10 NNP O
was VBD O
roughly RB O
doubled VBN O
in IN O
subjects NNS O
with IN O
concurrent JJ O
respiratory JJ O
infections NNS O
and CC O
the DT O
risk NN O
estimates NNS O
in IN O
those DT O
subjects NNS O
were VBD O
outside IN O
the DT O
95 CD O
% NN O
CI NN O
of IN O
the DT O
risk NN O
in IN O
patients NNS B-Species
without IN O
concurrent JJ O
respiratory JJ O
infections NNS O
. . O

A DT O
previous JJ O
admission NN O
for IN O
conduction NN O
disorders NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
heart NN O
block NN O
) -RRB- O
increased VBD O
the DT O
risk NN O
of IN O
a DT O
PM10 NN O
- HYPH O
related VBN O
subsequent JJ O
admission NN O
for IN O
any DT O
heart NN O
condition NN O
, , O
and CC O
a DT O
weaker JJR O
indication NN O
of IN O
effect NN O
modification NN O
was VBD O
seen VBN O
for IN O
persons NNS B-Species
with IN O
previous JJ O
admission NN O
for IN O
dysrhythmias NNS O
. . O

In IN O
contrast NN O
heart NN O
failure NN O
and CC O
previous JJ O
myocardial JJ O
infarctions NNS O
were VBD O
highly RB O
insignificant JJ O
as IN O
effect NN O
modifiers NNS O
. . O

Table NN O
5 CD O
shows VBZ O
the DT O
results NNS O
for IN O
COPD NNP O
. . O

Overall RB O
, , O
there EX O
is VBZ O
a DT O
1 CD O
. . O
89 CD O
% NN O
( : O
95 CD O
% NN O
CI NN O
, , O
0 CD O
. . O
8 CD O
< SYM O
FFFD NN O
> SYM O
3 CD O
. . O
0 CD O
) -RRB- O
increase NN O
in IN O
COPD NNP O
admissions NNS O
for IN O
a DT O
10 CD O
< SYM O
FFFD NN O
> SYM O
g NN O
/ SYM O
m3 CD O
increase NN O
in IN O
PM10 NN O
. . O

The DT O
results NNS O
of IN O
the DT O
stratified JJ O
analysis NN O
suggest VBP O
that IN O
preexisting VBG O
heart NN O
disease NN O
modifies VBZ O
Table NNP O
4 CD O
. . O

Percentage NN O
increase NN O
in IN O
hospital NN O
admissions NNS O
for IN O
CVD NN O
in IN O
all DT O
persons NNS B-Species
and CC O
by IN O
concurrent JJ O
diagnosis NN O
and CC O
previous JJ O
admissions NNS O
. . O

PM10 NN O
2 CD O
. . O
5 CD O
% NN O
CI NN O
97 CD O
. . O
5 CD O
% NN O
CI NN O
All DT O
persons NNS B-Species
1 CD O
. . O
31 CD O
By IN O
concurrent JJ O
diagnosis NN O
Respiratory JJ O
disease NN O
All DT O
respiratory JJ O
disease NN O
With IN O
1 CD O
. . O
65 CD O
Without IN O
0 CD O
. . O
98 CD O
Acute JJ O
bronchitis NN O
With IN O
2 CD O
. . O
50 CD O
Without IN O
1 CD O
. . O
7 CD O
Acute JJ O
respiratory JJ O
infections NNS O
With IN O
2 CD O
. . O
71 CD O
Without IN O
1 CD O
. . O
6 CD O
Pneumonia NN O
With IN O
1 CD O
. . O
95 CD O
Without IN O
1 CD O
. . O
3 CD O
COPD NN O
With IN O
1 CD O
. . O
59 CD O
Without IN O
1 CD O
. . O
8 CD O
By IN O
previous JJ O
admissions NNS O
Respiratory JJ O
disease NN O
All DT O
respiratory JJ O
disease NN O
With IN O
1 CD O
. . O
18 CD O
Without IN O
1 CD O
. . O
8 CD O
COPD NN O
With IN O
1 CD O
. . O
48 CD O
Without IN O
1 CD O
. . O
9 CD O
Asthma NN O
With IN O
1 CD O
. . O
71 CD O
Without IN O
1 CD O
. . O
8 CD O
Cardiovascular JJ O
disease NN O
Conduction NN O
disorders NNS O
With IN O
2 CD O
. . O
89 CD O
Without IN O
1 CD O
. . O
7 CD O
Cardiac JJ O
dyshrethmias NNS O
With IN O
1 CD O
. . O
61 CD O
Without IN O
1 CD O
. . O
4 CD O
0 CD O
. . O
97 CD O
1 CD O
. . O
66 CD O

the DT O
risk NN O
of IN O
COPD NNP O
admissions NNS O
on IN O
high JJ O
particle NN O
days NNS O
. . O

Previous JJ O
admissions NNS O
for IN O
any DT O
cardiovascular JJ O
disease NN O
increased VBD O
the DT O
risk NN O
of IN O
a DT O
PM10associated NNP O
COPD NNP O
admission NN O
approximately RB O
2 CD O
. . O
5 CD O
- HYPH O
fold NN O
. . O

A DT O
previous JJ O
heart NN O
failure NN O
admission NN O
caused VBD O
an DT O
even RB O
more RBR O
striking JJ O
increase NN O
in IN O
the DT O
PM10 NNP O
effect NN O
. . O

Previous JJ O
admissions NNS O
for IN O
dysrhythmias NNS O
and CC O
conduction NN O
defects NNS O
were VBD O
rare JJ O
( : O
Table NNP O
1 CD O
) -RRB- O
with IN O
no DT O
power NN O
to TO O
examine VB O
effect NN O
modifications NNS O
. . O

Listings NNS O
as IN O
concurrent JJ O
diagnoses NNS O
were VBD O
more RBR O
common JJ O
and CC O
here RB O
they PRP O
joined VBD O
heart NN O
failure NN O
in IN O
increasing VBG O
the DT O
risk NN O
of IN O
PM NNP O
10 CD O
- HYPH O
associated VBN O
COPD NNP O
admissions NNS O
. . O

For IN O
COPD NNP O
there EX O
was VBD O
also RB O
some DT O
indication NN O
that IN O
concurrent JJ O
pneumonia NN O
or CC O
an DT O
acute JJ O
respiratory JJ O
infection NN O
admission NN O
in IN O
the DT O
last JJ O
year NN O
increased VBD O
risk NN O
. . O

The DT O
low JJ O
numbers NNS O
made VBD O
these DT O
estimates NNS O
less RBR O
precise JJ O
, , O
however RB O
. . O

The DT O
percentage NN O
increase NN O
in IN O
pneumonia NN O
admission NN O
( -LRB- O
Table NNP O
6 CD O
) -RRB- O
for IN O
10 CD O
< SYM O
FFFD NN O
> SYM O
g NNP O
/ SYM O
m3 CD O
PM10 NN O
is VBZ O
higher JJR O
than IN O
for IN O
COPD NNP O
or CC O
CVD NN O
with IN O
an DT O
increase NN O
of IN O
2 CD O
. . O
34 CD O
% NN O
( : O
95 CD O
% NN O
CI NN O
, , O
1 CD O
. . O
66 CD O
< SYM O
FFFD NN O
> SYM O
3 CD O
. . O
0 CD O
) -RRB- O
. . O

As IN O
with IN O
COPD NNP O
, , O
persons NNS B-Species
with IN O
heart NN O
disease NN O
appeared VBD O
at IN O
higher JJR O
risk NN O
of IN O
pneumonia NN O
hospital NN O
admissions NNS O
associated VBN O
with IN O
particulate JJ O
air NN O
pollution NN O
. . O

Here RB O
diagnoses NNS O
suggestive JJ O
of IN O
impaired VBN O
autonomic JJ O
control NN O
of IN O
the DT O
heart NN O
, , O
such JJ O
as IN O
conduction NN O
disorders NNS O
or CC O
dysrhythmias NN O
, , O
were VBD O
associated VBN O
with IN O
increased VBN O
risk NN O
for IN O
PM NN O
10 CD O
effects NNS O
on IN O
pneumonia NN O
admissions NNS O
. . O

Unlike IN O
COPD NNP O
, , O
no DT O
difference NN O
was VBD O
seen VBN O
for IN O
congestive JJ O
heart NN O
failure NN O
. . O

Persons NNS B-Species
with IN O
asthma NN O
Table NN O
5 CD O
. . O

Percentage NN O
increase NN O
in IN O
hospital NN O
admissions NNS O
for IN O
COPD NN O
in IN O
all DT O
persons NNS B-Species
and CC O
by IN O
concurrent JJ O
diagnosis NN O
and CC O
previous JJ O
admissions NNS O
. . O

PM10 NN O
2 CD O
. . O
5 CD O
% NN O
CI NN O
97 CD O
. . O
5 CD O
% NN O
CI NN O
All DT O
persons NNS B-Species
1 CD O
. . O
89 CD O
By IN O
concurrent JJ O
diagnosis NN O
Respiratory JJ O
disease NN O
Pneumonia NN O
With IN O
4 CD O
. . O
0 CD O
Without IN O
1 CD O
. . O
51 CD O
Cardiovascular JJ O
disease NN O
Conduction NN O
disorders NNS O
With IN O
2 CD O
. . O
34 CD O
Without IN O
1 CD O
. . O
60 CD O
Cardiac JJ O
dysrhythmias NNS O
With IN O
3 CD O
. . O
9 CD O
Without IN O
1 CD O
. . O
43 CD O
Congestive JJ O
heart NN O
failure NN O
With IN O
2 CD O
. . O
90 CD O
Without IN O
1 CD O
. . O
39 CD O
By IN O
previous JJ O
admissions NNS O
Respiratory JJ O
disease NN O
Acute JJ O
respiratory JJ O
infections NNS O
With IN O
3 CD O
. . O
20 CD O
Without IN O
1 CD O
. . O
70 CD O
Cardiovascular JJ O
disease NN O
CVD NN O
With IN O
2 CD O
. . O
90 CD O
Without IN O
1 CD O
. . O
18 CD O
Congestive JJ O
heart NN O
failure NN O
With IN O
4 CD O
. . O
37 CD O
Without IN O
1 CD O
. . O
14 CD O
Within IN O
1 CD O
year NN O
6 CD O
. . O
4 CD O
0 CD O
. . O
80 CD O
2 CD O
. . O
99 CD O

had VBD O
twice PDT O
the DT O
risk NN O
of IN O
a DT O
PM10 NN O
- HYPH O
induced VBN O
pneumonia NN O
admission NN O
as IN O
persons NNS B-Species
without IN O
asthma NN O
. . O

Table NN O
7 CD O
shows VBZ O
the DT O
results NNS O
by IN O
sex NN O
, , O
age NN O
, , O
and CC O
race NN O
. . O

None NN O
of IN O
the DT O
effect NN O
size NN O
estimates NNS O
for IN O
any DT O
of IN O
the DT O
stratification NN O
variables NNS O
were VBD O
outside IN O
of IN O
the DT O
95 CD O
% NN O
CI NN O
for IN O
the DT O
opposite JJ O
strata NN O
. . O

There EX O
was VBD O
a DT O
tendency NN O
for IN O
the DT O
effect NN O
of IN O
PM10 NNP O
on IN O
CVD NNP O
admissions NNS O
to TO O
be VB O
higher JJR O
for IN O
females NNS O
, , O
whereas IN O
the DT O
effect NN O
on IN O
pneumonia NN O
admissions NNS O
was VBD O
higher JJR O
for IN O
males NNS O
. . O

In IN O
general JJ O
, , O
we PRP O
found VBD O
somewhat RB O
larger JJR O
effects NNS O
on IN O
whites NNS O
compared VBN O
to IN O
nonwhites NNS O
, , O
and CC O
for IN O
persons NNS B-Species
older JJR O
than IN O
75 CD O
years NNS O
of IN O
age NN O
compared VBN O
to IN O
younger JJR O
persons NNS B-Species
. . O

Discussion NN O
In IN O
this DT O
analysis NN O
we PRP O
examined VBD O
whether IN O
the DT O
effect NN O
of IN O
PM10 NNP O
on IN O
the DT O
risk NN O
of IN O
hospital NN O
admission NN O
for IN O
heart NN O
and CC O
lung NN O
disease NN O
was VBD O
different JJ O
depending VBG O
on IN O
the DT O
presence NN O
of IN O
comorbidities NNS O
. . O

We PRP O
found VBD O
that IN O
PM10 NNP O
was VBD O
associated VBN O
with IN O
hospital NN O
admissions NNS O
for IN O
all DT O
three CD O
causes NNS O
( , O
CVD NNP O
, , O
COPD NNP O
, , O
and CC O
pneumonia NN O
) -RRB- O
and CC O
we PRP O
found VBD O
not RB O
a DT O
general JJ O
increase NN O
in IN O
PM10 NN O
related VBN O
risk NN O
with IN O
comorbidities NNS O
, , O
but CC O
a DT O
specific JJ O
pattern NN O
that WDT O
is VBZ O
suggestive JJ O
of IN O
potential JJ O
mechanisms NNS O
and CC O
consistent JJ O
with IN O
other JJ O
recent JJ O
epidemiologic JJ O
and CC O
toxicologic JJ O
findings NNS O
. . O

One CD O
major JJ O
finding NN O
of IN O
this DT O
study NN O
is VBZ O
that IN O
preexisting VBG O
cardiovascular JJ O
disease NN O
, , O
particularly RB O
impaired VBN O
autonomic JJ O
control NN O
( , O
conduction NN O
defects NNS O
and CC O
dysrhythmias NN O
) , O
and CC O
heart NN O
failure NN O
, , O
substantially RB O
increased VBD O
the DT O
risk NN O
of IN O
respiratory JJ O
admissions NNS O
associated VBN O
with IN O
airborne JJ O
particles NNS O
. . O

In IN O
fact NN O
, , O
recent JJ O
human JJ B-Species
studies NNS O
have VBP O
shown VBN O
that IN O
exposure NN O
to IN O
particulate JJ O
air NN O
pollution NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
reduced VBN O
heart NN O
rate NN O
variability NN O
( : O
39 CD O
< SYM O
FFFD NN O
> SYM O
41 CD O
) -RRB- O
. . O

Reduced VBN O
heart NN O
rate NN O
variability NN O
is VBZ O
an DT O
adverse JJ O
response NN O
and CC O
a DT O
risk NN O
factor NN O
for IN O
arrhythmia NN O
. . O

A DT O
new JJ O
study NN O
of IN O
defibrillator NN O
discharges NNS O
in IN O
patients NNS B-Species
with IN O
implanted VBN O
cardioverter NN O
defibrillators NNS O
found VBD O
that IN O
discharges NNS O
were VBD O
associated VBN O
with IN O
air NN O
pollution NN O
( SYM O
42 CD O
) -RRB- O
. . O

Exposure NN O
to IN O
combustion NN O
Table NN O
6 CD O
. . O

Percentage NN O
increase NN O
in IN O
hospital NN O
admissions NNS O
for IN O
pneumonia NN O
in IN O
all DT O
persons NNS B-Species
and CC O
by IN O
concurrent JJ O
diagnosis NN O
and CC O
previous JJ O
admissions NNS O
. . O

PM10 NN O
All DT O
persons NNS B-Species
By IN O
concurrent JJ O
diagnosis NN O
Respiratory JJ O
disease NN O
Asthma NN O
With IN O
Without IN O
Cardiovascular JJ O
disease NN O
Conduction NN O
disorders NNS O
With IN O
Without IN O
Cardiac JJ O
dysrhythmias NN O
With IN O
Without IN O
By IN O
previous JJ O
admissions NNS O
Cardiovascular JJ O
disease NN O
Cardiac JJ O
dysrhythmias NNS O
With IN O
Without IN O
2 CD O
. . O
34 CD O
2 CD O
. . O
5 CD O
% NN O
CI NN O
97 CD O
. . O
5 CD O
% NN O
CI NN O
1 CD O
. . O
66 CD O
3 CD O
. . O
2 CD O

1 LS O
. . O
10 CD O
0 CD O
. . O
64 CD O
< SYM O
FFFD NN O
> NFP O
0 CD O
. . O
47 CD O
0 CD O
. . O
76 CD O
0 CD O
. . O
18 CD O
0 CD O
. . O
76 CD O
0 CD O
. . O
55 CD O
0 CD O
. . O
72 CD O
0 CD O
. . O
85 CD O
0 CD O
. . O
75 CD O

2 LS O
. . O
20 CD O
1 CD O
. . O
33 CD O
5 CD O
. . O
55 CD O
1 CD O
. . O
37 CD O
5 CD O
. . O
30 CD O
1 CD O
. . O
37 CD O
3 CD O
. . O
36 CD O
1 CD O
. . O
35 CD O
2 CD O
. . O
34 CD O
1 CD O
. . O
41 CD O

< NFP O
FFFD NN O
> NFP O
0 CD O
. . O
45 CD O
0 CD O
. . O
47 CD O
< SYM O
FFFD NN O
> NFP O
4 CD O
. . O
42 CD O
0 CD O
. . O
58 CD O
0 CD O
. . O
64 CD O
0 CD O
. . O
33 CD O
0 CD O
. . O
77 CD O
0 CD O
. . O
24 CD O

8 CD O
. . O
65 CD O
2 CD O
. . O
57 CD O
9 CD O
. . O
59 CD O
2 CD O
. . O
64 CD O
5 CD O
. . O
60 CD O
2 CD O
. . O
55 CD O
5 CD O
. . O
8 CD O
2 CD O
. . O
55 CD O

0 NFP O
. . O
45 CD O
0 CD O
. . O
76 CD O
< SYM O
FFFD NN O
> NFP O
0 CD O
. . O
40 CD O
0 CD O
. . O
78 CD O
< SYM O
FFFD NN O
> NFP O
0 CD O
. . O
43 CD O
0 CD O
. . O
77 CD O
0 CD O
. . O
22 CD O
0 CD O
. . O
76 CD O
0 CD O
. . O
75 CD O
0 CD O
. . O
72 CD O

1 LS O
. . O
91 CD O
1 CD O
. . O
41 CD O
3 CD O
. . O
40 CD O
1 CD O
. . O
40 CD O
3 CD O
. . O
89 CD O
1 CD O
. . O
39 CD O
5 CD O
. . O
63 CD O
1 CD O
. . O
38 CD O
2 CD O
. . O
48 CD O
1 CD O
. . O
36 CD O

4 CD O
. . O
18 CD O
2 CD O
. . O
7 CD O
7 CD O
. . O
92 CD O
1 CD O
. . O
99 CD O
< SYM O
FFFD NNP O
> NFP O
< : O
FFFD NN O
> NFP O

1 LS O
. . O
1 CD O
1 CD O
. . O
46 CD O
4 CD O
. . O
28 CD O
1 CD O
. . O
37 CD O
< SYM O
FFFD NNP O
> NFP O
< : O
FFFD NN O
> NFP O

7 CD O
. . O
46 CD O
2 CD O
. . O
69 CD O
11 CD O
. . O
69 CD O
2 CD O
. . O
61 CD O
< NN O
FFFD NN O
> : O
< : O
FFFD NN O
> NFP O

< NFP O
FFFD NN O
> NFP O
1 CD O
. . O
38 CD O
0 CD O
. . O
66 CD O
0 CD O
. . O
99 CD O
< SYM O
FFFD NN O
> NFP O
0 CD O
. . O
1 CD O
1 CD O
. . O
43 CD O
0 CD O
. . O
5 CD O
2 CD O
. . O
10 CD O

8 CD O
. . O
1 CD O
2 CD O
. . O
76 CD O
4 CD O
. . O
85 CD O
2 CD O
. . O
39 CD O
7 CD O
. . O
40 CD O
2 CD O
. . O
24 CD O
10 CD O
. . O
14 CD O

3 LS O
. . O
47 CD O
2 CD O
. . O
8 CD O

1 LS O
. . O
21 CD O
1 CD O
. . O
45 CD O

5 LS O
. . O
79 CD O
2 CD O
. . O
71 CD O

Increases NNS O
are VBP O
for IN O
a DT O
10 CD O
- HYPH O
< SYM O
FFFD NN O
> SYM O
g NN O
/ SYM O
m3 CD O
increase NN O
in IN O
PM10 NNP O
. . O

Increases NNS O
are VBP O
for IN O
a DT O
10 CD O
- HYPH O
< SYM O
FFFD NN O
> SYM O
g NN O
/ SYM O
m3 CD O
increase NN O
in IN O
PM10 NNP O
. . O

Increases NNS O
are VBP O
for IN O
a DT O
10 CD O
- HYPH O
< SYM O
FFFD NN O
> SYM O
g NN O
/ SYM O
m3 CD O
increase NN O
in IN O
PM10 NNP O
. . O

Environmental NNP O
Health NNP O
Perspectives NNPS O

< NFP O
FFFD NNP O
> : O
VOLUME NN O
108 CD O
| : O
NUMBER NN O
9 CD O
| SYM O
September NNP O
2000 CD O

843 CD O

Articles NNS O

< NFP O
FFFD NNP O
> NFP O

Zanobetti NNP O
et FW O
al FW O
. . O

Table NN O
7 CD O
. . O

Effect NN O
modification NN O
by IN O
sex NN O
, , O
race NN O
, , O
and CC O
age NN O
groups NNS O
for IN O
10 CD O
< SYM O
FFFD NNP O
> SYM O
g NNP O
/ SYM O
m3 CD O
PM10 NN O
. . O

% NN O
All DT O
persons NNS B-Species
Male JJ O
Female JJ O
White JJ O
Non JJ O
- HYPH O
white JJ O
Age NN O
> : O
75 CD O
Age NN O
75 CD O
1 CD O
. . O
89 CD O
1 CD O
. . O
34 CD O
2 CD O
. . O
19 CD O
1 CD O
. . O
65 CD O
1 CD O
. . O
7 CD O
2 CD O
. . O
20 CD O
1 CD O
. . O
33 CD O
COPD NN O
( : O
95 CD O
% NN O
CI NN O
) -RRB- O
( : O
0 CD O
. . O
80 CD O
, , O
2 CD O
. . O
99 CD O
) -RRB- O
( : O
< : O
FFFD NN O
> : O
0 CD O
. . O
14 CD O
, , O
2 CD O
. . O
84 CD O
) NFP O
( : O
0 CD O
. . O
81 CD O
, , O
3 CD O
. . O
59 CD O
) -RRB- O
( : O
0 CD O
. . O
51 CD O
, , O
2 CD O
. . O
81 CD O
) -RRB- O
( : O
< : O
FFFD NN O
> : O
1 CD O
. . O
11 CD O
, , O
3 CD O
. . O
3 CD O
) NFP O
( : O
0 CD O
. . O
72 CD O
, , O
3 CD O
. . O
69 CD O
) NFP O
( : O
0 CD O
. . O
3 CD O
, , O
2 CD O
. . O
65 CD O
) SYM O
% NN O
1 CD O
. . O
31 CD O
1 CD O
. . O
7 CD O
1 CD O
. . O
21 CD O
1 CD O
. . O
20 CD O
0 CD O
. . O
70 CD O
1 CD O
. . O
28 CD O
0 CD O
. . O
93 CD O
CVD NN O
( : O
95 CD O
% NN O
CI NN O
) -RRB- O
( , O
0 CD O
. . O
97 CD O
, , O
1 CD O
. . O
66 CD O
) NFP O
( : O
0 CD O
. . O
62 CD O
, , O
1 CD O
. . O
51 CD O
) NFP O
( : O
0 CD O
. . O
83 CD O
, , O
1 CD O
. . O
6 CD O
) SYM O
( : O
0 CD O
. . O
86 CD O
, , O
1 CD O
. . O
55 CD O
) NFP O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
3 CD O
) NFP O
( SYM O
0 CD O
. . O
88 CD O
, , O
1 CD O
. . O
69 CD O
) NFP O
( : O
0 CD O
. . O
51 CD O
, , O
1 CD O
. . O
35 CD O
) SYM O
% NN O
2 CD O
. . O
34 CD O
2 CD O
. . O
65 CD O
1 CD O
. . O
91 CD O
2 CD O
. . O
45 CD O
1 CD O
. . O
91 CD O
2 CD O
. . O
12 CD O
2 CD O
. . O
52 CD O
Pneumonia NN O
( : O
95 CD O
% NN O
CI NN O
) -RRB- O
( , O
1 CD O
. . O
66 CD O
, , O
3 CD O
. . O
2 CD O
) -RRB- O
( : O
1 CD O
. . O
81 CD O
, , O
3 CD O
. . O
5 CD O
) SYM O
( : O
1 CD O
. . O
11 CD O
, , O
2 CD O
. . O
72 CD O
) NFP O
( : O
1 CD O
. . O
77 CD O
, , O
3 CD O
. . O
14 CD O
) NFP O
( : O
0 CD O
. . O
69 CD O
, , O
3 CD O
. . O
14 CD O
) -RRB- O
( : O
1 CD O
. . O
38 CD O
, , O
2 CD O
. . O
86 CD O
) -RRB- O
( : O
1 CD O
. . O
57 CD O
, , O
3 CD O
. . O
48 CD O
) -RRB- O

Figures NNS O
shown VBN O
are VBP O
the DT O
percentage NN O
increase NN O
in IN O
admissions NNS O
( : O
95 CD O
% NN O
CI NN O
) -RRB- O
. . O

particles NNS O
has VBZ O
also RB O
been VBN O
associated VBN O
with IN O
arrhythmia NN O
in IN O
an DT O
animal NN O
model NN O
( , O
43 CD O
) -RRB- O
and CC O
changes NNS O
in IN O
ST NNP O
segments NNS O
have VBP O
been VBN O
noted VBN O
as RB O
well RB O
( HYPH O
44 CD O
) -RRB- O
. . O

This DT O
is VBZ O
the DT O
first JJ O
study NN O
to TO O
suggest VB O
persons NNS B-Species
with IN O
defects NNS O
in IN O
the DT O
electrical JJ O
control NN O
of IN O
the DT O
heart NN O
are VBP O
also RB O
at IN O
higher JJR O
risk NN O
of IN O
respiratory JJ O
illness NN O
after IN O
exposure NN O
to IN O
airborne JJ O
particles NNS O
. . O

These DT O
data NNS O
also RB O
suggest VBP O
that IN O
persons NNS B-Species
admitted VBN O
to IN O
hospitals NNS O
for IN O
pneumonia NN O
during IN O
an DT O
air NN O
pollution NN O
episode NN O
may MD O
be VB O
at IN O
high JJ O
risk NN O
for IN O
clinically RB O
significant JJ O
conduction NN O
disorders NNS O
during IN O
that DT O
hospital NN O
admission NN O
. . O

Patients NNS B-Species
with IN O
congestive JJ O
heart NN O
failure NN O
were VBD O
at IN O
greater JJR O
risk NN O
of IN O
hospital NN O
admissions NNS O
for IN O
COPD NN O
in IN O
association NN O
with IN O
airborne JJ O
particles NNS O
. . O

Heart NN O
failure NN O
and CC O
COPD NN O
is VBZ O
not RB O
an DT O
uncommon JJ O
combination NN O
. . O

The DT O
finding NN O
that IN O
these DT O
patients NNS B-Species
are VBP O
at IN O
higher JJR O
risk NN O
for IN O
admissions NNS O
associated VBN O
with IN O
particulate JJ O
air NN O
pollution NN O
is VBZ O
new JJ O
but CC O
is VBZ O
also RB O
consistent JJ O
with IN O
several JJ O
other JJ O
recent JJ O
reports NNS O
. . O

The DT O
spontaneous JJ O
hypertensive JJ O
rat NN B-Species
develops VBZ O
a DT O
model NN O
of IN O
heart NN O
failure NN O
, , O
and CC O
recent JJ O
studies NNS O
have VBP O
reported VBN O
greater JJR O
sensitivity NN O
to IN O
particulate JJ O
air NN O
pollution NN O
in IN O
these DT O
rats NNS B-Species
. . O

These DT O
include VBP O
both DT O
electrocardiogram NN O
abnormalities NNS O
( : O
44 CD O
) , O
and CC O
pulmonary JJ O
toxicity NN O
( SYM O
45 CD O
, , O
46 CD O
) -RRB- O
. . O

Similarly RB O
, , O
in IN O
an DT O
epidemiologic JJ O
study NN O
, , O
Hoek NNP O
et FW O
al NNP O
. . O

( SYM O
47 CD O
) -RRB- O
, , O
found VBD O
a DT O
higher JJR O
relative JJ O
risk NN O
of IN O
death NN O
with IN O
an DT O
increase NN O
in IN O
PM10 NN O
for IN O
congestive JJ O
heart NN O
failure NN O
deaths NNS O
than IN O
other JJ O
deaths NNS O
. . O

The DT O
potential JJ O
role NN O
of IN O
COPD NN O
in IN O
those DT O
heart NN O
failure NN O
deaths NNS O
was VBD O
not RB O
examined VBN O
. . O

Another DT O
consistent JJ O
pattern NN O
in IN O
our PRP$ O
data NNS O
is VBZ O
of IN O
acute JJ O
respiratory JJ O
infections NNS O
increasing VBG O
susceptibility NN O
to IN O
airborne JJ O
particles NNS O
. . O

Acute JJ O
bronchitis NN O
, , O
or CC O
more RBR O
generally RB O
acute JJ O
upper JJ O
respiratory JJ O
illnesses NNS O
, , O
as RB O
well RB O
as IN O
pneumonia NN O
, , O
increased VBN O
susceptibility NN O
to IN O
particle NN O
- HYPH O
associated VBN O
admissions NNS O
for IN O
CVD NN O
and CC O
COPD NNP O
. . O

The DT O
notion NN O
that IN O
air NN O
pollution NN O
exacerbates VBZ O
acute JJ O
respiratory JJ O
infections NNS O
is VBZ O
well RB O
supported VBN O
by IN O
studies NNS O
which WDT O
report VBP O
associations NNS O
between IN O
airborne JJ O
particles NNS O
and CC O
hospital NN O
admissions NNS O
for IN O
respiratory JJ O
infections NNS O
( SYM O
48 CD O
, , O
49 CD O
) -RRB- O
. . O

Zelikoff NNP O
et FW O
al NN O
. . O

( : O
50 CD O
) -RRB- O
exposed VBD O
rats NNS B-Species
infected VBN O
with IN O
streptococcus NN O
to IN O
concentrated VBN O
air NN O
particles NNS O
and CC O
reported VBD O
a DT O
significant JJ O
increase NN O
in IN O
bacterial JJ O
burdens NNS O
and CC O
in IN O
the DT O
extent NN O
of IN O
pneumonia NN O
compared VBN O
to IN O
animals NNS O
exposed VBN O
to IN O
filtrated JJ O
air NN O
. . O

This DT O
suggests VBZ O
an DT O
impaired VBN O
immune JJ O
response NN O
. . O

Similarly RB O
, , O
exposure NN O
to IN O
combustion NN O

particles NNS O
enhances VBZ O
influenza NN O
infections NNS O
in IN O
mice NNS B-Species
( SYM O
51 CD O
) -RRB- O
. . O

An DT O
impaired JJ O
defense NN O
to IN O
respiratory JJ O
infection NN O
is VBZ O
a DT O
major JJ O
reason NN O
that IN O
persons NNS B-Species
with IN O
COPD NNP O
require VBP O
hospital NN O
admission NN O
. . O

If IN O
airborne JJ O
particles NNS O
result VBP O
in IN O
further JJ O
impairment NN O
the DT O
effect NN O
modification NN O
we PRP O
observe VBP O
makes VBZ O
good JJ O
sense NN O
. . O

The DT O
effect NN O
modification NN O
for IN O
heart NN O
disease NN O
admissions NNS O
is VBZ O
more RBR O
relevant JJ O
. . O

This DT O
modification NN O
is VBZ O
consistent JJ O
with IN O
the DT O
earlier JJR O
report NN O
of IN O
Schwartz NNP O
( SYM O
19 CD O
) -RRB- O
, , O
who WP O
found VBD O
greater JJR O
reports NNS O
of IN O
respiratory JJ O
complications NNS O
on IN O
death NN O
certificates NNS O
with IN O
an DT O
underlying JJ O
cause NN O
of IN O
heart NN O
disease NN O
if IN O
the DT O
death NN O
occurred VBD O
on IN O
a DT O
day NN O
with IN O
high JJ O
levels NNS O
of IN O
airborne JJ O
particles NNS O
. . O

Although IN O
airborne JJ O
particle NN O
exposure NN O
has VBZ O
been VBN O
associated VBN O
with IN O
increased VBN O
exacerbation NN O
of IN O
asthma NN O
( , O
2 CD O
, , O
12 CD O
, , O
48 CD O
, , O
52 CD O
< SYM O
FFFD NNP O
> SYM O
59 CD O
) -RRB- O
, , O
this DT O
paper NN O
is VBZ O
the DT O
first JJ O
to TO O
suggest VB O
that IN O
asthmatics NNS O
are VBP O
more RBR O
susceptible JJ O
to IN O
PM10 NNP O
- HYPH O
induced VBN O
pneumonia NN O
exacerbation NN O
or CC O
to IN O
cardiovascular JJ O
effects NNS O
. . O

The DT O
effects NNS O
on IN O
pneumonia NN O
admissions NNS O
are VBP O
plausible JJ O
, , O
given VBN O
the DT O
impaired JJ O
ability NN O
to TO O
fight VB O
off RP O
infections NNS O
in IN O
asthmatics NNS O
with IN O
mucus NN O
plugs NNS O
and CC O
the DT O
evidence NN O
the DT O
airborne JJ O
particles NNS O
impair VBP O
the DT O
lungs NNS O
' POS O
ability NN O
to TO O
fight VB O
off RP O
bacterial JJ O
and CC O
viral JJ O
infections NNS O
, , O
as IN O
noted VBN O
earlier RBR O
. . O

The DT O
increased JJ O
cardiovascular JJ O
sensitivity NN O
, , O
albeit IN O
weaker JJR O
, , O
is VBZ O
interesting JJ O
. . O

If IN O
airborne JJ O
particles NNS O
affect VBP O
the DT O
cardiovascular JJ O
system NN O
via IN O
the DT O
role NN O
of IN O
the DT O
lung NN O
in IN O
autonomic JJ O
control NN O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
asthmatics NNS O
would MD O
be VB O
more RBR O
sensitive JJ O
to IN O
those DT O
effects NNS O
. . O

Animal NN O
models NNS O
of IN O
asthma NN O
showed VBD O
that IN O
combustion NN O
particles NNS O
enhance VBP O
the DT O
asthmatic JJ O
response NN O
to IN O
aeroallergen NN O
challenges NNS O
( SYM O
59 CD O
) -RRB- O
. . O

This DT O
suggests VBZ O
an DT O
enhancement NN O
of IN O
pulmonary JJ O
response NN O
in IN O
asthmatics NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
diagnosis NN O
of IN O
asthma NN O
is VBZ O
problematic JJ O
in IN O
the DT O
elderly JJ O
, , O
and CC O
crossover NN O
with IN O
COPD NNP O
is VBZ O
possible JJ O
. . O

The DT O
possibility NN O
that IN O
this DT O
explains VBZ O
our PRP$ O
results NNS O
is VBZ O
reduced VBN O
by IN O
our PRP$ O
failure NN O
to TO O
find VB O
previous JJ O
hospital NN O
admission NN O
for IN O
COPD NNP O
was VBD O
an DT O
effect NN O
modifier NN O
for IN O
the DT O
effect NN O
of IN O
particles NNS O
on IN O
cardiovascular JJ O
admissions NNS O
. . O

We PRP O
must MD O
acknowledge VB O
several JJ O
potential JJ O
limitations NNS O
of IN O
this DT O
study NN O
. . O

First RB O
, , O
we PRP O
considered VBD O
only RB O
previous JJ O
admissions NNS O
that WDT O
occurred VBD O
within IN O
Cook NNP O
County NNP O
. . O

Hence RB O
persons NNS B-Species
with IN O
previous JJ O
admissions NNS O
elsewhere RB O
would MD O
be VB O
misclassified VBN O
to IN O
our PRP$ O
reference NN O
group NN O
. . O

The DT O
effect NN O
of IN O
this DT O
would MD O
be VB O
to TO O
reduce VB O
the DT O
difference NN O
in IN O
PM NNP O
10 CD O
effect NN O
between IN O
the DT O
two CD O
groups NNS O
. . O

VOLUME NN O

Nevertheless RB O
, , O
we PRP O
identified VBD O
some DT O
interesting JJ O
interactions NNS O
. . O

We PRP O
cannot MD O
exclude VB O
the DT O
possibility NN O
that IN O
there EX O
are VBP O
areas NNS O
we PRP O
missed VBD O
for IN O
this DT O
reason NN O
. . O

We PRP O
also RB O
examined VBD O
interactions NNS O
in IN O
a DT O
log NN O
relative JJ O
risk NN O
model NN O
, , O
which WDT O
is VBZ O
inherently RB O
multiplicative JJ O
. . O

Although IN O
we PRP O
believe VBP O
this DT O
is VBZ O
justified VBN O
because IN O
doubling VBG O
the DT O
population NN O
exposed VBN O
would MD O
be VB O
expected VBN O
to TO O
double VB O
the DT O
pollution NN O
associated VBN O
admissions NNS O
, , O
it PRP O
results VBZ O
in IN O
a DT O
more RBR O
conservative JJ O
definition NN O
of IN O
interaction NN O
than IN O
would MD O
an DT O
additive JJ O
risk NN O
model NN O
. . O

Finally RB O
, , O
our PRP$ O
exposure NN O
is VBZ O
clearly RB O
measured VBN O
with IN O
error NN O
. . O

Most JJS O
of IN O
this DT O
error NN O
is VBZ O
Berkson NNP O
error NN O
( SYM O
60 CD O
) -RRB- O
and CC O
hence RB O
will MD O
introduce VB O
no DT O
bias NN O
, , O
and CC O
Zeger NNP O
et NN O
al NN O
. . O

( : O
60 CD O
) SYM O
showed VBD O
that IN O
the DT O
remaining VBG O
error NN O
would MD O
have VB O
to TO O
have VB O
pathologic JJ O
correlations NNS O
with IN O
other JJ O
variables NNS O
to TO O
result VB O
in IN O
an DT O
upward JJ O
bias NN O
. . O

Another DT O
important JJ O
result NN O
from IN O
this DT O
study NN O
, , O
of IN O
course NN O
, , O
is VBZ O
an DT O
estimate NN O
of IN O
the DT O
magnitude NN O
of IN O
the DT O
effect NN O
of IN O
airborne JJ O
particles NNS O
on IN O
public JJ O
health NN O
. . O

The DT O
PM10 NNP O
concentrations NNS O
in IN O
Chicago NNP O
during IN O
this DT O
period NN O
were VBD O
associated VBN O
with IN O
approximately RB O
1 CD O
, , O
600 CD O
additional JJ O
admissions NNS O
per IN O
year NN O
for IN O
heart NN O
disease NN O
, , O
740 CD O
additional JJ O
admissions NNS O
per IN O
year NN O
for IN O
pneumonia NN O
, , O
and CC O
170 CD O
additional JJ O
admissions NNS O
per IN O
year NN O
for IN O
COPD NNP O
. . O

These DT O
are VBP O
not RB O
trivial JJ O
increases NNS O
in IN O
serious JJ O
morbidity NN O
. . O

The DT O
results NNS O
of IN O
our PRP$ O
study NN O
should MD O
be VB O
replicated VBN O
in IN O
additional JJ O
cities NNS O
, , O
although IN O
they PRP O
do VBP O
begin VB O
to TO O
fill VB O
in RP O
some DT O
missing VBG O
information NN O
about IN O
the DT O
effects NNS O
of IN O
airborne JJ O
particles NNS O
on IN O
health NN O
. . O

More RBR O
generally RB O
airborne JJ O
particles NNS O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
broad JJ O
range NN O
of IN O
systemic JJ O
changes NNS O
including VBG O
heart NN O
rate NN O
variability NN O
( , O
39 CD O
< SYM O
FFFD NN O
> SYM O
41 CD O
) -RRB- O
, , O
increased VBN O
peripheral JJ O
neutrophils NNS O
( , O
61 CD O
< SYM O
FFFD NNP O
> SYM O
63 CD O
) -RRB- O
, , O
increased VBN O
plasma NN O
viscosity NN O
( , O
64 CD O
) -RRB- O
, , O
an DT O
increase NN O
in IN O
blood NN O
pressure NN O
( SYM O
65 CD O
) -RRB- O
, , O
and CC O
the DT O
outcomes NNS O
mentioned VBN O
previously RB O
. . O

The DT O
role NN O
of IN O
these DT O
systemic JJ O
changes NNS O
as IN O
potential JJ O
sources NNS O
of IN O
the DT O
specific JJ O
effect NN O
modifications NNS O
we PRP O
have VBP O
seen VBN O
should MD O
be VB O
an DT O
area NN O
of IN O
fruitful JJ O
research NN O
in IN O
the DT O
future NN O
. . O

REFERENCES NNS O
AND CC O
NOTES NNS O
1 CD O
. . O

Katsouyanni NNP O
K NNP O
, , O
Touloumi NNP O
G NNP O
, , O
Spix NNP O
C NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Balducci NNP O
F NNP O
, , O
Medina NNP O
S NNP O
, , O
Rossi NNP O
G NNP O
, , O
Wojtyniak NNP O
D NNP O
, , O
Sunyer NNP O
J NNP O
, , O
Bacharova NNP O
L NNP O
, , O
et FW O
al NNP O
. . O

Short JJ O
term NN O
effects NNS O
of IN O
ambient JJ O
sulphur NN O
dioxide NN O
and CC O
particulate NN O
matter NN O
on IN O
mortality NN O
in IN O
12 CD O
European JJ O
cities NNS O
: : O
results NNS O
from IN O
time NN O
series NN O
data NNS O
from IN O
the DT O
APHEA NNP O
project NN O
. . O

Br NNP O
Med NNP O
J NNP O
314 CD O
: : O
1658 CD O
< SYM O
FFFD NNP O
> SYM O
1663 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

Pope NNP O
CA NNP O
, , O
Dockery NNP O
DW NNP O
, , O
Schwartz NNP O
J NNP O
. . O
Review NN O
of IN O
epidemiologic JJ O
evidence NN O
of IN O
health NN O
effects NNS O
of IN O
particulate JJ O
air NN O
pollution NN O
. . O

Inhal NNP O
Toxicol NNP O
7 CD O
: : O
1 CD O
< SYM O
FFFD NNP O
> SYM O
18 CD O
( SYM O
1995 CD O
) -RRB- O
. . O

Schwartz NNP O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
daily JJ O
mortality NN O
: : O
a DT O
review NN O
and CC O
meta NN O
analysis NN O
. . O

Environ NNP O
Res NNP O
64 CD O
: : O
36 CD O
< SYM O
FFFD NNP O
> SYM O
52 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Dominici NNP O
F NNP O
, , O
Samet NNP O
J NNP O
, , O
Zeger NNP O
SL NNP O
. . O

Combining VBG O
evidence NN O
on IN O
air NN O
pollution NN O
and CC O
daily JJ O
mortality NN O
from IN O
the DT O
largest JJS O
20 CD O
US NNP O
cities NNS O
: : O
a DT O
hierarchical JJ O
modeling NN O
strategy NN O
. . O

R NNP O
Stat NNP O
Soc NNP O
Ser NNP O
A NNP O
, , O
in IN O
press NN O
. . O

Burnett NNP O
RT NNP O
, , O
Dales NNP O
RE NNP O
, , O
Raizenne NNP O
ME NNP O
, , O
Krewski NNP O
D NNP O
, , O
Summers NNP O
PW NNP O
, , O
Roberts NNP O
GR NNP O
, , O
Raad NNP O
- HYPH O
Young NNP O
M NNP O
, , O
Dann NNP O
T NNP O
, , O
Brooke NNP O
T NNP O
. , O
Effects NNS O
of IN O
low JJ O
ambient JJ O
levels NNS O
of IN O
ozone NN O
and CC O
sulfates NNS O
on IN O
the DT O
frequency NN O
of IN O
respiratory JJ O
admissions NNS O
to IN O
Ontario NNP O
hospitals NNS O
. . O

Environ NNP O
Res NNP O
65 CD O
: : O
172 CD O
< SYM O
FFFD NNP O
> SYM O
194 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Anderson NNP O
HR NNP O
, , O
Spix NNP O
C NNP O
, , O
Medina NNP O
S NNP O
, , O
Schouten NNP O
JP NNP O
, , O
Castellsague NNP O
J NNP O
, , O
Rossi NNP O
G NNP O
, , O
Zmirou NNP O
D NNP O
, , O
Touloumi NNP O
G NNP O
, , O
Wojtyniak NNP O
B NNP O
, , O
Ponka NNP O
A NNP O
, , O
et FW O
al NNP O
. . O

Air NN O
pollution NN O
and CC O
daily JJ O
admissions NNS O
for IN O

2 LS O
. . O

3 LS O
. . O

4 LS O
. . O

5 LS O
. . O

6 LS O
. . O

844 CD O

108 CD O
| SYM O
NUMBER NNP O
9 CD O
| SYM O
September NNP O
2000 CD O
< SYM O
FFFD NNP O
> SYM O
Environmental NNP O
Health NNP O
Perspectives NNPS O

Articles NNS O

< NFP O
FFFD NNP O
> NFP O

Effects NNS O
of IN O
particles NNS O
on IN O
sensitive JJ O
subgroups NNS O

7 LS O
. . O

8 LS O
. . O

9 LS O
. . O

10 CD O
. . O

11 CD O
. . O

12 CD O
. . O

13 CD O
. . O

14 CD O
. . O

15 CD O
. . O

16 CD O
. . O

17 CD O
. . O

18 CD O
. . O

19 CD O
. . O

20 CD O
. . O

21 CD O
. . O

22 CD O
. . O

23 CD O
. . O

24 CD O
. . O

25 CD O
. . O

26 CD O
. . O

27 CD O
. . O

28 CD O
. . O

29 CD O
. . O

30 CD O
. . O

chronic JJ O
obstructive JJ O
pulmonary NN O
disease NN O
in IN O
6 CD O
European JJ O
cities NNS O
: : O
results NNS O
from IN O
the DT O
APHEA NNP O
project NN O
. . O

Eur NN O
Respir NN O
J NNP O
10 CD O
: : O
1064 CD O
< SYM O
FFFD NNP O
> SYM O
1071 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

Schwartz NNP O
J NNP O
. . O
Short JJ O
term NN O
fluctuations NNS O
in IN O
air NN O
pollution NN O
and CC O
hospital NN O
admissions NNS O
of IN O
the DT O
elderly JJ O
for IN O
respiratory JJ O
disease NN O
. . O

Thorax NNP O
50 CD O
: : O
531 CD O
< SYM O
FFFD NNP O
> SYM O
538 CD O
( SYM O
1995 CD O
) -RRB- O
. . O

Schwartz NNP O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
hospital NN O
admissions NNS O
for IN O
heart NN O
disease NN O
in IN O
eight CD O
U NNP O
. . O
S NNP O
. . O
counties NNS O
. . O

Epidemiology NN O
10 CD O
: : O
17 CD O
< SYM O
FFFD NNP O
> SYM O
22 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

Schwartz NNP O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
hospital NN O
admissions NNS O
for IN O
the DT O
elderly JJ O
in IN O
Minneapolis NNP O
. . O

Arch NNP O
Environ NNP O
Health NNP O
49 CD O
: : O
366 CD O
< SYM O
FFFD NNP O
> SYM O
374 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Schwartz NNP O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
hospital NN O
admissions NNS O
for IN O
the DT O
elderly JJ O
in IN O
Birmingham NNP O
, , O
Alabama NNP O
. . O

Am NN O
J NNP O
Epidemiol NNP O
139 CD O
: : O
589 CD O
< SYM O
FFFD NNP O
> SYM O
598 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Schwartz NNP O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
hospital NN O
admissions NNS O
for IN O
the DT O
elderly JJ O
in IN O
Detroit NNP O
, , O
MI NNP O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
150 CD O
: : O
648 CD O
< SYM O
FFFD NNP O
> SYM O
655 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Pope NNP O
CA NNP O
III NNP O
. . O

Respiratory JJ O
disease NN O
associated VBN O
with IN O
community NN O
air NN O
pollution NN O
and CC O
a DT O
steel NN O
mill NN O
, , O
Utah NNP O
valley NN O
. . O

Am NNP O
J NNP O
Public NNP O
Health NNP O
79 CD O
: : O
623 CD O
< SYM O
FFFD NNP O
> SYM O
628 CD O
( SYM O
1989 CD O
) -RRB- O
. . O

Saldiva NNP O
PH NNP O
, , O
Pope NNP O
CA NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Dockery NNP O
DW NNP O
, , O
Lichtenfels NNP O
AJ NNP O
, , O
Salge NNP O
JM NNP O
, , O
Barone NNP O
I NNP O
, , O
Bohm NNP O
GM NNP O
. . O

Air NN O
pollution NN O
and CC O
mortality NN O
in IN O
elderly JJ O
people NNS B-Species
: : O
a DT O
time NN O
series NN O
study NN O
in IN O
Sao NNP O
Paulo NNP O
, , O
Brazil NNP O
. . O

Arch NNP O
Environ NNP O
Health NNP O
50 CD O
: : O
159 CD O
< SYM O
FFFD NNP O
> SYM O
163 CD O
( SYM O
1995 CD O
) -RRB- O
. . O

Schwartz NNP O
, , O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
hospital NN O
admissions NNS O
for IN O
cardiovascular JJ O
disease NN O
in IN O
Tucson NNP O
. . O

Epidemiology NN O
8 CD O
: : O
371 CD O
< SYM O
FFFD NNP O
> SYM O
177 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

Delfino NNP O
RJ NNP O
, , O
Murphy NNP O
Moulton NNP O
AM NNP O
, , O
Becklake NNP O
MR NNP O
. . O

Emergency NN O
room NN O
visits NNS O
for IN O
respiratory JJ O
illnesses NNS O
among IN O
the DT O
elderly JJ O
in IN O
Montreal NNP O
: : O
association NN O
with IN O
low JJ O
level NN O
ozone NN O
exposure NN O
. . O

Environ NNP O
Res NNP O
76 CD O
: : O
67 CD O
< SYM O
FFFD NNP O
> SYM O
77 CD O
( SYM O
1998 CD O
) -RRB- O
. . O

National NNP O
Research NNP O
Council NNP O
. . O

Research NNP O
Priorities NNPS O
for IN O
Airborne NNP O
Particulate NNP O
Matter NNP O
. . O

Washington NNP O
, , O
DC NNP O
: : O
National NNP O
Academy NNP O
Press NNP O
, , O
1998 CD O
. . O

Schwartz NNP O
J NNP O
, , O
Dockery NNP O
DW NNP O
. . O

Increased VBN O
mortality NN O
in IN O
Philadelphia NNP O
associated VBN O
with IN O
daily JJ O
air NN O
pollution NN O
concentrations NNS O
. . O

Am VBP O
Rev NNP O
Respir NNP O
Dis NNP O
145 CD O
: : O
600 CD O
< SYM O
FFFD NNP O
> SYM O
604 CD O
( SYM O
1992 CD O
) -RRB- O
. . O

Samet NNP O
JM NNP O
, , O
Zeger NNP O
SL NNP O
, , O
Berhane NNP O
K NNP O
. . O

The DT O
association NN O
of IN O
mortality NN O
and CC O
particulate NN O
air NN O
pollution NN O
. . O

In IN O
: : O
Particulate NNP O
Air NN O
Pollution NN O
and CC O
Daily NNP O
Mortality NNP O
. . O

The DT O
Phase NNP O
I NNP O
Report NNP O
of IN O
the DT O
Particle NNP O
Epidemiology NNP O
Evaluation NNP O
Project NNP O
. . O

Boston NNP O
, , O
MA NNP O
: : O
Health NNP O
Effects NNPS O
Institute NNP O
, , O
1995 CD O
. . O

Schwartz NNP O
J NNP O
. . O
What WP O
are VBP O
people NNS B-Species
dying VBG O
of IN O
on IN O
high JJ O
air NN O
pollution NN O
days NNS O
? . O

Environ NNP O
Res NNP O
64 CD O
: : O
26 CD O
< SYM O
FFFD NNP O
> SYM O
35 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Sunyer NNP O
J NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Tobias NNP O
A NNP O
, , O
MacFarlane NNP O
D NNP O
, , O
Garcia NNP O
J NNP O
, , O
Anto NNP O
JM NNP O
. . O

Patients NNS B-Species
with IN O
chronic JJ O
obstructive JJ O
pulmonary JJ O
disease NN O
are VBP O
a DT O
susceptible JJ O
population NN O
of IN O
dying VBG O
due IN O
to IN O
urban JJ O
particles NNS O
. . O

Am NNP O
J NNP O
Epidemiol NNP O
151 CD O
( , O
1 CD O
) SYM O
: : O
50 CD O
< SYM O
FFFD NNP O
> SYM O
56 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

Godleski NNP O
JJ NNP O
, , O
Sioutas NNP O
C NNP O
, , O
Katler NNP O
M NNP O
, , O
Koutrakis NNP O
P NNP O
. , O
Death NN O
from IN O
inhalation NN O
of IN O
concentrated VBN O
air NN O
particles NNS O
in IN O
animal NN O
models NNS O
of IN O
pulmonary JJ O
disease NN O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
153 CD O
: : O
A15 CD O
( SYM O
1996 CD O
) -RRB- O
. . O

Matsui NNP O
K NNP O
, , O
Goldman NNP O
L NNP O
. . O
Comorbidity NN O
as IN O
a DT O
correlate NN O
of IN O
length NN O
of IN O
stay NN O
for IN O
hospitalized VBN O
patients NNS B-Species
with IN O
acute JJ O
chest NN O
pain NN O
. . O

J NNP O
Gen NNP O
Intern NNP O
Med NNP O
11 CD O
: : O
262 CD O
< SYM O
FFFD NNP O
> SYM O
268 CD O
( SYM O
1996 CD O
) -RRB- O
. . O

Charlson NNP O
M NNP O
, , O
Szatrowshi NNP O
TP NNP O
, , O
Peterson NNP O
J NNP O
, , O
Gold NNP O
J NNP O
. . O
Validation NN O
of IN O
a DT O
combined VBN O
comorbidity NN O
index NN O
. . O

J NNP O
Clin NNP O
Epidemiol NNP O
47 CD O
: : O
1245 CD O
< SYM O
FFFD NNP O
> SYM O
1251 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Monane NNP O
M NNP O
, , O
Kanter NNP O
DS NNP O
, , O
Glynn NNP O
RJ NNP O
, , O
Avorn NNP O
J NNP O
. . O
Variability NN O
in IN O
length NN O
of IN O
hospitalization NN O
for IN O
stroke NN O
. . O

The DT O
role NN O
of IN O
managed VBN O
care NN O
in IN O
an DT O
elderly JJ O
population NN O
. . O

Arch NNP O
Neurol NNP O
53 CD O
: : O
848 CD O
( SYM O
1996 CD O
) -RRB- O
. . O

Hallstrom NNP O
AP NNP O
, , O
Cobb NNP O
LA NNP O
, , O
Yu NNP O
BH NNP O
. . O

Influence NN O
of IN O
comorbidity NN O
on IN O
the DT O
outcome NN O
of IN O
patients NNS B-Species
treated VBN O
for IN O
out IN O
- HYPH O
of IN O
- HYPH O
hospital NN O
ventricular JJ O
fibrillation NN O
. . O

Circulation NN O
93 CD O
: : O
2019 CD O
< SYM O
FFFD NNP O
> SYM O
2022 CD O
( SYM O
1996 CD O
) -RRB- O
. . O

Malenka NNP O
DJ NNP O
, , O
Mclerran NNP O
D NNP O
, , O
Roos NNP O
N NNP O
, , O
Fisher NNP O
ES NNP O
, , O
Wennberg NNP O
JE NNP O
. . O

Using VBG O
administrative JJ O
data NNS O
to TO O
describe VB O
case NN O
- HYPH O
mix NN O
: : O
a DT O
comparison NN O
with IN O
the DT O
medical JJ O
record NN O
. . O

J NNP O
Clin NNP O
Epidemiol NNP O
47 CD O
: : O
1027 CD O
< SYM O
FFFD NNP O
> SYM O
1032 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

Romano NNP O
PS NNP O
, , O
Roos NNP O
LL NNP O
, , O
Jollis NNP O
JG NNP O
. . O

Adapting VBG O
a DT O
clinical JJ O
comorbidity NN O
index NN O
for IN O
use NN O
with IN O
ICD NNP O
- HYPH O
9 CD O
- HYPH O
CM NN O
administrative JJ O
data NNS O
: : O
differing VBG O
perspectives NNS O
. . O

J NNP O
Clin NNP O
Epidemiol NNP O
46 CD O
: : O
1075 CD O
< SYM O
FFFD NNP O
> SYM O
1079 CD O
( SYM O
1993 CD O
) -RRB- O
. . O

Deyo NNP O
RA NNP O
, , O
Cherkin NNP O
DC NNP O
, , O
Ciol NNP O
MA NNP O
. . O

Adapting VBG O
a DT O
clinical JJ O
comorbidity NN O
index NN O
for IN O
use NN O
with IN O
ICD NN O
- HYPH O
9CM NNP O
administrative JJ O
databases NNS O
. . O

J NNP O
Clin NNP O
Epidemiol NNP O
45 CD O
: : O
613 CD O
< SYM O
FFFD NN O
> SYM O
619 CD O
( SYM O
1992 CD O
) -RRB- O
. . O

Charlson NNP O
ME NNP O
, , O
Pompei NNP O
P NNP O
, , O
Ales NNP O
KL NNP O
, , O
MacKenzie NNP O
CR NNP O
. . O

A DT O
new JJ O
method NN O
of IN O
classifying VBG O
prognostic JJ O
comorbidity NN O
in IN O
longitudinal JJ O
studies NNS O
: : O
development NN O
and CC O
validation NN O
. . O

J NNP O
Chronic NNP O
Dis NNP O
40 CD O
: : O
373 CD O
< SYM O
FFFD NNP O
> SYM O
383 CD O
( SYM O
1987 CD O
) -RRB- O
. . O

Librero NNP O
J NNP O
, , O
Peir NNP O
< , O
FFFD NNP O
> NFP O
S NNP O
, , O
Ordi NNP O
< : O
FFFD NNP O
> NFP O
ana CC O
R NN O
. . O

Chronic JJ O
comorbidity NN O
and CC O
outcomes NNS O
of IN O
hospital NN O
care NN O
: : O
length NN O
of IN O
stay NN O
, , O
mortality NN O
, , O
and CC O
readmission NN O
at IN O
30 CD O
and CC O
365 CD O
days NNS O
. . O

J NNP O
Clin NNP O
Epidemiol NNP O
52 CD O
: : O
171 CD O
< SYM O
FFFD NN O
> SYM O
179 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

31 CD O
. . O

Nehls NNP O
GJ NNP O
, , O
Akland NNP O
GG NNP O
. . O

Procedures NNS O
for IN O
handling VBG O
aerometric JJ O
data NNS O
. . O

J NNP O
Air NNP O
Pollut NNP O
Control NNP O
Assoc NNP O
23 CD O
: : O
180 CD O
< SYM O
FFFD NNP O
> SYM O
184 CD O
( SYM O
1973 CD O
) -RRB- O
. . O

32 CD O
. . O

Hastie NNP O
T NNP O
, , O
Tibshirani NNP O
R NNP O
. . O
Generalized NNP O
Additive NNP O
Models NNPS O
. . O

London NNP O
: : O
Chapman NNP O
and CC O
Hall NNP O
, , O
1990 CD O
. . O

33 CD O
. . O

Schwartz NNP O
J NNP O
. . O
Generalized VBN O
additive JJ O
models NNS O
in IN O
epidemiology NN O
. . O

In IN O
: : O
International NNP O
Biometric NNP O
Society NNP O
, , O
Invited NNP O
Papers NNPS O
. . O

17th JJ O
International NNP O
Biometric NNP O
Conference NNP O
, , O
8 CD O
< SYM O
FFFD NNP O
> SYM O
12 CD O
August NNP O
1994 CD O
, , O
Hamilton NNP O
, , O
Ontario NNP O
, , O
Canada NNP O
. . O

Washington NNP O
, , O
DC NNP O
: : O
International NNP O
Biometric NNP O
Society NNP O
, , O
1994 CD O
; : O
55 CD O
< SYM O
FFFD NNP O
> SYM O
80 CD O
. . O

34 CD O
. . O

Rossi NNP O
G NNP O
, , O
Vigotti NNP O
MA NNP O
, , O
Zanobetti NNP O
A NNP O
, , O
Repetto NNP O
F NNP O
, , O
Giannelle NNP O
V NNP O
, , O
Schwartz NNP O
J NNP O
. . O

Air NN O
pollution NN O
and CC O
cause VB O
specific JJ O
mortality NN O
in IN O
Milan NNP O
, , O
Italy NNP O
, , O
1980 CD O
< SYM O
FFFD NNP O
> SYM O
1989 CD O
. . O

Arch NNP O
Environ NNP O
Health NNP O
54 CD O
: : O
158 CD O
< SYM O
FFFD NNP O
> SYM O
164 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

35 CD O
. . O

Cleveland NNP O
WS NNP O
, , O
Devlin NNP O
SJ NNP O
. . O

Robust JJ O
locally RB O
- HYPH O
weighted VBN O
regression NN O
and CC O
smoothing VBG O
scatterplots NNS O
. . O

J NNP O
Am NNP O
Stat NNP O
Assoc NNP O
74 CD O
: : O
829 CD O
< SYM O
FFFD NNP O
> SYM O
836 CD O
( SYM O
1988 CD O
) -RRB- O
. . O

36 CD O
. . O

Akaike NNP O
H NNP O
. . O
Information NN O
theory NN O
and CC O
an DT O
extension NN O
of IN O
the DT O
maximum JJ O
likelihood NN O
principal NN O
. . O

In IN O
: : O
2nd NNP O
International NNP O
Symposium NNP O
on IN O
Information NNP O
Theory NNP O
( , O
Petrov NNP O
BN NNP O
, , O
Csaki NNP O
F NNP O
, , O
eds NNP O
) -RRB- O
. . O

Budapest NNP O
: : O
Akademiai NNP O
Kaiado NNP O
, , O
1973 CD O
; : O
267 CD O
< SYM O
FFFD NNP O
> SYM O
281 CD O
. . O

37 CD O
. . O

Brumback NNP O
BA NNP O
, , O
Ryan NNP O
LM NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Neas NNP O
LM NNP O
, , O
Stark NNP O
PC NNP O
, , O
Burge NNP O
HA NNP O
. . O

Transitional JJ O
regression NN O
models NNS O
with IN O
application NN O
to IN O
environmental JJ O
time NN O
series NN O
. . O

J NNP O
Acoust NNP O
Soc NNP O
Am NNP O
95 CD O
( SYM O
449 CD O
) NFP O
: : O
16 CD O
< SYM O
FFFD NNP O
> SYM O
28 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

38 CD O
. . O

Schwartz NNP O
J NNP O
. . O

The DT O
distributed VBN O
lag NN O
between IN O
air NN O
pollution NN O
and CC O
daily JJ O
deaths NNS O
. . O

Epidemiology NN O
11 CD O
: : O
320 CD O
< SYM O
FFFD NNP O
> SYM O
326 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

39 CD O
. . O

Pope NNP O
CA NNP O
III NNP O
, , O
Verrier NNP O
RL NNP O
, , O
Lovett NNP O
EG NNP O
, , O
Larson NNP O
AC NNP O
, , O
Raizenne NNP O
ME NNP O
, , O
Kanner NNP O
RE NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Villegas NNP O
GM NNP O
, , O
Dockery NNP O
DW NNP O
. . O

Heart NN O
rate NN O
variability NN O
associated VBN O
with IN O
particulate JJ O
air NN O
pollution NN O
. . O

Am NNP O
Heart NNP O
J NNP O
138 CD O
: : O
890 CD O
< SYM O
FFFD NNP O
> SYM O
899 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

40 CD O
. . O

Gold NNP O
DR NNP O
, , O
Litonjua NNP O
A NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Lovett NNP O
E NNP O
, , O
Larson NNP O
A NNP O
, , O
Nearing NNP O
B NNP O
, , O
Allen NNP O
G NNP O
, , O
Verrier NNP O
M NNP O
, , O
Cherry NNP O
R NNP O
, , O
Verrier NNP O
R NNP O
. . O
Ambient JJ O
pollution NN O
and CC O
heart NN O
rate NN O
variability NN O
. . O

Circulation NN O
101 CD O
( SYM O
11 CD O
) -RRB- O
: : O
1267 CD O
< SYM O
FFFD NNP O
> SYM O
1273 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

41 CD O
. . O

Liao NNP O
D NNP O
, , O
Creason NNP O
J NNP O
, , O
Shy NNP O
C NNP O
, , O
Williams NNP O
R NNP O
, , O
Watts NNP O
R NNP O
, , O
Zweidinger NNP O
R NNP O
. , O
Daily JJ O
variation NN O
of IN O
particulate JJ O
air NN O
pollution NN O
and CC O
poor JJ O
cardiac JJ O
autonomic JJ O
control NN O
in IN O
the DT O
elderly JJ O
. . O

Environ NNP O
Health NNP O
Perspect NNP O
107 CD O
: : O
521 CD O
< SYM O
FFFD NNP O
> SYM O
525 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

42 CD O
. . O

Peters NNP O
A NNP O
, , O
Liu NNP O
E NNP O
, , O
Verrier NNP O
RL NNP O
, , O
Schwartz NNP O
J NNP O
, , O
Gold NNP O
DR NNP O
, , O
Mittelman NNP O
M NNP O
, , O
Baliff NNP O
J NNP O
, , O
Allen NNP O
G NNP O
, , O
Monahan NNP O
K NNP O
, , O
Dockery NNP O
DW NNP O
. . O

Air NN O
pollution NN O
and CC O
incidences NNS O
of IN O
cardiac JJ O
arrhythmia NN O
. . O

Epidemiology NN O
11 CD O
( : O
1 CD O
) SYM O
: : O
11 CD O
< SYM O
FFFD NNP O
> SYM O
17 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

43 CD O
. . O

Godleski NNP O
JJ NNP O
, , O
Verrier NNP O
RL NNP O
, , O
Koutrakis NNP O
P NNP O
, , O
Catalano NNP O
P NNP O
. . O
Mechanisms NNS O
of IN O
Morbidity NN O
and CC O
Mortality NN O
from IN O
Exposure NN O
to IN O
Ambient NNP O
Air NNP O
Particles NNPS O
. . O

Health NNP O
Effects NNPS O
Institute NNP O
Research NNP O
Report NNP O
91 CD O
. . O

Cambridge NNP O
, , O
MA NNP O
: : O
Health NNP O
Effects NNPS O
Institute NNP O
, , O
2000 CD O
. . O

44 CD O
. . O

Watkinson NNP O
WP NNP O
, , O
Campen NNP O
MJ NNP O
, , O
Kodavanti NNP O
UP NNP O
, , O
Ledbetter NNP O
AD NNP O
, , O
Costa NNP O
DL NNP O
. . O

Effects NNS O
of IN O
inhaled VBN O
residual JJ O
oil NN O
fly NN O
ash NN O
particles NNS O
on IN O
electrocardiographic JJ O
and CC O
thermoregulatory JJ O
parameters NNS O
in IN O
normal JJ O
and CC O
compromised JJ O
rats NNS B-Species
[ -LRB- O
Abstract JJ O
] -RRB- O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
157 CD O
: : O
A150 CD O
( SYM O
1998 CD O
) -RRB- O
. . O

45 CD O
. . O

Watkinson NNP O
WP NNP O
, , O
Campen NNP O
MJ NNP O
, , O
Costa NNP O
DL NNP O
. . O

Cardiac JJ O
arrhythmia NN O
induction NN O
after IN O
exposure NN O
to IN O
residual JJ O
oil NN O
fly NN O
ash NN O
particles NNS O
in IN O
a DT O
rodent JJ O
model NN O
of IN O
pulmonary JJ O
hypertension NN O
. . O

Toxicol NNP O
Sci NNP O
41 CD O
: : O
209 CD O
< SYM O
FFFD NNP O
> SYM O
216 CD O
( SYM O
1998 CD O
) -RRB- O
. . O

46 CD O
. . O

Kodavanti NNP O
UP NNP O
, , O
Jackson NNP O
MC NNP O
, , O
Richards NNP O
J NNP O
, , O
Ledbetter NNP O
A NNP O
, , O
Costa NNP O
DL NNP O
. . O

Differential JJ O
pulmonary JJ O
responses NNS O
to IN O
inhaled VBN O
emission NN O
particulate NN O
matter NN O
( , O
PM NN O
) -RRB- O
in IN O
systemically RB O
hypertensive JJ O
vs NN O
. , O
normotensive JJ O
rats NNS B-Species
[ -LRB- O
Abstract JJ O
] -RRB- O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
157 CD O
: : O
A260 CD O
( SYM O
1998 CD O
) -RRB- O
. . O

47 CD O
. . O

Hoek NNP O
G NNP O
, , O
Brunekreef NNP O
B NNP O
, , O
van NNP O
Wijnen NNP O
JH NNP O
. . O

Cardiovascular JJ O
mortality NN O
response NN O
to IN O
air NN O
pollution NN O
is VBZ O
strongest JJS O
for IN O
heart NN O
failure NN O
and CC O
thrombotic JJ O
causes NNS O
of IN O
death NN O
[ -LRB- O
Abstract JJ O
] -RRB- O
. . O

Epidemiology NN O
10 CD O
: : O
S177 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

48 CD O
. . O

Bates NNP O
DV NNP O
, , O
Szito NNP O
R NNP O
. . O
Hospital NN O
admissions NNS O
and CC O
air NN O
pollutants NNS O
in IN O
southern JJ O
Ontario NNP O
: : O
the DT O
acid NN O
summer NN O
haze NN O
effect NN O
. . O

Environ NNP O
Res NNP O
43 CD O
: : O
317 CD O
< SYM O
FFFD NNP O
> SYM O
331 CD O
( SYM O
1987 CD O
) -RRB- O
. . O

49 CD O
. . O

Pope NNP O
CA NNP O
III NNP O
. . O

Respiratory JJ O
disease NN O
associated VBN O
with IN O
community NN O
air NN O
pollution NN O
and CC O
a DT O
steel NN O
mill NN O
, , O
Utah NNP O
valley NN O
. . O

Am NNP O
J NNP O
Public NNP O
Health NNP O
79 CD O
: : O
623 CD O
< SYM O
FFFD NNP O
> SYM O
628 CD O
( SYM O
1989 CD O
) -RRB- O
. . O

50 CD O
. . O

Zelikoff NNP O
JT NNP O
, , O
Nadziejko NNP O
C NNP O
, , O
Fang NNP O
T NNP O
, , O
Gordon NNP O
C NNP O
, , O
Premdass NNP O
C NNP O
, , O
Cohen NNP O
MD NNP O
. . O

Short JJ O
term NN O
, , O
low JJ O
- HYPH O
dose NN O
inhalation NN O
of IN O
ambient JJ O
particulate NN O
matter NN O
exacerbates VBZ O
ongoing JJ O
pneumococcal JJ O
infections NNS O
in IN O
Streptococcus NNP O
Pneumoniae NNP O
- HYPH O
infected VBN O
rates NNS O
. . O

In IN O
: : O
Proceedings NNP O
of IN O
the DT O
Third NNP O
Colloquium NNP O
on IN O
Particulate NNP O
Air NNP O
Pollution NNP O
and CC O
Human NNP B-Species
Health NNP O
( , O
Phalen NNP O
RF NNP O
, , O
Bell NNP O
YM NNP O
, , O
eds NNP O
) -RRB- O
. . O

Irvine NNP O
, , O
CA NNP O
: : O
Air NNP O
Pollution NNP O
Health NNP O
Effects NNPS O
Laboratory NNP O
, , O
University NNP O
of IN O
California NNP O
, , O
1999 CD O
; : O
8 CD O
- SYM O
94 CD O
< SYM O
FFFD NN O
> SYM O
8 CD O
- HYPH O
101 CD O
. . O

51 CD O
. . O

Clarke NNP O
RW NNP O
, , O
Hemenway NNP O
DR NNP O
, , O
Frank NNP O
R NNP O
, , O
Kleeberger NNP O
SR NNP O
, , O
Longphre NNP O
MV NNP O
, , O
Jakab NNP O
GJ NNP O
. . O

Particle NN O
associated VBN O
sulfate NN O
exposure NN O
enhances VBZ O
murine JJ O
influenza NN O
mortality NN O
[ -LRB- O
Abstract JJ O
] -RRB- O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
155 CD O
: : O
A245 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

52 CD O
. . O

Pope NNP O
CA NNP O
, , O
Dockery NNP O
DW NNP O
, , O
Spengler NNP O
JD NNP O
, , O
Raizenne NNP O
ME NNP O
. . O

Respiratory JJ O
health NN O
and CC O
PM10 NN O
pollution NN O
: : O
a DT O
daily JJ O
time NN O
series NN O
analysis NN O
. . O

Am VBP O
Rev NNP O
Respir NNP O
Dis NNP O
144 CD O
: : O
668 CD O
< SYM O
FFFD NNP O
> SYM O
674 CD O
( SYM O
1991 CD O
) -RRB- O
. . O

53 CD O
. . O

Schwartz NNP O
J NNP O
, , O
Koenig NNP O
J NNP O
, , O
Slater NNP O
D NNP O
, , O
Larson NNP O
T NNP O
. . O
Particulate NN O
air NN O
pollution NN O
and CC O
hospital NN O
emergency NN O
visits NNS O
for IN O
asthma NN O
in IN O
Seattle NNP O
. . O

Am VBP O
Rev NNP O
Respir NNP O
Dis NNP O
147 CD O
: : O
826 CD O
< SYM O
FFFD NNP O
> SYM O
831 CD O
( SYM O
1993 CD O
) -RRB- O
. . O

54 CD O
. . O

Thurston NNP O
GD NNP O
, , O
Ito NNP O
K NNP O
, , O
Lippman NNP O
M NNP O
, , O
Hayes NNP O
CG NNP O
, , O
Bates NNP O
DV NNP O
. . O

Respiratory JJ O
hospital NN O
admissions NNS O
and CC O
summertime JJ O
haze NN O
air NN O
pollution NN O
in IN O
Toronto NNP O
, , O
Ontario NNP O
: : O
consideration NN O
of IN O
the DT O
role NN O
of IN O
acid NN O
aerosols NNS O
. . O

Environ NNP O
Res NNP O
65 CD O
: : O
271 CD O
< SYM O
FFFD NNP O
> SYM O
290 CD O
( SYM O
1994 CD O
) -RRB- O
. . O

55 CD O
. . O

Norris NNP O
G NNP O
, , O
YoungPong NNP O
SN NNP O
, , O
Koenig NNP O
JQ NNP O
, , O
Larson NNP O
TV NN O
, , O
Sheppard NNP O
L NNP O
, , O
Stout NNP O
JW NNP O
. . O

An DT O
association NN O
between IN O
fine JJ O
particles NNS O
and CC O
asthma NN O
emergency NN O
department NN O
visits NNS O
for IN O
children NNS B-Species
in IN O
Seattle NNP O
. . O

Environ NNP O
Health NNP O
Perspect NNP O
107 CD O
: : O
489 CD O
< SYM O
FFFD NNP O
> SYM O
493 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

56 CD O
. . O

Hamada NNP O
K NNP O
, , O
Goldsmith NNP O
CW NNP O
, , O
Kobzik NNP O
L NNP O
. . O

Air NN O
pollutant NN O
aerosols NNS O
allow VBP O
airway NN O
sensitization NN O
to IN O
allergen NN O
in IN O
juvenile JJ O
mice NNS B-Species
. . O

Am VBP O
J NNP O
Resp NNP O
Crit NNP O
Care NNP O
Med NNP O
A28 NNP O
( , O
1999 CD O
) -RRB- O
. . O

57 CD O
. . O

Lambert NNP O
AL NNP O
, , O
Selgrade NNP O
M NNP O
, , O
Dong NNP O
W NNP O
, , O
Winsett NNP O
D NNP O
, , O
Gilmour NNP O
M NNP O
. , O
Enhanced VBN O
allergic JJ O
sensitization NN O
by IN O
residual JJ O
oil NN O
fly NN O
ash NN O
particles NNS O
is VBZ O
mediated VBN O
by IN O
soluble JJ O
metal NN O
constituents NNS O
[ -LRB- O
Abstract JJ O
] -RRB- O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
159 CD O
: : O
A26 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

58 CD O
. . O

Dailey NNP O
LA NNP O
, , O
Madden NNP O
MC NNP O
, , O
Devlin NNP O
RB NNP O
. . O

Do VBP O
airway NN O
epithelial JJ O
cells NNS O
from IN O
normal JJ O
and CC O
asthmatic JJ O
donors NNS O
respond VBP O
differently RB O
to IN O
an DT O
in FW O
vitro FW O
challenge NN O
with IN O
a DT O
particulate JJ O
pollutant NN O
? . O

[ -LRB- O
Abstract NN O
] -RRB- O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
157 CD O
: : O
A598 CD O
( SYM O
1998 CD O
) -RRB- O
. . O

59 CD O
. . O

Gilmour NNP O
MI NNP O
, , O
Winsett NNP O
D NNP O
, , O
Selgrade NNP O
MJ NNP O
, , O
Costa NNP O
DL NNP O
. . O

Residual JJ O
oil NN O
fly NN O
ash NN O
exposure NN O
enhances VBZ O
allergic JJ O
sensitization NN O
to TO O
house VB O
dust NN O
mite NN O
in IN O
rats NNS B-Species
and CC O
augments VBZ O
immune NN O
- HYPH O
mediated VBN O
inflammation NN O
[ -LRB- O
Abstract JJ O
] -RRB- O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
155 CD O
: : O
A244 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

60 CD O
. . O

Zeger NNP O
SL NNP O
, , O
Thomas NNP O
D NNP O
, , O
Dominici NNP O
F NNP O
, , O
Samet NNP O
JM NNP O
, , O
Schwartz NNP O
JM NNP O
, , O
Dockery NNP O
D NNP O
, , O
Cohen NNP O
A NNP O
. . O
Exposure NN O
measurement NN O
error NN O
in IN O
time NN O
< IN O
FFFD NN O
> NFP O
series NN O
studies NNS O
of IN O
air NN O
pollution NN O
: : O
concepts NNS O
and CC O
consequences NNS O
. . O

Environ NNP O
Health NNP O
Perspect NNP O
108 CD O
: : O
419 CD O
< SYM O
FFFD NNP O
> SYM O
426 CD O
( SYM O
2000 CD O
) -RRB- O
. . O

61 CD O
. . O

Salvi NNP O
S NNP O
, , O
Blomberg NNP O
A NNP O
, , O
Rudell NNP O
B NNP O
, , O
Kelly NNP O
F NNP O
, , O
Sandstrom NNP O
T NNP O
, , O
Holgate NNP O
ST NNP O
, , O
Frew NNP O
A NNP O
. . O
Acute JJ O
inflammatory JJ O
responses NNS O
in IN O
the DT O
airways NNS O
and CC O
peripheral JJ O
blood NN O
after IN O
short JJ O
- HYPH O
term NN O
exposure NN O
to IN O
diesel NN O
exhaust NN O
in IN O
healthy JJ O
human JJ B-Species
volunteers NNS O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
159 CD O
: : O
702 CD O
< SYM O
FFFD NNP O
> SYM O
709 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

62 CD O
. . O

Tan NNP O
WC NNP O
, , O
van NNP O
Eeden NNP O
S NNP O
, , O
Qiu NNP O
DW NNP O
, , O
Liam NNP O
BL NNP O
, , O
Dyachokova NNP O
Y NNP O
, , O
Hogg NNP O
JL NNP O
. . O

Particulate JJ O
air NN O
pollution NN O
, , O
bone NN O
marrow NN O
stimulation NN O
and CC O
the DT O
pathogenesis NN O
of IN O
excess JJ O
cardiovascular JJ O
and CC O
pulmonary JJ O
deaths NNS O
. . O

Am VBP O
J NNP O
Respir NNP O
Crit NNP O
Care NNP O
Med NNP O
155 CD O
: : O
1441 CD O
< SYM O
FFFD NNP O
> SYM O
1447 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

63 CD O
. . O

Gordon NNP O
T NNP O
, , O
Nadziejko NNP O
C NNP O
, , O
Schlesinger NNP O
R NNP O
, , O
Chen NNP O
LC NNP O
. . O

Pulmonary JJ O
and CC O
cardiovascular JJ O
effects NNS O
of IN O
acute JJ O
exposure NN O
to IN O
concentrated JJ O
ambient JJ O
particulate NN O
matter NN O
in IN O
rats NNS B-Species
. . O

Toxicol NNP O
Lett NNP O
96 CD O
< SYM O
FFFD NNP O
> SYM O
97 CD O
: : O
285 CD O
< SYM O
FFFD NN O
> SYM O
288 CD O
( SYM O
1998 CD O
) -RRB- O
. . O

64 CD O
. . O

Peters NNP O
A NNP O
, , O
Doering NNP O
A NNP O
, , O
Wichmann NNP O
HE NNP O
, , O
Koenig NNP O
W NNP O
. . O
Increased VBN O
plasma NN O
viscosity NN O
during IN O
an DT O
air NN O
pollution NN O
episode NN O
: : O
a DT O
link NN O
to IN O
mortality NN O
? . O

Lancet NNP O
349 CD O
( SYM O
9065 CD O
) SYM O
: : O
1582 CD O
< SYM O
FFFD NNP O
> SYM O
1587 CD O
( SYM O
1997 CD O
) -RRB- O
. . O

65 CD O
. . O

Peters NNP O
A NNP O
, , O
Stieberv NNP O
J NNP O
, , O
Doering NNP O
A NNP O
, , O
Wichmann NNP O
HE NNP O
. . O

Is VBZ O
systolic JJ O
blood NN O
pressure NN O
associated VBN O
with IN O
air NN O
pollution NN O
? . O

[ -LRB- O
Abstract NN O
] -RRB- O
. . O

Epidemiology NN O
10 CD O
( SYM O
4 CD O
) SYM O
: : O
S177 CD O
( SYM O
1999 CD O
) -RRB- O
. . O

Environmental NNP O
Health NNP O
Perspectives NNPS O

< NFP O
FFFD NNP O
> : O
VOLUME NN O
108 CD O
| : O
NUMBER NN O
9 CD O
| SYM O
September NNP O
2000 CD O

845 CD O

Syndrome NN O
of IN O
arachnomelia NN O
in IN O
Simmental NNP O
cattle NNS B-Species

Abstract JJ O

Background NN O

The DT O
syndrome NN O
of IN O
arachnomelia NN O
is VBZ O
an DT O
inherited VBN O
malformation NN O
mainly RB O
of IN O
limbs NNS O
, , O
back NN O
and CC O
head NN O
in IN O
cattle NNS B-Species
. . O

At IN O
present NN O
the DT O
arachnomelia NN O
syndrome NN O
has VBZ O
been VBN O
well RB O
known VBN O
mainly RB O
in IN O
Brown NNP O
Swiss NNP O
cattle NNS B-Species
. . O

Nevertheless RB O
, , O
the DT O
arachnomelia NN O
syndrome NN O
had VBD O
been VBN O
observed VBN O
in IN O
the DT O
Hessian JJ O
Simmental NNP O
population NN O
during IN O
the DT O
decade NN O
1964 CD O
- SYM O
1974 CD O
. . O

Recently RB O
, , O
stillborn JJ O
Simmental NNP O
calves NNS B-Species
were VBD O
observed VBN O
having VBG O
a DT O
morphology NN O
similar JJ O
to IN O
the DT O
arachnomelia NN O
syndrome NN O
. . O

The DT O
goal NN O
of IN O
this DT O
work NN O
was VBD O
the DT O
characterization NN O
of IN O
the DT O
morphology NN O
and CC O
genealogy NN O
of IN O
the DT O
syndrome NN O
in IN O
Simmental NNP O
to TO O
establish VB O
the DT O
basis NN O
for IN O
an DT O
effective JJ O
management NN O
of IN O
the DT O
disease NN O
. . O

Results NNS O

The DT O
first JJ O
pathologically RB O
confirmed VBN O
arachnomelia NN O
syndrome NN O
- HYPH O
cases NNS O
in IN O
the DT O
current JJ O
Simmental NNP O
population NN O
appeared VBD O
in IN O
the DT O
year NN O
2005 CD O
. . O

By IN O
2007 CD O
, , O
an DT O
additional JJ O
140 CD O
calves NNS B-Species
with IN O
the DT O
arachnomelia NN O
syndrome NN O
were VBD O
identified VBN O
. . O

The DT O
major JJ O
pathological JJ O
findings NNS O
were VBD O
malformed VBN O
bones NNS O
affecting VBG O
the DT O
head NN O
, , O
long JJ O
bones NNS O
of IN O
the DT O
legs NNS O
and CC O
the DT O
vertebral JJ O
column NN O
. . O

It PRP O
could MD O
be VB O
shown VBN O
that IN O
, , O
with IN O
the DT O
exception NN O
of IN O
two CD O
cases NNS O
that WDT O
were VBD O
considered VBN O
as IN O
phenocopies NNS O
, , O
all DT O
of IN O
the DT O
paternal JJ O
and CC O
about RB O
two CD O
- HYPH O
third NN O
of IN O
the DT O
maternal JJ O
pedigrees NNS O
of IN O
the DT O
affected VBN O
calves NNS B-Species
could MD O
be VB O
traced VBN O
back RB O
to IN O
one CD O
common JJ O
founder NN O
. . O

Together RB O
with IN O
the DT O
data NNS O
from IN O
experimental JJ O
matings NNS O
, , O
the DT O
pedigree NN O
data NNS O
support VBP O
an DT O
autosomal JJ O
recessive JJ O
mutation NN O
being VBG O
the DT O
etiology NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
. . O

The DT O
frequency NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
current JJ O
population NN O
was VBD O
estimated VBN O
to TO O
be VB O
3 CD O
. . O
32 CD O
% NN O
. . O

Conclusion NN O

We PRP O
describe VBP O
the DT O
repeated VBN O
occurrence NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
in IN O
Simmental NNP O
calves NNS B-Species
. . O

It PRP O
resembles VBZ O
completely RB O
the DT O
same JJ O
defect NN O
occurring VBG O
in IN O
the DT O
Brown NNP O
Swiss NNP O
breed NN O
. . O

The DT O
mutation NN O
became VBD O
relatively RB O
widespread JJ O
amongst IN O
the DT O
current JJ O
population NN O
. . O

Therefore RB O
, , O
a DT O
control NN O
system NN O
has VBZ O
to TO O
be VB O
established VBN O
and CC O
it PRP O
is VBZ O
highly RB O
desirable JJ O
to TO O
map VB O
the DT O
disease NN O
and CC O
develop VB O
a DT O
genetic JJ O
test NN O
system NN O
. . O

Background NN O

In IN O
the DT O
year NN O
2006 CD O
a DT O
syndrome NN O
was VBD O
described VBN O
in IN O
the DT O
German JJ O
and CC O
Austrian JJ O
Simmental NNP O
( , O
Fleckvieh NNP O
, , O
as IN O
it PRP O
is VBZ O
locally RB O
called VBN O
, , O
is VBZ O
the DT O
main JJ O
dual JJ O
- HYPH O
purpose NN O
breed NN O
in IN O
Germany NNP O
, , O
in IN O
short JJ O
called VBN O
Simmental NNP O
in IN O
the DT O
further JJ O
text NN O
) , O
population NN O
, , O
that WDT O
was VBD O
pathologically RB O
similar JJ O
to IN O
the DT O
arachnomelia NN O
syndrome NN O
in IN O
Brown NNP O
Swiss NNP O
cattle NNS B-Species
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
congenital JJ O
arachnomelia NN O
syndrome NN O
( , O
AS NNP O
, , O
OMIA NNP O
Phene NNP O
ID NNP O
139 CD O
, , O
Group NNP O
59 CD O
) -RRB- O
is VBZ O
mainly RB O
a DT O
malformation NN O
of IN O
the DT O
skeletal JJ O
system NN O
in IN O
cattle NNS B-Species
that WDT O
was VBD O
initially RB O
described VBN O
by IN O
Rieck NNP O
and CC O
Schade NNP O
[ -LRB- O
2 CD O
] -RRB- O
in IN O
Holstein NNP O
Friesian NNP O
, , O
Red NNP O
Holstein NNP O
and CC O
Simmental NNP O
. . O

The DT O
main JJ O
pathological JJ O
changes NNS O
are VBP O
skeletal JJ O
malformations NNS O
of IN O
the DT O
legs NNS O
, , O
the DT O
spinal JJ O
column NN O
and CC O
the DT O
skull NN O
. . O

The DT O
legs NNS O
are VBP O
thinner JJR O
and CC O
appear VBP O
longer JJR O
than IN O
normal JJ O
( , O
dolichostenomelia NN O
, , O
arachnomelia NN O
) -RRB- O
since IN O
the DT O
diameter NN O
of IN O
the DT O
diaphyses NNS O
is VBZ O
reduced VBN O
. . O

These DT O
long JJ O
bones NNS O
are VBP O
more RBR O
fragile JJ O
and CC O
, , O
in IN O
combination NN O
with IN O
stiffened VBN O
joints NNS O
, , O
they PRP O
tend VBP O
to TO O
fracture VB O
during IN O
calving NN O
. . O

The DT O
fetlock NN O
joints NNS O
are VBP O
deformed VBN O
, , O
often RB O
stiffened VBN O
and CC O
show VBP O
hyperextension NN O
. . O

The DT O
malformation NN O
of IN O
the DT O
spinal JJ O
column NN O
leads VBZ O
to IN O
kyphosis NN O
and CC O
scoliosis NN O
. . O

The DT O
skull NN O
malformations NNS O
are VBP O
characterized VBN O
by IN O
a DT O
shortened VBN O
lower JJR O
jaw NN O
( : O
brachygnathia NN O
inferior NN O
) -RRB- O
, , O
convex NN O
rounding NN O
of IN O
the DT O
frontal JJ O
bone NN O
leading VBG O
to IN O
a DT O
marked JJ O
stop NN O
( : O
"""" `` O
pointer NN O
head NN O
"""" '' O
) -RRB- O
and CC O
rotation NN O
of IN O
the DT O
anterior JJ O
cranium NN O
. . O

In IN O
some DT O
cases NNS O
, , O
additional JJ O
malformations NNS O
like IN O
hydrocephalus NN O
externus NN O
develop VBP O
[ -LRB- O
2 CD O
- SYM O
5 CD O
] -RRB- O
. . O

Since IN O
the DT O
report NN O
of IN O
Rieck NNP O
and CC O
Schade NNP O
[ -LRB- O
2 CD O
] -RRB- O
no DT O
further JJ O
cases NNS O
were VBD O
reported VBN O
in IN O
Simmental NNP O
cattle NNS B-Species
, , O
but CC O
in IN O
the DT O
1980s NNS O
the DT O
syndrome NN O
was VBD O
dispersed VBN O
in IN O
another DT O
breed NN O
, , O
the DT O
European JJ O
Brown NNP O
Swiss NNP O
cattle NNS B-Species
, , O
by IN O
the DT O
use NN O
of IN O
American NNP O
Brown NNP O
Swiss NNP O
sires NNS O
[ -LRB- O
4 CD O
, , O
6 CD O
] -RRB- O
. . O

In IN O
Brown NNP O
Swiss NNP O
an DT O
autosomal JJ O
recessive JJ O
mode NN O
of IN O
inheritance NN O
was VBD O
supposed VBN O
and CC O
a DT O
control NN O
program NN O
based VBN O
on IN O
the DT O
identification NN O
of IN O
carriers NNS O
by IN O
pedigree NN O
analyses NNS O
was VBD O
established VBN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Recently RB O
, , O
four CD O
cases NNS O
of IN O
arachnomelia NN O
syndrome NN O
were VBD O
reported VBN O
in IN O
Italy NNP O
[ -LRB- O
3 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
present VBP O
the DT O
data NNS O
of IN O
152 CD O
pathologically RB O
confirmed VBN O
cases NNS O
of IN O
arachnomelia NN O
syndrome NN O
in IN O
Simmental NNP O
that WDT O
were VBD O
collected VBN O
from IN O
October NNP O
2005 CD O
to IN O
March NNP O
2007 CD O
. . O

We PRP O
describe VBP O
the DT O
pathological JJ O
findings NNS O
, , O
the DT O
familial JJ O
occurrence NN O
and CC O
an DT O
estimate NN O
of IN O
the DT O
frequency NN O
of IN O
the DT O
diseases NNS O
allele NN O
in IN O
Simmental NNP O
cattle NNS B-Species
. . O

Additional JJ O
support NN O
for IN O
the DT O
mode NN O
of IN O
inheritance NN O
and CC O
the DT O
genetic JJ O
basis NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
is VBZ O
given VBN O
by IN O
the DT O
result NN O
of IN O
experimental JJ O
matings NNS O
of IN O
obligate JJ O
carriers NNS O
. . O

Results NNS O
and CC O
discussion NN O

AS IN O
has VBZ O
not RB O
been VBN O
reported VBN O
again RB O
in IN O
Simmental NNP O
since IN O
its PRP$ O
first JJ O
description NN O
in IN O
the DT O
1970s NNS O
, , O
more JJR O
than IN O
thirteen CD O
years NNS O
ago RB O
. . O

In IN O
autumn NN O
2004 CD O
a DT O
number NN O
of IN O
stillborn JJ O
calves NNS B-Species
with IN O
similar JJ O
malformations NNS O
of IN O
the DT O
legs NNS O
and CC O
head NN O
were VBD O
recorded VBN O
within IN O
the DT O
monitoring NN O
system NN O
of IN O
anomalies NNS O
in IN O
Simmental NNP O
. . O

Some DT O
of IN O
these DT O
calves NNS B-Species
were VBD O
sent VBN O
to IN O
the DT O
veterinary JJ O
service NN O
laboratory NN O
for IN O
examination NN O
, , O
and CC O
in IN O
December NNP O
2005 CD O
the DT O
first JJ O
15 CD O
cases NNS O
of IN O
AS NNP O
were VBD O
pathologically RB O
confirmed VBN O
. . O

Subsequently RB O
, , O
farmers NNS O
and CC O
veterinarians NNS O
had VBD O
been VBN O
encouraged VBN O
to TO O
report VB O
cases NNS O
by IN O
an DT O
information NN O
leaflet NN O
and CC O
various JJ O
articles NNS O
in IN O
local JJ O
trade NN O
journals NNS O
. . O

An DT O
increasing VBG O
number NN O
of IN O
suspected VBN O
cases NNS O
was VBD O
reported VBN O
and CC O
an DT O
additional JJ O
136 CD O
affected VBN O
calves NNS B-Species
were VBD O
identified VBN O
by IN O
pathological JJ O
examination NN O
by IN O
June NNP O
2007 CD O
. . O

Familial JJ O
occurrence NN O
and CC O
case NN O
presentation NN O
of IN O
the DT O
syndrome NN O
of IN O
arachnomelia NN O

The DT O
geographical JJ O
origins NNS O
of IN O
the DT O
cases NNS O
were VBD O
the DT O
southern JJ O
part NN O
of IN O
Germany NNP O
and CC O
Austria NNP O
, , O
reflecting VBG O
the DT O
regional JJ O
distribution NN O
of IN O
the DT O
Simmental NNP O
breed NN O
. . O

Both DT O
sexes NNS O
were VBD O
equally RB O
represented VBN O
in IN O
the DT O
152 CD O
( , O
80 CD O
male JJ O
, , O
72 CD O
female NN O
, , O
chi NN O
2 CD O
= SYM O
0 CD O
. . O
21 CD O
, , O
p NN O
= SYM O
0 CD O
. . O
64 CD O
) -RRB- O
affected VBN O
calves NNS B-Species
. . O

The DT O
largest JJS O
number NN O
of IN O
cases NNS O
was VBD O
registered VBN O
in IN O
2006 CD O
( : O
Figure NNP O
1 CD O
) -RRB- O
. . O

In IN O
retrospect NN O
, , O
it PRP O
could MD O
be VB O
shown VBN O
that IN O
the DT O
main JJ O
reason NN O
for IN O
the DT O
rapid JJ O
increase NN O
of IN O
cases NNS O
in IN O
the DT O
years NNS O
2005 CD O
and CC O
2006 CD O
was VBD O
the DT O
high JJ O
popularity NN O
of IN O
certain JJ O
sires NNS O
carrying VBG O
the DT O
AS NNP O
mutation NN O
( , O
ROMEL NNP O
, , O
ISO NNP O
- HYPH O
Nr NNP O
. , O
276000911043667 CD O
, , O
born VBN O
in IN O
1995 CD O
; : O
EGEL NNP O
, , O
276000915512806 CD O
, , O
1985 CD O
; : O
REXON NNP O
, , O
276000913008210 CD O
, , O
1989 CD O
) -RRB- O
. . O

The DT O
latter JJ O
two CD O
sires NNS O
represent VBP O
the DT O
key JJ O
- HYPH O
nodes NNS O
of IN O
the DT O
pedigree NN O
pathways NNS O
of IN O
the DT O
mutation NN O
from IN O
the DT O
founder NN O
into IN O
the DT O
current JJ O
population NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

ROMEL NNP O
, , O
for IN O
example NN O
, , O
sired VBD O
more JJR O
than IN O
40 CD O
, , O
0 CD O
cows NNS B-Species
4 CD O
to TO O
6 CD O
years NNS O
ago RB O
. . O

Furthermore RB O
, , O
115 CD O
sons NNS O
of IN O
ROMEL NNP O
born VBN O
from IN O
2001 CD O
to IN O
2005 CD O
are VBP O
registered VBN O
and CC O
listed VBN O
in IN O
the DT O
breeding NN O
database NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

These DT O
progeny NN O
were VBD O
now RB O
mated VBN O
to IN O
ROMEL NNP O
and CC O
sons NNS O
or CC O
grandsons NNS O
of IN O
EGEL NNP O
and CC O
REXON NNP O
resulting VBG O
in IN O
a DT O
high JJ O
probability NN O
for IN O
the DT O
occurrence NN O
of IN O
affected VBN O
calves NNS B-Species
. . O

Increasing VBG O
awareness NN O
of IN O
the DT O
disease NN O
and CC O
abandoning NN O
of IN O
selling VBG O
the DT O
semen NN O
from IN O
carriers NNS O
led VBD O
to IN O
a DT O
sharp JJ O
drop NN O
of IN O
cases NNS O
in IN O
2007 CD O
. . O

The DT O
disease NN O
was VBD O
successfully RB O
managed VBN O
by IN O
efficient JJ O
collaboration NN O
of IN O
the DT O
Institute NNP O
for IN O
Animal NNP O
Breeding NNP O
of IN O
the DT O
Bavarian NNP O
State NNP O
Research NNP O
Centre NNP O
for IN O
Agriculture NNP O
( , O
LfL NNP O
) -RRB- O
, , O
the DT O
Landeskuratorium NNP O
der NNP O
Erzeugerringe NNP O
f FW O
u FW O
r FW O
tierische FW O
Veredelung NNP O
in IN O
Bayern NNP O
e NNP O
. , O
V NNP O
( , O
LKV NNP O
) -RRB- O
, , O
the DT O
Bavarian NNP O
Animal NNP O
Health NNP O
Service NNP O
( -LRB- O
TGD NNP O
) -RRB- O
and CC O
breeding NN O
organizations NNS O
. . O

Pathological JJ O
findings NNS O

Calves NNS B-Species
under IN O
suspicion NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
were VBD O
sent VBN O
to IN O
the DT O
pathology NN O
department NN O
of IN O
the DT O
TGD NNP O
for IN O
macroscopic JJ O
examination NN O
. . O

The DT O
observed JJ O
major JJ O
pathological JJ O
findings NNS O
were VBD O
( , O
1 CD O
) SYM O
facial JJ O
deformation NN O
, , O
including VBG O
brachygnathia NN O
inferior JJ O
and CC O
concave JJ O
rounding NN O
of IN O
the DT O
maxilla NN O
forming VBG O
a DT O
dent NN O
( , O
' `` O
pointer NN O
- HYPH O
head NN O
' '' O
) -RRB- O
; : O
( , O
2 CD O
) SYM O
abnormally RB O
thin JJ O
diaphyses NNS O
of IN O
the DT O
long JJ O
bones NNS O
( , O
the DT O
outer JJ O
diameter NN O
of IN O
the DT O
diaphyses NNS O
is VBZ O
diminished VBN O
, , O
whereas IN O
the DT O
width NN O
of IN O
the DT O
substantia JJ O
compacta NN O
is VBZ O
normal JJ O
) , O
leading VBG O
to IN O
frequent JJ O
fractures NNS O
of IN O
the DT O
metacarpus NN O
and CC O
metatarsus NN O
in IN O
the DT O
course NN O
of IN O
forced VBN O
birth NN O
assistance NN O
( , O
' `` O
spider NN O
- HYPH O
legs NNS O
' '' O
, , O
dolichostenomelia NN O
) -RRB- O
. . O

The DT O
deformations NNS O
of IN O
other JJ O
bones NNS O
of IN O
the DT O
legs NNS O
were VBD O
less RBR O
apparent JJ O
and CC O
the DT O
scapula NN O
was VBD O
usually RB O
unaffected JJ O
; : O
( , O
3 CD O
) SYM O
angular JJ O
deformations NNS O
of IN O
the DT O
distal JJ O
parts NNS O
of IN O
the DT O
legs NNS O
characterized VBN O
by IN O
bilateral JJ O
stiff JJ O
and CC O
hyperextended JJ O
fetlocks NNS O
with IN O
the DT O
extremity NN O
of IN O
the DT O
toe NN O
forward RB O
and CC O
parallel JJ O
to IN O
the DT O
trunk NN O
of IN O
the DT O
body NN O
; : O
and CC O
( , O
4 CD O
) SYM O
defects NNS O
of IN O
the DT O
vertebral JJ O
column NN O
( , O
kyphosis NN O
and CC O
scoliosis NN O
) -RRB- O
, , O
but CC O
not RB O
of IN O
the DT O
ribs NNS O
( -LRB- O
Figure NN O
3A NN O
- HYPH O
C NN O
) -RRB- O
. . O

Additionally RB O
, , O
inconsistent JJ O
pathological JJ O
findings NNS O
included VBD O
cerebral JJ O
herniation NN O
combined VBN O
with IN O
a DT O
malformed VBN O
foramen NN O
magnum NN O
, , O
microphthalmia NN O
, , O
and CC O
external JJ O
and CC O
internal JJ O
hydrocephalus NN O
. . O

The DT O
latter JJ O
seem VBP O
to TO O
develop VB O
secondarily RB O
, , O
due IN O
to IN O
the DT O
enlarged JJ O
foramen NN O
magnum NN O
. . O

Histological JJ O
examination NN O
of IN O
selected VBN O
cases NNS O
revealed VBD O
the DT O
presence NN O
of IN O
hemorrhages NNS O
at IN O
the DT O
osteochondral JJ O
junction NN O
of IN O
the DT O
epiphysis NN O
and CC O
an DT O
abrupt JJ O
transmission NN O
from IN O
chondral JJ O
to IN O
osteogenic JJ O
tissue NN O
. . O

Cases NNS O
never RB O
showed VBD O
isolated VBN O
malformations NNS O
, , O
e UH O
. . O
g LS O
. . O
of IN O
the DT O
head NN O
or CC O
legs NNS O
, , O
but CC O
usually RB O
a DT O
combination NN O
of IN O
all DT O
pathological JJ O
findings NNS O
that WDT O
are VBP O
characteristic JJ O
for IN O
the DT O
syndrome NN O
. . O

Nevertheless RB O
, , O
the DT O
degree NN O
of IN O
the DT O
lesions NNS O
ranged VBD O
from IN O
obvious JJ O
spider NN O
- HYPH O
leg NN O
cases NNS O
to IN O
moderate JJ O
or CC O
mild JJ O
changes NNS O
, , O
making VBG O
a DT O
definite JJ O
diagnosis NN O
difficult JJ O
. . O

The DT O
latter JJ O
cases NNS O
( -LRB- O
3 CD O
) -RRB- O
were VBD O
excluded VBN O
from IN O
the DT O
initial JJ O
pedigree NN O
analyses NNS O
. . O

Meanwhile RB O
, , O
an DT O
indirect JJ O
gene NN O
test NN O
is VBZ O
available JJ O
that WDT O
has VBZ O
been VBN O
developed VBN O
at IN O
the DT O
Institute NNP O
for IN O
Animal NNP O
Breeding NNP O
of IN O
the DT O
Bavarian NNP O
State NNP O
Research NNP O
Centre NNP O
for IN O
Agriculture NNP O
( , O
ITZ NNP O
) -RRB- O
and CC O
it PRP O
could MD O
be VB O
shown VBN O
that IN O
these DT O
cases NNS O
are VBP O
most RBS O
probably RB O
not RB O
genetically RB O
affected VBN O
( : O
Buitkamp NNP O
et FW O
al NNP O
. . O
, , O
in IN O
preparation NN O
) -RRB- O
. . O

Carrier NN O
identification NN O

Two CD O
criteria NNS O
were VBD O
used VBN O
for IN O
carrier NN O
identification NN O
. . O

The DT O
first JJ O
was VBD O
the DT O
presence NN O
of IN O
a DT O
calf NN B-Species
that WDT O
was VBD O
diagnosed VBN O
by IN O
pathological JJ O
investigation NN O
. . O

In IN O
many JJ O
cases NNS O
more JJR O
than IN O
one CD O
affected JJ O
calf NN B-Species
per IN O
sire NN O
was VBD O
identified VBN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Some DT O
sires NNS O
had VBD O
only RB O
one CD O
affected VBN O
calf NN B-Species
, , O
but CC O
a DT O
large JJ O
number NN O
of IN O
risk NN O
- HYPH O
matings NNS O
. . O

In IN O
these DT O
cases NNS O
a DT O
second JJ O
criterion NN O
, , O
the DT O
statistical JJ O
evaluation NN O
of IN O
risk NN O
- HYPH O
matings NNS O
, , O
was VBD O
used VBN O
to TO O
identify VB O
potential JJ O
phenocopies NNS O
. . O

For IN O
this DT O
purpose NN O
, , O
the DT O
probability NN O
of IN O
observing VBG O
only RB O
a DT O
single JJ O
affected JJ O
calf NN B-Species
among IN O
a DT O
certain JJ O
number NN O
of IN O
risk NN O
- HYPH O
matings NNS O
of IN O
the DT O
sire NN O
in IN O
question NN O
was VBD O
calculated VBN O
. . O

Risk NN O
- HYPH O
matings NNS O
were VBD O
defined VBN O
as IN O
matings NNS O
with IN O
direct JJ O
progenies NNS O
of IN O
identified VBN O
AS NNP O
carriers NNS O
. . O

The DT O
probability NN O
of IN O
observing VBG O
an DT O
affected JJ O
calf NN B-Species
depends VBZ O
also RB O
on IN O
the DT O
probability NN O
that IN O
such PDT O
a DT O
calf NN B-Species
is VBZ O
reported VBN O
to IN O
the DT O
LKV NNP O
. . O

We PRP O
assumed VBD O
this DT O
probability NN O
to TO O
be VB O
50 CD O
% NN O
. . O

Under IN O
these DT O
conditions NNS O
, , O
the DT O
probability NN O
of IN O
observing VBG O
only RB O
one CD O
affected VBN O
calf NN B-Species
is VBZ O
lower JJR O
than IN O
1 CD O
. . O
0 CD O
percent NN O
, , O
if IN O
at IN O
least JJS O
104 CD O
risk NN O
- HYPH O
matings NNS O
are VBP O
given VBN O
for IN O
a DT O
single JJ O
sire NN O
. . O

In IN O
this DT O
case NN O
it PRP O
is VBZ O
very RB O
likely JJ O
that IN O
the DT O
single JJ O
affected VBN O
calf NN B-Species
is VBZ O
a DT O
phenocopy NN O
. . O

In IN O
2006 CD O
and CC O
2007 CD O
this DT O
was VBD O
the DT O
case NN O
for IN O
two CD O
sires NNS O
used VBN O
for IN O
artificial JJ O
insemination NN O
that WDT O
had VBD O
no DT O
pedigree NN O
connection NN O
to IN O
SEMPER NNP O
( , O
see VB O
below RB O
) -RRB- O
. . O

Experimental JJ O
matings NNS O
of IN O
obligate JJ O
carriers NNS O

Four CD O
out IN O
of IN O
seven CD O
cows NNS B-Species
that WDT O
were VBD O
known VBN O
AS NNP O
carriers NNS O
brought VBD O
to IN O
the DT O
facilities NNS O
of IN O
the DT O
ITZ NNP O
were VBD O
used VBN O
for IN O
embryo NN O
transfer NN O
( , O
Table NNP O
1 CD O
) -RRB- O
. . O

33 CD O
of IN O
the DT O
60 CD O
recipients NNS O
( : O
55 CD O
% NN O
) -RRB- O
were VBD O
confirmed VBN O
pregnant JJ O
on IN O
day NN O
35 CD O
. . O

Four CD O
of IN O
the DT O
33 CD O
pregnant JJ O
heifers NNS O
( : O
12 CD O
% NN O
) -RRB- O
aborted VBN O
between IN O
days NNS O
36 CD O
and CC O
49 CD O
of IN O
pregnancy NN O
. . O

Of IN O
the DT O
remaining VBG O
29 CD O
recipients NNS O
, , O
6 CD O
were VBD O
slaughtered VBN O
on IN O
day NN O
150 CD O
, , O
6 CD O
on IN O
day NN O
200 CD O
, , O
and CC O
17 CD O
animals NNS O
on IN O
day NN O
225 CD O
of IN O
pregnancy NN O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
. . O

Four CD O
fetuses NNS O
( , O
three CD O
male JJ O
and CC O
one CD O
female NN O
) CD O
out IN O
of IN O
29 CD O
( SYM O
14 CD O
% NN O
) , O
showed VBD O
the DT O
typical JJ O
pathological JJ O
changes NNS O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
as IN O
described VBN O
above RB O
( -LRB- O
Figure NNP O
4C NNP O
, , O
D NNP O
) -RRB- O
. . O

All DT O
other JJ O
fetuses NNS O
showed VBD O
no DT O
signs NNS O
of IN O
AS NNP O
( -LRB- O
Figure NNP O
4A NNP O
, , O
B NN O
) -RRB- O
. . O

Male JJ O
fetuses NNS O
represented VBD O
76 CD O
% NN O
( , O
22 CD O
of IN O
29 CD O
) , O
of IN O
pregnancies NNS O
( , O
chi NN O
2 CD O
= SYM O
3 CD O
. . O
123 CD O
, , O
p NN O
= SYM O
0 CD O
. . O
77 CD O
, , O
Yates NNP O
corrected VBN O
for IN O
sample NN O
size NN O
< $ O
30 CD O
) -RRB- O
. . O

Female JJ O
weight NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
, , O
crown NN O
- HYPH O
rump NN O
length NN O
at IN O
day NN O
225 CD O
and CC O
chest NN O
circumference NN O
at IN O
day NN O
225 CD O
of IN O
normal JJ O
fetuses NNS O
were VBD O
lower JJR O
than IN O
that DT O
of IN O
male JJ O
fetuses NNS O
. . O

Fetuses NNS O
that WDT O
were VBD O
affected VBN O
by IN O
the DT O
arachnomelia NN O
syndrome NN O
showed VBD O
lower JJR O
weight NN O
than IN O
normal JJ O
fetuses NNS O
. . O

The DT O
affected JJ O
and CC O
the DT O
normal JJ O
fetuses NNS O
had VBD O
similar JJ O
crown NN O
- HYPH O
rump NN O
length NN O
, , O
but CC O
the DT O
chest NN O
circumference NN O
of IN O
affected VBN O
fetuses NNS O
was VBD O
higher JJR O
than IN O
that DT O
of IN O
normal JJ O
fetuses NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Due IN O
to IN O
the DT O
small JJ O
number NN O
of IN O
affected VBN O
female JJ O
fetuses NNS O
, , O
a DT O
comparison NN O
with IN O
unaffected JJ O
animals NNS O
for IN O
sex NN O
was VBD O
not RB O
possible JJ O
. . O

To TO O
compare VB O
unaffected JJ O
and CC O
affected VBN O
animals NNS O
in IN O
total NN O
, , O
the DT O
data NNS O
were VBD O
analyzed VBN O
for IN O
statistical JJ O
differences NNS O
by IN O
the DT O
non AFX O
parametric JJ O
Mann NNP O
- HYPH O
Whitney NNP O
- HYPH O
Test NNP O
. . O

The DT O
only JJ O
trait NN O
that WDT O
was VBD O
significantly RB O
different JJ O
between IN O
unaffected JJ O
and CC O
affected VBN O
fetuses NNS O
was VBD O
the DT O
chest NN O
circumference NN O
( , O
p NN O
= SYM O
0 CD O
. . O
4 CD O
, , O
Table NN O
2 CD O
) -RRB- O
. . O

The DT O
body NN O
weight NN O
of IN O
AS NNP O
affected VBN O
calves NNS B-Species
was VBD O
tendentially RB O
lower JJR O
than IN O
that DT O
of IN O
normal JJ O
calves NNS B-Species
. . O

Since IN O
affected JJ O
calves NNS B-Species
did VBD O
not RB O
have VB O
different JJ O
crown NN O
- HYPH O
rump NN O
- HYPH O
length NN O
and CC O
their PRP$ O
chest NN O
circumference NN O
was VBD O
even RB O
higher JJR O
, , O
this DT O
can MD O
best RBS O
be VB O
explained VBN O
by IN O
a DT O
reduced VBN O
bone NN O
mass NN O
. . O

Pedigree NN O
Analysis NN O
and CC O
mode NN O
of IN O
inheritance NN O

Eight CD O
- HYPH O
generation NN O
pedigrees NNS O
of IN O
all DT O
cases NNS O
were VBD O
extracted VBN O
from IN O
the DT O
joint JJ O
German JJ O
and CC O
Austria NNP O
pedigree NN O
data NNS O
and CC O
screened VBN O
for IN O
common JJ O
ancestors NNS O
. . O

The DT O
pedigree NN O
of IN O
the DT O
majority NN O
of IN O
affected VBN O
calves NNS B-Species
( , O
paternal JJ O
line NN O
150 CD O
, , O
maternal JJ O
line NN O
106 CD O
out IN O
of IN O
152 CD O
, , O
Table NNP O
3 CD O
) -RRB- O
could MD O
be VB O
traced VBN O
back RB O
to IN O
one CD O
founder NN O
, , O
SEMPER NNP O
( , O
ISO NNP O
- HYPH O
Nr NNP O
. . O
27000979299305 CD O
) -RRB- O
, , O
a DT O
sire NN O
born VBN O
in IN O
1964 CD O
, , O
6 CD O
- SYM O
9 CD O
generations NNS O
before IN O
the DT O
affected JJ O
calves NNS B-Species
were VBD O
born VBN O
( : O
Figure NNP O
2 CD O
) -RRB- O
. . O

Most JJS O
of IN O
the DT O
affected VBN O
calves NNS B-Species
inherited VBD O
the DT O
AS NNP O
mutation NN O
via IN O
REXON NNP O
or CC O
EGEL NNP O
( : O
Table NNP O
3 CD O
, , O
Figure NNP O
2 CD O
) -RRB- O
. . O

In IN O
44 CD O
cases NNS O
the DT O
maternal JJ O
paths NNS O
were VBD O
not RB O
linked VBN O
to IN O
the DT O
common JJ O
pedigree NN O
( : O
Table NNP O
3 CD O
) -RRB- O
. . O

One CD O
explanation NN O
would MD O
be VB O
the DT O
existence NN O
of IN O
additional JJ O
, , O
hereto JJ O
unknown JJ O
origins NNS O
of IN O
the DT O
mutation NN O
. . O

This DT O
could MD O
happen VB O
if IN O
the DT O
AS NNP O
mutation NN O
is VBZ O
much RB O
more RBR O
ancient JJ O
and CC O
additional JJ O
pedigree NN O
paths NNS O
exist VBP O
or CC O
if IN O
an DT O
independent JJ O
mutation NN O
event NN O
happened VBD O
leading VBG O
to IN O
the DT O
same JJ O
phenotype NN O
. . O

An DT O
alternative JJ O
, , O
more RBR O
plausible JJ O
explanation NN O
could MD O
be VB O
the DT O
occurrence NN O
of IN O
misparentages NNS O
. . O

It PRP O
is VBZ O
well RB O
known VBN O
that IN O
in IN O
the DT O
pre JJ O
parentage NN O
- HYPH O
test NN O
era NN O
, , O
the DT O
frequency NN O
of IN O
false JJ O
paternity NN O
, , O
especially RB O
of IN O
the DT O
cows NNS B-Species
, , O
was VBD O
reasonable JJ O
high JJ O
( : O
up RB O
to TO O
23 CD O
% NN O
[ -LRB- O
9 CD O
] -RRB- O
) -RRB- O
. . O

Therefore RB O
, , O
there EX O
is VBZ O
a DT O
good JJ O
chance NN O
of IN O
a DT O
false JJ O
registry NN O
within IN O
6 CD O
- SYM O
9 CD O
generations NNS O
. . O

There EX O
is VBZ O
strong JJ O
support NN O
for IN O
the DT O
assumption NN O
that IN O
the DT O
AS NNP O
is VBZ O
regulated VBN O
by IN O
a DT O
single JJ O
autosomal JJ O
locus NN O
acting VBG O
in IN O
a DT O
recessive JJ O
manner NN O
. . O

First RB O
of IN O
all DT O
, , O
the DT O
pedigree NN O
structure NN O
of IN O
the DT O
affected VBN O
calves NNS B-Species
in IN O
Simmental NNP O
can MD O
best RBS O
be VB O
explained VBN O
by IN O
a DT O
recessive JJ O
mode NN O
of IN O
inheritance NN O
. . O

The DT O
paternal JJ O
branch NN O
of IN O
the DT O
pedigree NN O
could MD O
be VB O
traced VBN O
back RB O
to IN O
one CD O
sire NN O
, , O
SEMPER NNP O
, , O
for IN O
all DT O
affected VBN O
calves NNS B-Species
, , O
the DT O
maternal JJ O
branch NN O
in IN O
the DT O
majority NN O
of IN O
the DT O
cases NNS O
. . O

Inbreeding VBG O
loops NNS O
over IN O
a DT O
few JJ O
generations NNS O
are VBP O
present JJ O
in IN O
several JJ O
pedigrees NNS O
of IN O
affected VBN O
calves NNS B-Species
, , O
e UH O
. . O
g LS O
. . O
cases NNS O
P3364 CD O
and CC O
P1787 CD O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Sex NN O
- HYPH O
dependent JJ O
inheritance NN O
can MD O
obviously RB O
be VB O
excluded VBN O
and CC O
a DT O
dominant JJ O
mode NN O
with IN O
reduced VBN O
penetrance NN O
seems VBZ O
to TO O
be VB O
unlikely JJ O
. . O

Secondly RB O
, , O
the DT O
experimental JJ O
matings NNS O
resulted VBD O
in IN O
4 CD O
affected VBN O
and CC O
25 CD O
unaffected JJ O
fetuses NNS O
, , O
a DT O
result NN O
that WDT O
most RBS O
closely RB O
resembles VBZ O
the DT O
expectation NN O
of IN O
a DT O
recessive JJ O
mode NN O
of IN O
inheritance NN O
. . O

Thirdly RB O
, , O
the DT O
occurrence NN O
of IN O
cases NNS O
corresponded VBD O
well RB O
with IN O
the DT O
numbers NNS O
expected VBN O
under IN O
the DT O
assumption NN O
of IN O
a DT O
recessively RB O
acting VBG O
mutation NN O
. . O

We PRP O
tested VBD O
this DT O
on IN O
the DT O
progeny NN O
of IN O
ROMEL NNP O
, , O
the DT O
largest JJS O
dataset NN O
available JJ O
from IN O
one CD O
carrier NN O
. . O

We PRP O
analyzed VBD O
the DT O
period NN O
from IN O
the DT O
beginning NN O
of IN O
the DT O
recording NN O
system NN O
for IN O
malformations NNS O
to IN O
May NNP O
2007 CD O
. . O

In IN O
that DT O
period NN O
44 CD O
, , O
170 CD O
calves NNS B-Species
were VBD O
born VBN O
that WDT O
were VBD O
sired VBN O
by IN O
ROMEL NNP O
. . O

From IN O
these DT O
, , O
662 CD O
were VBD O
considered VBN O
as IN O
risk NN O
pairings NNS O
, , O
i PRP O
. . O
e NFP O
. . O
the DT O
mother NN O
had VBD O
a DT O
risk NN O
of IN O
0 CD O
. . O
5 CD O
to TO O
be VB O
a DT O
carrier NN O
( : O
i PRP O
. . O
e LS O
. . O
one CD O
of IN O
the DT O
grandparents NNS O
was VBD O
an DT O
obligate NN O
carrier NN O
) -RRB- O
and CC O
35 CD O
calves NNS B-Species
out IN O
of IN O
these DT O
were VBD O
diagnosed VBN O
as IN O
affected VBN O
. . O

Since IN O
it PRP O
is VBZ O
expected VBN O
that IN O
about RB O
1 CD O
/ SYM O
2 CD O
to TO O
1 CD O
/ SYM O
3 CD O
of IN O
the DT O
affected VBN O
calves NNS B-Species
were VBD O
recorded VBN O
, , O
this DT O
result NN O
is VBZ O
very RB O
close JJ O
to IN O
the DT O
expected VBN O
1 CD O
: SYM O
7 CD O
ratio NN O
of IN O
affected VBN O
to IN O
unaffected JJ O
calves NNS B-Species
. . O

Moreover RB O
, , O
these DT O
findings NNS O
are VBP O
concordant JJ O
with IN O
the DT O
historical JJ O
description NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
in IN O
Simmental NNP O
[ -LRB- O
2 CD O
] -RRB- O
and CC O
the DT O
analyses NNS O
of IN O
cases NNS O
in IN O
Brown NNP O
Swiss NNP O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Finally RB O
, , O
when WRB O
applying VBG O
linkage NN O
analyses NNS O
using VBG O
microsatellite NN O
markers NNS O
, , O
evaluations NNS O
with IN O
a DT O
model NN O
assuming VBG O
recessive JJ O
autosomal JJ O
inheritance NN O
gave VBD O
the DT O
highest JJS O
lod NN O
scores NNS O
( : O
Buitkamp NNP O
et FW O
al NNP O
. . O
, , O
in IN O
preparation NN O
) -RRB- O
. . O

Allelic JJ O
frequency NN O
of IN O
carriers NNS O
in IN O
the DT O
present JJ O
Simmental NNP O
cow NN B-Species
population NN O

Since IN O
the DT O
arachnomelia NN O
syndrome NN O
- HYPH O
allele NN O
was VBD O
passed VBN O
to IN O
the DT O
current JJ O
population NN O
through IN O
two CD O
parental JJ O
lines NNS O
( : O
REXON NNP O
and CC O
EGEL NNP O
) -RRB- O
and CC O
the DT O
main JJ O
carriers NNS O
are VBP O
known VBN O
, , O
it PRP O
is VBZ O
possible JJ O
to TO O
estimate VB O
the DT O
frequency NN O
of IN O
the DT O
disease NN O
allele NN O
by IN O
an DT O
allele NN O
- HYPH O
counting VBG O
method NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
allelic JJ O
frequency NN O
was VBD O
calculated VBN O
for IN O
all DT O
cows NNS B-Species
from IN O
the DT O
breeding NN O
population NN O
who WP O
were VBD O
alive JJ O
in IN O
June NNP O
2007 CD O
. . O

In IN O
10 CD O
. . O
4 CD O
percent NN O
of IN O
the DT O
pedigrees NNS O
of IN O
540 CD O
, , O
725 CD O
cows NNS B-Species
an DT O
identified VBN O
carrier NN O
was VBD O
found VBN O
and CC O
the DT O
probability NN O
that IN O
individual JJ O
cows NNS B-Species
were VBD O
carrier NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
- HYPH O
allele NN O
was VBD O
calculated VBN O
. . O

E UH O
. . O
g LS O
. . O
in IN O
14 CD O
, , O
740 CD O
and CC O
41 CD O
, , O
32 CD O
cases NNS O
a DT O
known VBN O
carrier NN O
appeared VBD O
as IN O
sire NN O
and CC O
grandsire NN O
, , O
respectively RB O
. . O

In IN O
these DT O
cases NNS O
the DT O
probability NN O
of IN O
transmitting VBG O
the DT O
allele NN O
is VBZ O
50 CD O
and CC O
25 CD O
percent NN O
, , O
respectively RB O
, , O
if IN O
no DT O
further JJ O
carrier NN O
is VBZ O
present JJ O
in IN O
the DT O
two CD O
generation NN O
pedigree NN O
. . O

The DT O
averaged JJ O
rate NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
carriers NNS O
based VBN O
on IN O
known VBN O
carriers NNS O
over IN O
all DT O
cows NNS B-Species
alive JJ O
in IN O
Bavarian NNP O
Simmental NNP O
was VBD O
3 CD O
. . O
32 CD O
percent NN O
. . O

Using VBG O
this DT O
approach NN O
, , O
the DT O
frequency NN O
of IN O
carriers NNS O
was VBD O
calculated VBN O
for IN O
each DT O
year NN O
( , O
always RB O
based VBN O
on IN O
the DT O
actual JJ O
datasets NNS O
from IN O
August NNP O
2008 CD O
) -RRB- O
from IN O
2003 CD O
to IN O
2008 CD O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
calculations NNS O
were VBD O
done VBN O
twice RB O
, , O
considering VBG O
all DT O
known VBN O
carriers NNS O
together RB O
, , O
and CC O
also RB O
by IN O
using VBG O
only RB O
ROMEL NNP O
as IN O
a DT O
carrier NN O
to TO O
show VB O
the DT O
numeric JJ O
contribution NN O
of IN O
his PRP$ O
progeny NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

For IN O
these DT O
analyses NNS O
, , O
the DT O
sires NNS O
that WDT O
are VBP O
designated VBN O
to TO O
be VB O
non JJ O
- HYPH O
carriers NNS O
by IN O
the DT O
number NN O
of IN O
risk NN O
pairings NNS O
without IN O
having VBG O
a DT O
case NN O
or CC O
the DT O
indirect JJ O
gene NN O
test NN O
are VBP O
set VBN O
as IN O
non JJ O
- HYPH O
carrier NN O
. . O

Therefore RB O
, , O
these DT O
frequencies NNS O
are VBP O
slightly RB O
lower JJR O
than IN O
the DT O
initial JJ O
frequency NN O
estimate NN O
of IN O
3 CD O
. . O
32 CD O
percent NN O
. . O

Conclusion NN O

The DT O
cases NNS O
of IN O
malformed JJ O
Simmental JJ O
calves NNS B-Species
presented VBN O
here RB O
showed VBD O
the DT O
same JJ O
morphology NN O
described VBN O
in IN O
the DT O
arachnomelia NN O
syndrome NN O
in IN O
Brown NNP O
Swiss NNP O
[ -LRB- O
e LS O
. . O
g LS O
. . O
[ -LRB- O
3 CD O
] -RRB- O
] -RRB- O
, , O
even RB O
though IN O
there EX O
is VBZ O
a DT O
certain JJ O
morphological JJ O
variation NN O
from IN O
mild NN O
to IN O
severe JJ O
malformations NNS O
. . O

The DT O
main JJ O
findings NNS O
, , O
brachygnathia NN O
inferior JJ O
and CC O
convex NN O
frontal JJ O
bone NN O
of IN O
the DT O
face NN O
, , O
deformation NN O
of IN O
vertebrae NN O
, , O
and CC O
dysplasia NN O
of IN O
the DT O
limbs NNS O
, , O
namely RB O
the DT O
diaphyses NNS O
of IN O
metatarsus NN O
and CC O
- HYPH O
carpus NN O
and CC O
the DT O
fetlocks NNS O
, , O
can MD O
best RBS O
be VB O
explained VBN O
by IN O
irregularly RB O
developed VBN O
bone NN O
structure NN O
at IN O
the DT O
corresponding VBG O
locations NNS O
. . O

Without IN O
pathological JJ O
examination NN O
it PRP O
is VBZ O
difficult JJ O
to TO O
distinguish VB O
the DT O
arachnomelia NN O
syndrome NN O
from IN O
other JJ O
malformations NNS O
of IN O
the DT O
limbs NNS O
. . O

Therefore RB O
, , O
low JJ O
numbers NNS O
of IN O
cases NNS O
in IN O
Simmental NNP O
probably RB O
passed VBD O
unrecognized JJ O
before IN O
2005 CD O
. . O

In IN O
that DT O
year NN O
the DT O
allelic JJ O
frequency NN O
of IN O
the DT O
disease NN O
in IN O
the DT O
cow NN B-Species
population NN O
increased VBD O
sharply RB O
because IN O
some DT O
sires NNS O
that WDT O
had VBD O
been VBN O
carriers NNS O
of IN O
the DT O
mutation NN O
had VBD O
become VBN O
very RB O
popular JJ O
2 CD O
- SYM O
4 CD O
years NNS O
before RB O
. . O

The DT O
identification NN O
of IN O
a DT O
common JJ O
ancestor NN O
, , O
the DT O
results NNS O
from IN O
the DT O
experimental JJ O
matings NNS O
and CC O
the DT O
analyses NNS O
of IN O
numbers NNS O
of IN O
cases NNS O
from IN O
risk NN O
matings NNS O
strongly RB O
support VBP O
the DT O
hypothesis NN O
of IN O
an DT O
autosomal JJ O
recessively RB O
inherited VBN O
disease NN O
. . O

Furthermore RB O
, , O
this DT O
assumption NN O
is VBZ O
concordant JJ O
with IN O
the DT O
historical JJ O
description NN O
of IN O
the DT O
syndrome NN O
in IN O
Simmental NNP O
and CC O
Brown NNP O
Swiss NNP O
. . O

The DT O
allelic JJ O
frequency NN O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
in IN O
the DT O
current JJ O
population NN O
is VBZ O
well RB O
above IN O
3 CD O
percent NN O
and CC O
a DT O
substantial JJ O
number NN O
of IN O
progeny NN O
from IN O
known VBN O
carriers NNS O
with IN O
superior JJ O
genetic JJ O
merit NN O
shall MD O
be VB O
used VBN O
as IN O
sires NNS O
during IN O
the DT O
next JJ O
years NNS O
. . O

Therefore RB O
, , O
a DT O
control NN O
system NN O
has VBZ O
to TO O
be VB O
established VBN O
and CC O
the DT O
arachnomelia NN O
syndrome NN O
- HYPH O
gene NN O
should MD O
be VB O
mapped VBN O
as IN O
a DT O
prerequisite NN O
for IN O
the DT O
development NN O
of IN O
an DT O
indirect JJ O
gene NN O
test NN O
for IN O
carrier NN O
identification NN O
. . O

The DT O
availability NN O
of IN O
pathologically RB O
well RB O
characterized VBN O
cases NNS O
from IN O
the DT O
field NN O
and CC O
from IN O
the DT O
ET NNP O
- HYPH O
generated VBN O
full JJ O
- HYPH O
sib NN O
families NNS O
will MD O
be VB O
an DT O
excellent JJ O
material NN O
for IN O
a DT O
genetic JJ O
mapping NN O
procedure NN O
. . O

Methods NNS O

Recording NN O
system NN O
for IN O
congenital JJ O
malformations NNS O

A DT O
system NN O
for IN O
monitoring VBG O
inherited VBN O
congenital JJ O
malformations NNS O
in IN O
Bavarian JJ O
cattle NNS B-Species
populations NNS O
was VBD O
established VBN O
by IN O
the DT O
Institute NNP O
for IN O
Animal NNP O
Breeding NNP O
of IN O
the DT O
Bavarian NNP O
State NNP O
Research NNP O
Centre NNP O
for IN O
Agriculture NNP O
( , O
ITZ NNP O
) -RRB- O
in IN O
cooperation NN O
with IN O
the DT O
Bavarian JJ O
milk NN O
recording NN O
organization NN O
( , O
LKV NNP O
) -RRB- O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
short JJ O
, , O
a DT O
questionnaire NN O
was VBD O
developed VBN O
for IN O
detailed JJ O
recording NN O
of IN O
malformed VBN O
calves NNS B-Species
. . O

The DT O
malformation NN O
was VBD O
described VBN O
according VBG O
to IN O
its PRP$ O
location NN O
( , O
e LS O
. . O
g LS O
. . O
head NN O
, , O
legs NNS O
) -RRB- O
and CC O
its PRP$ O
characteristics NNS O
( , O
e LS O
. . O
g LS O
. . O
hernia NN O
) -RRB- O
. . O

The DT O
standardized VBN O
data NNS O
were VBD O
stored VBN O
in IN O
a DT O
database NN O
at IN O
the DT O
LKV NNP O
, , O
that WDT O
is VBZ O
evaluated VBN O
monthly RB O
for IN O
a DT O
potential JJ O
genetic JJ O
background NN O
of IN O
malformations NNS O
. . O

Sires NNS O
that WDT O
fit VBP O
into IN O
the DT O
pedigree NN O
( , O
progeny NN O
of IN O
REXON NNP O
or CC O
EGEL NNP O
) -RRB- O
with IN O
at RB O
least RBS O
one CD O
affected VBN O
calf NN B-Species
with IN O
confirmed VBN O
paternity NN O
were VBD O
defined VBN O
as IN O
obligate JJ O
carriers NNS O
and CC O
marked VBN O
in IN O
the DT O
breeding NN O
information NN O
system NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
cases NNS O
without IN O
connection NN O
to IN O
the DT O
pedigree NN O
and CC O
only RB O
one CD O
recorded VBD O
calf NN B-Species
the DT O
number NN O
of IN O
"""" `` O
risk NN O
pairings NNS O
"""" '' O
( , O
matings NNS O
to IN O
cows NNS B-Species
where WRB O
at RB O
least RBS O
one CD O
parent NN O
is VBZ O
a DT O
known VBN O
carrier NN O
, , O
enabling VBG O
the DT O
calculation NN O
of IN O
the DT O
probability NN O
for IN O
the DT O
occurrence NN O
of IN O
cases NNS O
) -RRB- O
was VBD O
calculated VBN O
. . O

When WRB O
the DT O
probability NN O
that IN O
a DT O
case NN O
occurs VBZ O
was VBD O
above IN O
99 CD O
% NN O
for IN O
the DT O
sire NN O
in IN O
question NN O
the DT O
case NN O
was VBD O
considered VBN O
to TO O
be VB O
a DT O
phenocopy NN O
. . O

The DT O
number NN O
of IN O
calves NNS B-Species
affected VBN O
by IN O
the DT O
arachnomelia NN O
syndrome NN O
and CC O
their PRP$ O
parentage NN O
is VBZ O
routinely RB O
published VBN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Pathological JJ O
examinations NNS O

Pathological JJ O
examinations NNS O
followed VBD O
standard JJ O
procedures NNS O
. . O

Calves NNS B-Species
were VBD O
photographed VBN O
and CC O
size NN O
and CC O
weight NN O
measurements NNS O
were VBD O
recorded VBN O
. . O

Tissue NN O
specimens NNS O
from IN O
the DT O
condyle NN O
( , O
epiphysis NN O
) -RRB- O
and CC O
from IN O
the DT O
diaphysis NN O
of IN O
the DT O
femur NN O
were VBD O
collected VBN O
for IN O
histological JJ O
examination NN O
. . O

Specimens NNS O
were VBD O
fixed VBN O
in IN O
10 CD O
% NN O
formalin NN O
and CC O
kept VBN O
in IN O
a DT O
decalcifying JJ O
solution NN O
( , O
Ossafixonafor NNP O
) -RRB- O
for IN O
24 CD O
hours NNS O
. . O

Thereafter RB O
, , O
specimens NNS O
were VBD O
processed VBN O
in IN O
an DT O
automated JJ O
embedding NN O
system NN O
, , O
sectioned VBN O
at IN O
4 CD O
- SYM O
6 CD O
microns NNS O
and CC O
finally RB O
stained VBN O
with IN O
haematoxyline NN O
and CC O
eosin NN O
. . O

Experimental JJ O
matings NNS O
and CC O
embryo NN O
transfer NN O

Known VBN O
carriers NNS O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
( , O
seven CD O
cows NNS B-Species
that WDT O
had VBD O
produced VBN O
at RB O
least RBS O
one CD O
affected VBN O
calf NN B-Species
) , O
were VBD O
brought VBN O
to IN O
the DT O
facilities NNS O
of IN O
the DT O
ITZ NNP O
for IN O
embryo NN O
transfer NN O
( , O
Table NNP O
1 CD O
) -RRB- O
. . O

Late JJ O
morulae NN O
and CC O
blastocysts NNS O
collected VBN O
on IN O
day NN O
7 CD O
( HYPH O
day NN O
0 CD O
= SYM O
estrus NN O
) -RRB- O
from IN O
superovulated JJ O
donor NN O
cows NNS B-Species
were VBD O
nonsurgically RB O
transferred VBN O
to IN O
heifers NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Mode NN O
of IN O
inheritance NN O
and CC O
allele NN O
frequency NN O

The DT O
pedigree NN O
of IN O
all DT O
cases NNS O
was VBD O
constructed VBN O
from IN O
the DT O
pedigree NN O
that WDT O
is VBZ O
used VBN O
for IN O
the DT O
joint JJ O
breeding NN O
evaluation NN O
of IN O
Germany NNP O
and CC O
Austria NNP O
. . O

The DT O
graphical JJ O
presentation NN O
of IN O
the DT O
pedigree NN O
was VBD O
performed VBN O
with IN O
the DT O
Pedigraph NNP O
TM NNP O
software NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
allelic JJ O
frequency NN O
of IN O
the DT O
AS NNP O
mutation NN O
in IN O
the DT O
current JJ O
cow NN B-Species
population NN O
was VBD O
estimated VBN O
from IN O
ancestors NNS O
with IN O
known VBN O
genotypes NNS O
following VBG O
the DT O
allele NN O
- HYPH O
counting VBG O
method NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

For IN O
this DT O
reason NN O
two CD O
generation NN O
pedigrees NNS O
of IN O
herd NN O
book NN O
cows NNS B-Species
in IN O
Bavarian NNP O
Simmental NNP O
were VBD O
analyzed VBN O
for IN O
obligate JJ O
carriers NNS O
. . O

We PRP O
considered VBD O
all DT O
cows NNS B-Species
that WDT O
were VBD O
alive JJ O
in IN O
June NNP O
2007 CD O
and CC O
included VBD O
in IN O
the DT O
herd NN O
book NN O
. . O

All DT O
animals NNS O
were VBD O
bred VBN O
by IN O
the DT O
use NN O
of IN O
artificial JJ O
insemination NN O
. . O

Statistical JJ O
analyses NNS O

The DT O
non AFX O
parametric JJ O
Mann NNP O
- HYPH O
Whitney NNP O
- HYPH O
Test NNP O
was VBD O
performed VBN O
using VBG O
SPSS NNP O
Version NNP O
14 CD O
. . O
0 CD O
, , O
the DT O
Chi NNP O
- HYPH O
square NN O
test NN O
was VBD O
performed VBN O
using VBG O
R NN O
2 CD O
. . O
4 CD O
. . O
0 CD O
[ SYM O
14 CD O
] -RRB- O
. . O

Authors NNS O
' POS O
contributions NNS O

JB NNP O
drafted VBD O
the DT O
manuscript NN O
and CC O
analyzed VBD O
the DT O
pedigrees NNS O
. . O

BL NNP O
conceived VBD O
the DT O
monitoring NN O
system NN O
for IN O
inherited VBN O
diseases NNS O
. . O

RE NNP O
extracted VBD O
the DT O
data NNS O
from IN O
the DT O
database NN O
and CC O
estimated VBD O
the DT O
allelic JJ O
frequencies NNS O
of IN O
the DT O
arachnomelia NN O
syndrome NN O
. . O

HR NNP O
and CC O
MW NNP O
performed VBD O
the DT O
embryo NN O
collection NN O
, , O
transfer NN O
and CC O
recorded VBD O
the DT O
morpho NN O
- HYPH O
metrical JJ O
data NNS O
of IN O
the DT O
experimental JJ O
matings NNS O
. . O

BS NNP O
examined VBD O
the DT O
calves NNS B-Species
pathologically RB O
. . O

NM NNP O
and CC O
KG NNP O
participated VBD O
in IN O
study NN O
design NN O
and CC O
coordination NN O
and CC O
critically RB O
revised VBD O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Suggestions NNS O
Concerning VBG O
the DT O
Use NN O
of IN O
the DT O
Subclavian NN O
which WDT O
Arises VBZ O
from IN O
the DT O
Aorta NNP O
in IN O
the DT O
Treatment NN O
of IN O
the DT O
Tetralogy NN O
of IN O
Fallot NNP O
* NFP O

Abstract JJ O

Images NNS O

SUGGESTIONS NNS O
CONCERNING VBG O
THE DT O
USE NN O
OF IN O
THE DT O
SUBCLAVIAN NNP O

WHICH WDT O
ARISES VBZ O
FROM IN O
THE DT O
AORTA NNP O
IN IN O
THE DT O
TREATMENT NN O

OF IN O
THE DT O
TETRALOGY NN O
OF IN O
FALLOT NNP O
* NFP O

HARRIS NNP O
B NNP O
. . O

SHUMACKER NNP O
, , O
JR NNP O
. . O
* NFP O
* NFP O

In IN O
Blalock NNP O
' POS O
s POS O
early JJ O
experience NN O
with IN O
the DT O
operative JJ O
treatment NN O
of IN O
the DT O
tetralogy NN O
of IN O
Fallot NNP O
, , O
the DT O
two CD O
subclavian NN O
, , O
the DT O
innominate NN O
, , O
and CC O
carotid NN O
arteries NNS O
were VBD O
all DT O
used VBN O
for IN O
anastomosis NN O
to IN O
the DT O
pulmonary JJ O
artery NN O
. . O

Soon RB O
, , O
however RB O
, , O
it PRP O
became VBD O
evident JJ O
that IN O
use NN O
of IN O
the DT O
innominate NN O
or CC O
carotid NN O
was VBD O
followed VBN O
by IN O
a DT O
relatively RB O
high JJ O
incidence NN O
of IN O
complications NNS O
resulting VBG O
from IN O
cerebral JJ O
ischemia NN O
. . O

Blalock NNP O
suggested VBD O
, , O
therefore RB O
, , O
that IN O
the DT O
subclavian NN O
be VB O
used VBN O
by IN O
preference NN O
. . O

The DT O
subclavian JJ O
branch NN O
of IN O
the DT O
innominate NN O
does VBZ O
not RB O
become VB O
kinked VBN O
or CC O
badly RB O
angulated VBN O
when WRB O
it PRP O
is VBZ O
turned VBN O
down RP O
for IN O
the DT O
anastomosis NN O
, , O
and CC O
a DT O
good JJ O
functional JJ O
result NN O
almost RB O
invariably RB O
follows VBZ O
the DT O
completion NN O
of IN O
a DT O
satisfactory JJ O
anastomosis NN O
. . O

The DT O
subclavian NN O
which WDT O
arises VBZ O
directly RB O
from IN O
the DT O
aorta NN O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
tends VBZ O
to TO O
form VB O
a DT O
bad JJ O
angle NN O
when WRB O
it PRP O
is VBZ O
brought VBN O
down RP O
for IN O
the DT O
anastomosis NN O
, , O
and CC O
, , O
indeed RB O
, , O
near IN O
its PRP$ O
point NN O
of IN O
origin NN O
it PRP O
may MD O
be VB O
so RB O
flattened JJ O
out RP O
against IN O
the DT O
relatively RB O
rigid JJ O
aortic JJ O
wall NN O
as IN O
to TO O
obstruct VB O
all DT O
blood NN O
flow VB O
through IN O
it PRP O
. . O

These DT O
considerations NNS O
led VBD O
Blalock NNP O
to TO O
recommend VB O
the DT O
use NN O
of IN O
the DT O
former JJ O
except IN O
in IN O
infants NNS B-Species
under IN O
two CD O
years NNS O
of IN O
age NN O
in IN O
whom WP O
this DT O
artery NN O
may MD O
be VB O
too RB O
small JJ O
and CC O
in IN O
adults NNS O
or CC O
children NNS B-Species
over IN O
twelve CD O
years NNS O
old JJ O
or CC O
five CD O
feet NNS O
tall JJ O
with IN O
a DT O
left JJ O
aortic JJ O
arch NN O
in IN O
whom WP O
it PRP O
is VBZ O
often RB O
too RB O
short JJ O
to TO O
permit VB O
a DT O
satisfactory JJ O
anastomosis NN O
. . O
7 CD O
' '' O

In IN O
contrast NN O
, , O
Paine NNP O
and CC O
Varco NNP O
, , O
' '' O
Lam NNP O
, , O
6 CD O
Holman NNP O
, , O
' '' O
Olim NNP O
, , O
7 CD O
and CC O
others NNS O
have VBP O
preferred VBN O
to TO O
use VB O
the DT O
subclavian NN O
which WDT O
arises VBZ O
from IN O
the DT O
aorta NN O
and CC O
have VBP O
obtained VBN O
generally RB O
excellent JJ O
results NNS O
. . O

They PRP O
point VBP O
out RP O
that IN O
the DT O
tendency NN O
to IN O
kinking NN O
of IN O
the DT O
artery NN O
is VBZ O
more RBR O
a DT O
theoretical JJ O
than IN O
a DT O
practical JJ O
disadvantage NN O
, , O
that IN O
the DT O
exposure NN O
and CC O
dissection NN O
of IN O
both PDT O
the DT O
pulmonary JJ O
artery NN O
and CC O
the DT O
subclavian NN O
are VBP O
easier JJR O
on IN O
the DT O
side NN O
of IN O
the DT O
aortic JJ O
arch NN O
, , O
that IN O
both DT O
vessels NNS O
are VBP O
generally RB O
longer JJR O
than IN O
on IN O
the DT O
opposite JJ O
side NN O
and CC O
that IN O
, , O
as IN O
a DT O
general JJ O
rule NN O
, , O
the DT O
anastomosis NN O
can MD O
be VB O
accomplished VBN O
more RBR O
readily RB O
. . O

The DT O
practical JJ O
usefulness NN O
of IN O
a DT O
third JJ O
systemic JJ O
vessel NN O
, , O
namely RB O
the DT O
aorta NN O
, , O
was VBD O
demonstrated VBN O
by IN O
the DT O
development NN O
of IN O
a DT O
technique NN O
for IN O
side NN O
- HYPH O
to IN O
- HYPH O
side NN O
aortic JJ O
pulmonary JJ O
anastomosis NN O
by IN O
Potts NNP O
and CC O
his PRP$ O
associates NNS O
. , O
"""" '' O
0 NFP O
In IN O
spite NN O
of IN O
the DT O
preferences NNS O
held VBN O
by IN O
individual JJ O
operators NNS O
for IN O
use NN O
of IN O
one CD O
vessel NN O
or CC O
another DT O
, , O
the DT O
fact NN O
remains VBZ O
, , O
as IN O
Blalock NNP O
has VBZ O
emphasized VBN O
, , O
that IN O
there EX O
is VBZ O
always RB O
present JJ O
a DT O
usable JJ O
systemic JJ O
vessel NN O
provided VBN O
a DT O
suitable JJ O
pulmonary JJ O
artery NN O
is VBZ O
available JJ O
. . O

Nevertheless RB O
, , O
the DT O
choice NN O
of IN O
the DT O
systemic JJ O
artery NN O
in IN O
each DT O
individual JJ O
patient NN B-Species
is VBZ O
important JJ O
since IN O
in IN O
certain JJ O
cases NNS O
one CD O
or CC O
another DT O
is VBZ O
unsuitable JJ O
. . O

* NFP O
From IN O
the DT O
Department NNP O
of IN O
Surgery NNP O
, , O
the DT O
Indiana NNP O
University NNP O
Medical NNP O
Center NNP O
, , O
Indianapolis NNP O
, , O
Indiana NNP O
. . O

Aided VBN O
by IN O
a DT O
contract NN O
between IN O
the DT O
Office NNP O
of IN O
Naval NNP O
Research NNP O
, , O
Department NNP O
of IN O
the DT O
Navy NNP O
, , O
and CC O
Indiana NNP O
University NNP O
. . O

* NFP O
* NFP O
Resident NNP O
Surgeon NNP O
, , O
New NNP O
Haven NNP O
Hospital NNP O
, , O
1937 CD O
- SYM O
1938 CD O
. . O

Received VBN O
for IN O
publication NN O
April NNP O
26 CD O
, , O
1951 CD O
. . O

TREATMENT NN O
OF IN O
TETRALOGY NN O
OF IN O
FALLOT NNP O

It PRP O
has VBZ O
been VBN O
my PRP$ O
custom NN O
to TO O
follow VB O
a DT O
policy NN O
rather RB O
similar JJ O
to IN O
that DT O
outlined VBN O
by IN O
Blalock NNP O
. . O

The DT O
subclavian JJ O
branch NN O
of IN O
the DT O
innominate NN O
has VBZ O
generally RB O
been VBN O
preferred VBN O
in IN O
patients NNS B-Species
ranging VBG O
between IN O
two CD O
and CC O
twelve CD O
years NNS O
of IN O
age NN O
and CC O
in IN O
older JJR O
individuals NNS O
in IN O
whom WP O
there EX O
is VBZ O
a DT O
right JJ O
aortic JJ O
arch NN O
. . O

In IN O
others NNS O
the DT O
thoracotomy NN O
is VBZ O
usually RB O
made VBN O
on IN O
the DT O
side NN O
of IN O
the DT O
aortic JJ O
arch NN O
, , O
and CC O
either CC O
the DT O
aorta NN O
itself PRP O
or CC O
the DT O
subclavian NN O
arising VBG O
from IN O
the DT O
aorta NN O
is VBZ O
used VBN O
for IN O
the DT O
anastomosis NN O
. . O

My PRP$ O
experience NN O
with IN O
the DT O
use NN O
of IN O
the DT O
subclavian NN O
originating VBG O
from IN O
the DT O
aorta NN O
is VBZ O
small JJ O
and CC O
the DT O
results NNS O
have VBP O
not RB O
been VBN O
as RB O
good JJ O
as IN O
those DT O
which WDT O
others NNS O
have VBP O
reported VBN O
. . O

One CD O
eighteen CD O
- HYPH O
month NN O
- HYPH O
old JJ O
child NN B-Species
died VBD O
the DT O
day NN O
after IN O
operation NN O
and CC O
was VBD O
found VBN O
at IN O
post JJ O
- HYPH O
mortem NN O
examination NN O
to TO O
have VB O
an DT O
occluded VBN O
anastomosis NN O
. . O

In IN O
one CD O
three CD O
- HYPH O
year NN O
- HYPH O
old JJ O
child NN B-Species
and CC O
one CD O
twenty CD O
- HYPH O
year NN O
- HYPH O
old JJ O
woman NN B-Species
a DT O
poor JJ O
result NN O
was VBD O
obtained VBN O
and CC O
a DT O
second JJ O
operation NN O
upon IN O
the DT O
other JJ O
side NN O
was VBD O
necessary JJ O
. . O

In IN O
two CD O
additional JJ O
cases NNS O
the DT O
result NN O
was VBD O
only RB O
fair JJ O
. . O

Excluding VBG O
the DT O
patients NNS B-Species
mentioned VBN O
in IN O
the DT O
present JJ O
report NN O
, , O
only RB O
in IN O
two CD O
was VBD O
an DT O
unquestionably RB O
good JJ O
result NN O
obtained VBN O
. . O

Recently RB O
, , O
in IN O
several JJ O
cases NNS O
in IN O
which WDT O
failure NN O
seemed VBD O
evident JJ O
a DT O
modification NN O
has VBZ O
been VBN O
required VBN O
in IN O
order NN O
to TO O
obtain VB O
a DT O
functioning VBG O
shunt NN O
. . O

Since IN O
these DT O
modifications NNS O
proved VBD O
successful JJ O
and CC O
since IN O
these DT O
threats NNS O
of IN O
failure NN O
tax NN O
one CD O
' '' O
s POS O
ingenuiity NN O
at IN O
the DT O
time NN O
of IN O
operation NN O
, , O
I PRP O
have VBP O
thought VBN O
it PRP O
might MD O
be VB O
helpful JJ O
to TO O
describe VB O
the DT O
procedures NNS O
employed VBN O
and CC O
to TO O
illustrate VB O
them PRP O
with IN O
case NN O
reports NNS O
. . O

One CD O
is VBZ O
a DT O
method NN O
which WDT O
obviously RB O
has VBZ O
very RB O
limited JJ O
applicability NN O
, , O
while IN O
the DT O
otlher NN O
would MD O
seem VB O
to TO O
be VB O
rather RB O
generally RB O
applicable JJ O
. . O

The DT O
first JJ O
consists VBZ O
of IN O
the DT O
transplantation NN O
of IN O
the DT O
origin NN O
of IN O
the DT O
subclavian NN O
to IN O
a DT O
more RBR O
suitable JJ O
portion NN O
of IN O
the DT O
aorta NN O
. . O

Case NN O
report NN O

The DT O
patient NN B-Species
was VBD O
a DT O
19 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
girl NN B-Species
who WP O
had VBD O
been VBN O
cyanotic JJ O
since IN O
the DT O
age NN O
of IN O
six CD O
months NNS O
. . O

She PRP O
had VBD O
developed VBN O
normally RB O
but CC O
was VBD O
always RB O
limited VBN O
in IN O
exercise NN O
capacity NN O
. . O

In IN O
her PRP$ O
early JJ O
years NNS O
of IN O
school NN O
she PRP O
was VBD O
taken VBN O
to IN O
school NN O
by IN O
her PRP$ O
parents NNS O
and CC O
carried VBN O
to IN O
and CC O
from IN O
her PRP$ O
seat NN O
in IN O
the DT O
classroom NN O
. . O

She PRP O
did VBD O
reasonably RB O
well RB O
in IN O
high JJ O
school NN O
, , O
being VBG O
driven VBN O
to IN O
and CC O
from IN O
the DT O
school NN O
, , O
but CC O
she PRP O
got VBD O
into IN O
severe JJ O
difficulty NN O
when WRB O
she PRP O
attempted VBD O
to TO O
attend VB O
college NN O
. . O

The DT O
longer JJR O
distances NNS O
between IN O
classes NNS O
and CC O
the DT O
necessity NN O
for IN O
climbing NN O
stairs NNS O
precipitated VBD O
a DT O
downhill NN O
course NN O
, , O
with IN O
increasing VBG O
dyspnea NN O
, , O
more RBR O
marked JJ O
cyanosis NN O
and CC O
fatigue NN O
, , O
and CC O
the DT O
onset NN O
of IN O
bouts NNS O
of IN O
loss NN O
of IN O
consciousness NN O
. . O

The DT O
latter JJ O
occurred VBD O
several JJ O
times NNS O
daily RB O
. . O

One CD O
which WDT O
was VBD O
witnessed VBN O
by IN O
her PRP$ O
physician NN O
lasted VBD O
45 CD O
minutes NNS O
; : O
he PRP O
feared VBD O
it PRP O
would MD O
prove VB O
fatal JJ O
. . O

Ordinarily RB O
, , O
she PRP O
could MD O
not RB O
walk VB O
more JJR O
than IN O
half PDT O
a DT O
block NN O
. . O

There EX O
was VBD O
marked JJ O
cyanosis NN O
of IN O
the DT O
nails NNS O
and CC O
mucous JJ O
membranes NNS O
and CC O
to IN O
a DT O
lesser JJR O
extent NN O
of IN O
the DT O
skin NN O
. . O

Clubbing NN O
was VBD O
very RB O
prominent JJ O
. . O

All PDT O
the DT O
results NNS O
of IN O
physical JJ O
and CC O
laboratory NN O
examination NN O
fitted VBN O
in RB O
with IN O
a DT O
diagnosis NN O
of IN O
tetralogy NN O
of IN O
Fallot NNP O
. . O

The DT O
hematocrit NN O
ranged VBD O
between IN O
83 CD O
and CC O
90 CD O
. . O

Oxygen NN O
saturation NN O
of IN O
arterial JJ O
blood NN O
was VBD O
65 CD O
per NN O
cent NN O
at IN O
complete JJ O
rest NN O
. . O

The DT O
aortic JJ O
arch NN O
was VBD O
on IN O
the DT O
left JJ O
side NN O
. . O

On IN O
October NNP O
26 CD O
, , O
1949 CD O
a DT O
left JJ O
lateral JJ O
thoracotomy NN O
was VBD O
performed VBN O
, , O
the DT O
pleural JJ O
cavity NN O
being VBG O
entered VBN O
through IN O
the DT O
bed NN O
of IN O
the DT O
fifth JJ O
rib NN O
. . O

There EX O
was VBD O
evident JJ O
greatly RB O
increased VBN O
collateral JJ O
circulation NN O
in IN O
the DT O
mediastinum NN O
and CC O
hilum NN O
. . O

The DT O
pulmonary JJ O
artery NN O
appeared VBD O
to TO O
have VB O
markedly RB O
reduced VBN O
blood NN O
flow NN O
, , O
was VBD O
very RB O
short JJ O
, , O
small JJ O
, , O
and CC O
thin JJ O
- HYPH O
walled JJ O
. . O

Its PRP$ O
diameter NN O
was VBD O
less JJR O
than IN O
5 CD O
mm NNS O
. . O

The DT O
aorta NN O
seemed VBD O
to TO O
be VB O
bowed VBN O
out RP O
laterally RB O
in IN O
an DT O
unusual JJ O
fashion NN O
and CC O
the DT O
short JJ O
pulmonary NN O
artery NN O
could MD O
not RB O
possibly RB O
be VB O
brought VBN O
out RP O
over IN O
it PRP O
. . O

The DT O
subclavian JJ O
artery NN O
was VBD O
relatively RB O
small JJ O
, , O
having VBG O

487 CD O

YALE NNP O
JOURNAL NNP O
OF IN O
BIOLOGY NN O
AND CC O
MEDICINE NNP O

a DT O
diameter NN O
of IN O
only RB O
about RB O
4 CD O
mm NN O
. . O
but CC O
it PRP O
seemed VBD O
rather RB O
long JJ O
. . O

It PRP O
was VBD O
apparent JJ O
that IN O
a DT O
Pott NNP O
' POS O
s NN O
procedure NN O
was VBD O
impossible JJ O
and CC O
that IN O
an DT O
end NN O
- HYPH O
to IN O
- HYPH O
side NN O
subclavian JJ O
pulmonary NN O
artery NN O
anastomosis NN O
would MD O
be VB O
doomed VBN O
to IN O
failure NN O
. . O

Hence RB O
, , O
the DT O
subclavian JJ O
artery NN O
was VBD O
divided VBN O
at IN O
the DT O
level NN O
of IN O
its PRP$ O
first JJ O
branch NN O
, , O
the DT O
pulmonary JJ O
artery NN O
was VBD O
divided VBN O
proximally RB O
, , O
and CC O
an DT O
end NN O
- HYPH O
to IN O
- HYPH O
end NN O
subclavian JJ O
- HYPH O
pulmonary JJ O
anastomosis NN O
was VBD O
carried VBN O
out RP O
. . O

This DT O
was VBD O
done VBN O
with IN O
ease NN O
. . O

When WRB O
the DT O
clamps NNS O
were VBD O
removed VBN O
, , O
however RB O
, , O
no DT O
blood NN O
flowed VBD O
through IN O
it PRP O
. . O

The DT O
softwalled JJ O
subclavian NN O
was VBD O
completely RB O
flattened VBN O
out RP O
against IN O
the DT O
relatively RB O
rigid JJ O
aorta NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

When WRB O
the DT O
hilar JJ O
structures NNS O
were VBD O
forcibly RB O
elevated VBN O
in IN O
a DT O
cephalad NN O
direction NN O
the DT O
subclavian NN O
immediately RB O
filled VBD O
and CC O
pulsated VBD O
normally RB O
and CC O
a DT O
thrill NN O
could MD O
be VB O
felt VBN O
. . O

Simple JJ O
expansion NN O
of IN O
the DT O
lungs NNS O
, , O
however RB O
, , O
failed VBD O
to TO O
achieve VB O
this DT O
result NN O
and CC O
I PRP O
could MD O
conceive VB O
of IN O
no DT O
way NN O
in IN O
which WDT O
the DT O
hilar JJ O
region NN O
could MD O
be VB O
held VBN O
in IN O
a DT O
more RBR O
cephalad JJ O
direction NN O
. . O

The DT O
subclavian NN O
was VBD O
then RB O
ligated VBN O
at IN O
the DT O
point NN O
where WRB O
it PRP O
came VBD O
off IN O
the DT O
aorta NN O
and CC O
its PRP$ O
proximal JJ O
end NN O
was VBD O
anastomosed JJ O
end NN O
- HYPH O
to IN O
- HYPH O
side NN O
to IN O
the DT O
descending VBG O
aorta NN O
. . O

It PRP O
now RB O
pulsated VBD O
vigorously RB O
as IN O
did VBD O
the DT O
pulmonary JJ O
artery NN O
. . O

In IN O
spite NN O
of IN O
the DT O
good JJ O
pulsation NN O
no DT O
thrill NN O
was VBD O
palpable JJ O
. . O

The DT O
patient NN B-Species
had VBD O
an DT O
uneventful JJ O
but CC O
disappointing JJ O
convalescence NN O
. . O

She PRP O
remained VBD O
markedly RB O
cyanotic JJ O
and CC O
no DT O
continuous JJ O
bruit NN O
was VBD O
audible JJ O
. . O

When WRB O
she PRP O
left VBD O
the DT O
hospital NN O
14 CD O
days NNS O
after IN O
operation NN O
there EX O
was VBD O
no DT O
improvement NN O
in IN O
her PRP$ O
appearance NN O
, , O
hematocrit NN O
, , O
or CC O
arterial JJ O
oxygen NN O
saturation NN O
. . O

Surprisingly RB O
enough RB O
she PRP O
reported VBD O
progress NN O
on IN O
each DT O
follow NN O
- HYPH O
up NN O
examination NN O
. . O

By IN O
the DT O
end NN O
of IN O
seven CD O
weeks NNS O
she PRP O
was VBD O
obviously RB O
less RBR O
cyanotic JJ O
, , O
her PRP$ O
hematocrit NN O
was VBD O
77 CD O
, , O
and CC O
she PRP O
was VBD O
able JJ O
to TO O
walk VB O
a DT O
number NN O
of IN O
blocks NNS O
and CC O
to TO O
climb VB O
a DT O
flight NN O
of IN O
stairs NNS O
without IN O
difficulty NN O
. . O

She PRP O
reported VBD O
that IN O
she PRP O
had VBD O
danced VBN O
and CC O
roller NN O
- HYPH O
skated VBN O
without IN O
much JJ O
trouble NN O
. . O

Shortly RB O
thereafter RB O
a DT O
continuous JJ O
murmur NN O
was VBD O
audible JJ O
in IN O
the DT O
left JJ O
chest NN O
. . O

She PRP O
continued VBD O
to TO O
improve VB O
and CC O
in IN O
January NNP O
entered VBD O
a DT O
southern JJ O
college NN O
. . O

She PRP O
did VBD O
well RB O
. . O

At IN O
least JJS O
once RB O
a DT O
day NN O
, , O
often RB O
twice RB O
, , O
she PRP O
walked VBD O
without IN O
difficulty NN O
from IN O
the DT O
campus NN O
into IN O
town NN O
and CC O
back RB O
, , O
a DT O
distance NN O
of IN O
ten CD O
blocks NNS O
each DT O
way NN O
. . O

She PRP O
played VBD O
a DT O
little JJ O
tennis NN O
, , O
learned VBD O
to TO O
swim VB O
, , O
and CC O
began VBD O
to TO O
dance VB O
, , O
including VBG O
jitterbugging NN O
. . O

When WRB O
she PRP O
xvas VBZ O
seen VBN O
in IN O
June NNP O
, , O
her PRP$ O
color NN O
was VBD O
good JJ O
, , O
although IN O
there EX O
was VBD O
still RB O
slight JJ O
cyanosis NN O
of IN O
lips NNS O
and CC O
nail NN O
beds NNS O
. . O

There EX O
was VBD O
a DT O
very RB O
loud JJ O
, , O
continuous JJ O
murmur NN O
in IN O
the DT O
left JJ O
chest NN O
. . O

The DT O
following VBG O
fall NN O
she PRP O
transferred VBD O
to IN O
a DT O
midwestern JJ O
university NN O
. . O

She PRP O
got VBD O
along RB O
reasonably RB O
well RB O
but CC O
not RB O
as RB O
well RB O
as IN O
she PRP O
had VBD O
in IN O
a DT O
warmer JJR O
climate NN O
and CC O
on IN O
more JJR O
level NN O
terrain NN O
. . O

She PRP O
walked VBD O
four CD O
or CC O
five CD O
blocks NNS O
up IN O
and CC O
down IN O
hills NNS O
between IN O
classes NNS O
without IN O
difficulty NN O
in IN O
good JJ O
weather NN O
but CC O
complained VBD O
of IN O
some DT O
dyspnea NN O
and CC O
fatigue NN O
on IN O
cold JJ O
, , O
windy JJ O
days NNS O
. . O

She PRP O
attended VBD O
dances NNS O
and CC O
often RB O
danced VBD O
each DT O
number NN O
throughout IN O
the DT O
evening NN O
without IN O
trouble NN O
. . O

When WRB O
seen VBN O
in IN O
December NNP O
she PRP O
looked VBD O
well JJ O
. . O

Her PRP$ O
color NN O
was VBD O
good JJ O
and CC O
clubbing NN O
was VBD O
definitely RB O
less RBR O
marked JJ O
than IN O
it PRP O
had VBD O
been VBN O
previously RB O
. . O

She PRP O
had VBD O
a DT O
severe JJ O
cold NN O
at IN O
the DT O
time NN O
. . O

Her PRP$ O
oxygen NN O
saturation NN O
of IN O
arterial JJ O
blood NN O
was VBD O
75 CD O
per NN O
cent NN O
at IN O
rest NN O
and CC O
it PRP O
did VBD O
not RB O
fall VB O
when WRB O
she PRP O
stood VBD O
or CC O
still RB O
- HYPH O
walked VBD O
. . O

The DT O
hematocrit NN O
was VBD O
69 CD O
. . O

There EX O
was VBD O
audible JJ O
the DT O
same JJ O
loud JJ O
continuous JJ O
murmur NN O
in IN O
the DT O
left JJ O
chest NN O
. . O

Though IN O
the DT O
patient NN B-Species
has VBZ O
been VBN O
markedly RB O
improved VBN O
, , O
it PRP O
is VBZ O
recognized VBN O
that IN O
the DT O
result NN O
is VBZ O
not RB O
as RB O
good JJ O
as IN O
is VBZ O
commonly RB O
obtained VBN O
when WRB O
patients NNS B-Species
with IN O
more RBR O
adequate JJ O
pulmonary JJ O
arteries NNS O
are VBP O
treated VBN O
by IN O
the DT O
conventional JJ O
anastomosis NN O
of IN O
a DT O
systemic JJ O
artery NN O
to IN O
the DT O
side NN O
of IN O
the DT O
pulmonary JJ O
artery NN O
. . O

Nevertheless RB O
, , O
the DT O
patient NN B-Species
has VBZ O
thus RB O
far RB O
been VBN O
given VBN O
such JJ O
good JJ O
health NN O
and CC O
relatively RB O
normal JJ O
capacity NN O
for IN O
ordinary JJ O
activity NN O
that IN O
further JJ O
operation NN O
has VBZ O
seemed VBN O
unwarranted JJ O
, , O
though IN O
the DT O
possibility NN O
of IN O
some DT O
future JJ O
attempt NN O
at IN O
creation NN O
of IN O
an DT O
additional JJ O
shunt NN O
is VBZ O
being VBG O
kept VBN O
in IN O
mind NN O
. . O

The DT O
second JJ O
procedure NN O
embodies VBZ O
the DT O
cephalad NN O
transplantation NN O
of IN O
the DT O
pulmonary JJ O
artery NN O
by IN O
a DT O
plastic JJ O
repair NN O
of IN O
the DT O
incision NN O
in IN O
the DT O
hilar NN O
and CC O
mediastinal JJ O
pleural JJ O
structures NNS O
. . O

488 CD O

FIG NNP O
. . O

1 LS O
. . O

Drawing VBG O
illustrating VBG O
the DT O
condition NN O
which WDT O
existed VBD O
in IN O
the DT O
first JJ O
case NN O
after IN O
completion NN O
of IN O
the DT O
anastomosis NN O
( , O
A NNP O
) -RRB- O
and CC O
its PRP$ O
correction NN O
by IN O
transplantation NN O
of IN O
the DT O
origin NN O
of IN O
the DT O
subclavian NN O
( HYPH O
B NN O
) -RRB- O
. . O

FIG NNP O
. . O

2 LS O
. . O

Drawing VBG O
illustrating VBG O
correction NN O
of IN O
obstruction NN O
to IN O
blood NN O
flow NN O
through IN O
the DT O
subclavian JJ O
artery NN O
by IN O
inverted JJ O
T NN O
or CC O
L NN O
plastic NN O
closure NN O
of IN O
the DT O
defect NN O
in IN O
the DT O
hilar NN O
and CC O
mediastinal JJ O
structures NNS O
. . O

TREATMENT NN O
OF IN O
TETRALOGY NN O
OF IN O
FALLOT NNP O

Case NN O
reports VBZ O

The DT O
first JJ O
patient NN B-Species
was VBD O
a DT O
fully RB O
grown VBN O
young JJ O
man NN B-Species
of IN O
17 CD O
with IN O
tetralogy NN O
of IN O
Fallot NNP O
which WDT O
caused VBD O
considerable JJ O
incapacity NN O
. . O

He PRP O
was VBD O
admitted VBN O
to IN O
the DT O
hospital NN O
on IN O
July NNP O
18 CD O
, , O
1950 CD O
and CC O
was VBD O
operated VBN O
upon IN O
two CD O
days NNS O
later RBR O
. . O

He PRP O
was VBD O
known VBN O
to TO O
have VB O
a DT O
left JJ O
aortic JJ O
arch NN O
, , O
and CC O
a DT O
left JJ O
lateral JJ O
thoracotomy NN O
was VBD O
performed VBN O
. . O

The DT O
aorta NN O
was VBD O
freed VBN O
for IN O
a DT O
side NN O
- HYPH O
to IN O
- HYPH O
side NN O
anastomosis NN O
with IN O
the DT O
pulmonary JJ O
artery NN O
. . O

So RB O
much JJ O
difficulty NN O
was VBD O
encountered VBN O
, , O
however RB O
, , O
in IN O
placing VBG O
the DT O
aortic JJ O
clamp NN O
in IN O
proper JJ O
position NN O
for IN O
making VBG O
a DT O
satisfactory JJ O
incision NN O
in IN O
the DT O
aorta NN O
that IN O
the DT O
procedure NN O
was VBD O
abandoned VBN O
and CC O
an DT O
end NN O
- HYPH O
to IN O
- HYPH O
side NN O
subclavian JJ O
- HYPH O
pulmonary JJ O
artery NN O
anastomosis NN O
accomplished VBN O
instead RB O
. . O

The DT O
pulmonary JJ O
artery NN O
was VBD O
of IN O
fair JJ O
size NN O
, , O
having VBG O
an DT O
estimated VBN O
diameter NN O
of IN O
1 CD O
cm NNS O
. . O

The DT O
subclavian JJ O
artery NN O
appeared VBD O
to TO O
be VB O
quite RB O
long JJ O
and CC O
it PRP O
was VBD O
of IN O
very RB O
satisfactory JJ O
size NN O
, , O
having VBG O
a DT O
diameter NN O
of IN O
about RB O
6 CD O
mm NN O
. . O

To IN O
my PRP$ O
dismay NN O
, , O
the DT O
first JJ O
portion NN O
of IN O
the DT O
soft JJ O
- HYPH O
walled JJ O
subclavian JJ O
artery NN O
was VBD O
completely RB O
flattened VBN O
out RP O
against IN O
the DT O
rather RB O
rigid JJ O
wall NN O
of IN O
the DT O
aorta NN O
and CC O
no DT O
blood NN O
flow NN O
through IN O
it PRP O
could MD O
be VB O
demonstrated VBN O
, , O
there EX O
being VBG O
no DT O
subclavian JJ O
pulsation NN O
nor CC O
thrill NN O
in IN O
the DT O
pulmonary JJ O
artery NN O
. . O

If IN O
one CD O
forcefully RB O
elevated VBD O
the DT O
hilum NN O
of IN O
the DT O
lung NN O
in IN O
a DT O
cephalad NN O
direction NN O
, , O
the DT O
obstruction NN O
disappeared VBD O
, , O
the DT O
subclavian JJ O
artery NN O
began VBD O
to TO O
pulsate VB O
, , O
and CC O
a DT O
thrill NN O
could MD O
be VB O
palpated VBN O
. . O

When WRB O
the DT O
lung NN O
was VBD O
allowed VBN O
to TO O
assume VB O
its PRP$ O
usual JJ O
position NN O
, , O
the DT O
subclavian JJ O
obstruction NN O
was VBD O
again RB O
evident JJ O
and CC O
could MD O
not RB O
be VB O
prevented VBN O
by IN O
full JJ O
expansion NN O
of IN O
the DT O
lung NN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
hilar JJ O
region NN O
and CC O
the DT O
pulmonary JJ O
artery NN O
could MD O
be VB O
maintained VBN O
in IN O
a DT O
satisfactory JJ O
cephalad NN O
position NN O
by IN O
traction NN O
upward RB O
upon IN O
the DT O
cuff NN O
of IN O
hilar NN O
pleura NN O
and CC O
the DT O
adjacent JJ O
vascular JJ O
sheath NN O
and CC O
that IN O
these DT O
structures NNS O
were VBD O
sufficiently RB O
strong JJ O
so IN O
that IN O
traction NN O
could MD O
be VB O
maintained VBN O
upon IN O
them PRP O
with IN O
a DT O
small JJ O
hemostat NN O
. . O

The DT O
defect NN O
in IN O
the DT O
mediastinal JJ O
and CC O
hilar JJ O
tissues NNS O
was VBD O
then RB O
repaired VBN O
using VBG O
a DT O
sort NN O
of IN O
inverted JJ O
T NN O
- HYPH O
plastic NN O
closure NN O
. . O

By IN O
this DT O
maneuver NN O
success NN O
was VBD O
achieved VBN O
in IN O
elevating VBG O
the DT O
pulmonary JJ O
artery NN O
in IN O
a DT O
cephalad JJ O
direction NN O
so IN O
that IN O
the DT O
subclavian JJ O
obstruction NN O
was VBD O
relieved JJ O
and CC O
excellent JJ O
pulsation NN O
was VBD O
evident JJ O
( : O
Fig NNP O
. . O
2B NN O
) -RRB- O
. . O

A DT O
fairly RB O
good JJ O
continuous JJ O
thrill NN O
was VBD O
palpable JJ O
. . O

The DT O
patient NN B-Species
had VBD O
an DT O
uneventful JJ O
convalescence NN O
. . O

When WRB O
last RB O
seen VBN O
on IN O
January NNP O
16 CD O
, , O
1951 CD O
he PRP O
had VBD O
excellent JJ O
color NN O
without IN O
any DT O
visible JJ O
cyanosis NN O
. . O

The DT O
clubbing NN O
seemed VBD O
to TO O
have VB O
decreased VBN O
somewhat RB O
. . O

A DT O
continuous JJ O
murmur NN O
was VBD O
audible JJ O
. . O

He PRP O
stated VBD O
that IN O
he PRP O
noted VBD O
no DT O
limitation NN O
of IN O
exercise NN O
capacity NN O
. . O

In IN O
outlining VBG O
his PRP$ O
activities NNS O
he PRP O
said VBD O
that IN O
, , O
among IN O
other JJ O
things NNS O
, , O
he PRP O
was VBD O
doing VBG O
a DT O
great JJ O
deal NN O
of IN O
ice NN O
- HYPH O
skating NN O
and CC O
was VBD O
playing VBG O
ice NN O
hockey NN O
regularly RB O
. . O

He PRP O
was VBD O
planning VBG O
to TO O
start VB O
college NN O
work NN O
the DT O
following JJ O
month NN O
. . O

The DT O
second JJ O
patient NN B-Species
was VBD O
a DT O
16 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
boy NN B-Species
who WP O
had VBD O
been VBN O
cyanotic JJ O
since IN O
birth NN O
. . O

His PRP$ O
physical JJ O
development NN O
was VBD O
somewhat RB O
retarded JJ O
and CC O
he PRP O
was VBD O
slow JJ O
in IN O
learning VBG O
to TO O
sit VB O
and CC O
walk VB O
. . O

Until IN O
he PRP O
had VBD O
grown VBN O
old JJ O
enough RB O
to TO O
be VB O
self NN O
- HYPH O
conscious JJ O
about IN O
it PRP O
he PRP O
had VBD O
always RB O
squatted VBN O
when WRB O
he PRP O
was VBD O
tired JJ O
. . O

By IN O
perseverance NN O
he PRP O
had VBD O
managed VBN O
to TO O
do VB O
more JJR O
than IN O
one PRP O
would MD O
have VB O
suspected VBN O
he PRP O
could MD O
from IN O
the DT O
degree NN O
of IN O
his PRP$ O
cyanosis NN O
. . O

He PRP O
could MD O
walk VB O
as RB O
much JJ O
as IN O
five CD O
or CC O
six CD O
blocks NNS O
at IN O
a DT O
slow JJ O
pace NN O
. . O

He PRP O
was VBD O
fond JJ O
of IN O
drums NNS O
and CC O
managed VBD O
to TO O
play VB O
occasionally RB O
with IN O
an DT O
orchestra NN O
in IN O
a DT O
somewhat RB O
restricted JJ O
fashion NN O
. . O

For IN O
the DT O
past JJ O
few JJ O
months NNS O
he PRP O
had VBD O
had VBN O
more JJR O
dyspnea NN O
, , O
fatigability NN O
, , O
and CC O
seemed VBD O
to TO O
be VB O
going VBG O
downhill RB O
generally RB O
. . O

The DT O
results NNS O
of IN O
physical JJ O
and CC O
laboratory NN O
studies NNS O
were VBD O
rather RB O
typical JJ O
of IN O
the DT O
tetralogy NN O
of IN O
Fallot NNP O
. . O

Clubbing NN O
was VBD O
marked VBN O
, , O
the DT O
nailbeds NNS O
and CC O
mucous JJ O
membranes NNS O
were VBD O
a DT O
rather RB O
deep JJ O
purplish JJ O
- HYPH O
blue JJ O
color NN O
, , O
and CC O
the DT O
skin NN O
had VBD O
a DT O
dusky JJ O
cyanotic JJ O
tint NN O
. . O

The DT O
aortic JJ O
arch NN O
was VBD O
determined VBN O
to TO O
be VB O
on IN O
the DT O
left NN O
. . O

On IN O
July NNP O
21 CD O
, , O
1950 CD O
a DT O
left JJ O
lateral JJ O
thoracotomy NN O
was VBD O
performed VBN O
, , O
the DT O
pleural JJ O
cavity NN O
being VBG O
entered VBN O
through IN O
the DT O
bed NN O
of IN O
the DT O
fourth JJ O
rib NN O
. . O

There EX O
was VBD O
a DT O
rather RB O
marked JJ O
increase NN O
in IN O
the DT O
collateral JJ O
circulation NN O
in IN O
the DT O
mediastinum NN O
and CC O
the DT O
hilar JJ O
region NN O
. . O

The DT O
pulmonary NN O
artery NN O
was VBD O
easily RB O
dissected VBN O
free JJ O
. . O

It PRP O
was VBD O
fairly RB O
long JJ O
and CC O
was VBD O
about RB O
1 CD O
cm NN O
. . O
in IN O
diameter NN O
. . O

The DT O
subclavian JJ O
artery NN O
seemed VBD O
quite RB O
long JJ O
and CC O
was VBD O
of IN O
adequate JJ O
size NN O
, , O
having VBG O
a DT O
diameter NN O
of IN O
about RB O
5 CD O
mm NN O
. . O

An DT O
end NN O
- HYPH O
to IN O
- HYPH O
side NN O
sub9lavian JJ O
pulmonary NN O
anastomosis NN O
was VBD O
performed VBN O
. . O

Again RB O
in IN O
this DT O
case NN O
, , O
however RB O
, , O
the DT O
first JJ O
part NN O
of IN O
the DT O
subclavian NN O
was VBD O
acutely RB O
angulated JJ O
and CC O
completely RB O
flattened JJ O
out RP O
against IN O
the DT O
aortic JJ O
wall NN O
. . O

There EX O
was VBD O
no DT O

489 CD O

YALE NNP O
JOURNAL NNP O
OF IN O
BIOLOGY NN O
AND CC O
MEDICINE NNP O

pulsation NN O
in IN O
the DT O
subclavian NN O
and CC O
no DT O
thrill NN O
in IN O
the DT O
pulmonary NN O
. . O

In IN O
this DT O
instance NN O
also RB O
, , O
good JJ O
blood NN O
flow NN O
through IN O
the DT O
subclavian JJ O
artery NN O
was VBD O
evident JJ O
whenever WRB O
the DT O
hilar JJ O
structures NNS O
were VBD O
elevated VBN O
in IN O
a DT O
cephalad NN O
direction NN O
but CC O
no DT O
pulsation NN O
was VBD O
demonstrable JJ O
simply RB O
by IN O
expanding VBG O
fully RB O
the DT O
lung NN O
. . O

Again RB O
, , O
a DT O
sort NN O
of IN O
inverted JJ O
T NN O
- HYPH O
plastic JJ O
closure NN O
of IN O
the DT O
defect NN O
in IN O
the DT O
hilum NN O
and CC O
mediastinum NN O
brought VBD O
about RP O
a DT O
cephalad NN O
elevation NN O
of IN O
the DT O
pulmonary JJ O
artery NN O
so IN O
that IN O
tension NN O
was VBD O
released VBN O
and CC O
there EX O
was VBD O
excellent JJ O
pulsation NN O
in IN O
the DT O
subclavian JJ O
artery NN O
. . O

A DT O
thrill NN O
was VBD O
now RB O
palpable JJ O
. . O

Convalescence NN O
was VBD O
uneventful JJ O
. . O

Improvement NN O
in IN O
color NN O
was VBD O
evident JJ O
within IN O
a DT O
few JJ O
days NNS O
and CC O
his PRP$ O
color NN O
was VBD O
excellent JJ O
by IN O
the DT O
time NN O
he PRP O
was VBD O
discharged VBN O
from IN O
the DT O
hospital NN O
on IN O
the DT O
thirteenth JJ O
postoperative JJ O
day NN O
. . O

He PRP O
rapidly RB O
found VBD O
that IN O
he PRP O
was VBD O
now RB O
able JJ O
to TO O
lead VB O
a DT O
quite RB O
normal JJ O
sort NN O
of IN O
life NN O
. . O

When WRB O
he PRP O
was VBD O
seen VBN O
on IN O
December NNP O
9 CD O
he PRP O
stated VBD O
that IN O
he PRP O
had VBD O
no DT O
limitation NN O
in IN O
exercise NN O
capacity NN O
. . O

He PRP O
could MD O
walk VB O
rapidly RB O
without IN O
fatigue NN O
. . O

He PRP O
was VBD O
going VBG O
to IN O
school NN O
and CC O
was VBD O
playing VBG O
the DT O
drums NNS O
in IN O
a DT O
professional JJ O
orchestra NN O
three CD O
or CC O
four CD O
nights NNS O
each DT O
week NN O
. . O

There EX O
was VBD O
some DT O
diminution NN O
in IN O
the DT O
clubbing NN O
and CC O
his PRP$ O
color NN O
was VBD O
excellent JJ O
. . O

There EX O
was VBD O
a DT O
loud JJ O
continuous JJ O
bruit NN O
audible JJ O
in IN O
the DT O
chest NN O
. . O

On IN O
March NNP O
27 CD O
the DT O
arterial JJ O
oxygen NN O
saturation NN O
was VBD O
88 CD O
. . O
2 CD O
per NN O
cent NN O
. . O

When WRB O
I PRP O
first RB O
used VBD O
this DT O
procedure NN O
I PRP O
was VBD O
rather RB O
surprised JJ O
that IN O
such JJ O
tissues NNS O
would MD O
hold VB O
sutures NNS O
and CC O
serve VB O
satisfactorily RB O
to TO O
elevate VB O
the DT O
hilum NN O
. . O

On IN O
occasions NNS O
I PRP O
had VBD O
previously RB O
toyed VBN O
with IN O
the DT O
idea NN O
of IN O
suturing VBG O
hilar NN O
pleura NN O
to IN O
the DT O
mediastinal JJ O
pleura NN O
but CC O
had VBD O
abandoned VBN O
it PRP O
as RB O
impractical JJ O
because IN O
the DT O
sutures NNS O
seemed VBD O
to TO O
pull VB O
out RB O
whenever WRB O
there EX O
was VBD O
any DT O
tension NN O
whatsoever RB O
. . O

If IN O
the DT O
procedure NN O
is VBZ O
to TO O
be VB O
successful JJ O
, , O
it PRP O
is VBZ O
essential JJ O
that IN O
the DT O
sutures NNS O
encompass VBP O
any DT O
adjacent JJ O
areolar NN O
and CC O
fibrous JJ O
tissue NN O
and CC O
especially RB O
the DT O
so RB O
- HYPH O
called VBN O
vascular JJ O
sheath NN O
which WDT O
surrounds VBZ O
both CC O
pulmonary JJ O
artery NN O
and CC O
aorta NN O
and CC O
is VBZ O
dissected VBN O
free JJ O
during IN O
the DT O
course NN O
of IN O
the DT O
operation NN O
. . O

Fortunately RB O
, , O
in IN O
its PRP$ O
proximal JJ O
portion NN O
the DT O
sheath NN O
about IN O
the DT O
pulmonary JJ O
artery NN O
gains VBZ O
added VBN O
strength NN O
from IN O
the DT O
extension NN O
into IN O
it PRP O
of IN O
a DT O
reflection NN O
of IN O
the DT O
fibrous JJ O
pericardium NN O
. . O

Sutures NNS O
through IN O
the DT O
mediastinal JJ O
pleura NN O
in IN O
the DT O
region NN O
of IN O
the DT O
aortic JJ O
arch NN O
purposely RB O
include VBP O
the DT O
perivascular JJ O
tissues NNS O
which WDT O
have VBP O
been VBN O
stripped VBN O
off RP O
the DT O
aorta NN O
and CC O
subclavian JJ O
artery NN O
and CC O
also RB O
any DT O
other JJ O
available JJ O
tissue NN O
which WDT O
may MD O
lend VB O
strength NN O
, , O
such JJ O
as IN O
the DT O
divided VBN O
ends NNS O
of IN O
the DT O
supreme JJ O
intercostal JJ O
vein NN O
or CC O
other JJ O
vessels NNS O
which WDT O
lhave VBP O
been VBN O
transected VBN O
and CC O
ligated VBN O
. . O

The DT O
exact JJ O
method NN O
of IN O
repair NN O
will MD O
vary VB O
from IN O
case NN O
to IN O
case NN O
. . O

By IN O
placing VBG O
the DT O
sutures NNS O
properly RB O
it PRP O
would MD O
seem VB O
possible JJ O
sometimes RB O
to TO O
displace VB O
the DT O
pulmonary JJ O
artery NN O
laterally RB O
as RB O
well RB O
as IN O
in IN O
a DT O
cephalad NN O
direction NN O
if IN O
such PDT O
a DT O
maneuver NN O
was VBD O
thought VBN O
to TO O
be VB O
desirable JJ O
( : O
Fig NNP O
. . O
2C NN O
) -RRB- O
. . O

On IN O
occasions NNS O
one PRP O
would MD O
close VB O
the DT O
pleural JJ O
defect NN O
fairly RB O
snugly RB O
, , O
on IN O
others NNS O
leave VBP O
it PRP O
wide RB O
open JJ O
in IN O
places NNS O
. . O

Discussion NN O

Though IN O
there EX O
is VBZ O
always RB O
available JJ O
some DT O
suitable JJ O
systemic JJ O
vessel NN O
and CC O
though IN O
the DT O
major JJ O
concern NN O
in IN O
the DT O
operative JJ O
treatment NN O
of IN O
the DT O
tetralogy NN O
of IN O
Fallot NNP O
is VBZ O
the DT O
adequacy NN O
of IN O
the DT O
pulmonary JJ O
artery NN O
, , O
from IN O
time NN O
to IN O
time NN O
one CD O
may MD O
find VB O
the DT O
achievement NN O
of IN O
a DT O
satisfactory JJ O
result NN O
thwarted VBN O
by IN O
the DT O
local JJ O
anatomical JJ O
characteristics NNS O
regardless RB O
of IN O
one CD O
' '' O
s POS O
choice NN O
of IN O
procedure NN O
. . O

Consequently RB O
, , O
those DT O
modifications NNS O
which WDT O
may MD O
add VB O
to IN O
the DT O
likelihood NN O
of IN O
a DT O
successful JJ O
outcome NN O
are VBP O
important JJ O
. . O

Blalock NNP O
"""" `` O
' '' O
pointed VBD O
out RP O
the DT O
practicability NN O
of IN O
performing VBG O
an DT O
end NN O
- HYPH O
toend JJ O
subclavian JJ O
- HYPH O
pulmonary JJ O
artery NN O
anastomosis NN O
whenever WRB O
the DT O
pulmonary JJ O
artery NN O
is VBZ O
judged VBN O
too RB O
small JJ O
or CC O
the DT O
subclavian NN O
too RB O
short JJ O
for IN O
a DT O
satisfactory JJ O
end NN O

490 CD O

TREATMENT NN O
OF IN O
TETRALOGY NN O
OF IN O
FALLOT NNP O
491 CD O

to IN O
- HYPH O
side NN O
anastomosis NN O
. . O

Holman NNP O
' '' O
feels VBZ O
that IN O
a DT O
poorly RB O
functioning VBG O
shunt NN O
after IN O
end NN O
- HYPH O
to IN O
- HYPH O
side NN O
anastomosis NN O
can MD O
usually RB O
be VB O
corrected VBN O
by IN O
proximal JJ O
division NN O
of IN O
the DT O
subclavian JJ O
artery NN O
, , O
thus RB O
in IN O
effect NN O
converting VBG O
the DT O
procedure NN O
into IN O
an DT O
end NN O
- HYPH O
to IN O
- HYPH O
end NN O
anastomosis NN O
. . O

If IN O
a DT O
satisfactory JJ O
end NN O
- HYPH O
to IN O
- HYPH O
side NN O
suture NN O
of IN O
subclavian JJ O
and CC O
pulmonary JJ O
arteries NNS O
or CC O
side NN O
- HYPH O
to IN O
- HYPH O
side NN O
aortic JJ O
pulmonary NN O
anastomosis NN O
seems VBZ O
difficult JJ O
to TO O
achieve VB O
, , O
one CD O
may MD O
occasionally RB O
find VB O
it PRP O
useful JJ O
to TO O
divide VB O
the DT O
upper JJ O
lobe NN O
branch NN O
of IN O
the DT O
pulmonary JJ O
artery NN O
and CC O
carry VB O
out RP O
an DT O
end NN O
- HYPH O
to IN O
- HYPH O
end NN O
suture NN O
of IN O
the DT O
subclavian NN O
and CC O
the DT O
proximal JJ O
end NN O
of IN O
the DT O
upper JJ O
lobe NN O
branch NN O
. . O

Potts NNP O
and CC O
Smith NNP O
' POS O
performed VBD O
an DT O
anastomosis NN O
between IN O
the DT O
proximal JJ O
end NN O
of IN O
the DT O
upper JJ O
lobe NN O
branch NN O
and CC O
the DT O
side NN O
of IN O
the DT O
aorta NN O
in IN O
a DT O
case NN O
in IN O
which WDT O
complete JJ O
temporary JJ O
occlusion NN O
of IN O
the DT O
main JJ O
pulmonary NN O
artery NN O
was VBD O
withstood VBN O
poorly RB O
. . O

I PRP O
have VBP O
found VBN O
this DT O
principle NN O
of IN O
division NN O
of IN O
the DT O
upper JJ O
lobe NN O
branch NN O
and CC O
use NN O
of IN O
its PRP$ O
proximal JJ O
end NN O
of IN O
value NN O
in IN O
obtaining VBG O
a DT O
suitable JJ O
subclavian JJ O
pulmonary JJ O
anastomosis NN O
when WRB O
the DT O
subclavian NN O
seemed VBD O
to TO O
have VB O
inadequate JJ O
length NN O
. . O

On IN O
occasions NNS O
when WRB O
the DT O
systemic JJ O
vessel NN O
seems VBZ O
too RB O
short JJ O
, , O
one CD O
may MD O
elect VB O
to TO O
interpose VB O
a DT O
free JJ O
vascular JJ O
transplant NN O
, , O
3 CD O
"""" '' O
' '' O
a DT O
modification NN O
I PRP O
first RB O
employed VBD O
in IN O
1946 CD O
though IN O
unfortunately RB O
not RB O
with IN O
success NN O
in IN O
this DT O
instance NN O
. . O

The DT O
operation NN O
performed VBN O
in IN O
my PRP$ O
first JJ O
patient NN B-Species
constitutes VBZ O
in IN O
reality NN O
the DT O
use NN O
of IN O
the DT O
subclavian JJ O
artery NN O
as IN O
an DT O
autogenous JJ O
graft NN O
between IN O
the DT O
aorta NN O
and CC O
pulmonary JJ O
artery NN O
. . O

It PRP O
will MD O
obviously RB O
not RB O
often RB O
be VB O
the DT O
procedure NN O
of IN O
choice NN O
but CC O
sometimes RB O
may MD O
be VB O
found VBN O
a DT O
useful JJ O
measure NN O
in IN O
converting VBG O
an DT O
apparently RB O
inadequate JJ O
functional JJ O
shunt NN O
into IN O
a DT O
good JJ O
one NN O
. . O

If IN O
my PRP$ O
initial JJ O
experiences NNS O
with IN O
the DT O
plastic JJ O
repair NN O
of IN O
the DT O
defect NN O
in IN O
the DT O
mediastinal JJ O
and CC O
hilar JJ O
structures NNS O
are VBP O
characteristic JJ O
of IN O
what WP O
may MD O
be VB O
expected VBN O
of IN O
this DT O
procedure NN O
, , O
it PRP O
would MD O
seem VB O
to TO O
have VB O
wide JJ O
applicability NN O
whenever WRB O
a DT O
poorly RB O
functioning VBG O
subclavian JJ O
- HYPH O
pulmonary JJ O
shunt NN O
seems VBZ O
correctable JJ O
by IN O
cephalad NN O
transplantation NN O
of IN O
the DT O
hilar JJ O
structures NNS O
and CC O
the DT O
consequent JJ O
release NN O
of IN O
tension NN O
. . O

I PRP O
was VBD O
unaware JJ O
of IN O
any DT O
reference NN O
in IN O
the DT O
literature NN O
to IN O
its PRP$ O
use NN O
until IN O
belatedly RB O
I PRP O
discovered VBD O
that IN O
I PRP O
had VBD O
overlooked VBN O
a DT O
statement NN O
in IN O
the DT O
legend NN O
of IN O
one CD O
of IN O
the DT O
excellent JJ O
drawings NNS O
in IN O
Blalock NNP O
' POS O
s POS O
paper NN O
on IN O
surgical JJ O
procedures NNS O
in IN O
pulmonic JJ O
stenosis NN O
. . O
' '' O
Here RB O
he PRP O
states VBZ O
that IN O
suture NN O
of IN O
the DT O
pleura NN O
of IN O
the DT O
superior JJ O
aspect NN O
of IN O
the DT O
hilum NN O
to IN O
the DT O
mediastinal JJ O
pleura NN O
may MD O
effectively RB O
elevate VB O
a DT O
little JJ O
the DT O
pulmonary JJ O
artery NN O
. . O

Perhaps RB O
our PRP$ O
more RBR O
detailed JJ O
consideration NN O
of IN O
this DT O
maneuver NN O
may MD O
add VB O
to IN O
its PRP$ O
general JJ O
usefulness NN O
. . O

REFERENCES NNS O

1 CD O
Blalock NNP O
, , O
A NNP O
. . O
: : O
The DT O
technique NN O
of IN O
creation NN O
of IN O
an DT O
artificial JJ O
ductus NN O
arteriosus NN O
in IN O
the DT O

treatment NN O
of IN O
pulmonic JJ O
stenosis NN O
. . O

J NNP O
. . O

Thorac NNP O
. . O

Surg NNP O
. . O
, , O
1947 CD O
, , O
16 CD O
, , O
244 CD O
. . O

2 LS O
Blalock NNP O
, , O
A NNP O
. . O
: : O
Surgical JJ O
procedures NNS O
employed VBN O
and CC O
anatomical JJ O
variations NNS O
encountered VBN O

in IN O
the DT O
treatment NN O
of IN O
congenital JJ O
pulmonic JJ O
stenosis NN O
. . O

Surg UH O
. . O
, , O
Gyn NNP O
. . O

Obst NNP O
. . O
, , O
1948 CD O
, , O
87 CD O
, , O
385 CD O
. . O

3 CD O
Gross NN O
, , O
R NN O
. . O

E UH O
. . O
, , O
Bill NNP O
, , O
A DT O
. . O

H NNP O
. . O
, , O
Jr NNP O
. . O
, , O
and CC O
Pierce NNP O
, , O
E NNP O
. . O

C NN O
. . O
: : O
Methods NNS O
for IN O
preservation NN O
and CC O

transplantation NN O
of IN O
aortic JJ O
grafts NNS O
. . O

Observation NN O
on IN O
arterial JJ O
grafts NNS O
in IN O
dogs NNS B-Species
. . O

Report NN O
of IN O
transplantation NN O
of IN O
preserved VBN O
arterial JJ O
grafts NNS O
in IN O
nine CD O
human JJ B-Species
cases NNS O
. . O

Surg UH O
. . O
, , O
Gyn NNP O
. . O

Obst NNP O
. . O
, , O
1949 CD O
, , O
88 CD O
, , O
689 CD O
. . O

4 CD O
Holman NNP O
, , O
E NNP O
. . O
: : O
The DT O
surgery NN O
of IN O
pulmonary JJ O
stenosis NN O
. . O

Experiences NNS O
with IN O
left JJ O
subclavian NN O

to IN O
left VBN O
pulmonary JJ O
artery NN O
anastomosis NN O
. . O

J NNP O
. . O

Thorac NNP O
. . O

Surg NNP O
. . O
, , O
1949 CD O
, , O
18 CD O
, , O
827 CD O
. . O

5 CD O
Johnson NNP O
, , O
J NNP O
. . O
, , O
Kirby NNP O
, , O
C NNP O
. . O

K UH O
. . O
, , O
Greifenstein NNP O
, , O
F NNP O
. . O

E NNP O
. . O
, , O
and CC O
Costillo NNP O
, , O
A NNP O
. . O
: : O
The DT O
experimental JJ O

and CC O
clinical JJ O
use NN O
of IN O
vein NN O
grafts NNS O
to TO O
replace VB O
defects NNS O
of IN O
large JJ O
arteries NNS O
. . O

Surgery NN O
, , O
1949 CD O
, , O
26 CD O
, , O
945 CD O
. . O

492 CD O
YALE NN O
JOURNAL NN O
OF IN O
BIOLOGY NNP O
AND CC O
MEDICINE NNP O

6 CD O
Lam NNP O
, , O
C NNP O
. . O

R NNP O
. . O
: : O
The DT O
choice NN O
of IN O
the DT O
side NN O
for IN O
approach NN O
in IN O
operations NNS O
for IN O
pulmonary JJ O

stenosis NN O
. . O

J NNP O
. . O

Thorac NNP O
. . O

Surg NNP O
. . O
, , O
1949 CD O
, , O
18 CD O
, , O
661 CD O
. . O

7 CD O
Olim NNP O
, , O
C NNP O
. . O

B NN O
. . O
: : O
Experiences NNS O
in IN O
the DT O
surgical JJ O
treatment NN O
of IN O
congenital JJ O
pulmonary JJ O

stenosis NN O
. . O

American NNP O
Surgeon NNP O
, , O
1951 CD O
, , O
17 CD O
, , O
245 CD O
. . O

8 CD O
Paine NN O
, , O
J NNP O
. . O

R UH O
. . O
and CC O
Varco NNP O
, , O
R NN O
. . O

C NN O
. . O
: : O
Experiences NNS O
with IN O
the DT O
surgical JJ O
treatment NN O
of IN O
pul NN O

monic JJ O
stenosis NN O
. . O

Surgery NN O
, , O
1948 CD O
, , O
24 CD O
, , O
355 CD O
. . O

9 CD O
Potts NNS O
, , O
W NNP O
. . O

J NNP O
. . O
and CC O
Smith NNP O
, , O
S NNP O
. . O
: : O
New JJ O
surgical JJ O
procedures NNS O
in IN O
certain JJ O
cases NNS O
of IN O
congenital JJ O

pulmonary JJ O
stenosis NN O
. . O

Arch NNP O
. . O

Surg NNP O
. . O
, , O
1949 CD O
, , O
59 CD O
, , O
491 CD O
. . O

10 CD O
Potts NNS O
, , O
W NNP O
. . O

J NNP O
. . O
, , O
Smith NNP O
S NNP O
. . O
, , O
and CC O
Gibson NNP O
, , O
S NNP O
. . O
: : O
Anastomosis NN O
of IN O
the DT O
aorta NN O
to IN O
a DT O
pulmonary JJ O

artery NN O
; : O
certain JJ O
types NNS O
in IN O
congenital JJ O
heart NN O
disease NN O
. . O

J NNP O
. . O

Am UH O
. . O

M UH O
. . O

Ass NNP O
. . O
, , O
1946 CD O
, , O
132 CD O
, , O
627 CD O
. . O

Tissue NN O
remodeling NN O
: : O
a DT O
mating NN O
- HYPH O
induced VBN O
differentiation NN O
program NN O
for IN O
the DT O
Drosophila NNP B-Species
oviduct NN O

Abstract JJ O

Background NN O

In IN O
both CC O
vertebrates NNS O
and CC O
invertebrates NNS O
, , O
the DT O
oviduct NN O
is VBZ O
an DT O
epithelial JJ O
tube NN O
surrounded VBN O
by IN O
visceral JJ O
muscles NNS O
that WDT O
serves VBZ O
as IN O
a DT O
conduit NN O
for IN O
gamete NN O
transport NN O
between IN O
the DT O
ovary NN O
and CC O
uterus NN O
. . O

While IN O
Drosophila NNP O
is VBZ O
a DT O
model NN O
system NN O
for IN O
tubular JJ O
organ NN O
development NN O
, , O
few JJ O
studies NNS O
have VBP O
addressed VBN O
the DT O
development NN O
of IN O
the DT O
fly NN B-Species
' '' O
s NN O
oviduct NN O
. . O

Recent JJ O
studies NNS O
in IN O
Drosophila NNP O
have VBP O
identified VBN O
mating NN O
- HYPH O
responsive JJ O
genes NNS O
and CC O
proteins NNS O
whose WP$ O
levels NNS O
in IN O
the DT O
oviduct NN O
are VBP O
altered VBN O
by IN O
mating NN O
. . O

Since IN O
many JJ O
of IN O
these DT O
molecules NNS O
( , O
e LS O
. . O
g LS O
. . O
Muscle NNP O
LIM NNP O
protein NN O
84B NNP O
, , O
Coracle NNP O
, , O
Neuroglian NNP O
) , O
have VBP O
known VBN O
roles NNS O
in IN O
the DT O
differentiation NN O
of IN O
muscle NN O
and CC O
epithelia NN O
of IN O
other JJ O
organs NNS O
, , O
mating NN O
may MD O
trigger VB O
similar JJ O
differentiation NN O
events NNS O
in IN O
the DT O
oviduct NN O
. . O

This DT O
led VBD O
us PRP O
to TO O
hypothesize VB O
that IN O
mating NN O
mediates VBZ O
the DT O
last JJ O
stages NNS O
of IN O
oviduct NN O
differentiation NN O
in IN O
which WDT O
organ NN O
- HYPH O
specific JJ O
specializations NNS O
arise VBP O
. . O

Results NNS O

Using VBG O
electron NN O
- HYPH O
and CC O
confocal JJ O
- HYPH O
microscopy NN O
we PRP O
identified VBD O
tissue NN O
- HYPH O
wide JJ O
post NN O
- HYPH O
mating VBG O
changes NNS O
in IN O
the DT O
oviduct NN O
including VBG O
differentiation NN O
of IN O
cellular JJ O
junctions NNS O
, , O
remodeling NN O
of IN O
extracellular JJ O
matrix NN O
, , O
increased VBN O
myofibril NN O
formation NN O
, , O
and CC O
increased VBN O
innervation NN O
. . O

Analysis NN O
of IN O
once RB O
- HYPH O
and CC O
twice RB O
- HYPH O
mated VBN O
females NNS O
reveals VBZ O
that IN O
some DT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
respond VBP O
only RB O
to IN O
the DT O
first JJ O
mating NN O
, , O
while IN O
others NNS O
respond VBP O
to IN O
both DT O
matings NNS O
. . O

Conclusion NN O

We PRP O
uncovered VBD O
ultrastructural JJ O
changes NNS O
in IN O
the DT O
mated VBN O
oviduct NN O
that WDT O
are VBP O
consistent JJ O
with IN O
the DT O
roles NNS O
that WDT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
play VBP O
in IN O
muscle NN O
and CC O
epithelial JJ O
differentiation NN O
elsewhere RB O
. . O

This DT O
suggests VBZ O
that IN O
mating NN O
triggers VBZ O
the DT O
late JJ O
differentiation NN O
of IN O
the DT O
oviduct NN O
. . O

Furthermore RB O
, , O
we PRP O
suggest VBP O
that IN O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
that WDT O
respond VBP O
only RB O
to IN O
the DT O
first JJ O
mating NN O
are VBP O
involved VBN O
in IN O
the DT O
final JJ O
maturation NN O
of IN O
the DT O
oviduct NN O
while IN O
proteins NNS O
that WDT O
remain VBP O
responsive JJ O
to IN O
later JJ O
matings NNS O
are VBP O
also RB O
involved JJ O
in IN O
maintenance NN O
and CC O
ongoing JJ O
function NN O
of IN O
the DT O
oviduct NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
establish VBP O
the DT O
oviduct NN O
as IN O
an DT O
attractive JJ O
system NN O
to TO O
address VB O
mechanisms NNS O
that WDT O
regulate VBP O
the DT O
late JJ O
stages NNS O
of IN O
differentiation NN O
and CC O
maintenance NN O
of IN O
a DT O
tubular JJ O
organ NN O
. . O

Background NN O

Most JJS O
internal JJ O
organs NNS O
, , O
including VBG O
the DT O
vascular JJ O
and CC O
respiratory JJ O
systems NNS O
and CC O
the DT O
gastro JJ O
- HYPH O
intestinal JJ O
and CC O
urinary JJ O
- HYPH O
genital JJ O
tracts NNS O
are VBP O
comprised VBN O
of IN O
a DT O
single JJ O
epithelial JJ O
tube NN O
or CC O
a DT O
network NN O
of IN O
tubes NNS O
. . O

Tubular JJ O
organs NNS O
serve VBP O
as IN O
conduits NNS O
for IN O
the DT O
transport NN O
of IN O
gases NNS O
, , O
liquids NNS O
, , O
or CC O
solutes NNS O
, , O
and CC O
serve VBP O
as IN O
barriers NNS O
between IN O
biological JJ O
compartments NNS O
. . O

To TO O
create VB O
tubes NNS O
with IN O
specific JJ O
flow NN O
and CC O
barrier NN O
properties NNS O
, , O
the DT O
morphology NN O
of IN O
the DT O
tube NN O
must MD O
be VB O
precisely RB O
specified VBN O
during IN O
development NN O
and CC O
modulated VBN O
by IN O
physiology NN O
. . O

To TO O
accommodate VB O
specific JJ O
physiological JJ O
roles NNS O
, , O
tissue NN O
- HYPH O
specific JJ O
programs NNS O
for IN O
differentiation NN O
are VBP O
employed VBN O
at IN O
the DT O
last JJ O
stages NNS O
of IN O
development NN O
. . O

While IN O
much JJ O
is VBZ O
known VBN O
about IN O
the DT O
molecular JJ O
and CC O
cellular JJ O
basis NN O
of IN O
tube NN O
formation NN O
[ -LRB- O
1 CD O
- HYPH O
6 CD O
] -RRB- O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
mechanisms NNS O
that WDT O
regulate VBP O
the DT O
late JJ O
stages NNS O
of IN O
differentiation NN O
in IN O
which WDT O
organ NN O
- HYPH O
specific JJ O
specializations NNS O
arise VBP O
. . O

The DT O
conservation NN O
of IN O
genes NNS O
and CC O
similarity NN O
in IN O
tubular JJ O
organ NN O
design NN O
across IN O
taxa NN O
make VBP O
Drosophila NNP O
an DT O
excellent JJ O
model NN O
for IN O
understanding VBG O
organogenesis NN O
in IN O
higher JJR O
animals NNS O
. . O

In IN O
Drosophila NNP O
, , O
the DT O
best RBS O
understood VBN O
tubular JJ O
organs NNS O
from IN O
a DT O
developmental JJ O
point NN O
of IN O
view NN O
are VBP O
the DT O
trachea NN O
and CC O
salivary JJ O
gland NN O
. . O

Studies NNS O
of IN O
these DT O
organs NNS O
reveal VBP O
a DT O
general JJ O
program NN O
for IN O
tubular JJ O
organ NN O
development NN O
, , O
in IN O
which WDT O
combinatorial JJ O
expression NN O
of IN O
global JJ O
patterning NN O
genes NNS O
specifies VBZ O
positions NNS O
within IN O
the DT O
embryo NN O
for IN O
the DT O
subsequent JJ O
activation NN O
of IN O
tissue NN O
- HYPH O
specific JJ O
early JJ O
genes NNS O
and CC O
transcription NN O
factors NNS O
. . O

This DT O
program NN O
results VBZ O
in IN O
the DT O
activation NN O
of IN O
downstream JJ O
genes NNS O
involved VBN O
in IN O
terminal JJ O
differentiation NN O
of IN O
organ NN O
- HYPH O
specific JJ O
specializations NNS O
such JJ O
as IN O
the DT O
cuticle NN O
that WDT O
lines VBZ O
the DT O
tracheal JJ O
lumen NN O
[ -LRB- O
1 CD O
, , O
2 CD O
, , O
4 CD O
, , O
7 CD O
- SYM O
9 CD O
] -RRB- O
. . O

The DT O
Drosophila NNP B-Species
female JJ O
reproductive JJ O
tract NN O
is VBZ O
another DT O
tubular JJ O
system NN O
, , O
consisting VBG O
of IN O
the DT O
uterus NN O
and CC O
a DT O
common JJ O
oviduct NN O
( , O
the DT O
main JJ O
tube NN O
) , O
that WDT O
branches VBZ O
into IN O
two CD O
lateral JJ O
oviducts NNS O
. . O

Regional JJ O
differences NNS O
in IN O
function NN O
are VBP O
observed VBN O
along IN O
the DT O
length NN O
of IN O
the DT O
tract NN O
, , O
with IN O
egg NN O
activation NN O
occurring VBG O
largely RB O
at IN O
the DT O
proximal JJ O
end NN O
, , O
in IN O
the DT O
lateral JJ O
oviducts NNS O
, , O
and CC O
fertilization NN O
occurring VBG O
at IN O
the DT O
distal JJ O
end NN O
, , O
in IN O
the DT O
uterus NN O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Unlike IN O
other JJ O
tubular JJ O
organs NNS O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
development NN O
of IN O
the DT O
female JJ O
reproductive JJ O
tract NN O
. . O

However RB O
, , O
regional JJ O
differences NNS O
in IN O
function NN O
suggest VBP O
the DT O
presence NN O
of IN O
region NN O
- HYPH O
specific JJ O
differentiation NN O
programs NNS O
within IN O
the DT O
female JJ O
reproductive JJ O
tract NN O
. . O

In IN O
Drosophila NNP O
, , O
mating NN O
induces VBZ O
changes NNS O
in IN O
female JJ O
behavior NN O
and CC O
physiology NN O
via IN O
molecules NNS O
transmitted VBN O
in IN O
the DT O
seminal JJ O
fluid NN O
. . O

These DT O
changes NNS O
are VBP O
rapid JJ O
and CC O
lead VBP O
to IN O
a DT O
mated JJ O
female JJ O
state NN O
which WDT O
is VBZ O
profoundly RB O
different JJ O
from IN O
the DT O
unmated JJ O
female JJ O
state NN O
. . O

While IN O
an DT O
unmated JJ O
female NN O
lays VBZ O
few JJ O
eggs NNS O
and CC O
readily RB O
accepts VBZ O
the DT O
courtship NN O
efforts NNS O
of IN O
a DT O
male NN O
, , O
a DT O
mated JJ O
female NN O
exhibits VBZ O
increased VBN O
egg NN O
- HYPH O
laying NN O
and CC O
actively RB O
rejects VBZ O
males NNS O
[ -LRB- O
12 CD O
- SYM O
19 CD O
] -RRB- O
. . O

Microarray JJ O
studies NNS O
of IN O
whole JJ O
flies NNS B-Species
reveal VBP O
that IN O
the DT O
changes NNS O
in IN O
egg NN O
- HYPH O
laying VBG O
rate NN O
are VBP O
accompanied VBN O
by IN O
a DT O
change NN O
in IN O
gene NN O
expression NN O
. . O

Within IN O
three CD O
hours NNS O
of IN O
mating NN O
there EX O
is VBZ O
an DT O
increase NN O
in IN O
expression NN O
of IN O
a DT O
small JJ O
number NN O
of IN O
genes NNS O
[ -LRB- O
20 CD O
, , O
21 CD O
] -RRB- O
. . O

Rapid JJ O
changes NNS O
in IN O
gene NN O
expression NN O
, , O
as RB O
well RB O
as IN O
protein NN O
abundance NN O
, , O
have VBP O
also RB O
been VBN O
observed VBN O
in IN O
the DT O
female JJ O
reproductive JJ O
tract NN O
[ -LRB- O
22 CD O
, , O
23 CD O
] -RRB- O
. . O

In IN O
the DT O
upper JJ O
reproductive JJ O
tract NN O
( , O
lateral JJ O
and CC O
common JJ O
oviducts NNS O
, , O
hereafter RB O
, , O
oviduct NN O
) -RRB- O
, , O
mating NN O
induces VBZ O
an DT O
increase NN O
in IN O
immune JJ O
related JJ O
transcripts NNS O
and CC O
down RB O
regulates VBZ O
transcription NN O
factors NNS O
involved VBN O
in IN O
cell NN O
growth NN O
and CC O
differentiation NN O
. . O

At IN O
the DT O
protein NN O
level NN O
mating NN O
induces VBZ O
increased VBN O
abundance NN O
of IN O
proteins NNS O
associated VBN O
with IN O
muscle NN O
assembly NN O
and CC O
function NN O
and CC O
cytoskeletal JJ O
proteins NNS O
associated VBN O
with IN O
epithelial JJ O
morphogenesis NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Since IN O
many JJ O
of IN O
these DT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
act VBP O
in IN O
late JJ O
differentiation NN O
pathways NNS O
of IN O
muscle NN O
and CC O
epithelia NN O
elsewhere RB O
( , O
e LS O
. . O
g LS O
. . O
Bent NNP O
, , O
Muscle NNP O
LIM NNP O
protein NN O
84B NNP O
( , O
Mlp84B NNP O
) -RRB- O
, , O
Neuroglian NNP O
( , O
Nrg NNP O
) -RRB- O
, , O
Coracle NNP O
( , O
Cora NNP O
) -RRB- O
) -RRB- O
, , O
we PRP O
hypothesize VBP O
that IN O
mating NN O
triggers VBZ O
similar JJ O
differentiation NN O
in IN O
the DT O
oviduct NN O
. . O

To TO O
test VB O
our PRP$ O
hypothesis NN O
we PRP O
characterized VBD O
the DT O
ultrastructure NN O
of IN O
oviduct NN O
epithelia NN O
and CC O
muscle NN O
, , O
as RB O
well RB O
as IN O
the DT O
pattern NN O
of IN O
innervation NN O
before IN O
and CC O
after IN O
mating NN O
. . O

We PRP O
then RB O
examined VBD O
the DT O
effect NN O
of IN O
different JJ O
mating NN O
regimes NNS O
on IN O
oviduct NN O
mating NN O
- HYPH O
responsive JJ O
cytoskeletal JJ O
proteins NNS O
and CC O
on IN O
female JJ O
reproductive JJ O
output NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
active JJ O
tissue NN O
remodeling NN O
takes VBZ O
place NN O
in IN O
the DT O
oviduct NN O
epithelia NN O
and CC O
musculature NN O
in IN O
response NN O
to IN O
mating NN O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
a DT O
striking JJ O
increase NN O
in IN O
innervation NN O
of IN O
the DT O
oviduct NN O
after IN O
mating NN O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
the DT O
reproductive JJ O
tract NN O
is VBZ O
an DT O
attractive JJ O
system NN O
to TO O
address VB O
mechanisms NNS O
that WDT O
regulate VBP O
the DT O
late JJ O
stages NNS O
of IN O
tissue NN O
differentiation NN O
in IN O
a DT O
tubular JJ O
organ NN O
. . O

Unlike IN O
other JJ O
tubular JJ O
organs NNS O
, , O
the DT O
last JJ O
differentiation NN O
stage NN O
of IN O
the DT O
oviduct NN O
is VBZ O
triggered VBN O
by IN O
an DT O
extrinsic JJ O
cue NN O
( , O
mating NN O
) -RRB- O
. . O

This DT O
makes VBZ O
it PRP O
possible JJ O
to TO O
experimentally RB O
control VB O
the DT O
onset NN O
of IN O
differentiation NN O
, , O
with IN O
an DT O
opportunity NN O
to TO O
independently RB O
examine VB O
the DT O
effects NNS O
of IN O
mating NN O
and CC O
age NN O
. . O

In IN O
addition NN O
, , O
it PRP O
allows VBZ O
us PRP O
to TO O
examine VB O
processes NNS O
essential JJ O
for IN O
reproduction NN O
. . O

Results NNS O

Mating NN O
induces VBZ O
changes NNS O
in IN O
oviduct NN O
lumen NN O

Our PRP$ O
previous JJ O
molecular JJ O
profiling NN O
showed VBD O
that IN O
mating NN O
promotes VBZ O
changes NNS O
in IN O
actin NN O
- HYPH O
based VBN O
cytoskeletal JJ O
molecules NNS O
and CC O
suggests VBZ O
that IN O
mating NN O
triggers VBZ O
molecular JJ O
changes NNS O
and CC O
tissue NN O
remodeling NN O
in IN O
the DT O
female JJ O
reproductive JJ O
tract NN O
that WDT O
mediate VBP O
its PRP$ O
progression NN O
to IN O
a DT O
mature JJ O
functional JJ O
stage NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

To TO O
gain VB O
insight NN O
into IN O
the DT O
mechanisms NNS O
that WDT O
underlie VBP O
this DT O
progression NN O
, , O
we PRP O
used VBD O
light NN O
and CC O
electron NN O
microscopy NN O
to TO O
determine VB O
the DT O
morphological JJ O
status NN O
of IN O
the DT O
oviduct NN O
in IN O
unmated JJ O
and CC O
mated VBN O
3 CD O
- HYPH O
day NN O
old JJ O
females NNS O
. . O

In IN O
nearly RB O
all DT O
mated VBN O
reproductive JJ O
tracts NNS O
processed VBN O
for IN O
microscopy NN O
( , O
8 CD O
/ SYM O
9 CD O
) -RRB- O
, , O
an DT O
egg NN O
was VBD O
located VBN O
in IN O
one CD O
of IN O
the DT O
lateral JJ O
oviducts NNS O
, , O
whereas IN O
an DT O
egg NN O
was VBD O
never RB O
observed VBN O
in IN O
the DT O
oviduct NN O
of IN O
unmated JJ O
reproductive JJ O
tracts NNS O
( , O
5 CD O
/ SYM O
5 CD O
) -RRB- O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
observation NN O
is VBZ O
consistent JJ O
with IN O
previous JJ O
studies NNS O
that WDT O
report VBP O
increased JJ O
ovulation NN O
and CC O
egg NN O
- HYPH O
laying VBG O
at IN O
6 CD O
h CD O
post NN O
- HYPH O
mating NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

In IN O
all DT O
unmated JJ O
reproductive JJ O
tracts NNS O
examined VBN O
, , O
the DT O
region NN O
between IN O
the DT O
lateral JJ O
oviducts NNS O
and CC O
the DT O
middle NN O
of IN O
the DT O
common JJ O
oviduct NN O
was VBD O
either CC O
tapered VBN O
or CC O
constricted VBN O
, , O
whereas IN O
this DT O
region NN O
appeared VBD O
relaxed JJ O
in IN O
the DT O
mated JJ O
reproductive JJ O
tract NN O
( , O
Figure NNP O
1A NN O
and CC O
1D NN O
) -RRB- O
. . O

These DT O
observations NNS O
raise VBP O
the DT O
possibility NN O
that IN O
the DT O
lumen NN O
is VBZ O
narrow JJ O
in IN O
the DT O
unmated JJ O
oviduct NN O
and CC O
larger JJR O
in IN O
the DT O
mated VBN O
oviduct NN O
. . O

To TO O
address VB O
this DT O
possibility NN O
, , O
we PRP O
collected VBD O
serial JJ O
1 CD O
mu NN O
m NN O
longitudinal JJ O
sections NNS O
through IN O
the DT O
reproductive JJ O
tracts NNS O
of IN O
unmated JJ O
and CC O
mated VBN O
females NNS O
and CC O
stained VBD O
these DT O
sections NNS O
with IN O
toluidine NN O
blue NN O
to TO O
survey VB O
the DT O
appearance NN O
of IN O
the DT O
lumen NN O
along IN O
the DT O
entire JJ O
length NN O
of IN O
the DT O
oviduct NN O
( -LRB- O
Figure NN O
1B NN O
and CC O
1E CD O
) -RRB- O
. . O

Our PRP$ O
examination NN O
reveals VBZ O
that IN O
, , O
in IN O
unmated JJ O
reproductive JJ O
tracts NNS O
, , O
the DT O
lateral JJ O
oviduct NN O
lumen NN O
has VBZ O
an DT O
irregular JJ O
shape NN O
, , O
while IN O
the DT O
common JJ O
oviduct NN O
lumen NN O
appears VBZ O
straight JJ O
. . O

Moreover RB O
, , O
in IN O
all PDT O
the DT O
unmated JJ O
reproductive JJ O
tracts NNS O
sectioned VBN O
, , O
we PRP O
detected VBD O
patches NNS O
of IN O
darkly RB O
stained VBN O
material NN O
in IN O
the DT O
lumen NN O
of IN O
the DT O
lower JJR O
common JJ O
oviduct NN O
. . O

In IN O
the DT O
mated JJ O
reproductive JJ O
tract NN O
, , O
the DT O
lumen NN O
of IN O
the DT O
upper JJ O
oviduct NN O
( , O
defined VBN O
as IN O
the DT O
lateral JJ O
oviduct NN O
and CC O
upper JJ O
part NN O
of IN O
the DT O
common JJ O
oviduct NN O
) , O
has VBZ O
an DT O
irregular JJ O
shape NN O
, , O
and CC O
the DT O
lumen NN O
of IN O
the DT O
lower JJ O
oviduct NN O
( , O
defined VBN O
as IN O
the DT O
lower JJR O
part NN O
of IN O
common JJ O
oviduct NN O
) -RRB- O
appears VBZ O
straight RB O
. . O

In IN O
addition NN O
, , O
the DT O
lumen NN O
of IN O
the DT O
lower JJR O
oviduct NN O
appears VBZ O
wider JJR O
in IN O
mated JJ O
than IN O
unmated JJ O
reproductive JJ O
tracts NNS O
( -LRB- O
Figure NNP O
1C NNP O
and CC O
1F CD O
) -RRB- O
. . O

Interestingly RB O
, , O
darkly RB O
stained VBN O
material NN O
was VBD O
not RB O
detected VBN O
in IN O
the DT O
oviduct JJ O
lumen NN O
of IN O
mated VBN O
females NNS O
. . O

This DT O
observation NN O
appears VBZ O
to TO O
be VB O
consistent JJ O
with IN O
the DT O
description NN O
made VBN O
by IN O
Mahowald NNP O
et FW O
al NNP O
. . O

[ -LRB- O
25 CD O
] -RRB- O
, , O
who WP O
reported VBD O
that IN O
the DT O
oviduct NN O
lumen NN O
of IN O
unmated JJ O
females NNS O
is VBZ O
nearly RB O
filled VBN O
with IN O
an DT O
intima NN O
- HYPH O
like JJ O
matrix NN O
and CC O
that IN O
this DT O
matrix NN O
is VBZ O
reduced VBN O
after IN O
mating NN O
. . O

Because IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
mated JJ O
females NNS O
lay VBP O
eggs NNS O
, , O
it PRP O
is VBZ O
unclear JJ O
whether IN O
the DT O
lack NN O
of IN O
lumenal JJ O
material NN O
and CC O
increase NN O
in IN O
lumen NN O
size NN O
in IN O
mated JJ O
females NNS O
occurred VBD O
before IN O
or CC O
after IN O
the DT O
passage NN O
of IN O
eggs NNS O
. . O

We PRP O
suggest VBP O
that IN O
mating NN O
directly RB O
or CC O
indirectly RB O
induces VBZ O
morphological JJ O
changes NNS O
in IN O
the DT O
oviduct NN O
that WDT O
facilitate VBP O
egg NN O
passage NN O
through IN O
the DT O
duct NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
observations NNS O
lead VBP O
us PRP O
to TO O
propose VB O
that IN O
the DT O
oviduct NN O
lumen NN O
is VBZ O
closed JJ O
and CC O
/ SYM O
or CC O
obstructed VBN O
in IN O
the DT O
unmated JJ O
reproductive JJ O
tract NN O
, , O
and CC O
that IN O
mating NN O
induces VBZ O
changes NNS O
in IN O
the DT O
epithelia NN O
and CC O
/ SYM O
or CC O
muscle NN O
that WDT O
"""" `` O
open VBP O
"""" '' O
the DT O
oviduct NN O
lumen NN O
. . O

Initial JJ O
formation NN O
of IN O
cell NN O
- HYPH O
cell NN O
junctions NNS O
in IN O
oviduct NN O
epithelia NN O
is VBZ O
mating NN O
- HYPH O
independent JJ O

To TO O
determine VB O
whether IN O
mating NN O
induces VBZ O
specific JJ O
morphological JJ O
changes NNS O
in IN O
the DT O
oviduct NN O
epithelia NN O
post NN O
- HYPH O
mating NN O
, , O
we PRP O
next RB O
examined VBD O
the DT O
ultrastructure NN O
of IN O
the DT O
oviduct NN O
epithelia NN O
in IN O
unmated JJ O
and CC O
mated JJ O
reproductive JJ O
tracts NNS O
. . O

Since IN O
molecular JJ O
profiling NN O
demonstrates VBZ O
that IN O
proteins NNS O
associated VBN O
with IN O
cellular JJ O
junctions NNS O
such JJ O
as IN O
alpha NN O
- HYPH O
and CC O
beta NN O
- HYPH O
Spectrin NNP O
( -LRB- O
Spec NNP O
) -RRB- O
, , O
Cora NNP O
, , O
and CC O
Nrg NNP O
[ -LRB- O
23 CD O
] -RRB- O
increase VBP O
post NN O
- HYPH O
mating NN O
, , O
we PRP O
first RB O
determined VBD O
the DT O
status NN O
of IN O
the DT O
cellular JJ O
junctions NNS O
in IN O
the DT O
oviduct NN O
epithelia NN O
of IN O
unmated JJ O
females NNS O
, , O
and CC O
whether IN O
these DT O
junctions NNS O
change VBP O
post NN O
- HYPH O
mating NN O
. . O

In IN O
Drosophila NNP O
, , O
most RBS O
ectodermally RB O
derived VBN O
epithelia NN O
( , O
such JJ O
as IN O
the DT O
epidermis NN O
and CC O
trachea NN O
) -RRB- O
, , O
with IN O
a DT O
few JJ O
exceptions NNS O
, , O
are VBP O
joined VBN O
apically RB O
by IN O
a DT O
belt NN O
- HYPH O
like JJ O
adherens NNS O
junction NN O
called VBN O
the DT O
zonal JJ O
adherens NNS O
junction NN O
( , O
ZA NNP O
) , O
followed VBN O
basally RB O
by IN O
a DT O
septate NN O
junction NN O
( , O
SJ NNP O
) -RRB- O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Our PRP$ O
analysis NN O
reveals VBZ O
that IN O
the DT O
oviduct NN O
is VBZ O
lined VBN O
, , O
along IN O
its PRP$ O
entire JJ O
length NN O
, , O
by IN O
a DT O
monolayered JJ O
epithelium NN O
comprised VBN O
of IN O
squamous JJ O
- HYPH O
type NN O
cells NNS O
. . O

Although IN O
region NN O
- HYPH O
specific JJ O
differences NNS O
in IN O
morphology NN O
were VBD O
observed VBN O
, , O
all DT O
oviduct NN O
epithelia NN O
examined VBN O
, , O
in IN O
both CC O
unmated JJ O
and CC O
mated JJ O
females NNS O
, , O
are VBP O
joined VBN O
along IN O
their PRP$ O
lateral JJ O
membranes NNS O
by IN O
an DT O
extensive JJ O
SJ NN O
and CC O
lack VBP O
an DT O
apical JJ O
ZA NNP O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

SJs NNS O
and CC O
ZAs NNS O
form VBP O
complete JJ O
belts NNS O
that WDT O
surround VBP O
the DT O
epithelial JJ O
cell NN O
, , O
thus RB O
making VBG O
these DT O
junctions NNS O
easily RB O
visible JJ O
in IN O
transverse JJ O
sections NNS O
through IN O
the DT O
epithelium NN O
. . O

Because IN O
ZAs NNP O
were VBD O
not RB O
detected VBN O
in IN O
our PRP$ O
transverse JJ O
sections NNS O
through IN O
the DT O
oviduct NN O
, , O
this DT O
implies VBZ O
that IN O
ZAs NNS O
never RB O
formed VBD O
, , O
or CC O
developed VBD O
earlier RBR O
and CC O
were VBD O
lost VBN O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

Interestingly RB O
, , O
we PRP O
did VBD O
not RB O
detect VB O
any DT O
ultrastructural JJ O
differences NNS O
in IN O
the DT O
SJs NNPS O
at IN O
6 CD O
h NN O
post NN O
- HYPH O
mating NN O
, , O
but CC O
we PRP O
did VBD O
uncover VB O
differences NNS O
in IN O
SJ NNP O
ultrastructure NN O
in IN O
different JJ O
regions NNS O
of IN O
the DT O
oviduct NN O
. . O

Based VBN O
on IN O
their PRP$ O
ultrastructure NN O
, , O
two CD O
types NNS O
of IN O
SJs NNS O
, , O
smooth JJ O
and CC O
pleated JJ O
, , O
can MD O
be VB O
distinguished VBN O
in IN O
Drosophila NNP O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Smooth JJ O
SJs NNS O
are VBP O
distinguished VBN O
by IN O
the DT O
lack NN O
of IN O
visible JJ O
septae NN O
and CC O
the DT O
appearance NN O
of IN O
electron NN O
dense JJ O
material NN O
in IN O
the DT O
intercellular JJ O
space NN O
, , O
while IN O
pleated JJ O
SJs NNS O
are VBP O
distinguished VBN O
by IN O
the DT O
ladder NN O
- HYPH O
like JJ O
appearance NN O
of IN O
septae NN O
. . O

In IN O
the DT O
lateral JJ O
oviducts NNS O
and CC O
upper JJ O
common JJ O
oviduct NN O
, , O
septa NN O
were VBD O
not RB O
detected VBN O
in IN O
the DT O
SJ NNP O
, , O
thus RB O
these DT O
SJs NNPS O
represent VBP O
smooth JJ O
SJs NNS O
or CC O
an DT O
immature JJ O
stage NN O
of IN O
pleated VBN O
SJ NNP O
( -LRB- O
Figure NNP O
2A NNP O
, , O
2A NN O
' '' O
, , O
2A NNP O
"""" '' O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
a DT O
ladder NN O
- HYPH O
like JJ O
arrangement NN O
of IN O
septae NN O
was VBD O
often RB O
visible JJ O
in IN O
the DT O
SJs NNS O
of IN O
the DT O
lower JJR O
common JJ O
oviduct NN O
( -LRB- O
Figure NNP O
2C NNP O
' '' O
) -RRB- O
, , O
thus RB O
these DT O
SJs NNPS O
can MD O
be VB O
classified VBN O
as IN O
pleated VBN O
. . O

Unlike IN O
the DT O
smooth JJ O
- HYPH O
like JJ O
SJs NNS O
of IN O
the DT O
upper JJ O
oviduct NN O
, , O
the DT O
pleated VBN O
SJs NNS O
of IN O
the DT O
lower JJ O
oviduct NN O
are VBP O
followed VBN O
basally RB O
by IN O
spot NN O
type NN O
adherens NNS O
junction NN O
( , O
spot NN O
AJs NNP O
) -RRB- O
( , O
Figure NNP O
2B NNP O
, , O
2B NN O
' '' O
; , O
additional JJ O
file NN O
1 CD O
) -RRB- O
. . O

Further JJ O
analysis NN O
is VBZ O
necessary JJ O
to TO O
determine VB O
if IN O
the DT O
SJs NNS O
of IN O
the DT O
upper JJ O
and CC O
lower JJ O
oviduct NN O
represent VBP O
different JJ O
types NNS O
or CC O
different JJ O
developmental JJ O
stages NNS O
. . O

Our PRP$ O
findings NNS O
demonstrate VBP O
that IN O
the DT O
initial JJ O
formation NN O
of IN O
SJs NNPS O
, , O
as RB O
well RB O
as IN O
spot NN O
AJs NNS O
in IN O
the DT O
lower JJR O
oviduct NN O
, , O
are VBP O
mating VBG O
- HYPH O
independent JJ O
. . O

This DT O
raises VBZ O
an DT O
interesting JJ O
question NN O
. . O

Why WRB O
are VBP O
SJ NNP O
proteins NNS O
such JJ O
as IN O
Cora NNP O
and CC O
Nrg NNP O
up RB O
- HYPH O
regulated VBN O
post NN O
- HYPH O
mating VBG O
if IN O
SJs NNPS O
are VBP O
formed VBN O
prior RB O
to IN O
mating VBG O
? . O

It PRP O
is VBZ O
possible JJ O
that IN O
the DT O
increased VBN O
expression NN O
of IN O
SJ NNP O
proteins NNS O
is VBZ O
associated VBN O
with IN O
functional JJ O
changes NNS O
in IN O
polarized JJ O
secretion NN O
post NN O
- HYPH O
mating NN O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
SJs NNS O
play VBP O
an DT O
unexpected JJ O
role NN O
in IN O
regulating VBG O
the DT O
apical JJ O
secretion NN O
of IN O
specialized VBN O
extracellular JJ O
matrix NN O
molecules NNS O
in IN O
the DT O
trachea NN O
[ -LRB- O
27 CD O
, , O
28 CD O
] -RRB- O
, , O
and CC O
that IN O
these DT O
molecules NNS O
are VBP O
important JJ O
regulators NNS O
of IN O
lumen NN O
size NN O
. . O

Mating NN O
modulates VBZ O
apical JJ O
secretory NN O
activity NN O
in IN O
the DT O
oviduct NN O

Given VBN O
the DT O
presence NN O
of IN O
extensive JJ O
SJs NNS O
in IN O
the DT O
oviduct NN O
and CC O
the DT O
role NN O
of IN O
SJs NNS O
in IN O
regulating VBG O
apical JJ O
secretion NN O
of IN O
extracellular JJ O
matrix NN O
molecules NNS O
in IN O
other JJ O
epithelia NN O
( , O
e LS O
. . O
g LS O
. . O
trachea NN O
) -RRB- O
, , O
we PRP O
asked VBD O
if IN O
mating NN O
modulates VBZ O
apical JJ O
secretion NN O
in IN O
the DT O
oviduct NN O
epithelia NN O
. . O

Our PRP$ O
ultrastructural JJ O
analysis NN O
reveals VBZ O
that IN O
different JJ O
regions NNS O
of IN O
the DT O
oviduct NN O
display VBP O
different JJ O
apical JJ O
membrane NN O
morphology NN O
( , O
i NN O
. . O
e -RRB- O
microvilli NN O
or CC O
pleats NNS O
) -RRB- O
( , O
see VB O
Figures NNS O
2 CD O
and CC O
additional JJ O
file NN O
2A NN O
and CC O
2A NN O
) -RRB- O
, , O
but CC O
all DT O
epithelia NN O
are VBP O
covered VBN O
by IN O
an DT O
electron NN O
dense JJ O
apical JJ O
extracellular JJ O
matrix NN O
( , O
AECM NN O
) -RRB- O
and CC O
a DT O
thin JJ O
layer NN O
of IN O
cuticle NN O
. . O

We PRP O
found VBD O
that IN O
mating NN O
induces VBZ O
ultrastructural JJ O
changes NNS O
in IN O
the DT O
AECM NN O
and CC O
cuticle NN O
in IN O
both CC O
the DT O
upper JJ O
and CC O
lower JJ O
oviduct NN O
. . O

In IN O
the DT O
upper JJ O
oviduct NN O
of IN O
the DT O
unmated JJ O
female NN O
, , O
the DT O
AECM NN O
varies VBZ O
in IN O
thickness NN O
along IN O
the DT O
apical JJ O
surface NN O
( , O
Figure NNP O
3A NNP O
) -RRB- O
. . O

Some DT O
areas NNS O
have VBP O
little JJ O
AECM NN O
, , O
while IN O
other JJ O
areas NNS O
are VBP O
covered VBN O
by IN O
a DT O
distinct JJ O
layer NN O
of IN O
AECM NN O
( : O
~ SYM O
1 CD O
- HYPH O
2 CD O
mu NN O
m NN O
in IN O
thickness NN O
; : O
Figure NN O
3B NN O
) -RRB- O
. . O

However RB O
, , O
the DT O
AECM NNP O
of IN O
mated VBN O
females NNS O
is VBZ O
more RBR O
evenly RB O
distributed VBN O
along IN O
the DT O
apical JJ O
surface NN O
, , O
( , O
~ NFP O
2 CD O
mu NN O
m NN O
in IN O
thickness NN O
; : O
Figure NN O
3E CD O
) -RRB- O
. . O

Strikingly RB O
, , O
the DT O
AECM NNP O
and CC O
cuticle NN O
of IN O
mated VBN O
females NNS O
have VBP O
a DT O
ruffled JJ O
appearance NN O
, , O
suggesting VBG O
that IN O
the DT O
AECM NN O
and CC O
cuticle NN O
have VBP O
increased VBN O
in IN O
surface NN O
area NN O
( -LRB- O
Figure NNP O
3F NNP O
) -RRB- O
. . O

Electron NN O
dense JJ O
granules NNS O
up IN O
to IN O
~ $ O
1 CD O
. . O
5 CD O
mu NN O
m NN O
in IN O
diameter NN O
were VBD O
occasionally RB O
observed VBN O
in IN O
both CC O
the DT O
AECM NN O
and CC O
cell NN O
cytoplasm NN O
( -LRB- O
Figure NNP O
3F NNP O
) -RRB- O
. . O

Although IN O
further JJ O
analysis NN O
is VBZ O
needed VBN O
to TO O
determine VB O
the DT O
role NN O
of IN O
these DT O
granules NNS O
in IN O
the DT O
oviduct NN O
epithelia NN O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
these DT O
granules NNS O
participate VBP O
in IN O
the DT O
secretion NN O
and CC O
deposition NN O
of IN O
the DT O
AECM NNP O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
findings NNS O
suggest VBP O
that IN O
polarized JJ O
secretion NN O
via IN O
the DT O
AECM NNP O
, , O
while IN O
ongoing VBG O
in IN O
the DT O
upper JJ O
oviduct NN O
of IN O
the DT O
unmated JJ O
female NN O
is VBZ O
enhanced VBN O
and CC O
/ SYM O
or CC O
modulated VBN O
post NN O
- HYPH O
mating NN O
. . O

Post NN O
- HYPH O
mating VBG O
changes NNS O
in IN O
AECM NNP O
ultrastructure NN O
are VBP O
also RB O
observed VBN O
in IN O
the DT O
lower JJR O
common JJ O
oviduct NN O
. . O

However RB O
, , O
unlike IN O
the DT O
AECM NNP O
of IN O
the DT O
upper JJ O
oviduct NN O
, , O
the DT O
AECM NNP O
of IN O
the DT O
lower JJR O
oviduct NN O
is VBZ O
well RB O
developed JJ O
prior RB O
to IN O
mating NN O
. . O

In IN O
the DT O
lower JJ O
oviduct NN O
of IN O
the DT O
unmated JJ O
female NN O
, , O
the DT O
AECM NNP O
consists VBZ O
of IN O
an DT O
amorphous JJ O
electron NN O
dense JJ O
material NN O
and CC O
is VBZ O
unevenly RB O
distributed VBN O
, , O
forming VBG O
a DT O
thick JJ O
, , O
bulbous JJ O
layer NN O
above IN O
the DT O
plasma NN O
membrane NN O
in IN O
some DT O
regions NNS O
( , O
additional JJ O
file NN O
2 CD O
) -RRB- O
. . O

Matrix NN O
- HYPH O
like JJ O
material NN O
is VBZ O
also RB O
observed VBN O
in IN O
the DT O
lumen NN O
, , O
but CC O
this DT O
material NN O
is VBZ O
more JJR O
electron NN O
dense JJ O
than IN O
the DT O
AECM NNP O
( , O
additional JJ O
file NN O
2A NN O
and CC O
2A NN O
) -RRB- O
. . O

In IN O
the DT O
mated JJ O
female NN O
, , O
the DT O
AECM NNP O
is VBZ O
flattened VBN O
against IN O
the DT O
plasma NN O
membrane NN O
and CC O
is VBZ O
uniformly RB O
distributed VBN O
along IN O
the DT O
apical JJ O
surface NN O
( , O
additional JJ O
file NN O
2B NN O
and CC O
2B NN O
) -RRB- O
. . O

Matrix NN O
- HYPH O
like JJ O
material NN O
was VBD O
not RB O
observed VBN O
in IN O
the DT O
center NN O
of IN O
the DT O
lumen NN O
, , O
but CC O
small JJ O
pools NNS O
of IN O
very JJ O
electron NN O
dense JJ O
material NN O
were VBD O
detected VBN O
in IN O
the DT O
spaces NNS O
between IN O
the DT O
epithelial JJ O
folds NNS O
( , O
additional JJ O
file NN O
2C NN O
and CC O
2C NN O
) -RRB- O
. . O

This DT O
may MD O
explain VB O
why WRB O
lumenal JJ O
matrix NN O
was VBD O
not RB O
detected VBN O
at IN O
the DT O
light JJ O
microscopic JJ O
level NN O
in IN O
the DT O
mated VBN O
female JJ O
oviduct NN O
( , O
see VB O
Figure NNP O
1E CD O
and CC O
1F CD O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
observations NNS O
suggest VBP O
that IN O
the DT O
lower JJR O
common JJ O
oviduct NN O
is VBZ O
a DT O
site NN O
of IN O
active JJ O
apical JJ O
secretion NN O
in IN O
both CC O
mated JJ O
and CC O
unmated JJ O
females NNS O
, , O
and CC O
that IN O
matrix NN O
secretion NN O
, , O
particularly RB O
in IN O
the DT O
lumen NN O
, , O
is VBZ O
reduced VBN O
post NN O
- HYPH O
mating NN O
. . O

These DT O
findings NNS O
raise VBP O
the DT O
intriguing JJ O
possibility NN O
that IN O
the DT O
AECM NNP O
and CC O
lumenal NN O
matrix NN O
function NN O
as IN O
a DT O
plug NN O
in IN O
the DT O
lower JJ O
oviduct NN O
, , O
and CC O
that IN O
mating NN O
induces VBZ O
the DT O
breakdown NN O
of IN O
this DT O
plug NN O
. . O

Mating NN O
induces VBZ O
changes NNS O
in IN O
hemi NN O
- HYPH O
adherens NNS O
junctions NNS O
in IN O
upper JJ O
oviduct NN O

In IN O
addition NN O
to IN O
modulating VBG O
secretion NN O
at IN O
the DT O
apical JJ O
membrane NN O
, , O
mating NN O
induces VBZ O
changes NNS O
at IN O
the DT O
basolateral JJ O
membrane NN O
. . O

In IN O
many JJ O
epithelia NN O
, , O
one CD O
of IN O
the DT O
last JJ O
steps NNS O
of IN O
differentiation NN O
is VBZ O
the DT O
development NN O
of IN O
a DT O
layer NN O
of IN O
extracellular JJ O
matrix NN O
( , O
ECM NNP O
) -RRB- O
called VBN O
the DT O
basal JJ O
lamina NN O
that WDT O
covers VBZ O
the DT O
apical JJ O
and CC O
/ SYM O
or CC O
basal JJ O
membranes NNS O
and CC O
the DT O
concomitant JJ O
development NN O
of IN O
hemi NN O
- HYPH O
adherens NNS O
junctions NNS O
( -LRB- O
HAJs NNS O
) -RRB- O
. . O

HAJs NNS O
connect VBP O
the DT O
cell NN O
cytoskeleton NN O
with IN O
the DT O
ECM NNP O
and CC O
are VBP O
formed VBN O
at IN O
virtually RB O
all DT O
cell NN O
surfaces NNS O
that WDT O
contact VBP O
an DT O
ECM NNP O
. . O

HAJs NNP O
can MD O
be VB O
distinguished VBN O
at IN O
the DT O
ultrastructural JJ O
level NN O
as IN O
a DT O
patch NN O
- HYPH O
like JJ O
, , O
electron NN O
dense JJ O
undercoat NN O
of IN O
the DT O
plasma NN O
membrane NN O
that WDT O
opposes VBZ O
the DT O
basal JJ O
lamina NN O
( , O
[ -LRB- O
26 CD O
] -RRB- O
; : O
Figure NNP O
3G NNP O
, , O
3H CD O
) -RRB- O
. . O

In IN O
the DT O
Drosophila NNP B-Species
embryo NN O
, , O
the DT O
HAJs NNS O
and CC O
basal JJ O
lamina NN O
are VBP O
formed VBN O
at IN O
the DT O
same JJ O
time NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Because IN O
the DT O
basal JJ O
lamina NN O
is VBZ O
established VBN O
at IN O
a DT O
time NN O
when WRB O
the DT O
majority NN O
of IN O
extracellular JJ O
matrix NN O
molecules NNS O
are VBP O
actively RB O
secreted VBN O
[ -LRB- O
26 CD O
, , O
29 CD O
] -RRB- O
, , O
this DT O
suggests VBZ O
that IN O
the DT O
formation NN O
of IN O
HAJs NNP O
is VBZ O
tightly RB O
coordinated VBN O
with IN O
the DT O
secretion NN O
of IN O
the DT O
ECM NNP O
. . O

One CD O
of IN O
the DT O
most RBS O
striking JJ O
post NN O
- HYPH O
mating VBG O
changes NNS O
observed VBN O
in IN O
the DT O
oviduct JJ O
epithelia NN O
was VBD O
the DT O
appearance NN O
of IN O
numerous JJ O
HAJs NNS O
along IN O
the DT O
basolateral JJ O
membrane NN O
in IN O
the DT O
upper JJ O
oviduct NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

The DT O
importance NN O
of IN O
HAJs NNS O
, , O
particularly RB O
in IN O
the DT O
upper JJ O
oviduct NN O
, , O
is VBZ O
underscored VBN O
by IN O
the DT O
extensive JJ O
infolding NN O
of IN O
the DT O
basolateral JJ O
membrane NN O
that WDT O
is VBZ O
observed VBN O
in IN O
both CC O
unmated JJ O
and CC O
mated JJ O
females NNS O
( -LRB- O
Figure NNP O
3A NNP O
and CC O
3E CD O
) -RRB- O
. . O

The DT O
infolded JJ O
membrane NN O
gives VBZ O
rise NN O
to IN O
a DT O
highly RB O
branched VBN O
intercellular JJ O
space NN O
that WDT O
is VBZ O
filled VBN O
with IN O
an DT O
ECM NNP O
( -LRB- O
Figure NNP O
3C NNP O
and CC O
3G NN O
) -RRB- O
. . O

This DT O
ECM NNP O
is VBZ O
contiguous JJ O
with IN O
the DT O
basal JJ O
lamina NN O
that WDT O
surrounds VBZ O
the DT O
epithelia NN O
. . O

Few JJ O
HAJs NNS O
were VBD O
observed VBN O
in IN O
the DT O
upper JJ O
oviduct NN O
of IN O
the DT O
unmated JJ O
female NN O
, , O
and CC O
these DT O
were VBD O
largely RB O
restricted VBN O
to IN O
the DT O
basal JJ O
membrane NN O
, , O
and CC O
not RB O
observed VBN O
along IN O
the DT O
basolateral JJ O
infolding NN O
( -LRB- O
Figure NNP O
3C NNP O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
numerous JJ O
HAJs NNS O
appear VBP O
along IN O
the DT O
basolateral JJ O
infolding NN O
post NN O
- HYPH O
mating NN O
in IN O
this DT O
region NN O
of IN O
the DT O
oviduct NN O
( -LRB- O
Figure NNP O
3F NNP O
- HYPH O
3H CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
intercellular JJ O
space NN O
appears VBZ O
wider JJR O
post NN O
- HYPH O
mating NN O
( , O
Figure NNP O
3C NNP O
- HYPH O
3D CD O
and CC O
3G NN O
- HYPH O
3H CD O
) -RRB- O
, , O
suggesting VBG O
that IN O
mating NN O
induces VBZ O
increased VBN O
secretion NN O
and CC O
/ SYM O
or CC O
deposition NN O
of IN O
the DT O
ECM NNP O
in IN O
this DT O
cellular JJ O
compartment NN O
and CC O
brings VBZ O
the DT O
ECM NNP O
to IN O
a DT O
threshold NN O
concentration NN O
that WDT O
can MD O
support VB O
the DT O
development NN O
of IN O
HAJs NNS O
. . O

HAJs NNP O
were VBD O
also RB O
detected VBN O
along IN O
the DT O
basal JJ O
membrane NN O
, , O
but CC O
they PRP O
were VBD O
not RB O
detected VBN O
along IN O
the DT O
apical JJ O
membrane NN O
even RB O
though IN O
this DT O
membrane NN O
was VBD O
covered VBN O
by IN O
an DT O
ECM NNP O
. . O

Interestingly RB O
, , O
while IN O
the DT O
basolateral JJ O
membrane NN O
forms VBZ O
very RB O
shallow JJ O
folds NNS O
in IN O
the DT O
lower JJ O
oviduct NN O
( , O
see VBP O
additional JJ O
file NN O
2 CD O
) -RRB- O
, , O
HAJs NNS O
were VBD O
observed VBN O
along IN O
this DT O
membrane NN O
in IN O
unmated JJ O
reproductive JJ O
tracts NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
thus RB O
suggesting VBG O
that IN O
the DT O
epithelia NN O
is VBZ O
more RBR O
differentiated VBN O
in IN O
this DT O
region NN O
of IN O
the DT O
oviduct NN O
, , O
and CC O
that IN O
the DT O
differentiation NN O
of IN O
the DT O
upper JJ O
and CC O
lower JJ O
oviduct NN O
may MD O
be VB O
under IN O
different JJ O
control NN O
. . O

Muscle NN O
differentiation NN O
is VBZ O
enhanced JJ O
post NN O
- HYPH O
mating NN O

While IN O
we PRP O
uncovered VBD O
post NN O
- HYPH O
mating VBG O
changes NNS O
in IN O
the DT O
oviduct NN O
epithelia NN O
that WDT O
might MD O
facilitate VB O
its PRP$ O
transition NN O
to IN O
a DT O
high JJ O
egg NN O
- HYPH O
laying VBG O
state NN O
, , O
this DT O
transition NN O
may MD O
also RB O
be VB O
mediated VBN O
by IN O
changes NNS O
in IN O
oviduct NN O
muscle NN O
properties NNS O
and CC O
/ SYM O
or CC O
activity NN O
. . O

The DT O
oviduct NN O
is VBZ O
lined VBN O
by IN O
circular JJ O
muscle NN O
fibers NNS O
with IN O
supercontractile JJ O
characteristics NNS O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Our PRP$ O
previous JJ O
studies NNS O
showed VBD O
that IN O
mef2 NN O
and CC O
mlp84B NN O
genes NNS O
that WDT O
regulate VBP O
muscle NN O
differentiation NN O
, , O
are VBP O
expressed VBN O
and CC O
increased VBN O
post NN O
- HYPH O
mating NN O
in IN O
the DT O
oviduct NN O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
sperm NN O
storage NN O
regions NNS O
of IN O
the DT O
reproductive JJ O
tract NN O
[ -LRB- O
22 CD O
, , O
23 CD O
] -RRB- O
. . O

This DT O
suggests VBZ O
that IN O
mating NN O
induces VBZ O
muscle NN O
differentiation NN O
in IN O
the DT O
reproductive JJ O
tract NN O
. . O

Muscle NN O
differentiation NN O
is VBZ O
characterized VBN O
by IN O
the DT O
assembly NN O
of IN O
myofilaments NNS O
into IN O
bundles NNS O
called VBN O
myofibrils NNS O
. . O

As IN O
muscles NNS O
differentiate VBP O
, , O
myofibrils NNS O
and CC O
z NN O
- HYPH O
bodies NNS O
appear VBP O
simultaneously RB O
, , O
and CC O
increase VBP O
in IN O
number NN O
until IN O
the DT O
cytoplasm NN O
is VBZ O
filled VBN O
with IN O
myofibrils NNS O
[ -LRB- O
31 CD O
] -RRB- O
. . O

Like IN O
epithelia NN O
, , O
one CD O
of IN O
the DT O
last JJ O
steps NNS O
of IN O
muscle NN O
differentiation NN O
is VBZ O
the DT O
secretion NN O
of IN O
a DT O
basal JJ O
lamina NN O
that WDT O
surrounds VBZ O
the DT O
muscle NN O
fiber NN O
. . O

To TO O
determine VB O
if IN O
mating NN O
induces VBZ O
structural JJ O
changes NNS O
in IN O
muscles NNS O
( , O
such JJ O
as IN O
increased VBN O
myofibrils NNS O
) , O
we PRP O
examined VBD O
the DT O
ultrastructure NN O
of IN O
muscle NN O
fibers NNS O
in IN O
the DT O
upper JJ O
and CC O
lower JJ O
parts NNS O
of IN O
the DT O
oviduct NN O
. . O

Our PRP$ O
analysis NN O
revealed VBD O
that IN O
, , O
in IN O
both CC O
unmated JJ O
and CC O
mated JJ O
reproductive JJ O
tracts NNS O
, , O
the DT O
muscles NNS O
of IN O
the DT O
lower JJR O
oviduct NN O
are VBP O
highly RB O
differentiated VBN O
as IN O
evidenced VBN O
by IN O
the DT O
high JJ O
density NN O
of IN O
myofibrils NNS O
, , O
well RB O
developed JJ O
and CC O
aligned VBN O
z NN O
- HYPH O
bodies NNS O
, , O
and CC O
secretion NN O
of IN O
a DT O
thick JJ O
, , O
electron NN O
dense JJ O
basal JJ O
lamina NN O
( , O
Figure NNP O
4E CD O
and CC O
4F CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
muscle NN O
fibers NNS O
in IN O
the DT O
lateral JJ O
oviducts NNS O
and CC O
upper JJ O
common JJ O
oviduct NN O
appear VBP O
less RBR O
differentiated JJ O
than IN O
muscles NNS O
in IN O
the DT O
lower JJR O
common JJ O
oviduct NN O
, , O
as IN O
evidenced VBN O
by IN O
the DT O
lesser JJR O
density NN O
of IN O
myofibrils NNS O
and CC O
z NN O
- HYPH O
bodies NNS O
, , O
and CC O
little JJ O
or CC O
no DT O
basal JJ O
lamina NN O
( -LRB- O
Figure NN O
4A NN O
and CC O
4B NN O
) -RRB- O
. . O

Moreover RB O
, , O
the DT O
muscles NNS O
of IN O
the DT O
upper JJ O
oviduct NN O
appear VBP O
more RBR O
differentiated VBN O
in IN O
the DT O
mated VBN O
than IN O
in IN O
unmated JJ O
reproductive JJ O
tracts NNS O
( , O
Figure NNP O
4A NNP O
- HYPH O
4D NN O
) -RRB- O
. . O

Interestingly RB O
, , O
we PRP O
observed VBD O
neighboring VBG O
muscle NN O
fibers NNS O
in IN O
different JJ O
states NNS O
of IN O
differentiation NN O
in IN O
the DT O
lateral JJ O
oviducts NNS O
in IN O
both CC O
unmated JJ O
and CC O
mated JJ O
reproductive JJ O
tracts NNS O
, , O
but CC O
not RB O
elsewhere RB O
in IN O
the DT O
oviduct NN O
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
mating NN O
enhances VBZ O
the DT O
rate NN O
of IN O
muscle NN O
differentiation NN O
in IN O
the DT O
upper JJ O
oviduct NN O
, , O
and CC O
that IN O
muscle NN O
differentiation NN O
is VBZ O
delayed VBN O
in IN O
the DT O
upper JJ O
as IN O
compared VBN O
to IN O
the DT O
lower JJR O
oviduct NN O
. . O

The DT O
increased VBN O
muscle NN O
differentiation NN O
in IN O
the DT O
upper JJ O
oviduct NN O
is VBZ O
not RB O
dramatic JJ O
and CC O
likely RB O
reflects VBZ O
the DT O
short JJ O
post NN O
- HYPH O
mating NN O
period NN O
examined VBN O
in IN O
this DT O
study NN O
. . O

The DT O
delayed VBN O
differentiation NN O
of IN O
the DT O
upper JJ O
oviduct NN O
muscles NNS O
resembles VBZ O
the DT O
delay NN O
in IN O
the DT O
onset NN O
of IN O
development NN O
between IN O
the DT O
adult NN O
thoracic JJ O
muscles NNS O
and CC O
abdominal JJ O
muscles NNS O
during IN O
metamorphosis NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Since IN O
the DT O
ovaries NNS O
and CC O
the DT O
other JJ O
parts NNS O
of IN O
the DT O
reproductive JJ O
tract NN O
are VBP O
known VBN O
to TO O
have VB O
different JJ O
segmental JJ O
origins NNS O
[ -LRB- O
33 CD O
] -RRB- O
, , O
we PRP O
hypothesize VBP O
that IN O
different JJ O
parts NNS O
of IN O
the DT O
oviduct NN O
develop VBP O
at IN O
different JJ O
rates NNS O
or CC O
begin VBP O
development NN O
at IN O
different JJ O
times NNS O
. . O

Increased VBN O
innervation NN O
in IN O
the DT O
oviduct NN O
post NN O
- HYPH O
mating NN O

Nerve NN O
- HYPH O
muscle NN O
interactions NNS O
play VBP O
an DT O
important JJ O
role NN O
in IN O
regulating VBG O
adult NN O
muscle NN O
development NN O
and CC O
refining VBG O
the DT O
final JJ O
pattern NN O
of IN O
innervation NN O
[ -LRB- O
34 CD O
, , O
35 CD O
] -RRB- O
. . O

Given VBN O
that IN O
oviduct NN O
muscle NN O
differentiation NN O
is VBZ O
enhanced JJ O
post NN O
- HYPH O
mating NN O
, , O
we PRP O
predicted VBD O
that IN O
mating NN O
either CC O
directly RB O
or CC O
indirectly RB O
induces VBZ O
changes NNS O
in IN O
innervation NN O
. . O

To TO O
address VB O
this DT O
prediction NN O
, , O
we PRP O
quantified VBD O
the DT O
number NN O
of IN O
nerve JJ O
terminals NNS O
or CC O
boutons NNS O
innervating VBG O
the DT O
lateral JJ O
oviducts NNS O
and CC O
common JJ O
oviduct NN O
in IN O
unmated JJ O
and CC O
mated JJ O
reproductive JJ O
tracts NNS O
. . O

Studies NNS O
of IN O
oviduct NN O
innervation NN O
in IN O
Drosophila NNP O
reveal VBP O
that IN O
the DT O
fly NN B-Species
' '' O
s NN O
oviduct NN O
receives VBZ O
aminergic JJ O
, , O
peptidergic NN O
and CC O
glutamatergic JJ O
input NN O
[ -LRB- O
30 CD O
, , O
36 CD O
- HYPH O
39 CD O
] -RRB- O
. . O

In IN O
both CC O
larval JJ O
and CC O
adult NN O
Drosophila NNP O
, , O
different JJ O
types NNS O
of IN O
boutons NNS O
are VBP O
formed VBN O
by IN O
neurons NNS O
that WDT O
express VBP O
different JJ O
neurotransmitters NNS O
and CC O
modulators NNS O
[ -LRB- O
40 CD O
- SYM O
42 CD O
] -RRB- O
. . O

By IN O
similarity NN O
to IN O
the DT O
boutons NNS O
described VBN O
at IN O
the DT O
larval NN O
and CC O
adult NN O
neuromuscular JJ O
junction NN O
, , O
Middleton NNP O
et FW O
al NNP O
. . O

[ -LRB- O
30 CD O
] -RRB- O
report VB O
that IN O
the DT O
fly NN B-Species
' '' O
s NN O
oviduct NN O
is VBZ O
innervated VBN O
by IN O
glutamatergic JJ O
type NN O
I NN O
boutons NNS O
and CC O
tyraminergic NN O
/ SYM O
octopaminergic JJ O
type NN O
II NN O
boutons NNS O
. . O

Rodgriguez NNP O
- HYPH O
Valentin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
43 CD O
] -RRB- O
further RB O
report VB O
that IN O
the DT O
oviduct NN O
type NN O
II NN O
boutons NNS O
co NN O
- HYPH O
express VBP O
octopamine NN O
and CC O
glutamate NN O
. . O

The DT O
neurons NNS O
that WDT O
give VBP O
rise NN O
to IN O
the DT O
type NN O
I PRP O
innervation NN O
have VBP O
not RB O
been VBN O
identified VBN O
. . O

However RB O
, , O
it PRP O
is VBZ O
well RB O
established VBN O
that IN O
type NN O
II NN O
innervation NN O
arises VBZ O
from IN O
octopaminergic JJ O
neurons NNS O
located VBN O
in IN O
the DT O
abdominal JJ O
ganglion NN O
[ -LRB- O
30 CD O
, , O
43 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
some DT O
or CC O
all DT O
of IN O
these DT O
neurons NNS O
express VBP O
a DT O
GAL4 NNP O
insertion NN O
line NN O
for IN O
the DT O
bullwinkle NN O
( : O
bwk NN O
) -RRB- O
gene NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

Bwk NNP O
encodes VBZ O
a DT O
HMG NNP O
- HYPH O
box NN O
containing VBG O
putative JJ O
transcription NN O
factor NN O
[ -LRB- O
44 CD O
] -RRB- O
. . O

To TO O
determine VB O
if IN O
mating NN O
induces VBZ O
any DT O
changes NNS O
in IN O
the DT O
number NN O
of IN O
type NN O
I NN O
and CC O
II NN O
boutons NNS O
innervating VBG O
the DT O
oviduct NN O
muscles NNS O
, , O
we PRP O
used VBD O
the DT O
pan NN O
- HYPH O
neural JJ O
marker NN O
, , O
anti JJ O
- HYPH O
HRP NN O
to TO O
label VB O
all DT O
oviduct NN O
boutons NNS O
in IN O
unmated JJ O
and CC O
mated JJ O
females NNS O
. . O

To TO O
distinguish VB O
between IN O
type NN O
I NN O
and CC O
II NNP O
boutons NNS O
we PRP O
used VBD O
an DT O
antibody NN O
against IN O
the DT O
Disc NNP O
Large NNP O
( -LRB- O
DLG NNP O
) -RRB- O
protein NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Type NN O
I NN O
boutons NNS O
were VBD O
identified VBN O
by IN O
their PRP$ O
DLG NNP O
postsynaptic JJ O
staining NN O
and CC O
large JJ O
size NN O
( : O
> SYM O
8 CD O
mu NN O
m NN O
in IN O
diameter NN O
) -RRB- O
( -LRB- O
Figure NNP O
4G NNP O
) -RRB- O
, , O
while IN O
type NN O
II NN O
boutons NNS O
were VBD O
distinguished VBN O
by IN O
their PRP$ O
absence NN O
of IN O
DLG NNP O
staining NN O
and CC O
smaller JJR O
size NN O
( : O
< : O
2 CD O
mu NN O
m NN O
) -RRB- O
( -LRB- O
Figure NN O
4H CD O
) -RRB- O
. . O

We PRP O
find VBP O
that IN O
type NN O
I NN O
and CC O
II NNP O
boutons NNS O
innervate VBP O
the DT O
lateral JJ O
oviducts NNS O
and CC O
common JJ O
oviduct NN O
, , O
and CC O
that IN O
the DT O
type NN O
I PRP O
innervation NN O
is VBZ O
restricted VBN O
to IN O
a DT O
few JJ O
axons NNS O
that WDT O
run VBP O
parallel JJ O
to IN O
the DT O
length NN O
of IN O
the DT O
oviduct NN O
, , O
while IN O
the DT O
type NN O
II NN O
innervation NN O
is VBZ O
more RBR O
widespread JJ O
. . O

We PRP O
quantified VBD O
the DT O
number NN O
of IN O
boutons NNS O
in IN O
the DT O
lateral JJ O
oviducts NNS O
and CC O
common JJ O
oviduct NN O
and CC O
observed VBD O
a DT O
74 CD O
% NN O
increase NN O
in IN O
bouton NN O
number NN O
in IN O
the DT O
lateral JJ O
oviduct NN O
and CC O
a DT O
66 CD O
% NN O
increase NN O
in IN O
the DT O
common JJ O
oviduct NN O
post NN O
- HYPH O
mating NN O
( -LRB- O
Figure NN O
4I CD O
) -RRB- O
. . O

More RBR O
over RB O
, , O
we PRP O
observed VBD O
no DT O
significant JJ O
change NN O
in IN O
the DT O
number NN O
of IN O
type NN O
I NN O
boutons NNS O
in IN O
the DT O
lateral JJ O
oviduct NN O
and CC O
common JJ O
oviduct NN O
. . O

However RB O
, , O
we PRP O
detected VBD O
a DT O
1 CD O
. . O
5 CD O
- HYPH O
fold NN O
increase NN O
in IN O
the DT O
number NN O
of IN O
type NN O
II NN O
boutons NNS O
in IN O
the DT O
lateral JJ O
oviduct NN O
and CC O
a DT O
1 CD O
. . O
8 CD O
- HYPH O
fold NN O
increase NN O
in IN O
type NN O
II NN O
innervation NN O
in IN O
the DT O
common JJ O
oviduct NN O
. . O

Dramatic JJ O
increases NNS O
in IN O
bouton NN O
growth NN O
are VBP O
also RB O
observed VBN O
during IN O
development NN O
. . O

For IN O
example NN O
, , O
a DT O
ten CD O
- HYPH O
fold NN O
increase NN O
in IN O
bouton NN O
number NN O
is VBZ O
observed VBN O
at IN O
the DT O
neuromuscular JJ O
junction NN O
during IN O
the DT O
larval JJ O
period NN O
[ -LRB- O
46 CD O
] -RRB- O
. . O

To TO O
determine VB O
if IN O
the DT O
increase NN O
in IN O
type NN O
II NN O
innervation NN O
was VBD O
specific JJ O
to IN O
mating VBG O
or CC O
reflected VBD O
normal JJ O
growth NN O
in IN O
3 CD O
day NN O
- HYPH O
old JJ O
females NNS O
, , O
we PRP O
quantified VBD O
type NN O
I NN O
and CC O
II NN O
innervation NN O
in IN O
the DT O
oviducts NNS O
of IN O
5 CD O
day NN O
- HYPH O
old JJ O
unmated JJ O
females NNS O
. . O

We PRP O
found VBD O
no DT O
significant JJ O
difference NN O
in IN O
type NN O
I NN O
and CC O
II NN O
innervation NN O
in IN O
unmated JJ O
3 CD O
day NN O
- HYPH O
old JJ O
and CC O
5 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
, , O
indicating VBG O
that IN O
mating NN O
, , O
either CC O
directly RB O
or CC O
indirectly RB O
, , O
induces VBZ O
a DT O
dramatic JJ O
increase NN O
in IN O
type NN O
II NN O
innervation NN O
( -LRB- O
Figure NN O
4I CD O
) -RRB- O
. . O

To TO O
determine VB O
if IN O
the DT O
post NN O
- HYPH O
mating VBG O
increase NN O
in IN O
innervation NN O
is VBZ O
unique JJ O
to IN O
the DT O
oviduct NN O
, , O
we PRP O
asked VBD O
if IN O
mating NN O
induces VBZ O
a DT O
global JJ O
change NN O
in IN O
innervation NN O
. . O

We PRP O
quantified VBD O
bouton NN O
number NN O
in IN O
the DT O
adult NN O
ventral JJ O
midline NN O
muscles NNS O
of IN O
the DT O
5th JJ O
abdominal JJ O
segment NN O
. . O

These DT O
muscles NNS O
are VBP O
innervated VBN O
by IN O
boutons NNS O
that WDT O
increase VBP O
in IN O
number NN O
during IN O
metamorphosis NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

No DT O
significant JJ O
difference NN O
in IN O
bouton NN O
number NN O
was VBD O
detected VBN O
at IN O
these DT O
muscles NNS O
in IN O
unmated JJ O
and CC O
mated JJ O
females NNS O
( , O
additional JJ O
file NN O
3 CD O
) -RRB- O
. . O

Though IN O
further JJ O
analysis NN O
is VBZ O
needed VBN O
, , O
this DT O
suggests VBZ O
that IN O
the DT O
post NN O
- HYPH O
mating VBG O
increase NN O
in IN O
innervation NN O
is VBZ O
oviduct NN O
- HYPH O
specific JJ O
. . O

Because IN O
the DT O
type NN O
II NN O
boutons NNS O
are VBP O
octopaminergic JJ O
, , O
the DT O
increased JJ O
type NN O
II NN O
innervation NN O
may MD O
result VB O
in IN O
increased VBN O
octopamine NN O
( , O
OA NN O
) -RRB- O
release NN O
in IN O
the DT O
oviduct NN O
. . O

In IN O
support NN O
of IN O
this DT O
possibility NN O
, , O
we PRP O
have VBP O
preliminary JJ O
evidence NN O
that IN O
OA NNP O
is VBZ O
released VBN O
in IN O
the DT O
oviduct NN O
post NN O
- HYPH O
mating NN O
( , O
Heifetz NNP O
and CC O
Wolfner NNP O
, , O
in IN O
preparation NN O
) -RRB- O
. . O

Studies NNS O
in IN O
locust NN O
and CC O
Drosophila NNP O
demonstrate VBP O
that IN O
OA NNP O
inhibits VBZ O
oviduct NN O
contraction NN O
, , O
while IN O
glutamate NN O
activates VBZ O
oviduct NN O
contraction NN O
[ -LRB- O
30 CD O
, , O
43 CD O
, , O
48 CD O
] -RRB- O
. . O

In IN O
Drosophila NNP O
, , O
electrical JJ O
stimulation NN O
of IN O
the DT O
posterior JJ O
abdominal JJ O
nerve NN O
gives VBZ O
rise NN O
to IN O
a DT O
series NN O
of IN O
muscle NN O
contractions NNS O
in IN O
the DT O
oviduct NN O
followed VBN O
by IN O
a DT O
period NN O
of IN O
muscle NN O
fatigue NN O
or CC O
relaxation NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

This DT O
pattern NN O
of IN O
muscle NN O
contraction NN O
and CC O
relaxation NN O
may MD O
facilitate VB O
the DT O
proper JJ O
movement NN O
of IN O
the DT O
egg NN O
through IN O
the DT O
oviduct NN O
. . O

In IN O
their PRP$ O
study NN O
of IN O
bwk NN O
expressing VBG O
neurons NNS O
that WDT O
innervate VBP O
the DT O
oviduct NN O
, , O
Rodriguez NNP O
- HYPH O
Valentin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
43 CD O
] -RRB- O
show VBP O
that IN O
OA NN O
and CC O
glutamate NN O
interact VBP O
to TO O
produce VB O
the DT O
pattern NN O
of IN O
oviduct NN O
contraction NN O
and CC O
relaxation NN O
described VBN O
above RB O
. . O

It PRP O
is VBZ O
therefore RB O
possible JJ O
that IN O
the DT O
post NN O
- HYPH O
mating VBG O
increase NN O
in IN O
type NN O
II NN O
innervation NN O
in IN O
the DT O
oviduct NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
increased JJ O
rate NN O
of IN O
ovulation NN O
and CC O
egg NN O
- HYPH O
laying VBG O
observed JJ O
post NN O
- HYPH O
mating NN O
. . O

Female JJ O
mating NN O
history NN O
affects VBZ O
the DT O
enrichment NN O
of IN O
cytosekeletal JJ O
proteins NNS O
in IN O
the DT O
oviduct NN O

To TO O
gain VB O
insights NNS O
into IN O
the DT O
role NN O
of IN O
cytoskeletal JJ O
protein NN O
enrichment NN O
( , O
[ -LRB- O
23 CD O
] -RRB- O
; , O
additional JJ O
file NN O
4 CD O
) -RRB- O
in IN O
mediating VBG O
the DT O
morphological JJ O
changes NNS O
detected VBN O
in IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
different JJ O
mating NN O
regimes NNS O
on IN O
cytoskeletal JJ O
protein NN O
abundance NN O
. . O

We PRP O
focused VBD O
on IN O
a DT O
subset NN O
of IN O
mating NN O
- HYPH O
responsive JJ O
cytoskeletal JJ O
proteins NNS O
with IN O
well RB O
established VBN O
roles NNS O
in IN O
the DT O
differentiation NN O
of IN O
muscle NN O
and CC O
epithelia NN O
. . O

These DT O
include VBP O
: : O
( : O
i LS O
) -RRB- O
Mlp84B NN O
which WDT O
regulates VBZ O
the DT O
late JJ O
differentiation NN O
pathway NN O
of IN O
muscle NN O
[ -LRB- O
49 CD O
] -RRB- O
; : O
( , O
ii FW O
) -RRB- O
Cora NNP O
and CC O
Nrg NNP O
which WDT O
are VBP O
required VBN O
for IN O
the DT O
formation NN O
of IN O
septate NN O
junctions NNS O
in IN O
epithelia NN O
[ -LRB- O
50 CD O
] -RRB- O
, , O
and CC O
( -LRB- O
iii FW O
) -RRB- O
Hu NNP O
- HYPH O
li FW O
tai FW O
shao FW O
( , O
Hts NNP O
) -RRB- O
, , O
also RB O
known VBN O
as IN O
adducin NN O
- HYPH O
like JJ O
protein NN O
, , O
which WDT O
functions VBZ O
in IN O
assembly NN O
of IN O
the DT O
cytoskeletal JJ O
network NN O
. . O

Na NN O
+ CC O
pump NN O
alpha NN O
subunit NN O
( , O
ATP NNP O
alpha NN O
) -RRB- O
, , O
another DT O
protein NN O
associated VBN O
with IN O
septate NN O
junctions NNS O
in IN O
epithelia NN O
, , O
is VBZ O
not RB O
a DT O
mating NN O
- HYPH O
responsive JJ O
protein NN O
and CC O
was VBD O
used VBN O
as IN O
a DT O
control NN O
. . O

Using VBG O
western JJ O
blots NNS O
, , O
we PRP O
first RB O
determined VBD O
the DT O
abundance NN O
of IN O
the DT O
cytoskeletal JJ O
proteins NNS O
in IN O
oviducts NNS O
of IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
and CC O
mated JJ O
females NNS O
at IN O
6 CD O
hrs NNS O
post NN O
- HYPH O
mating NN O
. . O

We PRP O
confirmed VBD O
the DT O
proteomic JJ O
results NNS O
of IN O
Kalpenikov NNP O
et FW O
al FW O
. . O

[ -LRB- O
23 CD O
] -RRB- O
and CC O
found VBD O
that IN O
mating NN O
increases VBZ O
the DT O
abundance NN O
of IN O
all DT O
proteins NNS O
, , O
except IN O
ATP NNP O
alpha NN O
in IN O
mated VBN O
oviducts NNS O
relative JJ O
to IN O
their PRP$ O
abundance NN O
in IN O
unmated JJ O
oviducts NNS O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

To TO O
determine VB O
whether IN O
the DT O
increased VBN O
abundance NN O
of IN O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
persists VBZ O
for IN O
longer JJR O
times NNS O
post NN O
- HYPH O
mating NN O
, , O
we PRP O
examined VBD O
oviducts NNS O
of IN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
that WDT O
mated VBD O
once RB O
at IN O
3 CD O
days NNS O
of IN O
age NN O
, , O
and CC O
calculated VBD O
the DT O
abundance NN O
of IN O
the DT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
relative JJ O
to IN O
their PRP$ O
level NN O
in IN O
oviducts NNS O
of IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
females NNS O
. . O

We PRP O
found VBD O
no DT O
change NN O
or CC O
a DT O
slight JJ O
increase NN O
in IN O
the DT O
relative JJ O
abundance NN O
of IN O
all DT O
cytoskeletal JJ O
proteins NNS O
except IN O
Mlp84B NNP O
at IN O
7 CD O
days NNS O
post NN O
- HYPH O
mating NN O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Strikingly RB O
, , O
the DT O
level NN O
of IN O
Mlp84B NNP O
declines VBZ O
by IN O
7 CD O
days NNS O
post NN O
- HYPH O
mating VBG O
to IN O
the DT O
level NN O
observed VBN O
prior RB O
to IN O
mating NN O
. . O

Thus RB O
Mlp84B NNP O
levels NNS O
rise VBP O
and CC O
fall VBP O
after IN O
mating NN O
, , O
while IN O
the DT O
epithelial JJ O
- HYPH O
related VBN O
proteins NNS O
rapidly RB O
rise VBP O
and CC O
are VBP O
maintained VBN O
at IN O
a DT O
high JJ O
level NN O
after IN O
mating NN O
. . O

This DT O
raises VBZ O
the DT O
possibility NN O
that IN O
a DT O
second JJ O
mating NN O
might MD O
trigger VB O
an DT O
increase NN O
in IN O
Mlp84B NN O
protein NN O
expression NN O
as IN O
observed VBN O
in IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
at IN O
6 CD O
h CD O
post NN O
- HYPH O
mating NN O
. . O

To TO O
test VB O
this DT O
possibility NN O
, , O
females NNS O
were VBD O
mated VBN O
twice RB O
( , O
once RB O
at IN O
day NN O
3 CD O
, , O
and CC O
once RB O
on IN O
day NN O
10 CD O
of IN O
age NN O
) -RRB- O
, , O
and CC O
their PRP$ O
oviducts NNS O
were VBD O
examined VBN O
at IN O
6 CD O
hrs NNS O
after IN O
the DT O
second JJ O
mating NN O
. . O

We PRP O
calculated VBD O
the DT O
abundance NN O
of IN O
the DT O
cytoskeletal JJ O
proteins NNS O
in IN O
the DT O
twice RB O
mated VBN O
oviducts NNS O
relative JJ O
to IN O
their PRP$ O
abundance NN O
in IN O
oviducts NNS O
of IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
females NNS O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
a DT O
second JJ O
mating NN O
has VBZ O
little JJ O
or CC O
no DT O
effect NN O
on IN O
Mlp84B NNP O
abundance NN O
. . O

Thus RB O
, , O
Mlp84B NNP O
may MD O
represent VB O
a DT O
class NN O
of IN O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
that WDT O
is VBZ O
only RB O
needed VBN O
after IN O
the DT O
first JJ O
mating NN O
. . O

Interestingly RB O
, , O
the DT O
effect NN O
of IN O
the DT O
second JJ O
mating NN O
on IN O
the DT O
epithelial JJ O
- HYPH O
related VBN O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
appears VBZ O
to TO O
be VB O
different JJ O
for IN O
each DT O
protein NN O
. . O

While IN O
Cora NNP O
levels NNS O
drop VBP O
to IN O
the DT O
level NN O
observed VBN O
in IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
females NNS O
, , O
Nrg NNP O
and CC O
Hts NNPS O
are VBP O
maintained VBN O
at IN O
a DT O
high JJ O
level NN O
. . O

To TO O
determine VB O
if IN O
the DT O
changes NNS O
in IN O
cytoskeletal JJ O
protein NN O
abundance NN O
are VBP O
mating VBG O
- HYPH O
dependent JJ O
we PRP O
measured VBD O
their PRP$ O
abundance NN O
in IN O
the DT O
oviducts NNS O
of IN O
unmated JJ O
5 CD O
- HYPH O
and CC O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
. . O

We PRP O
calculated VBD O
their PRP$ O
abundance NN O
relative JJ O
to IN O
their PRP$ O
level NN O
in IN O
oviducts NNS O
of IN O
unmated JJ O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
. . O

We PRP O
rationalized VBD O
that IN O
if IN O
the DT O
change NN O
in IN O
cytoskeletal JJ O
protein NN O
abundance NN O
is VBZ O
mating VBG O
- HYPH O
dependent JJ O
we PRP O
will MD O
not RB O
see VB O
similar JJ O
changes NNS O
in IN O
unmated JJ O
females NNS O
. . O

We PRP O
observed VBD O
a DT O
slow JJ O
increase NN O
in IN O
the DT O
relative JJ O
abundance NN O
of IN O
all DT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
with IN O
time NN O
post NN O
- HYPH O
eclosion NN O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
. . O

Because IN O
unmated JJ O
females NNS O
lay VBP O
more JJR O
eggs NNS O
as IN O
they PRP O
age VBP O
( , O
see VB O
additional JJ O
file NN O
5C NNP O
) , O
one CD O
possible JJ O
interpretation NN O
of IN O
the DT O
increased VBN O
level NN O
of IN O
cytoskeletal JJ O
proteins NNS O
in IN O
unmated JJ O
females NNS O
is VBZ O
that IN O
these DT O
proteins NNS O
are VBP O
associated VBN O
with IN O
an DT O
intrinsic JJ O
program NN O
for IN O
oviduct NN O
maturation NN O
and CC O
that IN O
mating NN O
accelerates VBZ O
this DT O
process NN O
to TO O
maximize VB O
egg NN O
- HYPH O
laying VBG O
efficacy NN O
. . O

Alternatively RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
slow JJ O
increase NN O
in IN O
protein NN O
abundance NN O
observed VBN O
in IN O
unmated JJ O
females NNS O
is VBZ O
due IN O
to IN O
the DT O
passage NN O
of IN O
eggs NNS O
through IN O
the DT O
oviduct NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
mating NN O
is VBZ O
essential JJ O
to IN O
fine RB O
- HYPH O
tune VB O
the DT O
levels NNS O
of IN O
the DT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
examined VBN O
in IN O
this DT O
study NN O
. . O

Because IN O
the DT O
changes NNS O
in IN O
cytoskeletal JJ O
protein NN O
abundance NN O
are VBP O
different JJ O
in IN O
unmated JJ O
and CC O
mated JJ O
females NNS O
, , O
this DT O
suggests VBZ O
that IN O
the DT O
post NN O
- HYPH O
mating NN O
changes NNS O
are VBP O
mating VBG O
- HYPH O
dependent JJ O
. . O

Furthermore RB O
, , O
we PRP O
suggest VBP O
that IN O
these DT O
post NN O
- HYPH O
mating VBG O
changes NNS O
are VBP O
linked VBN O
to IN O
changes NNS O
in IN O
oviduct NN O
function NN O
. . O

Early JJ O
or CC O
prior JJ O
mating NN O
increases VBZ O
fecundity NN O

In IN O
Drosophila NNP O
, , O
female JJ O
fecundity NN O
decreases VBZ O
with IN O
age NN O
[ -LRB- O
51 CD O
- SYM O
54 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
this DT O
decrease NN O
is VBZ O
due JJ O
, , O
in IN O
part NN O
, , O
to IN O
the DT O
loss NN O
of IN O
germline NN O
and CC O
somatic JJ O
stem NN O
cells NNS O
[ -LRB- O
55 CD O
] -RRB- O
. . O

Since IN O
the DT O
expression NN O
of IN O
the DT O
oviduct NN O
cytoskeletal JJ O
proteins NNS O
examined VBN O
in IN O
this DT O
study NN O
change NN O
with IN O
age NN O
and CC O
mating NN O
experience NN O
, , O
the DT O
state NN O
of IN O
the DT O
oviduct NN O
may MD O
also RB O
play VB O
a DT O
role NN O
in IN O
fecundity NN O
. . O

To TO O
separate VB O
the DT O
effects NNS O
of IN O
age NN O
and CC O
mating NN O
, , O
we PRP O
measured VBD O
the DT O
fecundity NN O
of IN O
females NNS O
that WDT O
mated VBD O
twice RB O
, , O
first RB O
at IN O
3 CD O
days NNS O
post NN O
- HYPH O
eclosion NN O
and CC O
again RB O
at IN O
10 CD O
days NNS O
, , O
and CC O
compared VBD O
that DT O
to IN O
the DT O
fecundity NN O
of IN O
females NNS O
that WDT O
mated VBD O
once RB O
at IN O
3 CD O
days NNS O
and CC O
females NNS O
that WDT O
mated VBD O
once RB O
at IN O
10 CD O
days NNS O
. . O

Fecundity NN O
was VBD O
measured VBN O
as IN O
the DT O
number NN O
of IN O
eggs NNS O
laid VBN O
per IN O
day NN O
per IN O
female NN O
during IN O
the DT O
first JJ O
three CD O
days NNS O
after IN O
mating NN O
. . O

Once RB O
- HYPH O
mated VBN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
laid VBD O
nearly RB O
twice PDT O
as RB O
many JJ O
eggs NNS O
as IN O
once RB O
- HYPH O
mated VBN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
during IN O
the DT O
three CD O
days NNS O
examined VBN O
( : O
24 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
7 CD O
versus IN O
13 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
9 CD O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Twice RB O
- HYPH O
mated VBN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
also RB O
laid VBD O
about RB O
50 CD O
% NN O
more JJR O
eggs NNS O
than IN O
once RB O
- HYPH O
mated VBN O
females NNS O
of IN O
the DT O
same JJ O
age NN O
( : O
19 CD O
. . O
3 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
9 CD O
versus IN O
13 CD O
. . O
3 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
9 CD O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
, , O
but CC O
about RB O
20 CD O
% NN O
fewer JJR O
than IN O
laid VBN O
by RP O
once RB O
- HYPH O
mated VBN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
during IN O
the DT O
three CD O
days NNS O
examined VBN O
( : O
19 CD O
. . O
3 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
9 CD O
versus IN O
24 CD O
. . O
5 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
7 CD O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
( : O
Figure NN O
6A CD O
, , O
see VB O
also RB O
additional JJ O
file NN O
5A NN O
and CC O
5B NN O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
difference NN O
in IN O
fecundity NN O
between IN O
once RB O
- HYPH O
mated VBN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
and CC O
once RB O
- HYPH O
mated JJ O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
is VBZ O
not RB O
a DT O
result NN O
of IN O
age NN O
alone RB O
. . O

Rather RB O
the DT O
main JJ O
determinant NN O
of IN O
fecundity NN O
at IN O
10 CD O
days NNS O
is VBZ O
whether IN O
there EX O
had VBD O
been VBN O
a DT O
prior JJ O
mating NN O
at IN O
3 CD O
days NNS O
. . O

We PRP O
also RB O
calculated VBD O
the DT O
fertility NN O
( , O
number NN O
of IN O
adults NNS O
eclosed VBN O
) , O
of IN O
once RB O
- HYPH O
and CC O
twice RB O
- HYPH O
mated VBN O
females NNS O
. . O

Once RB O
- HYPH O
mated VBN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
are VBP O
more RBR O
fertile JJ O
than IN O
once RB O
- HYPH O
mated VBN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
( , O
69 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
6 CD O
% NN O
versus IN O
56 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
3 CD O
. . O
0 CD O
% NN O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
slightly RB O
more RBR O
fertile JJ O
than IN O
twice RB O
- HYPH O
mated VBN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
( : O
69 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
6 CD O
% NN O
versus IN O
62 CD O
. . O
7 CD O
+ NFP O
/ SYM O
- HYPH O
2 CD O
. . O
4 CD O
% NN O
, , O
p NN O
< NN O
0 CD O
. . O
15 CD O
) -RRB- O
( : O
Figure NN O
6B NN O
, , O
see VB O
also RB O
additional JJ O
file NN O
5D NN O
) -RRB- O
. . O

Because IN O
there EX O
is VBZ O
no DT O
significant JJ O
difference NN O
in IN O
fertility NN O
between IN O
once RB O
- HYPH O
mated JJ O
and CC O
twice RB O
- HYPH O
mated VBN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
, , O
this DT O
suggests VBZ O
that IN O
( : O
1 CD O
) SYM O
a DT O
prior JJ O
mating NN O
has VBZ O
no DT O
significant JJ O
effect NN O
on IN O
the DT O
fertility NN O
of IN O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
mated JJ O
females NNS O
and CC O
( , O
2 CD O
) , O
fertility NN O
decreases VBZ O
with IN O
age NN O
. . O

One CD O
intriguing JJ O
interpretation NN O
of IN O
these DT O
results NNS O
is VBZ O
that IN O
an DT O
early JJ O
mating NN O
increases VBZ O
fecundity NN O
which WDT O
partially RB O
compensates VBZ O
for IN O
the DT O
age NN O
- HYPH O
related VBN O
decrease NN O
in IN O
fertility NN O
. . O

Thus RB O
, , O
cytoskeletal JJ O
mating NN O
- HYPH O
responsive JJ O
protein NN O
changes NNS O
may MD O
be VB O
associated VBN O
with IN O
structural JJ O
changes NNS O
in IN O
the DT O
oviduct NN O
that WDT O
result VBP O
in IN O
increased VBN O
fecundity NN O
. . O

This DT O
may MD O
counteract VB O
the DT O
effects NNS O
of IN O
decreased VBN O
fertility NN O
on IN O
the DT O
reproductive JJ O
output NN O
. . O

Discussion NN O

Despite IN O
the DT O
use NN O
of IN O
Drosophila NNP O
as IN O
a DT O
model NN O
system NN O
for IN O
organ NN O
- HYPH O
level NN O
biology NN O
and CC O
the DT O
emerging VBG O
parallels NNS O
between IN O
mammalian JJ O
and CC O
Drosophila NNP B-Species
reproductive JJ O
biology NN O
[ -LRB- O
56 CD O
] -RRB- O
, , O
this DT O
is VBZ O
the DT O
first JJ O
integrative JJ O
tissue NN O
- HYPH O
wide JJ O
study NN O
of IN O
post NN O
- HYPH O
mating NN O
changes NNS O
in IN O
the DT O
Drosophila NNP B-Species
oviduct NN O
. . O

Our PRP$ O
results NNS O
provide VBP O
several JJ O
lines NNS O
of IN O
evidence NN O
at IN O
the DT O
molecular JJ O
, , O
morphological JJ O
and CC O
physiological JJ O
levels NNS O
suggesting VBG O
that IN O
mating NN O
induces VBZ O
tissue NN O
- HYPH O
wide JJ O
differentiation NN O
in IN O
the DT O
oviduct NN O
. . O

Moreover RB O
, , O
we PRP O
identify VBP O
ultrastructural JJ O
changes NNS O
in IN O
the DT O
mated VBN O
oviduct NN O
that WDT O
are VBP O
consistent JJ O
with IN O
the DT O
roles NNS O
that WDT O
some DT O
of IN O
the DT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
examined VBN O
in IN O
this DT O
study NN O
( , O
e LS O
. . O
g LS O
. . O
Mlp84B NNP O
, , O
Cora NNP O
, , O
Nrg NNP O
) -RRB- O
are VBP O
reported VBN O
to TO O
play VB O
in IN O
muscle NN O
and CC O
epithelial JJ O
differentiation NN O
elsewhere RB O
. . O

For IN O
example NN O
, , O
the DT O
increased VBN O
abundance NN O
of IN O
Mlp84B NNP O
, , O
a DT O
major JJ O
regulator NN O
of IN O
the DT O
late JJ O
differentiation NN O
pathway NN O
of IN O
muscle NN O
[ -LRB- O
49 CD O
] -RRB- O
is VBZ O
consistent JJ O
with IN O
the DT O
increased VBN O
muscle NN O
differentiation NN O
in IN O
the DT O
upper JJ O
oviduct NN O
post NN O
- HYPH O
mating NN O
( -LRB- O
Figure NNP O
4A NN O
- HYPH O
4F NN O
) -RRB- O
. . O

Similarly RB O
, , O
the DT O
increased VBN O
abundance NN O
of IN O
Cora NNP O
and CC O
Nrg NNP O
, , O
molecules NNS O
that WDT O
are VBP O
essential JJ O
for IN O
SJ NN O
development NN O
and CC O
function NN O
[ -LRB- O
50 CD O
] -RRB- O
is VBZ O
consistent JJ O
with IN O
the DT O
observation NN O
that IN O
SJs NNS O
in IN O
the DT O
upper JJ O
oviduct NN O
are VBP O
immature JJ O
and CC O
/ SYM O
or CC O
that IN O
mating NN O
induces VBZ O
changes NNS O
in IN O
the DT O
apical JJ O
extracellular JJ O
matrix NN O
whose WP$ O
secretion NN O
may MD O
be VB O
regulated VBN O
, , O
in IN O
part NN O
, , O
by IN O
SJs NNS O
as IN O
occurs VBZ O
in IN O
the DT O
trachea NN O
[ -LRB- O
27 CD O
, , O
28 CD O
] -RRB- O
. . O

Other JJ O
post NN O
- HYPH O
mating VBG O
changes NNS O
that WDT O
indicate VBP O
that IN O
mating NN O
induces VBZ O
tissue NN O
- HYPH O
wide JJ O
differentiation NN O
include VBP O
increased VBN O
HAJs NNS O
along IN O
the DT O
basolateral JJ O
membrane NN O
and CC O
increased VBN O
innervation NN O
. . O

Analysis NN O
of IN O
protein NN O
abundance NN O
following VBG O
different JJ O
mating NN O
regimes NNS O
( , O
unmated JJ O
, , O
once RB O
- HYPH O
mated VBN O
, , O
twice RB O
- HYPH O
mated JJ O
) , O
gave VBD O
us PRP O
further JJ O
insights NNS O
into IN O
the DT O
possible JJ O
roles NNS O
that WDT O
mating NN O
- HYPH O
responsive JJ O
proteins NNS O
play VBP O
in IN O
the DT O
oviduct NN O
. . O

For IN O
example NN O
, , O
Mlp84B NNP O
is VBZ O
only RB O
responsive JJ O
to IN O
the DT O
first JJ O
mating NN O
, , O
while IN O
the DT O
epithelial JJ O
proteins NNS O
examined VBN O
( , O
Cora NNP O
, , O
Nrg NNP O
and CC O
Hts NNPS O
) -RRB- O
are VBP O
responsive JJ O
to IN O
the DT O
first JJ O
and CC O
second JJ O
mating NN O
. . O

Furthermore RB O
, , O
the DT O
response NN O
to IN O
the DT O
second JJ O
mating NN O
is VBZ O
different JJ O
from IN O
the DT O
response NN O
to IN O
the DT O
first JJ O
mating NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
Mlp84B NNP O
is VBZ O
required VBN O
for IN O
the DT O
final JJ O
maturation NN O
of IN O
the DT O
oviduct NN O
, , O
while IN O
the DT O
epithelial JJ O
proteins NNS O
examined VBN O
are VBP O
required VBN O
for IN O
both CC O
the DT O
maturation NN O
and CC O
maintenance NN O
of IN O
the DT O
oviduct NN O
at IN O
a DT O
high JJ O
functional JJ O
state NN O
. . O

Moreover RB O
, , O
the DT O
post NN O
- HYPH O
mating VBG O
pattern NN O
of IN O
Mlp84B NNP O
supports VBZ O
the DT O
idea NN O
that IN O
the DT O
first JJ O
mating NN O
induces VBZ O
the DT O
final JJ O
maturation NN O
of IN O
the DT O
oviduct NN O
. . O

The DT O
rise NN O
and CC O
fall NN O
of IN O
Mlp84B NNP O
abundance NN O
after IN O
the DT O
first JJ O
mating NN O
( , O
Figure NNP O
5 CD O
) -RRB- O
parallels VBZ O
the DT O
expression NN O
pattern NN O
of IN O
Mlp84B NNP O
during IN O
development NN O
where WRB O
peaks NNS O
in IN O
Mlp84B NNP O
transcription NN O
occur VBP O
during IN O
periods NNS O
of IN O
embryogenesis NN O
and CC O
metamorphosis NN O
when WRB O
muscle NN O
is VBZ O
differentiating VBG O
[ -LRB- O
49 CD O
] -RRB- O
. . O

Using VBG O
different JJ O
mating NN O
regimes NNS O
we PRP O
tested VBD O
whether IN O
the DT O
first JJ O
/ SYM O
early JJ O
mating NN O
is VBZ O
essential JJ O
for IN O
maintenance NN O
of IN O
high JJ O
reproductive JJ O
output NN O
in IN O
the DT O
second JJ O
mating NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
mating NN O
at IN O
an DT O
early JJ O
age NN O
is VBZ O
essential JJ O
to TO O
achieve VB O
maximum JJ O
reproductive JJ O
output NN O
( , O
i LS O
. . O
e LS O
. . O
high JJ O
fecundity NN O
and CC O
fertility NN O
) -RRB- O
. . O

Since IN O
the DT O
first JJ O
mating NN O
increases VBZ O
reproductive JJ O
output NN O
( , O
evidence NN O
from IN O
our PRP$ O
mating NN O
regime NN O
experiments NNS O
) -RRB- O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
ultrastructural JJ O
changes NNS O
detected VBN O
in IN O
mated VBN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
females NNS O
lead VBP O
to IN O
a DT O
highly RB O
functional JJ O
oviduct NN O
. . O

We PRP O
suggest VBP O
that IN O
the DT O
final JJ O
maturation NN O
of IN O
the DT O
oviduct NN O
includes VBZ O
a DT O
mating NN O
- HYPH O
dependent JJ O
stage NN O
. . O

We PRP O
propose VBP O
that IN O
during IN O
the DT O
first JJ O
few JJ O
days NNS O
post NN O
- HYPH O
eclosion NN O
, , O
the DT O
oviduct NN O
undergoes VBZ O
the DT O
first JJ O
phase NN O
of IN O
differentiation NN O
, , O
after IN O
which WDT O
the DT O
oviduct NN O
is VBZ O
developmentally RB O
poised VBN O
for IN O
a DT O
rapid JJ O
response NN O
to IN O
an DT O
extrinsic JJ O
cue NN O
( , O
mating NN O
) -RRB- O
. . O

Mating NN O
then RB O
triggers VBZ O
the DT O
second JJ O
phase NN O
of IN O
maturation NN O
( , O
tissue NN O
remodeling NN O
and CC O
modulation NN O
) , O
which WDT O
is VBZ O
essential JJ O
for IN O
proper JJ O
oviduct NN O
function NN O
( -LRB- O
Figure NN O
7 CD O
) -RRB- O
. . O

We PRP O
further RB O
propose VBP O
that IN O
the DT O
second JJ O
phase NN O
of IN O
maturation NN O
consists VBZ O
of IN O
processes NNS O
that WDT O
are VBP O
mating VBG O
- HYPH O
independent JJ O
and CC O
- HYPH O
dependent JJ O
, , O
and CC O
that IN O
both DT O
of IN O
these DT O
pathways NNS O
are VBP O
essential JJ O
to TO O
produce VB O
a DT O
functional JJ O
oviduct NN O
. . O

For IN O
example NN O
, , O
initial JJ O
formation NN O
of IN O
SJs NNPS O
occurs VBZ O
prior RB O
to IN O
mating NN O
( -LRB- O
mating NN O
- HYPH O
independent JJ O
) , O
while IN O
the DT O
increased JJ O
apical JJ O
secretion NN O
and CC O
development NN O
of IN O
HAJs NNS O
are VBP O
mating VBG O
- HYPH O
dependent JJ O
. . O

The DT O
oviduct NN O
musculature NN O
is VBZ O
an DT O
example NN O
where WRB O
both DT O
mating NN O
- HYPH O
independent JJ O
and CC O
- HYPH O
dependent JJ O
processes NNS O
play VBP O
a DT O
role NN O
. . O

Muscles NNS O
are VBP O
highly RB O
differentiated VBN O
in IN O
the DT O
lower JJR O
oviduct NN O
prior RB O
to IN O
mating NN O
, , O
while IN O
muscle NN O
differentiation NN O
is VBZ O
ongoing VBG O
in IN O
the DT O
upper JJ O
oviduct NN O
and CC O
increases VBZ O
after IN O
mating NN O
. . O

Although IN O
the DT O
onset NN O
of IN O
muscle NN O
differentiation NN O
in IN O
both DT O
regions NNS O
is VBZ O
mating VBG O
- HYPH O
independent JJ O
, , O
the DT O
further JJ O
differentiation NN O
of IN O
muscle NN O
in IN O
the DT O
upper JJ O
oviduct NN O
is VBZ O
mating NN O
- HYPH O
dependent JJ O
. . O

Another DT O
possible JJ O
interpretation NN O
of IN O
the DT O
role NN O
of IN O
mating NN O
on IN O
oviduct NN O
maturation NN O
is VBZ O
that IN O
mating NN O
accelerates VBZ O
and CC O
synchronizes VBZ O
processes NNS O
that WDT O
are VBP O
essential JJ O
for IN O
the DT O
functional JJ O
maturation NN O
of IN O
the DT O
oviduct NN O
. . O

It PRP O
will MD O
therefore RB O
be VB O
interesting JJ O
to TO O
examine VB O
the DT O
oviducts NNS O
of IN O
older JJR O
females NNS O
to TO O
determine VB O
the DT O
status NN O
of IN O
oviduct NN O
maturation NN O
. . O

What WP O
is VBZ O
the DT O
benefit NN O
of IN O
mating NN O
- HYPH O
induced VBN O
differentiation NN O
of IN O
the DT O
oviduct NN O
tissues NNS O
? . O

Unmated JJ O
females NNS O
are VBP O
capable JJ O
of IN O
laying VBG O
eggs NNS O
, , O
albeit IN O
at IN O
a DT O
reduced VBN O
rate NN O
as IN O
compared VBN O
to IN O
mated JJ O
females NNS O
of IN O
the DT O
same JJ O
age NN O
. . O

One CD O
possible JJ O
interpretation NN O
is VBZ O
that IN O
reproduction NN O
is VBZ O
energetically RB O
costly JJ O
, , O
thus RB O
delaying VBG O
oviduct NN O
maturation NN O
until IN O
sperm NN O
is VBZ O
available JJ O
is VBZ O
advantageous JJ O
to IN O
the DT O
female NN O
. . O

This DT O
may MD O
reflect VB O
the DT O
evolution NN O
of IN O
a DT O
mechanism NN O
to TO O
optimize VB O
reproductive JJ O
capacity NN O
in IN O
early JJ O
adulthood NN O
in IN O
short RB O
- HYPH O
lived VBN O
animals NNS O
. . O

In IN O
summary NN O
, , O
we PRP O
have VBP O
identified VBN O
events NNS O
at IN O
the DT O
cellular JJ O
, , O
molecular JJ O
and CC O
physiological JJ O
levels NNS O
that WDT O
are VBP O
part NN O
of IN O
an DT O
efficient JJ O
and CC O
specific JJ O
program NN O
for IN O
reproduction NN O
. . O

Drosophila NNP O
affords VBZ O
us PRP O
the DT O
opportunity NN O
to TO O
uncover VB O
the DT O
signaling VBG O
pathways NNS O
that WDT O
coordinate VBP O
these DT O
events NNS O
to TO O
produce VB O
a DT O
physiologically RB O
functional JJ O
organ NN O
. . O

Methods NNS O

Flies NNS O

Wild JJ O
- HYPH O
type NN O
Canton NNP O
- HYPH O
S NNP O
flies NNS B-Species
were VBD O
used VBN O
for IN O
the DT O
fecundity NN O
/ SYM O
fertility NN O
experiments NNS O
and CC O
confocal JJ O
analysis NN O
. . O

Wild JJ O
- HYPH O
type NN O
Canton NNP O
- HYPH O
S5 NNP O
[ -LRB- O
57 CD O
] -RRB- O
flies NNS B-Species
were VBD O
used VBN O
for IN O
electron NN O
microscopy NN O
. . O

All DT O
flies NNS B-Species
were VBD O
kept VBN O
in IN O
a DT O
12 CD O
hrs NNS O
light NN O
/ SYM O
dark JJ O
cycle NN O
at IN O
23 CD O
+ SYM O
/ SYM O
- SYM O
2 CD O
degrees NNS O
C NN O
. . O

Upon IN O
eclosion NN O
, , O
females NNS O
and CC O
males NNS O
were VBD O
collected VBN O
on IN O
ice NN O
and CC O
held VBN O
separately RB O
until IN O
3 CD O
( , O
females NNS O
and CC O
males NNS O
) -RRB- O
or CC O
10 CD O
( SYM O
females NNS O
) -RRB- O
days NNS O
of IN O
age NN O
. . O

Sample NN O
preparation NN O

For IN O
all DT O
assays NNS O
( -LRB- O
unless IN O
described VBN O
differently RB O
) , O
unmated JJ O
females NNS O
were VBD O
placed VBN O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
and CC O
observed VBN O
until IN O
mating NN O
initiated VBD O
. . O

At IN O
the DT O
end NN O
of IN O
mating NN O
, , O
females NNS O
were VBD O
aspirated VBN O
into IN O
fresh JJ O
vials NNS O
and CC O
held VBN O
for IN O
6 CD O
hrs NNS O
. . O

At IN O
6 CD O
hrs NNS O
after IN O
the DT O
start NN O
of IN O
mating NN O
, , O
females NNS O
were VBD O
placed VBN O
on IN O
ice NN O
for IN O
dissection NN O
. . O

Previous JJ O
molecular JJ O
studies NNS O
indicate VBP O
changes NNS O
in IN O
protein NN O
abundance NN O
at IN O
3 CD O
hrs NNS O
post NN O
- HYPH O
mating NN O
. . O

We PRP O
hypothesize VBP O
that IN O
these DT O
molecular JJ O
changes NNS O
will MD O
translate VB O
into IN O
morphological JJ O
changes NNS O
in IN O
the DT O
next JJ O
few JJ O
hours NNS O
. . O

We PRP O
chose VBD O
to TO O
analyze VB O
the DT O
morphology NN O
of IN O
mated VBN O
females NNS O
at IN O
6 CD O
h CD O
post NN O
- HYPH O
mating VBG O
as IN O
opposed VBN O
to IN O
later JJ O
times NNS O
post NN O
- HYPH O
mating NN O
because IN O
the DT O
changes NNS O
observed VBN O
at IN O
later JJ O
times NNS O
may MD O
be VB O
due JJ O
, , O
in IN O
part NN O
, , O
to IN O
the DT O
high JJ O
rate NN O
of IN O
eggs NNS O
passing VBG O
through IN O
the DT O
oviduct NN O
. . O

Electron NN O
microscopy NN O

Reproductive JJ O
tracts NNS O
were VBD O
dissected VBN O
in IN O
Schneider NNP O
' POS O
s POS O
Drosophila NNP B-Species
medium NN O
( , O
Sigma NNP O
) -RRB- O
on IN O
ice NN O
and CC O
processed VBN O
for IN O
electron NN O
microscopy NN O
as IN O
described VBN O
in IN O
[ -LRB- O
42 CD O
] -RRB- O
. . O

Tracts NNS O
were VBD O
flat JJ O
- HYPH O
embedded VBN O
between IN O
two CD O
sheets NNS O
of IN O
Aclar NNP O
( : O
Electron NNP O
Microscopy NNP O
Sciences NNPS O
) -RRB- O
, , O
which WDT O
allowed VBD O
us PRP O
to TO O
image VB O
the DT O
entire JJ O
tract NN O
at IN O
the DT O
light JJ O
microscopic JJ O
level NN O
prior RB O
to IN O
sectioning NN O
. . O

Sections NNS O
were VBD O
cut VBN O
on IN O
a DT O
Reichart NNP O
Ultracut NNP O
microtome NN O
. . O

One CD O
- HYPH O
mu NN O
m NN O
thick JJ O
sections NNS O
were VBD O
stained VBN O
with IN O
1 CD O
% NN O
toluidine NN O
blue JJ O
, , O
and CC O
viewed VBN O
with IN O
a DT O
Zeiss NNP O
Axoplan NNP O
microscope NN O
. . O

Ultrathin JJ O
sections NNS O
( : O
~ $ O
100 CD O
nm CD O
) -RRB- O
were VBD O
mounted VBN O
on IN O
formvar JJ O
grids NNS O
, , O
stained VBN O
with IN O
lead NN O
citrate NN O
, , O
and CC O
viewed VBN O
with IN O
a DT O
Philips NNP O
/ SYM O
FEI NNP O
Morgagni NNP O
268 CD O
TEM NN O
at IN O
80 CD O
kV NN O
. . O

Our PRP$ O
analysis NN O
is VBZ O
based VBN O
on IN O
4 CD O
unmated JJ O
samples NNS O
and CC O
3 CD O
mated VBN O
samples NNS O
. . O

Two CD O
unmated JJ O
samples NNS O
were VBD O
cut VBN O
in IN O
the DT O
longitudinal JJ O
plane NN O
and CC O
two CD O
additional JJ O
unmated JJ O
samples NNS O
were VBD O
cut VBN O
in IN O
the DT O
transverse NN O
plane NN O
, , O
while IN O
one CD O
mated VBN O
sample NN O
was VBD O
cut VBN O
in IN O
the DT O
longitudinal JJ O
plane NN O
and CC O
two CD O
additional JJ O
mated VBN O
samples NNS O
were VBD O
cut VBN O
in IN O
the DT O
transverse NN O
plane NN O
. . O

For IN O
longitudinal JJ O
sections NNS O
, , O
the DT O
entire JJ O
tract NN O
was VBD O
re RB O
- HYPH O
embedded VBN O
and CC O
cut VBN O
. . O

For IN O
samples NNS O
cut VBN O
in IN O
the DT O
transverse NN O
plane NN O
, , O
the DT O
flat JJ O
- HYPH O
embedded VBN O
reproductive JJ O
tract NN O
was VBD O
divided VBN O
into IN O
three CD O
regions NNS O
: : O
( , O
1 CD O
) SYM O
lateral JJ O
oviducts NNS O
and CC O
upper JJ O
common JJ O
oviducts NNS O
, , O
( , O
2 CD O
) SYM O
middle JJ O
common JJ O
oviduct NN O
, , O
and CC O
( , O
3 CD O
) SYM O
lower JJR O
common JJ O
oviduct NN O
. . O

Each DT O
region NN O
was VBD O
re RB O
- HYPH O
embedded VBN O
and CC O
sectioned VBN O
. . O

It PRP O
is VBZ O
beyond IN O
the DT O
scope NN O
of IN O
this DT O
paper NN O
to TO O
describe VB O
all DT O
three CD O
regions NNS O
, , O
and CC O
our PRP$ O
analysis NN O
focuses VBZ O
on IN O
the DT O
uppermost JJ O
and CC O
lowermost JJ O
regions NNS O
. . O

Immunocytochemistry NN O

Reproductive JJ O
tracts NNS O
were VBD O
dissected VBN O
in IN O
Yamamoto NNP O
' POS O
s POS O
Ringer NNP O
( , O
10 CD O
mM NN O
MOPS NNP O
; : O
80 CD O
mM NN O
NaCl NNP O
; : O
10 CD O
mM NN O
KCL NNP O
; : O
0 CD O
. . O
2 CD O
mM NN O
MgCl2 NN O
; : O
0 CD O
. . O
1 CD O
mM NN O
CaCl2 NN O
) -RRB- O
with IN O
5 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) -RRB- O
sucrose NN O
on IN O
ice NN O
, , O
fixed VBN O
in IN O
4 CD O
% NN O
paraphormaldehyde NN O
in IN O
PBS NN O
( , O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
; : O
0 CD O
. . O
85 CD O
% NN O
NaCl NNP O
, , O
1 CD O
. . O
4 CD O
mM NN O
KH2 CD O
PO4 NN O
, , O
8 CD O
mM NN O
Na2 CD O
HPO4 NN O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
for IN O
45 CD O
min NN O
and CC O
then RB O
washed VBN O
in IN O
PBS NNP O
. . O

The DT O
reproductive JJ O
tracts NNS O
were VBD O
then RB O
incubated VBN O
in IN O
blocking NN O
solution NN O
( , O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
x SYM O
- : O
100 CD O
, , O
3 CD O
% NN O
NGS NNP O
, , O
0 CD O
. . O
1 CD O
% NN O
BSA NN O
) -RRB- O
for IN O
2 CD O
hrs NNS O
at IN O
room NN O
temperature NN O
. . O

The DT O
following VBG O
primary JJ O
antibodies NNS O
, , O
reagents NNS O
, , O
and CC O
dilutions NNS O
were VBD O
used VBN O
: : O
Cy3 NNP O
- HYPH O
conjugated VBN O
goat NN B-Species
anti JJ O
- HYPH O
HRP NNP O
, , O
1 CD O
: : O
200 CD O
( : O
Jackson NNP O
Immunochemicals NNP O
, , O
West NNP O
Grove NNP O
, , O
PA NNP O
) -RRB- O
; : O
mouse NN B-Species
anti AFX O
- HYPH O
Disc NNP O
Large NNP O
( -LRB- O
DLG NNP O
) -RRB- O
, , O
1 CD O
: : O
1000 CD O
( SYM O
Developmental NNP O
Hybridoma NNP O
Bank NNP O
) -RRB- O
, , O
Alexa NNP O
Fluor NNP O
488 CD O
- HYPH O
phalloidin NN O
, , O
1 CD O
: : O
200 CD O
( : O
Invitrogen NNP O
, , O
Molecular NNP O
Probes NNPS O
, , O
Scotland NNP O
) -RRB- O
. . O

Secondary JJ O
antibodies NNS O
were VBD O
Alexa NNP O
Flour NNP O
488 CD O
- HYPH O
conjugated VBN O
Goat NNP B-Species
anti JJ O
- HYPH O
mouse NNP B-Species
, , O
1 CD O
: SYM O
200 CD O
and CC O
Alexa NNP O
Flour NNP O
546 CD O
- HYPH O
conjugated VBN O
Goat NNP B-Species
anti JJ O
- HYPH O
rabbit NN B-Species
, , O
1 CD O
: : O
200 CD O
( , O
Invitrogen NNP O
, , O
Molecular NNP O
Probes NNPS O
, , O
Scotland NNP O
) -RRB- O
. . O

Reproductive JJ O
tracts NNS O
were VBD O
incubated VBN O
with IN O
the DT O
different JJ O
primary JJ O
antibodies NNS O
( , O
diluted VBN O
in IN O
PBS NNP O
+ SYM O
0 CD O
. . O
2 CD O
% NN O
Triton NNP O
x NNP O
- SYM O
100 CD O
) -RRB- O
for IN O
2 CD O
hr NN O
at IN O
room NN O
temperature NN O
, , O
washed VBN O
with IN O
PBST NNP O
, , O
incubated VBN O
with IN O
secondary JJ O
antibodies NNS O
for IN O
2 CD O
hrs NNS O
at IN O
room NN O
temperature NN O
and CC O
washed VBN O
with IN O
PBS NNP O
. . O

Reproductive JJ O
tracts NNS O
of IN O
the DT O
different JJ O
treatments NNS O
were VBD O
mounted VBN O
with IN O
Antifade NNP O
media NN O
[ -LRB- O
58 CD O
] -RRB- O
on IN O
a DT O
multi JJ O
- HYPH O
well NN O
glass NN O
slide NN O
( , O
Hendley NNP O
- HYPH O
Essex NNP O
, , O
UK NNP O
) -RRB- O
. . O

For IN O
each DT O
treatment NN O
( , O
unmated JJ O
, , O
mated VBN O
) , O
and CC O
antibody NN O
/ SYM O
reagent NN O
( , O
HRP NN O
, , O
DLG NNP O
, , O
phalloidin NN O
) -RRB- O
a DT O
minimum NN O
of IN O
ten CD O
reproductive JJ O
tracts NNS O
from IN O
at RB O
least RBS O
two CD O
independent JJ O
biological JJ O
replicates NNS O
were VBD O
prepared VBN O
. . O

Confocal JJ O
microscopy NN O

Reproductive JJ O
tracts NNS O
were VBD O
viewed VBN O
with IN O
a DT O
Zeiss NNP O
510 CD O
laser NN O
scanning NN O
confocal JJ O
microscope NN O
using VBG O
20 CD O
x SYM O
and CC O
60 CD O
x SYM O
objective NN O
with IN O
additional JJ O
zooming NN O
. . O

Optical JJ O
sections NNS O
from IN O
different JJ O
focal JJ O
plans NNS O
of IN O
each DT O
reproductive JJ O
tract NN O
region NN O
( , O
lateral JJ O
oviducts NNS O
, , O
common JJ O
oviduct NN O
, , O
uterus NN O
) , O
were VBD O
collected VBN O
and CC O
projected VBN O
as IN O
a DT O
reconstructed VBN O
three CD O
- HYPH O
dimensional JJ O
image NN O
using VBG O
LSM NNP O
image NN O
browser NN O
( , O
version NN O
3 CD O
, , O
5 CD O
, , O
0 CD O
, , O
376 CD O
) -RRB- O
software NN O
. . O

Image NN O
collections NNS O
were VBD O
identical JJ O
for IN O
each DT O
of IN O
the DT O
different JJ O
reproductive JJ O
tract NN O
regions NNS O
analyzed VBN O
. . O

Quantitation NN O
of IN O
bouton NN O
number NN O

To TO O
quantify VB O
the DT O
number NN O
of IN O
boutons NNS O
in IN O
the DT O
lateral JJ O
and CC O
common JJ O
oviducts NNS O
we PRP O
used VBD O
ImageJ NNP O
software NN O
( , O
1 CD O
. . O
37b CD O
, , O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
) -RRB- O
to TO O
analyze VB O
confocal JJ O
images NNS O
of IN O
anti JJ O
- HYPH O
HRP NN O
and CC O
anti JJ O
- HYPH O
DLG NN O
labeled VBN O
boutons NNS O
in IN O
the DT O
oviduct NN O
. . O

The DT O
number NN O
of IN O
boutons NNS O
per IN O
unit NN O
area NN O
was VBD O
quantified VBN O
with IN O
the DT O
Particle NNP O
Analysis NNP O
Tool NNP O
. . O

Briefly RB O
, , O
to TO O
differentiate VB O
between IN O
the DT O
boutons NNS O
, , O
the DT O
particle NN O
analysis NN O
tool NN O
requires VBZ O
the DT O
image NN O
to TO O
be VB O
a DT O
"""" `` O
binary JJ O
"""" '' O
image NN O
( , O
i PRP O
. . O
e -RRB- O
. . O
, , O
black JJ O
or CC O
white JJ O
) -RRB- O
, , O
thus RB O
we PRP O
first RB O
converted VBD O
the DT O
images NNS O
to IN O
gray JJ O
scale NN O
. . O

We PRP O
then RB O
set VBP O
a DT O
"""" `` O
threshold NN O
"""" '' O
range NN O
so IN O
that IN O
pixels NNS O
in IN O
the DT O
image NN O
whose WP$ O
value NN O
lies VBZ O
in IN O
this DT O
range NN O
are VBP O
converted VBN O
to IN O
black NN O
; : O
pixels NNS O
with IN O
values NNS O
outside IN O
this DT O
range NN O
are VBP O
converted VBN O
to IN O
white JJ O
. . O

We PRP O
next RB O
defined VBD O
a DT O
region NN O
of IN O
interest NN O
( : O
ROI NNP O
) -RRB- O
within IN O
the DT O
oviduct NN O
to TO O
count VB O
particles NNS O
( : O
i LS O
. . O
e LS O
. . O
count VB O
boutons NNS O
) -RRB- O
. . O

This DT O
ROI NNP O
was VBD O
saved VBN O
and CC O
served VBN O
to TO O
measure VB O
the DT O
number NN O
of IN O
boutons NNS O
per IN O
unit NN O
area NN O
in IN O
each DT O
treatment NN O
. . O

For IN O
each DT O
oviduct NN O
we PRP O
counted VBD O
the DT O
number NN O
of IN O
anti AFX O
- HYPH O
HRP NN O
and CC O
anti AFX O
- HYPH O
DLG NN O
labeled VBN O
boutons NNS O
in IN O
two CD O
ROIs NNS O
within IN O
the DT O
lateral JJ O
oviducts NNS O
and CC O
two CD O
ROIs NNS O
in IN O
the DT O
common JJ O
oviduct NN O
. . O

One CD O
- HYPH O
way NN O
ANOVA NNP O
( : O
SPSS NNP O
15 CD O
. . O
0 CD O
) -RRB- O
was VBD O
used VBN O
to TO O
measure VB O
the DT O
difference NN O
in IN O
bouton NN O
number NN O
per IN O
unit NN O
area NN O
in IN O
different JJ O
regions NNS O
of IN O
the DT O
oviducts NNS O
, , O
in IN O
both CC O
unmated JJ O
and CC O
mated JJ O
females NNS O
. . O

Quantitation NN O
of IN O
cytoskeleton NN O
proteins NNS O

Sample NN O
preparation NN O

To TO O
evaluate VB O
the DT O
effect NN O
of IN O
mating VBG O
on IN O
the DT O
abundance NN O
of IN O
the DT O
cytoskeleton NN O
proteins NNS O
tested VBN O
, , O
females NNS O
were VBD O
: : O
( : O
i PRP O
) -RRB- O
aged VBN O
for IN O
3 CD O
days NNS O
, , O
mated VBN O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
and CC O
their PRP$ O
oviducts NNS O
were VBD O
dissected VBN O
after IN O
6 CD O
hrs NNS O
post NN O
- HYPH O
mating NN O
( , O
Once3 NNP O
) -RRB- O
; : O
( : O
ii FW O
) -RRB- O
aged VBN O
for IN O
3 CD O
days NNS O
, , O
mated VBN O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
and CC O
their PRP$ O
oviducts NNS O
were VBD O
dissected VBN O
after IN O
7 CD O
days NNS O
( , O
Once3 NNP O
day10 CD O
) -RRB- O
; : O
( : O
iii CD O
) -RRB- O
aged VBN O
for IN O
3 CD O
days NNS O
, , O
mated VBN O
first RB O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
and CC O
held VBN O
singly JJ O
for IN O
7 CD O
days NNS O
. . O

At IN O
10 CD O
days NNS O
of IN O
age NN O
, , O
female JJ O
were VBD O
mated VBN O
again RB O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
. . O

Oviducts NNS O
were VBD O
dissected VBN O
at IN O
6 CD O
hrs NNS O
post NN O
- HYPH O
second NN O
mating NN O
( , O
Twice3 NNP O
& CC O
10 CD O
) -RRB- O
. . O

We PRP O
also RB O
examined VBD O
5 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
and CC O
10 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
females NNS O
( , O
UM5 NNP O
, , O
UM10 NNP O
respectively RB O
) -RRB- O
. . O

SDS NNP O
polyacrylamide NN O
gel NN O
electrophoresis NN O
( -LRB- O
SDS NN O
- HYPH O
PAGE NN O
) -RRB- O
and CC O
Western JJ O
blotting NN O

For IN O
each DT O
mating NN O
regime NN O
, , O
sixty CD O
oviducts NNS O
were VBD O
pooled VBN O
and CC O
30 CD O
mu NNS O
l NN O
of IN O
SDS NNP O
- HYPH O
PAGE NN O
sample NN O
buffer NN O
was VBD O
added VBN O
as IN O
described VBN O
in IN O
[ -LRB- O
59 CD O
] -RRB- O
. . O

Samples NNS O
were VBD O
boiled VBN O
, , O
and CC O
then RB O
frozen VBN O
at IN O
- SYM O
20 CD O
degrees NNS O
C NN O
until IN O
loading NN O
. . O

SDS NNP O
- HYPH O
PAGE NN O
was VBD O
performed VBN O
on IN O
12 CD O
% NN O
polyacrylamide NN O
gels NNS O
and CC O
western JJ O
blotted VBN O
as IN O
in IN O
[ -LRB- O
60 CD O
] -RRB- O
. . O

Proteins NNS O
were VBD O
cross NN O
- HYPH O
linked VBN O
to IN O
the DT O
filter NN O
. . O

The DT O
following VBG O
primary JJ O
antibodies NNS O
and CC O
dilutions NNS O
were VBD O
used VBN O
: : O
mouse NN B-Species
anti CC O
- HYPH O
Neuroglian NNP O
( , O
kindly RB O
provided VBN O
by IN O
M NNP O
. . O
Hortsch NNP O
) SYM O
1 CD O
: : O
250 CD O
; : O
Guinea NNP B-Species
pig NN I-Species
anti AFX O
- HYPH O
Coracle NNP O
( : O
kindly RB O
provided VBN O
by IN O
R NNP O
. . O
G NNP O
. . O
Fehon NNP O
) SYM O
1 CD O
: : O
2500 CD O
; : O
rabbit NN B-Species
anti AFX O
- HYPH O
Mlp84B NN O
( : O
kindly RB O
provided VBN O
by IN O
M NNP O
. . O
Beckerle NNP O
) SYM O
1 CD O
: : O
1000 CD O
; : O
mouse NNP B-Species
anti AFX O
- HYPH O
hts NNS O
( , O
1B1 CD O
, , O
Developmental NNP O
Studies NNPS O
Hybridoma NNP O
Bank NNP O
, , O
DSHB NNP O
) SYM O
1 CD O
: : O
75 CD O
; : O
mouse NNP B-Species
anti NNP O
- HYPH O
Na NNP O
, , O
K NNP O
- HYPH O
ATPase NNP O
( , O
alpha NN O
5 CD O
, , O
DSHB NNP O
) -RRB- O
1 CD O
: : O
100 CD O
. . O

Secondary JJ O
antibodies NNS O
included VBN O
: : O
anti JJ O
- HYPH O
Guinea NNP B-Species
pig NN I-Species
IgG NNP O
( , O
peroxidase NN O
conjugated VBN O
) -RRB- O
, , O
anti JJ O
- HYPH O
Rabbit NN B-Species
IgG NN O
and CC O
anti JJ O
- HYPH O
Mouse NNP B-Species
IgG NNP O
( , O
developed VBN O
in IN O
goat NN B-Species
, , O
Sigma NNP O
, , O
Israel NNP O
) SYM O
1 CD O
: : O
10 CD O
, , O
0 CD O
. . O

Proteins NNS O
were VBD O
visualized VBN O
using VBG O
an DT O
enhanced VBN O
chemiluminescence NN O
( , O
ECL NNP O
) -RRB- O
detection NN O
system NN O
( , O
Amersham NNP O
Piscataway NNP O
, , O
NJ NNP O
) -RRB- O
. . O

Analysis NN O

The DT O
developed VBN O
film NN O
was VBD O
scanned VBN O
and CC O
the DT O
signal NN O
intensity NN O
( , O
protein NN O
abundance NN O
) -RRB- O
of IN O
each DT O
band NN O
was VBD O
determined VBN O
using VBG O
ImageJ NNP O
software NN O
( , O
1 CD O
. . O
37d CD O
, , O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
) -RRB- O
. . O

We PRP O
evaluated VBD O
protein NN O
abundance NN O
by IN O
measuring VBG O
the DT O
mean JJ O
gray JJ O
value NN O
of IN O
a DT O
specific JJ O
band NN O
and CC O
the DT O
background NN O
. . O

The DT O
mean JJ O
gray JJ O
value NN O
of IN O
the DT O
background NN O
was VBD O
then RB O
subtracted VBN O
from IN O
that DT O
of IN O
the DT O
measured JJ O
band NN O
. . O

Relative JJ O
protein NN O
abundance NN O
in IN O
mated JJ O
oviduct NN O
vs IN O
. . O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
oviduct NN O
was VBD O
then RB O
calculated VBN O
. . O

Four CD O
independent JJ O
biological JJ O
replicates NNS O
were VBD O
prepared VBN O
for IN O
each DT O
mating NN O
status NN O
. . O

The DT O
reported JJ O
abundance NN O
( , O
see VB O
Figure NN O
5 CD O
) -RRB- O
is VBZ O
the DT O
relative JJ O
ratio NN O
( , O
mated VBN O
/ SYM O
unmated JJ O
or CC O
unmated JJ O
/ SYM O
unmated JJ O
) -RRB- O
of IN O
at RB O
least RBS O
three CD O
replicates NNS O
that WDT O
showed VBD O
the DT O
same JJ O
trend NN O
. . O

Examination NN O
of IN O
female JJ O
reproductive JJ O
output NN O

Mating NN O
regimes NNS O

To TO O
evaluate VB O
the DT O
effect NN O
of IN O
mating VBG O
on IN O
reproductive JJ O
output NN O
females NNS O
were VBD O
treated VBN O
as IN O
follows VBZ O
: : O
( : O
i PRP O
) -RRB- O
aged VBN O
for IN O
3 CD O
days NNS O
and CC O
mated VBN O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
( , O
Once3 NNP O
) -RRB- O
; : O
( : O
ii FW O
) -RRB- O
aged VBN O
for IN O
10 CD O
days NNS O
and CC O
mated VBN O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
( , O
Once10 NNP O
) -RRB- O
; : O
( : O
iii CD O
) -RRB- O
aged VBN O
for IN O
3 CD O
days NNS O
, , O
mated VBN O
first RB O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
, , O
held VBN O
for IN O
7 CD O
days NNS O
and CC O
mated VBN O
again RB O
with IN O
3 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
unmated JJ O
males NNS O
( , O
Twice3 NNP O
& CC O
10 CD O
) -RRB- O
. . O

In IN O
all DT O
cases NNS O
male JJ O
and CC O
female JJ O
pairs NNS O
were VBD O
observed VBN O
to TO O
record VB O
mating NN O
initiation NN O
and CC O
termination NN O
. . O

Analysis NN O

Following VBG O
mating NN O
, , O
females NNS O
were VBD O
aspirated VBN O
into IN O
fresh JJ O
vials NNS O
, , O
held VBN O
singly RB O
and CC O
allowed VBN O
to TO O
lay VB O
eggs NNS O
for IN O
6 CD O
hrs NNS O
, , O
then RB O
transferred VBN O
daily RB O
( : O
each DT O
24 CD O
hrs NNS O
) -RRB- O
to IN O
fresh JJ O
vials NNS O
. . O

The DT O
number NN O
of IN O
eggs NNS O
laid VBN O
and CC O
the DT O
number NN O
of IN O
eclosed VBN O
adults NNS O
were VBD O
counted VBN O
from IN O
vials NNS O
created VBN O
at IN O
6 CD O
hrs NNS O
, , O
1 CD O
, , O
2 CD O
and CC O
3 CD O
days NNS O
post NN O
- HYPH O
mating NN O
. . O

To TO O
ascertain VB O
the DT O
baseline NN O
of IN O
female JJ O
egg NN O
- HYPH O
laying VBG O
, , O
we PRP O
also RB O
included VBD O
in IN O
our PRP$ O
experiment NN O
unmated JJ O
females NNS O
that WDT O
were VBD O
kept VBN O
in IN O
the DT O
same JJ O
conditions NNS O
as IN O
mated JJ O
females NNS O
. . O

The DT O
number NN O
of IN O
eggs NNS O
laid VBN O
by IN O
unmated JJ O
females NNS O
was VBD O
counted VBN O
from IN O
vials NNS O
created VBN O
at IN O
6 CD O
hrs NNS O
, , O
1 CD O
, , O
2 CD O
and CC O
3 CD O
days NNS O
after IN O
placing VBG O
the DT O
females NNS O
in IN O
the DT O
holding VBG O
vials NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
also RB O
recorded VBD O
the DT O
pattern NN O
of IN O
unmated JJ O
female JJ O
egg NN O
- HYPH O
laying VBG O
for IN O
10 CD O
days NNS O
. . O

To TO O
determine VB O
the DT O
effect NN O
of IN O
different JJ O
mating NN O
regimes NNS O
on IN O
female JJ O
reproductive JJ O
output NN O
( : O
i LS O
. . O
e -RRB- O
. . O
fecundity NN O
and CC O
fertility NN O
) -RRB- O
, , O
we PRP O
used VBD O
One CD O
- HYPH O
way NN O
ANOVA NNP O
( : O
SPSS NN O
15 CD O
. . O
0 CD O
) -RRB- O
. . O

Abbreviations NNS O

Nrg NNP O
: : O
Neuroglian NNP O
; : O
Cora NNP O
: : O
Coracle NNP O
; : O
Spec NN O
: : O
alpha NN O
- HYPH O
and CC O
beta NN O
- HYPH O
Spectrin NNP O
; : O
SJ NN O
: : O
septate NN O
junction NN O
; : O
SSJ NNP O
: : O
smooth JJ O
septate NN O
junction NN O
; : O
PSJ NNP O
: : O
pleated VBN O
septate NN O
junction NN O
; : O
ZA NN O
: : O
zonal JJ O
adherens NNS O
junction NN O
; : O
AJ NN O
: : O
adherens NNP O
junction NN O
; : O
AECM NN O
: : O
apical JJ O
extracellular JJ O
matrix NN O
; : O
ECM NN O
: : O
extracellular JJ O
matrix NN O
; : O
HAJ NNP O
: : O
hemi NNP O
- HYPH O
adherens NNP O
junction NN O
; : O
SAJ NNP O
: : O
spot NN O
adherens NNS O
junction NN O
; : O
OA NN O
: : O
Octopamine NN O
; : O
Hts NNP O
: : O
Hu NNP O
- HYPH O
li NNP O
tai NNP O
shao NN O
; : O
ATP NNP O
alpha NN O
: : O
Na NN O
+ CC O
pump NN O
alpha NN O
subunit NN O
; : O
Mlp84B NN O
: : O
Muscle NN O
LIM NN O
protein NN O
at IN O
84B CD O
; : O
DLG NNP O
: : O
Disc NN O
Large JJ O
; : O
HRP NN O
: : O
horseradish JJ B-Species
peroxidas NN O
; : O
UM NN O
: : O
unmated JJ O
; : O
M NNP O
: : O
mated VBN O
. . O

Authors NNS O
' POS O
contributions NNS O

AK NNP O
and CC O
PKR NNP O
contributed VBD O
equally RB O
to IN O
this DT O
manuscript NN O
. . O

AK NNP O
, , O
PKR NNP O
and CC O
YH NNP O
conceived VBD O
and CC O
designed VBD O
the DT O
project NN O
and CC O
analyzed VBD O
the DT O
data NNS O
. . O

AK NNP O
performed VBD O
the DT O
confocal JJ O
, , O
Western JJ O
blots NNS O
and CC O
fertility NN O
assays NNS O
. . O

PKR NNP O
and CC O
AK NNP O
performed VBD O
the DT O
light JJ O
microscopy NN O
. . O

PKR NNP O
conducted VBD O
the DT O
electron NN O
microscopy NN O
. . O

AK NNP O
, , O
PKR NNP O
and CC O
YH NNP O
wrote VBD O
the DT O
manuscript NN O
. . O

RRH NNP O
contributed VBD O
to IN O
design NN O
of IN O
the DT O
study NN O
and CC O
revision NN O
of IN O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
participated VBD O
in IN O
the DT O
discussion NN O
and CC O
approval NN O
of IN O
the DT O
final JJ O
manuscript NN O
. . O

Supplementary JJ O
Material NN O

Efficacy NN O
of IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
( , O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
) -RRB- O
for IN O
the DT O
treatment NN O
of IN O
osteoarthritis NN O
affecting VBG O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O
of IN O
the DT O
foot NN O
( , O
hallux NN O
limitus NN O
) -RRB- O
: : O
study NN O
protocol NN O
for IN O
a DT O
randomised VBN O
placebo NN O
controlled VBN O
trial NN O

Abstract JJ O

Background NN O

Osteoarthritis NN O
of IN O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O
( : O
MPJ NNP O
) -RRB- O
of IN O
the DT O
foot NN O
, , O
termed VBN O
hallux NN O
limitus NN O
, , O
is VBZ O
common JJ O
and CC O
painful JJ O
. . O

Numerous JJ O
non JJ O
- HYPH O
surgical JJ O
interventions NNS O
have VBP O
been VBN O
proposed VBN O
for IN O
this DT O
disorder NN O
, , O
however RB O
there EX O
is VBZ O
limited JJ O
evidence NN O
for IN O
their PRP$ O
efficacy NN O
. . O

Intra NN O
- HYPH O
articular JJ O
injections NNS O
of IN O
hyaluronan NN O
have VBP O
shown VBN O
beneficial JJ O
effects NNS O
in IN O
case NN O
- HYPH O
series NN O
and CC O
clinical JJ O
trials NNS O
for IN O
the DT O
treatment NN O
of IN O
osteoarthritis NN O
of IN O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O
. . O

However RB O
, , O
no DT O
study NN O
has VBZ O
evaluated VBN O
the DT O
efficacy NN O
of IN O
this DT O
form NN O
of IN O
treatment NN O
using VBG O
a DT O
randomised VBN O
placebo NN O
controlled VBN O
trial NN O
. . O

This DT O
article NN O
describes VBZ O
the DT O
design NN O
of IN O
a DT O
randomised VBN O
placebo NN O
controlled VBN O
trial NN O
to TO O
evaluate VB O
the DT O
efficacy NN O
of IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
( , O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
) -RRB- O
to TO O
reduce VB O
pain NN O
and CC O
improve VB O
function NN O
in IN O
people NNS B-Species
with IN O
hallux NN O
limitus NN O
. . O

Methods NNS O

One CD O
hundred CD O
and CC O
fifty CD O
community NN O
- HYPH O
dwelling VBG O
men NNS B-Species
and CC O
women NNS B-Species
aged JJ O
18 CD O
years NNS O
and CC O
over RB O
with IN O
hallux NN O
limitus NN O
( , O
who WP O
satisfy VBP O
inclusion NN O
and CC O
exclusion NN O
criteria NNS O
) -RRB- O
will MD O
be VB O
recruited VBN O
. . O

Participants NNS B-Species
will MD O
be VB O
randomised VBN O
, , O
using VBG O
a DT O
computer NN O
- HYPH O
generated VBN O
random JJ O
number NN O
sequence NN O
, , O
to TO O
receive VB O
a DT O
single JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
of IN O
up IN O
to IN O
1 CD O
ml NN O
hyaluronan NN O
( HYPH O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
) -RRB- O
or CC O
sterile JJ O
saline NN O
( , O
placebo NN O
) -RRB- O
into IN O
the DT O
first JJ O
MPJ NNP O
. . O

The DT O
injections NNS O
will MD O
be VB O
performed VBN O
by IN O
an DT O
interventional JJ O
radiologist NN O
using VBG O
fluoroscopy NN O
to TO O
ensure VB O
accurate JJ O
deposition NN O
of IN O
the DT O
hyaluronan NN O
in IN O
the DT O
joint NN O
. . O

Participants NNS B-Species
will MD O
be VB O
given VBN O
the DT O
option NN O
of IN O
a DT O
second JJ O
and CC O
final JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
( , O
of IN O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
or CC O
sterile JJ O
saline NN O
according VBG O
to IN O
the DT O
treatment NN O
group NN O
they PRP O
are VBP O
in IN O
) : O
either CC O
1 CD O
or CC O
3 CD O
months NNS O
post JJ O
- HYPH O
treatment NN O
if IN O
there EX O
is VBZ O
no DT O
improvement NN O
in IN O
pain NN O
and CC O
the DT O
participant NN B-Species
has VBZ O
not RB O
experienced VBN O
severe JJ O
adverse JJ O
effects NNS O
after IN O
the DT O
first JJ O
injection NN O
. . O

The DT O
primary JJ O
outcome NN O
measures NNS O
will MD O
be VB O
the DT O
pain NN O
and CC O
function NN O
subscales NNS O
of IN O
the DT O
Foot NNP O
Health NNP O
Status NNP O
Questionnaire NNP O
. . O

The DT O
secondary JJ O
outcome NN O
measures NNS O
will MD O
be VB O
pain NN O
at IN O
the DT O
first JJ O
MPJ NNP O
( , O
during IN O
walking NN O
and CC O
at IN O
rest NN O
) -RRB- O
, , O
stiffness NN O
at IN O
the DT O
first JJ O
MPJ NNP O
, , O
passive JJ O
non JJ O
- HYPH O
weightbearing VBG O
dorsiflexion NN O
of IN O
the DT O
first JJ O
MPJ NNP O
, , O
plantar JJ O
flexion NN O
strength NN O
of IN O
the DT O
toe NN O
- HYPH O
flexors NNS O
of IN O
the DT O
hallux NN O
, , O
global JJ O
satisfaction NN O
with IN O
the DT O
treatment NN O
, , O
health NN O
- HYPH O
related VBN O
quality NN O
of IN O
life NN O
( , O
assessed VBN O
using VBG O
the DT O
Short NNP O
- HYPH O
Form NN O
- HYPH O
36 CD O
version NN O
two CD O
questionnaire NN O
) -RRB- O
, , O
magnitude NN O
of IN O
symptom NN O
change NN O
, , O
use NN O
of IN O
pain NN O
- HYPH O
relieving VBG O
medication NN O
and CC O
changes NNS O
in IN O
dynamic JJ O
plantar JJ O
pressure NN O
distribution NN O
( , O
maximum JJ O
force NN O
and CC O
peak NN O
pressure NN O
) -RRB- O
during IN O
walking NN O
. . O

Data NNS O
will MD O
be VB O
collected VBN O
at IN O
baseline NN O
, , O
then RB O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
post NN O
- HYPH O
treatment NN O
. . O

Data NNS O
will MD O
be VB O
analysed VBN O
using VBG O
the DT O
intention NN O
to TO O
treat VB O
principle NN O
. . O

Discussion NN O

This DT O
study NN O
is VBZ O
the DT O
first JJ O
randomised VBN O
placebo NN O
controlled VBN O
trial NN O
to TO O
evaluate VB O
the DT O
efficacy NN O
of IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
( , O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
) , O
for IN O
the DT O
treatment NN O
of IN O
osteoarthritis NN O
of IN O
the DT O
first JJ O
MPJ NNP O
( , O
hallux NN O
limitus NN O
) -RRB- O
. . O

The DT O
study NN O
has VBZ O
been VBN O
pragmatically RB O
designed VBN O
to TO O
ensure VB O
that IN O
the DT O
study NN O
findings NNS O
can MD O
be VB O
implemented VBN O
into IN O
clinical JJ O
practice NN O
if IN O
this DT O
form NN O
of IN O
treatment NN O
is VBZ O
found VBN O
to TO O
be VB O
an DT O
effective JJ O
treatment NN O
strategy NN O
. . O

Trial NN O
registration NN O

Australian JJ O
New NNP O
Zealand NNP O
Clinical NNP O
Trials NNS O
Registry NN O
: : O
ACTRN12607000654459 ADD O

Background NN O

Osteoarthritis NN O
( , O
OA NNP O
) -RRB- O
is VBZ O
a DT O
degenerative JJ O
joint NN O
disease NN O
that WDT O
commonly RB O
presents VBZ O
within IN O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O
( : O
MPJ NNP O
) -RRB- O
of IN O
the DT O
foot NN O
. . O

The DT O
terms NNS O
hallux NN O
limitus NN O
and CC O
hallux NN O
rigidus NN O
have VBP O
frequently RB O
been VBN O
used VBN O
interchangeably RB O
to TO O
describe VB O
differing VBG O
severities NNS O
of IN O
pain NN O
and CC O
limitation NN O
of IN O
motion NN O
associated VBN O
with IN O
OA NNP O
at IN O
the DT O
first JJ O
MPJ NNP O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Hallux NNP O
limitus NN O
is VBZ O
a DT O
progressive JJ O
osteoarthritic JJ O
condition NN O
of IN O
the DT O
first JJ O
MPJ NNP O
that WDT O
may MD O
advance VB O
to IN O
an DT O
end NN O
- HYPH O
stage NN O
presentation NN O
of IN O
hallux NN O
rigidus NN O
where WRB O
the DT O
joint NN O
fuses VBZ O
and CC O
there EX O
is VBZ O
a DT O
complete JJ O
restriction NN O
of IN O
motion NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

First JJ O
MPJ NNP O
OA NNP O
is VBZ O
the DT O
second JJ O
most RBS O
common JJ O
disorder NN O
affecting VBG O
the DT O
foot NN O
after IN O
hallux NN O
valgus NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
prevalence NN O
of IN O
the DT O
condition NN O
increases VBZ O
with IN O
age NN O
, , O
and CC O
it PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
radiographic JJ O
changes NNS O
in IN O
the DT O
first JJ O
MPJ NNP O
affect NN O
are VBP O
evident JJ O
in IN O
approximately RB O
46 CD O
% NN O
of IN O
women NNS B-Species
and CC O
32 CD O
% NN O
of IN O
men NNS B-Species
at IN O
60 CD O
years NNS O
of IN O
age NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Osteoarthritis NN O
at IN O
the DT O
first JJ O
MPJ NNP O
is VBZ O
characterised VBN O
by IN O
the DT O
symptoms NNS O
of IN O
pain NN O
and CC O
stiffness NN O
at IN O
the DT O
joint NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Secondary JJ O
painful JJ O
symptoms NNS O
relate VBP O
to IN O
compensations NNS O
during IN O
gait NN O
that WDT O
may MD O
occur VB O
due IN O
to IN O
the DT O
reduced VBN O
motion NN O
of IN O
the DT O
first JJ O
MPJ NNP O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
presence NN O
of IN O
pain NN O
associated VBN O
with IN O
first JJ O
MPJ NNP O
OA NNP O
impacts NNS O
on IN O
normal JJ O
walking NN O
and CC O
quality NN O
of IN O
life NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Treatment NN O
of IN O
hallux NN O
limitus NN O
involves VBZ O
conservative JJ O
measures NNS O
( , O
such JJ O
as IN O
physical JJ O
therapy NN O
, , O
foot NN O
orthoses NNS O
, , O
footwear NN O
modification NN O
, , O
joint JJ O
manipulation NN O
and CC O
injection NN O
with IN O
corticosteroid NN O
) , O
[ -LRB- O
5 CD O
] -RRB- O
, , O
or CC O
surgical JJ O
intervention NN O
( , O
either CC O
joint JJ O
- HYPH O
salvage NN O
or CC O
joint JJ O
- HYPH O
destructive JJ O
procedures NNS O
) -RRB- O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Pharmacological JJ O
treatment NN O
is VBZ O
also RB O
often RB O
undertaken VBN O
as IN O
an DT O
adjunct NN O
for IN O
pain NN O
relief NN O
in IN O
the DT O
management NN O
of IN O
hallux NN O
limitus NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

However RB O
, , O
although IN O
non JJ O
- HYPH O
steroidal JJ O
anti JJ O
- HYPH O
inflammatory JJ O
drugs NNS O
( -LRB- O
NSAIDs NNP O
) -RRB- O
and CC O
cyclooxygenase NN O
- HYPH O
2 CD O
inhibitors NNS O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
effective JJ O
in IN O
the DT O
management NN O
of IN O
various JJ O
forms NNS O
of IN O
OA NNP O
, , O
gastrointestinal JJ O
complications NNS O
remain VBP O
a DT O
concern NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
light NN O
of IN O
these DT O
limitations NNS O
with IN O
existing JJ O
treatments NNS O
, , O
an DT O
alternative JJ O
treatment NN O
termed VBN O
' `` O
viscosupplementation NN O
' '' O
- : O
the DT O
intra JJ O
- HYPH O
articular JJ O
injection NN O
of IN O
hyaluronan NN O
into IN O
arthritic JJ O
joints NNS O
with IN O
the DT O
aim NN O
of IN O
restoring VBG O
the DT O
viscoelasticity NN O
of IN O
the DT O
synovial JJ O
fluid NN O
[ -LRB- O
8 CD O
] -RRB- O
- , O
has VBZ O
been VBN O
proposed VBN O
and CC O
has VBZ O
attracted VBN O
considerable JJ O
attention NN O
in IN O
the DT O
medical JJ O
literature NN O
as IN O
a DT O
treatment NN O
for IN O
OA NNP O
[ -LRB- O
9 CD O
] -RRB- O
. . O

In IN O
particular JJ O
, , O
both CC O
the DT O
American NNP O
College NNP O
of IN O
Rheumatology NNP O
( , O
ACR NNP O
) -RRB- O
and CC O
European NNP O
League NNP O
Against IN O
Rheumatism NNP O
( , O
EULAR NNP O
) -RRB- O
recommend VBP O
hyaluronan NN O
in IN O
the DT O
management NN O
of IN O
OA NN O
of IN O
the DT O
knee NN O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Although IN O
the DT O
results NNS O
of IN O
systematic JJ O
reviews NNS O
investigating VBG O
the DT O
effectiveness NN O
of IN O
this DT O
type NN O
of IN O
treatment NN O
for IN O
knee NN O
OA NN O
are VBP O
controversial JJ O
, , O
the DT O
most RBS O
recent JJ O
update NN O
of IN O
the DT O
Cochrane NNP O
systematic JJ O
review NN O
evaluating VBG O
viscosupplementation NN O
for IN O
the DT O
treatment NN O
of IN O
knee NN O
OA NNP O
concluded VBD O
that IN O
viscosupplementation NN O
was VBD O
both CC O
safe JJ O
and CC O
effective JJ O
for IN O
the DT O
treatment NN O
of IN O
OA NN O
and CC O
was VBD O
superior JJ O
or CC O
equivalent JJ O
to IN O
any DT O
form NN O
of IN O
systemic JJ O
intervention NN O
or CC O
intra JJ O
- HYPH O
articular JJ O
corticosteroids NNS O
[ -LRB- O
9 CD O
, , O
12 CD O
] -RRB- O
. . O

Despite IN O
there EX O
being VBG O
a DT O
large JJ O
number NN O
of IN O
studies NNS O
investigating VBG O
the DT O
effectiveness NN O
of IN O
hyaluronan NN O
for IN O
knee NN O
OA NNP O
, , O
few JJ O
studies NNS O
have VBP O
investigated VBN O
the DT O
effects NNS O
of IN O
this DT O
form NN O
of IN O
treatment NN O
for IN O
OA NNP O
at IN O
the DT O
first JJ O
MPJ NNP O
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
a DT O
case NN O
- HYPH O
series NN O
retrospective JJ O
study NN O
, , O
14 CD O
patients NNS B-Species
with IN O
radiographically RB O
confirmed VBN O
OA NNP O
at IN O
the DT O
first JJ O
MPJ NNP O
that WDT O
received VBD O
up IN O
to TO O
3 CD O
intra NN O
- HYPH O
articular JJ O
injections NNS O
of IN O
1 CD O
ml CD O
hyaluronan NN O
( -LRB- O
Ostenil NNP O
( -LRB- O
R NNP O
) -RRB- O
Mini NNP O
) -RRB- O
( , O
sodium NN O
hyaluronate NN O
) -RRB- O
reported VBD O
a DT O
statistically RB O
significant JJ O
reduction NN O
in IN O
pain NN O
( , O
reported VBN O
using VBG O
a DT O
visual JJ O
analogue NN O
scale NN O
) -RRB- O
after IN O
6 CD O
months NNS O
[ -LRB- O
14 CD O
] -RRB- O
. . O

The DT O
treatment NN O
was VBD O
well RB O
tolerated VBN O
, , O
with IN O
3 CD O
/ SYM O
14 CD O
( SYM O
21 CD O
% NN O
) SYM O
participants NNS B-Species
reporting VBG O
mild JJ O
adverse JJ O
reactions NNS O
at IN O
the DT O
injection NN O
site NN O
. . O

In IN O
another DT O
study NN O
, , O
Pons NNP O
et FW O
al NNP O
[ -LRB- O
13 CD O
] -RRB- O
compared VBD O
a DT O
single JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
of IN O
1 CD O
ml NNP O
Ostenil NNP O
( -LRB- O
R NNP O
) , O
Mini NNP O
( , O
sodium NN O
hyaluronate NN O
) , O
with IN O
1 CD O
ml CD O
Trigon NNP O
depot NN O
( , O
R NNP O
) -RRB- O
( , O
triamcinolone NN O
acetonide NN O
, , O
a DT O
corticosteroid NN O
) -RRB- O
for IN O
the DT O
treatment NN O
of IN O
painful JJ O
, , O
grade NN O
1 CD O
hallux NN O
limitus NN O
( , O
Karasick NNP O
and CC O
Wapner NNP O
[ -LRB- O
15 CD O
] -RRB- O
scale NN O
) -RRB- O
in IN O
37 CD O
participants NNS B-Species
( , O
40 CD O
feet NNS O
) -RRB- O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Both DT O
treatment NN O
groups NNS O
showed VBD O
statistically RB O
significant JJ O
reductions NNS O
in IN O
pain NN O
at IN O
rest NN O
or CC O
on IN O
palpation NN O
for IN O
up IN O
to TO O
12 CD O
weeks NNS O
post NN O
- HYPH O
injection NN O
. . O

However RB O
, , O
hyaluronan JJ O
treatment NN O
resulted VBD O
in IN O
a DT O
statistically RB O
significant JJ O
greater JJR O
reduction NN O
in IN O
pain NN O
during IN O
walking NN O
and CC O
greater JJR O
improvement NN O
in IN O
the DT O
American NNP O
Orthopaedic NNP O
Foot NNP O
and CC O
Ankle NNP O
Society NNP O
( -LRB- O
AOFAS NNP O
) -RRB- O
hallux NN O
MPJ NNP O
score NN O
compared VBN O
to IN O
treatment NN O
with IN O
triamcinolone NN O
acetonide NN O
. . O

The DT O
treatment NN O
with IN O
hyaluronan NN O
was VBD O
well RB O
tolerated VBN O
, , O
with IN O
2 CD O
/ SYM O
20 CD O
( SYM O
10 CD O
% NN O
) SYM O
participants NNS B-Species
reporting VBG O
mild JJ O
adverse JJ O
reactions NNS O
at IN O
the DT O
injection NN O
site NN O
. . O

Although IN O
both DT O
of IN O
these DT O
studies NNS O
suggest VBP O
that IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
is VBZ O
safe JJ O
and CC O
effective JJ O
for IN O
the DT O
treatment NN O
of IN O
hallux NN O
limitus NN O
, , O
neither CC O
used VBD O
a DT O
placebo NN O
control NN O
group NN O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

This DT O
limitation NN O
is VBZ O
significant JJ O
as IN O
a DT O
placebo NN O
effect NN O
can MD O
account VB O
for IN O
79 CD O
% NN O
of IN O
the DT O
efficacy NN O
of IN O
intra JJ O
- HYPH O
articular JJ O
hyaluronan NN O
treatment NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Further RB O
, , O
both DT O
studies NNS O
are VBP O
limited VBN O
in IN O
that IN O
neither DT O
of IN O
the DT O
studies NNS O
used VBD O
blinding NN O
of IN O
both CC O
the DT O
participants NNS B-Species
and CC O
assessors NNS O
in IN O
their PRP$ O
protocols NNS O
. . O

It PRP O
is VBZ O
therefore RB O
possible JJ O
that IN O
the DT O
positive JJ O
effects NNS O
of IN O
hyaluronan NN O
may MD O
have VB O
been VBN O
overestimated VBN O
. . O

Accordingly RB O
, , O
the DT O
aims NNS O
of IN O
this DT O
project NN O
are VBP O
to TO O
conduct VB O
a DT O
double JJ O
blind JJ O
randomised VBN O
controlled VBN O
trial NN O
to TO O
determine VB O
the DT O
effectiveness NN O
of IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
( -LRB- O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
) -RRB- O
on IN O
( , O
i IN O
) SYM O
foot NN O
pain NN O
and CC O
function NN O
; : O
( , O
ii FW O
) -RRB- O
the DT O
range NN O
of IN O
motion NN O
of IN O
the DT O
first JJ O
MPJ NNP O
; : O
( , O
iii FW O
) LS O
the DT O
strength NN O
of IN O
the DT O
plantarflexor NN O
muscles NNS O
of IN O
the DT O
first JJ O
MPJ NNP O
; : O
( , O
iv IN O
) NFP O
the DT O
health NN O
related VBN O
quality NN O
of IN O
life NN O
; : O
and CC O
( , O
v IN O
) NFP O
the DT O
use NN O
of IN O
pain NN O
- HYPH O
relieving VBG O
medications NNS O
in IN O
people NNS B-Species
with IN O
hallux NN O
limitus NN O
. . O

The DT O
study NN O
protocol NN O
is VBZ O
presented VBN O
in IN O
this DT O
paper NN O
, , O
consistent JJ O
with IN O
the DT O
recommendations NNS O
of IN O
Editorial NNP O
Board NNP O
of IN O
BioMed NNP O
Central NNP O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Methods NNS O

Design NN O

This DT O
study NN O
is VBZ O
a DT O
parallel JJ O
group NN O
, , O
participant NN B-Species
and CC O
assessor NN O
blinded VBN O
, , O
randomised VBN O
controlled VBN O
trial NN O
with IN O
a DT O
6 CD O
month NN O
follow NN O
- HYPH O
up NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
developed VBN O
using VBG O
the DT O
principles NNS O
described VBN O
by IN O
Osteoarthritis NNP O
Research NNP O
Society NNP O
International NNP O
( : O
OARSI NNP O
) -RRB- O
Clinical NNP O
Trials NNPS O
Task NNP O
Force NNP O
guidelines NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Participants NNS B-Species
will MD O
be VB O
randomised VBN O
to TO O
receive VB O
a DT O
single JJ O
intra JJ O
- HYPH O
articular JJ O
injection NN O
of IN O
up IN O
to IN O
1 CD O
ml NN O
hyaluronan NN O
( HYPH O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
) NFP O
or CC O
sterile JJ O
saline NN O
( , O
placebo NN O
) -RRB- O
into IN O
the DT O
first JJ O
MPJ NNP O
. . O

Allocation NN O
to IN O
either CC O
the DT O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
or CC O
placebo NN O
groups NNS O
will MD O
be VB O
achieved VBN O
using VBG O
a DT O
computer NN O
- HYPH O
generated VBN O
random JJ O
number NN O
sequence NN O
. . O

The DT O
allocation NN O
sequence NN O
will MD O
be VB O
generated VBN O
and CC O
held VBN O
by IN O
an DT O
external JJ O
person NN B-Species
not RB O
directly RB O
involved VBN O
in IN O
the DT O
trial NN O
. . O

Concealment NN O
of IN O
the DT O
allocation NN O
sequence NN O
will MD O
be VB O
ensured VBN O
as IN O
each DT O
participant NN B-Species
' POS O
s NNS O
allocation NN O
will MD O
be VB O
contained VBN O
in IN O
a DT O
sealed VBN O
opaque JJ O
envelope NN O
. . O

Envelopes NNS O
will MD O
be VB O
made VBN O
opaque JJ O
by IN O
using VBG O
a DT O
sheet NN O
of IN O
aluminium NN O
foil NN O
inside IN O
the DT O
envelope NN O
. . O

In IN O
addition NN O
, , O
a DT O
system NN O
using VBG O
carbon NN O
paper NN O
will MD O
be VB O
employed VBN O
so IN O
the DT O
details NNS O
( , O
name NN O
and CC O
date NN O
of IN O
recruitment NN O
) -RRB- O
are VBP O
transferred VBN O
from IN O
the DT O
outside NN O
of IN O
the DT O
envelope NN O
to IN O
the DT O
paper NN O
inside IN O
the DT O
envelope NN O
containing VBG O
the DT O
allocation NN O
prior RB O
to IN O
opening VBG O
the DT O
seal NN O
. . O

Assessors NNS O
and CC O
participants NNS B-Species
will MD O
be VB O
blinded VBN O
to IN O
group NN O
allocation NN O
. . O

Participants NNS B-Species
will MD O
be VB O
given VBN O
the DT O
option NN O
of IN O
a DT O
second JJ O
and CC O
final JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
( , O
of IN O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
or CC O
sterile JJ O
saline NN O
according VBG O
to IN O
the DT O
treatment NN O
group NN O
they PRP O
are VBP O
in IN O
) , O
on IN O
days NNS O
30 CD O
or CC O
90 CD O
if IN O
there EX O
is VBZ O
no DT O
improvement NN O
in IN O
pain NN O
and CC O
the DT O
participant NN B-Species
has VBZ O
not RB O
experienced VBN O
severe JJ O
adverse JJ O
effects NNS O
after IN O
the DT O
first JJ O
injection NN O
) -RRB- O
. . O

Participants NNS B-Species

The DT O
Human NNP O
Studies NNPS O
Ethics NNP O
Committee NNP O
at IN O
La NNP O
Trobe NNP O
University NNP O
( , O
Human NNP O
Ethics NNP O
Committee NNP O
Application NNP O
No NNP O
. . O
7 CD O
- HYPH O
45 CD O
) -RRB- O
and CC O
the DT O
Radiation NNP O
Advisory NNP O
Committee NNP O
of IN O
the DT O
Victorian NNP O
Department NNP O
of IN O
Human NNP O
Services NNPS O
have VBP O
given VBN O
approval NN O
for IN O
the DT O
study NN O
. . O

Written VBN O
informed JJ O
consent NN O
will MD O
be VB O
obtained VBN O
from IN O
all DT O
participants NNS B-Species
prior RB O
to IN O
their PRP$ O
participation NN O
. . O

People NNS B-Species
with IN O
hallux NN O
limitus NN O
will MD O
be VB O
recruited VBN O
from IN O
a DT O
number NN O
of IN O
sources NNS O
: : O

( : O
i PRP O
) -RRB- O
advertisements NNS O
in IN O
relevant JJ O
Melbourne NNP O
( , O
Australia NNP O
) -RRB- O
newspapers NNS O
; : O

( : O
ii `` O
) NFP O
mail NN O
- HYPH O
out NN O
advertisements NNS O
to IN O
health NN O
- HYPH O
care NN O
practitioners NNS O
in IN O
Melbourne NNP O
; : O

( -LRB- O
iii NNP O
) -RRB- O
advertisements NNS O
using VBG O
relevant JJ O
internet NN O
web NN O
- HYPH O
sites NNS O
( , O
including VBG O
) -RRB- O
; : O

( : O
iv `` O
) NFP O
posters NNS O
displayed VBN O
in IN O
local JJ O
retirement NN O
villages NNS O
, , O
community NN O
centres NNS O
and CC O
universities NNS O
located VBN O
in IN O
Melbourne NNP O
. . O

Respondents NNS O
will MD O
initially RB O
be VB O
screened VBN O
by IN O
telephone NN O
interview NN O
to TO O
ensure VB O
they PRP O
are VBP O
suitable JJ O
for IN O
the DT O
study NN O
. . O

Suitable JJ O
individuals NNS O
will MD O
then RB O
be VB O
invited VBN O
to TO O
participate VB O
in IN O
the DT O
study NN O
and CC O
attend VB O
an DT O
initial JJ O
assessment NN O
. . O

To TO O
be VB O
included VBN O
in IN O
the DT O
study NN O
, , O
participants NNS B-Species
must MD O
meet VB O
the DT O
following VBG O
inclusion NN O
criteria NNS O
: : O

( : O
i PRP O
) -RRB- O
be VBP O
aged VBN O
at RB O
least RBS O
18 CD O
years NNS O
; : O

( : O
ii PRP O
) -RRB- O
report VB O
having VBG O
symptoms NNS O
of IN O
pain NN O
, , O
during IN O
walking NN O
or CC O
rest NN O
, , O
in IN O
the DT O
first JJ O
MPJ NNP O
for IN O
at RB O
least RBS O
3 CD O
months NNS O
; : O

( : O
iii NNP O
) -RRB- O
report VBP O
having VBG O
pain NN O
rated VBN O
at RB O
least RBS O
20 CD O
mm NN O
on IN O
a DT O
100 CD O
mm NN O
visual JJ O
analogue NN O
pain NN O
scale NN O
( : O
VAPS NNP O
) -RRB- O
; : O

( : O
iv PRP O
) -RRB- O
have VBP O
pain NN O
upon IN O
palpation NN O
of IN O
the DT O
dorsal JJ O
aspect NN O
of IN O
the DT O
first JJ O
MPJ NNP O
; : O

( : O
v XX O
) NFP O
radiographic JJ O
evidence NN O
of IN O
OA NNP O
( HYPH O
score NN O
1 CD O
or CC O
2 CD O
for IN O
either CC O
osteophytes NNS O
or CC O
joint JJ O
space NN O
narrowing VBG O
using VBG O
a DT O
previously RB O
published VBN O
radiographic JJ O
classification NN O
) -RRB- O
[ -LRB- O
19 CD O
] -RRB- O
at IN O
the DT O
first JJ O
MPJ NNP O
. . O

( NFP O
vi FW O
) -RRB- O
able JJ O
to TO O
walk VB O
household NN O
distances NNS O
( : O
> SYM O
50 CD O
meters NNS O
) -RRB- O
without IN O
the DT O
aid NN O
of IN O
a DT O
walker NN O
, , O
crutches NNS O
or CC O
cane NN O
; . O

( -LRB- O
vii NN O
) -RRB- O
be VB O
willing JJ O
to TO O
attend VB O
the DT O
La NNP O
Trobe NNP O
University NNP O
Medical NNP O
Centre NNP O
( , O
Melbourne NNP O
, , O
Australia NNP O
) , O
for IN O
treatment NN O
with IN O
either CC O
Synvisc NNP O
( , O
R NN O
) -RRB- O
or CC O
placebo NN O
( , O
single JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
) -RRB- O
and CC O
attend VB O
the DT O
Health NNP O
Sciences NNPS O
Clinic NNP O
at IN O
La NNP O
Trobe NNP O
University NNP O
( : O
Melbourne NNP O
, , O
Australia NNP O
) -RRB- O
for IN O
the DT O
initial JJ O
assessment NN O
and CC O
the DT O
outcome NN O
measurements NNS O
( , O
at IN O
baseline NN O
and CC O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
post NN O
- HYPH O
treatment NN O
) -RRB- O
; . O

( -LRB- O
viii NNP O
) , O
not RB O
receive VB O
other JJ O
intra JJ O
- HYPH O
articular JJ O
injections NNS O
into IN O
the DT O
first JJ O
MPJ NNP O
during IN O
the DT O
course NN O
of IN O
the DT O
study NN O
, , O
apart RB O
from IN O
those DT O
dictated VBN O
by IN O
the DT O
study NN O
; . O

( : O
ix IN O
) , O
be VB O
willing JJ O
to TO O
discontinue VB O
taking VBG O
all DT O
pain NN O
- HYPH O
relieving VBG O
medications NNS O
( , O
analgesics NNS O
and CC O
non JJ O
- HYPH O
steroidal JJ O
anti JJ O
- HYPH O
inflammatory JJ O
medications NNS O
( , O
NSAIDs NNP O
) -RRB- O
, , O
except IN O
paracetamol NN O
up IN O
to TO O
4 CD O
g CD O
/ SYM O
day NN O
, , O
taken VBN O
by IN O
mouth NN O
or CC O
applied VBN O
topically RB O
) : O
: : O

- : O
for IN O
at IN O
least JJS O
14 CD O
days NNS O
prior RB O
to IN O
the DT O
baseline NN O
assessment NN O
; . O

- : O
during IN O
the DT O
study NN O
period NN O
( , O
6 CD O
months NNS O
after IN O
the DT O
final JJ O
treatment NN O
with IN O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
) -RRB- O
. . O

Participants NNS B-Species
who WP O
do VBP O
take VB O
paracetamol NN O
need VBP O
to TO O
discontinue VB O
its PRP$ O
use NN O
at IN O
least JJS O
24 CD O
hours NNS O
prior RB O
to IN O
the DT O
baseline NN O
assessment NN O
and CC O
follow VB O
- HYPH O
up NN O
assessments NNS O
at IN O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
after IN O
the DT O
treatment NN O
; : O

( : O
x LS O
) -RRB- O
be VB O
willing JJ O
to TO O
not RB O
receive VB O
any DT O
physical JJ O
therapy NN O
on IN O
the DT O
involved JJ O
MPJ NNP O
or CC O
trial NN O
of IN O
shoe NN O
modifications NNS O
or CC O
foot NN O
orthoses NNS O
during IN O
the DT O
study NN O
period NN O
. . O

Exclusion NN O
criteria NNS O
for IN O
participants NNS B-Species
in IN O
this DT O
study NN O
will MD O
be VB O
: : O

( : O
i PRP O
) NFP O
Severe JJ O
radiographic JJ O
evidence NN O
of IN O
OA NNP O
( HYPH O
score NN O
3 CD O
for IN O
either CC O
osteophytes NNS O
or CC O
joint JJ O
space NN O
narrowing NN O
) -RRB- O
at IN O
the DT O
first JJ O
MPJ NNP O
using VBG O
a DT O
previously RB O
published VBN O
radiographic JJ O
classification NN O
[ -LRB- O
19 CD O
] -RRB- O
; : O

( : O
ii PRP O
) NFP O
previous JJ O
surgery NN O
on IN O
the DT O
first JJ O
MPJ NNP O
; : O

( : O
iii NNP O
) NFP O
intra JJ O
- HYPH O
articular JJ O
steroid NN O
, , O
or CC O
any DT O
other JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
at IN O
the DT O
first JJ O
MPJ NNP O
in IN O
the DT O
previous JJ O
6 CD O
months NNS O
; : O

( : O
iv `` O
) NFP O
treatment NN O
with IN O
systemic JJ O
steroid NN O
( , O
excluding VBG O
inhalation NN O
or CC O
topical JJ O
steroids NNS O
) -RRB- O
, , O
immunosuppressives NNS O
or CC O
anticoagulants NNS O
( , O
except IN O
for IN O
acetylsalicylic JJ O
acid NN O
at IN O
dosages NNS O
of IN O
up IN O
to TO O
325 CD O
mg NNS O
/ SYM O
day NN O
) -RRB- O
; : O

( : O
v NN O
) NFP O
presence NN O
of IN O
joint JJ O
infection NN O
( , O
s NNS O
) -RRB- O
of IN O
the DT O
foot NN O
; . O

( NFP O
vi FW O
) -RRB- O
significant JJ O
deformity NN O
of IN O
the DT O
first JJ O
MPJ NNP O
including VBG O
hallux NN O
abducto NN O
valgus NN O
( , O
grade NN O
of IN O
3 CD O
or CC O
4 CD O
scored VBD O
using VBG O
the DT O
Manchester NNP O
Scale NNP O
[ -LRB- O
20 CD O
] -RRB- O
; : O

( : O
vii NN O
) , O
presence NN O
of IN O
peripheral JJ O
vascular JJ O
disease NN O
. . O

Peripheral JJ O
vascular JJ O
disease NN O
will MD O
be VB O
considered VBN O
to TO O
be VB O
present JJ O
if IN O
any DT O
of IN O
the DT O
following VBG O
are VBP O
present JJ O
[ -LRB- O
21 CD O
] -RRB- O
; : O

* NFP O
past JJ O
history NN O
of IN O
, , O
vascular JJ O
surgery NN O
, , O
Raynaud NNP O
' POS O
s NN O
phenomenon NN O
, , O
vasculitis NN O
associated VBN O
with IN O
connective JJ O
tissue NN O
diseases NNS O
, , O
Buerger NNP O
' POS O
s NN O
disease NN O
, , O
arterial JJ O
emboli NN O
, , O
deep JJ O
vein NN O
thrombosis NN O
or CC O
lower JJR O
limb JJ O
ulcers NNS O
; . O

* NFP O
history NN O
of IN O
intermittent JJ O
claudication NN O
or CC O
rest NN O
pain NN O
; . O

* NFP O
presence NN O
of IN O
atrophy NN O
, , O
ulcers NNS O
or CC O
significant JJ O
oedema NN O
; . O

* NFP O
inability NN O
to TO O
palpate VB O
at RB O
least RBS O
one CD O
pedal NN O
pulse NN O
; . O

* NFP O
Ankle NNP O
Brachial NNP O
Pressure NNP O
Index NNP O
< NN O
0 CD O
. . O
9 CD O
; : O

( : O
viii NNP O
) , O
presence NN O
of IN O
one CD O
or CC O
more JJR O
conditions NNS O
that WDT O
can MD O
confound VB O
pain NN O
and CC O
functional JJ O
assessments NNS O
of IN O
the DT O
first JJ O
MPJ NNP O
, , O
such JJ O
as IN O
metatarsalgia NN O
, , O
plantar JJ O
fasciitis NN O
, , O
pre JJ O
- HYPH O
dislocation NN O
syndrome NN O
, , O
sprains NNS O
of IN O
the DT O
foot NN O
, , O
Achilles NNP O
tendinopathy NN O
, , O
degenerative JJ O
joint JJ O
disease NN O
of IN O
the DT O
foot NN O
( , O
other JJ O
than IN O
the DT O
first JJ O
MPJ NNP O
) -RRB- O
or CC O
painful JJ O
corns NNS O
and CC O
callus NN O
; . O

( : O
ix IN O
) , O
planning VBG O
to TO O
undergo VB O
any DT O
surgical JJ O
procedure NN O
or CC O
receive VB O
any DT O
injections NNS O
, , O
apart RB O
from IN O
those DT O
dictated VBN O
by IN O
the DT O
study NN O
, , O
at IN O
the DT O
involved JJ O
first JJ O
MPJ NNP O
during IN O
the DT O
study NN O
period NN O
; : O

( : O
x NN O
) , O
presence NN O
of IN O
systemic JJ O
inflammatory JJ O
condition NN O
or CC O
infection NN O
, , O
such JJ O
as IN O
inflammatory JJ O
arthritis NN O
, , O
diagnosed VBN O
with IN O
rheumatoid JJ O
arthritis NN O
, , O
ankylosing VBG O
spondylitis NN O
, , O
psoriatic JJ O
arthritis NN O
, , O
reactive JJ O
arthritis NN O
, , O
septic NN O
arthritis NN O
, , O
acute JJ O
pseudogout NN O
, , O
or CC O
any DT O
other JJ O
connective JJ O
tissue NN O
disease NN O
; . O

( : O
xi NN O
) , O
evidence NN O
of IN O
gout NN O
or CC O
other JJ O
musculoskeletal JJ O
disease NN O
other JJ O
than IN O
OA NNP O
within IN O
the DT O
feet NNS O
. . O

Gout NNP O
will MD O
be VB O
screened VBN O
for IN O
using VBG O
clinical JJ O
history NN O
and CC O
physical JJ O
assessment NN O
( , O
painful JJ O
joint NN O
, , O
abrupt JJ O
onset NN O
, , O
swelling NN O
) -RRB- O
, , O
radiographic JJ O
assessment NN O
( , O
asymmetrical JJ O
joint NN O
swelling NN O
, , O
subcortical JJ O
cysts NNS O
without IN O
erosion NN O
and CC O
tophi NN O
) , O
as RB O
well RB O
as IN O
serum NN O
uric NN O
acid NN O
levels NNS O
( , O
hyperuricaemia NN O
= : O
serum NN O
uric NN O
acid NN O
> : O
mean NN O
+ SYM O
2 CD O
SD NN O
from IN O
normal JJ O
population NN O
) -RRB- O
[ -LRB- O
22 CD O
] -RRB- O
; : O

( -LRB- O
xii NN O
) -RRB- O
active JJ O
skin NN O
disease NN O
or CC O
infection NN O
in IN O
the DT O
area NN O
of IN O
the DT O
injection NN O
site NN O
; . O

( : O
xiii NNP O
) -RRB- O
any DT O
medical JJ O
condition NN O
that WDT O
, , O
in IN O
the DT O
opinion NN O
of IN O
the DT O
investigators NNS O
, , O
makes VBZ O
the DT O
participant NN B-Species
unsuitable JJ O
for IN O
inclusion NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
severe JJ O
progressive JJ O
chronic JJ O
disease NN O
, , O
malignancy NN O
, , O
bleeding NN O
disorder NN O
, , O
clinically RB O
important JJ O
pain NN O
in IN O
a DT O
part NN O
of IN O
the DT O
musculoskeletal JJ O
system NN O
other JJ O
than IN O
the DT O
first JJ O
MPJ NNP O
, , O
or CC O
fibromyalgia NN O
) -RRB- O
; . O

( : O
xiv NN O
) , O
pregnant JJ O
or CC O
lactating VBG O
women NNS B-Species
, , O
or CC O
women NNS B-Species
who WP O
are VBP O
of IN O
child NN B-Species
bearing VBG O
age NN O
or CC O
have VBP O
not RB O
undergone VBN O
menopause NN O
( : O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
has VBZ O
not RB O
been VBN O
tested VBN O
in IN O
pregnant JJ O
women NNS B-Species
or CC O
women NNS B-Species
who WP O
are VBP O
nursing VBG O
) -RRB- O
; : O

( NFP O
xv LS O
) -RRB- O
cognitive JJ O
impairment NN O
( : O
defined VBN O
as IN O
a DT O
score NN O
of IN O
< NN O
7 CD O
on IN O
the DT O
Short NNP O
Portable NNP O
Mental NNP O
Status NNP O
Questionnaire NNP O
) -RRB- O
[ -LRB- O
23 CD O
] -RRB- O
; : O

( : O
xvi NN O
) -RRB- O
known VBN O
hypersensitivity NN O
( , O
allergy NN O
) -RRB- O
to IN O
hyaluronan JJ O
preparations NNS O
, , O
or CC O
to IN O
avian JJ O
proteins NNS O
, , O
feathers NNS O
or CC O
egg NN O
products NNS O
; . O

( NFP O
xvii FW O
) -RRB- O
involvement NN O
in IN O
any DT O
clinical JJ O
research NN O
study NN O
in IN O
the DT O
previous JJ O
3 CD O
months NNS O
that WDT O
could MD O
be VB O
considered VBN O
to TO O
affect VB O
the DT O
results NNS O
of IN O
this DT O
study NN O
. . O

Intra NN O
- HYPH O
articular JJ O
injections NNS O
for IN O
the DT O
treatment NN O
groups NNS O

Participants NNS B-Species
will MD O
be VB O
randomised VBN O
to TO O
receive VB O
a DT O
single JJ O
intra JJ O
- HYPH O
articular JJ O
injection NN O
of IN O
up IN O
to TO O
1 CD O
ml NNS O
of IN O
hyaluronan NN O
( , O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
; , O
Genzyme NNP O
Biosurgery NNP O
, , O
Genzyme NNP O
Corporation NNP O
, , O
NJ NNP O
, , O
USA NNP O
) -RRB- O
or CC O
sterile JJ O
saline NN O
( , O
placebo NN O
) -RRB- O
into IN O
the DT O
first JJ O
MPJ NNP O
. . O

Each DT O
2 CD O
ml CD O
ampoule NN O
of IN O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
contains VBZ O
16 CD O
mg NN O
of IN O
hylan NN O
G NNP O
- HYPH O
F NNP O
20 CD O
( HYPH O
cross NN O
- HYPH O
linked VBN O
hylan NN O
polymers NNS O
; : O
hylan NNP O
A NN O
and CC O
B NN O
) -RRB- O
, , O
17 CD O
mg NN O
sodium NN O
chloride NN O
, , O
0 CD O
. , O
32 CD O
mg NN O
disodium NN O
hydrogen NN O
phosphate NN O
, , O
0 CD O
. , O
8 CD O
mg NN O
sodium NN O
dihydrogen NN O
phosphate NN O
monohydrate NN O
. . O

The DT O
hyaluronan NN O
is VBZ O
extracted VBN O
from IN O
chicken NN B-Species
combs NNS O
and CC O
the DT O
purified JJ O
material NN O
has VBZ O
an DT O
average JJ O
molecular JJ O
weight NN O
of IN O
6 CD O
, , O
0 CD O
kDa NNS O
. . O

The DT O
injections NNS O
will MD O
be VB O
performed VBN O
by IN O
the DT O
same JJ O
experienced JJ O
interventional JJ O
radiologist NN O
( , O
AEZ NNP O
) -RRB- O
using VBG O
fluoroscopic JJ O
imaging NN O
to TO O
ensure VB O
accurate JJ O
deposition NN O
of IN O
the DT O
hyaluronan NN O
within IN O
the DT O
joint NN O
. . O

As IN O
the DT O
Synvisc NNP O
( -LRB- O
R NNP O
) -RRB- O
is VBZ O
provided VBN O
in IN O
ampoules NNS O
that WDT O
are VBP O
labelled VBN O
with IN O
the DT O
product NN O
name NN O
, , O
it PRP O
will MD O
not RB O
be VB O
possible JJ O
to TO O
blind VB O
the DT O
injector NN O
, , O
however RB O
this DT O
person NN B-Species
is VBZ O
not RB O
involved VBN O
in IN O
generation NN O
of IN O
the DT O
allocation NN O
order NN O
, , O
recruitment NN O
, , O
assessment NN O
or CC O
data NN O
analysis NN O
. . O

The DT O
intra JJ O
- HYPH O
articular JJ O
injection NN O
will MD O
be VB O
performed VBN O
using VBG O
a DT O
21 CD O
gauge NN O
( , O
0 CD O
. . O
80 CD O
x SYM O
19 CD O
mm NN O
) -RRB- O
Surflo NNP O
( -LRB- O
R NNP O
) -RRB- O
( , O
Terumo NNP O
( -LRB- O
R NNP O
) -RRB- O
Corp NNP O
. . O
, , O
Tokyo NNP O
, , O
Japan NNP O
) -RRB- O
winged VBN O
infusion NN O
set VBN O
under IN O
aseptic JJ O
procedures NNS O
. . O

Either CC O
a DT O
dorso NN O
- HYPH O
lateral JJ O
or CC O
dorso NN O
- HYPH O
medial JJ O
approach NN O
for IN O
injection NN O
will MD O
be VB O
used VBN O
at IN O
the DT O
discretion NN O
of IN O
the DT O
injector NN O
( , O
depending VBG O
on IN O
which WDT O
approach NN O
provides VBZ O
minimum JJ O
interference NN O
from IN O
the DT O
osteophytes NNS O
at IN O
the DT O
first JJ O
MPJ NNP O
joint NN O
margins NNS O
) -RRB- O
. . O

No DT O
anaesthetic NN O
will MD O
be VB O
used VBN O
. . O

If IN O
the DT O
participant NN B-Species
has VBZ O
bilateral JJ O
painful JJ O
first JJ O
MPJs NNPS O
, , O
only RB O
one CD O
side NN O
( , O
the DT O
most RBS O
painful JJ O
side NN O
) -RRB- O
will MD O
be VB O
treated VBN O
and CC O
used VBN O
for IN O
data NNS O
collection NN O
. . O

The DT O
injector NN O
will MD O
record VB O
the DT O
volume NN O
of IN O
the DT O
agent NN O
that WDT O
is VBZ O
injected VBN O
. . O

Participants NNS B-Species
will MD O
be VB O
given VBN O
the DT O
option NN O
of IN O
a DT O
second JJ O
and CC O
final JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
( , O
of IN O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
or CC O
sterile JJ O
saline NN O
according VBG O
to IN O
the DT O
treatment NN O
group NN O
they PRP O
are VBP O
in IN O
) , O
on IN O
days NNS O
30 CD O
or CC O
90 CD O
if IN O
there EX O
is VBZ O
no DT O
improvement NN O
in IN O
pain NN O
( , O
assessed VBN O
using VBG O
the DT O
VAPS NNP O
for IN O
pain NN O
during IN O
walking VBG O
or CC O
at IN O
rest NN O
) , O
and CC O
the DT O
participant NN B-Species
has VBZ O
not RB O
experienced VBN O
severe JJ O
adverse JJ O
effects NNS O
after IN O
the DT O
first JJ O
injection NN O
) -RRB- O
. . O

Assessments NNS O

Initial JJ O
assessments NNS O

An DT O
initial JJ O
assessment NN O
will MD O
be VB O
performed VBN O
to TO O
determine VB O
the DT O
eligibility NN O
of IN O
participants NNS B-Species
for IN O
this DT O
study NN O
. . O

Demographic JJ O
data NNS O
will MD O
be VB O
collected VBN O
including VBG O
the DT O
age NN O
, , O
gender NN O
, , O
height NN O
and CC O
weight NN O
of IN O
participants NNS B-Species
. . O

Data NNS O
will MD O
also RB O
be VB O
obtained VBN O
concerning VBG O
the DT O
presentation NN O
of IN O
symptoms NNS O
( : O
foot NN O
affected VBN O
, , O
duration NN O
of IN O
symptoms NNS O
) -RRB- O
. . O

If IN O
the DT O
participant NN B-Species
has VBZ O
bilateral JJ O
painful JJ O
first JJ O
MPJs NNPS O
, , O
the DT O
most RBS O
painful JJ O
side NN O
will MD O
be VB O
used VBN O
for IN O
data NN O
collection NN O
and CC O
subsequent JJ O
treatment NN O
. . O

To TO O
establish VB O
eligibility NN O
for IN O
the DT O
study NN O
, , O
participants NNS B-Species
will MD O
undergo VB O
a DT O
clinical JJ O
assessment NN O
, , O
have VB O
one CD O
set NN O
of IN O
dorso NN O
- HYPH O
plantar NN O
and CC O
lateral JJ O
weight NN O
- HYPH O
bearing VBG O
x NN O
- HYPH O
rays NNS O
taken VBN O
of IN O
their PRP$ O
feet NNS O
to TO O
grade VB O
the DT O
severity NN O
of IN O
first JJ O
MPJ NNP O
OA NNP O
as RB O
well RB O
as IN O
undergo VB O
a DT O
blood NN O
test NN O
to TO O
assess VB O
serum NN O
uric NN O
acid NN O
levels NNS O
( : O
to TO O
exclude VB O
gout NN O
) -RRB- O
. . O

Weightbearing VBG O
dorso NN O
- HYPH O
plantar JJ O
and CC O
lateral JJ O
radiographic JJ O
views NNS O
will MD O
be VB O
obtained VBN O
from IN O
both DT O
feet NNS O
with IN O
the DT O
participant NN B-Species
standing VBG O
in IN O
a DT O
relaxed JJ O
bipedal JJ O
stance NN O
position NN O
. . O

All DT O
x NN O
- HYPH O
rays NNS O
will MD O
be VB O
taken VBN O
by IN O
the DT O
same JJ O
medical JJ O
imaging NN O
department NN O
using VBG O
a DT O
Shimadzu NNP O
UD150LRII NNP O
50 CD O
kw NN O
/ SYM O
30 CD O
kHz NN O
Generator NNP O
and CC O
0 CD O
. . O
6 CD O
/ SYM O
1 CD O
. . O
2 CD O
P18DE NNP O
- HYPH O
80S CD O
high JJ O
speed NN O
x NN O
- HYPH O
ray NN O
tube NN O
from IN O
a DT O
ceiling NN O
suspended VBN O
tube NN O
mount NN O
. . O

AGFA NNP O
MD40 CD O
CR NN O
digital JJ O
phosphor NN O
plates NNS O
in IN O
a DT O
24 CD O
cm NN O
x SYM O
30 CD O
cm NN O
cassette NN O
will MD O
be VB O
used VBN O
. . O

For IN O
dorso NN O
- HYPH O
plantar JJ O
projections NNS O
, , O
the DT O
x NN O
- HYPH O
ray NN O
tube NN O
will MD O
be VB O
angled VBN O
15 CD O
degrees NNS O
cephalad NN O
and CC O
centered VBN O
at IN O
the DT O
base NN O
of IN O
the DT O
third JJ O
metatarsal NN O
. . O

For IN O
lateral JJ O
projections NNS O
, , O
the DT O
tube NN O
will MD O
be VB O
angled VBN O
90 CD O
degrees NNS O
and CC O
centered VBN O
at IN O
the DT O
base NN O
of IN O
the DT O
third JJ O
metatarsal NN O
. . O

The DT O
film NN O
focus NN O
distance NN O
will MD O
be VB O
set VBN O
at IN O
100 CD O
cm NNS O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Baseline NN O
assessments NNS O
and CC O
outcome NN O
measures NNS O

Participants NNS B-Species
who WP O
are VBP O
eligible JJ O
for IN O
the DT O
study NN O
will MD O
be VB O
invited VBN O
to TO O
attend VB O
a DT O
baseline NN O
assessment NN O
. . O

During IN O
the DT O
baseline NN O
assessment NN O
, , O
participants NNS B-Species
will MD O
undergo VB O
primary JJ O
and CC O
secondary JJ O
outcome NN O
measurements NNS O
prior RB O
to IN O
receiving VBG O
their PRP$ O
injection NN O
. . O

The DT O
outcome NN O
measurements NNS O
have VBP O
been VBN O
developed VBN O
in IN O
accordance NN O
of IN O
the DT O
recommendations NNS O
of IN O
the DT O
OARSI NNP O
Clinical NNP O
Trials NNPS O
Task NNP O
Force NNP O
guidelines NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Primary JJ O
outcome NN O
measures NNS O

Outcome NN O
measurements NNS O
( , O
primary JJ O
and CC O
secondary JJ O
) -RRB- O
will MD O
occur VB O
at IN O
four CD O
time NN O
- HYPH O
points NNS O
at IN O
baseline NN O
, , O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
post JJ O
- HYPH O
treatment NN O
( , O
after IN O
the DT O
intra JJ O
- HYPH O
articular JJ O
injection NN O
of IN O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
or CC O
placebo NN O
) -RRB- O
. . O

The DT O
assessor NN O
performing VBG O
the DT O
measurements NNS O
will MD O
be VB O
blinded VBN O
as IN O
to IN O
which WDT O
treatment NN O
group NN O
participants NNS B-Species
have VBP O
been VBN O
allocated VBN O
to IN O
. . O

Participants NNS B-Species
who WP O
receive VBP O
a DT O
second JJ O
treatment NN O
at IN O
day NN O
30 CD O
or CC O
90 CD O
will MD O
be VB O
followed VBN O
for IN O
a DT O
further JJ O
30 CD O
days NNS O
or CC O
90 CD O
days NNS O
respectively RB O
and CC O
undergo VBP O
outcome NN O
measurements NNS O
at IN O
7 CD O
or CC O
9 CD O
months NNS O
respectively RB O
. . O

The DT O
primary JJ O
outcome NN O
measures NNS O
will MD O
be VB O
the DT O
Pain NNP O
and CC O
Function NNP O
subscales NNS O
of IN O
the DT O
Foot NNP O
Health NNP O
Status NNP O
Questionnaire NNP O
( -LRB- O
FHSQ NNP O
) -RRB- O
[ -LRB- O
24 CD O
] -RRB- O
. . O

The DT O
FHSQ NNP O
includes VBZ O
13 CD O
questions NNS O
that WDT O
assess VBP O
four CD O
domains NNS O
of IN O
foot NN O
health NN O
, , O
Foot NN O
pain NN O
, , O
Foot NN O
function NN O
, , O
Footwear NN O
and CC O
General JJ O
foot NN O
health NN O
. . O

The DT O
FHSQ NNP O
has VBZ O
been VBN O
subjected VBN O
to IN O
an DT O
extensive JJ O
validation NN O
( , O
content NN O
, , O
criterion NN O
and CC O
construct NN O
validity NN O
) , O
process NN O
. . O

It PRP O
has VBZ O
a DT O
high JJ O
test NN O
- HYPH O
retest NN O
reliability NN O
( , O
intraclass NN O
correlation NN O
coefficients NNS O
ranging VBG O
from IN O
0 CD O
. . O
74 CD O
to IN O
0 CD O
. . O
92 CD O
) -RRB- O
and CC O
a DT O
high JJ O
degree NN O
of IN O
internal JJ O
consistency NN O
( : O
Cronbach NNP O
' POS O
s NN O
alpha NN O
ranging VBG O
from IN O
0 CD O
. . O
85 CD O
to IN O
0 CD O
. . O
88 CD O
) -RRB- O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Rigorous JJ O
reviews NNS O
have VBP O
rated VBN O
it PRP O
as IN O
one CD O
of IN O
the DT O
highest JJS O
quality NN O
foot NN O
health NN O
status NN O
measures NNS O
currently RB O
available JJ O
[ -LRB- O
25 CD O
- SYM O
27 CD O
] -RRB- O
. . O

Secondary JJ O
outcome NN O
measures NNS O

The DT O
secondary JJ O
outcome NN O
measures NNS O
will MD O
be VB O
: : O

( : O
i PRP O
) NFP O
Severity NN O
of IN O
pain NN O

Severity NN O
of IN O
pain NN O
at IN O
the DT O
first JJ O
MPJ NNP O
during IN O
walking VBG O
, , O
and CC O
during IN O
rest NN O
, , O
over IN O
the DT O
past JJ O
week NN O
will MD O
be VB O
assessed VBN O
using VBG O
a DT O
100 CD O
mm NN O
visual JJ O
analogue NN O
pain NN O
scale NN O
. . O

The DT O
left JJ O
side NN O
of IN O
the DT O
scale NN O
( : O
0 CD O
mm NN O
) -RRB- O
will MD O
be VB O
labelled VBN O
"""" `` O
no DT O
pain NN O
"""" '' O
and CC O
the DT O
right JJ O
side NN O
of IN O
the DT O
scale NN O
( : O
100 CD O
mm NN O
) -RRB- O
will MD O
be VB O
labelled VBN O
"""" `` O
worst JJS O
pain NN O
possible JJ O
"""" '' O
for IN O
each DT O
question NN O
[ -LRB- O
25 CD O
, , O
28 CD O
] -RRB- O
. . O

( : O
ii `` O
) NFP O
Severity NN O
and CC O
duration NN O
of IN O
stiffness NN O
at IN O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O

The DT O
severity NN O
of IN O
stiffness NN O
at IN O
the DT O
first JJ O
MPJ NNP O
during IN O
walking VBG O
over IN O
the DT O
past JJ O
week NN O
will MD O
be VB O
assessed VBN O
using VBG O
a DT O
100 CD O
mm NN O
visual JJ O
analogue NN O
scale NN O
. . O

The DT O
left JJ O
side NN O
of IN O
the DT O
scale NN O
( : O
0 CD O
mm NN O
) -RRB- O
will MD O
be VB O
labelled VBN O
"""" `` O
not RB O
stiff JJ O
at RB O
all RB O
"""" '' O
and CC O
the DT O
right JJ O
side NN O
of IN O
the DT O
scale NN O
( : O
100 CD O
mm NN O
) -RRB- O
will MD O
be VB O
labelled VBN O
"""" `` O
most RBS O
stiff JJ O
possible JJ O
"""" '' O
. . O

The DT O
average JJ O
duration NN O
of IN O
stiffness NN O
at IN O
the DT O
first JJ O
MPJ NNP O
over IN O
the DT O
past JJ O
week NN O
will MD O
be VB O
assessed VBN O
using VBG O
a DT O
four CD O
category NN O
scale NN O
response NN O
. . O

The DT O
responses NNS O
are VBP O
: : O
"""" `` O
none NN O
"""" '' O
, , O
"""" `` O
1 CD O
- SYM O
15 CD O
minutes NNS O
"""" '' O
, , O
"""" `` O
16 CD O
- SYM O
30 CD O
minutes NNS O
"""" '' O
and CC O
"""" `` O
greater JJR O
than IN O
30 CD O
minutes NNS O
"""" '' O
[ -LRB- O
29 CD O
] -RRB- O
. . O

( : O
iii NNP O
) NFP O
Passive JJ O
, , O
non JJ O
- HYPH O
weightbearing JJ O
dorsiflexion NN O
range NN O
of IN O
motion NN O
of IN O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O

First JJ O
MPJ NNP O
dorsiflexion NN O
range NN O
of IN O
motion NN O
will MD O
be VB O
measured VBN O
using VBG O
a DT O
goniometer NN O
as IN O
the DT O
maximum JJ O
angle NN O
at IN O
which WDT O
the DT O
hallux NN O
cannot MD O
be VB O
passively RB O
moved VBN O
into IN O
further JJ O
extension NN O
in IN O
a DT O
non AFX O
- HYPH O
weightbearing NN O
position NN O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
test NN O
will MD O
be VB O
performed VBN O
two CD O
times NNS O
and CC O
the DT O
average NN O
will MD O
be VB O
used VBN O
for IN O
analysis NN O
. . O

This DT O
measurement NN O
technique NN O
shows VBZ O
high JJ O
intra NN O
- HYPH O
reliability NN O
( : O
ICC NNP O
= SYM O
0 CD O
. . O
95 CD O
, , O
standard JJ O
error NN O
of IN O
mean NN O
= SYM O
1 CD O
. . O
3 CD O
degrees NNS O
) -RRB- O
[ -LRB- O
30 CD O
] -RRB- O
. . O

( : O
iv `` O
) NFP O
Plantar JJ O
flexion NN O
strength NN O
of IN O
the DT O
toe NN O
- HYPH O
flexors NNS O
of IN O
the DT O
hallux NN O

Plantar JJ O
flexion NN O
strength NN O
of IN O
the DT O
toe NN O
- HYPH O
flexors NNS O
of IN O
the DT O
hallux NN O
will MD O
be VB O
measured VBN O
using VBG O
the DT O
Mat NNP O
Scan NNP O
( -LRB- O
R NN O
) -RRB- O
plantar NN O
pressure NN O
measurement NN O
device NN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

Participants NNS B-Species
will MD O
be VB O
seated VBN O
with IN O
the DT O
hip NN O
, , O
knee NN O
, , O
and CC O
ankle NN O
at IN O
90 CD O
degrees NNS O
and CC O
their PRP$ O
foot NN O
placed VBN O
over IN O
the DT O
Mat NNP O
Scan NNP O
( HYPH O
R NNP O
) -RRB- O
plantar NN O
pressure NN O
measurement NN O
device NN O
( : O
Tekscan NNP O
, , O
Boston NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
( : O
Figure NNP O
3a CD O
) -RRB- O
. . O

This DT O
system NN O
consists VBZ O
of IN O
a DT O
5 CD O
- HYPH O
mm NN O
thick JJ O
floor NN O
mat NN O
( , O
432 CD O
x SYM O
368 CD O
mm NN O
) , O
incorporating VBG O
2288 CD O
resistive JJ O
sensors NNS O
( , O
1 CD O
. . O
4 CD O
sensors NNS O
/ SYM O
cm2 NN O
) -RRB- O
sampling NN O
at IN O
a DT O
rate NN O
of IN O
40 CD O
Hz NN O
. . O

The DT O
mat NN O
will MD O
be VB O
calibrated VBN O
for IN O
each DT O
participant NN B-Species
using VBG O
his PRP$ O
or CC O
her PRP$ O
own JJ O
bodyweight NN O
before IN O
each DT O
testing NN O
session NN O
. . O

Participants NNS B-Species
will MD O
be VB O
instructed VBN O
to TO O
use VB O
their PRP$ O
toe NN O
- HYPH O
flexor NN O
muscles NNS O
to TO O
maximally RB O
push VB O
their PRP$ O
hallux NN O
down RP O
on IN O
the DT O
MatScan NNP O
( HYPH O
R NNP O
) -RRB- O
device NN O
and CC O
forces NNS O
under IN O
the DT O
hallux NN O
will MD O
be VB O
recorded VBN O
( -LRB- O
Figure NNP O
3b NN O
) -RRB- O
. . O

The DT O
test NN O
will MD O
be VB O
performed VBN O
three CD O
times NNS O
for IN O
the DT O
hallux NN O
and CC O
the DT O
maximal JJ O
force NN O
will MD O
be VB O
used VBN O
for IN O
analysis NN O
. . O

The DT O
test NN O
- HYPH O
retest NN O
reliability NN O
of IN O
this DT O
measurement NN O
technique NN O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
high JJ O
, , O
with IN O
intraclass NN O
correlation NN O
coefficients NNS O
( , O
ICCs NNS O
) -RRB- O
= SYM O
0 CD O
. . O
88 CD O
( SYM O
95 CD O
% NN O
CI NN O
0 CD O
. . O
81 CD O
- SYM O
0 CD O
. . O
93 CD O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
. . O

( : O
vi FW O
) SYM O
Plantar NNP O
pressure NN O
measurement NN O

Plantar JJ O
pressures NNS O
will MD O
be VB O
recorded VBN O
during IN O
level JJ O
barefoot NN O
walking NN O
using VBG O
the DT O
MatScan NNP O
( -LRB- O
R NNP O
) -RRB- O
system NN O
( : O
Tekscan NNP O
( -LRB- O
R NNP O
) -RRB- O
, , O
Boston NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
two CD O
- HYPH O
step NN O
gait NN O
initiation NN O
protocol NN O
will MD O
be VB O
used VBN O
to TO O
obtain VB O
foot NN O
pressure NN O
data NNS O
, , O
as IN O
it PRP O
requires VBZ O
fewer JJR O
trials NNS O
than IN O
the DT O
mid JJ O
- HYPH O
gait NN O
protocol NN O
and CC O
has VBZ O
similar JJ O
re IN O
- HYPH O
test NN O
reliability NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Three CD O
trials NNS O
will MD O
be VB O
recorded VBN O
, , O
which WDT O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
sufficient JJ O
to TO O
ensure VB O
adequate JJ O
reliability NN O
of IN O
pressure NN O
data NNS O
[ -LRB- O
32 CD O
, , O
33 CD O
] -RRB- O
. . O

Following VBG O
data NN O
collection NN O
, , O
the DT O
Research NNP O
Foot NNP O
( -LRB- O
R NNP O
) -RRB- O
software NN O
( , O
version NN O
5 CD O
. . O
24 CD O
) -RRB- O
will MD O
be VB O
used VBN O
to TO O
construct VB O
individual JJ O
"""" `` O
masks NNS O
"""" '' O
to TO O
determine VB O
maximum JJ O
force NN O
( HYPH O
kg NN O
) -RRB- O
and CC O
peak NN O
pressure NN O
( HYPH O
kg NN O
/ SYM O
cm2 NN O
) -RRB- O
under IN O
seven CD O
regions NNS O
of IN O
the DT O
foot NN O
: : O
hallux NN O
, , O
lesser JJR O
toes NNS O
, , O
1st JJ O
MPJ NNP O
, , O
2nd JJ O
MPJ NNP O
, , O
3rd JJ O
to IN O
5th JJ O
MPJs NNS O
, , O
midfoot NN O
and CC O
heel NN O
( -LRB- O
Figure NNP O
4a CD O
) -RRB- O
. . O

For IN O
each DT O
region NN O
, , O
the DT O
median NN O
of IN O
the DT O
three CD O
trials NNS O
will MD O
be VB O
used VBN O
for IN O
analysis NN O
. . O

Typical JJ O
plantar JJ O
pressure NN O
recordings NNS O
from IN O
a DT O
participant NN B-Species
are VBP O
shown VBN O
in IN O
Figure NNP O
4b CD O
. . O

( NFP O
vi FW O
) , O
Global JJ O
satisfaction NN O
with IN O
the DT O
treatment NN O

Global JJ O
satisfaction NN O
with IN O
the DT O
treatment NN O
will MD O
be VB O
assessed VBN O
using VBG O
a DT O
5 CD O
- HYPH O
point NN O
Likert NNP O
scale NN O
, , O
as RB O
well RB O
as IN O
a DT O
dichotomous JJ O
( , O
yes UH O
/ SYM O
no DT O
) , O
scale NN O
. . O

The DT O
five CD O
point NN O
- HYPH O
Likert NNP O
scale NN O
will MD O
ask VB O
"""" `` O
How WRB O
satisfied JJ O
are VBP O
you PRP O
with IN O
the DT O
treatment NN O
you PRP O
received VBD O
for IN O
your PRP$ O
big JJ O
- HYPH O
toe NN O
joint NN O
pain NN O
? . O
"""" '' O
, , O
and CC O
will MD O
have VB O
the DT O
following VBG O
five CD O
responses NNS O
: : O
"""" `` O
Dissatisfied JJ O
"""" '' O
, , O
"""" `` O
Only RB O
moderately RB O
satisfied JJ O
"""" '' O
, , O
"""" `` O
Fairly RB O
satisfied JJ O
"""" '' O
, , O
"""" `` O
Clearly RB O
satisfied JJ O
"""" '' O
and CC O
"""" `` O
Very RB O
satisfied JJ O
"""" '' O
. . O

The DT O
dichotomous JJ O
scale NN O
of IN O
satisfaction NN O
will MD O
be VB O
answered VBN O
as IN O
"""" `` O
Yes UH O
"""" '' O
' '' O
or CC O
"""" `` O
No UH O
"""" '' O
in IN O
response NN O
to IN O
the DT O
question NN O
: : O
"""" `` O
Would MD O
you PRP O
recommend VB O
the DT O
treatment NN O
that WDT O
you PRP O
received VBD O
to IN O
someone NN O
else RB O
with IN O
big JJ O
- HYPH O
toe NN O
joint NN O
pain NN O
"""" '' O
. . O

( -LRB- O
vii NN O
) NFP O
Health NN O
related VBN O
quality NN O
of IN O
life NN O

The DT O
Short NNP O
- HYPH O
Form NN O
- HYPH O
36 CD O
( HYPH O
version NN O
two CD O
) -RRB- O
( , O
SF NN O
- HYPH O
36 CD O
) -RRB- O
questionnaire NN O
will MD O
be VB O
used VBN O
to TO O
assess VB O
health NN O
related VBN O
quality NN O
of IN O
life NN O
. . O

The DT O
SF NNP O
- HYPH O
36 CD O
is VBZ O
a DT O
36 CD O
question NN O
survey NN O
that WDT O
measures VBZ O
eight CD O
health NN O
concepts NNS O
most RBS O
affected VBN O
by IN O
disease NN O
and CC O
treatment NN O
. . O

The DT O
eight CD O
health NN O
concepts NNS O
can MD O
then RB O
be VB O
used VBN O
to TO O
form VB O
two CD O
summary JJ O
measures NNS O
: : O
Physical JJ O
health NN O
and CC O
Mental JJ O
health NN O
. . O

The DT O
Short NNP O
Form NNP O
- HYPH O
36 CD O
( , O
SF NNP O
- HYPH O
36 CD O
) -RRB- O
has VBZ O
been VBN O
extensively RB O
validated VBN O
and CC O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
widely RB O
used VBN O
instruments NNS O
to TO O
measure VB O
health NN O
status NN O
. . O

The DT O
SF NNP O
- HYPH O
36 CD O
shows VBZ O
content NN O
, , O
concurrent JJ O
, , O
criterion NN O
, , O
construct NN O
, , O
and CC O
predictive JJ O
evidence NN O
of IN O
validity NN O
. . O

The DT O
reliability NN O
of IN O
the DT O
eight CD O
concepts NNS O
and CC O
two CD O
summary JJ O
measures NNS O
has VBZ O
been VBN O
assessed VBN O
using VBG O
both CC O
internal JJ O
consistency NN O
and CC O
test NN O
- HYPH O
retest NN O
methods NNS O
. . O

Reliability NN O
statistics NNS O
have VBP O
exceeded VBN O
0 CD O
. . O
80 CD O
[ SYM O
34 CD O
- SYM O
37 CD O
] -RRB- O
. . O

( -LRB- O
viii NNP O
) -RRB- O
Self NN O
- HYPH O
reported VBN O
magnitude NN O
of IN O
symptom NN O
change NN O

Self NN O
- HYPH O
reported VBN O
magnitude NN O
of IN O
symptom NN O
change NN O
will MD O
be VB O
measured VBN O
using VBG O
a DT O
15 CD O
- HYPH O
point NN O
Likert NNP O
scale NN O
. . O

The DT O
scale NN O
will MD O
ask VB O
participants NNS B-Species
"""" `` O
how WRB O
much JJ O
have VBP O
your PRP$ O
symptoms NNS O
in IN O
your PRP$ O
big JJ O
- HYPH O
toe NN O
joint NN O
have VBP O
changed VBN O
from IN O
the DT O
beginning NN O
of IN O
the DT O
study NN O
to IN O
now RB O
? . O
"""" '' O
. . O

The DT O
fifteen JJ O
responses NNS O
will MD O
range VB O
from IN O
"""" `` O
A DT O
very RB O
great JJ O
deal NN O
better RB O
"""" '' O
to IN O
"""" `` O
A DT O
very RB O
great JJ O
deal NN O
worse JJR O
"""" '' O
. . O

( : O
ix IN O
) , O
Use NN O
of IN O
rescue NN O
medications NNS O
to TO O
relieve VB O
pain NN O
at IN O
the DT O
first JJ O
metatarsophalangeal JJ O
joint NN O

The DT O
number NN O
of IN O
participants NNS B-Species
who WP O
consumed VBD O
rescue NN O
medication NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
paracetamol NN O
) -RRB- O
and CC O
mean VBP O
consumption NN O
of IN O
rescue NN O
medication NN O
to TO O
relieve VB O
pain NN O
at IN O
the DT O
first JJ O
MPJ NNP O
( , O
mean JJ O
grams NNS O
of IN O
paracetamol NN O
/ SYM O
participant NN B-Species
/ SYM O
month NN O
] -RRB- O
will MD O
be VB O
assessed VBN O
using VBG O
a DT O
medications NNS O
diary NN O
that IN O
participants NNS B-Species
will MD O
self VB O
- HYPH O
complete JJ O
[ -LRB- O
38 CD O
, , O
39 CD O
] -RRB- O
. . O

The DT O
diary NN O
will MD O
be VB O
returned VBN O
to IN O
the DT O
assessor NN O
at IN O
monthly JJ O
intervals NNS O
for IN O
analysis NN O
. . O

( : O
x LS O
) NFP O
Frequency NN O
and CC O
severity NN O
of IN O
adverse JJ O
events NNS O
as IN O
safety NN O
variables NNS O

The DT O
frequency NN O
( , O
number NN O
of IN O
participants NNS B-Species
affected VBN O
and CC O
number NN O
of IN O
cases NNS O
) -RRB- O
and CC O
types NNS O
of IN O
adverse JJ O
events NNS O
( , O
including VBG O
adverse JJ O
drug NN O
reactions NNS O
) , O
in IN O
each DT O
treatment NN O
group NN O
during IN O
the DT O
trial NN O
will MD O
be VB O
recorded VBN O
using VBG O
a DT O
questionnaire NN O
that IN O
participants NNS B-Species
will MD O
complete VB O
during IN O
the DT O
follow NN O
- HYPH O
up NN O
appointments NNS O
at IN O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
post JJ O
- HYPH O
treatment NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

To TO O
classify VB O
the DT O
' `` O
type NN O
' '' O
of IN O
adverse JJ O
event NN O
, , O
a DT O
blinded JJ O
assessor NN O
will MD O
classify VB O
the DT O
adverse JJ O
event NN O
as IN O
being VBG O
serious JJ O
or CC O
non RB O
- HYPH O
serious JJ O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Any DT O
serious JJ O
adverse JJ O
events NNS O
, , O
defined VBN O
as IN O
adverse JJ O
events NNS O
leading VBG O
to IN O
serious JJ O
disability NN O
, , O
hospital NN O
admission NN O
, , O
or CC O
prolongation NN O
of IN O
hospitalisation NN O
, , O
life NN O
- HYPH O
threatening VBG O
events NNS O
; : O
or CC O
death NN O
) -RRB- O
will MD O
be VB O
further RB O
classified VBN O
using VBG O
the DT O
International NNP O
Classification NNP O
of IN O
Diseases NNPS O
( -LRB- O
ICD NNP O
) -RRB- O
codes NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Non RB O
- HYPH O
serious JJ O
adverse JJ O
events NNS O
will MD O
include VB O
both DT O
local JJ O
( , O
pain NN O
, , O
effusion NN O
and CC O
heat NN O
, , O
with IN O
each DT O
classified VBN O
as IN O
mild JJ O
, , O
moderate JJ O
, , O
severe JJ O
) , O
and CC O
systemic JJ O
adverse JJ O
events NNS O
. . O

An DT O
open JJ O
- HYPH O
response NN O
type NN O
format NN O
will MD O
also RB O
be VB O
available JJ O
for IN O
participant NN B-Species
responses NNS O
. . O

Sample NN O
size NN O

The DT O
sample NN O
size NN O
for IN O
the DT O
study NN O
has VBZ O
been VBN O
pre NN O
- HYPH O
specified VBN O
using VBG O
an DT O
a DT O
priori JJ O
power NN O
analysis NN O
using VBG O
the DT O
primary JJ O
outcome NN O
measure NN O
of IN O
the DT O
pain NN O
domain NN O
of IN O
the DT O
FHSQ NNP O
[ -LRB- O
42 CD O
] -RRB- O
. . O

One CD O
hundred CD O
and CC O
forty CD O
two CD O
participants NNS B-Species
( : O
i PRP O
. . O
e ADD O
. . O
71 CD O
per IN O
group NN O
) -RRB- O
will MD O
provide VB O
power NN O
of IN O
90 CD O
% NN O
to TO O
detect VB O
a DT O
minimally RB O
important JJ O
difference NN O
in IN O
the DT O
pain NN O
domain NN O
of IN O
the DT O
FHSQ NNP O
( : O
i LS O
. . O
e LS O
. . O
14 CD O
points NNS O
on IN O
the DT O
FHSQ NNP O
questionnaire NN O
) -RRB- O
with IN O
the DT O
significance NN O
level NN O
set VBN O
at IN O
p NN O
< NN O
0 CD O
. . O
5 CD O
. . O

A DT O
difference NN O
of IN O
14 CD O
points NNS O
was VBD O
determined VBN O
to TO O
be VB O
a DT O
clinically RB O
significant JJ O
difference NN O
worth JJ O
detecting VBG O
[ -LRB- O
43 CD O
] -RRB- O
and CC O
a DT O
standard JJ O
deviation NN O
of IN O
25 CD O
was VBD O
derived VBN O
from IN O
a DT O
previous JJ O
report NN O
[ -LRB- O
44 CD O
] -RRB- O
. . O

This DT O
calculation NN O
included VBD O
a DT O
5 CD O
% NN O
drop VB O
- HYPH O
out NN O
rate NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

However RB O
, , O
we PRP O
will MD O
aim VB O
to TO O
recruit VB O
150 CD O
participants NNS B-Species
( , O
~ $ O
75 CD O
participants NNS B-Species
per IN O
intervention NN O
group NN O
) -RRB- O
. . O

Further RB O
, , O
we PRP O
have VBP O
conservatively RB O
ignored VBN O
the DT O
extra JJ O
precision NN O
provided VBN O
by IN O
covariate NN O
analysis NN O
when WRB O
estimating VBG O
the DT O
sample NN O
size NN O
. . O

Statistical JJ O
analysis NN O

Statistical JJ O
analysis NN O
will MD O
be VB O
undertaken VBN O
using VBG O
SPSS NNP O
version NN O
14 CD O
. . O
0 CD O
( : O
SPSS NNP O
Corp NNP O
, , O
Chicago NNP O
, , O
Ill NNP O
, , O
USA NNP O
) -RRB- O
and CC O
STATA NNP O
8 CD O
( SYM O
Stata NNP O
Corp NNP O
, , O
College NNP O
Station NNP O
, , O
Tex NNP O
. . O
, , O
USA NNP O
) -RRB- O
statistical JJ O
software NN O
. . O

All DT O
analyses NNS O
will MD O
be VB O
conducted VBN O
on IN O
an DT O
intention NN O
- HYPH O
to IN O
- HYPH O
treat VB O
principle NN O
using VBG O
all DT O
randomised VBN O
participants NNS B-Species
[ -LRB- O
45 CD O
- SYM O
47 CD O
] -RRB- O
. . O

Missing VBG O
data NNS O
will MD O
be VB O
replaced VBN O
with IN O
the DT O
last JJ O
score NN O
carried VBN O
forward RB O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Standard JJ O
tests NNS O
for IN O
normal JJ O
distribution NN O
will MD O
be VB O
used VBN O
and CC O
transformation NN O
carried VBN O
out RP O
if IN O
required VBD O
. . O

Demographic JJ O
characteristics NNS O
( , O
gender NN O
, , O
age NN O
, , O
weight NN O
, , O
height NN O
, , O
body NN O
mass NN O
index NN O
) -RRB- O
will MD O
be VB O
determined VBN O
for IN O
the DT O
baseline NN O
visit NN O
for IN O
each DT O
treatment NN O
group NN O
. . O

Summary JJ O
statistics NNS O
will MD O
be VB O
calculated VBN O
for IN O
duration NN O
of IN O
symptoms NNS O
, , O
side NN O
affected VBN O
( , O
left JJ O
, , O
right JJ O
, , O
bilateral JJ O
) -RRB- O
, , O
grade NN O
of IN O
OA NN O
at IN O
the DT O
first JJ O
MPJ NNP O
[ -LRB- O
19 CD O
] -RRB- O
as RB O
well RB O
as IN O
all DT O
primary JJ O
and CC O
secondary JJ O
outcome NN O
measurements NNS O
for IN O
each DT O
treatment NN O
group NN O
. . O

Analyses NNS O
will MD O
be VB O
conducted VBN O
on IN O
1 CD O
, , O
3 CD O
and CC O
6 CD O
month NN O
outcome NN O
measures NNS O
. . O

The DT O
continuously RB O
- HYPH O
scored VBN O
outcome NN O
measures NNS O
at IN O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
will MD O
be VB O
compared VBN O
using VBG O
analysis NN O
of IN O
covariance NN O
with IN O
baseline NN O
scores NNS O
and CC O
intervention NN O
group NN O
entered VBN O
as IN O
independent JJ O
variables NNS O
[ -LRB- O
49 CD O
, , O
50 CD O
] -RRB- O
. . O

The DT O
exception NN O
to IN O
this DT O
will MD O
be VB O
the DT O
plantar JJ O
pressure NN O
measurements NNS O
which WDT O
will MD O
be VB O
analysed VBN O
at IN O
baseline NN O
, , O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
using VBG O
two CD O
- HYPH O
way NN O
repeated VBN O
measures NNS O
analysis NN O
of IN O
variance NN O
statistics NNS O
. . O

Post JJ O
- HYPH O
hoc NN O
comparisons NNS O
will MD O
be VB O
performed VBN O
using VBG O
Bonferroni NNP O
- HYPH O
adjusted VBN O
t NN O
- HYPH O
tests NNS O
. . O

Nominal JJ O
and CC O
ordinal JJ O
scaled JJ O
data NNS O
will MD O
be VB O
compared VBN O
at IN O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
using VBG O
Mann NNP O
- HYPH O
Whitney NNP O
U NNP O
- HYPH O
tests NNS O
and CC O
chi NN O
- HYPH O
square JJ O
analyses NNS O
( , O
or CC O
Fisher NNP O
' POS O
s NN O
exact JJ O
test NN O
where WRB O
appropriate JJ O
) -RRB- O
respectively RB O
. . O

Effect NN O
sizes NNS O
will MD O
be VB O
determined VBN O
using VBG O
Cohen NNP O
' POS O
s NNS O
d NN O
( , O
continuous JJ O
scaled JJ O
data NN O
) -RRB- O
or CC O
odds NNS O
ratios NNS O
( , O
nominal JJ O
scaled VBN O
data NN O
and CC O
ordinal JJ O
scaled VBN O
data NNS O
) -RRB- O
as RB O
appropriate JJ O
. . O

The DT O
outcome NN O
measurements NNS O
obtained VBN O
at IN O
7 CD O
or CC O
9 CD O
months NNS O
for IN O
participants NNS B-Species
that WDT O
receive VBP O
a DT O
second JJ O
and CC O
final JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
( , O
of IN O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
or CC O
sterile JJ O
saline NN O
according VBG O
to IN O
the DT O
treatment NN O
group NN O
they PRP O
are VBP O
in IN O
) -RRB- O
on IN O
days NNS O
30 CD O
or CC O
90 CD O
respectively RB O
, , O
will MD O
also RB O
be VB O
analysed VBN O
as IN O
described VBN O
above RB O
. . O

These DT O
analyses NNS O
will MD O
be VB O
classified VBN O
as IN O
secondary JJ O
outcomes NNS O
. . O

Discussion NN O

This DT O
study NN O
is VBZ O
a DT O
randomised VBN O
placebo NN O
controlled VBN O
trial NN O
designed VBN O
to TO O
investigate VB O
the DT O
efficacy NN O
of IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
( , O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
) -RRB- O
to TO O
reduce VB O
pain NN O
and CC O
improve VB O
function NN O
in IN O
people NNS B-Species
with IN O
OA NN O
of IN O
the DT O
first JJ O
MPJ NNP O
( HYPH O
hallux NNP O
limitus NN O
) -RRB- O
. . O

Two CD O
studies NNS O
have VBP O
previously RB O
investigated VBN O
the DT O
efficacy NN O
of IN O
intra JJ O
- HYPH O
articular JJ O
hyaluronan NN O
for IN O
the DT O
treatment NN O
of IN O
first JJ O
MPJ NNP O
OA NNP O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

However RB O
, , O
neither DT O
of IN O
these DT O
studies NNS O
used VBD O
a DT O
placebo NN O
control NN O
group NN O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
first JJ O
randomised VBN O
controlled VBN O
trial NN O
using VBG O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
for IN O
OA NNP O
of IN O
the DT O
first JJ O
MPJ NNP O
. . O

The DT O
use NN O
of IN O
a DT O
placebo NN O
control NN O
group NN O
is VBZ O
essential JJ O
for IN O
studies NNS O
evaluating VBG O
the DT O
effects NNS O
of IN O
intra JJ O
- HYPH O
articular JJ O
therapies NNS O
as IN O
there EX O
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
large JJ O
placebo NN O
response NN O
related VBN O
to IN O
the DT O
injection NN O
procedure NN O
and CC O
this DT O
may MD O
inflate VB O
the DT O
results NNS O
in IN O
uncontrolled JJ O
evaluations NNS O
[ -LRB- O
51 CD O
] -RRB- O
. . O

Indeed RB O
, , O
a DT O
recent JJ O
meta JJ O
- HYPH O
analysis NN O
of IN O
hyaluronan NN O
for IN O
knee NN O
OA NNP O
concluded VBD O
that IN O
a DT O
placebo NN O
effect NN O
accounted VBD O
for IN O
79 CD O
% NN O
of IN O
the DT O
efficacy NN O
of IN O
intra JJ O
- HYPH O
articular JJ O
hyaluronan NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

The DT O
study NN O
protocol NN O
and CC O
outcome NN O
measures NNS O
have VBP O
been VBN O
developed VBN O
in IN O
accordance NN O
of IN O
the DT O
recommendations NNS O
of IN O
the DT O
OARSI NNP O
Clinical NNP O
Trials NNPS O
Task NNP O
Force NNP O
guidelines NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

The DT O
outcome NN O
measures NNS O
are VBP O
pain NN O
and CC O
function NN O
subscales NNS O
of IN O
the DT O
FHSQ NNP O
, , O
pain NN O
and CC O
stiffness NN O
at IN O
the DT O
first JJ O
MPJ NNP O
, , O
range NN O
of IN O
motion NN O
( , O
dorsiflexion NN O
) -RRB- O
of IN O
the DT O
first JJ O
MPJ NNP O
, , O
plantar JJ O
flexion NN O
strength NN O
of IN O
muscles NNS O
of IN O
the DT O
first JJ O
MPJ NNP O
, , O
generic JJ O
health NN O
related VBN O
quality NN O
of IN O
life NN O
( , O
SF NNP O
- HYPH O
36 CD O
) -RRB- O
, , O
patient JJ B-Species
satisfaction NN O
with IN O
treatment NN O
, , O
consumption NN O
of IN O
rescue NN O
medication NN O
as RB O
well RB O
as IN O
frequency NN O
and CC O
nature NN O
of IN O
adverse JJ O
effects NNS O
. . O

These DT O
outcomes NNS O
will MD O
be VB O
measured VBN O
at IN O
baseline NN O
then RB O
at IN O
1 CD O
, , O
3 CD O
and CC O
6 CD O
months NNS O
after IN O
treatment NN O
. . O

Previous JJ O
research NN O
suggests VBZ O
that IN O
the DT O
effects NNS O
of IN O
intra JJ O
- HYPH O
articular JJ O
hyaluronan NN O
persist VBP O
for IN O
up IN O
to TO O
12 CD O
months NNS O
following VBG O
treatment NN O
[ -LRB- O
9 CD O
, , O
38 CD O
] -RRB- O
. . O

Thus RB O
, , O
the DT O
use NN O
of IN O
follow NN O
- HYPH O
up NN O
assessments NNS O
at IN O
6 CD O
month NN O
post NN O
- HYPH O
treatment NN O
will MD O
allow VB O
us PRP O
to TO O
determine VB O
if IN O
the DT O
effects NNS O
, , O
if IN O
any DT O
, , O
of IN O
intra JJ O
- HYPH O
articular JJ O
hyaluronan NN O
persist VBP O
in IN O
the DT O
longer JJR O
term NN O
. . O

Participants NNS B-Species
will MD O
be VB O
given VBN O
the DT O
option NN O
of IN O
a DT O
second JJ O
and CC O
final JJ O
intra NN O
- HYPH O
articular JJ O
injection NN O
( , O
of IN O
Synvisc NNP O
( -LRB- O
R NN O
) -RRB- O
or CC O
sterile JJ O
saline NN O
according VBG O
to IN O
the DT O
treatment NN O
group NN O
they PRP O
are VBP O
in IN O
) , O
on IN O
days NNS O
30 CD O
or CC O
90 CD O
if IN O
there EX O
is VBZ O
no DT O
improvement NN O
in IN O
their PRP$ O
symptoms NNS O
. . O

Although IN O
this DT O
has VBZ O
the DT O
potential NN O
to TO O
complicate VB O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
of IN O
the DT O
study NN O
, , O
this DT O
protocol NN O
was VBD O
included VBN O
as IN O
it PRP O
is VBZ O
likely JJ O
to TO O
be VB O
more RBR O
reflective JJ O
of IN O
clinical JJ O
practice NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
and CC O
this DT O
is VBZ O
in IN O
keeping NN O
with IN O
the DT O
pragmatic JJ O
nature NN O
of IN O
this DT O
trial NN O
. . O

In IN O
summary NN O
, , O
this DT O
project NN O
is VBZ O
the DT O
first RB O
randomised VBN O
controlled VBN O
trial NN O
to TO O
be VB O
conducted VBN O
to TO O
evaluate VB O
the DT O
efficacy NN O
of IN O
intra NN O
- HYPH O
articular JJ O
hyaluronan NN O
for IN O
reducing VBG O
pain NN O
and CC O
improving VBG O
function NN O
in IN O
people NNS B-Species
with IN O
hallux NN O
limitus NN O
. . O

The DT O
study NN O
protocol NN O
, , O
including VBG O
interventions NNS O
, , O
have VBP O
been VBN O
pragmatically RB O
designed VBN O
to TO O
ensure VB O
that IN O
the DT O
study NN O
findings NNS O
are VBP O
generaliseable JJ O
to IN O
clinical JJ O
practice NN O
. . O

Recruitment NN O
for IN O
the DT O
study NN O
will MD O
commence VB O
in IN O
June NNP O
2008 CD O
, , O
and CC O
we PRP O
expect VBP O
final JJ O
results NNS O
to TO O
be VB O
available JJ O
in IN O
mid JJ O
- HYPH O
2010 CD O
. . O

Competing VBG O
interests NNS O

HBM NNP O
and CC O
KBL NNP O
are VBP O
Editor NN O
- HYPH O
in IN O
- HYPH O
Chief NNP O
and CC O
Deputy NNP O
Editor NNP O
- HYPH O
in IN O
- HYPH O
Chief NNP O
, , O
respectively RB O
, , O
of IN O
Journal NNP O
of IN O
Foot NNP O
and CC O
Ankle NNP O
Research NNP O
. . O

It PRP O
is VBZ O
journal NN O
policy NN O
that IN O
editors NNS O
are VBP O
removed VBN O
from IN O
the DT O
peer NN O
review NN O
and CC O
editorial JJ O
decision NN O
making NN O
processes NNS O
for IN O
papers NNS O
they PRP O
have VBP O
co NN O
- HYPH O
authored VBN O
. . O

Authors NNS O
' POS O
contributions NNS O

SEM NNP O
, , O
HBM NNP O
, , O
KBL NNP O
and CC O
CJH NNP O
conceived VBD O
the DT O
idea NN O
and CC O
obtained VBD O
funding NN O
for IN O
the DT O
study NN O
. . O

SEM NNP O
, , O
HBM NNP O
, , O
KBL NNP O
, , O
AEZ NNP O
and CC O
JDL NNP O
designed VBD O
the DT O
trial NN O
protocol NN O
. . O

SEM NNP O
, , O
HBM NNP O
, , O
KBL NNP O
and CC O
GVZ NNP O
drafted VBD O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
have VBP O
read VBN O
and CC O
approved VBN O
the DT O
final JJ O
manuscript NN O
. . O

p8 NN O
inhibits VBZ O
the DT O
growth NN O
of IN O
human JJ B-Species
pancreatic JJ O
cancer NN O
cells NNS O
and CC O
its PRP$ O
expression NN O
is VBZ O
induced VBN O
through IN O
pathways NNS O
involved VBN O
in IN O
growth NN O
inhibition NN O
and CC O
repressed VBN O
by IN O
factors NNS O
promoting VBG O
cell NN O
growth NN O

Abstract JJ O

Background NN O

p8 NN O
is VBZ O
a DT O
stress NN O
- HYPH O
induced VBN O
protein NN O
with IN O
multiple JJ O
functions NNS O
and CC O
biochemically RB O
related VBN O
to IN O
the DT O
architectural JJ O
factor NN O
HMG NNP O
- HYPH O
I NNP O
/ SYM O
Y NNP O
. . O

We PRP O
analyzed VBD O
the DT O
expression NN O
and CC O
function NN O
of IN O
p8 NN O
in IN O
pancreatic JJ O
cancer NN O
- HYPH O
derived VBN O
cells NNS O
. . O

Methods NNS O

Expression NN O
of IN O
p8 NN O
was VBD O
silenced VBN O
in IN O
the DT O
human JJ B-Species
pancreatic JJ O
cancer NN O
cell NN O
lines NNS O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
by IN O
infection NN O
with IN O
a DT O
retrovirus NN O
expressing VBG O
p8 NN O
RNA NNP O
in IN O
the DT O
antisense JJ O
orientation NN O
. . O

Cell NN O
growth NN O
was VBD O
measured VBN O
in IN O
control NN O
and CC O
p8 NN O
- HYPH O
silenced VBN O
cells NNS O
. . O

Influence NN O
on IN O
p8 NN O
expression NN O
of IN O
the DT O
induction NN O
of IN O
intracellular JJ O
pathways NNS O
promoting VBG O
cellular JJ O
growth NN O
or CC O
growth NN O
arrest NN O
was VBD O
monitored VBN O
. . O

Results NNS O

p8 NN O
- HYPH O
silenced VBN O
cells NNS O
grew VBD O
more RBR O
rapidly RB O
than IN O
control NN O
cells NNS O
transfected VBN O
with IN O
the DT O
empty JJ O
retrovirus NN O
. . O

Activation NN O
of IN O
the DT O
Ras NNPS O
- HYPH O
- : O
> : O
Raf NNP O
- HYPH O
- : O
> : O
MEK NNP O
- HYPH O
- : O
> NFP O
ERK NNP O
and CC O
JNK NNP O
intracellular JJ O
pathways NNS O
down RB O
- HYPH O
regulated VBN O
p8 NN O
expression NN O
. . O

In IN O
addition NN O
, , O
the DT O
MEK1 NNP O
/ SYM O
2 CD O
inhibitor NN O
U0126 NNP O
and CC O
the DT O
JNK NNP O
inhibitor NN O
SP600125 NN O
up RB O
- HYPH O
regulates VBZ O
expression NN O
of IN O
p8 NN O
. . O

Conversely RB O
, , O
p38 NN O
or CC O
TGF NNP O
beta NN O
- HYPH O
1 CD O
induced VBN O
p8 NN O
expression NN O
whereas IN O
the DT O
specific JJ O
p38 NN O
inhibitor NN O
SB203580 NN O
down RB O
- HYPH O
regulated VBN O
p8 NN O
expression NN O
. . O

Finally RB O
, , O
TGF NNP O
beta NN O
- HYPH O
1 CD O
induction NN O
was VBD O
in IN O
part NN O
mediated VBN O
through IN O
p38 NN O
. . O

Conclusions NNS O

p8 NN O
inhibits VBZ O
the DT O
growth NN O
of IN O
human JJ B-Species
pancreatic JJ O
cancer NN O
cells NNS O
. . O

p8 NN O
expression NN O
is VBZ O
induced VBN O
through IN O
pathways NNS O
involved VBN O
in IN O
growth NN O
inhibition NN O
and CC O
repressed VBN O
by IN O
factors NNS O
that WDT O
promote VBP O
cell NN O
growth NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
p8 NN O
belongs VBZ O
to IN O
a DT O
pathway NN O
regulating VBG O
the DT O
growth NN O
of IN O
pancreatic JJ O
cancer NN O
cells NNS O
. . O

Background NN O

While IN O
studying VBG O
the DT O
molecular JJ O
response NN O
of IN O
the DT O
injured VBN O
pancreas NN O
, , O
we PRP O
identified VBD O
a DT O
new JJ O
gene NN O
, , O
called VBN O
p8 NN O
, , O
whose WP$ O
expression NN O
is VBZ O
strongly RB O
induced VBN O
during IN O
the DT O
acute JJ O
phase NN O
of IN O
pancreatitis NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Further JJ O
experiments NNS O
have VBP O
shown VBN O
that IN O
p8 NN O
mRNA NNP O
is VBZ O
activated VBN O
in IN O
almost RB O
all DT O
cells NNS O
in IN O
response NN O
to IN O
several JJ O
stresses NNS O
[ -LRB- O
2 CD O
] -RRB- O
, , O
including VBG O
minimal JJ O
stresses NNS O
such JJ O
as IN O
after IN O
routine JJ O
change NN O
of IN O
the DT O
culture NN O
medium NN O
in IN O
the DT O
absence NN O
of IN O
any DT O
added VBN O
substance NN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
p8 NN O
is VBZ O
a DT O
ubiquitous JJ O
protein NN O
induced VBN O
by IN O
cellular JJ O
stress NN O
. . O

The DT O
p8 NN O
gene NN O
was VBD O
cloned VBN O
in IN O
human NN B-Species
, , O
rat NN B-Species
, , O
mouse NN B-Species
, , O
and CC O
Xenopus NNP B-Species
laevis NNP I-Species
[ -LRB- O
1 CD O
, , O
4 CD O
- HYPH O
6 CD O
] -RRB- O
, , O
conceptually RB O
translated VBN O
from IN O
the DT O
Drosophila NNP B-Species
melanogaster NN I-Species
genome NN O
or CC O
deduced VBN O
from IN O
EST NNP O
libraries NNS O
( , O
Bos NNP B-Species
taurus NN I-Species
, , O
Xenopus NNP B-Species
tropicalis NN I-Species
, , O
Zebrafish NNP B-Species
, , O
Orzzias NNP B-Species
latipes NNP I-Species
, , O
Bombyx NNP B-Species
mori NN I-Species
and CC O
Paralichthys NNP B-Species
olivaceous JJ I-Species
) -RRB- O
. . O

The DT O
overall JJ O
degree NN O
of IN O
homology NN O
with IN O
human JJ B-Species
p8 NN O
ranged VBD O
from IN O
81 CD O
to IN O
40 CD O
% NN O
. . O

Secondary JJ O
structure NN O
prediction NN O
methods NNS O
indicated VBD O
that IN O
within IN O
the DT O
homologous JJ O
region NN O
of IN O
the DT O
eleven CD O
proteins NNS O
, , O
there EX O
is VBZ O
a DT O
basic JJ O
Helix NNP O
- HYPH O
Loop NNP O
- HYPH O
Helix NNP O
secondary JJ O
structure NN O
motif NN O
, , O
characteristic JJ O
of IN O
some DT O
classes NNS O
of IN O
transcription NN O
factors NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Even RB O
though IN O
a DT O
small JJ O
protein NN O
such JJ O
as IN O
p8 NN O
would MD O
not RB O
need VB O
a DT O
nuclear JJ O
localization NN O
signal NN O
( , O
NLS NNP O
) -RRB- O
to TO O
be VB O
transported VBN O
to IN O
the DT O
nucleus NN O
, , O
a DT O
clear JJ O
NLS NNP O
can MD O
be VB O
predicted VBN O
for IN O
the DT O
eleven CD O
proteins NNS O
comprising VBG O
a DT O
bipartite JJ O
domain NN O
of IN O
positively RB O
charged VBN O
aminoacids NNS O
. . O

In IN O
addition NN O
, , O
a DT O
nuclear JJ O
/ SYM O
cytoplasmic JJ O
location NN O
has VBZ O
been VBN O
demonstrated VBN O
for IN O
human JJ B-Species
p8 NN O
upon IN O
overexpression NN O
of IN O
the DT O
recombinant JJ O
protein NN O
and CC O
immunohistochemistry NN O
[ -LRB- O
4 CD O
] -RRB- O
, , O
and CC O
for IN O
recombinant JJ O
Xenopus NNP B-Species
laevis NN I-Species
p8 NN O
fused VBN O
to IN O
green JJ O
fluorescent NN O
protein NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Homology NN O
searching NN O
in IN O
databases NNS O
did VBD O
not RB O
reveal VB O
significant JJ O
similarity NN O
of IN O
p8 NN O
with IN O
other JJ O
proteins NNS O
of IN O
known VBN O
function NN O
. . O

However RB O
, , O
biochemical JJ O
properties NNS O
of IN O
the DT O
mammalian JJ O
p8 NN O
proteins NNS O
are VBP O
shared VBN O
by IN O
some DT O
high JJ O
mobility NN O
group NN O
proteins NNS O
( -LRB- O
HMG NNP O
) -RRB- O
[ -LRB- O
7 CD O
] -RRB- O
, , O
particularly RB O
by IN O
the DT O
HMG NNP O
- HYPH O
I NNP O
/ SYM O
Y NNP O
family NN O
. . O

The DT O
overall JJ O
identity NN O
of IN O
human JJ B-Species
p8 NN O
with IN O
human JJ B-Species
HMG NNP O
- HYPH O
I NN O
/ SYM O
Y NNP O
is VBZ O
only RB O
about RB O
35 CD O
% NN O
, , O
but CC O
the DT O
molecular JJ O
mass NN O
, , O
isoelectric JJ O
point NN O
, , O
hydrophilicity NN O
plot NN O
, , O
the DT O
resistance NN O
to IN O
denaturation NN O
after IN O
heating NN O
at IN O
100 CD O
degrees NNS O
C NN O
and CC O
the DT O
charge NN O
separation NN O
are VBP O
very RB O
similar JJ O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
p8 NN O
protein NN O
seems VBZ O
to TO O
bind VB O
DNA NN O
weakly RB O
, , O
as IN O
shown VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
, , O
without IN O
preference NN O
for IN O
DNA NNP O
sequences NNS O
. . O

Finally RB O
, , O
human JJ B-Species
p8 NN O
has VBZ O
also RB O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
substrate NN O
for IN O
protein NN O
kinase NN O
A NN O
in IN O
vitro FW O
and CC O
phosphorylated VBN O
p8 NN O
has VBZ O
a DT O
higher JJR O
content NN O
of IN O
secondary JJ O
structure NN O
and CC O
binding NN O
to IN O
DNA NN O
is VBZ O
highly RB O
increased VBN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

An DT O
architectural JJ O
role NN O
in IN O
transcription NN O
has VBZ O
been VBN O
proposed VBN O
for IN O
this DT O
protein NN O
, , O
in IN O
analogy NN O
with IN O
the DT O
HMG NNP O
- HYPH O
I NNP O
/ SYM O
Y NNP O
proteins NNS O
, , O
and CC O
a DT O
recent JJ O
work NN O
seems VBZ O
to TO O
confirm VB O
this DT O
hypothesis NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Functions NNS O
of IN O
p8 NN O
appear VBP O
to TO O
be VB O
multiple JJ O
and CC O
complex JJ O
. . O

For IN O
example NN O
, , O
p8 CD O
mRNA NNP O
expression NN O
was VBD O
strongly RB O
induced VBN O
in IN O
3T3 CD O
cells NNS O
upon IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
treatment NN O
which WDT O
in IN O
turn NN O
enhances VBZ O
the DT O
Smad NNP O
- HYPH O
transactivating VBG O
function NN O
responsible JJ O
for IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
activity NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

We PRP O
also RB O
found VBD O
that IN O
p8 NN O
is VBZ O
involved VBN O
in IN O
cell NN O
cycle NN O
regulation NN O
since IN O
p8 NN O
- HYPH O
deficient JJ O
embryonic JJ O
fibroblasts NNS O
grew VBD O
more RBR O
rapidly RB O
and CC O
incorporated VBD O
more JJR O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
and CC O
BrdU NNP O
than IN O
p8 NN O
- HYPH O
expressing VBG O
cells NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Moreover RB O
, , O
expression NN O
of IN O
p8 NN O
in IN O
breast NN O
cancer NN O
- HYPH O
derived VBN O
cells NNS O
seems VBZ O
to TO O
mediate VB O
the DT O
inhibition NN O
of IN O
cell NN O
growth NN O
induced VBN O
by IN O
1 CD O
, , O
25 CD O
- HYPH O
Dihydroxyvitamin NN O
D3 NNP O
[ -LRB- O
12 CD O
] -RRB- O
. . O

On IN O
the DT O
contrary NN O
, , O
we PRP O
also RB O
reported VBD O
that IN O
p8 NN O
may MD O
promote VB O
cell NN O
growth NN O
when WRB O
overexpressed VBN O
in IN O
Cos NNP O
- HYPH O
7 CD O
, , O
AR42J NNP O
and CC O
HeLa NNP O
cells NNS O
[ -LRB- O
1 CD O
, , O
4 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
p8 NN O
seems VBZ O
to TO O
be VB O
involved VBN O
in IN O
other JJ O
intracellular JJ O
functions NNS O
such JJ O
as IN O
apoptosis NN O
since IN O
p8 NN O
- HYPH O
expressing VBG O
fibroblasts NNS O
are VBP O
more RBR O
sensitive JJ O
than IN O
p8 NN O
- HYPH O
deficient JJ O
fibroblasts NNS O
to IN O
the DT O
apoptosis NN O
induced VBN O
by IN O
DNA NNP O
damage NN O
. . O

Also RB O
, , O
p8 NN O
is VBZ O
required VBN O
for IN O
endothelin NN O
- HYPH O
induced VBN O
mesangial JJ O
cell NN O
hypertrophy NN O
in IN O
diabetic JJ O
kidney NN O
, , O
in IN O
a DT O
mechanism NN O
involving VBG O
ERK NNP O
, , O
JNK NNP O
and CC O
PI3 NNP O
kinase NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

p8 NN O
seems VBZ O
to TO O
play VB O
a DT O
functional JJ O
role NN O
in IN O
the DT O
initiation NN O
of IN O
LH NNP O
beta NN O
gene NN O
expression NN O
during IN O
embryonic JJ O
cell NN O
differentiation NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Moreover RB O
, , O
the DT O
Drosophila NNP B-Species
melanogaster NN I-Species
p8 NN O
homologue NN O
is VBZ O
involved VBN O
in IN O
response NN O
to IN O
starvation NN O
and CC O
might MD O
be VB O
activated VBN O
to TO O
stop VB O
cell NN O
growth NN O
in IN O
case NN O
of IN O
nutrient NN O
deprivation NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Finally RB O
, , O
a DT O
particularly RB O
attractive JJ O
role NN O
in IN O
tumour NN O
progression NN O
was VBD O
recently RB O
proposed VBN O
for IN O
p8 NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Fibroblasts NNS O
obtained VBD O
from IN O
p8 NN O
- HYPH O
expressing VBG O
or CC O
p8 NN O
- HYPH O
deficient JJ O
animals NNS O
were VBD O
transformed VBN O
with IN O
a DT O
retroviral JJ O
vector NN O
expressing VBG O
both CC O
the DT O
rasV12 NN O
mutated VBN O
protein NN O
and CC O
the DT O
E1A NNP O
adenoviral JJ O
oncogene NN O
. . O

In IN O
soft JJ O
- HYPH O
agar NN O
assays NNS O
, , O
transformed VBN O
p8 NN O
- HYPH O
expressing VBG O
cells NNS O
formed VBN O
colonies NNS O
at IN O
high JJ O
frequency NN O
, , O
as IN O
expected VBN O
, , O
but CC O
p8 NN O
- HYPH O
deficient JJ O
transformed VBN O
fibroblasts NNS O
were VBD O
unable JJ O
to TO O
form VB O
colonies NNS O
. . O

Similarly RB O
, , O
transformed VBN O
p8 NN O
- HYPH O
expressing VBG O
cells NNS O
produced VBD O
tumours NNS O
in IN O
all DT O
athymic JJ O
nude JJ B-Species
mice NN I-Species
when WRB O
injected VBN O
subcutaneously RB O
or CC O
intraperitoneally RB O
, , O
whereas IN O
transformed VBN O
p8 NN O
- HYPH O
deficient JJ O
fibroblasts NNS O
did VBD O
not RB O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
studies NNS O
by IN O
another DT O
laboratory NN O
revealed VBD O
that IN O
expression NN O
of IN O
the DT O
Com1 NNP O
protein NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
which WDT O
is VBZ O
identical JJ O
to IN O
human JJ B-Species
p8 NN O
, , O
mediates VBZ O
the DT O
growth NN O
of IN O
tumour NN O
cells NNS O
after IN O
metastatic JJ O
establishment NN O
in IN O
a DT O
secondary JJ O
organ NN O
, , O
indicating VBG O
that IN O
activated VBN O
expression NN O
of IN O
Com1 NNP O
/ SYM O
p8 CD O
in IN O
metastatic JJ O
cells NNS O
is VBZ O
required VBN O
for IN O
tumour NN O
progression NN O
. . O

These DT O
results NNS O
strongly RB O
suggest VBP O
that IN O
p8 NN O
is VBZ O
involved VBN O
in IN O
the DT O
cellular JJ O
pathway NN O
( , O
s NNS O
) , O
required VBN O
for IN O
tumour NN O
progression NN O
and CC O
metastasis NN O
. . O

Our PRP$ O
aim NN O
is VBZ O
to TO O
check VB O
the DT O
relevance NN O
of IN O
p8 NN O
to IN O
cancer NN O
progression NN O
in IN O
human NN B-Species
. . O

As IN O
a DT O
first JJ O
step NN O
, , O
we PRP O
investigated VBD O
in IN O
the DT O
present JJ O
study NN O
the DT O
function NN O
of IN O
p8 NN O
in IN O
two CD O
cell NN O
lines NNS O
derived VBN O
from IN O
human JJ B-Species
pancreatic JJ O
cancer NN O
. . O

We PRP O
observed VBD O
that IN O
inhibition NN O
of IN O
p8 NN O
expression NN O
increased VBD O
the DT O
cells NNS O
growth NN O
rate NN O
. . O

In IN O
addition NN O
, , O
activations NNS O
of IN O
the DT O
Ras NNPS O
- HYPH O
- HYPH O
> : O
Raf NNP O
- HYPH O
- : O
> : O
MEK NNP O
- HYPH O
- HYPH O
> NFP O
ERK NNP O
and CC O
JNK NNP O
intracellular JJ O
pathways NNS O
, , O
which WDT O
promote VBP O
the DT O
growth NN O
of IN O
pancreatic JJ O
cells NNS O
, , O
down RB O
- HYPH O
regulated VBN O
p8 NN O
expression NN O
, , O
whereas IN O
activation NN O
of IN O
p38 NN O
or CC O
TGF NN O
beta NN O
- HYPH O
1 CD O
, , O
which WDT O
inhibit VBP O
cell NN O
growth NN O
, , O
induced VBD O
its PRP$ O
expression NN O
. . O

It PRP O
was VBD O
concluded VBN O
that IN O
i PRP O
/ SYM O
p8 NN O
inhibits VBZ O
the DT O
growth NN O
of IN O
human JJ B-Species
pancreatic JJ O
cancer NN O
cell NN O
lines NNS O
, , O
ii IN O
/ SYM O
p8 NN O
expression NN O
is VBZ O
induced VBN O
through IN O
pathways NNS O
involved VBN O
in IN O
growth NN O
inhibition NN O
and CC O
, , O
conversely RB O
, , O
repressed VBN O
by IN O
factors NNS O
that WDT O
promote VBP O
cell NN O
growth NN O
. . O

Results NNS O

p8 NN O
is VBZ O
silenced VBN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O
by IN O
infection NN O
with IN O
a DT O
retrovirus NN O
expressing VBG O
p8 NN O
RNA NN O
in IN O
the DT O
antisense JJ O
orientation NN O

Panc NN O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
pancreatic JJ O
cells NNS O
were VBD O
chosen VBN O
for IN O
this DT O
study NN O
because IN O
, , O
on IN O
the DT O
one CD O
hand NN O
, , O
both DT O
cells NNS O
express VBP O
higher JJR O
level NN O
of IN O
p8 NN O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
and CC O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
because IN O
Panc NNP O
- HYPH O
1 CD O
is VBZ O
wild JJ O
- HYPH O
type NN O
for IN O
Smad4 NNP O
/ SYM O
DPC4 NNP O
and CC O
mutated VBN O
for IN O
K NNP O
- HYPH O
ras NN O
, , O
while IN O
BxPc NNP O
- HYPH O
3 CD O
is VBZ O
Smad4 NNP O
/ SYM O
DPC4 NNP O
mutated VBN O
and CC O
K NN O
- HYPH O
ras NN O
wild JJ O
- HYPH O
type NN O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
, , O
therefore RB O
representing VBG O
different JJ O
mechanisms NNS O
of IN O
transformation NN O
and CC O
different JJ O
genetic JJ O
backgrounds NNS O
. . O

K NN O
- HYPH O
ras NNP O
and CC O
Smad4 NNP O
/ SYM O
DPC4 NNP O
mutations NNS O
are VBP O
the DT O
major JJ O
mechanisms NNS O
involved VBN O
in IN O
pancreatic JJ O
cancer NN O
development NN O
. . O

We PRP O
inhibited VBD O
p8 NN O
expression NN O
in IN O
both CC O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
pancreatic JJ O
cells NNS O
by IN O
infecting VBG O
cells NNS O
with IN O
a DT O
retrovirus NN O
expressing VBG O
the DT O
p8 NN O
asRNA NN O
( , O
antisense NN O
RNA NNP O
) -RRB- O
and CC O
carrying VBG O
the DT O
puromycin NN O
resistance NN O
. . O

The DT O
antibiotic NN O
- HYPH O
selected VBN O
cells NNS O
were VBD O
analyzed VBN O
by IN O
Western JJ O
blotting NN O
to TO O
evaluate VB O
the DT O
intracellular JJ O
amounts NNS O
of IN O
p8 NN O
protein NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
2 CD O
, , O
the DT O
p8 NN O
protein NN O
was VBD O
clearly RB O
visible JJ O
in IN O
both CC O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
pancreatic JJ O
cells NNS O
infected VBN O
with IN O
the DT O
empty JJ O
retrovirus NN O
but CC O
almost RB O
undetectable JJ O
in IN O
cells NNS O
infected VBN O
with IN O
the DT O
retrovirus NN O
encoding VBG O
the DT O
p8 NN O
asRNA NNP O
showed VBD O
, , O
indicating VBG O
that IN O
our PRP$ O
anti AFX O
- HYPH O
sense NN O
strategy NN O
is VBZ O
efficient JJ O
to TO O
silence VB O
p8 NN O
gene NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O
. . O

Preliminary JJ O
studies NNS O
had VBD O
been VBN O
conducted VBN O
to TO O
select VB O
the DT O
best JJS O
strategy NN O
to TO O
inhibit VB O
p8 NN O
expression NN O
. . O

We PRP O
compared VBD O
the DT O
efficacy NN O
of IN O
the DT O
stable JJ O
transfection NN O
of IN O
a DT O
siRNA NNP O
, , O
using VBG O
a DT O
retroviral JJ O
expression NN O
vector NN O
to IN O
the DT O
asRNA NN O
strategy NN O
described VBN O
above RB O
. . O

In IN O
our PRP$ O
hands NNS O
, , O
the DT O
antisense JJ O
strategy NN O
worked VBD O
best RBS O
, , O
as IN O
judged VBN O
from IN O
Western JJ O
blot NN O
assessment NN O
of IN O
p8 NN O
protein NN O
expression NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

p8 NN O
- HYPH O
silenced VBN O
pancreatic JJ O
cells NNS O
grow VBP O
more RBR O
rapidly RB O

We PRP O
compared VBD O
in IN O
the DT O
two CD O
cell NN O
lines NNS O
the DT O
influence NN O
on IN O
growth NN O
parameters NNS O
of IN O
blocking VBG O
p8 NN O
expression NN O
with IN O
the DT O
p8 NN O
asRNA NN O
. . O

Figure NN O
3 CD O
shows VBZ O
that IN O
both CC O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
cells NNS O
in IN O
which WDT O
p8 NN O
has VBZ O
been VBN O
silenced VBN O
grew VBN O
more RBR O
rapidly RB O
than IN O
cells NNS O
infected VBN O
with IN O
the DT O
empty JJ O
vector NN O
suggesting VBG O
that IN O
inhibition NN O
by IN O
p8 NN O
of IN O
pancreatic JJ O
cancer NN O
cell NN O
growth NN O
is VBZ O
independent JJ O
from IN O
the DT O
mechanism NN O
of IN O
transformation NN O
and CC O
genetic JJ O
background NN O
. . O

Serum NN O
- HYPH O
stimulated VBN O
cellular JJ O
growth NN O
down RB O
- HYPH O
regulates VBZ O
p8 NN O
expression NN O

Fetal JJ O
calf NN B-Species
serum NN O
, , O
which WDT O
contains VBZ O
a DT O
complex JJ O
mix NN O
of IN O
growth NN O
factors NNS O
, , O
can MD O
be VB O
used VBN O
as IN O
inductor NN O
of IN O
cell NN O
growth NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
4 CD O
expression NN O
of IN O
p8 NN O
mRNA NNP O
was VBD O
down IN O
- HYPH O
regulated VBN O
in IN O
both CC O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
when WRB O
the DT O
cells NNS O
were VBD O
shifted VBN O
from IN O
culture NN O
media NN O
containing VBG O
0 CD O
. . O
1 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
to IN O
media NN O
containing VBG O
10 CD O
% NN O
FCS NNP O
. . O

p8 NN O
protein NN O
showed VBD O
a DT O
similar JJ O
behavior NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
p8 NN O
expression NN O
is VBZ O
down RB O
- HYPH O
regulated VBN O
in IN O
growing VBG O
pancreatic JJ O
cells NNS O
. . O

The DT O
Ras NNPS O
- HYPH O
- HYPH O
> : O
Raf NNP O
- HYPH O
- : O
> : O
MEK NNP O
- HYPH O
- : O
> NFP O
ERK NNP O
pathway NN O
down RB O
- HYPH O
regulates VBZ O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O

Most JJS O
human JJ B-Species
pancreatic JJ O
cancers NNS O
harbor VBP O
mutations NNS O
in IN O
the DT O
K NNP O
- HYPH O
ras NNP O
oncogene NN O
, , O
which WDT O
happens VBZ O
relatively RB O
early RB O
in IN O
pancreatic JJ O
tumorigenesis NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

The DT O
oncogenic JJ O
mutation NN O
of IN O
the DT O
K NNP O
- HYPH O
ras NN O
gene NN O
stabilizes VBZ O
the DT O
Ras NNP O
protein NN O
in IN O
a DT O
GTP NN O
- HYPH O
bound VBN O
form NN O
, , O
which WDT O
is VBZ O
constitutively RB O
active JJ O
and CC O
make VB O
the DT O
cells NNS O
grow VB O
more RBR O
rapidly RB O
. . O

Contrary JJ O
to IN O
the DT O
activated VBN O
Ras NNP O
protein NN O
, , O
p8 NN O
inhibits VBZ O
cell NN O
growth NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

We PRP O
looked VBD O
whether IN O
the DT O
Ras NNPS O
- HYPH O
- HYPH O
> : O
Raf NNP O
- HYPH O
- : O
> : O
MEK NNP O
- HYPH O
- : O
> : O
ERK NNP O
pathway NN O
was VBD O
also RB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
p8 NN O
expression NN O
, , O
and CC O
which WDT O
step NN O
( -LRB- O
s VBZ O
) -RRB- O
were VBD O
critical JJ O
. . O

Figure NN O
5 CD O
shown VBN O
that DT O
expression NN O
of IN O
a DT O
mutated VBN O
form NN O
of IN O
the DT O
Ras NNP O
protein NN O
( , O
rasV12 NN O
) -RRB- O
in IN O
BxPc NNP O
- HYPH O
3 CD O
cells NNS O
, , O
which WDT O
are VBP O
wild JJ O
- HYPH O
type NN O
for IN O
ras NN O
, , O
resulted VBD O
in IN O
decreased VBN O
p8 NN O
mRNA NN O
concentration NN O
and CC O
protein NN O
level NN O
suggesting VBG O
that IN O
the DT O
activated VBN O
ras NN O
inhibits VBZ O
p8 NN O
expression NN O
. . O

Figure NN O
6 CD O
shows VBZ O
that IN O
overexpression NN O
of IN O
Raf NNP O
, , O
but CC O
not RB O
of IN O
Raf301 NNP O
( , O
a DT O
negative JJ O
mutant NN O
of IN O
Raf NNP O
) -RRB- O
, , O
and CC O
of IN O
ERK NNP O
also RB O
inhibited VBD O
the DT O
expression NN O
of IN O
the DT O
p8 NN O
- HYPH O
CAT NN O
construct NN O
in IN O
Panc NNP O
- HYPH O
1 CD O
as RB O
well RB O
as IN O
in IN O
BxPc NNP O
- HYPH O
3 CD O
. . O

Finally RB O
, , O
the DT O
MEK1 NNP O
/ SYM O
2 CD O
specific JJ O
inhibitor NN O
U0126 NNP O
[ -LRB- O
21 CD O
] -RRB- O
activated VBD O
p8 NN O
mRNA NN O
expression NN O
in IN O
pancreatic JJ O
cells NNS O
whether IN O
they PRP O
carry VBP O
mutated VBN O
ras NNS O
( , O
Panc NNP O
- HYPH O
1 CD O
) , O
or CC O
wild JJ O
- HYPH O
type NN O
( , O
BxPc NNP O
- HYPH O
3 CD O
) -RRB- O
. . O

Similar JJ O
results NNS O
were VBD O
observed VBN O
when WRB O
expression NN O
of IN O
the DT O
p8 NN O
protein NN O
was VBD O
monitored VBN O
by IN O
Western JJ O
blotting NN O
( -LRB- O
Figure NN O
7 CD O
) -RRB- O
. . O

Activation NN O
of IN O
the DT O
JNK NNP O
pathway NN O
down IN O
- HYPH O
regulates VBZ O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O

c LS O
- HYPH O
Jun NNP O
NH2 NNP O
- HYPH O
terminal NN O
kinase NN O
( : O
JNK NNP O
) -RRB- O
is VBZ O
another DT O
major JJ O
MAPK NNP O
pathway NN O
which WDT O
converts VBZ O
extracellular JJ O
signals NNS O
into IN O
expression NN O
of IN O
specific JJ O
target NN O
genes NNS O
through IN O
phosphorylation NN O
and CC O
activation NN O
of IN O
transcription NN O
factors NNS O
. . O

JNK NNP O
activation NN O
has VBZ O
been VBN O
implicated VBN O
in IN O
various JJ O
, , O
often RB O
opposite JJ O
cellular JJ O
responses NNS O
, , O
such JJ O
as IN O
cell NN O
proliferation NN O
, , O
transformation NN O
and CC O
apoptosis NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
8 CD O
, , O
overexpression NN O
of IN O
JNK NNP O
down RB O
- HYPH O
regulates VBZ O
the DT O
gene NN O
reporter NN O
activity NN O
of IN O
the DT O
p8 CD O
- HYPH O
CAT NN O
construct NN O
in IN O
Panc NNP O
- HYPH O
1 CD O
cells NNS O
. . O

Similar JJ O
results NNS O
were VBD O
found VBN O
in IN O
BxPc NNP O
- HYPH O
3 CD O
cells NNS O
. . O

Treatment NN O
of IN O
these DT O
cells NNS O
with IN O
the DT O
JNK NNP O
specific JJ O
inhibitor NN O
SP600125 NN O
[ -LRB- O
22 CD O
] -RRB- O
up RB O
- HYPH O
regulates VBZ O
expression NN O
of IN O
the DT O
p8 NN O
mRNA NN O
and CC O
p8 NN O
protein NN O
( -LRB- O
Figure NN O
9 CD O
) -RRB- O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
JNK NNP O
pathway NN O
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
p8 NN O
expression NN O
. . O

The DT O
p38 NN O
pathway NN O
up RB O
- HYPH O
regulates VBZ O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O

The DT O
p38 NN O
signal NN O
transduction NN O
pathway NN O
also RB O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
regulating VBG O
several JJ O
cell NN O
functions NNS O
including VBG O
growth NN O
, , O
response NN O
to IN O
inflammation NN O
, , O
differentiation NN O
and CC O
apoptosis NN O
. . O

In IN O
fact NN O
, , O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O
, , O
p38 NN O
is VBZ O
a DT O
strong JJ O
inhibitor NN O
of IN O
proliferation NN O
[ -LRB- O
23 CD O
] -RRB- O
contrary JJ O
to IN O
the DT O
Ras NNPS O
- HYPH O
- : O
> : O
Raf NNP O
- HYPH O
- : O
> : O
MEK NNP O
- HYPH O
- HYPH O
> NFP O
ERK NNP O
and CC O
JNK NNP O
pathways NNS O
. . O

We PRP O
therefore RB O
analyzed VBD O
the DT O
putative JJ O
role NN O
of IN O
the DT O
p38 NN O
pathway NN O
in IN O
regulating VBG O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O
. . O

Figure NN O
10 CD O
shows VBZ O
that IN O
over IN O
- HYPH O
expression NN O
of IN O
the DT O
plasmid NN O
encoding NN O
p38 NN O
significantly RB O
increases VBZ O
p8 CD O
- HYPH O
CAT NN O
activity NN O
in IN O
Panc NNP O
- HYPH O
1 CD O
as RB O
well RB O
as IN O
in IN O
BxPc NNP O
- HYPH O
3 CD O
cells NNS O
. . O

Then RB O
, , O
cells NNS O
were VBD O
treated VBN O
with IN O
SB203580 NN O
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
p38 NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
and CC O
p8 NN O
expression NN O
was VBD O
measured VBN O
. . O

p8 NN O
mRNA NNP O
as RB O
well RB O
as IN O
the DT O
encoded VBN O
protein NN O
were VBD O
down RB O
- HYPH O
regulated VBN O
after IN O
inhibition NN O
of IN O
the DT O
p38 NN O
activity NN O
( -LRB- O
Figure NNP O
11 CD O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
p38 NN O
pathway NN O
is VBZ O
a DT O
positive JJ O
regulator NN O
of IN O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O
. . O

TGF NNP O
beta NN O
- HYPH O
1 CD O
up IN O
- HYPH O
regulates VBZ O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cancer NN O
cells NNS O

The DT O
most RBS O
prominent JJ O
biological JJ O
activity NN O
of IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
is VBZ O
its PRP$ O
potent JJ O
inhibition NN O
of IN O
cell NN O
growth NN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
cell NN O
types NNS O
including VBG O
pancreatic JJ O
cells NNS O
. . O

TGF NNP O
beta NN O
- HYPH O
1 CD O
signals NNS O
are VBP O
sent VBN O
through IN O
two CD O
types NNS O
of IN O
transmembrane NN O
serine NN O
/ SYM O
threonine NN O
kinase NN O
receptors NNS O
. . O

In IN O
fact NN O
, , O
TGF NNP O
beta NN O
- HYPH O
1 CD O
binds NNS O
and CC O
brings VBZ O
together RB O
the DT O
type NN O
I NN O
and CC O
type NN O
II NNP O
receptors NNS O
. . O

In IN O
the DT O
resulting VBG O
complex NN O
, , O
the DT O
constitutively RB O
active JJ O
TGF NNP O
beta NN O
- HYPH O
1 CD O
type NN O
II NN O
receptor NN O
phosphorylates VBZ O
the DT O
type NN O
I NN O
receptor NN O
, , O
which WDT O
then RB O
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
transducing VBG O
the DT O
signal NN O
to IN O
downstream JJ O
components NNS O
to TO O
affect VB O
gene NN O
expression NN O
through IN O
phosphorylation NN O
of IN O
SMAD NNP O
proteins NNS O
. . O

Phosphorylated JJ O
receptor NN O
- HYPH O
regulated VBN O
SMADs NNPS O
then RB O
form VBP O
heteromeric JJ O
complexes NNS O
with IN O
the DT O
common JJ O
partner NN O
SMAD4 NNP O
. . O

These DT O
heteromeric JJ O
complexes NNS O
then RB O
move VBP O
to IN O
the DT O
nucleus NN O
, , O
where WRB O
SMAD4 NNP O
will MD O
bind VB O
DNA NN O
and CC O
contribute VB O
to IN O
transcriptional JJ O
activation NN O
. . O

In IN O
general JJ O
, , O
pancreatic JJ O
cancer NN O
cells NNS O
present JJ O
with IN O
defects NNS O
in IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
signaling NN O
and CC O
are VBP O
resistant JJ O
to IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
- HYPH O
mediated VBN O
growth NN O
suppression NN O
. . O

Since IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
and CC O
p8 CD O
are VBP O
inhibitors NNS O
of IN O
pancreatic JJ O
cell NN O
growth NN O
we PRP O
analyzed VBD O
whether IN O
p8 NN O
could MD O
mediate VB O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
the DT O
effect NN O
of IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
. . O

First RB O
, , O
we PRP O
found VBD O
that IN O
treatment NN O
of IN O
Panc NNP O
- HYPH O
1 CD O
cells NNS O
with IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
increased VBD O
p8 NN O
mRNA NN O
levels NNS O
and CC O
p8 NN O
protein NN O
as IN O
judged VBN O
by IN O
Western JJ O
blot NN O
( -LRB- O
Figure NNP O
12 CD O
) -RRB- O
. . O

Then RB O
, , O
to TO O
confirm VB O
that IN O
overexpression NN O
is VBZ O
regulated VBN O
at IN O
the DT O
transcriptional JJ O
level NN O
, , O
we PRP O
analyzed VBD O
the DT O
effect NN O
of IN O
some DT O
constructs NNS O
expressing VBG O
constitutively RB O
activated VBN O
type NN O
I NNP O
TGF NNP O
beta JJ O
receptor NN O
, , O
dominant JJ O
negative JJ O
type NN O
II NN O
TGF NNP O
beta NN O
receptor NN O
, , O
a DT O
dominant JJ O
negative JJ O
of IN O
Smad4 NNP O
and CC O
the DT O
wild JJ O
- HYPH O
type NN O
Smad4 NN O
on IN O
the DT O
p8 NN O
- HYPH O
CAT NN O
activity NN O
. . O

As IN O
expected VBN O
, , O
the DT O
constitutively RB O
activated VBN O
type NN O
I NNP O
TGF NNP O
beta NN O
receptor NN O
but CC O
not RB O
the DT O
dominant JJ O
negative JJ O
type NN O
II NNP O
TGF NNP O
beta NN O
receptor NN O
increased VBD O
CAT NNP O
activity NN O
. . O

Also RB O
, , O
expression NN O
of IN O
the DT O
Smad4 NNP O
, , O
contrary JJ O
to IN O
that DT O
of IN O
the DT O
negative JJ O
mutant JJ O
, , O
induced VBN O
p8 NN O
transcription NN O
( -LRB- O
Figure NNP O
13 CD O
) -RRB- O
. . O

Together RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
p8 NN O
is VBZ O
positively RB O
regulated VBN O
by IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
. . O

Beside IN O
the DT O
Smad NNP O
proteins NNS O
, , O
TGF NNP O
beta NN O
- HYPH O
1 CD O
also RB O
activates VBZ O
the DT O
p38 NN O
MAPK NNP O
pathway NN O
in IN O
pancreas NN O
- HYPH O
derived VBN O
cells NNS O
, , O
which WDT O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
induced VBN O
genes NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
analyzed VBD O
the DT O
p38 NN O
- HYPH O
dependent JJ O
effect NN O
of IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
on IN O
p8 NN O
transcription NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
13 CD O
, , O
inhibition NN O
of IN O
p38 NN O
activity NN O
with IN O
the DT O
SB203580 NNP O
specific JJ O
inhibitor NN O
decreased VBD O
about RB O
40 CD O
% NN O
the DT O
activity NN O
of IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
on IN O
the DT O
p8 NN O
promoter NN O
indicating VBG O
that IN O
the DT O
effect NN O
of IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
on IN O
p8 NN O
promoter NN O
is VBZ O
mediated VBN O
by IN O
both DT O
p38 NN O
- HYPH O
dependent JJ O
and CC O
p38 NN O
- HYPH O
independent JJ O
pathways NNS O
. . O

Discussion NN O

Pancreatic JJ O
adenocarcinoma NN O
is VBZ O
the DT O
fourth RB O
leading VBG O
cause NN O
of IN O
death NN O
from IN O
malignant JJ O
diseases NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

The DT O
aggressive JJ O
nature NN O
of IN O
the DT O
neoplasia NN O
, , O
the DT O
lack NN O
of IN O
early JJ O
detection NN O
, , O
and CC O
the DT O
limited VBN O
response NN O
to IN O
treatments NNS O
such JJ O
as IN O
chemotherapy NN O
and CC O
radiotherapy NN O
contribute VBP O
to IN O
the DT O
high JJ O
mortality NN O
rate NN O
of IN O
the DT O
disease NN O
. . O

Therefore RB O
, , O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
molecular JJ O
mechanism NN O
leading VBG O
to IN O
pancreatic JJ O
cancer NN O
remains VBZ O
a DT O
major JJ O
goal NN O
because IN O
it PRP O
may MD O
help VB O
proposing VBG O
strategies NNS O
for IN O
earlier JJR O
diagnosis NN O
and CC O
better JJR O
treatment NN O
. . O

The DT O
most RBS O
commonly RB O
altered VBN O
genes NNS O
in IN O
pancreatic JJ O
adenocarcinoma NN O
are VBP O
K NNP O
- HYPH O
ras NNP O
( : O
75 CD O
to TO O
100 CD O
% NN O
) -RRB- O
, , O
p16INK4a NN O
( : O
95 CD O
% NN O
) -RRB- O
, , O
p53 CD O
( SYM O
50 CD O
to TO O
75 CD O
% NN O
) -RRB- O
and CC O
DPC4 NN O
( : O
50 CD O
% NN O
) -RRB- O
[ -LRB- O
27 CD O
- SYM O
31 CD O
] -RRB- O
. . O

Whereas IN O
K NN O
- HYPH O
ras NNP O
is VBZ O
a DT O
proto NN O
- HYPH O
oncogene NN O
all PDT O
the DT O
others NNS O
are VBP O
tumour NN O
suppressor NN O
genes NNS O
. . O

Additional JJ O
genes NNS O
have VBP O
been VBN O
found VBN O
altered VBN O
at IN O
lower JJR O
frequency NN O
. . O

Panc NN O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
pancreatic JJ O
cells NNS O
were VBD O
chosen VBN O
for IN O
this DT O
study NN O
because IN O
they PRP O
both DT O
express VBP O
high JJ O
levels NNS O
of IN O
p8 NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
and CC O
because IN O
they PRP O
present VBP O
with IN O
different JJ O
mechanisms NNS O
of IN O
transformation NN O
and CC O
genetic JJ O
backgrounds NNS O
, , O
Panc NNP O
- HYPH O
1 CD O
being VBG O
wild JJ O
- HYPH O
type NN O
for IN O
Smad4 NNP O
/ SYM O
DPC4 NNP O
but CC O
mutated VBN O
for IN O
K NNP O
- HYPH O
ras NNP O
and CC O
BxPc NNP O
- HYPH O
3 CD O
mutated VBN O
for IN O
Smad4 NNP O
/ SYM O
DPC4 NNP O
and CC O
wild JJ O
- HYPH O
type NN O
for IN O
K NNP O
- HYPH O
ras NNP O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
. . O

This DT O
work NN O
presents VBZ O
evidences NNS O
that IN O
p8 NN O
inhibits VBZ O
the DT O
growth NN O
rate NN O
of IN O
pancreatic JJ O
cancer NN O
- HYPH O
derived VBN O
cells NNS O
and CC O
that IN O
the DT O
intracellular JJ O
pathways NNS O
promoting VBG O
cell NN O
growth NN O
down RB O
- HYPH O
regulate VBP O
p8 NN O
expression NN O
whereas IN O
those DT O
promoting VBG O
growth NN O
arrest NN O
up RB O
- HYPH O
regulate VBP O
its PRP$ O
expression NN O
. . O

Together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
p8 NN O
is VBZ O
downstream JJ O
of IN O
some DT O
cell NN O
growth NN O
regulators NNS O
and CC O
therefore RB O
regulation NN O
of IN O
p8 NN O
expression NN O
or CC O
its PRP$ O
activity NN O
could MD O
be VB O
used VBN O
as IN O
a DT O
target NN O
for IN O
treating VBG O
pancreatic JJ O
cancer NN O
. . O

Silencing VBG O
p8 NN O
expression NN O
was VBD O
able JJ O
to TO O
strongly RB O
promote VB O
cell NN O
growth NN O
in IN O
both DT O
cell NN O
types NNS O
, , O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
, , O
suggesting VBG O
that IN O
p8 NN O
may MD O
act VB O
downstream RB O
of IN O
the DT O
ras NN O
- HYPH O
or CC O
Smad4 NNP O
/ SYM O
DPC4 NNP O
- HYPH O
dependent JJ O
ways NNS O
. . O

Also RB O
, , O
we PRP O
found VBD O
that IN O
stimulating VBG O
cell NN O
growth NN O
by IN O
the DT O
complex JJ O
combination NN O
of IN O
growth NN O
factors NNS O
contained VBN O
in IN O
fetal JJ O
calf NN B-Species
serum NN O
down RB O
- HYPH O
regulated VBN O
expression NN O
of IN O
p8 NN O
whereas IN O
, , O
on IN O
the DT O
contrary NN O
, , O
treating VBG O
the DT O
cells NNS O
with IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
, , O
which WDT O
promotes VBZ O
cell NN O
cycle NN O
arrest NN O
, , O
stimulates VBZ O
p8 NN O
expression NN O
. . O

Therefore RB O
, , O
p8 NN O
gene NN O
expression NN O
seems VBZ O
to TO O
be VB O
regulated VBN O
in IN O
opposite JJ O
directions NNS O
by IN O
mechanisms NNS O
promoting VBG O
cell NN O
growth NN O
or CC O
cell NN O
cycle NN O
arrest NN O
. . O

It PRP O
is VBZ O
interesting JJ O
to TO O
note VB O
that IN O
while IN O
p8 NN O
expression NN O
is VBZ O
under IN O
the DT O
control NN O
of IN O
cell NN O
growth NN O
regulatory JJ O
pathways NNS O
such JJ O
as IN O
Ras NNP O
- HYPH O
- : O
> : O
Raf NNP O
- HYPH O
- : O
> : O
MEK NNP O
- HYPH O
- : O
> : O
ERK NNP O
, , O
JNK NNP O
, , O
p38 CD O
and CC O
TGF NNP O
beta NN O
- HYPH O
1 CD O
, , O
p8 NN O
can MD O
affect VB O
cell NN O
cycle NN O
progression NN O
, , O
suggesting VBG O
that IN O
p8 NN O
is VBZ O
a DT O
target NN O
for IN O
factors NNS O
regulating VBG O
pancreatic JJ O
cell NN O
growth NN O
. . O

A DT O
mechanism NN O
by IN O
which WDT O
p8 NN O
could MD O
regulate VB O
cell NN O
cycle NN O
progression NN O
in IN O
embryonic JJ O
fibroblasts NNS O
was VBD O
previously RB O
proposed VBN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
fact NN O
, , O
p8 NN O
seems VBZ O
to TO O
take VB O
action NN O
upstream RB O
from IN O
cyclin NN O
- HYPH O
dependent JJ O
kinases NNS O
because IN O
the DT O
intracellular JJ O
levels NNS O
and CC O
activities NNS O
of IN O
Cdk2 NNP O
and CC O
Cdk4 NNP O
are VBP O
decreased VBN O
when WRB O
p8 NN O
is VBZ O
expressed VBN O
. . O

Concomitantly RB O
, , O
the DT O
cyclin NN O
- HYPH O
dependent JJ O
kinase NN O
inhibitor NN O
p27 NN O
is VBZ O
expressed VBN O
at IN O
a DT O
low JJ O
level NN O
in IN O
p8 NN O
- HYPH O
deficient JJ O
cells NNS O
which WDT O
may MD O
explain VB O
the DT O
increased JJ O
activity NN O
of IN O
Cdk2 NNP O
and CC O
Cdk4 NNP O
. . O

The DT O
mechanism NN O
by IN O
which WDT O
p8 NN O
regulates VBZ O
the DT O
intracellular JJ O
level NN O
of IN O
those DT O
proteins NNS O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

However RB O
, , O
because IN O
p8 NN O
is VBZ O
a DT O
transcriptional JJ O
cofactor NN O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
regulation NN O
of IN O
expression NN O
of IN O
these DT O
molecules NNS O
takes VBZ O
place NN O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
at IN O
the DT O
transcription NN O
level NN O
. . O

Interestingly RB O
, , O
expression NN O
of IN O
p8 NN O
mRNA NNP O
seems VBZ O
to TO O
be VB O
regulated VBN O
in IN O
a DT O
cell NN O
type NN O
- HYPH O
and CC O
stimulus NN O
- HYPH O
specific JJ O
manner NN O
since IN O
, , O
for IN O
example NN O
, , O
p38 NN O
can MD O
induce VB O
p8 NN O
expression NN O
in IN O
response NN O
to IN O
stress NN O
in IN O
fibroblasts NNS O
[ -LRB- O
3 CD O
] -RRB- O
but CC O
not RB O
in IN O
renal JJ O
mesangial JJ O
cells NNS O
treated VBN O
with IN O
endothelin NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
pancreatic JJ O
cancer NN O
- HYPH O
derived VBN O
cells NNS O
p38 NN O
seems VBZ O
to TO O
play VB O
a DT O
major JJ O
role NN O
since IN O
it PRP O
is VBZ O
involved VBN O
in IN O
p8 NN O
activation NN O
as IN O
judged VBN O
by IN O
transient JJ O
transfection NN O
assays NNS O
and CC O
using VBG O
a DT O
specific JJ O
p38 NN O
inhibitor NN O
( -LRB- O
Figures NNS O
10 CD O
and CC O
11 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
p38 NN O
is VBZ O
also RB O
involved VBN O
in IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
- HYPH O
induced VBN O
p8 NN O
expression NN O
because IN O
about RB O
40 CD O
% NN O
of IN O
the DT O
TGF NNP O
beta NN O
- HYPH O
1 CD O
effect NN O
was VBD O
abolished VBN O
when WRB O
p38 NN O
activity NN O
was VBD O
specifically RB O
blocked VBN O
( -LRB- O
Figure NNP O
13 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
ERK NNP O
and CC O
JNK NNP O
are VBP O
inducers NNS O
of IN O
p8 NN O
expression NN O
in IN O
mesangial JJ O
cells NNS O
treated VBN O
with IN O
endothelin NN O
, , O
but CC O
not RB O
involved VBN O
in IN O
the DT O
activation NN O
of IN O
p8 NN O
in IN O
response NN O
to IN O
stress NN O
in IN O
fibroblasts NNS O
[ -LRB- O
3 CD O
] -RRB- O
, , O
and CC O
even RB O
repressors NNS O
in IN O
pancreatic JJ O
cells NNS O
( , O
Figures NNS O
5 CD O
, , O
6 CD O
, , O
7 CD O
, , O
8 CD O
and CC O
9 CD O
) -RRB- O
. . O

Finally RB O
, , O
PI3 NNP O
kinase NN O
is VBZ O
an DT O
inducer NN O
of IN O
p8 NN O
expression NN O
in IN O
both CC O
endothelin NN O
- HYPH O
mediated VBN O
p8 NN O
activation NN O
in IN O
mesangial JJ O
cells NNS O
[ -LRB- O
13 CD O
] -RRB- O
and CC O
pancreatic JJ O
cells NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Based VBN O
on IN O
these DT O
observations NNS O
, , O
overexpression NN O
of IN O
p8 NN O
could MD O
be VB O
considered VBN O
a DT O
possible JJ O
goal NN O
for IN O
treating VBG O
pancreatic JJ O
tumours NNS O
, , O
in IN O
order NN O
to TO O
limit VB O
their PRP$ O
growth NN O
. . O

However RB O
, , O
we PRP O
previously RB O
reported VBD O
that IN O
p8 NN O
repression NN O
would MD O
prevent VB O
rasV12 NN O
/ SYM O
E1A NNP O
transformed VBN O
fibroblasts NNS O
from IN O
evolving VBG O
as IN O
tumours NNS O
in IN O
nude JJ B-Species
mice NNS I-Species
[ -LRB- O
16 CD O
] -RRB- O
. . O

This DT O
apparent JJ O
contradiction NN O
needs VBZ O
to TO O
be VB O
resolved VBN O
before IN O
considering VBG O
p8 NN O
as IN O
a DT O
target NN O
for IN O
treating VBG O
cancer NN O
progression NN O
. . O

Conclusions NNS O

In IN O
conclusion NN O
( , O
see VB O
Figure NNP O
14 CD O
) -RRB- O
, , O
we PRP O
report VBP O
in IN O
this DT O
paper NN O
that IN O
inhibition NN O
of IN O
p8 NN O
expression NN O
by IN O
an DT O
anti AFX O
- HYPH O
sense NN O
strategy NN O
increases VBZ O
the DT O
growth NN O
rate NN O
of IN O
both CC O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
pancreatic JJ O
cancer NN O
- HYPH O
derived VBN O
cells NNS O
. . O

Moreover RB O
, , O
ERK NNP O
- HYPH O
and CC O
JNK NNP O
- HYPH O
mediated VBN O
pathways NNS O
down RB O
- HYPH O
regulate VBP O
p8 NN O
expression NN O
, , O
whereas IN O
p38 NN O
and CC O
TGF NNP O
beta NN O
- HYPH O
1 CD O
pathways NNS O
induce VBP O
p8 NN O
expression NN O
. . O

Also RB O
, , O
cell NN O
growth NN O
triggered VBN O
by IN O
expression NN O
of IN O
a DT O
RAS NNP O
mutated VBN O
protein NN O
or CC O
by IN O
10 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
induces VBZ O
down IN O
- HYPH O
regulation NN O
of IN O
p8 NN O
expression NN O
. . O

Together RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
p8 NN O
is VBZ O
an DT O
intracellular JJ O
cell NN O
growth NN O
inhibitor NN O
and CC O
that IN O
it PRP O
is VBZ O
oppositely RB O
regulated VBN O
by IN O
growth NN O
- HYPH O
promoting VBG O
or CC O
growth NN O
- HYPH O
inhibiting VBG O
factors NNS O
in IN O
pancreatic JJ O
cancer NN O
- HYPH O
derived VBN O
cells NNS O
. . O

Material NN O
and CC O
Methods NNPS O

Cell NN O
lines NNS O
and CC O
cell NN O
culture NN O
conditions NNS O

The DT O
human JJ B-Species
pancreatic JJ O
cancer NN O
cell NN O
lines NNS O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
were VBD O
a DT O
kind JJ O
gift NN O
of IN O
Dr NNP O
C NNP O
. . O

Susini NNP O
( , O
INSERM NNP O
U NNP O
. . O
531 CD O
, , O
Toulouse NNP O
) NFP O
and CC O
A NN O
. . O

Hajri NNP O
( , O
IRCAD NNP O
, , O
Strasbourg NNP O
) -RRB- O
respectively RB O
. . O

Panc NNP O
- HYPH O
1 CD O
cells NNS O
were VBD O
grown VBN O
in IN O
Dulbecco NNP O
' POS O
s NNS O
modified VBN O
Eagle NNP O
' POS O
s NN O
medium NN O
( , O
DMEM NNP O
) -RRB- O
supplemented VBN O
with IN O
10 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
, , O
2 CD O
mM NN O
L NN O
- HYPH O
glutamine NN O
, , O
100 CD O
IU NN O
/ SYM O
ml NN O
penicilin NN O
G NN O
and CC O
100 CD O
mu NN O
g NN O
/ SYM O
ml NN O
streptomycin NN O
. . O

BxPc NNP O
- HYPH O
3 CD O
were VBD O
cultivated VBN O
in IN O
RPMI NNP O
1640 CD O
medium NN O
in IN O
the DT O
presence NN O
of IN O
2 CD O
mM NN O
L NN O
- HYPH O
glutamine NN O
, , O
4 CD O
. . O
5 CD O
g NN O
/ SYM O
L NN O
glucose NN O
, , O
10 CD O
mM NN O
Hepes NNS O
, , O
1 CD O
. . O
0 CD O
mM NN O
sodium NN O
pyruvate NN O
, , O
10 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
and CC O
100 CD O
IU NN O
/ SYM O
ml NN O
penicilin NN O
G NN O
and CC O
100 CD O
mu NN O
g NN O
/ SYM O
ml NN O
streptomycin NN O
. . O

Human JJ B-Species
recombinant NN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
was VBD O
obtained VBN O
from IN O
Sigma NNP O
, , O
and CC O
specific JJ O
SB203580 NN O
, , O
U0126 NNP O
and CC O
SP600125 NN O
inhibitors NNS O
were VBD O
from IN O
Calbiochem NNP O
and CC O
utilized VBN O
at IN O
10 CD O
mu NNS O
M NNP O
. . O

Expression NN O
plasmids NNS O

Expression NN O
plamids VBZ O
encoding VBG O
p38 NN O
( , O
pCEFL NNP O
HA NNP O
p38 CD O
) -RRB- O
, , O
Erk2 NNP O
( , O
pcDNAIII NNP O
HA NNP O
ERK2 NNP O
) -RRB- O
, , O
JNK NNP O
( , O
pcDNAIIIB NNP O
HA NNP O
JNK NNP O
) -RRB- O
, , O
the DT O
wild JJ O
- HYPH O
type NN O
Raf NNP O
( , O
pcDNA NNP O
RAF NNP O
BXB NNP O
) -RRB- O
and CC O
the DT O
Raf NNP O
dominant JJ O
negative JJ O
( -LRB- O
pcDNA NNP O
RAF NNP O
301 CD O
K375W NN O
) -RRB- O
were VBD O
obtained VBN O
from IN O
O NNP O
Coso NNP O
( , O
University NNP O
of IN O
Buenos NNP O
Aires NNP O
) -RRB- O
. . O

Plamids NNS O
encoding VBG O
the DT O
constitutively RB O
activated VBN O
type NN O
I NNP O
TGF NNP O
beta NN O
receptor NN O
( , O
RI NNP O
ACT NNP O
) -RRB- O
, , O
the DT O
dominant JJ O
negative JJ O
type NN O
II NN O
TGF NNP O
beta NN O
receptor NN O
( -LRB- O
RII NNP O
DN NNP O
) -RRB- O
and CC O
the DT O
Smad4 NNP O
dominant JJ O
negative JJ O
( , O
DPC4 NNP O
1 CD O
- SYM O
514 CD O
a DT O
. . O
a DT O
. . O
) -RRB- O
were VBD O
obtained VBN O
from IN O
R NNP O
Urrutia NNP O
( , O
Mayo NNP O
Clinic NNP O
, , O
Rochester NNP O
) -RRB- O
and CC O
the DT O
wild JJ O
type NN O
Smad4 NNP O
was VBD O
from IN O
C NNP O
Heldin NNP O
( : O
Ludwig NNP O
Institute NNP O
, , O
Uppsala NNP O
) -RRB- O
. . O

Pancreatic JJ O
p8 NN O
- HYPH O
deficient JJ O
cells NNS O

To TO O
silence VB O
p8 NN O
expression NN O
in IN O
pancreatic JJ O
cells NNS O
, , O
we PRP O
infected VBD O
these DT O
cells NNS O
with IN O
a DT O
retrovirus NN O
expressing VBG O
human JJ B-Species
p8 NN O
in IN O
the DT O
antisense JJ O
orientation NN O
. . O

The DT O
retroviral JJ O
vector NN O
was VBD O
constructed VBN O
as IN O
follows VBZ O
: : O
human JJ B-Species
p8 NN O
cDNA NNP O
was VBD O
subcloned VBN O
in IN O
HindIII NNP O
and CC O
XhoI NNP O
restriction NN O
sites NNS O
of IN O
the DT O
pLPC NNP O
plasmid NN O
( , O
obtained VBN O
from IN O
S NNP O
. . O
Lowe NNP O
) -RRB- O
in IN O
the DT O
antisense JJ O
orientation NN O
. . O

Amphotrope NN O
human JJ B-Species
p8 NN O
expressing VBG O
retrovirus NN O
was VBD O
then RB O
generated VBN O
by IN O
transient JJ O
transfection NN O
using VBG O
Phoenix NNP O
amphotrope NN O
packaging NN O
cells NNS O
. . O

Viral JJ O
supernatant NN O
was VBD O
used VBN O
to TO O
infect VB O
Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
pancreatic JJ O
cells NNS O
and CC O
the DT O
population NN O
of IN O
p8 NN O
- HYPH O
silenced VBN O
cells NNS O
was VBD O
isolated VBN O
by IN O
selection NN O
in IN O
presence NN O
of IN O
puromycin NN O
( , O
1 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
. . O

As IN O
control NN O
, , O
cells NNS O
were VBD O
infected VBN O
with IN O
the DT O
pLPC NNP O
empty JJ O
vector NN O
. . O

p8 NN O
expression NN O
in IN O
arrested JJ O
and CC O
growing VBG O
cells NNS O

One CD O
million CD O
of IN O
Panc NNP O
- HYPH O
1 CD O
or CC O
BxPc NNP O
- HYPH O
3 CD O
cells NNS O
were VBD O
cultivated VBN O
on IN O
10 CD O
- HYPH O
cm NN O
Petri NNP O
plates NNS O
in IN O
standard JJ O
conditions NNS O
( , O
with IN O
10 CD O
% NN O
FCS NNP O
) -RRB- O
. . O

After IN O
48 CD O
h NN O
, , O
culture NN O
media NN O
were VBD O
changed VBN O
for IN O
fresh JJ O
media NNS O
with IN O
FCS NNP O
restricted VBN O
to IN O
0 CD O
. . O
1 CD O
% NN O
, , O
in IN O
order NN O
to TO O
stop VB O
growth NN O
. . O

After IN O
24 CD O
hours NNS O
of IN O
growth NN O
arrest NN O
, , O
culture NN O
medium NN O
was VBD O
replaced VBN O
either CC O
by IN O
medium NN O
with IN O
10 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
to TO O
resume VB O
cell NN O
growth NN O
or CC O
, , O
as IN O
control NN O
, , O
by IN O
medium NN O
with IN O
0 CD O
. . O
1 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
. . O

Twenty CD O
four CD O
hours NNS O
later RB O
cells NNS O
were VBD O
recovered VBN O
and CC O
RNA NN O
and CC O
protein NN O
extracted VBN O
. . O

p8 NN O
expression NN O
in IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
- HYPH O
treated VBN O
Panc NNP O
- HYPH O
1 CD O
cells NNS O

One CD O
million CD O
of IN O
Panc NNP O
- HYPH O
1 CD O
cells NNS O
were VBD O
cultivated VBN O
in IN O
10 CD O
- HYPH O
cm NN O
culture NN O
dishes NNS O
for IN O
48 CD O
hours NNS O
under IN O
standard JJ O
conditions NNS O
before IN O
TGF NNP O
beta NN O
- HYPH O
1 CD O
treatment NN O
. . O

Human JJ B-Species
recombinant JJ O
TGF NNP O
beta NN O
- HYPH O
1 CD O
( SYM O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
was VBD O
added VBN O
to IN O
cells NNS O
, , O
without IN O
changing VBG O
the DT O
culture NN O
medium NN O
, , O
and CC O
cells NNS O
were VBD O
collected VBN O
12 CD O
hours NNS O
later RB O
for IN O
RNA NN O
and CC O
protein NN O
preparation NN O
. . O

BxPc NNP O
- HYPH O
3 CD O
rasV12 NN O
- HYPH O
expressing VBG O
cells NNS O

pLPC NNP O
- HYPH O
rasV12 NNP O
and CC O
pLPC NN O
plasmids NNS O
were VBD O
obtained VBN O
from IN O
S NNP O
. . O

Lowe NNP O
. . O

Phoenix NNP O
amphotrope NN O
packaging NN O
cells NNS O
( , O
106 CD O
) -RRB- O
were VBD O
plated VBN O
in IN O
a DT O
6 CD O
- HYPH O
well NN O
plate NN O
, , O
incubated VBN O
for IN O
24 CD O
hours NNS O
, , O
then RB O
transfected VBN O
with IN O
PEI NNP O
with IN O
5 CD O
mu NN O
g NN O
of IN O
retroviral JJ O
plasmid NN O
. . O

After IN O
48 CD O
hours NNS O
, , O
the DT O
medium JJ O
containing VBG O
virus NN O
was VBD O
filtered VBN O
( : O
0 CD O
. . O
45 CD O
mu NN O
m NN O
filter NN O
, , O
Millipore NNP O
) -RRB- O
to TO O
obtain VB O
the DT O
viral JJ O
supernatant NN O
. . O

Target NNP O
BxPc NNP O
- HYPH O
3 CD O
were VBD O
plated VBN O
at IN O
2 CD O
x SYM O
105 CD O
cells NNS O
per IN O
35 CD O
- HYPH O
mm NN O
dish NN O
and CC O
incubated VBN O
overnight RB O
. . O

For IN O
infections NNS O
, , O
the DT O
culture NN O
medium NN O
was VBD O
replaced VBN O
by IN O
an DT O
appropriate JJ O
mix NN O
of IN O
the DT O
viral JJ O
supernatant NN O
and CC O
culture NN O
medium NN O
( , O
V NNP O
/ , O
V NN O
) -RRB- O
, , O
supplemented VBN O
with IN O
4 CD O
mu NN O
g NN O
/ SYM O
ml NN O
polybrene NN O
( , O
Sigma NNP O
) -RRB- O
, , O
and CC O
cells NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

BxPc NNP O
- HYPH O
3 CD O
rasV12 NNP O
- HYPH O
expressing VBG O
cells NNS O
were VBD O
selected VBN O
with IN O
puromycin NN O
( , O
1 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
. . O

Cells NNS O
infected VBN O
with IN O
the DT O
pLPC NNP O
empty JJ O
vector NN O
were VBD O
used VBN O
as IN O
control NN O
. . O

Western JJ O
- HYPH O
blot NN O
analyses NNS O

One CD O
hundred CD O
mu NN O
g NN O
of IN O
total JJ O
protein NN O
extracted VBN O
from IN O
cells NNS O
was VBD O
separated VBN O
with IN O
standard JJ O
procedures NNS O
on IN O
15 CD O
. . O
0 CD O
% NN O
SDS NNP O
- HYPH O
PAGE NN O
using VBG O
the DT O
Mini NNP O
Protean NNP O
System NNP O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
) -RRB- O
and CC O
transferred VBN O
to IN O
a DT O
nitrocellulose NN O
membrane NN O
( , O
Sigma NNP O
) -RRB- O
. . O

The DT O
intracellular JJ O
level NN O
of IN O
p8 NN O
was VBD O
estimated VBN O
by IN O
Western JJ O
blot NN O
using VBG O
a DT O
polyclonal JJ O
antibody NN O
( , O
1 CD O
: : O
1000 CD O
) -RRB- O
raised VBN O
against IN O
human JJ B-Species
p8 NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Growth NN O
curves NNS O

One CD O
hundred CD O
thousand CD O
cells NNS O
per IN O
well NN O
were VBD O
plated VBN O
in IN O
a DT O
series NN O
of IN O
35 CD O
- HYPH O
mm NN O
culture NN O
dishes NNS O
. . O

The DT O
cell NN O
number NN O
was VBD O
estimated VBN O
daily RB O
in IN O
triplicate NN O
, , O
during IN O
1 CD O
to TO O
5 CD O
days NNS O
, , O
in IN O
a DT O
haemocytometer NN O
. . O

Within IN O
experiments NNS O
, , O
each DT O
point NN O
was VBD O
determined VBN O
at IN O
least JJS O
two CD O
times NNS O
. . O

Cell NN O
transfection NN O
and CC O
gene NN O
reporter NN O
assays NNS O

Panc NNP O
- HYPH O
1 CD O
and CC O
BxPc NNP O
- HYPH O
3 CD O
( SYM O
105 CD O
) -RRB- O
were VBD O
cultivated VBN O
in IN O
30 CD O
mm NN O
diameter NN O
culture NN O
dishes NNS O
for IN O
24 CD O
hours NNS O
then RB O
transiently RB O
transfected VBN O
with IN O
0 CD O
. . O
5 CD O
mu NN O
g NN O
of IN O
p8 NN O
- HYPH O
CAT NN O
reporter NN O
plasmid NN O
and CC O
0 CD O
. . O
5 CD O
mu NN O
g NN O
of IN O
pCMV NN O
/ SYM O
beta NN O
gal NN O
plasmid NN O
( , O
to TO O
control VB O
transfection NN O
efficiency NN O
) , O
using VBG O
the DT O
Fugene NNP O
reagent NN O
in IN O
accordance NN O
with IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
( , O
Roche NNP O
Molecular NNP O
Biochemicals NNPS O
) -RRB- O
. . O

The DT O
p8 NNP O
- HYPH O
CAT NN O
plasmid NN O
is VBZ O
the DT O
previously RB O
reported VBN O
p NN O
- HYPH O
1471 CD O
/ SYM O
+ SYM O
37p8 CD O
- HYPH O
CAT NN O
promoter NN O
construct NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Reporter NN O
activities NNS O
were VBD O
measured VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Briefly RB O
, , O
cell NN O
extracts NNS O
were VBD O
prepared VBN O
with IN O
the DT O
reporter NN O
lysis NN O
buffer NN O
( : O
Promega NNP O
) -RRB- O
24 CD O
hours NNS O
after IN O
transfection NN O
and CC O
CAT NN O
activity NN O
was VBD O
determined VBN O
by IN O
the DT O
phase NN O
extraction NN O
procedure NN O
[ -LRB- O
32 CD O
] -RRB- O
and CC O
beta NN O
- HYPH O
galactosidase NN O
assay NN O
was VBD O
performed VBN O
essentially RB O
as IN O
described VBN O
in IN O
Sambrook NNP O
et FW O
al NNP O
. . O

[ -LRB- O
33 CD O
] -RRB- O
. . O

CAT NN O
activity NN O
was VBD O
normalized VBN O
to IN O
beta JJ O
- HYPH O
galactosidase NN O
activity NN O
. . O

Experiments NNS O
were VBD O
carried VBN O
out RP O
in IN O
triplicate NN O
and CC O
repeated VBN O
at IN O
least JJS O
two CD O
times NNS O
. . O

Expression NN O
plasmids NNS O
( : O
0 CD O
. . O
5 CD O
mu NN O
g NN O
) -RRB- O
were VBD O
co NN O
- HYPH O
transfected VBN O
with IN O
p8 NN O
- HYPH O
CAT NN O
and CC O
pCMV NN O
/ SYM O
beta NN O
gal NN O
plasmids NNS O
as IN O
indicated VBN O
. . O

RT NNP O
- HYPH O
PCR NN O
analysis NN O

RNA NNP O
was VBD O
extracted VBN O
using VBG O
the DT O
Trizol NNP O
( HYPH O
Life NNP O
Technologies NNPS O
) , O
procedure NN O
. . O

Total JJ O
RNA NNP O
( : O
1 CD O
mu NNS O
g NN O
) -RRB- O
was VBD O
analyzed VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
with IN O
the DT O
SuperScript NNP O
( -LRB- O
TM NNP O
) -RRB- O
One CD O
- HYPH O
step NN O
RT NNP O
- HYPH O
PCR NNP O
System NNP O
and CC O
the DT O
Platinum NNP O
Taq NNP O
kit NN O
( : O
Life NNP O
Technologies NNPS O
) -RRB- O
. . O

RT NNP O
- HYPH O
PCR NNP O
was VBD O
performed VBN O
using VBG O
different JJ O
numbers NNS O
of IN O
cycles NNS O
to TO O
verify VB O
that IN O
the DT O
conditions NNS O
chosen VBN O
were VBD O
within IN O
the DT O
linear JJ O
range NN O
. . O

The DT O
mRNA NNP O
coding VBG O
for IN O
p8 NN O
was VBD O
specifically RB O
amplified VBN O
with IN O
sense NN O
( : O
5 CD O
' `` O
GAAGAGAGGCAGGGAAGACA NNP O
3 CD O
' '' O
) -RRB- O
and CC O
antisense NN O
( , O
5 CD O
' '' O
CTGCCGTGCGTGTCTATTTA NN O
3 CD O
' '' O
) -RRB- O
primers NNS O
, , O
in IN O
positions NNS O
72 CD O
and CC O
643 CD O
of IN O
the DT O
cDNA NNP O
( -LRB- O
accession NN O
# NN O
NM NNP O
_ SYM O
12385 CD O
) -RRB- O
, , O
respectively RB O
. . O

As IN O
control NN O
, , O
the DT O
transcript NN O
coding VBG O
for IN O
the DT O
ribosomal JJ O
protein NN O
RL3 NNP O
was VBD O
specifically RB O
amplified VBN O
for IN O
22 CD O
cycles NNS O
with IN O
sense NN O
( , O
5 CD O
' '' O
GAAAGAAGTCGTGGAGGCTG NNP O
' '' O
) -RRB- O
and CC O
antisense NN O
( , O
5 CD O
' '' O
ATCTCATCCTGCCCAAACAC NN O
' '' O
) -RRB- O
primers NNS O
, , O
in IN O
positions NNS O
216 CD O
and CC O
637 CD O
of IN O
the DT O
cDNA NN O
, , O
respectively RB O
. . O

Author NN O
' '' O
s POS O
contributions NNS O

CM NNP O
prepared VBD O
cells NNS O
and CC O
retrovirus NN O
, , O
carried VBN O
out RP O
RNA NNP O
purification NN O
, , O
RT NN O
- HYPH O
PCR NNP O
, , O
Western JJ O
blots NNS O
, , O
and CC O
cell NN O
growth NN O
experiments NNS O
, , O
NL NNP O
carried VBD O
out RP O
CAT NNP O
assays NNS O
, , O
SV NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
and CC O
analysis NN O
of IN O
data NNS O
, , O
JLI NNP O
participated VBD O
in IN O
the DT O
analysis NN O
of IN O
data NNS O
and CC O
wrote VBD O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Enzymatic JJ O
multiplex NN O
DNA NN O
sequencing NN O
. . O

Abstract JJ O

The DT O
problem NN O
of IN O
reading VBG O
DNA NN O
sequence NN O
films NNS O
has VBZ O
been VBN O
reformulated VBN O
using VBG O
an DT O
easily RB O
implemented VBN O
, , O
multiplex JJ O
version NN O
of IN O
enzymatic JJ O
DNA NN O
sequencing NN O
. . O

By IN O
utilizing VBG O
a DT O
uniquely RB O
tagged JJ O
primer NN O
for IN O
each DT O
base NN O
- HYPH O
specific JJ O
sequencing NN O
reaction NN O
, , O
the DT O
four CD O
reactions NNS O
can MD O
be VB O
pooled VBN O
and CC O
electrophoresed VBN O
in IN O
a DT O
single JJ O
lane NN O
. . O

This DT O
approach NN O
has VBZ O
been VBN O
previously RB O
proposed VBN O
for IN O
use NN O
with IN O
fluorescently RB O
labelled VBN O
probes NNS O
( , O
1 CD O
) -RRB- O
, , O
and CC O
is VBZ O
analogous JJ O
to IN O
the DT O
principle NN O
used VBN O
in IN O
four CD O
- HYPH O
dye NN O
fluorescence NN O
sequencing NN O
except IN O
that IN O
the DT O
signals NNS O
are VBP O
resolved VBN O
following VBG O
electrophoresis NN O
( , O
2 CD O
) -RRB- O
. . O

After IN O
transfer NN O
to IN O
a DT O
nylon NN O
membrane NN O
, , O
images NNS O
are VBP O
obtained VBN O
separately RB O
for IN O
each DT O
of IN O
the DT O
four CD O
reactions NNS O
by IN O
hybridization NN O
using VBG O
oligonucleotide NN O
probes NNS O
. . O

The DT O
images NNS O
can MD O
then RB O
be VB O
superimposed VBN O
to TO O
reconstitute VB O
a DT O
complete JJ O
sequence NN O
pattern NN O
. . O

In IN O
this DT O
way NN O
the DT O
correction NN O
of IN O
gel NN O
distortion NN O
effects NNS O
and CC O
accurate JJ O
band NN O
registration NN O
are VBP O
considerably RB O
simplified JJ O
, , O
as IN O
each DT O
of IN O
the DT O
four CD O
base NN O
- HYPH O
specific JJ O
ladders NNS O
require VBP O
very RB O
similar JJ O
corrections NNS O
. . O

The DT O
methods NNS O
therefore RB O
provide VBP O
the DT O
basis NN O
for IN O
a DT O
second JJ O
generation NN O
of IN O
more RBR O
accurate JJ O
and CC O
reliable JJ O
film NN O
reading NN O
programs NNS O
, , O
as RB O
well RB O
as IN O
being VBG O
useful JJ O
for IN O
conventional JJ O
multiplex JJ O
sequencing NN O
. . O

Unlike IN O
the DT O
original JJ O
multiplex NN O
protocol NN O
( : O
3 CD O
) -RRB- O
, , O
the DT O
approach NN O
described VBN O
is VBZ O
suitable JJ O
for IN O
small JJ O
projects NNS O
, , O
as IN O
multiple JJ O
cloning NN O
vectors NNS O
are VBP O
not RB O
used VBN O
. . O

Although IN O
more JJR O
than IN O
one CD O
vector NN O
can MD O
be VB O
utilized VBN O
, , O
only RB O
a DT O
library NN O
of IN O
fragments NNS O
cloned VBN O
into IN O
any DT O
single JJ O
phage NN O
, , O
phagemid NN O
or CC O
plasmid NN O
vector NN O
is VBZ O
actually RB O
required VBN O
, , O
together RB O
with IN O
a DT O
set NN O
of IN O
tagged VBN O
oligonucleotide NN O
primers NNS O
. . O
Images NNS O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O
3301 CD O

Enzymatic JJ O
multiplex NN O
DNA NN O
sequencing NN O

Mark NNP O
Chee NNP O

Medical NNP O
Research NNP O
Council NNP O
Laboratory NNP O
of IN O
Molecular NNP O
Biology NNP O
, , O
Hills NNP O
Road NNP O
, , O
Cambridge NNP O
CB2 NNP O
20H CD O
, , O
UK NNP O

Received VBN O
March NNP O
15 CD O
, , O
1991 CD O
; : O
Revised VBN O
and CC O
Accepted VBN O
May NNP O
2 CD O
, , O
1991 CD O

ABSTRACT NNP O

The DT O
problem NN O
of IN O
reading VBG O
DNA NN O
sequence NN O
films NNS O
has VBZ O
been VBN O
reformulated VBN O
using VBG O
an DT O
easily RB O
implemented VBN O
, , O
multiplex JJ O
version NN O
of IN O
enzymatic JJ O
DNA NN O
sequencing NN O
. . O

By IN O
utilizing VBG O
a DT O
uniquely RB O
tagged JJ O
primer NN O
for IN O
each DT O
base NN O
- HYPH O
specific JJ O
sequencing NN O
reaction NN O
, , O
the DT O
four CD O
reactions NNS O
can MD O
be VB O
pooled VBN O
and CC O
electrophoresed VBN O
in IN O
a DT O
single JJ O
lane NN O
. . O

This DT O
approach NN O
has VBZ O
been VBN O
previously RB O
proposed VBN O
for IN O
use NN O
with IN O
fluorescently RB O
labelled VBN O
probes NNS O
( , O
1 CD O
) -RRB- O
, , O
and CC O
is VBZ O
analogous JJ O
to IN O
the DT O
principle NN O
used VBN O
in IN O
four CD O
- HYPH O
dye NN O
fluorescence NN O
sequencing NN O
except IN O
that IN O
the DT O
signals NNS O
are VBP O
resolved VBN O
following VBG O
electrophoresis NN O
( , O
2 CD O
) -RRB- O
. . O

After IN O
transfer NN O
to IN O
a DT O
nylon NN O
membrane NN O
, , O
images NNS O
are VBP O
obtained VBN O
separately RB O
for IN O
each DT O
of IN O
the DT O
four CD O
reactions NNS O
by IN O
hybridization NN O
using VBG O
oligonucleotide NN O
probes NNS O
. . O

The DT O
images NNS O
can MD O
then RB O
be VB O
superimposed VBN O
to TO O
reconstitute VB O
a DT O
complete JJ O
sequence NN O
pattern NN O
. . O

In IN O
this DT O
way NN O
the DT O
correction NN O
of IN O
gel NN O
distortion NN O
effects NNS O
and CC O
accurate JJ O
band NN O
registration NN O
are VBP O
considerably RB O
simplified VBN O
, , O
as IN O
each DT O
of IN O
the DT O
four CD O
basespecific JJ O
ladders NNS O
require VBP O
very RB O
similar JJ O
corrections NNS O
. . O

The DT O
methods NNS O
therefore RB O
provide VBP O
the DT O
basis NN O
for IN O
a DT O
second JJ O
generation NN O
of IN O
more RBR O
accurate JJ O
and CC O
reliable JJ O
film NN O
reading NN O
programs NNS O
, , O
as RB O
well RB O
as IN O
being VBG O
useful JJ O
for IN O
conventional JJ O
multiplex JJ O
sequencing NN O
. . O

Unlike IN O
the DT O
original JJ O
multiplex NN O
protocol NN O
( : O
3 CD O
) -RRB- O
, , O
the DT O
approach NN O
described VBN O
is VBZ O
suitable JJ O
for IN O
small JJ O
projects NNS O
, , O
as IN O
multiple JJ O
cloning NN O
vectors NNS O
are VBP O
not RB O
used VBN O
. . O

Although IN O
more JJR O
than IN O
one CD O
vector NN O
can MD O
be VB O
utilized VBN O
, , O
only RB O
a DT O
library NN O
of IN O
fragments NNS O
cloned VBN O
into IN O
any DT O
single JJ O
phage NN O
. . O
phagemid NN O
or CC O
plasmid NN O
vector NN O
is VBZ O
actually RB O
required VBN O
, , O
together RB O
with IN O
a DT O
set NN O
of IN O
tagged VBN O
oligonucleotide NN O
primers NNS O
. . O

INTRODUCTION NN O

The DT O
community NN O
of IN O
biologists NNS O
is VBZ O
undertaking VBG O
the DT O
sequencing NN O
of IN O
representative JJ O
genomes NNS O
of IN O
various JJ O
free JJ O
- HYPH O
living VBG O
organisms NNS O
, , O
ranging VBG O
in IN O
size NN O
from IN O
Mycoplasma NNP O
( , O
800kb CD O
) -RRB- O
to IN O
mammals NNS O
( , O
3 CD O
Gb NN O
) -RRB- O
( , O
4 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
largest JJS O
contiguous JJ O
DNA NNP O
sequences NNS O
which WDT O
have VBP O
been VBN O
determined VBN O
so RB O
far RB O
are VBP O
the DT O
genomes NNS O
of IN O
several JJ O
dsDNA NNP O
eukaryotic JJ O
viruses NNS O
( , O
5 CD O
, , O
6 CD O
, , O
7 CD O
, , O
8 CD O
, , O
9 CD O
) -RRB- O
and CC O
plant NN O
chloroplasts NNS O
( , O
10 CD O
, , O
11 CD O
, , O
12 CD O
) -RRB- O
. . O

The DT O
largest JJS O
of IN O
these DT O
is VBZ O
the DT O
229kb CD O
genome NN O
of IN O
human JJ B-Species
cytomegalovirus NN I-Species
( : O
8 CD O
) -RRB- O
. . O

The DT O
difficulty NN O
in IN O
sequencing VBG O
millions NNS O
of IN O
base NN O
pairs NNS O
of IN O
DNA NNP O
is VBZ O
that IN O
several JJ O
steps NNS O
in IN O
the DT O
methods NNS O
are VBP O
relatively RB O
labour JJ O
intensive JJ O
, , O
although IN O
the DT O
sequencing VBG O
reactions NNS O
themselves PRP O
are VBP O
rapid JJ O
and CC O
easily RB O
performed VBN O
. . O

Two CD O
limiting VBG O
steps NNS O
in IN O
conventional JJ O
procedures NNS O
are VBP O
the DT O
size NN O
fractionation NN O
of IN O
sequencing VBG O
reaction NN O
products NNS O
by IN O
gel NN O
electrophoresis NN O
and CC O
the DT O
subsequent JJ O
reading NN O
of IN O
sequence NN O
ladders NNS O
. . O

The DT O
former JJ O
problem NN O
can MD O
be VB O
overcome VBN O
by IN O
multiplexing NN O
, , O
which WDT O
theoretically RB O
allows VBZ O
an DT O
enormous JJ O
amount NN O
of IN O

data NNS O
to TO O
be VB O
obtained VBN O
from IN O
a DT O
single JJ O
gel NN O
by IN O
processing NN O
clones NNS O
as IN O
mixtures NNS O
rather RB O
than IN O
individually RB O
( : O
3 CD O
) -RRB- O
. . O

Each DT O
sequence NN O
in IN O
the DT O
mixture NN O
is VBZ O
labelled VBN O
by IN O
a DT O
unique JJ O
short JJ O
oligonucleotide NN O
' `` O
tag NN O
' '' O
sequence NN O
. . O

This DT O
allows VBZ O
the DT O
mixture NN O
to TO O
be VB O
resolved VBN O
following VBG O
electrophoresis NN O
: : O
the DT O
superimposed JJ O
sequence NN O
ladders NNS O
are VBP O
blotted VBN O
from IN O
the DT O
gel NN O
to IN O
a DT O
nylon NN O
membrane NN O
, , O
and CC O
detected VBN O
one CD O
at IN O
a DT O
time NN O
by IN O
hybridization NN O
using VBG O
tag NN O
- HYPH O
specific JJ O
oligonucleotide NN O
probes NNS O
. . O

In IN O
practice NN O
, , O
at RB O
least RBS O
50 CD O
sets NNS O
of IN O
sequences NNS O
can MD O
be VB O
obtained VBN O
from IN O
a DT O
single JJ O
gel NN O
( HYPH O
3 CD O
) -RRB- O
. . O

Unfortunately RB O
, , O
a DT O
bottleneck NN O
in IN O
the DT O
multiplex NN O
procedure NN O
is VBZ O
the DT O
reading NN O
of IN O
sequence NN O
films NNS O
. . O

In IN O
previous JJ O
large JJ O
- HYPH O
scale NN O
sequencing NN O
projects NNS O
this DT O
task NN O
has VBZ O
been VBN O
performed VBN O
with IN O
the DT O
aid NN O
of IN O
a DT O
sonic JJ O
digitizer NN O
( , O
13 CD O
, , O
14 CD O
) -RRB- O
. . O

Although IN O
film NN O
reading NN O
programs NNS O
have VBP O
been VBN O
under IN O
development NN O
for IN O
some DT O
time NN O
( , O
15 CD O
) -RRB- O
, , O
and CC O
some DT O
programs NNS O
are VBP O
commercially RB O
available JJ O
, , O
their PRP$ O
error NN O
rates NNS O
are VBP O
presently RB O
more RBR O
variable JJ O
and CC O
unpredictable JJ O
than IN O
that DT O
of IN O
a DT O
skilled JJ O
person NN O
and CC O
the DT O
accurate JJ O
interpretation NN O
of IN O
film NN O
- HYPH O
imaged VBN O
sequence NN O
ladders NNS O
by IN O
computer NN O
programs NNS O
is VBZ O
difficult JJ O
to TO O
achieve VB O
in IN O
routine JJ O
practice NN O
. . O

Programs NNS O
specifically RB O
designed VBN O
to TO O
read VB O
multiplex NN O
films NNS O
have VBP O
an DT O
advantage NN O
. . O

This DT O
is VBZ O
because IN O
a DT O
sequence NN O
image NN O
can MD O
be VB O
used VBN O
as IN O
an DT O
' `` O
internal JJ O
standard NN O
' '' O
to TO O
help VB O
interpret VB O
other JJ O
images NNS O
derived VBN O
from IN O
the DT O
same JJ O
membrane NN O
( , O
3 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
original JJ O
implementation NN O
of IN O
the DT O
multiplex NN O
strategy NN O
used VBD O
chemical JJ O
sequencing NN O
( , O
16 CD O
) -RRB- O
, , O
which WDT O
yields VBZ O
a DT O
more RBR O
complex JJ O
sequence NN O
ladder NN O
than IN O
the DT O
enzymatic JJ O
dideoxynucleotide NN O
chain NN O
- HYPH O
termination NN O
method NN O
( SYM O
17 CD O
) -RRB- O
. . O

Most JJS O
successful JJ O
large JJ O
scale NN O
sequencing NN O
projects NNS O
have VBP O
used VBN O
the DT O
chaintermination NN O
method NN O
and CC O
bacteriophage NN B-Species
M13 NN I-Species
vectors NNS O
, , O
which WDT O
allows VBZ O
the DT O
routine JJ O
production NN O
of IN O
clean JJ O
and CC O
easily RB O
interpretable JJ O
sequences NNS O
( SYM O
18 CD O
) -RRB- O
. . O

It PRP O
was VBD O
therefore RB O
decided VBN O
to TO O
adapt VB O
the DT O
original JJ O
multiplex JJ O
protocol NN O
for IN O
use NN O
with IN O
enzymatic JJ O
sequencing NN O
, , O
using VBG O
tagged VBN O
primers NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Eight CD O
oligonucleotide NN O
sequencing NN O
primers NNS O
were VBD O
synthesized VBN O
, , O
each DT O
37 CD O
nucleotides NNS O
in IN O
length NN O
. . O

The DT O
3 CD O
' '' O
end NN O
of IN O
each DT O
primer NN O
consists VBZ O
of IN O
the DT O
17 CD O
nucleotide NN O
M13 NN O
universal JJ O
priming NN O
sequence NN O
[ -LRB- O
GTAAAACGACGGCCAGT3 NNP O
' '' O
] -RRB- O
. . O

The DT O
5 CD O
' '' O
ends NNS O
of IN O
the DT O
primers NNS O
bear VBP O
different JJ O
20mer CD O
tag NN O
sequences NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

In IN O
four CD O
of IN O
the DT O
primers NNS O
, , O
UEO1C NNP O
, , O
UPOIC NNP O
, , O
UE02C NNP O
and CC O
UP02C NNP O
, , O
these DT O
tags NNS O
are VBP O
complementary JJ O
to IN O
the DT O
EO1 NNP O
, , O
PO1 NNP O
, , O
E02 NN O
and CC O
P02 NN O
probe NN O
sequences NNS O
respectively RB O
( , O
copied VBN O
from IN O
the DT O
original JJ O
' `` O
plex NN O
' '' O
vectors NNS O
( , O
3 CD O
) -RRB- O
) -RRB- O
. . O

A DT O
second JJ O
set NN O
of IN O
four CD O
primers NNS O
, , O
UJOL14C NNP O
, , O
UJOL15C NNP O
, , O
UJOL16C NNP O
and CC O
UJOL17C NNP O
, , O
have VBP O
the DT O
following VBG O
tag NN O
sequences NNS O
: : O
5 CD O
' '' O
CAAGTTTGAAGGTACTCATT NNP O
, , O
TATCAATTAAATTGTllTGA NNP O
, , O
GTGTTGCTACCCAAGAAGCA NNP O
, , O
and CC O
TGTCACTAGAGCTGTCACTT NNP O
, , O
respectively RB O
. . O

The DT O

? . O
= NFP O
) NFP O
1991 CD O
Oxford NNP O
University NNP O
Press NNP O

3302 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O

oligonucleotides NNS O
were VBD O
gel NN O
- HYPH O
purified VBN O
( : O
19 CD O
) , O
and CC O
used VBN O
to TO O
sequence VB O
ssDNA NNP O
templates NNS O
prepared VBN O
by IN O
phenol NN O
extraction NN O
( : O
20 CD O
) -RRB- O
or CC O
SDS NN O
denaturation NN O
( SYM O
21 CD O
) -RRB- O
. . O

Conventional JJ O
sequencing NN O
reactions NNS O
were VBD O
performed VBN O
as IN O
previously RB O
described VBN O
( SYM O
20 CD O
) -RRB- O
. . O

For IN O
hybridization NN O
experiments NNS O
, , O
radioactively RB O
labelled VBN O
nucleotides NNS O
were VBD O
omitted VBN O
from IN O
the DT O
sequencing NN O
reactions NNS O
. . O

Instead RB O
, , O
the DT O
21d CD O
of IN O
each DT O
nucleotide NN O
mix NN O
added VBD O
to IN O
the DT O
reaction NN O
mixture NN O
consisted VBD O
of IN O
the DT O
following VBG O
: : O
' '' O
A NN O
' '' O
mix NN O
: : O
6 CD O
. . O
25MtM NNP O
dATP NNP O
, , O
62 CD O
. . O
5lM NN O
ddATP NN O
; : O
' '' O
C NN O
' '' O
mix NN O
: : O
6 CD O
. . O
25MM CD O
dCTP NN O
, , O
40MtM NN O
ddCTP NN O
; : O
' '' O
G NN O
' '' O
mix NN O
: : O
6 CD O
. . O
25MtM NNP O
dGTP NNP O
, , O
80MtM NN O
ddGTP NN O
; : O
' '' O
T NN O
' '' O
mix NN O
: : O
6 CD O
. . O
25MM CD O
dTTP NNP O
, , O
250yM NNP O
ddTTP NNP O
; : O
as RB O
well RB O
as IN O
125MM CD O
of IN O
each DT O
of IN O
the DT O
three CD O
other JJ O
dNTPs NNS O
in IN O
each DT O
mix NN O
. . O

Apart RB O
from IN O
the DT O
use NN O
of IN O
these DT O
modified VBN O
mixes NNS O
, , O
no DT O
changes NNS O
were VBD O
made VBN O
to IN O
the DT O
conventional JJ O
sequencing NN O
procedure NN O
( : O
20 CD O
) -RRB- O
. . O

Sequencing VBG O
reactions NNS O
were VBD O
pooled VBN O
and CC O
ethanol NN O
precipitated VBN O
as IN O
appropriate JJ O
. . O

Precipitation NN O
in IN O
microtitre NN O
trays NNS O
was VBD O
carried VBN O
out RP O
as IN O
follows VBZ O
: : O
a DT O
mixture NN O
of IN O
3 CD O
. . O
2M1 CD O
3M NN O
NaAc NNP O
pH NN O
5 CD O
. . O
0 CD O
and CC O
112Mi1 CD O
EtOH NNP O
was VBD O
dispensed VBN O
to IN O
individual JJ O
wells NNS O
of IN O
a DT O
microtitre NN O
plate NN O
( , O
Falcon NNP O
3911 CD O
or CC O
Corning NNP O
25855 CD O
) -RRB- O
using VBG O
an DT O
8 CD O
- HYPH O
channel NN O
pipettor NN O
. . O

Each DT O
set NN O
of IN O
four CD O
reactions NNS O
was VBD O
added VBN O
to IN O
the DT O
EtOH NNP O
/ SYM O
NaAc NNP O
mixture NN O
, , O
and CC O
the DT O
tray NN O
sealed VBD O
using VBG O
a DT O
Falcon NNP O
3073 CD O
plate NN O
sealer NN O
. . O

The DT O
samples NNS O
were VBD O
mixed VBN O
by IN O
inversion NN O
and CC O
stored VBN O
at IN O
- HYPH O
20 CD O
? . O
C NN O
for IN O
30 CD O
minutes NNS O
. . O

The DT O
DNA NNP O
was VBD O
collected VBN O
by IN O
a DT O
20 CD O
minute NN O
centrifugation NN O
at IN O
4 CD O
0 CD O
rpm NN O
in IN O
an DT O
IEC NNP O
Centra NNP O
3C NNP O
centrifuge NN O
. . O

The DT O
sealer NN O
was VBD O
removed VBN O
, , O
and CC O
the DT O
plate NN O
inverted VBN O
to TO O
discard VB O
the DT O
supernatant NN O
. . O

After IN O
blotting VBG O
the DT O
tray NN O
on IN O
tissue NN O
paper NN O
, , O
200MI CD O
of IN O
95 CD O
% NN O
EtOH NNP O
was VBD O
added VBN O
to IN O
each DT O
well NN O
. . O

The DT O
plate NN O
was VBD O
covered JJ O
with IN O
a DT O
plastic JJ O
lid NN O
and CC O
recentrifuged VBN O
for IN O
2 CD O
minutes NNS O
. . O

The DT O
EtOH NNP O
was VBD O
discarded VBN O
and CC O
the DT O
plate NN O
inverted VBN O
for IN O
several JJ O
minutes NNS O
on IN O
tissue NN O
paper NN O
, , O
then RB O
left VBD O
for IN O
20 CD O
minutes NNS O
to TO O
air NN O
dry JJ O
. . O

Precipitated VBN O
samples NNS O
were VBD O
resuspended VBN O
in IN O
6M1 CD O
deionized VBN O
water NN O
by IN O
vortexing VBG O
on IN O
an DT O
SMI NNP O
multi NN O
- HYPH O
tube NN O
vortexer NN O
for IN O
1 CD O
minute NN O
. . O

Samples NNS O
were VBD O
denatured VBN O
and CC O
electrophoresed VBN O
on IN O
6 CD O
% NN O
polyacrylamide NN O
buffer NN O
gradient NN O
gels NNS O
as IN O
previously RB O
described VBN O
( $ O
20 CD O
) -RRB- O
. . O

Following VBG O
electrophoresis NN O
, , O
the DT O
gel NN O
was VBD O
transferred VBN O
to IN O
a DT O
dry JJ O
piece NN O
of IN O
Whatman NNP O
3MM NNP O
blotting VBG O
paper NN O
, , O
and CC O
placed VBN O
on IN O
a DT O
second JJ O
sheet NN O
of IN O
blotting VBG O
paper NN O
supported VBN O
on IN O
a DT O
glass NN O
plate NN O
and CC O
saturated VBN O
in IN O
4 CD O
x SYM O
SSC NNP O
( : O
SSC NNP O
: : O
150mM NNP O
NaCl NNP O
, , O
l5mM NN O
trisodium NN O
citrate NN O
) -RRB- O
. . O

This DT O
sheet NN O
was VBD O
wicked VBN O
in IN O
a DT O
tray NN O
containing VBG O
1 CD O
litre NN O
of IN O
4 CD O
x SYM O
SSC NNP O
. . O

The DT O
DNA NNP O
was VBD O
transferred VBN O
to IN O
a DT O
nylon NN O
membrane NN O
( , O
Amersham NNP O
Hybond NNP O
N NNP O
) -RRB- O
by IN O
capillary NN O
blotting VBG O
overnight RB O
( SYM O
22 CD O
) -RRB- O
. . O

DNA NNP O
was VBD O
fixed VBN O
to IN O
the DT O
membranes NNS O
by IN O
U NNP O
. . O
V NN O
. . O
crosslinking NN O
( SYM O
23 CD O
) -RRB- O
. . O

Plex NN O
oligonucleotide NN O
probes NNS O
were VBD O
a DT O
kind JJ O
gift NN O
of IN O
Dr NNP O
. . O
George NNP O
Church NNP O
. . O

Probes NNS O
were VBD O
tailed VBN O
at IN O
their PRP$ O
3 CD O
' '' O
ends NNS O
using VBG O
[ -LRB- O
a DT O
- HYPH O
32p CD O
] -RRB- O
dCTP NN O
as IN O
previously RB O
described VBN O
( : O
3 CD O
) -RRB- O
. . O

For IN O
the DT O
preparation NN O
of IN O
digoxigenin NN O
( -LRB- O
DIG NNP O
) -RRB- O
labelled VBN O
probes NNS O
, , O
identical JJ O
tailing NN O
reactions NNS O
were VBD O
carried VBN O
out RP O
substituting VBG O
I0pmols NNP O
of IN O
DIG NNP O
- HYPH O
II NNP O
dUTP NNP O
( -LRB- O
Boehringer NNP O
Mannheim NNP O
) -RRB- O
for IN O
[ -LRB- O
a DT O
- HYPH O
32P CD O
] -RRB- O
dCTP NN O
. . O

Membranes NNS O
were VBD O
prehybridized VBN O
for IN O
at RB O
least RBS O
10 CD O
minutes NNS O
in IN O
4 CD O
x SYM O
SSC NNP O
, , O
5 CD O
x SYM O
Denhardts NNS O
' POS O
( : O
0 CD O
. . O
1 CD O
% NN O
( HYPH O
w NN O
/ SYM O
v NN O
) -RRB- O
each DT O
of IN O
BSA NNP O
( , O
heated VBN O
at IN O
80 CD O
? , O
C NN O
for IN O
30 CD O
minutes NNS O
to TO O
inactivate VB O
any DT O
alkaline JJ O
phosphatase NN O
activity NN O
) -RRB- O
, , O
Ficoll NNP O
( , O
Pharmacia NNP O
) -RRB- O
and CC O
polyvinylpyrrolidone NN O
) -RRB- O
, , O
0 CD O
. . O
5 CD O
% NN O
( : O
w NN O
/ SYM O
v NN O
) -RRB- O
SDS NNP O
, , O
5mM NNP O
NaHPO4 NNP O
( SYM O
23 CD O
) -RRB- O
. . O

Hybridization NN O
was VBD O
carried VBN O
out RP O
in IN O
25 CD O
- HYPH O
50M1 CD O
of IN O
prehybridization NN O
buffer NN O
per IN O
cm2 NN O
of IN O
membrane NN O
. . O

The DT O
probe NN O
concentration NN O
was VBD O
approximately RB O
lnM NN O
. . O

After IN O
lh UH O
at IN O
42 CD O
? , O
C NN O
, , O
unbound JJ O
probe NN O
was VBD O
removed VBN O
by IN O
five CD O
1 CD O
minute NN O
washes NNS O
at IN O
room NN O
temperature NN O
in IN O
1 CD O
x SYM O
SSC NNP O
, , O
0 CD O
. . O
5 CD O
% NN O
SDS NNP O
( SYM O
200MI CD O
/ SYM O
cm2 NN O
membrane NN O
) -RRB- O
. . O

Radioactive JJ O
blots NNS O
were VBD O
covered VBN O
in IN O
Saran NNP O
wrap NN O
and CC O
exposed VBN O
to IN O
film NN O
immediately RB O
. . O

Detection NN O
of IN O
DIG NNP O
labelled VBN O
probes NNS O
used VBD O
an DT O
anti AFX O
- HYPH O
DIG NN O
antibodyalkaline NN O
phosphatase NN O
conjugate NN O
( , O
Boehringer NNP O
Mannheim NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
, , O
except IN O
that IN O
all DT O
volumes NNS O
were VBD O
reduced VBN O
by IN O
70 CD O
% NN O
and CC O
the DT O
conjugate NN O
was VBD O
used VBN O
at IN O
a DT O
1 CD O
: SYM O
10 CD O
0 CD O
dilution NN O
. . O

Blots NNS O
were VBD O
developed VBN O
in IN O
25M1 CD O
of IN O
100mM CD O
Tris NNS O
. . O
Cl NN O
pH9 CD O
. . O
5 CD O
, , O

mantane4 NN O
- HYPH O
methoxy4 NNP O
( -LRB- O
3 CD O
"""" '' O
- HYPH O
phosphoryloxy NN O
) -RRB- O
phenyl NN O
- HYPH O
1 CD O
, , O
2 CD O
- HYPH O
dioxetane NN O
) : O
; : O
Tropix NNP O
) -RRB- O
/ SYM O
cm2 CD O
for IN O
30 CD O
minutes NNS O
at IN O
37 CD O
? . O
C NN O
, , O
prior RB O
to IN O
exposure NN O
to IN O
film NN O
. . O

Probes NNS O
and CC O
dioxetane NN O
were VBD O
stripped VBN O
from IN O
the DT O
membranes NNS O
by IN O
two CD O
10 CD O
minute NN O
washes NNS O
at IN O
700C CD O
with IN O
0 CD O
. . O
2 CD O
% NN O
SDS NNP O
, , O
2mM NNP O
EDTA NNP O
( , O
200 CD O
, , O
ul CD O
/ SYM O
cm2 NN O
membrane NN O
) -RRB- O
. . O

The DT O
hybridization NN O
and CC O
washing NN O
procedures NNS O
were VBD O
carried VBN O
out RP O
in IN O
plastic JJ O
bags NNS O
. . O

However RB O
, , O
washing NN O
steps NNS O
have VBP O
also RB O
been VBN O
performed VBN O
with IN O
gentle JJ O
agitation NN O
in IN O
a DT O
perspex NN O
tub NN O
( , O
43 CD O
x SYM O
27 CD O
x SYM O
15cm CD O
) -RRB- O
mounted VBN O
on IN O
a DT O
reciprocal JJ O
shaker NN O
, , O
with IN O
equivalent JJ O
results NNS O
. . O

In IN O
the DT O
latter JJ O
case NN O
a DT O
minimum JJ O
wash NN O
volume NN O
of IN O
500mls NNS O
was VBD O
used VBN O
. . O

The DT O
use NN O
of IN O
a DT O
tub NN O
is VBZ O
more RBR O
convenient JJ O
for IN O
batch NN O
processing NN O
and CC O
should MD O
be VB O
straightforward JJ O
to TO O
automate VB O
. . O

RESULTS NNS O

Autoradiograms NNS O
revealed VBD O
no DT O
difference NN O
in IN O
sequence NN O
quality NN O
when WRB O
tagged VBN O
primers NNS O
were VBD O
used VBN O
instead RB O
of IN O
the DT O
17mer CD O
universal JJ O
primer NN O
in IN O
conventional JJ O
[ -LRB- O
a DT O
- HYPH O
35S NN O
] -RRB- O
dATP NN O
labelled VBN O
sequencing NN O
reactions NNS O
and CC O
in IN O
multiplex JJ O
hybridization NN O
experiments NNS O
using VBG O
[ -LRB- O
a DT O
- HYPH O
32P CD O
] -RRB- O
dCTP NN O
- HYPH O
tailed VBN O
probes NNS O
( , O
results NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Experiments NNS O
were VBD O
then RB O
conducted VBN O
to TO O
determine VB O
the DT O
feasibility NN O
of IN O
pooling VBG O
the DT O
four CD O
base NN O
reactions NNS O
for IN O
each DT O
clone NN O
and CC O
fractionating VBG O
them PRP O
in IN O
a DT O
single JJ O
lane NN O
to TO O
obtain VB O
a DT O
superimposed JJ O
but CC O
interpretable JJ O
set NN O
of IN O
sequence NN O
ladders NNS O
. . O

The DT O
question NN O
addressed VBN O
was VBD O
whether IN O
or CC O
not RB O
difficulties NNS O
in IN O
band NN O
registration NN O
might MD O
arise VB O
as IN O
a DT O
result NN O
of IN O
mobility NN O
differences NNS O
between IN O
the DT O
different JJ O
primer JJ O
sequences NNS O
and CC O
/ SYM O
or CC O
distortion NN O
of IN O
the DT O
membrane NN O
between IN O
probings NNS O
. . O

It PRP O
is VBZ O
relevant JJ O
that IN O
an DT O
automated JJ O
film NN O
reader NN O
employing VBG O
an DT O
internal JJ O
standard NN O
requires VBZ O
that IN O
the DT O
nylon NN O
membrane NN O
does VBZ O
not RB O
undergo VB O
significant JJ O
distortions NNS O
between IN O
probings NNS O
( , O
George NNP O
Church NNP O
, , O
personal JJ O
communication NN O
) -RRB- O
. . O

Clones NNS O
were VBD O
sequenced VBN O
using VBG O
the DT O
four CD O
tagged VBN O
primers NNS O
UEOlC NNP O
, , O
UPOIC NNP O
, , O
UE02C NNP O
, , O
and CC O
UP02C NNP O
, , O
one CD O
for IN O
each DT O
base NN O
reaction NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
A NNP O
, , O
C NNP O
, , O
G NNP O
and CC O
T NNP O
reactions NNS O
for IN O
each DT O
clone NN O
were VBD O
pooled VBN O
, , O
and CC O
processed VBN O
as IN O
described VBN O
above RB O
. . O

A DT O
complete JJ O
set NN O
of IN O
sequence NN O
autoradiograms NNS O
was VBD O
obtained VBN O
from IN O
four CD O
consecutive JJ O
rounds NNS O
of IN O
probing VBG O
with IN O
[ -LRB- O
a DT O
- HYPH O
32P CD O
] -RRB- O
dCTP NN O
- HYPH O
labelled VBN O
oligonucleotides NNS O
. . O

Alignment NN O
of IN O
the DT O
films NNS O
showed VBD O
that IN O
sequence NN O
- HYPH O
specific JJ O
mobility NN O
effects NNS O
and CC O
distortion NN O
of IN O
the DT O
membrane NN O
between IN O
probings NNS O
were VBD O
sufficiently RB O
minor JJ O
to TO O
allow VB O
accurate JJ O
registration NN O
of IN O
the DT O
bands NNS O
, , O
and CC O
hence RB O
accurate JJ O
reading NN O
of IN O
the DT O
sequence NN O
. . O

At IN O
least JJS O
200 CD O
nucleotides NNS O
of IN O
sequence NN O
could MD O
be VB O
read VBN O
accurately RB O
from IN O
a DT O
single JJ O
clone NN O
by IN O
simply RB O
tracing VBG O
the DT O
four CD O
sets NNS O
of IN O
bands NNS O
using VBG O
different JJ O
colours NNS O
, , O
overlaying VBG O
the DT O
tracings NNS O
, , O
and CC O
reading VBG O
the DT O
bands NNS O
sequentially RB O
. . O

In IN O
order NN O
to TO O
assess VB O
the DT O
practicality NN O
of IN O
reading VBG O
the DT O
sequences NNS O
by IN O
machine NN O
, , O
the DT O
images NNS O
were VBD O
scanned VBN O
to TO O
provide VB O
optical JJ O
density NN O
profiles NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

These DT O
profiles NNS O
were VBD O
overlaid JJ O
, , O
and CC O
were VBD O
found VBN O
to TO O
be VB O
sufficiently RB O
in IN O
register NN O
to TO O
allow VB O
accurate JJ O
interpretation NN O
of IN O
the DT O
sequence NN O
for IN O
at RB O
least RBS O
300 CD O
nucleotides NNS O
. . O

This DT O
was VBD O
essentially RB O
the DT O
limit NN O
of IN O
resolution NN O
of IN O
the DT O
gel NN O
for IN O
accurate JJ O
manual JJ O
reading NN O
. . O

In IN O
order NN O
to TO O
ensure VB O
that IN O
the DT O
relatively RB O
minor JJ O
mobility NN O
differences NNS O
observed VBN O
between IN O
the DT O
four CD O
primers NNS O
were VBD O
not RB O
coincidental JJ O
to IN O
the DT O
oligonucleotides NNS O
used VBN O
, , O
a DT O
second JJ O
set NN O
of IN O
four CD O
tagged VBN O
M13 NNP O
universal JJ O
primers NNS O
was VBD O
synthesised VBN O
, , O
this DT O
time NN O
incorporating VBG O
20mer CD O
sequences NNS O
derived VBN O
from IN O
the DT O
genome NN O
of IN O
murine NN O
herpesvirus NN O
- HYPH O
68 CD O
( , O
UJOL14C NNP O
, , O
15C CD O
, , O
16C CD O
, , O
17C CD O
) -RRB- O
. . O

Sequencing VBG O
reactions NNS O
were VBD O
performed VBN O
using VBG O
[ -LRB- O
cx NN O
- HYPH O
35S NN O
] -RRB- O
dATP NN O
to TO O
label VB O
the DT O
DNA NNP O
directly RB O
. . O

Various JJ O
templates NNS O
were VBD O
sequenced VBN O
, , O
and CC O
in IN O
all DT O
cases NNS O
correctly RB O
ordered VBN O
sequence NN O
ladders NNS O
were VBD O
obtained VBN O
following VBG O
conventional JJ O
electrophoresis NN O
in IN O
which WDT O
the DT O
four CD O
reactions NNS O
were VBD O
run VBN O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
( : O
results NNS O
not RB O
shown VBN O
) : O
. . O

Initial JJ O
hybridization NN O
experiments NNS O
were VBD O
conducted VBN O
using VBG O
[ -LRB- O
f IN O
- HYPH O
32p CD O
] -RRB- O

dCTP NNP O
tailed VBD O
oligonucleotide NN O
probes NNS O
. . O

However RB O
, , O
the DT O
use NN O
of IN O

lOOmM NNP O
NaCl NNP O
, , O
5OmM NNP O
MgC12 NNP O
, , O
0 CD O
. . O
15mM CD O
AMPPD NN O
( : O
[ -LRB- O
3 CD O
- HYPH O
( SYM O
2 CD O
' '' O
- HYPH O
ada NN O

B NN O

C NN O

' '' O
Ordinary JJ O
' '' O
Plex NNP O
' '' O
4 CD O
- HYPH O
CJ3 NN O
4 CD O
- HYPH O
rn NN O
+ CC O

Primeir NNP O
Primer NNP O

"""" `` O
All DT O
"""" `` O
C NNP O
"""" '' O
"""" `` O
G NN O
"""" '' O
"""" `` O
T NN O
"""" '' O

' `` O
Plex NNP O
' '' O
' '' O
Ordinary NNP O
' '' O
Pool NNP O
and CC O

Vector NN O
Vector NN O
fractionate JJ O

Resolve VB O
by IN O
sequential JJ O

hybridizations NNS O

Sequencing VBG O
reactions NNS O

SequencingreactIo NNP O
product NN O

Sequencing VBG O
reaction NN O
product NN O

- : O
n XX O
; : O

= NFP O
= NFP O

- : O
= . O

- : O
n LS O
: : O
= NFP O

Figure NN O
1 CD O
. . O
Approaches NNS O
to IN O
enzymatic JJ O
multiplex NN O
DNA NN O
sequencing NN O
. . O
a DT O
) NFP O
A DT O
set NN O
of IN O
sequence NN O
- HYPH O
tagged VBN O
vectors NNS O
can MD O
be VB O
used VBN O
. . O

The DT O
tag NN O
site NN O
is VBZ O
shown VBN O
in IN O
red NN O
, , O
and CC O
the DT O
insert NN O
to TO O
be VB O
sequenced VBN O
in IN O
blue NN O
. . O

However RB O
, , O
the DT O
original JJ O
plex NN O
vectors NNS O
( , O
3 CD O
) -RRB- O
are VBP O
plasmids NNS O
, , O
and CC O
therefore RB O
amenable JJ O
only RB O
to IN O
dsDNA NNP O
sequencing NN O
. , O
Sets NNS O
of IN O
bacteriophage NN B-Species
M13 NNP I-Species
vectors NNS O
have VBP O
been VBN O
constructed VBN O
bearing VBG O
either CC O
one CD O
( SYM O
32 CD O
) , O
or CC O
two CD O
[ -LRB- O
Chee NNP O
, , O
unpublished JJ O
] -RRB- O
of IN O
the DT O
plex JJ O
tag NN O
sites NNS O
flanking VBG O
the DT O
polylinker NN O
, , O
which WDT O
can MD O
be VB O
used VBN O
for IN O
this DT O
approach NN O
. . O

b LS O
) -RRB- O
The DT O
strategy NN O
used VBN O
in IN O
this DT O
paper NN O
. . O

In IN O
this DT O
case NN O
the DT O
tag NN O
site NN O
is VBZ O
carried VBN O
on IN O
the DT O
primer NN O
. . O

c LS O
) : O
If IN O
tagged VBN O
primers NNS O
are VBP O
used VBN O
, , O
there EX O
is VBZ O
no DT O
practical JJ O
impediment NN O
to IN O
performing VBG O
each DT O
base NN O
reaction NN O
using VBG O
a DT O
different JJ O
primer NN O
, , O
as IN O
depicted VBN O
. . O

The DT O
reactions NNS O
can MD O
then RB O
be VB O
pooled VBN O
in IN O
any DT O
combination NN O
desired VBN O
. . O

The DT O
configuration NN O
shown VBN O
, , O
in IN O
which WDT O
the DT O
four CD O
reactions NNS O
are VBP O
electrophoresed VBN O
in IN O
a DT O
single JJ O
lane NN O
, , O
is VBZ O
designed VBN O
to TO O
facilitate VB O
accurate JJ O
band NN O
registration NN O
and CC O
reading NN O
by IN O
an DT O
automatic JJ O
film NN O
reader NN O
. . O

In IN O
order NN O
to TO O
read VB O
the DT O
sequence NN O
manually RB O
, , O
base NN O
reactions NNS O
would MD O
be VB O
run VBN O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
. . O

The DT O
logistics NNS O
of IN O
processing VBG O
the DT O
reactions NNS O
are VBP O
essentially RB O
the DT O
same JJ O
with IN O
either DT O
configuration NN O
; : O
the DT O
same JJ O
number NN O
of IN O
probings NNS O
are VBP O
required VBN O
. . O

Figure NN O
2 CD O
. . O

Four CD O
overlaid JJ O
one CD O
- HYPH O
dimensional JJ O
optical JJ O
density NN O
profiles NNS O
for IN O
a DT O
single JJ O
clone NN O
shown VBN O
in IN O
two CD O
overlapping JJ O
sections NNS O
. . O

The DT O
optical JJ O
density NN O
profiles NNS O
are VBP O
unprocessed JJ O
, , O
except IN O
for IN O
a DT O
simple JJ O
transform NN O
to TO O
correct VB O
for IN O
the DT O
relative JJ O
displacement NN O
( , O
translation NN O
and CC O
rotation NN O
) -RRB- O
of IN O
the DT O
four CD O
images NNS O
from IN O
which WDT O
they PRP O
are VBP O
extracted VBN O
. . O

The DT O
profiles NNS O
read VBD O
5 CD O
' '' O
to IN O
3 CD O
' '' O
from IN O
right RB O
to IN O
left RB O
. . O

Nucleotides NNS O
positions NNS O
66 CD O
to TO O
214 CD O
from IN O
the DT O
start NN O
of IN O
the DT O
universal JJ O
priming NN O
site NN O
are VBP O
shown VBN O
. . O

The DT O
sequence NN O
is VBZ O
that DT O
of IN O
Bluescribe NNP O
M13 NNP O
+ CD O
( , O
template NN O
DNA NN O
obtained VBN O
by IN O
rescue NN O
with IN O
M13K07 NNP O
helper NN O
phage NN O
( : O
30 CD O
) -RRB- O
) -RRB- O
, , O
and CC O
was VBD O
determined VBN O
using VBG O
the DT O
primers NNS O
UEOIC NNP O
, , O
UPOIC NNP O
, , O
UE02C NNP O
, , O
and CC O
UP02C NNP O
for IN O
the DT O
T NNP O
, , O
C NNP O
, , O
G NNP O
and CC O
A NNP O

specific JJ O
reactions NNS O
respectively RB O
. . O

Detection NN O
was VBD O
by IN O
autoradiography NN O
following VBG O
hybridization NN O
with IN O
[ -LRB- O
a DT O
- HYPH O
32p CD O
] -RRB- O
dCTP NN O
tailed VBN O
plex NN O
probes NNS O
. . O

A DT O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O
3303 CD O

I PRP O

3304 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O

a LS O
) . O

175 CD O
- : O
. . O
. . O
. . O

- : O
w XX O

. . O
m UH O
; . O

b LS O
) -RRB- O

182 CD O

a DT O
: : O
. . O
. . O
. . O
. . O
. . O
. . O

F NNP O
. . O
VW NNP O

an DT O

- : O
w XX O

- : O
1 CD O

S NNP O
- HYPH O
K NN O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
i PRP O

' '' O
F NN O
C NN O
C NN O
; : O
A NN O
I1 NN O
' '' O
CG NN O
A NN O

Figure NN O
3 CD O
. . O

Four CD O
separate JJ O
base NN O
- HYPH O
specific JJ O
reactions NNS O
imaged VBN O
from IN O
a DT O
single JJ O
lane NN O
using VBG O
chemiluminescent NN O
detection NN O
. . O

The DT O
clones NNS O
sequenced VBN O
are VBP O
: : O
a LS O
) -RRB- O
Bluescribe NNP O
M13 NNP O
+ NN O
( , O
obtained VBN O
by IN O
rescue NN O
with IN O
M13K07 NNP O
helper NN O
phage NN O
( : O
30 CD O
) -RRB- O
) -RRB- O
and CC O
b LS O
) -RRB- O
an DT O
M13 NN O
recombinant JJ O
clone NN O
prepared VBN O
in IN O
a DT O
microtitre NN O
tray NN O
( SYM O
21 CD O
) -RRB- O
( , O
a DT O
kind NN O
gift NN O
of IN O
Victoria NNP O
Smith NNP O
) -RRB- O
. . O

Nucleotide NN O
positions NNS O
shown VBN O
on IN O
the DT O
figure NN O
are VBP O
numbered VBN O
from IN O
the DT O
start NN O
of IN O
the DT O
universal JJ O
priming NN O
site NN O
. . O

The DT O
clones NNS O
were VBD O
sequenced VBN O
using VBG O
UEOlC NNP O
, , O
UPOIC NNP O
, , O
UE02C NNP O
, , O
and CC O
UP02C NNP O
for IN O
the DT O
T NNP O
, , O
C NNP O
, , O
G NNP O
and CC O
A NNP O
specific JJ O
reactions NNS O
respectively RB O
. . O

The DT O
blot NN O
was VBD O
probed VBN O
with IN O
corresponding VBG O
DIG NNP O
- HYPH O
11 CD O
- HYPH O
dUTP NN O
labelled VBN O
oligonucleotides NNS O
. . O

radioactivity NN O
on IN O
the DT O
scale NN O
envisioned VBN O
for IN O
a DT O
large JJ O
sequencing NN O
project NN O
is VBZ O
undesirable JJ O
for IN O
reasons NNS O
of IN O
safety NN O
. . O

The DT O
relatively RB O
long JJ O
exposure NN O
times NNS O
required VBN O
( , O
6 CD O
to TO O
24 CD O
hours NNS O
) -RRB- O
and CC O
the DT O
short JJ O
half JJ O
lives NNS O
of IN O
the DT O
probes NNS O
might MD O
also RB O
be VB O
inconvenient JJ O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
a DT O
biotin NN O
/ SYM O
streptavidin NN O
/ SYM O
alkaline JJ O
phosphatase NN O
based VBN O
detection NN O
system NN O
used VBN O
in IN O
conjunction NN O
with IN O
a DT O
chemiluminescent JJ O
dioxetane NN O
substrate NN O
overcomes VBZ O
these DT O
disadvantages NNS O
( : O
24 CD O
, , O
25 CD O
, , O
26 CD O
) -RRB- O
. . O

We PRP O
utilized VBD O
a DT O
different JJ O
bridging NN O
system NN O
with IN O
similar JJ O
results NNS O
. . O

Digoxigenin NNP O
( -LRB- O
DIG NNP O
) -RRB- O
labelled VBD O
oligonucleotide NN O
probes NNS O
were VBD O
detected VBN O
using VBG O
anti JJ O
- HYPH O
DIG NN O
antibody NN O
- HYPH O
alkaline JJ O
phosphatase NN O
conjugates NNS O
and CC O
a DT O
chemiluminescent NN O
dioxetane NN O
substrate NN O
. . O

Exposure NN O
times NNS O
of IN O
10 CD O
to TO O
15 CD O
minutes NNS O
were VBD O
typically RB O
required VBN O
, , O
following VBG O
a DT O
one CD O
hour NN O
preincubation NN O
period NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
. . O

In IN O
our PRP$ O
hands NNS O
the DT O
DIG NNP O
bridging NN O
system NN O
was VBD O
similar JJ O
in IN O
sensitivity NN O
to IN O
the DT O
streptavidin NN O
based VBN O
system NN O
( : O
24 CD O
) -RRB- O
, , O
and CC O
the DT O
practical JJ O
lower JJR O
limit NN O
of IN O
template NN O
ssDNA NNP O
required VBN O
in IN O
order NN O
to TO O
obtain VB O
an DT O
easily RB O
interpretable JJ O
sequencing NN O
ladder NN O
was VBD O
estimated VBN O
to TO O
be VB O
in IN O
the DT O
range NN O
of IN O
20 CD O
to IN O
50fmols NNS O
per IN O
reaction NN O
. . O

However RB O
, , O
the DT O
sensitivity NN O
of IN O
detection NN O
was VBD O
limited VBN O
only RB O
by IN O
enzymaticallytrigger NN O
background NN O
luminescence NN O
, , O
and CC O
not RB O
by IN O
the DT O
level NN O
of IN O
signal NN O
obtained VBN O
. . O

The DT O
nonradioactive JJ O
methods NNS O
described VBN O
have VBP O
been VBN O
used VBN O
successfully RB O
in IN O
an DT O
8 CD O
- HYPH O
plex NN O
system NN O
. . O

DISCUSSION NN O

Although IN O
the DT O
original JJ O
multiplex NN O
protocol NN O
was VBD O
based VBN O
on IN O
a DT O
set NN O
of IN O
tagged VBN O
vectors NNS O
( , O
3 CD O
) -RRB- O
, , O
tagged VBN O
primers NNS O
have VBP O
also RB O
been VBN O
used VBN O
or CC O
proposed VBN O
for IN O
various JJ O
forms NNS O
of IN O
multiplex JJ O
DNA NN O
sequencing NN O
( , O
George NNP O
Church NNP O
, , O
personal JJ O
communication NN O
; : O
2 CD O
, , O
27 CD O
) -RRB- O
. . O

For IN O
example NN O
, , O
a DT O
proposal NN O
was VBD O
recently RB O
put VBN O
forward RP O
for IN O
multiplex JJ O
sequencing NN O
using VBG O
sequence NN O
- HYPH O
labelled VBN O
primers NNS O
and CC O
fluorophor NN O
- HYPH O
labelled VBN O
probes NNS O

( : O
1 CD O
) -RRB- O
, , O
similar JJ O
in IN O
principle NN O
to IN O
the DT O
methods NNS O
used VBN O
here RB O
. . O

However RB O
, , O
we PRP O
use VBP O
tagged VBN O
primers NNS O
and CC O
the DT O
superposition NN O
of IN O
the DT O
four CD O
sequencing VBG O
reactions NNS O
to TO O
address VB O
the DT O
problem NN O
of IN O
reading VBG O
DNA NN O
sequence NN O
films NNS O
; : O
a DT O
part NN O
of IN O
this DT O
solution NN O
is VBZ O
to TO O
utilize VB O
M13 NN O
dideoxynucleotide NN O
sequencing NN O
, , O
thereby RB O
improving VBG O
the DT O
quality NN O
of IN O
the DT O
data NNS O
to TO O
be VB O
analyzed VBN O
. . O

In IN O
addition NN O
, , O
the DT O
proposal NN O
for IN O
fluorophor NN O
- HYPH O
labelled VBN O
probes NNS O
does VBZ O
not RB O
take VB O
into IN O
consideration NN O
any DT O
of IN O
the DT O
practical JJ O
sequencing NN O
problems NNS O
addressed VBN O
here RB O
, , O
and CC O
, , O
in IN O
the DT O
version NN O
described VBN O
, , O
remains VBZ O
a DT O
promising JJ O
but CC O
unproven JJ O
scheme NN O
for IN O
large JJ O
scale NN O
DNA NN O
sequencing NN O
. . O

There EX O
are VBP O
several JJ O
advantages NNS O
to IN O
tagging VBG O
primers NNS O
instead RB O
of IN O
vectors NNS O
. . O

Firstly RB O
, , O
there EX O
is VBZ O
no DT O
need NN O
to TO O
prepare VB O
multiple JJ O
libraries NNS O
of IN O
clones NNS O
in IN O
special JJ O
vectors NNS O
. . O

This DT O
means VBZ O
that IN O
workers NNS O
can MD O
use VB O
vector NN O
/ SYM O
host NN O
combinations NNS O
that WDT O
yield VBP O
good JJ O
results NNS O
in IN O
their PRP$ O
hands NNS O
, , O
and CC O
an DT O
increased VBN O
depth NN O
of IN O
multiplexing NN O
can MD O
easily RB O
be VB O
accomodated VBN O
by IN O
synthesizing VBG O
more JJR O
primers NNS O
. . O

This DT O
should MD O
make VB O
multiplexing NN O
more RBR O
accessible JJ O
to IN O
workers NNS O
undertaking VBG O
smaller JJR O
projects NNS O
. . O

A DT O
theoretical JJ O
disadvantage NN O
of IN O
tagged VBN O
primers NNS O
is VBZ O
that IN O
the DT O
procedure NN O
can MD O
only RB O
be VB O
multiplexed VBN O
following VBG O
primer NN O
annealing VBG O
( , O
1 CD O
) -RRB- O
, , O
or CC O
following VBG O
the DT O
sequencing VBG O
reactions NNS O
( , O
this DT O
paper NN O
; : O
in IN O
practice NN O
, , O
pooling VBG O
immediately RB O
after IN O
the DT O
annealing VBG O
step NN O
might MD O
lead VB O
to IN O
increased VBN O
backgrounds NNS O
if IN O
one CD O
or CC O
more JJR O
primers NNS O
were VBD O
present JJ O
in IN O
excess NN O
over IN O
their PRP$ O
template NN O
DNAs NNS O
) -RRB- O
. . O

This DT O
is VBZ O
a DT O
relatively RB O
late JJ O
stage NN O
. . O

In IN O
the DT O
original JJ O
procedure NN O
( , O
3 CD O
) -RRB- O
, , O
clones NNS O
were VBD O
pooled VBN O
prior RB O
to IN O
amplification NN O
by IN O
growth NN O
, , O
an DT O
early JJ O
step NN O
. . O

However RB O
, , O
we PRP O
do VBP O
not RB O
believe VB O
the DT O
sacrifice NN O
to TO O
be VB O
of IN O
practical JJ O
importance NN O
when WRB O
using VBG O
phage NN O
vectors NNS O
. . O

In IN O
our PRP$ O
experience NN O
, , O
recombinant JJ O
M13 NNP O
phage NN O
have VBP O
variable JJ O
growth NN O
rates NNS O
and CC O
the DT O
effects NNS O
of IN O
competition NN O
are VBP O
likely JJ O
to TO O
severely RB O
limit VB O
the DT O
number NN O
of IN O
clones NNS O
that WDT O
can MD O
usefully RB O
be VB O
pooled VBN O
for IN O
growth NN O
. . O

In IN O
contrast NN O
, , O
by IN O
growing VBG O
clones NNS O
individually RB O
, , O
the DT O
depth NN O
of IN O
multiplexing NN O
is VBZ O
only RB O
really RB O
limited VBN O
by IN O
probe NN O
sensitivity NN O
. . O

We PRP O
have VBP O
not RB O
investigated VBN O
the DT O
factors NNS O
influencing VBG O
variability NN O
in IN O
phage NN O
growth NN O
rates NNS O
. . O

It PRP O
is VBZ O
worth JJ O
noting VBG O
that IN O
reliable JJ O
protocols NNS O
have VBP O
been VBN O
developed VBN O
for IN O
growing VBG O
large JJ O
numbers NNS O
of IN O
individual JJ O
M13 NNP O
clones NNS O
and CC O
preparing VBG O
high JJ O
quality NN O
ssDNA NNP O
templates NNS O
in IN O
microtitre NN O
trays NNS O
( , O
28 CD O
, , O
21 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
relatively RB O
simple JJ O
to TO O
prepare VB O
manually RB O
two CD O
microtitre JJ O
trays NNS O
of IN O
ssDNA NNP O
templates NNS O
( , O
192 CD O
clones NNS O
) -RRB- O
in IN O
a DT O
day NN O
. . O

Sufficient JJ O
clones NNS O
can MD O
be VB O
prepared VBN O
in IN O
a DT O
week NN O
to TO O
sequence VB O
a DT O
20kb CD O
fragment NN O
to IN O
a DT O
redundancy NN O
of IN O
10 CD O
( , O
Victoria NNP O
Smith NNP O
, , O
personal JJ O
communication NN O
) -RRB- O
. . O

In IN O
this DT O
laboratory NN O
, , O
ssDNA NNP O
is VBZ O
now RB O
prepared VBN O
with IN O
the DT O
aid NN O
of IN O
a DT O
commercially RB O
available JJ O
robotic JJ O
workstation NN O
( SYM O
21 CD O
) -RRB- O
. . O

As IN O
sequencing NN O
reactions NNS O
are VBP O
also RB O
carried VBN O
out RP O
in IN O
microtitre NN O
trays NNS O
, , O
manually RB O
or CC O
robotically RB O
( , O
20 CD O
, , O
29 CD O
) -RRB- O
, , O
the DT O
entire JJ O
M13 NN O
- HYPH O
based VBN O
dideoxynucleotide NN O
sequencing NN O
procedure NN O
is VBZ O
amenable JJ O
to IN O
automation NN O
( SYM O
29 CD O
) -RRB- O
. . O

For IN O
these DT O
reasons NNS O
we PRP O
see VBP O
little JJ O
practical JJ O
advantage NN O
in IN O
pooling VBG O
clones NNS O
early RB O
. . O

Finally RB O
, , O
by IN O
not RB O
pooling VBG O
clones NNS O
early RB O
, , O
the DT O
ability NN O
to TO O
easily RB O
retrieve VB O
individual JJ O
clones NNS O
is VBZ O
retained VBN O
, , O
which WDT O
may MD O
facilitate VB O
directed JJ O
sequencing NN O
later RB O
in IN O
a DT O
project NN O
should MD O
this DT O
become VB O
necessary JJ O
. . O

Multiplex NNP O
DNA NNP O
sequencing NN O
is VBZ O
currently RB O
limited VBN O
by IN O
the DT O
lack NN O
of IN O
a DT O
robust JJ O
computer NN O
program NN O
which WDT O
can MD O
correct VB O
for IN O
the DT O
large JJ O
variety NN O
of IN O
gel NN O
and CC O
sequencing NN O
artefacts NNS O
that WDT O
are VBP O
normally RB O
encountered VBN O
. . O

The DT O
foundation NN O
of IN O
a DT O
film NN O
reading NN O
program NN O
is VBZ O
the DT O
ability NN O
to TO O
bring VB O
into IN O
register VB O
precisely RB O
vertical JJ O
arrays NNS O
of IN O
base NN O
- HYPH O
specific JJ O
bands NNS O
. . O

This DT O
requires VBZ O
the DT O
ability NN O
to TO O
track VB O
lanes NNS O
, , O
correct VB O
for IN O
distortions NNS O
, , O
and CC O
order VB O
bands NNS O
based VBN O
on IN O
their PRP$ O
relative JJ O
spacing NN O
. . O

A DT O
method NN O
of IN O
sequencing NN O
which WDT O
has VBZ O
successfully RB O
overcome VBN O
the DT O
problem NN O
of IN O
sequence NN O
reading NN O
uses VBZ O
real JJ O
- HYPH O
time NN O
detection NN O
of IN O
fluorescently RB O
labelled VBN O
DNA NNP O
samples NNS O
migrating VBG O
through IN O
the DT O
gel NN O
( HYPH O
2 CD O
) -RRB- O
. . O

This DT O
system NN O
also RB O
utilizes VBZ O
the DT O
principle NN O
of IN O
running VBG O
the DT O
four CD O
base NN O
reactions NNS O
down IN O
the DT O
same JJ O
lane NN O
( SYM O
2 CD O
) -RRB- O
. . O

However RB O
, , O
bands NNS O
are VBP O
detected VBN O
at IN O
a DT O
fixed VBN O
location NN O

in IN O
space NN O
, , O
and CC O
their PRP$ O
detection NN O
is VBZ O
separated VBN O
in IN O
time NN O
. . O

Hence RB O
the DT O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O
3305 CD O

problem NN O
of IN O
gel NN O
distortion NN O
is VBZ O
essentially RB O
avoided VBN O
, , O
although IN O
corrections NNS O
for IN O
the DT O
different JJ O
mobilities NNS O
of IN O
the DT O
four CD O
dyes NNS O
must MD O
be VB O
carried VBN O
out RP O
. . O

In IN O
contrast NN O
, , O
we PRP O
utilize VBP O
the DT O
advantages NNS O
of IN O
single JJ O
lane NN O
electrophoresis NN O
to TO O
address VB O
the DT O
problem NN O
of IN O
superimposing VBG O
four CD O
relatively RB O
large JJ O
and CC O
complex JJ O
two CD O
- HYPH O
dimensional JJ O
images NNS O
. . O

Furthermore RB O
, , O
by IN O
using VBG O
sequence NN O
- HYPH O
tagged VBN O
oligonucleotides NNS O
which WDT O
are VBP O
detected VBN O
by IN O
hybridization NN O
, , O
a DT O
much RB O
greater JJR O
depth NN O
of IN O
multiplexing NN O
can MD O
realistically RB O
be VB O
achieved VBN O
than IN O
by IN O
real JJ O
- HYPH O
time NN O
detection NN O
. . O

The DT O
use NN O
of IN O
two CD O
- HYPH O
dimensional JJ O
colour NN O
traces NNS O
to TO O
depict VB O
the DT O
processed VBN O
output NN O
of IN O
a DT O
film NN O
reader NN O
is VBZ O
consistent JJ O
with IN O
the DT O
method NN O
of IN O
displaying VBG O
fluorescence NN O
traces NNS O
, , O
and CC O
should MD O
facilitate VB O
the DT O
checking NN O
and CC O
editing NN O
of IN O
sequence NN O
databases NNS O
in IN O
which WDT O
both DT O
kinds NNS O
of IN O
data NNS O
have VBP O
been VBN O
entered VBN O
. . O

The DT O
sequence NN O
compilation NN O
programs NNS O
used VBN O
in IN O
this DT O
laboratory NN O
, , O
which WDT O
are VBP O
already RB O
capable JJ O
of IN O
handling VBG O
large JJ O
shotgun NN O
databases NNS O
( , O
8 CD O
, , O
31 CD O
) -RRB- O
, , O
have VBP O
recently RB O
undergone VBN O
extensive JJ O
improvements NNS O
( : O
Rodger NNP O
Staden NNP O
, , O
personal JJ O
communication NN O
) -RRB- O
. . O

There EX O
is VBZ O
now RB O
an DT O
interactive JJ O
database NN O
editor NN O
which WDT O
allows VBZ O
the DT O
graphical JJ O
display NN O
of IN O
fluorescence NN O
traces NNS O
, , O
and CC O
it PRP O
is VBZ O
envisaged VBN O
that IN O
this DT O
feature NN O
could MD O
be VB O
extended VBN O
to TO O
allow VB O
the DT O
handling NN O
of IN O
data NNS O
from IN O
a DT O
film NN O
reader NN O
when WRB O
a DT O
suitable JJ O
machine NN O
is VBZ O
developed VBN O
. . O

ACKNOWLEDGEMENTS NNS O

I PRP O
am VBP O
particularly RB O
grateful JJ O
to IN O
George NNP O
Church NNP O
for IN O
thought NN O
- HYPH O
provoking VBG O
discussions NNS O
and CC O
gifts NNS O
of IN O
vectors NNS O
and CC O
oligonucleotide NN O
probes NNS O
and CC O
to IN O
John NNP O
Sulston NNP O
for IN O
advice NN O
. . O

I PRP O
also RB O
thank VBP O
Victoria NNP O
Smith NNP O
for IN O
the DT O
gift NN O
of IN O
DNA NNP O
samples NNS O
, , O
Bart NNP O
Barrell NNP O
for IN O
long JJ O
- HYPH O
term NN O
support NN O
, , O
Tom NNP O
O NNP O
' '' O
Keefe NNP O
of IN O
Milligen NNP O
/ SYM O
Biosearch NNP O
for IN O
lessons NNS O
in IN O
multiplexing NN O
and CC O
Amersham NNP O
International NNP O
for IN O
the DT O
optical JJ O
density NN O
overlays NNS O
shown VBN O
in IN O
Figure NN O
2 CD O
. . O

M UH O
. . O
C NN O
. . O

is VBZ O
supported VBN O
by IN O
a DT O
fellowship NN O
from IN O
Applied NNP O
Biosystems NNPS O
. . O

12 CD O
. . O

Hiratsuka NNP O
, , O
J NNP O
. . O
, , O
Shimada NNP O
, , O
H NNP O
. . O
, , O
Whittier NNP O
, , O
R NNP O
. . O
, , O
Ishibashi NNP O
, , O
T NNP O
. . O
, , O
Sakamoto NNP O
, , O
M NNP O
. . O
, , O
Mori NNP O
, , O

M UH O
. . O
, , O
Kondo NNP O
, , O
C NNP O
. . O
, , O
Honju NNP O
, , O
Y NNP O
. . O
, , O
Sun NNP O
, , O
C NNP O
. . O

- : O
R NN O
, , O
Meng NNP O
, , O
B NN O
. . O

- : O
Y UH O
, , O
Li NNP O
, , O
Y UH O
. . O

- : O
Q NN O
, , O
Kanno NNP O
, , O
A NNP O
. . O
, , O
Nisizawa NNP O
, , O
Y NNP O
. . O
, , O
Hirai NNP O
, , O
A NNP O
. . O
, , O
Shinozaki NNP O
, , O
K NNP O
. . O
and CC O
Sugiura NNP O
, , O
M NNP O
. . O

( -LRB- O
1989 CD O
) -RRB- O
Molecular NNP O
and CC O
General NNP O
Genetics NNP O
, , O
217 CD O
, , O
185 CD O
- HYPH O
194 CD O
. . O

13 CD O
. . O

Komaromy NNP O
, , O
M UH O
. . O
and CC O
Govan NNP O
, , O
H NNP O
. . O

( : O
1984 CD O
) SYM O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
12 CD O
, , O
675 CD O
- HYPH O
678 CD O
. . O

14 CD O
. . O

Staden NNP O
, , O
R NNP O
. . O

( : O
1984 CD O
) SYM O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
12 CD O
, , O
499 CD O
- HYPH O
503 CD O
. . O

15 CD O
. . O

Elder NN O
, , O
J NNP O
. . O

K UH O
. . O
, , O
Green NNP O
, , O
D NNP O
. . O

K UH O
. . O
and CC O
Southern JJ O
, , O
E UH O
. . O

M UH O
. . O

( -LRB- O
1986 CD O
) -RRB- O
Nucleic JJ O
Acids NNS O

Research NNP O
, , O
14 CD O
, , O
417 CD O
- HYPH O
424 CD O
. . O

16 CD O
. . O

Maxam NNP O
, , O
A NNP O
. . O

M UH O
. . O
and CC O
Gilbert NNP O
, , O
W NNP O
. . O

( -LRB- O
1977 CD O
) -RRB- O
Proceedings NNS O
of IN O
the DT O
National NNP O
Academy NNP O

of IN O
Sciences NNPS O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
, , O
74 CD O
, , O
560 CD O
- HYPH O
564 CD O
. . O

17 CD O
. . O

Sanger NNP O
, , O
F NNP O
. . O
, , O
Nicklen NNP O
, , O
S NNP O
. . O
and CC O
Coulson NNP O
, , O
A NNP O
. . O

R NN O
. . O

( -LRB- O
1977 CD O
) -RRB- O
Proceedings NNS O
of IN O
the DT O
National NNP O

Academy NNP O
of IN O
Sciences NNPS O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
, , O
74 CD O
, , O
5463 CD O
- HYPH O
5467 CD O
. . O

18 CD O
. . O

Sanger NNP O
, , O
F NNP O
. . O
, , O
Coulson NNP O
, , O
A NNP O
. . O

R NNP O
. . O
, , O
Barrell NNP O
, , O
B NNP O
. . O

G NNP O
. . O
, , O
Smith NNP O
, , O
A NNP O
. . O

J NNP O
. . O

H UH O
. . O
and CC O
Roe NNP O
, , O
B NNP O
. . O

A DT O
. . O

( -LRB- O
1980 CD O
) , O
Journal NNP O
of IN O
Molecular NNP O
Biology NNP O
, , O
143 CD O
, , O
161 CD O
- HYPH O
178 CD O
. . O

19 CD O
. . O

Applied NNP O
Biosystems NNP O
User NNP O
Bulletin NNP O
( : O
1987 CD O
) SYM O
13 CD O
, , O
11 CD O
- HYPH O
16 CD O
. . O

20 CD O
. . O

Bankier NNP O
, , O
A NN O
. . O

T NNP O
. . O
, , O
Weston NNP O
, , O
K NNP O
. . O

M UH O
. . O
and CC O
Barrell NNP O
, , O
B NNP O
. . O

G NNP O
. . O

( -LRB- O
1987 CD O
) -RRB- O
Methods NNS O
in IN O

Enzymology NNP O
, , O
155 CD O
, , O
51 CD O
- HYPH O
93 CD O
. . O

21 CD O
. . O

Smith NNP O
, , O
V NNP O
. . O
, , O
Brown NNP O
, , O
C NNP O
. . O

M UH O
. . O
, , O
Bankier NNP O
, , O
A NNP O
. . O

T UH O
. . O
and CC O
Barrell NNP O
, , O
B NNP O
. . O

G NNP O
. . O

( -LRB- O
1990 CD O
) SYM O
DNA NNP O

Sequence NN O
, , O
1 CD O
, , O
73 CD O
- HYPH O
78 CD O
. . O

22 CD O
. . O

Southern JJ O
, , O
E UH O
. . O

M UH O
. . O

( -LRB- O
1975 CD O
) -RRB- O
Journal NNP O
of IN O
Molecular NNP O
Biology NNP O
, , O
98 CD O
, , O
503 CD O
- HYPH O
517 CD O
. . O

23 CD O
. . O

Church NNP O
, , O
G NNP O
. . O

M UH O
. . O
and CC O
Gilbert NNP O
, , O
W NNP O
. . O

( -LRB- O
1984 CD O
) -RRB- O
Proceedings NNS O
of IN O
the DT O
National NNP O
Academy NNP O

of IN O
Sciences NNPS O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
, , O
81 CD O
, , O
1991 CD O
- SYM O
1995 CD O
. . O

24 CD O
. . O

Beck NNP O
, , O
S UH O
. . O
, , O
O UH O
' '' O
Keefe NNP O
, , O
T NNP O
. . O
, , O
Coull NNP O
, , O
J NNP O
. . O

M UH O
. . O
and CC O
Koster NNP O
, , O
H NNP O
. . O

( -LRB- O
1989 CD O
) SYM O
Nucleic JJ O
Acids NNS O

Research NNP O
, , O
17 CD O
, , O
5115 CD O
- HYPH O
5123 CD O
. . O

25 CD O
. . O

Tizard NNP O
, , O
R NNP O
. . O
, , O
Cate NNP O
, , O
R NN O
. . O

L NNP O
. . O
, , O
Ramachandran NNP O
, , O
K NNP O
. . O

L NNP O
. . O
, , O
Wysk NNP O
, , O
M NNP O
. . O
, , O
Voyta NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O

Murphy NNP O
, , O
0 CD O
. . O

J UH O
. . O
and CC O
Bronstein NNP O
, , O
I PRP O
. . O

( -LRB- O
1990 CD O
) -RRB- O
Proceedings NNPS O
of IN O
the DT O
National NNP O
Academy NNP O
of IN O
Sciences NNPS O
, , O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
, , O
87 CD O
, , O
4514 CD O
- HYPH O
4518 CD O
. . O

26 CD O
. . O

Beck NNP O
, , O
S UH O
. . O
and CC O
Koster NNP O
, , O
H NNP O
. . O

( : O
1990 CD O
) SYM O
Analytical NNP O
Chemistry NNP O
, , O
62 CD O
, , O
2558 CD O
- HYPH O
2570 CD O
. . O

27 CD O
. . O

Jacobson NNP O
, , O
K UH O
. . O

B NNP O
. . O
, , O
Arlinghaus NNP O
, , O
H NNP O
. . O

F NNP O
. . O
, , O
Schmitt NNP O
, , O
H NNP O
. . O

W UH O
. . O
, , O
Sachleben NNP O
, , O
R NNP O
. . O

A UH O
. . O
, , O

Brown NNP O
, , O
G NNP O
. . O

M NNP O
. . O
, , O
Thonnard NNP O
, , O
N NNP O
. . O
, , O
Sloop NNP O
, , O
F NNP O
. . O

V NNP O
. . O
, , O
Foote NNP O
, , O
R NN O
. . O

S UH O
. . O
, , O
Larimer NNP O
, , O
F NNP O
. . O

W UH O
. . O
, , O
Woychik NNP O
, , O
R NN O
. . O

P UH O
. . O
, , O
England NNP O
, , O
M NNP O
. . O

W NNP O
. . O
, , O
Burchett NNP O
, , O
K UH O
. . O

L NNP O
. . O
and CC O
Jacobson NNP O
, , O
D NNP O
. . O

A DT O
. . O

( : O
1991 CD O
) : O
Genomics NNP O
, , O
9 CD O
, , O
51 CD O
- SYM O
59 CD O
. . O

28 CD O
. . O

Eperon NNP O
, , O
I PRP O
. . O

C NN O
. . O

( -LRB- O
1986 CD O
) SYM O
Analytical NNP O
Biochemistry NNP O
, , O
56 CD O
, , O
406 CD O
- HYPH O
412 CD O
. . O

29 CD O
. . O

Bankier NNP O
, , O
A NN O
. . O

T UH O
. . O
and CC O
Barrell NNP O
, , O
B NNP O
. . O

G NNP O
. . O

( -LRB- O
1989 CD O
) : O
In IN O
Howe NNP O
, , O
C NNP O
. . O

J UH O
. . O
and CC O
Ward NNP O
, , O
E NNP O
. . O

S UH O
. . O

( : O
ed NN O
) -RRB- O
, , O
Nucleic JJ O
acids NNS O
sequencing NN O
: : O
a DT O
practical JJ O
approach NN O
. . O

IRL NNP O
Press NNP O
, , O
Oxford NNP O
, , O
Vol NNP O
. . O

1 CD O
, , O
pp UH O
. . O

37 CD O
- SYM O
78 CD O
. . O

30 CD O
. . O

Vieira NNP O
, , O
J NNP O
. . O
and CC O
Messing NNP O
, , O
J NNP O
. . O

( -LRB- O
1987 CD O
) -RRB- O
Methods NNS O
in IN O
Enzymology NNP O
, , O
153 CD O
, , O
3 CD O
- SYM O
11 CD O
. . O

31 CD O
. . O

Davison NNP O
, , O
A NNP O
. . O

DNA NNP O
Sequence NNP O
, , O
in IN O
press NN O
. . O

32 CD O
. . O

Heller NNP O
, , O
C NNP O
. . O
, , O
Radley NNP O
, , O
E NNP O
. . O
, , O
Khurshid NNP O
, , O
F NNP O
. . O

A DT O
. . O
and CC O
Beck NNP O
, , O
S NNP O
. . O

Gene NNP O
, , O
in IN O
press NN O
. . O

REFERENCES NNS O

1 LS O
. . O

Yang NNP O
, , O
M NNP O
. . O

M UH O
. . O
and CC O
Youvan NNP O
, , O
D NNP O
. . O

C NN O
. . O

( : O
1989 CD O
) SYM O
Biotechnology NNP O
, , O
7 CD O
, , O
576 CD O
- HYPH O
580 CD O
. . O

2 LS O
. . O

Smith NNP O
, , O
L NN O
. . O

M UH O
. . O
, , O
Sanders NNP O
, , O
J NNP O
. . O

Z NNP O
. . O
, , O
Kaiser NNP O
, , O
R NNP O
. . O

J NNP O
. . O
, , O
Hughes NNP O
, , O
P NNP O
. . O
, , O
Dodd NNP O
, , O
C NNP O
. . O
, , O
Connell NNP O
, , O

C NN O
. . O

R NNP O
. . O
, , O
Heiner NNP O
, , O
C NNP O
. . O
, , O
Kent NNP O
, , O
S NNP O
. . O

B NN O
. . O

H UH O
. . O
and CC O
Hood NNP O
, , O
L NNP O
. . O

E UH O
. . O

( : O
1986 CD O
) SYM O
Nature NNP O
, , O
321 CD O
, , O
674 CD O
- HYPH O
679 CD O
. . O

3 LS O
. . O

Church NNP O
, , O
G NNP O
. . O

M UH O
. . O
and CC O
Kieffer NNP O
- HYPH O
Higgins NNP O
, , O
S NNP O
. . O

( -LRB- O
1988 CD O
) SYM O
Science NNP O
, , O
240 CD O
, , O
185 CD O
- SYM O
188 CD O
. . O

4 LS O
. . O

Watson NNP O
, , O
J NNP O
. . O

D NNP O
. . O

( : O
1990 CD O
) SYM O
Science NNP O
, , O
248 CD O
, , O
44 CD O
- HYPH O
49 CD O
. . O

5 LS O
. . O

Baer NNP O
, , O
R NNP O
. . O
, , O
Bankier NNP O
, , O
A NNP O
. . O

T NNP O
. . O
, , O
Biggin NNP O
, , O
M NNP O
. . O

D NNP O
. . O
, , O
Deininger NNP O
, , O
P NN O
. . O

L NNP O
. . O
, , O
Farrell NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O

Gibson NNP O
, , O
T NNP O
. . O

J NNP O
. . O
, , O
Hatfull NNP O
, , O
G NNP O
. . O
, , O
Hudson NNP O
, , O
G NNP O
. . O

S UH O
. . O
, , O
Satchwell NNP O
, , O
S NNP O
. . O

C UH O
. . O
, , O
Seguin NNP O
, , O
C NNP O
. . O
, , O
Tuffnell NNP O
, , O
P NNP O
. . O

S UH O
. . O
and CC O
Barrell NNP O
, , O
B NNP O
. . O

G NNP O
. . O

( -LRB- O
1984 CD O
) SYM O
Nature NNP O
, , O
310 CD O
, , O
207 CD O
- HYPH O
211 CD O
. . O

6 LS O
. . O

Davison NNP O
, , O
A NNP O
. . O

J UH O
. . O
and CC O
Scott NNP O
, , O
J NNP O
. . O

E UH O
. . O

( -LRB- O
1986 CD O
) -RRB- O
Journal NNP O
of IN O
General NNP O
Virology NNP O
, , O
67 CD O
, , O

1759 CD O
- SYM O
1816 CD O
. . O

7 LS O
. . O

McGeoch NNP O
, , O
D NNP O
. . O

J NNP O
. . O
, , O
Dalrymple NNP O
, , O
M NNP O
. . O

A UH O
. . O
, , O
Davison NNP O
, , O
A NNP O
. . O

J NNP O
. . O
, , O
Dolan NNP O
, , O
A NNP O
. . O
, , O
Frame NNP O
, , O

M UH O
. . O

C UH O
. . O
, , O
McNab NNP O
, , O
D NNP O
. . O
, , O
Perry NNP O
, , O
L NNP O
. . O

J NNP O
. . O
, , O
Scott NNP O
, , O
J NNP O
. . O

E UH O
. . O
and CC O
Taylor NNP O
, , O
P NN O
. . O

( -LRB- O
1988 CD O
) -RRB- O
Journal NNP O
of IN O
General NNP O
Virology NNP O
, , O
69 CD O
, , O
1531 CD O
- SYM O
1574 CD O
. . O

8 LS O
. . O

Chee NNP O
, , O
M NNP O
. . O

S NNP O
. . O
, , O
Bankier NNP O
, , O
A DT O
. . O

T NNP O
. . O
, , O
Beck NNP O
, , O
S NNP O
. . O
, , O
Bohni NNP O
, , O
R NNP O
. . O
, , O
Brown NNP O
, , O
C NNP O
. . O

M UH O
. . O
, , O
Cerny NNP O
, , O

R NNP O
. . O
, , O
Horsnell NNP O
, , O
T NNP O
. . O
, , O
Hutchison NNP O
III NNP O
, , O
C NNP O
. . O

A DT O
. . O
, , O
Kouzarides NNP O
, , O
T NNP O
. . O
, , O
Martignetti NNP O
, , O
J NNP O
. . O

A NNP O
. . O
, , O
Satchwell NNP O
, , O
S NNP O
. . O

C UH O
. . O
, , O
Tomlinson NNP O
, , O
P NNP O
. . O
, , O
Weston NNP O
, , O
K NNP O
. . O

M UH O
. . O
and CC O
Barrell NNP O
, , O
B NNP O
. . O

G NNP O
. . O

( -LRB- O
1990 CD O
) -RRB- O
Current NNP O
Topics NNP O
in IN O
Microbiology NNP O
and CC O
Immunology NNP O
, , O
154 CD O
, , O
125 CD O
- SYM O
169 CD O
. . O

9 LS O
. . O

Goebel NNP O
, , O
S NNP O
. . O

J NNP O
. . O
, , O
Johnson NNP O
, , O
G NNP O
. . O

P UH O
. . O
, , O
Perkus NNP O
, , O
M NNP O
. . O

E UH O
. . O
, , O
Davis NNP O
, , O
S NNP O
. . O

W UH O
. . O
, , O
Winslow NNP O
, , O
J NNP O
. . O

P UH O
. . O
and CC O
Paoletti NNP O
, , O
E NN O
. . O

( : O
1990 CD O
) SYM O
Virology NNP O
, , O
179 CD O
, , O
247 CD O
- SYM O
266 CD O
. . O

10 CD O
. . O

Ohyama NNP O
, , O
K NNP O
. . O
, , O
Fukuzawa NNP O
, , O
H NNP O
. . O
, , O
Kohchi NNP O
, , O
T NNP O
. . O
, , O
Shirai NNP O
, , O
H NNP O
. . O
, , O
Sano NNP O
, , O
T NNP O
. . O
, , O
Sano NNP O
, , O
S NNP O
. . O
, , O

Umesono NNP O
, , O
K NNP O
. . O
, , O
Shiki NNP O
, , O
Y NNP O
. . O
, , O
Takeuchi NNP O
, , O
M NNP O
. . O
, , O
Chang NNP O
, , O
Z NNP O
. . O
, , O
Aota NNP O
, , O
S NNP O
. . O

- : O
I PRP O
, , O
Inokuchi NNP O
, , O
H NNP O
. . O
and CC O
Ozeki NNP O
, , O
H NNP O
. . O

( : O
1986 CD O
) SYM O
Nature NNP O
, , O
322 CD O
, , O
572 CD O
- HYPH O
574 CD O
. . O

11 CD O
. . O

Shinozaki NNP O
, , O
K UH O
. . O
, , O
Ohme NNP O
, , O
M NNP O
. . O
, , O
Tanaka NNP O
, , O
M NNP O
. . O
, , O
Wakasugi NNP O
, , O
T NNP O
. . O
, , O
Hayashida NNP O
, , O
N NNP O
. . O
, , O

Matsubayashi NNP O
, , O
T NNP O
. . O
, , O
Zaita NNP O
, , O
N NNP O
. . O
, , O
Chunwongse NNP O
, , O
J NNP O
. . O
, , O
Obokata NNP O
, , O
J NNP O
. . O
, , O
YamaguchiShinozaki NNP O
, , O
K NNP O
. . O
, , O
Ohto NNP O
, , O
C NNP O
. . O
, , O
Torazawa NNP O
, , O
K NNP O
. . O
, , O
Meng NNP O
, , O
B NNP O
. . O

Y UH O
. . O
, , O
Sugita NNP O
, , O
M NNP O
. . O
, , O
Deno NNP O
, , O
H NNP O
. . O
, , O
Kamogashira NNP O
, , O
T NNP O
. . O
, , O
Yamada NNP O
, , O
K NNP O
. . O
, , O
Kusuda NNP O
, , O
J NNP O
. . O
, , O
Takaiwa NNP O
, , O
F NNP O
. . O
, , O
Kato NNP O
, , O
A NNP O
. . O
, , O
Tohdoh NNP O
, , O
N NNP O
. . O
, , O
Shimada NNP O
, , O
H NNP O
. . O
and CC O
Sugiura NNP O
, , O
M NNP O
. . O

( -LRB- O
1986 CD O
) SYM O
EMBO NNP O
Journal NNP O
, , O
5 CD O
, , O
2043 CD O
- HYPH O
2049 CD O
. . O

Mapping VBG O
irradiation NN O
hybrids NNS O
to IN O
cosmid NN O
and CC O
yeast NN B-Species
artificial JJ O
chromosome NN O
libraries NNS O
by IN O
direct JJ O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
. . O

Abstract JJ O

A DT O
direct JJ O
hybridization NN O
protocol NN O
is VBZ O
described VBN O
for IN O
screening NN O
cosmid NN O
and CC O
yeast NN B-Species
artificial JJ O
chromosome NN O
libraries NNS O
with IN O
pools NNS O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
somatic JJ O
cell NN O
or CC O
irradiation NN O
hybrids NNS O
. . O

This DT O
method NN O
eliminates VBZ O
purification NN O
, , O
cloning NN O
and CC O
analysis NN O
of IN O
each DT O
individual JJ O
Alu NNP O
- HYPH O
PCR NNP O
product NN O
before IN O
library NN O
screening NN O
. . O

A DT O
series NN O
of IN O
human JJ B-Species
X NN O
chromosome NN O
irradiation NN O
hybrids NNS O
were VBD O
mapped VBN O
by IN O
this DT O
method NN O
, , O
using VBG O
a DT O
cosmid JJ O
reference NN O
library NN O
for IN O
comparisons NNS O
between IN O
overlapping JJ O
hybrids NNS O
to TO O
identify VB O
interesting JJ O
clones NNS O
for IN O
further JJ O
analysis NN O
. . O
Images NNS O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O
3315 CD O

Mapping VBG O
irradiation NN O
hybrids NNS O
to IN O
cosmid NN O
and CC O
yeast NN B-Species
artificial JJ O
chromosome NN O
libraries NNS O
by IN O
direct JJ O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O

Anthony NNP O
P NNP O
. . O
Monaco NNP O
* NFP O
, , O
Veronica NNP O
M NNP O
. . O
S NNP O
. . O
Lam2 NNP O
, , O
Gunther NNP O
Zehetner NNP O
, , O
Gregory NNP O
G NNP O
. . O
Lennon NNP O
, , O
Christal NNP O
Douglas NNP O
, , O
Dean NNP O
Nizetic NNP O
, , O
Peter NNP O
N NNP O
. . O
Goodfellow1 NNP O
and CC O
Hans NNP O
Lehrach NNP O

Genome NNP O
Analysis NNP O
Laboratory NNP O
and CC O
' POS O
Molecular NNP O
Human NNP O
Genetics NNPS O
Laboratory NNP O
, , O
Imperial NNP O
Cancer NNP O
Research NNP O
Fund NNP O
, , O
44 CD O
Lincoln NNP O
' '' O
s , O
Inn NNP O
Fields NNPS O
, , O
London NNP O
WC2A NNP O
3PX NNP O
, , O
UK NNP O
and CC O
2Department NNP O
of IN O
Biochemistry NNP O
, , O
Li NNP O
Shu NNP O
Fan NNP O
Building NNP O
, , O
Sassoon NNP O
Road NNP O
, , O
University NNP O
of IN O
Hong NNP O
Kong NNP O
, , O
Hong NNP O
Kong NNP O

Received VBN O
March NNP O
12 CD O
, , O
1991 CD O
; : O
Revised VBN O
and CC O
Accepted VBN O
May NNP O
16 CD O
, , O
1991 CD O

ABSTRACT NNP O

A DT O
direct JJ O
hybridization NN O
protocol NN O
is VBZ O
described VBN O
for IN O
screening NN O
cosmid NN O
and CC O
yeast NN B-Species
artificial JJ O
chromosome NN O
libraries NNS O
with IN O
pools NNS O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
somatic JJ O
cell NN O
or CC O
irradiation NN O
hybrids NNS O
. . O

This DT O
method NN O
eliminates VBZ O
purification NN O
, , O
cloning NN O
and CC O
analysis NN O
of IN O
each DT O
individual JJ O
AluPCR NNP O
product NN O
before IN O
library NN O
screening NN O
. . O

A DT O
series NN O
of IN O
human JJ B-Species
X NN O
chromosome NN O
irradiation NN O
hybrids NNS O
were VBD O
mapped VBN O
by IN O
this DT O
method NN O
, , O
using VBG O
a DT O
cosmid JJ O
reference NN O
library NN O
for IN O
comparisons NNS O
between IN O
overlapping JJ O
hybrids NNS O
to TO O
identify VB O
interesting JJ O
clones NNS O
for IN O
further JJ O
analysis NN O
. . O

INTRODUCTION NN O

The DT O
generation NN O
of IN O
human JJ B-Species
DNA NN O
probes NNS O
specific JJ O
for IN O
individual JJ O
chromosomes NNS O
and CC O
subregions NNS O
of IN O
chromosomes NNS O
has VBZ O
been VBN O
advanced VBN O
with IN O
Alu NNP O
- HYPH O
sequence NNP O
primed VBN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
( , O
Alu NNP O
- HYPH O
PCR NNP O
, , O
1 CD O
- HYPH O
3 CD O
) -RRB- O
. . O

This DT O
method NN O
specifically RB O
amplifies VBZ O
sequences NNS O
between IN O
Alu NNP O
repeats VBZ O
from IN O
human JJ B-Species
DNA NN O
in IN O
somatic JJ O
cell NN O
hybrids NNS O
and CC O
yeast NN B-Species
artificial JJ O
chromosomes NNS O
( -LRB- O
YACs NNS O
, , O
4 CD O
) -RRB- O
. . O

Individual JJ O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
can MD O
be VB O
purified VBN O
from IN O
agarose JJ O
gels NNS O
or CC O
ligated VBN O
into IN O
plasmid NN O
vectors NNS O
to TO O
screen VB O
for IN O
single JJ O
copy NN O
sequences NNS O
. . O

Unique NNP O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
are VBP O
then RB O
localized VBN O
to IN O
certain JJ O
chromosome NN O
regions NNS O
using VBG O
DNA NN O
blots NNS O
of IN O
somatic JJ O
cell NN O
hybrid NN O
panels NNS O
. . O

Once RB O
localized VBN O
, , O
Alu NNP O
- HYPH O
PCR NNP O
fragments NNS O
can MD O
be VB O
screened VBN O
against IN O
genomic JJ O
libraries NNS O
to TO O
isolate VB O
longer JJR O
DNA NN O
fragments NNS O
from IN O
the DT O
region NN O
of IN O
interest NN O
. . O

As IN O
an DT O
alternative NN O
to IN O
this DT O
multistep JJ O
process NN O
we PRP O
have VBP O
developed VBN O
a DT O
hybridization NN O
protocol NN O
for IN O
screening NN O
of IN O
cosmid NN O
and CC O
YAC NNP O
libraries NNS O
directly RB O
with IN O
pools NNS O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
. . O

Two CD O
new JJ O
human JJ B-Species
specific JJ O
Alu NNP O
primers NNS O
were VBD O
used VBN O
to TO O
generate VB O
DNA NN O
probes NNS O
from IN O
a DT O
series NN O
of IN O
irradiation NN O
- HYPH O
reduced VBN O
hybrids NNS O
containing VBG O
multiple JJ O
human JJ B-Species
X NN O
chromosome NN O
fragments NNS O
of IN O
1 CD O
- SYM O
2000 CD O
kb NN O
on IN O
a DT O
hamster NN O
chromosome NN O
background NN O
( : O
5 CD O
; : O
P NN O
. . O
N NNP O
. . O
G NNP O
. . O
, , O
unpublished JJ O
) -RRB- O
. . O

The DT O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
were VBD O
hybridized VBN O
as IN O
a DT O
pool NN O
of IN O
probes NNS O
to IN O
X NN O
- HYPH O
specific JJ O
cosmid NN O
and CC O
YAC NNP O
libraries NNS O
, , O
after IN O

competitive JJ O
reassociation NN O
with IN O
an DT O
excess NN O
of IN O
human JJ B-Species
DNA NN O
to IN O
both CC O
the DT O
library NN O
filters NNS O
and CC O
radioactively RB O
labelled VBN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
. . O

Comparisons NNS O
were VBD O
made VBN O
between IN O
clones NNS O
identified VBN O
by IN O
overlapping JJ O
irradiation NN O
hybrids NNS O
and CC O
single JJ O
copy NN O
DNA NN O
probes NNS O
hybridized VBN O
to IN O
the DT O
cosmid JJ O
and CC O
YAC NNP O
libraries NNS O
. . O

METHODS NNS O

Two CD O
human JJ B-Species
Alu NNP O
sequence NN O
primers NNS O
were VBD O
generated VBN O
which WDT O
were VBD O
shown VBN O
to TO O
be VB O
human JJ B-Species
specific JJ O
; : O
3144 CD O
from IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
Alu NNP O
: : O
5 CD O
' '' O
- HYPH O
GAGCGAGACTCCGTCTCAAA NNP O
- HYPH O
3 CD O
' '' O
and CC O
2729 CD O
from IN O
the DT O
5 CD O
' '' O
end NN O
of IN O
Alu NNP O
: : O
5 CD O
' '' O
- HYPH O
GTGGATCACCTGAGGTCAGG NNP O
- HYPH O
3 CD O
' '' O
. . O

All DT O
PCR NNP O
reactions NNS O
were VBD O
carried VBN O
out RP O
with IN O
100 CD O
ng NN O
of IN O
hybrid NN O
DNA NN O
and CC O
0 CD O
. . O
7 CD O
, , O
^ SYM O
g NN O
of IN O
a DT O
single JJ O
Alu NNP O
primer NN O
in IN O
100 CD O
d41 CD O
of IN O
0 CD O
. . O
1 CD O
M NN O
Tris NN O
- HYPH O
HCl NNP O
pH NN O
8 CD O
. . O
3 CD O
, , O
0 CD O
. . O
15 CD O
M NN O
MgCl2 NNP O
, , O
0 CD O
. . O
5 CD O
M NN O
KCI NNP O
, , O
200 CD O
AtM NN O
each DT O
of IN O
dNTPs NNS O
, , O
10 CD O
% NN O
dimethlysulfoxide NN O
, , O
and CC O
2 CD O
. . O
5 CD O
units NNS O
of IN O
Cetus NNP O
Taq NNP O
polymerase NN O
. . O

Reactions NNS O
were VBD O
30 CD O
cycles NNS O
of IN O
94 CD O
? . O
C NN O
for IN O
2 CD O
min NN O
, , O
57 CD O
? . O
C NN O
for IN O
2 CD O
min NN O
, , O
and CC O
74 CD O
? . O
C NN O
for IN O
4 CD O
min NN O
followed VBN O
by IN O
a DT O
final JJ O
extension NN O
time NN O
at IN O
74 CD O
? . O
C NN O
for IN O
9 CD O
min NN O
. . O

Reactions NNS O
products NNS O
were VBD O
analyzed VBN O
on IN O
1 CD O
% NN O
agarose JJ O
gels NNS O
and CC O
shown VBN O
to TO O
contain VB O
between IN O
five CD O
and CC O
twenty CD O
fragments NNS O
, , O
with IN O
sizes NNS O
ranging VBG O
from IN O
0 CD O
. . O
1 CD O
to IN O
2 CD O
. . O
0 CD O
kb NN O
. . O

Chinese JJ B-Species
hamster NN I-Species
DNA NN O
and CC O
no DT O
DNA NNP O
PCR NN O
reactions NNS O
were VBD O
done VBN O
to TO O
control VB O
for IN O
non JJ O
- HYPH O
human JJ B-Species
products NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Alu NNP O
- HYPH O
PCR NNP O
products NNS O
were VBD O
separated VBN O
from IN O
Alu NNP O
oligomers NNS O
over IN O
Qiagen NNP O
columns NNS O
, , O
and CC O
approximately RB O
50 CD O
- SYM O
100 CD O
ng NN O
were VBD O
labelled VBN O
by IN O
random JJ O
hexamer NN O
priming NN O
( , O
6 CD O
) -RRB- O
. . O

The DT O
radioactively RB O
labelled VBN O
pool NN O
of IN O
fragments NNS O
was VBD O
prehybridized VBN O
with IN O
37 CD O
. . O
5 CD O
, , O
^ CD O
g NN O
of IN O
total JJ O
human JJ B-Species
DNA NN O
and CC O
12 CD O
. . O
5 CD O
tsg NN O
of IN O
hamster NN O
DNA NN O
immobilized VBN O
on IN O
a DT O
cellulose NN O
support NN O
matrix NN O
, , O
prepared VBN O
as IN O
previously RB O
described VBN O
( : O
7 CD O
) -RRB- O
. . O

Reactions NNS O
were VBD O
at IN O
65 CD O
? . O
C NN O
in IN O
1 CD O
ml NNS O
of IN O
0 CD O
. . O
75M CD O
NaCl NNP O
, , O
0 CD O
. . O
05M CD O
sodium NN O
phosphate NN O
pH NN O
7 CD O
. . O
2 CD O
, , O
0 CD O
. . O
005M CD O
EDTA NNP O
, , O
0 CD O
. . O
1 CD O
% NN O
sodium NN O
dodecyl NN O
sulphate NN O
( : O
SDS NN O
) -RRB- O
, , O
0 CD O
. . O
5 CD O
mg NN O
/ SYM O
ml NN O
heparin NN O
, , O
and CC O
100 CD O
jig NN O
/ SYM O
ml NN O
denatured VBN O
salmon NN O
sperm NN O
DNA NN O
. . O

The DT O
cellulose NN O
was VBD O
pelleted VBN O
and CC O
the DT O
supernatant NN O
boiled VBD O
for IN O
2 CD O
min NN O
every DT O
12 CD O
- SYM O
16 CD O
hours NNS O
( : O
three CD O
times NNS O
in IN O
two CD O
days NNS O
) -RRB- O
. . O

Cosmid NNP O
and CC O
YAC NNP O
library NN O
filters NNS O
( -LRB- O
Hybond NNP O
N NNP O
+ CC O
, , O
Amersham NNP O
) -RRB- O
were VBD O
prehybridized VBN O
at IN O
42 CD O
? . O
C NN O
for IN O
16 CD O
hours NNS O
with IN O
100 CD O
jig NN O
/ SYM O
ml NNS O

* NFP O
To TO O
whom WP O
correspondence NN O
should MD O
be VB O
addressed VBN O
at IN O
Human NNP O
Genetics NNP O
Laboratory NNP O
, , O
Imperial NNP O
Cancer NNP O
Research NNP O
Fund NNP O
, , O
Institute NNP O
of IN O
Molecular NNP O
Medicine NNP O
, , O
John NNP O
Radcliffe NNP O
Hospital NNP O
, , O
Headington NNP O
, , O
Oxford NNP O
OX3 NNP O
9DU NNP O
, , O
UK NNP O

1991 CD O
Oxford NNP O
University NNP O
Press NNP O

3316 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O

Chromosome NN O
X NN O

. . O
, , O
. . O
. . O
, , O
. . O
, , O
< NFP O

_ NFP O
. . O
, , O
. . O

< NFP O
. . O
, , O

* NFP O
2 LS O
. . O
' '' O
1 CD O
- SYM O
7 CD O
- SYM O
_ : O

_ NFP O
- : O
_ NFP O
1 LS O
. . O

J NN O

, , O
. . O
1 LS O
. . O
. . O

- : O
1 CD O
, , O
_ : O
i LS O
- : O
_ : O
1 CD O
. . O

1 NFP O

1 CD O
' '' O
4 CD O
- HYPH O
- HYPH O
1 CD O
+ SYM O

1 CD O
1 CD O
L NN O
L NN O
. . O

i PRP O

. . O
1 LS O
. . O

_ NFP O
1 NFP O

1 CD O
1 CD O
s NN O
. . O

1 LS O
i . O

1 LS O
i : O
; : O
. . O

- : O
- : O
r NN O
' '' O
F NN O
1 CD O
- HYPH O

1 CD O
- SYM O
1 CD O
- HYPH O
l NN O

j NNP O
i NN O
- : O
_ : O
1 CD O
. . O

1 NFP O

- : O
_ : O
1 LS O
. . O
. . O

s LS O
- : O
S NN O
. . O

i PRP O
n RB O
- : O
. . O

. . O
. . O

: : O
, , O
1 CD O
' '' O
, , O
. . O

- : O
1 CD O
_ : O
E NN O
I PRP O
i PRP O
? . O

, , O
. . O

. . O
_ NFP O
_ NFP O
_ NFP O

G NNP O
- : O

. . O

* NFP O
. . O
- : O
. . O
, , O
. . O
, , O
z . O

_ NFP O

_ NFP O
, , O

z LS O
; : O
- : O
[ -LRB- O
X1 NN O

21 CD O
, , O
In IN O

27 CD O
38 CD O
45 CD O
48 CD O
54 CD O
74 CD O
86 CD O

I PRP O
1 CD O
I PRP O

I PRP O

I PRP O

107 CD O

MD NNP O

I PRP O

: : O
I PRP O
I PRP O

I PRP O
I PRP O

I PRP O
I PRP O

Figur NNP O
2a NNP O
and CC O
2b NN O
: : O
Hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
generated VBN O
with IN O
Alu NNP O
primer NN O
3144 CD O
from IN O
irradiation NN O
hybrid NN O
48 CD O
to TO O
duplicate VB O
copies NNS O
of IN O
22 CD O
x22cm NN O
filters NNS O
containing VBG O
9216 CD O
human JJ B-Species
X NN O
chromosome NN O
cosmids NNS O
( SYM O
8 CD O
) -RRB- O
. . O

2c NN O
: : O
Hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
generated VBN O
with IN O
Alu NNP O
primer NN O
3144 CD O
from IN O
an DT O
independent JJ O
hybrid NN O
( SYM O
54 CD O
) -RRB- O
to IN O
a DT O
third JJ O
identical JJ O
cosmid JJ O
filter NN O
. . O

Figure NN O
1 CD O
: : O
A DT O
schematic JJ O
diagram NN O
of IN O
the DT O
human JJ B-Species
X NN O
chromosome NN O
alongside IN O
the DT O
approximate JJ O
cytogenetic JJ O
location NN O
of IN O
fragments NNS O
identified VBN O
in IN O
nine CD O
irradiation NN O
hybrids NNS O
( , O
numbers NNS O
across IN O
the DT O
top NN O
) -RRB- O
. . O

The DT O
human JJ B-Species
X NN O
fragments NNS O
were VBD O
identified VBN O
by IN O
hybridization NN O
of IN O
27 CD O
known VBN O
DNA NNP O
markers NNS O
( , O
indicated VBN O
by IN O
a DT O
black JJ O
line NN O
; : O
P NN O
. . O
N NNP O
. . O
G NNP O
, , O
unpublished JJ O
) , O
or CC O
by IN O
cosmids NNS O
in IN O
common JJ O
with IN O
unique JJ O
X NN O
chromosome NN O
probes NNS O
in IN O
the DT O
reference NN O
library NN O
database NN O
( : O
open JJ O
boxes NNS O
and CC O
Table NN O
1 CD O
) -RRB- O
. . O

The DT O
size NN O
of IN O
the DT O
lines NNS O
and CC O
boxes NNS O
relate VBP O
to IN O
the DT O
best JJS O
cytogenetic JJ O
location NN O
of IN O
the DT O
probes NNS O
used VBN O
according VBG O
to IN O
Human NNP O
Gene NNP O
Mapping NNP O
10 CD O
. . O
5 CD O
( SYM O
14 CD O
) -RRB- O
and CC O
does VBZ O
not RB O
indicate VB O
the DT O
physical JJ O
extent NN O
of IN O
the DT O
irradiation NN O
hybrid NN O
fragments NNS O
. . O

denatured JJ O
and CC O
sheared VBN O
total JJ O
human JJ B-Species
DNA NN O
in IN O
50 CD O
% NN O
formamide NN O
, , O
4XSSC NNP O
, , O
0 CD O
. . O
5 CD O
M NN O
sodium NN O
phosphate NN O
pH NN O
7 CD O
. . O
2 CD O
, , O
0 CD O
. . O
1 CD O
M NN O
EDTA NNP O
, , O
10 CD O
% NN O
dextran NN O
sulphate NN O
, , O
1 CD O
. . O
0 CD O
% NN O
SDS NN O
, , O
50 CD O
isg NN O
/ SYM O
ml NN O
denatured VBN O
salmon NN O
sperm NN O
DNA NN O
and CC O
OxDenhardt NNP O
' POS O
s NN O
solution NN O
. . O

The DT O
radioactively RB O
labelled VBN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
were VBD O
denatured VBN O
and CC O
added VBN O
to IN O
fresh JJ O

hybridization NN O
solution NN O
without IN O
human JJ B-Species
DNA NN O
competitor NN O
at IN O
1 CD O
x SYM O
106 CD O

cpm NN O
/ SYM O
ml NN O
and CC O
hybridized VBN O
at IN O
42 CD O
? . O
C NN O
for IN O
16 CD O
hours NNS O
. . O

Filters NNS O
were VBD O
washed VBN O
in IN O
0 CD O
. . O
1 CD O
xSSC NN O
and CC O
1 CD O
. . O
0 CD O
% NN O
SDS NN O
, , O
twice RB O
at IN O
room NN O
temperature NN O
and CC O
twice RB O
at IN O
65 CD O
? . O
C NN O
for IN O
30 CD O
min NN O
each DT O
and CC O
exposed VBN O
to IN O
Kodak NNP O
X NNP O
- HYPH O
OMAT NNP O
film NN O
for IN O
2 CD O
- SYM O
3 CD O
days NNS O
at IN O
- HYPH O
70 CD O
? . O
C NN O
with IN O
an DT O
intensifying VBG O
screen NN O
. . O

For IN O
each DT O
hybridization NN O
, , O
two CD O
sets NNS O
of IN O
duplicate JJ O
cosmid NN O
filters NNS O
were VBD O
used VBN O
from IN O
the DT O
ICRF NNP O
reference NN O
library NN O
system NN O
( : O
8 CD O
) -RRB- O
, , O
each DT O
containing VBG O
9216 CD O
flow NN O
- HYPH O
sorted VBN O
human JJ B-Species
X NN O
chromosome NN O
cosmid NN O
clones NNS O
or CC O
approximately RB O
2 CD O
chromosome NN O
equivalents NNS O
on IN O
a DT O
22 CD O
x SYM O
22 CD O
cm NN O
filter NN O
( SYM O
9 CD O
) -RRB- O
. . O

The DT O
coordinates NNS O
of IN O
signals NNS O
positive JJ O
on IN O
duplicate JJ O
cosmid NN O
filters NNS O
were VBD O
entered VBN O
into IN O
the DT O
reference NN O
library NN O
database NN O
( , O
G NNP O
. . O
Z NNP O
, , O
unpublished JJ O
) , O
using VBG O
a DT O
digitizing VBG O
tablet NN O
. . O

For IN O
the DT O
X NN O
chromosome NN O
specific JJ O
YAC NNP O
library NN O
( , O
A NNP O
. . O
P NN O
. . O
M NNP O
. . O
and CC O
H NNP O
. . O
L NNP O
. . O
, , O
unpublished JJ O
) -RRB- O
, , O
about RB O
420 CD O
YAC NNP O
colonies NNS O
were VBD O
spotted VBN O
manually RB O
onto IN O
filters NNS O
from IN O
96 CD O
well RB O
microtiter NN O
dishes NNS O
using VBG O
a DT O
96 CD O
prong JJ O
device NN O
. . O

After IN O
growth NN O
on IN O
selective JJ O
media NNS O
for IN O
3 CD O
days NNS O
, , O
YAC NNP O
filters NNS O
were VBD O
processed VBN O
for IN O
hybridization NN O
as IN O
previously RB O
described VBN O
( SYM O
10 CD O
) -RRB- O
. . O

RESULTS NNS O

A DT O
panel NN O
of IN O
195 CD O
X NN O
chromosome NN O
irradiation NN O
hybrids NNS O
was VBD O
constructed VBN O
( , O
50 CD O
, , O
0 CD O
rads NNS O
) , O
and CC O
characterized VBN O
by IN O
DNA NN O
hybridization NN O
using VBG O
27 CD O
X NN O
chromosome NN O
markers NNS O
and CC O
flourescence NN O
in IN O
situ NN O
hybridization NN O
using VBG O
total JJ O
human JJ B-Species
DNA NN O
as IN O
probe NN O
( , O
Benham NNP O
et FW O
al NNP O
. . O
, , O
1989 CD O
; : O
P NN O
. . O
N NNP O
. . O
G NNP O
. . O
, , O
unpublished JJ O
) -RRB- O
. . O

This DT O
analysis NN O
indicated VBD O
that IN O
the DT O
hybrids NNS O
contained VBD O
multiple JJ O
small JJ O
fragments NNS O
( , O
4 CD O
- SYM O
10 CD O
fragments NNS O
of IN O
1000 CD O
- SYM O
5000 CD O
kb NN O
each DT O
) -RRB- O
with IN O
a DT O
preferential JJ O
retaining NN O
of IN O
centromere NN O
sequences NNS O
( : O
90 CD O
% NN O
) -RRB- O
. . O

From IN O
this DT O
panel NN O
, , O
nine CD O
irradiation NN O
hybrids NNS O
were VBD O
chosen VBN O
that WDT O
contained VBD O
less JJR O
than IN O
five CD O
different JJ O
regions NNS O
by IN O
DNA NN O
probe NN O
hybridizations NNS O
, , O
mostly RB O
from IN O
the DT O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
( -LRB- O
Fig NNP O
1 CD O
) -RRB- O
. . O

All DT O
nine CD O
hybrids NNS O
were VBD O
used VBN O
in IN O
PCR NNP O
reactions NNS O
with IN O
3 CD O
' '' O
- HYPH O
Alu NNP O
primer NN O
3144 CD O
and CC O
two CD O
were VBD O
used VBN O
with IN O
5 CD O
' '' O
- HYPH O
Alu NNP O

Figure NN O
3 CD O
: : O
Hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
generated VBN O
with IN O
Alu NNP O
primer NN O
3144 CD O
from IN O
irradiation NN O
hybrid NN O
54 CD O
to IN O
a DT O
filter NN O
containing VBG O
420 CD O
YAC NNP O
clones NNS O
from IN O
the DT O
human JJ B-Species
X NN O
chromosome NN O
. . O

The DT O
positive JJ O
YAC NNP O
was VBD O
also RB O
identified VBN O
in IN O
a DT O
separate JJ O
hybridization NN O
with IN O
the DT O
DMD NNP O
probe NN O
P20 NNP O
( SYM O
12 CD O
) -RRB- O
. . O

primer NN O
2729 CD O
. . O

Example NN O
hybridizations NNS O
to IN O
a DT O
human JJ B-Species
X NN O
chromosome NN O
cosmid NN O
filter NN O
in IN O
Fig NNP O
2 CD O
shows VBZ O
the DT O
intensity NN O
and CC O
reliability NN O
of IN O
positive JJ O
clones NNS O
identified VBN O
on IN O
duplicate JJ O
filters NNS O
with IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
the DT O
same JJ O
irradiation NN O
hybrid NN O
( SYM O
48 CD O
) -RRB- O
and CC O
the DT O
independence NN O
of IN O
clones NNS O
identified VBN O
with IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
a DT O
different JJ O
hybrid NN O
( SYM O
54 CD O
) -RRB- O
. . O

Fig NNP O
3 CD O
shows VBZ O
a DT O
single JJ O
positive JJ O
YAC NNP O
clone NN O
after IN O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
irradiation NN O
hybrid NN O
54 CD O
to IN O
a DT O
filter NN O
containing VBG O
about RB O
420 CD O
YAC NNP O
clones NNS O
specific JJ O
for IN O
the DT O
human JJ B-Species
X NN O
chromosome NN O
. . O

The DT O
total JJ O
number NN O
of IN O
cosmids NNS O
identified VBN O
with IN O
each DT O
pool NN O
of IN O
AluPCR NNP O
products NNS O
for IN O
each DT O
hybrid NN O
is VBZ O
shown VBN O
in IN O
Table NNP O
1 CD O
. . O

From IN O
the DT O
average JJ O
number NN O
of IN O
cosmids NNS O
identified VBN O
( , O
24 CD O
) , O
in IN O
four CD O
chromosome NN O
equivalents NNS O
screened VBN O
and CC O
the DT O
estimated VBN O
average JJ O
DNA NN O
content NN O
in IN O
each DT O
hybrid NN O
( : O
3000 CD O
- SYM O
15000 CD O
kb NN O
) -RRB- O
, , O
the DT O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
generated VBN O
by IN O
a DT O
single JJ O
primer NN O
were VBD O
calculated VBN O
on IN O
average JJ O
to TO O
be VB O
300 CD O
- SYM O
1500 CD O
kb NNS O
apart RB O
, , O
similar JJ O
to IN O
published VBN O
estimates NNS O
for IN O
this DT O
method NN O
( , O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Only RB O
3 CD O
- SYM O
4 CD O
cosmids NNS O
were VBD O
identified VBN O
in IN O
common JJ O
using VBG O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
generated VBN O
with IN O
either CC O
3 CD O
' '' O
or CC O
5 CD O
' '' O
Alu NNP O
primers NNS O
( , O
3144 CD O
or CC O
2729 CD O
) -RRB- O
from IN O
two CD O
hybrids NNS O
( SYM O
38 CD O
and CC O
45 CD O
) -RRB- O
. . O

This DT O
shows VBZ O
that IN O
separate JJ O
products NNS O
were VBD O
amplified VBN O
with IN O
the DT O
two CD O
Alu NNP O
primers NNS O
since IN O
they PRP O
prime JJ O
synthesis NN O
from IN O
opposite JJ O
ends NNS O
of IN O
the DT O
Alu NNP O
consensus NN O
sequence NN O
and CC O
Alu NNP O
sequences NNS O
are VBP O
oriented VBN O
in IN O
the DT O
genome NN O
either CC O
head NN O
to IN O
head NN O
, , O

A DT O

B NN O

C NN O

El NNP O

I0 NN O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O
3317 CD O

Table NN O
1 CD O
. . O

Cosmids NNS O
identified VBN O
by IN O
hybrids NNS O
and CC O
unique JJ O
probes NNS O

hybrids NNS O
21 CD O
27 CD O
38 CD O
38 CD O
45 CD O
45 CD O
48 CD O
54 CD O
74 CD O
86 CD O
107 CD O
unique JJ O

primer NN O
3144 CD O
3144 CD O
3144 CD O
2729 CD O
3144 CD O
2729 CD O
3144 CD O
3144 CD O
3144 CD O
33144 CD O
3144 CD O
probes NNS O

21 CD O
3144 CD O
59 CD O
1 CD O
27 CD O
3144 CD O
7 CD O
14 CD O
2 CD O
38 CD O
3144 CD O
3 CD O
1 CD O
28 CD O
2 CD O
38 CD O
2729 CD O
0 CD O
0 CD O
4 CD O
25 CD O
0 CD O
45 CD O
3144 CD O
13 CD O
2 CD O
2 CD O
0 CD O
32 CD O
3 CD O
45 CD O
2729 CD O
1 CD O
0 CD O
0 CD O
0 CD O
3 CD O
31 CD O
0 CD O
48 CD O
3144 CD O
10 CD O
2 CD O
4 CD O
0 CD O
2 CD O
0 CD O
28 CD O
3 CD O
54 CD O
3144 CD O
11 CD O
3 CD O
0 CD O
0 CD O
5 CD O
0 CD O
5 CD O
30 CD O
2 CD O
74 CD O
3144 CD O
5 CD O
0 CD O
0 CD O
0 CD O
4 CD O
0 CD O
5 CD O
12 CD O
20 CD O
3 CD O
86 CD O
3144 CD O
3 CD O
1 CD O
0 CD O
0 CD O
4 CD O
1 CD O
3 CD O
4 CD O
3 CD O
17 CD O
0 CD O
107 CD O
3144 CD O
1 CD O
0 CD O
1 CD O
1 CD O
0 CD O
0 CD O
3 CD O
0 CD O
0 CD O
0 CD O
13 CD O
0 CD O

tail NN O
to IN O
tail NN O
or CC O
head VB O
to IN O
tail NN O
relative JJ O
to IN O
each DT O
other JJ O
. . O

Therefore RB O
, , O
by IN O
using VBG O
the DT O
3 CD O
' '' O
- HYPH O
and CC O
5 CD O
' '' O
- HYPH O
Alu NNP O
primers NNS O
in IN O
separate JJ O
PCR NNP O
reactions NNS O
with IN O
the DT O
same JJ O
hybrid NN O
DNA NN O
, , O
the DT O
total JJ O
number NN O
of IN O
products NNS O
and CC O
cosmid NN O
clones NNS O
identified VBN O
was VBD O
almost RB O
doubled VBN O
. . O

Table NNP O
1 CD O
also RB O
indicates VBZ O
how WRB O
many JJ O
cosmids NNS O
were VBD O
identified VBN O
by IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
other JJ O
hybrids NNS O
, , O
and CC O
16 CD O
cosmids NNS O
previously RB O
identified VBN O
with IN O
unique JJ O
DNA NN O
probes NNS O
in IN O
the DT O
reference NN O
library NN O
database NN O
. . O

As IN O
can MD O
be VB O
seen VBN O
in IN O
Fig NNP O
1 CD O
and CC O
previous JJ O
irradiation NN O
hybrid NN O
analysis NN O
, , O
there EX O
is VBZ O
a DT O
preferential JJ O
retention NN O
of IN O
centromere JJ O
sequences NNS O
( , O
2 CD O
, , O
11 CD O
) -RRB- O
. . O

However RB O
, , O
there EX O
were VBD O
no DT O
cosmids NNS O
identified VBN O
in IN O
common JJ O
from IN O
all PDT O
the DT O
hybrids NNS O
positive JJ O
with IN O
centromere JJ O
sequences NNS O
. . O

This DT O
is VBZ O
probably RB O
due JJ O
to IN O
a DT O
paucity NN O
of IN O
Alu NNP O
repeats VBZ O
in IN O
the DT O
correct JJ O
orientation NN O
in IN O
alphoid JJ O
centromere NN O
sequences NNS O
and CC O
thus RB O
few JJ O
or CC O
no DT O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
would MD O
be VB O
amplified VBN O
from IN O
the DT O
centromere NN O
. . O

Cosmids NNS O
identified VBN O
in IN O
common JJ O
by IN O
several JJ O
irradiation NN O
hybrids NNS O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
were VBD O
most RBS O
likely JJ O
from IN O
regions NNS O
of IN O
overlap NN O
outside IN O
the DT O
centromere JJ O
area NN O
as IN O
shown VBN O
by IN O
the DT O
previous JJ O
DNA NNP O
probe NN O
characterization NN O
( , O
Fig NNP O
1 CD O
) -RRB- O
. . O

The DT O
overlap NN O
regions NNS O
between IN O
hybrids NNS O
were VBD O
also RB O
seen VBN O
by IN O
16 CD O
cosmids NNS O
( -LRB- O
Table NNP O
1 CD O
, , O
Fig NNP O
1 CD O
) -RRB- O
that WDT O
were VBD O
hybridization NN O
targets NNS O
of IN O
unique JJ O
DNA NN O
markers NNS O
in IN O
the DT O
reference NN O
library NN O
database NN O
that WDT O
mapped VBD O
in IN O
independent JJ O
experiments NNS O
to IN O
the DT O
overlap JJ O
region NN O
. . O

At IN O
least JJS O
for IN O
several JJ O
cosmids NNS O
this DT O
showed VBD O
that IN O
the DT O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
identified VBD O
target NN O
cosmids NNS O
that WDT O
were VBD O
definitely RB O
from IN O
the DT O
expected VBN O
region NN O
contained VBN O
in IN O
the DT O
hybrids NNS O
. . O

For IN O
example NN O
, , O
hybrids NNS O
21 CD O
and CC O
54 CD O
were VBD O
both DT O
shown VBN O
to TO O
contain VB O
part NN O
of IN O
the DT O
Duchenne NNP O
muscular JJ O
dystrophy NN O
( -LRB- O
DMD NNP O
) -RRB- O
locus NN O
( , O
Fig NNP O
1 CD O
; : O
P NN O
. . O
N NNP O
. . O
G NNP O
. . O
, , O
unpublished JJ O
) -RRB- O
and CC O
had VBD O
11 CD O
cosmids NNS O
in IN O
common JJ O
, , O
including VBG O
one CD O
identified VBN O
by IN O
the DT O
probe NN O
P20 NN O
from IN O
the DT O
deletion NN O
hotspot NN O
region NN O
of IN O
the DT O
DMD NNP O
gene NN O
( SYM O
12 CD O
) -RRB- O
. . O

In IN O
Fig NNP O
3 CD O
the DT O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
hybrid NN O
54 CD O
identified VBD O
a DT O
YAC NNP O
clone NN O
which WDT O
was VBD O
also RB O
positive JJ O
for IN O
the DT O
DMD NNP O
probe NN O
P20 NNP O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

This DT O
method NN O
also RB O
identified VBD O
fragments NNS O
in IN O
the DT O
hybrids NNS O
that WDT O
were VBD O
not RB O
seen VBN O
in IN O
the DT O
initial JJ O
DNA NN O
characterization NN O
( , O
Fig NNP O
1 CD O
and CC O
Table NNP O
1 CD O
) -RRB- O
. . O

Since IN O
the DT O
27 CD O
DNA NNP O
probes NNS O
were VBD O
not RB O
close JJ O
enough RB O
to IN O
each DT O
other JJ O
along IN O
the DT O
chromosome NN O
to TO O
detect VB O
all DT O
possible JJ O
hybrid JJ O
fragments NNS O
( : O
1000 CD O
- SYM O
5000 CD O
kb NN O
) -RRB- O
, , O
many JJ O
regions NNS O
would MD O
have VB O
been VBN O
untested JJ O
. . O

For IN O
example NN O
, , O
AluPCR NNP O
products NNS O
from IN O
hybrids NNS O
45 CD O
and CC O
48 CD O
identified VBD O
several JJ O
cosmids NNS O
, , O
also RB O
seen VBN O
by IN O
the DT O
cDNA NNP O
for IN O
chronic JJ O
granulomatous JJ O
disease NN O
gene NN O
( , O
CYBB NNP O
, , O
13 CD O
) -RRB- O
in IN O
Xp2 NNP O
1 CD O
. . O
1 CD O
, , O
although IN O
this DT O
region NN O
was VBD O
not RB O
tested VBN O
in IN O
the DT O
original JJ O
hybrid NN O
characterization NN O
. . O

DISCUSSION NN O

The DT O
direct JJ O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
somatic JJ O
cell NN O
hybrids NNS O
to IN O
genomic JJ O
libraries NNS O
can MD O
bypass VB O
gel NN O
purification NN O
or CC O
ligation NN O
of IN O
fragments NNS O
into IN O
plasmid NN O
vectors NNS O
and CC O
individual JJ O
analysis NN O
for IN O
single JJ O
copy NN O
sequences NNS O
. . O

Hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
as IN O

a DT O
pool NN O
to IN O
ordered VBN O
array NN O
libraries NNS O
such JJ O
as IN O
the DT O
flow NN O
- HYPH O
sorted VBN O
X NN O
chromosome NN O
cosmid NN O
library NN O
( , O
9 CD O
) -RRB- O
, , O
allows VBZ O
the DT O
direct JJ O
comparison NN O
of IN O
overlapping JJ O
hybrids NNS O
to TO O
pinpoint VB O
cosmids NNS O
most RBS O
likely JJ O
to TO O
be VB O
from IN O
the DT O
region NN O
of IN O
interest NN O
. . O

In IN O
conjunction NN O
with IN O
the DT O
reference NN O
library NN O
database NN O
( , O
G NNP O
. . O
Z NNP O
, , O
unpublished JJ O
) , O
with IN O
183 CD O
X NN O
chromosome NN O
probe NN O
hybridization NN O
entries NNS O
, , O
cosmids NNS O
identified VBN O
with IN O
both CC O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
and CC O
uniquely RB O
mapped VBN O
X NNP O
probes NNS O
immediately RB O
map VBP O
them PRP O
to IN O
the DT O
region NN O
of IN O
interest NN O
and CC O
proove NN O
that IN O
the DT O
method NN O
has VBZ O
worked VBN O
. . O

Similar JJ O
hybridization NN O
experiments NNS O
using VBG O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
four CD O
overlapping VBG O
irradiation NN O
hybrids NNS O
identified VBN O
four CD O
cosmids NNS O
in IN O
common JJ O
that WDT O
mapped VBD O
to IN O
the DT O
region NN O
of IN O
overlap NN O
by IN O
independent JJ O
experiments NNS O
( , O
F NNP O
. . O
Muscatelli NNP O
, , O
A NNP O
. . O
P NN O
. . O
M NNP O
. . O
, , O
P NN O
. . O
N NNP O
. . O
G NNP O
. . O
, , O
H NNP O
. . O
L NNP O
. . O
and CC O
M NNP O
. . O
Fontes NNP O
, , O
in IN O
preparation NN O
) -RRB- O
. . O

Since IN O
only RB O
27 CD O
probes NNS O
from IN O
the DT O
X NNP O
chromosome NN O
were VBD O
used VBN O
to TO O
initially RB O
characterize VB O
the DT O
hybrids NNS O
and CC O
the DT O
length NN O
of IN O
individual JJ O
human JJ B-Species
fragments NNS O
in IN O
the DT O
irradiation NN O
hybrids NNS O
is VBZ O
about RB O
1000 CD O
- SYM O
5000 CD O
kb NN O
, , O
many JJ O
regions NNS O
could MD O
have VB O
been VBN O
undetected JJ O
in IN O
the DT O
original JJ O
analysis NN O
. . O

The DT O
direct JJ O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
to IN O
the DT O
cosmid JJ O
reference NN O
library NN O
detected VBD O
such JJ O
fragments NNS O
since IN O
they PRP O
identified VBD O
cosmids NNS O
in IN O
common JJ O
with IN O
uniquely RB O
mapped VBN O
probes NNS O
in IN O
regions NNS O
not RB O
tested VBN O
originally RB O
( : O
Table NNP O
1 CD O
and CC O
Fig NNP O
1 CD O
) -RRB- O
. . O

This DT O
should MD O
prove VB O
to TO O
be VB O
a DT O
sensitive JJ O
and CC O
efficient JJ O
method NN O
to TO O
determine VB O
content NN O
and CC O
overlap NN O
of IN O
irradiation NN O
hybrids NNS O
in IN O
conjunction NN O
with IN O
DNA NN O
blot NN O
hybridization NN O
. . O

However RB O
, , O
since IN O
the DT O
exact JJ O
length NN O
of IN O
the DT O
human JJ B-Species
DNA NN O
fragments NNS O
for IN O
each DT O
hybrid NN O
and CC O
the DT O
spacing NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
along IN O
the DT O
chromosome NN O
is VBZ O
not RB O
known VBN O
, , O
it PRP O
is VBZ O
difficult JJ O
to TO O
directly RB O
correlate VB O
the DT O
number NN O
of IN O
target NN O
cosmids NNS O
to IN O
the DT O
DNA NN O
content NN O
of IN O
the DT O
hybrids NNS O
. . O

The DT O
direct JJ O
hybridization NN O
of IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
from IN O
irradiation NN O
or CC O
somatic JJ O
cell NN O
hybrids NNS O
to IN O
total JJ O
genomic JJ O
YAC NNP O
libraries NNS O
will MD O
be VB O
especially RB O
useful JJ O
to TO O
construct VB O
long JJ O
range NN O
YAC NNP O
contigs NNS O
from IN O
specific JJ O
subregions NNS O
of IN O
chromosomes NNS O
. . O

The DT O
dissection NN O
of IN O
a DT O
total JJ O
genomic JJ O
YAC NNP O
library NN O
by IN O
this DT O
method NN O
may MD O
be VB O
more RBR O
efficient JJ O
than IN O
generating VBG O
chromosome NN O
specific JJ O
YAC NNP O
libraries NNS O
from IN O
somatic JJ O
cell NN O
hybrids NNS O
( , O
usually RB O
a DT O
haploid JJ O
human JJ B-Species
chromosome NN O
on IN O
a DT O
diploid NN O
or CC O
greater JJR O
rodent JJ O
background NN O
) -RRB- O
or CC O
flow NN O
- HYPH O
sorted VBN O
chromosomes NNS O
, , O
because IN O
of IN O
the DT O
low JJ O
transformation NN O
efficiency NN O
of IN O
yeast NN B-Species
. . O

ACKNOWLEDGEMENTS NNS O

We PRP O
would MD O
like VB O
to TO O
thank VB O
Gert NNP O
- HYPH O
Jan NNP O
Van NNP O
Ommen NNP O
for IN O
the DT O
probe NN O
P20 NNP O
and CC O
Stuart NNP O
Orkin NNP O
for IN O
the DT O
CYBB NNP O
cDNA NNP O
probe NN O
. . O

A DT O
. . O
P NN O
. . O
M NNP O
is VBZ O
supported VBN O
in IN O
part NN O
by IN O
a DT O
research NN O
fellowship NN O
from IN O
the DT O
Muscular NNP O
Dystrophy NNP O
Association NNP O
of IN O
America NNP O
. . O

V NN O
. . O
M NNP O
. . O
S NN O
. . O
L NN O
. . O

is VBZ O
supported VBN O
in IN O
part NN O
by IN O
the DT O
Medical NNP O
Research NNP O
Grant NNP O
of IN O
the DT O
University NNP O
of IN O
Hong NNP O
Kong NNP O
. . O

Reference NN O
library NN O
filters NNS O
and CC O
cosmids NNS O
identified VBN O
by IN O
Alu NNP O
- HYPH O
PCR NNP O
products NNS O
can MD O
be VB O
requested VBN O
from IN O
the DT O
Reference NNP O
Library NNP O
Database NNP O
, , O
ICRF NNP O
, , O
44 CD O
Lincoln NNP O
' POS O
s NN O
Inn NNP O
Fields NNPS O
, , O
London NNP O
WC2A NNP O
3PX NNP O
, , O
U NNP O
. . O
K NNP O
. . O

3318 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
Vol NNP O
. . O

19 CD O
, , O
No UH O
. . O
12 CD O

REFERENCES NNS O

1 LS O
. . O

Nelson NNP O
, , O
D NNP O
. . O
L NNP O
. . O
, , O
Ledbetter NNP O
, , O
S NNP O
. . O
A NNP O
. . O
, , O
Corbo NNP O
, , O
L NNP O
. . O
, , O
Victoria NNP O
, , O
M NNP O
. . O
F NNP O
. . O
, , O
Ramirez NNP O
- HYPH O
Solis NNP O
, , O

R NNP O
. . O
, , O
Webster NNP O
, , O
T NNP O
. . O
D NNP O
. . O
, , O
Ledbetter NNP O
, , O
D NNP O
. . O
H NNP O
. . O
, , O
and CC O
Caskey NNP O
, , O
C NNP O
. . O
T NNP O
. . O

( -LRB- O
1989 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
, , O
86 CD O
: : O
6686 CD O
- HYPH O
6690 CD O
. . O

2 LS O
. . O

Ledbetter NNP O
, , O
S NNP O
. . O
A NNP O
. . O
, , O
Nelson NNP O
, , O
D NNP O
. . O
L NNP O
. . O
, , O
Warren NNP O
, , O
S NNP O
. . O
T NNP O
. . O
, , O
and CC O
Ledbetter NNP O
, , O
D NNP O
. . O
H NN O
. . O

( -LRB- O
1990 CD O
) NN O

Genomics NNP O
, , O
6 CD O
: : O
475 CD O
- SYM O
481 CD O
. . O

3 LS O
. . O

Cotter NNP O
, , O
F NNP O
. . O
E NNP O
. . O
, , O
Hampton NNP O
, , O
G NNP O
. . O
M NNP O
. . O
, , O
Nasipuri NNP O
, , O
S NNP O
. . O
, , O
Bodmer NNP O
, , O
W NNP O
. . O
F NNP O
. . O
, , O
and CC O
Young NNP O

B NN O
. . O
D NN O
. . O

( : O
1990 CD O
) : O
Genomics NNP O
, , O
7 CD O
: : O
257 CD O
- HYPH O
263 CD O
. . O

4 LS O
. . O

Burke NNP O
, , O
D NNP O
. . O
T NNP O
. . O
, , O
Carle NNP O
, , O
G NNP O
. . O
F NNP O
. . O
, , O
and CC O
Olson NNP O
, , O
M NNP O
. . O
V NN O
. . O

( : O
1987 CD O
) SYM O
Science NN O
, , O
236 CD O
: : O
806 CD O
- HYPH O
812 CD O
. . O

5 LS O
. . O

Benham NNP O
, , O
F NNP O
. . O
, , O
Hart NNP O
, , O
K NNP O
. . O
, , O
Crolla NNP O
, , O
J NNP O
. . O
, , O
Bobrow NNP O
, , O
M NNP O
. . O
, , O
Francavilla NNP O
, , O
M NNP O
. . O
, , O
and CC O

Goodfellow NNP O
, , O
P NN O
. . O
N NN O
. . O

( : O
1989 CD O
) : O
Genomics NNP O
, , O
4 CD O
: : O
509 CD O
- SYM O
517 CD O
. . O

6 LS O
. . O

Feinberg NNP O
, , O
A NNP O
. . O
P NN O
. . O
, , O
and CC O
Vogelstein NNP O
, , O
B NNP O
. . O

( NFP O
1984 CD O
) SYM O
Anal NNP O
. . O

Biochem NNP O
. . O
, , O
137 CD O
: : O
266 CD O
- HYPH O
267 CD O
. . O

7 LS O
. . O

Hochgeschwender NNP O
, , O
U NNP O
. . O
, , O
Sutciffe NNP O
, , O
J NNP O
. . O
G NNP O
. . O
, , O
and CC O
Brennan NNP O
, , O
M NNP O
. . O
B NN O
. . O

( -LRB- O
1989 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
, , O
86 CD O
: : O
8482 CD O
- HYPH O
8486 CD O
. . O

8 LS O
. . O

Lehrach NNP O
, , O
H NNP O
. . O
, , O
Drmanac NNP O
, , O
R NNP O
. . O
, , O
Hoheisel NNP O
, , O
J NNP O
. . O
, , O
Larin NNP O
, , O
Z NNP O
. . O
, , O
Lennon NNP O
, , O
G NNP O
. . O
, , O
Monaco NNP O
, , O

A DT O
. . O
P NN O
. . O
, , O
Nizetic NNP O
, , O
D NNP O
. . O
, , O
Zehetner NNP O
, , O
G NNP O
. . O
, , O
and CC O
Poustka NNP O
, , O
A NNP O
. . O

( -LRB- O
1990 CD O
) : O
In IN O
Davies NNP O
, , O
K UH O
. . O
E UH O
. . O

& CC O
Tilghman NNP O
, , O
S NNP O
. . O
M NN O
. . O

( : O
eds NNP O
. . O
) -RRB- O
, , O
Genome NN O
Analysis NNP O
Volume NNP O
1 CD O
: : O
Genetic JJ O
and CC O
Physical NNP O
Mapping NNP O
. . O

Cold NNP O
Spring NNP O
Harbor NNP O
Laboratory NNP O
Press NNP O
, , O
Cold NNP O
Spring NNP O
Harbor NNP O
, , O
pp NN O
. . O

39 CD O
- SYM O
81 CD O
. . O

9 LS O
. . O

Nizetic NNP O
, , O
D NNP O
. . O
, , O
Zehetner NNP O
, , O
G NNP O
. . O
, , O
Monaco NNP O
, , O
A NNP O
. . O
P NNP O
. . O
, , O
Gellen NNP O
, , O
L NNP O
. . O
, , O
Young NNP O
, , O
B NNP O
. . O
D NNP O
. . O
, , O
and CC O

Lehrach NNP O
, , O
H NNP O
. . O

( -LRB- O
1991 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
, , O
88 CD O
: : O
3233 CD O
- HYPH O
3237 CD O
. . O

10 CD O
. . O

Larin NNP O
, , O
Z NNP O
. . O
and CC O
Lehrach NNP O
, , O
H NNP O
. . O

( -LRB- O
1990 CD O
) SYM O
Genet NNP O
. . O

Res NNS O
. . O

Camb NNP O
. . O
, , O
56 CD O
: : O
203 CD O
- HYPH O
208 CD O
. . O

11 CD O
. . O

Cox NNP O
, , O
D NNP O
, , O
R NNP O
. . O
, , O
Pritchard NNP O
, , O
C NNP O
. . O
A NNP O
. . O
, , O
Uglum NNP O
, , O
E NNP O
. . O
, , O
Casher NNP O
, , O
D NNP O
. . O
, , O
Koborl NNP O
. . O

J UH O
. . O
and CC O
Myers NNP O
, , O

R NN O
. . O
M NN O
. . O

( : O
1989 CD O
) : O
Genomics NNP O
, , O
4 CD O
: : O
397 CD O
- HYPH O
407 CD O
. . O

12 CD O
. . O

Wapenaar NNP O
, , O
M NNP O
. . O
C NNP O
. . O
, , O
Kievits NNP O
, , O
T NNP O
. . O
, , O
Hart NNP O
, , O
K NNP O
. . O
A NNP O
. . O
, , O
Abbs NNP O
S NNP O
. . O
, , O
Blonden NNP O
, , O
L NNP O
. . O
A DT O
. . O
J NNP O
. . O
, , O

denDunnen NNP O
, , O
J NNP O
. . O
T NNP O
. . O
, , O
Grootscholten NNP O
, , O
P NN O
. . O
M NNP O
. . O
, , O
Bakker NNP O
, , O
E NNP O
. . O
, , O
Verellen NNP O
- HYPH O
Dumoulin NNP O
, , O
C NNP O
. . O
, , O
Bobrow NNP O
, , O
M NNP O
. . O
, , O
vanOmmen NNP O
, , O
G NNP O
. . O
J NNP O
. . O
B NNP O
. . O
, , O
and CC O
Pearson NNP O
, , O
P NN O
. . O
L NN O
. . O

( : O
1988 CD O
) : O
Genomics NNP O
, , O
2 CD O
: : O
101 CD O
- SYM O
108 CD O
. . O

13 CD O
. . O

Royer NNP O
- HYPH O
Pokora NNP O
, , O
B NNP O
. . O
, , O
Kunkel NNP O
, , O
L NNP O
. . O
M UH O
. . O
, , O
Monaco NNP O
, , O
A NNP O
. . O
P NNP O
. . O
, , O
Goff NNP O
, , O
S NNP O
. . O
C NNP O
. . O
, , O
Newburger NNP O
, , O

P UH O
. . O
E NNP O
. . O
, , O
Baehner NNP O
, , O
R NNP O
. . O
L NNP O
. . O
, , O
Cole NNP O
F NNP O
. . O
S NNP O
. . O
, , O
Curnette NNP O
J NNP O
. . O
T NNP O
. . O
, , O
and CC O
Orkin NNP O
, , O
S NNP O
. . O
A DT O
. . O

( : O
1986 CD O
) SYM O
Nature NNP O
, , O
322 CD O
: : O
32 CD O
- SYM O
38 CD O
. . O

14 CD O
. . O

Davies NNP O
, , O
K UH O
. . O
E NNP O
. . O
, , O
Mandel NNP O
, , O
J NNP O
. . O
L NNP O
. . O
, , O
Monaco NNP O
, , O
A NNP O
. . O
P NNP O
. . O
, , O
Nussbaum NNP O
, , O
R NNP O
. . O
L NNP O
. . O
and CC O
Willard NNP O
, , O

H UH O
. . O
F NN O
. . O

( -LRB- O
1990 CD O
) SYM O
Cytogenet NNP O
. . O

Cell NNP O
Genet NNP O
. . O

55 CD O
: : O
254 CD O
- HYPH O
313 CD O
. . O

The DT O
Caenorhabditis NNP B-Species
elegans NNS I-Species
genome NN O
contains VBZ O
monomorphic JJ O
minisatellites NNS O
and CC O
simple JJ O
sequences NNS O
. . O

Abstract JJ O

Many JJ O
species NNS O
have VBP O
been VBN O
shown VBN O
to TO O
contain VB O
tandemly RB O
repeated VBN O
short JJ O
sequence NN O
DNA NN O
known VBN O
as IN O
minisatellites NNS O
and CC O
simple JJ O
sequence NN O
motifs NNS O
. . O

Due IN O
to IN O
allelic JJ O
variation NN O
in IN O
the DT O
copy NN O
number NN O
of IN O
the DT O
repeat NN O
unit NN O
these DT O
loci NNS O
are VBP O
usually RB O
highly RB O
polymorphic JJ O
. . O

Here RB O
we PRP O
demonstrate VBP O
the DT O
presence NN O
of IN O
sequences NNS O
in IN O
the DT O
genome NN O
of IN O
the DT O
nematode NN O
Caenorhabditis NNP B-Species
elegans NNS I-Species
which WDT O
are VBP O
homologous JJ O
to IN O
two CD O
sets NNS O
of IN O
short JJ O
sequence NN O
DNA NN O
. . O

However RB O
, , O
when WRB O
two CD O
independent JJ O
strains NNS O
were VBD O
compared VBN O
no DT O
polymorphism NN O
for IN O
these DT O
sequences NNS O
could MD O
be VB O
detected VBN O
. . O
Images NNS O

Volume NN O
17 CD O
Number NNP O
23 CD O
1989 CD O
Nucleic NNP O
Acids NNP O
Research NNP O

The DT O
Caenorhabds NNP B-Species
elegans NNS I-Species
genome NN O
contains VBZ O
monomorphic JJ O
minisatellites NNS O
and CC O
simple JJ O
sequences NNS O
Andrd NNP O
G NNP O
. . O
Uitterlinden NNP O
, , O
P NNP O
. . O
Eline NNP O
Slagboom NNP O
, , O
Thomas NNP O
E NNP O
. . O
Johnsonl NNP O
and CC O
Jan NNP O
Vijg NNP O

Department NNP O
of IN O
Molecular NNP O
Biology NNP O
, , O
TNO NNP O
Institute NNP O
for IN O
Experimental NNP O
Gerontology NNP O
, , O
PO NNP O
Box NNP O
5815 CD O
, , O
2280 CD O
HV NNP O
Rijswijk NNP O
, , O
The DT O
Netherlands NNP O
and CC O
lInstitute NNP O
for IN O
Behavioral NNP O
Genetics NNP O
, , O
University NNP O
of IN O
Colorado NNP O
, , O
Boulder NNP O
, , O
CO NNP O
80309 CD O
, , O
USA NNP O

Received VBN O
October NNP O
27 CD O
, , O
1989 CD O
; : O
Accepted VBN O
November NNP O
3 CD O
, , O
1989 CD O

ABSTRACT NNP O

Many JJ O
species NNS O
have VBP O
been VBN O
shown VBN O
to TO O
contain VB O
tandemly RB O
repeated VBN O
short JJ O
sequence NN O
DNA NN O
kinown VBN O
as IN O
minisatellites NNS O
and CC O
simple JJ O
sequence NN O
motifs NNS O
. . O

Due IN O
to IN O
allelic JJ O
variation NN O
in IN O
the DT O
copy NN O
number NN O
of IN O
the DT O
repeat NN O
unit NN O
these DT O
loci NNS O
are VBP O
usually RB O
highly RB O
polymorphic JJ O
. . O

Here RB O
we PRP O
demonstrate VBP O
the DT O
presence NN O
of IN O
sequences NNS O
in IN O
the DT O
genome NN O
of IN O
the DT O
nematode NN O
Caenorhabditis NNP B-Species
elegans NNS I-Species
which WDT O
are VBP O
homologous JJ O
to IN O
two CD O
sets NNS O
of IN O
short JJ O
sequence NN O
DNA NN O
. . O

However RB O
, , O
when WRB O
two CD O
independent JJ O
strains NNS O
were VBD O
compared VBN O
no DT O
polymorphism NN O
for IN O
these DT O
sequences NNS O
could MD O
be VB O
detected VBN O
. . O

INTRODUCTION NN O

The DT O
genome NN O
of IN O
many JJ O
species NNS O
, , O
including VBG O
lower JJR O
organisms NNS O
, , O
contain VBP O
minisatellite NN O
sequences NNS O
and CC O
so RB O
- HYPH O
called VBN O
simple JJ O
sequence NN O
motifs NNS O
( , O
1 CD O
, , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

Due IN O
to IN O
extensive JJ O
variation NN O
in IN O
the DT O
number NN O
of IN O
repeat NN O
units NNS O
, , O
many JJ O
of IN O
these DT O
loci NNS O
have VBP O
been VBN O
shown VBN O
useful JJ O
as IN O
polymorphic JJ O
markers NNS O
, , O
e UH O
. . O
g LS O
. . O
for IN O
genetic JJ O
linkage NN O
studies NNS O
and CC O
identification NN O
purposes NNS O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
genome NN O
of IN O
the DT O
nematode NN O
Caenorhabditis NNP B-Species
elegans NNS I-Species
contains VBZ O
sequences NNS O
that WDT O
are VBP O
homologous JJ O
to IN O
the DT O
minisatellite NN O
core NN O
sequence NN O
33 CD O
. . O
6 CD O
( SYM O
1 CD O
) -RRB- O
and CC O
to IN O
the DT O
simple JJ O
sequence NN O
motif NN O
( -LRB- O
AGC NNP O
) -RRB- O
n -RRB- O
. . O

Surprisingly RB O
, , O
these DT O
sequences NNS O
did VBD O
not RB O
display VB O
polymorphism NN O
when WRB O
two CD O
independent JJ O
C NN B-Species
. . I-Species
elegans NNS I-Species
strains NNS O
, , O
Bristol NNP O
and CC O
Bergerac NNP O
, , O
were VBD O
compared VBN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
Genomic JJ O
DNA NN O
from IN O
nematodes NNS O

Genomic JJ O
DNA NNP O
was VBD O
isolated VBN O
according VBG O
to IN O
standard JJ O
procedures NNS O
from IN O
the DT O
two CD O
strains NNS O
Bergerac NNP O
( , O
BO NNP O
) -RRB- O
and CC O
Bristol NNP O
( HYPH O
strain NN O
N2 CD O
) -RRB- O
. . O

These DT O
strains NNS O
are VBP O
derived VBN O
from IN O
two CD O
different JJ O
individual JJ O
worms NNS O
isolated VBN O
in IN O
France NNP O
and CC O
England NNP O
, , O
respectively RB O
. . O

Southern JJ O
blotting NN O

Genomic JJ O
DNA NNP O
digests NNS O
( , O
5 CD O
Ag NN O
) -RRB- O
were VBD O
separated VBN O
in IN O
a DT O
1 CD O
% NN O
agarose NN O
gel NN O
in IN O
1 CD O
x SYM O
TAE NNP O
( SYM O
40 CD O
mM NN O
Tris NNS O
. . O
HCl NNP O
, , O
pH NN O
7 CD O
. . O
4 CD O
/ SYM O
20 CD O
mM NN O
sodium NN O
acetate NN O
/ SYM O
I NNP O
mM NNP O
NaEDTA NNP O
) -RRB- O
by IN O
electrophoresis NN O
at IN O
75 CD O
V NN O
for IN O
16 CD O
h NNS O
. . O

Separation NN O
patterns NNS O
were VBD O
transferred VBN O
to IN O
Zetaprobe NNP O
membrane NN O
( , O
BIORAD NNP O
) -RRB- O
in IN O
0 CD O
. . O
4 CD O
N NN O
NaOH NN O
, , O
0 CD O
. . O
6 CD O
M NN O
NaCl NN O
in IN O
a DT O
vacu NN O
- HYPH O
blot NN O
apparatus NN O
( : O
LKB NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

The DT O
minisatellite NN O
and CC O
simple JJ O
sequence NN O
probes NNS O
used VBD O
were VBD O
prepared VBN O
essentially RB O
as IN O
described VBN O
( SYM O
5 CD O
) -RRB- O
. . O

The DT O
Tcl NNP O
probe NN O
is VBZ O
a DT O
plasmid NN O
containing VBG O
an DT O
insert NN O
of IN O
the DT O
transposable JJ O
element NN O
Tcl NNP O
( HYPH O
4 CD O
) -RRB- O
. . O

All DT O
probes NNS O
were VBD O
labelled VBN O
by IN O
random JJ O
- HYPH O
priming VBG O
. . O

Hybridization NN O
was VBD O
performed VBN O
for IN O
12 CD O
h NN O
in IN O
7 CD O
% NN O
SDS NNS O
, , O
0 CD O
. . O
5 CD O
M NN O
phosphate NN O
buffer NN O
, , O
1 CD O
mM NN O
Na2EDTA NN O
at IN O
650C CD O
. . O

Blots NNS O
were VBD O
washed VBN O
twice RB O
in IN O
2 CD O
. . O
5 CD O
x SYM O
SSC NNP O
at IN O
650C CD O
and CC O
exposed VBN O
to IN O
Kodak NNP O
XAR NNP O
- HYPH O
5 CD O
film NN O
with IN O
intensifying VBG O
screens NNS O
. . O

Exposure NN O
times NNS O
are VBP O
indicated VBN O
in IN O
Fig NNP O
. . O

1 LS O
. . O

( : O
IRL NNP O
Press NNP O

Nucleic NNP O
Acids NNP O
Research NNP O

Volume NN O
17 CD O
Number NNP O
23 CD O
1989 CD O

9527 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

C NN B-Species
. . I-Species
elegans NNS I-Species

N NN O
0 CD O
$ $ O
8 CD O

_ NFP O
_ NFP O

: : O
, , O
s UH O
, , O
. . O
. . O
e NFP O
: : O
* NFP O
. . O

, , O
~ NFP O
: : O
: : O
: : O
: : O
: : O

. . O
4i CD O

. . O
t LS O
_ : O
: : O
- : O
: : O
: : O
? . O
J NN O
? . O
. . O
: : O

i PRP O
- : O

. . O
a DT O

E NN O
? . O
: : O
< NFP O
. . O

: : O
: : O
y LS O
: : O

* NFP O
1 NFP O

4 LS O
? . O
j XX O
* NFP O

. . O
- : O
I PRP O

kb NN O
- HYPH O
27 CD O

- : O
9A NN O
- : O

: : O
. . O
: : O
: : O
. . O
. . O
. . O
. . O
. . O
. . O
. . O

Mi NNP O
. . O
. . O
. . O
. . O

- : O
4v3 CD O

IC NN O
. . O
3 NFP O

If IN O
. . O
0r NFP O

MW NNP O

! . O
5 CD O
c6 NN O

I PRP O

"""" `` O
R NN O
1d CD O
~ NFP O
! . O

; : O
, , O

Figure NN O
1 CD O
. . O

Southern JJ O
hybridization NN O
analysis NN O
of IN O
Hae NNP O
III NNP O
, , O
Rsa NNP O
I NNP O
and CC O
Eco NNP O
RI NNP O
digested VBD O
genomic JJ O
DNA NN O
isolated VBN O
from IN O
the DT O
two CD O
C NN B-Species
. . I-Species
elegans NNS I-Species
strains VBZ O
Bristol NNP O
( HYPH O
N NNP O
) -RRB- O
and CC O
Bergerac NNP O
( -LRB- O
B NNP O
) -RRB- O
. . O

The DT O
probes NNS O
used VBD O
and CC O
the DT O
exposure NN O
times NNS O
of IN O
the DT O
autoradiograph NN O
are VBP O
indicated VBN O
below IN O
the DT O
figure NN O
. . O

kb NNP O
= : O
kilo NN O
basepairs NNS O
. . O

9528 CD O

* NFP O
: : O
. . O
. . O
? . O
. . O
; : O
. . O

. . O
* NFP O
. . O

i PRP O
. . O
. . O
. . O

: : O
"""" `` O
. . O

ANN NNP O
& CC O

' '' O
ROW NN O
: : O
. . O
lwmwww NN O
. . O

. . O
Ammkw UH O
. . O
l NFP O

4w CD O
, , O

9 CD O

_ NFP O
i PRP O
ob VBP O

Ill UH O
a DT O

Nucleic NNP O
Acids NNP O
Research NNP O

RESULTS NNS O

In IN O
Figure NN O
1 CD O
the DT O
hybridization NN O
patterns NNS O
are VBP O
shown VBN O
of IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
genomic JJ O
DNA NN O
digested VBN O
with IN O
Hae NNP O
II NNP O
, , O
Rsa NNP O
I NNP O
and CC O
Eco NNP O
RI NNP O
, , O
and CC O
subsequently RB O
hybridized VBN O
to IN O
minisatellite NN O
core NN O
probe NN O
33 CD O
. . O
6 CD O
, , O
the DT O
simple JJ O
sequence NN O
probe NN O
( , O
AGC NNP O
) -RRB- O
n , O
and CC O
Tcl NNP O
. . O

The DT O
latter JJ O
probe NN O
contains VBZ O
a DT O
member NN O
of IN O
the DT O
Tcl NNP O
family NN O
of IN O
transposable JJ O
elements NNS O
which WDT O
is VBZ O
present JJ O
in IN O
different JJ O
copy NN O
numbers NNS O
in IN O
the DT O
two CD O
different JJ O
strains NNS O
( , O
4 CD O
) -RRB- O
. . O

The DT O
hybridization NN O
patterns NNS O
of IN O
probes NNS O
33 CD O
. . O
6 CD O
and CC O
( : O
AGC NNP O
) -RRB- O
n VBN O
obtained VBN O
after IN O
Hae NNP O
Im NN O
and CC O
Rsa NNP O
I NN O
digestion NN O
and CC O
the DT O
differences NNS O
in IN O
intensities NNS O
of IN O
the DT O
hybridizing NN O
bands NNS O
is VBZ O
reminiscent JJ O
of IN O
DNA NN O
- HYPH O
fingerprint NN O
patterns NNS O
obtained VBN O
with IN O
these DT O
probes NNS O
in IN O
other JJ O
species NNS O
( , O
1 CD O
, , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

However RB O
, , O
identical JJ O
hybridization NN O
patterns NNS O
for IN O
the DT O
two CD O
strains NNS O
with IN O
the DT O
three CD O
enzymes NNS O
tested VBN O
indicated VBD O
that IN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
these DT O
sequences NNS O
are VBP O
monomorphic JJ O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Based VBN O
on IN O
the DT O
number NN O
of IN O
hybridizing VBG O
bands NNS O
we PRP O
estimate VBP O
the DT O
C NNP B-Species
. . I-Species
elegans NNS I-Species
genome NN O
to TO O
contain VB O
about IN O
30 CD O
33 CD O
. . O
6 CD O
homologous JJ O
loci NN O
and CC O
about RB O
20 CD O
( SYM O
AGC NNP O
) -RRB- O
n CC O
homologous JJ O
loci NN O
. . O

Rehybridization NN O
of IN O
the DT O
same JJ O
blot NN O
with IN O
a DT O
Tcl NNP O
probe NN O
revealed VBD O
extensive JJ O
RFLPs NNS O
due IN O
to IN O
the DT O
different JJ O
copy NN O
number NN O
of IN O
the DT O
transposon NN O
in IN O
the DT O
two CD O
strains NNS O
, , O
a DT O
phenomenon NN O
which WDT O
has VBZ O
been VBN O
described VBN O
previously RB O
by IN O
others NNS O
( , O
4 CD O
) -RRB- O
. . O

DISCUSSION NN O

The DT O
findings NNS O
presented VBN O
in IN O
this DT O
paper NN O
indicate VBP O
that IN O
polymorphism NN O
of IN O
minisatellite NN O
sequences NNS O
and CC O
simple JJ O
sequence NN O
motifs NNS O
, , O
is VBZ O
not RB O
a DT O
general JJ O
phenomenon NN O
in IN O
animal NN O
species NNS O
. . O

So RB O
far RB O
, , O
only RB O
some DT O
species NNS O
of IN O
whales NNS O
have VBP O
displayed VBN O
similar JJ O
high JJ O
levels NNS O
of IN O
monomorphism NN O
( : O
6 CD O
) -RRB- O
. . O

In IN O
other JJ O
species NNS O
thus RB O
far RB O
tested VBD O
both DT O
minisatellites NNS O
and CC O
simple JJ O
sequences NNS O
display VBP O
high RB O
to IN O
very RB O
high JJ O
levels NNS O
of IN O
polymorphism NN O
. . O

It PRP O
should MD O
be VB O
noted VBN O
, , O
however RB O
, , O
that IN O
at IN O
least JJS O
in IN O
humans NNS B-Species
, , O
a DT O
substantial JJ O
part NN O
of IN O
the DT O
minisatellites NNS O
detected VBN O
by IN O
core NN O
probes NNS O
also RB O
displays VBZ O
high JJ O
levels NNS O
of IN O
monomorphism NN O
as IN O
analysed VBN O
by IN O
cloning NN O
( , O
1 CD O
) , O
or CC O
by IN O
two CD O
- HYPH O
dimensional JJ O
DNA NN O
fingerprinting NN O
( : O
5 CD O
) -RRB- O
. . O

The DT O
fact NN O
that IN O
nematodes NNS O
are VBP O
hermaphrodites NNS O
, , O
and CC O
thus RB O
inbred VBN O
, , O
might MD O
be VB O
a DT O
contributing VBG O
factor NN O
to IN O
the DT O
observed VBN O
lack NN O
of IN O
polymorphism NN O
. . O

However RB O
, , O
the DT O
high JJ O
levels NNS O
of IN O
polymorphism NN O
detected VBN O
by IN O
the DT O
Tcl NNP O
probe NN O
do VBP O
not RB O
indicate VB O
a DT O
general JJ O
absence NN O
of IN O
events NNS O
causing VBG O
genetic JJ O
variation NN O
. . O

Indeed RB O
, , O
Eide NNP O
and CC O
Anderson NNP O
( : O
7 CD O
) -RRB- O
showed VBD O
that IN O
tandemly RB O
repeated VBN O
duplications NNS O
in IN O
the DT O
unc NNP O
- HYPH O
54 CD O
gene NN O
of IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
revert VBP O
at IN O
high JJ O
frequencies NNS O
. . O

Since IN O
in IN O
all DT O
cases NNS O
the DT O
revertants NNS O
had VBD O
the DT O
normal JJ O
genomic JJ O
configuration NN O
this DT O
suggests VBZ O
that IN O
unequal JJ O
crossing NN O
- HYPH O
over RB O
does VBZ O
occur VB O
in IN O
the DT O
nematode NN O
. . O

A DT O
more RBR O
likely JJ O
explanation NN O
for IN O
the DT O
monomorphic JJ O
nature NN O
of IN O
the DT O
sequences NNS O
detected VBN O
with IN O
33 CD O
. . O
6 CD O
and CC O
( : O
AGC NNP O
) -RRB- O
n : O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
is VBZ O
selection NN O
against IN O
sequence NN O
variants NNS O
at IN O
these DT O
loci NN O
. . O

This DT O
might MD O
be VB O
the DT O
result NN O
of IN O
the DT O
presence NN O
of IN O
a DT O
particular JJ O
subset NN O
of IN O
minisatellites NNS O
and CC O
/ SYM O
or CC O
simple JJ O
sequences NNS O
at IN O
sites NNS O
in IN O
the DT O
genome NN O
of IN O
this DT O
organism NN O
, , O
e UH O
. . O
g LS O
. . O
in IN O
coding VBG O
sequences NNS O
, , O
in IN O
which WDT O
variation NN O
in IN O
copy NN O
number NN O
of IN O
repeat NN O
units NNS O
cannot MD O
be VB O
tolerated VBN O
. . O

An DT O
example NN O
of IN O
such PDT O
a DT O
coding VBG O
sequence NN O
could MD O
be VB O
the DT O
High NNP O
Mobility NNP O
Group NNP O
proteins NNS O
which WDT O
usually RB O
have VBP O
stretches NNS O
of IN O
identical JJ O
( : O
acidic JJ O
) , O
amino NN O
acids NNS O
( SYM O
2 CD O
, , O
8 CD O
) -RRB- O
. . O

An DT O
interesting JJ O
observation NN O
in IN O
this DT O
respect NN O
is VBZ O
the DT O
demonstration NN O
of IN O
the DT O
absence NN O
of IN O
any DT O
protein NN O
polymorphisms NNS O
in IN O
electrophoretic JJ O
comparisons NNS O
for IN O
24 CD O
different JJ O
enzymes NNS O
between IN O
the DT O
Bristol NNP O
and CC O
Bergerac NNP O
strains NNS O
( , O
9 CD O
) -RRB- O
. . O

An DT O
important JJ O
step NN O
in IN O
understanding VBG O
this DT O
phenomenon NN O
will MD O
therefore RB O
be VB O
the DT O
isolation NN O
and CC O
analysis NN O
of IN O
individual JJ O
homologous JJ O
minisatellite NN O
and CC O
simple JJ O
sequence NN O
loci NN O
from IN O
a DT O
genomic JJ O
library NN O
of IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
. . O

REFERENCES NNS O

1 LS O
. . O

Jeffreys NNP O
, , O
A NNP O
. . O
J NNP O
. . O
, , O
Wilson NNP O
, , O
V NNP O
. . O
, , O
and CC O
Thein NNP O
, , O
S NNP O
. . O
L NNP O
. . O

( : O
1985 CD O
) SYM O
Nature NNP O
314 CD O
, , O
67 CD O
- SYM O
73 CD O
. . O

2 LS O
. . O

Tautz NNP O
, , O
D NNP O
. . O
, , O
Trick NNP O
M NNP O
. . O
, , O
and CC O
Dover NNP O
, , O
G NNP O
. . O
A DT O
. . O

( : O
1986 CD O
) SYM O
Nature NNP O
322 CD O
, , O
652 CD O
- HYPH O
656 CD O
. . O

3 LS O
. . O

Rogstad NNP O
, , O
S NNP O
. . O
H NNP O
. . O
, , O
Herwaldt NNP O
, , O
B NNP O
. . O
L NNP O
. . O
, , O
Schlesinger NNP O
, , O
P NNP O
. . O
H NNP O
. . O
, , O
and CC O
Krogstad NNP O
, , O
D NNP O
. . O
J NNP O
. . O

( : O
1989 CD O
) SYM O
Nucleic JJ O
Acids NNS O
Res NNP O
. . O

17 CD O
, , O
9 CD O
, , O
3610 CD O
. . O

4 LS O
. . O

Emmons NNP O
, , O
S NNP O
. . O
W NNP O
. . O
, , O
Yesner NNP O
, , O
L NNP O
. . O
, , O
Ruan NNP O
, , O
K NNP O
. . O
and CC O
Katzenberg NNP O
, , O
D NNP O
. . O

( -LRB- O
1983 CD O
) SYM O
Cell NNP O
32 CD O
, , O
55 CD O
- SYM O
65 CD O
. . O

9529 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

5 LS O
. . O

Uitterlinden NNP O
, , O
A NNP O
. . O
G NNP O
. . O
, , O
Slagboom NNP O
, , O
P NNP O
. . O
E NNP O
. . O
, , O
Knook NNP O
, , O
D NNP O
. . O
L NNP O
. . O
, , O
and CC O
Vijg NNP O
, , O
J NNP O
. . O

( -LRB- O
1989 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

USA NNP O
86 CD O
, , O
2742 CD O
- HYPH O
2746 CD O
. . O

6 LS O
. . O

Rus NNP O
Hoelzel NNP O
, , O
A NNP O
. . O
, , O
and CC O
Amos NNP O
, , O
W NNP O
. . O

( -LRB- O
1988 CD O
) SYM O
Nature NNP O
333 CD O
, , O
305 CD O
. . O

7 LS O
. . O

Eide NNP O
, , O
D NNP O
. . O
, , O
and CC O
Anderson NNP O
, , O
P NN O
. . O

( -LRB- O
1985 CD O
) -RRB- O
Genetics NNP O
109 CD O
, , O
67 CD O
- SYM O
79 CD O
. . O

8 LS O
. . O

Pentecost NNP O
, , O
B NNP O
. . O
T NNP O
. . O
, , O
Wright NNP O
, , O
J NNP O
. . O
M NNP O
. . O
, , O
and CC O
Dixon NNP O
, , O
G NNP O
. . O
H NN O
. . O

( : O
1985 CD O
) SYM O
Nucleic JJ O
Acids NNS O
Res NNP O
. . O

13 CD O
, , O
4871 CD O
- HYPH O
4888 CD O
. . O

9 LS O
. . O

Butler NNP O
et FW O
al NNP O
. . O

( : O
1981 CD O
) : O
J NN O
. . O

Molec NNP O
. . O

Evolution NNP O
18 CD O
, , O
18 CD O
- SYM O
23 CD O
. . O

9530 CD O

This DT O
article NN O
, , O
submitted VBN O
on IN O
disc NN O
, , O
has VBZ O
been VBN O
automatically RB O

converted VBN O
into IN O
this DT O
typeset NN O
format NN O
by IN O
the DT O
publisher NN O
. . O

How WRB O
can MD O
Health NNP O
Behavior NNP O
Theory NN O
be VB O
made VBN O
more RBR O
useful JJ O
for IN O
intervention NN O
research NN O
? . O

Abstract JJ O

Background NN O

The DT O
present JJ O
paper NN O
expresses VBZ O
the DT O
author NN O
' POS O
s POS O
views NNS O
about IN O
the DT O
practical JJ O
utility NN O
of IN O
Health NNP O
Behavior NNP O
Theory NNP O
for IN O
health NN O
behavior NN O
intervention NN O
research NN O
. . O

The DT O
views NNS O
are VBP O
skeptical JJ O
and CC O
perhaps RB O
even RB O
a DT O
bit NN O
exaggerated JJ O
. . O

They PRP O
are VBP O
, , O
however RB O
, , O
also RB O
based VBN O
on IN O
20 CD O
- HYPH O
plus CC O
years NNS O
of IN O
in IN O
- HYPH O
the DT O
- HYPH O
trenches NNS O
research NN O
focused VBN O
on IN O
improving VBG O
health NN O
behavior NN O
practice NN O
through IN O
research NN O
. . O

Discussion NN O

The DT O
author NN O
' POS O
s POS O
research NN O
has VBZ O
been VBN O
theoretically RB O
driven VBN O
and CC O
has VBZ O
involved VBN O
measurement NN O
of IN O
varying VBG O
variables NNS O
considered VBN O
to TO O
be VB O
important JJ O
theoretical JJ O
mediators NNS O
and CC O
moderators NNS O
of IN O
health NN O
behavior NN O
. . O

Regretfully RB O
, , O
much JJ O
of IN O
this DT O
work NN O
has VBZ O
found VBN O
these DT O
variables NNS O
wanting VBG O
in IN O
basic JJ O
scientific JJ O
merit NN O
. . O

Health NNP O
Behavior NNP O
Theory NNP O
as IN O
we PRP O
have VBP O
known VBN O
it PRP O
over IN O
the DT O
last JJ O
25 CD O
years NNS O
or CC O
so RB O
has VBZ O
been VBN O
dominated VBN O
by IN O
conceptualizations NNS O
of IN O
behavior NN O
change NN O
processes NNS O
that WDT O
highlight VBP O
cognitive JJ O
decision NN O
- HYPH O
making NN O
. . O

Although IN O
much JJ O
of IN O
health NN O
behavior NN O
practice NN O
targets VBZ O
what WP O
people NNS B-Species
do VBP O
rather RB O
than IN O
what WP O
they PRP O
think VBP O
, , O
the DT O
logic NN O
of IN O
focusing VBG O
on IN O
thoughts NNS O
is VBZ O
that IN O
what WP O
people NNS B-Species
think VBP O
about IN O
is VBZ O
the DT O
key NN O
to IN O
what WP O
they PRP O
will MD O
do VB O
in IN O
the DT O
future NN O
, , O
and CC O
that IN O
interventions NNS O
that WDT O
can MD O
measure VB O
and CC O
harness VB O
those DT O
processes NNS O
will MD O
succeed VB O
to IN O
a DT O
greater JJR O
extent NN O
than IN O
those DT O
that WDT O
do VBP O
not RB O
. . O

Unfortunately RB O
, , O
in IN O
the DT O
author NN O
' POS O
s POS O
experience NN O
, , O
the DT O
premise NN O
of IN O
cognitive JJ O
theories NNS O
has VBZ O
fallen VBN O
short JJ O
empirically RB O
in IN O
a DT O
number NN O
of IN O
ways NNS O
. . O

The DT O
cognitive JJ O
schemata NN O
favored VBN O
by IN O
most JJS O
health NN O
behavior NN O
theories NNS O
are VBP O
difficult JJ O
to TO O
measure VB O
, , O
they PRP O
do VBP O
not RB O
predict VB O
behavioral JJ O
outcomes NNS O
very RB O
well RB O
, , O
there EX O
is VBZ O
little JJ O
evidence NN O
that IN O
they PRP O
cause VBP O
behavior NN O
, , O
and CC O
they PRP O
are VBP O
hard JJ O
to TO O
change VB O
directly RB O
. . O

Summary NN O

It PRP O
is VBZ O
suggested VBN O
that IN O
health NN O
behavior NN O
researchers NNS O
reconsider VBP O
their PRP$ O
use NN O
of IN O
these DT O
theories NNS O
in IN O
favor NN O
of IN O
models NNS O
whose WP$ O
variables NNS O
are VBP O
more RBR O
accessible JJ O
to IN O
observation NN O
and CC O
experimental JJ O
manipulation NN O
and CC O
that WDT O
most RBS O
importantly RB O
have VBP O
strong JJ O
empirical JJ O
support NN O
. . O

Background NN O

The DT O
author NN O
has VBZ O
been VBN O
conducting VBG O
research NN O
on IN O
behavioral JJ O
treatment NN O
of IN O
obesity NN O
for IN O
about RB O
25 CD O
years NNS O
. . O

During IN O
that DT O
time NN O
, , O
the DT O
dominant JJ O
conceptual JJ O
models NNS O
guiding VBG O
intervention NN O
development NN O
have VBP O
been VBN O
cognitive JJ O
behavior NN O
models NNS O
that WDT O
have VBP O
their PRP$ O
origin NN O
in IN O
psychological JJ O
theory NN O
. . O

Those DT O
most RBS O
often RB O
cited VBN O
include VBP O
the DT O
Health NNP O
Belief NNP O
Model NNP O
[ -LRB- O
1 CD O
] -RRB- O
, , O
Protection NNP O
Motivation NNP O
Theory NNP O
[ -LRB- O
2 CD O
] -RRB- O
, , O
Subjective NNP O
Expected NNP O
Utility NNP O
Theory NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
the DT O
Theory NNP O
of IN O
Reasoned NNP O
Action NNP O
[ -LRB- O
4 CD O
] -RRB- O
, , O
Social NNP O
Cognitive NNP O
Theory NNP O
[ -LRB- O
5 CD O
] -RRB- O
, , O
and CC O
the DT O
Transtheoretical NNP O
Model NNP O
[ -LRB- O
6 CD O
] -RRB- O
. . O

All DT O
of IN O
these DT O
theories NNS O
are VBP O
concerned JJ O
with IN O
how WRB O
people NNS B-Species
make VBP O
behavioral JJ O
choices NNS O
and CC O
the DT O
general JJ O
idea NN O
is VBZ O
that IN O
people NNS B-Species
decide VBP O
what WP O
to TO O
do VB O
based VBN O
on IN O
the DT O
extent NN O
to TO O
which WDT O
they PRP O
expect VBP O
that IN O
their PRP$ O
choices NNS O
will MD O
produce VB O
results NNS O
that WDT O
they PRP O
value VBP O
. . O

Much JJ O
of IN O
the DT O
content NN O
of IN O
the DT O
theories NNS O
is VBZ O
concerned VBN O
with IN O
factors NNS O
that WDT O
may MD O
affect VB O
value NN O
/ SYM O
expectancy NN O
calculations NNS O
. . O

As IN O
summarized VBN O
by IN O
Weinstein NNP O
in IN O
a DT O
comparative JJ O
review NN O
of IN O
four CD O
social JJ O
psychological JJ O
theories NNS O
[ -LRB- O
7 CD O
] -RRB- O
, , O
variables NNS O
thought VBN O
to TO O
influence VB O
value NN O
/ SYM O
expectancy NN O
judgments NNS O
include VBP O
such JJ O
factors NNS O
as IN O
perceived VBN O
rewards NNS O
of IN O
current JJ O
behavior NN O
, , O
self NN O
- HYPH O
efficacy NN O
, , O
normative JJ O
beliefs NNS O
, , O
motivation NN O
, , O
and CC O
the DT O
perceived VBN O
consequences NNS O
of IN O
not RB O
changing VBG O
behavior NN O
. . O

Weinstein NNP O
' POS O
s POS O
summary NN O
is VBZ O
illustrative JJ O
of IN O
the DT O
fact NN O
that IN O
Health NNP O
Behavior NNP O
Theory NNP O
has VBZ O
tended VBN O
to TO O
be VB O
particularly RB O
interested JJ O
in IN O
understanding VBG O
people NNS B-Species
' POS O
s POS O
motivation NN O
to TO O
change VB O
behavior NN O
rather RB O
than IN O
ability NN O
to TO O
change VB O
. . O

Moreover RB O
, , O
motivation NN O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
result NN O
of IN O
a DT O
relatively RB O
complex JJ O
, , O
but CC O
logical JJ O
, , O
interpretation NN O
of IN O
large JJ O
quantities NNS O
of IN O
information NN O
about IN O
self NN O
and CC O
environment NN O
. . O

The DT O
theories NNS O
that WDT O
Weinstein NNP O
reviewed VBD O
deal VBP O
almost RB O
exclusively RB O
with IN O
behavioral JJ O
decision NN O
processes NNS O
in IN O
people NNS B-Species
' POS O
s POS O
minds NNS O
. . O

They PRP O
have VBP O
few JJ O
if IN O
any DT O
terms NNS O
relating VBG O
to IN O
how WRB O
information NN O
gets VBZ O
into IN O
peoples NNS O
minds NNS O
or CC O
how WRB O
subsets NNS O
of IN O
it PRP O
receive VBP O
more JJR O
or CC O
less JJR O
attention NN O
. . O

Broader JJR O
health NN O
behavior NN O
theories NNS O
such JJ O
as IN O
Social NNP O
Cognitive NNP O
Theory NNP O
or CC O
the DT O
Transtheoretical NNP O
model NN O
have VBP O
addressed VBN O
issues NNS O
and CC O
variables NNS O
outside IN O
the DT O
person NN B-Species
to IN O
a DT O
greater JJR O
extent NN O
, , O
but CC O
the DT O
fundamental JJ O
interest NN O
in IN O
and CC O
belief NN O
in IN O
psychological JJ O
variables NNS O
as IN O
the DT O
key JJ O
force NN O
in IN O
determining VBG O
health NN O
behavior NN O
remains VBZ O
. . O

The DT O
implications NNS O
of IN O
the DT O
focus NN O
of IN O
health NN O
behavior NN O
theory NN O
on IN O
psychological JJ O
determinants NNS O
of IN O
behavioral JJ O
decision NN O
- HYPH O
making VBG O
for IN O
my PRP$ O
own JJ O
research NN O
area NN O
of IN O
interest NN O
, , O
obesity NN O
treatment NN O
, , O
are VBP O
several JJ O
. . O

One CD O
is VBZ O
the DT O
inclusion NN O
of IN O
measures NNS O
of IN O
psychological JJ O
characteristics NNS O
in IN O
most JJS O
research NN O
protocols NNS O
( , O
e LS O
. . O
g LS O
. . O
, , O
assessment NN O
of IN O
behavioral JJ O
intentions NNS O
, , O
self NN O
- HYPH O
efficacy NN O
, , O
perception NN O
of IN O
barriers NNS O
to IN O
change NN O
, , O
perception NN O
of IN O
social JJ O
support NN O
, , O
and CC O
outcome NN O
expectations NNS O
) -RRB- O
. . O

A DT O
second JJ O
is VBZ O
the DT O
inclusion NN O
of IN O
treatment NN O
elements NNS O
that WDT O
specifically RB O
target VBP O
psychological JJ O
perceptions NNS O
and CC O
processes NNS O
independent JJ O
of IN O
the DT O
diet NN O
and CC O
physical JJ O
activity NN O
behaviors NNS O
that WDT O
actually RB O
produce VBP O
weight NN O
change NN O
( , O
e LS O
. . O
g LS O
. . O
, , O
how WRB O
to TO O
deal VB O
with IN O
emotional JJ O
eating NN O
, , O
how WRB O
to TO O
deal VB O
with IN O
the DT O
frustration NN O
of IN O
lapses NNS O
and CC O
relapses NNS O
, , O
and CC O
how WRB O
to TO O
talk VB O
to IN O
yourself PRP O
to TO O
increase VB O
self NN O
- HYPH O
motivation NN O
) -RRB- O
. . O

A DT O
third NN O
is VBZ O
the DT O
belief NN O
that IN O
psychological JJ O
reactions NNS O
to IN O
treatment NN O
experiences NNS O
themselves PRP O
are VBP O
very RB O
important JJ O
and CC O
deserve VBP O
independent JJ O
attention NN O
. . O

Common JJ O
behavioral JJ O
prescriptions NNS O
for IN O
weight NN O
- HYPH O
loss NN O
goals NNS O
and CC O
frequency NN O
of IN O
self NN O
- HYPH O
weighing NN O
are VBP O
exemplary JJ O
( , O
i PRP O
. . O
e LS O
. . O
, , O
recommending VBG O
infrequent JJ O
weighing NN O
to TO O
prevent VB O
discouraging VBG O
feedback NN O
about IN O
progress NN O
and CC O
encouraging VBG O
smaller JJR O
and CC O
thus RB O
"""" `` O
more RBR O
attainable JJ O
"""" '' O
behavior NN O
and CC O
weight NN O
- HYPH O
loss NN O
goals NNS O
in IN O
the DT O
belief NN O
that IN O
they PRP O
will MD O
be VB O
more RBR O
motivating JJ O
) -RRB- O
. . O

The DT O
problem NN O
with IN O
the DT O
emphasis NN O
on IN O
cognitive JJ O
variables NNS O
in IN O
weight NN O
- HYPH O
control NN O
research NN O
is VBZ O
that IN O
they PRP O
have VBP O
so RB O
far RB O
failed VBN O
to TO O
meet VB O
fundamental JJ O
scientific JJ O
criteria NNS O
for IN O
empirical JJ O
verification NN O
. . O

Thus RB O
, , O
they PRP O
also RB O
have VBP O
not RB O
led VBN O
to IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
weight NN O
- HYPH O
loss NN O
process NN O
, , O
have VBP O
not RB O
improved VBN O
our PRP$ O
ability NN O
to TO O
predict VB O
weight NN O
- HYPH O
loss NN O
outcomes NNS O
, , O
and CC O
have VBP O
not RB O
led VBN O
to IN O
improvement NN O
in IN O
treatment NN O
methods NNS O
. . O

In IN O
some DT O
cases NNS O
it PRP O
is VBZ O
even RB O
arguable JJ O
that IN O
they PRP O
have VBP O
made VBN O
treatment NN O
worse JJR O
. . O

I PRP O
will MD O
illustrate VB O
these DT O
problems NNS O
with IN O
results NNS O
from IN O
my PRP$ O
own JJ O
research NN O
. . O

Discussion NN O

Like IN O
most JJS O
behavioral JJ O
researchers NNS O
in IN O
the DT O
obesity NN O
area NN O
, , O
I PRP O
have VBP O
attempted VBN O
to TO O
measure VB O
elements NNS O
of IN O
health NN O
behavior NN O
theory NN O
in IN O
every DT O
obesity NN O
intervention NN O
project NN O
I PRP O
have VBP O
ever RB O
conducted VBN O
. . O

I PRP O
have VBP O
assessed VBN O
weight NN O
- HYPH O
loss NN O
goals NNS O
, , O
behavioral JJ O
and CC O
weight NN O
- HYPH O
loss NN O
self NN O
- HYPH O
efficacy NN O
, , O
psychological JJ O
well NN O
- HYPH O
being NN O
, , O
perceived VBN O
barriers NNS O
to IN O
diet NN O
and CC O
physical JJ O
activity NN O
change NN O
, , O
stages NNS O
- HYPH O
of IN O
- HYPH O
change NN O
, , O
and CC O
perceived VBN O
social JJ O
support NN O
. . O

How WRB O
well RB O
have VBP O
empirical JJ O
examinations NNS O
of IN O
these DT O
factors NNS O
fared VBD O
as IN O
predictors NNS O
of IN O
success NN O
in IN O
weight NN O
control NN O
? . O

Self NN O
- HYPH O
efficacy NN O

We PRP O
have VBP O
examined VBN O
the DT O
predictive JJ O
value NN O
of IN O
self NN O
- HYPH O
efficacy NN O
assessments NNS O
in IN O
several JJ O
of IN O
our PRP$ O
studies NNS O
and CC O
describe VB O
the DT O
results NNS O
from IN O
three CD O
of IN O
these DT O
here RB O
in IN O
more JJR O
detail NN O
[ -LRB- O
8 CD O
- SYM O
10 CD O
] -RRB- O
. . O

In IN O
the DT O
first JJ O
study NN O
, , O
self NN O
- HYPH O
efficacy NN O
was VBD O
assessed VBN O
at IN O
baseline NN O
, , O
posttreatment NN O
, , O
and CC O
one CD O
year NN O
later RB O
in IN O
85 CD O
men NNS B-Species
participating VBG O
in IN O
a DT O
15 CD O
- HYPH O
week NN O
weight NN O
- HYPH O
loss NN O
program NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
self NN O
- HYPH O
efficacy NN O
instrument NN O
had VBD O
subscales NNS O
for IN O
emotional JJ O
states NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
anxiety NN O
) , O
and CC O
situations NNS O
( , O
e UH O
. . O
g LS O
. . O
, , O
eating VBG O
away RB O
from IN O
home NN O
) -RRB- O
. . O

Higher JJR O
baseline NN O
self NN O
- HYPH O
efficacy NN O
on IN O
both DT O
subscales NNS O
was VBD O
associated VBN O
with IN O
greater JJR O
weight NN O
loss NN O
in IN O
treatment NN O
and CC O
at IN O
1 CD O
- HYPH O
and CC O
2 CD O
- HYPH O
year NN O
follow NN O
- HYPH O
up NN O
. . O

Emotional JJ O
self NN O
- HYPH O
efficacy NN O
at IN O
posttreatment NN O
did VBD O
not RB O
predict VB O
weight NN O
loss NN O
at IN O
1 CD O
- HYPH O
or CC O
2 CD O
- HYPH O
year NN O
follow NN O
- HYPH O
up NN O
. . O

Situational JJ O
self NN O
- HYPH O
efficacy NN O
at IN O
posttreatment NN O
predicted VBD O
weight NN O
loss NN O
at IN O
1 CD O
- HYPH O
year NN O
but CC O
not RB O
2 CD O
- HYPH O
year NN O
follow NN O
- HYPH O
up NN O
. . O

The DT O
second JJ O
study NN O
examined VBD O
mood NN O
and CC O
situational JJ O
self NN O
- HYPH O
efficacy NN O
in IN O
55 CD O
men NNS B-Species
and CC O
58 CD O
women NNS B-Species
before IN O
and CC O
after IN O
a DT O
16 CD O
- HYPH O
week NN O
weight NN O
- HYPH O
loss NN O
treatment NN O
with IN O
a DT O
1 CD O
- HYPH O
year NN O
follow NN O
- HYPH O
up NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Women NNS B-Species
had VBD O
lower JJR O
pretreatment NN O
self NN O
- HYPH O
efficacy NN O
than IN O
men NNS B-Species
. . O

Self NN O
- HYPH O
efficacy NN O
was VBD O
predictive JJ O
of IN O
weight NN O
loss NN O
and CC O
maintenance NN O
in IN O
men NNS B-Species
but CC O
not RB O
in IN O
women NNS B-Species
. . O

Change NN O
in IN O
self NN O
- HYPH O
efficacy NN O
over IN O
time NN O
was VBD O
positively RB O
related VBN O
to IN O
weight NN O
change NN O
in IN O
women NNS B-Species
but CC O
not RB O
in IN O
men NNS B-Species
. . O

The DT O
third JJ O
study NN O
examined VBD O
predictors NNS O
of IN O
weight NN O
change NN O
over IN O
a DT O
2 CD O
- HYPH O
year NN O
period NN O
in IN O
460 CD O
men NNS B-Species
and CC O
1172 CD O
women NNS B-Species
who WP O
received VBD O
a DT O
low JJ O
- HYPH O
intensity NN O
weight NN O
- HYPH O
loss NN O
intervention NN O
delivered VBN O
through IN O
their PRP$ O
HMO NNP O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
self NN O
- HYPH O
efficacy NN O
measure NN O
was VBD O
the DT O
WEL NNP O
questionnaire NN O
. . O

Men NNS B-Species
again RB O
were VBD O
found VBN O
to TO O
have VB O
higher JJR O
baseline NN O
self NN O
- HYPH O
efficacy NN O
than IN O
women NNS B-Species
. . O

Self NN O
- HYPH O
efficacy NN O
did VBD O
not RB O
predict VB O
weight NN O
change NN O
in IN O
men NNS B-Species
but CC O
was VBD O
positively RB O
, , O
though IN O
weakly RB O
, , O
related VBN O
to IN O
weight NN O
change NN O
at IN O
6 CD O
months NNS O
only RB O
in IN O
women NNS B-Species
. . O

Our PRP$ O
overall JJ O
conclusion NN O
from IN O
the DT O
analyses NNS O
described VBN O
above RB O
, , O
as RB O
well RB O
as IN O
others NNS O
not RB O
pursued VBN O
in IN O
as IN O
great JJ O
detail NN O
, , O
is VBZ O
that IN O
self NN O
- HYPH O
efficacy NN O
is VBZ O
a DT O
weak JJ O
predictor NN O
of IN O
weight NN O
loss NN O
and CC O
is VBZ O
inconsistent JJ O
across IN O
study NN O
populations NNS O
and CC O
gender NN O
. . O

It PRP O
tends VBZ O
to TO O
increase VB O
with IN O
weight NN O
loss NN O
. . O

However RB O
, , O
treatment NN O
- HYPH O
induced VBN O
increases NNS O
in IN O
efficacy NN O
are VBP O
not RB O
predictive JJ O
of IN O
longer JJR O
- HYPH O
term NN O
weight NN O
- HYPH O
loss NN O
success NN O
. . O

Barriers NNS O
to IN O
Adherence NNP O

We PRP O
have VBP O
also RB O
attempted VBN O
to TO O
measure VB O
barriers NNS O
to IN O
adherence NN O
to IN O
weight NN O
- HYPH O
control NN O
behaviors NNS O
in IN O
many JJ O
of IN O
our PRP$ O
studies NNS O
[ -LRB- O
11 CD O
- SYM O
14 CD O
] -RRB- O
. . O

The DT O
instruments NNS O
used VBN O
for IN O
this DT O
have VBP O
typically RB O
been VBN O
formatted VBN O
similarly RB O
to IN O
efficacy NN O
questionnaires NNS O
in IN O
that IN O
people NNS B-Species
are VBP O
asked VBN O
to TO O
indicate VB O
how WRB O
difficult JJ O
they PRP O
find VBP O
situational JJ O
, , O
knowledge NN O
, , O
and CC O
motivational JJ O
challenges NNS O
to IN O
achieving VBG O
diet NN O
and CC O
exercise NN O
changes NNS O
. . O

The DT O
findings NNS O
in IN O
these DT O
studies NNS O
have VBP O
been VBN O
quite RB O
consistent JJ O
. . O

Baseline NN O
assessments NNS O
of IN O
perceived VBN O
barriers NNS O
to IN O
behavior NN O
change NN O
are VBP O
not RB O
predictive JJ O
of IN O
weight NN O
change NN O
. . O

Weight NN O
loss NN O
is VBZ O
associated VBN O
with IN O
reported VBN O
decreases NNS O
in IN O
perceived VBN O
barriers NNS O
. . O

Treatment NN O
- HYPH O
induced VBN O
change NN O
in IN O
perceived VBN O
barriers NNS O
are VBP O
not RB O
predictive JJ O
of IN O
future JJ O
weight NN O
change NN O
. . O

In IN O
other JJ O
words NNS O
, , O
barrier NN O
perceptions NNS O
as IN O
we PRP O
have VBP O
measured VBN O
them PRP O
do VBP O
not RB O
appear VB O
to TO O
have VB O
pragmatic JJ O
significance NN O
. . O

Weight NN O
Goals NNS O

Goal NN O
- HYPH O
setting NN O
has VBZ O
long RB O
been VBN O
of IN O
interest NN O
to IN O
health NN O
behavior NN O
theory NN O
and CC O
in IN O
recent JJ O
years NNS O
has VBZ O
attracted VBN O
attention NN O
in IN O
weight NN O
- HYPH O
loss NN O
research NN O
when WRB O
it PRP O
was VBD O
realized VBN O
that IN O
most JJS O
people NNS B-Species
who WP O
enter VBP O
weight NN O
- HYPH O
loss NN O
treatments NNS O
want VBP O
to TO O
lose VB O
a DT O
lot NN O
more JJR O
weight NN O
than IN O
is VBZ O
realistic JJ O
given VBN O
the DT O
potency NN O
of IN O
current JJ O
weight NN O
- HYPH O
loss NN O
methodologies NNS O
[ -LRB- O
15 CD O
] -RRB- O
. . O

When WRB O
asked VBN O
to TO O
describe VB O
weight NN O
losses NNS O
they PRP O
deem VBP O
to TO O
represent VB O
"""" `` O
dream NN O
, , O
happy JJ O
, , O
acceptable JJ O
, , O
and CC O
disappointing JJ O
, , O
"""" '' O
many JJ O
individuals NNS O
in IN O
treatment NN O
fail VBP O
to TO O
reach VB O
even RB O
"""" `` O
disappointing JJ O
"""" '' O
weight NN O
losses NNS O
even RB O
though IN O
in IN O
objective JJ O
medical JJ O
terms NNS O
the DT O
results NNS O
are VBP O
positive JJ O
. . O

Based VBN O
on IN O
the DT O
argument NN O
that IN O
failure NN O
to TO O
reach VB O
gratifying JJ O
weight NN O
- HYPH O
loss NN O
goals NNS O
leads VBZ O
to IN O
psychological JJ O
distress NN O
that WDT O
lowers VBZ O
weight NN O
self NN O
- HYPH O
efficacy NN O
and CC O
undermines VBZ O
weight NN O
- HYPH O
loss NN O
efforts NNS O
, , O
it PRP O
has VBZ O
become VBN O
popular JJ O
to TO O
recommend VB O
counseling NN O
in IN O
weight NN O
- HYPH O
loss NN O
treatments NNS O
specifically RB O
targeting VBG O
the DT O
lowering NN O
of IN O
weight NN O
- HYPH O
loss NN O
goals NNS O
. . O

The DT O
theoretical JJ O
argument NN O
is VBZ O
that IN O
excessive JJ O
outcome NN O
expectations NNS O
undermine VBP O
behavioral JJ O
efforts NNS O
. . O

We PRP O
have VBP O
now RB O
completed VBN O
three CD O
sets NNS O
of IN O
formal JJ O
analyses NNS O
examining VBG O
whether IN O
weight NN O
goals NNS O
are VBP O
predictive JJ O
of IN O
weight NN O
- HYPH O
loss NN O
success NN O
. . O

In IN O
one CD O
of IN O
these DT O
analyses NNS O
the DT O
relationship NN O
between IN O
weight NN O
- HYPH O
loss NN O
goals NNS O
, , O
weight NN O
- HYPH O
loss NN O
goal NN O
attainment NN O
, , O
and CC O
long JJ O
- HYPH O
term NN O
( : O
30 CD O
months NNS O
) SYM O
weight NN O
- HYPH O
loss NN O
attainment NN O
and CC O
psychological JJ O
well NN O
- HYPH O
being NN O
were VBD O
assessed VBN O
in IN O
69 CD O
men NNS B-Species
and CC O
61 CD O
women NNS B-Species
participating VBG O
in IN O
an DT O
intensive JJ O
behavioral JJ O
treatment NN O
program NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Results NNS O
indicated VBD O
that IN O
weight NN O
- HYPH O
loss NN O
goals NNS O
were VBD O
unrealistically RB O
high JJ O
on IN O
average JJ O
and CC O
that IN O
lower JJR O
goals NNS O
were VBD O
more RBR O
likely JJ O
to TO O
be VB O
reached VBN O
. . O

Nevertheless RB O
, , O
weight NN O
- HYPH O
loss NN O
goals NNS O
did VBD O
not RB O
predict VB O
either CC O
short JJ O
- HYPH O
or CC O
long JJ O
- HYPH O
term NN O
weight NN O
losses NNS O
and CC O
were VBD O
not RB O
associated VBN O
with IN O
elevated VBN O
psychological JJ O
distress NN O
. . O

Two CD O
more JJR O
recent JJ O
analyses NNS O
we PRP O
have VBP O
conducted VBN O
looking VBG O
at IN O
weight NN O
- HYPH O
loss NN O
goals NNS O
as IN O
predictors NNS O
of IN O
success NN O
have VBP O
produced VBN O
similar JJ O
results NNS O
[ -LRB- O
Linde NNP O
JA NNP O
, , O
Jeffery NNP O
RW NNP O
, , O
Levy NNP O
RL NNP O
, , O
Pronk NNP O
NP NNP O
and CC O
Boyle NNP O
RG NNP O
, , O
unpublished JJ O
data NNS O
[ -LRB- O
17 CD O
] -RRB- O
] -RRB- O
. . O

Weight NN O
- HYPH O
loss NN O
goals NNS O
either CC O
did VBD O
not RB O
predict VB O
weight NN O
loss NN O
at RB O
all RB O
or CC O
were VBD O
slightly RB O
positively RB O
related VBN O
to IN O
weight NN O
- HYPH O
loss NN O
success NN O
. . O

Perceived VBN O
Social NNP O
Support NNP O

Perceived VBN O
social JJ O
support NN O
is VBZ O
another DT O
psychological JJ O
factor NN O
thought VBN O
to TO O
influence VB O
health NN O
behavior NN O
decision NN O
- HYPH O
making NN O
. . O

We PRP O
have VBP O
measured VBN O
social JJ O
support NN O
in IN O
a DT O
variety NN O
of IN O
ways NNS O
in IN O
our PRP$ O
studies NNS O
, , O
ranging VBG O
from IN O
single JJ O
- HYPH O
item NN O
questions NNS O
to IN O
multipaged VBN O
assessments NNS O
attempting VBG O
to TO O
differentiate VB O
among IN O
informational JJ O
, , O
instrumental JJ O
, , O
and CC O
emotional JJ O
support NN O
. . O

The DT O
results NNS O
, , O
unfortunately RB O
, , O
have VBP O
closely RB O
paralleled VBN O
those DT O
we PRP O
have VBP O
seen VBN O
with IN O
other JJ O
assessments NNS O
of IN O
barriers NNS O
to IN O
adherence NN O
. . O

Assessments NNS O
of IN O
social JJ O
support NN O
prior RB O
to IN O
treatment NN O
do VBP O
not RB O
predict VB O
weight NN O
loss NN O
. . O

Average JJ O
reports NNS O
of IN O
social JJ O
support NN O
tend VBP O
to TO O
parallel VB O
weight NN O
loss NN O
itself PRP O
. . O

When WRB O
people NNS B-Species
lose VBP O
weight NN O
they PRP O
report VBP O
more JJR O
social JJ O
support NN O
. . O

When WRB O
they PRP O
regain VBP O
, , O
they PRP O
report VBP O
less JJR O
. . O

In IN O
other JJ O
words NNS O
, , O
perceptions NNS O
of IN O
social JJ O
support NN O
are VBP O
not RB O
predictive JJ O
of IN O
success NN O
in IN O
weight NN O
- HYPH O
loss NN O
treatments NNS O
. . O

Frequency NN O
Weight NN O
Self NN O
- HYPH O
monitoring NN O

Self NN O
- HYPH O
monitoring NN O
of IN O
health NN O
behavior NN O
is VBZ O
incorporated VBN O
into IN O
many JJ O
health NN O
behavior NN O
theories NNS O
, , O
usually RB O
as IN O
part NN O
of IN O
a DT O
person NN B-Species
' POS O
s POS O
assessment NN O
of IN O
achieved VBN O
outcomes NNS O
. . O

Although IN O
self NN O
- HYPH O
monitoring NN O
is VBZ O
usually RB O
considered VBN O
a DT O
positive JJ O
element NN O
in IN O
the DT O
adoption NN O
of IN O
health NN O
behavior NN O
, , O
in IN O
obesity NN O
treatment NN O
frequent JJ O
self NN O
- HYPH O
monitoring NN O
of IN O
weight NN O
has VBZ O
tended VBN O
to TO O
be VB O
down RB O
- HYPH O
played VBN O
or CC O
even RB O
discouraged VBN O
on IN O
the DT O
grounds NNS O
that IN O
disappointing JJ O
results NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
less RBR O
than IN O
desired JJ O
weight NN O
change NN O
) -RRB- O
may MD O
undermine VB O
motivation NN O
. . O

This DT O
is VBZ O
another DT O
example NN O
in IN O
which WDT O
health NN O
behavior NN O
theory NN O
may MD O
have VB O
indirectly RB O
led VBN O
to IN O
incorrect JJ O
treatment NN O
recommendations NNS O
. . O

In IN O
weight NN O
- HYPH O
loss NN O
treatments NNS O
, , O
active JJ O
discouragement NN O
of IN O
frequent JJ O
self NN O
- HYPH O
observation NN O
of IN O
weight NN O
has VBZ O
become VBN O
popular JJ O
based VBN O
on IN O
the DT O
premise NN O
that IN O
more RBR O
frequent JJ O
weighting NN O
will MD O
cause VB O
psychological JJ O
stress NN O
and CC O
lower JJR O
self NN O
- HYPH O
efficacy NN O
. . O

Recently RB O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
relationship NN O
between IN O
frequency NN O
of IN O
self NN O
- HYPH O
weighing NN O
and CC O
body NN O
weight NN O
in IN O
both CC O
clinical JJ O
and CC O
population NN O
samples NNS O
and CC O
have VBP O
found VBN O
, , O
somewhat RB O
to IN O
our PRP$ O
surprise NN O
, , O
that IN O
frequency NN O
of IN O
self NN O
- HYPH O
weighing NN O
is VBZ O
one CD O
of IN O
the DT O
strongest JJS O
single JJ O
predictors NNS O
of IN O
body NN O
weight NN O
cross NN O
- HYPH O
sectionally RB O
, , O
and CC O
change NN O
in IN O
the DT O
frequency NN O
of IN O
self NN O
- HYPH O
weighing NN O
is VBZ O
one CD O
of IN O
the DT O
strongest JJS O
predictors NNS O
of IN O
weight NN O
change NN O
[ -LRB- O
Linde NNP O
JA NNP O
, , O
Jeffery NNP O
RW NNP O
and CC O
French NNP O
SA NNP O
, , O
unpublished JJ O
data NNS O
] -RRB- O
. . O

The DT O
direction NN O
of IN O
predictions NNS O
, , O
however RB O
, , O
is VBZ O
opposite JJ O
that IN O
derived VBN O
from IN O
theory NN O
. . O

People NNS B-Species
who WP O
weigh VBP O
themselves PRP O
more RBR O
weigh VBP O
less RBR O
and CC O
are VBP O
more RBR O
successful JJ O
in IN O
losing VBG O
weight NN O
. . O

Stage NN O
- HYPH O
of IN O
- HYPH O
Change NN O

A DT O
final JJ O
failure NN O
of IN O
current JJ O
health NN O
behavior NN O
theory NN O
to TO O
prove VB O
useful JJ O
in IN O
weight NN O
- HYPH O
control NN O
research NN O
is VBZ O
a DT O
recent JJ O
examination NN O
of IN O
the DT O
relationship NN O
between IN O
a DT O
stage NN O
- HYPH O
of IN O
- HYPH O
change NN O
measure NN O
adopted VBN O
from IN O
Prochaska NNP O
and CC O
short JJ O
- HYPH O
and CC O
long JJ O
- HYPH O
term NN O
weight NN O
loss NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Categories NNS O
of IN O
precontemplation NN O
, , O
contemplation NN O
, , O
preparation NN O
, , O
and CC O
action NN O
were VBD O
defined VBN O
based VBN O
on IN O
questions NNS O
about IN O
weight NN O
- HYPH O
loss NN O
intentions NNS O
and CC O
recent JJ O
weight NN O
- HYPH O
loss NN O
attempts NNS O
. . O

Despite IN O
a DT O
large JJ O
sample NN O
size NN O
, , O
excellent JJ O
follow NN O
- HYPH O
up NN O
rates NNS O
, , O
and CC O
well RB O
- HYPH O
measured VBN O
objective JJ O
outcomes NNS O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
demonstrate VB O
that IN O
staging VBG O
algorithms NNS O
recommended VBN O
by IN O
proponents NNS O
of IN O
the DT O
Transtheoretical NNP O
Model NNP O
could MD O
predict VB O
weight NN O
- HYPH O
loss NN O
outcomes NNS O
. . O

Experimental JJ O
Modification NN O
of IN O
Expectations NNS O

Our PRP$ O
most RBS O
recent JJ O
effort NN O
to TO O
utilize VB O
health NN O
behavior NN O
theory NN O
in IN O
obesity NN O
intervention NN O
research NN O
is VBZ O
a DT O
study NN O
that WDT O
attempted VBD O
to TO O
examine VB O
the DT O
effectiveness NN O
of IN O
experimentally RB O
- HYPH O
induced VBN O
outcome NN O
expectancies NNS O
on IN O
weight NN O
loss NN O
[ -LRB- O
Finch NNP O
EA NNP O
, , O
Linde NNP O
JA NNP O
, , O
Jeffery NNP O
RW NNP O
, , O
Rothman NNP O
AJ NNP O
and CC O
King NNP O
CM NNP O
, , O
unpublished JJ O
data NNS O
] -RRB- O
. . O

Obese JJ O
men NNS B-Species
and CC O
women NNS B-Species
participated VBD O
in IN O
an DT O
8 CD O
- HYPH O
week NN O
weight NN O
- HYPH O
loss NN O
program NN O
with IN O
18 CD O
- HYPH O
month NN O
follow NN O
- HYPH O
up NN O
in IN O
which WDT O
they PRP O
were VBD O
assigned VBN O
to IN O
one CD O
of IN O
two CD O
expectancy NN O
groups NNS O
. . O

The DT O
optimistic JJ O
group NN O
was VBD O
told VBN O
that IN O
focusing VBG O
exclusively RB O
on IN O
the DT O
positive JJ O
benefits NNS O
of IN O
weight NN O
loss NN O
would MD O
be VB O
valuable JJ O
in IN O
ensuring VBG O
that IN O
they PRP O
remained VBD O
motivated JJ O
in IN O
their PRP$ O
weight NN O
- HYPH O
loss NN O
efforts NNS O
and CC O
was VBD O
given VBN O
assignments NNS O
during IN O
weekly JJ O
group NN O
sessions NNS O
and CC O
homework NN O
between IN O
sessions NNS O
to TO O
reinforce VB O
this DT O
optimistic JJ O
mindset NN O
. . O

A DT O
"""" `` O
balanced JJ O
"""" '' O
expectancy NN O
group NN O
received VBD O
the DT O
instructions NNS O
that IN O
focusing VBG O
on IN O
both CC O
the DT O
positive JJ O
and CC O
negative JJ O
aspects NNS O
of IN O
weight NN O
loss NN O
, , O
a DT O
balanced JJ O
approach NN O
, , O
would MD O
be VB O
most RBS O
conducive JJ O
to IN O
maintaining VBG O
weight NN O
- HYPH O
loss NN O
motivation NN O
. . O

This DT O
group NN O
also RB O
received VBD O
assignments NNS O
to TO O
reinforce VB O
their PRP$ O
message NN O
. . O

Results NNS O
of IN O
this DT O
study NN O
indicated VBD O
that IN O
the DT O
expectation NN O
induction NN O
was VBD O
successful JJ O
initially RB O
but CC O
difficult JJ O
to TO O
maintain VB O
in IN O
the DT O
face NN O
of IN O
real JJ O
weight NN O
- HYPH O
loss NN O
experience NN O
. . O

We PRP O
were VBD O
also RB O
unable JJ O
to TO O
show VB O
that IN O
experimentally RB O
- HYPH O
induced VBN O
expectations NNS O
influenced VBN O
weight NN O
- HYPH O
loss NN O
success NN O
. . O

Summary NN O
and CC O
Conclusion NN O

To TO O
summarize VB O
the DT O
findings NNS O
described VBN O
above RB O
, , O
I PRP O
have VBP O
had VBN O
considerable JJ O
difficulty NN O
over IN O
the DT O
last JJ O
25 CD O
years NNS O
in IN O
confirming VBG O
that IN O
the DT O
psychosocial JJ O
variables NNS O
favored VBN O
by IN O
health NN O
behavior NN O
theory NN O
are VBP O
of IN O
much JJ O
value NN O
for IN O
obesity NN O
intervention NN O
research NN O
. . O

They PRP O
do VBP O
not RB O
predict VB O
weight NN O
loss NN O
well RB O
, , O
either CC O
as IN O
mediators NNS O
or CC O
moderators NNS O
. . O

There EX O
is VBZ O
little JJ O
evidence NN O
to TO O
support VB O
the DT O
idea NN O
that IN O
targeting VBG O
them PRP O
for IN O
intervention NN O
improves VBZ O
weight NN O
- HYPH O
loss NN O
outcomes NNS O
. . O

It PRP O
is VBZ O
, , O
of IN O
course NN O
, , O
arguable JJ O
that IN O
the DT O
weak JJ O
findings NNS O
relating VBG O
to IN O
health NN O
behavior NN O
theory NN O
variables NNS O
are VBP O
due IN O
in IN O
large JJ O
part NN O
to IN O
methodological JJ O
weaknesses NNS O
, , O
either CC O
in IN O
measurement NN O
tools NNS O
and CC O
/ SYM O
or CC O
their PRP$ O
frequency NN O
of IN O
measurement NN O
. . O

I PRP O
would MD O
argue VB O
, , O
however RB O
, , O
that IN O
25 CD O
years NNS O
is VBZ O
long JJ O
enough RB O
to TO O
wait VB O
for IN O
improved JJ O
methods NNS O
and CC O
that IN O
it PRP O
is VBZ O
time NN O
to TO O
look VB O
elsewhere RB O
for IN O
variables NNS O
that WDT O
better RBR O
predict VBP O
weight NN O
- HYPH O
change NN O
outcomes NNS O
and CC O
that DT O
, , O
therefore RB O
, , O
may MD O
form VB O
a DT O
better JJR O
basis NN O
for IN O
improving VBG O
future JJ O
treatments NNS O
. . O

Implication NN O
for IN O
Weight NN O
- HYPH O
Loss NN O
Treatment NN O

Given VBN O
the DT O
lack NN O
of IN O
success NN O
finding VBG O
support NN O
for IN O
cognitive JJ O
mediators NNS O
of IN O
behavior NN O
change NN O
in IN O
weight NN O
loss NN O
, , O
one PRP O
might MD O
surmise VB O
that IN O
progress NN O
in IN O
improving VBG O
weight NN O
- HYPH O
loss NN O
interventions NNS O
over IN O
the DT O
last JJ O
20 CD O
years NNS O
must MD O
have VB O
been VBN O
dreary JJ O
indeed RB O
. . O

Somewhat RB O
surprisingly RB O
, , O
however RB O
, , O
that DT O
is VBZ O
not RB O
the DT O
case NN O
. . O

In IN O
fact NN O
, , O
the DT O
short JJ O
- HYPH O
term NN O
( : O
6 CD O
to TO O
12 CD O
months NNS O
) , O
success NN O
of IN O
weight NN O
- HYPH O
loss NN O
treatments NNS O
has VBZ O
approximately RB O
doubled VBN O
over IN O
that DT O
time NN O
and CC O
several JJ O
variables NNS O
have VBP O
been VBN O
identified VBN O
that WDT O
reliably RB O
enhance VBP O
treatment NN O
outcomes NNS O
. . O

It PRP O
has VBZ O
been VBN O
clearly RB O
shown VBN O
experimentally RB O
that IN O
increasing VBG O
treatment NN O
length NN O
[ -LRB- O
19 CD O
] -RRB- O
, , O
prescribing VBG O
low JJ O
- HYPH O
energy NN O
intakes NNS O
[ -LRB- O
20 CD O
] -RRB- O
, , O
prescribing VBG O
high JJ O
- HYPH O
energy NN O
expenditure NN O
[ -LRB- O
21 CD O
] -RRB- O
, , O
using VBG O
a DT O
deposit NN O
contract NN O
and CC O
group NN O
- HYPH O
based VBN O
reward NN O
systems NNS O
[ -LRB- O
22 CD O
] -RRB- O
, , O
and CC O
simplifying VBG O
adherence NN O
to IN O
diet NN O
through IN O
meal NN O
substitutes NNS O
[ -LRB- O
23 CD O
] -RRB- O
and CC O
exercise NN O
by IN O
providing VBG O
exercise NN O
equipment NN O
[ -LRB- O
24 CD O
] -RRB- O
all DT O
improve VBP O
initial JJ O
weight NN O
loss NN O
. . O

From IN O
a DT O
theoretical JJ O
perspective NN O
, , O
however RB O
, , O
one CD O
thing NN O
is VBZ O
noteworthy JJ O
about IN O
these DT O
successful JJ O
innovations NNS O
. . O

Although IN O
not RB O
incompatible JJ O
with IN O
health NN O
behavior NN O
theory NN O
, , O
none NN O
of IN O
them PRP O
are VBP O
specifically RB O
derived VBN O
from IN O
cognitive JJ O
decision NN O
- HYPH O
making VBG O
models NNS O
. . O

Indeed RB O
, , O
health NN O
behavior NN O
theory NN O
does VBZ O
not RB O
include VB O
variables NNS O
like IN O
these DT O
in IN O
its PRP$ O
models NNS O
. . O

Where WRB O
Do VBP O
We PRP O
Go VB O
From IN O
Here RB O
? . O

The DT O
argument NN O
above RB O
about IN O
the DT O
practical JJ O
limitations NNS O
of IN O
many JJ O
popular JJ O
theories NNS O
of IN O
health NN O
behavior NN O
is VBZ O
not RB O
meant VBN O
to TO O
be VB O
a DT O
call NN O
to TO O
abandon VB O
theory NN O
. . O

Behavior NN O
scientists NNS O
have VBP O
amassed VBN O
much JJ O
useful JJ O
information NN O
about IN O
the DT O
principles NNS O
underlying VBG O
human JJ B-Species
behavior NN O
that WDT O
should MD O
be VB O
valuable JJ O
for IN O
health NN O
behavior NN O
interventions NNS O
. . O

Much JJ O
is VBZ O
known VBN O
about IN O
human JJ B-Species
perception NN O
, , O
learning NN O
, , O
motivation NN O
, , O
and CC O
responsiveness NN O
to IN O
environmental JJ O
opportunities NNS O
and CC O
contingencies NNS O
. . O

Health NN O
behavior NN O
intervention NN O
lies VBZ O
at IN O
the DT O
interface NN O
between IN O
people NNS B-Species
and CC O
their PRP$ O
environment NN O
. . O

Interventionists NNS O
change VBP O
aspects NNS O
of IN O
the DT O
environment NN O
( , O
cues NNS O
, , O
information NN O
, , O
behavioral JJ O
contingencies NNS O
) , O
with IN O
the DT O
intention NN O
of IN O
producing VBG O
changes NNS O
in IN O
how WRB O
people NNS B-Species
behave VBP O
. . O

What WP O
is VBZ O
needed VBN O
to TO O
advance VB O
health NN O
behavior NN O
intervention NN O
is VBZ O
theory NN O
that WDT O
addresses VBZ O
relationships NNS O
between IN O
modifiable JJ O
aspects NNS O
of IN O
the DT O
environment NN O
and CC O
behavior NN O
. . O

There EX O
is VBZ O
no DT O
doubt NN O
that IN O
cognitive JJ O
processes NNS O
are VBP O
involved VBN O
in IN O
these DT O
relationships NNS O
. . O

However RB O
, , O
the DT O
extent NN O
to TO O
which WDT O
current JJ O
theories NNS O
capture VBP O
this DT O
is VBZ O
questionable JJ O
. . O

Data NNS O
now RB O
available JJ O
suggest VBP O
that IN O
easily RB O
obtainable JJ O
information NN O
about IN O
people NNS B-Species
' POS O
s POS O
cognitive JJ O
processes NNS O
adds VBZ O
little JJ O
to IN O
our PRP$ O
ability NN O
to TO O
predict VB O
the DT O
results NNS O
of IN O
interventions NNS O
. . O

Thus RB O
, , O
it PRP O
may MD O
be VB O
wise JJ O
to TO O
pay VB O
more JJR O
attention NN O
to IN O
applied VBN O
theories NNS O
like IN O
classical JJ O
behavior NN O
theory NN O
[ -LRB- O
25 CD O
] -RRB- O
, , O
communications NNS O
theory NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
and CC O
learning VBG O
theory NN O
[ -LRB- O
27 CD O
] -RRB- O
than IN O
to IN O
those DT O
coming VBG O
out IN O
of IN O
the DT O
social JJ O
cognitive JJ O
traditions NNS O
. . O

Competing VBG O
interests NNS O

None NN O
declared VBD O
. . O
